Citrus Sinensis ID: 043074

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370---
Protein Sequence
MGPSIQALIAAAASFVVITLIFAIMLLFCKRTYKPPTYRTRAVNRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA
Secondary Structure (PSIPRED)
cccccEEHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEccccccccHHHHHHHHHHHHcccccccccEEEEEEEcccEEEEEEccccccHHHHHccccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEEEcccccccccccccccccccccccccccHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHccccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccEcHHHHHHHHccccHHccccccccccEEEcEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHEEEEEccccEEEEEEEcccccHHHHHccccHHcccccHHHccccccccHHHHHHHHHHHHHHHHHHHccccccccccccHHHEEEcccccEEEccccccccccHHHcEEEEEEEEccccccHHHHHHcccccccccHHHHHHEEEHHHcccccccccccccccHHHHHHHHHHHHccccHHHcccccccccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHccccc
Coil and Loop (DISEMBL)
MGPSIQALIAAAASFVVITLIFAIMLLFCkrtykpptyrtravnrpqpnrcsdlssialfdsasfdpslsqiSMSELidatdnfstdkiigdgsFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVengsldqwlhdtsrnddvdgskqlnslcplsWETRVKIVRGVANGLAYLhglekpiihrdikssnvlldsdfeahisdfglarridtshshvstqvagtmgymppeylggntaATVMLDVYSFGILMIEIATqirpnlpvvldgqevgLLEWARTMEARNKEIEmvdsnisreelseaGVREYFRIACMCtneksrerpAMSYVVQLLDELVA
Flexible Loop (DISEMBL)
MGPSIQALIAAAASFVVITLIFAIMLLFCKRTYKPPtyrtravnrpqpnrCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMetlgklrhrnIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDvdgskqlnslcplswETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEArnkeiemvdsnisreelseagvrEYFRIACMctneksrerpamSYVVQLLDELVA
Low Complexity Region (SEG)
MGPSIQALIAAAASFVVITLIFAIMLLFCKRTYKPPTYRTRAVNRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA
Disordered region (IsUnstruct)
*****QALIAAAASFVVITLIFAIMLLFCKRTYKPPTYRTR***************IALF**************SELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDT*********KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR*****************EAGVREYFRIACMCTN*********SYVVQLL*****
Disordered Region (DISOPRED)
***SIQA*IAAAASFVVITLIFAIMLLFC****************************************SQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN******GQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV*
Disordered Region (DISEMBL)
MGPSIQALIAAAASFVVITLIFAIMLLFCKRTYKPPTYRTRAVNRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA
Disordered Region (DISPRO)
*GPSIQALIAAAASFVVITLIFAIMLLFCKRTYK*********************************SLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD****
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGPSIQALIAAAASFVVITLIFAIMLLFCKRTYKPPTYRTRAVNRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	373	2.2.26 [Sep-21-2011]
Q9FN37	1036	Phytosulfokine receptor 2	no	no	0.798	0.287	0.448	1e-68
Q9C7S5	1095	Tyrosine-sulfated glycope	no	no	0.831	0.283	0.422	4e-68
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.793	0.248	0.438	2e-67
Q9LJF3	1164	Receptor-like protein kin	no	no	0.941	0.301	0.360	1e-64
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.962	0.307	0.370	1e-63
Q9ZVR7	1008	Phytosulfokine receptor 1	no	no	0.777	0.287	0.434	2e-63
Q8LPB4	1021	Phytosulfokine receptor 1	N/A	no	0.801	0.292	0.422	3e-63
Q9ZPS9	1143	Serine/threonine-protein	no	no	0.943	0.307	0.391	3e-62
Q3EDL4	472	Probable serine/threonine	no	no	0.777	0.614	0.379	7e-61
Q8L899	1207	Systemin receptor SR160 O	N/A	no	0.785	0.242	0.410	8e-61

>sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1

 Score =  260 bits (664), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 143/319 (44%), Positives = 196/319 (61%), Gaps = 21/319 (6%)

Query: 55   SSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKL 114
            S I LF S         +S+ EL+ +T+NFS   IIG G FG VYKA    G   A+K+L
Sbjct: 729  SKIVLFHSCG----CKDLSVEELLKSTNNFSQANIIGCGGFGLVYKANFPDGSKAAVKRL 784

Query: 115  DKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSR 174
              D  Q  REF+AE+E L +  H+N+V + GYC  G DR+LIY F+ENGSLD WLH+   
Sbjct: 785  SGDCGQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHER-- 842

Query: 175  NDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP-IIHRDIKSSNVLLDSDFE 233
               VDG+        L W+ R+KI +G A GLAYLH + +P +IHRD+KSSN+LLD  FE
Sbjct: 843  ---VDGNMT------LIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFE 893

Query: 234  AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
            AH++DFGLAR +    +HV+T + GT+GY+PPEY   +  AT   DVYSFG++++E+ T 
Sbjct: 894  AHLADFGLARLLRPYDTHVTTDLVGTLGYIPPEY-SQSLIATCRGDVYSFGVVLLELVTG 952

Query: 294  IRPNLPVVLDGQEV-GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTN 352
             RP    V  G+    L+     M+A  +E E++D+ I RE ++E  V E   IAC C +
Sbjct: 953  RRP--VEVCKGKSCRDLVSRVFQMKAEKREAELIDTTI-RENVNERTVLEMLEIACKCID 1009

Query: 353  EKSRERPAMSYVVQLLDEL 371
             + R RP +  VV  L++L
Sbjct: 1010 HEPRRRPLIEEVVTWLEDL 1028

Phytosulfokine receptor with a serine/threonine-protein kinase activity.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9C7S5|PSYR1_ARATH Tyrosine-sulfated glycopeptide receptor 1 OS=Arabidopsis thaliana GN=PSYR1 PE=2 SV=1

 Score =  258 bits (660), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 138/327 (42%), Positives = 203/327 (62%), Gaps = 17/327 (5%)

Query: 48   PNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGV 107
            P    D+S + LF ++ ++  +  +++ EL+ ATDNFS   IIG G FG VYKA L +G 
Sbjct: 769  PGSDKDISLVLLFGNSRYE--VKDLTIFELLKATDNFSQANIIGCGGFGLVYKATLDNGT 826

Query: 108  TVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQ 167
             +A+KKL  D     +EF+AE+E L + +H N+V + GYC     R+LIY F+ENGSLD 
Sbjct: 827  KLAVKKLTGDYGMMEKEFKAEVEVLSRAKHENLVALQGYCVHDSARILIYSFMENGSLDY 886

Query: 168  WLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP-IIHRDIKSSNV 226
            WLH     ++ +G  QL+      W  R+ I+RG ++GLAY+H + +P I+HRDIKSSN+
Sbjct: 887  WLH-----ENPEGPAQLD------WPKRLNIMRGASSGLAYMHQICEPHIVHRDIKSSNI 935

Query: 227  LLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
            LLD +F+A+++DFGL+R I    +HV+T++ GT+GY+PPEY G    AT+  DVYSFG++
Sbjct: 936  LLDGNFKAYVADFGLSRLILPYRTHVTTELVGTLGYIPPEY-GQAWVATLRGDVYSFGVV 994

Query: 287  MIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRI 346
            M+E+ T  RP + V        L+ W  TM+   K  E+ D+ + RE  +E  +     I
Sbjct: 995  MLELLTGKRP-MEVFRPKMSRELVAWVHTMKRDGKPEEVFDT-LLRESGNEEAMLRVLDI 1052

Query: 347  ACMCTNEKSRERPAMSYVVQLLDELVA 373
            ACMC N+   +RP +  VV  L  + A
Sbjct: 1053 ACMCVNQNPMKRPNIQQVVDWLKNIEA 1079

Tyrosine-sulfated glycopeptide receptor with a serine/threonine-protein kinase activity. Regulates, in response to tyrosine-sulfated glycopeptide binding, a signaling cascade involved in cellular proliferation and plant growth. Not involved in PSK perception.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  256 bits (654), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 136/310 (43%), Positives = 192/310 (61%), Gaps = 14/310 (4%)

Query: 63   ASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGF 122
            A F+  L ++ + ++++ATD+FS   IIGDG FG VYKA L    TVA+KKL +   QG 
Sbjct: 896  AMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGN 955

Query: 123  REFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSK 182
            REF AEMETLGK++H N+V +LGYC+   +++L+YE++ NGSLD WL + +   +V    
Sbjct: 956  REFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEV---- 1011

Query: 183  QLNSLCPLSWETRVKIVRGVANGLAYL-HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
                   L W  R+KI  G A GLA+L HG    IIHRDIK+SN+LLD DFE  ++DFGL
Sbjct: 1012 -------LDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGL 1064

Query: 242  ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVV 301
            AR I    SHVST +AGT GY+PPEY G +  AT   DVYSFG++++E+ T   P  P  
Sbjct: 1065 ARLISACESHVSTVIAGTFGYIPPEY-GQSARATTKGDVYSFGVILLELVTGKEPTGPDF 1123

Query: 302  LDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM 361
             + +   L+ WA     + K ++++D  +    L  + +R   +IA +C  E   +RP M
Sbjct: 1124 KESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLR-LLQIAMLCLAETPAKRPNM 1182

Query: 362  SYVVQLLDEL 371
              V++ L E+
Sbjct: 1183 LDVLKALKEI 1192

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  247 bits (630), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 140/388 (36%), Positives = 221/388 (56%), Gaps = 37/388 (9%)

Query: 3    PSIQALIAAAASFVVITLIFAIMLLFCKRTYKPPTYRTRAVNRPQPNRCSDLSSIAL--- 59
            P  Q++    ++ +V + +  +ML+          YR R V + +  R   + S+     
Sbjct: 768  PKKQSIATGMSAGIVFSFMCIVMLIMA-------LYRARKVQKKEKQREKYIESLPTSGS 820

Query: 60   -------------FDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSG 106
                          + A+F+  L +++ + L++AT+ FS D +IG G FG VYKAKL+ G
Sbjct: 821  SSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADG 880

Query: 107  VTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLD 166
              VAIKKL +   QG REF AEMET+GK++HRN+V +LGYC  G +R+L+YE+++ GSL+
Sbjct: 881  SVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLE 940

Query: 167  QWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP-IIHRDIKSSN 225
              LH+ ++   +           L W  R KI  G A GLA+LH    P IIHRD+KSSN
Sbjct: 941  TVLHEKTKKGGIF----------LDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSN 990

Query: 226  VLLDSDFEAHISDFGLARRIDTSHSHVS-TQVAGTMGYMPPEYLGGNTAATVMLDVYSFG 284
            VLLD DF A +SDFG+AR +    +H+S + +AGT GY+PPEY   +   T   DVYS+G
Sbjct: 991  VLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYY-QSFRCTAKGDVYSYG 1049

Query: 285  ILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYF 344
            ++++E+ +  +P  P    G++  L+ WA+ +    +  E++D  +  ++  +  +  Y 
Sbjct: 1050 VILLELLSGKKPIDPEEF-GEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYL 1108

Query: 345  RIACMCTNEKSRERPAMSYVVQLLDELV 372
            +IA  C +++  +RP M  V+ +  ELV
Sbjct: 1109 KIASQCLDDRPFKRPTMIQVMTMFKELV 1136

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  243 bits (621), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 140/378 (37%), Positives = 222/378 (58%), Gaps = 19/378 (5%)

Query: 4    SIQALIAAAASFVVITLIFAIMLLF-CKRTYKPPTYRTRAVNR-PQPNRCS-DLSSIA-- 58
            ++   + A  +F  +  +  +M L+  ++  K    R + +   P    CS  LSS+   
Sbjct: 773  TVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVPEP 832

Query: 59   -LFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKD 117
               + A+F+  L +++ + L++AT+ FS + ++G G FG VYKA+L  G  VAIKKL + 
Sbjct: 833  LSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRI 892

Query: 118  AFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDD 177
              QG REF AEMET+GK++HRN+V +LGYC  G +R+L+YE+++ GSL+  LH+ S    
Sbjct: 893  TGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSK-- 950

Query: 178  VDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP-IIHRDIKSSNVLLDSDFEAHI 236
              G   LN      W  R KI  G A GLA+LH    P IIHRD+KSSNVLLD DFEA +
Sbjct: 951  -KGGIYLN------WAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARV 1003

Query: 237  SDFGLARRIDTSHSHVS-TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIR 295
            SDFG+AR +    +H+S + +AGT GY+PPEY   +   T   DVYS+G++++E+ +  +
Sbjct: 1004 SDFGMARLVSALDTHLSVSTLAGTPGYVPPEYY-QSFRCTAKGDVYSYGVILLELLSGKK 1062

Query: 296  PNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKS 355
            P  P    G++  L+ WA+ +    +  E++D  +  ++  +  +  Y +IA  C +++ 
Sbjct: 1063 PIDPGEF-GEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRP 1121

Query: 356  RERPAMSYVVQLLDELVA 373
             +RP M  ++ +  E+ A
Sbjct: 1122 FKRPTMIQLMAMFKEMKA 1139

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4

 Score =  243 bits (620), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 135/311 (43%), Positives = 189/311 (60%), Gaps = 21/311 (6%)

Query: 65   FDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFRE 124
            F  +  ++S  +L+D+T++F    IIG G FG VYKA L  G  VAIKKL  D  Q  RE
Sbjct: 715  FQSNDKELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSGDCGQIERE 774

Query: 125  FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
            F AE+ETL + +H N+V + G+C    DR+LIY ++ENGSLD WLH+  RND        
Sbjct: 775  FEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHE--RNDGP------ 826

Query: 185  NSLCPLSWETRVKIVRGVANGLAYLH-GLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR 243
                 L W+TR++I +G A GL YLH G +  I+HRDIKSSN+LLD +F +H++DFGLAR
Sbjct: 827  ---ALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADFGLAR 883

Query: 244  RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD 303
             +    +HVST + GT+GY+PPEY G  + AT   DVYSFG++++E+ T  RP       
Sbjct: 884  LMSPYETHVSTDLVGTLGYIPPEY-GQASVATYKGDVYSFGVVLLELLTDKRPVDMCKPK 942

Query: 304  GQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFR---IACMCTNEKSRERPA 360
            G    L+ W   M+  ++  E+ D  I  +E      +E FR   IAC+C +E  ++RP 
Sbjct: 943  GCR-DLISWVVKMKHESRASEVFDPLIYSKE----NDKEMFRVLEIACLCLSENPKQRPT 997

Query: 361  MSYVVQLLDEL 371
               +V  LD++
Sbjct: 998  TQQLVSWLDDV 1008

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1

 Score =  242 bits (618), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 134/317 (42%), Positives = 191/317 (60%), Gaps = 18/317 (5%)

Query: 56   SIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLD 115
            S+ LF +     S +++S+ +++ +T +F+   IIG G FG VYKA L  G  VAIK+L 
Sbjct: 718  SVVLFHNKD---SNNELSLDDILKSTSSFNQANIIGCGGFGLVYKATLPDGTKVAIKRLS 774

Query: 116  KDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRN 175
             D  Q  REF+AE+ETL + +H N+V +LGYC    D++LIY +++NGSLD WLH     
Sbjct: 775  GDTGQMDREFQAEVETLSRAQHPNLVHLLGYCNYKNDKLLIYSYMDNGSLDYWLH----- 829

Query: 176  DDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLH-GLEKPIIHRDIKSSNVLLDSDFEA 234
            + VDG   L+      W+TR++I RG A GLAYLH   E  I+HRDIKSSN+LL   F A
Sbjct: 830  EKVDGPPSLD------WKTRLRIARGAAEGLAYLHQSCEPHILHRDIKSSNILLSDTFVA 883

Query: 235  HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            H++DFGLAR I    +HV+T + GT+GY+PPEY G  + AT   DVYSFG++++E+ T  
Sbjct: 884  HLADFGLARLILPYDTHVTTDLVGTLGYIPPEY-GQASVATYKGDVYSFGVVLLELLTGR 942

Query: 295  RPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEK 354
            RP + V        L+ W   M+   +E E+ D  I  ++ +E  +     IAC C  E 
Sbjct: 943  RP-MDVCKPRGSRDLISWVLQMKTEKRESEIFDPFIYDKDHAEEMLL-VLEIACRCLGEN 1000

Query: 355  SRERPAMSYVVQLLDEL 371
             + RP    +V  L+ +
Sbjct: 1001 PKTRPTTQQLVSWLENI 1017

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis.

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1

 Score =  239 bits (609), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 151/386 (39%), Positives = 213/386 (55%), Gaps = 34/386 (8%)

Query: 5    IQALIAAAASFVVITLIFAIMLLFCKRTYKPPTYRTRAVNRPQPNRCSDLSSIALFDSAS 64
            +  LI+AA+  ++I    A+             +  +AVN     +          + A+
Sbjct: 759  LGVLISAASVCILIVWAIAVRARRRDADDAKMLHSLQAVNSATTWKIEKEKEPLSINVAT 818

Query: 65   FDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFRE 124
            F   L ++  S+LI+AT+ FS   +IG G FG V+KA L  G +VAIKKL + + QG RE
Sbjct: 819  FQRQLRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLKDGSSVAIKKLIRLSCQGDRE 878

Query: 125  FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
            F AEMETLGK++HRN+V +LGYC  G +R+L+YEF++ GSL++ LH         G +  
Sbjct: 879  FMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMQYGSLEEVLH---------GPRTG 929

Query: 185  NSLCPLSWETRVKIVRGVANGLAYLHGLEKP-IIHRDIKSSNVLLDSDFEAHISDFGLAR 243
                 L WE R KI +G A GL +LH    P IIHRD+KSSNVLLD D EA +SDFG+AR
Sbjct: 930  EKRRILGWEERKKIAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDMEARVSDFGMAR 989

Query: 244  RIDTSHSHVS-TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVL 302
             I    +H+S + +AGT GY+PPEY   +   T   DVYS G++M+EI +  RP      
Sbjct: 990  LISALDTHLSVSTLAGTPGYVPPEYY-QSFRCTAKGDVYSIGVVMLEILSGKRPT----- 1043

Query: 303  DGQEVG---LLEWARTMEARNKEIEMVDSNISREELSEA---------GV-----REYFR 345
            D +E G   L+ W++      K +E++D ++ +E  SE+         GV       Y  
Sbjct: 1044 DKEEFGDTNLVGWSKMKAREGKHMEVIDEDLLKEGSSESLNEKEGFEGGVIVKEMLRYLE 1103

Query: 346  IACMCTNEKSRERPAMSYVVQLLDEL 371
            IA  C ++   +RP M  VV  L EL
Sbjct: 1104 IALRCVDDFPSKRPNMLQVVASLREL 1129

Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2

 Score =  234 bits (598), Expect = 7e-61,   Method: Compositional matrix adjust.
 Identities = 121/319 (37%), Positives = 192/319 (60%), Gaps = 29/319 (9%)

Query: 62  SASFDPSLSQI------SMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLD 115
           S +  P +S +      ++ EL  AT+    + +IG+G +G VY+  L+ G  VA+K L 
Sbjct: 126 SGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLL 185

Query: 116 KDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRN 175
            +  Q  +EF+ E+E +G++RH+N+V++LGYC  G  R+L+Y+FV+NG+L+QW+H     
Sbjct: 186 NNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHG---- 241

Query: 176 DDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLH-GLEKPIIHRDIKSSNVLLDSDFEA 234
                   +  + PL+W+ R+ I+ G+A GLAYLH GLE  ++HRDIKSSN+LLD  + A
Sbjct: 242 -------DVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNA 294

Query: 235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVML----DVYSFGILMIEI 290
            +SDFGLA+ + +  S+V+T+V GT GY+ PEY     A T ML    D+YSFGIL++EI
Sbjct: 295 KVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEY-----ACTGMLNEKSDIYSFGILIMEI 349

Query: 291 ATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMC 350
            T   P +       E  L++W ++M    +  E+VD  I  E  S   ++    +A  C
Sbjct: 350 ITGRNP-VDYSRPQGETNLVDWLKSMVGNRRSEEVVDPKIP-EPPSSKALKRVLLVALRC 407

Query: 351 TNEKSRERPAMSYVVQLLD 369
            +  + +RP M +++ +L+
Sbjct: 408 VDPDANKRPKMGHIIHMLE 426

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1

 Score =  234 bits (597), Expect = 8e-61,   Method: Compositional matrix adjust.
 Identities = 130/317 (41%), Positives = 199/317 (62%), Gaps = 24/317 (7%)

Query: 63   ASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGF 122
            A+F+  L +++ ++L++AT+ F  D ++G G FG VYKA+L  G  VAIKKL   + QG 
Sbjct: 867  AAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGD 926

Query: 123  REFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSK 182
            REF AEMET+GK++HRN+V +LGYC  G +R+L+YE+++ GSL+  LHD  +     G K
Sbjct: 927  REFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKT----GIK 982

Query: 183  QLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP-IIHRDIKSSNVLLDSDFEAHISDFGL 241
                   L+W  R KI  G A GLA+LH    P IIHRD+KSSNVLLD + EA +SDFG+
Sbjct: 983  -------LNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGM 1035

Query: 242  ARRIDTSHSHVS-TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPV 300
            AR +    +H+S + +AGT GY+PPEY      +T   DVYS+G++++E+ T  +P    
Sbjct: 1036 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKG-DVYSYGVVLLELLTGKQPT--- 1091

Query: 301  VLDGQEVG---LLEWARTMEARNKEIEMVDSNISREELS-EAGVREYFRIACMCTNEKSR 356
              D  + G   L+ W + + A+ K  ++ D  + +E+ S E  + ++ ++AC C +++  
Sbjct: 1092 --DSADFGDNNLVGWVK-LHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHW 1148

Query: 357  ERPAMSYVVQLLDELVA 373
            +RP M  V+ +  E+ A
Sbjct: 1149 KRPTMIQVMAMFKEIQA 1165

Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development.

Solanum peruvianum (taxid: 4082)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	373
359493147	364	PREDICTED: phytosulfokine receptor 2-lik	0.975	1.0	0.643	1e-135
449522742	383	PREDICTED: phytosulfokine receptor 2-lik	0.978	0.953	0.653	1e-133
449446401	383	PREDICTED: phytosulfokine receptor 2-lik	0.978	0.953	0.653	1e-133
224066613	367	predicted protein [Populus trichocarpa]	0.967	0.983	0.656	1e-130
255556534	384	receptor serine-threonine protein kinase	0.973	0.945	0.616	1e-128
147842499	343	hypothetical protein VITISV_022958 [Viti	0.911	0.991	0.650	1e-127
357443577	383	Serine/threonine protein kinase-like pro	0.951	0.926	0.609	1e-122
297791813	357	kinase family protein [Arabidopsis lyrat	0.919	0.960	0.603	1e-119
15238960	359	protein kinase family protein [Arabidops	0.930	0.966	0.596	1e-118
356535758	368	PREDICTED: phytosulfokine receptor 2-lik	0.970	0.983	0.584	1e-118

>gi|359493147|ref|XP_003634521.1| PREDICTED: phytosulfokine receptor 2-like [Vitis vinifera]

 Score =  486 bits (1250), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 240/373 (64%), Positives = 292/373 (78%), Gaps = 9/373 (2%)

Query: 1   MGPSIQALIAAAASFVVITLIFAIMLLFCKRTYKPPTYRTRAVNRPQPNRCSDLSSIALF 60
           M P+ +A++AA ASF  ITL  A++L+ C+   +    R  +  R +P + S L+SI++ 
Sbjct: 1   MPPAFEAILAATASFFFITLFLAVILIVCRGLKQ----RRSSEPRTRPIQSSSLTSISVG 56

Query: 61  DSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ 120
           +SA+FDPSL +ISM EL+ AT NF++D IIGDGSFG VYKA LS+GVTVA+KKL  DAFQ
Sbjct: 57  ESATFDPSLKRISMGELLAATRNFASDGIIGDGSFGMVYKACLSNGVTVAVKKLSPDAFQ 116

Query: 121 GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
           GFREFRAE ETL KL+HRNIV+ILGYC SG DRVLIYEF+E GSLDQWLHDTS +  +  
Sbjct: 117 GFREFRAETETLAKLQHRNIVQILGYCVSGSDRVLIYEFIEKGSLDQWLHDTSEDQQLST 176

Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG 240
            +      PLSWETR+KI+RGVA+GL+YLH L+ PIIHRDIK+SNVLLDS+FE HI+DFG
Sbjct: 177 PR-----LPLSWETRLKIIRGVADGLSYLHNLDTPIIHRDIKASNVLLDSEFEPHIADFG 231

Query: 241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPV 300
           LARRI+ SHSHVSTQVAGTMGYMPPEY  G T ATV  DVYSFGILMIEIAT  RPNLP 
Sbjct: 232 LARRIEWSHSHVSTQVAGTMGYMPPEYREGVTVATVKADVYSFGILMIEIATGRRPNLPT 291

Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
            LDG +VG+++WAR M A+ + +EMVDSN+SRE L E  VRE FRIA +CT+E SR+RP 
Sbjct: 292 RLDGTDVGIVQWARKMVAQERHMEMVDSNVSREGLRENEVRELFRIAHLCTSEISRDRPP 351

Query: 361 MSYVVQLLDELVA 373
           +S VV LL +L +
Sbjct: 352 ISLVVDLLYQLFS 364

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449522742|ref|XP_004168385.1| PREDICTED: phytosulfokine receptor 2-like [Cucumis sativus]

 Score =  479 bits (1233), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 243/372 (65%), Positives = 289/372 (77%), Gaps = 7/372 (1%)

Query: 1   MGPSIQALIAAAASFVVITLIFAIMLLFCKR-TYKPPTYRTRAVNRPQPNRCSDLSSIAL 59
           M  S   ++A+ ASF V TL    +   CK      PT R R V     +R  DLSS+ +
Sbjct: 1   MQSSSVLILASVASFSVATLFLFCIFFICKHFKSHHPTTRQRQVR----HRNIDLSSVTV 56

Query: 60  FDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF 119
            +SASFD SL +ISM+EL  AT NFS D ++GDGSFG VYKA+LSSG TVAIKKL+ DAF
Sbjct: 57  DESASFDSSL-RISMAELRSATKNFSNDLVVGDGSFGLVYKARLSSGATVAIKKLNPDAF 115

Query: 120 QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVD 179
           QGFREFRAEMETLGKLRHRNIVKILGYC SG DRVLIYEF+E GSLD  L++TS +DD D
Sbjct: 116 QGFREFRAEMETLGKLRHRNIVKILGYCVSGSDRVLIYEFIERGSLDNCLYETS-SDDQD 174

Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
               L S  PL W+TR+KI+RGVANGL+YLHGL +PIIHRDIK+ NVLLDS+FEAHI+DF
Sbjct: 175 SDGYLASRQPLPWDTRLKIMRGVANGLSYLHGLPQPIIHRDIKAGNVLLDSEFEAHIADF 234

Query: 240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           GLAR I+TS+SHVSTQ AGTMGYMPPEY  G T ATV  DVYSFGILM E+A   RPNLP
Sbjct: 235 GLARMIETSNSHVSTQFAGTMGYMPPEYRAGVTVATVKADVYSFGILMFEVAMGQRPNLP 294

Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
           ++LD +EVGL+EWAR + A+N+ +EMVD+ IS +EL E+ V+EYFRIAC+CT+EKS+ERP
Sbjct: 295 MLLDEREVGLIEWARILVAQNRHMEMVDATISNDELVESNVKEYFRIACLCTSEKSKERP 354

Query: 360 AMSYVVQLLDEL 371
            MS VV+LLD +
Sbjct: 355 PMSNVVELLDRI 366

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449446401|ref|XP_004140960.1| PREDICTED: phytosulfokine receptor 2-like [Cucumis sativus]

 Score =  479 bits (1233), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 243/372 (65%), Positives = 289/372 (77%), Gaps = 7/372 (1%)

Query: 1   MGPSIQALIAAAASFVVITLIFAIMLLFCKR-TYKPPTYRTRAVNRPQPNRCSDLSSIAL 59
           M  S   ++A+ ASF V TL    +   CK      PT R R V     +R  DLSS+ +
Sbjct: 1   MQSSSVLILASVASFSVATLFLFCIFFICKHFKSHHPTTRQRQVR----HRNIDLSSVTV 56

Query: 60  FDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF 119
            +SASFD SL +ISM+EL  AT NFS D ++GDGSFG VYKA+LSSG TVAIKKL+ DAF
Sbjct: 57  DESASFDSSL-RISMAELRSATKNFSNDLVVGDGSFGLVYKARLSSGATVAIKKLNPDAF 115

Query: 120 QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVD 179
           QGFREFRAEMETLGKLRHRNIVKILGYC SG DRVLIYEF+E GSLD  L++TS +DD D
Sbjct: 116 QGFREFRAEMETLGKLRHRNIVKILGYCVSGSDRVLIYEFIERGSLDNCLYETS-SDDQD 174

Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
               L S  PL W+TR+KI+RGVANGL+YLHGL +PIIHRDIK+ NVLLDS+FEAHI+DF
Sbjct: 175 SDGYLASRQPLPWDTRLKIMRGVANGLSYLHGLPQPIIHRDIKAGNVLLDSEFEAHIADF 234

Query: 240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           GLAR I+TS+SHVSTQ AGTMGYMPPEY  G T ATV  DVYSFGILM E+A   RPNLP
Sbjct: 235 GLARMIETSNSHVSTQFAGTMGYMPPEYRAGVTVATVKADVYSFGILMFEVAMGQRPNLP 294

Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
           ++LD +EVGL+EWAR + A+N+ +EMVD+ IS +EL E+ V+EYFRIAC+CT+EKS+ERP
Sbjct: 295 MLLDEREVGLIEWARILVAQNRHMEMVDATISNDELVESNVKEYFRIACLCTSEKSKERP 354

Query: 360 AMSYVVQLLDEL 371
            MS VV+LLD +
Sbjct: 355 PMSNVVELLDRI 366

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224066613|ref|XP_002302163.1| predicted protein [Populus trichocarpa] gi|222843889|gb|EEE81436.1| predicted protein [Populus trichocarpa]

 Score =  472 bits (1215), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 246/375 (65%), Positives = 289/375 (77%), Gaps = 14/375 (3%)

Query: 1   MGPSIQALIAAAASFVVITLIFAIMLLFCKRT----YKPPTYRTRAVNRPQPNRCSDLSS 56
           M  S+QA++AAAASF +ITLIFA +++ CK T    Y+    R    +R  PN   +LS 
Sbjct: 1   MDSSLQAVLAAAASFFLITLIFAFIVIVCKSTSNQDYRRRRQRHHHQSRTVPN--PELS- 57

Query: 57  IALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDK 116
           + + +SA+FDP +++ISM EL  +T NFS D IIGDGSFG VYKA L +G TVAIKKLD 
Sbjct: 58  MTIDESATFDPEMNRISMEELKVSTKNFSADLIIGDGSFGLVYKATLFTGSTVAIKKLDP 117

Query: 117 DAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRND 176
           DAFQGFREFRAEMETLGKLRHRNIVKILGYC SGL+RVLI EFVE GSLDQW+HDTS  +
Sbjct: 118 DAFQGFREFRAEMETLGKLRHRNIVKILGYCVSGLERVLILEFVERGSLDQWIHDTSSTN 177

Query: 177 DVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI 236
           +    K      PL WETR+K++RGVANGLAYLHGLE PIIHRDIK+SNVLLDS+FEAHI
Sbjct: 178 NEQFVK-----IPLPWETRIKVIRGVANGLAYLHGLETPIIHRDIKASNVLLDSEFEAHI 232

Query: 237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +DFGLARRID SHSHVSTQVAGTMGYMPPEY  G   ATV LDVYSFGILM E+AT  RP
Sbjct: 233 ADFGLARRIDASHSHVSTQVAGTMGYMPPEYREG-AGATVKLDVYSFGILMFEVATAERP 291

Query: 297 NLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSR 356
           NLP V++ +EV L+EW R M  +N+ +EM+DSN  +E LSE  V+EYFRIA +CT E   
Sbjct: 292 NLPKVVEEKEVWLIEWVRKMLGQNRHMEMLDSNTPKEGLSEDEVKEYFRIASLCTGE-CI 350

Query: 357 ERPAMSYVVQLLDEL 371
           +RPAMS VV LL +L
Sbjct: 351 DRPAMSEVVGLLKKL 365

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255556534|ref|XP_002519301.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223541616|gb|EEF43165.1| receptor serine-threonine protein kinase, putative [Ricinus communis]

 Score =  463 bits (1192), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 235/381 (61%), Positives = 284/381 (74%), Gaps = 18/381 (4%)

Query: 1   MGPSIQALIAAAASFVVITLIFAIMLLFCK----RTYKPPTYRTRAV------NRPQPNR 50
           M  ++Q ++AA ASF  +TL+FA + L  K    R +     R          NR  PN 
Sbjct: 1   MNSTVQLVLAATASFFFVTLLFAFIYLISKSSKHRRFNNNNQRLHHQIRGFNGNRTVPN- 59

Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVA 110
              LSS+ + +SA+FDP+L++ISM EL  AT+NFS   IIGDGSFGFVYKA LS G TVA
Sbjct: 60  -PQLSSVTIDESATFDPNLNRISMDELKLATNNFSPGLIIGDGSFGFVYKATLSDGTTVA 118

Query: 111 IKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH 170
           IKKLD DAFQGFREFRAEMETLGKL H NIV+ILGYC SG+DRVLIYEF+E G+LDQWLH
Sbjct: 119 IKKLDPDAFQGFREFRAEMETLGKLHHPNIVRILGYCISGVDRVLIYEFIEKGNLDQWLH 178

Query: 171 DTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS 230
           +TS +++        +  PLSWE R+KIV G+ANGLAYLH L+ PIIHRDIK+SNVLLD 
Sbjct: 179 ETSTDNEPL------TKSPLSWEMRIKIVMGIANGLAYLHQLDTPIIHRDIKASNVLLDG 232

Query: 231 DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           +FEAHI+DFGLAR ID SHSHVSTQVAGTMGYMPPEY  G T ATV  DV+SFGILMIEI
Sbjct: 233 EFEAHIADFGLARAIDASHSHVSTQVAGTMGYMPPEYKEGVTVATVRADVFSFGILMIEI 292

Query: 291 ATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMC 350
           AT  RPNLPVVL+G+EVGL+ WAR M  +++ +E++DS + ++ L+E  V+ YF IA MC
Sbjct: 293 ATGERPNLPVVLEGREVGLIVWARKMLEQDRHVEILDSKMCKQGLNEENVKGYFSIASMC 352

Query: 351 TNEKSRERPAMSYVVQLLDEL 371
           TNE   +RP MS VV LL++L
Sbjct: 353 TNEIQMDRPVMSEVVHLLNQL 373

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147842499|emb|CAN65219.1| hypothetical protein VITISV_022958 [Vitis vinifera]

 Score =  461 bits (1186), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 227/349 (65%), Positives = 274/349 (78%), Gaps = 9/349 (2%)

Query: 1   MGPSIQALIAAAASFVVITLIFAIMLLFCKRTYKPPTYRTRAVNRPQPNRCSDLSSIALF 60
           M P+ +A++AA ASF  ITL  A++L+ C+   +    R  +  R +P + S L+SI++ 
Sbjct: 1   MPPAFEAILAATASFFFITLFLAVILIVCRGLKQ----RRSSEPRTRPIQSSSLTSISVG 56

Query: 61  DSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ 120
           +SA+FDPSL +ISM EL+ AT NF++D IIGDGSFG VYKA LS+GVTVA+KKL  DAFQ
Sbjct: 57  ESATFDPSLKRISMGELLAATRNFASDGIIGDGSFGMVYKACLSNGVTVAVKKLSPDAFQ 116

Query: 121 GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
           GFREFRAE ETL KL+HRNIV+ILGYC SG DRVLIYEF+E GSLDQWLHDTS +  +  
Sbjct: 117 GFREFRAETETLAKLQHRNIVQILGYCVSGSDRVLIYEFIEKGSLDQWLHDTSEDQQLST 176

Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG 240
            +      PLSWETR+KI+RGVA+GL+YLH L+ PIIHRDIK+SNVLLDS+FE HI+DFG
Sbjct: 177 PR-----LPLSWETRLKIIRGVADGLSYLHNLDTPIIHRDIKASNVLLDSEFEPHIADFG 231

Query: 241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPV 300
           LARRI+ SHSHVSTQVAGTMGYMPPEY  G T ATV  DVYSFGILMIEIAT  RPNLP 
Sbjct: 232 LARRIEWSHSHVSTQVAGTMGYMPPEYREGVTVATVKADVYSFGILMIEIATGRRPNLPT 291

Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACM 349
            LDG +VG+++WAR M A+ + +EMVDSN+SRE L E  VRE FRIA +
Sbjct: 292 RLDGTDVGIVQWARKMVAQERHMEMVDSNVSREGLRENEVRELFRIAHL 340

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357443577|ref|XP_003592066.1| Serine/threonine protein kinase-like protein [Medicago truncatula] gi|355481114|gb|AES62317.1| Serine/threonine protein kinase-like protein [Medicago truncatula]

 Score =  443 bits (1140), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 226/371 (60%), Positives = 274/371 (73%), Gaps = 16/371 (4%)

Query: 14  SFVVITLIFAIMLLFCK-----RTYKPPTYRTRAVNRPQPNRCSDLSSIALFDSASFDPS 68
           SF V+T+I A ++L C+     +T +    RTR +  P     S  SS+ +  S S+DP+
Sbjct: 14  SFFVVTVILAAIILICQHRKTTQTRRNNQIRTRPLRNPNHYPTSS-SSLPVDASWSWDPN 72

Query: 69  LSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAE 128
           L +ISM EL  AT NFS   I+GDGSFG+VYKA LS+G TVA+KKL  DAFQGFREF AE
Sbjct: 73  L-KISMEELSRATKNFSNTLIVGDGSFGYVYKASLSTGATVAVKKLSPDAFQGFREFAAE 131

Query: 129 METLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS-------RNDDVDGS 181
           METL KLRH NIVKILGY ASG +R+L+YEF+E G+LDQWLH++S       +ND+V  S
Sbjct: 132 METLSKLRHHNIVKILGYWASGAERLLVYEFIEKGNLDQWLHESSPTSSSTHQNDEVSIS 191

Query: 182 KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
                  PL WETRVKI+RGVA+GL YLHGLEKPIIHRDIK+SNVLLDS+FEAHI+DFGL
Sbjct: 192 IDFIR-SPLPWETRVKIIRGVAHGLCYLHGLEKPIIHRDIKASNVLLDSEFEAHIADFGL 250

Query: 242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVV 301
           ARR+D SHSHVSTQVAGT+GYMPPEY  G+  A   +DVYSFG+LMIE  +  RPNL V 
Sbjct: 251 ARRMDKSHSHVSTQVAGTIGYMPPEYRDGSNVANPKVDVYSFGVLMIETVSGHRPNLAVK 310

Query: 302 LDGQEVGLLEWARTMEARNKEIEMVDSNISREE-LSEAGVREYFRIACMCTNEKSRERPA 360
           L+G ++GL+ WAR M+ RN E+EM+D NI REE L E  VREY RIACMCT E  ++RP 
Sbjct: 311 LEGNDIGLVNWARKMKERNTELEMLDGNIPREEGLKEESVREYVRIACMCTGELQKDRPE 370

Query: 361 MSYVVQLLDEL 371
           M  VV+LLD +
Sbjct: 371 MPEVVKLLDSM 381

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297791813|ref|XP_002863791.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297309626|gb|EFH40050.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  433 bits (1114), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 221/366 (60%), Positives = 274/366 (74%), Gaps = 23/366 (6%)

Query: 8   LIAAAASFVVITLIFAIMLLFCKRTYKPP--TYRTRAVNRPQPNRCSDLSSIALFDSASF 65
           L  + +S  ++ ++FA+++L C+R  +PP   +  R++N P P    DL++  +  + SF
Sbjct: 9   LATSTSSIFLLLIVFAVVMLVCRR--RPPIENHPRRSLNFPDP----DLNTETV--TESF 60

Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREF 125
           DPS+ +ISM+EL  AT NFS+D I+GDGSFG VYKA+LS+GV VA+KKLD DA QGFREF
Sbjct: 61  DPSICEISMAELTIATKNFSSDLIVGDGSFGLVYKAQLSNGVVVAVKKLDHDALQGFREF 120

Query: 126 RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN 185
            AEM+TLG+L+H NIV+ILGYC SGLDR+LIYEF+E  SLD WLH+T   DD +      
Sbjct: 121 AAEMDTLGRLKHPNIVRILGYCISGLDRILIYEFLEKSSLDYWLHET---DDENS----- 172

Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
              PL+W TRV I R VA GLAYLHGL KPIIHRDIKSSNVLLDSDF AHI+DFGLARR+
Sbjct: 173 ---PLTWPTRVNITRDVAKGLAYLHGLPKPIIHRDIKSSNVLLDSDFVAHIADFGLARRM 229

Query: 246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ 305
           D S SHVSTQVAGTMGYMPPEY  GNTAATV  DVYSFG+LM+E+AT+ RPNL V +D +
Sbjct: 230 DESRSHVSTQVAGTMGYMPPEYWEGNTAATVKADVYSFGVLMLELATRRRPNLTVFVDEK 289

Query: 306 EVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVV 365
           EVGL +WA  M  +++  EM+D        SE GV EYFRIAC+C  E +RERP M+ VV
Sbjct: 290 EVGLAQWAVIMVEQSRCYEMLD--FGGVGGSEKGVEEYFRIACLCIKESTRERPTMNQVV 347

Query: 366 QLLDEL 371
           +LL+EL
Sbjct: 348 ELLEEL 353

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15238960|ref|NP_199059.1| protein kinase family protein [Arabidopsis thaliana] gi|9759480|dbj|BAB10485.1| serine/threonine protein kinase-like protein [Arabidopsis thaliana] gi|38638690|gb|AAR25639.1| At5g42440 [Arabidopsis thaliana] gi|332007428|gb|AED94811.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  430 bits (1106), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 217/364 (59%), Positives = 266/364 (73%), Gaps = 17/364 (4%)

Query: 8   LIAAAASFVVITLIFAIMLLFCKRTYKPPTYRTRAVNRPQPNRCSDLSSIALFDSASFDP 67
           L  + +S  ++ ++F ++++ C+R  +PP       NR  P+   DL++  +  + SFDP
Sbjct: 9   LATSISSIFLLLIVFTVVMIVCRR--RPPIQNHPRRNRNFPDPDPDLNTETV--TESFDP 64

Query: 68  SLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRA 127
           S+ +ISM+EL  AT NFS+D I+GDGSFG VY+A+LS+GV VA+KKLD DA QGFREF A
Sbjct: 65  SICEISMAELTIATKNFSSDLIVGDGSFGLVYRAQLSNGVVVAVKKLDHDALQGFREFAA 124

Query: 128 EMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL 187
           EM+TLG+L H NIV+ILGYC SG DR+LIYEF+E  SLD WLH+T   +           
Sbjct: 125 EMDTLGRLNHPNIVRILGYCISGSDRILIYEFLEKSSLDYWLHETDEENS---------- 174

Query: 188 CPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT 247
            PL+W TRV I R VA GLAYLHGL KPIIHRDIKSSNVLLDSDF AHI+DFGLARRID 
Sbjct: 175 -PLTWSTRVNITRDVAKGLAYLHGLPKPIIHRDIKSSNVLLDSDFVAHIADFGLARRIDA 233

Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV 307
           S SHVSTQVAGTMGYMPPEY  GNTAATV  DVYSFG+LM+E+AT+ RPNL VV+D +EV
Sbjct: 234 SRSHVSTQVAGTMGYMPPEYWEGNTAATVKADVYSFGVLMLELATRRRPNLTVVVDEKEV 293

Query: 308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL 367
           GL +WA  M  +N+  EM+D        SE GV EYFRIAC+C  E +RERP M  VV+L
Sbjct: 294 GLAQWAVIMVEQNRCYEMLD--FGGVCGSEKGVEEYFRIACLCIKESTRERPTMVQVVEL 351

Query: 368 LDEL 371
           L+EL
Sbjct: 352 LEEL 355

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356535758|ref|XP_003536410.1| PREDICTED: phytosulfokine receptor 2-like [Glycine max]

 Score =  429 bits (1104), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 219/375 (58%), Positives = 272/375 (72%), Gaps = 13/375 (3%)

Query: 1   MGPSIQALIAAAASFVVITLIFAIMLLFCKRTYKPPTYRTRAVN---RPQPNRCSDLSSI 57
           M  ++QA++A+ ASF V+TL+ A  +L C+        R R+ +   RP P+R +  S  
Sbjct: 1   MEHALQAVVASIASFFVVTLLLAAAILLCQHHRNSTKTRARSSHIRTRPAPHREASSSLS 60

Query: 58  ALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKD 117
           A+  S S DP+L +IS  EL  ATDNFS   I+GDGSFG VYKA+LSSG TVA+KKL  D
Sbjct: 61  AVDASWSSDPNLIKISWDELARATDNFSPHLIVGDGSFGLVYKARLSSGATVAVKKLSPD 120

Query: 118 AFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDD 177
           AFQGFREF AEMETL +LRH NIVKIL Y ASG +R+L+YEF+E G+LDQWLH+   +  
Sbjct: 121 AFQGFREFTAEMETLSRLRHPNIVKILSYWASGPERLLVYEFIEKGNLDQWLHEPDLS-- 178

Query: 178 VDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS 237
                   SL PL W TRV I+RGVA+GL+YLHGL+KP+IHRDIK+SN+LLDS F+AHI+
Sbjct: 179 -------LSLSPLPWPTRVNIIRGVAHGLSYLHGLDKPVIHRDIKASNILLDSKFQAHIA 231

Query: 238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN 297
           DFGLARRID +HSHVSTQ AGT+GYMPPE + G+  A   +DVYSFGILMIE A+  RPN
Sbjct: 232 DFGLARRIDKTHSHVSTQFAGTIGYMPPECIEGSNVANREVDVYSFGILMIETASSHRPN 291

Query: 298 LPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISR-EELSEAGVREYFRIACMCTNEKSR 356
           LP+ L   ++G+++WAR M+ +N EIEMVD NISR E L E  V+EY RIAC CT E  +
Sbjct: 292 LPMKLGPDDIGMVQWARKMKEKNAEIEMVDVNISRGEGLREETVKEYVRIACECTREMQK 351

Query: 357 ERPAMSYVVQLLDEL 371
           ERP M  VVQ LD +
Sbjct: 352 ERPQMPQVVQWLDSM 366

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	373
TAIR|locus:2162296	359	AT5G42440 [Arabidopsis thalian	0.946	0.983	0.597	2.4e-108
TAIR|locus:2154709	1036	PSKR2 "phytosylfokine-alpha re	0.922	0.332	0.415	3.6e-64
TAIR|locus:2207056	1095	PSY1R "PSY1 receptor" [Arabido	0.831	0.283	0.422	1.3e-62
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.793	0.248	0.448	5.2e-62
TAIR|locus:2092810	1164	BRL3 "BRI1-like 3" [Arabidopsi	0.957	0.306	0.379	1.5e-60
UNIPROTKB|Q8RZV7	1294	P0413C03.22 "Putative extra sp	0.930	0.268	0.410	1.7e-60
TAIR|locus:2051628	1008	PSKR1 "phytosulfokin receptor	0.924	0.342	0.402	2.1e-60
TAIR|locus:2020457	1166	BRL1 "BRI1 like" [Arabidopsis	0.962	0.307	0.370	5.3e-60
TAIR|locus:2077730	512	AT3G59110 [Arabidopsis thalian	0.756	0.550	0.411	3.5e-59
TAIR|locus:2045620	494	AT2G42960 [Arabidopsis thalian	0.756	0.570	0.391	2.2e-57

TAIR|locus:2162296 AT5G42440 [Arabidopsis thaliana (taxid:3702)]

 Score = 1071 (382.1 bits), Expect = 2.4e-108, P = 2.4e-108
 Identities = 223/373 (59%), Positives = 271/373 (72%)

Query:     1 MGPSIQALIAAAASFVVITLI-FAIMLLFCKRTYKPPTYRTRAVNRPQPNRCSDLSSIAL 59
             M   I  ++A + S + + LI F ++++ C+R  +PP       NR  P+   DL++  +
Sbjct:     1 MDYQISLILATSISSIFLLLIVFTVVMIVCRR--RPPIQNHPRRNRNFPDPDPDLNTETV 58

Query:    60 FDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF 119
              +S  FDPS+ +ISM+EL  AT NFS+D I+GDGSFG VY+A+LS+GV VA+KKLD DA 
Sbjct:    59 TES--FDPSICEISMAELTIATKNFSSDLIVGDGSFGLVYRAQLSNGVVVAVKKLDHDAL 116

Query:   120 QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVD 179
             QGFREF AEM+TLG+L H NIV+ILGYC SG DR+LIYEF+E  SLD WLH+T       
Sbjct:   117 QGFREFAAEMDTLGRLNHPNIVRILGYCISGSDRILIYEFLEKSSLDYWLHETDEE---- 172

Query:   180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
                  NS  PL+W TRV I R VA GLAYLHGL KPIIHRDIKSSNVLLDSDF AHI+DF
Sbjct:   173 -----NS--PLTWSTRVNITRDVAKGLAYLHGLPKPIIHRDIKSSNVLLDSDFVAHIADF 225

Query:   240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
             GLARRID S SHVSTQVAGTMGYMPPEY  GNTAATV  DVYSFG+LM+E+AT+ RPNL 
Sbjct:   226 GLARRIDASRSHVSTQVAGTMGYMPPEYWEGNTAATVKADVYSFGVLMLELATRRRPNLT 285

Query:   300 VVLDGQEVGLLEWARTMEARNKEIEMVD-SNISREELSEAGVREYFRIACMCTNEKSRER 358
             VV+D +EVGL +WA  M  +N+  EM+D   +     SE GV EYFRIAC+C  E +RER
Sbjct:   286 VVVDEKEVGLAQWAVIMVEQNRCYEMLDFGGVCG---SEKGVEEYFRIACLCIKESTRER 342

Query:   359 PAMSYVVQLLDEL 371
             P M  VV+LL+EL
Sbjct:   343 PTMVQVVELLEEL 355

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2154709 PSKR2 "phytosylfokine-alpha receptor 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 660 (237.4 bits), Expect = 3.6e-64, P = 3.6e-64
 Identities = 154/371 (41%), Positives = 217/371 (58%)

Query:     7 ALIAAAASFVV-ITLIFAIMLLFCKRTYKPPTYRTRAVNRPQPNRCSDL---SSIALFDS 62
             +++    S  + ITL+ +++LL   R  K    R   V+    +  S     S I LF S
Sbjct:   679 SIVVLTISLAIGITLLLSVILLRISR--KDVDDRINDVDEETISGVSKALGPSKIVLFHS 736

Query:    63 ASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGF 122
                      +S+ EL+ +T+NFS   IIG G FG VYKA    G   A+K+L  D  Q  
Sbjct:   737 CG----CKDLSVEELLKSTNNFSQANIIGCGGFGLVYKANFPDGSKAAVKRLSGDCGQME 792

Query:   123 REFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSK 182
             REF+AE+E L +  H+N+V + GYC  G DR+LIY F+ENGSLD WLH+      VDG+ 
Sbjct:   793 REFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHER-----VDGNM 847

Query:   183 QLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP-IIHRDIKSSNVLLDSDFEAHISDFGL 241
              L       W+ R+KI +G A GLAYLH + +P +IHRD+KSSN+LLD  FEAH++DFGL
Sbjct:   848 TL------IWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEAHLADFGL 901

Query:   242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVV 301
             AR +    +HV+T + GT+GY+PPEY   +  AT   DVYSFG++++E+ T  RP    V
Sbjct:   902 ARLLRPYDTHVTTDLVGTLGYIPPEY-SQSLIATCRGDVYSFGVVLLELVTGRRP--VEV 958

Query:   302 LDGQEV-GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
               G+    L+     M+A  +E E++D+ I RE ++E  V E   IAC C + + R RP 
Sbjct:   959 CKGKSCRDLVSRVFQMKAEKREAELIDTTI-RENVNERTVLEMLEIACKCIDHEPRRRPL 1017

Query:   361 MSYVVQLLDEL 371
             +  VV  L++L
Sbjct:  1018 IEEVVTWLEDL 1028

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP

GO:0009611 "response to wounding" evidence=IGI

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2207056 PSY1R "PSY1 receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 647 (232.8 bits), Expect = 1.3e-62, P = 1.3e-62
 Identities = 138/327 (42%), Positives = 202/327 (61%)

Query:    48 PNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGV 107
             P    D+S + LF ++ ++  +  +++ EL+ ATDNFS   IIG G FG VYKA L +G 
Sbjct:   769 PGSDKDISLVLLFGNSRYE--VKDLTIFELLKATDNFSQANIIGCGGFGLVYKATLDNGT 826

Query:   108 TVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQ 167
              +A+KKL  D     +EF+AE+E L + +H N+V + GYC     R+LIY F+ENGSLD 
Sbjct:   827 KLAVKKLTGDYGMMEKEFKAEVEVLSRAKHENLVALQGYCVHDSARILIYSFMENGSLDY 886

Query:   168 WLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP-IIHRDIKSSNV 226
             WLH+       +G  QL+      W  R+ I+RG ++GLAY+H + +P I+HRDIKSSN+
Sbjct:   887 WLHENP-----EGPAQLD------WPKRLNIMRGASSGLAYMHQICEPHIVHRDIKSSNI 935

Query:   227 LLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
             LLD +F+A+++DFGL+R I    +HV+T++ GT+GY+PPEY G    AT+  DVYSFG++
Sbjct:   936 LLDGNFKAYVADFGLSRLILPYRTHVTTELVGTLGYIPPEY-GQAWVATLRGDVYSFGVV 994

Query:   287 MIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRI 346
             M+E+ T  RP + V        L+ W  TM+   K  E+ D+ + RE  +E  +     I
Sbjct:   995 MLELLTGKRP-MEVFRPKMSRELVAWVHTMKRDGKPEEVFDT-LLRESGNEEAMLRVLDI 1052

Query:   347 ACMCTNEKSRERPAMSYVVQLLDELVA 373
             ACMC N+   +RP +  VV  L  + A
Sbjct:  1053 ACMCVNQNPMKRPNIQQVVDWLKNIEA 1079

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP

GO:0004888 "transmembrane signaling receptor activity" evidence=IMP

GO:0009611 "response to wounding" evidence=IGI

GO:0031347 "regulation of defense response" evidence=IGI

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 643 (231.4 bits), Expect = 5.2e-62, P = 5.2e-62
 Identities = 139/310 (44%), Positives = 192/310 (61%)

Query:    63 ASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGF 122
             A F+  L ++ + ++++ATD+FS   IIGDG FG VYKA L    TVA+KKL +   QG 
Sbjct:   896 AMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGN 955

Query:   123 REFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSK 182
             REF AEMETLGK++H N+V +LGYC+   +++L+YE++ NGSLD WL    RN       
Sbjct:   956 REFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWL----RN------- 1004

Query:   183 QLNSLCPLSWETRVKIVRGVANGLAYLH-GLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
             Q   L  L W  R+KI  G A GLA+LH G    IIHRDIK+SN+LLD DFE  ++DFGL
Sbjct:  1005 QTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGL 1064

Query:   242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVV 301
             AR I    SHVST +AGT GY+PPEY G +  AT   DVYSFG++++E+ T   P  P  
Sbjct:  1065 ARLISACESHVSTVIAGTFGYIPPEY-GQSARATTKGDVYSFGVILLELVTGKEPTGPDF 1123

Query:   302 LDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM 361
              + +   L+ WA     + K ++++D  +    L  + +R   +IA +C  E   +RP M
Sbjct:  1124 KESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLR-LLQIAMLCLAETPAKRPNM 1182

Query:   362 SYVVQLLDEL 371
               V++ L E+
Sbjct:  1183 LDVLKALKEI 1192

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 629 (226.5 bits), Expect = 1.5e-60, P = 1.5e-60
 Identities = 143/377 (37%), Positives = 221/377 (58%)

Query:     4 SIQALIAAAASFVVITLIFAIMLLF-CKRTYKPPTYRTRAVNR-PQPNRCS-DLSSI--- 57
             SI   ++A   F  + ++  IM L+  ++  K    R + +   P     S  LSS+   
Sbjct:   772 SIATGMSAGIVFSFMCIVMLIMALYRARKVQKKEKQREKYIESLPTSGSSSWKLSSVHEP 831

Query:    58 ALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKD 117
                + A+F+  L +++ + L++AT+ FS D +IG G FG VYKAKL+ G  VAIKKL + 
Sbjct:   832 LSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQV 891

Query:   118 AFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDD 177
               QG REF AEMET+GK++HRN+V +LGYC  G +R+L+YE+++ GSL+  LH+ ++   
Sbjct:   892 TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGG 951

Query:   178 VDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP-IIHRDIKSSNVLLDSDFEAHI 236
             +           L W  R KI  G A GLA+LH    P IIHRD+KSSNVLLD DF A +
Sbjct:   952 IF----------LDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARV 1001

Query:   237 SDFGLARRIDTSHSHVSTQ-VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIR 295
             SDFG+AR +    +H+S   +AGT GY+PPEY   +   T   DVYS+G++++E+ +  +
Sbjct:  1002 SDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQ-SFRCTAKGDVYSYGVILLELLSGKK 1060

Query:   296 PNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKS 355
             P  P    G++  L+ WA+ +    +  E++D  +  ++  +  +  Y +IA  C +++ 
Sbjct:  1061 PIDPEEF-GEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRP 1119

Query:   356 RERPAMSYVVQLLDELV 372
              +RP M  V+ +  ELV
Sbjct:  1120 FKRPTMIQVMTMFKELV 1136

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 630 (226.8 bits), Expect = 1.7e-60, P = 1.7e-60
 Identities = 153/373 (41%), Positives = 219/373 (58%)

Query:     6 QALIAAAASFVVITLIFAIMLLFCKRTY---KPPTYRT--RAVNRPQPNRCSDL----SS 56
             +A+   A +FV+I ++  ++ ++ +R     +P  + +  +A    +P    +L    S 
Sbjct:   915 RAITICAFTFVII-IVLVLLAVYLRRKLVRSRPLAFESASKAKATVEPTSTDELLGKKSR 973

Query:    57 IAL-FDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLD 115
               L  + A+F+ +L +++  +++ AT+NFS   IIGDG FG VYKA L  G  VAIK+L 
Sbjct:   974 EPLSINLATFEHALLRVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLH 1033

Query:   116 KD-AFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSR 174
                 FQG REF AEMET+GK++H N+V +LGYC  G +R LIYE++ENGSL+ WL    R
Sbjct:  1034 GGHQFQGDREFLAEMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWL----R 1089

Query:   175 NDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLH-GLEKPIIHRDIKSSNVLLDSDFE 233
             N       + ++L  L W  R+KI  G A GLA+LH G    IIHRD+KSSN+LLD +FE
Sbjct:  1090 N-------RADALEALGWPDRLKICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFE 1142

Query:   234 AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
               +SDFGLAR I    +HVST +AGT GY+PPEY G    +T   DVYSFG++M+E+ T 
Sbjct:  1143 PRVSDFGLARIISACETHVSTDIAGTFGYIPPEY-GLTMKSTTKGDVYSFGVVMLELLTG 1201

Query:   294 IRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNE 353
               P     + G    L+ W R M AR K+ E+ D  +    +    +     IA  CT +
Sbjct:  1202 RPPTGQEEVQGGG-NLVGWVRWMIARGKQNELFDPCLPVSSVWREQMARVLAIARDCTAD 1260

Query:   354 KSRERPAMSYVVQ 366
             +  +RP M  VV+
Sbjct:  1261 EPFKRPTMLEVVK 1273

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0009554 "megasporogenesis" evidence=IMP

GO:0009556 "microsporogenesis" evidence=IMP

GO:0048658 "tapetal layer development" evidence=IMP

TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 625 (225.1 bits), Expect = 2.1e-60, P = 2.1e-60
 Identities = 148/368 (40%), Positives = 215/368 (58%)

Query:     7 ALIAAAASFVVITLIFAIMLLFCKRTYK--PPTYRTRAVNRPQPNRCSDLSSIALFDSAS 64
             A+  A  S  ++TL+  I+L   +R+ +  P    + ++NR +         + LF S  
Sbjct:   661 AIGIAFGSVFLLTLLSLIVLRARRRSGEVDPEIEESESMNRKELGEIGS-KLVVLFQSND 719

Query:    65 FDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFRE 124
                   ++S  +L+D+T++F    IIG G FG VYKA L  G  VAIKKL  D  Q  RE
Sbjct:   720 -----KELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSGDCGQIERE 774

Query:   125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
             F AE+ETL + +H N+V + G+C    DR+LIY ++ENGSLD WLH+  RND   G    
Sbjct:   775 FEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHE--RND---GP--- 826

Query:   185 NSLCPLSWETRVKIVRGVANGLAYLH-GLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR 243
              +L  L W+TR++I +G A GL YLH G +  I+HRDIKSSN+LLD +F +H++DFGLAR
Sbjct:   827 -AL--LKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADFGLAR 883

Query:   244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD 303
              +    +HVST + GT+GY+PPEY G  + AT   DVYSFG++++E+ T  RP       
Sbjct:   884 LMSPYETHVSTDLVGTLGYIPPEY-GQASVATYKGDVYSFGVVLLELLTDKRPVDMCKPK 942

Query:   304 GQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY 363
             G    L+ W   M+  ++  E+ D  I  +E  +   R    IAC+C +E  ++RP    
Sbjct:   943 GCR-DLISWVVKMKHESRASEVFDPLIYSKENDKEMFR-VLEIACLCLSENPKQRPTTQQ 1000

Query:   364 VVQLLDEL 371
             +V  LD++
Sbjct:  1001 LVSWLDDV 1008

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP;IDA

GO:0009611 "response to wounding" evidence=IGI

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0045087 "innate immune response" evidence=IMP

GO:0031347 "regulation of defense response" evidence=IGI

TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)]

 Score = 624 (224.7 bits), Expect = 5.3e-60, P = 5.3e-60
 Identities = 140/378 (37%), Positives = 221/378 (58%)

Query:     4 SIQALIAAAASFVVITLIFAIMLLF-CKRTYKPPTYRTRAVNR-PQPNRCS-DLSSIA-- 58
             ++   + A  +F  +  +  +M L+  ++  K    R + +   P    CS  LSS+   
Sbjct:   773 TVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVPEP 832

Query:    59 -LFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKD 117
                + A+F+  L +++ + L++AT+ FS + ++G G FG VYKA+L  G  VAIKKL + 
Sbjct:   833 LSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRI 892

Query:   118 AFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDD 177
               QG REF AEMET+GK++HRN+V +LGYC  G +R+L+YE+++ GSL+  LH+ S    
Sbjct:   893 TGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKK- 951

Query:   178 VDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP-IIHRDIKSSNVLLDSDFEAHI 236
               G   LN      W  R KI  G A GLA+LH    P IIHRD+KSSNVLLD DFEA +
Sbjct:   952 --GGIYLN------WAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARV 1003

Query:   237 SDFGLARRIDTSHSHVSTQ-VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIR 295
             SDFG+AR +    +H+S   +AGT GY+PPEY   +   T   DVYS+G++++E+ +  +
Sbjct:  1004 SDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQ-SFRCTAKGDVYSYGVILLELLSGKK 1062

Query:   296 PNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKS 355
             P  P    G++  L+ WA+ +    +  E++D  +  ++  +  +  Y +IA  C +++ 
Sbjct:  1063 PIDPGEF-GEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRP 1121

Query:   356 RERPAMSYVVQLLDELVA 373
              +RP M  ++ +  E+ A
Sbjct:  1122 FKRPTMIQLMAMFKEMKA 1139

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)]

 Score = 607 (218.7 bits), Expect = 3.5e-59, P = 3.5e-59
 Identities = 123/299 (41%), Positives = 190/299 (63%)

Query:    73 SMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETL 132
             ++ +L  AT+ F+ + +IG+G +G VYK +L +G  VA+KKL  +  Q  +EFR E+E +
Sbjct:   179 TLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVAVKKLLNNLGQAEKEFRVEVEAI 238

Query:   133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
             G +RH+N+V++LGYC  G++R+L+YE+V +G+L+QWLH           KQ      L+W
Sbjct:   239 GHVRHKNLVRLLGYCIEGVNRMLVYEYVNSGNLEQWLHGAM-------GKQST----LTW 287

Query:   193 ETRVKIVRGVANGLAYLH-GLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
             E R+KI+ G A  LAYLH  +E  ++HRDIK+SN+L+D DF A +SDFGLA+ +D+  SH
Sbjct:   288 EARMKILVGTAQALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLLDSGESH 347

Query:   252 VSTQVAGTMGYMPPEYLGGNTAA-TVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL 310
             ++T+V GT GY+ PEY   NT       D+YSFG+L++E  T   P +       EV L+
Sbjct:   348 ITTRVMGTFGYVAPEY--ANTGLLNEKSDIYSFGVLLLETITGRDP-VDYERPANEVNLV 404

Query:   311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD 369
             EW + M    +  E+VDS I     + A ++    +A  C + ++++RP MS VV++L+
Sbjct:   405 EWLKMMVGTRRAEEVVDSRIEPPPATRA-LKRALLVALRCVDPEAQKRPKMSQVVRMLE 462

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)]

 Score = 590 (212.7 bits), Expect = 2.2e-57, P = 2.2e-57
 Identities = 117/299 (39%), Positives = 187/299 (62%)

Query:    73 SMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETL 132
             ++ +L  AT+ F+   ++G+G +G VY+ KL +G  VA+KKL  +  Q  +EFR E+E +
Sbjct:   172 TLRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAI 231

Query:   133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
             G +RH+N+V++LGYC  G+ R+L+YE+V +G+L+QWLH   R     G+        L+W
Sbjct:   232 GHVRHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQH---GN--------LTW 280

Query:   193 ETRVKIVRGVANGLAYLH-GLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
             E R+KI+ G A  LAYLH  +E  ++HRDIK+SN+L+D +F A +SDFGLA+ +D+  SH
Sbjct:   281 EARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESH 340

Query:   252 VSTQVAGTMGYMPPEYLGGNTAA-TVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL 310
             ++T+V GT GY+ PEY   NT       D+YSFG+L++E  T   P +       EV L+
Sbjct:   341 ITTRVMGTFGYVAPEY--ANTGLLNEKSDIYSFGVLLLEAITGRDP-VDYGRPANEVNLV 397

Query:   311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD 369
             EW + M    +  E+VD  +     S++ ++    ++  C + ++ +RP MS V ++L+
Sbjct:   398 EWLKMMVGTRRAEEVVDPRLEPRP-SKSALKRALLVSLRCVDPEAEKRPRMSQVARMLE 455

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	373
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-55
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-50
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-50
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-50
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-38
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-31
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-26
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-26
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-26
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-25
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-25
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-24
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-24
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-24
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-24
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-22
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-21
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-21
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-21
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-21
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-20
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-19
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-19
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-18
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-18
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-17
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-17
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-17
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-16
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-16
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-15
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-14
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-13
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-13
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-10
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-10
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	8e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	5e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.003
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  180 bits (459), Expect = 2e-55
 Identities = 71/204 (34%), Positives = 104/204 (50%), Gaps = 20/204 (9%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVKILGYC 147
           +G+G FG VY A+   +G  VAIK + K+      E    E+E L KL H NIVK+ G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  L+ E+ E GSL   L +                  LS +  ++I+  +  GL 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEG--------------KLSEDEILRILLQILEGLE 106

Query: 208 YLHGLEKPIIHRDIKSSNVLLDSD-FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE 266
           YLH     IIHRD+K  N+LLDSD  +  ++DFGL++ + +  S + T V GT  YM PE
Sbjct: 107 YLH--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPE 163

Query: 267 YLGGNTAATVMLDVYSFGILMIEI 290
            L G    +   D++S G+++ E+
Sbjct: 164 VLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  169 bits (431), Expect = 2e-50
 Identities = 82/290 (28%), Positives = 123/290 (42%), Gaps = 43/290 (14%)

Query: 87  DKIIGDGSFGFVYKAKLS-----SGVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNI 140
            K +G+G+FG VYK  L        V VA+K L +DA  Q   EF  E   + KL H NI
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           VK+LG C      +++ E++  G L  +L      +             LS    +    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-------------LSLSDLLSFAL 110

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +A G+ YL    K  IHRD+ + N L+  +    ISDFGL+R +     +        +
Sbjct: 111 QIARGMEYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI 168

Query: 261 GYMPPEYL--GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA 318
            +M PE L  G  T+ +   DV+SFG+L+ EI T         +   EV  LE+ +    
Sbjct: 169 RWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTLGEE-PYPGMSNAEV--LEYLKKGYR 222

Query: 319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLL 368
             K                    E +++   C  E   +RP  S +V++L
Sbjct: 223 LPKPPNCPP--------------ELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  168 bits (429), Expect = 3e-50
 Identities = 82/290 (28%), Positives = 123/290 (42%), Gaps = 44/290 (15%)

Query: 87  DKIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNI 140
            K +G+G+FG VYK KL        V VA+K L +DA  Q   EF  E   + KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           VK+LG C       ++ E++E G L  +L                    LS    +    
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--------------LSLSDLLSFAL 109

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +A G+ YL    K  IHRD+ + N L+  +    ISDFGL+R +     +        +
Sbjct: 110 QIARGMEYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI 167

Query: 261 GYMPPEYL--GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA 318
            +M PE L  G  T+ +   DV+SFG+L+ EI T         +  +EV  LE+ +    
Sbjct: 168 RWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTLGEQ-PYPGMSNEEV--LEYLKNGYR 221

Query: 319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLL 368
             +                    E + +   C  E   +RP  S +V++L
Sbjct: 222 LPQPPNCPP--------------ELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  168 bits (428), Expect = 4e-50
 Identities = 87/297 (29%), Positives = 128/297 (43%), Gaps = 50/297 (16%)

Query: 88  KIIGDGSFGFVYKAKLSSG----VTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVK 142
           K +G+G+FG VYK KL         VA+K L +DA +  R +F  E   + KL H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           +LG C       L+ E++E G L  +L   SR       K       LS +  +     +
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLR-KSRPVFPSPEKS-----TLSLKDLLSFAIQI 114

Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG- 261
           A G+ YL    K  +HRD+ + N L+  D    ISDFGL+R +     +       T G 
Sbjct: 115 AKGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGK 168

Query: 262 ----YMPPEYLGGN--TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE--VGLLEWA 313
               +M PE L     T+ +   DV+SFG+L+ EI T           G     GL    
Sbjct: 169 LPIRWMAPESLKDGIFTSKS---DVWSFGVLLWEIFT----------LGATPYPGL---- 211

Query: 314 RTMEARNKEI-EMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD 369
                 N+E+ E +     R    E    E + +   C      +RP  S +V+ L+
Sbjct: 212 -----SNEEVLEYLRKG-YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  168 bits (428), Expect = 4e-50
 Identities = 74/212 (34%), Positives = 106/212 (50%), Gaps = 21/212 (9%)

Query: 84  FSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKD--AFQGFREFRAEMETLGKLRHRNI 140
           +   + +G GSFG VYKAK   +G  VA+K L K     +  +  R E+  L +L H NI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V+++          L+ E+ E G L  +L                   PLS +   KI  
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS---------------RGGPLSEDEAKKIAL 105

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +  GL YLH     IIHRD+K  N+LLD +    I+DFGLA+++  S S ++T V GT 
Sbjct: 106 QILRGLEYLH--SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTP 162

Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            YM PE L G       +DV+S G+++ E+ T
Sbjct: 163 WYMAPEVLLGGNGYGPKVDVWSLGVILYELLT 194

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  160 bits (408), Expect = 3e-47
 Identities = 72/218 (33%), Positives = 104/218 (47%), Gaps = 28/218 (12%)

Query: 84  FSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIV 141
           +   + +G+GSFG VY A+   +G  VAIK + K   +  RE    E++ L KL+H NIV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++           L+ E+ E G L   L    R               LS +     +R 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR---------------LSEDEARFYLRQ 105

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           + + L YLH   K I+HRD+K  N+LLD D    ++DFGLAR++D       T   GT  
Sbjct: 106 ILSALEYLH--SKGIVHRDLKPENILLDEDGHVKLADFGLARQLD--PGEKLTTFVGTPE 161

Query: 262 YMPPEYLGG---NTAATVMLDVYSFGILMIEIATQIRP 296
           YM PE L G     A     D++S G+++ E+ T   P
Sbjct: 162 YMAPEVLLGKGYGKAV----DIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  158 bits (403), Expect = 2e-46
 Identities = 66/219 (30%), Positives = 99/219 (45%), Gaps = 36/219 (16%)

Query: 87  DKIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNI 140
            K +G+G+FG VYK  L      +   VA+K L + A  +   EF  E   + KL H NI
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V++LG C  G    ++ E++  G L  +L                    L+ +  +++  
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE--------------KLTLKDLLQMAL 109

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +A G+ YL    K  +HRD+ + N L+  +    ISDFGL+R I               
Sbjct: 110 QIAKGMEYLE--SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED----DYYRKRGG 163

Query: 261 GY-----MPPEYL--GGNTAATVMLDVYSFGILMIEIAT 292
           G      M PE L  G  T+ +   DV+SFG+L+ EI T
Sbjct: 164 GKLPIKWMAPESLKDGKFTSKS---DVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  137 bits (348), Expect = 3e-38
 Identities = 71/215 (33%), Positives = 104/215 (48%), Gaps = 32/215 (14%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKK--LDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +++G GSFG VY A    +G  +A+K   L  D+ +       E+  L  L+H NIV+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 145 G-YCASGLDRVLIY-EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-VRG 201
           G       + + I+ E+V  GSL               S  L     L  E  ++   R 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSL---------------SSLLKKFGKLP-EPVIRKYTRQ 109

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST-QVAGTM 260
           +  GLAYLH     I+HRDIK +N+L+DSD    ++DFG A+R+    +   T  V GT 
Sbjct: 110 ILEGLAYLH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167

Query: 261 GYMPPEYLGGN---TAATVMLDVYSFGILMIEIAT 292
            +M PE + G     AA    D++S G  +IE+AT
Sbjct: 168 YWMAPEVIRGEEYGRAA----DIWSLGCTVIEMAT 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 8e-37
 Identities = 72/214 (33%), Positives = 109/214 (50%), Gaps = 24/214 (11%)

Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD--KDAFQGFREFRAEMETLGKLRHRN 139
           N+    +IG G+FG VYK   L +G  VAIK++   K   +  +    E++ L  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI- 198
           IVK +G   +     +I E+ ENGSL Q +                   P   E+ V + 
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP-------------FP---ESLVAVY 104

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           V  V  GLAYLH  E+ +IHRDIK++N+L   D    ++DFG+A +++         V G
Sbjct: 105 VYQVLQGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVG 161

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           T  +M PE +  + A+T   D++S G  +IE+ T
Sbjct: 162 TPYWMAPEVIEMSGASTAS-DIWSLGCTVIELLT 194

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  130 bits (329), Expect = 1e-35
 Identities = 69/209 (33%), Positives = 102/209 (48%), Gaps = 30/209 (14%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILG--Y 146
           IG G FG VYKA+   +G  VAIK +  ++ +   +   E++ L K +H NIVK  G   
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
               L   ++ EF   GSL   L  T++               L+      + + +  GL
Sbjct: 68  KKDEL--WIVMEFCSGGSLKDLLKSTNQ--------------TLTESQIAYVCKELLKGL 111

Query: 207 AYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE 266
            YLH     IIHRDIK++N+LL SD E  + DFGL+ ++  S +     + GT  +M PE
Sbjct: 112 EYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPE 167

Query: 267 YLGG---NTAATVMLDVYSFGILMIEIAT 292
            + G   +  A    D++S GI  IE+A 
Sbjct: 168 VINGKPYDYKA----DIWSLGITAIELAE 192

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  122 bits (306), Expect = 1e-31
 Identities = 75/226 (33%), Positives = 106/226 (46%), Gaps = 28/226 (12%)

Query: 83  NFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRH-R 138
           ++   + +G+GSFG VY A+      VA+K L K      +    F  E++ L  L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+  +        L+ E+V+ GSL+  L    R              PLS    + I
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK------------GPLSESEALFI 106

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-FEAHISDFGLARRIDTSHSHVSTQ-- 255
           +  + + L YLH   K IIHRDIK  N+LLD D     + DFGLA+ +    S  S    
Sbjct: 107 LAQILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPAL 164

Query: 256 ---VAGTMGYMPPEYLGGNTAA--TVMLDVYSFGILMIEIATQIRP 296
                GT GYM PE L G + A  +   D++S GI + E+ T + P
Sbjct: 165 PSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210

Length = 384

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 5e-29
 Identities = 71/228 (31%), Positives = 118/228 (51%), Gaps = 38/228 (16%)

Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQG--FREFRAEMET 131
           ID +   + +K+IG G FG V + +L       + VAIK L K         +F  E   
Sbjct: 1   IDPSY-VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASI 58

Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           +G+  H NI+++ G        ++I E++ENGSLD++L     ND              +
Sbjct: 59  MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR---ENDG-----------KFT 104

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
               V ++RG+A+G+ YL   E   +HRD+ + N+L++S+    +SDFGL+RR++ S + 
Sbjct: 105 VGQLVGMLRGIASGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162

Query: 252 VSTQVAGTMGYMP-----PEYLGGN--TAATVMLDVYSFGILMIEIAT 292
            +T+     G +P     PE +     T+A+   DV+SFGI+M E+ +
Sbjct: 163 YTTK----GGKIPIRWTAPEAIAYRKFTSAS---DVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  110 bits (277), Expect = 4e-28
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 30/218 (13%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLD-KDAFQGFREF-RAEMETLGKLRHRNIVKIL 144
           K IG GSFG VY  +  S G    +K++D  +  +  RE    E++ L KL H NI+K  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK-- 63

Query: 145 GYCASGLDRVLIY---EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            Y  S  ++  +    E+ + G L Q +            KQ     P   E  +     
Sbjct: 64  -YYESFEEKGKLCIVMEYADGGDLSQKIK-----------KQKKEGKPFPEEQILDWFVQ 111

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +   L YLH   + I+HRDIK  N+ L S+    + DFG+++ + ++     T V GT  
Sbjct: 112 LCLALKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPY 168

Query: 262 YMPPEYLGG---NTAATVMLDVYSFGILMIEIATQIRP 296
           Y+ PE       N  +    D++S G ++ E+ T   P
Sbjct: 169 YLSPELCQNKPYNYKS----DIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  109 bits (276), Expect = 1e-27
 Identities = 69/219 (31%), Positives = 109/219 (49%), Gaps = 40/219 (18%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKD-AFQGF-----REFRAEMETLGKLRHRNI 140
             IG+G++G VYKA+   +G  VA+KK+  +   +GF     RE    ++ L KLRH NI
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIRE----IKLLQKLRHPNI 60

Query: 141 VKILGYCASGL--DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSW--ET 194
           V++     S       +++E+++        HD            L  L   P     E+
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMD--------HD------------LTGLLDSPEVKFTES 100

Query: 195 RVK-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
           ++K  ++ +  GL YLH     I+HRDIK SN+L+++D    ++DFGLAR     +S   
Sbjct: 101 QIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158

Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           T    T+ Y PPE L G T     +D++S G ++ E+  
Sbjct: 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 6e-27
 Identities = 74/229 (32%), Positives = 100/229 (43%), Gaps = 37/229 (16%)

Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG G FG V       G  VA+K L KD     + F AE   +  LRH N+V++LG    
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
           G    ++ E++  GSL  +L   SR   V    Q                  V  G+ YL
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFA-----------LDVCEGMEYL 118

Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP----- 264
              EK  +HRD+ + NVL+  D  A +SDFGLA+                 G +P     
Sbjct: 119 E--EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---------DSGKLPVKWTA 167

Query: 265 PEYLGGNTAATVMLDVYSFGILMIEIATQIR---PNLPV--VLDGQEVG 308
           PE L     +T   DV+SFGIL+ EI +  R   P +P+  V+   E G
Sbjct: 168 PEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG 215

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  106 bits (266), Expect = 1e-26
 Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 21/211 (9%)

Query: 84  FSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKI 143
           F+ ++ +G G FG V++    + V VAIK L  D     ++F+ E++ L +LRH++++ +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG-SKQLNSLCPLSWETRVKIVRGV 202
              C+ G    +I E +E GSL  +L         +G    + SL  ++ +        V
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSP------EGQVLPVASLIDMACQ--------V 113

Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTMG 261
           A G+AYL   E+  IHRD+ + N+L+  D    ++DFGLAR I +  +     ++     
Sbjct: 114 AEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YK 169

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           +  PE     T +T   DV+SFGIL+ E+ T
Sbjct: 170 WTAPEAASHGTFSTKS-DVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  106 bits (266), Expect = 2e-26
 Identities = 70/242 (28%), Positives = 111/242 (45%), Gaps = 21/242 (8%)

Query: 83  NFSTDKIIGDGSFGFVYKAKL-----SSGVT-VAIKKLDK-DAFQGFREFRAEMETLGKL 135
           N      +G G FG V+ AK        G T V +K L K        EFR E++   KL
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
            H+N+V++LG C       +I E+ + G L Q+L  T   D+           PLS + +
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPP------PLSTKQK 119

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           V +   +A G+ +L       +HRD+ + N L+ S  E  +S   L++ +  S  +    
Sbjct: 120 VALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ-IRPNLPV----VLDGQEVGLL 310
               + ++ PE +  +  +T   DV+SFG+LM E+ TQ   P   +    VL+  + G L
Sbjct: 178 ALIPLRWLAPEAVQEDDFST-KSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236

Query: 311 EW 312
           E 
Sbjct: 237 EL 238

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  106 bits (266), Expect = 2e-26
 Identities = 85/319 (26%), Positives = 138/319 (43%), Gaps = 64/319 (20%)

Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAF-QGFREFRAEMETLGK 134
           D  +  K +G+G+FG V KA        +   TVA+K L  DA  +   +  +EME +  
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH-------DTSRNDDVDGSKQLNS 186
           + +H+NI+ +LG C       ++ E+  +G+L  +L          S +D     + L  
Sbjct: 72  IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 187 --LCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR 244
             L   +++        VA G+ +L    K  IHRD+ + NVL+  D    I+DFGLAR 
Sbjct: 132 KDLVSFAYQ--------VARGMEFLA--SKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181

Query: 245 I-------DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT---QI 294
           I        T++  +  +      +M PE L      T   DV+SFG+L+ EI T     
Sbjct: 182 IHHIDYYRKTTNGRLPVK------WMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSP 234

Query: 295 RPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEK 354
            P +PV    +   LL+    ME           N +         +E + +   C +E 
Sbjct: 235 YPGIPV---EELFKLLKEGYRMEK--------PQNCT---------QELYHLMRDCWHEV 274

Query: 355 SRERPAMSYVVQLLDELVA 373
             +RP    +V+ LD ++ 
Sbjct: 275 PSQRPTFKQLVEDLDRMLT 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  105 bits (265), Expect = 4e-26
 Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 34/221 (15%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA--EMETLGKL 135
           D  + +   + IG+G+ G VYKA   ++G  VAIKK+     +   +     E+  +   
Sbjct: 16  DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDC 72

Query: 136 RHRNIVKILGYCASGLDRVLIY---EFVENGSLDQWL--HDTSRNDDVDGSKQLNSLCPL 190
           +H NIV       S L    ++   E+++ GSL   +  +    N+      Q+  +C  
Sbjct: 73  KHPNIVDYYD---SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP-----QIAYVC-- 122

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS 250
                    R V  GL YLH   + +IHRDIKS N+LL  D    ++DFG A ++    S
Sbjct: 123 ---------REVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171

Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
             ++ V GT  +M PE +         +D++S GI+ IE+A
Sbjct: 172 KRNSVV-GTPYWMAPEVIKRKDYGP-KVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  104 bits (263), Expect = 4e-26
 Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 57/300 (19%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKL---DKDAFQGFREFRAEMETLGKLRH 137
            +    K++G GS G VYK +   +G   A+KK+     + F+  ++   E++TL     
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCES 58

Query: 138 RNIVKILG-YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
             +VK  G +   G    ++ E+++ GSL           D+           L+     
Sbjct: 59  PYVVKCYGAFYKEGEIS-IVLEYMDGGSLA----------DLLKKVGKIPEPVLA----- 102

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            I R +  GL YLH     IIHRDIK SN+L++S  E  I+DFG+++ ++ +    +T V
Sbjct: 103 YIARQILKGLDYLHTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV 161

Query: 257 AGTMGYMPPEYLGG---NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA 313
            GT+ YM PE + G   + AA    D++S G+ ++E A    P LP        G   + 
Sbjct: 162 -GTVTYMSPERIQGESYSYAA----DIWSLGLTLLECALGKFPFLP-------PGQPSFF 209

Query: 314 RTMEARNKE--IEMVDSNISREELSEAGVREYFR--IACMCTNEKSRERPAMSYVVQLLD 369
             M+A        +     S E          FR  I+  C  +  ++RP+     +LL 
Sbjct: 210 ELMQAICDGPPPSLPAEEFSPE----------FRDFISA-CLQKDPKKRPS---AAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  105 bits (264), Expect = 6e-26
 Identities = 75/227 (33%), Positives = 111/227 (48%), Gaps = 34/227 (14%)

Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKL----DKDAF--QGFREFRAEMETLGKL 135
            F     IG+G++G VY+A+  +SG  VA+KK+    ++D       RE       L  L
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITL----LLNL 63

Query: 136 RHRNIVKILGYCA-SGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           RH NIV++        LD + L+ E+ E         D +   D       N   P S E
Sbjct: 64  RHPNIVELKEVVVGKHLDSIFLVMEYCE--------QDLASLLD-------NMPTPFS-E 107

Query: 194 TRVK-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           ++VK ++  +  GL YLH  E  IIHRD+K SN+LL       I+DFGLAR        +
Sbjct: 108 SQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165

Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           + +V  T+ Y  PE L G T  T  +D+++ G ++ E+    +P LP
Sbjct: 166 TPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLP 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  104 bits (262), Expect = 8e-26
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 33/224 (14%)

Query: 88  KIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIV 141
           K +G+G FG V   +      ++G  VA+K L+     Q   +F  E+E L  L H NIV
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 142 KILGYCASGLDRV--LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           K  G C     R   LI E++ +GSL  +L    R+ D    K+L           +   
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRL-----------LLFS 115

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             +  G+ YL    +  IHRD+ + N+L++S+    ISDFGLA+ +     +        
Sbjct: 116 SQICKGMDYLG--SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYY---YVKE 170

Query: 260 MGYMP-----PEYLGGNTAATVMLDVYSFGILMIEIATQIRPNL 298
            G  P     PE L  +   +   DV+SFG+ + E+ T   P+ 
Sbjct: 171 PGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQ 213

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  104 bits (260), Expect = 1e-25
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 20/215 (9%)

Query: 90  IGDGSFGFVYKAKLSSGVT------VAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVK 142
           +G+G+FG V+  +            VA+K L + A    R+ F  E E L   +H NIVK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLC-PLSWETRVKIVRG 201
             G C  G   ++++E++E+G L+++L       D    K  +S    L+    ++I   
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGP--DAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT-- 259
           +A+G+ YL       +HRD+ + N L+  D    I DFG++R + T+  +   +V G   
Sbjct: 131 IASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGGHTM 185

Query: 260 --MGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
             + +MPPE +      T   DV+SFG+++ EI T
Sbjct: 186 LPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  103 bits (258), Expect = 3e-25
 Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 14/211 (6%)

Query: 90  IGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVK 142
           +G+G+FG VYK +L       S  +VAIK L ++A    + EFR E E +  L+H NIV 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVD-GSKQLNSLCPLSWETRVKIVRG 201
           +LG C       +++E++ +G L ++L   S + DV   S        L     + I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS-HSHVSTQVAGTM 260
           +A G+ YL       +HRD+ + N L+       ISDFGL+R I ++ +  V ++    +
Sbjct: 133 IAAGMEYLSS--HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190

Query: 261 GYMPPE-YLGGNTAATVMLDVYSFGILMIEI 290
            +MPPE  L G    T   D++SFG+++ EI
Sbjct: 191 RWMPPEAILYGKF--TTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  102 bits (258), Expect = 3e-25
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 33/218 (15%)

Query: 84  FSTDKIIGDGSFGFVYKAK-LSSGVTVAIKK--LDKDAFQGF-----REFRAEMETLGKL 135
           +   + +G+G++G VYKA+   +G  VA+KK  LD +  +G      RE    +  L +L
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALRE----ISLLKEL 55

Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           +H NIVK+L    +     L++E+ +   L ++L                   PLS    
Sbjct: 56  KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG--------------PLS-PNL 99

Query: 196 VK-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
           +K I+  +  GLAY H     I+HRD+K  N+L++ D    ++DFGLAR          T
Sbjct: 100 IKSIMYQLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYT 156

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
               T+ Y  PE L G+   +  +D++S G +  E+ T
Sbjct: 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  102 bits (256), Expect = 4e-25
 Identities = 67/213 (31%), Positives = 110/213 (51%), Gaps = 24/213 (11%)

Query: 87  DKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIV 141
            K+IG G FG V++  L       V VAIK L     +  R +F +E   +G+  H NI+
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++ G        ++I E++ENG+LD++L D   +D    S QL           V ++RG
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQL-----------VGMLRG 115

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +A G+ YL  +    +HRD+ + N+L++S+ E  +SDFGL+R ++       T   G + 
Sbjct: 116 IAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173

Query: 262 --YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
             +  PE +      +   DV+SFGI+M E+ +
Sbjct: 174 IRWTAPEAIAYRKFTSAS-DVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  102 bits (257), Expect = 4e-25
 Identities = 69/225 (30%), Positives = 116/225 (51%), Gaps = 20/225 (8%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVT-------VAIKKLDKDA-FQGFREFRAEMETLG 133
           +N    + IG G+FG V++A+ + G+        VA+K L ++A      +F+ E   + 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 63

Query: 134 KLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS-------RNDDVDGSKQLNS 186
           +  H NIVK+LG CA G    L++E++  G L+++L   S        +      K   +
Sbjct: 64  EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123

Query: 187 LCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI- 245
             PLS   ++ I + VA G+AYL   E+  +HRD+ + N L+  +    I+DFGL+R I 
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
              +   S   A  + +MPPE +  N   T   DV+++G+++ EI
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  101 bits (254), Expect = 7e-25
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 27/212 (12%)

Query: 88  KIIGDGSFGFVYKA-KLSSGVTVAIKKL-----DKDAFQGFREFRAEMETLGKLRHRNIV 141
           +++G GSFG VY+   L  G   A+K++      +   +  ++   E+  L KL+H NIV
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 142 KILGYCASGLDRVLIY-EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           + LG      D + I+ E V  GSL               +K L               R
Sbjct: 66  QYLGTEREE-DNLYIFLELVPGGSL---------------AKLLKKYGSFPEPVIRLYTR 109

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +  GL YLH   +  +HRDIK +N+L+D++    ++DFG+A+++       S    G+ 
Sbjct: 110 QILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSP 165

Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +M PE +       +  D++S G  ++E+AT
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT 197

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 1e-24
 Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 33/216 (15%)

Query: 88  KIIGDGSFGFVYKA-----KLSSGVTVAIKKL-DKDAFQGFREFRAEMETLGKLRHRNIV 141
           K++G G+FG VYK           + VAIK L ++ + +  +E   E   +  + H ++V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 142 KILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           ++LG C S   +V LI + +  G L  ++ +   + D  GS+ L     L+W  ++    
Sbjct: 73  RLLGICLS--SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYL-----LNWCVQI---- 118

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
             A G++YL   EK ++HRD+ + NVL+ +     I+DFGLA+ +D           G  
Sbjct: 119 --AKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEG-- 170

Query: 261 GYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
           G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 171 GKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 1e-24
 Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 36/213 (16%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHRNIVKILG- 145
           IG G++G VYKA+ +++G  VAIK  KL+      F   + E+  L + RH NIV   G 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 146 YCASGLDRVLI-YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
           Y     D++ I  E+   GSL      T                PLS      + R    
Sbjct: 69  Y--LRRDKLWIVMEYCGGGSLQDIYQVTRG--------------PLSELQIAYVCRETLK 112

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
           GLAYLH   K  IHRDIK +N+LL  D +  ++DFG++ ++  + +   + + GT  +M 
Sbjct: 113 GLAYLHETGK--IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMA 169

Query: 265 PEYL------GGNTAATVMLDVYSFGILMIEIA 291
           PE        G +       D+++ GI  IE+A
Sbjct: 170 PEVAAVERKGGYDGKC----DIWALGITAIELA 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 2e-24
 Identities = 72/227 (31%), Positives = 104/227 (45%), Gaps = 27/227 (11%)

Query: 77  LIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           L D T  F   ++IG+G++G VYKA+   +G  VAIK +D        E + E   L K 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKY 59

Query: 136 -RHRNIVKILG-YCASGLDRV-----LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLC 188
             H NI    G +             L+ E    GS+          D V G ++     
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV---------TDLVKGLRKKGK-- 108

Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
            L  E    I+R    GLAYLH  E  +IHRDIK  N+LL  + E  + DFG++ ++D++
Sbjct: 109 RLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166

Query: 249 HSHVSTQVAGTMGYMPPEYLGGNTAATVML----DVYSFGILMIEIA 291
               +T + GT  +M PE +  +           DV+S GI  IE+A
Sbjct: 167 LGRRNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 3e-24
 Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 24/214 (11%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHRNIVKILGY 146
           IG+G++G VYKA+   +G  VAIKK+            A  E++ L +L H NI+K+L  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK-IVRGVANG 205
                D  L++EF++   L + + D  R               L  E+ +K  +  +  G
Sbjct: 67  FRHKGDLYLVFEFMDT-DLYKLIKDRQR--------------GLP-ESLIKSYLYQLLQG 110

Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
           LA+ H     I+HRD+K  N+L++++    ++DFGLAR   +     +  V  T  Y  P
Sbjct: 111 LAFCH--SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAP 167

Query: 266 EYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           E L G+   +  +D++S G +  E+ ++ RP  P
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSR-RPLFP 200

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  100 bits (251), Expect = 3e-24
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 30/208 (14%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKL------DKDAFQGFREFRAEMETLGKLRHRNIVK 142
           IG+G+ G V+KAK   +G TVA+KK+           Q  RE +A        +H  +VK
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQA----CQHPYVVK 63

Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK-IVRG 201
           +L     G   VL+ E++    L + L D  R              PL  E +VK  +R 
Sbjct: 64  LLDVFPHGSGFVLVMEYMP-SDLSEVLRDEER--------------PLP-EAQVKSYMRM 107

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+AY+H     I+HRD+K +N+L+ +D    I+DFGLAR        + +    T  
Sbjct: 108 LLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRW 165

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIE 289
           Y  PE L G       +D+++ G +  E
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAE 193

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 98.9 bits (247), Expect = 5e-24
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 27/212 (12%)

Query: 84  FSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVK 142
           F   + +G+GS+G VYKA    +G  VAIK +  +     +E   E+  L +     IVK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62

Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
             G      D  ++ E+   GS+   +  T++               L+ E    I+   
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK--------------TLTEEEIAAILYQT 108

Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
             GL YLH      IHRDIK+ N+LL+ + +A ++DFG++ ++  + +  +T V GT  +
Sbjct: 109 LKGLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFW 165

Query: 263 MPPEYL---GGNTAATVMLDVYSFGILMIEIA 291
           M PE +   G N  A    D++S GI  IE+A
Sbjct: 166 MAPEVIQEIGYNNKA----DIWSLGITAIEMA 193

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 98.9 bits (246), Expect = 9e-24
 Identities = 60/211 (28%), Positives = 111/211 (52%), Gaps = 12/211 (5%)

Query: 90  IGDGSFGFVYKAKLSS------GVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVK 142
           +G+G+FG V+ A+  +       + VA+K L K+A +  R +F+ E E L  L+H++IV+
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTVLQHQHIVR 71

Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
             G C  G   ++++E++ +G L+++L     +  +    +  +   L+    + I   +
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTMG 261
           A+G+ YL  L    +HRD+ + N L+       I DFG++R I  T +  V  +    + 
Sbjct: 132 ASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           +MPPE +      T   D++SFG+++ EI T
Sbjct: 190 WMPPESILYRKFTTES-DIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 98.8 bits (247), Expect = 1e-23
 Identities = 67/227 (29%), Positives = 110/227 (48%), Gaps = 33/227 (14%)

Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE---FRA--EMETLGKLR 136
            +   K +G+G++  VYKA+   +G  VAIKK+     +  ++   F A  E++ L +L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS---RNDDVDGSKQ-LNSLCPLSW 192
           H NI+ +L       +  L++EF+E   L++ + D S      D+   K  +        
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADI---KSYMLMTL---- 112

Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
                       GL YLH     I+HRD+K +N+L+ SD    ++DFGLAR   + +  +
Sbjct: 113 -----------RGLEYLH--SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159

Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           + QV  T  Y  PE L G     V +D++S G +  E+  +  P LP
Sbjct: 160 THQVV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPFLP 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 97.4 bits (243), Expect = 3e-23
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 20/221 (9%)

Query: 82  DNFSTDKIIGDGSFGFVYK---AKLSSGV---TVAIKKL-DKDAFQGFREFRAEMETLGK 134
           +  +  + +G GSFG VY+     +  G     VAIK + +  + +   EF  E   + +
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65

Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
               ++V++LG  ++G   +++ E +  G L  +L       +         L P + + 
Sbjct: 66  FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAE-----NNPGLGPPTLQK 120

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVS 253
            +++   +A+G+AYL    K  +HRD+ + N ++  D    I DFG+ R I +T +    
Sbjct: 121 FIQMAAEIADGMAYLA--AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178

Query: 254 TQVAGTMGYMPPEYL--GGNTAATVMLDVYSFGILMIEIAT 292
            +    + +M PE L  G  T  +   DV+SFG+++ E+AT
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKS---DVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 96.5 bits (241), Expect = 5e-23
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 35/220 (15%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLD------KDAFQGFREFRAEMETLGKLRHRNI 140
           + IG GSFG V K +  S G  +  K++D      K+  Q   E       L +L+H NI
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNI----LRELKHPNI 61

Query: 141 VKILGYCASGLDR-----VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           V+   Y    +DR      ++ E+ E G L Q +    +               +  E  
Sbjct: 62  VR---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK-----------YIEEEFI 107

Query: 196 VKIVRGVANGLAYLHGLEKP---IIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
            +I+  +   L   H    P   ++HRD+K +N+ LD++    + DFGLA+ +    S  
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167

Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            T V GT  YM PE L   +      D++S G L+ E+  
Sbjct: 168 KTYV-GTPYYMSPEQLNHMSYDEKS-DIWSLGCLIYELCA 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 96.0 bits (239), Expect = 6e-23
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 29/210 (13%)

Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVKILGYCA 148
           IG G+FG VYK  L     VA+K          +  F  E E L +  H NIVK++G C 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 ++ E V  GSL  +L    +  +    K+L           +++    A G+ Y
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLR---KKKNRLTVKKL-----------LQMSLDAAAGMEY 108

Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP---- 264
           L    K  IHRD+ + N L+  +    ISDFG++R  +     VS      +  +P    
Sbjct: 109 LE--SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS----DGLKQIPIKWT 162

Query: 265 -PEYLGGNTAA-TVMLDVYSFGILMIEIAT 292
            PE L  N    T   DV+S+GIL+ E  +
Sbjct: 163 APEAL--NYGRYTSESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 96.3 bits (240), Expect = 6e-23
 Identities = 75/289 (25%), Positives = 119/289 (41%), Gaps = 49/289 (16%)

Query: 90  IGDGSFGFV----YKAKLSSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V    Y  K    V VA+K L ++    G +EF  E   + +L H  IV+++
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
           G C  G   +L+ E    G L ++L         D               +V      A 
Sbjct: 63  GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSD---------LKELAHQV------AM 106

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT--MGY 262
           G+AYL    K  +HRD+ + NVLL +  +A ISDFG++R +     +     AG   + +
Sbjct: 107 GMAYLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKW 164

Query: 263 MPPE--YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVV-LDGQEVGLLEWARTMEAR 319
             PE    G  ++ +   DV+S+G+ + E  +      P   + G EV            
Sbjct: 165 YAPECINYGKFSSKS---DVWSYGVTLWEAFS--YGAKPYGEMKGAEV------------ 207

Query: 320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLL 368
              I M++S   R    E   +E + I   C   +  +RP  S +    
Sbjct: 208 ---IAMLESG-ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 96.4 bits (240), Expect = 8e-23
 Identities = 65/225 (28%), Positives = 112/225 (49%), Gaps = 36/225 (16%)

Query: 88  KIIGDGSFGFVYKA-KLSSGVTVAIKKL---------DKDAFQGFRE-FRAEMETLGKLR 136
           ++IG G++G VY A  +++G  +A+K++              +   +  R+E+ETL  L 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIV+ LG+  +     +  E+V  GS+   L    R +                E  V
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFE----------------EQLV 110

Query: 197 K-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS-T 254
           +     V  GLAYLH   K I+HRD+K+ N+L+D+D    ISDFG++++ D  + +    
Sbjct: 111 RFFTEQVLEGLAYLH--SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM 168

Query: 255 QVAGTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
            + G++ +M PE +       +A V  D++S G +++E+    RP
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKV--DIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 76/293 (25%), Positives = 121/293 (41%), Gaps = 46/293 (15%)

Query: 84  FSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKI 143
              ++ +G G FG V+    +    VA+K L K        F  E + + KLRH  +V++
Sbjct: 8   LKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQL 66

Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQ-LNSLCPLSWETRVKIVRGV 202
              C+      ++ E++  GSL  +L         +G K  L  L        V +   +
Sbjct: 67  YAVCSEEEPIYIVTEYMSKGSLLDFLKSG------EGKKLRLPQL--------VDMAAQI 112

Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
           A G+AYL    +  IHRD+ + N+L+  +    I+DFGLAR I+             + +
Sbjct: 113 AEGMAYLE--SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKW 170

Query: 263 MPPEYLGGNTAA-----TVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME 317
             PE      AA     T+  DV+SFGIL+ EI T  R   P  +  +EV          
Sbjct: 171 TAPE------AANYGRFTIKSDVWSFGILLTEIVTYGRVPYP-GMTNREV---------- 213

Query: 318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                +E V+    R         E + +   C ++   ERP   Y+   L++
Sbjct: 214 -----LEQVERGY-RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 95.7 bits (239), Expect = 2e-22
 Identities = 67/243 (27%), Positives = 95/243 (39%), Gaps = 58/243 (23%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDK----------DAFQGFREFRAEME 130
           D+F   KIIG+GSF  V  AK   +    AIK LDK                     E E
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI-------EKE 53

Query: 131 TLGKL-RHRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLC 188
            L +L  H  I+K L Y     + +  + E+  NG L Q++                   
Sbjct: 54  VLTRLNGHPGIIK-LYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-------------- 98

Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
            L  +        +   L YLH   K IIHRD+K  N+LLD D    I+DFG A+ +D +
Sbjct: 99  -LDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155

Query: 249 HSHVSTQVA-------------------GTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
            S  S +                     GT  Y+ PE L    A     D+++ G ++ +
Sbjct: 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSS-DLWALGCIIYQ 214

Query: 290 IAT 292
           + T
Sbjct: 215 MLT 217

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 23/207 (11%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHRNIVKILGY 146
           +G G+ G V K     +G  +A+K  +L+ +     ++   E++ L K     IV   G 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
             +  D  +  E+++ GSLD+ L +           ++     L      KI   V  GL
Sbjct: 68  FYNNGDISICMEYMDGGSLDKILKE--------VQGRIPER-ILG-----KIAVAVLKGL 113

Query: 207 AYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE 266
            YLH   K IIHRD+K SN+L++S  +  + DFG++ ++  S   ++    GT  YM PE
Sbjct: 114 TYLHEKHK-IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYMAPE 169

Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQ 293
            + GN   +V  D++S G+ +IE+AT 
Sbjct: 170 RIQGND-YSVKSDIWSLGLSLIELATG 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 94.9 bits (236), Expect = 2e-22
 Identities = 70/243 (28%), Positives = 120/243 (49%), Gaps = 23/243 (9%)

Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLR 136
           ++ TD     K+ G G +G VY+       +TVA+K L +D  +   EF  E   + +++
Sbjct: 3   MERTDITMKHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 60

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H N+V++LG C       +I EF+  G+L  +L + +R       +++N++  L   T+ 
Sbjct: 61  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-------QEVNAVVLLYMATQ- 112

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVST 254
                +++ + YL   +K  IHRD+ + N L+  +    ++DFGL+R    DT  +H   
Sbjct: 113 -----ISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 165

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR 314
           +    + +  PE L  N  +    DV++FG+L+ EIAT      P +   Q   LLE   
Sbjct: 166 KFP--IKWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY 222

Query: 315 TME 317
            ME
Sbjct: 223 RME 225

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 94.5 bits (235), Expect = 3e-22
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 31/226 (13%)

Query: 84  FSTDKIIGDGSFGFVYKAKLS----SGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRH 137
               KI+G+G FG V + +LS    S + VA+K  KLD   +    EF +E   +    H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 138 RNIVKILGYCASGLDR------VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
            N++K++G C            ++I  F+++G L  +L   SR       ++L    PL 
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGG--LPEKL----PL- 112

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
            +T +K +  +A G+ YL    +  IHRD+ + N +L  D    ++DFGL+++I +   +
Sbjct: 113 -QTLLKFMVDIALGMEYLS--NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYY 169

Query: 252 VSTQVAGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIATQ 293
              ++A     MP +++   + A    T   DV++FG+ M EIAT+
Sbjct: 170 RQGRIAK----MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.3 bits (235), Expect = 3e-22
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYC 147
           IG G+   VY A  L +   VAIK++D +  Q    E R E++ + +  H N+VK   Y 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY--YT 66

Query: 148 ASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
           +  +   L  +  ++  GSL            +D  K       L       +++ V  G
Sbjct: 67  SFVVGDELWLVMPYLSGGSL------------LDIMKSSYPRGGLDEAIIATVLKEVLKG 114

Query: 206 LAYLH--GLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT---SHSHVSTQVAGTM 260
           L YLH  G     IHRDIK+ N+LL  D    I+DFG++  +         V     GT 
Sbjct: 115 LEYLHSNGQ----IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170

Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +M PE +          D++SFGI  IE+AT
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELAT 202

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 93.7 bits (234), Expect = 4e-22
 Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 33/216 (15%)

Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKD---AFQGFREFRAEMETLGKLRHRNIVKILG 145
           +G GSFG V    K  +G   A+K L K      +       E   L ++ H  IVK+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58

Query: 146 YCA--SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK-IVRGV 202
           + A  +     L+ E+   G L                  L+     S E R +     +
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGEL---------------FSHLSKEGRFS-EERARFYAAEI 102

Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
              L YLH     II+RD+K  N+LLD+D    ++DFGLA+ + +  S  +T   GT  Y
Sbjct: 103 VLALEYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEY 159

Query: 263 MPPEYL--GGNTAATVMLDVYSFGILMIEIATQIRP 296
           + PE L   G   A   +D +S G+L+ E+ T   P
Sbjct: 160 LAPEVLLGKGYGKA---VDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 94.3 bits (234), Expect = 6e-22
 Identities = 81/315 (25%), Positives = 139/315 (44%), Gaps = 53/315 (16%)

Query: 83  NFSTDKIIGDGSFGFVYKAK------LSSGVTVAIKKLDKDAFQG-FREFRAEMETLGKL 135
           N    K +G+G FG V KA        +   TVA+K L ++A     R+  +E   L ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH------------DTSRN---DDVDG 180
            H +++K+ G C+     +LI E+ + GSL  +L             D +RN    D   
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 181 SKQLN--SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD 238
            + L    L   +W+        ++ G+ YL   E  ++HRD+ + NVL+    +  ISD
Sbjct: 121 ERALTMGDLISFAWQ--------ISRGMQYLA--EMKLVHRDLAARNVLVAEGRKMKISD 170

Query: 239 FGLARRIDTSHSHVS-TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN 297
           FGL+R +    S+V  ++    + +M  E L  +   T   DV+SFG+L+ EI T     
Sbjct: 171 FGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP 229

Query: 298 LPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRE 357
            P +   +   LL+    ME               E  SE    E + +   C  ++  +
Sbjct: 230 YPGIAPERLFNLLKTGYRME-------------RPENCSE----EMYNLMLTCWKQEPDK 272

Query: 358 RPAMSYVVQLLDELV 372
           RP  + + + L++++
Sbjct: 273 RPTFADISKELEKMM 287

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 93.8 bits (233), Expect = 6e-22
 Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 28/214 (13%)

Query: 87  DKIIGDGSFGFVYKAKLSSG----VTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNI 140
           +++IG G FG V + +L       + VAIK L K  +  +  R+F +E   +G+  H NI
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           + + G        ++I EF+ENG+LD +L    +ND      QL           V ++R
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQL-----------VGMLR 113

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
           G+A G+ YL   E   +HRD+ + N+L++S+    +SDFGL+R ++   S   T  +   
Sbjct: 114 GIAAGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD-PTYTSSLG 170

Query: 261 GYMPPEYLGGNTAA----TVMLDVYSFGILMIEI 290
           G +P  +      A    T   DV+S+GI+M E+
Sbjct: 171 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 92.8 bits (231), Expect = 1e-21
 Identities = 77/300 (25%), Positives = 124/300 (41%), Gaps = 57/300 (19%)

Query: 88  KIIGDGSFGFVYKAKLSSG----VTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVK 142
           K +GDGSFG V + + S+     + VA+K L  D       +F  E   +  L H N+++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 143 ILGYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           + G     L    +++ E    GSL   L       D  G   +++LC  + +       
Sbjct: 61  LYGVV---LTHPLMMVTELAPLGSLLDRLRK-----DALGHFLISTLCDYAVQ------- 105

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +ANG+ YL    K  IHRD+ + N+LL SD +  I DFGL R +  +  H   +    +
Sbjct: 106 -IANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162

Query: 261 --GYMPPEYL--GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE--VGLLEWAR 314
              +  PE L     + A+   DV+ FG+ + E+ T           G+E   GL     
Sbjct: 163 PFAWCAPESLRTRTFSHAS---DVWMFGVTLWEMFTY----------GEEPWAGL----- 204

Query: 315 TMEARNKEI-EMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA 373
                  +I + +D    R E  EA  ++ + +   C      +RP       L + L  
Sbjct: 205 ----SGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTF---AALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 92.3 bits (229), Expect = 2e-21
 Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 29/216 (13%)

Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKL-----DKDAFQG-FREFRAEMETLGKLRHRNIV 141
           +++G G++G VY    + G  +A+K++     +  A +  + + + E++ L  L+H NIV
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           + LG C       +  EFV  GS+               S  LN   PL      K  + 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSI---------------SSILNRFGPLPEPVFCKYTKQ 110

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-----DTSHSHVSTQV 256
           + +G+AYLH     ++HRDIK +NV+L  +    + DFG ARR+       +HS++   +
Sbjct: 111 ILDGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            GT  +M PE +   +      D++S G  + E+AT
Sbjct: 169 HGTPYWMAPEVI-NESGYGRKSDIWSIGCTVFEMAT 203

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 26/210 (12%)

Query: 89  IIGDGSFGFVYKAK-LSSGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRH---RNIVK 142
           +IG G++G VY+ K + +G  VA+K   LD        + + E+  L +LR     NI K
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQPPNITK 66

Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
             G    G    +I E+ E GS+                + L    P++ +    I+R V
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSV----------------RTLMKAGPIAEKYISVIIREV 110

Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
              L Y+H  +  +IHRDIK++N+L+ +     + DFG+A  ++ + S  ST V GT  +
Sbjct: 111 LVALKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYW 167

Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           M PE +          D++S GI + E+AT
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 13/212 (6%)

Query: 90  IGDGSFGFVYKAK------LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKI 143
           +G+G+FG V+ A+          + VA+K L        ++F+ E E L  L+H +IVK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 144 LGYCASGLDRVLIYEFVENGSLDQWL--HDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            G C  G   ++++E++++G L+++L  H       VDG +   +   L     + I   
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG-QPRQAKGELGLSQMLHIASQ 131

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTM 260
           +A+G+ YL    +  +HRD+ + N L+ ++    I DFG++R +  T +  V       +
Sbjct: 132 IASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +MPPE +      T   DV+SFG+++ EI T
Sbjct: 190 RWMPPESIMYRKFTTES-DVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 93.0 bits (232), Expect = 3e-21
 Identities = 70/232 (30%), Positives = 104/232 (44%), Gaps = 49/232 (21%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKL---DKDAFQGFREFRAEMETLGKLRHRNIVKI 143
           K IG G++G V  A    +G  VAIKK+     D     R  R E++ L  LRH NI+ +
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGL 64

Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDV---------DGSKQLNSLCPLSWET 194
           L         +L                    +DV         D  K + S  PL+ + 
Sbjct: 65  L--------DILRPP------------SPEDFNDVYIVTELMETDLHKVIKSPQPLT-DD 103

Query: 195 RVK-----IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSH 249
            ++     I+RG    L YLH     +IHRD+K SN+L++S+ +  I DFGLAR +D   
Sbjct: 104 HIQYFLYQILRG----LKYLH--SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157

Query: 250 SHVS--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
                 T+   T  Y  PE L  ++  T  +D++S G +  E+ T+ +P  P
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPLFP 208

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 91.6 bits (228), Expect = 3e-21
 Identities = 66/220 (30%), Positives = 104/220 (47%), Gaps = 35/220 (15%)

Query: 90  IGDGSFGFVYKA-KLSSGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHRNIVKILGY 146
           IG G+FG VY A  L +G  +A+K  ++  +  +  +E   EM+ L  L+H N+VK  G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG- 66

Query: 147 CASGLDRVLIY-EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN- 204
                ++V I+ E+   G+L++ L    R  D                    ++R     
Sbjct: 67  VEVHREKVYIFMEYCSGGTLEELLEHG-RILDE------------------HVIRVYTLQ 107

Query: 205 ---GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
              GLAYLH     I+HRDIK +N+ LD +    + DFG A ++  + + +  +V    G
Sbjct: 108 LLEGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165

Query: 262 ---YMPPE-YLGGNTAATV-MLDVYSFGILMIEIATQIRP 296
              YM PE   GG         D++S G +++E+AT  RP
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 91.1 bits (226), Expect = 5e-21
 Identities = 68/223 (30%), Positives = 115/223 (51%), Gaps = 31/223 (13%)

Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAF--QGFREFRAEMET 131
           IDA+     +K+IG G FG V   +L       + VAIK L K  +  +  R+F +E   
Sbjct: 1   IDAS-CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFLSEASI 58

Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           +G+  H NI+ + G        +++ E++ENGSLD +L    ++D      QL       
Sbjct: 59  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQL------- 108

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
               V ++RG+A+G+ YL  +    +HRD+ + N+L++S+    +SDFGL+R ++     
Sbjct: 109 ----VGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162

Query: 252 VSTQVAGTMG--YMPPEYLGGN--TAATVMLDVYSFGILMIEI 290
             T   G +   +  PE +     T+A+   DV+S+GI+M E+
Sbjct: 163 AYTTRGGKIPIRWTAPEAIAYRKFTSAS---DVWSYGIVMWEV 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 91.1 bits (227), Expect = 8e-21
 Identities = 72/218 (33%), Positives = 116/218 (53%), Gaps = 41/218 (18%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKL--DKDAFQGF-----REFRAEMETLGKLRHRNIV 141
           I +G++G VY+A+   +G  VA+KKL  +K+  +GF     RE       L KL+H NIV
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREI----NILLKLQHPNIV 67

Query: 142 KI----LGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
            +    +G   S LD++ ++ E+VE        HD      ++  KQ     P   ++ V
Sbjct: 68  TVKEVVVG---SNLDKIYMVMEYVE--------HDL--KSLMETMKQ-----PFL-QSEV 108

Query: 197 K-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           K ++  + +G+A+LH  +  I+HRD+K+SN+LL++     I DFGLAR    S     TQ
Sbjct: 109 KCLMLQLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQ 165

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           +  T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.3 bits (224), Expect = 8e-21
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 26/222 (11%)

Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKK-----LDKDAFQGFREFRAEMETLGKLR 136
           N+   K++G G+FG VY    + +G  +A+K+        +  +       E++ L  L+
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H  IV+  G         +  E++  GS+     D           QL +   L+     
Sbjct: 63  HERIVQYYGCLRDDETLSIFMEYMPGGSV----KD-----------QLKAYGALTETVTR 107

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS--T 254
           K  R +  G+ YLH     I+HRDIK +N+L DS     + DFG ++R+ T  S  +   
Sbjct: 108 KYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK 165

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
            V GT  +M PE + G        DV+S G  ++E+ T+  P
Sbjct: 166 SVTGTPYWMSPEVISGEGYGR-KADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 91.0 bits (226), Expect = 9e-21
 Identities = 78/248 (31%), Positives = 118/248 (47%), Gaps = 44/248 (17%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKK--LDKDAFQGF--REFRAEMETLGKLR 136
           D F     IG+G++G VYKA+   +G  VA+KK  LD +  +GF     R E++ L +L 
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIR-EIKILRQLN 64

Query: 137 HRNIVKILGYCASGLDRV----------LIYEFVEN---GSLDQWLHDTSRNDDVDGSKQ 183
           HRNIV +        D +          L++E++++   G L+  L   S +      KQ
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQ 124

Query: 184 LNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR 243
           L                    GL Y H  +K  +HRDIK SN+LL++  +  ++DFGLAR
Sbjct: 125 L------------------LEGLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164

Query: 244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD 303
             ++  S   T    T+ Y PPE L G       +DV+S G ++ E+ T+     P+   
Sbjct: 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK----KPIFQA 220

Query: 304 GQEVGLLE 311
            QE+  LE
Sbjct: 221 NQELAQLE 228

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 90.9 bits (225), Expect = 1e-20
 Identities = 72/235 (30%), Positives = 115/235 (48%), Gaps = 20/235 (8%)

Query: 82  DNFSTDKIIGDGSFGFVY--------KAKLSSGVTVAIKKLDKDAFQ-GFREFRAEMETL 132
           D  +  K +G+G FG V         K K    VTVA+K L  DA +    +  +EME +
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 133 GKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLC--P 189
             + +H+NI+ +LG C       +I E+   G+L ++L    R   ++ S  +  +    
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYSYDIARVPDEQ 133

Query: 190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT-S 248
           ++++  V     VA G+ YL    +  IHRD+ + NVL+  +    I+DFGLAR ++   
Sbjct: 134 MTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191

Query: 249 HSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT---QIRPNLPV 300
           +   +T     + +M PE L  +   T   DV+SFG+LM EI T      P +PV
Sbjct: 192 YYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 89.9 bits (223), Expect = 1e-20
 Identities = 68/214 (31%), Positives = 105/214 (49%), Gaps = 32/214 (14%)

Query: 89  IIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           ++G G++G VY A+ LS+ V +AIK++ +   +  +    E+     L+HRNIV+ LG  
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 148 ASGLDRVLIY-EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW--ETRVKIVRGVAN 204
           +       I+ E V  GSL   L           SK      PL    +T +   + +  
Sbjct: 75  SEN-GFFKIFMEQVPGGSLSALLR----------SK----WGPLKDNEQTIIFYTKQILE 119

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDS-DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYM 263
           GL YLH  +  I+HRDIK  NVL+++      ISDFG ++R+   +    T   GT+ YM
Sbjct: 120 GLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYM 176

Query: 264 PPEYL-----GGNTAATVMLDVYSFGILMIEIAT 292
            PE +     G    A    D++S G  ++E+AT
Sbjct: 177 APEVIDKGPRGYGAPA----DIWSLGCTIVEMAT 206

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 89.5 bits (222), Expect = 1e-20
 Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 34/217 (15%)

Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLD------KDAFQGFREFRAEMETLGKLRHRNIVK 142
           IG GSFG V+K  + +     A+K++D      ++  +   E R     L KL    I++
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR----VLAKLDSSYIIR 63

Query: 143 ILGYCASGLDRVLIY---EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
              Y  S LD+  +    E+ ENG L + L             Q     PL  +   +  
Sbjct: 64  ---YYESFLDKGKLNIVMEYAENGDLHKLLK-----------MQRGR--PLPEDQVWRFF 107

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             +  GLA+LH   K I+HRDIKS N+ LD+     I D G+A+ +  + +  +T V GT
Sbjct: 108 IQILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GT 164

Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             Y+ PE L  +       DV++ G+++ E  T   P
Sbjct: 165 PYYLSPE-LCEDKPYNEKSDVWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 90.4 bits (224), Expect = 2e-20
 Identities = 74/236 (31%), Positives = 113/236 (47%), Gaps = 22/236 (9%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL--------SSGVTVAIKKLDKDAF-QGFREFRAEMETL 132
           D     K +G+G FG V +A+            VTVA+K L  +A  +   +  +EME +
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 133 GKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH---DTSRNDDVDGSKQLNSLC 188
             + +H+NI+ +LG C       +I E+   G+L ++L        +   D +K      
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-- 129

Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DT 247
            LS++  V     VA G+ YL    +  IHRD+ + NVL+  D    I+DFGLAR + D 
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187

Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT---QIRPNLPV 300
            +   ++     + +M PE L  +   T   DV+SFGILM EI T      P +PV
Sbjct: 188 DYYKKTSNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 89.9 bits (223), Expect = 3e-20
 Identities = 86/303 (28%), Positives = 131/303 (43%), Gaps = 47/303 (15%)

Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +N S  K +G G+FG V +A      K  + + VA+K L   A    RE   +E++ +  
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           L  H NIV +LG C  G   ++I E+   G L  +L    R  +   +  L  L   S++
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR---RKRESFLT--LEDLLSFSYQ 149

Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
                   VA G+A+L    K  IHRD+ + NVLL       I DFGLAR I    ++V 
Sbjct: 150 --------VAKGMAFLA--SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV 199

Query: 254 TQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT---QIRPNLPVVLDGQEVGL 309
              A   + +M PE +      T   DV+S+GIL+ EI +      P +PV         
Sbjct: 200 KGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPV--------- 249

Query: 310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD 369
                     +K  +++     R    E    E + I   C +    +RP    +VQL+ 
Sbjct: 250 ---------DSKFYKLIKEGY-RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299

Query: 370 ELV 372
           + +
Sbjct: 300 KQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 89.4 bits (221), Expect = 3e-20
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 12/217 (5%)

Query: 83  NFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR 136
           N    + +G+G+FG V+ A+          + VA+K L   +    ++F  E E L  L+
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H +IVK  G C  G   ++++E++++G L+++L   +   D     + N    L+    +
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLR--AHGPDAVLMAEGNRPAELTQSQML 123

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQ 255
            I + +A G+ YL    +  +HRD+ + N L+  +    I DFG++R +  T +  V   
Sbjct: 124 HIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
               + +MPPE +      T   DV+S G+++ EI T
Sbjct: 182 TMLPIRWMPPESIMYRKFTTES-DVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 88.4 bits (219), Expect = 4e-20
 Identities = 72/219 (32%), Positives = 100/219 (45%), Gaps = 25/219 (11%)

Query: 88  KIIGDGSFGFVYKAKL------SSG-VTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRN 139
             +G G+FG VY+          SG + VA+K L K A  Q  +EF  E   +    H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IVK+LG C     + +I E +E G L  +L         D   +      L+ +  + I 
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLR--------DARVERFGPPLLTLKELLDIC 112

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLL-----DSDFEAHISDFGLARRIDTS-HSHVS 253
             VA G  YL  +    IHRD+ + N L+     D+D    I DFGLAR I  S +    
Sbjct: 113 LDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170

Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +    + +M PE L  +   T   DV+SFG+LM EI T
Sbjct: 171 GEGLLPVRWMAPESL-LDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 87.9 bits (218), Expect = 7e-20
 Identities = 68/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)

Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAF-QGFREFRAEMETL 132
             D+ +  + +G G+FG VY+            + VA+K L +    Q   +F  E   +
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            K  H+NIV+++G     L R ++ E +  G L  +L + +R      S        L+ 
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRE-NRPRPERPS-------SLTM 115

Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHISDFGLARRI-DTS 248
           +  +   R VA G  YL   E   IHRDI + N LL        A I+DFG+AR I   S
Sbjct: 116 KDLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS 173

Query: 249 HSHVSTQVAGTMGYMPPE-YLGGNTAATVMLDVYSFGILMIEI 290
           +     +    + +MPPE +L G    T   DV+SFG+L+ EI
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.9 bits (218), Expect = 8e-20
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 25/213 (11%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +GDG+FG VYKA+   +G+  A K +  ++ +   +F  E++ L + +H NIV +     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV-RGVANGLA 207
                 ++ EF + G+LD  + +  R               L+ E +++ V R +   L 
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELER--------------GLT-EPQIRYVCRQMLEALN 117

Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           +LH     +IHRD+K+ N+LL  D +  ++DFG++ +  ++     T + GT  +M PE 
Sbjct: 118 FLH--SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEV 174

Query: 268 LGGNT----AATVMLDVYSFGILMIEIATQIRP 296
           +   T          D++S GI +IE+A Q+ P
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELA-QMEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 87.6 bits (217), Expect = 8e-20
 Identities = 71/225 (31%), Positives = 115/225 (51%), Gaps = 37/225 (16%)

Query: 89  IIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFR---------AEMETLGKLRHR 138
           +IG GSFG VY     SSG  +A+K+++  +     + R          E+  L +L+H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 139 NIVKILGYCASGLDRVLIY-EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           NIV+ LG  +   D + I+ E+V  GS+   L       +  G+ +         ET V+
Sbjct: 67  NIVQYLG-SSLDADHLNIFLEYVPGGSVAALL-------NNYGAFE---------ETLVR 109

Query: 198 -IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
             VR +  GL YLH   + IIHRDIK +N+L+D+     ISDFG++++++ +     T  
Sbjct: 110 NFVRQILKGLNYLH--NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG 167

Query: 257 A-----GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           A     G++ +M PE +   T+ T   D++S G L++E+ T   P
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 69/222 (31%), Positives = 113/222 (50%), Gaps = 21/222 (9%)

Query: 82  DNFSTDKIIGDGSFGFVYKA---KLSSGVTVAIKKLDKDAFQG-FREFRAEMETLGKL-R 136
           ++   + +IG+G+FG V +A   K    +  AIK L + A +   R+F  E+E L KL  
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS--KQLNSLCPLSWET 194
           H NI+ +LG C +     +  E+   G+L  +L   SR  + D +  K+  +   L+ + 
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLR-KSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
            ++    VA G+ YL   EK  IHRD+ + NVL+  +  + I+DFGL+R  +        
Sbjct: 121 LLQFASDVATGMQYLS--EKQFIHRDLAARNVLVGENLASKIADFGLSRGEE-------V 171

Query: 255 QVAGTMGYMPPEYLG----GNTAATVMLDVYSFGILMIEIAT 292
            V  TMG +P  ++       +  T   DV+SFG+L+ EI +
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 1e-19
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)

Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH 137
           ID ++  +  K +G G FG V+  K    + VAIK + + A     +F  E + + KL H
Sbjct: 1   IDPSE-LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSH 58

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            N+V++ G C       ++ E++ NG L  +L          G++ L  +C         
Sbjct: 59  PNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMC--------- 106

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
               V   + YL       IHRD+ + N L+  D    +SDFGLAR +       S    
Sbjct: 107 --SDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK 162

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
             + + PPE    +  ++   DV+SFG+LM E+ +
Sbjct: 163 FPVKWAPPEVFDYSRFSSKS-DVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 1e-19
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 17/203 (8%)

Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V++   ++   VA+K L        ++F AE + + KLRH  ++++   C  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E ++ GSL ++L            + L           + +   VA+G+AYL
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQG-------GAGRALK------LPQLIDMAAQVASGMAYL 119

Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG 269
               +  IHRD+ + NVL+  +    ++DFGLAR I              + +  PE   
Sbjct: 120 E--AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL 177

Query: 270 GNTAATVMLDVYSFGILMIEIAT 292
            N   ++  DV+SFGIL+ EI T
Sbjct: 178 YN-RFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 87.3 bits (216), Expect = 1e-19
 Identities = 79/309 (25%), Positives = 126/309 (40%), Gaps = 62/309 (20%)

Query: 88  KIIGDGSFGFV--YK---AKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIV 141
           +++G+G FG V  Y    A   +G  VA+K L ++  Q     ++ E+  L  L H NIV
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 142 KILGYCASGLDRV--LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           K  G C+    +   LI E+V  GSL  +L                    L+    +   
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----------------LNLAQLLLFA 113

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH--VSTQVA 257
           + +  G+AYLH   +  IHRD+ + NVLLD+D    I DFGLA+ +   H +  V     
Sbjct: 114 QQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME 317
             + +   E L  N  +    DV+SFG+ + E+ T                         
Sbjct: 172 SPVFWYAVECLKENKFSYAS-DVWSFGVTLYELLTHCDSKQ------------------S 212

Query: 318 ARNKEIEMVD------SNISREELSEAGVR---------EYFRIACMCTNEKSRERPAMS 362
              K  EM+       + +   EL E G+R         E + +   C   +++ RP   
Sbjct: 213 PPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272

Query: 363 YVVQLLDEL 371
            ++ +L E+
Sbjct: 273 SLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 70/217 (32%), Positives = 108/217 (49%), Gaps = 38/217 (17%)

Query: 89  IIGDGSFGFVYKAK-LSSGVTVAIKK----LDKDAFQGF--REFRAEMETLGKLRHRNIV 141
            IG+G++G VYKA+ L++G  VA+KK    L ++       RE  A ++ L    H NIV
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLESFEHPNIV 64

Query: 142 KILGYCA-----SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP---LSWE 193
           ++L  C        L   L++E V     DQ L                  CP   L  E
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSK------------CPKPGLPPE 107

Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
           T   ++R +  G+ +LH     I+HRD+K  N+L+ SD +  I+DFGLA RI +    ++
Sbjct: 108 TIKDLMRQLLRGVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADFGLA-RIYSFEMALT 164

Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + V  T+ Y  PE L  ++ AT  +D++S G +  E+
Sbjct: 165 SVVV-TLWYRAPEVLLQSSYATP-VDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 67/215 (31%), Positives = 112/215 (52%), Gaps = 21/215 (9%)

Query: 89  IIGDGSFGFVYKAKLSSG---VTVAIKKLDKDAFQG-FREFRAEMETLGKL-RHRNIVKI 143
           +IG+G+FG V KA++      +  AIK++ + A +   R+F  E+E L KL  H NI+ +
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL--NSLCPLSWETRVKIVRG 201
           LG C       L  E+  +G+L  +L   SR  + D +  +  ++   LS +  +     
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           VA G+ YL   +K  IHRD+ + N+L+  ++ A I+DFGL+R  +         V  TMG
Sbjct: 133 VARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTMG 183

Query: 262 YMPPEYLG----GNTAATVMLDVYSFGILMIEIAT 292
            +P  ++       +  T   DV+S+G+L+ EI +
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 86.5 bits (214), Expect = 2e-19
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 18/206 (8%)

Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG G FG V+         VAIK + ++      +F  E + + KL H  +V++ G C  
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                L++EF+E+G L  +L    R                S ET + +   V  G+AYL
Sbjct: 71  RSPICLVFEFMEHGCLSDYLR-AQRGK-------------FSQETLLGMCLDVCEGMAYL 116

Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG 269
                 +IHRD+ + N L+  +    +SDFG+ R +       ST     + +  PE   
Sbjct: 117 E--SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFS 174

Query: 270 GNTAATVMLDVYSFGILMIEIATQIR 295
            +  ++   DV+SFG+LM E+ ++ +
Sbjct: 175 FSKYSSKS-DVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 86.5 bits (214), Expect = 2e-19
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 29/225 (12%)

Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKL------DKDAFQGFREFRAEMETLGKL 135
            +   + +G G+F   Y+A+ + +G  +A+K++        +  +     R E+  + +L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
            H +I+++LG         L  E++  GS+   L                          
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---------------AFKEAVI 105

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE-AHISDFGLARRID---TSHSH 251
           +     +  GL+YLH  E  IIHRD+K +N+L+DS  +   I+DFG A R+    T    
Sbjct: 106 INYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163

Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
              Q+ GT+ +M PE L G        DV+S G ++IE+AT   P
Sbjct: 164 FQGQLLGTIAFMAPEVLRGEQYGR-SCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 86.4 bits (214), Expect = 2e-19
 Identities = 80/291 (27%), Positives = 129/291 (44%), Gaps = 39/291 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +     K +G G FG V+    +    VAIK L K        F AE   + +L+H  +V
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64

Query: 142 KILGYCASGLDRVLIY-EFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIV 199
           ++  Y     + + I  E++ENGSL  +L         +G K  +N L  ++ +      
Sbjct: 65  RL--YAVVTQEPIYIITEYMENGSLVDFLKTP------EGIKLTINKLIDMAAQ------ 110

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             +A G+A++    K  IHRD++++N+L+       I+DFGLAR I+ +           
Sbjct: 111 --IAEGMAFIE--RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP 166

Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR 319
           + +  PE +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE        
Sbjct: 167 IKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-------- 217

Query: 320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
            +   M   +   EEL E            C  EK  ERP   Y+  +L++
Sbjct: 218 -RGYRMPRPDNCPEELYELMRL--------CWKEKPEERPTFEYLRSVLED 259

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 86.2 bits (213), Expect = 2e-19
 Identities = 76/284 (26%), Positives = 121/284 (42%), Gaps = 34/284 (11%)

Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           K +G G FG V+    ++   VA+K L K      + F  E   +  L+H  +V++    
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  +I E++  GSL  +L       D  G   L  L   S +        +A G+A
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFL-----KSDEGGKVLLPKLIDFSAQ--------IAEGMA 117

Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           Y+    K  IHRD++++NVL+       I+DFGLAR I+ +           + +  PE 
Sbjct: 118 YIE--RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175

Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +   +  T+  DV+SFGIL+ EI T  +   P + +         +  M A  +   M  
Sbjct: 176 INFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSN---------SDVMSALQRGYRMPR 225

Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
                +EL        + I   C  EK+ ERP   Y+  +LD+ 
Sbjct: 226 MENCPDEL--------YDIMKTCWKEKAEERPTFDYLQSVLDDF 261

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 60/216 (27%), Positives = 91/216 (42%), Gaps = 25/216 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKL----DKDAFQGFREFRAEMETLGKLRH 137
           +       +G+G+ G V K +L +   +   K          Q  ++   E+E     + 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKS 58

Query: 138 RNIVKILGYCASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
             IVK  G         +    E+ E GSLD       +     G K L           
Sbjct: 59  PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG---------- 108

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
            KI   V  GL+YLH   + IIHRDIK SN+LL    +  + DFG++  +  S +   T 
Sbjct: 109 -KIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT- 164

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
             GT  YM PE + G    ++  DV+S G+ ++E+A
Sbjct: 165 --GTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVA 197

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.1 bits (214), Expect = 3e-19
 Identities = 71/217 (32%), Positives = 103/217 (47%), Gaps = 36/217 (16%)

Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           IG GSFG VYKA    +   VAIK +D ++A     + + E++ L + R   I K   Y 
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK---YY 65

Query: 148 ASGLDRV---LIYEFVENGS-LDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA 203
            S L      +I E+   GS LD                 L     L       I+R V 
Sbjct: 66  GSFLKGSKLWIIMEYCGGGSCLD-----------------LLKPGKLDETYIAFILREVL 108

Query: 204 NGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYM 263
            GL YLH   K  IHRDIK++N+LL  + +  ++DFG++ ++ ++ S  +T V GT  +M
Sbjct: 109 LGLEYLHEEGK--IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWM 165

Query: 264 PPEYL---GGNTAATVMLDVYSFGILMIEIATQIRPN 297
            PE +   G +  A    D++S GI  IE+A    P 
Sbjct: 166 APEVIKQSGYDEKA----DIWSLGITAIELAKGEPPL 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 30/219 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKL-----DKDAFQ-GFREFRAEMETLGK 134
           + +    ++G+G++G V K +  ++G  VAIKK      D+D  +   RE +     L +
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVK----VLRQ 56

Query: 135 LRHRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           LRH NIV +         R+ L++E+VE   L+    + S                L  +
Sbjct: 57  LRHENIVNLKEAFRRK-GRLYLVFEYVERTLLELL--EASPGG-------------LPPD 100

Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
                +  +   +AY H     IIHRDIK  N+L+       + DFG AR +    +   
Sbjct: 101 AVRSYIWQLLQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158

Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           T    T  Y  PE L G+T     +DV++ G +M E+  
Sbjct: 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 85.7 bits (213), Expect = 5e-19
 Identities = 71/227 (31%), Positives = 108/227 (47%), Gaps = 52/227 (22%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA--EMETLGKL-RHRNIVKI 143
           K +GDG+FG VY A+   +G  VAIKK+ K  F  + E     E+++L KL  H NIVK+
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKL 63

Query: 144 LGYCASGLDRVLIYE-FVENGSL-------DQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
                         E F EN  L       +  L+   ++             P S E+ 
Sbjct: 64  -------------KEVFRENDELYFVFEYMEGNLYQLMKDRKGK---------PFS-ESV 100

Query: 196 VK-IVRGVANGLAYLH--GLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSH--- 249
           ++ I+  +  GLA++H  G      HRD+K  N+L+       I+DFGLAR I +     
Sbjct: 101 IRSIIYQILQGLAHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156

Query: 250 SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
            +VST+      Y  PE L  +T+ +  +D+++ G +M E+ T  RP
Sbjct: 157 DYVSTR-----WYRAPEILLRSTSYSSPVDIWALGCIMAELYTL-RP 197

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.4 bits (212), Expect = 5e-19
 Identities = 64/222 (28%), Positives = 94/222 (42%), Gaps = 32/222 (14%)

Query: 83  NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHR 138
           +F   ++IG G+FG V   +   +    A+K ++K         R    E   L +L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 139 NIVKILGYCASGLDRVLIYEFVE--NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
            +V +     S  D   +Y  V+   G  D   H             L+     S E +V
Sbjct: 61  FLVNL---WYSFQDEENMYLVVDLLLGG-DLRYH-------------LSQKVKFS-EEQV 102

Query: 197 KI-VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           K  +  +   L YLH   K IIHRDIK  N+LLD     HI+DF +A ++  +   ++T 
Sbjct: 103 KFWICEIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTS 158

Query: 256 VAGTMGYMPPE-YLGGNTAATVMLDVYSFGILMIEIATQIRP 296
            +GT GYM PE       +  V  D +S G+   E     RP
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAV--DWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 85.5 bits (211), Expect = 6e-19
 Identities = 69/214 (32%), Positives = 104/214 (48%), Gaps = 27/214 (12%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILG-YC 147
           +GDG+FG VYKAK   +G   A K ++  + +   ++  E+E L    H  IVK+LG + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
             G   ++I EF   G++D  + +  R        Q+  +C           R +   L 
Sbjct: 80  WDGKLWIMI-EFCPGGAVDAIMLELDRGLT---EPQIQVIC-----------RQMLEALQ 124

Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL-ARRIDTSHSHVSTQVAGTMGYMPPE 266
           YLH     IIHRD+K+ NVLL  D +  ++DFG+ A+ + T     S    GT  +M PE
Sbjct: 125 YLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPE 180

Query: 267 YLGGNTAATV----MLDVYSFGILMIEIATQIRP 296
            +   T          D++S GI +IE+A QI P
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMA-QIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 85.1 bits (210), Expect = 7e-19
 Identities = 67/215 (31%), Positives = 111/215 (51%), Gaps = 21/215 (9%)

Query: 89  IIGDGSFGFVYKAKLSSG---VTVAIKKLDKDAFQG-FREFRAEMETLGKL-RHRNIVKI 143
           +IG+G+FG V KA++      +  AIK++ + A +   R+F  E+E L KL  H NI+ +
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS--KQLNSLCPLSWETRVKIVRG 201
           LG C       L  E+  +G+L  +L   SR  + D +     ++   LS +  +     
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           VA G+ YL   +K  IHRD+ + N+L+  ++ A I+DFGL+R  +         V  TMG
Sbjct: 121 VARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTMG 171

Query: 262 YMPPEYLG----GNTAATVMLDVYSFGILMIEIAT 292
            +P  ++       +  T   DV+S+G+L+ EI +
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 25/213 (11%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +GDG+FG VYKA+   +GV  A K +D  + +   ++  E++ L    H NIVK+L    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV-RGVANGLA 207
              +  ++ EF   G++D  + +  R              PL+ E ++++V +     L 
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELER--------------PLT-EPQIRVVCKQTLEALN 117

Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           YLH  E  IIHRD+K+ N+L   D +  ++DFG++ + +T          GT  +M PE 
Sbjct: 118 YLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDSFIGTPYWMAPEV 174

Query: 268 LGGNTAA----TVMLDVYSFGILMIEIATQIRP 296
           +   T+         DV+S GI +IE+A QI P
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEMA-QIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 84.2 bits (208), Expect = 1e-18
 Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 39/280 (13%)

Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           K +G G FG V   K      VAIK + K+      EF  E + + KL H  +V++ G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  ++ E++ NG L  +L +  +        QL  +C           + V  G+A
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKRFQ---PSQLLEMC-----------KDVCEGMA 114

Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPP 265
           YL    K  IHRD+ + N L+D      +SDFGL+R +  D   S V ++    + + PP
Sbjct: 115 YLE--SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPP 170

Query: 266 EYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEM 325
           E L  +  ++   DV++FG+LM E+ +              +G + + R   +   E   
Sbjct: 171 EVLLYSKFSSKS-DVWAFGVLMWEVYS--------------LGKMPYERFNNSETVEKVS 215

Query: 326 VDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVV 365
               + R  L+   V   + I   C +EK+ ERP    ++
Sbjct: 216 QGLRLYRPHLASEKV---YAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 58/216 (26%), Positives = 107/216 (49%), Gaps = 26/216 (12%)

Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG-----FREFRAEMETLGKLR 136
           NF   + +G+G++  VYK +  ++G  VA+K++  DA +G      RE    +  + +L+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIRE----ISLMKELK 56

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIV++     +    +L++E+++         D  +  D  G +       L   T  
Sbjct: 57  HENIVRLHDVIHTENKLMLVFEYMDK--------DLKKYMDTHGVR-----GALDPNTVK 103

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                +  G+A+ H  E  ++HRD+K  N+L++   E  ++DFGLAR      +  S +V
Sbjct: 104 SFTYQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEV 161

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
             T+ Y  P+ L G+   +  +D++S G +M E+ T
Sbjct: 162 V-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 63/222 (28%), Positives = 112/222 (50%), Gaps = 18/222 (8%)

Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSSGVT-------VAIKKLDKDAFQGFR-EFRAEMET 131
           A +  +  + +G GSFG VY+  ++ GV        VAIK +++ A    R EF  E   
Sbjct: 4   AREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62

Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           + +    ++V++LG  + G   ++I E +  G L  +L   S   +++ +       P S
Sbjct: 63  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNP---VQAPPS 117

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHS 250
            +  +++   +A+G+AYL+      +HRD+ + N ++  DF   I DFG+ R I +T + 
Sbjct: 118 LKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 175

Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
               +    + +M PE L  +   T   DV+SFG+++ EIAT
Sbjct: 176 RKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 28/215 (13%)

Query: 88  KIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVK 142
           + +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 143 ILGYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDD-VDGSKQLNSLCPLSWETRVKIV 199
             G C S   R   L+ E++  GSL  +L    ++ + +D  K L      + +      
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLL----YASQ------ 116

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVA 257
             +  G+ YL    K  +HRD+ + N+L++S+    I DFGL + +  D  +  V     
Sbjct: 117 --ICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE 172

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
             + +  PE L  +   +V  DV+SFG+++ E+ T
Sbjct: 173 SPIFWYAPESLTESK-FSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 84.0 bits (208), Expect = 3e-18
 Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 47/227 (20%)

Query: 89  IIGDGSFGFVYKAK-LSSGVTVAIKKL----DKDAF--QGFREFRAEMETLGKLRHRNIV 141
            IG G+FG V+KA+   +   VA+KK+    +K+ F     RE +     L  L+H N+V
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 74

Query: 142 KILGYC---ASGLDR-----VLIYEFVENGSLDQWLHDTSR---NDDVDGSKQLNSLCPL 190
            ++  C   A+  +R      L++EF E        HD +    N +V            
Sbjct: 75  NLIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVK----------F 116

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR----RID 246
           +     K+++ + NGL Y+H     I+HRD+K++N+L+  D    ++DFGLAR      +
Sbjct: 117 TLSEIKKVMKMLLNGLYYIH--RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174

Query: 247 TSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           +  +  + +V  T+ Y PPE L G       +D++  G +M E+ T+
Sbjct: 175 SKPNRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 83.1 bits (205), Expect = 3e-18
 Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 35/285 (12%)

Query: 87  DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGY 146
           +K +G G FG V+ A  +    VA+K + K        F AE   +  L+H  +VK L  
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK-LHA 68

Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
             +     +I EF+  GSL  +L     +      + L  L   S +        +A G+
Sbjct: 69  VVTKEPIYIITEFMAKGSLLDFLKSDEGS-----KQPLPKLIDFSAQ--------IAEGM 115

Query: 207 AYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE 266
           A++   ++  IHRD++++N+L+ +     I+DFGLAR I+ +           + +  PE
Sbjct: 116 AFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173

Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            +   +  T+  DV+SFGIL++EI T  R   P + + + +  LE    M          
Sbjct: 174 AINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-------- 224

Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
                     E    E + I   C   +  ERP   Y+  +LD+ 
Sbjct: 225 ---------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 83.7 bits (207), Expect = 6e-18
 Identities = 98/372 (26%), Positives = 151/372 (40%), Gaps = 92/372 (24%)

Query: 35  PPTYRTRAVNRPQPNRCSDLS--------SIAL-----FDSASFDPSLSQISMSELIDAT 81
           P     R   + +P R  DL+        S+A+       S+S   S S  +      A 
Sbjct: 11  PLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSASGSAPSAA 70

Query: 82  DNFST-DKI--IGDGSFGFVYKAK-LSSGVTVAIKKL---DKDAFQGFREFRAEMETLGK 134
            + S  +++  IG G+ G VYK     +G   A+K +    +D  +  R+   E+E L  
Sbjct: 71  KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR--RQICREIEILRD 128

Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           + H N+VK         +  ++ EF++ GSL+           +   + L  +       
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE--------GTHIADEQFLADV------- 173

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG----LARRIDTSHS 250
                R + +G+AYLH   + I+HRDIK SN+L++S     I+DFG    LA+ +D  +S
Sbjct: 174 ----ARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNS 227

Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVML------DVYSFGILMIEIATQIRPNLPVVLDG 304
            V     GT+ YM PE +  NT            D++S G+ ++E      P   V   G
Sbjct: 228 SV-----GTIAYMSPERI--NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP-FGVGRQG 279

Query: 305 QEVGLLEWARTMEARNKEIEMVDS-----NISREELSEAGVREYFR--IACMCTNEKSRE 357
                 +WA  M A    I M          SRE          FR  I+C    E ++ 
Sbjct: 280 ------DWASLMCA----ICMSQPPEAPATASRE----------FRHFISCCLQREPAKR 319

Query: 358 RPAMSYVVQLLD 369
             AM    QLL 
Sbjct: 320 WSAM----QLLQ 327

Length = 353

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 82.8 bits (205), Expect = 6e-18
 Identities = 60/190 (31%), Positives = 99/190 (52%), Gaps = 17/190 (8%)

Query: 109 VAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVKILGYCASGLDRVL--IYEFVENGSL 165
           VA+K L  DA    R +F  E++ L +L   NI ++LG C    D  L  I E++ENG L
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV--DPPLCMIMEYMENGDL 106

Query: 166 DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSN 225
           +Q+L    ++         NS   LS+ T + +   +A+G+ YL  L    +HRD+ + N
Sbjct: 107 NQFL---QKHVAETSGLACNSK-SLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRN 160

Query: 226 VLLDSDFEAHISDFGLARRIDTS-HSHVSTQVAGTMGYMPPE--YLGGNTAATVMLDVYS 282
            L+  ++   I+DFG++R + +S +  V  +    + +M  E   LG  T  +   DV++
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKS---DVWA 217

Query: 283 FGILMIEIAT 292
           FG+ + EI T
Sbjct: 218 FGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 47/226 (20%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKK--LDKDAFQG-----FREFRAEMETLGKLRHRNIV 141
           IG+G++G VYKA+   +G  VA+KK  L+ +  +G      RE    +  L +L H NIV
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIRE----ISLLKELNHPNIV 61

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV--KIV 199
           ++L    S     L++EF+                D+D  K ++S      +  +    +
Sbjct: 62  RLLDVVHSENKLYLVFEFL----------------DLDLKKYMDSSPLTGLDPPLIKSYL 105

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR------RIDTSHSHVS 253
             +  G+AY H     ++HRD+K  N+L+D +    ++DFGLAR      R  T H  V 
Sbjct: 106 YQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT-HEVV- 161

Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
                T+ Y  PE L G+   +  +D++S G +  E+  + RP  P
Sbjct: 162 -----TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR-RPLFP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 76/241 (31%), Positives = 112/241 (46%), Gaps = 29/241 (12%)

Query: 68  SLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR 126
           SL  I +S L D    F   +++G+G++G VYK + + +G   AIK +D    +   E +
Sbjct: 2   SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIK 60

Query: 127 AEMETLGKL-RHRNIVKILGY----CASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVD 179
            E+  L K   HRNI    G        G D  L  + EF   GS+   + +T  N    
Sbjct: 61  LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN---- 116

Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
                     L  +    I R +  GLA+LH     +IHRDIK  NVLL  + E  + DF
Sbjct: 117 ---------ALKEDWIAYICREILRGLAHLHA--HKVIHRDIKGQNVLLTENAEVKLVDF 165

Query: 240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLG--GNTAAT--VMLDVYSFGILMIEIATQIR 295
           G++ ++D +    +T + GT  +M PE +    N  AT     D++S GI  IE+A    
Sbjct: 166 GVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Query: 296 P 296
           P
Sbjct: 225 P 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 73/229 (31%), Positives = 113/229 (49%), Gaps = 20/229 (8%)

Query: 88  KIIGDGSFGFVY--------KAKLSSGVTVAIKKLDKDAF-QGFREFRAEMETLGKL-RH 137
           K +G+G FG V         K K +  VTVA+K L  DA  +   +  +EME +  + +H
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLC--PLSWETR 195
           +NI+ +LG C       ++ E+   G+L ++L    R   +D S     L    L+++  
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLR-ARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVST 254
           V     VA G+ YL    +  IHRD+ + NVL+  D    I+DFGLAR + +  +   +T
Sbjct: 137 VSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT---QIRPNLPV 300
                + +M PE L  +   T   DV+SFG+L+ EI T      P +PV
Sbjct: 195 NGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 64/211 (30%), Positives = 94/211 (44%), Gaps = 29/211 (13%)

Query: 89  IIGDGSFGFVYKAK-LSSGVTVAIKKL----DKDAFQ--GFREFRAEMETLGKLRHRNIV 141
           ++G+GS+G V K K   +G  VAIKK     D    +    RE R     L +LRH N+V
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR----MLKQLRHENLV 63

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            ++          L++EFV++  LD            D  K  N L         K +  
Sbjct: 64  NLIEVFRRKKRLYLVFEFVDHTVLD------------DLEKYPNGL---DESRVRKYLFQ 108

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ + H     IIHRDIK  N+L+       + DFG AR +  +   V T    T  
Sbjct: 109 ILRGIEFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYTDYVATRW 165

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE L G+T     +D+++ G L+ E+ T
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 18/206 (8%)

Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           K +G G FG V+  K  + + VAIK +++ A     +F  E + + KL H  +V++ G C
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  ++ EF+ENG L   L+   +         L S+C           + V  G+ 
Sbjct: 69  TQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMC-----------QDVCEGME 114

Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           YL       IHRD+ + N L+ S     +SDFG+ R +       S+     + + PPE 
Sbjct: 115 YLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEV 172

Query: 268 LGGNTAATVMLDVYSFGILMIEIATQ 293
              +  ++   DV+SFG+LM E+ T+
Sbjct: 173 FNFSKYSSKS-DVWSFGVLMWEVFTE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 84.1 bits (208), Expect = 2e-17
 Identities = 73/286 (25%), Positives = 128/286 (44%), Gaps = 38/286 (13%)

Query: 89  IIGDGSFGFVYKAK-LSSGVTVAIKKL-DKDAFQGFREFRAEMETLGKLRHRNIVKILGY 146
           +I  G  G  YK K + +G+   +K++ D ++        +E+  +GKL+H NIVK++G 
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGL 751

Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
           C S     LI+E++E  +L + L +                  LSWE R KI  G+A  L
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVLRN------------------LSWERRRKIAIGIAKAL 793

Query: 207 AYLHGLEKP-IIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
            +LH    P ++  ++    +++D   E H+    L   + T      +       Y+ P
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAP 847

Query: 266 EYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEM 325
           E        T   D+Y FG+++IE+ T   P       G    ++EWAR   + +  ++M
Sbjct: 848 E-TRETKDITEKSDIYGFGLILIELLTGKSPADAEF--GVHGSIVEWARYCYS-DCHLDM 903

Query: 326 -VDSNISREELS-EAGVREYFRIACMCTNEKSRERPAMSYVVQLLD 369
            +D +I  +    +  + E   +A  CT      RP  + V++ L+
Sbjct: 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 28/218 (12%)

Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHRN 139
           NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IVK+L    +     L++EF+              + D+   K+     PLS    + ++
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL--------------HQDL---KKFMDASPLS-GIPLPLI 102

Query: 200 RG----VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     +  GLA+ H     ++HRD+K  N+L++++    ++DFGLAR         + +
Sbjct: 103 KSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           V  T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 161 VV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 94/360 (26%), Positives = 142/360 (39%), Gaps = 93/360 (25%)

Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           DN    K +G G+FG V +A      K  + + VA+K L   A    RE   +E++ L  
Sbjct: 38  DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97

Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENG------------------SLDQWLHDTS-- 173
           L +H+NIV +LG C  G   ++I E+   G                  +L +    +S  
Sbjct: 98  LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDY 157

Query: 174 ----------RND----------------------DVDGSKQL---NSLCPLSWETRVKI 198
                     R+D                          SK         PL  +  ++ 
Sbjct: 158 KNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRF 217

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
              VA G+ +L    K  IHRD+ + NVLL     A I DFGLAR I    ++V   V G
Sbjct: 218 SSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKG 272

Query: 259 T----MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR 314
                + +M PE +  +   TV  DV+S+GIL+ EI +  +   P               
Sbjct: 273 NARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGKSPYP--------------- 316

Query: 315 TMEARNKEIEMVDS--NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV 372
            +   +K  +MV     +SR + +     E + I  MC N +  ERP  S + QL+   +
Sbjct: 317 GILVNSKFYKMVKRGYQMSRPDFAP---PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)

Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVKILGY 146
           +++G G+FG V+K  L     VA+K   +D  Q  + +F +E   L +  H NIVK++G 
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
           C       ++ E V  G    +L    + D++  +KQL           VK     A G+
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLR--KKKDELK-TKQL-----------VKFALDAAAGM 106

Query: 207 AYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE 266
           AYL    K  IHRD+ + N L+  +    ISDFG++R+ D      S      + +  PE
Sbjct: 107 AYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE 164

Query: 267 YL--GGNTAATVMLDVYSFGILMIE 289
            L  G  ++ +   DV+S+GIL+ E
Sbjct: 165 ALNYGRYSSES---DVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 33/223 (14%)

Query: 87  DKI--IGDGSFGFVYKAK-LSSGVTVAIKK--LDKDAFQGFREFRA-EMETLGKLRHRNI 140
           +K+  IG+G++G V+KAK   +   VA+K+  LD D  +G       E+  L +L+H+NI
Sbjct: 3   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNI 61

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V++     S     L++E+                 D D  K  +S    + +   +IV+
Sbjct: 62  VRLYDVLHSDKKLTLVFEYC----------------DQDLKKYFDS---CNGDIDPEIVK 102

Query: 201 GVAN----GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                   GLA+ H     ++HRD+K  N+L++ + E  ++DFGLAR         S +V
Sbjct: 103 SFMFQLLKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV 160

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
             T+ Y PP+ L G    +  +D++S G +  E+A   RP  P
Sbjct: 161 V-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 73/245 (29%), Positives = 110/245 (44%), Gaps = 36/245 (14%)

Query: 80  ATDNFSTDKIIGDGSFGFVY--------KAKLSSGVTVAIKKLDKDAFQ-GFREFRAEME 130
             D     K +G+G FG V         K K +    VA+K L  DA +    +  +EME
Sbjct: 16  PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75

Query: 131 TLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH-------DTSRNDDVDGSK 182
            +  + +H+NI+ +LG C       +I E+   G+L ++L        +   N      +
Sbjct: 76  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135

Query: 183 QLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA 242
           QL      S++  V     VA G+ YL    K  IHRD+ + NVL+  D    I+DFGLA
Sbjct: 136 QL------SFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 187

Query: 243 RRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIAT---QIR 295
           R I     H+      T G +P +++      +   T   DV+SFG+L+ EI T      
Sbjct: 188 RDI----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243

Query: 296 PNLPV 300
           P +PV
Sbjct: 244 PGVPV 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 80/300 (26%), Positives = 131/300 (43%), Gaps = 54/300 (18%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKK------LDKDAFQGFREFRAEMETLG 133
             NF  +K IG G F  VYKA  L  G  VA+KK      +D  A Q   +   E++ L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57

Query: 134 KLRHRNIVKILGYCASGLDR---VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL 190
           +L H N++K   Y AS ++     ++ E  + G L + +    +   +   + +      
Sbjct: 58  QLDHPNVIK---YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI------ 108

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT--- 247
            W+  V++     + L ++H   K I+HRDIK +NV + +     + D GL R   +   
Sbjct: 109 -WKYFVQL----CSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161

Query: 248 -SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE 306
            +HS V     GT  YM PE +  N       D++S G L+ E+A    P       G +
Sbjct: 162 AAHSLV-----GTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSP-----FYGDK 210

Query: 307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ 366
           + L    + +E    +   + ++   EEL +        +   C N    +RP +SYV+Q
Sbjct: 211 MNLYSLCKKIE--KCDYPPLPADHYSEELRD--------LVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 80.5 bits (198), Expect = 3e-17
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 34/231 (14%)

Query: 88  KIIGDGSFGFVYKAKLS---SGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHRNIVK 142
           K +G+G FG V + +L+   S + VA+K  K+         +F +E   + +  H N+++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 143 ILGYCASGLDR------VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP--LSWET 194
           ++G C   ++       V+I  F+++G L  +L  +   D           CP  L  + 
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD-----------CPQYLPTQM 113

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
            VK +  +A+G+ YL    K  IHRD+ + N +L+ +    ++DFGL+++I     +   
Sbjct: 114 LVKFMTDIASGMEYLS--SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ- 170

Query: 255 QVAGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIATQIRPNLPVV 301
              G +  MP +++   + A    T   DV+SFG+ M EIAT+ +   P V
Sbjct: 171 ---GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 80.5 bits (198), Expect = 3e-17
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 30/225 (13%)

Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKL--DKDAFQGFREFRA---EMETLGKLR 136
           N+   K++G G+FG VY    + +G  +A K++  D ++ +  +E  A   E++ L  L+
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 137 HRNIVKILGYCASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           H  IV+  G      ++ L    E++  GS+                 QL +   L+   
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSV---------------KDQLKAYGALTESV 107

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT---SHSH 251
             K  R +  G++YLH     I+HRDIK +N+L DS     + DFG ++R+ T   S + 
Sbjct: 108 TRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165

Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           + + V GT  +M PE + G        DV+S G  ++E+ T+  P
Sbjct: 166 IRS-VTGTPYWMSPEVISGEGYGR-KADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 33/217 (15%)

Query: 90  IGDGSFGFVYKAKLS-SGVTVAIKKLD---KDAFQGFREFRAEMETLGKLRHRNIVKILG 145
           IG GSFG VY A+   +   VAIKK+    K + + +++   E+  L +LRH N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
                    L+ E+             S +D ++  K+     PL       I  G   G
Sbjct: 83  CYLREHTAWLVMEYCLG----------SASDILEVHKK-----PLQEVEIAAICHGALQG 127

Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
           LAYLH  E+  IHRDIK+ N+LL       ++DFG A  +  ++S V     GT  +M P
Sbjct: 128 LAYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAP 180

Query: 266 EYL----GGNTAATVMLDVYSFGILMIEIATQIRPNL 298
           E +     G     V  DV+S GI  IE+A + +P L
Sbjct: 181 EVILAMDEGQYDGKV--DVWSLGITCIELAER-KPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 71/250 (28%), Positives = 112/250 (44%), Gaps = 57/250 (22%)

Query: 80  ATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKL----DKDAF--QGFREFRAEMETL 132
              ++     +G+G+FG VYKA ++ +G  VA+KK+    +KD F     RE +     L
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61

Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQ---------WLHDTS---RNDDVDG 180
            KL+H N+V ++          +  E  +     +           HD S    N  V  
Sbjct: 62  KKLKHPNVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV-- 110

Query: 181 SKQLNSLCPLSWETRVK-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
             +L        E+++K  +  +  G+ YLH  E  I+HRDIK++N+L+D+     I+DF
Sbjct: 111 --KLT-------ESQIKCYMLQLLEGINYLH--ENHILHRDIKAANILIDNQGILKIADF 159

Query: 240 GLARRIDTS----------HSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
           GLAR  D             +   T +  T  Y PPE L G    T  +D++  G +  E
Sbjct: 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAE 219

Query: 290 IATQIRPNLP 299
           + T+ RP L 
Sbjct: 220 MFTR-RPILQ 228

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 79.6 bits (196), Expect = 7e-17
 Identities = 56/205 (27%), Positives = 109/205 (53%), Gaps = 12/205 (5%)

Query: 107 VTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL 165
           V VA+K L  D  +  R +F  E++ + +L++ NI+++LG C S     +I E++ENG L
Sbjct: 45  VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104

Query: 166 DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSN 225
           +Q+L   S+ +        N++  +S    + +   +A+G+ YL  L    +HRD+ + N
Sbjct: 105 NQFL---SQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRN 159

Query: 226 VLLDSDFEAHISDFGLARRIDTS-HSHVSTQVAGTMGYMPPE--YLGGNTAATVMLDVYS 282
            L+ + +   I+DFG++R + +  +  +  +    + +M  E   LG  T A+   DV++
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS---DVWA 216

Query: 283 FGILMIEIATQIRPNLPVVLDGQEV 307
           FG+ + E+ T  +     +L  ++V
Sbjct: 217 FGVTLWEMFTLCKEQPYSLLSDEQV 241

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.3 bits (195), Expect = 8e-17
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 30/225 (13%)

Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKL--DKDAFQGFREFRA---EMETLGKLR 136
           N+   K++G G+FG VY      +G  +A+K++  D D+ +  +E  A   E++ L  LR
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 137 HRNIVKILGYCASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           H  IV+  G      ++ L    E++  GS+                 QL +   L+   
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI---------------KDQLKAYGALTENV 107

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT---SHSH 251
             +  R +  G++YLH     I+HRDIK +N+L DS     + DFG ++RI T   S + 
Sbjct: 108 TRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG 165

Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           + + V GT  +M PE + G        DV+S    ++E+ T+  P
Sbjct: 166 IKS-VTGTPYWMSPEVISGEGYGR-KADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 78.9 bits (194), Expect = 8e-17
 Identities = 69/282 (24%), Positives = 121/282 (42%), Gaps = 37/282 (13%)

Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 71

Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L                    L     V +   +A+G+AY+
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKGEMGK-------------YLRLPQLVDMAAQIASGMAYV 118

Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 119 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176

Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +       
Sbjct: 177 YGRF--TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE------- 227

Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
               E L +        + C C  ++  ERP   Y+   L++
Sbjct: 228 --CPESLHD--------LMCQCWRKEPEERPTFEYLQAFLED 259

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 79.0 bits (194), Expect = 9e-17
 Identities = 72/232 (31%), Positives = 109/232 (46%), Gaps = 29/232 (12%)

Query: 77  LIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           L D    F   +++G+G++G VYK + + +G   AIK +D    +   E + E+  L K 
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKY 59

Query: 136 -RHRNIVKILGYCAS----GLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLC 188
             HRNI    G        G+D  L  + EF   GS+   + +T  N             
Sbjct: 60  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT------------ 107

Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
            L  E    I R +  GL++LH  +  +IHRDIK  NVLL  + E  + DFG++ ++D +
Sbjct: 108 -LKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164

Query: 249 HSHVSTQVAGTMGYMPPEYLG--GNTAATVML--DVYSFGILMIEIATQIRP 296
               +T + GT  +M PE +    N  AT     D++S GI  IE+A    P
Sbjct: 165 VGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 36/216 (16%)

Query: 82  DNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           DNF     IG+GS G V  A   S+G  VA+KK+D    Q       E+  +   +H NI
Sbjct: 22  DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V++      G +  ++ EF+E G+L   +  T  N++     Q+ ++C            
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----QIATVC-----------L 122

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV---- 256
            V   L++LH   + +IHRDIKS ++LL SD    +SDFG         + VS +V    
Sbjct: 123 AVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFC-------AQVSKEVPRRK 173

Query: 257 --AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
              GT  +M PE +      T  +D++S GI++IE+
Sbjct: 174 SLVGTPYWMAPEVISRLPYGT-EVDIWSLGIMVIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 69/210 (32%), Positives = 99/210 (47%), Gaps = 22/210 (10%)

Query: 87  DKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIV 141
           D+ IG G+FG V+       G  VA+KK+    FQ      R FR E++ L   +H N++
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPN-VFQNLVSCKRVFR-ELKMLCFFKHDNVL 62

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-VR 200
             L      L    I  F E   + + +         D  K + S  PLS +  VK+ + 
Sbjct: 63  SALDI----LQPPHIDPFEEIYVVTELMQS-------DLHKIIVSPQPLSSD-HVKVFLY 110

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +  GL YLH     I+HRDIK  N+L++S+    I DFGLAR  +   S   TQ   T 
Sbjct: 111 QILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            Y  PE L G+   T  +D++S G +  E+
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 29/217 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKA----KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLR 136
           ++ +  + IG+G FG VY+       +  + VA+K          RE F  E   + +  
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 137 HRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           H +IVK++G      + V ++ E    G L  +L     +              L   + 
Sbjct: 66  HPHIVKLIGVITE--NPVWIVMELAPLGELRSYLQVNKYS--------------LDLASL 109

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     ++  LAYL    K  +HRDI + NVL+ S     + DFGL+R ++    + +++
Sbjct: 110 ILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK 167

Query: 256 VAGTMGYMPPEYLGGN--TAATVMLDVYSFGILMIEI 290
               + +M PE +     T+A+   DV+ FG+ M EI
Sbjct: 168 GKLPIKWMAPESINFRRFTSAS---DVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 12/210 (5%)

Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKL-DKDAFQGFREFRAEMETLGKLRHRNIVKI 143
           +G+ +FG +YK  L          VAIK L D +  Q + EF+ E   + +L H NIV +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE--TRVKIVRG 201
           LG         +++E++  G L ++L   S + DV  S   +     S +    + I   
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS-HSHVSTQVAGTM 260
           +A G+ YL       +H+D+ + N+L+       ISD GL+R I ++ +  V  +    +
Sbjct: 133 IAAGMEYLS--SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190

Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +MPPE +     ++   D++SFG+++ EI
Sbjct: 191 RWMPPEAIMYGKFSSDS-DIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 78.2 bits (192), Expect = 2e-16
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 30/225 (13%)

Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKL--DKDAFQGFREFRA---EMETLGKLR 136
           N+   K++G G+FG VY      +G  +A+K++  D ++ +  +E  A   E++ L  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 137 HRNIVKILGYCASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           H  IV+  G     ++R L    E +  GS+                 QL S   L+   
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSI---------------KDQLKSYGALTENV 107

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT---SHSH 251
             K  R +  G++YLH     I+HRDIK +N+L DS     + DFG ++R+ T   S + 
Sbjct: 108 TRKYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG 165

Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           + + V GT  +M PE + G        D++S G  ++E+ T+  P
Sbjct: 166 MKS-VTGTPYWMSPEVISGEGYGR-KADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 78.2 bits (192), Expect = 2e-16
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 22/210 (10%)

Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G++G VYKA  L +G   A+K +  +    F   + E+  + + +H NIV   G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
           S     +  E+   GSL    H T                PLS      + R    GLAY
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTG---------------PLSELQIAYVCRETLQGLAY 121

Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL 268
           LH   K  +HRDIK +N+LL  + +  ++DFG+A +I  + +   + + GT  +M PE  
Sbjct: 122 LHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVA 178

Query: 269 G--GNTAATVMLDVYSFGILMIEIATQIRP 296
               N     + D+++ GI  IE+A +++P
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELA-ELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 77.3 bits (190), Expect = 3e-16
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 34/217 (15%)

Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           +IIG+G FG V + + + G  VA+K +  D     + F  E   + KL H+N+V++LG  
Sbjct: 12  EIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 148 A-SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
             +GL   ++ E +  G+L  +L    R           +L  +    +  +   VA G+
Sbjct: 69  LHNGL--YIVMELMSKGNLVNFLRTRGR-----------ALVSVIQLLQFSL--DVAEGM 113

Query: 207 AYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR----RIDTSHSHVSTQVAGTMGY 262
            YL    K ++HRD+ + N+L+  D  A +SDFGLAR     +D S   V         +
Sbjct: 114 EYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK--------W 163

Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
             PE L     ++   DV+S+G+L+ E+ +  R   P
Sbjct: 164 TAPEALKHKKFSS-KSDVWSYGVLLWEVFSYGRAPYP 199

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 67/223 (30%), Positives = 100/223 (44%), Gaps = 32/223 (14%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLG 133
           D    +   + IG G++G V  A    SG  VAIKK+   AF       R  R E++ L 
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLR-ELKILR 59

Query: 134 KLRHRNIVKILGYC----ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP 189
             +H NI+ I        A   D  ++ + +E+  L   +H          S Q     P
Sbjct: 60  HFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIH----------SDQ-----P 103

Query: 190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS- 248
           L+ E     +  +  GL Y+H     +IHRD+K SN+L++ D E  I DFG+AR + +S 
Sbjct: 104 LTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161

Query: 249 --HSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
             H +  T+   T  Y  PE L      T  +D++S G +  E
Sbjct: 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAE 204

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 71/217 (32%), Positives = 107/217 (49%), Gaps = 41/217 (18%)

Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLR-HRNIVKI 143
           +G G++G V+KA    +   VA+KK+  DAF+      R FR E+  L +L  H NIVK+
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTFR-EIMFLQELGDHPNIVKL 72

Query: 144 LGY--CASGLDRVLIYEFVENGSLDQWLHDTSRND---DVDGSKQLNSLCPLSWETRVKI 198
           L      +  D  L++E++E    D  LH   R +   DV   K+              I
Sbjct: 73  LNVIKAENDKDIYLVFEYMET---D--LHAVIRANILEDV--HKRY-------------I 112

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ--- 255
           +  +   L Y+H     +IHRD+K SN+LL+SD    ++DFGLAR +     +       
Sbjct: 113 MYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170

Query: 256 --VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             VA T  Y  PE L G+T  T  +D++S G ++ E+
Sbjct: 171 DYVA-TRWYRAPEILLGSTRYTKGVDMWSVGCILGEM 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 77.0 bits (189), Expect = 4e-16
 Identities = 77/292 (26%), Positives = 123/292 (42%), Gaps = 37/292 (12%)

Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN 139
             ++    K +G+G FG V+    +    VA+K L K        F  E + + KLRH  
Sbjct: 4   PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62

Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           +V++     S     ++ E++  GSL  +L D       +G         L     V + 
Sbjct: 63  LVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDG------EGRA-------LKLPNLVDMA 108

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             VA G+AY+  +    IHRD++S+N+L+       I+DFGLAR I+ +           
Sbjct: 109 AQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP 166

Query: 260 MGYMPPE-YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA 318
           + +  PE  L G    T+  DV+SFGIL+ E+ T+ R   P + + + +  +E    M  
Sbjct: 167 IKWTAPEAALYGRF--TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC 224

Query: 319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                   D  IS  EL              C  +   ERP   Y+   L++
Sbjct: 225 PQ------DCPISLHEL-----------MLQCWKKDPEERPTFEYLQSFLED 259

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 77.1 bits (190), Expect = 4e-16
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 22/217 (10%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRN 139
           ++  T   +G G+ G V K K + +G  +A K +   A    R +   E++ + + R   
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64

Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IV   G   +  +  +  EF++ GSLD               +      P+  E   KI 
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSLD---------------RIYKKGGPIPVEILGKIA 109

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             V  GL YL+ + + I+HRDIK SN+L++S  +  + DFG++  +  S   ++    GT
Sbjct: 110 VAVVEGLTYLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGT 165

Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             YM PE + G    TV  DV+S GI +IE+A    P
Sbjct: 166 STYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 77.3 bits (190), Expect = 5e-16
 Identities = 60/224 (26%), Positives = 116/224 (51%), Gaps = 30/224 (13%)

Query: 90  IGDGSFG-----------------FVYKAKLSSGVTVAIKKLDKDAFQGFR-EFRAEMET 131
           +G+G FG                 F      +  V VA+K L +DA +  R +F  E++ 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           + +L+  NI+++L  C +     +I E++ENG L+Q+L   SR++  + +++ + +  +S
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFL---SRHEPQEAAEKADVVT-IS 128

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHS 250
           + T + +   +A+G+ YL  L    +HRD+ + N L+  ++   I+DFG++R +    + 
Sbjct: 129 YSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186

Query: 251 HVSTQVAGTMGYMPPE--YLGGNTAATVMLDVYSFGILMIEIAT 292
            +  +    + +M  E   LG  T A+   DV++FG+ + EI T
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTAS---DVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 77.2 bits (191), Expect = 5e-16
 Identities = 68/225 (30%), Positives = 97/225 (43%), Gaps = 38/225 (16%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFRE---FRAEMETLGKLRH 137
           D+F   K +G GSFG V   +   SG   A+K L K      ++      E   L  +RH
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 138 RNIVKILG--YCASGLDRVLIYEFVENGSLDQWLHDTSR-NDDVDGSKQLNSLCPLSWET 194
             +V + G     S L   L+ E+V  G L   L  + R  + V                
Sbjct: 61  PFLVNLYGSFQDDSNL--YLVMEYVPGGELFSHLRKSGRFPEPV---------------A 103

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
           R    + V   L YLH L+  I++RD+K  N+LLDSD    I+DFG A+R+        T
Sbjct: 104 RFYAAQ-VVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RTYT 157

Query: 255 QVAGTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
            + GT  Y+ PE +   G   A     D ++ GIL+ E+     P
Sbjct: 158 -LCGTPEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 76.6 bits (188), Expect = 5e-16
 Identities = 69/219 (31%), Positives = 99/219 (45%), Gaps = 31/219 (14%)

Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           + IG G FG V       G  VA+K +  DA    + F AE   + +LRH N+V++LG  
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 148 A---SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
                GL   ++ E++  GSL  +L   SR   V G   L           +K    V  
Sbjct: 69  VEEKGGL--YIVTEYMAKGSLVDYLR--SRGRSVLGGDCL-----------LKFSLDVCE 113

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
            + YL       +HRD+ + NVL+  D  A +SDFGL +   ++       V  T     
Sbjct: 114 AMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----A 167

Query: 265 PEYLGGNTAATVMLDVYSFGILMIEIATQIR---PNLPV 300
           PE L     +T   DV+SFGIL+ EI +  R   P +P+
Sbjct: 168 PEALREKKFSTKS-DVWSFGILLWEIYSFGRVPYPRIPL 205

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 77.4 bits (191), Expect = 6e-16
 Identities = 67/312 (21%), Positives = 112/312 (35%), Gaps = 57/312 (18%)

Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKK--LDKDAFQGFREFRAEMETLGKLRHRNIVKILG 145
           K   D     + K K  +   VA+KK  LD  + +  +  + E+ T  +L+H NI+  + 
Sbjct: 8   KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66

Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK-IVRGVAN 204
                 +  ++   +  GS +  L    +    +G            E  +  I++ V N
Sbjct: 67  SFIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLP----------ELAIAFILKDVLN 112

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS-------HSHVSTQVA 257
            L Y+H   K  IHR +K+S++LL  D +  +S    +  +          H        
Sbjct: 113 ALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF-PKSSV 169

Query: 258 GTMGYMPPEYLGGNTAA-TVMLDVYSFGILMIEIA-----------TQ-----IRPNLPV 300
             + ++ PE L  N        D+YS GI   E+A           TQ     +R  +P 
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPC 229

Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVR----EYFRIACMCTNEKSR 356
           +LD     L E                 N  R+ +     R     + +   +C      
Sbjct: 230 LLDKSTYPLYE----DSMSQSRSSNEHPNN-RDSVDHPYTRTFSEHFHQFVELCLQRDPE 284

Query: 357 ERPAMSYVVQLL 368
            RP+ S   QLL
Sbjct: 285 SRPSAS---QLL 293

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 77.3 bits (190), Expect = 6e-16
 Identities = 54/190 (28%), Positives = 99/190 (52%), Gaps = 13/190 (6%)

Query: 109 VAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQ 167
           VA+K L  DA +  R +F  E++ L +L+  NI+++LG C       +I E++ENG L+Q
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 168 WLH----DTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKS 223
           +L     D    +  D     + L  +S+ + + +   +A+G+ YL  L    +HRD+ +
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLAT 166

Query: 224 SNVLLDSDFEAHISDFGLARRIDT-SHSHVSTQVAGTMGYMPPE--YLGGNTAATVMLDV 280
            N L+  +    I+DFG++R +    +  +  +    + +M  E   +G  T A+   DV
Sbjct: 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTAS---DV 223

Query: 281 YSFGILMIEI 290
           ++FG+ + EI
Sbjct: 224 WAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 76.5 bits (188), Expect = 8e-16
 Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 31/226 (13%)

Query: 84  FSTDKIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRH 137
           F+  +++G G FG V +A+L     S   VA+K L  D F      EF  E   + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 138 RNIVKILGYCASGLDR------VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
            N++K++G       +      ++I  F+++G L  +L   SR     G +       L 
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSR----IGEEPFT----LP 111

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
            +T V+ +  +A+G+ YL    K  IHRD+ + N +L+ +    ++DFGL+++I +   +
Sbjct: 112 LQTLVRFMIDIASGMEYLS--SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY 169

Query: 252 VSTQVAGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIATQ 293
                 G    +P ++L   + A    T   DV++FG+ M EI T+
Sbjct: 170 RQ----GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 76.0 bits (187), Expect = 9e-16
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 32/226 (14%)

Query: 88  KIIGDGSFGFVYKAKL----SSGVTVAIKKLDK-DAFQGFREFRAEMETLGKLRHRNIVK 142
           ++IG G FG VY   L       +  A+K L++    +   +F  E   +    H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 143 ILGYC--ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           +LG C  + G   V++  ++++G L  ++   + N  V   K L           +    
Sbjct: 61  LLGICLPSEGSPLVVL-PYMKHGDLRNFIRSETHNPTV---KDL-----------IGFGL 105

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-----DTSHSHVSTQ 255
            VA G+ YL    K  +HRD+ + N +LD  F   ++DFGLAR I      + H+H  T 
Sbjct: 106 QVAKGMEYL--ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH--TG 161

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVV 301
               + +M  E L      T   DV+SFG+L+ E+ T+  P  P V
Sbjct: 162 AKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDV 206

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 75.6 bits (186), Expect = 1e-15
 Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 30/218 (13%)

Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLD-KDAFQGFREFRA-EMETLGKLRHRN 139
           +F   K +G GS+G VYK K LS     A+K++D     Q  RE    E+  L  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 140 IVKILGYCASGLDR---VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP--LSWET 194
           I+    Y  + LD     ++ E+   G L + +            K+   L P    W  
Sbjct: 61  II---SYKEAFLDGNKLCIVMEYAPFGDLSKAISK---------RKKKRKLIPEQEIWRI 108

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
            ++++RG    L  LH  E+ I+HRD+KS+N+LL ++    I D G+++ +    +   T
Sbjct: 109 FIQLLRG----LQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKT 160

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Q+ GT  YM PE +      +   D++S G L+ E+AT
Sbjct: 161 QI-GTPHYMAPE-VWKGRPYSYKSDIWSLGCLLYEMAT 196

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 75.5 bits (185), Expect = 1e-15
 Identities = 76/282 (26%), Positives = 123/282 (43%), Gaps = 37/282 (13%)

Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V +     S
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VVS 71

Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ EF+  GSL  +L +       DG         L     V +   +A+G+AY+
Sbjct: 72  EEPIYIVTEFMGKGSLLDFLKEG------DGKY-------LKLPQLVDMAAQIADGMAYI 118

Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    IHRD++++N+L+  +    I+DFGLAR I+ +           + +  PE  L
Sbjct: 119 ERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176

Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ +EV        +E   +   M   
Sbjct: 177 YGRF--TIKSDVWSFGILLTELVTKGRVPYPGMVN-REV--------LEQVERGYRMPCP 225

Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
               E L E        +  +C  +   ERP   Y+   L++
Sbjct: 226 QGCPESLHE--------LMKLCWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 76/297 (25%), Positives = 126/297 (42%), Gaps = 42/297 (14%)

Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKK------LDKDAFQGFREFRAEMETLGKL 135
           NF  +K IG G F  VY+A  L     VA+KK      +D  A Q   +   E++ L +L
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59

Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
            H N++K L       +  ++ E  + G L Q +    +   +   + +       W+  
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-------WKYF 112

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           V++   V       H   + ++HRDIK +NV + +     + D GL R   +S +  +  
Sbjct: 113 VQLCSAVE------HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHS 165

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART 315
           + GT  YM PE +  N       D++S G L+ E+A    P       G ++ L      
Sbjct: 166 LVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSP-----FYGDKMNLFSLC-- 217

Query: 316 MEARNKEIEMVD-SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
                ++IE  D   +  E  SE  +RE   +  MC      +RP + YV Q+  ++
Sbjct: 218 -----QKIEQCDYPPLPTEHYSEK-LRE---LVSMCIYPDPDQRPDIGYVHQIAKQM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 37/222 (16%)

Query: 90  IGDGSFGFVYKAKLSSGVT---VAIKKL--DKDAFQGF-----REFRAEMETLGKLRHRN 139
           IG G++G VYKAK  +G      AIKK   DK+ + G      RE    +  L +L+H N
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLRELKHEN 63

Query: 140 IVKILGYCASGLDRV--LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           +V ++       D+   L++++ E+  L Q +    +         +         + VK
Sbjct: 64  VVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAK----RVSIP-------PSMVK 111

Query: 198 -IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH----ISDFGLARRIDTSHSHV 252
            ++  + NG+ YLH     ++HRD+K +N+L+  +        I D GLAR  +     +
Sbjct: 112 SLLWQILNGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169

Query: 253 ST--QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           +    V  T+ Y  PE L G    T  +D+++ G +  E+ T
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 63/220 (28%), Positives = 91/220 (41%), Gaps = 48/220 (21%)

Query: 90  IGDGSFGFVYKAKLS-SGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIVKILG 145
           +G G++G V  A  + +G  VAIKKL +    A    R +R E+  L  + H N++    
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVI---- 77

Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRND-----------DVDGSKQLNSLCPLSWET 194
                            G LD +   +S  D             D +  +     LS + 
Sbjct: 78  -----------------GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ-KLSDDH 119

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
              +V  +  GL Y+H     IIHRD+K SN+ ++ D E  I DFGLAR  D       T
Sbjct: 120 IQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTD----DEMT 173

Query: 255 QVAGTMGYMPPE--YLGGNTAATVMLDVYSFGILMIEIAT 292
               T  Y  PE      +   TV  D++S G +M E+ T
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTV--DIWSVGCIMAELLT 211

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 69/226 (30%), Positives = 109/226 (48%), Gaps = 21/226 (9%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF--REFRAEMETLGKL 135
           D    +     IG+G++G V  A    +GV VAIKK+     Q F  R  R E++ L + 
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRF 60

Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           +H NI+ IL      + R   +E   +  + Q L +T      D  K + +   LS +  
Sbjct: 61  KHENIIGILD-----IIRPPSFESFNDVYIVQELMET------DLYKLIKTQ-HLSNDHI 108

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS-- 253
              +  +  GL Y+H     ++HRD+K SN+LL+++ +  I DFGLAR  D  H H    
Sbjct: 109 QYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166

Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFP 211

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 24/213 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHR 138
           D++   + +G+GS+  VYK K   +G  VA+K  +L ++    F   R E   L  L+H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63

Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIV +     +     L++E+V    L Q++            K    L P      VK+
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHT-DLCQYM-----------DKHPGGLHP----ENVKL 107

Query: 199 -VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
            +  +  GL+Y+H  ++ I+HRD+K  N+L+    E  ++DFGLA R  +  SH  +   
Sbjct: 108 FLFQLLRGLSYIH--QRYILHRDLKPQNLLISDTGELKLADFGLA-RAKSVPSHTYSNEV 164

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            T+ Y PP+ L G+T  +  LD++  G + +E+
Sbjct: 165 VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 74.6 bits (183), Expect = 3e-15
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 29/214 (13%)

Query: 88  KIIGDGSFGFVYKAKL-----SSGVTVAIKKL-DKDAFQGFREFRAEMETLGKLRHRNIV 141
           K++G G FG V+K        S  + VAIK + D+   Q F+E    M  +G L H  IV
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++LG C  G    L+ +    GSL    H     D +D  + LN      W  ++     
Sbjct: 73  RLLGICP-GASLQLVTQLSPLGSLLD--HVRQHRDSLDPQRLLN------WCVQI----- 118

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTM 260
            A G+ YL   E  ++HR++ + N+LL SD    I+DFG+A  +      +  ++    +
Sbjct: 119 -AKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175

Query: 261 GYMPPE--YLGGNTAATVMLDVYSFGILMIEIAT 292
            +M  E    G  T  +   DV+S+G+ + E+ +
Sbjct: 176 KWMALESILFGRYTHQS---DVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 27/215 (12%)

Query: 90  IGDGSFGFVYK--AKLSSGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHRNIVKILG 145
           +G+G++  V+K  +KL+  + VA+K  +L+ +        R E+  L  L+H NIV +  
Sbjct: 13  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70

Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-VRGVAN 204
              +     L++E++++  L Q+L         D    L S+        VKI +  +  
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYL---------DNCGNLMSM------HNVKIFMFQLLR 114

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
           GL+Y H  ++ I+HRD+K  N+L++   E  ++DFGLAR         S +V  T+ Y P
Sbjct: 115 GLSYCH--KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRP 171

Query: 265 PEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           P+ L G+T  +  +D++  G ++ E+AT  RP  P
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATG-RPMFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 24/210 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           DNF     IG+GS G V  A + SSG  VA+KK+D    Q       E+  +   +H N+
Sbjct: 23  DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V++      G +  ++ EF+E G+L   +  T  N++     Q+ ++C            
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----QIAAVC-----------L 123

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            V   L+ LH   + +IHRDIKS ++LL  D    +SDFG   ++        + V GT 
Sbjct: 124 AVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTP 180

Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +M PE +         +D++S GI++IE+
Sbjct: 181 YWMAPELI-SRLPYGPEVDIWSLGIMVIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 69/243 (28%), Positives = 108/243 (44%), Gaps = 32/243 (13%)

Query: 83  NFSTDKIIGDGSFGFVYKA-KLS---SGVTVAIKKLDKDAF----QGFREFRAEMETLGK 134
           NF   K++G G++G V+   K+S   SG   A+K L K       +     R E + L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 135 LRHRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           +R    +  L Y      ++ LI +++  G L   L    R                  E
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----------------E 104

Query: 194 TRVKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
             V+I  G +   L +LH L   II+RDIK  N+LLDS+    ++DFGL++         
Sbjct: 105 QEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER 162

Query: 253 STQVAGTMGYMPPEYL-GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE 311
           +    GT+ YM P+ + GG+      +D +S G+LM E+ T      P  +DG++    E
Sbjct: 163 AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS---PFTVDGEKNSQAE 219

Query: 312 WAR 314
            +R
Sbjct: 220 ISR 222

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 21/202 (10%)

Query: 90  IGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           IG+GS G V  A+   SG  VA+K +D    Q       E+  +   +H+N+V++     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
            G +  ++ EF++ G+L   +  T  N++     Q+ ++C             V   L Y
Sbjct: 89  VGEELWVLMEFLQGGALTDIVSQTRLNEE-----QIATVC-----------ESVLQALCY 132

Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL 268
           LH   + +IHRDIKS ++LL  D    +SDFG   +I        + V GT  +M PE +
Sbjct: 133 LHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVI 189

Query: 269 GGNTAATVMLDVYSFGILMIEI 290
              T     +D++S GI++IE+
Sbjct: 190 -SRTPYGTEVDIWSLGIMVIEM 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 34/224 (15%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           ++F   + IG G++G VYKA+ +++G   AIK +  +  + F   + E+  +   +H NI
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 141 VKILGYCASGLDRVLIY---EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           V    Y  S L R  ++   EF   GSL    H T                PLS      
Sbjct: 69  V---AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---------------PLSESQIAY 110

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           + R    GL YLH   K  +HRDIK +N+LL  +    ++DFG++ +I  + +   + + 
Sbjct: 111 VSRETLQGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI- 167

Query: 258 GTMGYMPPEYL-----GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  +M PE       GG      + D+++ GI  IE+A +++P
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQ---LCDIWAVGITAIELA-ELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 21/202 (10%)

Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           IG G+ G VY A  +++G  VAIK+++            E+  + + +H NIV  L    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
            G +  ++ E++  GSL   + +T  ++      Q+ ++C           R     L +
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEG-----QIAAVC-----------RECLQALEF 130

Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL 268
           LH     +IHRDIKS N+LL  D    ++DFG   +I    S  ST V GT  +M PE +
Sbjct: 131 LHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 187

Query: 269 GGNTAATVMLDVYSFGILMIEI 290
               A    +D++S GI+ IE+
Sbjct: 188 -TRKAYGPKVDIWSLGIMAIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 22/221 (9%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLR 136
           D  + F+  + IG GSFG VYK     +   VAIK +D ++A     + + E+  L +  
Sbjct: 1   DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
              I +  G    G    +I E++  GS                +  L    PL      
Sbjct: 61  SPYITRYYGSYLKGTKLWIIMEYLGGGS----------------ALDLLKPGPLEETYIA 104

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            I+R +  GL YLH   K  IHRDIK++NVLL    +  ++DFG+A ++  +    +T V
Sbjct: 105 TILREILKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN 297
            GT  +M PE +   +A     D++S GI  IE+A    PN
Sbjct: 163 -GTPFWMAPEVI-KQSAYDFKADIWSLGITAIELAKGEPPN 201

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 74.2 bits (182), Expect = 6e-15
 Identities = 57/211 (27%), Positives = 103/211 (48%), Gaps = 16/211 (7%)

Query: 90  IGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVK 142
           +G GSFG VY+       K  +   VA+K +++ A    R EF  E   +      ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           +LG  + G   +++ E + +G L  +L    R+   +         P   E  +++   +
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEM-IQMAAEI 128

Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTMG 261
           A+G+AYL+   K  +HRD+ + N ++  DF   I DFG+ R I +T +     +    + 
Sbjct: 129 ADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           +M PE L  +   T   D++SFG+++ EI +
Sbjct: 187 WMAPESL-KDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 74.3 bits (182), Expect = 6e-15
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 21/202 (10%)

Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           IG+GS G V  A +  +G  VA+KK+D    Q       E+  +    H N+V +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
            G +  ++ EF+E G+L   +  T  N++     Q+ ++C LS          V   L+Y
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTRMNEE-----QIATVC-LS----------VLRALSY 133

Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL 268
           LH   + +IHRDIKS ++LL SD    +SDFG   ++        + V GT  +M PE +
Sbjct: 134 LH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVI 190

Query: 269 GGNTAATVMLDVYSFGILMIEI 290
                 T  +D++S GI++IE+
Sbjct: 191 SRLPYGT-EVDIWSLGIMVIEM 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 73.9 bits (181), Expect = 9e-15
 Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 30/237 (12%)

Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLD---KDAFQG 121
           DP ++++   +  D    FS  + IG GSFG VY A+ + +   VAIKK+    K + + 
Sbjct: 1   DPDVAELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 58

Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS 181
           +++   E+  L KLRH N ++  G         L+ E+             S +D ++  
Sbjct: 59  WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG----------SASDLLEVH 108

Query: 182 KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
           K+     PL       +  G   GLAYLH     +IHRD+K+ N+LL       + DFG 
Sbjct: 109 KK-----PLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGS 161

Query: 242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATV--MLDVYSFGILMIEIATQIRP 296
           A  +  ++  V     GT  +M PE +           +DV+S GI  IE+A +  P
Sbjct: 162 ASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 31/201 (15%)

Query: 105 SGVTVAIKKLDKDAFQGFRE---FRAEMETLGKLRHRNIVKILGYCASGLDRVL-IYEFV 160
           +G  VAIK L  DA +   +   FR E     +L H NIV +L    +    +  ++E+V
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRD 220
              +L + L         DG         L      +++  V + LA  H   + I+HRD
Sbjct: 62  PGRTLREVLAA-------DG--------ALPAGETGRLMLQVLDALACAH--NQGIVHRD 104

Query: 221 IKSSNVLLD-SDFEAH--ISDFGL------ARRIDTSHSHVSTQVAGTMGYMPPEYLGGN 271
           +K  N+++  +    H  + DFG+       R  D +    +T+V GT  Y  PE L G 
Sbjct: 105 LKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGE 164

Query: 272 TAATVMLDVYSFGILMIEIAT 292
              T   D+Y++G++ +E  T
Sbjct: 165 -PVTPNSDLYAWGLIFLECLT 184

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 78/291 (26%), Positives = 131/291 (45%), Gaps = 44/291 (15%)

Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLD----KDAFQGFREFRAEMETLGKLRH 137
           NF  +K IG G F  VY+A  L  GV VA+KK+      DA +   +   E++ L +L H
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDA-KARADCIKEIDLLKQLNH 61

Query: 138 RNIVKILGYCASGLDRV---LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
            N++K   Y AS ++     ++ E  + G L + +    +   +   K +       W+ 
Sbjct: 62  PNVIK---YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-------WKY 111

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
            V++     + L ++H   + ++HRDIK +NV + +     + D GL R   +S +  + 
Sbjct: 112 FVQL----CSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAH 164

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR 314
            + GT  YM PE +  N       D++S G L+ E+A    P       G ++ L     
Sbjct: 165 SLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSP-----FYGDKMNLYSLC- 217

Query: 315 TMEARNKEIEMVD-SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYV 364
                 K+IE  D   +  +  SE    E  ++  MC N    +RP ++YV
Sbjct: 218 ------KKIEQCDYPPLPSDHYSE----ELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 27/213 (12%)

Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKI 143
           +G+G FG V   +      ++G  VA+K L  ++      + + E+E L  L H NIVK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 144 LGYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            G C         LI EF+ +GSL ++L    RN +    KQ      L +  ++     
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQ-----LKYAVQI----- 118

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH--VSTQVAGT 259
              G+ YL    +  +HRD+ + NVL++S+ +  I DFGL + I+T   +  V   +   
Sbjct: 119 -CKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP 175

Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           + +  PE L   +   +  DV+SFG+ + E+ T
Sbjct: 176 VFWYAPECL-IQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 28/214 (13%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHRNIVKILGY 146
           IG+G++G VYK +   +G  VA+KK+  ++ +      A  E+  L +L+H NIV +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG----V 202
                   LI+EF+                 +D  K L+SL P       ++V+     +
Sbjct: 68  LMQESRLYLIFEFL----------------SMDLKKYLDSL-PKGQYMDAELVKSYLYQI 110

Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
             G+ + H   + ++HRD+K  N+L+D+     ++DFGLAR        V T    T+ Y
Sbjct: 111 LQGILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-VRVYTHEVVTLWY 167

Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             PE L G+   +  +D++S G +  E+AT+ +P
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATK-KP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 60/214 (28%), Positives = 109/214 (50%), Gaps = 25/214 (11%)

Query: 90  IGDGSFGFVYK--AKLSSGVTVAIKKLDKDAFQGF--REFRAEMETLGKLRHRNIVKILG 145
           +G+G++  VYK  +KL+  + VA+K++  +  +G      R E+  L  L+H NIV +  
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
              +     L++E+++   L Q+L      DD   S  ++++    ++        +  G
Sbjct: 72  IIHTEKSLTLVFEYLDK-DLKQYL------DDCGNSINMHNVKLFLFQ--------LLRG 116

Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
           L Y H   + ++HRD+K  N+L++   E  ++DFGLAR         S +V  T+ Y PP
Sbjct: 117 LNYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPP 173

Query: 266 EYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           + L G+T  +  +D++  G +  E++T  RP  P
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTG-RPLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 30/237 (12%)

Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLD---KDAFQG 121
           DP ++++   E  D    F+  + IG GSFG VY A+ + +   VAIKK+    K + + 
Sbjct: 11  DPEIAELFFKE--DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK 68

Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS 181
           +++   E++ L +++H N ++  G         L+ E+             S +D ++  
Sbjct: 69  WQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG----------SASDLLEVH 118

Query: 182 KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
           K+     PL       I  G   GLAYLH     +IHRDIK+ N+LL    +  ++DFG 
Sbjct: 119 KK-----PLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGS 171

Query: 242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATV--MLDVYSFGILMIEIATQIRP 296
           A     ++S V     GT  +M PE +           +DV+S GI  IE+A +  P
Sbjct: 172 ASIASPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 61/213 (28%), Positives = 90/213 (42%), Gaps = 36/213 (16%)

Query: 90  IGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFRE---FRAEMETLGKLRHRNIVKILG 145
           +G G FG V   K+ S   T A+K + K       +     +E E L +  H  IVK   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVK--- 57

Query: 146 YCASGLDRVLIY---EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
              +  D+  IY   E+   G L   L D    D+              +  R   +  V
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDE--------------YTARF-YIACV 102

Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
                YLH   + II+RD+K  N+LLDS+    + DFG A+++  S     T   GT  Y
Sbjct: 103 VLAFEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL-KSGQKTWTFC-GTPEY 158

Query: 263 MPPEYL---GGNTAATVMLDVYSFGILMIEIAT 292
           + PE +   G + +     D +S GIL+ E+ T
Sbjct: 159 VAPEIILNKGYDFSV----DYWSLGILLYELLT 187

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 27/205 (13%)

Query: 89  IIGDGSFGFVYKA-KLSSGVTVAIKKLDKD-AFQGFREFRAEMETLGKLRHRNIVKILGY 146
           I+G G+ G VYKA  L +   +A+K +  D   +  ++  +E+E L K     I+   G 
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
                   +  EF++ GSLD +       + V G                +I   V  GL
Sbjct: 68  FFVENRISICTEFMDGGSLDVY---RKIPEHVLG----------------RIAVAVVKGL 108

Query: 207 AYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE 266
            YL  L+  I+HRD+K SN+L+++  +  + DFG++ ++  S   ++    GT  YM PE
Sbjct: 109 TYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPE 163

Query: 267 YLGGNTAATVMLDVYSFGILMIEIA 291
            + G     +  DV+S GI  +E+A
Sbjct: 164 RISGEQYG-IHSDVWSLGISFMELA 187

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 70/215 (32%), Positives = 102/215 (47%), Gaps = 36/215 (16%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKL------DKDAFQGFREFRAEMETLGKLRHRNIVK 142
           IG G++G VYKA+   SG  VA+K +      D       RE  A ++ L    H NIV+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREV-ALLKRLEAFDHPNIVR 66

Query: 143 ILGYCASG-LDR----VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP--LSWETR 195
           ++  CA+   DR     L++E V                D D    L+ + P  L  ET 
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV----------------DQDLRTYLDKVPPPGLPAETI 110

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
             ++R    GL +LH     I+HRD+K  N+L+ S  +  ++DFGLAR    S     T 
Sbjct: 111 KDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTP 166

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           V  T+ Y  PE L  +T AT  +D++S G +  E+
Sbjct: 167 VVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 37/99 (37%), Positives = 51/99 (51%), Gaps = 6/99 (6%)

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           KI   +   L YLH     +IHRD+K SNVL++ + +  + DFG++  +    S   T  
Sbjct: 107 KIAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTID 163

Query: 257 AGTMGYMPPEYLGGNTAAT---VMLDVYSFGILMIEIAT 292
           AG   YM PE +          V  DV+S GI MIE+AT
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT 202

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 71.8 bits (176), Expect = 4e-14
 Identities = 63/229 (27%), Positives = 110/229 (48%), Gaps = 36/229 (15%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKL---DKDAFQGFREFRAEMETLGKLRH 137
           D +   + IG+G++G VYKA+   +  T+A+KK+    +D        R E+  L +++H
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQH 60

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV- 196
            NIV++     S     L++E++                D+D  K ++S    +   R+ 
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYL----------------DLDLKKHMDSSPDFAKNPRLI 104

Query: 197 -----KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHS 250
                +I+RG+A    Y H     ++HRD+K  N+L+D    A  ++DFGLAR       
Sbjct: 105 KTYLYQILRGIA----YCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158

Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
             + +V  T+ Y  PE L G+   +  +D++S G +  E+  Q +P  P
Sbjct: 159 TFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ-KPLFP 205

Length = 294

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 31/215 (14%)

Query: 88  KIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIV 141
           K++G G+FG VYK        +  + VAIK L++    +   EF  E   +  + H ++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++LG C S   + L+ + + +G L  ++H+   + D  GS+ L     L+W  ++     
Sbjct: 73  RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHE---HKDNIGSQLL-----LNWCVQI----- 118

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
            A G+ YL   E+ ++HRD+ + NVL+ S     I+DFGLAR ++      +       G
Sbjct: 119 -AKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD----GG 171

Query: 262 YMPPEYLGGNT----AATVMLDVYSFGILMIEIAT 292
            MP +++          T   DV+S+G+ + E+ T
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 71.7 bits (175), Expect = 4e-14
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 21/221 (9%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH 137
           D    ++  + IG G+ G V+ A  +++G  VAIK+++            E+  + +L++
Sbjct: 16  DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKN 75

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV  L     G +  ++ E++  GSL   + +T  ++      Q+ ++C         
Sbjct: 76  PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDE-----AQIAAVC--------- 121

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
             R     L +LH     +IHRDIKS NVLL  D    ++DFG   +I    S  ST V 
Sbjct: 122 --RECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 176

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNL 298
           GT  +M PE +    A    +D++S GI+ IE+     P L
Sbjct: 177 GTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 24/218 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRN 139
           D+F     +G G+ G V K     SG+ +A K +  +     R +   E++ L +     
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSR-NDDVDGSKQLNSLCPLSWETRVKI 198
           IV   G   S  +  +  E ++ GSLDQ L    R  +++ G                KI
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG----------------KI 104

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
              V  GL YL    K I+HRD+K SN+L++S  E  + DFG++ ++      ++    G
Sbjct: 105 SIAVLRGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVG 160

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           T  YM PE L G T  TV  D++S G+ ++E+A    P
Sbjct: 161 TRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 28/224 (12%)

Query: 83  NFSTDKIIGDGSFGFVYKAKLSSGVTV----AIKKLDKDAF----QGFREFRAEMETLGK 134
           NF   K++G G++G V+  +  +G       A+K L K A     +     R E   L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 135 LRHRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           +R    +  L Y      ++ LI ++V  G +  + H   R++                E
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEM--FTHLYQRDN--------------FSE 104

Query: 194 TRVKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
             V+   G +   L +LH L   I++RDIK  N+LLDS+    ++DFGL++   +     
Sbjct: 105 DEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER 162

Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT+ YM PE + G       +D +S GIL+ E+ T   P
Sbjct: 163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 70.8 bits (173), Expect = 5e-14
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 23/219 (10%)

Query: 83  NFSTDKIIGDGSFGFVYKAKLSSGVTVAIKK---LDKDAFQGFREFRAEMETLGKLRHRN 139
            +   K IG+GSFG +Y AK  S     + K   L K   +     + E+  L K++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKI 198
           IV             ++ E+ + G L + ++   R   V  S+ Q+     LSW  ++ +
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRIN---RQRGVLFSEDQI-----LSWFVQISL 112

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-FEAHISDFGLARRIDTSHSHVSTQVA 257
                 GL ++H  ++ I+HRDIKS N+ L  +   A + DFG+AR+++ S     T   
Sbjct: 113 ------GLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CV 163

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +  N       D++S G ++ E+ T   P
Sbjct: 164 GTPYYLSPE-ICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 70.4 bits (172), Expect = 8e-14
 Identities = 74/283 (26%), Positives = 120/283 (42%), Gaps = 45/283 (15%)

Query: 90  IGDGSFGFVYKA-----KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V K      K    V V I K D +      E   E   + +L +  IV+++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
           G C      +L+ E  E G L+++L    +N  V   K +  L           V  V+ 
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFL---QKNKHVT-EKNITEL-----------VHQVSM 106

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT--MGY 262
           G+ YL   E   +HRD+ + NVLL +   A ISDFGL++ +    ++   +  G   + +
Sbjct: 107 GMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKW 164

Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIE-IATQIRPNLPVVLDGQEVGLLEWARTMEARNK 321
             PE +     ++   DV+SFG+LM E  +   +P     + G EV              
Sbjct: 165 YAPECMNYYKFSSKS-DVWSFGVLMWEAFSYGQKPYKG--MKGNEV-------------- 207

Query: 322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYV 364
             +M++S   R E  +    E + +  +C      ERP  + V
Sbjct: 208 -TQMIESG-ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 24/226 (10%)

Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR-EFRAEMETLG 133
           EL D  D+F     +G G+ G V K +   SG+ +A K +  +     R +   E++ L 
Sbjct: 1   ELKD--DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58

Query: 134 KLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           +     IV   G   S  +  +  E ++ GSLDQ L +  R               +  E
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---------------IPEE 103

Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
              K+   V  GLAYL   +  I+HRD+K SN+L++S  E  + DFG++ ++  S   ++
Sbjct: 104 ILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 159

Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
               GT  YM PE L G T  +V  D++S G+ ++E+A    P  P
Sbjct: 160 NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.9 bits (174), Expect = 8e-14
 Identities = 37/106 (34%), Positives = 55/106 (51%), Gaps = 12/106 (11%)

Query: 197 KIVRGVANGLAYL---HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
           K+   +   L YL   HG    +IHRD+K SN+LLD+     + DFG++ R+  S +   
Sbjct: 118 KMTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK-- 171

Query: 254 TQVAGTMGYMPPEYLGGNTAAT---VMLDVYSFGILMIEIATQIRP 296
           T+ AG   YM PE +          +  DV+S GI ++E+AT   P
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 70.9 bits (173), Expect = 8e-14
 Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 21/227 (9%)

Query: 73  SMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMET 131
           S+  + D    ++  + IG G+ G VY A  +++G  VAIK+++            E+  
Sbjct: 10  SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV 69

Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           + + ++ NIV  L     G +  ++ E++  GSL   + +T  ++      Q+ ++C   
Sbjct: 70  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-----QIAAVC--- 121

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
                   R     L +LH     +IHRDIKS N+LL  D    ++DFG   +I    S 
Sbjct: 122 --------RECLQALDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171

Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNL 298
            ST V GT  +M PE +    A    +D++S GI+ IE+     P L
Sbjct: 172 RSTMV-GTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 70.8 bits (173), Expect = 9e-14
 Identities = 69/235 (29%), Positives = 108/235 (45%), Gaps = 30/235 (12%)

Query: 70  SQISMSELIDATDNFSTDKIIGDGSFGFVYK-AKLSSGVTVAIKKLD--KDAFQGFREFR 126
           S + +  L D TD +   + IG G++G VYK      G   A+K LD   D  +   E  
Sbjct: 10  SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE---EIE 66

Query: 127 AEMETLGKL-RHRNIVKILG--YCA---SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
           AE   L  L  H N+VK  G  Y A    G    L+ E    GS+ + +          G
Sbjct: 67  AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC----G 122

Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG 240
            +   ++  +S+     I+ G   GL +LH     IIHRD+K +N+LL ++    + DFG
Sbjct: 123 QRLDEAM--ISY-----ILYGALLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFG 173

Query: 241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIA 291
           ++ ++ ++    +T V GT  +M PE +      + +     DV+S GI  IE+ 
Sbjct: 174 VSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 60/215 (27%), Positives = 110/215 (51%), Gaps = 27/215 (12%)

Query: 90  IGDGSFGFVYK--AKLSSGVTVAIKKLDKDAFQGF--REFRAEMETLGKLRHRNIVKILG 145
           +G+G++  V+K  +KL+  + VA+K++  +  +G      R E+  L  L+H NIV +  
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-VRGVAN 204
              +     L++E+++   L Q++      DD      +++         VKI +  +  
Sbjct: 72  IVHTDKSLTLVFEYLDK-DLKQYM------DDCGNIMSMHN---------VKIFLYQILR 115

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
           GLAY H   + ++HRD+K  N+L++   E  ++DFGLAR         S +V  T+ Y P
Sbjct: 116 GLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRP 172

Query: 265 PEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           P+ L G++  +  +D++  G +  E+A+  RP  P
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASG-RPLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 62/214 (28%), Positives = 88/214 (41%), Gaps = 28/214 (13%)

Query: 88  KIIGDGSFGFVYKA-KLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIVKI 143
           K I  G+FG VY A K S+G   AIK L K    A       +AE   +        V  
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 144 LGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           L Y     D + L+ E++  G     +            K L  L P  W    + +  V
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLI------------KTLGGL-PEDWAK--QYIAEV 106

Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
             G+  LH   + IIHRDIK  N+L+D      ++DFGL+R     +   + +  GT  Y
Sbjct: 107 VLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDY 159

Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           + PE + G      M D +S G ++ E      P
Sbjct: 160 LAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 65/215 (30%), Positives = 95/215 (44%), Gaps = 35/215 (16%)

Query: 88  KIIGDGSFGFVYKAKLS-SGVTVAIKKLDK------DAFQGFREFRAEMETLGKLRHRNI 140
           K IG G++G V  AK S +   VAIKK+        DA +  RE +     L  L H N+
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK----LLRHLDHENV 66

Query: 141 VKILGYCASGL-----DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           + I             D  ++YE      +D  LH   R      S Q      LS +  
Sbjct: 67  IAIKDIMPPPHREAFNDVYIVYEL-----MDTDLHQIIR------SSQ-----TLSDDHC 110

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
              +  +  GL Y+H     ++HRD+K SN+LL+++ +  I DFGLAR        ++  
Sbjct: 111 QYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEY 168

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           V  T  Y  PE L   +  T  +DV+S G +  E+
Sbjct: 169 VV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 22/221 (9%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLR 136
           D  + F+  + IG GSFG V+K     +   VAIK +D ++A     + + E+  L +  
Sbjct: 1   DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
              + K  G    G    +I E++  GS                +  L    P       
Sbjct: 61  SPYVTKYYGSYLKGTKLWIIMEYLGGGS----------------ALDLLRAGPFDEFQIA 104

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            +++ +  GL YLH  +K  IHRDIK++NVLL    +  ++DFG+A ++  +    +T V
Sbjct: 105 TMLKEILKGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN 297
            GT  +M PE +   +A     D++S GI  IE+A    PN
Sbjct: 163 -GTPFWMAPEVI-QQSAYDSKADIWSLGITAIELAKGEPPN 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 71/220 (32%), Positives = 107/220 (48%), Gaps = 35/220 (15%)

Query: 88  KIIGDGSFGFVYKAK----LSSGVTVAIKKLDKDAFQGFREFRAEME--TLGKLRHRNIV 141
           K++G GSFG V+  +      +G   A+K L K   +     R +ME   L ++ H  IV
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 142 KILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-V 199
           K L Y      ++ LI +F+  G L   L           SK++     +  E  VK  +
Sbjct: 62  K-LHYAFQTEGKLYLILDFLRGGDLFTRL-----------SKEV-----MFTEEDVKFYL 104

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR-IDTSHSHVSTQVAG 258
             +A  L +LH L   II+RD+K  N+LLD +    ++DFGL++  ID  H   +    G
Sbjct: 105 AELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCG 160

Query: 259 TMGYMPPEYLG--GNTAATVMLDVYSFGILMIEIATQIRP 296
           T+ YM PE +   G+T +    D +SFG+LM E+ T   P
Sbjct: 161 TVEYMAPEVVNRRGHTQSA---DWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 28/213 (13%)

Query: 90  IGDGSFGFVYKAKLS-SGVTVAIKKLD---KDAFQGFREFRAEMETLGKLRHRNIVKILG 145
           IG GSFG VY A  S +   VA+KK+    K   + +++   E++ L +L+H N ++  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
                    L+ E+             S +D ++  K+     PL       I  G   G
Sbjct: 89  CYLKEHTAWLVMEYCLG----------SASDLLEVHKK-----PLQEVEIAAITHGALQG 133

Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
           LAYLH     +IHRDIK+ N+LL    +  ++DFG A +   ++S V     GT  +M P
Sbjct: 134 LAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAP 186

Query: 266 EYLGGNTAATV--MLDVYSFGILMIEIATQIRP 296
           E +           +DV+S GI  IE+A +  P
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 29/223 (13%)

Query: 90  IGDGSFGFVYKAKLSSGVT---VAIKKLDKDAFQG--FREFRAEMETLGKLRHRNIVKIL 144
           +G+GS+  VYK +  S +T   VA+K++  +  +G  F   R E   L  L+H NIV + 
Sbjct: 13  LGEGSYATVYKGR--SKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69

Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-VRGVA 203
               +     L++E+++   L Q++      DD  G   +++         V++ +  + 
Sbjct: 70  DIIHTKKTLTLVFEYLDT-DLKQYM------DDCGGGLSMHN---------VRLFLFQLL 113

Query: 204 NGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYM 263
            GLAY H   + ++HRD+K  N+L+    E  ++DFGLAR         S +V  T+ Y 
Sbjct: 114 RGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYR 170

Query: 264 PPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE 306
           PP+ L G+T  +  LD++  G +  E+AT  RP  P   D ++
Sbjct: 171 PPDVLLGSTEYSTSLDMWGVGCIFYEMATG-RPLFPGSTDVED 212

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 23/220 (10%)

Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRNIVKILGY 146
           +G+GS+  VYK     +G  VA+K +     +G  F   R E   L  L+H NIV +   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDI 71

Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
             +      ++E++    L Q++            +    L P  +  R+ + + +  GL
Sbjct: 72  IHTKETLTFVFEYMHT-DLAQYM-----------IQHPGGLHP--YNVRLFMFQ-LLRGL 116

Query: 207 AYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE 266
           AY+HG  + I+HRD+K  N+L+    E  ++DFGLAR         S++V  T+ Y PP+
Sbjct: 117 AYIHG--QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPD 173

Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE 306
            L G T  +  LD++  G + IE+  Q +P  P V D  E
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEM-LQGQPAFPGVSDVFE 212

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 57/243 (23%), Positives = 98/243 (40%), Gaps = 51/243 (20%)

Query: 87  DKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA--------------EMET 131
              +G+G++G V KA    +G  VAIKK+                           E++ 
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 132 LGKLRHRNIVKILG-YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL 190
           + +++H NI+ ++  Y        L+ + + +                D  K ++    L
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFIN-LVMDIMAS----------------DLKKVVDRKIRL 116

Query: 191 SWETRVK-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR----- 244
           + E++VK I+  + NGL  LH  +   +HRD+  +N+ ++S     I+DFGLARR     
Sbjct: 117 T-ESQVKCILLQILNGLNVLH--KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPP 173

Query: 245 --------IDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
                            T    T+ Y  PE L G       +D++S G +  E+ T  +P
Sbjct: 174 YSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KP 232

Query: 297 NLP 299
             P
Sbjct: 233 LFP 235

Length = 335

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 65/255 (25%), Positives = 115/255 (45%), Gaps = 40/255 (15%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKL---DKDAFQGFREFRAEMETLGKLRH 137
           D+    K +G G+FG V+  +   S    A+K +   +    +  +    E   L ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 138 RNIVKILGYCASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
             I+++  +      R L  + E+V  G L  +L    RN     S + ++   L + + 
Sbjct: 61  PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL----RN-----SGRFSNSTGLFYAS- 108

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
            +IV      L YLH  E  I++RD+K  N+LLD +    ++DFG A+++        T 
Sbjct: 109 -EIV----CALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKL---RDRTWT- 157

Query: 256 VAGTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP----NLPVVLDGQEVG 308
           + GT  Y+ PE +   G N A    +D ++ GIL+ E+     P    N   + +    G
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKA----VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213

Query: 309 LLEWARTMEARNKEI 323
            LE+ R ++   K++
Sbjct: 214 KLEFPRHLDLYAKDL 228

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 68.6 bits (167), Expect = 4e-13
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 22/215 (10%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLR 136
           D  + F+  + IG GSFG V+K     +   VAIK +D ++A     + + E+  L +  
Sbjct: 1   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
              + K  G         +I E++  GS    L                   PL      
Sbjct: 61  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----------------PLDETQIA 104

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            I+R +  GL YLH  +K  IHRDIK++NVLL    E  ++DFG+A ++  +    +T V
Sbjct: 105 TILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            GT  +M PE +   +A     D++S GI  IE+A
Sbjct: 163 -GTPFWMAPEVI-KQSAYDSKADIWSLGITAIELA 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 72/237 (30%), Positives = 112/237 (47%), Gaps = 26/237 (10%)

Query: 76  ELIDATDNFSTDKIIGDGSFGFVYK-AKLSSGVTVAIKKLDKDAFQGFR-EFRAEMETLG 133
           EL D  D+F     +G G+ G V+K +   SG+ +A K +  +     R +   E++ L 
Sbjct: 1   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58

Query: 134 KLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           +     IV   G   S  +  +  E ++ GSLDQ L    R              P    
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-------------IPEQIL 105

Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
            +V I   V  GL YL    K I+HRD+K SN+L++S  E  + DFG++ ++  S   ++
Sbjct: 106 GKVSI--AVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 159

Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL 310
               GT  YM PE L G T  +V  D++S G+ ++E+A    P  P   D +E+ L+
Sbjct: 160 NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPP--DAKELELM 213

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 67.7 bits (165), Expect = 6e-13
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 28/208 (13%)

Query: 90  IGDGSFGFV----YKAKLSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V    YK +    + VAIK L  +  +  R E   E E + +L +  IV+++
Sbjct: 3   LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 145 GYC-ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA 203
           G C A  L  +L+ E    G L+++L  + + D++            +    V+++  V+
Sbjct: 62  GVCEAEAL--MLVMEMASGGPLNKFL--SGKKDEI------------TVSNVVELMHQVS 105

Query: 204 NGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT--MG 261
            G+ YL G  K  +HRD+ + NVLL +   A ISDFGL++ +    S+   + AG   + 
Sbjct: 106 MGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK 163

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIE 289
           +  PE +     ++   DV+S+GI M E
Sbjct: 164 WYAPECINFRKFSS-RSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 67.7 bits (166), Expect = 6e-13
 Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 39/223 (17%)

Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQG---FREFRAEMETLGKLRHRNIVKILG 145
           I  G++G V+ A K S+G   AIK + K          +   E + L + +   +VK+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 146 YCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
           Y   G   + L+ E++  G L               +  L ++  L  +     +  +  
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDL---------------ASLLENVGSLDEDVARIYIAEIVL 104

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA----------RRIDTSHSHVST 254
            L YLH     IIHRD+K  N+L+DS+    ++DFGL+             D        
Sbjct: 105 ALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK--- 159

Query: 255 QVAGTMGYMPPE-YLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           ++ GT  Y+ PE  LG   + TV  D +S G ++ E    I P
Sbjct: 160 RIVGTPDYIAPEVILGQGHSKTV--DWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 67.6 bits (165), Expect = 7e-13
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 30/219 (13%)

Query: 82  DNFST--DKIIGDGSFGFVYKA--KLSSG--VTVAIKKL-DKDAFQGFREFRAEMETLGK 134
           DN S   ++I+G G FG + +   KL S   + VAI  L    + +  R F AE  TLG+
Sbjct: 3   DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62

Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
             H NIV++ G    G   +++ E++ NG+LD +L    +++    + QL  + P     
Sbjct: 63  FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLP----- 114

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
                 G+A+G+ YL   E   +H+ + +  VL++SD    IS F   +  D S +  +T
Sbjct: 115 ------GLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE-DKSEAIYTT 165

Query: 255 QVAGTMG-YMPPEYL--GGNTAATVMLDVYSFGILMIEI 290
               +   +  PE +     ++A+   DV+SFGI+M E+
Sbjct: 166 MSGKSPVLWAAPEAIQYHHFSSAS---DVWSFGIVMWEV 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 67.9 bits (166), Expect = 8e-13
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 28/223 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLG----KLR 136
           D +   + IG+G++G VYKA+  ++G  VA+KK            R EM+  G     LR
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-----------RLEMDEEGIPPTALR 49

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH------DTSRNDDVDGSKQLNSLCPL 190
             +++++L      + R+L  E VE  +    L+      D+     +D + +     PL
Sbjct: 50  EISLLQMLSESIY-IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGR-PL 107

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSH 249
             +T    +  +  G+A+ H     ++HRD+K  N+L+D       I+D GL R      
Sbjct: 108 PAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV 165

Query: 250 SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
              + ++  T+ Y  PE L G+T  +  +D++S G +  E++ 
Sbjct: 166 KSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 89/350 (25%), Positives = 138/350 (39%), Gaps = 80/350 (22%)

Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D     K++G G+FG V +A      K SS  TVA+K L + A     E +A M  L  L
Sbjct: 7   DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS--EHKALMSELKIL 64

Query: 136 ----RHRNIVKILGYCASGLDRVL-IYEFVENGSLDQWL--------------------- 169
                H N+V +LG C      ++ I EF + G+L  +L                     
Sbjct: 65  IHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRF 124

Query: 170 ------------------------HDTSRNDDVDGSKQLNSL--CPLSWETRVKIVRGVA 203
                                      S +   +  ++ + L   PL+ E  +     VA
Sbjct: 125 RAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVA 184

Query: 204 NGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG-TMGY 262
            G+ +L    +  IHRD+ + N+LL  +    I DFGLAR I     +V    A   + +
Sbjct: 185 RGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242

Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE 322
           M PE +  +   T   DV+SFG+L+ EI +      P    G ++            N+E
Sbjct: 243 MAPESI-FDKVYTTQSDVWSFGVLLWEIFSLGASPYP----GVQI------------NEE 285

Query: 323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV 372
                 + +R    E    E +RI   C     +ERP  S +V++L +L+
Sbjct: 286 FCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 77/295 (26%), Positives = 120/295 (40%), Gaps = 63/295 (21%)

Query: 90  IGDGSFGFVYKAKLSSGVT-VAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVKILGYC 147
           IG G+FG V+  +L +  T VA+K   +      + +F  E   L +  H NIV+++G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  ++ E V+ G    +L         +G +       L  +  +++V   A G+ 
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRT-------EGPR-------LKVKELIQMVENAAAGME 108

Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP--- 264
           YL    K  IHRD+ + N L+       ISDFG++R  +    + ST   G M  +P   
Sbjct: 109 YLE--SKHCIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYAST---GGMKQIPVKW 162

Query: 265 --PEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE 322
             PE L     ++   DV+SFGIL+ E  +              +G + +A         
Sbjct: 163 TAPEALNYGRYSSES-DVWSFGILLWEAFS--------------LGAVPYANL------- 200

Query: 323 IEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERPAMSYVVQLL 368
                SN    E  E GVR           +R+   C      +RP+ S V Q L
Sbjct: 201 -----SNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 35/213 (16%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKK---------LDKDAFQGFREFRAEMETLGKLRHRN 139
           IG+GS+G V+K +   +G  VAIKK         + K A    RE R     L +L+H N
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL---REIR----MLKQLKHPN 61

Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           +V ++          L++E+ ++      L++  +N      + +            KI+
Sbjct: 62  LVNLIEVFRRKRKLHLVFEYCDH----TVLNELEKN-----PRGVPE------HLIKKII 106

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
                 + + H      IHRD+K  N+L+    +  + DFG AR +       +  VA T
Sbjct: 107 WQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-T 163

Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
             Y  PE L G+T     +DV++ G +  E+ T
Sbjct: 164 RWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 33/218 (15%)

Query: 88  KIIGDGSFGFVYKAKL----SSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHRNIVK 142
           +++G+GSFG   +A L    +S    A+K++    +     + R E   L K++H NIV 
Sbjct: 6   RVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62

Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP----LSWETRVKI 198
                 +     ++ E+ + G L Q +             Q   L P    L W  ++ +
Sbjct: 63  FKESFEADGHLYIVMEYCDGGDLMQKIKL-----------QRGKLFPEDTILQWFVQMCL 111

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
                 G+ ++H  EK ++HRDIKS N+ L  + +  + DFG AR + +  ++  T V G
Sbjct: 112 ------GVQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-G 162

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           T  Y+PPE +  N       D++S G ++ E+ T   P
Sbjct: 163 TPYYVPPE-IWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 21/219 (9%)

Query: 73  SMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMET 131
           S+  + D    ++  + IG G+ G VY A  +++G  VAI++++            E+  
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           + + ++ NIV  L     G +  ++ E++  GSL   + +T  ++      Q+ ++C   
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-----QIAAVC--- 122

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
                   R     L +LH     +IHRDIKS N+LL  D    ++DFG   +I    S 
Sbjct: 123 --------RECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172

Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            ST V GT  +M PE +    A    +D++S GI+ IE+
Sbjct: 173 RSTMV-GTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 25/218 (11%)

Query: 90  IGDGSFGFVYKAKLS-SGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHRNIVKILGY 146
           +G G++G VYK     +GVT+A+K  +L+ D  + F +   E++ L K     IV   G 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYGA 67

Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
                   +  E+++ GSLD+ L+      +      L            +I   V  GL
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLR-----------RITYAVVKGL 115

Query: 207 AYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE 266
            +L   E  IIHRD+K +NVL++ + +  + DFG++  +  S   ++    G   YM PE
Sbjct: 116 KFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAKTNIGCQSYMAPE 171

Query: 267 YLGGNTAA-----TVMLDVYSFGILMIEIATQIRPNLP 299
            +           TV  DV+S G+ ++E+A    P  P
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 39/218 (17%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLD-KDAFQGFREFRA---EMETLGKLRHRNIVK 142
           +++G GS+G V   +  + G    IKKL+ ++A +  RE +A   E + L +L+H NIV 
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR--RERKAAEQEAQLLSQLKHPNIV- 62

Query: 143 ILGYCAS--GLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP----LSWET 194
              Y  S  G D +L  +  F E G L   L            +Q   L P    + W  
Sbjct: 63  --AYRESWEGEDGLLYIVMGFCEGGDLYHKL-----------KEQKGKLLPENQVVEWFV 109

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
           ++      A  L YLH  EK I+HRD+K+ NV L       + D G+AR ++      ST
Sbjct: 110 QI------AMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST 161

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            + GT  YM PE L  N       DV++ G  + E+AT
Sbjct: 162 LI-GTPYYMSPE-LFSNKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 66/224 (29%), Positives = 103/224 (45%), Gaps = 33/224 (14%)

Query: 74  MSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDK---DAFQGFREFRAEM 129
              + + T+ +   + +G G+FG V  A+   +G  VAIKK+ K         R +R E+
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-EL 60

Query: 130 ETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHD--TSRNDDVDGSKQLNSL 187
           + L  LRH NI+ +     S L+   IY   E    D  LH   TSR             
Sbjct: 61  KLLKHLRHENIISLSDIFISPLED--IYFVTELLGTD--LHRLLTSR------------- 103

Query: 188 CPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT 247
            PL  +     +  +  GL Y+H     ++HRD+K SN+L++ + +  I DFGLAR  D 
Sbjct: 104 -PLEKQFIQYFLYQILRGLKYVH--SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160

Query: 248 SHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             + +VST+      Y  PE +       V +D++S G +  E+
Sbjct: 161 QMTGYVSTRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEM 199

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 28/216 (12%)

Query: 90  IGDGSFGFVYKA--KLSSGVTVAIK----------KLDKDAFQGFREFRAEMETLGK-LR 136
           +G G+FG VYK   K +    +A+K          K  ++  +   +  +E+  + + LR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIV+            ++ + +E   L +  +           +++       W   V
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-------WNIFV 120

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++V      L YLH  EK I+HRD+  +N++L  D +  I+DFGLA++         T V
Sbjct: 121 QMVLA----LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKLTSV 173

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            GT+ Y  PE +  N       DV++FG ++ ++ T
Sbjct: 174 VGTILYSCPEIV-KNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)

Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 82

Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 83  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 128

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 129 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 182

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 65.3 bits (159), Expect = 5e-12
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 21/206 (10%)

Query: 90  IGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILG 145
           +G G FG V   ++ ++G   A KKL+K      +G+     E   L K+  R IV +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR-VKIVRGVAN 204
              +  D  L+   +  G L   +++    +            P   E R       + +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEEN------------PGFPEPRACFYTAQIIS 108

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
           GL +LH  ++ II+RD+K  NVLLD+D    ISD GLA  +    S  +   AGT G+M 
Sbjct: 109 GLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMA 165

Query: 265 PEYLGGNTAATVMLDVYSFGILMIEI 290
           PE L G       +D ++ G+ + E+
Sbjct: 166 PELLQGE-EYDFSVDYFALGVTLYEM 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 73/274 (26%), Positives = 111/274 (40%), Gaps = 71/274 (25%)

Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D     K +G G+FG V +A      K ++  TVA+K L + A     E RA M  L  L
Sbjct: 7   DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 64

Query: 136 ----RHRNIVKILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRND-------------- 176
                H N+V +LG C   G   ++I EF + G+L  +L  + R +              
Sbjct: 65  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLR-SKRGEFVPYKTKDARFRQG 123

Query: 177 -------DVDGSKQLNSLC--------------------------------PLSWETRVK 197
                    D  ++L+S+                                  L+ E  + 
Sbjct: 124 KSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLIC 183

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
               VA G+ +L    +  IHRD+ + N+LL  +    I DFGLAR I     +V    A
Sbjct: 184 YSFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 258 G-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
              + +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 242 RLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 24/206 (11%)

Query: 90  IGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILG 145
           +G G FG V   ++ ++G   A KKLDK      +G +    E + L K+  R IV +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG-VAN 204
              +  D  L+   +  G L   +++                 P   E R       +  
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGE--------------PGFPEARAIFYAAQIIC 106

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
           GL +LH  ++ I++RD+K  NVLLD      ISD GLA  ++          AGT GYM 
Sbjct: 107 GLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMA 162

Query: 265 PEYLGGNTAATVMLDVYSFGILMIEI 290
           PE L G       +D ++ G  + E+
Sbjct: 163 PEVLQGEV-YDFSVDWFALGCTLYEM 187

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 30/213 (14%)

Query: 88  KIIGDGSFGFV-YKAKLSSGVTVAIKKLDKDAFQ----GFREFRAEMETLGKLRHRNIVK 142
           K +G G++G V       +G  VAIKKL +  FQ      R +R E+  L  ++H N++ 
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYR-ELRLLKHMKHENVIG 78

Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSK--QLNSLCPLSWETRVK-IV 199
           +L              F  + SLD++ HD        G+   +L     LS E R++ +V
Sbjct: 79  LLDV------------FTPDLSLDRF-HDFYLVMPFMGTDLGKLMKHEKLS-EDRIQFLV 124

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             +  GL Y+H     IIHRD+K  N+ ++ D E  I DFGLAR+ D+      T    T
Sbjct: 125 YQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVT 178

Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
             Y  PE +      T  +D++S G +M E+ T
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 89/350 (25%), Positives = 139/350 (39%), Gaps = 81/350 (23%)

Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D     K +G G+FG V +A      K +S  TVA+K L + A     E++A M  L  L
Sbjct: 7   DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS--EYKALMTELKIL 64

Query: 136 ----RHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLH-------------------- 170
                H N+V +LG C   G   ++I E+ + G+L  +L                     
Sbjct: 65  IHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMK 124

Query: 171 -----------DTSRND-------------DVDGSKQLNSL--CPLSWETRVKIVRGVAN 204
                       +S                DV+  ++ + L   PL+ E  +     VA 
Sbjct: 125 QKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVAR 184

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG-TMGYM 263
           G+ +L    +  IHRD+ + N+LL  +    I DFGLAR I     +V    A   + +M
Sbjct: 185 GMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242

Query: 264 PPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP-VVLDGQEVGLLEWARTMEARNKE 322
            PE +  +   T   DV+SFG+L+ EI +      P V +D +    L+    M A    
Sbjct: 243 APESI-FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA---- 297

Query: 323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV 372
                         E    E + I   C +    +RP  S +V++L +L+
Sbjct: 298 -------------PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 37/98 (37%), Positives = 52/98 (53%), Gaps = 5/98 (5%)

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           KI       L YL   E  IIHRD+K SN+LLD +    + DFG++ ++  S +   T+ 
Sbjct: 111 KIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--KTRD 167

Query: 257 AGTMGYMPPEYLGGNTAA--TVMLDVYSFGILMIEIAT 292
           AG   YM PE +  +      V  DV+S GI + E+AT
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVAT 205

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 28/210 (13%)

Query: 88  KIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEM---ETLGKLRHRNIVKI 143
           +++G GSFG V  A+L  SG   A+K L KD      +    M     L   R+   +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 144 LGYCASGLDRVL-IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG- 201
           L  C    DR+  + EFV  G L   +  + R D                E R +     
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----------------EARARFYAAE 104

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV-AGTM 260
           + + L +LH  +K II+RD+K  NVLLD +    ++DFG+ +  +   +  +T    GT 
Sbjct: 105 ITSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTP 160

Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            Y+ PE L         +D ++ G+L+ E+
Sbjct: 161 DYIAPEIL-QEMLYGPSVDWWAMGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 24/216 (11%)

Query: 90  IGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVK 142
           +G+  FG VYK  L           VAIK L   A    RE F+ E     +L+H NIV 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDV---DGSKQLNS-LCPLSWETRVKI 198
           +LG         +I+ +  +  L ++L   S + DV   D  K + S L P  +   V I
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF---VHI 129

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           V  +A G+ +L      ++H+D+ + NVL+       ISD GL R +  +  +   ++ G
Sbjct: 130 VTQIAAGMEFLS--SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY---KLMG 184

Query: 259 T----MGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
                + +M PE +      ++  D++S+G+++ E+
Sbjct: 185 NSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 16/159 (10%)

Query: 88  KIIGDGSFGFVYKAKLSSGVT---VAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIVKI 143
           K IG+G FG V   +++SG T   V +K+L   A  Q   +F  E +    L+H N+++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA 203
           LG C      +L+ EF   G L  +L    + + +  +    +L  ++ E        +A
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELM--TPDPTTLQRMACE--------IA 110

Query: 204 NGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA 242
            GL +LH  +   IH D+   N LL +D    I D+GL+
Sbjct: 111 LGLLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 37/224 (16%)

Query: 83  NFSTDKIIGDGSFGFVYKAKLSS---GVTVAIKKLDKDAFQGF----REFRAEMETLGKL 135
            +   K +G G++G V  A+ +      TVAIKK+  + F       R  R E++ L   
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAKRALR-ELKLLRHF 58

Query: 136 R-HRNIV-----KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP 189
           R H+NI       I+       + + +YE +    L Q +           S Q     P
Sbjct: 59  RGHKNITCLYDMDIVFP--GNFNELYLYEELMEADLHQIIR----------SGQ-----P 101

Query: 190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSH 249
           L+       +  +  GL Y+H     ++HRD+K  N+L+++D E  I DFGLAR    + 
Sbjct: 102 LTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159

Query: 250 SHVS---TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
              +   T+   T  Y  PE +    + T  +DV+S G ++ E+
Sbjct: 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 32/243 (13%)

Query: 83  NFSTDKIIGDGSFGFVYKA-KLS---SGVTVAIKKLDKDAF----QGFREFRAEMETLGK 134
           NF   +++G G++G V+   K+    +G   A+K L K       +     R E + L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 135 LRHRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           +R    +  L Y      ++ LI ++V  G L   L+                      E
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT----------------E 104

Query: 194 TRVKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           + V++    +   L +LH L   II+RDIK  N+LLDS+    ++DFGL++         
Sbjct: 105 SEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER 162

Query: 253 STQVAGTMGYMPPEYL-GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE 311
           +    GT+ YM PE + GG+      +D +S G+L  E+ T      P  +DG++    E
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS---PFTVDGEQNSQSE 219

Query: 312 WAR 314
            +R
Sbjct: 220 ISR 222

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 38/231 (16%)

Query: 88  KIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVK 142
           ++IG G  G VY A        VA+KK+ +D         + F  E +    L H  IV 
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK----I 198
           +   C+ G        ++E  +L   L    + + +  SK       L+ +T V     I
Sbjct: 67  VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SK------ELAEKTSVGAFLSI 118

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA---------------- 242
              +   + Y+H   K ++HRD+K  N+LL    E  I D+G A                
Sbjct: 119 FHKICATIEYVH--SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176

Query: 243 -RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            R I  S   +  ++ GT  YM PE L G   A+   D+Y+ G+++ ++ T
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 26/223 (11%)

Query: 90  IGDGSFGFVYKAKLSSGVTVA---IKKL-DKDAFQGFREFRAEMETLGKLRHRNIVKILG 145
           IG+G FG V   +   G++ A   +K+L           F  E++   +L H N+++ LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
            C   +  +L+ EF   G L  +L   S    V    Q + L  ++ E        VA+G
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLR--SNRGMVAQMAQKDVLQRMACE--------VASG 112

Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA-RRIDTSHSHVSTQVAGTMGYMP 264
           L +LH  +   IH D+   N  L +D    I D+GLA  +    +       A  + ++ 
Sbjct: 113 LLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLA 170

Query: 265 PEYL---GGNTAA---TVMLDVYSFGILMIEI---ATQIRPNL 298
           PE +   G +      T   +++S G+ M E+   A Q  P+L
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 36/217 (16%)

Query: 83  NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRHR 138
           +F   + +G GSFG V  AK   +G   AIK L K      ++ +    E   L +L H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 139 NIVKIL-GYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
            IV ++  +     +RV  + EFV  G L   L    R  + D +K  ++   L++E   
Sbjct: 79  FIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPN-DVAKFYHAELVLAFE--- 132

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                      YLH   K II+RD+K  N+LLD+     ++DFG A+++       +  +
Sbjct: 133 -----------YLH--SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTL 175

Query: 257 AGTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEI 290
            GT  Y+ PE +   G   A    +D ++ G+L+ E 
Sbjct: 176 CGTPEYLAPEVIQSKGHGKA----VDWWTMGVLLYEF 208

Length = 329

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 61/193 (31%), Positives = 86/193 (44%), Gaps = 37/193 (19%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR---AEMETLGK-LRHRNIVK 142
           K+IG GSFG V  AK  + G   A+K L K A    +E +   AE   L K ++H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 143 ILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            L Y     D++  + ++V  G L  + H                   L  E      R 
Sbjct: 61  -LHYSFQTADKLYFVLDYVNGGEL--FFH-------------------LQRERSFPEPRA 98

Query: 202 ------VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                 +A+ L YLH L   II+RD+K  N+LLDS     ++DFGL +     HS  ++ 
Sbjct: 99  RFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTST 155

Query: 256 VAGTMGYMPPEYL 268
             GT  Y+ PE L
Sbjct: 156 FCGTPEYLAPEVL 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 43/217 (19%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG------FREFRAEMETLGKLR-HRNIV 141
           IG+G+F  V KA+   +G   AIK + K  F+        RE +A    L +L  H NI+
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQA----LRRLSPHPNIL 61

Query: 142 KILGYCASGLDRV-----LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           ++        DR      L++E          L D +  + + G K+     PL  E RV
Sbjct: 62  RL---IEVLFDRKTGRLALVFE----------LMDMNLYELIKGRKR-----PLP-EKRV 102

Query: 197 K-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           K  +  +   L ++H     I HRDIK  N+L+  D    ++DFG  R I +   +  T+
Sbjct: 103 KSYMYQLLKSLDHMHR--NGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TE 157

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
              T  Y  PE L  +      +D+++ G +  EI +
Sbjct: 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 63/214 (29%), Positives = 93/214 (43%), Gaps = 25/214 (11%)

Query: 84  FSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQ----GFREFRAEMETLGKLRHR 138
           +++ K +G G++G V  A    +G  VAIKKL +  FQ      R +R E+  L  ++H 
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYR-ELTLLKHMQHE 74

Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+         GL  V       +   D +L       D+          PLS +    +
Sbjct: 75  NV--------IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH----PLSEDKVQYL 122

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           V  +  GL Y+H     IIHRD+K  N+ ++ D E  I DFGLAR  D       T    
Sbjct: 123 VYQMLCGLKYIH--SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVV 176

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           T  Y  PE +         +D++S G +M E+ T
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.6 bits (152), Expect = 7e-11
 Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 4/109 (3%)

Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
           PL  E  + I R +   LAYLHG  + IIHRD+K+ N+ LD    A + DFG A ++D  
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238

Query: 249 -HSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             +      +GT+    PE L  +       D++S G+++ E++ +   
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.3 bits (149), Expect = 8e-11
 Identities = 52/220 (23%), Positives = 101/220 (45%), Gaps = 42/220 (19%)

Query: 90  IGDGSFGFVYKAKL---SSG--------VTVAIKKLDKDAFQGFREFRAEMETLGKLRHR 138
           +G G+F  +YK  L   S          V+V +K L  D  +    F      + +L H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-RDSLAFFETASLMSQLSHK 61

Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           ++VK+ G C    + +++ E+V+ G LD +LH           ++ N++  L W  ++ +
Sbjct: 62  HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLH-----------REKNNV-SLHW--KLDV 106

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLL--DSDFE-----AHISDFGLARRIDTSHSH 251
            + +A+ L YL   +K ++H ++   N+L+      E       +SD G+   + +    
Sbjct: 107 AKQLASALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER 164

Query: 252 VSTQVAGTMGYMPPEYL-GGNTAATVMLDVYSFGILMIEI 290
           V       + ++ PE +  G  + T+  D +SFG  ++EI
Sbjct: 165 VE-----RIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 64/211 (30%), Positives = 94/211 (44%), Gaps = 34/211 (16%)

Query: 90  IGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVK 142
           +G G++G V   Y  +L     VA+KKL +  FQ      R +R E+  L  ++H N++ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVKKLSR-PFQSLIHARRTYR-ELRLLKHMKHENVIG 78

Query: 143 ILGY---CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           +L       S  +   +Y  V N      L     N+ V   K       LS E    ++
Sbjct: 79  LLDVFTPATSIENFNEVY-LVTN------LMGADLNNIVKCQK-------LSDEHVQFLI 124

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             +  GL Y+H     IIHRD+K SNV ++ D E  I DFGLAR+ D       T    T
Sbjct: 125 YQLLRGLKYIH--SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVAT 178

Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             Y  PE +         +D++S G +M E+
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 36/216 (16%)

Query: 88  KIIGDGSFG--FVYKAKLSSGVTVAIKKLD--KDAFQGFREFRAEMETLGKLRHRNIVKI 143
           K IG+GSFG   + K+K   G    IK+++  K + +   E R E+  L  ++H NIV+ 
Sbjct: 6   KKIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63

Query: 144 LGYCASGLDRVLIY---EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP----LSWETRV 196
             Y  S  +   +Y   ++ E G L + +           + Q   L P    L W   V
Sbjct: 64  --YQESFEENGNLYIVMDYCEGGDLYKKI-----------NAQRGVLFPEDQILDW--FV 108

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +I       LA  H  ++ I+HRDIKS N+ L  D    + DFG+AR ++++     T +
Sbjct: 109 QIC------LALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI 162

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            GT  Y+ PE +  N       D+++ G ++ E+ T
Sbjct: 163 -GTPYYLSPE-ICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 68/226 (30%), Positives = 102/226 (45%), Gaps = 36/226 (15%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQ----GFREFRAEMETLGKLRHRNIVK 142
           ++IG GS+G V  A    +G  VAIKK+  D F+      R  R E++ L  LRH +IV+
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILR-EIKLLRLLRHPDIVE 63

Query: 143 ILGYCASGLDR-----VLIYEFVENGSLDQWLHDTSR-NDDVDGSKQLNSLCPLSWETRV 196
           I         R      +++E +E+      LH   + NDD            L+ E   
Sbjct: 64  IKHIMLPPSRREFKDIYVVFELMESD-----LHQVIKANDD------------LTPEHHQ 106

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVST 254
             +  +   L Y+H     + HRD+K  N+L ++D +  I DFGLAR    DT  +   T
Sbjct: 107 FFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 164

Query: 255 QVAGTMGYMPPEYLGG-NTAATVMLDVYSFGILMIEIATQIRPNLP 299
               T  Y  PE  G   +  T  +D++S G +  E+ T  +P  P
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFP 209

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 36/214 (16%)

Query: 90  IGDGSFGFVY-----KAKLSSGVTVAIKKLDKDAFQGFREFRAEMET--LGKLRHRNIVK 142
           +G GSFG VY     KA     + V +K++           +A  E   L KL H  IVK
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 143 ILGYCASGLDR---VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
              + AS L+R    +I E+ E   LD  L +           Q+       W  ++ + 
Sbjct: 67  ---FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV-----CEWFIQLLL- 117

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
                G+ Y+H  ++ I+HRD+K+ N+ L ++    I DFG++R +  S   ++T   GT
Sbjct: 118 -----GVHYMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGS-CDLATTFTGT 168

Query: 260 MGYMPPEYL---GGNTAATVMLDVYSFGILMIEI 290
             YM PE L   G ++ +    D++S G ++ E+
Sbjct: 169 PYYMSPEALKHQGYDSKS----DIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 60/212 (28%), Positives = 90/212 (42%), Gaps = 33/212 (15%)

Query: 89  IIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEM------ETLGKLRHRNIV 141
           ++G G FG V  A+   +G   AIK L K       E  + M      ET    RH  +V
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 142 KILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQ--LNSLCPLSWETRVKI 198
            +   C    D V  + E+   G L   +H      DV    +    + C          
Sbjct: 66  NLFA-CFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAAC---------- 109

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
              V  GL YLH  E  I++RD+K  N+LLD++    I+DFGL +         ++   G
Sbjct: 110 ---VVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMGFGDRTSTFCG 163

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           T  ++ PE L   T+ T  +D +  G+L+ E+
Sbjct: 164 TPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEM 194

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 64/234 (27%), Positives = 108/234 (46%), Gaps = 38/234 (16%)

Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHRN 139
            +   +++G G+FG V+  +  +    V IK++  +         A  E + L  L H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 140 IVKILGYCASGL-DRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           I+    Y  + L D+ L  + E+   G+L +++     N  +D    L+          V
Sbjct: 61  II---EYYENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDTILHFF--------V 108

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-DFEAHISDFGLARRIDTSHSHVSTQ 255
           +I+      LA  H   K I+HRD+K+ N+LLD       I DFG++ +I +S S   T 
Sbjct: 109 QIL------LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGIS-KILSSKSKAYT- 160

Query: 256 VAGTMGYMPPEYLGG---NTAATVMLDVYSFGILMIEIATQIRP----NLPVVL 302
           V GT  Y+ PE   G   N  +    D+++ G ++ E+A+  R     NLP ++
Sbjct: 161 VVGTPCYISPELCEGKPYNQKS----DIWALGCVLYELASLKRAFEAANLPALV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 63/244 (25%), Positives = 95/244 (38%), Gaps = 58/244 (23%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF--QGF-REFRAEMETLGKLRH 137
           D+F   K+IG G+FG V+  +   +G   A+K L K     +      RAE + L     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 138 RNIVKILGYCASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
             IVK+  Y +   +  L  + E++  G L   L    R D                  R
Sbjct: 61  PWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEE-----------TAR 104

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI--SDFGLARRIDTSHS--- 250
             I   V   L  +H L    IHRDIK  N+L+D+D   HI  +DFGL ++++ +     
Sbjct: 105 FYIAELVL-ALDSVHKLG--FIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREY 159

Query: 251 -------------------------HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGI 285
                                      +    GT  Y+ PE L G T   +  D +S G+
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGV 218

Query: 286 LMIE 289
           ++ E
Sbjct: 219 ILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 31/219 (14%)

Query: 84  FSTDKIIGDGSFGFVYKAK-LSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLRH 137
           F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++ 
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI- 118

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
                A G+ YL   E+ ++HRD+ + NVL+ +     I+DFGLA+ +            
Sbjct: 119 -----AKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK--EYHAE 169

Query: 258 GTMGYMPPEYLGGNT----AATVMLDVYSFGILMIEIAT 292
           G  G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 170 G--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 27/188 (14%)

Query: 88  KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFR---AEMETLGK-LRHRNIVK 142
           K+IG GSFG V  AK    G   A+K L K      +E +   AE   L K ++H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 143 ILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-VR 200
            L Y     +++  + +FV  G L  + H            Q     P   E R +    
Sbjct: 61  -LHYSFQTTEKLYFVLDFVNGGEL--FFH-----------LQRERSFP---EPRARFYAA 103

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +A+ L YLH +   I++RD+K  N+LLDS     ++DFGL +    + S  +T   GT 
Sbjct: 104 EIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTP 160

Query: 261 GYMPPEYL 268
            Y+ PE +
Sbjct: 161 EYLAPEVI 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 43/224 (19%)

Query: 90  IGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G GS G V+ A  S     VA+KK+     Q  +    E++ + +L H NIVK+     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV----- 67

Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLC-----------------PLS 191
                   YE +     D         +DV    +LNS+                  PLS
Sbjct: 68  --------YEVLGPSGSDL-------TEDVGSLTELNSVYIVQEYMETDLANVLEQGPLS 112

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-DFEAHISDFGLARRIDTSHS 250
            E     +  +  GL Y+H     ++HRD+K +NV +++ D    I DFGLAR +D  +S
Sbjct: 113 EEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170

Query: 251 HVS--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           H    ++   T  Y  P  L      T  +D+++ G +  E+ T
Sbjct: 171 HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 59.3 bits (143), Expect = 6e-10
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 31/215 (14%)

Query: 88  KIIGDGSFGFVYKAKLSSG-----VTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIV 141
           K++G G+FG VYK           + VAIK L ++   +  +E   E   +  +    + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++LG C +   + L+ + +  G L   L     N D  GS+ L     L+W  ++     
Sbjct: 73  RLLGICLTSTVQ-LVTQLMPYGCL---LDYVRENKDRIGSQDL-----LNWCVQI----- 118

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
            A G++YL   E  ++HRD+ + NVL+ S     I+DFGLAR +D       T+     G
Sbjct: 119 -AKGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYHADGG 171

Query: 262 YMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
            +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 172 KVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 64/209 (30%), Positives = 90/209 (43%), Gaps = 26/209 (12%)

Query: 88  KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEM--ETLGKLRHRNIVKIL 144
           K++G GSFG V  A+L   G   A+K L KD      +    M  + +  L   N     
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 145 GYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGS-KQLNSLCPLSWETRVKIVRG 201
            YC       L +  EF+  G L   + D  R D    +      +C             
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC------------- 107

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
              GL +LH   K II+RD+K  NV+LD D    I+DFG+ +      +  ST   GT  
Sbjct: 108 ---GLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPD 161

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           Y+ PE L G    T  +D +SFG+L+ E+
Sbjct: 162 YIAPEILQG-LKYTFSVDWWSFGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 58.6 bits (142), Expect = 7e-10
 Identities = 44/187 (23%), Positives = 83/187 (44%), Gaps = 21/187 (11%)

Query: 88  KIIGDGSFG--FVYKAKLSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKI 143
           +++G G+FG   +Y+ +      V  K+++      +  R+   E+  L  L+H NI+  
Sbjct: 6   RVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64

Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA 203
             +       ++  E+   G+L   +        V    QL        E  +  +  + 
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKI--------VRQKGQL-----FEEEMVLWYLFQIV 111

Query: 204 NGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYM 263
           + ++Y+H  +  I+HRDIK+ N+ L       + DFG+++ + + +S   T V GT  YM
Sbjct: 112 SAVSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYM 168

Query: 264 PPEYLGG 270
            PE   G
Sbjct: 169 SPELCQG 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 58.7 bits (143), Expect = 7e-10
 Identities = 46/162 (28%), Positives = 71/162 (43%), Gaps = 26/162 (16%)

Query: 137 HRNIVKILGYCASGLDR-VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           + N +K L Y  + L   VLI +++++G L     D  + +             LS    
Sbjct: 68  NPNFIK-LYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEG-----------KLSEAEV 111

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFEAHISDFGLARRIDTSHSHVST 254
            KI+R +   L  LH     IIH DIK  NVL D +    ++ D+GL + I T   +   
Sbjct: 112 KKIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY--- 166

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
              GT+ Y  PE + G+       D ++ G+L  E+ T   P
Sbjct: 167 --DGTLDYFSPEKIKGHNYDVSF-DWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 4/86 (4%)

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
           GL +LH  +K II+RD+K  NVLLD D    I+DFG+ +         ST   GT  Y+ 
Sbjct: 108 GLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIA 164

Query: 265 PEYLGGNTAATVMLDVYSFGILMIEI 290
           PE L G       +D +SFG+L+ E+
Sbjct: 165 PEILKGQK-YNESVDWWSFGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 39/215 (18%)

Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           IG G+FG VY+  K  +    A+K L K      +E  A+ E    +  RNI+       
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNILVRTLLDE 54

Query: 149 S----GL--------DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           S    GL        D  L+ +++  G L   L    R                  E R 
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS----------------EDRA 98

Query: 197 KI-VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           K  +  +   L +LH  +  I++RD+K  N+LLD+     + DFGL++  + + +  +  
Sbjct: 99  KFYIAELVLALEHLH--KYDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNT 155

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             GT  Y+ PE L      T  +D +S G+L+ E+
Sbjct: 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 33/214 (15%)

Query: 90  IGDGSFGFVYKAK--LSSGVTVAIKKL------DKDAFQGFREFRAEMETLGKLRHRNIV 141
           IG+G++G V+KA+   + G  VA+K++      +       RE  A +  L    H N+V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPNVV 67

Query: 142 KILGYCA-SGLDR----VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           ++   C  S  DR     L++E V+   L  +L            K      P   ET  
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-----------DKVPEPGVPT--ETIK 113

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            ++  +  GL +LH     ++HRD+K  N+L+ S  +  ++DFGLAR    S     T V
Sbjct: 114 DMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSV 169

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             T+ Y  PE L  ++ AT  +D++S G +  E+
Sbjct: 170 VVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 32/212 (15%)

Query: 88  KIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEM------ETLGKLRHRNI 140
           K++G GSFG V  A+L  +    A+K L KD      +    M         G  +H  +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58

Query: 141 VKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
            + L  C    DR+  + E+V  G L   +  + R D                E R +  
Sbjct: 59  TQ-LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFD----------------EPRARFY 101

Query: 200 RG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
              +  GL +LH  E+ II+RD+K  NVLLDS+    I+DFG+ +         ST   G
Sbjct: 102 AAEIVLGLQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST-FCG 158

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           T  Y+ PE L         +D ++ G+L+ E+
Sbjct: 159 TPDYIAPEILSY-QPYGPAVDWWALGVLLYEM 189

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 5/86 (5%)

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
           GL ++H   + +++RD+K +N+LLD      ISD GLA        H S    GT GYM 
Sbjct: 109 GLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 163

Query: 265 PEYLGGNTAATVMLDVYSFGILMIEI 290
           PE L   TA     D +S G ++ ++
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKL 189

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 66/232 (28%), Positives = 108/232 (46%), Gaps = 38/232 (16%)

Query: 76  ELIDATDNFSTDK------IIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAE 128
           ++ID   N S +K      IIG+GSFG VY+A  + +   VAIKK+ +D     RE    
Sbjct: 54  KMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE---- 109

Query: 129 METLGKLRHRNIVKILGYCASGLDRV--------LIYEFVENGSLDQWLHDTSRNDDVDG 180
           +  +  L H NI+ +  Y  +   +         ++ EF+   ++ +++   +RN     
Sbjct: 110 LLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARN----- 163

Query: 181 SKQLNSLCPLSWETRVKIVR-GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISD 238
               N   PL     VK+    +   LAY+H   K I HRD+K  N+L+D +     + D
Sbjct: 164 ----NHALPL---FLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCD 214

Query: 239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           FG A+ +      VS     +  Y  PE + G T  T  +D++S G ++ E+
Sbjct: 215 FGSAKNLLAGQRSVS--YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264

Length = 440

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 53/183 (28%), Positives = 79/183 (43%), Gaps = 21/183 (11%)

Query: 90  IGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILG 145
           +G G FG V   ++ ++G   A KKLDK   +   G +    E E L K+    IV +  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
              S     L+   +  G L   +++                  L  E  +     +  G
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERG-------------LEMERVIHYSAQITCG 107

Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
           + +LH ++  I++RD+K  NVLLD      +SD GLA  ++       TQ AGT GYM P
Sbjct: 108 ILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAP 163

Query: 266 EYL 268
           E L
Sbjct: 164 EIL 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 26/224 (11%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR- 136
           D +D +   + IG G++G V+K     +G   A+K LD        E  AE   L  L  
Sbjct: 15  DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSD 73

Query: 137 HRNIVKILGY-----CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           H N+VK  G        +G    L+ E    GS+     D  +     G +    +    
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVT----DLVKGFLKRGERMEEPIIAY- 128

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
                 I+     GL +LH      IHRD+K +N+LL ++    + DFG++ ++ ++   
Sbjct: 129 ------ILHEALMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 180

Query: 252 VSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIA 291
            +T V GT  +M PE +      ++      DV+S GI  IE+ 
Sbjct: 181 RNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG 223

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 32/176 (18%)

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT-- 259
           VA G+++L    K  IHRD+ + N+LL       I DFGLAR I    ++V   V G   
Sbjct: 223 VAKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNAR 277

Query: 260 --MGYMPPEYLGGNTAATVMLDVYSFGILMIEI---ATQIRPNLPVVLDGQEVGLLEWAR 314
             + +M PE +  N   T   DV+S+GIL+ EI    +   P +PV  D +   +++   
Sbjct: 278 LPVKWMAPESI-FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYKMIKEGY 334

Query: 315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
            M +                  E    E + I   C +    +RP    +VQL+++
Sbjct: 335 RMLS-----------------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 27/223 (12%)

Query: 90  IGDGSFGFVYKAKLSSGVTVA---IKKLDKDA-FQGFREFRAEMETLGKLRHRNIVKILG 145
           IG+G FG V  +++ +   VA   +K+L  +A  +   EF  + +    L+H NI++ LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
            C   +  +L++E+ E G L  +L   S+      + QL  L  ++ E        +A G
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQRMACE--------IAAG 111

Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA-RRIDTSHSHVSTQVAGTMGYMP 264
           + ++H      +H D+   N  L SD    + D+G+   R    +          + ++ 
Sbjct: 112 VTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLA 169

Query: 265 PEYLGGNTAATVMLD------VYSFGILMIEI---ATQIRPNL 298
           PE +G      +  +      V++ G+ + E+   A Q   +L
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 58.6 bits (141), Expect = 2e-09
 Identities = 65/279 (23%), Positives = 112/279 (40%), Gaps = 44/279 (15%)

Query: 42  AVNRPQPNRCSDLSSIAL-FDSASFDPSLSQISMSELIDATDNFSTD-KIIGD---GSFG 96
           A     P+   D  +  L FD A  D +         +   D F    ++I D   G+FG
Sbjct: 103 ASAGDGPSGAEDSDASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFG 162

Query: 97  ---------FVYKAKLSSGVTVA----------IKKLDKDAFQGFREFRAEMETLGKLRH 137
                       +A+   GV             I K  K   +   +   E+  LG+L H
Sbjct: 163 KIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222

Query: 138 RNIVKILGYCASGLDRVLIYE---FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
            NI+KI        + +L  E   ++     D  L+    ++  D   +     PL  +T
Sbjct: 223 ENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDR-----PLLKQT 269

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
           R  I++ +   + Y+H  +K +IHRDIK  N+ L+ D +  + DFG A   +        
Sbjct: 270 R-AIMKQLLCAVEYIH--DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
              GT+    PE L G+    +  D++S G++++++ + 
Sbjct: 327 GWVGTVATNSPEILAGDGYCEIT-DIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 5/86 (5%)

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
           GL ++H   + +++RD+K +N+LLD      ISD GLA        H S    GT GYM 
Sbjct: 109 GLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 163

Query: 265 PEYLGGNTAATVMLDVYSFGILMIEI 290
           PE L    A     D +S G ++ ++
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKL 189

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 25/187 (13%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMET----LGKLRHRNIVK 142
           K+IG GSFG V  A+  +     A+K L K A    +E +  M      L  ++H  +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 143 ILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            L +     D++  + +++  G L   L                  C L    R      
Sbjct: 61  -LHFSFQTADKLYFVLDYINGGELFYHLQ--------------RERCFLEPRARFYAAE- 104

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +A+ L YLH L   I++RD+K  N+LLDS     ++DFGL +  +  H+  ++   GT  
Sbjct: 105 IASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPE 161

Query: 262 YMPPEYL 268
           Y+ PE L
Sbjct: 162 YLAPEVL 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 32/216 (14%)

Query: 92  DGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVKILG 145
           +G+FG ++   L          V +K +   A +        E   L  L H+NI+ IL 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 146 YCASGLDRVLI-YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
            C    +   + Y ++  G+L  +L    R  + +  + L      S +  V +   +A 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQ-CRLGEANNPQAL------STQQLVHMAIQIAC 128

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG--- 261
           G++YLH     +IH+DI + N ++D + +  I+D  L+R +     H        +G   
Sbjct: 129 GMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-------CLGDNE 179

Query: 262 -----YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
                +M  E L     ++   DV+SFG+L+ E+ T
Sbjct: 180 NRPVKWMALESLVNKEYSSAS-DVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 24/212 (11%)

Query: 84  FSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRN 139
           F   +++G G FG V   ++ ++G   A K+L+K   +   G      E + L K+  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           +V  L Y     D + +   + NG  D   H  +  +            P   E R    
Sbjct: 62  VVN-LAYAYETKDALCLVLTIMNGG-DLKFHIYNMGN------------PGFEEERALFY 107

Query: 200 RG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
              +  GL  LH   +  ++RD+K  N+LLD      ISD GLA +I    S +  +V G
Sbjct: 108 AAEILCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-G 163

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           T+GYM PE L  N   T+  D +  G L+ E+
Sbjct: 164 TVGYMAPEVL-NNQRYTLSPDYWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 56.1 bits (135), Expect = 8e-09
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 28/210 (13%)

Query: 88  KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKL----RHRNIVK 142
           K++G GSFG V+ A+L  +    AIK L KD      +    M     L     H  +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 143 ILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           +  YC       L +  E++  G L   +    + D            P +     +I+ 
Sbjct: 61  L--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFD-----------LPRATFYAAEII- 106

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
               GL +LH   K I++RD+K  N+LLD+D    I+DFG+ +      +   T   GT 
Sbjct: 107 ---CGLQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTP 160

Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            Y+ PE L G    T  +D +SFG+L+ E+
Sbjct: 161 DYIAPEILLGQKYNT-SVDWWSFGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 57/187 (30%), Positives = 82/187 (43%), Gaps = 26/187 (13%)

Query: 190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSH 249
           LS+   V     VANG+ +L    K  +HRD+ + NVL+       I DFGLAR I    
Sbjct: 236 LSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDS 293

Query: 250 SHVST-QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT---QIRPNLPVVLDGQ 305
           +++S       + +M PE +  N   T + DV+SFGIL+ EI T      P LP  ++ Q
Sbjct: 294 NYISKGSTFLPLKWMAPESI-FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP--MNEQ 350

Query: 306 EVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVV 365
               ++    M    K     D              E + I   C  EK   RP  S +V
Sbjct: 351 FYNAIKRGYRMA---KPAHASD--------------EIYEIMQKCWEEKFEIRPDFSQLV 393

Query: 366 QLLDELV 372
            L+ +L+
Sbjct: 394 HLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.1 bits (135), Expect = 9e-09
 Identities = 61/232 (26%), Positives = 100/232 (43%), Gaps = 36/232 (15%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSG--VTVAIKKLDKDAFQGFREFR---AEMETLGKLR 136
           ++F+  + +G GSFG V  A   +     VAIK+ +K      ++     +E + L  + 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H   V + G         L+ EFV  G    +L    R  +  G           +  ++
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGC---------FYAAQI 140

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            ++        YL  L   I++RD+K  N+LLD D    ++DFG A+ +DT     +  +
Sbjct: 141 VLI------FEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTL 188

Query: 257 AGTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP---NLPVVL 302
            GT  Y+ PE L   G   AA    D ++ GI + EI     P   N P+++
Sbjct: 189 CGTPEYIAPEILLNVGHGKAA----DWWTLGIFIYEILVGCPPFYANEPLLI 236

Length = 340

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 17/143 (11%)

Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
           S  DR   Y+   +  +   L D       DGS+ L +L  LS+  +V      A G+ +
Sbjct: 206 SNYDRPASYKGSNDSEVKNLLSD-------DGSEGLTTLDLLSFTYQV------ARGMEF 252

Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST-QVAGTMGYMPPEY 267
           L    K  +HRD+ + NVLL       I DFGLAR I    ++VS       + +M PE 
Sbjct: 253 L--ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPES 310

Query: 268 LGGNTAATVMLDVYSFGILMIEI 290
           +  N   T + DV+S+GIL+ EI
Sbjct: 311 IFDNLYTT-LSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 36/209 (17%)

Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRHRNIVKILG 145
           +G G +G V+ A K  +G  VA+K++ K       E R    E + L   +   +VK+L 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67

Query: 146 YCASGLDRV-LIYEFVENGSLDQWLHDTS--RNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           Y     + + L  E+V  G     L++      D                  R  +    
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED----------------HARFYMAEMF 111

Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT-SHSHVSTQVAGTMG 261
              +  LH L    IHRD+K  N L+D+     ++DFGL++ I T ++S     V G+  
Sbjct: 112 E-AVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPD 163

Query: 262 YMPPEYL-GGNTAATVMLDVYSFGILMIE 289
           YM PE L G     TV  D +S G ++ E
Sbjct: 164 YMAPEVLRGKGYDFTV--DYWSLGCMLYE 190

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 70/220 (31%), Positives = 95/220 (43%), Gaps = 48/220 (21%)

Query: 88  KIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQ-------GFREFRAEMETLGKL-RHR 138
           K IG G+ G V  A    +G  VAIKKL +  FQ        +RE       L KL  H+
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSR-PFQNVTHAKRAYREL-----VLMKLVNHK 75

Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL--NSLCP-----LS 191
           NI+ +L              F    SL+++        DV    +L   +LC      L 
Sbjct: 76  NIIGLLNV------------FTPQKSLEEF-------QDVYLVMELMDANLCQVIQMDLD 116

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
            E    ++  +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   TS   
Sbjct: 117 HERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 174

Query: 252 VSTQVAGTMGYMPPEY-LGGNTAATVMLDVYSFGILMIEI 290
               V  T  Y  PE  LG      V  D++S G +M E+
Sbjct: 175 TPYVV--TRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 37/217 (17%)

Query: 90  IGDGSFGFVYKAKLSSGV--------TVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +G G+F  ++K                V +K LDK        F      + +L H+++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
              G C  G + +++ E+V+ GSLD +L            K+  +L  +SW+        
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL------------KKNKNLINISWKLE------ 104

Query: 202 VANGLAY-LHGLE-KPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
           VA  LA+ LH LE K + H ++ + NVLL  + +    +      I  S   +S  V   
Sbjct: 105 VAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPF---IKLSDPGISITVLPK 161

Query: 260 ------MGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
                 + ++PPE +      ++  D +SFG  + EI
Sbjct: 162 EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEI 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 62/188 (32%), Positives = 84/188 (44%), Gaps = 27/188 (14%)

Query: 88  KIIGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFRE---FRAEMETLGK-LRHRNIVK 142
           K+IG GSFG V  AK  S G   A+K L K      +E     AE   L K L+H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 143 ILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            L Y     +++  + ++V  G L  + H                 C L  E R +    
Sbjct: 61  -LHYSFQTAEKLYFVLDYVNGGEL--FFHLQRER------------CFL--EPRARFYAA 103

Query: 202 -VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            VA+ + YLH L   II+RD+K  N+LLDS     ++DFGL +         ST   GT 
Sbjct: 104 EVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTP 160

Query: 261 GYMPPEYL 268
            Y+ PE L
Sbjct: 161 EYLAPEVL 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 30/102 (29%), Positives = 51/102 (50%), Gaps = 5/102 (4%)

Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
           PL  +  + I + +  GL YLH     IIHRD+K+ N+ ++   +  I D G A+    +
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210

Query: 249 HSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            + +   +AGT+    PE L          D++S GI++ E+
Sbjct: 211 PAFLG--LAGTVETNAPEVL-ARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 53.6 bits (129), Expect = 6e-08
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 33/220 (15%)

Query: 88  KIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAF----QGFREFRAEMETLGKLRHRN 139
           K++G G +G V++ +      +G   A+K L K       +     +AE   L  ++H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IV ++    +G    LI E++  G L   L       + +G    ++ C    E  +   
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHL-------EREGIFMEDTACFYLSEISL--- 111

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
                 L +LH  ++ II+RD+K  N+LLD+     ++DFGL +        V+    GT
Sbjct: 112 -----ALEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGT 163

Query: 260 MGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           + YM PE L   G   A    +D +S G LM ++ T   P
Sbjct: 164 IEYMAPEILMRSGHGKA----VDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 53.3 bits (128), Expect = 6e-08
 Identities = 55/209 (26%), Positives = 85/209 (40%), Gaps = 27/209 (12%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRHRNIVKI 143
           K++G G+FG V   +  ++G   A+K L K+      E      E   L   RH  +   
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA- 59

Query: 144 LGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG- 201
           L Y     DR+  + E+   G L   L                S   +  E R +     
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHL----------------SRERVFSEDRARFYGAE 103

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           + + L YLH     +++RD+K  N++LD D    I+DFGL +    S         GT  
Sbjct: 104 IVSALGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPE 160

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           Y+ PE L  N      +D +  G++M E+
Sbjct: 161 YLAPEVLEDNDYGRA-VDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 56/232 (24%), Positives = 99/232 (42%), Gaps = 58/232 (25%)

Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRA---------EMETLGKLRHRNI 140
           +G G++G VYKAK   G      K D+D     ++            E+  L +L+H N+
Sbjct: 9   VGRGTYGHVYKAKRKDG------KDDRD--YALKQIEGTGISMSACREIALLRELKHPNV 60

Query: 141 VKILGYCASGLDRV--LIYEFVENGSLDQW----LHDTSRNDDVDGSKQLNSLCPLSWET 194
           + +     S  DR   L++++ E+   D W     H  S+ +                + 
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKAN----------------KK 101

Query: 195 RVKIVRG--------VANGLAYLHGLEKPIIHRDIKSSNVLLDSD----FEAHISDFGLA 242
            V++ RG        + +G+ YLH     ++HRD+K +N+L+  +        I+D G A
Sbjct: 102 PVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159

Query: 243 RRIDTSHSHVS--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           R  ++    ++    V  T  Y  PE L G    T  +D+++ G +  E+ T
Sbjct: 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 25/215 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA----EMETLGKLR 136
           + F    ++G+G++G V K +   +   VAIKK  KD+ +   E +     E++ L  L+
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDS-EENEEVKETTLRELKMLRTLK 58

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
             NIV++           L++E+VE   L+               +  N + P   E   
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVEKNMLELL------------EEMPNGVPP---EKVR 103

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
             +  +   + + H  +  I+HRDIK  N+L+  +    + DFG AR +    +   T+ 
Sbjct: 104 SYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY 161

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
             T  Y  PE L G       +D++S G ++ E++
Sbjct: 162 VATRWYRSPELLLGAPYGKA-VDMWSVGCILGELS 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 9e-08
 Identities = 58/182 (31%), Positives = 82/182 (45%), Gaps = 39/182 (21%)

Query: 82  DNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDK-DAFQGFRE----FRAEMETLGKL 135
           D+F + K+IG G+FG V    K  +G   A+KKL K +  +  +E     RAE + L + 
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE--KEQVAHVRAERDILAEA 58

Query: 136 RHRNIVKILGYCASGLDRV---LIYEFVENGSLDQWL--HDTSRNDDVDGSKQLNSLCPL 190
            +  +VK+  Y  S  D     LI E++  G +   L   DT   +              
Sbjct: 59  DNPWVVKL--YY-SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-------------- 101

Query: 191 SWETRVKIVRGVANGLA--YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
             ETR  I   +   LA   +H L    IHRDIK  N+LLD+     +SDFGL   +  S
Sbjct: 102 --ETRFYIAETI---LAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154

Query: 249 HS 250
           H 
Sbjct: 155 HR 156

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 27/209 (12%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRHRNIVKI 143
           K++G G+FG V   +  +SG   A+K L K+      E      E   L   RH  +   
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS- 59

Query: 144 LGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG- 201
           L Y     DR+  + E+V  G L  + H +                 +  E R +     
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGEL--FFHLSRER--------------VFSEDRTRFYGAE 103

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           + + L YLH     I++RD+K  N++LD D    I+DFGL +   T  + + T   GT  
Sbjct: 104 IVSALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPE 160

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           Y+ PE L  N      +D +  G++M E+
Sbjct: 161 YLAPEVLEDNDYGRA-VDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 4/104 (3%)

Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
           PL       + R + + + Y+HG  + IIHRDIK+ NVL++   +  + DFG A     S
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313

Query: 249 HSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            S      +AGT+    PE L G+      +D++S G+++ E A
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 47/194 (24%), Positives = 90/194 (46%), Gaps = 34/194 (17%)

Query: 107 VTVAIKKLD---KDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENG 163
           + V +K LD   +D    F E  + M    ++ H++IV + G C   ++ +++ EFVE G
Sbjct: 33  IKVILKVLDPSHRDISLAFFETASMMR---QVSHKHIVLLYGVCVRDVENIMVEEFVEFG 89

Query: 164 SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKS 223
            LD ++H  S                L+   + K+ + +A+ L+YL   +K ++H ++ +
Sbjct: 90  PLDLFMHRKSD--------------VLTTPWKFKVAKQLASALSYLE--DKDLVHGNVCT 133

Query: 224 SNVLL-----DSDFEAHI--SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATV 276
            N+LL     D +    I  SD G+   + +    V       + ++ PE +  +   ++
Sbjct: 134 KNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-----RIPWIAPECVEDSKNLSI 188

Query: 277 MLDVYSFGILMIEI 290
             D +SFG  + EI
Sbjct: 189 AADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 36/214 (16%)

Query: 88  KIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQ----GFREFRAEMETLGKLRHRNIVK 142
           K IG G+ G V  A     G+ VA+KKL +  FQ      R +R E+  L  + H+NI+ 
Sbjct: 27  KPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYR-ELVLLKCVNHKNIIS 84

Query: 143 ILGYCASG------LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           +L             D  L+ E ++  +L Q +H                   L  E   
Sbjct: 85  LLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIH-----------------MELDHERMS 126

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            ++  +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  + + T  
Sbjct: 127 YLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NFMMTPY 182

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             T  Y  PE + G       +D++S G +M E+
Sbjct: 183 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEL 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 28/216 (12%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEM---ETLGKLR 136
             NF    ++G GSFG V  A+   +    AIK L KD      +    M     L    
Sbjct: 1   DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58

Query: 137 HRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
               +  L  C   +DR+  + E+V  G L   +    +  +                  
Sbjct: 59  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQA--------------- 103

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           V     ++ GL +LH   + II+RD+K  NV+LDS+    I+DFG+ +  +     V+T+
Sbjct: 104 VFYAAEISVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTR 159

Query: 256 V-AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
              GT  Y+ PE +         +D +++G+L+ E+
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGK-SVDWWAYGVLLYEM 194

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 32/86 (37%), Positives = 48/86 (55%), Gaps = 5/86 (5%)

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
           GL  LH  ++ I++RD+K  N+LLD      ISD GLA  +    + +  +V GT+GYM 
Sbjct: 114 GLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMA 169

Query: 265 PEYLGGNTAATVMLDVYSFGILMIEI 290
           PE +  N   T   D ++ G L+ E+
Sbjct: 170 PEVV-KNERYTFSPDWWALGCLLYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 26/209 (12%)

Query: 88  KIIGDGSFGFVYKAKLSSGVTV-AIKKLDKDAFQGFREFRAEM---ETLGKLRHRNIVKI 143
           K++G GSFG V  A+L     V AIK L KD      +    M     L        +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 144 LGYCASGLDRVL-IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG- 201
           L  C    DR+  + E+V  G L   +  + + D                E R +     
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD----------------EPRSRFYAAE 104

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           V   L +LH     +I+RD+K  N+LLD++    ++DFG+ +     +   +T   GT  
Sbjct: 105 VTLALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPD 161

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           Y+ PE L         +D ++ G+LM E+
Sbjct: 162 YIAPEIL-QELEYGPSVDWWALGVLMYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 27/209 (12%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRHRNIVKI 143
           K++G G+FG V   +  ++G   A+K L K+      E      E   L   RH   +  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTA 59

Query: 144 LGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG- 201
           L Y     DR+  + E+   G L  + H  SR               +  E R +     
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGEL--FFH-LSRER-------------VFTEERARFYGAE 103

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           + + L YLH   + +++RDIK  N++LD D    I+DFGL +   +  + + T   GT  
Sbjct: 104 IVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPE 160

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           Y+ PE L  N      +D +  G++M E+
Sbjct: 161 YLAPEVLEDNDYGRA-VDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 22/214 (10%)

Query: 90  IGDGSFGFVYKAKLSSGV---TVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGY 146
           +G G++G VYKAK   G      A+K+++            E+  L +L+H N++ +   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQKV 66

Query: 147 CASGLDRV--LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
             S  DR   L++++ E+   D W H    +     +K+   L P S      ++  + +
Sbjct: 67  FLSHSDRKVWLLFDYAEH---DLW-HIIKFHRASKANKKPMQL-PRSMVK--SLLYQILD 119

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDF----EAHISDFGLARRIDTSHSHVST--QVAG 258
           G+ YLH     ++HRD+K +N+L+  +        I+D G AR  ++    ++    V  
Sbjct: 120 GIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           T  Y  PE L G    T  +D+++ G +  E+ T
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 26/214 (12%)

Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEM---ETLGKLRHR 138
           +F+   ++G GSFG V  A +  +    AIK L KD      +    M     L      
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 139 NIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +  L  C   +DR+  + E+V  G L   +    R  +                  V 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHA---------------VF 105

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV- 256
               +A GL +LH   K II+RD+K  NV+LDS+    I+DFG+ +  +     V+T+  
Sbjct: 106 YAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTF 161

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            GT  Y+ PE +         +D ++FG+L+ E+
Sbjct: 162 CGTPDYIAPEIIAYQPYGK-SVDWWAFGVLLYEM 194

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 4/95 (4%)

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           ++  L YLH  E+ II+RD+K  NVLLDS+    ++D+G+ +         ++   GT  
Sbjct: 105 ISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPN 161

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           Y+ PE L G       +D ++ G+LM E+     P
Sbjct: 162 YIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 26/209 (12%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRHRNIVKI 143
           K++G G+FG V   K  ++G   A+K L K+      E      E   L   RH   +  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTA 59

Query: 144 LGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG- 201
           L Y     DR+  + E+   G L  + H  SR                  E R +     
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGEL--FFH-LSRERVFS-------------EDRARFYGAE 103

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           + + L YLH  EK +++RD+K  N++LD D    I+DFGL +      + + T   GT  
Sbjct: 104 IVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPE 161

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           Y+ PE L  N      +D +  G++M E+
Sbjct: 162 YLAPEVLEDNDYGRA-VDWWGLGVVMYEM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 8/93 (8%)

Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS--DFGLARRIDTSHSHVSTQVAGTMGYM 263
           L  LH     +I+RD+K  N+LL  D++ HI+  DFGL  +++      +    GT  Y+
Sbjct: 106 LENLHKFN--VIYRDLKPENILL--DYQGHIALCDFGLC-KLNMKDDDKTNTFCGTPEYL 160

Query: 264 PPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
            PE L G+   T  +D ++ G+L+ E+ T + P
Sbjct: 161 APELLLGH-GYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.9 bits (121), Expect = 5e-07
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 26/209 (12%)

Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIV 141
           K IG G+ G V   Y A L     VAIKKL +   +     R +R E+  +  + H+NI+
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 79

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L              F    SL+++       + +D +        L  E    ++  
Sbjct: 80  SLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 127

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T  
Sbjct: 128 MLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY 183

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           Y  PE + G       +D++S G +M E+
Sbjct: 184 YRAPEVILG-MGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 4/92 (4%)

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
            L +LH  E+ II+RD+K  NVLLD+D    ++D+G+ +         ++   GT  Y+ 
Sbjct: 108 ALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIA 164

Query: 265 PEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           PE L G       +D ++ G+LM E+     P
Sbjct: 165 PEILRGEEYG-FSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 6e-07
 Identities = 33/86 (38%), Positives = 46/86 (53%), Gaps = 5/86 (5%)

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
           GL  LH   + I++RD+K  N+LLD      ISD GLA  I    + +  +V GT+GYM 
Sbjct: 114 GLEDLH--RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMA 169

Query: 265 PEYLGGNTAATVMLDVYSFGILMIEI 290
           PE +  N   T   D +  G L+ E+
Sbjct: 170 PEVV-KNERYTFSPDWWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 50.2 bits (120), Expect = 7e-07
 Identities = 27/79 (34%), Positives = 38/79 (48%), Gaps = 5/79 (6%)

Query: 217 IHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL-----GGN 271
           +HRDIK  NVL+D      ++DFG A R+  +    S    GT  Y+ PE L      G 
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 272 TAATVMLDVYSFGILMIEI 290
               V  D +S G++  E+
Sbjct: 184 GTYGVECDWWSLGVIAYEM 202

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 30/215 (13%)

Query: 84  FSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFR-EFRA--EMETLGKLRHRN 139
           F   +++G G FG V   ++ ++G   A KKL+K   +  + E  A  E   L K+  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 140 IVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQL---NSLCPLSWETR 195
           +V  L Y     D + L+   +  G L   +++   N   D  + +     LC       
Sbjct: 62  VVS-LAYAYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELC------- 112

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                    GL  L    + I++RD+K  N+LLD      ISD GLA +I    + V  +
Sbjct: 113 --------CGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGR 161

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           V GT+GYM PE +  N   T   D +  G L+ E+
Sbjct: 162 V-GTVGYMAPEVI-NNEKYTFSPDWWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 29/170 (17%)

Query: 82  DNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIK------KLDKDAFQGFREFRAEMETLGK 134
           + F   K I  G+FG VY   K ++    A+K       ++K+      + +AE + L  
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVH---QVQAERDALAL 60

Query: 135 LRHRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            +   IV  L Y     + V L+ E++  G +   LH     D+               E
Sbjct: 61  SKSPFIVH-LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE---------------E 104

Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR 243
             VK +  VA  L YLH     IIHRD+K  N+L+ ++    ++DFGL++
Sbjct: 105 MAVKYISEVALALDYLH--RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 50.2 bits (120), Expect = 9e-07
 Identities = 70/261 (26%), Positives = 106/261 (40%), Gaps = 50/261 (19%)

Query: 52  SDLSSIALFDSASFDPSLSQI-----SMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSG 106
            D    AL  + + D  LS+       +++L    ++F   K+IG G+FG V   +  S 
Sbjct: 8   YDCDIPALRKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSS 67

Query: 107 VTV-AIKKLDKD--------AFQGFREFRAEMETLGKLRHRN---IVKILGYCASGLDRV 154
             V A+K L K         AF  F E R  M       H N   IV++  + A   D+ 
Sbjct: 68  KQVYAMKLLSKFEMIKRSDSAF--FWEERDIMA------HANSEWIVQL--HYAFQDDKY 117

Query: 155 L--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGL 212
           L  + E++  G L   +     N D+          P  W  R      V   L  +H +
Sbjct: 118 LYMVMEYMPGGDLVNLM----SNYDI----------PEKW-ARFYTAE-VVLALDAIHSM 161

Query: 213 EKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL---G 269
               IHRD+K  N+LLD      ++DFG   ++D +         GT  Y+ PE L   G
Sbjct: 162 G--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 270 GNTAATVMLDVYSFGILMIEI 290
           G+       D +S G+ + E+
Sbjct: 220 GDGYYGRECDWWSVGVFLYEM 240

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 30/85 (35%), Positives = 47/85 (55%), Gaps = 4/85 (4%)

Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
           L +LH  E+ II+RD+K  NVLLD++    ++D+G+ +         ST   GT  Y+ P
Sbjct: 109 LNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIAP 165

Query: 266 EYLGGNTAATVMLDVYSFGILMIEI 290
           E L G       +D ++ G+LM E+
Sbjct: 166 EILRGEDYG-FSVDWWALGVLMFEM 189

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA-RRIDTSHSHVSTQV 256
           I R V   + YLH  E  IIHRDIK+ N+ ++   +  + DFG A   +D + +      
Sbjct: 187 IERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW- 243

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           AGT+    PE L  +      +D++S GI++ E+AT
Sbjct: 244 AGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 6/90 (6%)

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV-AGTM 260
           +A GL +LH   K II+RD+K  NV+LD++    I+DFG+ +  +      +T+   GT 
Sbjct: 110 IAIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTP 165

Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            Y+ PE +         +D ++FG+L+ E+
Sbjct: 166 DYIAPEII-AYQPYGKSVDWWAFGVLLYEM 194

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 2/92 (2%)

Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTMGYMP 264
           LA  H   K +IHRDIKS+N+LL S+    + DFG ++    T    V     GT  Y+ 
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 265 PEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           PE +      +   D++S G+L+ E+ T  RP
Sbjct: 214 PE-IWRRKPYSKKADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 66/232 (28%), Positives = 101/232 (43%), Gaps = 32/232 (13%)

Query: 70  SQISMSELIDAT----DNFSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQ-- 120
           +     E+ D+T      +   K IG G+ G V   Y A L     VAIKKL +  FQ  
Sbjct: 8   NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILER--NVAIKKLSR-PFQNQ 64

Query: 121 --GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDV 178
               R +R E+  +  + H+NI+ +L              F    SL+++       + +
Sbjct: 65  THAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELM 111

Query: 179 DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD 238
           D +        L  E    ++  +  G+ +LH     IIHRD+K SN+++ SD    I D
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILD 169

Query: 239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           FGLAR   T  S + T    T  Y  PE + G       +D++S G +M E+
Sbjct: 170 FGLARTAGT--SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 25/167 (14%)

Query: 82  DNFSTDKIIGDGSFGFV-YKAKLSSGVTVAIKKLDK-DAFQG--FREFRAEMETLGKLRH 137
           ++F T K+IG G+FG V    K  +G   A+K L K + F+       +AE + L +   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWL--HDTSRNDDVDGSKQLNSLCPLSWETR 195
             +V +           LI EF+  G L   L  +DT  ++DV               TR
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTF-SEDV---------------TR 104

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA 242
             +   V   +  +H L    IHRDIK  N+L+D      +SDFGL+
Sbjct: 105 FYMAECVL-AIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.1 bits (112), Expect = 8e-06
 Identities = 27/78 (34%), Positives = 37/78 (47%), Gaps = 4/78 (5%)

Query: 217 IHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL----GGNT 272
           +HRDIK  NVLLD +    ++DFG   R+    +  S    GT  Y+ PE L     G  
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 273 AATVMLDVYSFGILMIEI 290
                 D +S G+ M E+
Sbjct: 184 RYGPECDWWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.4 bits (110), Expect = 8e-06
 Identities = 46/193 (23%), Positives = 90/193 (46%), Gaps = 36/193 (18%)

Query: 109 VAIKKLD---KDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL 165
           V +K LD   +D    F E  + M    ++ H ++  + G C  G + +++ EFVE+G L
Sbjct: 47  VVLKVLDPSHRDIALAFFETASLMS---QVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103

Query: 166 DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSN 225
           D  L            ++     P++W  ++ + + +A+ L+YL   +K ++H ++ + N
Sbjct: 104 DVCL------------RKEKGRVPVAW--KITVAQQLASALSYLE--DKNLVHGNVCAKN 147

Query: 226 VLL--------DSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVM 277
           +LL         S F   +SD G++    +    V       + ++ PE + G  + +  
Sbjct: 148 ILLARLGLAEGTSPF-IKLSDPGVSFTALSREERVE-----RIPWIAPECVPGGNSLSTA 201

Query: 278 LDVYSFGILMIEI 290
            D +SFG  ++EI
Sbjct: 202 ADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 35/221 (15%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTV-AIKKLDKDAFQGFRE-----FRAEMETLGKL 135
           +++   K+IG G+FG V   +  S   V A+K L K  F+  +      F  E + +   
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSK--FEMIKRSDSAFFWEERDIMAFA 100

Query: 136 RHRNIVKILGYCASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
               +V++  +CA   D+ L  + E++  G L   +     N DV          P  W 
Sbjct: 101 NSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLM----SNYDV----------PEKWA 144

Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHV 252
                   V   L  +H +   +IHRD+K  N+LLD      ++DFG   ++D T     
Sbjct: 145 KFY--TAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200

Query: 253 STQVAGTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEI 290
            T V GT  Y+ PE L   GG+       D +S G+ + E+
Sbjct: 201 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 52/174 (29%), Positives = 75/174 (43%), Gaps = 25/174 (14%)

Query: 82  DNFSTDKIIGDGSFGFV-YKAKLSSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRH 137
           ++F + K+IG G+FG V    K  +G   A+K L K      +     RAE + L +   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWL--HDTSRNDDVDGSKQLNSLCPLSWETR 195
             +VK+       L+  LI EF+  G +   L   DT   +                ET+
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE----------------ETQ 104

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSH 249
             I   V   +  +H L    IHRDIK  N+LLDS     +SDFGL   +  +H
Sbjct: 105 FYIAETVL-AIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 53/190 (27%), Positives = 79/190 (41%), Gaps = 28/190 (14%)

Query: 82  DNFSTDKIIGDGSFGFV-YKAKLSSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRH 137
           D+F + K+IG G+FG V    K  +G   A+K L K      +     RAE + L +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWL--HDTSRNDDVDGSKQLNSLCPLSWETR 195
             +VK+        +  LI EF+  G +   L   DT   +                 T+
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE----------------ATQ 104

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
             I   V   +  +H L    IHRDIK  N+LLD+     +SDFGL   +  +H    T+
Sbjct: 105 FYIAETVL-AIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH---RTE 158

Query: 256 VAGTMGYMPP 265
               + + PP
Sbjct: 159 FYRNLTHNPP 168

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 46.3 bits (109), Expect = 2e-05
 Identities = 61/248 (24%), Positives = 102/248 (41%), Gaps = 51/248 (20%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFRE-----FRAEMETLGKLR 136
           + +   K IG+G FG V+  K     T         +++G +E        E+  + +L+
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKR--TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70

Query: 137 HRNIVKILGYCASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           H+NIV+ +    +  ++ L  + EF + G       D SRN      K       +    
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAG-------DLSRNI----QKCYKMFGKIEEHA 119

Query: 195 RVKIVRGVANGLAYLHGLE-----KPIIHRDIKSSNVLLDSDFE---------------- 233
            V I R + + LAY H L+     + ++HRD+K  N+ L +                   
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179

Query: 234 -AHISDFGLARRI---DTSHSHVSTQVAGTMGYMPPEYLGGNTAA-TVMLDVYSFGILMI 288
            A I DFGL++ I     +HS V     GT  Y  PE L   T +     D+++ G ++ 
Sbjct: 180 IAKIGDFGLSKNIGIESMAHSCV-----GTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234

Query: 289 EIATQIRP 296
           E+ +   P
Sbjct: 235 ELCSGKTP 242

Length = 1021

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 47/204 (23%), Positives = 87/204 (42%), Gaps = 29/204 (14%)

Query: 97  FVYKAKLSSG-VTV-AIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGY---CASGL 151
            +YK   ++  V +   KK  K           E++ L ++   NI+KI G+       L
Sbjct: 35  SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 152 DRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLH 210
            R+ LI E+   G L + L D  ++              LS++T++ +      GL  L+
Sbjct: 95  PRLSLILEYCTRGYLREVL-DKEKD--------------LSFKTKLDMAIDCCKGLYNLY 139

Query: 211 G-LEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG 269
               KP  ++++ S + L+  +++  I   GL + +    S    +    M Y   + L 
Sbjct: 140 KYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKIL----SSPPFKNVNFMVYFSYKMLN 193

Query: 270 G-NTAATVMLDVYSFGILMIEIAT 292
              +  T+  D+YS G+++ EI T
Sbjct: 194 DIFSEYTIKDDIYSLGVVLWEIFT 217

Length = 283

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 8/96 (8%)

Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +  S  K +G G+FG V +A      K  + +TVA+K L   A    RE   +E++ L  
Sbjct: 35  NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94

Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWL 169
           L  H NIV +LG C  G   ++I E+   G L  +L
Sbjct: 95  LGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 67/273 (24%), Positives = 107/273 (39%), Gaps = 68/273 (24%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVT-VAIKKLDKDAF-------QGFREFRAEMETLG 133
           ++F T K+I +G++G VY  +        A+KK++K          Q F     E + L 
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF----VERDILT 56

Query: 134 KLRHRNIVKILGYCASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
              +  +V +  +C+    R L  + E+VE G               D +  L ++  L 
Sbjct: 57  FAENPFVVSM--FCSFETKRHLCMVMEYVEGG---------------DCATLLKNIGALP 99

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR-------- 243
            +            L YLH     I+HRD+K  N+L+ S     ++DFGL++        
Sbjct: 100 VDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157

Query: 244 RIDTSHSHVST------QVAGTMGYMPPEYLGGNTAATVML--------DVYSFGILMIE 289
            +   H    T      QV GT  Y+ PE         V+L        D ++ GI++ E
Sbjct: 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPE---------VILRQGYGKPVDWWAMGIILYE 208

Query: 290 IATQIRP---NLPVVLDGQEV-GLLEWARTMEA 318
                 P   + P  L GQ +   +EW    EA
Sbjct: 209 FLVGCVPFFGDTPEELFGQVISDDIEWPEGDEA 241

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 33/120 (27%), Positives = 53/120 (44%), Gaps = 9/120 (7%)

Query: 217 IHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL---GGNTA 273
           IHRD+K  N+LLD      ++DFG   +++           GT  Y+ PE L   GG+  
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223

Query: 274 ATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISRE 333
                D +S G+ + E+     P     L G       +++ M  +N      D++IS+E
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMNHKNSLTFPDDNDISKE 277

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 15/172 (8%)

Query: 126 RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN 185
           R+E+  L    H  IVK      S    +LI E+   G L++ +            ++L 
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-----------KQRLK 161

Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
              P        +   +   L  +H   + ++HRD+KS+N+ L       + DFG +++ 
Sbjct: 162 EHLPFQEYEVGLLFYQIVLALDEVH--SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219

Query: 246 DTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             S S  V++   GT  Y+ PE L      +   D++S G+++ E+ T  RP
Sbjct: 220 SDSVSLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 57/243 (23%), Positives = 90/243 (37%), Gaps = 64/243 (26%)

Query: 88  KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREF---RAEMETLGKLRHRNIVKI 143
           K++G G  G V+  +L  +G   A+K LDK       +      E E L  L H  +  +
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR--- 200
                +     L+ ++   G L + L                  C        ++ R   
Sbjct: 67  YASFQTETYLCLVMDYCPGGELFRLLQRQPGK------------C-----LSEEVARFYA 109

Query: 201 -GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI--SDFGLARRIDTSHSHVSTQVA 257
             V   L YLH L   I++RD+K  N+LL      HI  SDF L+++ D     VS  + 
Sbjct: 110 AEVLLALEYLHLLG--IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALR 165

Query: 258 ----------------------------GTMGYMPPEYLGGN--TAATVMLDVYSFGILM 287
                                       GT  Y+ PE + G+   +A   +D ++ GIL+
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA---VDWWTLGILL 222

Query: 288 IEI 290
            E+
Sbjct: 223 YEM 225

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 4/78 (5%)

Query: 217 IHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL----GGNT 272
           +HRDIK  NVLLD +    ++DFG   +++   +  S+   GT  Y+ PE L     G  
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183

Query: 273 AATVMLDVYSFGILMIEI 290
                 D +S G+ M E+
Sbjct: 184 KYGPECDWWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 39.7 bits (93), Expect = 5e-04
 Identities = 32/152 (21%), Positives = 50/152 (32%), Gaps = 28/152 (18%)

Query: 98  VYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV--KILGYCASGLDRVL 155
           VY           +K          RE    +  L  L  + +   K+L    S     L
Sbjct: 14  VYLLGTKDE-DYVLKINPSREKGADREREVAI--LQLLARKGLPVPKVLASGESDGWSYL 70

Query: 156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP 215
           + E++E  +LD+                      +S E +  I   +A  LA LH L   
Sbjct: 71  LMEWIEGETLDE----------------------VSEEEKEDIAEQLAELLAKLHQLPLL 108

Query: 216 -IIHRDIKSSNVLLDSDFEAHISDFGLARRID 246
            + H D+   N+L+D      I D+  A    
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 4/78 (5%)

Query: 217 IHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL----GGNT 272
           +HRDIK  N+L+D +    ++DFG   ++    +  S+   GT  Y+ PE L     G  
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183

Query: 273 AATVMLDVYSFGILMIEI 290
                 D +S G+ M E+
Sbjct: 184 KYGPECDWWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 8/97 (8%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK---LS---SGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           DN    + +G G+FG V +A    LS   S + VA+K L   A    ++   +E++ +  
Sbjct: 37  DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSH 96

Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH 170
           L  H NIV +LG C  G    +I E+   G L  +LH
Sbjct: 97  LGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLH 133

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 27/73 (36%), Positives = 37/73 (50%), Gaps = 6/73 (8%)

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           ++R V  GL  LH +   I+HRDIK  N+L+  D +  I DFG A  +D         + 
Sbjct: 314 VMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAA--VDMCTGINFNPLY 369

Query: 258 GTMG--YMPPEYL 268
           G +   Y PPE L
Sbjct: 370 GMLDPRYSPPEEL 382

Length = 507

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	373
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
smart00090	237	RIO RIO-like kinase.	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.69
KOG1243	690	consensus Protein kinase [General function predict	99.61
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.61
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.59
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.43
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.38
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.34
KOG3087	229	consensus Serine/threonine protein kinase [General	99.33
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.31
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.31
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.16
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.1
COG4248	637	Uncharacterized protein with protein kinase and he	99.06
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.04
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.98
PRK09902	216	hypothetical protein; Provisional	98.92
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.92
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.85
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.72
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.68
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.58
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.49
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.48
PF01636	239	APH: Phosphotransferase enzyme family This family	98.42
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.35
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.35
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.32
PLN02876	822	acyl-CoA dehydrogenase	98.32
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.27
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.21
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.18
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.08
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.07
PRK10593	297	hypothetical protein; Provisional	98.02
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.02
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.88
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.87
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.82
PRK05231	319	homoserine kinase; Provisional	97.81
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.77
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.7
PLN02236	344	choline kinase	97.43
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.4
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.37
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.16
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.15
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.07
PLN02756	418	S-methyl-5-thioribose kinase	97.06
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.97
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.93
PRK11768	325	serine/threonine protein kinase; Provisional	96.87
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.69
KOG2270	520	consensus Serine/threonine protein kinase involved	96.69
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.69
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.58
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.58
COG2334	331	Putative homoserine kinase type II (protein kinase	96.56
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.53
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.47
PRK06148	1013	hypothetical protein; Provisional	96.43
PRK12396	409	5-methylribose kinase; Reviewed	96.39
PF02439	38	Adeno_E3_CR2: Adenovirus E3 region protein CR2; In	96.21
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.9
PTZ00384	383	choline kinase; Provisional	95.85

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-56  Score=398.63  Aligned_cols=290  Identities=46%  Similarity=0.756  Sum_probs=247.0

Q ss_pred             CCcccChHHHHHhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEE
Q 043074           68 SLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC  147 (373)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  147 (373)
                      ....+++.++..+|++|...+.||+|+||.||+|.+.++..||||++........++|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56778999999999999999999999999999999999999999988765543145699999999999999999999999


Q ss_pred             eeCC-eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceeecCCCCc
Q 043074          148 ASGL-DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHG-LEKPIIHRDIKSSN  225 (373)
Q Consensus       148 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~-~~~~i~H~dlk~~N  225 (373)
                      .+.+ ..+|||||+++|+|.++++.....             +++|..+++|+.++|+||+|||. ...+|+||||||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-------------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN  207 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-------------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN  207 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-------------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence            9998 599999999999999999876532             39999999999999999999996 34479999999999


Q ss_pred             eEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCC
Q 043074          226 VLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ  305 (373)
Q Consensus       226 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~  305 (373)
                      ||+|+++++||+|||+|+..............||.+|+|||.+.. ...+.++|||||||+|+||+||+.|..... ...
T Consensus       208 ILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~  285 (361)
T KOG1187|consen  208 ILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRG  285 (361)
T ss_pred             eeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCC-Ccc
Confidence            999999999999999996543211111111179999999999974 568999999999999999999998754333 233


Q ss_pred             cccHHHHHHHHHHhccccccccCccccccCCH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          306 EVGLLEWARTMEARNKEIEMVDSNISREELSE-AGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ...+.+|........+..+.+|+.+.....+. .....+..+...|++.+|++||+|.+|++.|+.+.
T Consensus       286 ~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  286 ELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             cccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            44589999888888889999999987444343 67888999999999999999999999999997653

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-52  Score=375.04  Aligned_cols=257  Identities=33%  Similarity=0.512  Sum_probs=210.1

Q ss_pred             CCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccccc--HHHHHHHHHHHhcCCCCCccceeeEEeeCC-eeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRNIVKILGYCASGL-DRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  159 (373)
                      .+...+.+|+|+||+||+|.+.....||+|++.......  .+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            344456699999999999999755559999997654433  458999999999999999999999999887 79999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-ceeecCCCCceEeCCCC-ceEEe
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP-IIHRDIKSSNVLLDSDF-EAHIS  237 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~-i~H~dlk~~Nill~~~~-~~kl~  237 (373)
                      +++|+|.++++.....             .+++..+++++.||++||.|||  +.+ ||||||||+|+|++.++ ++||+
T Consensus       122 ~~~GsL~~~l~~~~~~-------------~l~~~~~l~~aldiArGm~YLH--~~~~iIHrDLK~~NiLv~~~~~~~KI~  186 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKR-------------KLPLKVRLRIALDIARGMEYLH--SEGPIIHRDLKSDNILVDLKGKTLKIA  186 (362)
T ss_pred             CCCCcHHHHHhhcccC-------------CCCHHHHHHHHHHHHHHHHHHh--cCCCeeecccChhhEEEcCCCCEEEEC
Confidence            9999999999875211             3999999999999999999999  666 99999999999999997 99999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCC-CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN-TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      |||+++...... ...+...||+.|||||++.+. ..++.++||||||+++|||+||..||......       ......
T Consensus       187 DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-------~~~~~v  258 (362)
T KOG0192|consen  187 DFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-------QVASAV  258 (362)
T ss_pred             CCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHHH
Confidence            999998765432 223336799999999999853 56899999999999999999999997653321       111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .          ....+..++..++..+..++..||+.||++||++.+++..|+.+.
T Consensus       259 ~----------~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~  304 (362)
T KOG0192|consen  259 V----------VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM  304 (362)
T ss_pred             H----------hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence            1          111122225557889999999999999999999999999998764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-53  Score=360.78  Aligned_cols=252  Identities=29%  Similarity=0.433  Sum_probs=207.5

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-eeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGL-DRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  159 (373)
                      +.+..+.||+|..|+||++.++ +++-+|+|++..... ...+++.+|+++++..+|||||.++|.|.... ...++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4556788999999999999775 788999999944332 34678999999999999999999999999998 49999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      |++|||++++.....               +++...-+++.++++||.|||+ ..+|+||||||+|+|++..|+|||+||
T Consensus       160 MDgGSLd~~~k~~g~---------------i~E~~L~~ia~~VL~GL~YLh~-~~~IIHRDIKPsNlLvNskGeVKicDF  223 (364)
T KOG0581|consen  160 MDGGSLDDILKRVGR---------------IPEPVLGKIARAVLRGLSYLHE-ERKIIHRDIKPSNLLVNSKGEVKICDF  223 (364)
T ss_pred             cCCCCHHHHHhhcCC---------------CCHHHHHHHHHHHHHHHHHHhh-ccCeeeccCCHHHeeeccCCCEEeccc
Confidence            999999999987643               8999999999999999999995 488999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |.+..+..+   ......||..|||||.+.+. .|+.++||||||+.++|+.+|+.|+.+.  .+...   .|..-+.. 
T Consensus       224 GVS~~lvnS---~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~--~~~~~---~~~~Ll~~-  293 (364)
T KOG0581|consen  224 GVSGILVNS---IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPP--NPPYL---DIFELLCA-  293 (364)
T ss_pred             cccHHhhhh---hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCc--CCCCC---CHHHHHHH-
Confidence            999987654   45678899999999999965 4889999999999999999999997664  11111   12222211 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                        +.....+.+..+    .++.+++.++..||++||.+||+++|+++
T Consensus       294 --Iv~~ppP~lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  294 --IVDEPPPRLPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             --HhcCCCCCCCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              111122233222    36779999999999999999999999975

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-53  Score=380.22  Aligned_cols=255  Identities=27%  Similarity=0.451  Sum_probs=212.4

Q ss_pred             CCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCC
Q 043074           84 FSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENG  163 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  163 (373)
                      +...+.||+|.||.||.|.++....||+|.++.... ..+.|.+|+.+|++|+|+|||+++|+|..+...+||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            344678999999999999998888999999976533 3478899999999999999999999999988999999999999


Q ss_pred             CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecccc
Q 043074          164 SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR  243 (373)
Q Consensus       164 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  243 (373)
                      +|.+||+.....             .++..+.+.++.|||+||+||+  ++++|||||..+||||++++.|||+|||+|+
T Consensus       287 sLl~yLr~~~~~-------------~l~~~~Ll~~a~qIaeGM~YLe--s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  287 SLLDYLRTREGG-------------LLNLPQLLDFAAQIAEGMAYLE--SKNYIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             cHHHHhhhcCCC-------------ccchHHHHHHHHHHHHHHHHHH--hCCccchhhhhhheeeccCceEEEccccccc
Confidence            999999983332             2888999999999999999999  7899999999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcccc
Q 043074          244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEI  323 (373)
Q Consensus       244 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (373)
                      ....+.........-+..|.|||.+. ...++.+||||||||+||||+|-+..+++....      .+....        
T Consensus       352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~-~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------~ev~~~--------  416 (468)
T KOG0197|consen  352 LIGDDEYTASEGGKFPIKWTAPEALN-YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------EEVLEL--------  416 (468)
T ss_pred             ccCCCceeecCCCCCCceecCHHHHh-hCCcccccceeehhhhHHHHhccCCCCCCCCCH------HHHHHH--------
Confidence            66555444444444567899999998 556899999999999999999966554543332      222222        


Q ss_pred             ccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          324 EMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                        ++...+... |..||.+++++|..||+.+|++|||++.+...|+++.
T Consensus       417 --le~GyRlp~-P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  417 --LERGYRLPR-PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             --HhccCcCCC-CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence              222222223 7778999999999999999999999999999999874

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.7e-53  Score=393.79  Aligned_cols=269  Identities=29%  Similarity=0.464  Sum_probs=218.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  153 (373)
                      ..+....+.||+|+||+||+|+..      +...||||.++..... ...+|++|++.+..++|||||+++|+|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            456666789999999999999642      4567999999877666 577899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++|+|||..|||.+||.......+....-.- ...+++..+.+.|+.|||.||.||.  ++.+|||||..+|+||+++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~-~~~~L~~~q~L~iA~QIAaGM~YLs--~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQD-TPPPLSTSQFLHIATQIAAGMEYLS--SHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHH--hCcccccchhhhhceeccceE
Confidence            9999999999999999987765443311111 1456999999999999999999999  788999999999999999999


Q ss_pred             eEEeeeccccccCCCCCcc-cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHH
Q 043074          234 AHISDFGLARRIDTSHSHV-STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  311 (373)
                      |||+|||+++..-..+... .....-+.+|||||.+. ...+|.+||||||||+|||+++ |+.|++... ++       
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-y~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-n~-------  712 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-NQ-------  712 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhh-cCcccchhhhhhhhhhhhhhhccccCcccccc-hH-------
Confidence            9999999999764443332 22334467999999998 5669999999999999999997 677755422 11       


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                               ++++.+..+-.-+ .+++||.+++.||..||+.+|++||+++||-..|+..
T Consensus       713 ---------EVIe~i~~g~lL~-~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  713 ---------EVIECIRAGQLLS-CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             ---------HHHHHHHcCCccc-CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence                     1112222222222 2888999999999999999999999999999999875

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-52  Score=372.03  Aligned_cols=247  Identities=25%  Similarity=0.423  Sum_probs=210.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .+|...+.||+|+|+.+|.++. .+|+.||+|++.+...   ...+.+.+|+++.+.|+|||||+++++|++.++.|+|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5789999999999999999976 8899999999976333   23567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      |+|+.++|..+++..+               ++++.++..+++||+.||.|||  +.+|+|||||..|+|++++.+|||+
T Consensus        98 ELC~~~sL~el~Krrk---------------~ltEpEary~l~QIv~GlkYLH--~~~IiHRDLKLGNlfL~~~~~VKIg  160 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK---------------PLTEPEARYFLRQIVEGLKYLH--SLGIIHRDLKLGNLFLNENMNVKIG  160 (592)
T ss_pred             EecCCccHHHHHHhcC---------------CCCcHHHHHHHHHHHHHHHHHH--hcCceecccchhheeecCcCcEEec
Confidence            9999999999998544               3999999999999999999999  7889999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+|..+..+.. ...+.+|||-|.|||++. ....+..+||||+||+||.|+.|++||....       +.+......
T Consensus       161 DFGLAt~le~~~E-rk~TlCGTPNYIAPEVl~-k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------vkety~~Ik  231 (592)
T KOG0575|consen  161 DFGLATQLEYDGE-RKKTLCGTPNYIAPEVLN-KSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------VKETYNKIK  231 (592)
T ss_pred             ccceeeeecCccc-ccceecCCCcccChhHhc-cCCCCCchhhhhhhhHHHhhhhCCCCcccch-------HHHHHHHHH
Confidence            9999998865533 345689999999999998 4457889999999999999999999986422       222222222


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .       -+..+     |...+.+..+||.++|+.||.+|||+++|+.
T Consensus       232 ~-------~~Y~~-----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  232 L-------NEYSM-----PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             h-------cCccc-----ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1       11111     4455678999999999999999999999985

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.7e-52  Score=355.62  Aligned_cols=254  Identities=27%  Similarity=0.380  Sum_probs=205.5

Q ss_pred             hcCCCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCcccccc-------HHHHHHHHHHHhcCCCCCccceeeEEeeCC
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG-------FREFRAEMETLGKLRHRNIVKILGYCASGL  151 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  151 (373)
                      ..+.|.+.+.||+|+||.|-+|. .++|+.||||++++.....       ...+.+|+++|++|+|||||++++++....
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            45678889999999999999994 5689999999997643322       234679999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..|+|+||++||+|.+++..+..               +.+..-..+++|++.|+.|||  +.||+||||||+|||++.+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~---------------l~ed~~K~~f~Qll~avkYLH--~~GI~HRDiKPeNILl~~~  312 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY---------------LREDLGKLLFKQLLTAVKYLH--SQGIIHRDIKPENILLSND  312 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc---------------cccchhHHHHHHHHHHHHHHH--HcCcccccCCcceEEeccC
Confidence            99999999999999999987764               667777889999999999999  8999999999999999766


Q ss_pred             ---CceEEeeeccccccCCCCCcccccccccccccCccccCCC--CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          232 ---FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN--TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       232 ---~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                         ..+||+|||+|+..+  ......+.+|||.|.|||++.+.  ..+..+.|+||+||+||-+++|.+||.+...+.  
T Consensus       313 ~e~~llKItDFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--  388 (475)
T KOG0615|consen  313 AEDCLLKITDFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--  388 (475)
T ss_pred             CcceEEEecccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--
Confidence               679999999999875  34456789999999999999742  334558899999999999999999986544332  


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       .+.+-.    ..++-  .+.     ...-...+++..++|.+||..||++|||+.|+++
T Consensus       389 -sl~eQI----~~G~y--~f~-----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  389 -SLKEQI----LKGRY--AFG-----PLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             -cHHHHH----hcCcc--ccc-----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence             111110    00000  000     0113445678999999999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-51  Score=350.41  Aligned_cols=199  Identities=30%  Similarity=0.490  Sum_probs=179.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcc--ccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKD--AFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+.+.  ..+..+.+..|+.+|+.++|||||++++++.+++..||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            457888889999999999999764 6899999999776  4445677899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC------
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD------  231 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~------  231 (373)
                      |||.||+|.+|++....               +++.++..++.||+.||++||  +++|+||||||+|||++..      
T Consensus        89 EyC~gGDLs~yi~~~~~---------------l~e~t~r~Fm~QLA~alq~L~--~~~IiHRDLKPQNiLLs~~~~~~~~  151 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGR---------------LPEATARHFMQQLASALQFLH--ENNIIHRDLKPQNILLSTTARNDTS  151 (429)
T ss_pred             EeCCCCCHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCcceEEeccCCCCCCC
Confidence            99999999999998763               899999999999999999999  8999999999999999865      


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCC
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP  299 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  299 (373)
                      -.+||+|||+|+.+.+  .....+.+|++-|||||++. ...|+.|+|+||+|+++|++++|..||..
T Consensus       152 ~~LKIADFGfAR~L~~--~~~a~tlcGSplYMAPEV~~-~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  152 PVLKIADFGFARFLQP--GSMAETLCGSPLYMAPEVIM-SQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             ceEEecccchhhhCCc--hhHHHHhhCCccccCHHHHH-hccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            4689999999998763  34556789999999999997 56699999999999999999999999754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-51  Score=337.98  Aligned_cols=255  Identities=26%  Similarity=0.384  Sum_probs=204.4

Q ss_pred             CCCCCCeeecCCCceEEEE-EeCCCCEEEEEEeCcc--ccccHHHHHHHHHHHhcCCCCCccceee-EEeeCCe-eEEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKD--AFQGFREFRAEMETLGKLRHRNIVKILG-YCASGLD-RVLIY  157 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~  157 (373)
                      +|++.+.||.|+||+||++ +..+|..+|.|.+.-.  +.+....+..|+.+|++|+|||||++++ -+.+++. .++||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            5777889999999999999 5678999999988633  2334567899999999999999999998 4455444 88999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhc--CCCCceeecCCCCceEeCCCCceE
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHG--LEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~--~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |+|..|+|.+.++..+....           .+++.++++++.|++.||.++|+  -..-+.||||||.||+++.+|.||
T Consensus       100 E~c~~GDLsqmIk~~K~qkr-----------~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvK  168 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKR-----------LIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVK  168 (375)
T ss_pred             HhhcccCHHHHHHHHHhccc-----------cCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCcee
Confidence            99999999999987765432           38999999999999999999995  223389999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||+++.+.... ......+|||.||+||.+.++ .|+.+|||||+||++|||+.-.+||+..       .+.+.-..
T Consensus       169 LGDfGL~r~l~s~~-tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~L~~K  239 (375)
T KOG0591|consen  169 LGDFGLGRFLSSKT-TFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLSLCKK  239 (375)
T ss_pred             eccchhHhHhcchh-HHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccc-------cHHHHHHH
Confidence            99999999876433 344567899999999999854 5899999999999999999999998653       23332222


Q ss_pred             HHHhccccccccCccccccCC-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELS-EAGVREYFRIACMCTNEKSRERPAMSYVVQLL  368 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L  368 (373)
                      ..+-       +    ...++ ...+..+..++..|+..||+.||+...++..+
T Consensus       240 I~qg-------d----~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  240 IEQG-------D----YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             HHcC-------C----CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            2211       0    01113 66788999999999999999999965555444

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-50  Score=372.62  Aligned_cols=256  Identities=28%  Similarity=0.516  Sum_probs=216.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC----CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ....+.++||.|.||.|++|+++    ....||||.++....+ ...+|+.|+.+|.+++||||++|.|+........+|
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            45667889999999999999875    3467999999876554 466899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +|||++|+|+.||+++...              +++.+..-++++|+.||.||.  +.++|||||..+|||++.+..+|+
T Consensus       709 TEyMENGsLDsFLR~~DGq--------------ftviQLVgMLrGIAsGMkYLs--dm~YVHRDLAARNILVNsnLvCKV  772 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQ--------------FTVIQLVGMLRGIASGMKYLS--DMNYVHRDLAARNILVNSNLVCKV  772 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCc--------------eEeehHHHHHHHHHHHhHHHh--hcCchhhhhhhhheeeccceEEEe
Confidence            9999999999999988753              999999999999999999999  888999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccc--cccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAG--TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +|||+++.+.+......+...|  +.+|.|||.+. ...++.+|||||||+++||.++ |..|+.+..-       .+  
T Consensus       773 sDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-------Qd--  842 (996)
T KOG0196|consen  773 SDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-------QD--  842 (996)
T ss_pred             ccccceeecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccch-------HH--
Confidence            9999999876554333333333  46899999997 6679999999999999999876 7788655321       11  


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                              .++.++...+... +.+||..+++||.+||++|-.+||++.+|+..|++++
T Consensus       843 --------VIkaIe~gyRLPp-PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  843 --------VIKAIEQGYRLPP-PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             --------HHHHHHhccCCCC-CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence                    2222333333333 7889999999999999999999999999999999986

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.7e-50  Score=331.31  Aligned_cols=264  Identities=22%  Similarity=0.308  Sum_probs=205.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      +.|+...++|+|+||.|++++.+ +|+.||||++..+..  ...+..++|+++|++++|+|+|.++.+|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46778889999999999999765 699999999854333  224557899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      ||+. ++.+.+.....+              ++.....+++.|++.|+.|+|  +++++||||||+||||+.+|.+||||
T Consensus        82 ~~dh-TvL~eLe~~p~G--------------~~~~~vk~~l~Q~l~ai~~cH--k~n~IHRDIKPENILit~~gvvKLCD  144 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNG--------------VPSELVKKYLYQLLKAIHFCH--KNNCIHRDIKPENILITQNGVVKLCD  144 (396)
T ss_pred             ecch-HHHHHHHhccCC--------------CCHHHHHHHHHHHHHHhhhhh--hcCeecccCChhheEEecCCcEEecc
Confidence            9966 555556655543              888999999999999999999  89999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH-HH-----
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL-EW-----  312 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~-~~-----  312 (373)
                      ||+|+.+.. .....+..+.|.+|.|||.+.|..+|..+.||||+||++.||++|.+-| |..++-.+...+ ..     
T Consensus       145 FGFAR~L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~-PG~SDiDQLy~I~ktLG~L~  222 (396)
T KOG0593|consen  145 FGFARTLSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW-PGRSDIDQLYLIRKTLGNLI  222 (396)
T ss_pred             chhhHhhcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC-CCcchHHHHHHHHHHHcccC
Confidence            999998865 3445567788999999999999889999999999999999999997654 433332221111 11     


Q ss_pred             --HHHHHHhccccccccC-------ccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          313 --ARTMEARNKEIEMVDS-------NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       313 --~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                        .......+.....+.-       .+.+.  -.....-+.+++..||+.||.+|++.++++.
T Consensus       223 prhq~iF~~N~~F~Gv~lP~~~~~epLe~k--~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  223 PRHQSIFSSNPFFHGVRLPEPEHPEPLERK--YPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHHHHhccCCceeeeecCCCCCccchhhh--cccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence              1111112222111110       11111  1123447889999999999999999999874

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-48  Score=330.66  Aligned_cols=242  Identities=28%  Similarity=0.379  Sum_probs=201.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|++.++||+|+||.|+.++. ++++.+|+|++++....   ..+....|..+|.+++||.||+++..|.+....|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            45899999999999999999954 57899999999775443   356788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +||+.||.|..+|.+...               +++..+.-++..|+.||.|||  +++|+||||||+|||+|++|+++|
T Consensus       104 ld~~~GGeLf~hL~~eg~---------------F~E~~arfYlaEi~lAL~~LH--~~gIiyRDlKPENILLd~~GHi~L  166 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGR---------------FSEDRARFYLAEIVLALGYLH--SKGIIYRDLKPENILLDEQGHIKL  166 (357)
T ss_pred             EeccCCccHHHHHHhcCC---------------cchhHHHHHHHHHHHHHHHHH--hCCeeeccCCHHHeeecCCCcEEE
Confidence            999999999999987664               889999999999999999999  899999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||+++..-.. .......+||+.|||||++.+. .++.++|.||+|+++|||++|.+||....       ...+....
T Consensus       167 tDFgL~k~~~~~-~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~-------~~~~~~~I  237 (357)
T KOG0598|consen  167 TDFGLCKEDLKD-GDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAED-------VKKMYDKI  237 (357)
T ss_pred             eccccchhcccC-CCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCcc-------HHHHHHHH
Confidence            999999864332 3344558999999999999865 58999999999999999999999986532       12222222


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP  359 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  359 (373)
                      ....         +  ...+.-.+.+..+++...|+.||++|.
T Consensus       238 ~~~k---------~--~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  238 LKGK---------L--PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             hcCc---------C--CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            2211         0  011222345889999999999999995

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-48  Score=336.07  Aligned_cols=254  Identities=28%  Similarity=0.439  Sum_probs=204.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCC--eeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGL--DRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  158 (373)
                      .++...+.||+|+||.||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            46777899999999999999765 58999999987764444667899999999999999999999754444  6889999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC-CCceEEe
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-DFEAHIS  237 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~-~~~~kl~  237 (373)
                      |+++|+|.+++..... .             +++..+.++.+||++||+|||  +++++|+||||+|||++. ++.+||+
T Consensus        97 y~~~GsL~~~~~~~g~-~-------------l~E~~v~~ytr~iL~GL~ylH--s~g~vH~DiK~~NiLl~~~~~~~Kla  160 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG-K-------------LPEPLVRRYTRQILEGLAYLH--SKGIVHCDIKPANILLDPSNGDVKLA  160 (313)
T ss_pred             ccCCCcHHHHHHHcCC-C-------------CCHHHHHHHHHHHHHHHHHHH--hCCEeccCcccceEEEeCCCCeEEec
Confidence            9999999999998764 2             899999999999999999999  899999999999999999 7999999


Q ss_pred             eeccccccCC--CCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          238 DFGLARRIDT--SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       238 Dfg~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |||++.....  ..........||+.|||||++........++|||||||++.||+||..||...      ....++...
T Consensus       161 DFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~  234 (313)
T KOG0198|consen  161 DFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLL  234 (313)
T ss_pred             cCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHH
Confidence            9999987653  22223345789999999999984222335899999999999999999886542      011111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      .....     ..+     .++...+.+..+++.+|++.||++|||++++++.
T Consensus       235 ig~~~-----~~P-----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  235 IGRED-----SLP-----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             HhccC-----CCC-----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            11111     111     3355667799999999999999999999999874

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.1e-48  Score=339.10  Aligned_cols=263  Identities=27%  Similarity=0.318  Sum_probs=208.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASG--LDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  155 (373)
                      .+.|+..++||+|.||.||+|+ ..+|+.||+|++..+..  .......+|+.+|++|+||||+++.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            4577778899999999999995 56899999999866553  3345678999999999999999999988776  68999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |+|||+. +|..++....-.              |++.++..+++|++.||+|||  .+++.|||||.+|||||.+|.+|
T Consensus       196 VFeYMdh-DL~GLl~~p~vk--------------ft~~qIKc~mkQLl~Gl~~cH--~~gvlHRDIK~SNiLidn~G~LK  258 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVK--------------FTEPQIKCYMKQLLEGLEYCH--SRGVLHRDIKGSNILIDNNGVLK  258 (560)
T ss_pred             EEecccc-hhhhhhcCCCcc--------------cChHHHHHHHHHHHHHHHHHh--hcCeeeccccccceEEcCCCCEE
Confidence            9999955 999988765432              999999999999999999999  89999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||+|+.+........+..+-|.+|.|||++.|...|+.+.|+||.||+|.||+.|++.+......+    -++-+..
T Consensus       259 iaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve----Ql~kIfk  334 (560)
T KOG0600|consen  259 IADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE----QLHKIFK  334 (560)
T ss_pred             eccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH----HHHHHHH
Confidence            999999998877776667778889999999999999999999999999999999999987743322111    1111111


Q ss_pred             HHHh-----ccccccc-----------cCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          316 MEAR-----NKEIEMV-----------DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       316 ~~~~-----~~~~~~~-----------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      +...     +...+..           ...+ .+. ....+....+|+..+|..||.+|.|+.++++
T Consensus       335 lcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l-~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  335 LCGSPTEDYWPVSKLPHATIFKPQQPYKRRL-RET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             HhCCCChhccccccCCcccccCCCCcccchH-HHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1100     0000000           0111 001 2233557889999999999999999998874

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-47  Score=328.20  Aligned_cols=263  Identities=24%  Similarity=0.384  Sum_probs=210.7

Q ss_pred             hcCCCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCcccccc-HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ..+.|++.+.||.|..+.||+|. ...+..||||+++-..... .+.+++|+..|+.++||||++++..|..+...|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            34689999999999999999995 5678999999997655443 578999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      .||.+||+.+.+...-...             +++..+..|++++++||.|||  .+|.||||+|+.||||+++|.|||+
T Consensus       104 pfMa~GS~ldIik~~~~~G-------------l~E~~Ia~iLre~LkaL~YLH--~~G~IHRdvKAgnILi~~dG~VkLa  168 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDG-------------LEEASIATILREVLKALDYLH--QNGHIHRDVKAGNILIDSDGTVKLA  168 (516)
T ss_pred             hhhcCCcHHHHHHHHcccc-------------ccHHHHHHHHHHHHHHHHHHH--hcCceecccccccEEEcCCCcEEEc
Confidence            9999999999998765543             899999999999999999999  8999999999999999999999999


Q ss_pred             eeccccccCCCCCcc--c-ccccccccccCccc-cCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          238 DFGLARRIDTSHSHV--S-TQVAGTMGYMPPEY-LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~--~-~~~~g~~~y~aPE~-~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |||.+..+.......  . ....||+.|||||+ .+.-..|+.|+||||||++..||.+|..||.....-.      ...
T Consensus       169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl  242 (516)
T KOG0582|consen  169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLL  242 (516)
T ss_pred             CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHH
Confidence            999988765543221  1 45689999999999 4445668999999999999999999999976543211      000


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .  ...+......-..+..+. .......+.+++..||+.||.+|||++++++
T Consensus       243 ~--tLqn~pp~~~t~~~~~d~-~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  243 L--TLQNDPPTLLTSGLDKDE-DKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             H--HhcCCCCCcccccCChHH-hhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            1  111111111101111111 2233458999999999999999999999975

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=342.71  Aligned_cols=251  Identities=27%  Similarity=0.378  Sum_probs=212.6

Q ss_pred             hcCCCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ....|...+.||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|..++..|.|||
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            35688888999999999999995 56789999999988777767789999999999999999999999988899999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++|+|.+.+....                +++.++..|++++++||+|||  .++|+|||||.+|||++.+|.+||+|
T Consensus       351 ym~ggsLTDvVt~~~----------------~~E~qIA~Icre~l~aL~fLH--~~gIiHrDIKSDnILL~~~g~vKltD  412 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKTR----------------MTEGQIAAICREILQGLKFLH--ARGIIHRDIKSDNILLTMDGSVKLTD  412 (550)
T ss_pred             ecCCCchhhhhhccc----------------ccHHHHHHHHHHHHHHHHHHH--hcceeeeccccceeEeccCCcEEEee
Confidence            999999999997765                899999999999999999999  89999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||+|..+..... ......|||.|||||+.. ...|.++.||||||++++||+-|.+|++.....       .-......
T Consensus       413 FGFcaqi~~~~~-KR~TmVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl-------rAlyLIa~  483 (550)
T KOG0578|consen  413 FGFCAQISEEQS-KRSTMVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RALYLIAT  483 (550)
T ss_pred             eeeeeccccccC-ccccccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChH-------HHHHHHhh
Confidence            999998765544 344567999999999997 566899999999999999999999997642111       11111111


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .      -.+.+.   .++..+..+.+|+.+||+.|+.+||++.||++
T Consensus       484 n------g~P~lk---~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  484 N------GTPKLK---NPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             c------CCCCcC---CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            1      111221   15566779999999999999999999999986

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.9e-47  Score=311.01  Aligned_cols=266  Identities=26%  Similarity=0.383  Sum_probs=208.7

Q ss_pred             CCCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCcccccc--HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ++|...+.+|+|.||.||+|+ .++|+.||||+++.....+  .....+|++.|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            467788899999999999995 5689999999997654432  4567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+ ..+|+..++....              .++..++..++.++++|++|||  .+.|.||||||.|+|++++|.+||+|
T Consensus        82 fm-~tdLe~vIkd~~i--------------~l~pa~iK~y~~m~LkGl~y~H--~~~IlHRDlKPnNLLis~~g~lKiAD  144 (318)
T KOG0659|consen   82 FM-PTDLEVVIKDKNI--------------ILSPADIKSYMLMTLKGLAYCH--SKWILHRDLKPNNLLISSDGQLKIAD  144 (318)
T ss_pred             ec-cccHHHHhccccc--------------ccCHHHHHHHHHHHHHHHHHHH--hhhhhcccCCccceEEcCCCcEEeec
Confidence            99 5699999987654              3889999999999999999999  89999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH---------
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL---------  309 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~---------  309 (373)
                      ||+++.+........ ..+-|.+|.|||.+.|...|+...||||.||++.||+-|. |+++...+-.+...         
T Consensus       145 FGLAr~f~~p~~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~-P~fpG~sDidQL~~If~~LGTP~  222 (318)
T KOG0659|consen  145 FGLARFFGSPNRIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV-PFFPGDSDIDQLSKIFRALGTPT  222 (318)
T ss_pred             ccchhccCCCCcccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC-CCCCCCchHHHHHHHHHHcCCCC
Confidence            999998876544332 3367999999999999999999999999999999999864 55554443322111         


Q ss_pred             -HHHHHHHH-HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          310 -LEWARTME-ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       310 -~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                       .+|..-.. .+....+.+... ........++....+++..|+..||.+|++++|.++.
T Consensus       223 ~~~WP~~~~lpdY~~~~~~P~~-~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  223 PDQWPEMTSLPDYVKIQQFPKP-PLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccCccccccccHHHHhcCCCC-ccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence             11100000 000001111111 1111234456677999999999999999999998863

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=338.42  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=208.9

Q ss_pred             HHhcCCCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCe
Q 043074           78 IDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF---QGFREFRAEMETLGKL-RHRNIVKILGYCASGLD  152 (373)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  152 (373)
                      ....++|.+++.||+|+|++|++|+ .++++.+|||++.+...   ...+.+..|-+.|.+| .||.|++|+..|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            3445789999999999999999995 45799999999976433   2234577899999999 79999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      +|+|+||+++|+|.++|.+.+.               |++.....++.+|+.||+|||  ++|||||||||+|||+|+++
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs---------------fde~caR~YAAeIldAleylH--~~GIIHRDlKPENILLd~dm  211 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS---------------FDETCARFYAAEILDALEYLH--SNGIIHRDLKPENILLDKDG  211 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc---------------chHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeEcCCC
Confidence            9999999999999999998764               899999999999999999999  89999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCc----------cc--ccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCc
Q 043074          233 EAHISDFGLARRIDTSHSH----------VS--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPV  300 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~----------~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  300 (373)
                      +++|+|||.|+.+......          ..  ..++||..|.+||++. ....+..+|+|+|||++|+|+.|.+||...
T Consensus       212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-~~~~~~~sDiWAlGCilyQmlaG~PPFra~  290 (604)
T KOG0592|consen  212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN-DSPAGPSSDLWALGCILYQMLAGQPPFRAA  290 (604)
T ss_pred             cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhc-CCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence            9999999999987543211          11  4478999999999998 455788999999999999999999998642


Q ss_pred             ccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .      .+..+.+-+.        ++..+     ++..++.+.+|+.+.|..||++|++.++|-+
T Consensus       291 N------eyliFqkI~~--------l~y~f-----p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  291 N------EYLIFQKIQA--------LDYEF-----PEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             c------HHHHHHHHHH--------hcccC-----CCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            1      1222222111        22222     4444578999999999999999999998865

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=335.64  Aligned_cols=265  Identities=26%  Similarity=0.421  Sum_probs=209.8

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccccc-HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      +.+...+.++||+|.||+|.++....+..||+|+++...... .++|.+|+++|.+++||||++++|+|..++..++|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            345677889999999999999999888999999998876665 4789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++|+|.+|+..+....             +......+|+.||+.||+||.  +.+++||||.++|||++.++++||+|
T Consensus       616 YmEnGDLnqFl~aheapt-------------~~t~~~vsi~tqiasgmaYLe--s~nfVHrd~a~rNcLv~~e~~iKiad  680 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPT-------------AETAPGVSICTQIASGMAYLE--SLNFVHRDLATRNCLVDGEFTIKIAD  680 (807)
T ss_pred             HHhcCcHHHHHHhccCcc-------------cccchhHHHHHHHHHHHHHHH--hhchhhccccccceeecCcccEEecC
Confidence            999999999998875322             344566789999999999999  67799999999999999999999999


Q ss_pred             eccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh--CCCCCCCcccCCCcccHHHHHHH
Q 043074          239 FGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT--QIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       239 fg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~--g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      ||+++.+-..+. .......-+.+|||||.+. ...++.+||+|+||+++||+++  ...|+.....+    ...+-...
T Consensus       681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsil-lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e----~vven~~~  755 (807)
T KOG1094|consen  681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE----QVVENAGE  755 (807)
T ss_pred             cccccccccCCceeeecceeeeeeehhHHHHH-hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH----HHHHhhhh
Confidence            999996533332 2333445578999999987 4568999999999999999875  55664322111    11111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                      +...    .....-+.   .+.-|+..+++++..||..+.++||+++++...|++.
T Consensus       756 ~~~~----~~~~~~l~---~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  756 FFRD----QGRQVVLS---RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hcCC----CCcceecc---CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1100    00011111   2667888999999999999999999999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=337.31  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=206.7

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcc----cc-ccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCe
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKD----AF-QGFREFRAEMETLGKLR-HRNIVKILGYCASGLD  152 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  152 (373)
                      ...+|.+.+.||+|+||.|+.|.. .+++.||+|++++.    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            456899999999999999999954 57899999987664    11 23456778999999998 9999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC-
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-  231 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~-  231 (373)
                      .++||||+.+|+|.+++....               ++.+.++..+++|++.|++|||  +++|+||||||+|+|++.+ 
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g---------------~l~E~~ar~~F~Qlisav~y~H--~~gi~HRDLK~ENilld~~~  157 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKG---------------RLKEDEARKYFRQLISAVAYCH--SRGIVHRDLKPENILLDGNE  157 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcC---------------CCChHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEecCCC
Confidence            999999999999999999843               2889999999999999999999  7999999999999999999 


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCC-CCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNT-AATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  310 (373)
                      +++||+|||++.... .........+||+.|+|||++.+.. +...++||||+||+||.|++|..||.+..       ..
T Consensus       158 ~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-------~~  229 (370)
T KOG0583|consen  158 GNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-------VP  229 (370)
T ss_pred             CCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-------HH
Confidence            999999999998764 2334566789999999999999877 66799999999999999999999987611       11


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHH-HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAG-VREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ........         ...   .++... +.++..++.+||..||.+|+++.+++.
T Consensus       230 ~l~~ki~~---------~~~---~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  230 NLYRKIRK---------GEF---KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             HHHHHHhc---------CCc---cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            11111100         000   012222 568999999999999999999999983

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-47  Score=371.08  Aligned_cols=264  Identities=27%  Similarity=0.426  Sum_probs=211.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC--CC----CEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS--SG----VTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~--~~----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  153 (373)
                      ..+....+.||+|.||.||.|...  ++    ..||+|.+.+... +...+|.+|..+|+.++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            345667789999999999999653  23    3489999976544 4467899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++++|||++|+|..||++.+.....        ...++..+.+.++.|||+|+.||+  ++++|||||..+|+|+++...
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~--------~~~L~~~dLl~~a~dvA~G~~YLe--~~~fvHRDLAaRNCLL~~~r~  840 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQ--------PSNLSMRDLLAFALDVAKGMNYLE--SKHFVHRDLAARNCLLDERRV  840 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCC--------CCCCCHHHHHHHHHHHhhhhHHHH--hCCCcCcchhhhheeecccCc
Confidence            9999999999999999987543221        123899999999999999999999  899999999999999999999


Q ss_pred             eEEeeeccccccCCCCCcccccc-cccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          234 AHISDFGLARRIDTSHSHVSTQV-AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      |||+|||+|+.+........... .-...|||||.+.. ..++.++|||||||++||++|.+.++++...+..-  +..|
T Consensus       841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v--~~~~  917 (1025)
T KOG1095|consen  841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV--LLDV  917 (1025)
T ss_pred             EEEcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHH--HHHH
Confidence            99999999995543332222222 33568999999984 56899999999999999999977776664433211  1111


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                          ...+        +  .+. +..||..++++|.+||+.+|++||++..|++.+..++
T Consensus       918 ----~~gg--------R--L~~-P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  918 ----LEGG--------R--LDP-PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             ----HhCC--------c--cCC-CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence                1111        1  122 7778889999999999999999999999999888765

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-48  Score=337.17  Aligned_cols=267  Identities=26%  Similarity=0.333  Sum_probs=206.2

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHH--HHHHHHHHhcCC-CCCccceeeEEeeCC-eeE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFRE--FRAEMETLGKLR-HRNIVKILGYCASGL-DRV  154 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~  154 (373)
                      ..++|...+.||.|.||.||+|+. .+|..||||++++.-.. +++  =++|++.|++++ ||||+++.+++.+.+ ..+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            456899999999999999999964 47899999999654332 333  368999999998 999999999998887 999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +||||| ..+|.++++....              ++++..+..|+.||++||+|+|  ++|+.|||+||+|||+.....+
T Consensus        87 fVfE~M-d~NLYqLmK~R~r--------------~fse~~irnim~QilqGL~hiH--k~GfFHRDlKPENiLi~~~~~i  149 (538)
T KOG0661|consen   87 FVFEFM-DCNLYQLMKDRNR--------------LFSESDIRNIMYQILQGLAHIH--KHGFFHRDLKPENILISGNDVI  149 (538)
T ss_pred             eeHHhh-hhhHHHHHhhcCC--------------cCCHHHHHHHHHHHHHHHHHHH--hcCcccccCChhheEeccccee
Confidence            999999 6799999987743              4999999999999999999999  8999999999999999988899


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH---
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE---  311 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---  311 (373)
                      ||+|||+|+......  ..+..+.|.+|+|||++.....|+.+.||||+||+++|+.+-++-|-...+.++...+.+   
T Consensus       150 KiaDFGLARev~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLG  227 (538)
T KOG0661|consen  150 KIADFGLAREVRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLG  227 (538)
T ss_pred             EecccccccccccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhC
Confidence            999999999875433  235567899999999999888999999999999999999987654433222222112221   


Q ss_pred             ------HHHHHHHhccccccc--cCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 ------WARTMEARNKEIEMV--DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                            |...........-.+  ......+.+-..++.+..+++.+|+..||.+|||++|.++
T Consensus       228 tP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  228 TPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             CCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence                  211111100000000  0011111112336789999999999999999999999886

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=334.95  Aligned_cols=240  Identities=31%  Similarity=0.474  Sum_probs=203.8

Q ss_pred             CCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCC
Q 043074           85 STDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGS  164 (373)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  164 (373)
                      ...+.||+|+.|.||+|+++ ++.||||+++.-.       .-+++-|++|+||||+.+.|+|....-+|+|||||+.|.
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            34678999999999999986 7899999885322       247888999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccc
Q 043074          165 LDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       165 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                      |...|+....               ++......|..+||.||.|||  .+.|||||||+-||||+.+..|||+|||-++.
T Consensus       199 L~~VLka~~~---------------itp~llv~Wsk~IA~GM~YLH--~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e  261 (904)
T KOG4721|consen  199 LYEVLKAGRP---------------ITPSLLVDWSKGIAGGMNYLH--LHKIIHRDLKSPNILISYDDVVKISDFGTSKE  261 (904)
T ss_pred             HHHHHhccCc---------------cCHHHHHHHHHHhhhhhHHHH--HhhHhhhccCCCceEeeccceEEeccccchHh
Confidence            9999987653               888999999999999999999  78899999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccc
Q 043074          245 IDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIE  324 (373)
Q Consensus       245 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (373)
                      ....  .....+.||..|||||++. +...++|.|||||||+||||+||.-|+.+.....                 ++-
T Consensus       262 ~~~~--STkMSFaGTVaWMAPEvIr-nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----------------IIw  321 (904)
T KOG4721|consen  262 LSDK--STKMSFAGTVAWMAPEVIR-NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----------------IIW  321 (904)
T ss_pred             hhhh--hhhhhhhhhHhhhCHHHhh-cCCcccccceehhHHHHHHHHhcCCCccccchhe-----------------eEE
Confidence            6543  2344578999999999998 5568999999999999999999999965533221                 122


Q ss_pred             cccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          325 MVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                      .+......-..+..||.-+.-|+.+||+..|..||++++++..|+
T Consensus       322 GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  322 GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            222333333337888999999999999999999999999999885

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.4e-46  Score=337.28  Aligned_cols=272  Identities=29%  Similarity=0.440  Sum_probs=203.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe------CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeC-C
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASG-L  151 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  151 (373)
                      .++|++.+.||+|+||.||+|..      .+++.||+|++..... .....+.+|+.++..+ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46889999999999999999963      2356899999865432 2345688999999999 899999999988764 4


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCC-----------------------------------------------ccccc
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVD-----------------------------------------------GSKQL  184 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~-----------------------------------------------~~~~~  184 (373)
                      ..+++|||+++|+|.+++..........                                               .....
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            5789999999999999997643210000                                               00000


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCc-cccccccccccc
Q 043074          185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYM  263 (373)
Q Consensus       185 ~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~  263 (373)
                      ....++++.++..++.|++.||+|||  +++++||||||+||+++.++.+||+|||+++........ ......++..|+
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence            01235889999999999999999999  799999999999999999999999999999865322211 122234567899


Q ss_pred             CccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHH
Q 043074          264 PPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVRE  342 (373)
Q Consensus       264 aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (373)
                      |||.+.+ ..++.++|||||||++|||++ |..||.......      ....... .+..     ..     .+..++..
T Consensus       244 aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~-~~~~-----~~-----~~~~~~~~  305 (338)
T cd05102         244 APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLK-DGTR-----MR-----APENATPE  305 (338)
T ss_pred             CcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHh-cCCC-----CC-----CCCCCCHH
Confidence            9999874 447889999999999999997 888864322110      1111111 1100     01     12334568


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          343 YFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       343 l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      +.+++.+||+.||++|||+.++++.|++++
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-44  Score=320.48  Aligned_cols=246  Identities=22%  Similarity=0.269  Sum_probs=198.2

Q ss_pred             CeeecCCCceEEEEEeCCCCEEEEEEeCcccccc---HHHHHHHHHHHhcCCCCCccceeeEEee----CCeeEEEEEec
Q 043074           88 KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQG---FREFRAEMETLGKLRHRNIVKILGYCAS----GLDRVLIYEFV  160 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  160 (373)
                      ..||+|++|.||+|.. +|+.||+|.+.......   .+.+.+|+.++.+++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999988 58999999997654333   4667899999999999999999999876    35678999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++|+|.+++....               .+++...++++.|++.||.|||+ ..+++||||||+||++++++.+||+|||
T Consensus       105 ~~g~L~~~l~~~~---------------~~~~~~~~~i~~~i~~~l~~lH~-~~~~~Hrdlkp~nill~~~~~~kl~dfg  168 (283)
T PHA02988        105 TRGYLREVLDKEK---------------DLSFKTKLDMAIDCCKGLYNLYK-YTNKPYKNLTSVSFLVTENYKLKIICHG  168 (283)
T ss_pred             CCCcHHHHHhhCC---------------CCChhHHHHHHHHHHHHHHHHHh-cCCCCCCcCChhhEEECCCCcEEEcccc
Confidence            9999999997643               28899999999999999999993 2478899999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCC-CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGG-NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      +++......    ....++..|+|||.+.+ ...++.++|||||||++|||++|..||....       ..+........
T Consensus       169 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-------~~~~~~~i~~~  237 (283)
T PHA02988        169 LEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-------TKEIYDLIINK  237 (283)
T ss_pred             hHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhc
Confidence            998653221    23457889999999875 2468899999999999999999999975421       11111111111


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                      +     ...     ..+..++..+.+++.+||+.||++|||++++++.|+++
T Consensus       238 ~-----~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        238 N-----NSL-----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             C-----CCC-----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            0     011     11334567899999999999999999999999999876

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1e-45  Score=332.04  Aligned_cols=260  Identities=30%  Similarity=0.461  Sum_probs=209.2

Q ss_pred             HHHhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           77 LIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      .....+.+.+.+.||+|.||+||+|.+..  .||||.++....  +..+.|.+|+..+++-+|.||+-+.|+|..+.. .
T Consensus       387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            33445667788999999999999999863  699999966444  346789999999999999999999999998877 8


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +|+.+|+|.+|..+++.....              |...+.+.|++|+++||.|||  .++|||||||..|||+.++++|
T Consensus       464 IiTqwCeGsSLY~hlHv~etk--------------fdm~~~idIAqQiaqGM~YLH--AK~IIHrDLKSnNIFl~~~~kV  527 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETK--------------FDMNTTIDIAQQIAQGMDYLH--AKNIIHRDLKSNNIFLHEDLKV  527 (678)
T ss_pred             eeehhccCchhhhhccchhhh--------------hhHHHHHHHHHHHHHhhhhhh--hhhhhhhhccccceEEccCCcE
Confidence            999999999999999876532              888999999999999999999  8999999999999999999999


Q ss_pred             EEeeeccccccCCC-CCcccccccccccccCccccCC--CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          235 HISDFGLARRIDTS-HSHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       235 kl~Dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      ||+|||++..-..- .........|...|||||++..  ...|++.+||||||+++|||++|..|+.....+        
T Consensus       528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--------  599 (678)
T KOG0193|consen  528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--------  599 (678)
T ss_pred             EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--------
Confidence            99999999643211 1111223456778999999863  456899999999999999999999996522211        


Q ss_pred             HHHHHHHhccccccccCcccc---ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          312 WARTMEARNKEIEMVDSNISR---EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                               .++-++......   .....+|+.++.+|+..||..++++||.+.+|+..|+.++
T Consensus       600 ---------qIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  600 ---------QIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             ---------heEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence                     122222222111   1124567889999999999999999999999999988775

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-45  Score=334.54  Aligned_cols=257  Identities=28%  Similarity=0.446  Sum_probs=203.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC--CC---CEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS--SG---VTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLD  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~--~~---~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  152 (373)
                      -++..+.++||+|+||.||+|.++  ++   ..||+|..+...   .....++.+|+++|++++|||||+++|++.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            345566789999999999999754  22   238999987522   3456789999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++|||+|+||+|.++|.+....              ++..+.++++.+.+.||+|||  +++++||||..+|+|++.++
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~--------------v~~~ek~~~~~~AA~Gl~YLh--~k~~IHRDIAARNcL~~~~~  299 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKS--------------LPTLEKLRFCYDAARGLEYLH--SKNCIHRDIAARNCLYSKKG  299 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCC--------------CCHHHHHHHHHHHHhHHHHHH--HCCCcchhHhHHHheecCCC
Confidence            99999999999999999987752              899999999999999999999  89999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHH
Q 043074          233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  311 (373)
                      .+||+|||+++... ..........-+..|+|||.+... .++.++|||||||++||+++ |..|+....       ..+
T Consensus       300 ~vKISDFGLs~~~~-~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~-------~~~  370 (474)
T KOG0194|consen  300 VVKISDFGLSRAGS-QYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMK-------NYE  370 (474)
T ss_pred             eEEeCccccccCCc-ceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCC-------HHH
Confidence            99999999987643 111111112346789999999844 68999999999999999998 566643311       111


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .......         ... +...+...|..+..++.+||..||++||+|.++.+.|+.+.
T Consensus       371 v~~kI~~---------~~~-r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~  421 (474)
T KOG0194|consen  371 VKAKIVK---------NGY-RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE  421 (474)
T ss_pred             HHHHHHh---------cCc-cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence            1111111         111 11114456779999999999999999999999999998764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=303.94  Aligned_cols=236  Identities=25%  Similarity=0.368  Sum_probs=200.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccccc---HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQG---FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|+..+.||.|+||.|.+++.+ +|..+|+|++++.....   .+...+|..+|+.+.||.++++.+.+.+.+..++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            47888899999999999999765 68899999998866543   445788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||.+||-|..++++..+               +++..+.-++.||+.||+|||  +.+|++|||||+|||+|.+|.+||+
T Consensus       124 eyv~GGElFS~Lrk~~r---------------F~e~~arFYAAeivlAleylH--~~~iiYRDLKPENiLlD~~G~iKit  186 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR---------------FSEPHARFYAAEIVLALEYLH--SLDIIYRDLKPENLLLDQNGHIKIT  186 (355)
T ss_pred             eccCCccHHHHHHhcCC---------------CCchhHHHHHHHHHHHHHHHH--hcCeeeccCChHHeeeccCCcEEEE
Confidence            99999999999998774               899999999999999999999  7889999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||.|+....    ...+.+|||.|+|||.+. .+.+..++|.|||||++|||+.|.+||++...      +..+.+-..
T Consensus       187 DFGFAK~v~~----rT~TlCGTPeYLAPEii~-sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI~~  255 (355)
T KOG0616|consen  187 DFGFAKRVSG----RTWTLCGTPEYLAPEIIQ-SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKILE  255 (355)
T ss_pred             eccceEEecC----cEEEecCCccccChHHhh-cCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHHHh
Confidence            9999998642    245689999999999998 45689999999999999999999999876433      111111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCC
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRER  358 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  358 (373)
                                ..+   .+|.-...++.+|+...|+.|-.+|
T Consensus       256 ----------~~v---~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  256 ----------GKV---KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ----------Ccc---cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                      111   1144445689999999999999888

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-45  Score=318.90  Aligned_cols=269  Identities=29%  Similarity=0.455  Sum_probs=202.7

Q ss_pred             CCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhc--CCCCCccceeeEEeeCC----eeEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGK--LRHRNIVKILGYCASGL----DRVLI  156 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lv  156 (373)
                      ..++.+++|+|.||.||||.+. ++.||||++.....   ..+.+|-++.+.  ++|+||+++++.-..+.    .++||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            3445678999999999999986 69999999975443   456667666555  57999999999875544    88999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhc-------CCCCceeecCCCCceEeC
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHG-------LEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~-------~~~~i~H~dlk~~Nill~  229 (373)
                      ++|.+.|+|.+||..+.                ++|....+++..+++||+|||+       .+.+|+|||||++||||.
T Consensus       287 t~fh~kGsL~dyL~~nt----------------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK  350 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKANT----------------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK  350 (534)
T ss_pred             eeeccCCcHHHHHHhcc----------------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc
Confidence            99999999999999876                9999999999999999999994       466899999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCcc-cccccccccccCccccCCCCCCC-----ccccchhhhHHHHHHHhCCCCCCCcccC
Q 043074          230 SDFEAHISDFGLARRIDTSHSHV-STQVAGTMGYMPPEYLGGNTAAT-----VMLDVYSFGILMIEIATQIRPNLPVVLD  303 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~-----~~~DiwslG~~l~el~~g~~p~~~~~~~  303 (373)
                      +|+++.|+|||+|..+....... .-..+||.+|||||++.|.-.+.     .+.||||+|.+||||++.-.-.++....
T Consensus       351 ~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp  430 (534)
T KOG3653|consen  351 NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP  430 (534)
T ss_pred             cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence            99999999999999886443221 22368999999999998754443     4689999999999999875544332222


Q ss_pred             CCcccHHHH------HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          304 GQEVGLLEW------ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       304 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      +....+-.-      ...+.. ....+...+.+............+++.+..||+.||+.|.|+.=+.+.+.++.
T Consensus       431 ~Yqlpfe~evG~hPt~e~mq~-~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  431 EYQLPFEAEVGNHPTLEEMQE-LVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             cccCchhHHhcCCCCHHHHHH-HHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            211111111      111110 01112223344333334455678999999999999999999999998887763

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=296.03  Aligned_cols=269  Identities=22%  Similarity=0.314  Sum_probs=215.8

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeC-----Ce
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASG-----LD  152 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  152 (373)
                      ...++|++.+.||+|||+.|+.++ ..++..+|+|++.....++.+..++|++..++++|||+++++++...+     ..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            346799999999999999999996 568999999999887777788899999999999999999999887443     35


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .|++++|...|+|.+.+......+.           .+++.+.+.++.++++||++||....+++||||||.||++.+++
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~-----------~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~  166 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGN-----------FVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG  166 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCC-----------ccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC
Confidence            8999999999999999988776543           38999999999999999999996555699999999999999999


Q ss_pred             ceEEeeeccccccCCCCCc--------ccccccccccccCccccCC--CCCCCccccchhhhHHHHHHHhCCCCCCCccc
Q 043074          233 EAHISDFGLARRIDTSHSH--------VSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRPNLPVVL  302 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~  302 (373)
                      .+++.|||.+....-.-..        .......|..|.|||.+.-  ....++++|||||||+||+|+.|..||.....
T Consensus       167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~  246 (302)
T KOG2345|consen  167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ  246 (302)
T ss_pred             ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence            9999999999764211100        0112356889999999852  34568899999999999999999999866554


Q ss_pred             CCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhC
Q 043074          303 DGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA  373 (373)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~~  373 (373)
                      .+....+.              .....+.... ....++.+.+++.+|++.||.+||++.+++..++++++
T Consensus       247 ~GgSlaLA--------------v~n~q~s~P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li~  302 (302)
T KOG2345|consen  247 QGGSLALA--------------VQNAQISIPN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLIA  302 (302)
T ss_pred             cCCeEEEe--------------eeccccccCC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhcC
Confidence            33222110              0111111111 12256789999999999999999999999999998874

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-45  Score=333.15  Aligned_cols=248  Identities=23%  Similarity=0.296  Sum_probs=208.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .-|.+++.||+|+.|.|-.|++ .+|+..|||++.+....   ....+.+|+-+|+.+.|||++++++++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4578889999999999999965 58999999999765221   1345779999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|-|.+++...+.               +++.++.+++.||+.|+.|+|  ..+|+||||||+|+|+|..+++||+
T Consensus        92 Eyv~gGELFdylv~kG~---------------l~e~eaa~ff~QIi~gv~yCH--~~~icHRDLKpENlLLd~~~nIKIA  154 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP---------------LPEREAAHFFRQILDGVSYCH--AFNICHRDLKPENLLLDVKNNIKIA  154 (786)
T ss_pred             EecCCchhHHHHHhhCC---------------CCCHHHHHHHHHHHHHHHHHh--hhcceeccCCchhhhhhcccCEeee
Confidence            99999999999987663               999999999999999999999  7889999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+|..-.  ......+.||.|.|.|||++.|.++...++||||+||+||.|+||..||.+    +....++.   ...
T Consensus       155 DFGMAsLe~--~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLl---KV~  225 (786)
T KOG0588|consen  155 DFGMASLEV--PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLL---KVQ  225 (786)
T ss_pred             ccceeeccc--CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHH---HHH
Confidence            999997532  233456679999999999999999999999999999999999999999763    22212211   111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      .  -.          -.++...+.+..+|+++|+..||++|.|++||++.
T Consensus       226 ~--G~----------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  226 R--GV----------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             c--Cc----------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            0  00          11255567789999999999999999999999864

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-46  Score=318.57  Aligned_cols=248  Identities=22%  Similarity=0.358  Sum_probs=210.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCcccccc---HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG---FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ..+|++.+.||+|.||.|-++. ...|+.||||.++++..++   .-.+++|+++|..|+||||++++.+|++.+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            4578889999999999999995 4789999999998876654   33578999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||..+|.|.+|+.....               +++.++.++++||.+|+.|+|  +++++|||||.+|||+|.++++||
T Consensus       132 MEYaS~GeLYDYiSer~~---------------LsErEaRhfFRQIvSAVhYCH--knrVvHRDLKLENILLD~N~NiKI  194 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGS---------------LSEREARHFFRQIVSAVHYCH--KNRVVHRDLKLENILLDQNNNIKI  194 (668)
T ss_pred             EEecCCccHHHHHHHhcc---------------ccHHHHHHHHHHHHHHHHHHh--hccceecccchhheeecCCCCeee
Confidence            999999999999998774               999999999999999999999  899999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++-.+..  ....++++|++-|.+||++.|.++-.+..|-||||++||.|+.|..||......       ...++ 
T Consensus       195 ADFGLSNly~~--~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQ-  264 (668)
T KOG0611|consen  195 ADFGLSNLYAD--KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQ-  264 (668)
T ss_pred             eccchhhhhcc--ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHH-
Confidence            99999987643  345677899999999999999888899999999999999999999997532110       11111 


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                               +...   ......-|....-+|+|||-.||++|-|+.+|...
T Consensus       265 ---------Is~G---aYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  265 ---------ISRG---AYREPETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ---------hhcc---cccCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                     1111   11122334578899999999999999999998764

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-45  Score=327.75  Aligned_cols=246  Identities=26%  Similarity=0.403  Sum_probs=207.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+...  +..+.+.+|+++++.++||||+.++++|++..+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888899999999999999654 688999999976544  346678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+.| +|..++.+...               +++..+..++.|+..||.|||  +++|.|||+||.|||++.++++|++|
T Consensus        82 ~a~g-~L~~il~~d~~---------------lpEe~v~~~a~~LVsaL~yLh--s~rilhrd~kPqniLl~~~~~~Klcd  143 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK---------------LPEEQVRAIAYDLVSALYYLH--SNRILHRDMKPQNILLEKGGTLKLCD  143 (808)
T ss_pred             hhhh-hHHHHHHhccC---------------CCHHHHHHHHHHHHHHHHHHH--hcCcccccCCcceeeecCCCceeech
Confidence            9965 99999987654               999999999999999999999  79999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||+|+.+... ....+...|||.|||||+.. ...|+..+|+||+||++||+++|++||+..       .+....+....
T Consensus       144 Fg~Ar~m~~~-t~vltsikGtPlYmAPElv~-e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------si~~Lv~~I~~  214 (808)
T KOG0597|consen  144 FGLARAMSTN-TSVLTSIKGTPLYMAPELVE-EQPYDHTSDLWSLGCILYELYVGQPPFYAR-------SITQLVKSILK  214 (808)
T ss_pred             hhhhhhcccC-ceeeeeccCcccccCHHHHc-CCCccchhhHHHHHHHHHHHhcCCCCchHH-------HHHHHHHHHhc
Confidence            9999987653 34456678999999999998 456899999999999999999999998642       12222222211


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .         .   -..+......+.+++...|+.||.+|.+-.+++.
T Consensus       215 d---------~---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  215 D---------P---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             C---------C---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            1         0   0114466778999999999999999999888764

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.8e-44  Score=315.51  Aligned_cols=256  Identities=25%  Similarity=0.400  Sum_probs=202.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC----CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ++|++.+.||+|+||.||+|.++    .+..||+|.++..... ....+.+|+..+.+++||||+++++++..+...++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46888999999999999999653    4668999998765432 245688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++|+|.+++.....              ++++.+++.++.|++.||+|||  +++++||||||+||+++.++.+++
T Consensus        85 ~e~~~~~~L~~~l~~~~~--------------~l~~~~~~~~~~~i~~al~~lH--~~~iiH~dikp~nili~~~~~~~l  148 (266)
T cd05064          85 TEYMSNGALDSFLRKHEG--------------QLVAGQLMGMLPGLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKI  148 (266)
T ss_pred             EEeCCCCcHHHHHHhCCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCEeeccccHhhEEEcCCCcEEE
Confidence            999999999999976432              2899999999999999999999  899999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      +|||.+...............++..|+|||.+.+ ..++.++|||||||++||+++ |..||.....       ......
T Consensus       149 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-------~~~~~~  220 (266)
T cd05064         149 SGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------QDVIKA  220 (266)
T ss_pred             CCCcccccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHH
Confidence            9999876532221111112335678999999874 457889999999999999875 8888643211       111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ... .     ...     ..+..++..+.+++.+||+.+|.+||++++|.+.|++++
T Consensus       221 ~~~-~-----~~~-----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~  266 (266)
T cd05064         221 VED-G-----FRL-----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV  266 (266)
T ss_pred             HHC-C-----CCC-----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence            110 0     000     113446678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.6e-45  Score=324.70  Aligned_cols=246  Identities=25%  Similarity=0.324  Sum_probs=204.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|++.+.||+|+||.||+++ ..+|..+|+|++++....   ..+.++.|-.+|...++|+||+++..|.+...+|||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            5789999999999999999995 457999999999886553   355688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||++||++..+|.....               |++..+..++.+++-|+..+|  +.|++||||||+|+|||..|++||
T Consensus       220 MEylPGGD~mTLL~~~~~---------------L~e~~arfYiaE~vlAI~~iH--~~gyIHRDIKPdNlLiD~~GHiKL  282 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKDT---------------LTEDWARFYIAETVLAIESIH--QLGYIHRDIKPDNLLIDAKGHIKL  282 (550)
T ss_pred             EEecCCccHHHHHHhcCc---------------CchHHHHHHHHHHHHHHHHHH--HcCcccccCChhheeecCCCCEee
Confidence            999999999999987763               999999999999999999999  899999999999999999999999


Q ss_pred             eeeccccccCC----------------------C-CC------c-----------------ccccccccccccCccccCC
Q 043074          237 SDFGLARRIDT----------------------S-HS------H-----------------VSTQVAGTMGYMPPEYLGG  270 (373)
Q Consensus       237 ~Dfg~~~~~~~----------------------~-~~------~-----------------~~~~~~g~~~y~aPE~~~~  270 (373)
                      +|||++..+..                      + ..      .                 .....+|||.|+|||++.+
T Consensus       283 SDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~  362 (550)
T KOG0605|consen  283 SDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG  362 (550)
T ss_pred             ccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc
Confidence            99999954311                      0 00      0                 0112479999999999996


Q ss_pred             CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHh
Q 043074          271 NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMC  350 (373)
Q Consensus       271 ~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  350 (373)
                      .+ |+..+|.|||||++|||+.|.+||........-..+..|...+....               ...+..+..++|.+|
T Consensus       363 kg-Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~---------------~~~~s~eA~DLI~rl  426 (550)
T KOG0605|consen  363 KG-YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE---------------EVDLSDEAKDLITRL  426 (550)
T ss_pred             CC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC---------------cCcccHHHHHHHHHH
Confidence            55 89999999999999999999999877655544444555544332211               222336899999999


Q ss_pred             cCCCCCCCCC
Q 043074          351 TNEKSRERPA  360 (373)
Q Consensus       351 l~~~p~~RPs  360 (373)
                      +. ||.+|.-
T Consensus       427 l~-d~~~RLG  435 (550)
T KOG0605|consen  427 LC-DPENRLG  435 (550)
T ss_pred             hc-CHHHhcC
Confidence            99 9999975

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-44  Score=309.54  Aligned_cols=273  Identities=27%  Similarity=0.396  Sum_probs=213.7

Q ss_pred             ChHHHHHhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhc--CCCCCccceeeEEeeC
Q 043074           73 SMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGK--LRHRNIVKILGYCASG  150 (373)
Q Consensus        73 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~  150 (373)
                      ++--..+...+..+.+.||+|.||.||+|++. |+.||||++.....   +.+.+|.++.+.  |+|+||+.+++.-..+
T Consensus       202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             hhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            33334456678888999999999999999996 89999999976544   345566666655  5999999999876444


Q ss_pred             ----CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhc------CCCCceeec
Q 043074          151 ----LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHG------LEKPIIHRD  220 (373)
Q Consensus       151 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~------~~~~i~H~d  220 (373)
                          .+.+||++|.+.|||.|||....                ++....++++..++.||+|||-      -++.|.|||
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~r~t----------------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRD  341 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLNRNT----------------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRD  341 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHhhcc----------------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccc
Confidence                36789999999999999998754                8999999999999999999992      355699999


Q ss_pred             CCCCceEeCCCCceEEeeeccccccCCCCCc---ccccccccccccCccccCCCCC-----CCccccchhhhHHHHHHHh
Q 043074          221 IKSSNVLLDSDFEAHISDFGLARRIDTSHSH---VSTQVAGTMGYMPPEYLGGNTA-----ATVMLDVYSFGILMIEIAT  292 (373)
Q Consensus       221 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~-----~~~~~DiwslG~~l~el~~  292 (373)
                      ||++||||..++.+.|+|+|+|.........   ..+..+||.+|||||++...-.     .-..+||||||.++||+..
T Consensus       342 lKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  342 LKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             cccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999876543222   2345789999999999974221     1235899999999999975


Q ss_pred             C----------CCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 043074          293 Q----------IRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMS  362 (373)
Q Consensus       293 g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (373)
                      .          +.||++....+....  +    + ..--..+.+.+.+.....+.++...+.++|..||..||.-|-|+-
T Consensus       422 Rc~~ggi~eey~~Pyyd~Vp~DPs~e--e----M-rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltAL  494 (513)
T KOG2052|consen  422 RCESGGIVEEYQLPYYDVVPSDPSFE--E----M-RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTAL  494 (513)
T ss_pred             HhhcCCEehhhcCCcccCCCCCCCHH--H----H-hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHH
Confidence            2          456666554443211  1    1 111223556677777777888899999999999999999999999


Q ss_pred             HHHHHHHhhh
Q 043074          363 YVVQLLDELV  372 (373)
Q Consensus       363 ~l~~~L~~l~  372 (373)
                      -+-+.|.++.
T Consensus       495 riKKtl~~l~  504 (513)
T KOG2052|consen  495 RIKKTLAKLS  504 (513)
T ss_pred             HHHHHHHHHh
Confidence            9999888764

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-46  Score=321.72  Aligned_cols=249  Identities=26%  Similarity=0.369  Sum_probs=207.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCcccccc-HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ...|...+.||+|+||.||+|. ..+++.||+|++.....+. .+++.+|+.++.+++++||.++++.+..+...+++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            3467777899999999999995 4579999999998766554 5788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      ||.||++.+.+.....               +.+..+.-++++++.|+.|||  ..+.+|||||+.||++..+|.+|++|
T Consensus        92 y~~gGsv~~lL~~~~~---------------~~E~~i~~ilre~l~~l~ylH--~~~kiHrDIKaanil~s~~g~vkl~D  154 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGNI---------------LDEFEIAVILREVLKGLDYLH--SEKKIHRDIKAANILLSESGDVKLAD  154 (467)
T ss_pred             HhcCcchhhhhccCCC---------------CccceeeeehHHHHHHhhhhh--hcceecccccccceeEeccCcEEEEe
Confidence            9999999999986652               467777788999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||.+.......... .+..||+.|||||++. ...|+.++||||||++.+||++|.+|+.+...-....           
T Consensus       155 fgVa~ql~~~~~rr-~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-----------  221 (467)
T KOG0201|consen  155 FGVAGQLTNTVKRR-KTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-----------  221 (467)
T ss_pred             cceeeeeechhhcc-ccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-----------
Confidence            99998875544333 6788999999999998 5568999999999999999999999965433311000           


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                        .+.+.-.+.+     ...+...+.+++..||+.||+.||++.++++
T Consensus       222 --lIpk~~PP~L-----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  222 --LIPKSAPPRL-----DGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             --eccCCCCCcc-----ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence              0111111222     3345668999999999999999999999986

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.9e-44  Score=321.67  Aligned_cols=276  Identities=24%  Similarity=0.399  Sum_probs=202.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCC-----------------CCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccc
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSS-----------------GVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVK  142 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~  142 (373)
                      .++|++.+.||+|+||.||++.+++                 +..||+|.+...... ....+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578889999999999999996532                 346999998764333 3457889999999999999999


Q ss_pred             eeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcc----cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 043074          143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS----KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIH  218 (373)
Q Consensus       143 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~----~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H  218 (373)
                      +++++.+....++||||+++|+|.+++............    ........+++...++++.|++.||.|||  +.+++|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~ivH  161 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS--SLNFVH  161 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--HCCccc
Confidence            999999999999999999999999999764322111000    00111224789999999999999999999  789999


Q ss_pred             ecCCCCceEeCCCCceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhC--CC
Q 043074          219 RDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ--IR  295 (373)
Q Consensus       219 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g--~~  295 (373)
                      |||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+ ..++.++||||||+++|||+++  ..
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999865432211 1223345788999999874 4478899999999999999975  34


Q ss_pred             CCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          296 PNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       296 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                      |+....    .................  ...     ...+..++..+.+++.+||+.||++|||+.+|.+.|++
T Consensus       241 p~~~~~----~~~~~~~~~~~~~~~~~--~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELT----DEQVIENAGEFFRDQGR--QVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCC----HHHHHHHHHHHhhhccc--ccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            433211    11122222111111000  000     00123456689999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=331.71  Aligned_cols=257  Identities=24%  Similarity=0.468  Sum_probs=213.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCC-CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ..++...++||-|.||.||.|.|+. .-.||||.++.+.. ..++|+.|+.+|+.++|||+|+++|+|.....+|+|+||
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            4466778899999999999998864 67899999966543 468999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      |..|+|.+||+.+....             ++--..+.++.||..||.||.  ++++|||||..+|+|+.++..||++||
T Consensus       345 M~yGNLLdYLRecnr~e-------------v~avvLlyMAtQIsSaMeYLE--kknFIHRDLAARNCLVgEnhiVKvADF  409 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSE-------------VPAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHIVKVADF  409 (1157)
T ss_pred             ccCccHHHHHHHhchhh-------------cchhHHHHHHHHHHHHHHHHH--HhhhhhhhhhhhhccccccceEEeecc
Confidence            99999999999887653             677788999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      |+++.+..+.........-...|.|||.+. ...++.++|||+|||+|||+.| |+.| +|...      +.+       
T Consensus       410 GLsRlMtgDTYTAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsP-YPGid------lSq-------  474 (1157)
T KOG4278|consen  410 GLSRLMTGDTYTAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSP-YPGID------LSQ-------  474 (1157)
T ss_pred             chhhhhcCCceecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCC-CCCcc------HHH-------
Confidence            999987543322222233356899999987 5558899999999999999998 5555 44222      111       


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                         ++..+....+.+. ++.||+.+++||++||+.+|.+||++.|+-+.++.++
T Consensus       475 ---VY~LLEkgyRM~~-PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  475 ---VYGLLEKGYRMDG-PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             ---HHHHHhccccccC-CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence               1222333333344 7788999999999999999999999999999999886

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2e-44  Score=320.15  Aligned_cols=267  Identities=19%  Similarity=0.234  Sum_probs=198.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ++|++.+.||+|+||.||++..+ +++.+|+|++.....  ...+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47888999999999999999775 688999999865432  234567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |++++++..+.....               .+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+||+|
T Consensus        81 ~~~~~~l~~~~~~~~---------------~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nill~~~~~~kl~D  143 (287)
T cd07848          81 YVEKNMLELLEEMPN---------------GVPPEKVRSYIYQLIKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCD  143 (287)
T ss_pred             cCCCCHHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEee
Confidence            998877765543221               2889999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH--------
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL--------  310 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~--------  310 (373)
                      ||++...............|++.|+|||.+.+. .++.++|||||||++|||++|..||.............        
T Consensus       144 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  222 (287)
T cd07848         144 FGFARNLSEGSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA  222 (287)
T ss_pred             ccCcccccccccccccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCH
Confidence            999987643332233345689999999999754 47889999999999999999998875432111000000        


Q ss_pred             HHHHHHHHhccccccccCcccc-----ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 EWARTMEARNKEIEMVDSNISR-----EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ++...............+....     .......+..+.+++.+||+.||++|||++++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         223 EQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000000000000000     0001124567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=316.48  Aligned_cols=253  Identities=27%  Similarity=0.375  Sum_probs=199.4

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc--------------cHHHHHHHHHHHhcCCCCCcccee
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ--------------GFREFRAEMETLGKLRHRNIVKIL  144 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~niv~l~  144 (373)
                      .-++|++.+.||+|.||.|-+|+. .+++.||||++.+....              ..+.+.+|+.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            357899999999999999999964 47999999999664332              135789999999999999999999


Q ss_pred             eEEeeC--CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCceeecC
Q 043074          145 GYCASG--LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP-LSWETRVKIVRGVANGLAYLHGLEKPIIHRDI  221 (373)
Q Consensus       145 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~-l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dl  221 (373)
                      .+..+.  +..|||+|||..|.+...-..                ++ +++.++++++++++.||+|||  .++|+||||
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d----------------~~els~~~Ar~ylrDvv~GLEYLH--~QgiiHRDI  236 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD----------------KPELSEQQARKYLRDVVLGLEYLH--YQGIIHRDI  236 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCC----------------cccccHHHHHHHHHHHHHHHHHHH--hcCeecccc
Confidence            999765  578999999998877432111                12 899999999999999999999  799999999


Q ss_pred             CCCceEeCCCCceEEeeeccccccCCCC----CcccccccccccccCccccCC---CCCCCccccchhhhHHHHHHHhCC
Q 043074          222 KSSNVLLDSDFEAHISDFGLARRIDTSH----SHVSTQVAGTMGYMPPEYLGG---NTAATVMLDVYSFGILMIEIATQI  294 (373)
Q Consensus       222 k~~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~el~~g~  294 (373)
                      ||+|+|++++|+|||+|||.+..+....    ........|||.|+|||.+.+   ....+.+.||||+||+||.|+.|+
T Consensus       237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~  316 (576)
T KOG0585|consen  237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ  316 (576)
T ss_pred             chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence            9999999999999999999998762221    112233679999999999876   345678899999999999999999


Q ss_pred             CCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          295 RPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       295 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      .||.+...       .+...         +.+...+.... ..+....+.+++.++|++||.+|.+..+|...
T Consensus       317 ~PF~~~~~-------~~l~~---------KIvn~pL~fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  317 LPFFDDFE-------LELFD---------KIVNDPLEFPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             CCcccchH-------HHHHH---------HHhcCcccCCC-cccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            99865321       11111         11222332222 22445689999999999999999999988643

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.7e-44  Score=331.52  Aligned_cols=272  Identities=28%  Similarity=0.402  Sum_probs=203.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe------CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASGLD  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  152 (373)
                      .++|++.+.||+|+||.||+|..      .++..||+|+++.... ...+.+.+|+.++..+ +||||+++++++.++..
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45789999999999999999963      2466899999865432 2345688999999999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCc----------------------------------------------------
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDG----------------------------------------------------  180 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~----------------------------------------------------  180 (373)
                      .++||||+++|+|.+++...........                                                    
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999976432100000                                                    


Q ss_pred             --------ccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCc-
Q 043074          181 --------SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH-  251 (373)
Q Consensus       181 --------~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  251 (373)
                              ........++++..+.+++.||+.||.|||  +++++||||||+||+++.++.+||+|||+++........ 
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                    000001124889999999999999999999  789999999999999999999999999999865432221 


Q ss_pred             ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhccccccccCcc
Q 043074          252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNI  330 (373)
Q Consensus       252 ~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (373)
                      ......++..|+|||.+.+ ..++.++||||||+++|||++ |..|+......   .....+   ... +.  .   .  
T Consensus       272 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~---~~~-~~--~---~--  336 (375)
T cd05104         272 VKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKM---IKE-GY--R---M--  336 (375)
T ss_pred             ccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHH---HHh-Cc--c---C--
Confidence            1122334667999999974 457889999999999999998 66665332111   111111   111 00  0   0  


Q ss_pred             ccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          331 SREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                         ..+...+.++.+++.+||+.||++||++.+|++.|++.+
T Consensus       337 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~~  375 (375)
T cd05104         337 ---LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL  375 (375)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhhC
Confidence               002223568999999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-44  Score=330.47  Aligned_cols=273  Identities=29%  Similarity=0.453  Sum_probs=204.8

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe------CCCCEEEEEEeCccccc-cHHHHHHHHHHHhcC-CCCCccceeeEEeeCC
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKL-RHRNIVKILGYCASGL  151 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  151 (373)
                      ..++|++.+.||+|+||.||+|..      .++..||+|.+...... ..+.+.+|+.+++.+ +|+||+++++++....
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            345789999999999999999863      23457999999754332 345688999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCC-----------------------------------------------------
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDV-----------------------------------------------------  178 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~-----------------------------------------------------  178 (373)
                      ..++||||+++|+|.+++.........                                                     
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            999999999999999998654211000                                                     


Q ss_pred             --CcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCc-cccc
Q 043074          179 --DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH-VSTQ  255 (373)
Q Consensus       179 --~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~  255 (373)
                        ..........++++.++++++.|++.||.|||  +++++||||||+||++++++.+||+|||+++........ ....
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA--SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence              00000011235889999999999999999999  799999999999999999999999999999765332211 1122


Q ss_pred             ccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhccccccccCcccccc
Q 043074          256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREE  334 (373)
Q Consensus       256 ~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (373)
                      ..++..|+|||++.+ ..++.++|||||||++|||++ |..||.......      .+...... .     .....    
T Consensus       274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~-~-----~~~~~----  336 (374)
T cd05106         274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKR-G-----YQMSR----  336 (374)
T ss_pred             CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHc-c-----cCccC----
Confidence            335668999999874 458899999999999999997 888865422111      01111100 0     00111    


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          335 LSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                       +...+.++.+++.+||+.||++||++.++++.|++++
T Consensus       337 -~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         337 -PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence             1223468999999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=8.4e-44  Score=315.60  Aligned_cols=250  Identities=26%  Similarity=0.320  Sum_probs=197.0

Q ss_pred             CCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           84 FSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      |+..+.||+|+||.||++.. .+++.||+|.+.+....   ....+.+|+.++.+++|+|++++.+++.+.+..++|+||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66778999999999999965 57999999998654322   234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++|+|.+++......             .+++..+..++.|++.||+|||  +.+++||||||+||++++++.++|+||
T Consensus        82 ~~~g~L~~~~~~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nill~~~~~~kl~Df  146 (285)
T cd05631          82 MNGGDLKFHIYNMGNP-------------GFDEQRAIFYAAELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDL  146 (285)
T ss_pred             cCCCcHHHHHHhhCCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeC
Confidence            9999999888654321             2889999999999999999999  799999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++.......  ......||..|+|||.+.+ ..++.++|||||||++|||++|..||........   .......... 
T Consensus       147 g~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~-  219 (285)
T cd05631         147 GLAVQIPEGE--TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKE-  219 (285)
T ss_pred             CCcEEcCCCC--eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhc-
Confidence            9998653221  2234568999999999974 4578899999999999999999999764322110   0011000000 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA-----MSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~l~~  366 (373)
                            ..     ...+...+..+.+++.+||+.||.+||+     ++++++
T Consensus       220 ------~~-----~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         220 ------DQ-----EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ------cc-----ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                  00     0112234568999999999999999997     677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.9e-44  Score=318.20  Aligned_cols=266  Identities=20%  Similarity=0.310  Sum_probs=198.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|+..+.||.|+||.||+|..+ ++..||+|.+...... ....+.+|+.++++++||||+++++++.+....++|+||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            57888999999999999999754 6899999998654322 234677999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      ++ ++|.+++.....              .+++..+..++.|++.||+|||  +++++||||||+||+++.++.+||+||
T Consensus        85 ~~-~~l~~~l~~~~~--------------~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~Df  147 (288)
T cd07871          85 LD-SDLKQYLDNCGN--------------LMSMHNVKIFMFQLLRGLSYCH--KRKILHRDLKPQNLLINEKGELKLADF  147 (288)
T ss_pred             CC-cCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEECcC
Confidence            96 599998875432              2788999999999999999999  799999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH---------H
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL---------L  310 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~---------~  310 (373)
                      |+++...... .......+++.|+|||.+.+...++.++||||+||++|||++|..||............         .
T Consensus       148 G~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (288)
T cd07871         148 GLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEE  226 (288)
T ss_pred             cceeeccCCC-ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChH
Confidence            9997643222 12233467899999999876666888999999999999999999997543211100000         0


Q ss_pred             HHHHHHHHhccccccccCccccc---cCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 EWARTMEARNKEIEMVDSNISRE---ELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .|.. ............+.....   ......+.+..+++.+||+.||++|||++|+++
T Consensus       227 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         227 TWPG-ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             Hhhc-cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0000 000000000000000000   001122457889999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.7e-44  Score=319.09  Aligned_cols=265  Identities=23%  Similarity=0.310  Sum_probs=198.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++...... ....+.+|+.+++.++||||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999765 6899999998654332 23456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+ .++|.+++.....              .+++..+..++.|++.||+|||  +++++||||||+||++++++.+||+|
T Consensus        84 ~~-~~~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kl~D  146 (303)
T cd07869          84 YV-HTDLCQYMDKHPG--------------GLHPENVKLFLFQLLRGLSYIH--QRYILHRDLKPQNLLISDTGELKLAD  146 (303)
T ss_pred             CC-CcCHHHHHHhCCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECC
Confidence            99 5688888765432              2788999999999999999999  79999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||++....... .......+++.|+|||.+.+...++.++|||||||++|||++|..||.......   ...........
T Consensus       147 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~  222 (303)
T cd07869         147 FGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ---DQLERIFLVLG  222 (303)
T ss_pred             CCcceeccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH---HHHHHHHHHhC
Confidence            99987543222 222345678999999998766667889999999999999999999975422110   00000000000


Q ss_pred             hcc--------ccccccC-ccc---ccc-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNK--------EIEMVDS-NIS---REE-----LSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~--------~~~~~~~-~~~---~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...        ......+ ...   ...     .....+..+.+++.+||+.||++|||++++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         223 TPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             CCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000        0000000 000   000     00012346889999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.1e-44  Score=313.08  Aligned_cols=257  Identities=28%  Similarity=0.455  Sum_probs=208.2

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ...+|++.+.||.|+||.||+|...++..+++|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34578889999999999999998888999999999877665567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++......             .+++..+..++.|++.|+.|||  +++++|+||+|+||++++++.+||+||
T Consensus        84 ~~~~~L~~~~~~~~~~-------------~~~~~~~~~~~~~i~~al~~lH--~~~i~h~dl~~~nilv~~~~~~kl~d~  148 (261)
T cd05148          84 MEKGSLLAFLRSPEGQ-------------VLPVASLIDMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADF  148 (261)
T ss_pred             cccCCHHHHHhcCCCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeccccCcceEEEcCCceEEEccc
Confidence            9999999999865432             2889999999999999999999  889999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      |.+......... .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..|+....       ..+.......
T Consensus       149 g~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-------~~~~~~~~~~  219 (261)
T cd05148         149 GLARLIKEDVYL-SSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-------NHEVYDQITA  219 (261)
T ss_pred             cchhhcCCcccc-ccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-------HHHHHHHHHh
Confidence            999875432211 223345678999999874 457889999999999999998 677753321       0111111111


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                            .....     .+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       220 ------~~~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 ------GYRMP-----CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ------CCcCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                  01111     1334456899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.8e-44  Score=302.53  Aligned_cols=267  Identities=24%  Similarity=0.282  Sum_probs=202.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccccc--HHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRNIVKILGYCASG--LDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  156 (373)
                      +.|+..+.|++|+||.||+|+.+ +++.||+|+++......  --..++|+.+|.+.+|||||.+..+....  +..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            46778899999999999999764 78999999996544321  12357899999999999999999987543  578999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      ||||+. +|..++...+.              ++...++.-++.|+++|++|||  ++.|+|||||++|+|++..|.+||
T Consensus       156 Me~~Eh-DLksl~d~m~q--------------~F~~~evK~L~~QlL~glk~lH--~~wilHRDLK~SNLLm~~~G~lKi  218 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQ--------------PFLPGEVKTLMLQLLRGLKHLH--DNWILHRDLKTSNLLLSHKGILKI  218 (419)
T ss_pred             HHHHHh-hHHHHHHhccC--------------CCchHHHHHHHHHHHHHHHHHh--hceeEecccchhheeeccCCcEEe
Confidence            999954 99999998874              3899999999999999999999  899999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH------
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL------  310 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~------  310 (373)
                      +|||+|+.++.+. ...+..+-|.+|.|||.+.|...|+++.|+||+||++.||+++.+-|.....-++...+.      
T Consensus       219 aDFGLAR~ygsp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtP  297 (419)
T KOG0663|consen  219 ADFGLAREYGSPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTP  297 (419)
T ss_pred             cccchhhhhcCCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCC
Confidence            9999999987653 335566789999999999999999999999999999999999876543322211111110      


Q ss_pred             ---HHHHHH--HHhc--cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 ---EWARTM--EARN--KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ---~~~~~~--~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                         .|....  ...+  ...+..-..+...+......+.-++++..+|..||.+|.|+++.++
T Consensus       298 te~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  298 SEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence               010000  0000  0000000111111111113467889999999999999999999875

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.3e-43  Score=308.98  Aligned_cols=256  Identities=26%  Similarity=0.438  Sum_probs=204.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      .++|++.+.||+|+||.||+|...++..|++|.+..... ..+.+.+|+.+++.++|+||+++++.+.+....++++||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            357888999999999999999888888999999865433 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++++|.+++......             .+++..+..++.|++.||+|||  +.+++|+||||+||+++.++.++|+|||
T Consensus        84 ~~~~L~~~l~~~~~~-------------~~~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~dfg  148 (261)
T cd05072          84 AKGSLLDFLKSDEGG-------------KVLLPKLIDFSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFG  148 (261)
T ss_pred             CCCcHHHHHHHhcCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEecCCCcEEECCCc
Confidence            999999999764322             2788999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      ++...............++..|+|||.+.+ ..++.++||||||+++|+|++ |..|+....    ..   .........
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~----~~---~~~~~~~~~  220 (261)
T cd05072         149 LARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMS----NS---DVMSALQRG  220 (261)
T ss_pred             cceecCCCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCC----HH---HHHHHHHcC
Confidence            998764332222223345678999999874 447889999999999999998 777753211    11   111111110


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                            .....     ...++.++.+++.+||+.+|++||+++++.+.|+++
T Consensus       221 ------~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         221 ------YRMPR-----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ------CCCCC-----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                  00000     122456899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-44  Score=325.34  Aligned_cols=253  Identities=24%  Similarity=0.334  Sum_probs=201.2

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||+|... +++.||+|++.+...   ...+.+.+|+.++..++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999765 689999999975432   23456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++....               .+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+||+
T Consensus        81 e~~~g~~L~~~l~~~~---------------~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kL~  143 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---------------VLSEDHARFYMAEMFEAVDALH--ELGYIHRDLKPENFLIDASGHIKLT  143 (333)
T ss_pred             eCCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEEE
Confidence            9999999999997543               2889999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||++.....    ......||+.|+|||.+.+. .++.++|||||||++|||++|..||.......       ......
T Consensus       144 Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~  211 (333)
T cd05600         144 DFGLSKGIVT----YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-------TWENLK  211 (333)
T ss_pred             eCcCCccccc----ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHH-------HHHHHH
Confidence            9999976533    23345689999999999855 57889999999999999999999975422111       001111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      ...   ..+....... .....+.++.+++.+||+.+|.+||+++++++.
T Consensus       212 ~~~---~~~~~~~~~~-~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         212 YWK---ETLQRPVYDD-PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             hcc---ccccCCCCCc-cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000   0011110000 012345688999999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.7e-43  Score=307.59  Aligned_cols=252  Identities=26%  Similarity=0.422  Sum_probs=199.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      ++|++.+.||+|+||.||++..+++..+++|.+..... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            35777889999999999999988888999998864432 34678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +|+|.+++.....              .+++..+..++.|++.||.|||  +++++|+||+|+||++++++.+||+|||.
T Consensus        83 ~~~L~~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~d~g~  146 (256)
T cd05114          83 NGCLLNYLRQRQG--------------KLSKDMLLSMCQDVCEGMEYLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGM  146 (256)
T ss_pred             CCcHHHHHHhCcc--------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcceEEEcCCCeEEECCCCC
Confidence            9999999875432              2889999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      ++..............++..|+|||.+.+ ..++.++|+||||+++|||++ |..|+....       ..+.........
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-------~~~~~~~i~~~~  218 (256)
T cd05114         147 TRYVLDDEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-------NYEVVEMISRGF  218 (256)
T ss_pred             ccccCCCceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHHCCC
Confidence            98654322222222335568999999874 457889999999999999999 777754321       111111111100


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                         ....        +...+..+.+++.+||+.||.+||++.++++.|.
T Consensus       219 ---~~~~--------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         219 ---RLYR--------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ---CCCC--------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               0000        1223457899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-43  Score=323.19  Aligned_cols=261  Identities=20%  Similarity=0.209  Sum_probs=196.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|.+.+.||+|+||.||++.. .+++.||+|....      ..+.+|+.++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            36899999999999999999965 4789999997542      3467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      + .++|..++....               .+++.+++.++.|++.||.|||  +++|+||||||+||+++.++.+||+||
T Consensus       165 ~-~~~L~~~l~~~~---------------~l~~~~~~~i~~qi~~aL~ylH--~~~IvHrDiKP~NIll~~~~~vkL~DF  226 (391)
T PHA03212        165 Y-KTDLYCYLAAKR---------------NIAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDF  226 (391)
T ss_pred             C-CCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHhEEEcCCCCEEEEeC
Confidence            9 578988886543               2889999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcc----cHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV----GLLEWART  315 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~----~~~~~~~~  315 (373)
                      |+++..............||+.|+|||++.+ ..++.++|||||||++|||++|..|++.........    .+......
T Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~  305 (391)
T PHA03212        227 GAACFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR  305 (391)
T ss_pred             CcccccccccccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence            9997543222223344679999999999975 457889999999999999999998866433211100    00000000


Q ss_pred             H---------------HHhc-ccccc--ccCccccc-cCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          316 M---------------EARN-KEIEM--VDSNISRE-ELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       316 ~---------------~~~~-~~~~~--~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .               .... .....  ..+..... ......+.++.+++.+||+.||++|||++|+++
T Consensus       306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0               0000 00000  00000000 001234668999999999999999999999985

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-44  Score=317.92  Aligned_cols=244  Identities=22%  Similarity=0.295  Sum_probs=197.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||+|..+ +++.+|+|++.....   ...+.+.+|+.+++.++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999765 689999999865332   23456789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.....               +++..+..++.|++.||+|||  +++++||||||+||+++.++.+||+
T Consensus        81 e~~~~~~L~~~~~~~~~---------------~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~NIli~~~~~~kl~  143 (291)
T cd05612          81 EYVPGGELFSYLRNSGR---------------FSNSTGLFYASEIVCALEYLH--SKEIVYRDLKPENILLDKEGHIKLT  143 (291)
T ss_pred             eCCCCCCHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEE
Confidence            99999999999976542               888999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++.....    .....|++.|+|||.+.+. .++.++|||||||++|||++|..||.....       ........
T Consensus       144 Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------~~~~~~i~  211 (291)
T cd05612         144 DFGFAKKLRDR----TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNP-------FGIYEKIL  211 (291)
T ss_pred             ecCcchhccCC----cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHH
Confidence            99999865322    2235689999999998754 478899999999999999999999754211       11111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA-----MSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~l~~  366 (373)
                      .. .      ..     ++...+..+.+++.+||+.||.+||+     ++++++
T Consensus       212 ~~-~------~~-----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         212 AG-K------LE-----FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             hC-C------cC-----CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            10 0      01     12223557899999999999999995     777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-43  Score=320.63  Aligned_cols=252  Identities=24%  Similarity=0.313  Sum_probs=198.7

Q ss_pred             CCCCCCeeecCCCceEEEEEe----CCCCEEEEEEeCcccc----ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCee
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAF----QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDR  153 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  153 (373)
                      +|++.+.||+|+||.||++..    .+++.||+|++.+...    ...+.+..|+.++..+ +||||+++++++.+....
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999964    3688999999865322    2235678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++||||+++|+|.+++....               .+++.++..++.||+.||.|||  +.+++||||||+|||++.++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nili~~~~~  143 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---------------NFSEDEVRFYSGEIILALEHLH--KLGIVYRDIKLENILLDSEGH  143 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHeEECCCCC
Confidence            99999999999999987543               2889999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          234 AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +||+|||+++..............||+.|+|||.+.+...++.++|||||||++|||++|..||.......   ......
T Consensus       144 ~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~~~  220 (332)
T cd05614         144 VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN---TQSEVS  220 (332)
T ss_pred             EEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC---CHHHHH
Confidence            99999999986543333333345789999999999866567889999999999999999999975322111   111111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                      .....       .+..+     +...+..+.+++.+||+.||++||     +++++++
T Consensus       221 ~~~~~-------~~~~~-----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         221 RRILK-------CDPPF-----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHHhc-------CCCCC-----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            11111       11111     223355789999999999999999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.4e-43  Score=309.22  Aligned_cols=255  Identities=24%  Similarity=0.440  Sum_probs=202.7

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      +|.+.+.||+|+||.||+|..+ ++..+++|.+.... .....+.+|+..++.++||||+++++++......++++||++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            5777889999999999999654 58899999986543 334678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +++|.+++......             .+++..++.++.|++.||+|||  +++++||||||+||++++++.+||+|||+
T Consensus        86 ~~~L~~~~~~~~~~-------------~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~df~~  150 (263)
T cd05052          86 YGNLLDYLRECNRQ-------------EVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGL  150 (263)
T ss_pred             CCcHHHHHHhCCCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCcEEeCCCcc
Confidence            99999999764322             2889999999999999999999  78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      +...............++..|+|||.+.+. .++.++||||||+++|||++ |..|+....       ..+........ 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~-------~~~~~~~~~~~-  221 (263)
T cd05052         151 SRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKG-  221 (263)
T ss_pred             ccccccceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHHCC-
Confidence            987643322222223345689999988744 47889999999999999998 777753211       11111111110 


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                           ....     .+..++.++.+++.+||+.||++||++.++++.|++++
T Consensus       222 -----~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         222 -----YRME-----RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             -----CCCC-----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence                 1111     13334568999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.4e-42  Score=352.91  Aligned_cols=260  Identities=27%  Similarity=0.481  Sum_probs=205.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      ..+...+.||+|+||.||+|.. .++..||+|.+.......    ..|++.+++++||||+++++++.+....++||||+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            4567778999999999999976 578999999986543221    35688999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCceeecCCCCceEeCCCCceEEeee
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGL-EKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~-~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      ++|+|.++++.                  ++|.++.+++.|+++||+|||+. ..+++||||||+||+++.++..++. |
T Consensus       766 ~~g~L~~~l~~------------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~  826 (968)
T PLN00113        766 EGKNLSEVLRN------------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L  826 (968)
T ss_pred             CCCcHHHHHhc------------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-e
Confidence            99999999952                  78999999999999999999952 5689999999999999999888775 6


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |.......     .....+++.|+|||.+.+ ..++.++|||||||++|||+||+.|+....  +.......|.......
T Consensus       827 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~  898 (968)
T PLN00113        827 SLPGLLCT-----DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEF--GVHGSIVEWARYCYSD  898 (968)
T ss_pred             cccccccc-----CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCccc--CCCCcHHHHHHHhcCc
Confidence            65543211     122357899999999874 458899999999999999999999974322  2234566676554433


Q ss_pred             ccccccccCccccc-cCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          320 NKEIEMVDSNISRE-ELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       320 ~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ......+++.+... ..+.+...++.+++.+||+.||++||+++++++.|+++.
T Consensus       899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  952 (968)
T PLN00113        899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS  952 (968)
T ss_pred             cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence            33333344444222 224556678899999999999999999999999999874

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-43  Score=307.28  Aligned_cols=256  Identities=25%  Similarity=0.407  Sum_probs=203.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      .++|++.+.||+|++|.||+|..+++..||+|.+..... ..+++.+|+.++++++|||++++++++...+..++++||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            456888899999999999999887788999999865443 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++++|.+++......             .+++..+..++.|++.|+.|||  +++++|+||||+||++++++.++|+|||
T Consensus        84 ~~~~L~~~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~dfg  148 (261)
T cd05068          84 KYGSLLEYLQGGAGR-------------ALKLPQLIDMAAQVASGMAYLE--AQNYIHRDLAARNVLVGENNICKVADFG  148 (261)
T ss_pred             cCCcHHHHHhccCCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCcceEEEcCCCCEEECCcc
Confidence            999999999765421             2899999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      ++................+..|+|||.+.+ ..++.++||||||+++|||++ |..|+....    ....   ...... 
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~---~~~~~~-  219 (261)
T cd05068         149 LARVIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMT----NAEV---LQQVDQ-  219 (261)
T ss_pred             eEEEccCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCC----HHHH---HHHHHc-
Confidence            998765322211122223457999999874 457889999999999999999 777753211    0001   111110 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                        .   ...     ..+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       220 --~---~~~-----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         220 --G---YRM-----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             --C---CCC-----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence              0   000     11233456899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-44  Score=324.64  Aligned_cols=244  Identities=24%  Similarity=0.302  Sum_probs=201.5

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcCC-CCCccceeeEEeeCCee
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLR-HRNIVKILGYCASGLDR  153 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~  153 (373)
                      ...++|.+.++||+|+||+|+++..+ +++.+|||.+++...-   ..+....|..++.... ||.+++++.+|.+..+.
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34578999999999999999999765 6889999999886653   3566778888888775 99999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      |+||||+.||++..+.+...                +++..+.-++..|+.||+|||  +++|||||||.+|||+|.+|+
T Consensus       445 ~fvmey~~Ggdm~~~~~~~~----------------F~e~rarfyaAev~l~L~fLH--~~~IIYRDlKLdNiLLD~eGh  506 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIHTDV----------------FSEPRARFYAAEVVLGLQFLH--ENGIIYRDLKLDNLLLDTEGH  506 (694)
T ss_pred             EEEEEecCCCcEEEEEeccc----------------ccHHHHHHHHHHHHHHHHHHH--hcCceeeecchhheEEcccCc
Confidence            99999999999555444332                899999999999999999999  899999999999999999999


Q ss_pred             eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          234 AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +||+|||+++..-. .....++.+|||.|+|||++.+ ..|+.+.|.|||||+||||+.|..||.....++.-..+    
T Consensus       507 ~kiADFGlcKe~m~-~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI----  580 (694)
T KOG0694|consen  507 VKIADFGLCKEGMG-QGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI----  580 (694)
T ss_pred             EEecccccccccCC-CCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----
Confidence            99999999987432 2335667999999999999985 55999999999999999999999997643332211110    


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                         ..       -+     ..+|..++.+...++.++|..||++|.-+
T Consensus       581 ---~~-------d~-----~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  581 ---VN-------DE-----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---hc-------CC-----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence               00       01     11266677899999999999999999876

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.2e-43  Score=315.63  Aligned_cols=263  Identities=25%  Similarity=0.346  Sum_probs=200.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|++.+.||+|+||.||++..+ ++..+|+|.+..... ...+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999765 688899999865432 234578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++++|.+++....               .+++..+..++.|++.||.|||+ ..+++||||||+||+++.++.+||+|
T Consensus        84 ~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~D  147 (331)
T cd06649          84 HMDGGSLDQVLKEAK---------------RIPEEILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCD  147 (331)
T ss_pred             cCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHhh-cCCEEcCCCChhhEEEcCCCcEEEcc
Confidence            999999999997644               28889999999999999999994 34699999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||++......   ......|++.|+|||.+.+. .++.++|||||||++|||++|..|+.......    +.........
T Consensus       148 fg~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~  219 (331)
T cd06649         148 FGVSGQLIDS---MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVV  219 (331)
T ss_pred             Cccccccccc---ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhccccc
Confidence            9998765322   22335689999999999754 47889999999999999999999975322110    0000000000


Q ss_pred             h--c-------------------------------cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 043074          319 R--N-------------------------------KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVV  365 (373)
Q Consensus       319 ~--~-------------------------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~  365 (373)
                      .  .                               ...+.+.............+.++.+++.+||+.||++|||+++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell  299 (331)
T cd06649         220 DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLM  299 (331)
T ss_pred             ccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHh
Confidence            0  0                               000000000000000122456899999999999999999999998


Q ss_pred             HH
Q 043074          366 QL  367 (373)
Q Consensus       366 ~~  367 (373)
                      +.
T Consensus       300 ~h  301 (331)
T cd06649         300 NH  301 (331)
T ss_pred             cC
Confidence            64

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8e-44  Score=321.86  Aligned_cols=244  Identities=24%  Similarity=0.332  Sum_probs=197.3

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|.+.+.||+|+||.||+|..+ +++.||+|.+.....   ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57888899999999999999765 689999999865432   23456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.....               +++..+..++.|++.||+|||  +++++||||||+|||++.++.+||+
T Consensus        98 e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kl~  160 (329)
T PTZ00263         98 EFVVGGELFTHLRKAGR---------------FPNDVAKFYHAELVLAFEYLH--SKDIIYRDLKPENLLLDNKGHVKVT  160 (329)
T ss_pred             cCCCCChHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEECCCCCEEEe
Confidence            99999999999976542               788899999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++.....    .....||+.|+|||.+.+. .++.++|||||||++|||++|..||.....       ........
T Consensus       161 Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~  228 (329)
T PTZ00263        161 DFGFAKKVPDR----TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKIL  228 (329)
T ss_pred             eccCceEcCCC----cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHh
Confidence            99999865332    2235689999999999754 468899999999999999999999754211       11111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA-----MSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~l~~  366 (373)
                      . .        ..   ..+...+..+.+++.+||+.||.+||+     +++++.
T Consensus       229 ~-~--------~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        229 A-G--------RL---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             c-C--------Cc---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            0 0        00   012223457899999999999999997     566653

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-43  Score=319.85  Aligned_cols=241  Identities=21%  Similarity=0.279  Sum_probs=193.4

Q ss_pred             CeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCC
Q 043074           88 KIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENG  163 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  163 (373)
                      +.||+|+||.||++.. .+|+.+|+|++.+...   .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999965 4789999999875432   22346778999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecccc
Q 043074          164 SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR  243 (373)
Q Consensus       164 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  243 (373)
                      +|.+++....               .+++..+..++.||+.||+|||  +.+|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~L~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~  143 (323)
T cd05571          81 ELFFHLSRER---------------VFSEDRARFYGAEIVSALGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCK  143 (323)
T ss_pred             cHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            9999987644               2889999999999999999999  7899999999999999999999999999987


Q ss_pred             ccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcccc
Q 043074          244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEI  323 (373)
Q Consensus       244 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (373)
                      ..... ........||+.|+|||.+.+ ..++.++|||||||++|||++|..||......    ..   ...... .   
T Consensus       144 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~---~~~~~~-~---  210 (323)
T cd05571         144 EGISD-GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KL---FELILM-E---  210 (323)
T ss_pred             ccccC-CCcccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHH----HH---HHHHHc-C---
Confidence            53221 122334578999999999975 45788999999999999999999997542111    11   111100 0   


Q ss_pred             ccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          324 EMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                         +..     ++...+.++.+++.+||+.||++||     ++.++++
T Consensus       211 ---~~~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         211 ---EIR-----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             ---CCC-----CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence               011     1233456899999999999999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.9e-43  Score=319.40  Aligned_cols=249  Identities=26%  Similarity=0.367  Sum_probs=193.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|+..+.||+|+||.||+|... +++.||+|++...... ....+.+|+++++.++|+||+++++++......++|+||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45667789999999999999764 6899999998654332 245788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++|+|.+..                   ..++..+..++.||+.||.|||  +++++||||||+|||+++++.+||+||
T Consensus       154 ~~~~~L~~~~-------------------~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~Df  212 (353)
T PLN00034        154 MDGGSLEGTH-------------------IADEQFLADVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADF  212 (353)
T ss_pred             CCCCcccccc-------------------cCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEccc
Confidence            9999986432                   1567788899999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+++....... ......||..|+|||.+..    ....+.++|||||||++|||++|..||.....       .+|...
T Consensus       213 G~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-------~~~~~~  284 (353)
T PLN00034        213 GVSRILAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-------GDWASL  284 (353)
T ss_pred             ccceecccccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------ccHHHH
Confidence            99986543221 1234568999999998743    23345689999999999999999999752111       112211


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      .......   ..     ...+..++.++.+++.+||+.||++||++.|+++.
T Consensus       285 ~~~~~~~---~~-----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        285 MCAICMS---QP-----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HHHHhcc---CC-----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111000   00     01123345689999999999999999999999863

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=332.88  Aligned_cols=259  Identities=23%  Similarity=0.347  Sum_probs=209.6

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeCCC-CEEEEEEeCccccccHHHHHHHHHHHhcCC-CCCccceeeE-Eee------C
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLSSG-VTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILGY-CAS------G  150 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~------~  150 (373)
                      ...++++.+.|.+|||+.||.+....+ ..+|+|++-..+....+.+.+|+++|++|+ |+|||.+++. ...      .
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            345677889999999999999976655 999999987777778889999999999997 9999999993 211      2


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      -+.+|.||||.+|+|-+++.+.-...             |++.++++|+.|+++|+++||.++.+|||||||-+||||+.
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-------------lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~  181 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTR-------------LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA  181 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhcc-------------CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC
Confidence            35678999999999999998765432             99999999999999999999988889999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCccc--------ccccccccccCccccC--CCCCCCccccchhhhHHHHHHHhCCCCCCCc
Q 043074          231 DFEAHISDFGLARRIDTSHSHVS--------TQVAGTMGYMPPEYLG--GNTAATVMLDVYSFGILMIEIATQIRPNLPV  300 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~~--------~~~~g~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  300 (373)
                      +|+.||||||.+...........        -...-|+.|+|||.+.  +...+++|+|||||||+||-|+....||...
T Consensus       182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            99999999999975433221100        1124589999999886  3456899999999999999999999997542


Q ss_pred             ccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      -    ..                ..+........ ....+..+.+||..||+.||.+||++-++++.+.++.
T Consensus       262 g----~l----------------aIlng~Y~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  262 G----KL----------------AILNGNYSFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             c----ce----------------eEEeccccCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence            1    11                11222222222 3467789999999999999999999999999998775

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.9e-44  Score=312.07  Aligned_cols=249  Identities=33%  Similarity=0.537  Sum_probs=190.5

Q ss_pred             CCCeeecCCCceEEEEEeC-----CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           86 TDKIIGDGSFGFVYKAKLS-----SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ..+.||.|.||.||+|.++     .+..|+||.++.... ...+.+.+|++.+++++||||++++|++......++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3468999999999999775     367899999965433 2367899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++|+|.+++......             .+++.+++.++.|++.||.|||  +++++|+||+++||++++++.+||+||
T Consensus        83 ~~~g~L~~~L~~~~~~-------------~~~~~~~~~i~~~i~~~l~~Lh--~~~iiH~~l~~~nill~~~~~~Kl~~f  147 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKE-------------PLSEQQRLSIAIQIAEALSYLH--SNNIIHGNLSPSNILLDSNGQVKLSDF  147 (259)
T ss_dssp             -TTEBHHHHHHHTCTT-------------TSBHHHHHHHHHHHHHHHHHHH--HTTEEEST-SGGGEEEETTTEEEEEST
T ss_pred             cccccccccccccccc-------------cccccccccccccccccccccc--ccccccccccccccccccccccccccc
Confidence            9999999999987222             2899999999999999999999  788999999999999999999999999


Q ss_pred             ccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHH
Q 043074          240 GLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       240 g~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |++........ ...........|+|||.+.+. .++.++||||||+++|||++ |..|+...       ...++.....
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~p~~~~-------~~~~~~~~~~  219 (259)
T PF07714_consen  148 GLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKFPFSDY-------DNEEIIEKLK  219 (259)
T ss_dssp             TTGEETTTSSSEEESTTSESGGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSGTTTTS-------CHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccc-------cccccccccc
Confidence            99987632221 222334567789999998743 47999999999999999999 55664221       1122222221


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLL  368 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L  368 (373)
                      . ...          ...+..++..+++++.+||+.||++||+++++++.|
T Consensus       220 ~-~~~----------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  220 Q-GQR----------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             T-TEE----------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             c-ccc----------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1 111          011333456899999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4e-43  Score=311.14  Aligned_cols=269  Identities=28%  Similarity=0.446  Sum_probs=205.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCC------CCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSS------GVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      ++|++.+.||+|+||.||+|....      ...+++|.+...... ....+.+|+..+..++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            367888999999999999997532      257999998654332 3456889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcc-cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGS-KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      +++||+++++|.+++............ ........+++.+++.++.|++.||.|||  +++++|+||||+||++++++.
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccccceEEEcCCCc
Confidence            999999999999999865432211100 00001124889999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHH
Q 043074          234 AHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  311 (373)
                      ++|+|||+++....... .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..|+......       +
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------~  234 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------E  234 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------H
Confidence            99999999986533221 12233456788999999874 457889999999999999998 88886542211       1


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                      .......          ... ...+..++.++.+++.+||+.||.+||++++|++.|+.+
T Consensus       235 ~~~~i~~----------~~~-~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         235 VIEMIRS----------RQL-LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHHHHc----------CCc-CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            1111110          000 111445677999999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-43  Score=306.28  Aligned_cols=256  Identities=29%  Similarity=0.503  Sum_probs=203.2

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCC----CCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSS----GVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ++|++.+.||+|+||.||+|.++.    ...+++|.+...... ....+.+|+..+++++||||+++++++.+....+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578889999999999999997642    457999998654433 345688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +||+++++|.+++.....              .+++..+..++.|++.|+.|||  +++++|+||||+||++++++.++|
T Consensus        84 ~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~di~p~nili~~~~~~~l  147 (266)
T cd05033          84 TEYMENGSLDKFLRENDG--------------KFTVGQLVGMLRGIASGMKYLS--EMNYVHRDLAARNILVNSNLVCKV  147 (266)
T ss_pred             EEcCCCCCHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCCEEE
Confidence            999999999999976442              2899999999999999999999  799999999999999999999999


Q ss_pred             eeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHH
Q 043074          237 SDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      +|||+++........ ......++..|+|||.+.+ ..++.++||||||+++|||++ |..|+.....       .....
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-------~~~~~  219 (266)
T cd05033         148 SDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-------QDVIK  219 (266)
T ss_pred             CccchhhcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCH-------HHHHH
Confidence            999999876522221 1122334678999999874 457889999999999999998 8888643211       11111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .....      ...     ..+..++..+.+++.+||+.+|++||++++|++.|++++
T Consensus       220 ~~~~~------~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         220 AVEDG------YRL-----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             HHHcC------CCC-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            11100      000     012334568999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.5e-43  Score=324.81  Aligned_cols=273  Identities=26%  Similarity=0.380  Sum_probs=205.4

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCC-CCCccceeeEEeeCC
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLR-HRNIVKILGYCASGL  151 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  151 (373)
                      ..++|.+.+.||+|+||.||+|...      .+..||+|++...... ..+.+.+|+.++.++. ||||+++++++.+..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            4568999999999999999999642      2347999999654333 2457889999999996 999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCc------------------------------------------c--------
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDG------------------------------------------S--------  181 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~------------------------------------------~--------  181 (373)
                      ..++||||+++|+|.+++...........                                          .        
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999999999999976431100000                                          0        


Q ss_pred             -------------------------------cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          182 -------------------------------KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       182 -------------------------------~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                                                     ........+++.+++.++.|++.||+|||  +.+++|+||||+||+++.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dikp~Nill~~  272 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA--SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHhEEEeC
Confidence                                           00000124888999999999999999999  789999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCccc
Q 043074          231 DFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVG  308 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~  308 (373)
                      ++.+||+|||+++........ ......++..|+|||.+.+ ..++.++||||||+++|||++ |..|+.....+.   .
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---~  348 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---T  348 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---H
Confidence            999999999999865332211 1222346778999999875 447889999999999999997 778764322111   0


Q ss_pred             HHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          309 LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .   ...... .     ...     ..+..++..+.+++.+||+.||++||++.+|.+.|++++
T Consensus       349 ~---~~~~~~-~-----~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         349 F---YNKIKS-G-----YRM-----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             H---HHHHhc-C-----CCC-----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            0   000100 0     000     113345678999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-44  Score=288.40  Aligned_cols=249  Identities=29%  Similarity=0.418  Sum_probs=207.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      -++|++++.||+|.||.||.|+. +++..||+|++.+....   ...++.+|+++-..|+||||++++++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            35889999999999999999965 47889999999765433   246789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +||.++|.|...|......             ++++.....+..|+|.||.|+|  .++++||||||+|+|++..+..|+
T Consensus       101 lEya~~gel~k~L~~~~~~-------------~f~e~~~a~Yi~q~A~Al~y~h--~k~VIhRdiKpenlLlg~~~~lki  165 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMK-------------RFDEQRAATYIKQLANALLYCH--LKRVIHRDIKPENLLLGSAGELKI  165 (281)
T ss_pred             EEecCCchHHHHHHhcccc-------------cccccchhHHHHHHHHHHHHhc--cCCcccCCCCHHHhccCCCCCeec
Confidence            9999999999999855433             2888889999999999999999  899999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||.+....   .......+||..|.+||...+. ..+...|+|++|++.||++.|.+||.....++       ..+..
T Consensus       166 AdfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-------tYkrI  234 (281)
T KOG0580|consen  166 ADFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-------TYKRI  234 (281)
T ss_pred             cCCCceeecC---CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHH-------HHHHH
Confidence            9999987543   3345568899999999999854 47889999999999999999999987644111       11111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                             ..++-.+     +...+....++|.+|+..+|.+|.+..|+++.
T Consensus       235 -------~k~~~~~-----p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  235 -------RKVDLKF-----PSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             -------HHccccC-----CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                   1112222     44556689999999999999999999998763

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.7e-44  Score=316.81  Aligned_cols=251  Identities=24%  Similarity=0.335  Sum_probs=209.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe-eEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLD-RVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  157 (373)
                      ++|...+.+|+|+||.++..+.+ ++..+++|.+.-...  ...+...+|+.++++++|||||.+.+.|..++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999999654 678999999854433  334567899999999999999999999988887 99999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      +||+||+|.+.+.+.+...             +++..+..|+.|++.|+.|||  ++.|+|||||+.|||++.++.|+|+
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~-------------f~E~~i~~~~~Q~~~av~ylH--~~~iLHRDlK~~Nifltk~~~VkLg  148 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVL-------------FPEERILKWFVQILLAVNYLH--ENRVLHRDLKCANIFLTKDKKVKLG  148 (426)
T ss_pred             eecCCCCHHHHHHHHhhcc-------------ccHHHHHHHHHHHHHHHHHHH--hhhhhcccchhhhhhccccCceeec
Confidence            9999999999998876322             899999999999999999999  8999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+|+..+... .......||+.|++||.+.+ ..|..++|||||||++|||++-+.+|.......       ...   
T Consensus       149 DfGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-------Li~---  216 (426)
T KOG0589|consen  149 DFGLAKILNPED-SLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-------LIL---  216 (426)
T ss_pred             chhhhhhcCCch-hhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHH-------HHH---
Confidence            999999987654 24456789999999999984 568999999999999999999998875533221       111   


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                         ++....-..     .+.....++..++..|++.+|..||++.+++..
T Consensus       217 ---ki~~~~~~P-----lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  217 ---KINRGLYSP-----LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ---HHhhccCCC-----CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence               111111222     255557789999999999999999999999864

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.1e-42  Score=303.63  Aligned_cols=252  Identities=26%  Similarity=0.409  Sum_probs=199.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      ++|.+.+.||+|+||.||+|+.+++..+|+|.+..... ..+.+.+|+.++.+++||||+++++++.+....+++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            35778889999999999999887777899999875433 34678999999999999999999999998888999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +|+|.+++.....              .+++..++.++.|++.||+|||  +.+++|+||||+||++++++.+||+|||.
T Consensus        83 ~~~l~~~i~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~d~g~  146 (256)
T cd05113          83 NGCLLNYLREHGK--------------RFQPSQLLEMCKDVCEGMAYLE--SKQFIHRDLAARNCLVDDQGCVKVSDFGL  146 (256)
T ss_pred             CCcHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCCEEECCCcc
Confidence            9999999976432              2889999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      ++..............++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....       ......... .
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~-~  217 (256)
T cd05113         147 SRYVLDDEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-------SETVEKVSQ-G  217 (256)
T ss_pred             ceecCCCceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHhc-C
Confidence            886543322222223456789999998743 47889999999999999998 8887542111       011111111 0


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                      .     ...     .+...+..+.+++.+||+.||.+||++.++++.|+
T Consensus       218 ~-----~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         218 L-----RLY-----RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             C-----CCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            0     000     01123468999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-43  Score=313.53  Aligned_cols=240  Identities=23%  Similarity=0.278  Sum_probs=190.8

Q ss_pred             eecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCH
Q 043074           90 IGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL  165 (373)
Q Consensus        90 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  165 (373)
                      ||+|+||.||++... +++.||+|.+....   ......+.+|+.++.+++||||+++++++.+....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999764 68899999986532   22345678899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecccccc
Q 043074          166 DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI  245 (373)
Q Consensus       166 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  245 (373)
                      .+++....               .+++..+..++.|++.||.|||  +++++||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~  143 (312)
T cd05585          81 FHHLQREG---------------RFDLSRARFYTAELLCALENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCKLN  143 (312)
T ss_pred             HHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHeEECCCCcEEEEECcccccC
Confidence            99997643               2889999999999999999999  799999999999999999999999999998754


Q ss_pred             CCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcccccc
Q 043074          246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEM  325 (373)
Q Consensus       246 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (373)
                      .... .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||....       ..........       
T Consensus       144 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~-------~~~~~~~~~~-------  207 (312)
T cd05585         144 MKDD-DKTNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-------VNEMYRKILQ-------  207 (312)
T ss_pred             ccCC-CccccccCCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCC-------HHHHHHHHHc-------
Confidence            2221 22334568999999999975 457889999999999999999999975421       1111111111       


Q ss_pred             ccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          326 VDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       326 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                        ...   .++...+..+.+++.+||+.||++||++..+.+.
T Consensus       208 --~~~---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~  244 (312)
T cd05585         208 --EPL---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEI  244 (312)
T ss_pred             --CCC---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence              000   1133345688999999999999999865444333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.1e-42  Score=304.44  Aligned_cols=255  Identities=27%  Similarity=0.458  Sum_probs=202.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      .++|++.++||+|+||.||+|..++++.+|+|.+..... ....+.+|+.++++++|||++++++++. ....++++||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            457888999999999999999988899999999875443 3467889999999999999999999874 45689999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      .+++|.+++......             .+++.++..++.|++.||+|||  +.+++|+||||+||++++++.++|+|||
T Consensus        83 ~~~~L~~~~~~~~~~-------------~~~~~~~~~i~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~dfg  147 (260)
T cd05067          83 ENGSLVDFLKTPEGI-------------KLTINKLIDMAAQIAEGMAFIE--RKNYIHRDLRAANILVSETLCCKIADFG  147 (260)
T ss_pred             CCCCHHHHHHhcCCC-------------CCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHHhEEEcCCCCEEEccCc
Confidence            999999998754422             2889999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      ++...............++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....    .   .+........
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~---~~~~~~~~~~  219 (260)
T cd05067         148 LARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMT----N---PEVIQNLERG  219 (260)
T ss_pred             ceeecCCCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCC----h---HHHHHHHHcC
Confidence            998764332222223345678999999874 447889999999999999999 888864321    1   1111111110


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                            ....     .+...+.++.+++.+||+.+|++||+++++.+.|+++
T Consensus       220 ------~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         220 ------YRMP-----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             ------CCCC-----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence                  0001     1223456899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=318.08  Aligned_cols=256  Identities=24%  Similarity=0.429  Sum_probs=211.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC---C--CCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS---S--GVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      .+.....+.||.|-||.||+|...   .  .-.||||..+.+... ..+.|+.|..+|++++||||++++|+|.+. ..+
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence            345566788999999999999542   2  345889998775443 467899999999999999999999999765 678


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +|||.++.|-|..|+...+..              ++......++.||+.||+|||  +..++||||..+|||+.+.--|
T Consensus       467 ivmEL~~~GELr~yLq~nk~s--------------L~l~tL~ly~~Qi~talaYLe--SkrfVHRDIAaRNiLVsSp~CV  530 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDS--------------LPLRTLTLYCYQICTALAYLE--SKRFVHRDIAARNILVSSPQCV  530 (974)
T ss_pred             EEEecccchhHHHHHHhcccc--------------chHHHHHHHHHHHHHHHHHHH--hhchhhhhhhhhheeecCccee
Confidence            999999999999999987754              888999999999999999999  7889999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      ||+|||+++.+..+.....+...-+..|||||.+. ...++.+||||.|||.+||+++ |..||....            
T Consensus       531 KLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk------------  597 (974)
T KOG4257|consen  531 KLADFGLSRYLEDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVK------------  597 (974)
T ss_pred             eecccchhhhccccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCcccccc------------
Confidence            99999999998776655555555567899999997 6779999999999999999986 667764321            


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                           +...+-.+.+.- +-..+++||..++.++.+||..+|.+||++.++...|.+++
T Consensus       598 -----NsDVI~~iEnGe-RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  598 -----NSDVIGHIENGE-RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             -----ccceEEEecCCC-CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence                 112222222222 22338889999999999999999999999999999998875

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.9e-43  Score=305.65  Aligned_cols=256  Identities=25%  Similarity=0.424  Sum_probs=201.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      .++|++.+.||+|+||.||+|...++..|++|.+..... ..+.+.+|+.+++.++||||+++++.+.+ ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            357889999999999999999877777899999975433 33578899999999999999999998754 5578999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++|+|.+++......             .+++..+..++.|++.||+|||  +.+++|+||||+||++++++.++|+|||
T Consensus        83 ~~~~L~~~~~~~~~~-------------~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~Nill~~~~~~~L~dfg  147 (262)
T cd05071          83 SKGSLLDFLKGEMGK-------------YLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFG  147 (262)
T ss_pred             CCCcHHHHHhhcccc-------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcccEEEcCCCcEEeccCC
Confidence            999999999754321             2789999999999999999999  7999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      .++..............++..|+|||...+ ..++.++||||||+++|||++ |..|+.... .   .   ........ 
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-~---~---~~~~~~~~-  218 (262)
T cd05071         148 LARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMV-N---R---EVLDQVER-  218 (262)
T ss_pred             ceeeccccccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-h---H---HHHHHHhc-
Confidence            998664433222223445678999998864 447889999999999999999 666643211 0   0   11111100 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                           ....     ..+...+..+.+++.+||+.||++||++.++++.|++.+
T Consensus       219 -----~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         219 -----GYRM-----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             -----CCCC-----CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence                 0000     113345678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.2e-42  Score=303.78  Aligned_cols=260  Identities=24%  Similarity=0.386  Sum_probs=205.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||+|... +++.+|+|.+.....   .....+.+|+.+++.++|||++++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47889999999999999999754 789999998754322   22346789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++++|.+++.......           ..+++..+..++.|++.||.|||  +++++|+||+|+||+++.++.++|+
T Consensus        82 e~~~~~~L~~~~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~nil~~~~~~~~l~  148 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQK-----------RLIPERTVWKYFVQLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLG  148 (267)
T ss_pred             EecCCCcHHHHHHHhhhcc-----------CCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCCHHHEEEcCCCCEEEC
Confidence            9999999999886533211           12788999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||++........ ......+++.|+|||.+.+. ..+.++|+||||+++|||++|..|+......     ...+.....
T Consensus       149 d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-----~~~~~~~~~  221 (267)
T cd08228         149 DLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LFSLCQKIE  221 (267)
T ss_pred             ccccceeccchhH-HHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCcccccc-----HHHHHHHHh
Confidence            9999886543221 12234678899999998754 4788999999999999999999997542211     112221111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                      ..          ..........+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       222 ~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         222 QC----------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             cC----------CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            10          001111234556899999999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3e-43  Score=318.79  Aligned_cols=245  Identities=23%  Similarity=0.292  Sum_probs=196.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCC--CCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSS--GVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      .++|.+.+.||+|+||.||+|..++  +..||+|.+.+...   .....+.+|+.++..++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3478889999999999999997542  36899999865322   234567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||+++|+|.+++.....               +++..+..++.|++.||.|||  +.+++||||||+|||++.++.+|
T Consensus       109 v~Ey~~~g~L~~~i~~~~~---------------~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~ik  171 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNKR---------------FPNDVGCFYAAQIVLIFEYLQ--SLNIVYRDLKPENLLLDKDGFIK  171 (340)
T ss_pred             EEeCCCCCcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEE
Confidence            9999999999999976542               889999999999999999999  79999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||++......    .....||+.|+|||++.+ ..++.++|||||||++|||++|..||.....      . .....
T Consensus       172 L~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~-~~~~~  239 (340)
T PTZ00426        172 MTDFGFAKVVDTR----TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEP------L-LIYQK  239 (340)
T ss_pred             EecCCCCeecCCC----cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCH------H-HHHHH
Confidence            9999999865322    234568999999999975 4478899999999999999999999754211      0 00111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                      ... ..      ..     ++...+..+.+++.+||+.||++|+     +++++++
T Consensus       240 i~~-~~------~~-----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        240 ILE-GI------IY-----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             Hhc-CC------CC-----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            110 00      00     1222345788999999999999995     8888765

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-42  Score=307.56  Aligned_cols=267  Identities=25%  Similarity=0.449  Sum_probs=205.1

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      ++|.+.+.||+|+||.||+|...      ++..||+|.+...... ....+.+|+++++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            46778899999999999999753      3478999999765444 3567899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +||||+++++|.+++........... ........+++.++..++.|++.|+.|||  +++++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLK-SPDSPMGELTLSQLLQIAVQIASGMVYLA--SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhc-ccccccccccHHHHHHHHHHHHHHHHHHh--hCCeeccccccceEEEcCCCeE
Confidence            99999999999999987543211110 00011224889999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHH
Q 043074          235 HISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  312 (373)
                      +|+|||+++....... .......+++.|+|||.+.+ ..++.++||||||+++|||++ |..|+......    .....
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~----~~~~~  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----EVIEC  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH
Confidence            9999999976432221 11223345778999999875 457889999999999999998 88886432111    11111


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                         .. .+..          ...+...+..+.+++.+||+.||.+||++.|+++.|++
T Consensus       237 ---~~-~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         237 ---IT-QGRL----------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ---HH-cCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence               11 0000          01122345689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.8e-42  Score=303.03  Aligned_cols=253  Identities=26%  Similarity=0.413  Sum_probs=200.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      ++|++.+.||+|+||.||+|..+++..+++|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            47888999999999999999888888999999876443 3357889999999999999999999875 456789999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +++|.+++......             .+++.++..++.|++.||.|||  +++++|+||||+||++++++.++|+|||+
T Consensus        84 ~~~L~~~~~~~~~~-------------~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~Nili~~~~~~~l~dfg~  148 (260)
T cd05070          84 KGSLLDFLKDGEGR-------------ALKLPNLVDMAAQVAAGMAYIE--RMNYIHRDLRSANILVGDGLVCKIADFGL  148 (260)
T ss_pred             CCcHHHHHHhcCCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEEeCCceEEeCCcee
Confidence            99999999764322             2889999999999999999999  78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      +...............++..|+|||.+.+ ..++.++|+||||+++|||++ |..|+....       ..+........ 
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-------~~~~~~~~~~~-  219 (260)
T cd05070         149 ARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMN-------NREVLEQVERG-  219 (260)
T ss_pred             eeeccCcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHHcC-
Confidence            98654332222222345668999999864 447889999999999999999 677753311       11111111110 


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                           ....     .+...+..+.+++.+||+.+|++|||+.++.+.|++
T Consensus       220 -----~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 -----YRMP-----CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -----CCCC-----CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                 0011     123345689999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=8.6e-43  Score=310.10  Aligned_cols=263  Identities=23%  Similarity=0.325  Sum_probs=191.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-C-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcC---CCCCccceeeEEe-----e
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-S-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKL---RHRNIVKILGYCA-----S  149 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~  149 (373)
                      ++|++.+.||+|+||.||+|.. . +++.||+|.+......  ....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            4788999999999999999975 3 4688999988653322  223456677776665   6999999999885     3


Q ss_pred             CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       150 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      ....++|+||++ ++|.+++......             .+++..+..++.|++.||.|||  +++++||||||+||+++
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~-------------~~~~~~~~~i~~qi~~aL~~lH--~~~iiH~dlkp~Nil~~  144 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEP-------------GVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVT  144 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEc
Confidence            456899999995 6999998764432             2889999999999999999999  79999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          230 SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      .++.+||+|||+++.....  .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||......+....+
T Consensus       145 ~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i  221 (290)
T cd07862         145 SSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI  221 (290)
T ss_pred             CCCCEEEccccceEeccCC--cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence            9999999999999865432  22334568999999999874 45788999999999999999999987543221110000


Q ss_pred             HH---------HHHHHHHhccccccccCc--cccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 LE---------WARTMEARNKEIEMVDSN--ISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 ~~---------~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..         |.......   ...+...  ..........+..+.+++.+||+.||++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         222 LDVIGLPGEEDWPRDVALP---RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHHhCCCChhhchhhhccc---chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00         00000000   0000000  0000011224567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-42  Score=318.95  Aligned_cols=254  Identities=20%  Similarity=0.257  Sum_probs=200.4

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ..++|++.+.||+|+||.||++..+ ++..||+|.+.+...   .....+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3468899999999999999999764 688999999865321   223457789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||+++|+|.+++....                +++..+..++.|++.||+|||  +++++||||||+|||++.++.+|
T Consensus       121 v~Ey~~gg~L~~~l~~~~----------------l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~k  182 (370)
T cd05596         121 VMEYMPGGDLVNLMSNYD----------------IPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLK  182 (370)
T ss_pred             EEcCCCCCcHHHHHHhcC----------------CCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEcCCCCEE
Confidence            999999999999987542                778888999999999999999  79999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCC---CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN---TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      |+|||++...............||+.|+|||.+.+.   ..++.++|||||||++|||++|..||......       ..
T Consensus       183 L~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~  255 (370)
T cd05596         183 LADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GT  255 (370)
T ss_pred             EEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------HH
Confidence            999999987643332233446799999999998643   24788999999999999999999997643211       11


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRE--RPAMSYVVQ  366 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~l~~  366 (373)
                      .........       .+.... ....+.++.+++.+||+.+|.+  ||++.++++
T Consensus       256 ~~~i~~~~~-------~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         256 YSKIMDHKN-------SLTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             HHHHHcCCC-------cCCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            111111000       000000 1123568899999999999988  999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.8e-42  Score=312.22  Aligned_cols=199  Identities=30%  Similarity=0.450  Sum_probs=170.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999765 688899998865432 234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++++|.+++....               .+++..+..++.|++.||.|||+ ..+++|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~l~~~l~~lH~-~~~ivH~dlkp~Nili~~~~~~kL~D  147 (333)
T cd06650          84 HMDGGSLDQVLKKAG---------------RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCD  147 (333)
T ss_pred             cCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChhhEEEcCCCCEEEee
Confidence            999999999997643               27889999999999999999994 34799999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCC
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP  299 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  299 (373)
                      ||++......   ......|+..|+|||.+.+. .++.++|||||||++|||++|..|+..
T Consensus       148 fg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         148 FGVSGQLIDS---MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             CCcchhhhhh---ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9998765322   12334688999999999754 478899999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-42  Score=307.46  Aligned_cols=267  Identities=26%  Similarity=0.413  Sum_probs=199.6

Q ss_pred             CCCCCeeecCCCceEEEEEe-----CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEE
Q 043074           84 FSTDKIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASG--LDRVL  155 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  155 (373)
                      |+..+.||+|+||.||++..     .++..||+|.+..... .....+.+|+.+++.++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37889999999999988642     3678899999876533 2345788999999999999999999987653  45789


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      +|||+++++|.+++....                +++.++..++.|++.||.|||  +++++|+||||+||++++++.++
T Consensus        86 v~e~~~~~~l~~~~~~~~----------------l~~~~~~~i~~~l~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~  147 (283)
T cd05080          86 IMEYVPLGSLRDYLPKHK----------------LNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVK  147 (283)
T ss_pred             EecCCCCCCHHHHHHHcC----------------CCHHHHHHHHHHHHHHHHHHH--HCCeeccccChheEEEcCCCcEE
Confidence            999999999999997543                899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          236 ISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |+|||+++........  ......++..|+|||.+.+ ...+.++||||||+++|||++|..|+........  ....+.
T Consensus       148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~  224 (283)
T cd05080         148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE--EMIGPK  224 (283)
T ss_pred             EeecccccccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh--hhhccc
Confidence            9999999875432211  1122335667999999874 4478899999999999999999988643221100  000000


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .............+..... ..+..++.++.+++.+||+.||++|||++++++.|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         225 QGQMTVVRLIELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             ccccchhhhhhhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0000000000011111111 113345678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7e-43  Score=314.92  Aligned_cols=241  Identities=22%  Similarity=0.284  Sum_probs=192.2

Q ss_pred             CeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCC
Q 043074           88 KIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENG  163 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  163 (373)
                      +.||+|+||.||++.. .+|..||+|.+.....   .....+.+|+.+++.++||||+++++++......++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999975 4789999999865422   23446778999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecccc
Q 043074          164 SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR  243 (373)
Q Consensus       164 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  243 (373)
                      +|..++....               .+++..+..++.|++.||.|||  +++++||||||+|||++.++.+||+|||+++
T Consensus        81 ~L~~~l~~~~---------------~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  143 (323)
T cd05595          81 ELFFHLSRER---------------VFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCK  143 (323)
T ss_pred             cHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEEcCCCCEEecccHHhc
Confidence            9999887543               2889999999999999999999  7899999999999999999999999999987


Q ss_pred             ccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcccc
Q 043074          244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEI  323 (373)
Q Consensus       244 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (373)
                      ...... .......||+.|+|||.+.+. .++.++|||||||++|||++|..||......       ........ .   
T Consensus       144 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~~~~-~---  210 (323)
T cd05595         144 EGISDG-ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILM-E---  210 (323)
T ss_pred             cccCCC-CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHhc-C---
Confidence            532211 122345689999999999754 4788999999999999999999997542211       00011100 0   


Q ss_pred             ccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          324 EMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                         ...     .+...+.++.+++.+||+.||++||     ++.++++
T Consensus       211 ---~~~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         211 ---EIR-----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ---CCC-----CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence               001     1223456889999999999999998     7887764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.1e-42  Score=310.07  Aligned_cols=255  Identities=22%  Similarity=0.391  Sum_probs=198.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCC----EEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGV----TVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      .+|+..+.||+|+||.||+|.+. ++.    .||+|.+..... ...+.+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46888999999999999999753 333    489999865433 3346788999999999999999999998765 5679


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ++||+++|+|.+++.....              .+++..++.++.|++.||+|||  +++++||||||+||++++++.+|
T Consensus        86 v~e~~~~g~l~~~l~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH--~~~iiH~dlkp~Nill~~~~~~k  149 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD--------------NIGSQYLLNWCVQIAKGMNYLE--ERRLVHRDLAARNVLVKTPQHVK  149 (316)
T ss_pred             eeecCCCCCHHHHHHhccc--------------cCCHHHHHHHHHHHHHHHHHHH--hcCeeccccchhheEecCCCcEE
Confidence            9999999999999986542              2788999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCcc-cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          236 ISDFGLARRIDTSHSHV-STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |+|||+++......... .....++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....       ..++.
T Consensus       150 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-------~~~~~  221 (316)
T cd05108         150 ITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEIS  221 (316)
T ss_pred             EccccccccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-------HHHHH
Confidence            99999998765332221 122234668999999874 457889999999999999998 888754311       11111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .... ...       ..  . .+..++..+.+++.+||+.||.+||++.+++..|.++.
T Consensus       222 ~~~~-~~~-------~~--~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         222 SILE-KGE-------RL--P-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             HHHh-CCC-------CC--C-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1111 100       00  0 02234457899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.7e-43  Score=320.22  Aligned_cols=253  Identities=20%  Similarity=0.241  Sum_probs=200.3

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|.+.+.||+|+||.||++... +++.+|+|++.....   .....+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999754 789999999975432   23456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.....              .+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+||+
T Consensus        81 e~~~~~~L~~~l~~~~~--------------~l~~~~~~~~~~qi~~aL~~lH--~~~i~H~Dlkp~NIll~~~~~~kL~  144 (330)
T cd05601          81 EYQPGGDLLSLLNRYED--------------QFDEDMAQFYLAELVLAIHSVH--QMGYVHRDIKPENVLIDRTGHIKLA  144 (330)
T ss_pred             CCCCCCCHHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeEcccCchHheEECCCCCEEec
Confidence            99999999999986532              2889999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCC-----CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG-----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      |||++...............||+.|+|||.+.+     ...++.++|||||||++|||++|..||.....       ...
T Consensus       145 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~  217 (330)
T cd05601         145 DFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-------AKT  217 (330)
T ss_pred             cCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-------HHH
Confidence            999998765433333334568999999999863     34567899999999999999999999754221       111


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..........   +.    ... ....+..+.+++.+|++ ||.+||++.+++.
T Consensus       218 ~~~i~~~~~~---~~----~~~-~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         218 YNNIMNFQRF---LK----FPE-DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHHcCCCc---cC----CCC-CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            1111111000   00    000 11234578999999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=324.16  Aligned_cols=252  Identities=24%  Similarity=0.357  Sum_probs=201.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|.+.+.||+|+||.||+|... +++.||+|++.+...   .....+.+|+.++..++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47888999999999999999765 789999999865432   23456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++++|.+++....               .+++..+..++.|++.||+|||  +.+++||||||+||+++.++.+||+
T Consensus        81 e~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~qi~~aL~~LH--~~giiH~Dlkp~NIll~~~~~~kL~  143 (350)
T cd05573          81 EYMPGGDLMNLLIRKD---------------VFPEETARFYIAELVLALDSVH--KLGFIHRDIKPDNILIDADGHIKLA  143 (350)
T ss_pred             cCCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEee
Confidence            9999999999998653               2889999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCC----------------------------CcccccccccccccCccccCCCCCCCccccchhhhHHHHH
Q 043074          238 DFGLARRIDTSH----------------------------SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE  289 (373)
Q Consensus       238 Dfg~~~~~~~~~----------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~e  289 (373)
                      |||++.......                            ........||+.|+|||.+.+. .++.++|||||||++||
T Consensus       144 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~e  222 (350)
T cd05573         144 DFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYE  222 (350)
T ss_pred             cCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhh
Confidence            999998654332                            1122345689999999999854 57899999999999999


Q ss_pred             HHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 043074          290 IATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA-MSYVVQL  367 (373)
Q Consensus       290 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~l~~~  367 (373)
                      |++|..||......       .........       ...+.... ....+..+.+++.+|++ ||.+||+ +.++++.
T Consensus       223 ll~g~~Pf~~~~~~-------~~~~~i~~~-------~~~~~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         223 MLYGFPPFYSDTLQ-------ETYNKIINW-------KESLRFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             hccCCCCCCCCCHH-------HHHHHHhcc-------CCcccCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            99999997543211       111111110       00010000 11135689999999997 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-42  Score=303.82  Aligned_cols=250  Identities=28%  Similarity=0.419  Sum_probs=198.0

Q ss_pred             CCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +|++.+.||+|+||.||++..+++..+++|.+..... ....+.+|+++++.++||||+++++++......++|+||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            5778899999999999999887778899999865433 235678899999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      ++|.+++.....              .+++..+..++.|++.||+|||  +.+++||||||+||++++++.+||+|||++
T Consensus        84 ~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~  147 (256)
T cd05059          84 GCLLNYLRERKG--------------KLGTEWLLDMCSDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLA  147 (256)
T ss_pred             CCHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHhhEEECCCCcEEECCcccc
Confidence            999999975432              2889999999999999999999  789999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhcc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARNK  321 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (373)
                      +..............++..|+|||.+.+ ..++.++|+||||+++|||++ |..|+......       +.......   
T Consensus       148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~---  216 (256)
T cd05059         148 RYVLDDQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------EVVESVSA---  216 (256)
T ss_pred             eecccccccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-------HHHHHHHc---
Confidence            7654322111122223457999999875 447889999999999999999 67775432110       11111110   


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLL  368 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L  368 (373)
                         .....     .+..++.++.+++.+||+.+|++||++.++++.|
T Consensus       217 ---~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         217 ---GYRLY-----RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---CCcCC-----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               01111     1223466899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=300.30  Aligned_cols=269  Identities=25%  Similarity=0.313  Sum_probs=203.9

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeC--ccccccHHHHHHHHHHHhcCCCCCccceeeEEee-----C
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLD--KDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS-----G  150 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~  150 (373)
                      ....+|...+.||+|+||.|+.+.. .+|+.||||++.  -......+...+|+++|+.++|+||+.+.+++..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            3445676678999999999999965 479999999986  2333446678899999999999999999998865     3


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      +..|+|+|+| +.+|.+.++....               ++.....-+++|+++||.|+|  +.+++||||||+|++++.
T Consensus        99 ~DvYiV~elM-etDL~~iik~~~~---------------L~d~H~q~f~YQiLrgLKyiH--SAnViHRDLKPsNll~n~  160 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQQD---------------LTDDHAQYFLYQILRGLKYIH--SANVIHRDLKPSNLLLNA  160 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcCcc---------------ccHHHHHHHHHHHHHhcchhh--cccccccccchhheeecc
Confidence            5789999999 7799999987653               888999999999999999999  789999999999999999


Q ss_pred             CCceEEeeeccccccCCC-CCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          231 DFEAHISDFGLARRIDTS-HSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      +...||+|||+|+..... .....+....|.+|.|||++.....|+.+.||||.||++.||++|++-|.......+..-+
T Consensus       161 ~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI  240 (359)
T KOG0660|consen  161 DCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLI  240 (359)
T ss_pred             CCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHH
Confidence            999999999999987543 1223355678999999999988888999999999999999999998765433222111001


Q ss_pred             HHH--------HHHHH---Hhcccccccc--CccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 LEW--------ARTME---ARNKEIEMVD--SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 ~~~--------~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .+.        .....   ... ..+.+.  +................+++.+||..||.+|+|++|.++
T Consensus       241 ~~~lGtP~~e~l~~i~s~~ar~-yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  241 LELLGTPSEEDLQKIRSEKARP-YIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHhcCCCCHHHHHHhccHHHHH-HHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            000        00000   000 000000  111111112244568899999999999999999999875

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.3e-43  Score=315.54  Aligned_cols=272  Identities=29%  Similarity=0.451  Sum_probs=201.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe------CCCCEEEEEEeCccccc-cHHHHHHHHHHHhcC-CCCCccceeeEEee-CC
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKL-RHRNIVKILGYCAS-GL  151 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-~~  151 (373)
                      .++|++.+.||+|+||.||+|..      .+++.||+|++...... ..+.+.+|+.++.++ +|+||+++++++.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            35789999999999999999953      23578999998654322 245678899999999 79999999998864 45


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcc----------------------------------------------cccC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGS----------------------------------------------KQLN  185 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~----------------------------------------------~~~~  185 (373)
                      ..++++||+++++|.+++............                                              ....
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            778999999999999998654321000000                                              0000


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCcc-cccccccccccC
Q 043074          186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV-STQVAGTMGYMP  264 (373)
Q Consensus       186 ~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~a  264 (373)
                      ...++++..+..++.|++.||+|||  +++|+||||||+||++++++.++|+|||+++......... .....++..|+|
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH--~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            0125899999999999999999999  8999999999999999999999999999998754322211 223345678999


Q ss_pred             ccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHH
Q 043074          265 PEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREY  343 (373)
Q Consensus       265 PE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  343 (373)
                      ||.+.+ ..++.++|||||||++|||++ |..|+......+      ...... .....     .     ..+...+.++
T Consensus       244 PE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~-~~~~~-----~-----~~~~~~~~~~  305 (337)
T cd05054         244 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRL-KEGTR-----M-----RAPEYATPEI  305 (337)
T ss_pred             cHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHH-hccCC-----C-----CCCccCCHHH
Confidence            999875 457889999999999999998 888864321111      011111 11100     0     0122334579


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          344 FRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       344 ~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .+++.+||+.+|++||++.++++.|++++
T Consensus       306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         306 YSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            99999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.8e-42  Score=317.14  Aligned_cols=255  Identities=20%  Similarity=0.258  Sum_probs=199.1

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ..++|++.+.||+|+||.||++... +++.+|+|.+.+...   .....+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            4578999999999999999999765 688999999865322   223457789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||+++|+|.+++....                +++..+..++.||+.||+|||  +++|+||||||+|||+++++.+|
T Consensus       121 v~Ey~~gg~L~~~l~~~~----------------~~~~~~~~~~~qil~aL~~LH--~~~IvHrDLKp~NILl~~~~~~k  182 (370)
T cd05621         121 VMEYMPGGDLVNLMSNYD----------------VPEKWAKFYTAEVVLALDAIH--SMGLIHRDVKPDNMLLDKHGHLK  182 (370)
T ss_pred             EEcCCCCCcHHHHHHhcC----------------CCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEE
Confidence            999999999999996542                788899999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCC---CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN---TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      |+|||++...............||+.|+|||++.+.   ..++.++|||||||++|||++|..||......       ..
T Consensus       183 L~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------~~  255 (370)
T cd05621         183 LADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------GT  255 (370)
T ss_pred             EEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------HH
Confidence            999999987643332233456799999999998643   23678999999999999999999997543211       11


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRE--RPAMSYVVQL  367 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~l~~~  367 (373)
                      ..........       +.... ....+..+.+++..|++.++.+  ||++.++++.
T Consensus       256 ~~~i~~~~~~-------~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         256 YSKIMDHKNS-------LNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHHHhCCcc-------cCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            1111110000       00000 1223557889999999865544  8899998763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-42  Score=316.43  Aligned_cols=266  Identities=23%  Similarity=0.284  Sum_probs=193.3

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeC-----CeeE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASG-----LDRV  154 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~  154 (373)
                      +|++.+.||+|+||.||+|..+ ++..||+|.+....  ......+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999754 78999999986432  22345688999999999999999999988543     2479


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +||||+ +++|.+++....               .+++..+..++.|++.||.|||  +.+++||||||+|||++.++.+
T Consensus        81 lv~e~~-~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~  142 (338)
T cd07859          81 VVFELM-ESDLHQVIKAND---------------DLTPEHHQFFLYQLLRALKYIH--TANVFHRDLKPKNILANADCKL  142 (338)
T ss_pred             EEEecC-CCCHHHHHHhcc---------------cCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcE
Confidence            999999 579999887543               2899999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCC--cccccccccccccCccccCCC-CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc---
Q 043074          235 HISDFGLARRIDTSHS--HVSTQVAGTMGYMPPEYLGGN-TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG---  308 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~---  308 (373)
                      ||+|||+++.......  .......||+.|+|||++.+. ..++.++|||||||++|||++|..||...........   
T Consensus       143 kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~  222 (338)
T cd07859         143 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITD  222 (338)
T ss_pred             EEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Confidence            9999999986432211  122345689999999998642 4578899999999999999999998744221100000   


Q ss_pred             -----HHHHHHHHHH--hccccccccCccccc--cCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          309 -----LLEWARTMEA--RNKEIEMVDSNISRE--ELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       309 -----~~~~~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                           ...+......  .......+.......  ......+..+.+++.+||+.||++||+++++++
T Consensus       223 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                 0000000000  000000000000000  000113457889999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.4e-42  Score=313.50  Aligned_cols=241  Identities=22%  Similarity=0.271  Sum_probs=192.8

Q ss_pred             CeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCC
Q 043074           88 KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENG  163 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  163 (373)
                      +.||+|+||.||++... +++.||+|++.+...   .....+.+|+.+++.++||||+++.+++.+....++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999754 689999999965432   23456788999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecccc
Q 043074          164 SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR  243 (373)
Q Consensus       164 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  243 (373)
                      +|.+++....               .+++.++..++.||+.||+|||  +++++||||||+|||++.++.+||+|||+++
T Consensus        81 ~L~~~l~~~~---------------~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~NIll~~~~~~kL~DfG~~~  143 (328)
T cd05593          81 ELFFHLSRER---------------VFSEDRTRFYGAEIVSALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCK  143 (328)
T ss_pred             CHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeEECCCCcEEEecCcCCc
Confidence            9999887543               2889999999999999999999  7999999999999999999999999999987


Q ss_pred             ccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcccc
Q 043074          244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEI  323 (373)
Q Consensus       244 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (373)
                      ..... ........||+.|+|||.+.+. .++.++|||||||++|||++|..||.....       .........     
T Consensus       144 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~-------~~~~~~~~~-----  209 (328)
T cd05593         144 EGITD-AATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILM-----  209 (328)
T ss_pred             cCCCc-ccccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCH-------HHHHHHhcc-----
Confidence            53221 1122345689999999999744 478899999999999999999999754211       111111100     


Q ss_pred             ccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          324 EMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                        -...+     +...+.++.+++.+||+.||++||     ++.++++
T Consensus       210 --~~~~~-----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         210 --EDIKF-----PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             --CCccC-----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence              00111     223455789999999999999997     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.2e-42  Score=319.57  Aligned_cols=266  Identities=24%  Similarity=0.311  Sum_probs=198.0

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-----eeE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASGL-----DRV  154 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  154 (373)
                      +|+..+.||+|+||.||++.. .+++.||+|.+....  ....+.+.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999975 478999999986532  223457889999999999999999999998776     789


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +|+||+. ++|.+++....               .+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+
T Consensus        81 lv~e~~~-~~l~~~~~~~~---------------~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nili~~~~~~  142 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ---------------PLSSDHVKVFLYQILRGLKYLH--SAGILHRDIKPGNLLVNSNCVL  142 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHHEEECCCCCE
Confidence            9999995 68888776443               2899999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc------
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG------  308 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~------  308 (373)
                      ||+|||+++..............+++.|+|||.+.+...++.++|||||||++|||++|..||...........      
T Consensus       143 kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g  222 (372)
T cd07853         143 KICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG  222 (372)
T ss_pred             EeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence            99999999865433333333456788999999998766688899999999999999999999754322110000      


Q ss_pred             ---HHHHHHHHHHh-ccccc-cccCc-cc-cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          309 ---LLEWARTMEAR-NKEIE-MVDSN-IS-REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       309 ---~~~~~~~~~~~-~~~~~-~~~~~-~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                         ...+....... ..... ..... .. ........+.++.+++.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             CCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence               00000000000 00000 00000 00 00011223567899999999999999999999985

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.1e-42  Score=325.67  Aligned_cols=252  Identities=20%  Similarity=0.242  Sum_probs=200.1

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-C-CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-S-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      .|.+.+.||+|++|.||++... + +..|++|.+..........+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888899999999999999643 4 6788888876555444556788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++|+|.+++......           ..++++.++..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||
T Consensus       148 ~gg~L~~~l~~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~~~~~~kL~DFg  214 (478)
T PTZ00267        148 SGGDLNKQIKQRLKE-----------HLPFQEYEVGLLFYQIVLALDEVH--SRKMMHRDLKSANIFLMPTGIIKLGDFG  214 (478)
T ss_pred             CCCCHHHHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCcCHHhEEECCCCcEEEEeCc
Confidence            999999988653211           114889999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          241 LARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       241 ~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      +++....... .......||+.|+|||.+.+ ..++.++|||||||++|||++|..|+....       .......... 
T Consensus       215 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-------~~~~~~~~~~-  285 (478)
T PTZ00267        215 FSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPS-------QREIMQQVLY-  285 (478)
T ss_pred             CceecCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh-
Confidence            9987643321 12344568999999999875 457889999999999999999999974321       1111111111 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      +.    ..      ..+...+..+.+++.+||+.||++||++.+++.
T Consensus       286 ~~----~~------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        286 GK----YD------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CC----CC------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            00    00      012234568999999999999999999999874

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.9e-42  Score=306.27  Aligned_cols=268  Identities=24%  Similarity=0.438  Sum_probs=204.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ++|.+.+.||+|+||.||++...      ++..+++|.+..........+.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            57888899999999999999642      345689999876655555678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |+||+++++|.+++..........  ........+++.+++.++.|++.||+|||  +++++||||||+||++++++.++
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~--~~~~~~~~l~~~~~~~~~~ql~~aL~~lH--~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLM--AEGNRPAELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccc--cccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEccCCcEE
Confidence            999999999999997654211100  00011224899999999999999999999  89999999999999999999999


Q ss_pred             EeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          236 ISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |+|||+++....... .......++..|+|||.+.+ ..++.++||||||+++|||++ |..|+......       ...
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------~~~  232 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EVI  232 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHH
Confidence            999999986532221 11222345678999999874 457889999999999999998 77775332110       111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .... ....     ...     +...+..+.+++.+||+.||.+|||+.++.+.|+++.
T Consensus       233 ~~i~-~~~~-----~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         233 ECIT-QGRV-----LQR-----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHHH-cCCc-----CCC-----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            1111 0100     001     1223457999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-43  Score=322.86  Aligned_cols=251  Identities=25%  Similarity=0.302  Sum_probs=195.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+.++..++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47888999999999999999764 68999999996532   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++....               .+++..+..++.|++.||+|||  +.+++||||||+|||++.++.++|+
T Consensus        81 E~~~~g~L~~~l~~~~---------------~l~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~  143 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---------------TFTEEETRFYIAETILAIDSIH--KLGYIHRDIKPDNLLLDAKGHIKLS  143 (364)
T ss_pred             CCCCCcHHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEe
Confidence            9999999999997643               2899999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCc-------------------------------------ccccccccccccCccccCCCCCCCccccc
Q 043074          238 DFGLARRIDTSHSH-------------------------------------VSTQVAGTMGYMPPEYLGGNTAATVMLDV  280 (373)
Q Consensus       238 Dfg~~~~~~~~~~~-------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~Di  280 (373)
                      |||++..+......                                     ......||+.|+|||++.+ ..++.++||
T Consensus       144 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di  222 (364)
T cd05599         144 DFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDW  222 (364)
T ss_pred             ecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeee
Confidence            99998754221100                                     0112468999999999874 457889999


Q ss_pred             hhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 043074          281 YSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA  360 (373)
Q Consensus       281 wslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (373)
                      |||||++|||++|..||......       +....... ..      ..+.... ....+..+.+++.+|+. +|.+|++
T Consensus       223 wSlG~il~el~~G~~Pf~~~~~~-------~~~~~i~~-~~------~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~  286 (364)
T cd05599         223 WSLGVIMYEMLVGYPPFCSDNPQ-------ETYRKIIN-WK------ETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLG  286 (364)
T ss_pred             ecchhHHHHhhcCCCCCCCCCHH-------HHHHHHHc-CC------CccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCC
Confidence            99999999999999997543211       11111110 00      0000000 11224578899999996 9999998


Q ss_pred             ---HHHHHH
Q 043074          361 ---MSYVVQ  366 (373)
Q Consensus       361 ---~~~l~~  366 (373)
                         +.++++
T Consensus       287 ~~~~~~ll~  295 (364)
T cd05599         287 NNGVNEIKS  295 (364)
T ss_pred             CCCHHHHhc
Confidence               777765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.5e-44  Score=303.63  Aligned_cols=262  Identities=26%  Similarity=0.330  Sum_probs=196.0

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-----eeEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGL-----DRVLI  156 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  156 (373)
                      .|...+++|+|+||.||+|... +++.||||+.-.+...    -.+|+.+|+.++|||||++..+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            5666789999999999999754 5799999998554432    247999999999999999999885432     23589


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC-CceE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-FEAH  235 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~-~~~k  235 (373)
                      |||++. +|.++++.....+.           .++...+.-+..||++||+|||  ..+|+||||||.|+|+|.+ |.+|
T Consensus       101 leymP~-tL~~~~r~~~~~~~-----------~mp~~~iKLYt~Qlfrgl~yLh--~~~IcHRDIKPqNlLvD~~tg~LK  166 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQ-----------RMPLLEIKLYTYQLFRGLAYLH--SHGICHRDIKPQNLLVDPDTGVLK  166 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCC-----------CCceeeeHHHHHHHHHHHHHHH--hcCcccCCCChheEEEcCCCCeEE
Confidence            999965 99999986422211           2777788889999999999999  7999999999999999976 8999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH---
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW---  312 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---  312 (373)
                      |+|||.|+........  .....|..|+|||.+.|...|+.+.||||.||++.||+-|++-|...+...+...+...   
T Consensus       167 icDFGSAK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  167 ICDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT  244 (364)
T ss_pred             eccCCcceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence            9999999987655443  34457889999999999999999999999999999999998765443332222211111   


Q ss_pred             -----HHHHHHhccccccccCccccc----cCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          313 -----ARTMEARNKEIEMVDSNISRE----ELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       313 -----~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                           ...+....  ...-.+.+...    ......+.+..+++.++|+.+|.+|.++.|++.
T Consensus       245 Pt~e~I~~mn~~y--~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  245 PTREDIKSMNPNY--TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CCHHHHhhcCccc--ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                 11111110  01111111111    124445678999999999999999999998874

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.9e-42  Score=302.15  Aligned_cols=256  Identities=25%  Similarity=0.359  Sum_probs=201.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|++.+.||+|+||.||+|.. .+++.+++|++..........+.+|+.++++++||||+++++++......++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35789999999999999999976 46889999998765544556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++....               ++++..+..++.|++.||.|||  +.+++||||+|+||+++.++.++|+||
T Consensus        88 ~~~~~L~~~~~~~~---------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nill~~~~~~~l~df  150 (267)
T cd06646          88 CGGGSLQDIYHVTG---------------PLSELQIAYVCRETLQGLAYLH--SKGKMHRDIKGANILLTDNGDVKLADF  150 (267)
T ss_pred             CCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEECcC
Confidence            99999999987543               2889999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCC--CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |++........ ......++..|+|||.+.+  ...++.++|+||||+++|||++|..|+...........         
T Consensus       151 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~---------  220 (267)
T cd06646         151 GVAAKITATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL---------  220 (267)
T ss_pred             ccceeeccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee---------
Confidence            99986543221 1223467889999998752  33467899999999999999999998643221110000         


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLL  368 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L  368 (373)
                         ............  .....+..+.+++.+||+.+|++||+++++++.|
T Consensus       221 ---~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         221 ---MSKSNFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ---eecCCCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence               000000000000  0122356899999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2e-42  Score=306.03  Aligned_cols=268  Identities=23%  Similarity=0.414  Sum_probs=203.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      .+|...+.||+|+||.||++...      ++..+++|.+..........+.+|+++++.++|+||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46778899999999999999532      356789998876655556789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ++||+++++|.+++....................+++..++.++.|++.|++|||  +.+++|+||||+||++++++.+|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~nil~~~~~~~k  162 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA--SLHFVHRDLATRNCLVGQGLVVK  162 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH--HCCeecccccHhhEEEcCCCCEE
Confidence            9999999999999986543211111111111224889999999999999999999  89999999999999999999999


Q ss_pred             EeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          236 ISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |+|||++........ .......+++.|+|||.+.+. .++.++|||||||++|||++ |..|+......       +..
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~  234 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------EAI  234 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------HHH
Confidence            999999976532221 112223356789999998754 47889999999999999998 77775432110       001


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                      .... ...     ...     .+..++..+.+++.+||+.||.+||++.+|++.|++
T Consensus       235 ~~~~-~~~-----~~~-----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         235 ECIT-QGR-----ELE-----RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHH-cCc-----cCC-----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            1010 000     000     122345679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.7e-42  Score=310.20  Aligned_cols=244  Identities=22%  Similarity=0.312  Sum_probs=189.3

Q ss_pred             CeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||++..+ +++.+|+|++.+...   .....+..|+.++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999764 688999999975432   2344577888888776 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|..++....               .+++..+..++.|++.||.|||  +++++||||||+||+++.++.+||+|||++
T Consensus        81 ~~L~~~~~~~~---------------~l~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dikp~Nili~~~~~~kL~DfG~~  143 (329)
T cd05618          81 GDLMFHMQRQR---------------KLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC  143 (329)
T ss_pred             CCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence            99999886543               2889999999999999999999  789999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCC-cccHHHHHHHHHHhcc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ-EVGLLEWARTMEARNK  321 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~  321 (373)
                      +...... .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||........ ......+.........
T Consensus       144 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~  221 (329)
T cd05618         144 KEGLRPG-DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ  221 (329)
T ss_pred             ccccCCC-CccccccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC
Confidence            7532221 12234578999999999975 4478899999999999999999999753221111 1111122211111110


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                            ..     .+...+..+.+++.+||+.||++||++
T Consensus       222 ------~~-----~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         222 ------IR-----IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             ------CC-----CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                  01     123345578999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8e-43  Score=321.57  Aligned_cols=251  Identities=21%  Similarity=0.279  Sum_probs=192.6

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .|...+.||+|+||.||+|.. .+++.+|+|++.+...   .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            577889999999999999965 4688999999965432   234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++|+|.+++....               .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|
T Consensus        82 ~~~gg~L~~~l~~~~---------------~~~e~~~~~~~~qi~~aL~~LH--~~givHrDlKp~Nili~~~~~~kL~D  144 (381)
T cd05626          82 YIPGGDMMSLLIRME---------------VFPEVLARFYIAELTLAIESVH--KMGFIHRDIKPDNILIDLDGHIKLTD  144 (381)
T ss_pred             cCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCcHHHEEECCCCCEEEee
Confidence            999999999997654               2888899999999999999999  79999999999999999999999999


Q ss_pred             eccccccCCCCC----------------------------------------------cccccccccccccCccccCCCC
Q 043074          239 FGLARRIDTSHS----------------------------------------------HVSTQVAGTMGYMPPEYLGGNT  272 (373)
Q Consensus       239 fg~~~~~~~~~~----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~  272 (373)
                      ||++........                                              .......||+.|+|||.+.+ .
T Consensus       145 FGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~  223 (381)
T cd05626         145 FGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-K  223 (381)
T ss_pred             CcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-C
Confidence            999764311000                                              00123468999999999875 4


Q ss_pred             CCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHH--h
Q 043074          273 AATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACM--C  350 (373)
Q Consensus       273 ~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--c  350 (373)
                      .++.++|||||||++|||++|..||........       ...... .      ...+.... ....+.++.+++.+  |
T Consensus       224 ~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-------~~~i~~-~------~~~~~~~~-~~~~s~~~~dli~~ll~  288 (381)
T cd05626         224 GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTET-------QLKVIN-W------ENTLHIPP-QVKLSPEAVDLITKLCC  288 (381)
T ss_pred             CCCCccceeehhhHHHHHHhCCCCCcCCCHHHH-------HHHHHc-c------ccccCCCC-CCCCCHHHHHHHHHHcc
Confidence            478899999999999999999999754321110       000000 0      00000000 11234577888887  4


Q ss_pred             cCCCCCCCCCHHHHHH
Q 043074          351 TNEKSRERPAMSYVVQ  366 (373)
Q Consensus       351 l~~~p~~RPs~~~l~~  366 (373)
                      +..+|..||++.+++.
T Consensus       289 ~~~~~~~R~~~~~~l~  304 (381)
T cd05626         289 SAEERLGRNGADDIKA  304 (381)
T ss_pred             CcccccCCCCHHHHhc
Confidence            4556667999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-42  Score=301.37  Aligned_cols=256  Identities=26%  Similarity=0.445  Sum_probs=204.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      .++|.+.+.||+|+||.||++..+++..+++|.+..... ....+.+|+.++++++|+|++++++++.+....++++||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            468899999999999999999888888999999875443 3467889999999999999999999999989999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++++|.+++......             .+++..+..++.|++.|+.|||  +++++|+||+|+||++++++.++|+|||
T Consensus        84 ~~~~L~~~i~~~~~~-------------~~~~~~~~~~~~~i~~al~~lh--~~~i~h~di~p~nili~~~~~~~l~d~g  148 (261)
T cd05034          84 SKGSLLDFLKSGEGK-------------KLRLPQLVDMAAQIAEGMAYLE--SRNYIHRDLAARNILVGENLVCKIADFG  148 (261)
T ss_pred             CCCCHHHHHhccccC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcchheEEEcCCCCEEECccc
Confidence            999999999765422             2899999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      ++...............++..|+|||.+.+ ...+.++|+||||+++|||++ |..|+....    ..   ........ 
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~----~~---~~~~~~~~-  219 (261)
T cd05034         149 LARLIEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMT----NR---EVLEQVER-  219 (261)
T ss_pred             cceeccchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCC----HH---HHHHHHHc-
Confidence            998764322222222334568999999874 447889999999999999999 777753211    11   11111110 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                           ......     +...+..+.+++.+||+.+|++||+++++.+.|+++
T Consensus       220 -----~~~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         220 -----GYRMPR-----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             -----CCCCCC-----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence                 000011     222356899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4e-42  Score=305.87  Aligned_cols=270  Identities=24%  Similarity=0.459  Sum_probs=205.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      .+|.+.+.||+|+||.||+|...      ++..+++|.+..........+.+|+..+++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35777889999999999999642      355689999876655555678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCC-CcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDV-DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      ||||+++++|.+++......... ...........+++..++.++.|++.|++|||  +++++||||||+||+++.++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil~~~~~~~  162 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA--SQHFVHRDLATRNCLVGANLLV  162 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEccCCcE
Confidence            99999999999999765421100 00000001113899999999999999999999  8999999999999999999999


Q ss_pred             EEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHH
Q 043074          235 HISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  312 (373)
                      +|+|||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++ |..|+......       +.
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~  234 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------EV  234 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HH
Confidence            9999999976533221 12233456788999999875 457889999999999999999 88886432211       11


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .... ......          ..+..++..+.+++.+||+.||++||++.+|++.|+++.
T Consensus       235 ~~~~-~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         235 IECI-TQGRVL----------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             HHHH-hCCCCC----------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            1111 111000          012234568999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.5e-41  Score=298.46  Aligned_cols=262  Identities=26%  Similarity=0.403  Sum_probs=207.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||+|... +++.+++|.++....   .....+.+|++++++++|+|++++++++.+.+..++++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999765 799999998864222   23457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++++|.+++.......           ..+++.++..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+
T Consensus        82 e~~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~nil~~~~~~~~l~  148 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQK-----------RLIPERTIWKYFVQLCSALEHMH--SKRIMHRDIKPANVFITATGVVKLG  148 (267)
T ss_pred             ecCCCCCHHHHHHHhcccC-----------CCcCHHHHHHHHHHHHHHHHHHH--hCCEecCCcChhhEEECCCCcEEEe
Confidence            9999999999987543211           13889999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||++........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..|+....     ...........
T Consensus       149 d~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~  221 (267)
T cd08224         149 DLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKKIE  221 (267)
T ss_pred             ccceeeeccCCCc-ccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCC-----ccHHHHHhhhh
Confidence            9999876543221 1233457889999999874 447889999999999999999999964322     11111111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhC
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA  373 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~~  373 (373)
                      .          ...........+..+.+++.+||+.+|++||++.+|++.|+++.+
T Consensus       222 ~----------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~  267 (267)
T cd08224         222 K----------CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA  267 (267)
T ss_pred             c----------CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence            0          000111112455689999999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-45  Score=292.05  Aligned_cols=251  Identities=22%  Similarity=0.332  Sum_probs=200.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCc--cccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDK--DAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++.|++.+.||+|.|+.|+++. ..+|+.+|+|+++.  -...+.+++.+|+.+.+.|+||||+++.+...+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            4678888899999999999994 45799999998753  33345778999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC---CCce
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---DFEA  234 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~---~~~~  234 (373)
                      |++.|++|..-+-...               .+++..+-..++||+++|.|+|  .++|+|||+||+|+++-+   ..-+
T Consensus        90 e~m~G~dl~~eIV~R~---------------~ySEa~aSH~~rQiLeal~yCH--~n~IvHRDvkP~nllLASK~~~A~v  152 (355)
T KOG0033|consen   90 DLVTGGELFEDIVARE---------------FYSEADASHCIQQILEALAYCH--SNGIVHRDLKPENLLLASKAKGAAV  152 (355)
T ss_pred             ecccchHHHHHHHHHH---------------HHHHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeeeeccCCCce
Confidence            9999999977665442               1788899999999999999999  899999999999999953   3469


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      ||+|||++...+  .........|||.|||||++.. ..++..+|||+.||+||-|+.|.+||++....+    +.+   
T Consensus       153 KL~~FGvAi~l~--~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r----lye---  222 (355)
T KOG0033|consen  153 KLADFGLAIEVN--DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYE---  222 (355)
T ss_pred             eecccceEEEeC--CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH----HHH---
Confidence            999999999887  3445566789999999999984 558999999999999999999999987633221    111   


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                         +.......++    ... =....++..+++++||..||.+|.|+.|.+.
T Consensus       223 ---~I~~g~yd~~----~~~-w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  223 ---QIKAGAYDYP----SPE-WDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ---HHhccccCCC----Ccc-cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence               1001111111    111 1223558899999999999999999998764

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.1e-42  Score=310.11  Aligned_cols=244  Identities=22%  Similarity=0.313  Sum_probs=190.0

Q ss_pred             CeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||++..+ +++.||+|++++...   ...+.+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999764 688999999975432   2345578899999888 699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|.+++....               .+++..+..++.|++.||.|||  +++++||||||+||+++.++.+||+|||++
T Consensus        81 g~L~~~~~~~~---------------~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~  143 (329)
T cd05588          81 GDLMFHMQRQR---------------KLPEEHARFYSAEISLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMC  143 (329)
T ss_pred             CCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEECcCccc
Confidence            99999886543               2899999999999999999999  899999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCC-cccHHHHHHHHHHhcc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ-EVGLLEWARTMEARNK  321 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~  321 (373)
                      +..... ........||+.|+|||.+.+ ..++.++|+|||||++|||++|..||........ ......+.........
T Consensus       144 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  221 (329)
T cd05588         144 KEGIRP-GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ  221 (329)
T ss_pred             cccccC-CCccccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC
Confidence            753211 122334578999999999975 4478899999999999999999999753222111 1111122221111110


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                            ..+     +...+..+.+++.+||+.||.+||++
T Consensus       222 ------~~~-----p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         222 ------IRI-----PRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             ------CCC-----CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence                  011     22334578999999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.1e-43  Score=297.27  Aligned_cols=270  Identities=24%  Similarity=0.348  Sum_probs=199.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc-cc-HHHHHHHHHHHhcCCCCC-ccceeeEEeeCC------
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF-QG-FREFRAEMETLGKLRHRN-IVKILGYCASGL------  151 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------  151 (373)
                      ..|...++||+|+||+||+|.. .+|+.||+|++.-... ++ -....+|+.+++.++|+| |+.+++++.+.+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3566667899999999999965 4789999999865543 22 345689999999999999 999999998877      


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..++|+||+ .-+|..++.......           ..++...+..++.||+.||+|||  +++|+||||||.||+|+++
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~-----------~g~~~~~ik~~m~Qll~gl~~~H--~~~IlHRDLKPQNlLi~~~  156 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKP-----------QGLPPRLIKSFMRQLLRGLAFLH--SHGILHRDLKPQNLLISSS  156 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccc-----------cCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCcceEEECCC
Confidence            789999999 669999999876421           01666889999999999999999  8999999999999999999


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc-ccHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE-VGLL  310 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~-~~~~  310 (373)
                      |.+||+|||+|+....+... .+...+|.+|.|||++.|...|+...||||+||++.||+++++- ++...+..+ ..+.
T Consensus       157 G~lKlaDFGlAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L-FpG~se~~ql~~If  234 (323)
T KOG0594|consen  157 GVLKLADFGLARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL-FPGDSEIDQLFRIF  234 (323)
T ss_pred             CcEeeeccchHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC-CCCCcHHHHHHHHH
Confidence            99999999999976544332 45567899999999999988899999999999999999996554 333332110 0000


Q ss_pred             HHHHHH-HHhccc-cccccCc--cc----cccCCHHHH---HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          311 EWARTM-EARNKE-IEMVDSN--IS----REELSEAGV---REYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       311 ~~~~~~-~~~~~~-~~~~~~~--~~----~~~~~~~~~---~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      .....- ...+.. ....+..  ..    ........+   ....+++.+||+.+|.+|.|++..++.
T Consensus       235 ~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  235 RLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            000000 000000 0000000  00    000011111   378899999999999999999998864

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.6e-43  Score=287.13  Aligned_cols=255  Identities=22%  Similarity=0.341  Sum_probs=205.1

Q ss_pred             HHhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc--------cHHHHHHHHHHHhcC-CCCCccceeeEE
Q 043074           78 IDATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ--------GFREFRAEMETLGKL-RHRNIVKILGYC  147 (373)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~l~~~~  147 (373)
                      ....++|...+.||.|..+.|-++.. ++|.+.|+|++......        ..+.-.+|+.+|+++ .||||+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            44567888889999999999999854 47899999988532221        134457899999999 599999999999


Q ss_pred             eeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceE
Q 043074          148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVL  227 (373)
Q Consensus       148 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nil  227 (373)
                      .++...++|+|.|+.|.|.+++.....               +++.+..++++|+.+|++|||  .++|+||||||+|||
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~Vt---------------lSEK~tR~iMrqlfegVeylH--a~~IVHRDLKpENIL  155 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKVT---------------LSEKETRRIMRQLFEGVEYLH--ARNIVHRDLKPENIL  155 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhhee---------------ecHHHHHHHHHHHHHHHHHHH--HhhhhhcccChhhee
Confidence            999999999999999999999986653               899999999999999999999  899999999999999


Q ss_pred             eCCCCceEEeeeccccccCCCCCcccccccccccccCccccC-----CCCCCCccccchhhhHHHHHHHhCCCCCCCccc
Q 043074          228 LDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG-----GNTAATVMLDVYSFGILMIEIATQIRPNLPVVL  302 (373)
Q Consensus       228 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~  302 (373)
                      ++++-++||+|||++..+.+  .......+|||+|+|||.+.     +.+.|+...|+||+||++|.|+.|.+||+.   
T Consensus       156 lddn~~i~isDFGFa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH---  230 (411)
T KOG0599|consen  156 LDDNMNIKISDFGFACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH---  230 (411)
T ss_pred             eccccceEEeccceeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH---
Confidence            99999999999999987653  34556789999999999875     456788899999999999999999999743   


Q ss_pred             CCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          303 DGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                                .+++.....+.+. .-.+.... =.+.+....+++.+||+.||.+|.|++|.+.
T Consensus       231 ----------RkQmlMLR~ImeG-kyqF~spe-Wadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  231 ----------RKQMLMLRMIMEG-KYQFRSPE-WADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ----------HHHHHHHHHHHhc-ccccCCcc-hhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                      1111111111000 01111111 2345668999999999999999999999875

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.6e-42  Score=311.31  Aligned_cols=241  Identities=24%  Similarity=0.333  Sum_probs=191.4

Q ss_pred             CeeecCCCceEEEEEe----CCCCEEEEEEeCcccc----ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           88 KIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAF----QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +.||+|+||.||++..    .+++.||+|.+.....    .....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999964    3578999999865322    2234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++.....               +++..+..++.|++.||.|||  +++++||||||+||+++.++.+||+||
T Consensus        82 ~~~~~L~~~~~~~~~---------------~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Df  144 (323)
T cd05584          82 LSGGELFMHLEREGI---------------FMEDTACFYLSEISLALEHLH--QQGIIYRDLKPENILLDAQGHVKLTDF  144 (323)
T ss_pred             CCCchHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEeeC
Confidence            999999999876542               788888999999999999999  799999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |+++...... .......||+.|+|||.+.+. .++.++|||||||++|||++|..||.....       ......... 
T Consensus       145 g~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~-------~~~~~~~~~-  214 (323)
T cd05584         145 GLCKESIHEG-TVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENR-------KKTIDKILK-  214 (323)
T ss_pred             cCCeecccCC-CcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCH-------HHHHHHHHc-
Confidence            9987543222 122345689999999999754 468899999999999999999999753211       111111111 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                      .        ..   ..+...+..+.+++.+||+.||++||     +++++++
T Consensus       215 ~--------~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         215 G--------KL---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             C--------CC---CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            0        00   01223345789999999999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.5e-42  Score=314.83  Aligned_cols=258  Identities=19%  Similarity=0.251  Sum_probs=199.9

Q ss_pred             HHHhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe
Q 043074           77 LIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLD  152 (373)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  152 (373)
                      +....++|++.+.||+|+||.||++..+ +++.+|+|.+.+...   .....+.+|+.+++.++||||+++++++.++..
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3445679999999999999999999765 688999999864322   223457789999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++||||+++|+|.+++....                +++..+..++.|++.||.|||  +++|+||||||+||+++.++
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~~----------------~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NIll~~~~  179 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNYD----------------VPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSG  179 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhcC----------------CCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEECCCC
Confidence            999999999999999987543                788888999999999999999  89999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCcccccccccccccCccccCCC---CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN---TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      .+||+|||+++..............||+.|+|||++.+.   ..++.++|||||||++|||++|..||.....       
T Consensus       180 ~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------  252 (371)
T cd05622         180 HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------  252 (371)
T ss_pred             CEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-------
Confidence            999999999987654333333456799999999998643   2368899999999999999999999754221       


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRE--RPAMSYVVQL  367 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~l~~~  367 (373)
                      .............       +.... ....+..+.+++.+|++.++.+  ||+++++++.
T Consensus       253 ~~~~~~i~~~~~~-------~~~~~-~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         253 VGTYSKIMNHKNS-------LTFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHHHHHHHcCCCc-------ccCCC-cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            1111111111000       00000 1234567899999999844433  7788888764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-41  Score=301.53  Aligned_cols=266  Identities=25%  Similarity=0.398  Sum_probs=200.3

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-----CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS--GLDRV  154 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  154 (373)
                      ++|++.+.||+|+||.||++..     .++..|++|.+........+.+.+|+.++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4788889999999999999964     3588999999977665556788999999999999999999998743  34678


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +|+||+++++|.+++.....              .+++..+..++.|++.||+|||  +++++||||||+||++++++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~--------------~l~~~~~~~~~~~l~~aL~~LH--~~~i~H~dlkp~nili~~~~~~  147 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRE--------------RLDHRKLLLYASQICKGMEYLG--SKRYVHRDLATRNILVESENRV  147 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCc--------------CCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHhhEEECCCCeE
Confidence            99999999999999975432              2889999999999999999999  8999999999999999999999


Q ss_pred             EEeeeccccccCCCCCcc--cccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCC-----Ccc
Q 043074          235 HISDFGLARRIDTSHSHV--STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDG-----QEV  307 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-----~~~  307 (373)
                      ||+|||++..........  .....++..|+|||.+.+ ..++.++||||||+++|||++|..|+......-     ...
T Consensus       148 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd05081         148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDK  226 (284)
T ss_pred             EECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccc
Confidence            999999998754322211  111223456999999874 447889999999999999999876643221110     000


Q ss_pred             cHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                      ...........      .+...... ..+..++.++.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       227 ~~~~~~~~~~~------~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         227 QGQMIVYHLIE------LLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             ccccchHHHHH------HHhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00000000000      00000000 11233456899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.1e-42  Score=302.01  Aligned_cols=262  Identities=25%  Similarity=0.413  Sum_probs=206.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||++.. .+++.+++|.+.....   .....+.+|+.+++.++||||+++++++.++...++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999975 4789999998865322   23457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++++|.+++.......           ..+++..++.++.|++.||.|||  +++++|+||+|+||+++.++.++|+
T Consensus        82 e~~~~~~L~~~~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~  148 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQK-----------RLIPEKTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLG  148 (267)
T ss_pred             EecCCCCHHHHHHHhhccC-----------CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEC
Confidence            9999999999987533211           13889999999999999999999  8999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||++........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|..|+.....     ....+.....
T Consensus       149 dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~  221 (267)
T cd08229         149 DLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIE  221 (267)
T ss_pred             cchhhhccccCCc-ccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhhhh
Confidence            9999876543221 12234688899999998744 478899999999999999999999653211     1111111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhC
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA  373 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~~  373 (373)
                            ....+..    .....+..+.+++.+||+.||.+|||+.+|++.++++.|
T Consensus       222 ------~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  267 (267)
T cd08229         222 ------QCDYPPL----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMHA  267 (267)
T ss_pred             ------cCCCCCC----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhcC
Confidence                  0001111    122356689999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.4e-42  Score=311.72  Aligned_cols=244  Identities=25%  Similarity=0.315  Sum_probs=190.3

Q ss_pred             CCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHH---hcCCCCCccceeeEEeeCCeeEEE
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETL---GKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      |++.+.||+|+||.||+|... +++.||+|.+.+...   ...+.+.+|+.++   +.++||||+++++++.++...++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567789999999999999754 689999999965431   2234566666554   566899999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++++|..++....                +++..+..++.|++.||.|||  +.+++||||||+||+++.++.+||
T Consensus        81 ~E~~~~~~L~~~~~~~~----------------l~~~~~~~~~~qi~~al~~lH--~~~ivHrdlkp~Nill~~~~~~kL  142 (324)
T cd05589          81 MEYAAGGDLMMHIHTDV----------------FSEPRAVFYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKI  142 (324)
T ss_pred             EcCCCCCcHHHHhhcCC----------------CCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCcEEe
Confidence            99999999998886432                899999999999999999999  799999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||+++..... ........|++.|+|||.+.+ ..++.++|||||||++|||++|..||.....       .......
T Consensus       143 ~Dfg~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~-------~~~~~~i  213 (324)
T cd05589         143 ADFGLCKEGMGF-GDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-------EEVFDSI  213 (324)
T ss_pred             CcccCCccCCCC-CCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHH
Confidence            999998753221 122334678999999999975 4578899999999999999999999753211       1111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                      ....       ..     .+...+..+.+++.+||+.||.+||     ++.++++
T Consensus       214 ~~~~-------~~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         214 VNDE-------VR-----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HhCC-------CC-----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            1100       00     1223456789999999999999999     4556554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.1e-42  Score=298.96  Aligned_cols=254  Identities=26%  Similarity=0.433  Sum_probs=199.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      ++|.+.+.||+|++|.||++..+.+..+++|.+..... ..+.+.+|+.+++.++|||++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            46888899999999999999887777899998865432 3356889999999999999999999875 456789999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +++|.+++......             .+++..+..++.|++.||.|||  +.+++|+||||+||++++++.++|+|||+
T Consensus        84 ~~~L~~~~~~~~~~-------------~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dl~~~Nill~~~~~~~l~dfg~  148 (260)
T cd05069          84 KGSLLDFLKEGDGK-------------YLKLPQLVDMAAQIADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGL  148 (260)
T ss_pred             CCCHHHHHhhCCCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCeEEECCCcc
Confidence            99999999764321             2789999999999999999999  78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      +...............++..|+|||...+ ...+.++||||||+++|||++ |..|+....    ......   ....  
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~---~~~~--  218 (260)
T cd05069         149 ARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMV----NREVLE---QVER--  218 (260)
T ss_pred             ceEccCCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHH---HHHc--
Confidence            97654332222223345678999998874 447889999999999999999 777754321    111111   1110  


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                          .....     .+...+..+.+++.+||+.||++||+++++++.|++.
T Consensus       219 ----~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  260 (260)
T cd05069         219 ----GYRMP-----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY  260 (260)
T ss_pred             ----CCCCC-----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                00011     1234466899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.2e-42  Score=307.23  Aligned_cols=265  Identities=20%  Similarity=0.340  Sum_probs=198.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|...+.||+|+||.||+|..+ +++.+|+|.+...... ....+.+|+.++++++||||+++++++..+...++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57888999999999999999764 6888999998654332 234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      ++ ++|.+++.....              .+++..+..++.|++.||+|||  +++++||||||+||+++.++.+||+||
T Consensus        86 ~~-~~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Df  148 (309)
T cd07872          86 LD-KDLKQYMDDCGN--------------IMSMHNVKIFLYQILRGLAYCH--RRKVLHRDLKPQNLLINERGELKLADF  148 (309)
T ss_pred             CC-CCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECcc
Confidence            96 588888765432              2788999999999999999999  799999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH---------H
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL---------L  310 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~---------~  310 (373)
                      |++........ ......+++.|+|||.+.+...++.++||||||+++|||++|..||............         .
T Consensus       149 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  227 (309)
T cd07872         149 GLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE  227 (309)
T ss_pred             ccceecCCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            99976433221 1223457889999999876666888999999999999999999987543221100000         0


Q ss_pred             HHHHHHHHhccccccccC-ccccc---cCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 EWARTMEARNKEIEMVDS-NISRE---ELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .|.....  .......+. .....   ......+.++.+++.+||+.||.+|||+.++++
T Consensus       228 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         228 TWPGISS--NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HHhhhcc--hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            1100000  000000000 00000   001223557899999999999999999999886

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9e-42  Score=303.49  Aligned_cols=270  Identities=26%  Similarity=0.396  Sum_probs=203.3

Q ss_pred             CCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      +|++.+.||+|+||.||+|...      ....+++|.+..... .....+.+|+.+++.++||||+++++.+......++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999642      235788888865443 234578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCc---------ccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCce
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDG---------SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV  226 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~---------~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Ni  226 (373)
                      ++||+.+++|.+++...........         ........++++..++.++.|++.||.|||  +.+++||||||+||
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~dikp~ni  158 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVHRDLAARNV  158 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH--HCCeehhhhhhheE
Confidence            9999999999999876432111000         000111235899999999999999999999  89999999999999


Q ss_pred             EeCCCCceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCC
Q 043074          227 LLDSDFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDG  304 (373)
Q Consensus       227 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~  304 (373)
                      ++++++.+||+|||+++........ ......++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....   
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---  234 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---  234 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence            9999999999999999865332221 1222345678999998864 447889999999999999998 877753211   


Q ss_pred             CcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhC
Q 043074          305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA  373 (373)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~~  373 (373)
                       ...+.++   ...      .....     .+..++..+.+++.+||+.+|++||++.++++.|++++.
T Consensus       235 -~~~~~~~---~~~------~~~~~-----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         235 -PERLFNL---LKT------GYRME-----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -HHHHHHH---HhC------CCCCC-----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence             1111111   110      00111     123345689999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-42  Score=304.36  Aligned_cols=251  Identities=25%  Similarity=0.287  Sum_probs=197.1

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      +|+..+.||+|+||.||++... +++.||+|.+......   ....+.+|+.+++.++||||+++++.+.++...++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4777889999999999999754 6899999998654322   23456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++|+|.+++......             .+++..+..++.|++.||.|||  +.+++||||||+||++++++.++|+|
T Consensus        81 ~~~~~~L~~~~~~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~D  145 (285)
T cd05605          81 LMNGGDLKFHIYNMGNP-------------GFDEERAVFYAAEITCGLEDLH--RERIVYRDLKPENILLDDYGHIRISD  145 (285)
T ss_pred             ccCCCcHHHHHHhcCcC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHEEECCCCCEEEee
Confidence            99999999988654321             2889999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||++.......  ......|++.|+|||.+.+ ..++.++||||+|+++|||++|..||.......   ...........
T Consensus       146 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~  219 (285)
T cd05605         146 LGLAVEIPEGE--TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKE  219 (285)
T ss_pred             CCCceecCCCC--ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhh
Confidence            99997653221  1233468999999999974 447889999999999999999999975422110   00111111100


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                             ...     ..+...+..+.+++.+||+.||++||     +++++++
T Consensus       220 -------~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         220 -------DQE-----EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             -------ccc-----ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence                   000     11233456889999999999999999     7778754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.7e-41  Score=296.39  Aligned_cols=246  Identities=28%  Similarity=0.412  Sum_probs=193.4

Q ss_pred             eeecCCCceEEEEEe---CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCC
Q 043074           89 IIGDGSFGFVYKAKL---SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENG  163 (373)
Q Consensus        89 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  163 (373)
                      .||+|+||.||+|.+   .++..+|+|+++....  ...+.+.+|+.+++.++||||+++++++. ....++|+||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999964   3578899999865432  23467889999999999999999999875 45678999999999


Q ss_pred             CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecccc
Q 043074          164 SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR  243 (373)
Q Consensus       164 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  243 (373)
                      +|.+++....               .+++..+..++.|++.||+|||  +++++||||||+||+++.++.+||+|||++.
T Consensus        81 ~L~~~l~~~~---------------~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~  143 (257)
T cd05116          81 PLNKFLQKNK---------------HVTEKNITELVHQVSMGMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSK  143 (257)
T ss_pred             cHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchhhEEEcCCCeEEECCCcccc
Confidence            9999997543               2889999999999999999999  8999999999999999999999999999998


Q ss_pred             ccCCCCCcc--cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          244 RIDTSHSHV--STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       244 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      .........  .....++..|+|||.+.+ ..++.++|+||||+++|||++ |..||.....       ..+....... 
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~i~~~-  214 (257)
T cd05116         144 ALGADENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-------NEVTQMIESG-  214 (257)
T ss_pred             ccCCCCCeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCC-
Confidence            764332211  112234578999998863 457889999999999999998 8888643211       1122211111 


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                      ..     .     ..+..++.++.+++.+||+.||++||++.+|.+.|++.
T Consensus       215 ~~-----~-----~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         215 ER-----M-----ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CC-----C-----CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            00     0     11333556899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.9e-42  Score=317.52  Aligned_cols=274  Identities=30%  Similarity=0.412  Sum_probs=205.4

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCcccccc-HHHHHHHHHHHhcCC-CCCccceeeEEeeCC
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQG-FREFRAEMETLGKLR-HRNIVKILGYCASGL  151 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  151 (373)
                      ..++|.+.+.||+|+||.||+|.+.      ++..||+|+++...... ...+.+|+.++.++. ||||+++++++.+..
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3456788899999999999999753      34689999997643332 346889999999997 999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCC------------------------------------------------------
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDD------------------------------------------------------  177 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~------------------------------------------------------  177 (373)
                      ..++|+||+++|+|.++++.......                                                      
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            99999999999999999976532100                                                      


Q ss_pred             -----------------------------CCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe
Q 043074          178 -----------------------------VDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL  228 (373)
Q Consensus       178 -----------------------------~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill  228 (373)
                                                   ............+++...+.++.|++.||+|||  +++++||||||+||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrdlkp~NiLl  272 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA--SKNCVHRDLAARNVLI  272 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCcCcccCCcceEEE
Confidence                                         000000112234788999999999999999999  7899999999999999


Q ss_pred             CCCCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCc
Q 043074          229 DSDFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQE  306 (373)
Q Consensus       229 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~  306 (373)
                      ++++.+||+|||+++....... .......++..|+|||.+.+ ..++.++||||||+++|||++ |..|+......   
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~---  348 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN---  348 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch---
Confidence            9999999999999986432211 11222356788999999874 447889999999999999998 77775321110   


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhC
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA  373 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~~  373 (373)
                          +........+     ....     .+..++.++.+++.+||+.+|.+||++++|++.|+++++
T Consensus       349 ----~~~~~~~~~~-----~~~~-----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~~  401 (401)
T cd05107         349 ----EQFYNAIKRG-----YRMA-----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLLT  401 (401)
T ss_pred             ----HHHHHHHHcC-----CCCC-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhC
Confidence                0001111100     0000     122345689999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-43  Score=320.75  Aligned_cols=252  Identities=23%  Similarity=0.267  Sum_probs=193.2

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|.+.+.||+|+||.||++.. .+++.||+|++.+...   .....+.+|+++++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4788899999999999999965 4789999999865322   23456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++....               .+++..+..++.|++.||+|||  +.+++||||||+|||++.++.+||+
T Consensus        81 E~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~ql~~aL~~LH--~~givHrDlkp~NIll~~~~~~kl~  143 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---------------TFSEDVTRFYMAECVLAIEAVH--KLGFIHRDIKPDNILIDRGGHIKLS  143 (377)
T ss_pred             eCCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEEe
Confidence            9999999999997543               2888999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCCc----------------------------------------------ccccccccccccCccccCCC
Q 043074          238 DFGLARRIDTSHSH----------------------------------------------VSTQVAGTMGYMPPEYLGGN  271 (373)
Q Consensus       238 Dfg~~~~~~~~~~~----------------------------------------------~~~~~~g~~~y~aPE~~~~~  271 (373)
                      |||+++.+......                                              ......||+.|+|||++.+ 
T Consensus       144 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  222 (377)
T cd05629         144 DFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-  222 (377)
T ss_pred             ecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-
Confidence            99999643211000                                              0012468999999999975 


Q ss_pred             CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhc
Q 043074          272 TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCT  351 (373)
Q Consensus       272 ~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  351 (373)
                      ..++.++|||||||++|||++|..||......       +..........       .+.... ....+.++.+++.+|+
T Consensus       223 ~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~-------~~~~p~-~~~~s~~~~dli~~lL  287 (377)
T cd05629         223 QGYGQECDWWSLGAIMFECLIGWPPFCSENSH-------ETYRKIINWRE-------TLYFPD-DIHLSVEAEDLIRRLI  287 (377)
T ss_pred             CCCCCceeeEecchhhhhhhcCCCCCCCCCHH-------HHHHHHHccCC-------ccCCCC-CCCCCHHHHHHHHHHh
Confidence            45788999999999999999999997532211       10111110000       000000 1123457889999999


Q ss_pred             CCCCCCC---CCHHHHHHH
Q 043074          352 NEKSRER---PAMSYVVQL  367 (373)
Q Consensus       352 ~~~p~~R---Ps~~~l~~~  367 (373)
                      + +|.+|   |++.+++..
T Consensus       288 ~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         288 T-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             c-CHhhcCCCCCHHHHhcC
Confidence            7 66665   588887753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-42  Score=323.38  Aligned_cols=267  Identities=22%  Similarity=0.310  Sum_probs=192.0

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeC--------
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASG--------  150 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------  150 (373)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++....    ....+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            356899999999999999999976 468999999885432    2335799999999999999999876432        


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      ...++||||++ ++|.+++.......           ..+++..+..++.|++.||+|||  +.+|+||||||+|||++.
T Consensus       140 ~~l~lvmE~~~-~~l~~~~~~~~~~~-----------~~l~~~~~~~~~~qi~~gL~yLH--~~~IiHrDLKp~NILl~~  205 (440)
T PTZ00036        140 IFLNVVMEFIP-QTVHKYMKHYARNN-----------HALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDP  205 (440)
T ss_pred             eEEEEEEecCC-ccHHHHHHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCcCHHHEEEcC
Confidence            24568999996 57877775432211           13889999999999999999999  789999999999999986


Q ss_pred             CC-ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          231 DF-EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       231 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      ++ .+||+|||+++......  ......||+.|+|||++.+...++.++|||||||++|||++|.+||............
T Consensus       206 ~~~~vkL~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  283 (440)
T PTZ00036        206 NTHTLKLCDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI  283 (440)
T ss_pred             CCCceeeeccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            64 79999999998654322  2223567999999999876667899999999999999999999987543221100000


Q ss_pred             HHHH-----HHHHHhcccccc-----ccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 LEWA-----RTMEARNKEIEM-----VDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 ~~~~-----~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....     ............     +...-....++...+.++.+++.+||+.||.+|||+.++++
T Consensus       284 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            0000     000000000000     00000001112234568999999999999999999999874

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.4e-42  Score=304.96  Aligned_cols=273  Identities=29%  Similarity=0.435  Sum_probs=205.5

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCC
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASGL  151 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  151 (373)
                      ..++|+..+.||+|+||.||++...      +...+++|.+..... .....+.+|+.++.++ +|+||+++++++..+.
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            3457888899999999999999753      236789999865432 2345688999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCccc-ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      ..+++|||+++|+|.+++............. .......+++..++.++.|++.||+|||  +++++||||||+||++++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA--SKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCccccccceeeEEEcC
Confidence            9999999999999999997653211111100 0012234899999999999999999999  799999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCccc
Q 043074          231 DFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVG  308 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~  308 (373)
                      ++.+||+|||+++........ ......++..|+|||.+.+ ..++.++|||||||++|||++ |..|+.....      
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------  240 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------  240 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCH------
Confidence            999999999999875433211 1122334678999999864 457889999999999999998 7777532111      


Q ss_pred             HHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhC
Q 043074          309 LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA  373 (373)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~~  373 (373)
                       .+....... ..     ..     ..+..++..+.+++.+||+.||++|||+.++++.|++++.
T Consensus       241 -~~~~~~~~~-~~-----~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~~  293 (293)
T cd05053         241 -EELFKLLKE-GY-----RM-----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRMLT  293 (293)
T ss_pred             -HHHHHHHHc-CC-----cC-----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhhC
Confidence             111111110 00     00     0123345689999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-41  Score=300.78  Aligned_cols=265  Identities=25%  Similarity=0.429  Sum_probs=200.9

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLD  152 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  152 (373)
                      ..++|++.+.||+|+||.||+|...      ++..+|+|.+..... .....+.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3567999999999999999998643      356799999864332 234568899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++|+||+++++|.+++..........     ....++++..++.++.|++.||.|||  +.+++|+||||+||++++++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENN-----PVQAPPSLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDF  156 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCcccccc-----ccccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCcchheEEEcCCC
Confidence            999999999999999997643221100     00113788999999999999999999  78999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHH
Q 043074          233 EAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~  310 (373)
                      .++|+|||+++........ ......++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....       ..
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-------~~  228 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-------NE  228 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HH
Confidence            9999999998765332211 1122345778999999874 457889999999999999999 566653211       11


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                      ........ ...          ...+..++..+.+++.+||+.||++||++.++++.|++
T Consensus       229 ~~~~~~~~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         229 QVLRFVME-GGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHHHHc-CCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            11111111 000          01123345689999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=305.87  Aligned_cols=256  Identities=23%  Similarity=0.251  Sum_probs=196.1

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||++... +++.||+|++.+...   ...+.+.+|+.++..++|+||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999999764 689999999865321   22345788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.+...              .+++..+..++.|++.||+|||  +++++||||||+|||++.++.+||+
T Consensus        81 e~~~g~~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~  144 (331)
T cd05597          81 DYYVGGDLLTLLSKFED--------------RLPEDMARFYLAEMVLAIDSVH--QLGYVHRDIKPDNVLLDKNGHIRLA  144 (331)
T ss_pred             ecCCCCcHHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeEECCCCHHHEEECCCCCEEEE
Confidence            99999999999976432              2888999999999999999999  8999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |||++...............||+.|+|||++.+    ...++.++|||||||++|||++|..||....       ..+..
T Consensus       145 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~-------~~~~~  217 (331)
T cd05597         145 DFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETY  217 (331)
T ss_pred             ECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC-------HHHHH
Confidence            999997654433322333568999999999863    3456789999999999999999999975421       11111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCC--CCCCHHHHHHH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSR--ERPAMSYVVQL  367 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~--~RPs~~~l~~~  367 (373)
                      ...........     +  .......+..+.+++.+|+..+++  .||+++++++.
T Consensus       218 ~~i~~~~~~~~-----~--~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         218 GKIMNHKEHFQ-----F--PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHHcCCCccc-----C--CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            11111110000     0  000112455788899988865433  37888888753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.1e-42  Score=300.68  Aligned_cols=256  Identities=29%  Similarity=0.505  Sum_probs=201.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CC---CEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SG---VTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ++|+..+.||+|+||.||+|... ++   ..+++|.+..... ...+.+.+|+++++.++|||++++.+++.+....++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46778899999999999999764 23   3689998865432 2345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++++|.+++.....              .+++.++..++.|++.|++|||  +.+++|+||||+||++++++.+||
T Consensus        85 ~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nili~~~~~~kl  148 (268)
T cd05063          85 TEYMENGALDKYLRDHDG--------------EFSSYQLVGMLRGIAAGMKYLS--DMNYVHRDLAARNILVNSNLECKV  148 (268)
T ss_pred             EEcCCCCCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEEcCCCcEEE
Confidence            999999999999975432              2889999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccc--cccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          237 SDFGLARRIDTSHSHVST--QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +|||++............  ....+..|+|||.+.+ ..++.++||||||+++|||++ |..|+.....       .++.
T Consensus       149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~~~  220 (268)
T cd05063         149 SDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HEVM  220 (268)
T ss_pred             CCCccceecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHHH
Confidence            999999866433222111  1223457999999874 447889999999999999997 8888643211       1111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ......          .... .+.+++..+.+++.+||+.+|++||++.++++.|++++
T Consensus       221 ~~i~~~----------~~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         221 KAINDG----------FRLP-APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             HHHhcC----------CCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            111110          0011 12344668999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.2e-41  Score=299.33  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=197.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|+..+.||+|+||.||+|.. .++..+|+|.+..... ...+.+.+|++++.+++||||+++++++......++|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999965 5789999999865432 2345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|..+.                   .+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.++|+||
T Consensus        81 ~~~~~l~~~~-------------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nill~~~~~~~l~df  139 (279)
T cd06619          81 MDGGSLDVYR-------------------KIPEHVLGRIAVAVVKGLTYLW--SLKILHRDVKPSNMLVNTRGQVKLCDF  139 (279)
T ss_pred             CCCCChHHhh-------------------cCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCCHHHEEECCCCCEEEeeC
Confidence            9999997652                   1778889999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++......   ......++..|+|||.+.+. .++.++|+||||+++|+|++|..|+..............+...... 
T Consensus       140 g~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  214 (279)
T cd06619         140 GVSTQLVNS---IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-  214 (279)
T ss_pred             Ccceecccc---cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-
Confidence            999765432   22335688999999999754 4788999999999999999999997653322211111111111100 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                           .....+.    ....+.++.+++.+||+.||.+||+++++++.
T Consensus       215 -----~~~~~~~----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         215 -----EDPPVLP----VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -----cCCCCCC----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                 0011111    11234578999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.1e-42  Score=297.25  Aligned_cols=247  Identities=26%  Similarity=0.385  Sum_probs=192.4

Q ss_pred             CeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCH
Q 043074           88 KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL  165 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  165 (373)
                      +.||+|+||.||+|... +++.+|+|.+..... .....+.+|++++++++||||+++++++......++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999764 788999998765432 2345789999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecccccc
Q 043074          166 DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI  245 (373)
Q Consensus       166 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  245 (373)
                      .+++.....              .+++.+++.++.|++.||.|||  +++++|+||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~~~~~~--------------~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  144 (252)
T cd05084          81 LTFLRTEGP--------------RLKVKELIQMVENAAAGMEYLE--SKHCIHRDLAARNCLVTEKNVLKISDFGMSREE  144 (252)
T ss_pred             HHHHHhCCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEEcCCCcEEECccccCccc
Confidence            999875432              2889999999999999999999  889999999999999999999999999998764


Q ss_pred             CCCCCcc-cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhcccc
Q 043074          246 DTSHSHV-STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARNKEI  323 (373)
Q Consensus       246 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (373)
                      ....... ......+..|+|||.+.+. .++.++||||||+++|||++ |..|+.....       .........     
T Consensus       145 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-------~~~~~~~~~-----  211 (252)
T cd05084         145 EDGVYASTGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSN-------QQTREAIEQ-----  211 (252)
T ss_pred             ccccccccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCH-------HHHHHHHHc-----
Confidence            3211111 1111234579999998754 47889999999999999998 6666532111       011111110     


Q ss_pred             ccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          324 EMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                           .... ..+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus       212 -----~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         212 -----GVRL-PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             -----CCCC-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence                 0000 113344668999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2e-42  Score=316.95  Aligned_cols=200  Identities=29%  Similarity=0.424  Sum_probs=171.2

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|+..+.||+|+||.||++... +++.||+|++.+...   .....+.+|+.++..++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47888999999999999999654 689999999965432   22356788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++....               ++++..+..++.|++.||+|||  +++|+||||||+|||++.++.+||+
T Consensus        81 E~~~gg~L~~~l~~~~---------------~l~~~~~~~~~~qi~~aL~~lH--~~givHrDlKp~NILi~~~~~vkL~  143 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---------------TLTEEETQFYIAETVLAIDSIH--QLGFIHRDIKPDNLLLDSKGHVKLS  143 (363)
T ss_pred             cCCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCCEEEe
Confidence            9999999999997643               2899999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCC----------------------------------cccccccccccccCccccCCCCCCCccccchhh
Q 043074          238 DFGLARRIDTSHS----------------------------------HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSF  283 (373)
Q Consensus       238 Dfg~~~~~~~~~~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Diwsl  283 (373)
                      |||+++.......                                  .......||+.|+|||++.+. .++.++|||||
T Consensus       144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSl  222 (363)
T cd05628         144 DFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSL  222 (363)
T ss_pred             eccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhh
Confidence            9999875432110                                  001235799999999999754 47889999999


Q ss_pred             hHHHHHHHhCCCCCCC
Q 043074          284 GILMIEIATQIRPNLP  299 (373)
Q Consensus       284 G~~l~el~~g~~p~~~  299 (373)
                      ||++|||++|..||..
T Consensus       223 Gvil~ell~G~~Pf~~  238 (363)
T cd05628         223 GVIMYEMLIGYPPFCS  238 (363)
T ss_pred             HHHHHHHHhCCCCCCC
Confidence            9999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-41  Score=303.72  Aligned_cols=272  Identities=22%  Similarity=0.403  Sum_probs=201.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-----------------CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccc
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-----------------SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVK  142 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~  142 (373)
                      .++|++.+.||+|+||.||++...                 ++..+|+|.+...... ....+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357899999999999999998532                 2346899998754332 3457889999999999999999


Q ss_pred             eeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCC
Q 043074          143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIK  222 (373)
Q Consensus       143 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk  222 (373)
                      +++++......++++||+++++|.+++..........    ......+++.++..++.|++.||+|||  +.+++|+|||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dlk  157 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE----KADVVTISYSTLIFMATQIASGMKYLS--SLNFVHRDLA  157 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccc----cccccccCHHHHHHHHHHHHHHHHHHH--HCCeecccCC
Confidence            9999999999999999999999999998754322111    111223889999999999999999999  7899999999


Q ss_pred             CCceEeCCCCceEEeeeccccccCCCCCcc-cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh--CCCCCCC
Q 043074          223 SSNVLLDSDFEAHISDFGLARRIDTSHSHV-STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT--QIRPNLP  299 (373)
Q Consensus       223 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~--g~~p~~~  299 (373)
                      |+||++++++.++|+|||+++......... .....++..|+|||...+. .++.++|+|||||++|||++  |..|+..
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            999999999999999999998653322111 1223346789999987643 47889999999999999998  5566533


Q ss_pred             cccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                      ....    ............... ...     ... +..++..+.+++.+||+.||++||++.+|++.|++
T Consensus       237 ~~~~----~~~~~~~~~~~~~~~-~~~-----~~~-~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         237 LSDE----QVIENTGEFFRDQGR-QVY-----LPK-PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             cChH----HHHHHHHHHHhhccc-ccc-----CCC-CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            2111    111111111110000 000     000 22345789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-41  Score=300.93  Aligned_cols=255  Identities=22%  Similarity=0.358  Sum_probs=195.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCC----EEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGV----TVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ++|+..+.||+|+||.||+|.+. ++.    .+++|.+...... ....+..|+..+..++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46778899999999999999763 344    4777877543322 24567788889999999999999998764 45778


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ++||+++|+|.+++.....              .+++..+..++.|++.||.|||  +++++|+||||+||++++++.+|
T Consensus        86 i~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~k  149 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRD--------------SLDPQRLLNWCVQIAKGMYYLE--EHRMVHRNLAARNILLKSDSIVQ  149 (279)
T ss_pred             EEEeCCCCcHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEE
Confidence            9999999999999976442              2899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          236 ISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |+|||+++........ ......++..|+|||.+.+ ..++.++||||||+++|||++ |..|+.....    ....+. 
T Consensus       150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~~~-  223 (279)
T cd05111         150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEVPDL-  223 (279)
T ss_pred             EcCCccceeccCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH-
Confidence            9999999865432221 2233456778999999874 447889999999999999998 8887643211    111111 


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                         ...+...  .        .+..++..+.+++.+||+.||++||++.++++.|..+.
T Consensus       224 ---~~~~~~~--~--------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         224 ---LEKGERL--A--------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             ---HHCCCcC--C--------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence               1111110  0        01223457889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-41  Score=296.85  Aligned_cols=259  Identities=26%  Similarity=0.452  Sum_probs=198.0

Q ss_pred             CCCCCeeecCCCceEEEEEeC----CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe-----
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLD-----  152 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  152 (373)
                      |.+.+.||+|+||.||+|...    .+..||+|.+.....  .....+.+|+..++.++|||++++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567889999999999999754    246799999865432  234578899999999999999999998866544     


Q ss_pred             -eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          153 -RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       153 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                       .++++||+++|+|..++........         ...+++..+..++.|++.||.|||  +.+++||||||+||+++++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~---------~~~~~~~~~~~~~~~i~~aL~~lH--~~~i~H~dlkp~Nil~~~~  149 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGL---------PEKLPLQTLLKFMVDIALGMEYLS--NRNFIHRDLAARNCMLRED  149 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCC---------cccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchheEEECCC
Confidence             7899999999999999865432110         113889999999999999999999  7899999999999999999


Q ss_pred             CceEEeeeccccccCCCCCcc-cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccH
Q 043074          232 FEAHISDFGLARRIDTSHSHV-STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~  309 (373)
                      +.+||+|||+++......... .....++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....    .   
T Consensus       150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~----~---  221 (273)
T cd05035         150 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVE----N---  221 (273)
T ss_pred             CeEEECCccceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC----H---
Confidence            999999999998754332211 122334678999999864 457889999999999999999 666653211    1   


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .+....... ..     ...     .+..++..+.+++.+||+.||++||++.++++.|++++
T Consensus       222 ~~~~~~~~~-~~-----~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         222 HEIYDYLRH-GN-----RLK-----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             HHHHHHHHc-CC-----CCC-----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            111111111 00     011     13344668999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.3e-42  Score=308.23  Aligned_cols=240  Identities=25%  Similarity=0.326  Sum_probs=187.7

Q ss_pred             CeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||+|... +++.||+|.+.....   ...+.+..|..++... +||||+++++++..+...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999764 688999999865432   2234455667776654 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|.+++.....               +++..+..++.|++.||.|||  +++++||||||+||+++.++.+||+|||++
T Consensus        81 g~L~~~~~~~~~---------------~~~~~~~~~~~qi~~al~~LH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a  143 (316)
T cd05592          81 GDLMFHIQSSGR---------------FDEARARFYAAEIICGLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMC  143 (316)
T ss_pred             CcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHeEECCCCCEEEccCcCC
Confidence            999999876432               888999999999999999999  799999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE  322 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (373)
                      +...... .......||+.|+|||.+.+. .++.++|||||||++|||++|..||.....       .........   .
T Consensus       144 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~---~  211 (316)
T cd05592         144 KENMNGE-GKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDE-------DELFDSILN---D  211 (316)
T ss_pred             eECCCCC-CccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHc---C
Confidence            7643222 223345789999999999754 478899999999999999999999754211       111111110   0


Q ss_pred             cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 043074          323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMS-YVV  365 (373)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~l~  365 (373)
                          .+     ..+...+.++.+++.+||+.||++||++. +++
T Consensus       212 ----~~-----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         212 ----RP-----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             ----CC-----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                01     11233455789999999999999999975 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.7e-42  Score=305.07  Aligned_cols=259  Identities=30%  Similarity=0.440  Sum_probs=201.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASGLD  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  152 (373)
                      .++|.+.+.||+|+||.||++...      ++..+|+|.++.... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            357888999999999999999641      345799999875433 2345688999999999 79999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++++||+++|+|.+++......             .+++.++..++.|++.||.|||  +++++|+||||+||+++.++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~-------------~l~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~  178 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRES-------------FLTLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNVLLTHGK  178 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCeehhhhccceEEEcCCC
Confidence            99999999999999999754321             2789999999999999999999  78999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHH
Q 043074          233 EAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~  310 (373)
                      .++++|||+++........ ......++..|+|||.+.+. .++.++||||||+++|||++ |..|+.......      
T Consensus       179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------  251 (302)
T cd05055         179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------  251 (302)
T ss_pred             eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------
Confidence            9999999999865432211 11223456789999998744 47889999999999999998 888754322110      


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ...... ...     ....     .+...+.++.+++.+||+.+|++||++.++++.|++++
T Consensus       252 ~~~~~~-~~~-----~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         252 KFYKLI-KEG-----YRMA-----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             HHHHHH-HcC-----CcCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence            011111 000     0000     01223458999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-41  Score=296.84  Aligned_cols=241  Identities=22%  Similarity=0.384  Sum_probs=187.4

Q ss_pred             CeeecCCCceEEEEEeCC-------------CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           88 KIIGDGSFGFVYKAKLSS-------------GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      +.||+|+||.||+|...+             ...+++|.+..........+.+|+.++..++||||+++++++.+....+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999997532             2358889887655544557888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc-
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE-  233 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~-  233 (373)
                      +++||+++|+|..++.....              ++++..+++++.|++.||+|||  +++++||||||+||+++.++. 
T Consensus        81 lv~e~~~~~~l~~~~~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~  144 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSD--------------VLTTPWKFKVAKQLASALSYLE--DKDLVHGNVCTKNILLAREGID  144 (262)
T ss_pred             EEEecccCCCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHhh--hCCeECCCCCcccEEEecCCcc
Confidence            99999999999998875432              2889999999999999999999  799999999999999987654 


Q ss_pred             ------eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCc
Q 043074          234 ------AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQE  306 (373)
Q Consensus       234 ------~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~  306 (373)
                            ++++|||++......     ....++..|+|||.+.+...++.++|||||||++|||++ |..|+....     
T Consensus       145 ~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----  214 (262)
T cd05077         145 GECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-----  214 (262)
T ss_pred             CCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-----
Confidence                  899999998754321     224577889999998755668889999999999999985 666643211     


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                        ..+.. ....  ...     ..     ....+.++.+++.+||+.||.+||++.+|++.|+
T Consensus       215 --~~~~~-~~~~--~~~-----~~-----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         215 --LAEKE-RFYE--GQC-----ML-----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             --hhHHH-HHHh--cCc-----cC-----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence              11110 0000  000     00     1112357899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.7e-41  Score=293.06  Aligned_cols=247  Identities=27%  Similarity=0.401  Sum_probs=195.1

Q ss_pred             CeeecCCCceEEEEEeCCCCEEEEEEeCcccccc-HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCHH
Q 043074           88 KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLD  166 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  166 (373)
                      +.||+|+||.||+|...++..+|+|.+....... ...+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3689999999999988888999999986654332 346889999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccC
Q 043074          167 QWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID  246 (373)
Q Consensus       167 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  246 (373)
                      +++.....              .+++..+..++.|++.||.|+|  +++++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  144 (250)
T cd05085          81 SFLRKKKD--------------ELKTKQLVKFALDAAAGMAYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSRQED  144 (250)
T ss_pred             HHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeecccChheEEEcCCCeEEECCCccceecc
Confidence            99865432              2789999999999999999999  8999999999999999999999999999987643


Q ss_pred             CCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhcccccc
Q 043074          247 TSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARNKEIEM  325 (373)
Q Consensus       247 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (373)
                      ...........++..|+|||.+.+ ..++.++||||||+++|++++ |..|+.....       ......... .     
T Consensus       145 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-------~~~~~~~~~-~-----  210 (250)
T cd05085         145 DGIYSSSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTN-------QQAREQVEK-G-----  210 (250)
T ss_pred             ccccccCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHHc-C-----
Confidence            322211222334567999999874 457889999999999999998 7777643211       111111111 0     


Q ss_pred             ccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          326 VDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       326 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                      ...     ..+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus       211 ~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         211 YRM-----SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCC-----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            000     112234568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.7e-42  Score=311.59  Aligned_cols=242  Identities=22%  Similarity=0.284  Sum_probs=191.6

Q ss_pred             CeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCC
Q 043074           88 KIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENG  163 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  163 (373)
                      +.||+|+||.||++.. .+++.||+|.+.+...   .....+.+|+.++..++||||+++.+++.+....++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999965 4789999999965432   22345678999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecccc
Q 043074          164 SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR  243 (373)
Q Consensus       164 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  243 (373)
                      +|..++....               .+++..+..++.||+.||.|||+ ..+++||||||+|||++.++.+||+|||+++
T Consensus        81 ~L~~~l~~~~---------------~l~~~~~~~~~~qi~~aL~~lH~-~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~  144 (325)
T cd05594          81 ELFFHLSRER---------------VFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCK  144 (325)
T ss_pred             cHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCCCCeEEECCCCCEEEecCCCCe
Confidence            9999887543               28999999999999999999993 2789999999999999999999999999987


Q ss_pred             ccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcccc
Q 043074          244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEI  323 (373)
Q Consensus       244 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (373)
                      ...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||......       ........ .   
T Consensus       145 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~~~~~i~~-~---  211 (325)
T cd05594         145 EGIKDG-ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILM-E---  211 (325)
T ss_pred             ecCCCC-cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHH-------HHHHHHhc-C---
Confidence            532221 122345689999999999754 5788999999999999999999997542111       11111100 0   


Q ss_pred             ccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          324 EMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                         ...+     +...+.++.+++.+||+.||++|+     ++.++++
T Consensus       212 ---~~~~-----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         212 ---EIRF-----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             ---CCCC-----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence               0011     222345789999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.4e-41  Score=301.32  Aligned_cols=267  Identities=23%  Similarity=0.351  Sum_probs=201.2

Q ss_pred             CCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCcccccc-HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      +|.+.+.||+|+||.||+|...      ++..||+|.+....... .+.+.+|+.++..++||||+++++++.+....++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4666788999999999999753      25789999997554332 3568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcc-cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGS-KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      ++||+.+++|.+++............ ........+++..+.+++.|++.||.|||  +++++||||||+||++++++.+
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH--~~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HcCccccccchhheEecCCCce
Confidence            99999999999998644321111100 00111224888999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHH
Q 043074          235 HISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  312 (373)
                      ||+|||+++....... .......+++.|+|||.+.+. .++.++||||||+++|||++ |..|+...       ...++
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~-------~~~~~  235 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGY-------SNQDV  235 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCC-------CHHHH
Confidence            9999999886533221 112233457789999998643 47889999999999999998 66664321       11122


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                      ........ .          ...+..++..+.+++.+||+.+|.+||++++|+..|++
T Consensus       236 ~~~i~~~~-~----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEMIRNRQ-V----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHcCC-c----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            22111110 0          01133456789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3e-41  Score=302.12  Aligned_cols=272  Identities=28%  Similarity=0.414  Sum_probs=205.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe--------CCCCEEEEEEeCccc-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeC
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL--------SSGVTVAIKKLDKDA-FQGFREFRAEMETLGKL-RHRNIVKILGYCASG  150 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  150 (373)
                      .++|.+.+.||+|+||.||++..        .++..+++|.+.... ....+.+.+|+..+..+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            45788889999999999999963        134579999886543 23356788999999999 799999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCc-ccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDG-SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      ...+++|||+++|+|.+++........... .........+++.+++.++.|++.||.|||  +++++||||||+||+++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Nili~  171 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA--SQKCIHRDLAARNVLVT  171 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH--HCCeeecccccceEEEc
Confidence            999999999999999999987543211100 000001124889999999999999999999  78999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcc
Q 043074          230 SDFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEV  307 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~  307 (373)
                      +++.+||+|||+++........ ......+++.|+|||.+.+ ..++.++||||||+++|||++ |..|+...       
T Consensus       172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~-------  243 (304)
T cd05101         172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-------  243 (304)
T ss_pred             CCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccC-------
Confidence            9999999999999876432222 1222345678999999875 447889999999999999998 56664221       


Q ss_pred             cHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhC
Q 043074          308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA  373 (373)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~~  373 (373)
                      ...++.........           ...+..++..+.+++.+||+.+|.+||++.++++.|+++++
T Consensus       244 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         244 PVEELFKLLKEGHR-----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             CHHHHHHHHHcCCc-----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            11122221111100           00123456689999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.7e-41  Score=302.60  Aligned_cols=268  Identities=27%  Similarity=0.426  Sum_probs=200.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCC-C--CEEEEEEeCccc-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSS-G--VTVAIKKLDKDA-FQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~-~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ++|++.+.||+|+||.||+|..++ +  ..+++|.++... ....+.+.+|+.++.++ +||||+++++++.+....+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578889999999999999997643 3  347888876432 23345788999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcc-cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGS-KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      +||+++++|.+++............ ........+++..++.++.|++.||+|||  +++++||||||+||++++++.+|
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS--EKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999764422111000 00011224889999999999999999999  79999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      |+|||++.......  .......+..|+|||.+.+ ..++.++|||||||++|||++ |..||.....       .+...
T Consensus       160 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-------~~~~~  229 (297)
T cd05089         160 IADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-------AELYE  229 (297)
T ss_pred             ECCcCCCcccccee--ccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH
Confidence            99999986432111  1111223457999999874 447889999999999999998 8888643221       11111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ....      .....     .+..++..+.+++.+||+.+|.+||++.++++.|++++
T Consensus       230 ~~~~------~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         230 KLPQ------GYRME-----KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             HHhc------CCCCC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1110      01111     12234568999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.7e-42  Score=322.80  Aligned_cols=257  Identities=24%  Similarity=0.306  Sum_probs=201.1

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCC----
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGL----  151 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  151 (373)
                      ...++|.+.+.||+|+||.||++.. .+++.||+|.+.....  .....+.+|+..+..++|+|++++.+.+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3457999999999999999999964 4799999999865432  23456788999999999999999888764332    


Q ss_pred             ----eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceE
Q 043074          152 ----DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVL  227 (373)
Q Consensus       152 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nil  227 (373)
                          ..++||||+++|+|.+++.......           .++++..+..++.|++.||.|||  +++++||||||+|||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~-----------~~l~e~~~~~i~~qll~aL~~lH--~~~IiHrDLKP~NIL  175 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTN-----------RTFREHEAGLLFIQVLLAVHHVH--SKHMIHRDIKSANIL  175 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccC-----------CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEE
Confidence                3679999999999999997543211           13889999999999999999999  789999999999999


Q ss_pred             eCCCCceEEeeeccccccCCCC-CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          228 LDSDFEAHISDFGLARRIDTSH-SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       228 l~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                      ++.++.+||+|||+++...... ........||+.|+|||.+.+ ..++.++|||||||++|||++|..||....     
T Consensus       176 l~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----  249 (496)
T PTZ00283        176 LCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGEN-----  249 (496)
T ss_pred             EeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----
Confidence            9999999999999998754322 122334678999999999975 447889999999999999999999974321     


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                        ..+....... ..    .      ...+...+.++.+++.+||+.||.+||++.+++..
T Consensus       250 --~~~~~~~~~~-~~----~------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        250 --MEEVMHKTLA-GR----Y------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             --HHHHHHHHhc-CC----C------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence              1111111111 00    0      01133445689999999999999999999998763

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.5e-41  Score=299.18  Aligned_cols=264  Identities=25%  Similarity=0.404  Sum_probs=204.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCC-----CCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEee-CCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSS-----GVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCAS-GLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  153 (373)
                      .++|++.+.||+|+||.||+|...+     +..|++|.+..... .....+.+|+.++++++|||++++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4688889999999999999997654     68899998865432 234568899999999999999999998765 5678


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      +++++|+++++|.+++.........       ....+++.+++.++.|++.||+|||  +++++|+||||+||++++++.
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~di~p~nil~~~~~~  155 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEAN-------NPQALSTQQLVHMAIQIACGMSYLH--KRGVIHKDIAARNCVIDEELQ  155 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccc-------cccCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCHhhEEEcCCCc
Confidence            8999999999999999765432100       1123899999999999999999999  899999999999999999999


Q ss_pred             eEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHH
Q 043074          234 AHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  311 (373)
                      +||+|||+++.+...... ......++..|+|||.+.+ ..++.++||||||+++||+++ |..|+....    .   .+
T Consensus       156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~---~~  227 (280)
T cd05043         156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEID----P---FE  227 (280)
T ss_pred             EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCC----H---HH
Confidence            999999999865433221 1122345678999999874 447889999999999999999 888864321    1   11


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      +...... .     ..  .  .. ...++.++.+++.+||+.||++|||+.++++.|+++.
T Consensus       228 ~~~~~~~-~-----~~--~--~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         228 MAAYLKD-G-----YR--L--AQ-PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             HHHHHHc-C-----CC--C--CC-CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            1111111 0     00  0  01 2334568999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-41  Score=306.38  Aligned_cols=236  Identities=23%  Similarity=0.303  Sum_probs=187.9

Q ss_pred             CeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||+|..+ +++.||+|++.+..   ....+.+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999765 68899999986532   22345667888888776 699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|.+++.....               +++..+..++.|++.||+|||  +++++||||||+||+++.++.+||+|||++
T Consensus        81 g~L~~~i~~~~~---------------l~~~~~~~~~~ql~~~L~~lH--~~~ivH~dlkp~NIli~~~~~~kL~DfG~~  143 (320)
T cd05590          81 GDLMFHIQKSRR---------------FDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMC  143 (320)
T ss_pred             chHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeeCCCC
Confidence            999999876542               889999999999999999999  899999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE  322 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (373)
                      +...... .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||.....       ......... .. 
T Consensus       144 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~-~~-  212 (320)
T cd05590         144 KEGIFNG-KTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEAILN-DE-  212 (320)
T ss_pred             eecCcCC-CcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhc-CC-
Confidence            7542221 22334568999999999874 4578899999999999999999999753211       111111111 00 


Q ss_pred             cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                             .   ..+...+.++.+++.+||+.||.+||++
T Consensus       213 -------~---~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         213 -------V---VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -------C---CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence                   0   0122345578999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-41  Score=301.02  Aligned_cols=268  Identities=25%  Similarity=0.395  Sum_probs=201.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-----CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ++|++.+.||+|+||.||+|..     .++..+++|.+..... .....+.+|+.+++.++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999964     2467899999865333 334578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCccc--ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSK--QLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~--~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      +|||+++++|.+++.............  .......+++.+.+.++.|++.||.|||  +++++|+||||+||++++++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hcCeehhccccceEEEcCCCc
Confidence            999999999999986543211111000  0001123789999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHH
Q 043074          234 AHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  311 (373)
                      +||+|||+++....... .......++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....       ..
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------~~  234 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------QE  234 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence            99999999986533221 122233456789999998744 47889999999999999998 7777543210       01


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                      ....... ...     .     ..+..++..+.+++.+||+.||.+||++.+|.+.|..
T Consensus       235 ~~~~~~~-~~~-----~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 VIEMVRK-RQL-----L-----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHc-CCc-----C-----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1111111 000     0     0123345689999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4e-41  Score=296.58  Aligned_cols=259  Identities=24%  Similarity=0.419  Sum_probs=194.7

Q ss_pred             CCCCCeeecCCCceEEEEEeCC-CC--EEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeC------Ce
Q 043074           84 FSTDKIIGDGSFGFVYKAKLSS-GV--TVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASG------LD  152 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  152 (373)
                      |.+.+.||+|+||.||+|...+ +.  .+|+|.++...  ....+.+.+|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999997654 32  58999886542  23356788999999999999999999987432      24


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++++||+++|+|.+++.......         ....+++.....++.|++.||+|||  +++++||||||+||++++++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~  149 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGD---------CPQYLPTQMLVKFMTDIASGMEYLS--SKSFIHRDLAARNCMLNENM  149 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccC---------CcccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhheEEcCCC
Confidence            689999999999999885432211         0113889999999999999999999  79999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHH
Q 043074          233 EAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~  310 (373)
                      .+||+|||+++........ ......+++.|+|||.+.+ ..++.++||||||+++|||++ |..|+... .   ..   
T Consensus       150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~-~---~~---  221 (272)
T cd05075         150 NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGV-E---NS---  221 (272)
T ss_pred             CEEECCCCcccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCC-C---HH---
Confidence            9999999999876432211 1122345678999999874 457889999999999999999 66665321 1   11   


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ........ +...     .     .+..++..+.+++.+||+.||++|||+.++++.|++++
T Consensus       222 ~~~~~~~~-~~~~-----~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         222 EIYDYLRQ-GNRL-----K-----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             HHHHHHHc-CCCC-----C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            11111111 1100     0     12234557999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.9e-41  Score=296.61  Aligned_cols=256  Identities=27%  Similarity=0.479  Sum_probs=201.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-C---CCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-S---GVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ++|++.+.||+|+||.||+|... +   +..+++|.++.... ...+.+.+|+.++.+++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999753 2   34799999865432 2345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++++|.+++.....              .+++.++..++.|++.|+.|||  +.+++|+||||+||+++.++.++|
T Consensus        84 ~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~i~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~~~~~l  147 (267)
T cd05066          84 TEYMENGSLDAFLRKHDG--------------QFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILVNSNLVCKV  147 (267)
T ss_pred             EEcCCCCCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCEeehhhchhcEEECCCCeEEe
Confidence            999999999999976432              2889999999999999999999  799999999999999999999999


Q ss_pred             eeeccccccCCCCCcccc--cccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          237 SDFGLARRIDTSHSHVST--QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +|||++............  ...++..|+|||.+.+ ..++.++|+||||+++||+++ |..|+......    ....  
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~----~~~~--  220 (267)
T cd05066         148 SDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ----DVIK--  220 (267)
T ss_pred             CCCCcccccccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHH----HHHH--
Confidence            999999876543322111  1223567999999874 447889999999999999886 88886432111    1111  


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                       ....      .....     .+..++..+.+++.+||+.+|.+||++.++++.|++++
T Consensus       221 -~~~~------~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         221 -AIEE------GYRLP-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             -HHhC------CCcCC-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence             1110      00001     12234568899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1e-41  Score=300.95  Aligned_cols=245  Identities=26%  Similarity=0.317  Sum_probs=190.8

Q ss_pred             eecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCH
Q 043074           90 IGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL  165 (373)
Q Consensus        90 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  165 (373)
                      ||+|+||.||++..+ +|+.+|+|.+......   ....+..|++++++++||||+++.+++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999764 6899999998653322   233456799999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecccccc
Q 043074          166 DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI  245 (373)
Q Consensus       166 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  245 (373)
                      .+++......             ++++..+..++.|++.||+|||  +.+++||||||+||+++.++.++|+|||++...
T Consensus        81 ~~~~~~~~~~-------------~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~  145 (277)
T cd05607          81 KYHIYNVGER-------------GLEMERVIHYSAQITCGILHLH--SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL  145 (277)
T ss_pred             HHHHHhcccc-------------CCCHHHHHHHHHHHHHHHHHHH--HCCEEEccCChHhEEEcCCCCEEEeeceeeeec
Confidence            9988654322             2888999999999999999999  799999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcccccc
Q 043074          246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEM  325 (373)
Q Consensus       246 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (373)
                      ....  ......|+..|+|||.+.+.. ++.++|||||||++|||++|..|+.......   ..........        
T Consensus       146 ~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~---~~~~~~~~~~--------  211 (277)
T cd05607         146 KDGK--TITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV---AKEELKRRTL--------  211 (277)
T ss_pred             CCCc--eeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchh---hHHHHHHHhh--------
Confidence            4322  223346889999999997554 8889999999999999999999975422111   1111111110        


Q ss_pred             ccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          326 VDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       326 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       ......  .....+.++.+++.+||+.||++||+++|+++
T Consensus       212 -~~~~~~--~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         212 -EDEVKF--EHQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             -cccccc--ccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence             000000  01123557899999999999999999977654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-41  Score=294.56  Aligned_cols=251  Identities=25%  Similarity=0.401  Sum_probs=199.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc-----cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ-----GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ++|...+.||+|++|.||++.. .+++.+++|.+......     ....+.+|+.++++++||||+++++++.+....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788999999999999999965 46899999988643221     23467889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ++||+++++|.+++....               .+++..+..++.|++.||.|||  +.+++|+||+|+||++++++.++
T Consensus        82 v~e~~~~~~l~~~~~~~~---------------~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nilv~~~~~~~  144 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---------------ALTETVTRKYTRQILEGVEYLH--SNMIVHRDIKGANILRDSAGNVK  144 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEE
Confidence            999999999999987643               2788999999999999999999  88999999999999999999999


Q ss_pred             EeeeccccccCCCCCccc--ccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVS--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |+|||+++..........  ....++..|+|||.+.+. .++.++||||||+++|||++|..|+.....      ... .
T Consensus       145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~-~  216 (263)
T cd06625         145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAA-I  216 (263)
T ss_pred             EeecccceeccccccccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccch------HHH-H
Confidence            999999976543221111  234577899999999854 478899999999999999999999643210      000 0


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      ...... .    ..     ...+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       217 ~~~~~~-~----~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         217 FKIATQ-P----TN-----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHHhcc-C----CC-----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            000000 0    00     11133455689999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.3e-41  Score=298.97  Aligned_cols=263  Identities=24%  Similarity=0.425  Sum_probs=201.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-----CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeC--Cee
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASG--LDR  153 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  153 (373)
                      ..|++.+.||+|+||.||.+..     .++..|++|.+..... .....+.+|+.+++.++|||++++.+++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3567889999999999999963     3578899999865432 2345788999999999999999999998765  567


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++|+||+++++|.+++.....              .+++.++..++.|++.||+|||  +++++||||||+||+++.++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~--------------~~~~~~~~~i~~~i~~aL~~lH--~~gi~H~dlkp~Nil~~~~~~  147 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKN--------------KINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQ  147 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeecccchheEEEcCCCC
Confidence            899999999999999865432              2889999999999999999999  899999999999999999999


Q ss_pred             eEEeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCC-------
Q 043074          234 AHISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDG-------  304 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-------  304 (373)
                      ++|+|||+++........  ......++..|+|||.+.+ ..++.++||||||+++|||+++..|........       
T Consensus       148 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~  226 (284)
T cd05079         148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT  226 (284)
T ss_pred             EEECCCccccccccCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccc
Confidence            999999999876433221  1123456678999999874 457889999999999999999877643211100       


Q ss_pred             -CcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          305 -QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       305 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                       .......+..... ...         ... .+..++..+.+++.+||+.||.+||++.++++.|++++
T Consensus       227 ~~~~~~~~~~~~~~-~~~---------~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         227 HGQMTVTRLVRVLE-EGK---------RLP-RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             cccccHHHHHHHHH-cCc---------cCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence             0000111111110 000         000 12234568999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.1e-41  Score=296.39  Aligned_cols=255  Identities=26%  Similarity=0.457  Sum_probs=201.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      .++|++.+.||+|+||.||++...++..+++|.+..... ..+.+.+|+.+++.++|+|++++.+.+.+ ...++++||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh-HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            467889999999999999999887788899998865432 34678899999999999999999999887 7789999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++++|.+++......             .+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||
T Consensus        83 ~~~~L~~~~~~~~~~-------------~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~  147 (260)
T cd05073          83 AKGSLLDFLKSDEGS-------------KQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFG  147 (260)
T ss_pred             CCCcHHHHHHhCCcc-------------ccCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCCc
Confidence            999999999764322             2788999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      .+...............++..|+|||.+.+ ..++.++|+||||+++|++++ |..|+....    ......+.   .. 
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~----~~~~~~~~---~~-  218 (260)
T cd05073         148 LARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----NPEVIRAL---ER-  218 (260)
T ss_pred             ceeeccCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCC----HHHHHHHH---hC-
Confidence            997654332222223345678999999874 457889999999999999999 777753211    11111111   00 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                      .     ....     .+...+.++.+++.+||+.+|++||++.++.+.|+++
T Consensus       219 ~-----~~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         219 G-----YRMP-----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             C-----CCCC-----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            0     0000     1223456899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.7e-42  Score=301.90  Aligned_cols=247  Identities=24%  Similarity=0.340  Sum_probs=191.9

Q ss_pred             eecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCH
Q 043074           90 IGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL  165 (373)
Q Consensus        90 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  165 (373)
                      ||+|+||+||++... +++.+|+|.+......   ..+.+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999754 7899999998654332   234567899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecccccc
Q 043074          166 DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI  245 (373)
Q Consensus       166 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  245 (373)
                      .+++.......           ..+++..+..++.|++.||.|||  +++++||||||+||+++.++.++|+|||++...
T Consensus        81 ~~~~~~~~~~~-----------~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  147 (280)
T cd05608          81 RYHIYNVDEEN-----------PGFPEPRACFYTAQIISGLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL  147 (280)
T ss_pred             HHHHHhccccC-----------CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEeeCccceec
Confidence            98885432211           13899999999999999999999  789999999999999999999999999999765


Q ss_pred             CCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcccccc
Q 043074          246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEM  325 (373)
Q Consensus       246 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (373)
                      ..... ......||+.|+|||.+.+. .++.++||||||+++|||++|..||........   ........         
T Consensus       148 ~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~---------  213 (280)
T cd05608         148 KDGQS-KTKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRI---------  213 (280)
T ss_pred             CCCCc-cccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---HHHHHHhh---------
Confidence            43222 22345689999999999854 578899999999999999999999754321110   00100000         


Q ss_pred             ccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          326 VDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       326 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                      .....   ..+...+..+.+++.+||+.||++||     +++++++
T Consensus       214 ~~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         214 LNDSV---TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cccCC---CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            00110   11233456899999999999999999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.4e-42  Score=319.74  Aligned_cols=251  Identities=21%  Similarity=0.272  Sum_probs=193.1

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||++.. .+++.||+|.+.+...   .....+.+|+.+++.++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3688899999999999999975 4689999999865332   22356788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.....               +++..+..++.||+.||+|||  +++|+||||||+|||++.++.+||+
T Consensus        81 E~~~~g~L~~~i~~~~~---------------~~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~ikL~  143 (376)
T cd05598          81 DYIPGGDMMSLLIRLGI---------------FEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLT  143 (376)
T ss_pred             eCCCCCcHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHEEECCCCCEEEE
Confidence            99999999999976432               788889999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCC------------------------------------------CcccccccccccccCccccCCCCCCC
Q 043074          238 DFGLARRIDTSH------------------------------------------SHVSTQVAGTMGYMPPEYLGGNTAAT  275 (373)
Q Consensus       238 Dfg~~~~~~~~~------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~  275 (373)
                      |||++..+....                                          ........||+.|+|||++.+ ..++
T Consensus       144 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~  222 (376)
T cd05598         144 DFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYT  222 (376)
T ss_pred             eCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCC
Confidence            999975321000                                          000123468999999999975 4478


Q ss_pred             ccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCC
Q 043074          276 VMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKS  355 (373)
Q Consensus       276 ~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p  355 (373)
                      .++|||||||++|||++|..||......       ++...... ..      ....... ....+.++.+++.+|+ .+|
T Consensus       223 ~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~-~~------~~~~~~~-~~~~s~~~~~li~~l~-~~p  286 (376)
T cd05598         223 QLCDWWSVGVILYEMLVGQPPFLADTPA-------ETQLKVIN-WE------TTLHIPS-QAKLSREASDLILRLC-CGA  286 (376)
T ss_pred             cceeeeeccceeeehhhCCCCCCCCCHH-------HHHHHHhc-cC------ccccCCC-CCCCCHHHHHHHHHHh-cCH
Confidence            8999999999999999999997543211       11111110 00      0000000 1123456778888876 499


Q ss_pred             CCCC---CHHHHHH
Q 043074          356 RERP---AMSYVVQ  366 (373)
Q Consensus       356 ~~RP---s~~~l~~  366 (373)
                      .+|+   ++.+++.
T Consensus       287 ~~R~~~~t~~ell~  300 (376)
T cd05598         287 EDRLGKNGADEIKA  300 (376)
T ss_pred             hhcCCCCCHHHHhC
Confidence            9999   7888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=295.95  Aligned_cols=250  Identities=28%  Similarity=0.444  Sum_probs=201.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      ++|++.+.||.|+||.||+|... |+.+++|.+..... ..+.+.+|+.+++.++|+|++++++++.+....++|+||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            47888899999999999999875 88999999976544 45678999999999999999999999998999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +++|.+++......             .+++..+..++.|++.||.|||  +++++|+||||+||+++.++.++|+|||.
T Consensus        84 ~~~L~~~~~~~~~~-------------~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~Nili~~~~~~~l~d~g~  148 (256)
T cd05039          84 KGSLVDYLRSRGRA-------------VITLAQQLGFALDVCEGMEYLE--EKNFVHRDLAARNVLVSEDLVAKVSDFGL  148 (256)
T ss_pred             CCcHHHHHHhcCCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCccchhcccceEEEeCCCCEEEccccc
Confidence            99999999765422             2899999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      ++......    .....+..|+|||.+.+ ..++.++||||||+++||+++ |..|+......       .... .....
T Consensus       149 ~~~~~~~~----~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~-~~~~~  215 (256)
T cd05039         149 AKEASQGQ----DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVP-HVEKG  215 (256)
T ss_pred             cccccccc----ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHH-HHhcC
Confidence            98753221    12334567999999874 447889999999999999997 88875432110       1111 10000


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                           ....     .+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       216 -----~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         216 -----YRME-----APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -----CCCC-----CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                 0011     1223456899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.5e-42  Score=308.94  Aligned_cols=241  Identities=23%  Similarity=0.291  Sum_probs=190.3

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCC-CCccceeeEEeeCCeeEEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRH-RNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  157 (373)
                      +|++.+.||+|+||.||+|..+ +++.||+|++.+..   ....+.+..|..++..++| ++|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999765 57899999987542   2234567789999999976 46888999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.....               +++..+..++.|++.||.|||  +++++||||||+|||++.++.+||+
T Consensus        81 E~~~~g~L~~~~~~~~~---------------~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kL~  143 (324)
T cd05587          81 EYVNGGDLMYHIQQVGK---------------FKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIA  143 (324)
T ss_pred             cCCCCCcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEEcCCCCEEEe
Confidence            99999999999875442               889999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||......    ..   .....
T Consensus       144 Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~---~~~i~  214 (324)
T cd05587         144 DFGMCKENIFGG-KTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----EL---FQSIM  214 (324)
T ss_pred             ecCcceecCCCC-CceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HH---HHHHH
Confidence            999987532211 123345689999999999754 4788999999999999999999997532211    11   11111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                      .       ....     .+...+.++.+++.+||+.||.+||+.
T Consensus       215 ~-------~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         215 E-------HNVS-----YPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             c-------CCCC-----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            0       0011     122335578999999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.8e-42  Score=318.31  Aligned_cols=250  Identities=20%  Similarity=0.267  Sum_probs=190.9

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      +|+..+.||+|+||.||+|.. .+++.+|+|.+.+...   .....+.+|+.++++++||||+++++.+.++...++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            578889999999999999965 4688999999865432   234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++|+|.+++....               .+++..+..++.||+.||+|||  +.+|+||||||+|||++.++.+||+|
T Consensus        82 ~~~gg~L~~~l~~~~---------------~~~e~~~~~~~~qi~~al~~lH--~~~ivHrDlKp~NILl~~~g~~kL~D  144 (382)
T cd05625          82 YIPGGDMMSLLIRMG---------------IFPEDLARFYIAELTCAVESVH--KMGFIHRDIKPDNILIDRDGHIKLTD  144 (382)
T ss_pred             CCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEEeE
Confidence            999999999987643               2788889999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCC----------------------------------------------CcccccccccccccCccccCCCC
Q 043074          239 FGLARRIDTSH----------------------------------------------SHVSTQVAGTMGYMPPEYLGGNT  272 (373)
Q Consensus       239 fg~~~~~~~~~----------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~  272 (373)
                      ||++..+....                                              ........||+.|+|||++.+. 
T Consensus       145 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-  223 (382)
T cd05625         145 FGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-  223 (382)
T ss_pred             CCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-
Confidence            99975321100                                              0001224689999999999754 


Q ss_pred             CCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcC
Q 043074          273 AATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTN  352 (373)
Q Consensus       273 ~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  352 (373)
                      .++.++|||||||++|||++|..||......       +.......       ......... ....+.+..+++.+|+ 
T Consensus       224 ~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~-------~~~~~~~p~-~~~~s~~~~~li~~l~-  287 (382)
T cd05625         224 GYTQLCDWWSVGVILYEMLVGQPPFLAQTPL-------ETQMKVIN-------WQTSLHIPP-QAKLSPEASDLIIKLC-  287 (382)
T ss_pred             CCCCeeeEEechHHHHHHHhCCCCCCCCCHH-------HHHHHHHc-------cCCCcCCCC-cccCCHHHHHHHHHHc-
Confidence            4788999999999999999999997543211       10111100       000010000 1122446778887776 


Q ss_pred             CCCCCCCC---HHHHHH
Q 043074          353 EKSRERPA---MSYVVQ  366 (373)
Q Consensus       353 ~~p~~RPs---~~~l~~  366 (373)
                      .+|.+|++   +.++++
T Consensus       288 ~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         288 RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             cCHhHcCCCCCHHHHhc
Confidence            49999997   766653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.4e-42  Score=308.59  Aligned_cols=241  Identities=22%  Similarity=0.282  Sum_probs=190.2

Q ss_pred             CeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||+|..+ +++.||+|++.+...   ...+.+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999765 578999999875432   2334567888888866 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|..++.....               +++..+..++.|++.||.|||  +++++||||||+||+++.++.+||+|||++
T Consensus        81 ~~L~~~l~~~~~---------------~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~Nill~~~~~~kL~Dfg~~  143 (321)
T cd05591          81 GDLMFQIQRSRK---------------FDEPRSRFYAAEVTLALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMC  143 (321)
T ss_pred             CcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEeecccc
Confidence            999998875542               889999999999999999999  789999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE  322 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (373)
                      ....... .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||.....       ..........   
T Consensus       144 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-------~~~~~~i~~~---  211 (321)
T cd05591         144 KEGILNG-VTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNE-------DDLFESILHD---  211 (321)
T ss_pred             eecccCC-ccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcC---
Confidence            7543222 22334568999999999874 4578899999999999999999999753221       1111111110   


Q ss_pred             cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHH
Q 043074          323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-------AMSYVVQ  366 (373)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-------s~~~l~~  366 (373)
                            ..   ..+...+.++.+++.+||+.||++||       +++++++
T Consensus       212 ------~~---~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         212 ------DV---LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             ------CC---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                  00   01222346889999999999999999       6777654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-42  Score=311.91  Aligned_cols=238  Identities=26%  Similarity=0.309  Sum_probs=190.0

Q ss_pred             CeeecCCCceEEEEEe----CCCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           88 KIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      +.||+|+||.||++..    .+|+.+|+|++.+....  ....+..|++++++++||||+++++++.++...++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999864    36889999999754322  23456789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +|+|.+++....               .+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+||+|||+
T Consensus        82 ~~~L~~~l~~~~---------------~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~  144 (318)
T cd05582          82 GGDLFTRLSKEV---------------MFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGL  144 (318)
T ss_pred             CCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHeEECCCCcEEEeeccC
Confidence            999999986543               2899999999999999999999  78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK  321 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (373)
                      +....... .......|++.|+|||.+.+ ..++.++|||||||++|||++|..|+.....       ..........  
T Consensus       145 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~-------~~~~~~i~~~--  213 (318)
T cd05582         145 SKESIDHE-KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-------KETMTMILKA--  213 (318)
T ss_pred             CcccCCCC-CceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCH-------HHHHHHHHcC--
Confidence            87653322 12234578999999999875 4468899999999999999999999753211       1111111110  


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY  363 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~  363 (373)
                             ..   ..+...+..+.+++.+||+.||++||++.+
T Consensus       214 -------~~---~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         214 -------KL---GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -------CC---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                   00   012234567899999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.3e-41  Score=293.61  Aligned_cols=250  Identities=26%  Similarity=0.344  Sum_probs=200.3

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +|.+.+.||+|++|.||++..+ ++..+++|.+....  ......+.+|+++++.++|||++++++++.+....++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999764 68999999986432  23356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++......             .+++..++.++.|++.||.|||  +.+++|+||+|+||++++++.++|+||
T Consensus        81 ~~~~~L~~~l~~~~~~-------------~~~~~~~~~i~~~l~~al~~lH--~~~i~h~dl~~~nili~~~~~~~l~df  145 (256)
T cd08529          81 AENGDLHKLLKMQRGR-------------PLPEDQVWRFFIQILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDL  145 (256)
T ss_pred             CCCCcHHHHHHHhcCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEeCCCCEEEccc
Confidence            9999999999865321             2889999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++........ ......+++.|+|||.+.+ ..++.++|+||||+++|||++|..|+.....    ...   .....  
T Consensus       146 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~---~~~~~--  214 (256)
T cd08529         146 GVAKLLSDNTN-FANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GAL---ILKII--  214 (256)
T ss_pred             ccceeccCccc-hhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHH---HHHHH--
Confidence            99886643322 2233467889999999874 4478899999999999999999999653221    000   11110  


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                          ....     ...+...+..+.+++.+||+.+|++||++.++++.
T Consensus       215 ----~~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         215 ----RGVF-----PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ----cCCC-----CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                0000     11122446689999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.3e-41  Score=302.39  Aligned_cols=203  Identities=23%  Similarity=0.339  Sum_probs=162.6

Q ss_pred             CCeeecCCCceEEEEEeC---CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeEEEEEecC
Q 043074           87 DKIIGDGSFGFVYKAKLS---SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS--GLDRVLIYEFVE  161 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  161 (373)
                      .+.||+|+||.||+|..+   +++.+|+|.+.....  ...+.+|+.++++++||||+++++++..  +...++++||+ 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence            468999999999999754   568899999865432  2456789999999999999999998854  45678999999 


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe----CCCCceEEe
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL----DSDFEAHIS  237 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill----~~~~~~kl~  237 (373)
                      +++|.+++.........      .....+++..+..++.|++.||.|||  +++++||||||+|||+    +.++.+||+
T Consensus        83 ~~~l~~~~~~~~~~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivHrDlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07868          83 EHDLWHIIKFHRASKAN------KKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             CCCHHHHHHhccccccc------CCcccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence            56888887654321110      01123889999999999999999999  7899999999999999    456789999


Q ss_pred             eeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCc
Q 043074          238 DFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPV  300 (373)
Q Consensus       238 Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  300 (373)
                      |||+++........  ......+|+.|+|||.+.+...++.++||||+||++|||++|..||...
T Consensus       155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            99999876433221  2234578999999999987666889999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=301.76  Aligned_cols=272  Identities=23%  Similarity=0.399  Sum_probs=199.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCC---------------CCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCcccee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSS---------------GVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKIL  144 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~  144 (373)
                      .++|++.+.||+|+||.||++....               ...||+|.+...... ....+.+|++++++++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578999999999999999986432               235899998654332 345688999999999999999999


Q ss_pred             eEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCC
Q 043074          145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS  224 (373)
Q Consensus       145 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~  224 (373)
                      +++......++||||+++++|.+++..........   .......+++..++.++.|++.||+|||  +.+++|+||||+
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~  158 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFT---HANNIPSVSIANLLYMAVQIASGMKYLA--SLNFVHRDLATR  158 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhcccccccc---ccccCCcccHHHHHHHHHHHHHHHHHHH--hcCeeccccChh
Confidence            99999999999999999999999997543211100   0011123788999999999999999999  789999999999


Q ss_pred             ceEeCCCCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhC--CCCCCCcc
Q 043074          225 NVLLDSDFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ--IRPNLPVV  301 (373)
Q Consensus       225 Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g--~~p~~~~~  301 (373)
                      ||++++++.+||+|||++........ .......++..|+|||.+.+ ..++.++|+||||+++|||+++  ..|+....
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            99999999999999999976533221 11122345678999999874 4478899999999999999984  44533211


Q ss_pred             cCCCcccHHHHHHHHHH-hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          302 LDGQEVGLLEWARTMEA-RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       302 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                      .    ............ ......       .. .+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus       238 ~----~~~~~~~~~~~~~~~~~~~-------~~-~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         238 D----EQVIENTGEFFRNQGRQIY-------LS-QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             h----HHHHHHHHHhhhhcccccc-------CC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            1    111111111110 000000       00 022235689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.5e-41  Score=299.91  Aligned_cols=267  Identities=22%  Similarity=0.299  Sum_probs=197.8

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +|++.+.||+|++|.||+|... ++..|++|.+.....  .....+.+|+.++++++|||++++++++.++...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4777889999999999999764 689999999864332  2245678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      ++ ++|.+++.......            .+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~-~~l~~~~~~~~~~~------------~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~~l~df  145 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQ------------YMDAELVKSYLYQILQGILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADF  145 (285)
T ss_pred             CC-CCHHHHHhcCCCCC------------cCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEEcCCCcEEECcc
Confidence            96 68988887644321            3889999999999999999999  799999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc---------HH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG---------LL  310 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~---------~~  310 (373)
                      |++....... .......+++.|+|||.+.+...++.++||||||+++|||++|..|+...........         ..
T Consensus       146 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
T cd07861         146 GLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTED  224 (285)
T ss_pred             cceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9997654332 1222345688999999987666678899999999999999999988754221100000         00


Q ss_pred             HHHH--HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 EWAR--TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .|..  .................... ....+.++.+++.+||+.||.+|||+.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         225 VWPGVTSLPDYKNTFPKWKKGSLRSA-VKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhhcchhhHHHHhhccccCcchhHHh-cCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000  00000000000000000000 1123557889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.8e-41  Score=296.21  Aligned_cols=255  Identities=27%  Similarity=0.481  Sum_probs=199.6

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CC---CEEEEEEeCccc-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SG---VTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .|++.+.||+|+||.||+|... ++   ..|++|.+.... ......+..|+.+++.++||||+++++++.++...++|+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            5677899999999999999764 23   369999987543 233567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++++|.+++.....              .+++.+++.++.|++.|+.|||  +++++|+||||+||+++.++.++|+
T Consensus        85 e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~~l~~al~~lH--~~g~~H~dl~p~nili~~~~~~kl~  148 (269)
T cd05065          85 EFMENGALDSFLRQNDG--------------QFTVIQLVGMLRGIAAGMKYLS--EMNYVHRDLAARNILVNSNLVCKVS  148 (269)
T ss_pred             ecCCCCcHHHHHhhCCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCEeecccChheEEEcCCCcEEEC
Confidence            99999999999876432              2889999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCCcc--ccccc--ccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHH
Q 043074          238 DFGLARRIDTSHSHV--STQVA--GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~--~~~~~--g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  312 (373)
                      |||++..........  .....  .+..|+|||.+.+ ..++.++||||||+++||+++ |..|+......    ....+
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~----~~~~~  223 (269)
T cd05065         149 DFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVINA  223 (269)
T ss_pred             CCccccccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----HHHHH
Confidence            999987654322111  11111  2357999999874 457889999999999999886 88886432211    11111


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .   ..      .....     .+.+++..+.+++.+||+.+|.+||++.+++..|++++
T Consensus       224 i---~~------~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         224 I---EQ------DYRLP-----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             H---Hc------CCcCC-----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            1   10      00000     12344668899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4e-41  Score=298.98  Aligned_cols=267  Identities=22%  Similarity=0.406  Sum_probs=201.5

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLD  152 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  152 (373)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+..... .....+.+|+..++.++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3568999999999999999999643      245799998865432 223457889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++||||+++|+|.+++..........     .....+++..+..++.|++.||.|||  +++++||||||+||++++++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dikp~nili~~~~  156 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENN-----PGRPPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDF  156 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccC-----CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCCChheEEEcCCC
Confidence            999999999999999997643221100     01123678889999999999999999  89999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHH
Q 043074          233 EAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~  310 (373)
                      .++|+|||+++........ ......++..|+|||.+.+ ..++.++|+|||||++|||++ |..|+....       ..
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-------~~  228 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-------NE  228 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-------HH
Confidence            9999999999865332211 1122345678999999874 447889999999999999999 566653211       11


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      +......... .     .     ..+..++..+.+++.+||+.||++||++.++++.|++.+
T Consensus       229 ~~~~~~~~~~-~-----~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         229 QVLKFVMDGG-Y-----L-----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHHHHcCC-C-----C-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1111111000 0     0     012233568999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.6e-41  Score=303.40  Aligned_cols=265  Identities=21%  Similarity=0.331  Sum_probs=198.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|...+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.++||||+++++++.++...++|+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57888999999999999999764 6889999998654332 234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      ++ ++|.+++.....              .+++..+..++.|++.||.|||  +.+++|+||||+||++++++.++|+||
T Consensus        86 ~~-~~l~~~l~~~~~--------------~~~~~~~~~~~~qi~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~df  148 (301)
T cd07873          86 LD-KDLKQYLDDCGN--------------SINMHNVKLFLFQLLRGLNYCH--RRKVLHRDLKPQNLLINERGELKLADF  148 (301)
T ss_pred             cc-cCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHHHEEECCCCcEEECcC
Confidence            96 699988875432              2788999999999999999999  799999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc---------HH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG---------LL  310 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~---------~~  310 (373)
                      |++........ ......+++.|+|||.+.+...++.++||||||+++|||++|..||...........         ..
T Consensus       149 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  227 (301)
T cd07873         149 GLARAKSIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEE  227 (301)
T ss_pred             cchhccCCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence            99976533221 122345688999999987666678899999999999999999988754321100000         00


Q ss_pred             HHHHHHHHhcccccccc-Ccccc---ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 EWARTMEARNKEIEMVD-SNISR---EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .|.....  .......+ +....   .......+..+.+++.+||+.||.+|||++++++
T Consensus       228 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         228 TWPGILS--NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hchhhhc--cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0100000  00000000 00000   0011223557899999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.9e-42  Score=307.15  Aligned_cols=241  Identities=24%  Similarity=0.293  Sum_probs=191.3

Q ss_pred             CeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||++..+ ++..||+|.+.+..   ......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999765 57899999997543   22345567888888887 699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|..++.....               +++..+..++.|++.||.|||  +.+++||||||+||++++++.+||+|||++
T Consensus        81 ~~L~~~~~~~~~---------------l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  143 (318)
T cd05570          81 GDLMFHIQRSGR---------------FDEPRARFYAAEIVLGLQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMC  143 (318)
T ss_pred             CCHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--hCCeEccCCCHHHeEECCCCcEEecccCCC
Confidence            999998876532               899999999999999999999  799999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE  322 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (373)
                      +...... .......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.....       ..........   
T Consensus       144 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~-------~~~~~~i~~~---  211 (318)
T cd05570         144 KEGILGG-VTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDE-------DELFQSILED---  211 (318)
T ss_pred             eecCcCC-CcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHcC---
Confidence            7532221 122335689999999999754 478899999999999999999999753221       1111111110   


Q ss_pred             cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 043074          323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM-----SYVVQ  366 (373)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~~l~~  366 (373)
                          ...     .+...+..+.+++.+||+.||++||++     .++++
T Consensus       212 ----~~~-----~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         212 ----EVR-----YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ----CCC-----CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                000     122345688999999999999999999     77754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.8e-41  Score=294.95  Aligned_cols=247  Identities=26%  Similarity=0.388  Sum_probs=192.5

Q ss_pred             eeecCCCceEEEEEeC---CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCC
Q 043074           89 IIGDGSFGFVYKAKLS---SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGS  164 (373)
Q Consensus        89 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  164 (373)
                      .||+|+||.||+|.+.   ++..||+|.+...... ..+.+.+|+.++++++||||+++++++.. ...++|+||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999653   4567999998655432 24568899999999999999999998854 57889999999999


Q ss_pred             HHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccc
Q 043074          165 LDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       165 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                      |.+++.....              .+++.++++++.|++.||.|||  +++++|+||||+||+++.++.+||+|||++..
T Consensus        81 L~~~l~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  144 (257)
T cd05115          81 LNKFLSGKKD--------------EITVSNVVELMHQVSMGMKYLE--GKNFVHRDLAARNVLLVNQHYAKISDFGLSKA  144 (257)
T ss_pred             HHHHHHhCCC--------------CCCHHHHHHHHHHHHHHHHHHH--hcCeeecccchheEEEcCCCcEEeccCCcccc
Confidence            9999875432              2899999999999999999999  78999999999999999999999999999986


Q ss_pred             cCCCCCcc--cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhcc
Q 043074          245 IDTSHSHV--STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARNK  321 (373)
Q Consensus       245 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (373)
                      ........  .....++..|+|||.+.+ ..++.++||||||+++||+++ |..|+.....       .++...... ..
T Consensus       145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~-~~  215 (257)
T cd05115         145 LGADDSYYKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-------PEVMSFIEQ-GK  215 (257)
T ss_pred             ccCCccceeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHC-CC
Confidence            54332211  111223568999999874 447889999999999999996 8888643211       111111111 10


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                      .          ...+..++.++.+++.+||+.||++||++.+|.+.|+++
T Consensus       216 ~----------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         216 R----------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             C----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            0          111334567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1e-41  Score=306.37  Aligned_cols=240  Identities=25%  Similarity=0.326  Sum_probs=188.8

Q ss_pred             CeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||+|..+ ++..||+|.+++...   ........|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999765 688999999975421   2334566777777754 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|..++....               .+++.++..++.|++.||+|||  +++++||||||+||+++.++.++|+|||++
T Consensus        81 g~L~~~i~~~~---------------~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~  143 (316)
T cd05620          81 GDLMFHIQDKG---------------RFDLYRATFYAAEIVCGLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMC  143 (316)
T ss_pred             CcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEeCccCCC
Confidence            99999987643               2888999999999999999999  799999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE  322 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (373)
                      +..... ........||+.|+|||.+.+. .++.++|||||||++|||++|..||.....       ..........   
T Consensus       144 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~-------~~~~~~~~~~---  211 (316)
T cd05620         144 KENVFG-DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-------DELFESIRVD---  211 (316)
T ss_pred             eecccC-CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhC---
Confidence            753211 1223346789999999999754 478899999999999999999999753221       1111111100   


Q ss_pred             cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 043074          323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMS-YVV  365 (373)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~l~  365 (373)
                          ...+     +...+.++.+++.+||+.||++||++. ++.
T Consensus       212 ----~~~~-----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         212 ----TPHY-----PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ----CCCC-----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                0111     222345789999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.5e-41  Score=301.32  Aligned_cols=251  Identities=24%  Similarity=0.344  Sum_probs=202.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ..+|+..+.||.|+||.||+|.. .++..+++|.+........+.+.+|+.+++.++|||++++++.+..+...++|+||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            45888899999999999999975 47899999999776666667788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++....                +++.++..++.|++.||.|||  +.+++|+||||+||+++.++.++|+||
T Consensus        99 ~~~~~L~~~~~~~~----------------~~~~~~~~i~~ql~~aL~~LH--~~gi~H~dLkp~Nill~~~~~~kl~df  160 (296)
T cd06654          99 LAGGSLTDVVTETC----------------MDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDF  160 (296)
T ss_pred             cCCCCHHHHHHhcC----------------CCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCEEECcc
Confidence            99999999986432                788999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++....... .......+++.|+|||.+.+ ...+.++|||||||++|+|++|..||......       .+.......
T Consensus       161 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-------~~~~~~~~~  231 (296)
T cd06654         161 GFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATN  231 (296)
T ss_pred             ccchhccccc-cccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-------HhHHHHhcC
Confidence            9987643222 11223467889999999874 44678999999999999999999997542211       111111100


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      .      ...+   ..+...+..+.+++.+||+.||++||++.++++.
T Consensus       232 ~------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         232 G------TPEL---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             C------CCCC---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            0      0000   0123345678999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.4e-42  Score=301.87  Aligned_cols=242  Identities=21%  Similarity=0.365  Sum_probs=189.9

Q ss_pred             CeeecCCCceEEEEEeCC--------CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           88 KIIGDGSFGFVYKAKLSS--------GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +.||+|+||.||+|..+.        ...+++|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999996532        334888888665555556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc------
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE------  233 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~------  233 (373)
                      +++|+|.+++.....              .+++..++.++.|++.||+|||  +++++||||||+||+++.++.      
T Consensus        81 ~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~~~~~~  144 (258)
T cd05078          81 VKFGSLDTYLKKNKN--------------LINISWKLEVAKQLAWALHFLE--DKGLTHGNVCAKNVLLIREEDRKTGNP  144 (258)
T ss_pred             CCCCcHHHHHhcCCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccceEEEecccccccCCC
Confidence            999999999986543              2889999999999999999999  899999999999999987765      


Q ss_pred             --eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          234 --AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       234 --~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                        ++++|||.+.....     .....++..|+|||.+.+...++.++||||||+++|||++|..++......      ..
T Consensus       145 ~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~------~~  213 (258)
T cd05078         145 PFIKLSDPGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS------QK  213 (258)
T ss_pred             ceEEecccccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH------HH
Confidence              69999998865432     123457888999999986566788999999999999999996543321111      01


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                      .......        ...+     +.....++.+++.+||+.||++|||++++++.|+
T Consensus       214 ~~~~~~~--------~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         214 KLQFYED--------RHQL-----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHHHc--------cccC-----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1110100        0011     2222357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=305.17  Aligned_cols=252  Identities=25%  Similarity=0.356  Sum_probs=209.8

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccccc---HHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQG---FREFRAEMETLGKLR-HRNIVKILGYCASGLDRV  154 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  154 (373)
                      ..+.|++.+.||.|.||.||++..+ +|+.+|+|.+.+.....   .+.+.+|+.+|+++. ||||+++.+++++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4568899999999999999999765 59999999997765543   358899999999998 999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC---
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD---  231 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~---  231 (373)
                      +|||++.||.|.+.+....                +++..+..++.|++.++.|||  ..+++||||||+|+|+...   
T Consensus       113 lvmEL~~GGeLfd~i~~~~----------------~sE~da~~~~~~il~av~~lH--~~gvvHrDlKpEN~L~~~~~~~  174 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKKH----------------YSERDAAGIIRQILEAVKYLH--SLGVVHRDLKPENLLLASKDEG  174 (382)
T ss_pred             EEEEecCCchHHHHHHHcc----------------CCHHHHHHHHHHHHHHHHHHH--hCCceeccCCHHHeeeccccCC
Confidence            9999999999999998661                889999999999999999999  7999999999999999543   


Q ss_pred             -CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH
Q 043074          232 -FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       232 -~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  310 (373)
                       +.+|++|||++.....  .......+||+.|+|||++.+ ..++...||||+|+++|.|++|.+||..........   
T Consensus       175 ~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---  248 (382)
T KOG0032|consen  175 SGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---  248 (382)
T ss_pred             CCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---
Confidence             4799999999998765  445667899999999999974 568999999999999999999999987644332111   


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                          ..       ..-+.....+. -......+.+++..|+..||.+|+|+.++++.
T Consensus       249 ----~i-------~~~~~~f~~~~-w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  249 ----AI-------LRGDFDFTSEP-WDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ----HH-------HcCCCCCCCCC-ccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                00       00111222222 33446789999999999999999999999873

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.5e-41  Score=305.16  Aligned_cols=240  Identities=24%  Similarity=0.330  Sum_probs=188.8

Q ss_pred             CeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||+|... +++.||+|.+.....   ........|..++... +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999765 578999999865421   2234566777777764 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|.+++....               .+++.++..++.|++.||.|||  +++++||||||+||+++.++.+||+|||++
T Consensus        81 g~L~~~l~~~~---------------~~~~~~~~~~~~qi~~al~~LH--~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  143 (316)
T cd05619          81 GDLMFHIQSCH---------------KFDLPRATFYAAEIICGLQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMC  143 (316)
T ss_pred             CcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEccCCcc
Confidence            99999997643               2888999999999999999999  799999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE  322 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (373)
                      +...... .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||.....       .+........   
T Consensus       144 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~---  211 (316)
T cd05619         144 KENMLGD-AKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-------EELFQSIRMD---  211 (316)
T ss_pred             eECCCCC-CceeeecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhC---
Confidence            7532211 12234568999999999875 4478899999999999999999999754211       1111111100   


Q ss_pred             cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 043074          323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMS-YVV  365 (373)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~l~  365 (373)
                          ...     .+...+..+.+++.+||+.||++||++. ++.
T Consensus       212 ----~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         212 ----NPC-----YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ----CCC-----CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence                011     1223345789999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.9e-41  Score=303.13  Aligned_cols=268  Identities=28%  Similarity=0.431  Sum_probs=199.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCC--EEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGV--TVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ++|++.+.||+|+||.||+|.++ ++.  .+++|.+..... .....+.+|+.++.++ +||||+++++++.++...++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            57888899999999999999764 444  457777654332 2345788999999999 899999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcc-cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGS-KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      +||+++++|.+++............ ........+++.+++.++.|++.|++|||  +++++||||||+||++++++.+|
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dlkp~Nili~~~~~~k  164 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAK  164 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEecCCCcEE
Confidence            9999999999999765422111000 00001123889999999999999999999  89999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      |+|||++......  .......++..|+|||.+.+ ..++.++||||||+++|||+| |..||......       +...
T Consensus       165 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~  234 (303)
T cd05088         165 IADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYE  234 (303)
T ss_pred             eCccccCcccchh--hhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChH-------HHHH
Confidence            9999998642211  11111224567999998864 447889999999999999998 88886432111       1111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ....      .....     .+...+..+.+++.+||+.+|++||++.++++.|++++
T Consensus       235 ~~~~------~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         235 KLPQ------GYRLE-----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             HHhc------CCcCC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1110      00000     02223457899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.6e-41  Score=298.86  Aligned_cols=256  Identities=23%  Similarity=0.372  Sum_probs=198.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCC----EEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGV----TVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      .++|+..+.||+|+||.||+|.+. ++.    .||+|.+...... ..+.+.+|+.++..++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            357888899999999999999753 444    4899998654332 345788999999999999999999998754 577


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +++||+++|+|.+++.....              .+++..++.++.|++.||+|||  +++++||||||+||++++++.+
T Consensus        85 l~~~~~~~g~l~~~l~~~~~--------------~~~~~~~~~~~~qi~~~L~~lH--~~~iiH~dlkp~Nil~~~~~~~  148 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKD--------------RIGSQDLLNWCVQIAKGMSYLE--EVRLVHRDLAARNVLVKSPNHV  148 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEEEcCCCcE
Confidence            99999999999999976432              2899999999999999999999  7999999999999999999999


Q ss_pred             EEeeeccccccCCCCCcc-cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHH
Q 043074          235 HISDFGLARRIDTSHSHV-STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  312 (373)
                      ||+|||+++......... .....++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....    ...+..+
T Consensus       149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~~  223 (279)
T cd05109         149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIP----AREIPDL  223 (279)
T ss_pred             EECCCCceeecccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHH
Confidence            999999998764332211 112234678999999874 447889999999999999998 777753211    1111111


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..    ....     .     ..+..++..+.+++.+||+.||++||++.++++.|+++.
T Consensus       224 ~~----~~~~-----~-----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         224 LE----KGER-----L-----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             HH----CCCc-----C-----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            11    1000     0     012234568999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.4e-41  Score=302.14  Aligned_cols=271  Identities=29%  Similarity=0.397  Sum_probs=203.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC--------CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeC
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS--------SGVTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASG  150 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  150 (373)
                      .++|.+.+.||+|+||.||++...        +...+|+|.+..... .....+.+|+.++..+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            357899999999999999999642        235699999976432 3345688899999999 799999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcc-cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGS-KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      ...++|+||+++|+|.+++............ ........+++.++++++.|++.||+|||  +.+++||||||+||+++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nill~  174 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHHheEEc
Confidence            9999999999999999999765432110000 00001123899999999999999999999  78999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcc
Q 043074          230 SDFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEV  307 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~  307 (373)
                      .++.+||+|||.+......... ......++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....      
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------  247 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------  247 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------
Confidence            9999999999998765322111 1112234568999999875 447889999999999999998 666653211      


Q ss_pred             cHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                       ..+........ .         .. ..+..++.++.+++.+||+.+|.+||++.++++.|++++
T Consensus       248 -~~~~~~~~~~~-~---------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         248 -VEELFKLLKEG-H---------RM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             -HHHHHHHHHcC-C---------CC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence             11111111111 0         00 113334568999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-40  Score=304.53  Aligned_cols=194  Identities=25%  Similarity=0.354  Sum_probs=164.1

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ...+|.+.+.||+|+||.||+|... ++..||+|......      ...|+.++++++||||+++++++..+...++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3468999999999999999999765 57889999754332      3468999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      ++ .++|.+++.....              ++++..+..++.||+.||.|||  +++|+||||||+|||++.++.+||+|
T Consensus       138 ~~-~~~l~~~l~~~~~--------------~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kl~D  200 (357)
T PHA03209        138 HY-SSDLYTYLTKRSR--------------PLPIDQALIIEKQILEGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGD  200 (357)
T ss_pred             cc-CCcHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEec
Confidence            99 5688888865432              3899999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCC
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP  299 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  299 (373)
                      ||+++.....  .......||+.|+|||.+.+. .++.++|||||||++|||+++..|++.
T Consensus       201 fG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~  258 (357)
T PHA03209        201 LGAAQFPVVA--PAFLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFE  258 (357)
T ss_pred             CccccccccC--cccccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCcccc
Confidence            9999753221  122345689999999999754 478899999999999999997776543

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.8e-41  Score=300.44  Aligned_cols=272  Identities=24%  Similarity=0.387  Sum_probs=202.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCC-----------------CCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccc
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSS-----------------GVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVK  142 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~  142 (373)
                      .++|++.+.||+|+||.||++....                 +..|++|.+...... ..+.+.+|+.++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578999999999999999986532                 246899998765433 3567889999999999999999


Q ss_pred             eeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCC
Q 043074          143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIK  222 (373)
Q Consensus       143 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk  222 (373)
                      +++++..+...++++||+++++|.+++..........    ......+++..++.++.|++.||+|||  +.+++|+|||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~al~~LH--~~~i~H~dlk  157 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL----ACNSKSLSFSTLLYMATQIASGMRYLE--SLNFVHRDLA  157 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc----cccCCCCCHHHHHHHHHHHHHHHHHHH--HcCccccccc
Confidence            9999999999999999999999999998765321110    011123899999999999999999999  7899999999


Q ss_pred             CCceEeCCCCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh--CCCCCCC
Q 043074          223 SSNVLLDSDFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT--QIRPNLP  299 (373)
Q Consensus       223 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~--g~~p~~~  299 (373)
                      |+||+++.++.++|+|||+++....... .......++..|+|||.+.+ ..++.++||||||+++|||++  +..|+..
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            9999999999999999999976533221 12233456778999999874 347889999999999999998  4455422


Q ss_pred             cccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                      ..    ..............      ......... +..++.++.+++.+||+.||.+||++.+|++.|++
T Consensus       237 ~~----~~~~~~~~~~~~~~------~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         237 LT----DQQVIENAGHFFRD------DGRQIYLPR-PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             cC----hHHHHHHHHhcccc------ccccccCCC-ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            11    11111111111000      000000111 22345689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-41  Score=298.98  Aligned_cols=240  Identities=21%  Similarity=0.367  Sum_probs=186.1

Q ss_pred             eeecCCCceEEEEEeCC-------------------------CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccce
Q 043074           89 IIGDGSFGFVYKAKLSS-------------------------GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKI  143 (373)
Q Consensus        89 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  143 (373)
                      .||+|+||.||+|.+..                         ...|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999996421                         13588998876554445678889999999999999999


Q ss_pred             eeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCC
Q 043074          144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKS  223 (373)
Q Consensus       144 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~  223 (373)
                      ++++.+....++||||+++|+|..++.....              .+++..+..++.|++.||+|||  +++++||||||
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp  145 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--------------RVPVAWKITVAQQLASALSYLE--DKNLVHGNVCA  145 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--cCCccCCCCCc
Confidence            9999999999999999999999999875432              2889999999999999999999  78999999999


Q ss_pred             CceEeCCCC-------ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHH-hCCC
Q 043074          224 SNVLLDSDF-------EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA-TQIR  295 (373)
Q Consensus       224 ~Nill~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~-~g~~  295 (373)
                      +||+++..+       .+|++|||++......     ....++..|+|||.+.+...++.++||||||+++|||+ +|..
T Consensus       146 ~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~  220 (274)
T cd05076         146 KNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEV  220 (274)
T ss_pred             ccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999997643       3899999988643211     12346788999999876566789999999999999995 6777


Q ss_pred             CCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          296 PNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       296 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                      |+......    ....+.   ..        ....     +......+.+++.+||+.+|++||++.++++.|+
T Consensus       221 p~~~~~~~----~~~~~~---~~--------~~~~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         221 PLKERTPS----EKERFY---EK--------KHRL-----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             CccccChH----HHHHHH---Hh--------ccCC-----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            75432111    111110   00        0011     1112346899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.1e-41  Score=293.23  Aligned_cols=252  Identities=27%  Similarity=0.446  Sum_probs=199.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      .+|++.+.||.|+||.||++.+.++..+++|.+..... ....+.+|++++++++|||++++++++......++++||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            36777899999999999999887788999999865433 23578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +++|.+++.....              ++++..+..++.|++.|++|||  +.+++|+||||+||+++.++.++|+|||+
T Consensus        83 ~~~L~~~~~~~~~--------------~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~  146 (256)
T cd05112          83 HGCLSDYLRAQRG--------------KFSQETLLGMCLDVCEGMAYLE--SSNVIHRDLAARNCLVGENQVVKVSDFGM  146 (256)
T ss_pred             CCcHHHHHHhCcc--------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccccccceEEEcCCCeEEECCCcc
Confidence            9999999875432              2789999999999999999999  78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      +...............++..|+|||.+.+ ..++.++||||||+++|||++ |..|+.....       .........  
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~--  216 (256)
T cd05112         147 TRFVLDDQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-------SEVVETINA--  216 (256)
T ss_pred             eeecccCcccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHhC--
Confidence            87653322211222334678999999874 447889999999999999998 7777543111       111111110  


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                       ......        +...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       217 -~~~~~~--------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         217 -GFRLYK--------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -CCCCCC--------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence             001111        1112458999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5e-41  Score=299.03  Aligned_cols=253  Identities=26%  Similarity=0.378  Sum_probs=201.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|++.+.||.|+||.||+|... ++..+++|.+........+.+.+|+.+++.++|||++++++.+..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            467899999999999999999765 5889999999776665667788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|..++.+...              .+++..+..++.|++.|+.|||  +.+++||||||+||+++.++.++|+||
T Consensus        91 ~~~~~l~~~~~~~~~--------------~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~df  154 (292)
T cd06644          91 CPGGAVDAIMLELDR--------------GLTEPQIQVICRQMLEALQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADF  154 (292)
T ss_pred             CCCCcHHHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHh--cCCeeecCCCcceEEEcCCCCEEEccC
Confidence            999999988765432              2899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |++....... .......++..|+|||.+.+    ...++.++|+|||||++|||++|..|+.....       ......
T Consensus       155 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~  226 (292)
T cd06644         155 GVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLK  226 (292)
T ss_pred             ccceeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHH
Confidence            9987543221 12233457889999999852    23467789999999999999999998643211       111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....      ..+..   ..+...+.++.+++.+||+.||++||++.++++
T Consensus       227 ~~~~------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         227 IAKS------EPPTL---SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HhcC------CCccC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1100      00111   012234557899999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.5e-41  Score=295.73  Aligned_cols=256  Identities=23%  Similarity=0.373  Sum_probs=190.6

Q ss_pred             CeeecCCCceEEEEEeC---CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCC
Q 043074           88 KIIGDGSFGFVYKAKLS---SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENG  163 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  163 (373)
                      +.||+|+||.||+|...   ++..+++|.+...... ....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            35899999999999764   3467899988654432 2346888999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecccc
Q 043074          164 SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR  243 (373)
Q Consensus       164 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  243 (373)
                      +|.+++........          ...++..+..++.|++.|++|||  +.+++|+||||+||+++.+++++|+|||++.
T Consensus        81 ~L~~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~  148 (269)
T cd05087          81 DLKGYLRSCRKAEL----------MTPDPTTLQRMACEIALGLLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSH  148 (269)
T ss_pred             cHHHHHHHhhhccc----------ccccHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEECCccccc
Confidence            99999976432110          12677888899999999999999  7899999999999999999999999999987


Q ss_pred             ccCCCCCc-ccccccccccccCccccCCCC------CCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHH
Q 043074          244 RIDTSHSH-VSTQVAGTMGYMPPEYLGGNT------AATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       244 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~------~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      ........ ......++..|+|||.+.+..      .++.++|+||||+++|||++ |..||......    .....   
T Consensus       149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~~~~~---  221 (269)
T cd05087         149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----QVLTY---  221 (269)
T ss_pred             cccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----HHHHH---
Confidence            54322211 122345678899999986321      35779999999999999996 88886332111    11111   


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                       ...........+.+     ....+..+.+++..|| .+|++|||+++|+..|+
T Consensus       222 -~~~~~~~~~~~~~~-----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         222 -TVREQQLKLPKPRL-----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             -HhhcccCCCCCCcc-----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence             00011111111111     2223457889999999 68999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.9e-41  Score=297.97  Aligned_cols=269  Identities=28%  Similarity=0.474  Sum_probs=203.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  153 (373)
                      .++|+..+.||+|+||.||++...      ++..+++|.+..... .....+.+|+.+++.++|||++++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888999999999999999753      467899999865433 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcc-------cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCce
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGS-------KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV  226 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~-------~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Ni  226 (373)
                      ++++||+++|+|.+++............       ........+++.+++.++.|++.||+|||  +++++||||||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH--~~~i~H~dl~p~ni  161 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDLATRNC  161 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCeecccccHhhe
Confidence            9999999999999999865422111110       00111224889999999999999999999  78999999999999


Q ss_pred             EeCCCCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCC
Q 043074          227 LLDSDFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDG  304 (373)
Q Consensus       227 ll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~  304 (373)
                      ++++++.++|+|||++........ ........+..|+|||.+.+. .++.++|||||||++|||++ |..|+.....  
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~--  238 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--  238 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            999999999999999876432211 112223346679999998744 47889999999999999998 7677643211  


Q ss_pred             CcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                           .++...... ....          ..+...+.++.+++.+||+.||.+||++.|+++.|++
T Consensus       239 -----~~~~~~~~~-~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         239 -----EEVIYYVRD-GNVL----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -----HHHHHHHhc-CCCC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                 111111111 1100          0122345689999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.6e-41  Score=297.46  Aligned_cols=252  Identities=26%  Similarity=0.466  Sum_probs=191.9

Q ss_pred             CeeecCCCceEEEEEeC----CCCEEEEEEeCccc-cccHHHHHHHHHHHhcCCCCCccceeeEEe-eCCeeEEEEEecC
Q 043074           88 KIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVE  161 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  161 (373)
                      +.||+|+||.||+|...    ++..+|+|.+.... ....+.+.+|+.+++.++|||++++++++. .+...++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36899999999999753    24579999885432 233567889999999999999999999775 4556789999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +|+|.+++......              .++..+..++.|++.||.|||  +.+++||||||+||++++++.+||+|||+
T Consensus        81 ~~~L~~~~~~~~~~--------------~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlk~~nili~~~~~~kl~dfg~  144 (262)
T cd05058          81 HGDLRNFIRSETHN--------------PTVKDLIGFGLQVAKGMEYLA--SKKFVHRDLAARNCMLDESFTVKVADFGL  144 (262)
T ss_pred             CCCHHHHHHhcCCC--------------CCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCccc
Confidence            99999999754321              677888999999999999999  78999999999999999999999999999


Q ss_pred             ccccCCCCC---cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          242 ARRIDTSHS---HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       242 ~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ++.......   .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+++...      ..+.......
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~  217 (262)
T cd05058         145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLLQ  217 (262)
T ss_pred             cccccCCcceeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhc
Confidence            976432211   11122345678999999874 4578899999999999999997666443211      1111111111


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhC
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA  373 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~~  373 (373)
                       ..       ..   ..+...+..+.+++.+||+.+|++||++.++++.|+++++
T Consensus       218 -~~-------~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         218 -GR-------RL---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             -CC-------CC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence             00       00   0022234589999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7e-41  Score=292.36  Aligned_cols=249  Identities=26%  Similarity=0.409  Sum_probs=197.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEE-eeCCeeEEEEEec
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC-ASGLDRVLIYEFV  160 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~  160 (373)
                      ++|++.+.||+|+||.||++... +..+++|.+.....  .+.+.+|+.++++++|+|++++++++ .++...++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888899999999999999765 78899999865432  35788999999999999999999976 4556789999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++++|.+++......             .+++..++.++.|++.||+|||  +++++||||||+||++++++.+||+|||
T Consensus        83 ~~~~L~~~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg  147 (256)
T cd05082          83 AKGSLVDYLRSRGRS-------------VLGGDCLLKFSLDVCEAMEYLE--ANNFVHRDLAARNVLVSEDNVAKVSDFG  147 (256)
T ss_pred             CCCcHHHHHHhcCCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCEeccccchheEEEcCCCcEEecCCc
Confidence            999999998765432             2789999999999999999999  7999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      +++......    ....++..|+|||.+.+ ..++.++||||||+++|||++ |..|+...       ...+....... 
T Consensus       148 ~~~~~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-------~~~~~~~~~~~-  214 (256)
T cd05082         148 LTKEASSTQ----DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------PLKDVVPRVEK-  214 (256)
T ss_pred             cceeccccC----CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHhc-
Confidence            987643221    22334568999999874 457889999999999999998 77775321       11111111111 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                           ....     ..+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       215 -----~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         215 -----GYKM-----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -----CCCC-----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                 0011     11234466899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.1e-41  Score=303.91  Aligned_cols=244  Identities=21%  Similarity=0.306  Sum_probs=190.5

Q ss_pred             CeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||++... +++.+|+|++.+...   ...+.+.+|+.++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999764 678999999976432   2345578899998888 699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|..++....               .+++..+..++.|++.||+|||  +++++||||||+||+++.++.+||+|||++
T Consensus        81 ~~L~~~~~~~~---------------~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~  143 (327)
T cd05617          81 GDLMFHMQRQR---------------KLPEEHARFYAAEICIALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMC  143 (327)
T ss_pred             CcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEeCCCCEEEeccccc
Confidence            99999887543               2899999999999999999999  789999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE  322 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (373)
                      +...... .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||........ ....++........  
T Consensus       144 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~--  218 (327)
T cd05617         144 KEGLGPG-DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILEK--  218 (327)
T ss_pred             eeccCCC-CceecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHhC--
Confidence            7532211 22334678999999999975 4578899999999999999999999754332221 11112221111110  


Q ss_pred             cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 043074          323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMS  362 (373)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (373)
                            ..   ..+...+..+.+++.+||+.||++||++.
T Consensus       219 ------~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         219 ------PI---RIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             ------CC---CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence                  00   01223345789999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.8e-41  Score=298.50  Aligned_cols=250  Identities=25%  Similarity=0.319  Sum_probs=195.9

Q ss_pred             CCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      |+..+.||+|+||.||++... +++.+|+|.+......   ....+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999654 7899999998654322   234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++......             .+++..+..++.|++.||.|||  +.+++||||||+||++++++.++|+||
T Consensus        82 ~~g~~L~~~l~~~~~~-------------~l~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nil~~~~~~~~l~Df  146 (285)
T cd05630          82 MNGGDLKFHIYHMGEA-------------GFEEGRAVFYAAEICCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDL  146 (285)
T ss_pred             cCCCcHHHHHHHhccc-------------CCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeec
Confidence            9999999998654322             2889999999999999999999  799999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++.......  ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||.........   ........  
T Consensus       147 g~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~--  218 (285)
T cd05630         147 GLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVK--  218 (285)
T ss_pred             cceeecCCCc--cccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhh--
Confidence            9987643221  12234689999999999754 4788999999999999999999997542211100   00000000  


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA-----MSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~l~~  366 (373)
                           .....     .+...+..+.+++.+||+.||++|||     ++++++
T Consensus       219 -----~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         219 -----EVQEE-----YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -----hhhhh-----cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                 00001     12233457899999999999999999     778775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.1e-41  Score=311.94  Aligned_cols=262  Identities=22%  Similarity=0.295  Sum_probs=194.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      ..|.+.+.||+|+||.||++... +++.||+|....      ..+.+|+.++++++|+||+++++++..+...++|+|++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            46889999999999999999764 578899996432      23568999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                       .++|.+++.....              ++++.+++.++.|++.||.|||  +++|+||||||+|||++.++.+||+|||
T Consensus       243 -~~~L~~~l~~~~~--------------~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDLKP~NILl~~~~~vkL~DFG  305 (461)
T PHA03211        243 -RSDLYTYLGARLR--------------PLGLAQVTAVARQLLSAIDYIH--GEGIIHRDIKTENVLVNGPEDICLGDFG  305 (461)
T ss_pred             -CCCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCEEECcCCHHHEEECCCCCEEEcccC
Confidence             5789888865432              2899999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH-HHHHHHHHH
Q 043074          241 LARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL-LEWARTMEA  318 (373)
Q Consensus       241 ~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~  318 (373)
                      +++....... .......||..|+|||++.+. .++.++|||||||++|||++|..|++........... .........
T Consensus       306 la~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~  384 (461)
T PHA03211        306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQ  384 (461)
T ss_pred             CceecccccccccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHh
Confidence            9986533221 122345689999999999754 4788999999999999999998876554322211111 011111100


Q ss_pred             hccccccc--------------------cCccccccCC--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          319 RNKEIEMV--------------------DSNISREELS--EAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       319 ~~~~~~~~--------------------~~~~~~~~~~--~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      .......+                    ..........  ......+.+++.+||+.||++|||+.|+++.
T Consensus       385 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        385 AQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00000000                    0000000000  0123468899999999999999999999864

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-41  Score=294.46  Aligned_cols=263  Identities=28%  Similarity=0.440  Sum_probs=196.0

Q ss_pred             CeeecCCCceEEEEEeC-CCC--EEEEEEeCccc-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLS-SGV--TVAIKKLDKDA-FQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||+|..+ ++.  .+++|.+.... ....+.+.+|+.++.++ +||||+++++++......+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999765 343  46888886433 23345788999999999 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCc-ccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          163 GSLDQWLHDTSRNDDVDG-SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      |+|.+++........... .........+++.++..++.|++.|++|||  +++++|+||||+||++++++.+||+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccccceEEEcCCCeEEECCCCC
Confidence            999999976542211100 001111224889999999999999999999  79999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      +......  ........+..|+|||.+.+ ..++.++||||||+++|||++ |..||.....       .+........ 
T Consensus       159 ~~~~~~~--~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------~~~~~~~~~~-  227 (270)
T cd05047         159 SRGQEVY--VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYEKLPQG-  227 (270)
T ss_pred             ccccchh--hhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCH-------HHHHHHHhCC-
Confidence            8632211  11111223567999999864 457889999999999999997 8888643211       1111111110 


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhC
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA  373 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~~  373 (373)
                           ....     .+..++.++.+++.+||+.||.+||++.+++..|++++.
T Consensus       228 -----~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~  270 (270)
T cd05047         228 -----YRLE-----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  270 (270)
T ss_pred             -----CCCC-----CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence                 0000     122345589999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.7e-41  Score=305.86  Aligned_cols=256  Identities=20%  Similarity=0.234  Sum_probs=196.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||++..+ +++.+|+|.+.+...   .....+.+|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47888999999999999999765 578899999865321   12345788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.+...              .+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+||+
T Consensus        81 ey~~~g~L~~~l~~~~~--------------~l~~~~~~~~~~qi~~al~~lH--~~~iiHrDlkp~Nili~~~~~~kL~  144 (332)
T cd05623          81 DYYVGGDLLTLLSKFED--------------RLPEDMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRLA  144 (332)
T ss_pred             eccCCCcHHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEe
Confidence            99999999999976432              2888999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |||++...............||+.|+|||++.+    ...++.++|||||||++|||++|..||....       ..+..
T Consensus       145 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-------~~~~~  217 (332)
T cd05623         145 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETY  217 (332)
T ss_pred             ecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-------HHHHH
Confidence            999987654333222334578999999999862    3457889999999999999999999975421       11111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRE--RPAMSYVVQL  367 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~l~~~  367 (373)
                      ........       ..........++.++.+++.+|+..++.+  ||++.++++.
T Consensus       218 ~~i~~~~~-------~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         218 GKIMNHKE-------RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHhCCCc-------cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            11111100       00000111234568899999988665444  6888888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1e-40  Score=293.72  Aligned_cols=255  Identities=23%  Similarity=0.375  Sum_probs=199.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCC----CCEEEEEEeCccc-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSS----GVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ++|.+.+.||+|+||.||+|...+    ...+++|...... ....+.+.+|+.+++.++||||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            467888999999999999997543    3468999886654 3345678899999999999999999998875 457899


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +||+++++|.+++.....              .+++..+..++.|++.||+|||  +.+++|+||||+||+++.++.++|
T Consensus        85 ~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~l~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l  148 (270)
T cd05056          85 MELAPLGELRSYLQVNKY--------------SLDLASLILYSYQLSTALAYLE--SKRFVHRDIAARNVLVSSPDCVKL  148 (270)
T ss_pred             EEcCCCCcHHHHHHhCCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeccccChheEEEecCCCeEE
Confidence            999999999999976432              2889999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      +|||+++..............++..|+|||.+.+ ..++.++||||||+++||+++ |..||......    ....+   
T Consensus       149 ~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~---  220 (270)
T cd05056         149 GDFGLSRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGR---  220 (270)
T ss_pred             ccCceeeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHH---
Confidence            9999998654332222222334568999999864 457889999999999999996 88886432211    11111   


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ... ..       ..   ..+..++..+.+++.+|+..+|.+|||+.++++.|+++.
T Consensus       221 ~~~-~~-------~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         221 IEN-GE-------RL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             HHc-CC-------cC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            110 00       00   113344668999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.3e-41  Score=295.88  Aligned_cols=255  Identities=24%  Similarity=0.355  Sum_probs=187.9

Q ss_pred             eeecCCCceEEEEEeCC---CCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCC
Q 043074           89 IIGDGSFGFVYKAKLSS---GVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGS  164 (373)
Q Consensus        89 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  164 (373)
                      .||+|+||.||+|...+   ...+++|.+...... ....+.+|+..++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999996543   356888877544332 24567899999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccc
Q 043074          165 LDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       165 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                      |.+++........          ...++.....++.|++.|++|||  +.+++||||||+||++++++.+||+|||++..
T Consensus        82 L~~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  149 (269)
T cd05042          82 LKNYLRSNRGMVA----------QMAQKDVLQRMACEVASGLLWLH--QADFIHSDLALRNCQLTADLSVKIGDYGLALE  149 (269)
T ss_pred             HHHHHHhcccccc----------ccccHHHHHHHHHHHHHHHHHHH--hcCEecccccHhheEecCCCcEEEeccccccc
Confidence            9999977543210          11567888999999999999999  78999999999999999999999999999875


Q ss_pred             cCCCCC-cccccccccccccCccccCC------CCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHH
Q 043074          245 IDTSHS-HVSTQVAGTMGYMPPEYLGG------NTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       245 ~~~~~~-~~~~~~~g~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      ...... .......++..|+|||++..      ...++.++||||||+++|||++ |..|+.. ....      +.....
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~-~~~~------~~~~~~  222 (269)
T cd05042         150 QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD-LSDE------QVLKQV  222 (269)
T ss_pred             cccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc-CCHH------HHHHHH
Confidence            322211 11122345678999998742      2346789999999999999999 5555432 1110      001111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                      .. .     ....+.....+...+..+.+++..|| .||++||++++|++.|.
T Consensus       223 ~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         223 VR-E-----QDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             hh-c-----cCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            00 1     11111112223345567888999999 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-41  Score=296.24  Aligned_cols=264  Identities=25%  Similarity=0.445  Sum_probs=202.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  153 (373)
                      .++|.+.+.||+|+||.||+|..+      ++..|++|.+..... .....+.+|+.++..++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            357888999999999999999754      246899999865432 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++|+||+++|+|.+++.........     ......+++..++.++.|++.||.|||  +.+++|+||||+||+++.++.
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~di~p~nill~~~~~  157 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAEN-----NPGLGPPTLQKFIQMAAEIADGMAYLA--AKKFVHRDLAARNCMVAEDLT  157 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhh-----ccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccChheEEEcCCCC
Confidence            9999999999999999764432110     001123789999999999999999999  899999999999999999999


Q ss_pred             eEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHH
Q 043074          234 AHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  311 (373)
                      +||+|||+++....... .......++..|+|||.+.+ ..++.++||||||+++||+++ |..|+.....    .....
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~~  232 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----EEVLK  232 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCH----HHHHH
Confidence            99999999986543321 12223456788999999864 447889999999999999998 7777532111    11111


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                      +   .. ...     ...     .+..++..+.+++.+||+.+|++|||+.++++.|++
T Consensus       233 ~---~~-~~~-----~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         233 F---VI-DGG-----HLD-----LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             H---Hh-cCC-----CCC-----CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            1   11 100     001     122346689999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.1e-41  Score=296.81  Aligned_cols=262  Identities=25%  Similarity=0.422  Sum_probs=203.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-----CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEee--CCee
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-----SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCAS--GLDR  153 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  153 (373)
                      +.|+..+.||+|+||.||++...     ++..+|+|.+...... ..+.+.+|++.++.++||||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46777889999999999999753     4688999999765543 45678999999999999999999999877  5678


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++++||+++++|.+++.....              .+++..+..++.|++.||+|||  +++++|+||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~--------------~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~nil~~~~~~  147 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD--------------QINLKRLLLFSSQICKGMDYLG--SQRYIHRDLAARNILVESEDL  147 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc--------------ccCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCC
Confidence            999999999999999976542              2899999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc-----
Q 043074          234 AHISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE-----  306 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~-----  306 (373)
                      ++|+|||.+.........  ......++..|+|||.+.+. .++.++||||||+++|||++|..|+.........     
T Consensus       148 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~  226 (284)
T cd05038         148 VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA  226 (284)
T ss_pred             EEEcccccccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccc
Confidence            999999999876532211  11122345679999998744 5788999999999999999999886543222111     


Q ss_pred             ---ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          307 ---VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       307 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                         .....+......          ...... +..++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus       227 ~~~~~~~~~~~~~~~----------~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         227 QGQMIVTRLLELLKE----------GERLPR-PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cccccHHHHHHHHHc----------CCcCCC-CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence               001111111110          000111 234456899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-41  Score=306.24  Aligned_cols=241  Identities=24%  Similarity=0.292  Sum_probs=190.4

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      +|.+.+.||+|+||.||+|... +++.||+|.+.+...   ...+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999765 678999999875432   2234566777887777 5899999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.....               +++.++..++.|++.||+|||  +.+++||||||+|||+++++.+||+
T Consensus        81 E~~~~g~L~~~~~~~~~---------------~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kL~  143 (323)
T cd05616          81 EYVNGGDLMYQIQQVGR---------------FKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIA  143 (323)
T ss_pred             cCCCCCCHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCEEecCCCHHHeEECCCCcEEEc
Confidence            99999999999876442               889999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++...... .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||.....    ..+   .....
T Consensus       144 DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~---~~~i~  214 (323)
T cd05616         144 DFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DEL---FQSIM  214 (323)
T ss_pred             cCCCceecCCCC-CccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCH----HHH---HHHHH
Confidence            999987543221 12234568999999999975 4578999999999999999999999753211    111   11111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                      ..       ...     .+...+.++.+++.+||+.||.+|++.
T Consensus       215 ~~-------~~~-----~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         215 EH-------NVA-----YPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             hC-------CCC-----CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            10       001     122345678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.2e-41  Score=299.35  Aligned_cols=264  Identities=22%  Similarity=0.285  Sum_probs=198.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ++|+..+.||+|+||.||+|..+ +++.|++|.+.....  ...+.+.+|+.++++++|||++++++++..+...++|+|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47888899999999999999765 689999998854332  223567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++++|..++....               .+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.++|+|
T Consensus        81 ~~~~~~l~~~~~~~~---------------~~~~~~~~~~~~ql~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~~l~d  143 (286)
T cd07847          81 YCDHTVLNELEKNPR---------------GVPEHLIKKIIWQTLQAVNFCH--KHNCIHRDVKPENILITKQGQIKLCD  143 (286)
T ss_pred             ccCccHHHHHHhCCC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCChhhEEEcCCCcEEECc
Confidence            999988888765433               2899999999999999999999  79999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH--
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM--  316 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--  316 (373)
                      ||++........ ......++..|+|||.+.+...++.++|+||||+++|||++|..||......+   .........  
T Consensus       144 fg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~~~~~  219 (286)
T cd07847         144 FGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD---QLYLIRKTLGD  219 (286)
T ss_pred             cccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC
Confidence            999987643321 12234577899999998766667889999999999999999998875322111   011100000  


Q ss_pred             -----HH---hccccccc-cCccc-cc---cCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 -----EA---RNKEIEMV-DSNIS-RE---ELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 -----~~---~~~~~~~~-~~~~~-~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                           ..   ........ .+... ..   ......+..+.+++.+||+.||++||++.+++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         220 LIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                 00   00000000 00000 00   000123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.6e-41  Score=303.27  Aligned_cols=237  Identities=24%  Similarity=0.296  Sum_probs=185.8

Q ss_pred             CeeecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHH-HHhcCCCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEME-TLGKLRHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||+|... +++.||+|++.+....   ....+..|.. +++.++||||+++++.+.+....++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999764 7899999998654321   2234455544 56788999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|..++....               .+++..+..++.||+.||.|||  +++++||||||+|||++.++.+||+|||++
T Consensus        81 g~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH--~~givH~dikp~NIll~~~~~~kl~Dfg~~  143 (323)
T cd05575          81 GELFFHLQRER---------------SFPEPRARFYAAEIASALGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLC  143 (323)
T ss_pred             CCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeccCCC
Confidence            99999987643               2888999999999999999999  789999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE  322 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (373)
                      +..... ........||+.|+|||.+.+ ..++.++|||||||++|||++|..||.....       .+........   
T Consensus       144 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~---  211 (323)
T cd05575         144 KEGIEH-SKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEMYDNILNK---  211 (323)
T ss_pred             cccccC-CCccccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcC---
Confidence            753221 122334568999999999875 4478899999999999999999999754211       1111111110   


Q ss_pred             cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 043074          323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMS  362 (373)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (373)
                          ...+     ....+..+.+++.+||+.||++||++.
T Consensus       212 ----~~~~-----~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         212 ----PLRL-----KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ----CCCC-----CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                0011     122355789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=290.61  Aligned_cols=248  Identities=27%  Similarity=0.429  Sum_probs=194.0

Q ss_pred             CeeecCCCceEEEEEeC-C---CCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLS-S---GVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||+|... .   +..+++|.+...... ..+.+.+|+.+++.++|||++++++++. ....++|+||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999643 2   378999998765542 3457889999999999999999999876 4567999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      ++|.+++.....               +++..+..++.|++.||+|||  +.+++|+||||+||+++.++.+||+|||++
T Consensus        80 ~~L~~~l~~~~~---------------~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~nili~~~~~~kl~df~~~  142 (257)
T cd05060          80 GPLLKYLKKRRE---------------IPVSDLKELAHQVAMGMAYLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMS  142 (257)
T ss_pred             CcHHHHHHhCCC---------------CCHHHHHHHHHHHHHHHHHHh--hcCeeccCcccceEEEcCCCcEEecccccc
Confidence            999999976542               889999999999999999999  789999999999999999999999999999


Q ss_pred             cccCCCCCccc--ccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          243 RRIDTSHSHVS--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       243 ~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      +..........  ....++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....    ......+.   .. 
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~----~~~~~~~~---~~-  213 (257)
T cd05060         143 RALGAGSDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK----GAEVIAML---ES-  213 (257)
T ss_pred             ceeecCCcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCC----HHHHHHHH---Hc-
Confidence            87643322211  11223467999999874 447889999999999999998 888764321    11111111   11 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ...          ...+..++..+.+++.+||+.+|++||++.++++.|+++-
T Consensus       214 ~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         214 GER----------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCc----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            100          0113334568999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.2e-41  Score=294.55  Aligned_cols=253  Identities=26%  Similarity=0.380  Sum_probs=199.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      ++|.+.+.||+|+||.||+|.. .+++.+++|.++.........+.+|+.+++.++||||+++++.+......++++||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4677888999999999999965 468899999987665555567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++++|.+++....               .+++.++..++.|++.|+.|||  +.+++|+||||+||+++.++.++|+|||
T Consensus        89 ~~~~L~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd06645          89 GGGSLQDIYHVTG---------------PLSESQIAYVSRETLQGLYYLH--SKGKMHRDIKGANILLTDNGHVKLADFG  151 (267)
T ss_pred             CCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECcce
Confidence            9999999987543               2889999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccC--CCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLG--GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ++....... .......|+..|+|||.+.  ....++.++|+|||||++|+|++|..|+.......       .......
T Consensus       152 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-------~~~~~~~  223 (267)
T cd06645         152 VSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-------ALFLMTK  223 (267)
T ss_pred             eeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-------hHHhhhc
Confidence            987654322 1223456889999999874  23447789999999999999999999965422110       0000000


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .     ...+.....  ....+..+.+++.+||+.||++||++++|++
T Consensus       224 ~-----~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         224 S-----NFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             c-----CCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0     000000000  1123457899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-40  Score=307.22  Aligned_cols=262  Identities=19%  Similarity=0.257  Sum_probs=196.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC---CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS---SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ..+|.+.+.||+|+||.||++...   .+..|++|.+...     ....+|+.+++.++||||+++++++......+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999643   4678999988653     23468999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      |++ +++|.+++....               ++++.+++.++.|++.||.|||  +++|+||||||+|||++.++.++|+
T Consensus       166 e~~-~~~l~~~l~~~~---------------~l~~~~~~~i~~ql~~aL~~LH--~~givHrDlkp~Nill~~~~~~~l~  227 (392)
T PHA03207        166 PKY-KCDLFTYVDRSG---------------PLPLEQAITIQRRLLEALAYLH--GRGIIHRDVKTENIFLDEPENAVLG  227 (392)
T ss_pred             hhc-CCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEc
Confidence            999 578888884332               2899999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          238 DFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       238 Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      |||++......... ......||+.|+|||.+.+. .++.++|||||||++|||++|..||...........+.......
T Consensus       228 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~  306 (392)
T PHA03207        228 DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM  306 (392)
T ss_pred             cCccccccCcccccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh
Confidence            99999765433221 22345789999999999754 47889999999999999999999986644332111111111110


Q ss_pred             HHhcc----------------ccccccCccccc--cCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNK----------------EIEMVDSNISRE--ELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~----------------~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .....                ......+.....  ......+.++.+++.+||+.||++||++.+++.
T Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        307 QVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             ccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence            00000                000000000000  000112457889999999999999999999985

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-41  Score=298.18  Aligned_cols=253  Identities=32%  Similarity=0.465  Sum_probs=197.1

Q ss_pred             CCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHH--HHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFR--EFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      |++.+.||+|+||.||++... +++.+|+|.+.........  ...+|+..+++++||||+++++++.+....++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            566789999999999999765 5678999999776554322  3456999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++++|.+++....               .+++.++..++.|++.||.+||  +.+++|+||||+||+++.++.++|+|||
T Consensus        81 ~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~L~~Lh--~~~i~H~dikp~NIl~~~~~~~~l~Dfg  143 (260)
T PF00069_consen   81 PGGSLQDYLQKNK---------------PLSEEEILKIAYQILEALAYLH--SKGIVHRDIKPENILLDENGEVKLIDFG  143 (260)
T ss_dssp             TTEBHHHHHHHHS---------------SBBHHHHHHHHHHHHHHHHHHH--HTTEEESSBSGGGEEESTTSEEEESSGT
T ss_pred             ccccccccccccc---------------cccccccccccccccccccccc--cccccccccccccccccccccccccccc
Confidence            9999999998333               2899999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      .+..... .........++..|+|||.+......+.++||||+|+++|+|++|..|+......    ............ 
T Consensus       144 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~----~~~~~~~~~~~~-  217 (260)
T PF00069_consen  144 SSVKLSE-NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD----DQLEIIEKILKR-  217 (260)
T ss_dssp             TTEESTS-TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH----HHHHHHHHHHHT-
T ss_pred             ccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccch----hhhhhhhhcccc-
Confidence            9976421 2223345668899999999874456889999999999999999999997653100    000100000000 


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .    +......   .......+.+++.+||+.||++||++.++++
T Consensus       218 ~----~~~~~~~---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  218 P----LPSSSQQ---SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             H----HHHHTTS---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             c----ccccccc---cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0    0000000   0001268999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.7e-41  Score=305.58  Aligned_cols=255  Identities=22%  Similarity=0.232  Sum_probs=195.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|.+.+.||+|+||.||++... +++.||+|.+.+...   .....+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999765 688999999865321   22345788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.....              .+++..+..++.|++.||+|||  +++++||||||+||+++.++.+||+
T Consensus        81 Ey~~gg~L~~~l~~~~~--------------~l~~~~~~~~~~qi~~~L~~lH--~~~iiHrDlkp~Nill~~~~~~kl~  144 (331)
T cd05624          81 DYYVGGDLLTLLSKFED--------------RLPEDMARFYIAEMVLAIHSIH--QLHYVHRDIKPDNVLLDMNGHIRLA  144 (331)
T ss_pred             eCCCCCcHHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCchHHEEEcCCCCEEEE
Confidence            99999999999976432              2888999999999999999999  8999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCC----CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN----TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |||++...............||+.|+|||.+.+.    ..++.++||||||+++|||++|..||.....       .+..
T Consensus       145 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~  217 (331)
T cd05624         145 DFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETY  217 (331)
T ss_pred             eccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-------HHHH
Confidence            9999987654333223345689999999998642    3467899999999999999999999753221       1111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRE--RPAMSYVVQ  366 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~l~~  366 (373)
                      .......       ............+.++.+++.+|+..++++  |++++++++
T Consensus       218 ~~i~~~~-------~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         218 GKIMNHE-------ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             HHHHcCC-------CcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            1111100       000000001223567899999999866544  457777654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3e-41  Score=298.10  Aligned_cols=261  Identities=26%  Similarity=0.415  Sum_probs=199.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  153 (373)
                      .++|.+.+.||+|+||.||+|.+.      .+..|++|.+...... ....+.+|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            457888999999999999999764      3577899988654433 245688999999999999999999999998899


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC-
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-  232 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~-  232 (373)
                      ++|+||+++++|.+++........        ....+++..+++++.||+.||+|||  +++++|+||||+||+++.++ 
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~nil~~~~~~  154 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPE--------RPSSLTMKDLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGP  154 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCC--------CCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchheEEEeccCC
Confidence            999999999999999977643211        1113899999999999999999999  78999999999999998764 


Q ss_pred             --ceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCccc
Q 043074          233 --EAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVG  308 (373)
Q Consensus       233 --~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~  308 (373)
                        .+||+|||+++........ .......+..|+|||.+.+ ..++.++|||||||++|||++ |..||.....      
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~------  227 (277)
T cd05036         155 GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN------  227 (277)
T ss_pred             CcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence              5999999999875322111 1112233567999999874 448899999999999999997 7777542111      


Q ss_pred             HHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          309 LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                       ............           ...+..++..+.+++.+||+.+|++||++.+|++.|++
T Consensus       228 -~~~~~~~~~~~~-----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         228 -QEVMEFVTGGGR-----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             -HHHHHHHHcCCc-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence             011111111000           01123345689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.6e-40  Score=297.82  Aligned_cols=258  Identities=27%  Similarity=0.346  Sum_probs=198.2

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|++.+.||+|+||.||++... ++..+++|.+..... .....+.+|++++++++||||+++++++.+++..++|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46888999999999999999754 688899998865432 2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++....               ++++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+||
T Consensus        81 ~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dl~p~nil~~~~~~~~l~df  144 (308)
T cd06615          81 MDGGSLDQVLKKAG---------------RIPENILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDF  144 (308)
T ss_pred             cCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHh-hCCEEECCCChHHEEEecCCcEEEccC
Confidence            99999999997653               28899999999999999999994 358999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH-
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA-  318 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  318 (373)
                      |++......   ......++..|+|||.+.+. .++.++|+||||+++|+|++|..|+.......    ...+...... 
T Consensus       145 g~~~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~  216 (308)
T cd06615         145 GVSGQLIDS---MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE----LEAMFGRPVSE  216 (308)
T ss_pred             CCccccccc---ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhh----HHHhhcCcccc
Confidence            998754322   12345688999999998754 47889999999999999999999964322111    0000000000 


Q ss_pred             --------------------------hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          319 --------------------------RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       319 --------------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                                                .........+.+    .....+.++.+++.+||+.||++||++.++++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         217 GEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKL----PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccC----cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                      000000000000    011245579999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-40  Score=290.25  Aligned_cols=248  Identities=27%  Similarity=0.452  Sum_probs=196.2

Q ss_pred             CeeecCCCceEEEEEeCC--C--CEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLSS--G--VTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|++|.||+|.+.+  +  ..+|+|.+..... ...+.+.+|+..+++++||||+++++.+.+ ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999997643  3  3689999977666 456788999999999999999999999988 889999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      ++|.+++......             .+++...+.++.|++.||+|||  +++++|+||+|+||+++.++.+||+|||++
T Consensus        80 ~~L~~~l~~~~~~-------------~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~di~p~nil~~~~~~~kl~dfg~~  144 (257)
T cd05040          80 GSLLDRLRKDALG-------------HFLISTLCDYAVQIANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLM  144 (257)
T ss_pred             CcHHHHHHhcccc-------------cCcHHHHHHHHHHHHHHHHHHH--hCCccccccCcccEEEecCCEEEecccccc
Confidence            9999999865421             2899999999999999999999  899999999999999999999999999999


Q ss_pred             cccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          243 RRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       243 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      +........  ......++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....       ..+........
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~~~~~~~~~  216 (257)
T cd05040         145 RALPQNEDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-------GSQILKKIDKE  216 (257)
T ss_pred             ccccccccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhc
Confidence            876442221  1122446778999999874 447889999999999999998 888864211       11111111110


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                      ..       ..   ..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       217 ~~-------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         217 GE-------RL---ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CC-------cC---CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            00       00   012334568999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.5e-41  Score=292.83  Aligned_cols=250  Identities=22%  Similarity=0.316  Sum_probs=199.4

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      +|++.+.||.|+||.||++... ++..+++|.+.... ....+.+.+|+.+++.++|||++++++.+.++...++++||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999764 68999999985432 233467788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++++|.+++......             .+++.....++.|++.||.|||  +++++|+||||+||++++++.++++|||
T Consensus        81 ~~~~l~~~~~~~~~~-------------~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dl~p~nili~~~~~~~l~dfg  145 (255)
T cd08219          81 DGGDLMQKIKLQRGK-------------LFPEDTILQWFVQMCLGVQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFG  145 (255)
T ss_pred             CCCcHHHHHHhccCC-------------CCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEECCCCcEEEcccC
Confidence            999999988754322             2788999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      .+....... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||....       .......... .
T Consensus       146 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-------~~~~~~~~~~-~  215 (255)
T cd08219         146 SARLLTSPG-AYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANS-------WKNLILKVCQ-G  215 (255)
T ss_pred             cceeecccc-cccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCC-------HHHHHHHHhc-C
Confidence            997654322 122335688899999998754 47889999999999999999999975321       1111111110 0


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      . .         ...+...+..+.+++.+||+.||++||++.+++..
T Consensus       216 ~-~---------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         216 S-Y---------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             C-C---------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            0 0         01123345578999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=310.94  Aligned_cols=246  Identities=28%  Similarity=0.397  Sum_probs=202.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ..|...+.||.|+||.||.++. .+...||||+++....   ..+.++.+|+..|++++|||++.+.|+|......||||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            4566678899999999999964 5788999999865433   45778999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||| -||-.|++.-.+.              |+.+-++..|+.+.+.||+|||  +.+.||||||..|||+++.|.|||+
T Consensus       106 EYC-lGSAsDlleVhkK--------------plqEvEIAAi~~gaL~gLaYLH--S~~~IHRDiKAGNILLse~g~VKLa  168 (948)
T KOG0577|consen  106 EYC-LGSASDLLEVHKK--------------PLQEVEIAAITHGALQGLAYLH--SHNRIHRDIKAGNILLSEPGLVKLA  168 (948)
T ss_pred             HHH-hccHHHHHHHHhc--------------cchHHHHHHHHHHHHHHHHHHH--HhhHHhhhccccceEecCCCeeeec
Confidence            999 7799998876654              4889999999999999999999  7889999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccC--CCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG--GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |||.|....     ....++|||.|||||++.  ..+.|+-+.||||||++..||.-.++|.+....      +..    
T Consensus       169 DFGSAsi~~-----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSA----  233 (948)
T KOG0577|consen  169 DFGSASIMA-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSA----  233 (948)
T ss_pred             cccchhhcC-----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHH----
Confidence            999997654     245678999999999985  456789999999999999999999999653211      111    


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      +   ..+...-.+.+.    ..+.+..+++++..||+.-|.+|||.++++.
T Consensus       234 L---YHIAQNesPtLq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  234 L---YHIAQNESPTLQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             H---HHHHhcCCCCCC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            0   011111112221    4456779999999999999999999999875

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.2e-41  Score=294.72  Aligned_cols=255  Identities=27%  Similarity=0.404  Sum_probs=199.3

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .+++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++++
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            34556666678999999999999754 67889999987766656678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC-CCce
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL--SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-DFEA  234 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~-~~~~  234 (373)
                      ||+++++|.+++.....              ++  ++..+..++.|++.||+|||  +++++||||||+||+++. ++.+
T Consensus        85 e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~qi~~al~~lH--~~~i~h~dl~p~nil~~~~~~~~  148 (268)
T cd06624          85 EQVPGGSLSALLRSKWG--------------PLKDNEQTIIFYTKQILEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVV  148 (268)
T ss_pred             ecCCCCCHHHHHHHhcc--------------cCCCcHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCeE
Confidence            99999999999975422              14  77888999999999999999  789999999999999976 6799


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCC-CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN-TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +|+|||++........ ......+++.|+|||.+.+. ..++.++|+||||+++|+|++|..|+......    ....+.
T Consensus       149 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~----~~~~~~  223 (268)
T cd06624         149 KISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP----QAAMFK  223 (268)
T ss_pred             EEecchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh----hhhHhh
Confidence            9999999876532221 12234578899999998643 34678999999999999999999986432110    011111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .....       ..+     ..+...+.++.+++.+||+.+|.+||++.++++
T Consensus       224 ~~~~~-------~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         224 VGMFK-------IHP-----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hhhhc-------cCC-----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            10000       011     113345568999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.2e-41  Score=298.01  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=197.3

Q ss_pred             CCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      |++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++..+...++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567788999999999999765 5778899998766555567788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      ++|..++.....              ++++..+..++.|++.||.|||  +.+++||||||+||+++.++.++|+|||++
T Consensus        87 ~~l~~~~~~~~~--------------~l~~~~~~~~~~qi~~~L~~LH--~~~i~H~dlkp~nili~~~~~~kl~dfg~~  150 (282)
T cd06643          87 GAVDAVMLELER--------------PLTEPQIRVVCKQTLEALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVS  150 (282)
T ss_pred             CcHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEccCCCEEEcccccc
Confidence            999998765322              3899999999999999999999  789999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ....... .......++..|+|||.+..    ...++.++|||||||++|||++|..|+......       ........
T Consensus       151 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~  222 (282)
T cd06643         151 AKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAK  222 (282)
T ss_pred             ccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-------HHHHHHhh
Confidence            7643221 12233468899999999742    334677899999999999999999986432110       00011100


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .      ....+.   .+...+.++.+++.+||+.||.+||++.++++
T Consensus       223 ~------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         223 S------EPPTLA---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             c------CCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0      000110   12234568999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.8e-41  Score=298.30  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=202.4

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ...+|+..+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++..+...++|+|
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            346899999999999999999975 4799999999976655555678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++++|.+++....                +++.++..++.|++.||.|||  +.+++||||||+||+++.++.++|+|
T Consensus        97 ~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~l~~~L~~LH--~~~i~H~dL~p~Nili~~~~~~~l~D  158 (297)
T cd06656          97 YLAGGSLTDVVTETC----------------MDEGQIAAVCRECLQALDFLH--SNQVIHRDIKSDNILLGMDGSVKLTD  158 (297)
T ss_pred             ccCCCCHHHHHHhCC----------------CCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEECc
Confidence            999999999986532                788999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||++........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..........           
T Consensus       159 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-----------  225 (297)
T cd06656         159 FGFCAQITPEQS-KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----------  225 (297)
T ss_pred             CccceEccCCcc-CcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-----------
Confidence            999876533221 1233467889999999874 447889999999999999999999975432211000           


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                        ..   ..........+...+..+.+++.+||+.||++||++.++++
T Consensus       226 --~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         226 --LI---ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             --ee---ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00   00000000112334567899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-41  Score=307.42  Aligned_cols=272  Identities=28%  Similarity=0.407  Sum_probs=199.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe------CCCCEEEEEEeCccccc-cHHHHHHHHHHHhcC-CCCCccceeeEEeeC-C
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKL-RHRNIVKILGYCASG-L  151 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  151 (373)
                      .++|++.+.||+|+||.||+|..      .+++.||||.+...... ....+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            45899999999999999999963      35788999999754332 345688999999999 689999999988654 5


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCC----------------------------------------------------
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVD----------------------------------------------------  179 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~----------------------------------------------------  179 (373)
                      ..++++||+++|+|.+++..........                                                    
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999997543110000                                                    


Q ss_pred             cccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCc-ccccccc
Q 043074          180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH-VSTQVAG  258 (373)
Q Consensus       180 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g  258 (373)
                      ..........+++..+..++.|++.||+|||  +++++||||||+||++++++.+||+|||++......... ......+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence            0000000124788999999999999999999  799999999999999999999999999999865322111 1122345


Q ss_pred             cccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCH
Q 043074          259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSE  337 (373)
Q Consensus       259 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (373)
                      +..|+|||.+.+ ..++.++||||||+++|||++ |..|+......      ......... ...     ...     +.
T Consensus       244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~-~~~-----~~~-----~~  305 (343)
T cd05103         244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKE-GTR-----MRA-----PD  305 (343)
T ss_pred             CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhc-cCC-----CCC-----CC
Confidence            678999999874 457889999999999999997 77775321111      011111111 000     000     11


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          338 AGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..+..+.+++..||+.||++||++.+|++.|++++
T Consensus       306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            23457899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3e-41  Score=297.37  Aligned_cols=254  Identities=28%  Similarity=0.421  Sum_probs=197.7

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEeeC------
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCASG------  150 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------  150 (373)
                      ++.+.|+..+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45677888899999999999999754 68899999986543 3345778999999998 699999999998653      


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      ...++++||+++++|.+++......             .+++..+..++.|++.|++|||  +++++|+||+|+||++++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~-------------~l~~~~~~~~~~qi~~~l~~LH--~~~ivh~dl~~~nili~~  146 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGN-------------TLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTE  146 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHEEECC
Confidence            4578999999999999999864322             2889999999999999999999  789999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          231 DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                      ++.++|+|||++....... .......|+..|+|||.+.+    ...++.++|||||||++|||++|..|+.+....   
T Consensus       147 ~~~~~l~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---  222 (272)
T cd06637         147 NAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---  222 (272)
T ss_pred             CCCEEEccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---
Confidence            9999999999987653322 12334568899999999853    234677899999999999999999997532211   


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                         ..... .. .     .......    ...++..+.+++.+||+.||.+||++.++++
T Consensus       223 ---~~~~~-~~-~-----~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         223 ---RALFL-IP-R-----NPAPRLK----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             ---HHHHH-Hh-c-----CCCCCCC----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence               00000 00 0     0011111    1223457899999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-40  Score=289.89  Aligned_cols=255  Identities=31%  Similarity=0.460  Sum_probs=200.1

Q ss_pred             CeeecCCCceEEEEEeCC----CCEEEEEEeCcccccc-HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLSS----GVTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||+|....    +..+++|.+....... .+.+.+|++.+..++|+|++++++++.+....++++||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999997653    8899999997655443 56788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      ++|.+++.......      ......++++.++..++.|++.||+|||  +++++|+||+|+||++++++.++|+|||.+
T Consensus        81 ~~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          81 GDLLDYLRKSRPVF------PSPEKSTLSLKDLLSFAIQIAKGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             CcHHHHHhhccccc------cccccccCCHHHHHHHHHHHHHHHHHHH--cCCcccCccCcceEEECCCCcEEEcccccc
Confidence            99999998763210      0000113899999999999999999999  799999999999999999999999999999


Q ss_pred             cccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          243 RRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       243 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      ........ .......++..|+|||.+.+. .++.++||||||+++|||++ |..|+....       .......... .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~~-~  223 (262)
T cd00192         153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLS-------NEEVLEYLRK-G  223 (262)
T ss_pred             cccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHHc-C
Confidence            87654321 122334578899999998754 57889999999999999999 477754321       1111111111 0


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                           .     ....+..++.++.+++.+||+.||++||++.++++.|+
T Consensus       224 -----~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 -----Y-----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -----C-----CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                 0     01113344678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-41  Score=306.67  Aligned_cols=263  Identities=22%  Similarity=0.266  Sum_probs=195.1

Q ss_pred             HHhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeC----
Q 043074           78 IDATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASG----  150 (373)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----  150 (373)
                      ....++|+..+.||+|+||.||+|.. .+++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            34567899999999999999999965 4788999999865432  2335677899999999999999999987543    


Q ss_pred             --CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe
Q 043074          151 --LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL  228 (373)
Q Consensus       151 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill  228 (373)
                        ...+++++++ +++|.+++....                +++..+..++.|++.||.|||  +++++||||||+||++
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~~----------------l~~~~~~~i~~qi~~aL~~LH--~~~ivHrdikp~Nil~  151 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQK----------------LSDEHVQFLIYQLLRGLKYIH--SAGIIHRDLKPSNVAV  151 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHH--HCCeecccCChhhEEE
Confidence              3468999988 889988876432                889999999999999999999  7999999999999999


Q ss_pred             CCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc
Q 043074          229 DSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG  308 (373)
Q Consensus       229 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  308 (373)
                      +.++.+||+|||+++.....    .....||+.|+|||.+.+...++.++|||||||++|+|++|..||.......   .
T Consensus       152 ~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~  224 (343)
T cd07878         152 NEDCELRILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---Q  224 (343)
T ss_pred             CCCCCEEEcCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---H
Confidence            99999999999999865432    2335689999999999765668889999999999999999999874322110   0


Q ss_pred             HHHHHHHHH--------H-hccccccccC---cccccc---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          309 LLEWARTME--------A-RNKEIEMVDS---NISREE---LSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       309 ~~~~~~~~~--------~-~~~~~~~~~~---~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      +..+.....        . ..........   ......   ........+.+++.+||+.||.+|||+.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         225 LKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000000        0 0000000000   000000   00112345789999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.8e-41  Score=326.90  Aligned_cols=268  Identities=23%  Similarity=0.296  Sum_probs=202.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||+|... +++.||+|++......   ..+.+.+|+.++++++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57889999999999999999764 6899999998654322   2456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++...........    ....++++..+++++.|++.||+|||  +++++||||||+||+++.++.++|+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e----~~~~~lsv~~iL~I~~QIa~AL~yLH--s~GIIHRDLKPeNILLd~dg~vKLi  155 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSK----ELAEKTSVGAFLSIFHKICATIEYVH--SKGVLHRDLKPDNILLGLFGEVVIL  155 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccch----hhhcccCHHHHHHHHHHHHHHHHHHH--HCCccccCCchheEEEcCCCCEEEE
Confidence            99999999999975432211100    01123678889999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCC-----------------cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCc
Q 043074          238 DFGLARRIDTSHS-----------------HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPV  300 (373)
Q Consensus       238 Dfg~~~~~~~~~~-----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  300 (373)
                      |||+++.......                 .......||+.|+|||.+.+. .++.++|||||||++|||++|..|+...
T Consensus       156 DFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             ecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            9999986521110                 011224689999999998754 4788999999999999999999997542


Q ss_pred             ccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhhh
Q 043074          301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-AMSYVVQLLDELV  372 (373)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~l~~~L~~l~  372 (373)
                      ....     ..+..      ...   .+ ... ......+..+.+++.+||+.||++|| +++++.+.|++.+
T Consensus       235 ~~~k-----i~~~~------~i~---~P-~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        235 KGRK-----ISYRD------VIL---SP-IEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             chhh-----hhhhh------hcc---Ch-hhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1110     00000      000   00 000 00123456789999999999999995 5677777777653

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-42  Score=317.66  Aligned_cols=252  Identities=23%  Similarity=0.392  Sum_probs=203.5

Q ss_pred             CCCCeeecCCCceEEEEEe-CC----CCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           85 STDKIIGDGSFGFVYKAKL-SS----GVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~-~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ...++||+|+||+||+|.+ ..    +.+||+|++..... +...++++|+..|.+++|||+++++|+|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3457899999999999964 22    45789999865544 34578999999999999999999999998776 789999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |++.|+|.+|++.++..              +..+..+.|..||++||.|||  ++.++||||..+|+||.+-..+||+|
T Consensus       778 ~mP~G~LlDyvr~hr~~--------------igsq~lLnw~~QIAkgM~YLe--~qrlVHrdLaaRNVLVksP~hvkitd  841 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDN--------------IGSQDLLNWCYQIAKGMKYLE--EQRLVHRDLAARNVLVKSPNHVKITD  841 (1177)
T ss_pred             hcccchHHHHHHHhhcc--------------ccHHHHHHHHHHHHHHHHHHH--hcchhhhhhhhhheeecCCCeEEEEe
Confidence            99999999999987653              888999999999999999999  89999999999999999999999999


Q ss_pred             eccccccCCCCCcccccc-cccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQV-AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      ||+++............. .-.+.|||=|.+. ...++.++|||||||++||++| |..|+......+        +...
T Consensus       842 fgla~ll~~d~~ey~~~~gK~pikwmale~i~-~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------I~dl  912 (1177)
T KOG1025|consen  842 FGLAKLLAPDEKEYSAPGGKVPIKWMALESIR-IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------IPDL  912 (1177)
T ss_pred             cchhhccCcccccccccccccCcHHHHHHHhh-ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------hhHH
Confidence            999998765554433322 2356799999987 5668999999999999999998 666644322221        1111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                               +...-+-.+ +..|+.+++.++.+||..|+..||+++++...+.++.
T Consensus       913 ---------le~geRLsq-PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  913 ---------LEKGERLSQ-PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             ---------HhccccCCC-CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence                     111111122 6778889999999999999999999999999988764

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.4e-41  Score=298.93  Aligned_cols=266  Identities=23%  Similarity=0.324  Sum_probs=197.6

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +|+..+.||+|+||.||+|... +|..+++|.+......  ....+.+|+.++++++|||++++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778889999999999999764 6899999998653221  234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      ++ ++|.+++.....              .+++..+..++.||++||.|||  +.+++|+||||+||+++.++.++|+||
T Consensus        81 ~~-~~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dl~~~nil~~~~~~~~l~df  143 (284)
T cd07839          81 CD-QDLKKYFDSCNG--------------DIDPEIVKSFMFQLLKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADF  143 (284)
T ss_pred             CC-CCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEcCCCcEEECcc
Confidence            96 588887765332              2899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc----------H
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG----------L  309 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~----------~  309 (373)
                      |+++....... ......++..|+|||.+.+...++.++|||||||++|||++|..|+.+.........          .
T Consensus       144 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  222 (284)
T cd07839         144 GLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  222 (284)
T ss_pred             chhhccCCCCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence            99986543222 122345688999999987666678899999999999999999999654332111000          0


Q ss_pred             HHHHHHHHHhc-cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 LEWARTMEARN-KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..|........ ...................+.++.+++.+||+.||.+|||++++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00100000000 0000000000000111234568899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.9e-41  Score=298.87  Aligned_cols=265  Identities=25%  Similarity=0.334  Sum_probs=201.6

Q ss_pred             cChHHHHHhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEe-
Q 043074           72 ISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCA-  148 (373)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-  148 (373)
                      +.++.+....++|++.+.||+|+||.||++... +++.+++|.+..... ....+.+|+.+++.+ +|||++++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            344555667889999999999999999999654 688999998865332 235678899999999 6999999999874 


Q ss_pred             ----eCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCC
Q 043074          149 ----SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS  224 (373)
Q Consensus       149 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~  224 (373)
                          ++...++||||+++++|.+++.......           ..+++..+..++.|++.||.|||  +.+++||||||+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~  153 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG-----------ERMEEPIIAYILHEALMGLQHLH--VNKTIHRDVKGN  153 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccC-----------ccccHHHHHHHHHHHHHHHHHHH--hCCccccCCCHH
Confidence                4457899999999999999886432111           13888999999999999999999  789999999999


Q ss_pred             ceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCCc
Q 043074          225 NVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPV  300 (373)
Q Consensus       225 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~~  300 (373)
                      ||++++++.++|+|||++........ ......|++.|+|||.+..    ...++.++|||||||++|||++|..|+...
T Consensus       154 nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~  232 (286)
T cd06638         154 NILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL  232 (286)
T ss_pred             hEEECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999876543221 2233468899999998753    234678999999999999999999997542


Q ss_pred             ccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      ....      .    .....   ........   .+...+..+.+++.+||+.||++||++.++++.
T Consensus       233 ~~~~------~----~~~~~---~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         233 HPMR------A----LFKIP---RNPPPTLH---QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             chhH------H----Hhhcc---ccCCCccc---CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            2110      0    00000   00000110   122234579999999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=294.48  Aligned_cols=270  Identities=21%  Similarity=0.316  Sum_probs=212.6

Q ss_pred             HHHHHhcCCCCCCCeeecCCCceEEEEEe------CCCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEE
Q 043074           75 SELIDATDNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYC  147 (373)
Q Consensus        75 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~  147 (373)
                      +++....++++...++-+|.||.||.|.+      ++.+.|.+|.++....+ ....++.|...+..+.|||+.++.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            34444567888889999999999999954      34566788888655443 356788999999999999999999998


Q ss_pred             eeC-CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCce
Q 043074          148 ASG-LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV  226 (373)
Q Consensus       148 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Ni  226 (373)
                      ... ...+.++.++.-|+|..|+..++.. +..+.+      .++..+...++.|++.|++|||  +.+++|.||..+|+
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~-~~~~aq------tvtt~qlV~masQla~am~hlh--~~~ViHkDiAaRNC  427 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGD-DPSYAQ------TVTTIQLVLMASQLAMAMEHLH--NHGVIHKDIAARNC  427 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccC-CCcccc------chhHHHHHHHHHHHHHHHHHHH--hcCcccchhhhhcc
Confidence            654 5678889999999999999977632 222222      3788899999999999999999  89999999999999


Q ss_pred             EeCCCCceEEeeeccccccCCCCCccc-ccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCC
Q 043074          227 LLDSDFEAHISDFGLARRIDTSHSHVS-TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDG  304 (373)
Q Consensus       227 ll~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~  304 (373)
                      +|++..+|||+|=.+++.+.+.+.+.. ....++..||+||.+. +..++.++|+|||||+||||+| |+.|+..-+.  
T Consensus       428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~-n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--  504 (563)
T KOG1024|consen  428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ-NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--  504 (563)
T ss_pred             eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHh-hhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--
Confidence            999999999999999998766655443 3345567899999998 5668999999999999999998 5566432111  


Q ss_pred             CcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                        ..+..+             +....+..+ +.+||++++.+|..||...|++||+++|++.-|.++-
T Consensus       505 --fEm~~y-------------lkdGyRlaQ-P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  505 --FEMEHY-------------LKDGYRLAQ-PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             --HHHHHH-------------HhccceecC-CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence              111111             111222222 7889999999999999999999999999999998864

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.5e-41  Score=301.48  Aligned_cols=261  Identities=25%  Similarity=0.341  Sum_probs=198.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ++|+..+.||+|+||.||+|..+ +++.+|+|.+......  ..+.+.+|+++++.++||||+++++++.++...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888899999999999999775 5899999988553322  24567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++++|..+.....               .+++.++..++.|++.||+|||  +.+++|+||+|+||++++++.++|+|
T Consensus        81 ~~~~~~l~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~LH--~~~i~h~~l~p~ni~~~~~~~~~l~d  143 (286)
T cd07846          81 FVDHTVLDDLEKYPN---------------GLDESRVRKYLFQILRGIEFCH--SHNIIHRDIKPENILVSQSGVVKLCD  143 (286)
T ss_pred             cCCccHHHHHHhccC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCcEEEEe
Confidence            999999988765432               2889999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||++....... .......++..|+|||.+.+...++.++||||||+++|||++|.+|+.....      ...+......
T Consensus       144 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~------~~~~~~~~~~  216 (286)
T cd07846         144 FGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD------IDQLYHIIKC  216 (286)
T ss_pred             eeeeeeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch------HHHHHHHHHH
Confidence            99998654332 2223345788999999987666678899999999999999999877643211      1111110000


Q ss_pred             hcccc--------------ccccCccc----cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEI--------------EMVDSNIS----REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~--------------~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .....              ....+...    ........+..+.+++.+||+.+|.+||++.++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         217 LGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00000              00000000    00001233568999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.2e-40  Score=300.09  Aligned_cols=203  Identities=23%  Similarity=0.342  Sum_probs=161.8

Q ss_pred             CCeeecCCCceEEEEEeC---CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeEEEEEecC
Q 043074           87 DKIIGDGSFGFVYKAKLS---SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS--GLDRVLIYEFVE  161 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  161 (373)
                      ...||+|+||.||+|..+   ++..+|+|.+.....  ...+.+|+.+++.++||||+++++++..  +...++|+||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999764   457899999865432  2457789999999999999999998853  457789999985


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe----CCCCceEEe
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL----DSDFEAHIS  237 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill----~~~~~~kl~  237 (373)
                       ++|.+++.........      .....+++..+..++.|++.||.|||  +.+++||||||+||++    +.++.+||+
T Consensus        84 -~~l~~~~~~~~~~~~~------~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07867          84 -HDLWHIIKFHRASKAN------KKPMQLPRSMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             -CcHHHHHHhhhccccC------CCCccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence             5888887643221110      01123889999999999999999999  7899999999999999    566799999


Q ss_pred             eeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCc
Q 043074          238 DFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPV  300 (373)
Q Consensus       238 Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  300 (373)
                      |||+++........  ......+|+.|+|||.+.+...++.++|||||||++|||+||..||...
T Consensus       155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            99999876443221  1234567899999999976666889999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.4e-41  Score=299.64  Aligned_cols=250  Identities=25%  Similarity=0.364  Sum_probs=201.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ..+|+..+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+..++.++|||++++++++..+...++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            45788999999999999999964 57899999999766555567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|..++....                +++.++..++.|++.|++|||  +.+++|+||+|+||+++.++.++|+||
T Consensus        98 ~~~~~L~~~~~~~~----------------l~~~~~~~i~~~l~~al~~LH--~~~i~H~dL~p~Nili~~~~~~kl~df  159 (296)
T cd06655          98 LAGGSLTDVVTETC----------------MDEAQIAAVCRECLQALEFLH--ANQVIHRDIKSDNVLLGMDGSVKLTDF  159 (296)
T ss_pred             cCCCcHHHHHHhcC----------------CCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccC
Confidence            99999999886532                889999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++........ ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||......       .........
T Consensus       160 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-------~~~~~~~~~  230 (296)
T cd06655         160 GFCAQITPEQS-KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RALYLIATN  230 (296)
T ss_pred             ccchhcccccc-cCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhc
Confidence            99876543221 1233467889999999874 44788999999999999999999997442211       111111110


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      . .     ..+   ..+...+..+.+++.+||+.||.+||++.+++.
T Consensus       231 ~-~-----~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         231 G-T-----PEL---QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             C-C-----ccc---CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            0 0     000   012334567899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-40  Score=304.46  Aligned_cols=264  Identities=24%  Similarity=0.265  Sum_probs=192.5

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-----
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASGL-----  151 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  151 (373)
                      ..++|+..+.||+|+||.||++.. .++..||+|.+....  ......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            357899999999999999999965 468999999986532  223456789999999999999999999886443     


Q ss_pred             -eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          152 -DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       152 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                       ..++||||+. ++|.+.+..                 .+++..+..++.|++.||.|||  +++++||||||+||+++.
T Consensus        99 ~~~~lv~e~~~-~~l~~~~~~-----------------~~~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlkp~NIl~~~  158 (359)
T cd07876          99 QDVYLVMELMD-ANLCQVIHM-----------------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKS  158 (359)
T ss_pred             ceeEEEEeCCC-cCHHHHHhc-----------------cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECC
Confidence             4699999995 567666632                 1778889999999999999999  799999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc----
Q 043074          231 DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE----  306 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~----  306 (373)
                      ++.+||+|||+++.....  .......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.........    
T Consensus       159 ~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~  235 (359)
T cd07876         159 DCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI  235 (359)
T ss_pred             CCCEEEecCCCccccccC--ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999999764322  12234568999999999975 45788999999999999999999997643211000    


Q ss_pred             ----ccHHHHHHH-------HHHhccccccc--cC---ccc---cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          307 ----VGLLEWART-------MEARNKEIEMV--DS---NIS---REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       307 ----~~~~~~~~~-------~~~~~~~~~~~--~~---~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                          .....+...       ...........  ..   ...   ........+..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         236 EQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                000000000       00000000000  00   000   00001122457899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-40  Score=294.90  Aligned_cols=254  Identities=25%  Similarity=0.389  Sum_probs=199.3

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|++.+.||+|+||.||++..+ ++..+|+|.+.... ......+.+|+.++++++||||+++++.+......++|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46788899999999999999765 78999999886532 22346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|..++......            ..+++..+..++.|++.||.|||+ +.+++|+||||+||+++.++.++|+||
T Consensus        81 ~~~~~l~~~~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~df  147 (286)
T cd06622          81 MDAGSLDKLYAGGVAT------------EGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDF  147 (286)
T ss_pred             cCCCCHHHHHHhcccc------------CCCCHHHHHHHHHHHHHHHHHHHh-cCCEeeCCCCHHHEEECCCCCEEEeec
Confidence            9999999998764211            128999999999999999999994 358999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCC-----CCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNT-----AATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      |++.......   .....+++.|+|||.+.+..     .++.++|+|||||++|+|++|..||......       .+..
T Consensus       148 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~  217 (286)
T cd06622         148 GVSGNLVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-------NIFA  217 (286)
T ss_pred             CCcccccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-------hHHH
Confidence            9987653221   22345788999999985432     3578999999999999999999997442111       1111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....   .......     ..+...+.++.+++.+||+.+|++||++.+++.
T Consensus       218 ~~~~---~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         218 QLSA---IVDGDPP-----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHH---HhhcCCC-----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            1110   0000001     113345678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.3e-41  Score=295.81  Aligned_cols=263  Identities=27%  Similarity=0.430  Sum_probs=201.3

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      ++|+..+.||+|+||.||+|..+      +...+++|.+...... ....+.+|+.++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888899999999999999753      3467999988664443 3467899999999999999999999999989999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +|+||+++|+|.+++.........      ....++++..+..++.|++.||+|||  +.+++|+||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~------~~~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEK------LKPPPLSTKQKVALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             EEEEecCCCcHHHHHHhccccccc------ccccCCCHHHHHHHHHHHHHHHHHhh--hcCcccCcCccceEEEeCCCcE
Confidence            999999999999999765522110      01113899999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +++|||++...............++..|+|||.+.+. ..+.++||||||+++|+|++ |..|+.....    .   ...
T Consensus       157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----~---~~~  228 (275)
T cd05046         157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----E---EVL  228 (275)
T ss_pred             EEcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccch----H---HHH
Confidence            9999999875433222222334567789999988743 46788999999999999999 5666532111    1   111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                      ..... ..    ....     .+..++..+.+++.+||+.+|.+||++.+++..|++
T Consensus       229 ~~~~~-~~----~~~~-----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         229 NRLQA-GK----LELP-----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             HHHHc-CC----cCCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            11110 00    0000     122345689999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-40  Score=290.50  Aligned_cols=250  Identities=27%  Similarity=0.384  Sum_probs=201.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|+..+.||+|+||.||+|... ++..+++|.+.....  .+.+.+|++++++++|||++++++++.+....++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            367889999999999999999876 478999999865543  57889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++.....              .+++..+..++.|++.||.|||  +.+++|+||+|+||++++++.++|+||
T Consensus        80 ~~~~~L~~~l~~~~~--------------~l~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~ni~~~~~~~~~l~df  143 (256)
T cd06612          80 CGAGSVSDIMKITNK--------------TLTEEEIAAILYQTLKGLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADF  143 (256)
T ss_pred             CCCCcHHHHHHhCcc--------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEECCCCcEEEccc
Confidence            999999999875432              2899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++........ ......++..|+|||.+.+. .++.++||||||+++|+|++|..|+.......          .....
T Consensus       144 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----------~~~~~  211 (256)
T cd06612         144 GVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----------AIFMI  211 (256)
T ss_pred             ccchhcccCcc-ccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----------hhhhh
Confidence            99987543321 22334578899999998754 57889999999999999999999864321110          00000


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..   .....+   ..+...+..+.+++.+||+.||++||++.++++
T Consensus       212 ~~---~~~~~~---~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         212 PN---KPPPTL---SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             cc---CCCCCC---CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            00   000000   112334568999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.3e-41  Score=302.23  Aligned_cols=240  Identities=22%  Similarity=0.272  Sum_probs=186.0

Q ss_pred             CeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHH-HHHhcCCCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEM-ETLGKLRHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||++... +++.+|+|++.+...   .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999765 678899999865332   1223344444 456788999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|.+++.....               +++..+..++.||+.||.|||  +.+++||||||+||+++.++.+||+|||++
T Consensus        81 ~~L~~~~~~~~~---------------~~~~~~~~~~~qi~~~L~~lH--~~giiHrDlkp~Nili~~~~~~kl~DfG~a  143 (325)
T cd05602          81 GELFYHLQRERC---------------FLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLC  143 (325)
T ss_pred             CcHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEEccCCCC
Confidence            999999976432               778888899999999999999  799999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE  322 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (373)
                      +..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.....       .+........   
T Consensus       144 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~---  211 (325)
T cd05602         144 KENIEH-NGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDNILNK---  211 (325)
T ss_pred             cccccC-CCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCH-------HHHHHHHHhC---
Confidence            754221 122334578999999999975 4578899999999999999999999754221       1111111110   


Q ss_pred             cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 043074          323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVV  365 (373)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~  365 (373)
                            ..   ......+..+.+++.+||+.||.+||++.+.+
T Consensus       212 ------~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         212 ------PL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             ------Cc---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence                  00   01223345789999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-41  Score=297.79  Aligned_cols=254  Identities=23%  Similarity=0.379  Sum_probs=202.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|++.+.||.|+||.||++... ++..+++|.+........+.+.+|++++++++|||++++++.+.++...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467889999999999999999764 6889999999766555567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++.....              ++++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+||
T Consensus        84 ~~~~~L~~~~~~~~~--------------~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~nili~~~~~~~l~d~  147 (280)
T cd06611          84 CDGGALDSIMLELER--------------GLTEPQIRYVCRQMLEALNFLH--SHKVIHRDLKAGNILLTLDGDVKLADF  147 (280)
T ss_pred             cCCCcHHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEECCCCCEEEccC
Confidence            999999999876432              2899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |++........ ......+++.|+|||.+..    ...++.++|+||||+++|||++|..|+......       .....
T Consensus       148 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------~~~~~  219 (280)
T cd06611         148 GVSAKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------RVLLK  219 (280)
T ss_pred             ccchhhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------HHHHH
Confidence            99876433221 2233468889999998752    234677899999999999999999996532110       11111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      ....      ..+.+   ..+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       220 ~~~~------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         220 ILKS------EPPTL---DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             HhcC------CCCCc---CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            1100      00111   0122345688999999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.7e-41  Score=298.29  Aligned_cols=261  Identities=25%  Similarity=0.346  Sum_probs=200.2

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +|++.+.||+|+||.||+|... +|..+++|++.....  .....+.+|+.++++++|||++++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999764 689999999865442  2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      + +++|.+++.....              ++++.++..++.|++.||+|||  +.+++|+||||+||+++.++.++|+||
T Consensus        81 ~-~~~L~~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~~~~~~~~~l~df  143 (286)
T cd07832          81 M-PSDLSEVLRDEER--------------PLPEAQVKSYMRMLLKGVAYMH--ANGIMHRDLKPANLLISADGVLKIADF  143 (286)
T ss_pred             c-CCCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCHHHEEEcCCCcEEEeee
Confidence            9 9999999875442              3899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++...............++..|+|||.+.+...++.++||||+|++++||++|.+|+... .+     ...+.......
T Consensus       144 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~-~~-----~~~~~~~~~~~  217 (286)
T cd07832         144 GLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE-ND-----IEQLAIVFRTL  217 (286)
T ss_pred             eecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC-CH-----HHHHHHHHHHc
Confidence            9998765433222334568889999999876666788999999999999999996554321 11     11111111100


Q ss_pred             ccc----------c---ccc----cCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NKE----------I---EMV----DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~----------~---~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...          .   ..+    ...........+.+..+.+++.+||+.||++||+++++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         218 GTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            000          0   000    0000000011223578999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-40  Score=288.67  Aligned_cols=255  Identities=27%  Similarity=0.372  Sum_probs=203.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|+..+.||+|+||.||++... ++..+++|.+........+.+.+|+.++++++||||+++++++.++...+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            467888999999999999999764 6788999999776555667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++.....              ++++.++..++.|++.||.|||  +.+++|+||+|+||++++++.++|+||
T Consensus        82 ~~~~~l~~~~~~~~~--------------~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~  145 (262)
T cd06613          82 CGGGSLQDIYQVTRG--------------PLSELQIAYVCRETLKGLAYLH--ETGKIHRDIKGANILLTEDGDVKLADF  145 (262)
T ss_pred             CCCCcHHHHHHhhcc--------------CCCHHHHHHHHHHHHHHHHHHH--hCCceecCCChhhEEECCCCCEEECcc
Confidence            999999999876522              2889999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCC--CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN--TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |.+....... .......++..|+|||.+.+.  ..++.++|+||||+++|||++|..|+.......       -.....
T Consensus       146 g~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------~~~~~~  217 (262)
T cd06613         146 GVSAQLTATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------ALFLIS  217 (262)
T ss_pred             ccchhhhhhh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHH
Confidence            9987654321 122335678899999998643  257889999999999999999999965322110       000000


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .  .   .+....  .......+.++.+++.+||+.+|.+||++.+++.
T Consensus       218 ~--~---~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         218 K--S---NFPPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             h--c---cCCCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0  0   000000  0013344668999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.3e-40  Score=297.63  Aligned_cols=271  Identities=28%  Similarity=0.415  Sum_probs=201.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC--------CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeC
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS--------SGVTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASG  150 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  150 (373)
                      .++|.+.+.||+|+||.||++...        ....+|+|.+..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            357888999999999999999642        245689998865432 3345688999999999 699999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcc-cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGS-KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      ...++++||+++|+|.+++............ ........+++.++.+++.|++.||.|||  +++++||||||+||+++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nill~  168 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARNVLVT  168 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeeccccceeEEEc
Confidence            9999999999999999999775421100000 00001124899999999999999999999  89999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCcc-cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcc
Q 043074          230 SDFEAHISDFGLARRIDTSHSHV-STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEV  307 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~  307 (373)
                      +++.+||+|||+++......... .....++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....      
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~------  241 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP------  241 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCC------
Confidence            99999999999998654322111 112234467999999874 457889999999999999999 666653211      


Q ss_pred             cHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                       ......... ....     .     ..+..++.++.+++.+||+.||++||++.++++.|+++.
T Consensus       242 -~~~~~~~~~-~~~~-----~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         242 -VEELFKLLR-EGHR-----M-----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             -HHHHHHHHH-cCCC-----C-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence             111111111 1100     0     112334568899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=309.63  Aligned_cols=245  Identities=30%  Similarity=0.442  Sum_probs=202.9

Q ss_pred             eeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCHHH
Q 043074           89 IIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQ  167 (373)
Q Consensus        89 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  167 (373)
                      +||+|.||+||.|++. +...+|||-+..........+..|+...++++|.|||+++|.+.+++..-+.||..+||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999754 567899999977666666778999999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCCCCCcccccCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC-CCCceEEeeeccccc
Q 043074          168 WLHDTSRNDDVDGSKQLNSLCPL--SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFEAHISDFGLARR  244 (373)
Q Consensus       168 ~l~~~~~~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~  244 (373)
                      +++..-.              |+  ++.++--+.+||++||.|||  ++.|||||||-+|+||+ -.|.+||+|||-+++
T Consensus       662 LLrskWG--------------PlKDNEstm~fYtkQILeGLkYLH--en~IVHRDIKGDNVLvNTySGvlKISDFGTsKR  725 (1226)
T KOG4279|consen  662 LLRSKWG--------------PLKDNESTMNFYTKQILEGLKYLH--ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKR  725 (1226)
T ss_pred             HHHhccC--------------CCccchhHHHHHHHHHHHHhhhhh--hcceeeccccCCcEEEeeccceEEecccccchh
Confidence            9986432              46  77888889999999999999  89999999999999996 568999999999998


Q ss_pred             cCCCCCcccccccccccccCccccC-CCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcccc
Q 043074          245 IDTSHSHVSTQVAGTMGYMPPEYLG-GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEI  323 (373)
Q Consensus       245 ~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (373)
                      +..-. ....++.||..|||||++. |...|..++|||||||++.||.||++||...-...  ..       +..  ...
T Consensus       726 LAgin-P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AA-------MFk--VGm  793 (1226)
T KOG4279|consen  726 LAGIN-PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AA-------MFK--VGM  793 (1226)
T ss_pred             hccCC-ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hh-------hhh--hcc
Confidence            74322 2344577999999999996 45678999999999999999999999976432211  11       111  111


Q ss_pred             ccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          324 EMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..+.+.     ++.+.+.+..+++.+|+.+||.+||+++++++
T Consensus       794 yKvHP~-----iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  794 YKVHPP-----IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             eecCCC-----CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            122233     38888999999999999999999999999875

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.3e-41  Score=296.09  Aligned_cols=250  Identities=24%  Similarity=0.296  Sum_probs=195.0

Q ss_pred             CCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           84 FSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      |+..+.||+|+||.||++.. .+++.+|+|.+......   ....+.+|+.+++.++|+|++++.+.+.+++..++++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            56678899999999999966 47889999998654322   234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++......             ++++..+..++.|++.||.|||  +.+++||||||+||++++++.++|+||
T Consensus        82 ~~~~~L~~~~~~~~~~-------------~~~~~~~~~~~~ql~~~l~~lH--~~~iiH~dikp~Nili~~~~~~kl~Df  146 (285)
T cd05632          82 MNGGDLKFHIYNMGNP-------------GFEEERALFYAAEILCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDL  146 (285)
T ss_pred             ccCccHHHHHHHhcCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEECCCCCEEEecC
Confidence            9999999988654322             2899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++.......  ......|+..|+|||.+.+ ..++.++|+||||+++|||++|..||.......   ........... 
T Consensus       147 g~~~~~~~~~--~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~-  219 (285)
T cd05632         147 GLAVKIPEGE--SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLE-  219 (285)
T ss_pred             CcceecCCCC--cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhc-
Confidence            9987643221  1233568999999999975 447889999999999999999999975321110   00111111100 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA-----MSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~l~~  366 (373)
                            .....     ....+..+.+++..||+.||++||+     +.+++.
T Consensus       220 ------~~~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         220 ------TEEVY-----SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ------ccccc-----CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                  00011     2223457899999999999999999     556654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-41  Score=291.00  Aligned_cols=247  Identities=28%  Similarity=0.393  Sum_probs=195.0

Q ss_pred             CeeecCCCceEEEEEeCCCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCHH
Q 043074           88 KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLD  166 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  166 (373)
                      +.||.|+||.||++...+++.|++|.+...... ....+.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999998766999999998765443 4567899999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccC
Q 043074          167 QWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID  246 (373)
Q Consensus       167 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  246 (373)
                      +++.....              .+++.....++.|++.|++|||  +++++||||+|+||+++.++.++|+|||++....
T Consensus        81 ~~l~~~~~--------------~~~~~~~~~~~~~~~~~l~~lH--~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          81 TFLRKKKN--------------RLTVKKLLQMSLDAAAGMEYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             HHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            99975432              2788999999999999999999  8999999999999999999999999999997653


Q ss_pred             CCCCccc-ccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhccccc
Q 043074          247 TSHSHVS-TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARNKEIE  324 (373)
Q Consensus       247 ~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (373)
                      ....... .....+..|+|||.+.+. .++.++|+||||+++|||++ |..|+.....       ..........     
T Consensus       145 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-------~~~~~~~~~~-----  211 (251)
T cd05041         145 GGIYTVSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSN-------QQTRERIESG-----  211 (251)
T ss_pred             CCcceeccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCH-------HHHHHHHhcC-----
Confidence            2111111 112235679999998754 57889999999999999999 6666433211       1111111100     


Q ss_pred             cccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          325 MVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                       .  .   ...+...+.++.+++.+||+.+|.+||++.++++.|+
T Consensus       212 -~--~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         212 -Y--R---MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             -C--C---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence             0  0   0113344668999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.1e-41  Score=302.26  Aligned_cols=241  Identities=22%  Similarity=0.284  Sum_probs=190.2

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  157 (373)
                      +|+..+.||+|+||.||++... +++.||+|++.+...   ...+.+..|..++..+. |++|+++.+++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667789999999999999754 689999999875432   23355778888888885 577888999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++....               .+++.++..++.|++.||.|||  +++++||||||+||+++.++.+||+
T Consensus        81 Ey~~~g~L~~~i~~~~---------------~l~~~~~~~i~~qi~~al~~lH--~~~ivHrDikp~Nill~~~~~ikL~  143 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---------------KFKEPQAVFYAAEISVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIA  143 (323)
T ss_pred             cCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEe
Confidence            9999999999987543               2899999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++...... .......||+.|+|||.+.+ ..++.++|||||||++|||++|..|+.....       ........
T Consensus       144 Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~  214 (323)
T cd05615         144 DFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-------DELFQSIM  214 (323)
T ss_pred             ccccccccCCCC-ccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHH
Confidence            999987543221 12234568999999999875 4478899999999999999999999754221       11111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                      ..       ...     .+...+.++.+++.+||+.||.+|++.
T Consensus       215 ~~-------~~~-----~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         215 EH-------NVS-----YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             hC-------CCC-----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            10       001     122334578999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8.5e-41  Score=296.05  Aligned_cols=261  Identities=28%  Similarity=0.411  Sum_probs=202.2

Q ss_pred             cChHHHHHhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEee
Q 043074           72 ISMSELIDATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCAS  149 (373)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  149 (373)
                      .+..++..+.+.|++.+.||.|+||.||+|.. .+++.+++|.+..... ....+..|+.++.++ +|+|++++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            45566666778999999999999999999976 4688999999865432 235678899999998 69999999998853


Q ss_pred             ------CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCC
Q 043074          150 ------GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKS  223 (373)
Q Consensus       150 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~  223 (373)
                            ....+++|||+++|+|.+++......             .+++..+..++.|++.|+.|||  +.+++|+||+|
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-------------~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dl~~  149 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-------------ALKEDWIAYICREILRGLAHLH--AHKVIHRDIKG  149 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCH
Confidence                  45789999999999999999764432             2788889999999999999999  78999999999


Q ss_pred             CceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCC
Q 043074          224 SNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLP  299 (373)
Q Consensus       224 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~  299 (373)
                      +||++++++.++|+|||++........ ......|+..|+|||.+..    ...++.++|+|||||++|||++|..|+..
T Consensus       150 ~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~  228 (282)
T cd06636         150 QNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD  228 (282)
T ss_pred             HHEEECCCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence            999999999999999999876532221 1233568889999998752    23467789999999999999999999754


Q ss_pred             cccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .....   ..    ...      ........    ....++..+.+++.+||+.||.+||++.+|++
T Consensus       229 ~~~~~---~~----~~~------~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         229 MHPMR---AL----FLI------PRNPPPKL----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             cCHHh---hh----hhH------hhCCCCCC----cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            22110   00    000      00001111    12234568999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.2e-41  Score=302.63  Aligned_cols=263  Identities=20%  Similarity=0.262  Sum_probs=192.7

Q ss_pred             CCCeeecC--CCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           86 TDKIIGDG--SFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        86 ~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      +.++||+|  +|++||++.. .+|+.||+|.+.....  ...+.+.+|+.+++.++||||+++++++.+++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  6789999965 5789999999965432  22356778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++|+|.+++......             .+++..+..++.|++.||+|||  +++++||||||+||+++.++.++++||+
T Consensus        82 ~~~~l~~~~~~~~~~-------------~l~~~~~~~i~~qi~~~L~~LH--~~~iiH~dlkp~Nil~~~~~~~~l~~~~  146 (327)
T cd08227          82 AYGSAKDLICTHFMD-------------GMSELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLR  146 (327)
T ss_pred             CCCcHHHHHHhhccC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCChhhEEEecCCcEEEcccc
Confidence            999999999754322             2889999999999999999999  7899999999999999999999999998


Q ss_pred             cccccCCCCCc------ccccccccccccCccccCCC-CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          241 LARRIDTSHSH------VSTQVAGTMGYMPPEYLGGN-TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       241 ~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      ...........      ......++..|+|||.+.+. ..++.++|||||||++|||++|..||........   .....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~  223 (327)
T cd08227         147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKL  223 (327)
T ss_pred             hhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHh
Confidence            76543211110      11123466789999998753 3578899999999999999999999754321110   00000


Q ss_pred             HHH----------HHh----ccccccccC----------------ccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 043074          314 RTM----------EAR----NKEIEMVDS----------------NISREELSEAGVREYFRIACMCTNEKSRERPAMSY  363 (373)
Q Consensus       314 ~~~----------~~~----~~~~~~~~~----------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~  363 (373)
                      ...          ...    .......+.                ...........+.++.+++.+||+.||++|||+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e  303 (327)
T cd08227         224 NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAST  303 (327)
T ss_pred             cCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHH
Confidence            000          000    000000000                00000112234568999999999999999999999


Q ss_pred             HHH
Q 043074          364 VVQ  366 (373)
Q Consensus       364 l~~  366 (373)
                      +++
T Consensus       304 ll~  306 (327)
T cd08227         304 LLN  306 (327)
T ss_pred             Hhc
Confidence            986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.5e-40  Score=290.69  Aligned_cols=248  Identities=27%  Similarity=0.424  Sum_probs=196.8

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc---------cHHHHHHHHHHHhcCCCCCccceeeEEeeCCe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---------GFREFRAEMETLGKLRHRNIVKILGYCASGLD  152 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  152 (373)
                      +|.+...||+|++|.||+|.. .++..+++|.+......         ..+.+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            477788999999999999965 46889999988654322         12457889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++++||+++++|.+++....               ++++..+..++.|++.||+|||  +.+++|+||+|+||++++++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~~l~~~l~~lH--~~~ivH~di~p~nil~~~~~  143 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---------------AFEETLVRNFVRQILKGLNYLH--NRGIIHRDIKGANILVDNKG  143 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---------------CccHHHHHHHHHHHHHHHHHHH--hcCcccccCCHHHEEEcCCC
Confidence            999999999999999997643               2888999999999999999999  78999999999999999999


Q ss_pred             ceEEeeeccccccCCCCC-----cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcc
Q 043074          233 EAHISDFGLARRIDTSHS-----HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV  307 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  307 (373)
                      .++|+|||.++.......     .......|+..|+|||.+.+. .++.++|+||||+++|+|++|..|+.....     
T Consensus       144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----  217 (267)
T cd06628         144 GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-----  217 (267)
T ss_pred             CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccH-----
Confidence            999999999987642111     111224578899999998754 467889999999999999999999753211     


Q ss_pred             cHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       .    .......   ....+.     .+...+..+.+++.+||+.||.+||++.++++
T Consensus       218 -~----~~~~~~~---~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         218 -L----QAIFKIG---ENASPE-----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -H----HHHHHHh---ccCCCc-----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence             0    0000000   011111     13345668999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.3e-40  Score=292.20  Aligned_cols=250  Identities=26%  Similarity=0.443  Sum_probs=197.7

Q ss_pred             CCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccc------ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF------QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      +|...+.||+|+||.||+|...+++.+|+|.+.....      .....+.+|+.+++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4778899999999999999888899999998864322      1234588899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +||+++++|.+++.+..               ++++..+..++.|++.||+|||  +.+++|+||+|+||++++++.++|
T Consensus        81 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l  143 (265)
T cd06631          81 MEFVPGGSISSILNRFG---------------PLPEPVFCKYTKQILDGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKL  143 (265)
T ss_pred             EecCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHhEEECCCCeEEe
Confidence            99999999999997543               2788999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCC-----CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          237 SDFGLARRIDTSH-----SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       237 ~Dfg~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +|||++.......     ........++..|+|||.+.+. .++.++|+||||+++|+|++|..|+.....      ...
T Consensus       144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~  216 (265)
T cd06631         144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDR------LAA  216 (265)
T ss_pred             ccchhhHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCCh------HHH
Confidence            9999998653211     1122234678899999998754 478899999999999999999999753211      000


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .. .....    ....+.+     +...+.++.+++.+||+.+|++||++.++++
T Consensus       217 ~~-~~~~~----~~~~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         217 MF-YIGAH----RGLMPRL-----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HH-Hhhhc----cCCCCCC-----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00 00000    0011111     2234568899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.6e-41  Score=297.68  Aligned_cols=265  Identities=24%  Similarity=0.284  Sum_probs=189.8

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcC---CCCCccceeeEEee-----CC
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKL---RHRNIVKILGYCAS-----GL  151 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~  151 (373)
                      +|++.+.||+|+||.||+|... +++.||+|.+......  ....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999664 6899999998653322  123455677766655   79999999998754     34


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..++++||++ ++|.+++......             .+++..+..++.|++.||.|||  +.+++||||||+||+++.+
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~-------------~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~  144 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPP-------------GLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSG  144 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCC
Confidence            5789999996 5898888764332             2889999999999999999999  7899999999999999999


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +.+||+|||++.......  ......+|..|+|||.+.+ ..++.++|||||||++|||++|.+||..............
T Consensus       145 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~  221 (288)
T cd07863         145 GQVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD  221 (288)
T ss_pred             CCEEECccCccccccCcc--cCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHH
Confidence            999999999998654322  1233467899999999874 4478899999999999999999988644322110000000


Q ss_pred             HHHH-----HHHhccc-cccccCccc--cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WART-----MEARNKE-IEMVDSNIS--REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~-----~~~~~~~-~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      +...     ....... .....+...  ........+..+.+++.+||+.||++|||+.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         222 LIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000     0000000 000000000  00011234567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-40  Score=291.84  Aligned_cols=239  Identities=22%  Similarity=0.414  Sum_probs=187.2

Q ss_pred             CeeecCCCceEEEEEeCCCC-----------EEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           88 KIIGDGSFGFVYKAKLSSGV-----------TVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      +.||+|+||.||+|...+..           .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999765332           5778877654433 5778899999999999999999999988 778999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC----
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF----  232 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~----  232 (373)
                      +||+++|+|.+++.....              .+++..+..++.|++.||+|||  +++++|+||||+||+++.++    
T Consensus        79 ~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dlkp~Nill~~~~~~~~  142 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN--------------NVSLHWKLDVAKQLASALHYLE--DKKLVHGNVCGKNILVARYGLNEG  142 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc--------------CCCHHHHHHHHHHHHHHHHHHh--hCCeecccCccceEEEecCccccC
Confidence            999999999999986542              2889999999999999999999  89999999999999999887    


Q ss_pred             ---ceEEeeeccccccCCCCCcccccccccccccCccccCCC-CCCCccccchhhhHHHHHHHhC-CCCCCCcccCCCcc
Q 043074          233 ---EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN-TAATVMLDVYSFGILMIEIATQ-IRPNLPVVLDGQEV  307 (373)
Q Consensus       233 ---~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~  307 (373)
                         .+||+|||++.....     .....++..|+|||.+.+. ..++.++||||||+++|||++| ..|+.... .   .
T Consensus       143 ~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~---~  213 (259)
T cd05037         143 YVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-S---S  213 (259)
T ss_pred             CceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-c---h
Confidence               799999999986533     2223466789999998755 4678899999999999999995 45433221 1   0


Q ss_pred             cHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                         .+...... .       ......     ....+.+++.+||+.+|.+||++.++++.|+
T Consensus       214 ---~~~~~~~~-~-------~~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         214 ---EKERFYQD-Q-------HRLPMP-----DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ---hHHHHHhc-C-------CCCCCC-----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               11111110 0       001010     1158999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-41  Score=307.16  Aligned_cols=238  Identities=24%  Similarity=0.306  Sum_probs=185.4

Q ss_pred             CeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHH-HHhcCCCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEME-TLGKLRHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||++.. .+|+.+|+|++.+...   .....+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999975 4789999999865422   22334555554 46778999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|..++....               ++++..+..++.||+.||+|||  +.+++||||||+||+++.++.+||+|||++
T Consensus        81 ~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~al~~lH--~~givH~Dlkp~NIll~~~~~~kL~DfG~~  143 (325)
T cd05604          81 GELFFHLQRER---------------SFPEPRARFYAAEIASALGYLH--SINIVYRDLKPENILLDSQGHVVLTDFGLC  143 (325)
T ss_pred             CCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEeecCCc
Confidence            99998887543               2889999999999999999999  789999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE  322 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (373)
                      +..... ........||+.|+|||.+.+ ..++.++|||||||++|||++|..||.....       .+........   
T Consensus       144 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~~~~~---  211 (325)
T cd05604         144 KEGIAQ-SDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-------AEMYDNILHK---  211 (325)
T ss_pred             ccCCCC-CCCcccccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCH-------HHHHHHHHcC---
Confidence            753221 122334568999999999975 4478899999999999999999999754221       1111111110   


Q ss_pred             cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 043074          323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY  363 (373)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~  363 (373)
                          ...+     ....+..+.+++.+|++.||.+||++.+
T Consensus       212 ----~~~~-----~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         212 ----PLVL-----RPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             ----CccC-----CCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence                0001     1123457889999999999999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.7e-40  Score=296.43  Aligned_cols=263  Identities=24%  Similarity=0.295  Sum_probs=197.7

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-----cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-----GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      +|...+.||+|+||.||+|... +++.|++|.+......     ....+..|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999764 6899999999655432     234567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+ +++|.+++.....              .+++..+..++.|+++||.|||  +++++|+||+|+||+++.++.++|
T Consensus        81 ~e~~-~~~L~~~i~~~~~--------------~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nill~~~~~~~l  143 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSI--------------VLTPADIKSYMLMTLRGLEYLH--SNWILHRDLKPNNLLIASDGVLKL  143 (298)
T ss_pred             Eccc-CCCHHHHHhccCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCChhhEEEcCCCCEEE
Confidence            9999 9999999976431              2899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++......... .....+++.|+|||.+.+...++.++|+|||||++|||++|.+|+.... +.   ....-....
T Consensus       144 ~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-~~---~~~~~~~~~  218 (298)
T cd07841         144 ADFGLARSFGSPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-DI---DQLGKIFEA  218 (298)
T ss_pred             ccceeeeeccCCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-cH---HHHHHHHHH
Confidence            999999876443221 2223467789999998765667889999999999999999966543211 10   000000000


Q ss_pred             H--------Hh-ccccccc----cCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          317 E--------AR-NKEIEMV----DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       317 ~--------~~-~~~~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      .        .. .......    .............+..+.+++.+||+.||++|||+.++++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         219 LGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0        00 0000000    00000011112335689999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.1e-42  Score=312.40  Aligned_cols=250  Identities=25%  Similarity=0.327  Sum_probs=191.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|+..+.||+|+||.||++..+ +++.||+|++....   ......+.+|+.++..++||||+++++.+.+....++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999764 68999999986532   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++....               .+++..+..++.|++.||.|||  +.+++||||||+||+++.++.++|+
T Consensus        81 E~~~gg~L~~~l~~~~---------------~l~~~~~~~~~~qi~~~L~~lH--~~givHrDLkp~NIli~~~~~vkL~  143 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---------------TLSEEATQFYIAETVLAIDAIH--QLGFIHRDIKPDNLLLDAKGHVKLS  143 (360)
T ss_pred             eCCCCccHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEe
Confidence            9999999999997643               2889999999999999999999  8999999999999999999999999


Q ss_pred             eeccccccCCCCC----------------------------------cccccccccccccCccccCCCCCCCccccchhh
Q 043074          238 DFGLARRIDTSHS----------------------------------HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSF  283 (373)
Q Consensus       238 Dfg~~~~~~~~~~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Diwsl  283 (373)
                      |||++........                                  .......||+.|+|||++.+ ..++.++|||||
T Consensus       144 DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSl  222 (360)
T cd05627         144 DFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSL  222 (360)
T ss_pred             eccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccc
Confidence            9999875421110                                  00123468999999999975 447889999999


Q ss_pred             hHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC---
Q 043074          284 GILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA---  360 (373)
Q Consensus       284 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---  360 (373)
                      ||++|||++|..||......       ............. .+.+       ....+.++.+++.+|+. ||.+|++   
T Consensus       223 Gvilyel~tG~~Pf~~~~~~-------~~~~~i~~~~~~~-~~p~-------~~~~s~~~~~li~~l~~-~p~~R~~~~~  286 (360)
T cd05627         223 GVIMYEMLIGYPPFCSETPQ-------ETYRKVMNWKETL-VFPP-------EVPISEKAKDLILRFCT-DSENRIGSNG  286 (360)
T ss_pred             cceeeecccCCCCCCCCCHH-------HHHHHHHcCCCce-ecCC-------CCCCCHHHHHHHHHhcc-ChhhcCCCCC
Confidence            99999999999997543211       1111111000000 0000       01124478888888774 9999996   


Q ss_pred             HHHHH
Q 043074          361 MSYVV  365 (373)
Q Consensus       361 ~~~l~  365 (373)
                      +.+++
T Consensus       287 ~~ei~  291 (360)
T cd05627         287 VEEIK  291 (360)
T ss_pred             HHHHh
Confidence            45544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-40  Score=290.98  Aligned_cols=255  Identities=24%  Similarity=0.407  Sum_probs=199.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCC----EEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGV----TVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      .+|++.+.||+|+||.||+|..+ ++.    .+++|.+...... ....+.+|+..+++++|||++++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            46788899999999999999754 333    5899988665432 34678899999999999999999999987 78899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |+||+++|+|.+++.....              .+++..++.++.|++.||+|||  +.+++|+||||+||++++++.+|
T Consensus        86 v~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~di~p~nil~~~~~~~k  149 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD--------------NIGSQYLLNWCVQIAKGMSYLE--EKRLVHRDLAARNVLVKTPQHVK  149 (279)
T ss_pred             EEecCCCCcHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCEEecccCcceEEEcCCCeEE
Confidence            9999999999999976543              2889999999999999999999  79999999999999999999999


Q ss_pred             EeeeccccccCCCCCccc-ccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVS-TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |+|||+++.......... ....++..|+|||.+.+ ..++.++|+||||+++||+++ |..|+....       ..++.
T Consensus       150 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~~~~  221 (279)
T cd05057         150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-------AVEIP  221 (279)
T ss_pred             ECCCcccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-------HHHHH
Confidence            999999987643222111 11223568999998863 457889999999999999998 888864321       11111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .... ....       .   ..+..++..+.+++.+||..||.+||++.++++.|++++
T Consensus       222 ~~~~-~~~~-------~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         222 DLLE-KGER-------L---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             HHHh-CCCC-------C---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            1111 1100       0   002223457899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.6e-40  Score=290.72  Aligned_cols=255  Identities=20%  Similarity=0.368  Sum_probs=187.0

Q ss_pred             eeecCCCceEEEEEeCCC---CEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCC
Q 043074           89 IIGDGSFGFVYKAKLSSG---VTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGS  164 (373)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  164 (373)
                      .||+|+||.||+|...++   ..+++|.+..... ...+.+.+|+..++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999965433   3456777654432 335678999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccc
Q 043074          165 LDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       165 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                      |.+++.+.....           ...++..+..++.|++.||+|||  +.+++||||||+||+++.++.++|+|||++..
T Consensus        82 L~~~l~~~~~~~-----------~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~  148 (268)
T cd05086          82 LKSYLSQEQWHR-----------RNSQLLLLQRMACEIAAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS  148 (268)
T ss_pred             HHHHHHhhhccc-----------ccccHHHHHHHHHHHHHHHHHHH--HCCeeccCCccceEEEcCCccEEecccccccc
Confidence            999998653211           12667788899999999999999  78999999999999999999999999999864


Q ss_pred             cCCC-CCcccccccccccccCccccCCC------CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          245 IDTS-HSHVSTQVAGTMGYMPPEYLGGN------TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       245 ~~~~-~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      .... .........++..|+|||++.+.      ..++.++||||||+++|||+++..+++.....      .+......
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~  222 (268)
T cd05086         149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVI  222 (268)
T ss_pred             cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH
Confidence            3211 11122345678899999987521      23477899999999999999865443321111      11111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                       ........++.+.     ......+.+++..|| .+|.+||++++|++.|.
T Consensus       223 -~~~~~~~~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         223 -KDQQVKLFKPQLE-----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             -hhcccccCCCccC-----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence             1111122222222     223457888999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-40  Score=293.79  Aligned_cols=256  Identities=28%  Similarity=0.385  Sum_probs=201.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|++.+.||+|+||.||++... ++..+|+|++..... ...+.+.+|+++++.++||||+++++++......++|+||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46778889999999999999754 688999998765432 3356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++....               ++++.....++.|++.||.|||+ ..+++|+||+|+||++++++.++|+||
T Consensus        85 ~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~d~  148 (284)
T cd06620          85 MDCGSLDRIYKKGG---------------PIPVEILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDF  148 (284)
T ss_pred             CCCCCHHHHHHhcc---------------CCCHHHHHHHHHHHHHHHHHHHH-hcCeeccCCCHHHEEECCCCcEEEccC
Confidence            99999999887643               28899999999999999999994 358999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCC----cccHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ----EVGLLEWART  315 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~  315 (373)
                      |++.......   .....|+..|+|||.+.+. .++.++|+|||||++|+|++|..||........    ......+...
T Consensus       149 gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (284)
T cd06620         149 GVSGELINSI---ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ  224 (284)
T ss_pred             Ccccchhhhc---cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence            9986542221   2235688999999998744 578899999999999999999999765433211    1111222221


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      ....      ..+.+.    ....+..+.+++.+||+.||.+||++.++++.
T Consensus       225 ~~~~------~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         225 IVQE------PPPRLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             Hhhc------cCCCCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1110      011110    12255689999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-40  Score=291.36  Aligned_cols=248  Identities=27%  Similarity=0.389  Sum_probs=199.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|+..+.||.|++|.||+|... ++..+++|.+.... ......+.+|+.+++.++|+|++++.+++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46788899999999999999764 68899999986544 23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++....                +++..+..++.|++.|+.|||  +.+++|+||+|+||++++++.++|+||
T Consensus        81 ~~~~~L~~~~~~~~----------------~~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~  142 (274)
T cd06609          81 CGGGSCLDLLKPGK----------------LDETYIAFILREVLLGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADF  142 (274)
T ss_pred             eCCCcHHHHHhhcC----------------CCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccc
Confidence            99999999987542                889999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |+++...... .......+++.|+|||.+.+.. ++.++||||||+++|+|++|..|+......       ........ 
T Consensus       143 g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~~-  212 (274)
T cd06609         143 GVSGQLTSTM-SKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPM-------RVLFLIPK-  212 (274)
T ss_pred             ccceeecccc-cccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchH-------HHHHHhhh-
Confidence            9998765432 1223346788999999997544 889999999999999999999997432210       01111100 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                           ...+.+...    ..+..+.+++.+||+.+|++||+++++++
T Consensus       213 -----~~~~~~~~~----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         213 -----NNPPSLEGN----KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -----cCCCCCccc----ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                 011111111    14557899999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-41  Score=297.29  Aligned_cols=268  Identities=23%  Similarity=0.287  Sum_probs=200.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ++|++.+.||+|+||.||+|..+ +++.|++|.++....  ...+.+.+|++++++++|+||+++++++.+++..++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999765 688999999865332  234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |++++.+..+.....               .+++.++..++.|++.||.|||  .++++|+||+|+||++++++.+||+|
T Consensus        81 ~~~~~~l~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~ni~~~~~~~~kl~d  143 (288)
T cd07833          81 YVERTLLELLEASPG---------------GLPPDAVRSYIWQLLQAIAYCH--SHNIIHRDIKPENILVSESGVLKLCD  143 (288)
T ss_pred             cCCCCHHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEEe
Confidence            998877766654432               2889999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||++...............++..|+|||.+.+...++.++|+||||+++|+|++|..|+.....................
T Consensus       144 ~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  223 (288)
T cd07833         144 FGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP  223 (288)
T ss_pred             eecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99998765443323334567889999999986646889999999999999999999886432111000000000000000


Q ss_pred             -------hcccccc------ccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 -------RNKEIEM------VDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 -------~~~~~~~------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                             .......      .+........+..++.++.+++.+||+.+|++||+++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                   0000000      00000000112234678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-41  Score=303.29  Aligned_cols=241  Identities=23%  Similarity=0.292  Sum_probs=186.0

Q ss_pred             eecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcC---CCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           90 IGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKL---RHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        90 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      ||+|+||.||+|..+ +++.||+|++.+....   .......|..++...   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999764 6899999998653322   223345566666655   699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|.+++.....               +++..+..++.||+.||+|||  +++++||||||+|||++.++.++|+|||++
T Consensus        81 g~L~~~l~~~~~---------------~~~~~~~~~~~qil~al~~LH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a  143 (330)
T cd05586          81 GELFWHLQKEGR---------------FSEDRAKFYIAELVLALEHLH--KYDIVYRDLKPENILLDATGHIALCDFGLS  143 (330)
T ss_pred             ChHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEecCCcC
Confidence            999998875432               889999999999999999999  789999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE  322 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (373)
                      +...... .......||+.|+|||.+.+...++.++|||||||++|||++|..||.....       ......... .  
T Consensus       144 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~~~~~i~~-~--  212 (330)
T cd05586         144 KANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQMYRNIAF-G--  212 (330)
T ss_pred             cCCCCCC-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------HHHHHHHHc-C--
Confidence            7543222 2233457899999999987666678999999999999999999999754221       111111110 0  


Q ss_pred             cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHH
Q 043074          323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA----MSYVVQ  366 (373)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~~l~~  366 (373)
                          ...+..    ...+..+.+++.+||+.||.+||+    +.++++
T Consensus       213 ----~~~~~~----~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         213 ----KVRFPK----NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ----CCCCCC----ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence                011111    123457889999999999999984    555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.8e-40  Score=288.78  Aligned_cols=258  Identities=25%  Similarity=0.399  Sum_probs=203.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|++.+.||.|+||.||+|... ++..+++|.+..... .....+.+|++.++.++|+|++++++.+..+...++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47888999999999999999754 688999999865432 2456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++.......            .+++..+..++.|++.||+|||  +.+++|+||+|+||++++++.++|+||
T Consensus        81 ~~~~~l~~~~~~~~~~~------------~~~~~~~~~~~~ql~~al~~lh--~~~i~h~~l~p~ni~~~~~~~~~l~df  146 (267)
T cd06610          81 LSGGSLLDIMKSSYPRG------------GLDEAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADF  146 (267)
T ss_pred             cCCCcHHHHHHHhcccC------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEccc
Confidence            99999999997643211            2889999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCCCc---ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          240 GLARRIDTSHSH---VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       240 g~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      |++.........   ......++..|+|||.+.....++.++|+||||+++|||++|..|+.......   .....   .
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~---~  220 (267)
T cd06610         147 GVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLT---L  220 (267)
T ss_pred             chHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHH---h
Confidence            999876543222   22334678899999998755468889999999999999999999975332110   01010   0


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..       ..............+..+.+++.+||+.||++||++.++++
T Consensus       221 ~~-------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         221 QN-------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cC-------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00       01111111101234568999999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2e-40  Score=303.20  Aligned_cols=265  Identities=24%  Similarity=0.254  Sum_probs=193.5

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeC------
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASG------  150 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  150 (373)
                      ..++|+..+.||+|+||.||++.. .+++.+|+|.+.....  .....+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999965 4688999999865332  2345677899999999999999999988543      


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      ...++||||++ ++|.+.+..                 .+++..+..++.|++.||.|||  +++++||||||+||+++.
T Consensus        95 ~~~~lv~e~~~-~~l~~~~~~-----------------~l~~~~~~~~~~qi~~aL~~LH--~~givHrDikp~Nill~~  154 (355)
T cd07874          95 QDVYLVMELMD-ANLCQVIQM-----------------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKS  154 (355)
T ss_pred             ceeEEEhhhhc-ccHHHHHhh-----------------cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEECC
Confidence            35689999995 567776642                 1788899999999999999999  899999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH-
Q 043074          231 DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL-  309 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~-  309 (373)
                      ++.+||+|||+++......  ......||+.|+|||.+.+. .++.++|||||||++|||++|..||............ 
T Consensus       155 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  231 (355)
T cd07874         155 DCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI  231 (355)
T ss_pred             CCCEEEeeCcccccCCCcc--ccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999998654322  22345689999999999754 4788999999999999999999997543211100000 


Q ss_pred             -------HHHH-------HHHHHhccc-cccccC-----ccc--cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          310 -------LEWA-------RTMEARNKE-IEMVDS-----NIS--REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       310 -------~~~~-------~~~~~~~~~-~~~~~~-----~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                             .++.       ......... .....+     ...  ...........+.+++.+||+.||++|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   0000       000000000 000000     000  000111234578999999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.9e-40  Score=299.13  Aligned_cols=237  Identities=24%  Similarity=0.316  Sum_probs=184.8

Q ss_pred             CeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHH-HHhcCCCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEME-TLGKLRHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||+|... +++.+|+|.+.+...   .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999764 688999999865432   12234455554 57889999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      ++|..++....               .+++..+..++.||+.||.|||  +.+++||||||+||+++.++.+||+|||++
T Consensus        81 ~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  143 (321)
T cd05603          81 GELFFHLQRER---------------CFLEPRARFYAAEVASAIGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLC  143 (321)
T ss_pred             CCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEccCCCC
Confidence            99998886543               2788899999999999999999  789999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE  322 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (373)
                      +...... .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||....       ..........    
T Consensus       144 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~----  210 (321)
T cd05603         144 KEGVEPE-ETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------VSQMYDNILH----  210 (321)
T ss_pred             ccCCCCC-CccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCC-------HHHHHHHHhc----
Confidence            7532221 22334568999999999874 447889999999999999999999975421       1111111111    


Q ss_pred             cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 043074          323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMS  362 (373)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (373)
                           ...   ..+...+..+.+++.+||+.||.+||+..
T Consensus       211 -----~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         211 -----KPL---QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -----CCC---CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                 000   01222345789999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.7e-40  Score=285.62  Aligned_cols=251  Identities=31%  Similarity=0.493  Sum_probs=197.8

Q ss_pred             CCCCCeeecCCCceEEEEEeCC-----CCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           84 FSTDKIIGDGSFGFVYKAKLSS-----GVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      +++.+.||.|+||.||++...+     +..+|+|.+...... ..+.+.+|+..+..++|+|++++++++.+.+..++++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999997653     488999999765543 4568899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++++|.+++.......             +++.++..++.|++.||+|||  +.+++|+||+|+||++++++.++|+
T Consensus        81 e~~~~~~l~~~~~~~~~~~-------------~~~~~~~~~~~ql~~~l~~lh--~~~~~h~dl~~~nil~~~~~~~~l~  145 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKE-------------LSLSDLLSFALQIARGMEYLE--SKNFIHRDLAARNCLVGENLVVKIS  145 (258)
T ss_pred             eccCCCCHHHHHHhhhhcc-------------CCHHHHHHHHHHHHHHHHHHh--cCCeeecccccceEEEccCCeEEEc
Confidence            9999999999997654321             789999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      |||++...............+++.|+|||.+. ...++.++|+||+|+++++|++ |..|+...       .........
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-------~~~~~~~~~  217 (258)
T smart00219      146 DFGLSRDLYDDDYYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-------SNEEVLEYL  217 (258)
T ss_pred             ccCCceecccccccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHH
Confidence            99999876543222221233678999999985 4557889999999999999998 55654321       111111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLL  368 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L  368 (373)
                      .... .     .     ..+...+.++.+++.+||+.||++|||+.++++.|
T Consensus       218 ~~~~-~-----~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      218 KKGY-R-----L-----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             hcCC-C-----C-----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            1100 0     0     11222566899999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.9e-40  Score=287.30  Aligned_cols=247  Identities=27%  Similarity=0.452  Sum_probs=195.2

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      ++|++.+.||+|+||.||++.. +++.+++|.+....  ....+.+|+.+++.++|||++++++++... ..++++||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4688889999999999999975 57889999986543  235788999999999999999999998654 4789999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +++|.+++......             .+++..++.++.|++.|+.|||  +.+++||||||+||+++.++.++|+|||+
T Consensus        82 ~~~L~~~l~~~~~~-------------~~~~~~~~~~~~qi~~al~~lH--~~~~~H~dl~p~nili~~~~~~kl~Dfg~  146 (254)
T cd05083          82 KGNLVNFLRTRGRA-------------LVSVIQLLQFSLDVAEGMEYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGL  146 (254)
T ss_pred             CCCHHHHHHhcCcC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCcEEECCCcc
Confidence            99999999765432             2789999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      +......    ......+..|+|||.+.+ ..++.++|+||||+++|||++ |..|+....       ..+....... .
T Consensus       147 ~~~~~~~----~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~~~-~  213 (254)
T cd05083         147 ARVGSMG----VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-------LKEVKECVEK-G  213 (254)
T ss_pred             ceecccc----CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCC-------HHHHHHHHhC-C
Confidence            8764321    112234567999999864 457889999999999999998 777754321       1111111111 0


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                           ...    . .+...+..+.+++.+||+.+|.+||++.++++.|++
T Consensus       214 -----~~~----~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         214 -----YRM----E-PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -----CCC----C-CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                 000    0 122345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.6e-40  Score=297.67  Aligned_cols=270  Identities=28%  Similarity=0.409  Sum_probs=201.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC--------CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCC
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS--------SGVTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASGL  151 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  151 (373)
                      .+|.+.+.||+|+||.||++...        ++..+++|.+..... ...+.+.+|+.+++++ +||||+++++++....
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999642        123689998865432 2356788999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCc-ccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDG-SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      ..++++||+++|+|.+++........... .........+++.+++.++.|++.||+|||  +++++||||||+||+++.
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Nill~~  169 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA--SQKCIHRDLAARNVLVTE  169 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEEEcC
Confidence            99999999999999999976432110000 000001224889999999999999999999  799999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCcc-cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCccc
Q 043074          231 DFEAHISDFGLARRIDTSHSHV-STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVG  308 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~  308 (373)
                      ++.+||+|||+++......... .....++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....       
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------  241 (334)
T cd05100         170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-------  241 (334)
T ss_pred             CCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-------
Confidence            9999999999998654322111 122234567999999874 447889999999999999998 666653211       


Q ss_pred             HHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          309 LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..++...... ...         .. .+..++.++.+++.+||+.+|.+||++.++++.|++++
T Consensus       242 ~~~~~~~~~~-~~~---------~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         242 VEELFKLLKE-GHR---------MD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HHHHHHHHHc-CCC---------CC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            1122211111 000         00 12234568999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=8.4e-40  Score=285.53  Aligned_cols=250  Identities=20%  Similarity=0.291  Sum_probs=200.4

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +|+..+.||.|+||.||.++. .++..+++|.+....  ......+.+|+.++++++|+||+++++++.+....++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            578889999999999999964 468899999886543  33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++......             .+++.++..++.|++.||.|||  +.+++|+||+|+||++++++.+||+||
T Consensus        81 ~~~~~L~~~~~~~~~~-------------~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~ni~~~~~~~~kl~d~  145 (256)
T cd08221          81 ANGGTLYDKIVRQKGQ-------------LFEEEMVLWYLFQIVSAVSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDF  145 (256)
T ss_pred             cCCCcHHHHHHhcccc-------------CCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChHhEEEeCCCCEEECcC
Confidence            9999999999765321             2889999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++........ ......+++.|+|||.+.+. ..+.++|+||||+++|||++|..|+....       ..+....... 
T Consensus       146 ~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~~~~-  215 (256)
T cd08221         146 GISKILGSEYS-MAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATN-------PLNLVVKIVQ-  215 (256)
T ss_pred             cceEEcccccc-cccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHc-
Confidence            99986543332 23345688999999998754 37789999999999999999999864321       1111111111 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      ..        . . ......+..+.+++.+||+.+|.+||++.++++.
T Consensus       216 ~~--------~-~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         216 GN--------Y-T-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CC--------C-C-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            00        0 0 0123345689999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-40  Score=290.48  Aligned_cols=248  Identities=25%  Similarity=0.387  Sum_probs=198.4

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCC---CCCccceeeEEeeCCeeEEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLR---HRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .|+..+.||+|+||.||+|.. .+++.+++|.+..... .....+.+|+.+++.++   |||++++++++.++...++|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477788999999999999975 5789999999865432 33456888999999986   999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++++|.+++....                +++..++.++.|++.||.|||  +.+++|+||+|+||++++++.++|+
T Consensus        82 e~~~~~~L~~~~~~~~----------------l~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~p~ni~i~~~~~~~l~  143 (277)
T cd06917          82 EYAEGGSVRTLMKAGP----------------IAEKYISVIIREVLVALKYIH--KVGVIHRDIKAANILVTNTGNVKLC  143 (277)
T ss_pred             ecCCCCcHHHHHHccC----------------CCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHHEEEcCCCCEEEc
Confidence            9999999999986532                889999999999999999999  8899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||++........ ......|+..|+|||.+.+...++.++|+||||+++|+|++|..|+......       .+...  
T Consensus       144 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~~~~~--  213 (277)
T cd06917         144 DFGVAALLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-------RAMML--  213 (277)
T ss_pred             cCCceeecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-------hhhhc--
Confidence            9999987654332 2233468889999999876566788999999999999999999997532111       11000  


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                          ......+.+..    ...+.++.+++.+||+.||++||++.+++.
T Consensus       214 ----~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         214 ----IPKSKPPRLED----NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ----cccCCCCCCCc----ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                00001111111    114568999999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-41  Score=294.87  Aligned_cols=249  Identities=20%  Similarity=0.353  Sum_probs=210.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccccc--HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ..-|.+.+.||+|.|..|-++++ -+|..||||++.+.....  ...+.+|+..|+.++|||||+++.+..+....|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            45678889999999999999953 489999999998866554  346889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe-CCCCceEE
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL-DSDFEAHI  236 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill-~~~~~~kl  236 (373)
                      |.-.+|+|.+||.++..+              +++..+.+++.||+.|+.|+|  +..+|||||||+|+.+ ..-|-|||
T Consensus        97 ELGD~GDl~DyImKHe~G--------------l~E~La~kYF~QI~~AI~YCH--qLHVVHRDLKPENVVFFEKlGlVKL  160 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEG--------------LNEDLAKKYFAQIVHAISYCH--QLHVVHRDLKPENVVFFEKLGLVKL  160 (864)
T ss_pred             EecCCchHHHHHHhhhcc--------------ccHHHHHHHHHHHHHHHHHHh--hhhhhcccCCcceeEEeeecCceEe
Confidence            999999999999887754              899999999999999999999  7889999999999765 56688999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++-.+.+  ....+..+|...|-|||++.|..+..++.|||||||+||-|++|++||......+.           
T Consensus       161 TDFGFSNkf~P--G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-----------  227 (864)
T KOG4717|consen  161 TDFGFSNKFQP--GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-----------  227 (864)
T ss_pred             eeccccccCCC--cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-----------
Confidence            99999987654  34556789999999999999998889999999999999999999999754322211           


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                            ..++..+  +-..+.....++.++|..||..||++|.+.++|+.
T Consensus       228 ------LTmImDC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  228 ------LTMIMDC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ------hhhhhcc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                  0111111  12236777889999999999999999999999875

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.3e-40  Score=285.78  Aligned_cols=248  Identities=24%  Similarity=0.385  Sum_probs=198.7

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-----ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-----QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      +|+..+.||+|++|.||+|..+ ++..|++|.+.....     +..+.+.+|+.+++.++|+|++++++++.++...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999765 789999999855332     2345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +||+++++|.+++....               ++++..+..++.|++.|++|||  +.+++|+||+|+||+++.++.+||
T Consensus        81 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~~~ni~~~~~~~~kl  143 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---------------SFPEPVIRLYTRQILLGLEYLH--DRNTVHRDIKGANILVDTNGVVKL  143 (258)
T ss_pred             EEecCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEE
Confidence            99999999999997643               2889999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++.......  ......++..|+|||.+.....++.++|+||||+++|+|++|..|+.....       .......
T Consensus       144 ~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~  214 (258)
T cd06632         144 ADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKI  214 (258)
T ss_pred             ccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHH
Confidence            9999987653322  223456788999999986444478899999999999999999999654320       0111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .... .         ....+...+..+.+++.+||+.+|.+||++.+++.
T Consensus       215 ~~~~-~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         215 GRSK-E---------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             Hhcc-c---------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            1000 0         01112334568899999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.2e-41  Score=304.93  Aligned_cols=198  Identities=28%  Similarity=0.396  Sum_probs=168.5

Q ss_pred             CCCCCCeeecCCCceEEEE-EeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-C-----CCccceeeEEeeCCeeEE
Q 043074           83 NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-H-----RNIVKILGYCASGLDRVL  155 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  155 (373)
                      +|.+.+.||+|+||.|.+| +.++++.||||+++.... -.++...|+.+|..|+ |     -|+|+++++|...++.|+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            6788899999999999999 556899999999976543 3456678999999996 4     489999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC--c
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF--E  233 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~--~  233 (373)
                      |+|.+ ..+|.++++.+....             ++...+..|+.||+.||.+||  +.+|||+||||+||||.+.+  .
T Consensus       266 VfELL-~~NLYellK~n~f~G-------------lsl~~ir~~~~Qil~~L~~L~--~l~IIHcDLKPENILL~~~~r~~  329 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRG-------------LSLPLVRKFAQQILTALLFLH--ELGIIHCDLKPENILLKDPKRSR  329 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCC-------------CCHHHHHHHHHHHHHHHHHHH--hCCeeeccCChhheeeccCCcCc
Confidence            99999 679999999887543             999999999999999999999  89999999999999997543  7


Q ss_pred             eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccC
Q 043074          234 AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD  303 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~  303 (373)
                      +||+|||.+.....    .......+..|.|||++.|.+ |+.+.|||||||++.||++| .|.++...+
T Consensus       330 vKVIDFGSSc~~~q----~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG-~PLfpG~ne  393 (586)
T KOG0667|consen  330 IKVIDFGSSCFESQ----RVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTG-EPLFPGDNE  393 (586)
T ss_pred             eeEEecccccccCC----cceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcC-ccccCCCCH
Confidence            99999999986432    222556788999999999655 88899999999999999999 555554433

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5e-40  Score=301.44  Aligned_cols=264  Identities=23%  Similarity=0.253  Sum_probs=192.9

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeC------
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASG------  150 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  150 (373)
                      ..++|+..+.||+|+||.||++... +++.||+|++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3568999999999999999999654 68899999986532  22345678899999999999999999987543      


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      ...++||||++ ++|.+++..                 .+++..+..++.|++.||+|||  +++++||||||+||+++.
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~-----------------~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~  161 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQM-----------------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKS  161 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHh-----------------cCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEECC
Confidence            35799999995 577777642                 1788899999999999999999  799999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH-
Q 043074          231 DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL-  309 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~-  309 (373)
                      ++.+||+|||+++......  ......+|+.|+|||++.+ ..++.++|||||||++|||++|..||............ 
T Consensus       162 ~~~~kL~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  238 (364)
T cd07875         162 DCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI  238 (364)
T ss_pred             CCcEEEEeCCCccccCCCC--cccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999998654321  2234568999999999975 45788999999999999999999997543211100000 


Q ss_pred             -------HHHHHHHH-------Hhcccccc-----ccCcccc---ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 -------LEWARTME-------ARNKEIEM-----VDSNISR---EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 -------~~~~~~~~-------~~~~~~~~-----~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                             .++.....       ........     +......   ..........+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         239 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                   00000000       00000000     0000000   0001112357899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.7e-40  Score=289.12  Aligned_cols=248  Identities=26%  Similarity=0.375  Sum_probs=200.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ..|+..+.||.|+||.||+|... ++..+|+|.+..... .....+.+|+.+++.++||||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35777789999999999999764 688999999865432 3356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++....                +++.+...++.|++.||+|||  +.+++|+||+|+||+++.++.++|+||
T Consensus        84 ~~~~~L~~~i~~~~----------------l~~~~~~~~~~~l~~~l~~lh--~~~ivH~dl~p~Nil~~~~~~~~l~df  145 (277)
T cd06640          84 LGGGSALDLLRAGP----------------FDEFQIATMLKEILKGLDYLH--SEKKIHRDIKAANVLLSEQGDVKLADF  145 (277)
T ss_pred             CCCCcHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHH--hCCccCcCCChhhEEEcCCCCEEEccc
Confidence            99999999986532                788899999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++....... .......++..|+|||.+.+. ..+.++|+||||+++|||++|..|+.......       .....   
T Consensus       146 g~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~~~---  213 (277)
T cd06640         146 GVAGQLTDTQ-IKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMR-------VLFLI---  213 (277)
T ss_pred             ccceeccCCc-cccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-------Hhhhh---
Confidence            9997654322 122334578889999998744 47889999999999999999999865322110       00000   


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                             ... .........+..+.+++.+||+.+|++||++.+++..
T Consensus       214 -------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         214 -------PKN-NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -------hcC-CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                   000 0112245567889999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-40  Score=291.11  Aligned_cols=268  Identities=22%  Similarity=0.314  Sum_probs=196.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|+..+.||+|++|.||+|..+ +++.|++|.+...... ....+.+|+++++.++||||+++++++.+....++|+|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            367888999999999999999765 6899999998654322 22456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+. ++|.+++.....              .+++..+..++.|++.||.|||  +.+++|+||||+||++++++.+||+|
T Consensus        84 ~~~-~~L~~~~~~~~~--------------~~~~~~~~~~~~ql~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~d  146 (291)
T cd07844          84 YLD-TDLKQYMDDCGG--------------GLSMHNVRLFLFQLLRGLAYCH--QRRVLHRDLKPQNLLISERGELKLAD  146 (291)
T ss_pred             cCC-CCHHHHHHhCCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCHHHEEEcCCCCEEECc
Confidence            996 599998876542              2889999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc----------
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG----------  308 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~----------  308 (373)
                      ||+++....... ......++..|+|||.+.+...++.++||||+|+++|+|++|..||...........          
T Consensus       147 fg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  225 (291)
T cd07844         147 FGLARAKSVPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPT  225 (291)
T ss_pred             cccccccCCCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCC
Confidence            999876432221 122234678899999987656678899999999999999999988743321100000          


Q ss_pred             HHHHHHHHHHhcccc---cccc-CccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          309 LLEWARTMEARNKEI---EMVD-SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       309 ~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...|...........   .... ..+............+.+++.+||+.||++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         226 EETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            000000000000000   0000 000000000001257789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.6e-39  Score=283.87  Aligned_cols=249  Identities=24%  Similarity=0.345  Sum_probs=196.8

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEee-CCeeEEEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCAS-GLDRVLIYE  158 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  158 (373)
                      +|++.+.||+|++|.||++..+ +++.+++|.+.....  ...+.+.+|++++++++|+|++++.+.+.. ....++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999754 578999999865432  234568889999999999999999988764 446789999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++++|.+++......             ++++.++..++.|++.|+++||  +.+++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~~l~~~l~~~~~~-------------~l~~~~~~~~~~~l~~~l~~lH--~~~i~H~di~p~nil~~~~~~~~l~d  145 (257)
T cd08223          81 FCEGGDLYHKLKEQKGK-------------LLPENQVVEWFVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGD  145 (257)
T ss_pred             ccCCCcHHHHHHHhcCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCchhEEEecCCcEEEec
Confidence            99999999999764322             2889999999999999999999  88999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||++....... .......+++.|+|||.+.+ ..++.++|+||||+++++|++|..|+....       ..........
T Consensus       146 f~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-------~~~~~~~~~~  216 (257)
T cd08223         146 LGIARVLENQC-DMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKD-------MNSLVYRIIE  216 (257)
T ss_pred             ccceEEecccC-CccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHh
Confidence            99998664322 22334567889999999875 447789999999999999999998864321       1111111111


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       ..    + +     ..+...+..+.+++.+||+.||++||++.++++
T Consensus       217 -~~----~-~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         217 -GK----L-P-----PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             -cC----C-C-----CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             00    0 0     113345568999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.3e-40  Score=288.19  Aligned_cols=254  Identities=26%  Similarity=0.415  Sum_probs=196.4

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc----------cHHHHHHHHHHHhcCCCCCccceeeEEeeCC
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ----------GFREFRAEMETLGKLRHRNIVKILGYCASGL  151 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  151 (373)
                      +|...+.||.|+||.||+|.. .+++.+|+|.+......          ..+.+.+|+.+++.++|||++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            577788999999999999965 46899999987532111          1245778999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..++|+||+++++|.+++....               ++++..+..++.|++.||.|||  +++++|+||+|+||+++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~~~nil~~~~  144 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---------------RFEEQLVRFFTEQVLEGLAYLH--SKGILHRDLKADNLLVDAD  144 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---------------CCCHHHHHHHHHHHHHHHHHHh--hCCeeecCCChhhEEEcCC
Confidence            9999999999999999997653               2888999999999999999999  7899999999999999999


Q ss_pred             CceEEeeeccccccCCCCCc-ccccccccccccCccccCCCC-CCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          232 FEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNT-AATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      +.++|+|||++......... ......++..|+|||.+.+.. .++.++|+||||+++||+++|..|+.....      .
T Consensus       145 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~  218 (272)
T cd06629         145 GICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------I  218 (272)
T ss_pred             CeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------H
Confidence            99999999999765322211 122345788999999987543 478899999999999999999999642111      0


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       .......... ....+...     .....+..+.+++.+||+.+|.+||++.++++
T Consensus       219 -~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         219 -AAMFKLGNKR-SAPPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             -HHHHHhhccc-cCCcCCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence             1011110000 00001111     12234568999999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.6e-40  Score=292.33  Aligned_cols=265  Identities=22%  Similarity=0.310  Sum_probs=196.8

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +|+..+.||.|++|.||+|... ++..+++|.+......  ....+.+|++++++++||||+++++++.++...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778889999999999999764 6899999988654322  235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +. ++|.+++......             .+++..+..++.|++.||+|||  +.+++|+||+|+||+++.++.+||+||
T Consensus        81 ~~-~~l~~~~~~~~~~-------------~l~~~~~~~~~~~i~~~l~~lh--~~~i~H~~l~p~nill~~~~~~~l~df  144 (284)
T cd07860          81 LH-QDLKKFMDASPLS-------------GIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADF  144 (284)
T ss_pred             cc-cCHHHHHHhCCCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEeec
Confidence            95 6899988764432             2899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH------
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA------  313 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~------  313 (373)
                      |++........ ......++..|+|||.+.+...++.++||||||+++|||+||..|+..............+.      
T Consensus       145 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  223 (284)
T cd07860         145 GLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV  223 (284)
T ss_pred             cchhhcccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            99876543221 12233467889999998766667889999999999999999999875422111000000000      


Q ss_pred             -----HHHHHh-ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          314 -----RTMEAR-NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       314 -----~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                           ...... ..........+  .......+..+.+++.+||+.||++||+++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         224 VWPGVTSLPDYKPSFPKWARQDF--SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhhhHHHHHHhhcccccccCH--HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                 000000 00000000000  0001123457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.9e-40  Score=292.07  Aligned_cols=255  Identities=23%  Similarity=0.395  Sum_probs=196.1

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCC----EEEEEEeCcccccc-HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGV----TVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ++|+..+.||+|+||.||+|.+. ++.    .+++|.+....... ...+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            46778889999999999999653 444    57888886544322 34688999999999999999999998754 4679


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ++||+++|+|.+++.....              .+++..++.++.|++.||.|||  +++++|+||||+||+++.++.+|
T Consensus        86 v~e~~~~g~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dikp~Nill~~~~~~k  149 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKD--------------NIGSQLLLNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVK  149 (303)
T ss_pred             eehhcCCCCHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHh--hcCeeccccccceeeecCCCceE
Confidence            9999999999999876432              2889999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          236 ISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |+|||+++........ ......++..|+|||.+.+ ..++.++||||||+++|||++ |..|+.....    .....+ 
T Consensus       150 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~~~~~-  223 (303)
T cd05110         150 ITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----REIPDL-  223 (303)
T ss_pred             EccccccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH-
Confidence            9999999865432221 1122345678999999874 447889999999999999997 7777543210    111111 


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                        . .....       ..   .+..++..+.+++..||..+|++||++.++++.|+++.
T Consensus       224 --~-~~~~~-------~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         224 --L-EKGER-------LP---QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             --H-HCCCC-------CC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              1 11110       00   01223457899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.9e-40  Score=311.25  Aligned_cols=265  Identities=19%  Similarity=0.214  Sum_probs=187.2

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCC------CCCccceeeEEeeC-
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR------HRNIVKILGYCASG-  150 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~-  150 (373)
                      ...++|++.+.||+|+||.||+|.. .+++.||||+++.... ..+....|+.+++.++      |.+++++++++... 
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            3467899999999999999999965 4688899999864322 2234556777766664      45688888888654 


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      ...++|+|++ +++|.+++....               ++++..+..++.||+.||.|||+ +.+|+||||||+|||++.
T Consensus       205 ~~~~iv~~~~-g~~l~~~l~~~~---------------~l~~~~~~~i~~qi~~aL~yLH~-~~gIiHrDlKP~NILl~~  267 (467)
T PTZ00284        205 GHMCIVMPKY-GPCLLDWIMKHG---------------PFSHRHLAQIIFQTGVALDYFHT-ELHLMHTDLKPENILMET  267 (467)
T ss_pred             ceEEEEEecc-CCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCHHHEEEec
Confidence            5788999988 789999887543               28999999999999999999993 258999999999999987


Q ss_pred             CC----------------ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCC
Q 043074          231 DF----------------EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI  294 (373)
Q Consensus       231 ~~----------------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~  294 (373)
                      ++                .+||+|||.+....    .......||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~  342 (467)
T PTZ00284        268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGK  342 (467)
T ss_pred             CCcccccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCC
Confidence            65                49999999876432    223346789999999999854 5788999999999999999999


Q ss_pred             CCCCCcccCCCcccH--------HHHHHHHH-----HhccccccccCccc--------c--ccCCHHHHHHHHHHHHHhc
Q 043074          295 RPNLPVVLDGQEVGL--------LEWARTME-----ARNKEIEMVDSNIS--------R--EELSEAGVREYFRIACMCT  351 (373)
Q Consensus       295 ~p~~~~~~~~~~~~~--------~~~~~~~~-----~~~~~~~~~~~~~~--------~--~~~~~~~~~~l~~l~~~cl  351 (373)
                      .||...........+        ..|.....     ........+.+...        .  ..........+.+|+.+||
T Consensus       343 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL  422 (467)
T PTZ00284        343 LLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL  422 (467)
T ss_pred             CCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhC
Confidence            997543211100000        01111000     00000000000000        0  0000111346889999999


Q ss_pred             CCCCCCCCCHHHHHH
Q 043074          352 NEKSRERPAMSYVVQ  366 (373)
Q Consensus       352 ~~~p~~RPs~~~l~~  366 (373)
                      +.||++|||++|+++
T Consensus       423 ~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        423 HYDRQKRLNARQMTT  437 (467)
T ss_pred             CcChhhCCCHHHHhc
Confidence            999999999999986

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.5e-40  Score=286.85  Aligned_cols=249  Identities=26%  Similarity=0.395  Sum_probs=192.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc-----ccHHHHHHHHHHHhcCCCCCccceeeEEee--CCee
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF-----QGFREFRAEMETLGKLRHRNIVKILGYCAS--GLDR  153 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  153 (373)
                      .+|+..+.||+|+||.||++.. .++..+++|.+.....     .....+.+|+.+++.++||||+++++++.+  +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4788899999999999999965 4689999998864322     223567889999999999999999998865  3577


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++++||+++++|.+++....               .+++...+.++.|++.||+|||  +.+++|+||+|+||+++.++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~qi~~~l~~LH--~~~i~H~~l~p~nil~~~~~~  144 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---------------ALTESVTRKYTRQILEGMSYLH--SNMIVHRDIKGANILRDSAGN  144 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCC
Confidence            89999999999999997543               2788999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCC--cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          234 AHISDFGLARRIDTSHS--HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      ++|+|||+++.......  .......++..|+|||.+.+ ..++.++||||||+++|||++|..|+.....       ..
T Consensus       145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~  216 (266)
T cd06651         145 VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MA  216 (266)
T ss_pred             EEEccCCCccccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccch-------HH
Confidence            99999999876532111  11123457889999999875 4578899999999999999999999653211       01


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .......     ...     ....+...+..+..++ +||..+|++||++++|++
T Consensus       217 ~~~~~~~-----~~~-----~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         217 AIFKIAT-----QPT-----NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHHHHhc-----CCC-----CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1111100     000     1111334455677777 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.1e-39  Score=283.18  Aligned_cols=252  Identities=28%  Similarity=0.415  Sum_probs=200.2

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +|+..+.||+|+||.||+|... +++.+++|.+......  ..+.+.+|+.+++.++|+||+++++.+.+....++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5778899999999999999754 7899999998765543  467789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++....               .+++..+..++.|++.||.|||  +.+++|+||+|+||++++++.+||+||
T Consensus        81 ~~~~~L~~~~~~~~---------------~~~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~kl~d~  143 (264)
T cd06626          81 CSGGTLEELLEHGR---------------ILDEHVIRVYTLQLLEGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDF  143 (264)
T ss_pred             CCCCcHHHHHhhcC---------------CCChHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccc
Confidence            99999999987643               2788899999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccc---cccccccccCccccCCCC--CCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          240 GLARRIDTSHSHVST---QVAGTMGYMPPEYLGGNT--AATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       240 g~~~~~~~~~~~~~~---~~~g~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      |++............   ...++..|+|||.+.+..  ..+.++||||||+++|++++|..||.....        .|..
T Consensus       144 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--------~~~~  215 (264)
T cd06626         144 GCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--------EFQI  215 (264)
T ss_pred             ccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--------hHHH
Confidence            999876443322221   346788999999987533  368899999999999999999999753221        1111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ......    ...+.+..   ....+..+.+++.+||+.+|.+||++.+++.
T Consensus       216 ~~~~~~----~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         216 MFHVGA----GHKPPIPD---SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHhc----CCCCCCCc---ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111100    00111100   1123567889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1e-39  Score=286.87  Aligned_cols=252  Identities=25%  Similarity=0.418  Sum_probs=198.6

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc------ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF------QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      +|+..+.||+|++|.||++.. .++..+++|.+.....      ...+.+.+|+..+++++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999965 5789999999864331      124578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC-ce
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-EA  234 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~-~~  234 (373)
                      |+||+++++|.+++....               ++++..+..++.|++.||.|||  +++++|+||+|+||+++.++ .+
T Consensus        81 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~ql~~al~~LH--~~~i~H~~i~~~nil~~~~~~~~  143 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---------------AFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRL  143 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEE
Confidence            999999999999997543               2889999999999999999999  78999999999999998776 59


Q ss_pred             EEeeeccccccCCCCCc---ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          235 HISDFGLARRIDTSHSH---VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +|+|||.+.........   ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..|+......    ....
T Consensus       144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~  218 (268)
T cd06630         144 RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS----NHLA  218 (268)
T ss_pred             EEcccccccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCc----chHH
Confidence            99999999876433111   1223457889999999874 45788999999999999999999986432111    1111


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .......          .......+...+.++.+++.+||+.+|.+||++.+++.
T Consensus       219 ~~~~~~~----------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         219 LIFKIAS----------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHHhc----------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            1111100          00011224455678999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.3e-41  Score=297.67  Aligned_cols=249  Identities=25%  Similarity=0.355  Sum_probs=196.7

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      .|.....||+|+||.||++... ++..+++|.+........+.+.+|+..++.++|||++++++.+..++..++|+||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            3444567999999999999754 688999999876555555678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +++|.+++....                +++.++..++.|++.||.|||  +++++||||||+||++++++.++|+|||+
T Consensus       103 ~~~L~~~~~~~~----------------l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kL~dfg~  164 (292)
T cd06658         103 GGALTDIVTHTR----------------MNEEQIATVCLSVLRALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGF  164 (292)
T ss_pred             CCcHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEccCcc
Confidence            999999885432                788999999999999999999  78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK  321 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (373)
                      +........ ......++..|+|||.+.+ ..++.++|+||||+++|||++|..|+.....    .   ........   
T Consensus       165 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~---~~~~~~~~---  232 (292)
T cd06658         165 CAQVSKEVP-KRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----L---QAMRRIRD---  232 (292)
T ss_pred             hhhcccccc-cCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H---HHHHHHHh---
Confidence            876533221 2233567889999999864 4478899999999999999999999753211    0   00111100   


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                         .+......   ....+..+.+++.+||+.||.+|||++++++.
T Consensus       233 ---~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         233 ---NLPPRVKD---SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ---cCCCcccc---ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               11111111   11234578899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.8e-40  Score=292.56  Aligned_cols=264  Identities=26%  Similarity=0.364  Sum_probs=201.5

Q ss_pred             cChHHHHHhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEee
Q 043074           72 ISMSELIDATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCAS  149 (373)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  149 (373)
                      ++..++..+.++|.+.+.||+|+||.||++.. .+++.+++|.+..... ....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            34455666788999999999999999999976 4688999999865432 235677899999998 79999999999865


Q ss_pred             C-----CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCC
Q 043074          150 G-----LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS  224 (373)
Q Consensus       150 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~  224 (373)
                      .     ...++|+||+++++|.+++.......           ..+++..+..++.|++.||.|||  +.+++|+||||+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~-----------~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~  157 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICG-----------QRLDEAMISYILYGALLGLQHLH--NNRIIHRDVKGN  157 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcC-----------CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHH
Confidence            3     35899999999999999886532111           13889999999999999999999  789999999999


Q ss_pred             ceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCC----CCCccccchhhhHHHHHHHhCCCCCCCc
Q 043074          225 NVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNT----AATVMLDVYSFGILMIEIATQIRPNLPV  300 (373)
Q Consensus       225 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~~DiwslG~~l~el~~g~~p~~~~  300 (373)
                      ||+++.++.+||+|||++........ ......++..|+|||.+....    .++.++|||||||++|||++|..|+...
T Consensus       158 nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~  236 (291)
T cd06639         158 NILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM  236 (291)
T ss_pred             HEEEcCCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence            99999999999999999886543221 122345788999999875432    2578999999999999999999996542


Q ss_pred             ccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...   ..+    ..... ..     ...+.   .+......+.+++.+||+.||++||++.++++
T Consensus       237 ~~~---~~~----~~~~~-~~-----~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         237 HPV---KTL----FKIPR-NP-----PPTLL---HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             cHH---HHH----HHHhc-CC-----CCCCC---cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            110   000    00000 00     00110   02233457999999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.4e-40  Score=291.45  Aligned_cols=246  Identities=28%  Similarity=0.401  Sum_probs=196.4

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      .|+..+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++++++||||+++++++..+...++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4556678999999999999654 678899999875432 33457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++++|.+++...                ++++..+..++.|++.|+.|||  +++++|+||+|+||++++++.++|+|||
T Consensus        85 ~~~~L~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lH--~~~ivH~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06642          85 GGGSALDLLKPG----------------PLEETYIATILREILKGLDYLH--SERKIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             CCCcHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHh--cCCeeccCCChheEEEeCCCCEEEcccc
Confidence            999999988643                2888999999999999999999  7999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      ++....... .......++..|+|||.+.+. .++.++|+||||+++|||++|..|+.......       +.....   
T Consensus       147 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~~~~---  214 (277)
T cd06642         147 VAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------VLFLIP---  214 (277)
T ss_pred             ccccccCcc-hhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhh-------HHhhhh---
Confidence            997654322 112234578899999998754 47889999999999999999999864321110       000000   


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                         ....+     ......+..+.+++.+||+.+|.+||++.+++.
T Consensus       215 ---~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         215 ---KNSPP-----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             ---cCCCC-----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence               00011     112344568999999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-40  Score=311.74  Aligned_cols=273  Identities=19%  Similarity=0.250  Sum_probs=188.4

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC--CCCEEEEEEe--------------Cc---cccccHHHHHHHHHHHhcCCCCCc
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS--SGVTVAIKKL--------------DK---DAFQGFREFRAEMETLGKLRHRNI  140 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~--------------~~---~~~~~~~~~~~e~~~l~~l~h~ni  140 (373)
                      ..++|++.+.||+|+||.||++..+  ++...+.|.+              .+   ........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3578999999999999999998643  2222222211              00   111123467899999999999999


Q ss_pred             cceeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeec
Q 043074          141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRD  220 (373)
Q Consensus       141 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~d  220 (373)
                      +++++++.+....+++++++ .++|.+++........          .......+..++.|++.||.|||  +++|+|||
T Consensus       226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~----------~~~~~~~~~~i~~ql~~aL~yLH--~~gIiHrD  292 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWK----------DRPLLKQTRAIMKQLLCAVEYIH--DKKLIHRD  292 (501)
T ss_pred             CcEeEEEEECCeeEEEEecc-ccCHHHHHhhcccccc----------ccccHHHHHHHHHHHHHHHHHHH--hCCeecCC
Confidence            99999999999999999999 5678777754332110          01345677889999999999999  78999999


Q ss_pred             CCCCceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCc
Q 043074          221 IKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPV  300 (373)
Q Consensus       221 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  300 (373)
                      |||+|||++.++.+||+|||+++.+............||..|+|||++.+. .++.++|||||||++|||++|..++...
T Consensus       293 LKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~  371 (501)
T PHA03210        293 IKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGD  371 (501)
T ss_pred             CCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence            999999999999999999999987654433334456799999999999754 4788999999999999999998664432


Q ss_pred             ccCCCcccHHHHHHHHHHhc--------cccccc-----c---CccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 043074          301 VLDGQEVGLLEWARTMEARN--------KEIEMV-----D---SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYV  364 (373)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~-----~---~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l  364 (373)
                      ........+...........        +....+     .   ..+.........+..+.+++.+||+.||++|||+.|+
T Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el  451 (501)
T PHA03210        372 GGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL  451 (501)
T ss_pred             CCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH
Confidence            22111111111111000000        000000     0   0000000000123467788999999999999999999


Q ss_pred             HH
Q 043074          365 VQ  366 (373)
Q Consensus       365 ~~  366 (373)
                      ++
T Consensus       452 L~  453 (501)
T PHA03210        452 LA  453 (501)
T ss_pred             hh
Confidence            86

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.2e-40  Score=288.11  Aligned_cols=256  Identities=23%  Similarity=0.385  Sum_probs=197.5

Q ss_pred             CCCCCCeeecCCCceEEEEEeCC--CCEEEEEEeCccc----------cccHHHHHHHHHHHhc-CCCCCccceeeEEee
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLSS--GVTVAIKKLDKDA----------FQGFREFRAEMETLGK-LRHRNIVKILGYCAS  149 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  149 (373)
                      +|++.+.||+|+||.||+|..+.  ++.+++|.+....          ......+.+|+.++.+ ++|||++++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999997654  7889999875322          1123456788888765 799999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       150 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      +...++++||+++++|.+++.......           ..+++..++.++.|++.||.|||+ ..+++|+||+|+||+++
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh~-~~~i~H~dl~~~nil~~  148 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKK-----------QRFTEERIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIMLG  148 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHhcc-CCceeecCCCHHHEEEC
Confidence            999999999999999999886432111           138899999999999999999993 36799999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          230 SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      +++.++|+|||.+.......  ......++..|+|||.+.+ ..++.++|+||||+++|||++|..|+....       .
T Consensus       149 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-------~  218 (269)
T cd08528         149 EDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTN-------M  218 (269)
T ss_pred             CCCcEEEecccceeeccccc--ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccC-------H
Confidence            99999999999998754332  2334568889999999975 447889999999999999999999864321       1


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                      ..........  .   . ....    ....+..+.+++.+||+.||++||++.++...+++
T Consensus       219 ~~~~~~~~~~--~---~-~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         219 LSLATKIVEA--V---Y-EPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             HHHHHHHhhc--c---C-CcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            1111111110  0   0 0000    11234579999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.2e-40  Score=292.98  Aligned_cols=251  Identities=25%  Similarity=0.345  Sum_probs=201.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|.+.+.||+|+||.||++.. .++..+++|.+........+.+.+|+.+++.++|||++++++.+..+...++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            35888899999999999999965 46889999998765555556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++.+..                +++.++..++.|++.||.|||  +++++|+||+|+||+++.++.++|+||
T Consensus        98 ~~~~~L~~~~~~~~----------------l~~~~~~~i~~~l~~al~~LH--~~gi~H~dL~p~Nili~~~~~~kL~df  159 (293)
T cd06647          98 LAGGSLTDVVTETC----------------MDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDF  159 (293)
T ss_pred             CCCCcHHHHHhhcC----------------CCHHHHHHHHHHHHHHHHHHH--hCCEeeccCCHHHEEEcCCCCEEEccC
Confidence            99999999987542                788999999999999999999  889999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++........ ......+++.|+|||.+.+ ..++.++|+||||+++|++++|..||..........   .    ....
T Consensus       160 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~---~----~~~~  230 (293)
T cd06647         160 GFCAQITPEQS-KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---L----IATN  230 (293)
T ss_pred             cceeccccccc-ccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee---e----hhcC
Confidence            99876543322 2233467889999999874 447889999999999999999999975422111000   0    0000


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      .      .+.   ...+...+..+.+++.+||+.+|.+||++.+++..
T Consensus       231 ~------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         231 G------TPE---LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             C------CCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0      000   01122345679999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.7e-39  Score=289.59  Aligned_cols=255  Identities=22%  Similarity=0.286  Sum_probs=197.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|+..+.||+|+||.||++... +++.|++|.+.....   .....+.+|+.+++.++||||+++++.+.++...++|+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888899999999999999764 578999999866542   23456789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++++|.+++....               ++++..+..++.|++.||.|||  +.+++||||||+||+++.++.++|+
T Consensus        81 e~~~g~~L~~~l~~~~---------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~NIll~~~~~~~l~  143 (305)
T cd05609          81 EYVEGGDCATLLKNIG---------------ALPVDMARMYFAETVLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLT  143 (305)
T ss_pred             ecCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHEEECCCCCEEEe
Confidence            9999999999997643               2889999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCC--------------cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccC
Q 043074          238 DFGLARRIDTSHS--------------HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD  303 (373)
Q Consensus       238 Dfg~~~~~~~~~~--------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~  303 (373)
                      |||+++.......              .......++..|+|||.+.+ ..++.++|+||||+++|||++|..|+....  
T Consensus       144 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~--  220 (305)
T cd05609         144 DFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDT--  220 (305)
T ss_pred             eCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence            9999864211100              01112356788999999874 457889999999999999999999975321  


Q ss_pred             CCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          304 GQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                           ..++........ .   ..+.     .....+..+.+++.+||+.||++||+..++.+.|+.
T Consensus       221 -----~~~~~~~~~~~~-~---~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         221 -----PEELFGQVISDD-I---EWPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             -----HHHHHHHHHhcc-c---CCCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence                 111111111100 0   0000     011245678999999999999999997766666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.1e-40  Score=291.77  Aligned_cols=266  Identities=24%  Similarity=0.316  Sum_probs=197.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASG--LDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  156 (373)
                      ++|+..+.||.|+||.||+|..+ +++.+++|.++.....  ....+.+|+.++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999775 6889999998654322  223567899999999999999999998877  889999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +||+. ++|.+++.....              .+++..+..++.|++.||+|||  +++++|+||||+||+++.++.++|
T Consensus        85 ~e~~~-~~L~~~~~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~~~~~~~l  147 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ--------------PFLQSEVKCLMLQLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKI  147 (293)
T ss_pred             ehhcC-cCHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCcEEE
Confidence            99996 599998876442              2899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH-------
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL-------  309 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~-------  309 (373)
                      +|||++........ ......+++.|+|||.+.+....+.++|+||||+++|||++|..|+...........+       
T Consensus       148 ~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~  226 (293)
T cd07843         148 CDFGLAREYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP  226 (293)
T ss_pred             eecCceeeccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999987654321 1223456889999999876666788999999999999999999987543211100000       


Q ss_pred             --HHHHHH--HHHhc-ccc-ccccCccccccCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 --LEWART--MEARN-KEI-EMVDSNISREELSEA-GVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 --~~~~~~--~~~~~-~~~-~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                        ..|...  ..... ... ......+ ...++.. .+..+.+++.+||+.||++|||+.|++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         227 TEKIWPGFSELPGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             chHHHHHhhccchhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence              001000  00000 000 0000000 0111111 3567899999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-40  Score=289.38  Aligned_cols=257  Identities=29%  Similarity=0.410  Sum_probs=199.7

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEeeCC-----
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCASGL-----  151 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----  151 (373)
                      .++++|++.+.||+|++|.||+|..+ +++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35689999999999999999999764 678999999876543 336788999999999 6999999999996644     


Q ss_pred             -eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          152 -DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       152 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                       ..++|+||+++++|.+++.......           ..+++..+..++.|++.||.|||  +.+++|+||+|+||++++
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~-----------~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~~l~p~ni~~~~  148 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKG-----------KRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTK  148 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEEcc
Confidence             4899999999999999987543111           13889999999999999999999  789999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          231 DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                      ++.++|+|||++....... .......++..|+|||.+.+    ...++.++||||||+++|+|++|..|+......   
T Consensus       149 ~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---  224 (275)
T cd06608         149 NAEVKLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---  224 (275)
T ss_pred             CCeEEECCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---
Confidence            9999999999987653322 22233557889999998753    234677899999999999999999997532111   


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...    ....      ......+.   .+...+..+.+++.+||+.||++|||+.++++
T Consensus       225 ~~~----~~~~------~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         225 RAL----FKIP------RNPPPTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HHH----HHhh------ccCCCCCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            000    0000      00111111   12335568999999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-40  Score=283.33  Aligned_cols=251  Identities=23%  Similarity=0.294  Sum_probs=201.3

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccccc---HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQG---FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      +.|+..+.||.|.-|+||+++.+ ++..+|+|++.+.....   ......|.++|+.++||.++.|++.++++...|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            46677889999999999999876 46889999998765543   345677999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      |||+||+|..+.++....-             +++..+.-++..++-||+|||  ..|||+|||||+||||.++|++-|+
T Consensus       157 eyCpGGdL~~LrqkQp~~~-------------fse~~aRFYaAEvl~ALEYLH--mlGivYRDLKPENILvredGHIMLs  221 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKR-------------FSESAARFYAAEVLLALEYLH--MLGIVYRDLKPENILVREDGHIMLS  221 (459)
T ss_pred             ecCCCccHHHHHhhCCCCc-------------cchhhHHHHHHHHHHHHHHHH--hhceeeccCCcceeEEecCCcEEee
Confidence            9999999999998776543             899999999999999999999  8999999999999999999999999


Q ss_pred             eeccccccCCC----------------------------------C---------------------Ccccccccccccc
Q 043074          238 DFGLARRIDTS----------------------------------H---------------------SHVSTQVAGTMGY  262 (373)
Q Consensus       238 Dfg~~~~~~~~----------------------------------~---------------------~~~~~~~~g~~~y  262 (373)
                      ||.++......                                  .                     ...+...+||-.|
T Consensus       222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEY  301 (459)
T KOG0610|consen  222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEY  301 (459)
T ss_pred             eccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccc
Confidence            99988653110                                  0                     0112235789999


Q ss_pred             cCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHH
Q 043074          263 MPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVRE  342 (373)
Q Consensus       263 ~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (373)
                      .|||++.|+. .+.+.|.|+||+++|||+.|.-||.......   .+.+.             +...+.-.. ....+..
T Consensus       302 lAPEvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~---Tl~NI-------------v~~~l~Fp~-~~~vs~~  363 (459)
T KOG0610|consen  302 LAPEVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---TLRNI-------------VGQPLKFPE-EPEVSSA  363 (459)
T ss_pred             ccceeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchh---hHHHH-------------hcCCCcCCC-CCcchhH
Confidence            9999999766 6779999999999999999999986533221   11111             112222112 1244578


Q ss_pred             HHHHHHHhcCCCCCCCCC----HHHHH
Q 043074          343 YFRIACMCTNEKSRERPA----MSYVV  365 (373)
Q Consensus       343 l~~l~~~cl~~~p~~RPs----~~~l~  365 (373)
                      +.+||++.|.+||++|..    +.||-
T Consensus       364 akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  364 AKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             HHHHHHHHhccChhhhhccccchHHhh
Confidence            999999999999999988    55553

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-40  Score=290.60  Aligned_cols=261  Identities=23%  Similarity=0.319  Sum_probs=196.0

Q ss_pred             CCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      |+..+.||.|++|.||+|..+ +|..|++|++.....  ...+.+.+|++.++.++|||++++++++.++...++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999764 799999999865432  22356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                       +++|.+++......             .+++..+..++.|++.||+|||  +++++|+||+|+||+++.++.++|+|||
T Consensus        81 -~~~l~~~~~~~~~~-------------~~~~~~~~~~~~~i~~~L~~lH--~~~~~H~dl~p~nil~~~~~~~~l~df~  144 (283)
T cd07835          81 -DLDLKKYMDSSPLT-------------GLDPPLIKSYLYQLLQGIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFG  144 (283)
T ss_pred             -CcCHHHHHhhCCCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCcEEEeecc
Confidence             57999998765421             2899999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH----
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM----  316 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----  316 (373)
                      ++......... .....++..|+|||.+.+...++.++|+||||+++|+|++|..||.......   .+.......    
T Consensus       145 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~  220 (283)
T cd07835         145 LARAFGVPVRT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID---QLFRIFRTLGTPD  220 (283)
T ss_pred             cccccCCCccc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCC
Confidence            99765432221 1223468899999988765567889999999999999999998865322111   000100000    


Q ss_pred             ----------HHhc-cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 ----------EARN-KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ----------~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                                .... .......... . ......+..+.+++.+||+.||.+||+++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         221 EDVWPGVTSLPDYKPTFPKWARQDL-S-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hHHhhhhhhchhhhhhcccccccch-h-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                      0000 0000000000 0 001223457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-41  Score=305.09  Aligned_cols=245  Identities=27%  Similarity=0.436  Sum_probs=194.7

Q ss_pred             CCCCeeecCCCceEEEEEe-CCCCEEEEEEeCc----cccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe--eEEEE
Q 043074           85 STDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDK----DAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLD--RVLIY  157 (373)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  157 (373)
                      +...+||+|+|-+||+|.+ .+|.+||--.++.    ......+.|..|+.+|+.|+||||++++..+.+..+  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4456899999999999954 4688887433321    222335779999999999999999999999987765  67899


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC-CceEE
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-FEAHI  236 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~-~~~kl  236 (373)
                      |.+..|+|..|+.+.+.               ++.....+|++||++||.|||+.+.+|+|||||.+||||+.+ |.|||
T Consensus       123 EL~TSGtLr~Y~kk~~~---------------vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKI  187 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRR---------------VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKI  187 (632)
T ss_pred             ecccCCcHHHHHHHhcc---------------CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceee
Confidence            99999999999998875               888999999999999999999989999999999999999865 89999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|+|+|.....+..   ....|||.|||||.+.  ..|++..||||||+.++||+|+..|+.   .......++      
T Consensus       188 GDLGLAtl~r~s~a---ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYs---EC~n~AQIY------  253 (632)
T KOG0584|consen  188 GDLGLATLLRKSHA---KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYS---ECTNPAQIY------  253 (632)
T ss_pred             cchhHHHHhhcccc---ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChh---hhCCHHHHH------
Confidence            99999998765442   3378999999999996  458999999999999999999998832   222222211      


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                         .++...+.+.-    +...-..++.++|.+|+.. .++|||+.|++.
T Consensus       254 ---KKV~SGiKP~s----l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  254 ---KKVTSGIKPAA----LSKVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ---HHHHcCCCHHH----hhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence               12222222221    1222245899999999999 899999999985

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.4e-39  Score=285.62  Aligned_cols=253  Identities=28%  Similarity=0.418  Sum_probs=200.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|+..+.||+|+||.||++..+ +++.+++|.+..... .....+.+|++.+++++||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777889999999999999765 689999999876543 3345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCceeecCCCCceEeCCCCceEEee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLE-KPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~-~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      +++++|.+++.....              ++++.....++.|++.|++|||  + .+++|+||+|+||++++++.++|+|
T Consensus        81 ~~~~~L~~~~~~~~~--------------~~~~~~~~~~~~~l~~~l~~lH--~~~~i~H~dl~~~ni~~~~~~~~~l~d  144 (265)
T cd06605          81 MDGGSLDKILKEVQG--------------RIPERILGKIAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCD  144 (265)
T ss_pred             cCCCcHHHHHHHccC--------------CCCHHHHHHHHHHHHHHHHHHc--CCCCeecCCCCHHHEEECCCCCEEEee
Confidence            999999999986531              3888999999999999999999  7 8999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||.+........   ....++..|+|||.+.+. .++.++||||||+++|+|++|..|+.+.....  ....+.......
T Consensus       145 ~g~~~~~~~~~~---~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~  218 (265)
T cd06605         145 FGVSGQLVNSLA---KTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPP--DGIFELLQYIVN  218 (265)
T ss_pred             cccchhhHHHHh---hcccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccc--ccHHHHHHHHhc
Confidence            999876532211   125678899999998754 57889999999999999999999975432211  111222211111


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .      ..+.+.    ....+.++.+++.+||..||++||++.+++.
T Consensus       219 ~------~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         219 E------PPPRLP----SGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             C------CCCCCC----hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            0      001110    1115568999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-39  Score=318.94  Aligned_cols=256  Identities=21%  Similarity=0.361  Sum_probs=195.7

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCAS--GLDRV  154 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  154 (373)
                      ..++|.+.+.||+|+||.||++... ++..+++|.+.....  .....+..|+.++..++||||+++++++.+  ....+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3568999999999999999999764 577889998865432  234578899999999999999999998854  35689


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCceeecCCCCceEeC
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLE-----KPIIHRDIKSSNVLLD  229 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~-----~~i~H~dlk~~Nill~  229 (373)
                      +||||+++|+|.+++......           ...+++..++.|+.||+.||.|||+..     .+|+||||||+|||++
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~-----------~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~  159 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKM-----------FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS  159 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhc-----------cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence            999999999999999764321           113899999999999999999999422     4699999999999996


Q ss_pred             C-----------------CCceEEeeeccccccCCCCCcccccccccccccCccccCCC-CCCCccccchhhhHHHHHHH
Q 043074          230 S-----------------DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN-TAATVMLDVYSFGILMIEIA  291 (373)
Q Consensus       230 ~-----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~  291 (373)
                      .                 .+.+||+|||++.......  ......||+.|+|||++.+. ..++.++|||||||+||||+
T Consensus       160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL  237 (1021)
T PTZ00266        160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC  237 (1021)
T ss_pred             cCccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence            4                 2358999999998654322  22345689999999998643 45788999999999999999


Q ss_pred             hCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          292 TQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       292 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      +|..||....      ............        +.+.    ....+.++.+|+..||+.+|.+||++.+++.
T Consensus       238 TGk~PF~~~~------~~~qli~~lk~~--------p~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        238 SGKTPFHKAN------NFSQLISELKRG--------PDLP----IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HCCCCCCcCC------cHHHHHHHHhcC--------CCCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            9999975321      111111111110        1111    1112457999999999999999999999983

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.5e-39  Score=289.43  Aligned_cols=267  Identities=22%  Similarity=0.250  Sum_probs=195.4

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccccc-HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++++|.+.+.||+|+||.||+|.. .++..+++|.+....... ...+.+|+.+++.++|+||+++.+++.++...++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            357899999999999999999965 468899999986544332 235678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+. ++|.+++.....              .+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.++|+
T Consensus        83 e~~~-~~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~  145 (291)
T cd07870          83 EYMH-TDLAQYMIQHPG--------------GLHPYNVRLFMFQLLRGLAYIH--GQHILHRDLKPQNLLISYLGELKLA  145 (291)
T ss_pred             eccc-CCHHHHHHhCCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEEcCCCcEEEe
Confidence            9995 788777654322              2778888999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH-HH---
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE-WA---  313 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~---  313 (373)
                      |||+++...... .......+++.|+|||.+.+...++.++||||||+++|||++|..||.......  ..+.. |.   
T Consensus       146 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~  222 (291)
T cd07870         146 DFGLARAKSIPS-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLG  222 (291)
T ss_pred             ccccccccCCCC-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcC
Confidence            999987643222 112334568899999998765557889999999999999999999975432110  00000 00   


Q ss_pred             -------HHHHHhccccccccCcccccc-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          314 -------RTMEARNKEIEMVDSNISREE-----LSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       314 -------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                             .....................     .....+..+.+++.+|++.||++|||+.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         223 VPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             CCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                   000000000000000000000     00011457889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.8e-39  Score=285.52  Aligned_cols=254  Identities=30%  Similarity=0.452  Sum_probs=194.2

Q ss_pred             CeeecCCCceEEEEEeCC-------CCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           88 KIIGDGSFGFVYKAKLSS-------GVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +.||+|+||.||+|..++       +..+++|.+..... .....+.+|+.+++.++||||+++++++......++++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999997542       25789998865432 3356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC-----ce
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-----EA  234 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~-----~~  234 (373)
                      +++++|.+++........        ....+++.+++.++.|++.||.|||  +.+++|+||+|+||+++.++     .+
T Consensus        81 ~~~~~L~~~l~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~~~~  150 (269)
T cd05044          81 MEGGDLLSYLRDARVERF--------GPPLLTLKELLDICLDVAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVV  150 (269)
T ss_pred             cCCCcHHHHHHHhhhccc--------CCccccHHHHHHHHHHHHHHHHHHH--hCCcccCCCChheEEEecCCCCCCcce
Confidence            999999999976432110        0112788999999999999999999  78999999999999999887     89


Q ss_pred             EEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHH
Q 043074          235 HISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  312 (373)
                      +++|||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....    .   .+.
T Consensus       151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~----~---~~~  222 (269)
T cd05044         151 KIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALN----N---QEV  222 (269)
T ss_pred             EECCcccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccC----H---HHH
Confidence            9999999976533221 11122345678999999874 447889999999999999998 888753211    1   111


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                      ...... ..       ..   ..+...+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus       223 ~~~~~~-~~-------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         223 LQHVTA-GG-------RL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             HHHHhc-CC-------cc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            111100 00       00   1133456789999999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.4e-39  Score=282.60  Aligned_cols=249  Identities=21%  Similarity=0.326  Sum_probs=198.7

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +|+..+.||+|+||.+|++.. .+++.+++|.+....  ....+.+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478889999999999999965 468999999986432  22345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++......             .+++.+++.++.|++.|+.|||  +.+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~l~~~~~~~~~~-------------~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~l~~~nil~~~~~~~~l~d~  145 (256)
T cd08218          81 CEGGDLYKKINAQRGV-------------LFPEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTIKLGDF  145 (256)
T ss_pred             CCCCcHHHHHHhccCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEEeec
Confidence            9999999998754321             2788999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++........ ......|++.|+|||.+.+. ..+.++|+||||+++++|++|..|+....       ..+....... 
T Consensus       146 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~~~~-  215 (256)
T cd08218         146 GIARVLNSTVE-LARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGN-------MKNLVLKIIR-  215 (256)
T ss_pred             cceeecCcchh-hhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCC-------HHHHHHHHhc-
Confidence            99976543221 12234578899999998754 47889999999999999999999864321       1111111110 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      +.     ..     ..+...+..+.+++.+||+.+|.+||++.++++
T Consensus       216 ~~-----~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         216 GS-----YP-----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CC-----CC-----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            00     00     113344568999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=292.99  Aligned_cols=252  Identities=23%  Similarity=0.320  Sum_probs=198.1

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|+..+.||+|++|.||++... +++.+|+|.+......   ..+.+.+|++.++.++||||+++++.+.++...++|+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999765 5899999999765433   3456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+.+++|.+++......             .+++..+..++.|++.||+|||  +.+++|+||||+||+++.++.++|+
T Consensus        81 e~~~~~~L~~~~~~~~~~-------------~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~  145 (316)
T cd05574          81 DYCPGGELFRLLQRQPGK-------------CLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHESGHIMLS  145 (316)
T ss_pred             EecCCCCHHHHHHhCCCC-------------ccCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChHHeEEcCCCCEEEe
Confidence            999999999998754322             2889999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCc----------------------------ccccccccccccCccccCCCCCCCccccchhhhHHHHH
Q 043074          238 DFGLARRIDTSHSH----------------------------VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE  289 (373)
Q Consensus       238 Dfg~~~~~~~~~~~----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~e  289 (373)
                      |||++.........                            ......|+..|+|||.+.+. .++.++||||||+++|+
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~  224 (316)
T cd05574         146 DFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYE  224 (316)
T ss_pred             ecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHH
Confidence            99998764322110                            11124578899999999754 46889999999999999


Q ss_pred             HHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC----HHHHH
Q 043074          290 IATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA----MSYVV  365 (373)
Q Consensus       290 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~~l~  365 (373)
                      |++|..|+......      ..+....          ........ ....+..+.+++.+||+.||++||+    +.+++
T Consensus       225 l~~g~~pf~~~~~~------~~~~~~~----------~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll  287 (316)
T cd05574         225 MLYGTTPFKGSNRD------ETFSNIL----------KKEVTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK  287 (316)
T ss_pred             HhhCCCCCCCCchH------HHHHHHh----------cCCccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence            99999996432211      0111000          00100000 1114668999999999999999999    77766


Q ss_pred             H
Q 043074          366 Q  366 (373)
Q Consensus       366 ~  366 (373)
                      .
T Consensus       288 ~  288 (316)
T cd05574         288 Q  288 (316)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.9e-39  Score=288.48  Aligned_cols=244  Identities=25%  Similarity=0.331  Sum_probs=197.1

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||++... +++.+|+|.+.....   ...+.+.+|++++++++||||+++++++.++...++|+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999764 689999999865432   23456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++++|.+++....               .+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.+||+
T Consensus        81 e~~~~~~L~~~~~~~~---------------~l~~~~~~~~~~qil~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~  143 (290)
T cd05580          81 EYVPGGELFSHLRKSG---------------RFPEPVARFYAAQVVLALEYLH--SLDIVYRDLKPENLLLDSDGYIKIT  143 (290)
T ss_pred             ecCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEe
Confidence            9999999999987653               2889999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||++......    .....+++.|+|||.+.+. ..+.++||||||+++|+|++|..|+.....      . .......
T Consensus       144 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~-~~~~~~~  211 (290)
T cd05580         144 DFGFAKRVKGR----TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNP------I-QIYEKIL  211 (290)
T ss_pred             eCCCccccCCC----CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCH------H-HHHHHHh
Confidence            99999875433    2334688999999998744 578899999999999999999999654221      0 0000000


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                       ..      ...+     +...+..+.+++.+||+.||.+||     +++++++
T Consensus       212 -~~------~~~~-----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         212 -EG------KVRF-----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -cC------CccC-----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence             00      0111     222356889999999999999999     7777653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2e-39  Score=289.08  Aligned_cols=247  Identities=24%  Similarity=0.355  Sum_probs=195.8

Q ss_pred             CCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      |.....||+|+||.||++... ++..|++|.+........+.+.+|+..+..++|||++++++++..+...++++||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            333457999999999999754 6899999998665544556788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      ++|.+++....                +++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||++
T Consensus       103 ~~L~~~~~~~~----------------~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dl~p~Nill~~~~~~kL~dfg~~  164 (297)
T cd06659         103 GALTDIVSQTR----------------LNEEQIATVCESVLQALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSDFGFC  164 (297)
T ss_pred             CCHHHHHhhcC----------------CCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHeEEccCCcEEEeechhH
Confidence            99999875432                889999999999999999999  789999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE  322 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (373)
                      ....... .......++..|+|||.+.+. .++.++||||||+++|||++|..|+......       +.........  
T Consensus       165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~--  233 (297)
T cd06659         165 AQISKDV-PKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-------QAMKRLRDSP--  233 (297)
T ss_pred             hhccccc-ccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhccC--
Confidence            7653322 122335688999999998754 4788999999999999999999997532111       1111111100  


Q ss_pred             cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                          ......   ....+..+.+++.+||+.+|.+||+++++++
T Consensus       234 ----~~~~~~---~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         234 ----PPKLKN---AHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             ----CCCccc---cCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                000000   1123457899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-40  Score=290.60  Aligned_cols=262  Identities=26%  Similarity=0.300  Sum_probs=197.4

Q ss_pred             CCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEE
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASG--LDRVLIYE  158 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  158 (373)
                      |++.+.||+|+||.||+|... ++..+++|.+....  ......+.+|+.++++++|||++++++++.+.  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            566788999999999999765 58899999997653  23345688999999999999999999999888  88999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |++ ++|.+++.....              .+++..++.++.|++.||+|||  +.+++|+||+|+||++++++.++|+|
T Consensus        81 ~~~-~~l~~~~~~~~~--------------~~~~~~~~~i~~~i~~al~~LH--~~~~~h~dl~p~nil~~~~~~~~l~d  143 (287)
T cd07840          81 YMD-HDLTGLLDSPEV--------------KFTESQIKCYMKQLLEGLQYLH--SNGILHRDIKGSNILINNDGVLKLAD  143 (287)
T ss_pred             ccc-ccHHHHHhccCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEEcCCCCEEEcc
Confidence            996 589888865421              2899999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||++...............++..|+|||.+.+...++.++||||||+++|||++|..|+.......    ..........
T Consensus       144 ~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~----~~~~~~~~~~  219 (287)
T cd07840         144 FGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE----QLEKIFELCG  219 (287)
T ss_pred             ccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhC
Confidence            999987654432223334567889999988765667889999999999999999998865432111    0000000000


Q ss_pred             hc-----ccccc------ccC-----ccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RN-----KEIEM------VDS-----NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~-----~~~~~------~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..     .....      ...     ....+.....++..+.+++.+||+.||.+||+++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         220 SPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             CCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00     00000      000     00000111113668999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-41  Score=306.84  Aligned_cols=249  Identities=24%  Similarity=0.420  Sum_probs=199.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC--CC--CEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS--SG--VTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      +.....++||+|+||.|++|.|.  +|  ..||||.+...... ....|++|+.+|.+|+|+|+++|+|+..+ ....+|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            34556789999999999999775  34  45899999776655 57899999999999999999999999887 678899


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +|.++.|+|.+.|++....             .|-......++.||+.||.||.  .+++|||||..+|+++-..-.|||
T Consensus       189 ~ELaplGSLldrLrka~~~-------------~llv~~Lcdya~QiA~aM~YLe--skrlvHRDLAARNlllasprtVKI  253 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKA-------------ILLVSRLCDYAMQIAKAMQYLE--SKRLVHRDLAARNLLLASPRTVKI  253 (1039)
T ss_pred             hhhcccchHHHHHhhcccc-------------ceeHHHHHHHHHHHHHHHHHHh--hhhhhhhhhhhhhheecccceeee
Confidence            9999999999999883322             2778888999999999999999  799999999999999999999999


Q ss_pred             eeeccccccCCCCCccc--ccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCC-CCCCCcccCCCcccHHHHH
Q 043074          237 SDFGLARRIDTSHSHVS--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI-RPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~-~p~~~~~~~~~~~~~~~~~  313 (373)
                      +|||+.+.++.......  ....-...|+|||.+. ...++.++|||+|||++|||+|++ .||.. ...      ..  
T Consensus       254 ~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G-~~g------~q--  323 (1039)
T KOG0199|consen  254 CDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVG-CRG------IQ--  323 (1039)
T ss_pred             ecccceeccCCCCcceEecCCCcCcccccCHhHhc-cccccccchhhhhhhhHHhhhccCCCCCCC-CCH------HH--
Confidence            99999998765443321  1223356899999997 566899999999999999999965 44322 110      11  


Q ss_pred             HHHHHhcccccccc--CccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          314 RTMEARNKEIEMVD--SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       314 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                              +.+.+|  ..+.+   +..|++.+++++..||..+|.+|||+..|.+.
T Consensus       324 --------IL~~iD~~erLpR---Pk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  324 --------ILKNIDAGERLPR---PKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             --------HHHhccccccCCC---CCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence                    111222  22222   67788999999999999999999999999743

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.4e-39  Score=282.93  Aligned_cols=252  Identities=27%  Similarity=0.456  Sum_probs=203.1

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|++.+.||+|++|.||++... +++.+++|.+..... .....+.+|+..+.+++|+|++++++++..+...++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888899999999999999765 599999999876554 3456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCceeecCCCCceEeCCCCceEEee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLE-KPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~-~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      +++++|.+++....               ++++..++.++.|+++|+.|||  + .+++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~L~~~l~~~~---------------~l~~~~~~~~~~~l~~~l~~lh--~~~~~~H~~l~~~ni~~~~~~~~~l~d  143 (264)
T cd06623          81 MDGGSLADLLKKVG---------------KIPEPVLAYIARQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIAD  143 (264)
T ss_pred             cCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHh--ccCCCccCCCCHHHEEECCCCCEEEcc
Confidence            99999999997652               2899999999999999999999  7 9999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||.+......... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..|+.....    ....+...... 
T Consensus       144 f~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~-  216 (264)
T cd06623         144 FGISKVLENTLDQ-CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAIC-  216 (264)
T ss_pred             CccceecccCCCc-ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHHHh-
Confidence            9999876433222 123457889999999874 4578899999999999999999999644322    01111111111 


Q ss_pred             hccccccccCccccccCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEA-GVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                           .......     +.. .+..+.+++.+||+.+|++||++.++++.
T Consensus       217 -----~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         217 -----DGPPPSL-----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -----cCCCCCC-----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 0011111     222 45689999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.9e-39  Score=287.65  Aligned_cols=248  Identities=28%  Similarity=0.394  Sum_probs=195.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .+.|+..+.||+|+||.||+|... +++.|++|.+.....   .....+.+|+.+++.++|||++++.+++.+....++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            456888899999999999999764 689999999864332   2335688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +||+. |+|.+++.....              ++++..+..++.|++.||.|||  +.+++|+||+|+||++++++.++|
T Consensus        94 ~e~~~-g~l~~~~~~~~~--------------~l~~~~~~~~~~ql~~~L~~LH--~~~i~H~dl~p~nIl~~~~~~~kL  156 (307)
T cd06607          94 MEYCL-GSASDILEVHKK--------------PLQEVEIAAICHGALQGLAYLH--SHERIHRDIKAGNILLTEPGTVKL  156 (307)
T ss_pred             HHhhC-CCHHHHHHHccc--------------CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEECCCCCEEE
Confidence            99995 678777754332              2899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCC--CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      +|||++......     ....++..|+|||.+.+  ...++.++||||||+++|||++|..|+.....       .....
T Consensus       157 ~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-------~~~~~  224 (307)
T cd06607         157 ADFGSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALY  224 (307)
T ss_pred             eecCcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-------HHHHH
Confidence            999998754322     23457889999998742  34578899999999999999999998643211       01011


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      .... ..     .+.    ......+..+.+++.+||+.||++||++.+++..
T Consensus       225 ~~~~-~~-----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         225 HIAQ-ND-----SPT----LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHhc-CC-----CCC----CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000 00     001    1123356689999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.3e-39  Score=288.80  Aligned_cols=268  Identities=21%  Similarity=0.296  Sum_probs=199.4

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      +|+..+.||.|++|.||+|... ++..|++|.+...... ....+.+|+.++++++|||++++++++.+.+..++|+||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778899999999999999765 6889999998765433 2456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      + ++|.+++.......            ++++..+..++.|++.||.|||  +.+++|+||+|+||++++++.++|+|||
T Consensus        81 ~-~~l~~~~~~~~~~~------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~h~dl~p~ni~~~~~~~~~l~d~g  145 (284)
T cd07836          81 D-KDLKKYMDTHGVRG------------ALDPNTVKSFTYQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFG  145 (284)
T ss_pred             C-ccHHHHHHhcCCCC------------CcCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCcEEEeecc
Confidence            7 58988887544211            3899999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH--------
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW--------  312 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~--------  312 (373)
                      ++........ ......++..|++||.+.+...++.++|+||||+++|+|++|..|+...............        
T Consensus       146 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (284)
T cd07836         146 LARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTEST  224 (284)
T ss_pred             hhhhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence            9976543221 1223456889999999876666788999999999999999999987543321110000000        


Q ss_pred             HHHHHHhccccccccCc--cccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          313 ARTMEARNKEIEMVDSN--ISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .................  ..........+..+.+++.+|++.||.+||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         225 WPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000000000000000  0000111234568899999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.8e-39  Score=283.74  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=193.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-----ccHHHHHHHHHHHhcCCCCCccceeeEEeeC--Cee
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-----QGFREFRAEMETLGKLRHRNIVKILGYCASG--LDR  153 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  153 (373)
                      ++|++.+.||+|+||.||+|... +++.|++|.+.....     ...+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47888999999999999999764 689999998753221     2245678899999999999999999988664  467


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++++||+++++|.+++....               .+++....+++.|++.||.|||  +.+++|+||+|+||+++.++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~  144 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---------------ALTENVTRKYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVGN  144 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEecCCCC
Confidence            89999999999999987543               2788889999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCC--cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          234 AHISDFGLARRIDTSHS--HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      ++|+|||++........  .......++..|+|||.+.+ ...+.++|+||||+++|||++|..|+....      ....
T Consensus       145 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~------~~~~  217 (265)
T cd06652         145 VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFE------AMAA  217 (265)
T ss_pred             EEECcCccccccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccc------hHHH
Confidence            99999999986532111  11223457889999999875 447889999999999999999999964321      0000


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       ......     ..     .....+......+.+++.+|+. +|++||+++++++
T Consensus       218 -~~~~~~-----~~-----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         218 -IFKIAT-----QP-----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -HHHHhc-----CC-----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence             000000     00     0111244556688899999995 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-39  Score=289.11  Aligned_cols=271  Identities=21%  Similarity=0.269  Sum_probs=197.5

Q ss_pred             CCCCCCeeecCCCceEEEEEeC---CCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS---SGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASG--LDRV  154 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  154 (373)
                      +|++.+.||+|+||.||+|...   ++..||+|.+....   ....+.+.+|+.++..++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4777889999999999999764   47899999997633   23345678899999999999999999999888  7899


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC----
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS----  230 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~----  230 (373)
                      +|+||++ ++|.+++........          .++++..+..++.|++.||.|||  +.+++||||||+||+++.    
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH--~~~i~h~dlkp~Nil~~~~~~~  147 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKR----------VSIPPSMVKSLLWQILNGVHYLH--SNWVLHRDLKPANILVMGEGPE  147 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCC----------cCcCHHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEEcCCCCc
Confidence            9999995 577777754432211          13889999999999999999999  789999999999999999    


Q ss_pred             CCceEEeeeccccccCCCCC--cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc
Q 043074          231 DFEAHISDFGLARRIDTSHS--HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG  308 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  308 (373)
                      ++.+||+|||++........  .......++..|+|||.+.+...++.++||||||+++++|++|..|+...........
T Consensus       148 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~  227 (316)
T cd07842         148 RGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSN  227 (316)
T ss_pred             cceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccc
Confidence            89999999999987543322  1123346788999999987666678899999999999999999999765433321000


Q ss_pred             ------HHHHHHHH-----------HHhccccc---ccc-CccccccCCH------HHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          309 ------LLEWARTM-----------EARNKEIE---MVD-SNISREELSE------AGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       309 ------~~~~~~~~-----------~~~~~~~~---~~~-~~~~~~~~~~------~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                            +......+           ........   ... ..........      .....+.+++.+||+.||++|||+
T Consensus       228 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~  307 (316)
T cd07842         228 PFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA  307 (316)
T ss_pred             hhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH
Confidence                  00000000           00000000   000 0000000001      234578999999999999999999


Q ss_pred             HHHHH
Q 043074          362 SYVVQ  366 (373)
Q Consensus       362 ~~l~~  366 (373)
                      .++++
T Consensus       308 ~eil~  312 (316)
T cd07842         308 EEALE  312 (316)
T ss_pred             HHHhc
Confidence            99975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-42  Score=285.12  Aligned_cols=249  Identities=27%  Similarity=0.385  Sum_probs=205.4

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      -|.+.++||+|+||.||++.+ .+|..+|||.+....  +..++.+|+.+|++.+.|++|+++|.+......++|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            456678999999999999955 479999999986544  45788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      -|+..+.++....              ++++.++..+++.-+.||+|||  ...-+|||||..|||++.+|..||+|||.
T Consensus       112 AGSiSDI~R~R~K--------------~L~E~EIs~iL~~TLKGL~YLH--~~~KIHRDIKAGNILLNT~G~AKLADFGV  175 (502)
T KOG0574|consen  112 AGSISDIMRARRK--------------PLSEQEISAVLRDTLKGLQYLH--DLKKIHRDIKAGNILLNTDGIAKLADFGV  175 (502)
T ss_pred             CCcHHHHHHHhcC--------------CccHHHHHHHHHHHHhHHHHHH--HHHHHHhhcccccEEEcccchhhhhhccc
Confidence            9999999986654              4999999999999999999999  66689999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK  321 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (373)
                      +..+.... .......|||.|||||++. .-.|..++||||||++..||..|++|+.+-..-...             -.
T Consensus       176 AGQLTDTM-AKRNTVIGTPFWMAPEVI~-EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-------------FM  240 (502)
T KOG0574|consen  176 AGQLTDTM-AKRNTVIGTPFWMAPEVIE-EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-------------FM  240 (502)
T ss_pred             cchhhhhH-HhhCccccCcccccHHHHH-HhccchhhhHhhhcchhhhhhcCCCCccccccccee-------------Ee
Confidence            98764322 2345678999999999997 455888999999999999999999996543221100             00


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      +.....+.+.+   ++..+.++.+++.+||-.+|++|-|+.++++.
T Consensus       241 IPT~PPPTF~K---PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  241 IPTKPPPTFKK---PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ccCCCCCCCCC---hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            11111122222   67778899999999999999999999988763

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.5e-39  Score=286.80  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=192.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHH-HhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMET-LGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ++|++.+.||+|+||.||++..+ +|+.||+|.++.... .....+..|... ++.++|||++++++++..+...++++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888899999999999999765 699999999876432 223445566665 566789999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CceeecCCCCceEeCCCCceEEe
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEK-PIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~-~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      |++ |+|.+++.......           ..+++..++.++.|++.||+|||  ++ +++||||||+||+++.++.+||+
T Consensus        81 ~~~-~~l~~~l~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH--~~~~i~h~dlkp~nil~~~~~~~kl~  146 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKG-----------LTIPEDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLC  146 (283)
T ss_pred             hhc-ccHHHHHHHhccCC-----------CCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEEEe
Confidence            995 78988886543211           13899999999999999999999  65 89999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCC---CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN---TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      |||++.......  ......++..|+|||.+.+.   ..++.++|+||||+++|||++|..|+.....     .... ..
T Consensus       147 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~-~~  218 (283)
T cd06617         147 DFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----PFQQ-LK  218 (283)
T ss_pred             eccccccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----CHHH-HH
Confidence            999998653221  12234578899999988642   3467899999999999999999999643211     0101 00


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...      ......+.    ....+.++.+++.+||+.+|.+||++.++++
T Consensus       219 ~~~------~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         219 QVV------EEPSPQLP----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHH------hcCCCCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000      01111111    1223568999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.5e-39  Score=283.07  Aligned_cols=258  Identities=24%  Similarity=0.446  Sum_probs=194.0

Q ss_pred             CCCCCeeecCCCceEEEEEeC----CCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC------
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASGL------  151 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  151 (373)
                      |.+.+.||+|+||.||+|...    ++..+|+|.+....  ....+.+.+|+.+++.++|||++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566788999999999999653    46889999986543  233567889999999999999999999886532      


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..+++++|+.+|+|.+++........         ...+++.....++.|++.||+|||  +++++||||||+||+++++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~---------~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~nili~~~  149 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEE---------PFTLPLQTLVRFMIDIASGMEYLS--SKNFIHRDLAARNCMLNEN  149 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCC---------CCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccchhhEEEcCC
Confidence            24688999999999998764332111         112788999999999999999999  7899999999999999999


Q ss_pred             CceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccH
Q 043074          232 FEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~  309 (373)
                      +.+||+|||+++........ ......+++.|++||.+.+ ..++.++||||||+++|||++ |..|+....    ....
T Consensus       150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~----~~~~  224 (273)
T cd05074         150 MTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE----NSEI  224 (273)
T ss_pred             CCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCC----HHHH
Confidence            99999999999865432211 1222345678999999864 447889999999999999999 666643211    1111


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                      ..+.   . ....     ..     .+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       225 ~~~~---~-~~~~-----~~-----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         225 YNYL---I-KGNR-----LK-----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHH---H-cCCc-----CC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1111   0 0000     00     0123356899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.3e-39  Score=284.35  Aligned_cols=261  Identities=25%  Similarity=0.367  Sum_probs=197.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASG--LDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  157 (373)
                      ++|...+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36778889999999999999764 688999999875433 2346788999999999999999999988653  4689999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++++|.+++.......           ..+++..+..++.|++.||.|||  +.+++|+||+|+||++++++.++|+
T Consensus        81 e~~~~~~L~~~l~~~~~~~-----------~~l~~~~~~~i~~~i~~~L~~lH--~~~i~H~dl~~~nil~~~~~~~~l~  147 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRG-----------GRIGEKVLGKIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLC  147 (287)
T ss_pred             EecCCCCHHHHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecCCeEEEe
Confidence            9999999999876432211           12788999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||++.......   .....++..|+|||.+.+ ..++.++||||||+++|+|++|..|+......  .....+......
T Consensus       148 dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~  221 (287)
T cd06621         148 DFGVSGELVNSL---AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP--PLGPIELLSYIV  221 (287)
T ss_pred             eccccccccccc---cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCC--CCChHHHHHHHh
Confidence            999987643221   123457888999999874 45788999999999999999999997544221  111112211111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .. .. ..+......   ....+..+.+++.+||+.||++|||+.|+++
T Consensus       222 ~~-~~-~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         222 NM-PN-PELKDEPGN---GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             cC-Cc-hhhccCCCC---CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            10 00 011111100   1123568999999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.6e-39  Score=279.84  Aligned_cols=248  Identities=21%  Similarity=0.353  Sum_probs=196.8

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +|+..+.||+|+||.||++.. .++..+++|.+.....  .....+.+|+.++++++|||++++++.+..+...++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            577889999999999999965 4788999999865432  2356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC-ceEEee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-EAHISD  238 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~-~~kl~D  238 (373)
                      +++++|.+++......             .+++..+..++.|++.|+.|||  +++++|+||+|+||++++++ .++|+|
T Consensus        81 ~~~~~L~~~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~~l~d  145 (256)
T cd08220          81 APGGTLAEYIQKRCNS-------------LLDEDTILHFFVQILLALHHVH--TKLILHRDLKTQNILLDKHKMVVKIGD  145 (256)
T ss_pred             CCCCCHHHHHHHhccc-------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEcc
Confidence            9999999999764322             2889999999999999999999  78999999999999998654 579999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||.+.......  ......++..|+|||.+.+ ...+.++||||||+++|+|++|..|+.....       .........
T Consensus       146 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------~~~~~~~~~  215 (256)
T cd08220         146 FGISKILSSKS--KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANL-------PALVLKIMS  215 (256)
T ss_pred             CCCceecCCCc--cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCch-------HHHHHHHHh
Confidence            99998754322  2223567889999999875 4478899999999999999999988643211       111111110


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .      ...     ..+...+..+.+++.+||+.||++|||+.++++
T Consensus       216 ~------~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         216 G------TFA-----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             c------CCC-----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            0      000     112234568999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-41  Score=303.44  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=203.3

Q ss_pred             CCCCCCeeecCCCceEEEEEeCC-CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      .|.+...||.|+||.||++..++ +-..|-|++........+++.-|+++|..++||+||++++.|.-.+.+++..|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            45566789999999999997654 44456788887777778899999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      ||-.+..+-.-..              ++++.++.-+++|++.||.|||  +++|+|||||..|||++-+|.++|+|||.
T Consensus       113 GGAVDaimlEL~r--------------~LtE~QIqvvc~q~ldALn~LH--s~~iIHRDLKAGNiL~TldGdirLADFGV  176 (1187)
T KOG0579|consen  113 GGAVDAIMLELGR--------------VLTEDQIQVVCYQVLDALNWLH--SQNIIHRDLKAGNILLTLDGDIRLADFGV  176 (1187)
T ss_pred             CchHhHHHHHhcc--------------ccchHHHHHHHHHHHHHHHHHh--hcchhhhhccccceEEEecCcEeeecccc
Confidence            9999988876554              3999999999999999999999  79999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      +.... ........+.|||.|||||+...    ..+|+.++||||||++|.||..+.+|......       ....-   
T Consensus       177 SAKn~-~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVll---  245 (1187)
T KOG0579|consen  177 SAKNK-STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLL---  245 (1187)
T ss_pred             cccch-hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHH---
Confidence            87532 22334456889999999998752    45689999999999999999999988432111       11111   


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                         ++.+.-.+.+..   +......+.+++..||..||..||++.++++
T Consensus       246 ---KiaKSePPTLlq---PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  246 ---KIAKSEPPTLLQ---PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ---HHhhcCCCcccC---cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence               111111122222   4556778999999999999999999999986

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.5e-39  Score=288.98  Aligned_cols=258  Identities=25%  Similarity=0.325  Sum_probs=193.0

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +|...+.||+|+||.||++... ++..+|+|.+..... .....+.+|+.++.++. ||||+++++++..+...++++||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556678999999999999654 689999999865433 23456889999999996 99999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +. +++.++........          ...+++..+..++.|++.||+|||+ +.+++||||||+||+++.++.++|+||
T Consensus        85 ~~-~~l~~l~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~df  152 (288)
T cd06616          85 MD-ISLDKFYKYVYEVL----------KSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDF  152 (288)
T ss_pred             cc-CCHHHHHHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHhh-cCCeeccCCCHHHEEEccCCcEEEeec
Confidence            85 56655433211000          0138999999999999999999994 358999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCC--CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN--TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |++........  .....|+..|+|||.+.+.  ..++.++||||||+++|||++|..|+....      ..   .....
T Consensus       153 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~---~~~~~  221 (288)
T cd06616         153 GISGQLVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SV---FDQLT  221 (288)
T ss_pred             chhHHhccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hH---HHHHh
Confidence            99976543221  1223578899999998755  367889999999999999999999964321      00   01111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                         +......+.+.... ....+.++.+++.+||+.||++|||+.+|+..
T Consensus       222 ---~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         222 ---QVVKGDPPILSNSE-EREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             ---hhcCCCCCcCCCcC-CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               11111111111111 23356689999999999999999999998863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=312.99  Aligned_cols=274  Identities=31%  Similarity=0.461  Sum_probs=210.3

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC----C----CCEEEEEEeCccccc-cHHHHHHHHHHHhcC-CCCCccceeeEEee
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS----S----GVTVAIKKLDKDAFQ-GFREFRAEMETLGKL-RHRNIVKILGYCAS  149 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  149 (373)
                      ..++..+.+.||+|.||.|++|...    .    ...||||.++..... ..+.+..|+++|+.+ +|+||+.++|+|.+
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3445566779999999999999642    1    457999998764443 456789999999999 59999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhcCCCCCCCCccc-ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe
Q 043074          150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL  228 (373)
Q Consensus       150 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill  228 (373)
                      +...++|.||+..|+|.++++..+......... ...+...++..+.+.++.||+.|++||+  +.+++||||..+|||+
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~--~~~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA--SVPCVHRDLAARNVLI  451 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh--hCCccchhhhhhhEEe
Confidence            999999999999999999999887111111110 0000023899999999999999999999  7889999999999999


Q ss_pred             CCCCceEEeeeccccccCCCCCccccccc--ccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          229 DSDFEAHISDFGLARRIDTSHSHVSTQVA--GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       229 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                      ..+..+||+|||+++..............  -...|||||.+.. ..++.+|||||||++||||+|.+.++++.....  
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--  528 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--  528 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--
Confidence            99999999999999975444333222222  2446999999985 668999999999999999999777666542211  


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..+.++             +....+.+. |..|+.+++++|..||+.+|++||++.++.+.|++.+
T Consensus       529 ~~l~~~-------------l~~G~r~~~-P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  529 EELLEF-------------LKEGNRMEQ-PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             HHHHHH-------------HhcCCCCCC-CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            111111             111111122 6777889999999999999999999999999998854

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.1e-40  Score=296.06  Aligned_cols=250  Identities=22%  Similarity=0.357  Sum_probs=210.2

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccccc--HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      .....|.+.+.||+|.|+.|.++.. .++..||||.+++.....  ...+.+|+++|..++|||||+++.+.......|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            3457899999999999999999965 479999999998765543  3458899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||+.+|.+.+++.....               ..+.++..++.|+.+|++|||  ++.|+|||||++|+|++.+-++|
T Consensus       133 V~eya~~ge~~~yl~~~gr---------------~~e~~ar~~F~q~vsaveYcH--~k~ivHrdLk~eNilL~~~mnik  195 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR---------------MKEKEARAKFRQIVSAVEYCH--SKNIVHRDLKAENILLDENMNIK  195 (596)
T ss_pred             EEEeccCchhHHHHHhccc---------------chhhhhhhhhHHHHHHHHHHh--hcceeccccchhhccccccccee
Confidence            9999999999999998875               566888999999999999999  89999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||++..+.  ........+|++.|.|||++.|..+..++.|+||+|+++|.|++|..||.....-+-.         
T Consensus       196 IaDfgfS~~~~--~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------  264 (596)
T KOG0586|consen  196 IADFGFSTFFD--YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------  264 (596)
T ss_pred             eeccccceeec--ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------
Confidence            99999998875  3445667899999999999999888899999999999999999999997542221100         


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                          .   +.+..++   .++.-...+..++++++|-++|.+|++++++.+
T Consensus       265 ----~---rvl~gk~---rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  265 ----P---RVLRGKY---RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ----c---hheeeee---cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence                0   0011111   113333447889999999999999999999865

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-38  Score=282.92  Aligned_cols=248  Identities=25%  Similarity=0.350  Sum_probs=197.6

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      .|...+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++|||++++++++..++..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            344557999999999999975 4788999999865554455678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +++|.+++....                +++.++..++.|++.||+|||  +++++||||+|+||+++.++.++|+|||.
T Consensus       100 ~~~L~~~~~~~~----------------~~~~~~~~~~~ql~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~d~g~  161 (285)
T cd06648         100 GGALTDIVTHTR----------------MNEEQIATVCLAVLKALSFLH--AQGVIHRDIKSDSILLTSDGRVKLSDFGF  161 (285)
T ss_pred             CCCHHHHHHhCC----------------CCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChhhEEEcCCCcEEEccccc
Confidence            999999987622                888999999999999999999  78999999999999999999999999998


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK  321 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (373)
                      +........ ......|++.|+|||.+.+. .++.++||||||+++|||++|..|+....       ...........  
T Consensus       162 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~-------~~~~~~~~~~~--  230 (285)
T cd06648         162 CAQVSKEVP-RRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEP-------PLQAMKRIRDN--  230 (285)
T ss_pred             chhhccCCc-ccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCC-------HHHHHHHHHhc--
Confidence            875433221 22334588899999998754 47889999999999999999999975421       11111111111  


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                          ..+....   +...+..+.+++.+||+.+|++||++.++++
T Consensus       231 ----~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         231 ----LPPKLKN---LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ----CCCCCcc---cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence                0011110   1123468999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=294.70  Aligned_cols=264  Identities=23%  Similarity=0.332  Sum_probs=194.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeC-----Cee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASG-----LDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  153 (373)
                      .++|++.+.||+|+||.||+|.. .+|..||+|.+..... .....+.+|+.+++.++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999965 4789999999864332 2345678899999999999999999987544     357


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++++||+. ++|.+++....                +++..+..++.|++.||+|||  +.+++||||||+||+++.++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~----------------l~~~~~~~i~~ql~~aL~~LH--~~~ivH~dlkp~Nill~~~~~  144 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQH----------------LSNDHIQYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTNCD  144 (336)
T ss_pred             EEEehhcc-cCHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCC
Confidence            99999995 58888775432                889999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          234 AHISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +||+|||++.........  ......|+..|+|||.+.+...++.++||||||+++|+|++|..|+......    ....
T Consensus       145 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~----~~~~  220 (336)
T cd07849         145 LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL----HQLN  220 (336)
T ss_pred             EEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHH
Confidence            999999999865432211  1223467889999998765566788999999999999999999886432110    0000


Q ss_pred             HHHHHHHhc-----------c---cccccc--CccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          312 WARTMEARN-----------K---EIEMVD--SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       312 ~~~~~~~~~-----------~---~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      .........           .   ......  ............+.++.+++.+||+.||++||++.++++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         221 LILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000           0   000000  0000000011224578999999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.4e-39  Score=283.00  Aligned_cols=247  Identities=25%  Similarity=0.334  Sum_probs=199.3

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      +|++.+.||.|+||.||++... ++..+++|.+.+...   ...+.+.+|++.+++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999765 689999999965432   235678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+.+++|.+++....               ++++..+..++.|+++||.|||  +++++|+||+|+||++++++.++|+|
T Consensus        81 ~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~l~d  143 (258)
T cd05578          81 LLLGGDLRYHLSQKV---------------KFSEEQVKFWICEIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITD  143 (258)
T ss_pred             CCCCCCHHHHHHhcC---------------CcCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEEcCCCCEEEee
Confidence            999999999997652               2889999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||.+.......  ......++..|+|||.+.+. ..+.++|+||||+++|+|++|..|+......     ...+......
T Consensus       144 ~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~  215 (258)
T cd05578         144 FNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQE  215 (258)
T ss_pred             cccccccCCCc--cccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhc
Confidence            99988654322  22335578899999998754 4788999999999999999999996543321     1111111111


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH--HHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM--SYVV  365 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~~l~  365 (373)
                      .           .....+...+..+.+++.+||+.||.+||++  ++++
T Consensus       216 ~-----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         216 T-----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             c-----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            0           0111133445789999999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.2e-39  Score=283.34  Aligned_cols=248  Identities=27%  Similarity=0.380  Sum_probs=197.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +-|+..+.||+|+||.||+|.. .++..+|+|.+..... .....+.+|+..+.+++||||+++++++..+...++|+||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            3466788999999999999965 4688999999865433 2345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++....                +++..+..++.|++.|+.|||  +.+++|+||+|+||+++.++.++|+||
T Consensus        84 ~~~~~l~~~i~~~~----------------~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~Ni~i~~~~~~~l~df  145 (277)
T cd06641          84 LGGGSALDLLEPGP----------------LDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADF  145 (277)
T ss_pred             CCCCcHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHc--cCCeecCCCCHHhEEECCCCCEEEeec
Confidence            99999999986432                889999999999999999999  799999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++....... .......++..|+|||.+.+ ...+.++|+||||+++|+|++|..|+.....       ..+.......
T Consensus       146 g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~  216 (277)
T cd06641         146 GVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHP-------MKVLFLIPKN  216 (277)
T ss_pred             ccceecccch-hhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccch-------HHHHHHHhcC
Confidence            9987653321 11223457889999999874 4467899999999999999999998643111       0111111100


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      .           ........+..+.+++.+||+.+|.+||++.+++..
T Consensus       217 ~-----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 N-----------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             C-----------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0           011123345689999999999999999999999883

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.6e-39  Score=285.52  Aligned_cols=253  Identities=28%  Similarity=0.385  Sum_probs=202.5

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      +..+.|+..+.||+|++|.||+|..+ ++..+++|.+..... ..+.+.+|++.++.++|+|++++++.+......++++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            35667888899999999999999775 688999999976544 4567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++++|.+++.....              .+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+
T Consensus        95 e~~~~~~L~~~l~~~~~--------------~l~~~~~~~i~~~i~~~L~~lH--~~gi~H~dl~p~ni~i~~~~~~~l~  158 (286)
T cd06614          95 EYMDGGSLTDIITQNFV--------------RMNEPQIAYVCREVLQGLEYLH--SQNVIHRDIKSDNILLSKDGSVKLA  158 (286)
T ss_pred             eccCCCcHHHHHHHhcc--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCChhhEEEcCCCCEEEC
Confidence            99999999999987641              2899999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||++........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|..|+......       .......
T Consensus       159 d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------~~~~~~~  229 (286)
T cd06614         159 DFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RALFLIT  229 (286)
T ss_pred             ccchhhhhccchh-hhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHH
Confidence            9999876533221 12234578899999998744 4788999999999999999999996432111       0011110


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      . .        ..........++..+.+++.+||+.+|.+||++.++++
T Consensus       230 ~-~--------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         230 T-K--------GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             h-c--------CCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0 0        00000112224568999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.7e-39  Score=290.23  Aligned_cols=264  Identities=26%  Similarity=0.303  Sum_probs=194.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASG--LDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  155 (373)
                      .++|+..+.||+|+||.||+|..+ +|+.||+|.+......  ....+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            457899999999999999999764 6899999998643322  123456899999999999999999998655  56899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |+||+. ++|.+++.....              .+++.++..++.|++.||+|||  +.+++||||||+||++++++.+|
T Consensus        86 v~e~~~-~~l~~~l~~~~~--------------~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~k  148 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPT--------------PFSESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLK  148 (309)
T ss_pred             EEecCC-CCHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEE
Confidence            999995 589888875432              3899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||++........ ......++..|+|||.+.+...++.++||||||+++|||++|..|+.......    ...-...
T Consensus       149 L~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~----~~~~~~~  223 (309)
T cd07845         149 IADFGLARTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE----QLDLIIQ  223 (309)
T ss_pred             ECccceeeecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHH
Confidence            999999987643321 12223457789999998766667889999999999999999998864322111    0000000


Q ss_pred             HHHh--ccc---------ccc--cc-Ccccc-ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          316 MEAR--NKE---------IEM--VD-SNISR-EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       316 ~~~~--~~~---------~~~--~~-~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....  ...         ...  +. ..... .......+..+.+++.+||+.||++|||+++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         224 LLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000  000         000  00 00000 0000113567889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.7e-39  Score=278.12  Aligned_cols=249  Identities=29%  Similarity=0.456  Sum_probs=201.1

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      +|+..+.||+|++|.||++... ++..+++|++..........+.+|+..++.++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4677889999999999999775 688999999977665556788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +++|.+++.....              .+++..+..++.|++.||.|||  +.+++|+||+|+||++++++.++|+|||.
T Consensus        81 ~~~L~~~~~~~~~--------------~~~~~~~~~i~~~i~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~~~  144 (253)
T cd05122          81 GGSLKDLLKSTNQ--------------TLTESQIAYVCKELLKGLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGL  144 (253)
T ss_pred             CCcHHHHHhhcCC--------------CCCHHHHHHHHHHHHHHHHHhh--cCCEecCCCCHHHEEEccCCeEEEeeccc
Confidence            9999999876531              2899999999999999999999  79999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK  321 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (373)
                      +........  .....++..|+|||.+.+.. .+.++|+||||+++++|++|..|+.....       .........  .
T Consensus       145 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~--~  212 (253)
T cd05122         145 SAQLSDTKA--RNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPP-------MKALFKIAT--N  212 (253)
T ss_pred             ccccccccc--ccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCch-------HHHHHHHHh--c
Confidence            987644321  23456788999999987544 78899999999999999999998653211       011111110  0


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..    +....   +...+..+.+++.+||+.||++|||+.++++
T Consensus       213 ~~----~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         213 GP----PGLRN---PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CC----CCcCc---ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00    00100   1112568999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.7e-39  Score=285.34  Aligned_cols=257  Identities=20%  Similarity=0.265  Sum_probs=183.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCC----CCEEEEEEeCccccccH-----------HHHHHHHHHHhcCCCCCccceee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSS----GVTVAIKKLDKDAFQGF-----------REFRAEMETLGKLRHRNIVKILG  145 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~  145 (373)
                      .++|.+.+.||+|+||.||+|...+    +..+++|..........           .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3689999999999999999997653    44566665432221110           01223344566778999999999


Q ss_pred             EEeeCC----eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecC
Q 043074          146 YCASGL----DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDI  221 (373)
Q Consensus       146 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dl  221 (373)
                      ++....    ..+++++++ ..++.+.+....               +.++..+..++.|++.||+|||  +.+++||||
T Consensus        91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---------------~~~~~~~~~i~~qi~~~l~~lH--~~~iiHrDi  152 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIK---------------CKNKKLIKNIMKDMLTTLEYIH--EHGISHGDI  152 (294)
T ss_pred             eeeEecCCceEEEEEEehh-ccCHHHHHHhhc---------------cCCHHHHHHHHHHHHHHHHHHH--hCCeecCCC
Confidence            765543    346778877 446766665432               1567888999999999999999  789999999


Q ss_pred             CCCceEeCCCCceEEeeeccccccCCCCCc------ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCC
Q 043074          222 KSSNVLLDSDFEAHISDFGLARRIDTSHSH------VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIR  295 (373)
Q Consensus       222 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~  295 (373)
                      ||+|||++.++.++|+|||+++.+......      ......||+.|+|||...+. .++.++|||||||++|||++|..
T Consensus       153 Kp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~  231 (294)
T PHA02882        153 KPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKL  231 (294)
T ss_pred             CHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCC
Confidence            999999999999999999999876432211      11234689999999998754 47899999999999999999999


Q ss_pred             CCCCcccCCCccc--HHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          296 PNLPVVLDGQEVG--LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       296 p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                      ||...........  ..++......         ....    ...++..+.+++..|++.+|++||++.++.+.|+
T Consensus       232 P~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        232 PWKGFGHNGNLIHAAKCDFIKRLHE---------GKIK----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             CCCccccchHHHHHhHHHHHHHhhh---------hhhc----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            9764422221110  0111111111         0010    1223568999999999999999999999998763

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.6e-39  Score=283.30  Aligned_cols=243  Identities=25%  Similarity=0.279  Sum_probs=186.6

Q ss_pred             eeecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHh---cCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           89 IIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLG---KLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        89 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      .||+|+||.||++... +++.+|+|.+.+....   ....+.+|..++.   ..+|||++.+.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999764 6899999988654322   1122344444333   3479999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +++|.+++....               .+++..+..++.|++.||.|||  +.+++|+||||+||++++++.++|+|||+
T Consensus        81 ~~~L~~~i~~~~---------------~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dikp~Nil~~~~~~~~l~dfg~  143 (279)
T cd05633          81 GGDLHYHLSQHG---------------VFSEKEMRFYATEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGL  143 (279)
T ss_pred             CCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCcCCCCCCHHHEEECCCCCEEEccCCc
Confidence            999999987543               2899999999999999999999  78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK  321 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (373)
                      +.......   .....|+..|+|||.+.+...++.++|||||||++|||++|..||.......    . ........   
T Consensus       144 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~-~~~~~~~~---  212 (279)
T cd05633         144 ACDFSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----K-HEIDRMTL---  212 (279)
T ss_pred             ceeccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC----H-HHHHHHhh---
Confidence            87653322   2234689999999998644557889999999999999999999975432211    1 11111100   


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQL  367 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~~  367 (373)
                         ....     ..+...+.++.+++.+||+.||++||     +++++++.
T Consensus       213 ---~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         213 ---TVNV-----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ---cCCc-----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence               0111     11334566899999999999999999     58888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.1e-39  Score=285.26  Aligned_cols=262  Identities=21%  Similarity=0.235  Sum_probs=191.3

Q ss_pred             CCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCC-CCCccceeeEEeeC--CeeEEEEE
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLR-HRNIVKILGYCASG--LDRVLIYE  158 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  158 (373)
                      |++.+.||+|+||.||+|... +++.+|+|.+...... ......+|+..+.++. |+|++++++++.++  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566788999999999999754 6899999998654222 2234457888888885 99999999999887  88999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |++ ++|.+++.....              .+++.++..++.|++.||.|||  +.+++||||+|+||+++. +.+||+|
T Consensus        81 ~~~-~~l~~~l~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~p~ni~l~~-~~~kl~d  142 (282)
T cd07831          81 LMD-MNLYELIKGRKR--------------PLPEKRVKSYMYQLLKSLDHMH--RNGIFHRDIKPENILIKD-DILKLAD  142 (282)
T ss_pred             cCC-ccHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEcC-CCeEEEe
Confidence            996 588888765432              2899999999999999999999  789999999999999999 9999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc--------HH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG--------LL  310 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~--------~~  310 (373)
                      ||++........  .....++..|+|||.+.+...++.++|||||||++|||++|..|+......+....        ..
T Consensus       143 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~  220 (282)
T cd07831         143 FGSCRGIYSKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA  220 (282)
T ss_pred             cccccccccCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCH
Confidence            999987543221  12345788999999876556678899999999999999999888643221110000        00


Q ss_pred             HHHHHHHHhccccccccCcccc---ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 EWARTMEARNKEIEMVDSNISR---EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .|....... .......+....   .......+..+.+++.+||+.||++||+++++++
T Consensus       221 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         221 EVLKKFRKS-RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHHHhhccc-ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            110000000 000000000000   0011234678999999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.3e-39  Score=288.59  Aligned_cols=262  Identities=21%  Similarity=0.277  Sum_probs=194.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ++|+..+.||+|++|.||+|..+ +++.|++|.+.....  ...+.+.+|+.++++++||||+++++++.++...++|+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            47888899999999999999765 688999999865432  223567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC-CCceEEe
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-DFEAHIS  237 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~-~~~~kl~  237 (373)
                      |++ ++|.+++......             .+++..+..++.||+.||+|||  +++++|+||+|+||+++. ++.+||+
T Consensus        82 ~~~-~~l~~~~~~~~~~-------------~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dl~p~nill~~~~~~~kl~  145 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDF-------------AKNPRLIKTYLYQILRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLA  145 (294)
T ss_pred             ccc-ccHHHHHHhCCCC-------------CcCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCcceEEEECCCCEEEEc
Confidence            995 5888887654321             2678888899999999999999  789999999999999985 5679999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||++....... .......+++.|+|||.+.+...++.++||||||+++|+|++|..|+......+      .......
T Consensus       146 dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~------~~~~~~~  218 (294)
T PLN00009        146 DFGLARAFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID------ELFKIFR  218 (294)
T ss_pred             ccccccccCCCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHH
Confidence            999997654321 112234568899999998766667889999999999999999998875422110      0000000


Q ss_pred             Hhccccccc-------------cCccccc---cCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMV-------------DSNISRE---ELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~-------------~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .........             .+.....   ......+..+.+++.+|++.+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        219 ILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             HhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000000000             0000000   001123457899999999999999999999885

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.1e-39  Score=288.93  Aligned_cols=265  Identities=26%  Similarity=0.313  Sum_probs=195.8

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-----
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGL-----  151 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  151 (373)
                      ..++|++.+.||+|+||.||+|..+ +++.|++|.++....  .....+.+|+.+++.++|||++++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4568999999999999999999875 588999999865432  22345678999999999999999999987654     


Q ss_pred             -----eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCce
Q 043074          152 -----DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV  226 (373)
Q Consensus       152 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Ni  226 (373)
                           ..++|+||+++ ++.+++.....              .+++..+..++.|++.||+|||  +.+++|+||+|+||
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------------~~~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~ni  147 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGLV--------------HFSEDHIKSFMKQLLEGLNYCH--KKNFLHRDIKCSNI  147 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHE
Confidence                 78999999965 77777765421              2899999999999999999999  78999999999999


Q ss_pred             EeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          227 LLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       227 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                      ++++++.+||+|||++...............++..|+|||.+.+....+.++|||||||++|||++|..|+......   
T Consensus       148 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---  224 (302)
T cd07864         148 LLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---  224 (302)
T ss_pred             EECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---
Confidence            99999999999999998654333222223345778999998876555788999999999999999999886532211   


Q ss_pred             ccHHHHHHHHHHhccc-----------cccccC-----ccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          307 VGLLEWARTMEARNKE-----------IEMVDS-----NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~-----------~~~~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       ...............           ....+.     ...... ....+..+.+++.+||+.||.+||++.++++
T Consensus       225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         225 -AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             -HHHHHHHHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             000000000000000           000000     000000 1123568999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4e-39  Score=292.48  Aligned_cols=269  Identities=25%  Similarity=0.303  Sum_probs=196.6

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcc--ccccHHHHHHHHHHHhcC-CCCCccceeeEEee--CCee
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKD--AFQGFREFRAEMETLGKL-RHRNIVKILGYCAS--GLDR  153 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--~~~~  153 (373)
                      ..++|++.+.||+|+||.||+|... ++..+++|++...  .......+.+|+.+++++ +||||+++++++..  +...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3468888999999999999999765 6889999988542  222345677899999999 99999999998854  3468


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++|+||++ ++|.+++....                +++..+..++.|++.||+|||  +++++|+||||+||+++.++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~----------------~~~~~~~~i~~qi~~~L~~LH--~~~i~H~dl~p~nill~~~~~  145 (337)
T cd07852          85 YLVFEYME-TDLHAVIRANI----------------LEDVHKRYIMYQLLKALKYIH--SGNVIHRDLKPSNILLNSDCR  145 (337)
T ss_pred             EEEecccc-cCHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCc
Confidence            99999996 69999886541                788999999999999999999  799999999999999999999


Q ss_pred             eEEeeeccccccCCCCC----cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          234 AHISDFGLARRIDTSHS----HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      +||+|||++........    .......++..|+|||.+.+...++.++|+||||+++|+|++|..|+............
T Consensus       146 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~  225 (337)
T cd07852         146 VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI  225 (337)
T ss_pred             EEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999999986543221    12233467889999998876666788999999999999999999886432211100000


Q ss_pred             HHH--------HHHH--HHhccccccccCc--cccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          310 LEW--------ARTM--EARNKEIEMVDSN--ISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       310 ~~~--------~~~~--~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      ..+        ....  .........+...  ..........+.++.+++.+||+.||++|||+.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         226 IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000        0000  0000000000000  00000011245689999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.6e-39  Score=288.85  Aligned_cols=265  Identities=23%  Similarity=0.309  Sum_probs=192.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCC------
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGL------  151 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  151 (373)
                      .++|+..+.||+|+||.||+|... +++.||+|.+......  ....+.+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457889999999999999999764 6899999988543322  2234568999999999999999999986654      


Q ss_pred             --eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          152 --DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       152 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                        ..++|+||+. ++|.+++.....              .+++.++..++.|++.||.|||  +++++|+||||+||+++
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~--------------~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dl~p~nil~~  153 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNV--------------KFTLSEIKKVMKMLLNGLYYIH--RNKILHRDMKAANILIT  153 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEC
Confidence              4499999995 588888765432              2899999999999999999999  78999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCc---ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          230 SDFEAHISDFGLARRIDTSHSH---VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                      .++.+||+|||++.........   ......++..|+|||.+.+...++.++||||||+++|||++|..|+......   
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~---  230 (310)
T cd07865         154 KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ---  230 (310)
T ss_pred             CCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH---
Confidence            9999999999999866433221   1123456788999999876666788999999999999999999886432211   


Q ss_pred             ccHHHHHHHHHH--------hccccc---------cccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          307 VGLLEWARTMEA--------RNKEIE---------MVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       307 ~~~~~~~~~~~~--------~~~~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       ...........        ......         ...........+......+.+++.+||+.||.+|||+.++++
T Consensus       231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         231 -HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             -HHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence             00000000000        000000         000000000000112346789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6e-39  Score=286.07  Aligned_cols=265  Identities=22%  Similarity=0.254  Sum_probs=194.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCC-CCCccceeeEEeeCCe-----
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLR-HRNIVKILGYCASGLD-----  152 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----  152 (373)
                      ++|+..+.||+|+||.||+|... +++.||+|.+......  ....+.+|+.+++.++ ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999764 6899999987654322  2356788999999995 6999999999877665     


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC-C
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-D  231 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~-~  231 (373)
                      .++|+||+++ +|.+++.......          ..++++..++.++.||+.||.|||  +++++||||+|+||+++. +
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~----------~~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~~~nil~~~~~  147 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGP----------GRPLPAKTIKSFMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQK  147 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccC----------CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEEecCC
Confidence            7999999975 8988887543210          113899999999999999999999  789999999999999998 8


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +.+||+|||+++........ .....+++.|+|||.+.+...++.++|+||||+++|+|++|..|+......      ..
T Consensus       148 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~  220 (295)
T cd07837         148 GLLKIADLGLGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL------QQ  220 (295)
T ss_pred             CeEEEeecccceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH------HH
Confidence            89999999999865432211 122346788999998876666788999999999999999999886532111      01


Q ss_pred             HHHHHHHhcccccccc------------Cccc---cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEMVD------------SNIS---REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~------------~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ................            +...   ........+.++.+++.+||+.||.+||++.+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         221 LLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            1000000000000000            0000   00001224567899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.3e-39  Score=291.26  Aligned_cols=266  Identities=25%  Similarity=0.328  Sum_probs=196.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEe----eCCeeE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCA----SGLDRV  154 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~  154 (373)
                      ++|++.+.||.|+||.||+|..+ ++..|++|.+.....  .....+.+|+.+++.++||||+++++++.    .....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            68888999999999999999654 699999999865422  23456778999999999999999999875    335689


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +|+||+. ++|.+++....               .+++..+..++.|++.||.|||  +++++||||||+||++++++.+
T Consensus        85 lv~e~~~-~~l~~~~~~~~---------------~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~  146 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQ---------------PLTEEHIRYFLYQLLRGLKYIH--SANVIHRDLKPSNLLVNEDCEL  146 (334)
T ss_pred             EEEehhh-hhHHHHhccCC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcE
Confidence            9999994 68999886543               2899999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCC---cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCC------
Q 043074          235 HISDFGLARRIDTSHS---HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ------  305 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~------  305 (373)
                      ||+|||++........   .......++..|+|||.+.+...++.++||||||+++|||++|..||........      
T Consensus       147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~  226 (334)
T cd07855         147 RIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS  226 (334)
T ss_pred             EecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHH
Confidence            9999999976533221   1122346888999999987655678999999999999999999999754321100      


Q ss_pred             -----cccHHHHHHHHHHhccccccccC--ccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          306 -----EVGLLEWARTMEARNKEIEMVDS--NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       306 -----~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                           ............. ....+....  ...........+..+.+++.+||+.+|.+||++.+++.
T Consensus       227 ~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         227 VLGSPSEEVLNRIGSDRV-RKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HhCCChhHhhhhhchhhH-HHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                 0000000000000 000000000  00000011223668999999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6e-39  Score=291.22  Aligned_cols=264  Identities=24%  Similarity=0.294  Sum_probs=195.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeC-----Ce
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASG-----LD  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  152 (373)
                      .++|.+.+.||+|+||.||++.. .++..||+|.+....  ......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45788999999999999999965 478999999986532  22345677899999999999999999987644     34


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++++||+. ++|.+++....               ++++..+..++.|++.||.|||  +++++|+||||+||+++.++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~---------------~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dlkp~Nil~~~~~  145 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ---------------TLSDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLNANC  145 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCC
Confidence            799999994 78988887543               2899999999999999999999  78999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      .+||+|||++....... .......++..|+|||.+.+...++.++||||||+++|+|++|..||.......    ....
T Consensus       146 ~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~  220 (337)
T cd07858         146 DLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH----QLKL  220 (337)
T ss_pred             CEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH----HHHH
Confidence            99999999998754332 222334578899999988654557889999999999999999999864321100    0000


Q ss_pred             HHHHHH-----------hccc---ccccc--CccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          313 ARTMEA-----------RNKE---IEMVD--SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       313 ~~~~~~-----------~~~~---~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      ......           ....   .+.+.  ............+..+.+++.+||+.||++|||++++++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         221 ITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000000           0000   00000  0000000112345678999999999999999999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-38  Score=279.28  Aligned_cols=242  Identities=25%  Similarity=0.289  Sum_probs=193.1

Q ss_pred             eecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCH
Q 043074           90 IGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL  165 (373)
Q Consensus        90 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  165 (373)
                      ||.|++|.||++... ++..+++|.+.+...   ...+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999765 589999999865432   2345688999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecccccc
Q 043074          166 DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI  245 (373)
Q Consensus       166 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  245 (373)
                      .+++.+...               +++..+..++.|++.||.|||  +++++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~~~l~~~~~---------------l~~~~~~~~~~~i~~~l~~lH--~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~  143 (262)
T cd05572          81 WTILRDRGL---------------FDEYTARFYIACVVLAFEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL  143 (262)
T ss_pred             HHHHhhcCC---------------CCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEEcCCCCEEEeeCCccccc
Confidence            999976532               788999999999999999999  799999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcccccc
Q 043074          246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEM  325 (373)
Q Consensus       246 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (373)
                      ....  ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..|+.....+     ............     
T Consensus       144 ~~~~--~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~-----  210 (262)
T cd05572         144 KSGQ--KTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDED-----PMEIYNDILKGN-----  210 (262)
T ss_pred             Cccc--ccccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-----HHHHHHHHhccC-----
Confidence            4332  1223467889999999874 44788999999999999999999997543321     111111111000     


Q ss_pred             ccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 043074          326 VDSNISREELSEAGVREYFRIACMCTNEKSRERPA-----MSYVVQ  366 (373)
Q Consensus       326 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~l~~  366 (373)
                        .   ....+...+..+.+++.+||+.||++||+     ++|+++
T Consensus       211 --~---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         211 --G---KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             --C---CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence              0   01112333668999999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.4e-38  Score=277.96  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=196.9

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +|...+.||+|+||.||+|..+ ++..+++|.+.....  ...+.+.+|+.+++.++|+|++++++.+.+....++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4777889999999999999765 588999999865422  2345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc-eEEee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE-AHISD  238 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~-~kl~D  238 (373)
                      +++++|.+++......             .+++..+..++.|++.||.|||  +.+++|+||+|+||++++++. ++|+|
T Consensus        81 ~~~~~L~~~~~~~~~~-------------~~~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~~~l~d  145 (257)
T cd08225          81 CDGGDLMKRINRQRGV-------------LFSEDQILSWFVQISLGLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGD  145 (257)
T ss_pred             CCCCcHHHHHHhccCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEcCCCCeEEecc
Confidence            9999999999764322             2789999999999999999999  789999999999999998864 69999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||.+........ ......|++.|+|||.+.+. .++.++|+||||+++|||++|..|+....       ...+......
T Consensus       146 ~~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~  216 (257)
T cd08225         146 FGIARQLNDSME-LAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVLKICQ  216 (257)
T ss_pred             cccchhccCCcc-cccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHhc
Confidence            999987643221 22234578899999988744 47889999999999999999999964321       1112111111


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .  .   . ..     .....+..+.+++.+||+.+|++|||+.+++.
T Consensus       217 ~--~---~-~~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         217 G--Y---F-AP-----ISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             c--c---C-CC-----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0  0   0 00     12223458999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-38  Score=278.65  Aligned_cols=253  Identities=24%  Similarity=0.359  Sum_probs=197.9

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeEEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCAS--GLDRVLIY  157 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  157 (373)
                      +|++.+.||.|+||.||++.. .++..+++|.+.....  ...+.+.+|+.+++.++|||++++++++..  +...++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999965 4788999999865432  234568889999999999999999997753  45678999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcC---CCCceeecCCCCceEeCCCCce
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGL---EKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~---~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      ||+++++|.+++.......           .++++..++.++.|++.||.|||..   +.+++|+||+|+||++++++.+
T Consensus        81 e~~~~~~L~~~l~~~~~~~-----------~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~  149 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKER-----------KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNV  149 (265)
T ss_pred             hhccCCCHHHHHHHHhhcc-----------cCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCE
Confidence            9999999999997643211           1389999999999999999999943   5789999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      ||+|||++........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..|+....       ......
T Consensus       150 kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~  220 (265)
T cd08217         150 KLGDFGLAKILGHDSS-FAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARN-------QLQLAS  220 (265)
T ss_pred             EEecccccccccCCcc-cccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcC-------HHHHHH
Confidence            9999999987643321 1233468899999999875 447889999999999999999999965422       111111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .... .     ..     ...+...+..+.+++.+||+.+|++||++.+|++
T Consensus       221 ~~~~-~-----~~-----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         221 KIKE-G-----KF-----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             HHhc-C-----CC-----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            1110 0     00     1113345668999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=281.13  Aligned_cols=265  Identities=24%  Similarity=0.346  Sum_probs=198.0

Q ss_pred             CCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      |...+.||.|++|.||++... +++.+++|.+......  ....+.+|+.++++++|+||+++++++.++...++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            556788999999999999764 7889999998654433  3457788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      + ++|.+++.....              ++++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||
T Consensus        81 ~-~~l~~~l~~~~~--------------~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df~  143 (283)
T cd05118          81 D-TDLYKLIKDRQR--------------GLPESLIKSYLYQLLQGLAFCH--SHGILHRDLKPENLLINTEGVLKLADFG  143 (283)
T ss_pred             C-CCHHHHHHhhcc--------------cCCHHHHHHHHHHHHHHHHHHH--HCCeeecCcCHHHEEECCCCcEEEeeee
Confidence            6 488888876432              2899999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH---------H
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL---------E  311 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~---------~  311 (373)
                      .+....... .......++..|+|||.+.+....+.++|+||||+++|+|++|+.|+......+......         .
T Consensus       144 ~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (283)
T cd05118         144 LARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV  222 (283)
T ss_pred             eeEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHh
Confidence            998765433 122234577889999998766568899999999999999999998864322111000000         0


Q ss_pred             HHHHHHH-hccccccc-cCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEA-RNKEIEMV-DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      |...... ........ .............+.++.+++.+||+.||.+||++.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         223 WPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             cccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000000 00000000 0000001112345778999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3e-38  Score=275.87  Aligned_cols=250  Identities=29%  Similarity=0.427  Sum_probs=201.9

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASG--LDRVLIY  157 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  157 (373)
                      +|...+.||+|++|.||+|... ++..+++|.+.....  ...+.+.+|+..+++++||||+++++.+.+.  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999765 789999999866543  3456788999999999999999999999888  8899999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++++|.+++....               .+++..+..++.|++.||+|||  +.+++|+||+|+||+++.++.++|+
T Consensus        81 e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~l~~~l~~lh--~~~~~h~dl~p~ni~i~~~~~~~l~  143 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---------------KLPEPVIRKYTRQILEGLAYLH--SNGIVHRDIKGANILVDSDGVVKLA  143 (260)
T ss_pred             EecCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEc
Confidence            9999999999997654               2899999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          238 DFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       238 Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      |||.+......... ......++..|+|||.+.+.. .+.++||||||+++++|++|..|+....      ...   ...
T Consensus       144 d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~---~~~  213 (260)
T cd06606         144 DFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELG------NPM---AAL  213 (260)
T ss_pred             ccccEEecccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC------chH---HHH
Confidence            99999876543321 123356788999999987543 7889999999999999999999975433      000   011


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .....       .......+...+..+.+++.+|++.||++||++.+++.
T Consensus       214 ~~~~~-------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         214 YKIGS-------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             Hhccc-------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11000       00011123444678999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.2e-38  Score=281.54  Aligned_cols=244  Identities=25%  Similarity=0.327  Sum_probs=189.8

Q ss_pred             eecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCH
Q 043074           90 IGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL  165 (373)
Q Consensus        90 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  165 (373)
                      ||+|+||+||++..+ +++.+++|.+.....   .....+.+|++++++++|||++++++.+...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999654 689999999865332   2234567899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecccccc
Q 043074          166 DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI  245 (373)
Q Consensus       166 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  245 (373)
                      .+++......             .+++.++..++.|++.||.|||  +.+++|+||+|+||++++++.++|+|||.+...
T Consensus        81 ~~~l~~~~~~-------------~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~  145 (277)
T cd05577          81 KYHIYNVGEP-------------GFPEARAIFYAAQIICGLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL  145 (277)
T ss_pred             HHHHHHcCcC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccCcchhhh
Confidence            9999765432             2889999999999999999999  789999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcccccc
Q 043074          246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEM  325 (373)
Q Consensus       246 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (373)
                      ...  .......++..|+|||.+.+.. ++.++||||||+++|+|++|..|+.........   ..    ...  ... .
T Consensus       146 ~~~--~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~----~~~--~~~-~  212 (277)
T cd05577         146 KGG--KKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EE----LKR--RTL-E  212 (277)
T ss_pred             ccC--CccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HH----HHh--ccc-c
Confidence            431  1222345778999999987544 788999999999999999999997543221100   00    000  000 0


Q ss_pred             ccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          326 VDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       326 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                      ....     .+...+..+.+++.+||+.||++||     ++.+++.
T Consensus       213 ~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         213 MAVE-----YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cccc-----CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            0011     1223356889999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-38  Score=287.09  Aligned_cols=248  Identities=27%  Similarity=0.396  Sum_probs=194.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      +.|...+.||+|+||.||++.. .++..+++|.+.....   .....+.+|+.+++.++|||++++++++.++...++|+
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            3467788999999999999975 4688999999865332   22456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+. |+|.+++.....              ++++.++..++.|++.|+.|||  +++++|+||+|+||+++.++.++|+
T Consensus       105 e~~~-g~l~~~~~~~~~--------------~l~~~~~~~i~~~i~~~l~~lH--~~~i~H~dL~p~Nil~~~~~~~kl~  167 (317)
T cd06635         105 EYCL-GSASDLLEVHKK--------------PLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLA  167 (317)
T ss_pred             eCCC-CCHHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcccEEECCCCCEEEe
Confidence            9996 588777754332              3899999999999999999999  8999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCC--CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |||++.....     .....+++.|+|||.+.+  ....+.++|||||||++|||++|..|+.....       ......
T Consensus       168 dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~  235 (317)
T cd06635         168 DFGSASIASP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYH  235 (317)
T ss_pred             cCCCccccCC-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-------HHHHHH
Confidence            9999875432     223457889999998742  34578899999999999999999999654210       011111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLL  368 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L  368 (373)
                      ......      ..    ......+..+.+++.+||+.+|.+||++.++++.+
T Consensus       236 ~~~~~~------~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         236 IAQNES------PT----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             HHhccC------CC----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            111000      00    11223456799999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.8e-38  Score=281.11  Aligned_cols=252  Identities=23%  Similarity=0.311  Sum_probs=195.5

Q ss_pred             CCCCCCeeecCCCceEEEEEe----CCCCEEEEEEeCcccc----ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCee
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAF----QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDR  153 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  153 (373)
                      +|++.+.||+|+||.||++..    .+|..||+|.+.....    ...+.+.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999975    3689999999865322    2235678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++|+||+++++|.+++....               ++++..+..++.|++.||.|||  +.+++||||+|+||+++.++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~  143 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---------------RFKEQEVQIYSGEIVLALEHLH--KLGIIYRDIKLENILLDSNGH  143 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEECCCCC
Confidence            99999999999999997643               2788999999999999999999  799999999999999999999


Q ss_pred             eEEeeeccccccCCCCCcccccccccccccCccccCCC-CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          234 AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN-TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      ++|+|||++...............|+..|+|||.+.+. ...+.++||||||+++|+|++|..|+....   .......+
T Consensus       144 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~---~~~~~~~~  220 (290)
T cd05613         144 VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG---EKNSQAEI  220 (290)
T ss_pred             EEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC---ccccHHHH
Confidence            99999999987543322222335678899999998643 346788999999999999999999964211   11111122


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                      .......       ...     .+...+..+.+++.+||+.||++||     +..+++.
T Consensus       221 ~~~~~~~-------~~~-----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         221 SRRILKS-------EPP-----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHhhcc-------CCC-----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            1111110       011     1223456889999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-39  Score=286.72  Aligned_cols=252  Identities=22%  Similarity=0.293  Sum_probs=197.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCc--cccccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDK--DAFQGFREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ...|++.+.||+||.+.||++...+.+.+|+|++..  .+.+...-|.+|+..|.+|+ |.+|+++++|-..++..|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            357888999999999999999888788888887643  33344667999999999995 999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||= .-+|..+|.+....              +....+..+..|++.|+.++|  ..||||.||||.|+|+-. |.+||+
T Consensus       440 E~G-d~DL~kiL~k~~~~--------------~~~~~lk~ywkqML~aV~~IH--~~gIVHSDLKPANFLlVk-G~LKLI  501 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSI--------------DPDWFLKFYWKQMLLAVKTIH--QHGIVHSDLKPANFLLVK-GRLKLI  501 (677)
T ss_pred             ecc-cccHHHHHHhccCC--------------CchHHHHHHHHHHHHHHHHHH--HhceeecCCCcccEEEEe-eeEEee
Confidence            987 67999999887653              332377889999999999999  899999999999999854 589999


Q ss_pred             eeccccccCCCCCc-ccccccccccccCccccCCCC----------CCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          238 DFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNT----------AATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       238 Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----------~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                      |||.|..+...... .....+||+.||+||.+....          ..+.++|||||||+||+|+.|+.||..       
T Consensus       502 DFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~-------  574 (677)
T KOG0596|consen  502 DFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ-------  574 (677)
T ss_pred             eechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-------
Confidence            99999987655433 334578999999999986321          257789999999999999999999642       


Q ss_pred             ccHH-HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          307 VGLL-EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       307 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                        +. .|.+-...     ...+..+.....+..  .++.+++..||..||++||+..+|++
T Consensus       575 --~~n~~aKl~aI-----~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  575 --IINQIAKLHAI-----TDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             --HHHHHHHHHhh-----cCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence              22 12221111     111112222222222  24999999999999999999999986

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.3e-38  Score=282.95  Aligned_cols=256  Identities=23%  Similarity=0.312  Sum_probs=198.7

Q ss_pred             CCCCCCeeecCCCceEEEEEe----CCCCEEEEEEeCcccc----ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCee
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAF----QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDR  153 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  153 (373)
                      +|++.+.||+|+||.||++..    .++..+|+|.+.+...    ...+.+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367788999999999999964    3578899999865322    2234678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++|+||+++++|.+++....               .+++..+..++.|+++||.|||  +.+++|+||+|+||+++.++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~ql~~~l~~lH--~~~~~H~dl~p~nil~~~~~~  143 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---------------HFTESEVRVYIAEIVLALDHLH--QLGIIYRDIKLENILLDSEGH  143 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---------------CcCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCC
Confidence            99999999999999987543               2888999999999999999999  799999999999999999999


Q ss_pred             eEEeeeccccccCCCCCcccccccccccccCccccCCCC-CCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          234 AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNT-AATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      ++|+|||+++..............++..|+|||.+.+.. ..+.++|+||||+++|||++|..|+....   ........
T Consensus       144 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~---~~~~~~~~  220 (288)
T cd05583         144 VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG---EQNSQSEI  220 (288)
T ss_pred             EEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc---ccchHHHH
Confidence            999999998875443322233346788999999986432 36788999999999999999999964321   11111111


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                      .......       ....     +...+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       221 ~~~~~~~-------~~~~-----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         221 SRRILKS-------KPPF-----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHHHHcc-------CCCC-----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            1111110       0111     22344578999999999999999999888877653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.8e-39  Score=284.92  Aligned_cols=243  Identities=24%  Similarity=0.341  Sum_probs=193.2

Q ss_pred             CeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCHH
Q 043074           88 KIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLD  166 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  166 (373)
                      ..||+|+||.||++.. .++..+++|.+..........+.+|+.+++.++|+|++++++.+..++..++++||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            5799999999999976 478999999986554445567889999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccC
Q 043074          167 QWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID  246 (373)
Q Consensus       167 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  246 (373)
                      +++....                +++.....++.|++.|++|||  +.+++|+||+|+||++++++.++|+|||++....
T Consensus       106 ~~~~~~~----------------~~~~~~~~~~~ql~~~l~~lH--~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~  167 (292)
T cd06657         106 DIVTHTR----------------MNEEQIAAVCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  167 (292)
T ss_pred             HHHhcCC----------------CCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEcccccceecc
Confidence            9875432                788999999999999999999  7899999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccc
Q 043074          247 TSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV  326 (373)
Q Consensus       247 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (373)
                      .... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..|+......       +.......      ..
T Consensus       168 ~~~~-~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-------~~~~~~~~------~~  232 (292)
T cd06657         168 KEVP-RRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRD------NL  232 (292)
T ss_pred             cccc-cccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh------hC
Confidence            3221 2233567889999999864 44688999999999999999999996532110       11111100      01


Q ss_pred             cCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       327 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...+..   ....+..+.+++.+||+.||.+||++.++++
T Consensus       233 ~~~~~~---~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         233 PPKLKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CcccCC---cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            111100   1123457889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.8e-39  Score=290.08  Aligned_cols=264  Identities=21%  Similarity=0.254  Sum_probs=194.2

Q ss_pred             cCCCC-CCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccccc--------------HHHHHHHHHHHhcCCCCCcccee
Q 043074           81 TDNFS-TDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQG--------------FREFRAEMETLGKLRHRNIVKIL  144 (373)
Q Consensus        81 ~~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~  144 (373)
                      .++|. +.+.||.|+||.||+|..+ +++.||+|.+.......              ...+.+|+++++.++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            34565 4577999999999999754 68999999986543221              12467899999999999999999


Q ss_pred             eEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCC
Q 043074          145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS  224 (373)
Q Consensus       145 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~  224 (373)
                      +++......++++||+. |+|.+++....               .+++.....++.|++.||.|||  +.+++|+||+|+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---------------~~~~~~~~~~~~ql~~aL~~LH--~~~i~H~dl~~~  148 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI---------------RLTESQVKCILLQILNGLNVLH--KWYFMHRDLSPA  148 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHH
Confidence            99999999999999995 69999886533               2889999999999999999999  799999999999


Q ss_pred             ceEeCCCCceEEeeeccccccCCCC-------------CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHH
Q 043074          225 NVLLDSDFEAHISDFGLARRIDTSH-------------SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA  291 (373)
Q Consensus       225 Nill~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~  291 (373)
                      ||+++.++.++|+|||++.......             ........++..|+|||.+.+...++.++|+||||+++|||+
T Consensus       149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~  228 (335)
T PTZ00024        149 NIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL  228 (335)
T ss_pred             HeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence            9999999999999999998654111             111122346778999999876666788999999999999999


Q ss_pred             hCCCCCCCcccCCCcccHHHHHHHHHHhccc-----------cccccCcccc--ccCCHHHHHHHHHHHHHhcCCCCCCC
Q 043074          292 TQIRPNLPVVLDGQEVGLLEWARTMEARNKE-----------IEMVDSNISR--EELSEAGVREYFRIACMCTNEKSRER  358 (373)
Q Consensus       292 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~R  358 (373)
                      +|..|+......+    ..............           ..........  .......+..+.+++.+||+.+|++|
T Consensus       229 tg~~p~~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  304 (335)
T PTZ00024        229 TGKPLFPGENEID----QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER  304 (335)
T ss_pred             hCCCCCCCCCHHH----HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhc
Confidence            9998865332111    11100000000000           0000000000  00011235678999999999999999


Q ss_pred             CCHHHHHH
Q 043074          359 PAMSYVVQ  366 (373)
Q Consensus       359 Ps~~~l~~  366 (373)
                      |++++++.
T Consensus       305 ~s~~~~l~  312 (335)
T PTZ00024        305 ISAKEALK  312 (335)
T ss_pred             cCHHHHhc
Confidence            99999985

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5e-38  Score=275.89  Aligned_cols=249  Identities=25%  Similarity=0.322  Sum_probs=190.4

Q ss_pred             HHHHHhcCCCCCCCee--ecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEeeC
Q 043074           75 SELIDATDNFSTDKII--GDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCASG  150 (373)
Q Consensus        75 ~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  150 (373)
                      .+.....++|.+.+.+  |+|+||.||++.. .++..+++|.+........     |+.....+ +|||++++++.+...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence            3444455677777766  9999999999965 4688899999865433221     22222222 699999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      +..++||||+++++|.+++....               ++++.++..++.|++.||.|||  +.+++||||+|+||+++.
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~  144 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEG---------------KLSEAEVKKIIRQLVEALNDLH--KHNIIHNDIKLENVLYDR  144 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEeC
Confidence            99999999999999999997653               2899999999999999999999  788999999999999999


Q ss_pred             CC-ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          231 DF-EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       231 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      ++ .++|+|||++......     ....++..|+|||.+.+. .++.++||||||+++|||++|..|+......  ....
T Consensus       145 ~~~~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~  216 (267)
T PHA03390        145 AKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDE--ELDL  216 (267)
T ss_pred             CCCeEEEecCccceecCCC-----ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcc--hhhH
Confidence            98 9999999998765322     223578899999999754 4788999999999999999999997632211  1112


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA-MSYVVQ  366 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~l~~  366 (373)
                      ..+.....   .       ..   ......+..+.+++.+||+.||.+||+ ++++++
T Consensus       217 ~~~~~~~~---~-------~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        217 ESLLKRQQ---K-------KL---PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHhhc---c-------cC---CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            22211110   0       00   112234568999999999999999996 588874

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-38  Score=286.10  Aligned_cols=261  Identities=21%  Similarity=0.280  Sum_probs=189.5

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCcc--ccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCC
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKD--AFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGS  164 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  164 (373)
                      .+.+|.|+++.|+++.. +++.+|+|++...  .....+.+.+|+..++.++||||+++++++.+....++++||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455555555555544 6899999998654  23345678999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccc
Q 043074          165 LDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       165 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                      |.+++......             .+++.....++.|++.||.|||  +.+++||||||+||+++.++.++|+|||.+..
T Consensus        86 l~~~l~~~~~~-------------~~~~~~~~~~~~~l~~~L~~LH--~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~  150 (314)
T cd08216          86 CEDLLKTHFPE-------------GLPELAIAFILKDVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVS  150 (314)
T ss_pred             HHHHHHHhccc-------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCcceEEEecCCceEEecCcccee
Confidence            99999865322             2788899999999999999999  78999999999999999999999999998875


Q ss_pred             cCCCCC------cccccccccccccCccccCCC-CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH--
Q 043074          245 IDTSHS------HVSTQVAGTMGYMPPEYLGGN-TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART--  315 (373)
Q Consensus       245 ~~~~~~------~~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--  315 (373)
                      ......      .......++..|+|||.+.+. ..++.++|+||||+++|||++|..||.......   ...+....  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~---~~~~~~~~~~  227 (314)
T cd08216         151 MIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKVRGTV  227 (314)
T ss_pred             eccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccC
Confidence            532111      111234567789999998653 347889999999999999999999976432111   00000000  


Q ss_pred             --------HHHhccccc-----cccCcc---ccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          316 --------MEARNKEIE-----MVDSNI---SREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       316 --------~~~~~~~~~-----~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                              .........     ..+...   ...........++.+++.+||+.||++|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         228 PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             ccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                    000000000     000000   001112334567899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-38  Score=273.66  Aligned_cols=247  Identities=30%  Similarity=0.469  Sum_probs=200.2

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +|++.+.||+|++|.||++... +++.+++|.+.....  .....+.+|++++++++|||++++++++.++...++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999654 678999999976654  3456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++....               ++++..+..++.|++.|+.|||  +.+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~L~~~~~~~~---------------~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~  143 (254)
T cd06627          81 AENGSLRQIIKKFG---------------PFPESLVAVYVYQVLQGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADF  143 (254)
T ss_pred             CCCCcHHHHHHhcc---------------CCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEECCCCCEEEecc
Confidence            99999999987653               2899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |.+......... .....++..|+|||...+.. .+.++|+||+|+++|+|++|..|+.....     ....|.  ... 
T Consensus       144 ~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~--~~~-  213 (254)
T cd06627         144 GVATKLNDVSKD-DASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFR--IVQ-  213 (254)
T ss_pred             ccceecCCCccc-ccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH--Hhc-
Confidence            999876543321 23346788999999987544 78899999999999999999998653210     000110  100 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       ..    ...     .+...+..+.+++.+||+.+|++||++.+++.
T Consensus       214 -~~----~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         214 -DD----HPP-----LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -cC----CCC-----CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             00    011     12233568999999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.5e-38  Score=278.93  Aligned_cols=243  Identities=23%  Similarity=0.350  Sum_probs=192.9

Q ss_pred             eecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCH
Q 043074           90 IGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL  165 (373)
Q Consensus        90 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  165 (373)
                      ||.|+||.||++... +++.+++|.+.....   ...+.+.+|+.++++++|||++++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999775 599999999866543   3355788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecccccc
Q 043074          166 DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI  245 (373)
Q Consensus       166 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  245 (373)
                      .+++....               .+++..+..++.|++.||+|||  +.+++|+||+|+||++++++.++|+|||++...
T Consensus        81 ~~~l~~~~---------------~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~  143 (265)
T cd05579          81 ASLLENVG---------------SLDEDVARIYIAEIVLALEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVG  143 (265)
T ss_pred             HHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HcCeecCCCCHHHeEEcCCCCEEEEecccchhc
Confidence            99997644               2899999999999999999999  899999999999999999999999999998764


Q ss_pred             CCCCC-------cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          246 DTSHS-------HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       246 ~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      .....       .......++..|+|||...+.. .+.++|+||||+++|+|++|..|+.....       .........
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~  215 (265)
T cd05579         144 LVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETP-------EEIFQNILN  215 (265)
T ss_pred             ccCcccccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhc
Confidence            33211       1223345778999999987544 78899999999999999999999653221       111111110


Q ss_pred             hccccccccCccccccCCHH--HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEA--GVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                       ..    ..    .   +..  .+..+.+++.+||+.+|.+||++..+.+.|+
T Consensus       216 -~~----~~----~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         216 -GK----IE----W---PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -CC----cC----C---CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence             00    00    0   111  2568999999999999999999966665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-39  Score=293.42  Aligned_cols=273  Identities=25%  Similarity=0.376  Sum_probs=202.3

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCC------eeE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGL------DRV  154 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~  154 (373)
                      .+...+.||+|+||.||+|+. .+|+.||||.++..... ..+...+|+++|++++|||||+++++-++..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            344567899999999999974 58999999999774433 3556789999999999999999999865543      568


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe--CCCC
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL--DSDF  232 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill--~~~~  232 (373)
                      +|||||.+|||...+.+.....            .+++.+.+.++.++..||.|||  .++|+||||||.||++  .++|
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~------------GLpE~e~l~lL~d~~~al~~Lr--En~IvHRDlKP~NIvl~~Gedg  159 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAY------------GLPESEFLDLLSDLVSALRHLR--ENGIVHRDLKPGNIVLQIGEDG  159 (732)
T ss_pred             EEEeecCCCcHHHHhcCccccc------------CCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEeecCCC
Confidence            9999999999999998766433            4999999999999999999999  8999999999999998  3334


Q ss_pred             --ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH
Q 043074          233 --EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       233 --~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  310 (373)
                        -.||+|||.|+..+..  .......||..|++||.+..+.+++...|.|||||++|+++||..||.|.-.... ..-.
T Consensus       160 q~IyKLtDfG~Arel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~-~~~~  236 (732)
T KOG4250|consen  160 QSIYKLTDFGAARELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN-NKEI  236 (732)
T ss_pred             ceEEeeecccccccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc-cchh
Confidence              4799999999987543  3566789999999999998667889999999999999999999999877543321 1112


Q ss_pred             HHHHHHHHhccccccccCccc--------ccc---CCHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHhhh
Q 043074          311 EWARTMEARNKEIEMVDSNIS--------REE---LSEAGVREYFRIACMCTNEKSRERP--AMSYVVQLLDELV  372 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~--------~~~---~~~~~~~~l~~l~~~cl~~~p~~RP--s~~~l~~~L~~l~  372 (373)
                      .|........-+.-..++...        ...   ........+-..+..+|..||++|=  .+.+....+.+++
T Consensus       237 ~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  237 MWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             hhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence            232221111111111111111        011   1222334566677778888888887  6655555555543

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.6e-38  Score=277.27  Aligned_cols=242  Identities=24%  Similarity=0.267  Sum_probs=186.3

Q ss_pred             eeecCCCceEEEEEe-CCCCEEEEEEeCccccc---cHHHHHHHHH---HHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           89 IIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEME---TLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        89 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      .||+|+||.||++.. .+++.||+|.+.+....   ....+..|..   .++...|||++++.+++.+....++|+||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999965 46899999998654322   1122334433   4444579999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +++|.+++....               .+++..+..++.|++.|+.|||  +.+++||||||+||+++.++.++|+|||+
T Consensus        81 g~~L~~~l~~~~---------------~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~nili~~~~~~kl~dfg~  143 (278)
T cd05606          81 GGDLHYHLSQHG---------------VFSEAEMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGL  143 (278)
T ss_pred             CCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCEEcCCCCHHHEEECCCCCEEEccCcC
Confidence            999999886543               2899999999999999999999  78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK  321 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (373)
                      +.......   .....|+..|+|||.+.+...++.++||||+|+++|||++|..||........    .......     
T Consensus       144 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~----~~~~~~~-----  211 (278)
T cd05606         144 ACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMT-----  211 (278)
T ss_pred             ccccCccC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch----HHHHHHh-----
Confidence            87653221   22346899999999987555578899999999999999999999754322110    0000000     


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                        ......+     +...+.++.+++.+|++.+|.+||     ++.++++
T Consensus       212 --~~~~~~~-----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         212 --LTMAVEL-----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             --hccCCCC-----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence              0011111     222356899999999999999999     8988875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.8e-38  Score=286.59  Aligned_cols=264  Identities=25%  Similarity=0.276  Sum_probs=193.3

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeC------
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASG------  150 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  150 (373)
                      ..++|+..+.||+|+||.||++.. .+++.||+|.+.+..  ......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999975 478999999986432  22345677899999999999999999988543      


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      ...++|+||+. ++|.+.+...                 +++..+..++.|++.||+|||  +.+++||||||+||+++.
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~-----------------l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nil~~~  153 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD-----------------LDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKS  153 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc-----------------CCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECC
Confidence            35699999994 5888877532                 677888999999999999999  789999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcc---
Q 043074          231 DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV---  307 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~---  307 (373)
                      ++.+||+|||+++......  ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||..........   
T Consensus       154 ~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~  230 (353)
T cd07850         154 DCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII  230 (353)
T ss_pred             CCCEEEccCccceeCCCCC--CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            9999999999998754322  1233457889999999875 457889999999999999999999875322100000   


Q ss_pred             -----cHHHHHHHHH-------Hhcccc------ccccCccc---cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          308 -----GLLEWARTME-------ARNKEI------EMVDSNIS---REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       308 -----~~~~~~~~~~-------~~~~~~------~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                           ...++.....       ......      +.......   ........+..+.+++.+||+.||++|||+.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         231 EQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 0000000000       000000      00000000   00001234567899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.1e-38  Score=285.53  Aligned_cols=263  Identities=22%  Similarity=0.299  Sum_probs=190.4

Q ss_pred             CeeecC--CCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDG--SFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      ..||+|  +||+||++.. .+++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++..+...++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  8999999976 4799999999865432  2346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      ++|.+++......             .+++..+..++.|++.||+|||  +++++||||||+||+++.++.++++||+.+
T Consensus        84 ~~l~~~l~~~~~~-------------~~~~~~~~~~~~qi~~aL~~lH--~~~ivHrDlkp~Nill~~~~~~~~~~~~~~  148 (328)
T cd08226          84 GSANSLLKTYFPE-------------GMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHL  148 (328)
T ss_pred             CCHHHHHHhhccc-------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEeCCCcEEEechHHH
Confidence            9999998875432             2888999999999999999999  789999999999999999999999999865


Q ss_pred             cccCCCCCc------ccccccccccccCccccCCC-CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH-----
Q 043074          243 RRIDTSHSH------VSTQVAGTMGYMPPEYLGGN-TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL-----  310 (373)
Q Consensus       243 ~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~-----  310 (373)
                      .........      ......++..|+|||.+.+. ..++.++|||||||++|||++|..|+.............     
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  228 (328)
T cd08226         149 YSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPY  228 (328)
T ss_pred             hhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCC
Confidence            433211110      01112345679999998753 346889999999999999999999975432111000000     


Q ss_pred             -HH-------HHHHHHh----------------ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 -EW-------ARTMEAR----------------NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 -~~-------~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       .|       .......                ..........+ .......++..+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             CCccccccchhhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence             00       0000000                00000000011 11113446778999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-38  Score=289.92  Aligned_cols=267  Identities=22%  Similarity=0.257  Sum_probs=193.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeC---------
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASG---------  150 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------  150 (373)
                      ..+|...+.||.|+||.||+|.. .++..|++|.+........+.+.+|+.+++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            36888999999999999999965 46899999998766656667788999999999999999999876543         


Q ss_pred             -----CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCc
Q 043074          151 -----LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSN  225 (373)
Q Consensus       151 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~N  225 (373)
                           ...++|+||++ ++|.+++....                +++..+..++.|++.||.|||  +.+++||||||+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------------l~~~~~~~~~~qi~~aL~~LH--~~givH~dikp~N  144 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQGP----------------LSEEHARLFMYQLLRGLKYIH--SANVLHRDLKPAN  144 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHH
Confidence                 35789999996 68988875432                889999999999999999999  7899999999999


Q ss_pred             eEeC-CCCceEEeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCccc
Q 043074          226 VLLD-SDFEAHISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVL  302 (373)
Q Consensus       226 ill~-~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~  302 (373)
                      |+++ +++.++|+|||++.........  ......++..|+|||.+.+...++.++|||||||++|+|++|..||.....
T Consensus       145 ili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~  224 (342)
T cd07854         145 VFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE  224 (342)
T ss_pred             EEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9997 4567899999999765432211  112335788999999876555678899999999999999999999754321


Q ss_pred             CCCcccHH---------HHHHHHHHhccccc--cccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          303 DGQEVGLL---------EWARTMEARNKEIE--MVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       303 ~~~~~~~~---------~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ........         .+............  ...............+.++.+++.+||+.||.+||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         225 LEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            11000000         00000000000000  000000000001123457889999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.6e-39  Score=289.61  Aligned_cols=267  Identities=25%  Similarity=0.322  Sum_probs=198.9

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-----eeE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASGL-----DRV  154 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  154 (373)
                      +|++.+.||.|++|.||+|... ++..+++|.+....  ....+.+.+|+.+++.++||||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999765 58999999987643  233467889999999999999999999987765     789


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +++||++ ++|.+++....               ++++..+..++.|++.||+|||  +.+++|+||||+||+++.++.+
T Consensus        81 lv~e~~~-~~l~~~l~~~~---------------~l~~~~~~~i~~~l~~~l~~LH--~~gi~H~dlkp~nili~~~~~~  142 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ---------------PLTDDHIQYFLYQILRGLKYLH--SANVIHRDLKPSNILVNSNCDL  142 (330)
T ss_pred             EEecchh-hhHHHHHhCCC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCE
Confidence            9999996 58988887543               2899999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCC--cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          235 HISDFGLARRIDTSHS--HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      +|+|||++........  .......++..|+|||.+.+....+.++|+||||+++|+|++|..||...............
T Consensus       143 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~  222 (330)
T cd07834         143 KICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV  222 (330)
T ss_pred             EEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHh
Confidence            9999999987654321  12233457889999999986656889999999999999999999987543221100000000


Q ss_pred             HH-----HH--HHhccccccc---cC--ccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          313 AR-----TM--EARNKEIEMV---DS--NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       313 ~~-----~~--~~~~~~~~~~---~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      ..     ..  .........+   ..  ...........+..+.+++.+||+.+|.+||++++++..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             cCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            00     00  0000000000   00  000000112245689999999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-38  Score=275.05  Aligned_cols=249  Identities=25%  Similarity=0.389  Sum_probs=194.3

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc-----cccHHHHHHHHHHHhcCCCCCccceeeEEeeC--Cee
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA-----FQGFREFRAEMETLGKLRHRNIVKILGYCASG--LDR  153 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  153 (373)
                      ++|++.+.||+|+||.||+|.. .++..+++|.+....     ......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4788999999999999999975 468999999874321     12345788999999999999999999998664  467


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++++||+++++|.+++....               ++++....+++.|++.||.|||  +.+++|+||+|+||+++.++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---------------~l~~~~~~~~~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~  144 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---------------ALTENVTRRYTRQILQGVSYLH--SNMIVHRDIKGANILRDSAGN  144 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCC
Confidence            89999999999999987543               2788899999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCC--cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          234 AHISDFGLARRIDTSHS--HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      ++|+|||+++.......  .......++..|+|||.+.+. ..+.++|+||||+++|+|++|..||.....      ...
T Consensus       145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~  217 (264)
T cd06653         145 VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAA  217 (264)
T ss_pred             EEECccccccccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCH------HHH
Confidence            99999999986532111  112234578899999998754 478899999999999999999999643210      000


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       ......     ...     ....+...+..+.+++.+||+ +|.+||+..+++.
T Consensus       218 -~~~~~~-----~~~-----~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         218 -IFKIAT-----QPT-----KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -HHHHHc-----CCC-----CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence             000000     000     111244456789999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-38  Score=273.99  Aligned_cols=244  Identities=25%  Similarity=0.280  Sum_probs=186.8

Q ss_pred             CeeecCCCceEEEEEe-CCCCEEEEEEeCccccc---cHHHHHHHHHH-HhcCCCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMET-LGKLRHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||+|.. .+++.||+|.+.+....   ....+..|... ....+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4699999999999965 46899999998654322   12234445444 4445899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      ++|.+++....               ++++..+..++.|++.||.|||  +.+++|+||+|+||++++++.++|+|||++
T Consensus        82 ~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  144 (260)
T cd05611          82 GDCASLIKTLG---------------GLPEDWAKQYIAEVVLGVEDLH--QRGIIHRDIKPENLLIDQTGHLKLTDFGLS  144 (260)
T ss_pred             CCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEeecccc
Confidence            99999997643               2888999999999999999999  789999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE  322 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (373)
                      +....     .....++..|+|||.+.+.. ++.++||||||+++|||++|..|+.....       .............
T Consensus       145 ~~~~~-----~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~  211 (260)
T cd05611         145 RNGLE-----NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETP-------DAVFDNILSRRIN  211 (260)
T ss_pred             eeccc-----cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcccC
Confidence            75432     22345788999999987654 78899999999999999999999743211       1111111110000


Q ss_pred             cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          323 IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                         ..     ......++..+.+++.+||+.||++||++.++.+.|.
T Consensus       212 ---~~-----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         212 ---WP-----EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ---CC-----CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence               00     0112234568999999999999999998866655543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=264.10  Aligned_cols=251  Identities=23%  Similarity=0.390  Sum_probs=195.1

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +.+....||+|+.|.|++++.. +|..+|||.+.+... +..+.++..+.++..- ++|+||+.+|+|..+...++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            3445567999999999999765 688999999966443 3456677777776665 499999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      | ...++.++.....              ++++.-+=++...+..||.||.. +++++|||+||+|||+|+.|++|++||
T Consensus       173 M-s~C~ekLlkrik~--------------piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDF  236 (391)
T KOG0983|consen  173 M-STCAEKLLKRIKG--------------PIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDF  236 (391)
T ss_pred             H-HHHHHHHHHHhcC--------------CchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecc
Confidence            9 5577777776553              48888888899999999999986 788999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCC--CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |.+-++-.+..  .+...|.+.|||||.+.-  ...|+.++||||||+.++||.||+.|+..-.   .+.....-..   
T Consensus       237 GIsGrlvdSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~---tdFe~ltkvl---  308 (391)
T KOG0983|consen  237 GISGRLVDSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK---TDFEVLTKVL---  308 (391)
T ss_pred             cccceeecccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC---ccHHHHHHHH---
Confidence            99987754433  344568899999999863  4567889999999999999999999954311   1111111111   


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                            ....+.+....   ..+..+.+++..||+.|+.+||.+.++++
T Consensus       309 ------n~ePP~L~~~~---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  309 ------NEEPPLLPGHM---GFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             ------hcCCCCCCccc---CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                  11112232211   14568999999999999999999999875

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-40  Score=318.95  Aligned_cols=254  Identities=29%  Similarity=0.423  Sum_probs=204.2

Q ss_pred             hcCCCCCCCeeecCCCceEEEE-EeCCCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .+-+++....||.|.||.||.| ...+|.-.|+|-+....  ......+.+|.+++..++|||+|+++|+-.+.+..++.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            3567788889999999999999 45689999999875433  33456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      ||||.+|+|.+.+...+.               .++.....+..|++.|++|||  +.|||||||||.||+++.+|.+|+
T Consensus      1313 MEyC~~GsLa~ll~~gri---------------~dE~vt~vyt~qll~gla~LH--~~gIVHRDIK~aNI~Ld~~g~iK~ 1375 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI---------------EDEMVTRVYTKQLLEGLAYLH--EHGIVHRDIKPANILLDFNGLIKY 1375 (1509)
T ss_pred             HHHhccCcHHHHHHhcch---------------hhhhHHHHHHHHHHHHHHHHH--hcCceecCCCccceeeecCCcEEe
Confidence            999999999999986653               445555667899999999999  899999999999999999999999


Q ss_pred             eeeccccccCCCCCc---ccccccccccccCccccCCCC--CCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          237 SDFGLARRIDTSHSH---VSTQVAGTMGYMPPEYLGGNT--AATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +|||.|.........   ......||+.|||||++.+..  ....++||||+||+..||+||+.||.....        +
T Consensus      1376 ~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--------e 1447 (1509)
T KOG4645|consen 1376 GDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--------E 1447 (1509)
T ss_pred             ecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--------h
Confidence            999999987654322   233468999999999998643  346689999999999999999999643221        1


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      |.        +...+...- ..++|+..+.+-.+++.+||+.||++|=++.|+++.
T Consensus      1448 ~a--------IMy~V~~gh-~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1448 WA--------IMYHVAAGH-KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             hH--------HHhHHhccC-CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            21        111111111 233367788899999999999999999888777653

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.5e-39  Score=309.10  Aligned_cols=253  Identities=26%  Similarity=0.398  Sum_probs=185.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc-cccHHHHHHHHHHHhcCCCCCccceeeEEeeC--------
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIVKILGYCASG--------  150 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------  150 (373)
                      .++|+..+.||+||||.||+++.+ ||+.||||++.... ......+.+|++.+++|+|||||+++..+.+.        
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            356777889999999999999876 89999999986553 23356788999999999999999988755210        


Q ss_pred             --------------------------------------------------------------------------------
Q 043074          151 --------------------------------------------------------------------------------  150 (373)
Q Consensus       151 --------------------------------------------------------------------------------  150 (373)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             -------------------------------CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHH
Q 043074          151 -------------------------------LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV  199 (373)
Q Consensus       151 -------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~  199 (373)
                                                     ...|+-||||+..+|.++++.+...              -.-...++++
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--------------~~~d~~wrLF  703 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--------------SQRDEAWRLF  703 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--------------hhhHHHHHHH
Confidence                                           1125667777777777777665431              0346788999


Q ss_pred             HHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccC---------C--------CCCcccccccccccc
Q 043074          200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID---------T--------SHSHVSTQVAGTMGY  262 (373)
Q Consensus       200 ~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~---------~--------~~~~~~~~~~g~~~y  262 (373)
                      ++|++||.|+|  +.|+|||||||.||++++++.|||+|||+|....         .        +.....+...||.-|
T Consensus       704 reIlEGLaYIH--~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalY  781 (1351)
T KOG1035|consen  704 REILEGLAYIH--DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALY  781 (1351)
T ss_pred             HHHHHHHHHHH--hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeee
Confidence            99999999999  8999999999999999999999999999998721         0        011134557899999


Q ss_pred             cCccccCCCC--CCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHH
Q 043074          263 MPPEYLGGNT--AATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGV  340 (373)
Q Consensus       263 ~aPE~~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (373)
                      +|||++.+..  .|+.|+|+||||++|+||+.   ||...+      .-......+. .+.....  .     .+..+..
T Consensus       782 vAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM------ERa~iL~~LR-~g~iP~~--~-----~f~~~~~  844 (1351)
T KOG1035|consen  782 VAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM------ERASILTNLR-KGSIPEP--A-----DFFDPEH  844 (1351)
T ss_pred             ecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH------HHHHHHHhcc-cCCCCCC--c-----ccccccc
Confidence            9999998766  69999999999999999975   322111      1111111111 1111110  1     1122233


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          341 REYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..-..+|+++++.||.+|||+.|++.
T Consensus       845 ~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  845 PEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             hHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            45678999999999999999999975

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.1e-38  Score=281.53  Aligned_cols=254  Identities=25%  Similarity=0.431  Sum_probs=192.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .++|++.+.||+|+||.||+|..+ +++.+|+|.+...... ....+..|+..+.+. .||||+++++++.++...++++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            457888999999999999999876 4899999998654332 234566677766666 4999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+ +++|.+++.....              ++++..+..++.|++.||+|||+ ..+++||||+|+||++++++.+||+
T Consensus        94 e~~-~~~l~~l~~~~~~--------------~l~~~~~~~i~~~i~~~l~~lH~-~~~i~H~dl~p~nill~~~~~~kL~  157 (296)
T cd06618          94 ELM-STCLDKLLKRIQG--------------PIPEDILGKMTVAIVKALHYLKE-KHGVIHRDVKPSNILLDASGNVKLC  157 (296)
T ss_pred             ecc-CcCHHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHh-hCCEecCCCcHHHEEEcCCCCEEEC
Confidence            998 5578777765332              28999999999999999999993 2589999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCC---CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN---TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      |||++........  .....++..|+|||.+.+.   ..++.++||||||+++|+|++|..|+......      .+...
T Consensus       158 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~  229 (296)
T cd06618         158 DFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLT  229 (296)
T ss_pred             ccccchhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHH
Confidence            9999876543221  1223467889999998643   34678999999999999999999996432110      01111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      ......      ......   ....+.++.+++.+||+.||.+||++.++++.
T Consensus       230 ~~~~~~------~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         230 KILQEE------PPSLPP---NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHhcCC------CCCCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111100      011100   11234579999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=265.86  Aligned_cols=255  Identities=20%  Similarity=0.312  Sum_probs=200.3

Q ss_pred             CeeecCCCceEEEE-EeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEEecCCCCH
Q 043074           88 KIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLIYEFVENGSL  165 (373)
Q Consensus        88 ~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  165 (373)
                      +.||+|+|+.|-.+ ...+|.++|||++.+........+.+|++++.+.+ |+||++++++|+++...|||||-|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            57999999999998 57799999999999987777788999999999985 99999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC---ceEEeeeccc
Q 043074          166 DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF---EAHISDFGLA  242 (373)
Q Consensus       166 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~  242 (373)
                      ..+|.+...               +++.++.++.++|+.||.|||  ++||.||||||+|||-.+..   -+||+||.+.
T Consensus       164 LshI~~~~~---------------F~E~EAs~vvkdia~aLdFlH--~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLg  226 (463)
T KOG0607|consen  164 LSHIQKRKH---------------FNEREASRVVKDIASALDFLH--TKGIAHRDLKPENILCESPNKVSPVKICDFDLG  226 (463)
T ss_pred             HHHHHHhhh---------------ccHHHHHHHHHHHHHHHHHHh--hcCcccccCCccceeecCCCCcCceeeeccccc
Confidence            999988764               999999999999999999999  89999999999999997654   4899999887


Q ss_pred             cccCC--CC----CcccccccccccccCccccC----CCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc---ccH
Q 043074          243 RRIDT--SH----SHVSTQVAGTMGYMPPEYLG----GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE---VGL  309 (373)
Q Consensus       243 ~~~~~--~~----~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~---~~~  309 (373)
                      .....  +-    .......+|+..|||||+..    ....|+.+.|.|||||+||-|++|.+||......+-.   ...
T Consensus       227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~  306 (463)
T KOG0607|consen  227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV  306 (463)
T ss_pred             cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence            64321  11    11223457888999999864    3456889999999999999999999998776643311   000


Q ss_pred             HHH-HHHHHHhccccccccCc---cccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 LEW-ARTMEARNKEIEMVDSN---ISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 ~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ... ...+.      +.++..   +.... =...+.+..+++...+..|+.+|.++.+++.
T Consensus       307 Cr~CQ~~LF------esIQEGkYeFPdkd-WahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  307 CRVCQNKLF------ESIQEGKYEFPDKD-WAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cHHHHHHHH------HHHhccCCcCChhh-hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            000 01111      111111   11111 1234678889999999999999999988765

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=281.31  Aligned_cols=247  Identities=25%  Similarity=0.315  Sum_probs=201.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .+.|+..++||+|+||.|+-+.. .+|+.+|.|.+.+...+   +....++|-.+|.+++.+.||.+-..|++.+..++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            46788889999999999999964 47999999998664433   345678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +..|+||+|.-+|.+.....             +++..++-++.+|+.||++||  +.+||+|||||+|||+|+.|+++|
T Consensus       264 LtlMNGGDLkfHiyn~g~~g-------------F~e~ra~FYAAEi~cGLehlH--~~~iVYRDLKPeNILLDd~GhvRI  328 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPG-------------FDEQRARFYAAEIICGLEHLH--RRRIVYRDLKPENILLDDHGHVRI  328 (591)
T ss_pred             EEeecCCceeEEeeccCCCC-------------CchHHHHHHHHHHHhhHHHHH--hcceeeccCChhheeeccCCCeEe
Confidence            99999999999998877533             999999999999999999999  899999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|.|+|..+....  ......||.+|||||++.+.. |+...|.|||||++|||+.|..||...-.-      ..|   .
T Consensus       329 SDLGLAvei~~g~--~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK------vk~---e  396 (591)
T KOG0986|consen  329 SDLGLAVEIPEGK--PIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEK------VKR---E  396 (591)
T ss_pred             eccceEEecCCCC--ccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhh------hhH---H
Confidence            9999998765433  334458999999999998655 899999999999999999999996421110      000   0


Q ss_pred             HHhccccccccCccc--cccCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 043074          317 EARNKEIEMVDSNIS--REELSEAGVREYFRIACMCTNEKSRERPAMS  362 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (373)
                              .+|....  ...+++..+++...+....|+.||++|.-.+
T Consensus       397 --------Evdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  397 --------EVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             --------HHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence                    0111110  1122455567889999999999999997543

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.1e-38  Score=284.12  Aligned_cols=247  Identities=28%  Similarity=0.393  Sum_probs=192.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      +.|+..+.||+|+||.||+|... ++..+++|.+.....   .....+.+|+.+++.++|+|++++.+++......++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34666788999999999999764 678899998864322   23456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+. |+|.+++.....              ++++.++..++.|++.|+.|||  +.+++||||+|+||+++.++.++|+
T Consensus        95 e~~~-~~l~~~~~~~~~--------------~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~kl~  157 (308)
T cd06634          95 EYCL-GSASDLLEVHKK--------------PLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLG  157 (308)
T ss_pred             EccC-CCHHHHHHHcCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHhEEECCCCcEEEC
Confidence            9995 688887754332              2888999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCC--CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |||++......     ....+++.|+|||.+.+  ....+.++|||||||++|+|++|..|+......       +....
T Consensus       158 dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~  225 (308)
T cd06634         158 DFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYH  225 (308)
T ss_pred             CcccceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------HHHHH
Confidence            99998764322     23457889999998742  234678999999999999999999996542111       01111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      ... .     ..+..    .....+..+.+++.+||+.+|.+||++.+++..
T Consensus       226 ~~~-~-----~~~~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         226 IAQ-N-----ESPAL----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             Hhh-c-----CCCCc----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            100 0     00111    122345679999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.9e-38  Score=278.61  Aligned_cols=248  Identities=27%  Similarity=0.373  Sum_probs=198.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  156 (373)
                      ++|.+.+.||+|+||.||++... ++..+++|++.+...   ...+.+.+|+.++++++ ||||+++++++.++...++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47888999999999999999764 789999999865322   23456788999999998 99999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      ||++++++|.+++....               .+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.+++
T Consensus        81 ~e~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~ql~~~l~~Lh--~~~~~H~dl~~~ni~i~~~~~~~l  143 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---------------SLDEKCTRFYAAEILLALEYLH--SKGIIHRDLKPENILLDKDMHIKI  143 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEe
Confidence            99999999999997654               2899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCC-------------------cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCC
Q 043074          237 SDFGLARRIDTSHS-------------------HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN  297 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~-------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  297 (373)
                      +|||++........                   .......++..|+|||...+ ...+.++|+||||++++++++|..|+
T Consensus       144 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~  222 (280)
T cd05581         144 TDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPF  222 (280)
T ss_pred             cCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCC
Confidence            99999986543221                   12223457889999998874 44788999999999999999999996


Q ss_pred             CCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHH
Q 043074          298 LPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM----SYVVQ  366 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~~l~~  366 (373)
                      .....      ... ......       ....     .+...+..+.+++.+||+.||.+||++    ++++.
T Consensus       223 ~~~~~------~~~-~~~~~~-------~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         223 RGSNE------YLT-FQKILK-------LEYS-----FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             CCccH------HHH-HHHHHh-------cCCC-----CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            53220      000 011100       0111     123335689999999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.6e-37  Score=271.18  Aligned_cols=251  Identities=25%  Similarity=0.399  Sum_probs=201.2

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +|...+.||.|+||.||++... ++..+++|.+.....  .....+.+|++.++.++|||++++.+.+..+...++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999764 689999999876543  3456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++.......           .++++.++..++.|++.||.|||  +.+++|+||+|+||++++++.++|+||
T Consensus        81 ~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lh--~~~~~H~dl~~~nil~~~~~~~~l~d~  147 (258)
T cd08215          81 ADGGDLSQKIKKQKKEG-----------KPFPEEQILDWFVQLCLALKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDF  147 (258)
T ss_pred             cCCCcHHHHHHHhhccC-----------CCcCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHHeEEcCCCcEEECCc
Confidence            99999999998753111           13899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |.+....... .......+++.|+|||.+.+. ..+.++|+||+|+++++|++|..|+....       ...........
T Consensus       148 ~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~  218 (258)
T cd08215         148 GISKVLSSTV-DLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-------LLELALKILKG  218 (258)
T ss_pred             cceeecccCc-ceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCc-------HHHHHHHHhcC
Confidence            9998754432 223335688899999998744 47889999999999999999999864321       11111111110


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       .     ..     ..+...+..+.+++.+||+.+|++||++.++++
T Consensus       219 -~-----~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         219 -Q-----YP-----PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -C-----CC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             0     11     112244568999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-38  Score=276.79  Aligned_cols=265  Identities=27%  Similarity=0.345  Sum_probs=195.9

Q ss_pred             CCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEEec
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      |.+.+.||.|++|.||+|... +++.+++|.+...... ......+|+..+.+++ |||++++++++.++...++|+||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999999875 5788999998654322 2234457899999998 999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                       +|+|.+++......             .+++.++..++.|++.+|.|||  +++++|+||+|+||++++++.++|+|||
T Consensus        81 -~~~l~~~~~~~~~~-------------~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~dl~~~ni~i~~~~~~~l~d~~  144 (283)
T cd07830          81 -EGNLYQLMKDRKGK-------------PFSESVIRSIIYQILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFG  144 (283)
T ss_pred             -CCCHHHHHHhcccc-------------cCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCCEEEeecc
Confidence             88999988765421             2899999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc---------ccHHH
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE---------VGLLE  311 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~---------~~~~~  311 (373)
                      .+........  .....++..|+|||.+.+...++.++|+||||+++|||++|..|+.........         .....
T Consensus       145 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (283)
T cd07830         145 LAREIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD  222 (283)
T ss_pred             cceeccCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhh
Confidence            9986543221  223457889999998866666788999999999999999998876432211100         00011


Q ss_pred             HHHHHHHhccccccccCcccc--ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISR--EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      |.............+......  .......+..+.+++.+||+.||++||+++|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            211111111110000000000  0001111467999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-38  Score=287.02  Aligned_cols=271  Identities=21%  Similarity=0.271  Sum_probs=197.8

Q ss_pred             ChHHHHHhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEee
Q 043074           73 SMSELIDATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCAS  149 (373)
Q Consensus        73 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  149 (373)
                      ...++....++|.+.+.||+|+||.||+|.. .++..||+|++.....  ...+.+.+|+.++++++||||+++.+++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            3456777889999999999999999999964 5789999999865322  234567889999999999999999998854


Q ss_pred             C------CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCC
Q 043074          150 G------LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKS  223 (373)
Q Consensus       150 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~  223 (373)
                      .      ...+++++++ +++|.+++....                +++..+..++.|++.||+|||  +.+++||||||
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~----------------l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp  148 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQK----------------LTDDHVQFLIYQILRGLKYIH--SADIIHRDLKP  148 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCh
Confidence            3      3467888877 889988876432                889999999999999999999  78999999999


Q ss_pred             CceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccC
Q 043074          224 SNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD  303 (373)
Q Consensus       224 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~  303 (373)
                      +||+++.++.+||+|||++.....    ......++..|+|||.+.+...++.++|||||||++|||++|..|+......
T Consensus       149 ~NIll~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~  224 (345)
T cd07877         149 SNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI  224 (345)
T ss_pred             HHEEEcCCCCEEEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999999999999999876432    1223457889999999876556788999999999999999999986432111


Q ss_pred             CCcccHHH--------HHHHHHH--hccccccccC--ccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          304 GQEVGLLE--------WARTMEA--RNKEIEMVDS--NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       304 ~~~~~~~~--------~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ........        .......  .......+..  ...........+..+.+++.+|++.||.+||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         225 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            00000000        0000000  0000000000  00000000112457899999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.9e-38  Score=283.83  Aligned_cols=267  Identities=24%  Similarity=0.298  Sum_probs=192.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCC------
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGL------  151 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  151 (373)
                      .++|++.+.||+|+||.||+|..+ +++.+++|.+......  ....+.+|+++++.++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999764 6899999988543322  1235678999999999999999999875433      


Q ss_pred             --eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          152 --DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       152 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                        ..++|+||+. ++|...+.....              .+++..+..++.|+++||.|||  +.+++|+||||+||+++
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~~--------------~~~~~~~~~i~~~l~~al~~lH--~~~i~H~dl~p~nil~~  149 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPSV--------------KLTESQIKCYMLQLLEGINYLH--ENHILHRDIKAANILID  149 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhcccc--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEC
Confidence              4689999995 577777764322              2899999999999999999999  78999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCc----------ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCC
Q 043074          230 SDFEAHISDFGLARRIDTSHSH----------VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP  299 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  299 (373)
                      +++.++|+|||+++........          ......+++.|+|||.+.+...++.++||||||+++|||++|..|+..
T Consensus       150 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~  229 (311)
T cd07866         150 NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             CCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999865432211          112235678899999987666678899999999999999999988643


Q ss_pred             cccCCCcccHHH---------HHHH---HHHhc-cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          300 VVLDGQEVGLLE---------WART---MEARN-KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       300 ~~~~~~~~~~~~---------~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .........+..         |...   ..... .........+.. . .......+.+++.+||+.||++|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         230 KSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-R-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHH-H-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            222110000000         0000   00000 000000000000 0 0112357889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.3e-37  Score=276.96  Aligned_cols=244  Identities=29%  Similarity=0.423  Sum_probs=191.1

Q ss_pred             CCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      |...+.||+|+||.||+|... ++..+++|.+......   ....+.+|+.+++.++|||++++++++.+....++|+||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566678999999999999754 6889999998653332   235678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +. |+|.+++.....              ++++.++..++.|++.|+.|||  +.+++|+||+|+||+++.++.++|+||
T Consensus       103 ~~-~~l~~~l~~~~~--------------~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dl~p~nili~~~~~~kL~df  165 (313)
T cd06633         103 CL-GSASDLLEVHKK--------------PLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADF  165 (313)
T ss_pred             CC-CCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChhhEEECCCCCEEEeec
Confidence            95 688887764332              3889999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCC--CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |++....     ......|+..|+|||.+.+  ...++.++||||||+++|||++|..|+.....       ........
T Consensus       166 g~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~  233 (313)
T cd06633         166 GSASKSS-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIA  233 (313)
T ss_pred             CCCcccC-----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHH
Confidence            9986432     1223567889999999842  34578899999999999999999999654321       11111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .. ..     +...    ....+..+.+++.+||+.+|.+||++.+++.
T Consensus       234 ~~-~~-----~~~~----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         234 QN-DS-----PTLQ----SNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             hc-CC-----CCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00 00     1110    1223457899999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.1e-38  Score=283.24  Aligned_cols=266  Identities=24%  Similarity=0.272  Sum_probs=196.0

Q ss_pred             HHhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEee-CCee
Q 043074           78 IDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCAS-GLDR  153 (373)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  153 (373)
                      ...+++|+..+.||.|+||.||++... +++.+++|.+.+..  ....+.+.+|+.+++.++|||++++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            446789999999999999999999654 78999999885432  2234567889999999999999999998865 5678


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++++||+ +++|.+++....                +++.....++.|++.||.|||  +.+++|+||+|+||++++++.
T Consensus        86 ~lv~e~~-~~~L~~~~~~~~----------------~~~~~~~~~~~ql~~aL~~LH--~~~iiH~dl~p~Nili~~~~~  146 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSRP----------------LEKQFIQYFLYQILRGLKYVH--SAGVVHRDLKPSNILINENCD  146 (328)
T ss_pred             EEEeehh-ccCHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEeECCCCC
Confidence            8999999 679988886432                778888899999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH----
Q 043074          234 AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL----  309 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~----  309 (373)
                      ++|+|||.+......    .....++..|+|||.+.+...++.++||||||+++|+|++|..|+............    
T Consensus       147 ~~l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~  222 (328)
T cd07856         147 LKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLL  222 (328)
T ss_pred             EEeCccccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999998754321    123456888999999865556788999999999999999999886432210000000    


Q ss_pred             ----HHHHHHHHHhccccccccCccccccC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          310 ----LEWARTMEARNKEIEMVDSNISREEL-----SEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       310 ----~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                          .+|...... ....+.+.........     ....+..+.+++.+||+.+|++||++.+++..
T Consensus       223 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         223 GTPPDDVINTICS-ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCCCHHHHHhccc-hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                001000000 0000000000000000     11234689999999999999999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.5e-38  Score=284.54  Aligned_cols=266  Identities=24%  Similarity=0.310  Sum_probs=196.6

Q ss_pred             HHHhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCC--
Q 043074           77 LIDATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGL--  151 (373)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--  151 (373)
                      ++...++|+..+.||+|+||.||++.. .++..||+|.+.....  .....+.+|+.+++.++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            455678999999999999999999964 4789999999854322  22346789999999999999999999886553  


Q ss_pred             ----eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceE
Q 043074          152 ----DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVL  227 (373)
Q Consensus       152 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nil  227 (373)
                          ..++|+||+ +++|.+++....                +++..+..++.|++.||+|||  +.+++||||||+||+
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~~----------------l~~~~~~~i~~qi~~al~~LH--~~gi~H~dlkp~Nil  150 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHEK----------------LSEDRIQFLVYQMLKGLKYIH--AAGIIHRDLKPGNLA  150 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEE
Confidence                458999999 789998886432                889999999999999999999  789999999999999


Q ss_pred             eCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcc
Q 043074          228 LDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV  307 (373)
Q Consensus       228 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  307 (373)
                      ++.++.++|+|||++......    .....+++.|+|||.+.+...++.++|+||||+++|+|++|..|+..........
T Consensus       151 l~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~  226 (343)
T cd07880         151 VNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLM  226 (343)
T ss_pred             EcCCCCEEEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999999765322    2234568899999998754557889999999999999999999975432110000


Q ss_pred             c--------HHHHHHHHHHhc--cccccccCccccc---cCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          308 G--------LLEWARTMEARN--KEIEMVDSNISRE---ELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       308 ~--------~~~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .        ...|........  .....+. .....   ......+..+.+++.+|++.||++|||+.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         227 EIMKVTGTPSKEFVQKLQSEDAKNYVKKLP-RFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHhcCCCCHHHHHhhcchhHHHHHHhcc-ccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0        000100000000  0000000 00000   001223457899999999999999999999883

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.7e-39  Score=267.03  Aligned_cols=207  Identities=26%  Similarity=0.332  Sum_probs=171.7

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC---C--CCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEee-CC
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS---S--GVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCAS-GL  151 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~  151 (373)
                      ....|+....||+|.||.||++.-+   +  ...+|+|+++.....  .-....+|+..++.++|||++.+..++.+ +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3457888999999999999999432   2  347899999654322  12356789999999999999999999877 78


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..++++||.+. +|...|+.++....          ..++-..+.+++-||+.|+.|||  ++-++||||||.|||+..+
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~----------~~lp~~mvKsilwQil~Gv~YLH--~NWvlHRDLKPaNIlvmgd  168 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKA----------KQLPRSMVKSILWQILDGVHYLH--SNWVLHRDLKPANILVMGD  168 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchh----------ccCCHHHHHHHHHHHHhhhHHHh--hhheeeccCCcceEEEecc
Confidence            89999999955 88888877654322          13888999999999999999999  7899999999999999877


Q ss_pred             ----CceEEeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCC
Q 043074          232 ----FEAHISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP  299 (373)
Q Consensus       232 ----~~~kl~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  299 (373)
                          |.|||+|||+++.+..+-..  .....+-|.+|.|||.+.|...|+.+.||||.||++.||+|-.+-|..
T Consensus       169 gperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  169 GPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             CCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence                89999999999988655322  234567799999999999999999999999999999999997665543

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.2e-37  Score=282.26  Aligned_cols=266  Identities=22%  Similarity=0.247  Sum_probs=189.7

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-C--CCEEEEEEeCcccc--ccHHHHHHHHHHHhcC-CCCCccceeeEEeeC----Ce
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-S--GVTVAIKKLDKDAF--QGFREFRAEMETLGKL-RHRNIVKILGYCASG----LD  152 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~  152 (373)
                      +|.+.+.||+|+||.||++... +  +..+|+|.+.....  ...+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999764 3  77899999864322  2245678899999999 599999999875432    45


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .+++++|+ +++|.+++....               .+++..+..++.|++.||.|||  +.+++||||||+||+++.++
T Consensus        81 ~~~~~e~~-~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~aL~~LH--~~givH~dlkp~Nili~~~~  142 (332)
T cd07857          81 LYLYEELM-EADLHQIIRSGQ---------------PLTDAHFQSFIYQILCGLKYIH--SANVLHRDLKPGNLLVNADC  142 (332)
T ss_pred             EEEEEecc-cCCHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHeEEcCCC
Confidence            67888888 478999886543               2889999999999999999999  89999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCc---ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc-
Q 043074          233 EAHISDFGLARRIDTSHSH---VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG-  308 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-  308 (373)
                      .++|+|||+++........   ......|+..|+|||.+.+...++.++||||||+++|+|++|..|+........... 
T Consensus       143 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~  222 (332)
T cd07857         143 ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQI  222 (332)
T ss_pred             CEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHH
Confidence            9999999999865432211   122346889999999887656678899999999999999999988654221100000 


Q ss_pred             -------HHHHHHHHHHhc--ccccccc--CccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          309 -------LLEWARTMEARN--KEIEMVD--SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       309 -------~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                             ..++........  .......  +...........+..+.+++.+||+.||++|||+.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         223 LQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                   000000000000  0000000  000000001112457999999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1e-37  Score=272.25  Aligned_cols=249  Identities=24%  Similarity=0.360  Sum_probs=198.7

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +|++.+.||.|+||.||++..+ ++..+++|.+.....  .....+.+|+.+++.++|+||+++.+++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778889999999999999654 788999999865432  2345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++.......           ..+++..+..++.|++.||.|||  +.+++|+||+|+||++++++.+||+||
T Consensus        81 ~~~~~L~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~al~~lh--~~~i~h~~l~~~ni~~~~~~~~kl~d~  147 (256)
T cd08530          81 APFGDLSKAISKRKKKR-----------KLIPEQEIWRIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDL  147 (256)
T ss_pred             cCCCCHHHHHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEEecCCcEEEeec
Confidence            99999999987633211           13889999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++......   ......++..|+|||.+.+ ..++.++|+||||+++|||++|..|+.....       ........ .
T Consensus       148 g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~-~  215 (256)
T cd08530         148 GISKVLKKN---MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSM-------QDLRYKVQ-R  215 (256)
T ss_pred             cchhhhccC---CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHh-c
Confidence            999876443   2223457889999999874 4477899999999999999999999643211       01111110 0


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                               . .....+...+.++.+++.+||+.+|++||++.++++
T Consensus       216 ---------~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         216 ---------G-KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ---------C-CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                     0 001113355678999999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-38  Score=277.69  Aligned_cols=264  Identities=25%  Similarity=0.322  Sum_probs=196.4

Q ss_pred             CCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      |+..+.||+|++|.||+|... +++.+++|.+....  ....+.+..|+.++++++|+|++++++++.+....++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456678999999999999765 58999999987653  223456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      + ++|.+++.....              .+++..+..++.|++.||.|||  +.+++|+||+|+||++++++.++|+|||
T Consensus        81 ~-~~l~~~i~~~~~--------------~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~~l~~~ni~~~~~~~~~l~d~g  143 (282)
T cd07829          81 D-MDLKKYLDKRPG--------------PLSPNLIKSIMYQLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFG  143 (282)
T ss_pred             C-cCHHHHHHhhcc--------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChheEEEcCCCCEEEecCC
Confidence            6 699999986531              2899999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH---------HH
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL---------LE  311 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~---------~~  311 (373)
                      .+........ ......++..|+|||.+.+...++.++||||||+++|||++|..|+............         ..
T Consensus       144 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
T cd07829         144 LARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES  222 (282)
T ss_pred             cccccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHH
Confidence            9987543322 1223345778999999876656888999999999999999998876432211000000         00


Q ss_pred             HHHHHHH--hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEA--RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      |......  ................ ....+..+.+++.+||+.||++||++.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         223 WPGVTKLPDYKPTFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HHhhcccccccccccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000000  0000000000000011 1112568999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=268.70  Aligned_cols=243  Identities=23%  Similarity=0.302  Sum_probs=198.9

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccH---HHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF---REFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ..++|...++||+|.||.|.+++-+ +++.+|+|++++...-..   ..-+.|-.+|+..+||.+..+...|.+.+..|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3478999999999999999999654 799999999987655432   234568889999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||..||.|.-++.....               +++....-+-..|..||.|||  +++|++||||.+|.|+|.+|++|
T Consensus       246 VMeyanGGeLf~HLsrer~---------------FsE~RtRFYGaEIvsAL~YLH--s~~ivYRDlKLENLlLDkDGHIK  308 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRERV---------------FSEDRTRFYGAEIVSALGYLH--SRNIVYRDLKLENLLLDKDGHIK  308 (516)
T ss_pred             EEEEccCceEeeehhhhhc---------------ccchhhhhhhHHHHHHhhhhh--hCCeeeeechhhhheeccCCceE
Confidence            9999999999998877553               788888888899999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||+++.- -.........+|||.|+|||++..+ .|..+.|.|-+||++|||++|+.||+...-+    .+.+..-.
T Consensus       309 itDFGLCKE~-I~~g~t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~----kLFeLIl~  382 (516)
T KOG0690|consen  309 ITDFGLCKEE-IKYGDTTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE----KLFELILM  382 (516)
T ss_pred             eeecccchhc-ccccceeccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchh----HHHHHHHh
Confidence            9999999863 2344556779999999999999854 5899999999999999999999998753221    11111100


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA  360 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (373)
                                -+-+     ++....++...++...|..||.+|.-
T Consensus       383 ----------ed~k-----FPr~ls~eAktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  383 ----------EDLK-----FPRTLSPEAKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             ----------hhcc-----CCccCCHHHHHHHHHHhhcChHhhcC
Confidence                      0111     14455668899999999999999953

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=270.17  Aligned_cols=261  Identities=26%  Similarity=0.325  Sum_probs=190.1

Q ss_pred             CCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcC---CCCCccceeeEEeeCCe-----
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKL---RHRNIVKILGYCASGLD-----  152 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----  152 (373)
                      |++.+.||+|+||.||+|..+ ++..+|+|.+......  ....+.+|+.++.++   +|||++++++++.+...     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            566789999999999999876 5899999999643322  123456777776665   69999999999988776     


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++++||+. ++|.+++......             .+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~-------------~l~~~~~~~~~~~i~~al~~LH--~~~i~h~~l~~~nili~~~~  144 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKP-------------GLPPETIKDLMRQLLRGVDFLH--SHRIVHRDLKPQNILVTSDG  144 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhEEEccCC
Confidence            899999996 5899988764422             2899999999999999999999  78999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      .++|+|||++.......  ......++..|+|||.+.+. .++.++|+||||+++|||++|.+|+.......   ....+
T Consensus       145 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~  218 (287)
T cd07838         145 QVKIADFGLARIYSFEM--ALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKI  218 (287)
T ss_pred             CEEEeccCcceeccCCc--ccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHH
Confidence            99999999997754322  11233468889999998754 47889999999999999999987754322110   11111


Q ss_pred             HHHHHHhccc---------cccccCcccc--ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          313 ARTMEARNKE---------IEMVDSNISR--EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       313 ~~~~~~~~~~---------~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..........         ..........  .......+..+.+++.+||+.||++||++.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         219 FDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            1100000000         0000000000  0112234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-37  Score=282.58  Aligned_cols=263  Identities=24%  Similarity=0.330  Sum_probs=191.2

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeC-----
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASG-----  150 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  150 (373)
                      ...++|...+.||+|+||.||+|.. .++..||+|.+.....  .....+.+|+.+++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            3457899999999999999999975 4689999999865322  2234678999999999999999999988654     


Q ss_pred             -CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          151 -LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       151 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                       ...++|+||+. .+|..+...                 .+++..+..++.|++.||+|||  +.+++||||||+||+++
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~-----------------~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dlkp~NIll~  151 (342)
T cd07879          92 FQDFYLVMPYMQ-TDLQKIMGH-----------------PLSEDKVQYLVYQMLCGLKYIH--SAGIIHRDLKPGNLAVN  151 (342)
T ss_pred             CceEEEEecccc-cCHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEC
Confidence             34689999995 477766521                 1888999999999999999999  78999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          230 SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      .++.++|+|||+++.....    .....++..|+|||.+.+...++.++||||||+++|||++|..||............
T Consensus       152 ~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~  227 (342)
T cd07879         152 EDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI  227 (342)
T ss_pred             CCCCEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999999998764321    223457889999999876555788999999999999999999997543211000000


Q ss_pred             --------HHHHHHHHHh--ccccccccCccccccC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 --------LEWARTMEAR--NKEIEMVDSNISREEL---SEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 --------~~~~~~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                              ..+.......  ....... +.......   ....+..+.+++.+||+.||++||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         228 LKVTGVPGPEFVQKLEDKAAKSYIKSL-PKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HHhcCCCCHHHHHHhcccchHHHHhhc-CCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    0000000000  0000000 00000000   0123457889999999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=244.38  Aligned_cols=266  Identities=22%  Similarity=0.311  Sum_probs=202.8

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +|.-.++||+|.||+||+|+. .+++.||+|.+..+...  .-....+|+-+++.++|.|||+++++...+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            455567899999999999964 46889999998654332  235678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      | ..+|..|.......              ++.+...+++.|+++||.|+|  ++++.|||+||.|.+|+.+|+.|++||
T Consensus        83 c-dqdlkkyfdslng~--------------~d~~~~rsfmlqllrgl~fch--shnvlhrdlkpqnllin~ngelkladf  145 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNGD--------------LDPEIVRSFMLQLLRGLGFCH--SHNVLHRDLKPQNLLINRNGELKLADF  145 (292)
T ss_pred             h-hHHHHHHHHhcCCc--------------CCHHHHHHHHHHHHhhhhhhh--hhhhhhccCCcceEEeccCCcEEeccc
Confidence            9 66899888776543              888999999999999999999  788999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |+++.++.+-... +...-|.+|.+|.++.|.+-|+...|+||-||++.|+...+.|.+|......+..-+-|.-.....
T Consensus       146 glarafgipvrcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~e  224 (292)
T KOG0662|consen  146 GLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  224 (292)
T ss_pred             chhhhcCCceEee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcc
Confidence            9999887654333 334568999999999998889999999999999999999999977654433222212221111111


Q ss_pred             cc--c-cccccCccccc--------cCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NK--E-IEMVDSNISRE--------ELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~--~-~~~~~~~~~~~--------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..  . .+..|......        ++-......-++++...+.-+|.+|.+++..++
T Consensus       225 d~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  225 DQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            00  0 11111111110        111222334567888888899999999998765

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-38  Score=285.19  Aligned_cols=265  Identities=23%  Similarity=0.284  Sum_probs=195.1

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe---
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASGLD---  152 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  152 (373)
                      ...++|+..+.||+|++|.||+|... ++..||+|.+....  ......+.+|+.+++.++|||++++.+++.....   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999765 68899999986532  2234567789999999999999999998766554   


Q ss_pred             ---eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          153 ---RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       153 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                         .++|+||+ +++|.+++....                +++..+..++.|++.||.|||  +.+++|+||+|+||+++
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~~----------------l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nill~  152 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQK----------------LSDDHIQFLVYQILRGLKYIH--SAGIIHRDLKPSNIAVN  152 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEC
Confidence               89999999 779999887532                899999999999999999999  78999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          230 SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      +++.++|+|||++......    .....++..|+|||.+.+...++.++||||||+++|||++|..||...........+
T Consensus       153 ~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i  228 (343)
T cd07851         153 EDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI  228 (343)
T ss_pred             CCCCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            9999999999999865332    223457888999999865556788999999999999999999986432211000000


Q ss_pred             HH--------HHHHHHHh--ccccccccCcccc--ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 LE--------WARTMEAR--NKEIEMVDSNISR--EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 ~~--------~~~~~~~~--~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .+        +.......  ......+...-..  .......+..+.+++.+||+.||++|||+.+|++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         229 MNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            00        00000000  0000000000000  0000112568999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=302.36  Aligned_cols=258  Identities=23%  Similarity=0.237  Sum_probs=210.2

Q ss_pred             HHHHHhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeC
Q 043074           75 SELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASG  150 (373)
Q Consensus        75 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  150 (373)
                      .++....++|.+.++||+|+||.|..++.+ +++.||+|++++..   ...-.-|..|-.+|..-+.+=|++++-.|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344556789999999999999999999764 68899999998732   22345688999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      .+.|+||||++||+|-.++.+...               +++..+.-++..|.-||.-||  +.|+|||||||+|||+|.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~~---------------~pE~~ArFY~aEiVlAldslH--~mgyVHRDiKPDNvLld~  210 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFDR---------------LPEDWARFYTAEIVLALDSLH--SMGYVHRDIKPDNVLLDK  210 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcCC---------------ChHHHHHHHHHHHHHHHHHHH--hccceeccCCcceeEecc
Confidence            999999999999999999987762               889999999999999999999  789999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCcccccccccccccCccccCC---C-CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          231 DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG---N-TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                      .|++||+|||.|..+...+.-.+...+|||.|.+||++..   . ..|+..+|.||+||++|||+.|.-||+.....   
T Consensus       211 ~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv---  287 (1317)
T KOG0612|consen  211 SGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV---  287 (1317)
T ss_pred             cCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH---
Confidence            9999999999999998777777777899999999999852   2 56899999999999999999999999864322   


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHH
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA---MSYVV  365 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~~l~  365 (373)
                          +........       ...+..+. ..+.+.+..+||++.+. +|+.|..   ++++-
T Consensus       288 ----eTY~KIm~h-------k~~l~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  288 ----ETYGKIMNH-------KESLSFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             ----HHHHHHhch-------hhhcCCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence                221111111       11121111 23467789999998885 6777776   55553

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-40  Score=266.59  Aligned_cols=259  Identities=27%  Similarity=0.337  Sum_probs=197.3

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ++.+....||.|+||+|+|-.++ +|+..|||++..... ....+++.|.+...+- ++||||+++|.+-..+..|+.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            34455678999999999999654 799999999977655 4567788898875555 69999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      .| .-||..+...-..-.          ...+++.-.-.|......||.||.. ...|+|||+||+|||++..|.+||+|
T Consensus       144 LM-d~SlDklYk~vy~vq----------~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILldr~G~vKLCD  211 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYSVQ----------KSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILLDRHGDVKLCD  211 (361)
T ss_pred             HH-hhhHHHHHHHHHHHH----------hccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEEecCCCEeeec
Confidence            99 567766554321100          0127777777888888999999986 66799999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCC-CCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTA-ATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      ||.+..+..+.  ..+.-.|...|||||.+..... ++-+|||||||++|+|+.||..|+.            .|...+.
T Consensus       212 FGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr------------~w~svfe  277 (361)
T KOG1006|consen  212 FGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR------------KWDSVFE  277 (361)
T ss_pred             ccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc------------hHHHHHH
Confidence            99998765432  2233457788999999975444 8899999999999999999999954            3444444


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      +...+...=.+.+..+.-..+....+..++..|+.+|-++||++.++.+
T Consensus       278 ql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  278 QLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            3333322222222222223345668999999999999999999998875

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-38  Score=258.99  Aligned_cols=253  Identities=21%  Similarity=0.265  Sum_probs=194.8

Q ss_pred             hcCCCCCC-CeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEeeC----Ce
Q 043074           80 ATDNFSTD-KIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCASG----LD  152 (373)
Q Consensus        80 ~~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~  152 (373)
                      .+++|++. ++||-|-.|.|..+.. .+++.+|+|++...     ...++|++..-.. .|||||.+++++.+.    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45677664 5899999999999965 47999999998543     3457888876555 599999999988543    45


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC--
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS--  230 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~--  230 (373)
                      ..+|||.|+||.|.+.+.+....             ++++.++..|++||+.|+.|||  ..+|.||||||+|+|...  
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~-------------afTErea~eI~~qI~~Av~~lH--~~nIAHRDlKpENLLyt~t~  198 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQ-------------AFTEREASEIMKQIGLAVRYLH--SMNIAHRDLKPENLLYTTTS  198 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccc-------------cchHHHHHHHHHHHHHHHHHHH--hcchhhccCChhheeeecCC
Confidence            67899999999999999887754             3999999999999999999999  688999999999999964  


Q ss_pred             -CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          231 -DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       231 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                       +..+||+|||+|+....  .......+-||.|.|||++. ...|+...|+||+||++|-|++|.+||++........++
T Consensus       199 ~na~lKLtDfGFAK~t~~--~~~L~TPc~TPyYvaPevlg-~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgM  275 (400)
T KOG0604|consen  199 PNAPLKLTDFGFAKETQE--PGDLMTPCFTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM  275 (400)
T ss_pred             CCcceEecccccccccCC--CccccCCcccccccCHHHhC-chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhH
Confidence             45799999999987543  22344567899999999996 455889999999999999999999999875432211111


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                          +.-...      -...+..+. =...++...++|+.+|..+|.+|.|+++++.
T Consensus       276 ----k~rI~~------gqy~FP~pE-Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  276 ----KRRIRT------GQYEFPEPE-WSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             ----HhHhhc------cCccCCChh-HhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence                110000      000111111 1234678899999999999999999999875

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-36  Score=266.31  Aligned_cols=250  Identities=25%  Similarity=0.309  Sum_probs=190.8

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc-----cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA-----FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      +|.+.+.||+|+||.||++... .+..+++|.++...     ......+..|+.+++.++|||++++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5788899999999999999764 34445555554321     11233566789999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +||+++++|.+++.......           ..+++..++.++.|++.||.|||  +.+++|+||+|+||++++ +.++|
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~~l~~~nili~~-~~~~l  146 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTG-----------KTLSENQVCEWFIQLLLGVHYMH--QRRILHRDLKAKNIFLKN-NLLKI  146 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcc-----------cccCHHHHHHHHHHHHHHHHHHH--HcCccccCCChhheEeec-CCEee
Confidence            99999999999987532211           13899999999999999999999  799999999999999975 56999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||.+....... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..|+....       ........
T Consensus       147 ~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~  217 (260)
T cd08222         147 GDFGVSRLLMGSC-DLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRI  217 (260)
T ss_pred             cccCceeecCCCc-ccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHH
Confidence            9999987653322 12233457889999999864 446778999999999999999999864311       11111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..      ...+     ..+...+.++.+++.+||+.||++||++.++++
T Consensus       218 ~~------~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         218 VE------GPTP-----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             Hc------CCCC-----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            10      0111     113455678999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=283.68  Aligned_cols=262  Identities=28%  Similarity=0.430  Sum_probs=212.8

Q ss_pred             cChHHHHHhcCCCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEe-
Q 043074           72 ISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCA-  148 (373)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-  148 (373)
                      +.++.+.+.++.|++.+.||.|.+|.||+++ .++++..|+|+.......+ +++..|.++++.. .|||++.++|++. 
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            4455556678899999999999999999996 4578889999987665443 6677889999988 5999999999984 


Q ss_pred             ----eCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCC
Q 043074          149 ----SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS  224 (373)
Q Consensus       149 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~  224 (373)
                          .++.+|||||||.+||..++++.....             .+.|..+.-|++.++.|+.+||  ++.++|||+|-.
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~-------------rl~E~~IaYI~re~lrgl~HLH--~nkviHRDikG~  152 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGN-------------RLKEEWIAYILREILRGLAHLH--NNKVIHRDIKGQ  152 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhccc-------------chhhHHHHHHHHHHHHHHHHHh--hcceeeecccCc
Confidence                457899999999999999999887633             2899999999999999999999  888999999999


Q ss_pred             ceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCC----CCCCccccchhhhHHHHHHHhCCCCCCCc
Q 043074          225 NVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN----TAATVMLDVYSFGILMIEIATQIRPNLPV  300 (373)
Q Consensus       225 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~el~~g~~p~~~~  300 (373)
                      |||++.++.|||.|||.+....... .......|||.|||||++...    ..|+..+|+||||++..||.-|.+|+.+.
T Consensus       153 NiLLT~e~~VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm  231 (953)
T KOG0587|consen  153 NVLLTENAEVKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM  231 (953)
T ss_pred             eEEEeccCcEEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence            9999999999999999998875432 334557899999999998642    34577899999999999999999996553


Q ss_pred             ccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....          .+.   .+.+...+++.+   +.....++.++|..||..|.++||++.++++
T Consensus       232 HPmr----------aLF---~IpRNPPPkLkr---p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  232 HPMR----------ALF---LIPRNPPPKLKR---PKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             chhh----------hhc---cCCCCCCccccc---hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            3221          111   122222333332   5667789999999999999999999999875

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-36  Score=261.12  Aligned_cols=236  Identities=26%  Similarity=0.322  Sum_probs=189.5

Q ss_pred             eecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCH
Q 043074           90 IGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL  165 (373)
Q Consensus        90 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  165 (373)
                      ||.|+||.||++... +++.+++|.+......   ....+..|+.+++.++|||++++++.+.++...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999765 5899999998765433   345788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecccccc
Q 043074          166 DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI  245 (373)
Q Consensus       166 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  245 (373)
                      .+++....               .+++.....++.|++.|+.|||  +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~~~l~~~~---------------~l~~~~~~~~~~qi~~~l~~lh--~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  143 (250)
T cd05123          81 FSHLSKEG---------------RFSEERARFYAAEIVLALEYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKEL  143 (250)
T ss_pred             HHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcceEEEcCCCcEEEeecCcceec
Confidence            99997654               2889999999999999999999  799999999999999999999999999999875


Q ss_pred             CCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcccccc
Q 043074          246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEM  325 (373)
Q Consensus       246 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (373)
                      .... .......++..|+|||...+. ..+.++|+||||+++|++++|..|+.....       .........       
T Consensus       144 ~~~~-~~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~-------  207 (250)
T cd05123         144 SSEG-SRTNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILK-------  207 (250)
T ss_pred             ccCC-CcccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhc-------
Confidence            4321 122345678899999998754 367889999999999999999999643211       111111110       


Q ss_pred             ccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 043074          326 VDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY  363 (373)
Q Consensus       326 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~  363 (373)
                        ...   ..+...+..+.+++.+||..||++||++.+
T Consensus       208 --~~~---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         208 --DPL---RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             --CCC---CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence              001   112233568899999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-37  Score=279.27  Aligned_cols=240  Identities=23%  Similarity=0.302  Sum_probs=194.2

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .++.|.....+|.|+|+.|-.+.. .+++..++|++.+...    +..+|+.++... +||||+++.+.+.++.+.++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            467888888999999999998854 5788999999977632    234677666555 6999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe-CCCCceEE
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL-DSDFEAHI  236 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill-~~~~~~kl  236 (373)
                      |.+.++-+.+.+.....               +. .++..|+.+|+.|+.|||  .+|++||||||+|||+ ++.++++|
T Consensus       396 e~l~g~ell~ri~~~~~---------------~~-~e~~~w~~~lv~Av~~LH--~~gvvhRDLkp~NIL~~~~~g~lrl  457 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE---------------FC-SEASQWAAELVSAVDYLH--EQGVVHRDLKPGNILLDGSAGHLRL  457 (612)
T ss_pred             hhccccHHHHHHHhcch---------------hH-HHHHHHHHHHHHHHHHHH--hcCeeecCCChhheeecCCCCcEEE
Confidence            99999988877765542               33 788889999999999999  7999999999999999 68999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||.++....+    ....+-|..|.|||++. ...+++++|+||||++||+|++|+.|+.....+      .+     
T Consensus       458 tyFG~a~~~~~~----~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~e-----  521 (612)
T KOG0603|consen  458 TYFGFWSELERS----CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IE-----  521 (612)
T ss_pred             EEechhhhCchh----hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HH-----
Confidence            999999876543    22335578899999998 566999999999999999999999996543322      11     


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                               +..++.........+.+..+|+.+||+.||.+||++.++..
T Consensus       522 ---------i~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  522 ---------IHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ---------HHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                     11112222224566779999999999999999999999864

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.9e-36  Score=291.91  Aligned_cols=145  Identities=30%  Similarity=0.434  Sum_probs=129.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|.+.+.||+|+||.||+|... +++.||+|++......   ....+..|+.++..++||||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999765 6899999998654322   2356788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+.+++|.+++.....               +++..++.++.||+.||.|||  ..+|+||||||+|||++.++.+||+
T Consensus        84 Ey~~g~~L~~li~~~~~---------------l~~~~~~~i~~qil~aL~yLH--~~gIiHrDLKP~NILl~~~g~vkL~  146 (669)
T cd05610          84 EYLIGGDVKSLLHIYGY---------------FDEEMAVKYISEVALALDYLH--RHGIIHRDLKPDNMLISNEGHIKLT  146 (669)
T ss_pred             eCCCCCCHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHH--hCCEEeCCccHHHEEEcCCCCEEEE
Confidence            99999999999975432               788899999999999999999  7899999999999999999999999


Q ss_pred             eecccc
Q 043074          238 DFGLAR  243 (373)
Q Consensus       238 Dfg~~~  243 (373)
                      |||+++
T Consensus       147 DFGls~  152 (669)
T cd05610         147 DFGLSK  152 (669)
T ss_pred             eCCCCc
Confidence            999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=6.5e-36  Score=257.82  Aligned_cols=219  Identities=21%  Similarity=0.161  Sum_probs=173.1

Q ss_pred             CCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCHHHHhhc
Q 043074           93 GSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHD  171 (373)
Q Consensus        93 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  171 (373)
                      |.+|.||++.. .+++.+|+|.+....     .+.+|...+....|||++++++++.+....+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999965 478999999997643     223455555556799999999999999999999999999999999875


Q ss_pred             CCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCc
Q 043074          172 TSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH  251 (373)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  251 (373)
                      ..               ++++..+..++.|++.||.|||  +++++||||||+||+++.++.++++|||.+......   
T Consensus        79 ~~---------------~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---  138 (237)
T cd05576          79 FL---------------NIPEECVKRWAAEMVVALDALH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---  138 (237)
T ss_pred             hc---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---
Confidence            43               2889999999999999999999  899999999999999999999999999988665322   


Q ss_pred             ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccc
Q 043074          252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNIS  331 (373)
Q Consensus       252 ~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (373)
                       .....++..|+|||.+.+ ..++.++|+||+|+++|||++|..|+.......               .   .....   
T Consensus       139 -~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~---~~~~~---  195 (237)
T cd05576         139 -CDGEAVENMYCAPEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------N---THTTL---  195 (237)
T ss_pred             -cccCCcCccccCCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------c---ccccc---
Confidence             122345678999999864 346889999999999999999987743211100               0   00000   


Q ss_pred             cccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          332 REELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                        ..+...+..+.+++.+||+.||++||++
T Consensus       196 --~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         196 --NIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             --CCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence              0123345689999999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4e-37  Score=272.36  Aligned_cols=243  Identities=27%  Similarity=0.341  Sum_probs=190.4

Q ss_pred             CCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCC
Q 043074           87 DKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENG  163 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  163 (373)
                      .++||+|.||+||-|+. ++|+.||||++++...  +...++++|+.+|+++.||.||.+...|++.+..++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            47899999999999964 5899999999977544  34578999999999999999999999999999999999999544


Q ss_pred             CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC---CceEEeeec
Q 043074          164 SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD---FEAHISDFG  240 (373)
Q Consensus       164 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg  240 (373)
                      =|+-.+.....              .+++..-.-+..||+.||.|||  .++|+|+||||+|||+.+.   .++||+|||
T Consensus       649 MLEMILSsEkg--------------RL~er~TkFlvtQIL~ALr~LH--~knIvHCDLKPENVLLas~~~FPQvKlCDFG  712 (888)
T KOG4236|consen  649 MLEMILSSEKG--------------RLPERITKFLVTQILVALRYLH--FKNIVHCDLKPENVLLASASPFPQVKLCDFG  712 (888)
T ss_pred             HHHHHHHhhcc--------------cchHHHHHHHHHHHHHHHHHhh--hcceeeccCCchheeeccCCCCCceeecccc
Confidence            44444444333              2888888889999999999999  8999999999999999654   579999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      .|+.++..  .......|||.|+|||++. ++.|...-|+||.||++|--++|.-||........+            ..
T Consensus       713 fARiIgEk--sFRrsVVGTPAYLaPEVLr-nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ------------IQ  777 (888)
T KOG4236|consen  713 FARIIGEK--SFRRSVVGTPAYLAPEVLR-NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ------------IQ  777 (888)
T ss_pred             ceeecchh--hhhhhhcCCccccCHHHHh-hccccccccceeeeEEEEEEecccccCCCccchhHH------------hh
Confidence            99987643  3445678999999999998 566888999999999999999999997543221111            01


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVV  365 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~  365 (373)
                      +...++.+.-     =.+...+..++|...|+..-++|-+...-+
T Consensus       778 NAaFMyPp~P-----W~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  778 NAAFMYPPNP-----WSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             ccccccCCCc-----hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            1111111110     123345778888889999888888876654

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=263.47  Aligned_cols=256  Identities=25%  Similarity=0.381  Sum_probs=197.5

Q ss_pred             CCCCCCCeeecCCCceEEEE-EeCCCCEEEEEEeCcccc-cc------HHHHHHHHHHHhcCCCCCccceeeEEe-eCCe
Q 043074           82 DNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAF-QG------FREFRAEMETLGKLRHRNIVKILGYCA-SGLD  152 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~-~~------~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~  152 (373)
                      ++|-+.++||+|+|+.||++ ++...+.||+|+-..+.. .+      .+...+|..+.+.|+||.||++++++. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            46677789999999999999 556788999998532221 11      234678999999999999999999985 5567


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC--
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS--  230 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~--  230 (373)
                      +|-|+|||+|.+|+-||.+++.               +++.++..|+.||+.||.||...+.+|+|-||||.|||+.+  
T Consensus       543 FCTVLEYceGNDLDFYLKQhkl---------------mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt  607 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKL---------------MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT  607 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhh---------------hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence            8899999999999999998874               89999999999999999999988899999999999999954  


Q ss_pred             -CCceEEeeeccccccCCCCCc------ccccccccccccCccccC-C--CCCCCccccchhhhHHHHHHHhCCCCCCCc
Q 043074          231 -DFEAHISDFGLARRIDTSHSH------VSTQVAGTMGYMPPEYLG-G--NTAATVMLDVYSFGILMIEIATQIRPNLPV  300 (373)
Q Consensus       231 -~~~~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~-~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~  300 (373)
                       -|.+||+|||+++.+......      ......||.+|++||.+. +  .+..+.+.||||+||++|.++.|+.||...
T Consensus       608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence             478999999999988543222      234467999999999875 2  456788999999999999999999997543


Q ss_pred             ccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 043074          301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVV  365 (373)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~  365 (373)
                      ....   .+++       .+.+.+.-...+..   -+....+...+|++||+.--++|....++.
T Consensus       688 qsQQ---dILq-------eNTIlkAtEVqFP~---KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  688 QSQQ---DILQ-------ENTILKATEVQFPP---KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hhHH---HHHh-------hhchhcceeccCCC---CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            2221   1111       11122111111111   223455889999999999988898877764

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=261.77  Aligned_cols=242  Identities=24%  Similarity=0.309  Sum_probs=194.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccccc---HHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQG---FREFRAEMETLGKL-RHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  155 (373)
                      ..+|....+||+|+||.|.++..+ +.+.+|||+++++..-.   .+--..|-.+|... +-|.+++++.++.+-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            347888899999999999999654 57789999998765432   23334567777766 47889999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||+.||+|--++++...               +.+..+.-++..|+-||-+||  +++|++||||.+|||++.+|++|
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk---------------FKEp~AvFYAaEiaigLFFLh--~kgIiYRDLKLDNvmLd~eGHiK  490 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK---------------FKEPVAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIK  490 (683)
T ss_pred             EEEEecCchhhhHHHHhcc---------------cCCchhhhhhHHHHHHhhhhh--cCCeeeeeccccceEeccCCceE
Confidence            9999999999999988764               777888889999999999999  89999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||+++..-. ......+.+|||.|+|||++. .++|+.+.|.|||||+||||+.|++||.....++    +..   .
T Consensus       491 i~DFGmcKEni~-~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e----lF~---a  561 (683)
T KOG0696|consen  491 IADFGMCKENIF-DGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----LFQ---A  561 (683)
T ss_pred             eeeccccccccc-CCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH----HHH---H
Confidence            999999986432 234456689999999999997 6679999999999999999999999976533221    111   1


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA  360 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (373)
                      .... +           -.++...+.+...+....+..+|.+|.-
T Consensus       562 I~eh-n-----------vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  562 IMEH-N-----------VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHHc-c-----------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence            1110 0           0114445667888888999999999954

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.3e-35  Score=279.61  Aligned_cols=276  Identities=18%  Similarity=0.252  Sum_probs=171.9

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-C----CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeE------Ee
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-S----GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGY------CA  148 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~  148 (373)
                      ..++|.+.+.||+|+||.||+|... +    +..||+|++......  +....|  .+....+.+++.+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999764 4    689999987543221  111111  1222223333322221      24


Q ss_pred             eCCeeEEEEEecCCCCHHHHhhcCCCCCCCCc-----ccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCC
Q 043074          149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG-----SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKS  223 (373)
Q Consensus       149 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~-----~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~  223 (373)
                      .+...++|+||+.+++|.+++...........     ..............+..++.|++.||.|||  +++|+||||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH--~~gIiHRDLKP  283 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH--STGIVHRDVKP  283 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH--HCCEEeCcCCH
Confidence            56688999999999999999875432100000     000000011233456689999999999999  78999999999


Q ss_pred             CceEeCC-CCceEEeeeccccccCCCCCcccccccccccccCccccCCCC---------------------CCCccccch
Q 043074          224 SNVLLDS-DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNT---------------------AATVMLDVY  281 (373)
Q Consensus       224 ~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---------------------~~~~~~Diw  281 (373)
                      +|||+++ ++.+||+|||+++..............+++.|+|||.+....                     .++.++|||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            9999986 579999999999866443333444567899999999653211                     133456999


Q ss_pred             hhhHHHHHHHhCCCCCCCccc------CCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCC
Q 043074          282 SFGILMIEIATQIRPNLPVVL------DGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKS  355 (373)
Q Consensus       282 slG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p  355 (373)
                      ||||++|||+++..|......      .........|.......  ....+....   ...........+|+.+||+.||
T Consensus       364 SlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~---~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR--ASPDLRRGF---EVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             HHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc--cchhhhhhh---hhccccchHHHHHHHHHccCCc
Confidence            999999999987655221100      00011112222111110  000000000   0000112245689999999999


Q ss_pred             CCCCCHHHHHH
Q 043074          356 RERPAMSYVVQ  366 (373)
Q Consensus       356 ~~RPs~~~l~~  366 (373)
                      ++|||++++++
T Consensus       439 ~kR~ta~e~L~  449 (566)
T PLN03225        439 RQRISAKAALA  449 (566)
T ss_pred             ccCCCHHHHhC
Confidence            99999999986

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=258.66  Aligned_cols=263  Identities=17%  Similarity=0.228  Sum_probs=194.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCC--C----CccceeeEEeeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH--R----NIVKILGYCASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~l~~~~~~~~~~  153 (373)
                      +++|.+...+|+|.||.|..+.+ .++..||+|+++.-. .-.+..+-|++++.++.+  |    .++++.++|.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            78999999999999999999954 457899999985432 223456779999999942  2    378888899999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC---
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---  230 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~---  230 (373)
                      |+|+|.+ |-|+.+++..+...             +++...+..|+.|++++++|||  +.+++|.||||+|||+.+   
T Consensus       167 Civfell-G~S~~dFlk~N~y~-------------~fpi~~ir~m~~QL~~sv~fLh--~~kl~HTDLKPENILfvss~~  230 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYI-------------PFPIDHIRHMGYQLLESVAFLH--DLKLTHTDLKPENILFVSSEY  230 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCcc-------------ccchHHHHHHHHHHHHHHHHHH--hcceeecCCChheEEEeccce
Confidence            9999999 77999999876543             5899999999999999999999  788999999999999832   


Q ss_pred             -----------------CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhC
Q 043074          231 -----------------DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ  293 (373)
Q Consensus       231 -----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g  293 (373)
                                       +..++++|||.|..-..    .....+.|..|.|||++.|- .++.++||||+||+|.|+.+|
T Consensus       231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e----~hs~iVsTRHYRAPEViLgL-GwS~pCDvWSiGCIL~ElytG  305 (415)
T KOG0671|consen  231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE----HHSTIVSTRHYRAPEVILGL-GWSQPCDVWSIGCILVELYTG  305 (415)
T ss_pred             EEEeccCCccceeccCCCcceEEEecCCcceecc----CcceeeeccccCCchheecc-CcCCccCceeeeeEEEEeecc
Confidence                             23589999999986432    22556789999999999964 478899999999999999999


Q ss_pred             CCCCCCcccCCCcccHHHH--------------HHHHHHhcccc-----------ccccCc--cc-cccCCHHHHHHHHH
Q 043074          294 IRPNLPVVLDGQEVGLLEW--------------ARTMEARNKEI-----------EMVDSN--IS-REELSEAGVREYFR  345 (373)
Q Consensus       294 ~~p~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~-----------~~~~~~--~~-~~~~~~~~~~~l~~  345 (373)
                      ..-|.... +.++..+.+-              .......++..           ...+..  +. .-........++++
T Consensus       306 ~~LFqtHe-n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD  384 (415)
T KOG0671|consen  306 ETLFQTHE-NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD  384 (415)
T ss_pred             ceecccCC-cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence            87654433 2221111110              00000001000           000000  00 00113345568999


Q ss_pred             HHHHhcCCCCCCCCCHHHHHH
Q 043074          346 IACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       346 l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      |+..||..||.+|+|+.|++.
T Consensus       385 Ll~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  385 LLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHHccCccccccHHHHhc
Confidence            999999999999999999875

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.2e-34  Score=250.46  Aligned_cols=238  Identities=30%  Similarity=0.392  Sum_probs=189.8

Q ss_pred             CCceEEEEEeC-CCCEEEEEEeCcccccc-HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCHHHHhhc
Q 043074           94 SFGFVYKAKLS-SGVTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHD  171 (373)
Q Consensus        94 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  171 (373)
                      +||.||+|... +++.+++|++....... .+.+.+|+..+++++|+|++++++.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999876 58999999997765544 67899999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCc
Q 043074          172 TSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH  251 (373)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  251 (373)
                      ...               +++..+..++.+++.++.|||  +.+++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~~---------------~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--  141 (244)
T smart00220       81 RGR---------------LSEDEARFYARQILSALEYLH--SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--  141 (244)
T ss_pred             ccC---------------CCHHHHHHHHHHHHHHHHHHH--HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--
Confidence            432               788999999999999999999  7899999999999999999999999999998765432  


Q ss_pred             ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccc
Q 043074          252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNIS  331 (373)
Q Consensus       252 ~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (373)
                      ......++..|++||.+.+ ...+.++||||||+++++|++|..|+....   .......+   ....         ...
T Consensus       142 ~~~~~~~~~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~---~~~~~~~~---~~~~---------~~~  205 (244)
T smart00220      142 LLTTFVGTPEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDD---QLLELFKK---IGKP---------KPP  205 (244)
T ss_pred             ccccccCCcCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHH---Hhcc---------CCC
Confidence            2334567889999999874 446779999999999999999998864321   11111111   1100         000


Q ss_pred             cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          332 REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ........+.++.+++.+||..+|++||++.++++
T Consensus       206 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      206 FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            00000004568999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-37  Score=247.58  Aligned_cols=261  Identities=26%  Similarity=0.382  Sum_probs=190.4

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc-ccc-HHHHHHHHHHHhcCCCCCccceeeEEee--------CC
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA-FQG-FREFRAEMETLGKLRHRNIVKILGYCAS--------GL  151 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~  151 (373)
                      .|.-..++|+|.||.||+++.+ +|+.||+|++--.. ..+ -....+|+++|..++|+|++.++..|.+        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            4445568999999999999654 67888887652211 112 2456889999999999999999998743        23


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..++||.+|+. +|..++......              ++..++.+++.++..||.|+|  ...|+|||+|+.|+||+.+
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~~vr--------------~sls~Ikk~Mk~Lm~GL~~iH--r~kilHRDmKaaNvLIt~d  160 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNRKVR--------------FSLSEIKKVMKGLMNGLYYIH--RNKILHRDMKAANVLITKD  160 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCcccc--------------ccHHHHHHHHHHHHHHHHHHH--HhhHHhhcccHhhEEEcCC
Confidence            57999999954 898888766432              899999999999999999999  6889999999999999999


Q ss_pred             CceEEeeeccccccCCCCCcc---cccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc
Q 043074          232 FEAHISDFGLARRIDTSHSHV---STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG  308 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  308 (373)
                      |.+||+|||+++.+..+....   .+...-|.+|.+||.+.|...++++.|||.-||++.||+|+.+-+.. ..+.   .
T Consensus       161 gilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg-nteq---q  236 (376)
T KOG0669|consen  161 GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG-NTEQ---Q  236 (376)
T ss_pred             ceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC-ChHH---H
Confidence            999999999998875543322   33455699999999999999999999999999999999998654221 1111   1


Q ss_pred             HHHHHHHHHHhccccccccC---------c-----cccccC--------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          309 LLEWARTMEARNKEIEMVDS---------N-----ISREEL--------SEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~---------~-----~~~~~~--------~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      -+.....+..  .....+.+         .     +.....        +..-..+..+++.+++..||.+||++.+++.
T Consensus       237 ql~~Is~LcG--s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  237 QLHLISQLCG--SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             HHHHHHHHhc--cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            1111111111  00000000         0     100000        0011237889999999999999999998875

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.3e-34  Score=267.00  Aligned_cols=274  Identities=22%  Similarity=0.299  Sum_probs=181.7

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-----------------CCCCEEEEEEeCccccccHHH--------------HHHH
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-----------------SSGVTVAIKKLDKDAFQGFRE--------------FRAE  128 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e  128 (373)
                      ..++|.+.++||+|+||.||+|..                 .+++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999953                 235689999986543322222              3346


Q ss_pred             HHHHhcCCCCCc-----cceeeEEee--------CCeeEEEEEecCCCCHHHHhhcCCCCCCCC-------cc--cccCC
Q 043074          129 METLGKLRHRNI-----VKILGYCAS--------GLDRVLIYEFVENGSLDQWLHDTSRNDDVD-------GS--KQLNS  186 (373)
Q Consensus       129 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~-------~~--~~~~~  186 (373)
                      +..+.+++|.++     ++++++|..        ....++|+||+++++|.++++.........       +.  .....
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777766554     677777643        356799999999999999997542210000       00  00001


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCcccccccccccccCcc
Q 043074          187 LCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE  266 (373)
Q Consensus       187 ~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE  266 (373)
                      ...+++..+..++.|++.+|.|||  +.+++||||||+||+++.++.+||+|||++...............+++.|+|||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH--~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH--RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            123678899999999999999999  789999999999999999999999999999765332221112233478999999


Q ss_pred             ccCCCCC---------------------CCccccchhhhHHHHHHHhCCC-CCCCcccCC-----CcccHHHHHHHHHHh
Q 043074          267 YLGGNTA---------------------ATVMLDVYSFGILMIEIATQIR-PNLPVVLDG-----QEVGLLEWARTMEAR  319 (373)
Q Consensus       267 ~~~~~~~---------------------~~~~~DiwslG~~l~el~~g~~-p~~~~~~~~-----~~~~~~~~~~~~~~~  319 (373)
                      .+.....                     ...+.||||+||++++|++|.. |+.....-.     .......|.....  
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~--  458 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG--  458 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc--
Confidence            8753211                     1124699999999999999876 432111000     0111112211000  


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCC---CCCCCHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKS---RERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~~l~~  366 (373)
                          ..++-..     .........+++.++|..+|   .+|+|++|+++
T Consensus       459 ----~~~~~~~-----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 ----QKYDFSL-----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ----cCCCccc-----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence                0011010     12235678999999998765   68999999985

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-36  Score=263.68  Aligned_cols=242  Identities=25%  Similarity=0.293  Sum_probs=196.1

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCC-EEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGV-TVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .++.....||-|+||.|=+++.++.. .+|+|++++....   ..+.+..|-.+|...+.|.||+++..|.+....|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34555667999999999999876443 3888888765543   3566889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      |-|-||.|...++....               ++..+..-++..+++|++|||  .++|++|||||+|.+++.+|-+||.
T Consensus       500 EaClGGElWTiLrdRg~---------------Fdd~tarF~~acv~EAfeYLH--~k~iIYRDLKPENllLd~~Gy~KLV  562 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGS---------------FDDYTARFYVACVLEAFEYLH--RKGIIYRDLKPENLLLDNRGYLKLV  562 (732)
T ss_pred             HhhcCchhhhhhhhcCC---------------cccchhhhhHHHHHHHHHHHH--hcCceeccCChhheeeccCCceEEe
Confidence            99999999999987764               777788889999999999999  8999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+|+.+...  ...-+++|||.|.|||++. ++..+.+.|.||||+++|||++|.+||.....-      ..+     
T Consensus       563 DFGFAKki~~g--~KTwTFcGTpEYVAPEIIL-nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm------ktY-----  628 (732)
T KOG0614|consen  563 DFGFAKKIGSG--RKTWTFCGTPEYVAPEIIL-NKGHDRAVDYWALGILIYELLTGSPPFSGVDPM------KTY-----  628 (732)
T ss_pred             ehhhHHHhccC--CceeeecCCcccccchhhh-ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH------HHH-----
Confidence            99999987643  2344689999999999998 555788999999999999999999997543211      111     


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA  360 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (373)
                        +.+.+.+|    .-.+|...+....+++.+.+..+|.+|.-
T Consensus       629 --n~ILkGid----~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  629 --NLILKGID----KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             --HHHHhhhh----hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence              11111111    11124455667889999999999999976

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-34  Score=260.69  Aligned_cols=217  Identities=24%  Similarity=0.371  Sum_probs=182.6

Q ss_pred             CCCCCCeeecCCCceEEEE-EeCCCCEEEEEEeCcccccc---HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQG---FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      -|..++-||-|+||+|.++ +..+...+|+|.+.+.+.-.   ...+..|-.+|..-+++-||+|+..|.+.+.+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            3455677999999999999 45667889999997755432   3356789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |++||++-.+|.+..-               |.+..+..++..+..|+++.|  +.|+|||||||+|||||.+|++||+|
T Consensus       710 YIPGGDmMSLLIrmgI---------------FeE~LARFYIAEltcAiesVH--kmGFIHRDiKPDNILIDrdGHIKLTD  772 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMGI---------------FEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTD  772 (1034)
T ss_pred             ccCCccHHHHHHHhcc---------------CHHHHHHHHHHHHHHHHHHHH--hccceecccCccceEEccCCceeeee
Confidence            9999999999987763               777778888899999999999  89999999999999999999999999


Q ss_pred             eccccccC---CC-------C-------------------------------CcccccccccccccCccccCCCCCCCcc
Q 043074          239 FGLARRID---TS-------H-------------------------------SHVSTQVAGTMGYMPPEYLGGNTAATVM  277 (373)
Q Consensus       239 fg~~~~~~---~~-------~-------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~  277 (373)
                      ||+|.-+.   .+       +                               .......+||+.|+|||++.. ..++..
T Consensus       773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~  851 (1034)
T KOG0608|consen  773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQL  851 (1034)
T ss_pred             ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCcccc
Confidence            99996431   00       0                               000112579999999999984 458889


Q ss_pred             ccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          278 LDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       278 ~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      +|.||.||+||||+.|+.||......+....+.+|...+.
T Consensus       852 cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~  891 (1034)
T KOG0608|consen  852 CDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLH  891 (1034)
T ss_pred             chhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccc
Confidence            9999999999999999999999888888888888876653

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=241.39  Aligned_cols=250  Identities=21%  Similarity=0.318  Sum_probs=198.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  155 (373)
                      .++|.+..+||.|+|+.|..++++ +.+.+|+|++++.-..   +..=+..|-.+..+. +||.+|.+..+|.+....++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            468999999999999999999764 6788999998764332   223345666777666 69999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |.||.+||+|--++++.+.               ++++.+.-+...|+-||.|||  ..||++||||.+|+|+|..|++|
T Consensus       329 vieyv~ggdlmfhmqrqrk---------------lpeeharfys~ei~lal~flh--~rgiiyrdlkldnvlldaeghik  391 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK---------------LPEEHARFYSAEICLALNFLH--ERGIIYRDLKLDNVLLDAEGHIK  391 (593)
T ss_pred             EEEEecCcceeeehhhhhc---------------CcHHHhhhhhHHHHHHHHHHh--hcCeeeeeccccceEEccCCcee
Confidence            9999999999887776654               889999999999999999999  89999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|+|+++..-. .....++.+|||.|.|||.+.|. .|....|.|+|||+++||+.|+.||.-.-.+..+...-++..+
T Consensus       392 ltdygmcke~l~-~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq  469 (593)
T KOG0695|consen  392 LTDYGMCKEGLG-PGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ  469 (593)
T ss_pred             ecccchhhcCCC-CCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH
Confidence            999999986432 34456678999999999999865 4888999999999999999999997654444444444444433


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA  360 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (373)
                      ......+      ++     +...+.....++...|++||.+|..
T Consensus       470 vilekqi------ri-----prslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  470 VILEKQI------RI-----PRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             HHhhhcc------cc-----cceeehhhHHHHHHhhcCCcHHhcC
Confidence            3221111      11     2233345667888899999999854

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-34  Score=265.41  Aligned_cols=247  Identities=26%  Similarity=0.364  Sum_probs=184.2

Q ss_pred             CCCCCCeeecCCCce-EEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEEec
Q 043074           83 NFSTDKIIGDGSFGF-VYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      -|...+.+|.|+.|+ ||+|... |+.||||++-....   .-..+|+..|+.- +||||+++++.-.+....|+..|.|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            445567899999886 6999874 89999999854332   3457899999988 5999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC---C--CceE
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---D--FEAH  235 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~---~--~~~k  235 (373)
                       ..+|.+++........           ...-...+.+..|+++||++||  ..+|+||||||.||||+.   +  ..++
T Consensus       586 -~~sL~dlie~~~~d~~-----------~~~~i~~~~~l~q~~~GlaHLH--sl~iVHRDLkPQNILI~~~~~~~~~ra~  651 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVE-----------MQSDIDPISVLSQIASGLAHLH--SLKIVHRDLKPQNILISVPSADGTLRAK  651 (903)
T ss_pred             -hhhHHHHHhccccchh-----------hcccccHHHHHHHHHHHHHHHH--hcccccccCCCceEEEEccCCCcceeEE
Confidence             6799999987511110           0111456788999999999999  688999999999999976   2  5789


Q ss_pred             EeeeccccccCCCCCcc--cccccccccccCccccCCCCCCCccccchhhhHHHHHHHhC-CCCCCCcccCCCcccHHHH
Q 043074          236 ISDFGLARRIDTSHSHV--STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ-IRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~~  312 (373)
                      |+|||+++.+.......  .....||.+|+|||++.+.. .+.+.||||+||++|..++| ..||.+....+ . .    
T Consensus       652 iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~-N----  724 (903)
T KOG1027|consen  652 ISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-A-N----  724 (903)
T ss_pred             ecccccccccCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhh-h-h----
Confidence            99999999986544332  34567899999999998544 46689999999999999998 45654322111 0 0    


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                         ....+.....+      .. ..++  +..++|.+|++.+|..||++.+|+.
T Consensus       725 ---Il~~~~~L~~L------~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  725 ---ILTGNYTLVHL------EP-LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ---hhcCccceeee------cc-CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence               00000000001      11 1222  8899999999999999999999873

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.8e-34  Score=229.43  Aligned_cols=262  Identities=19%  Similarity=0.266  Sum_probs=197.9

Q ss_pred             hcCCCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CCCccceeeEEeeC--CeeEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILGYCASG--LDRVL  155 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~l  155 (373)
                      ..++|++.+++|.|.|++||.|. ..+++.++||+++.-.   .+.+.+|+++|..|. ||||++++++..+.  ....|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            45789999999999999999994 5678999999997643   257889999999997 99999999998765  45679


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC-Cce
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-FEA  234 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~-~~~  234 (373)
                      |+||..+.+...+...                  ++..++...+.+++.||.|+|  +.||.|||+||.|++||.. -..
T Consensus       113 iFE~v~n~Dfk~ly~t------------------l~d~dIryY~~elLkALdyCH--S~GImHRDVKPhNvmIdh~~rkL  172 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYPT------------------LTDYDIRYYIYELLKALDYCH--SMGIMHRDVKPHNVMIDHELRKL  172 (338)
T ss_pred             HhhhhccccHHHHhhh------------------hchhhHHHHHHHHHHHHhHHH--hcCcccccCCcceeeechhhcee
Confidence            9999998888776542                  777888899999999999999  7999999999999999965 468


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH-----
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL-----  309 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~-----  309 (373)
                      +|+|+|+|....+...  ..-...+..|--||.+...+.++..-|+|||||+|..|+..+.||+....+..+..-     
T Consensus       173 rlIDWGLAEFYHp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL  250 (338)
T KOG0668|consen  173 RLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL  250 (338)
T ss_pred             eeeecchHhhcCCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence            9999999988754322  223345667899999988888899999999999999999999998876665433221     


Q ss_pred             -----HHHHHHHHHh--cccccccc-------CccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 -----LEWARTMEAR--NKEIEMVD-------SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 -----~~~~~~~~~~--~~~~~~~~-------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                           ..+.......  .+-...+.       ..+.......-..++..+++...|..|-.+|||++|...
T Consensus       251 Gt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  251 GTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                 1111111000  00000000       011111101112468899999999999999999998764

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-34  Score=224.73  Aligned_cols=204  Identities=27%  Similarity=0.410  Sum_probs=164.0

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ..+.......||+|++|.|-+-++ .+|...|+|.+..... +.....++|+++..+. .+|.+|.++|........++.
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            344455567899999999988864 5899999999865433 3356678888876555 799999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      ||.| .-||+.+..+.-...           ..+++...=+|+..+..||.|||+ +..++|||+||+||||+.+|+||+
T Consensus       124 ME~M-~tSldkfy~~v~~~g-----------~~ipE~vlGkIa~Svv~al~~L~~-kL~vIHRDvKPsNiLIn~~GqVKi  190 (282)
T KOG0984|consen  124 MELM-DTSLDKFYRKVLKKG-----------GTIPEDVLGKIAVSVVHALEFLHS-KLSVIHRDVKPSNILINYDGQVKI  190 (282)
T ss_pred             HHHh-hhhHHHHHHHHHhcC-----------CcCchHHhhHhHHHHHHHHHHHHH-HhhhhhccCCcceEEEccCCcEEE
Confidence            9999 568887765433221           137888888999999999999997 677999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCC---CCCCCccccchhhhHHHHHHHhCCCCCC
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG---NTAATVMLDVYSFGILMIEIATQIRPNL  298 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~  298 (373)
                      ||||.+-.+.++-..  +...|...|||||.+..   +..|+-+|||||||+++.||.+++.|+.
T Consensus       191 CDFGIsG~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  191 CDFGISGYLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             cccccceeehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence            999999876543221  22346778999999863   3468899999999999999999999954

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=5e-34  Score=255.21  Aligned_cols=197  Identities=28%  Similarity=0.407  Sum_probs=171.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--------cHHHHHHHHHHHhcCC---CCCccceeeEEee
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--------GFREFRAEMETLGKLR---HRNIVKILGYCAS  149 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  149 (373)
                      .+|...+.+|+|+||.|+.|.++ +...|+||.+.+...-        ..-.+..|+.+|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46888999999999999999765 5678899988764331        1223567999999997   9999999999999


Q ss_pred             CCeeEEEEEecC-CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe
Q 043074          150 GLDRVLIYEFVE-NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL  228 (373)
Q Consensus       150 ~~~~~lv~e~~~-~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill  228 (373)
                      ++.+|++||... +-+|.++|.....               +++.++..|++|++.|+++||  +.+|+|||||-+|+.+
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~---------------m~E~eAk~IFkQV~agi~hlh--~~~ivhrdikdenviv  703 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPR---------------MDEPEAKLIFKQVVAGIKHLH--DQGIVHRDIKDENVIV  703 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCc---------------cchHHHHHHHHHHHhcccccc--ccCceecccccccEEE
Confidence            999999999764 4599999987764               899999999999999999999  8999999999999999


Q ss_pred             CCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCC
Q 043074          229 DSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNL  298 (373)
Q Consensus       229 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  298 (373)
                      +.+|-+||+|||.+.....   .....++||..|.|||++.|+++....-|||++|++||.++....|++
T Consensus       704 d~~g~~klidfgsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  704 DSNGFVKLIDFGSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ecCCeEEEeeccchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999999999976532   233457899999999999999988999999999999999998888865

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.6e-31  Score=225.67  Aligned_cols=211  Identities=34%  Similarity=0.558  Sum_probs=182.2

Q ss_pred             eecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCHHH
Q 043074           90 IGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQ  167 (373)
Q Consensus        90 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  167 (373)
                      ||+|++|.||++... +++.+++|.+...... ..+.+.+|+..++.++|++++++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999775 4899999999766543 34678899999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC-CCceEEeeeccccccC
Q 043074          168 WLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-DFEAHISDFGLARRID  246 (373)
Q Consensus       168 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~  246 (373)
                      ++.....              ++++..+..++.+++.++.+||  +.+++|+||+|.||+++. ++.++|+|||.+....
T Consensus        81 ~~~~~~~--------------~~~~~~~~~~~~~l~~~l~~lh--~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~  144 (215)
T cd00180          81 LLKENEG--------------KLSEDEILRILLQILEGLEYLH--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT  144 (215)
T ss_pred             HHHhccC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEcc
Confidence            9986531              2889999999999999999999  789999999999999999 8999999999998764


Q ss_pred             CCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccc
Q 043074          247 TSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV  326 (373)
Q Consensus       247 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (373)
                      .... ......+...|++||........+.++|+|++|+++++|                                    
T Consensus       145 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------  187 (215)
T cd00180         145 SDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------  187 (215)
T ss_pred             CCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------
Confidence            3321 123345678899999987543678899999999999999                                    


Q ss_pred             cCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       327 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                                    ..+.+++.+|++.||.+||++.++++.
T Consensus       188 --------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                          268899999999999999999999865

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=235.55  Aligned_cols=267  Identities=23%  Similarity=0.319  Sum_probs=193.4

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-----eeE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASGL-----DRV  154 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  154 (373)
                      +.+..+-||-|+||.||.+.+ .+|+.|+.|++..--  ....+.+.+|++++.-.+|.|++..+++..-..     +.|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            455667899999999999965 579999999885422  223456789999999999999999998875543     346


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +++|.| ..+|...+-...               +++-..+.-+.+||++||+|||  +.+|.||||||.|.|++++...
T Consensus       134 V~TELm-QSDLHKIIVSPQ---------------~Ls~DHvKVFlYQILRGLKYLH--sA~ILHRDIKPGNLLVNSNCvL  195 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIVSPQ---------------ALTPDHVKVFVYQILRGLKYLH--TANILHRDIKPGNLLVNSNCIL  195 (449)
T ss_pred             HHHHHH-HhhhhheeccCC---------------CCCcchhhhhHHHHHhhhHHHh--hcchhhccCCCccEEeccCceE
Confidence            788888 568877776443               3777888889999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH--
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW--  312 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~--  312 (373)
                      ||+|||+++..........+...-|..|.|||.+.|...|+.+.||||.||++.||+..+--|......+...-+.+.  
T Consensus       196 KICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLG  275 (449)
T KOG0664|consen  196 KICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLG  275 (449)
T ss_pred             EecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhC
Confidence            999999999876666656666677899999999999999999999999999999998876554332222111101110  


Q ss_pred             ---HHHHH--HhccccccccCcc--------ccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          313 ---ARTME--ARNKEIEMVDSNI--------SREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       313 ---~~~~~--~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                         ...+.  ..+.....+....        ..-..+.....+...+..+++..||.+|.+-.+.+..
T Consensus       276 TPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  276 TPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             CCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence               00000  0011111111111        1111122333466778889999999999998876643

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8.3e-32  Score=236.72  Aligned_cols=131  Identities=27%  Similarity=0.407  Sum_probs=112.4

Q ss_pred             CCCCCCCeeecCCCceEEEE-EeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-----C---CCccceeeEEe----
Q 043074           82 DNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-----H---RNIVKILGYCA----  148 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~----  148 (373)
                      .+|.+.++||=|.|++||++ +..+.+.||+|+.+.... -.+....|+++|++++     |   .+||+|++.|.    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            68888999999999999999 456788999999865432 2356789999999983     3   46999999884    


Q ss_pred             eCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe
Q 043074          149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL  228 (373)
Q Consensus       149 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill  228 (373)
                      ++.+.|+|+|++ |.+|..+|.......             ++...+.+|++||+.||.|||+ ..+|+|.||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrG-------------lpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRG-------------LPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCC-------------CcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeee
Confidence            567899999999 889999998876554             8999999999999999999998 7899999999999997

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=9.5e-33  Score=250.79  Aligned_cols=256  Identities=25%  Similarity=0.368  Sum_probs=205.8

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      +..++|.....+|+|.||.|||++. .+++..|+|.++-.......-+.+|+-+++..+||||+.++|.+......++.|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            3457899999999999999999965 478999999998877777778889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      |||.+|+|++..+-..               ++++.++..+++..++||+|||  +.+-+|||||-.||++++.|.+|++
T Consensus        92 EycgggslQdiy~~Tg---------------plselqiayvcRetl~gl~ylh--s~gk~hRdiKGanilltd~gDvkla  154 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTG---------------PLSELQIAYVCRETLQGLKYLH--SQGKIHRDIKGANILLTDEGDVKLA  154 (829)
T ss_pred             EecCCCcccceeeecc---------------cchhHHHHHHHhhhhccchhhh--cCCcccccccccceeecccCceeec
Confidence            9999999999766544               4899999999999999999999  7889999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccC--CCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG--GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |||.+..+... ......+.||+.|||||+..  ....|...+|||++|+...|+--.++|.++...-+         .-
T Consensus       155 Dfgvsaqitat-i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr---------~l  224 (829)
T KOG0576|consen  155 DFGVSAQITAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR---------AL  224 (829)
T ss_pred             ccCchhhhhhh-hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH---------HH
Confidence            99999776432 23345678999999999863  24457889999999999999988887744322111         00


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...   ....+++.-.++  .....+.+.+++..|+..+|++||+++.++.
T Consensus       225 ~Lm---TkS~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  225 FLM---TKSGFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHh---hccCCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            000   011122221111  2233567899999999999999999987764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.6e-30  Score=220.81  Aligned_cols=199  Identities=35%  Similarity=0.515  Sum_probs=170.4

Q ss_pred             CCCCCeeecCCCceEEEEEeCC-CCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           84 FSTDKIIGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      |...+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999998764 899999999876554 56788899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +++|.+++......              +++.....++.+++.++.+||  +.+++|+|++|+||+++.++.++|+|||.
T Consensus        81 ~~~L~~~~~~~~~~--------------~~~~~~~~~~~~l~~~l~~lh--~~~i~h~di~~~ni~v~~~~~~~l~d~g~  144 (225)
T smart00221       81 GGDLFDYLRKKGGK--------------LSEEEARFYLRQILEALEYLH--SLGIVHRDLKPENILLGMDGLVKLADFGL  144 (225)
T ss_pred             CCCHHHHHHhcccC--------------CCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeeCce
Confidence            99999999865421              678899999999999999999  78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCC
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNL  298 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  298 (373)
                      +...............++..|++||.+.+...++.++|+|+||++++||++|..||.
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      145 ARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             eeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            987654321122334577889999998434556779999999999999999999963

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=222.97  Aligned_cols=255  Identities=25%  Similarity=0.299  Sum_probs=189.4

Q ss_pred             CCCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCcc--ccccHHHHHHHHHHHhcCCCCCccceeeEEeeC------Ce
Q 043074           82 DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKD--AFQGFREFRAEMETLGKLRHRNIVKILGYCASG------LD  152 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  152 (373)
                      .+|.-.+.+|.|.- .|..+. .-.+++|++|++...  .....+...+|...+..++|+||++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46777778889987 566663 336899999987432  223456778999999999999999999998543      35


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .|+|||+| ..+|.+.+.-.                 ++=.++..++.|++.|++|||  +.+|+||||||+||++..+.
T Consensus        96 ~y~v~e~m-~~nl~~vi~~e-----------------lDH~tis~i~yq~~~~ik~lh--s~~IihRdLkPsnivv~~~~  155 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILME-----------------LDHETISYILYQMLCGIKHLH--SAGIIHRDLKPSNIVVNSDC  155 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHHh-----------------cchHHHHHHHHHHHHHHHHHH--hcceeecccCcccceecchh
Confidence            68999999 77999988722                 566788899999999999999  79999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      .+||.|||+++.-+..  -..+....|..|.|||++.|.. +.+..||||+||++.||++|..-|..      ...+.+|
T Consensus       156 ~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g------~d~idQ~  226 (369)
T KOG0665|consen  156 TLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPG------KDHIDQW  226 (369)
T ss_pred             heeeccchhhcccCcc--cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecC------chHHHHH
Confidence            9999999999875543  2455677899999999998766 88999999999999999998765321      1122233


Q ss_pred             HHHHHHhcc--------------cc-------------ccccCccccc--cCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 043074          313 ARTMEARNK--------------EI-------------EMVDSNISRE--ELSEAGVREYFRIACMCTNEKSRERPAMSY  363 (373)
Q Consensus       313 ~~~~~~~~~--------------~~-------------~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~  363 (373)
                      .+-....+.              ..             +.+...+-..  ..+..-.....+++.+||-.||++|.+.++
T Consensus       227 ~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~d  306 (369)
T KOG0665|consen  227 NKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDD  306 (369)
T ss_pred             HHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHH
Confidence            222111111              10             0010000000  001122447889999999999999999999


Q ss_pred             HHH
Q 043074          364 VVQ  366 (373)
Q Consensus       364 l~~  366 (373)
                      +++
T Consensus       307 aL~  309 (369)
T KOG0665|consen  307 ALR  309 (369)
T ss_pred             Hhc
Confidence            875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=4.1e-31  Score=229.01  Aligned_cols=267  Identities=24%  Similarity=0.336  Sum_probs=201.7

Q ss_pred             HHhcCCCCCCCeeecCCCceEEEEEeC----CCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCe
Q 043074           78 IDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILGYCASGLD  152 (373)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  152 (373)
                      ....+.|...++||+|.|++||++.+.    .++.||+|.+...+..  ..+.+|++.|..+. +.||+++.+++..++.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            345678899999999999999999543    4788999999765544  46789999999995 9999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC-C
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-D  231 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~-~  231 (373)
                      ..+|+||++.....++...                  ++..++...++.++.||+++|  .+||+|||+||+|++.+. .
T Consensus       110 v~ivlp~~~H~~f~~l~~~------------------l~~~~i~~Yl~~ll~Al~~~h--~~GIvHRDiKpsNFL~n~~t  169 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS------------------LSLAEIRWYLRNLLKALAHLH--KNGIVHRDIKPSNFLYNRRT  169 (418)
T ss_pred             eEEEecccCccCHHHHHhc------------------CCHHHHHHHHHHHHHHhhhhh--ccCccccCCCcccccccccc
Confidence            9999999999999998864                  778899999999999999999  899999999999999975 4


Q ss_pred             CceEEeeeccccccCC----------------C-----------------C----------CcccccccccccccCcccc
Q 043074          232 FEAHISDFGLARRIDT----------------S-----------------H----------SHVSTQVAGTMGYMPPEYL  268 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~----------------~-----------------~----------~~~~~~~~g~~~y~aPE~~  268 (373)
                      +.-.|.|||+|.....                +                 .          ........||++|.|||++
T Consensus       170 ~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL  249 (418)
T KOG1167|consen  170 QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVL  249 (418)
T ss_pred             CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHH
Confidence            6789999999982100                0                 0          0011124689999999999


Q ss_pred             CCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc-HH------HHHHHHHHhcc--c---------------cc
Q 043074          269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG-LL------EWARTMEARNK--E---------------IE  324 (373)
Q Consensus       269 ~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-~~------~~~~~~~~~~~--~---------------~~  324 (373)
                      ...+.-+++.||||.||+++-++++..||+-...+-.... +.      +..+.....++  .               .+
T Consensus       250 ~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~  329 (418)
T KOG1167|consen  250 FRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFE  329 (418)
T ss_pred             hhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchh
Confidence            8877778999999999999999999999776554432211 11      01111111111  0               01


Q ss_pred             ccc-Cc--------cccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          325 MVD-SN--------ISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       325 ~~~-~~--------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .++ ..        ..........+..+++++.+|+..||.+|.|+++.++
T Consensus       330 s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  330 TLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            110 00        1111112233458999999999999999999999875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=2.3e-31  Score=235.54  Aligned_cols=197  Identities=22%  Similarity=0.267  Sum_probs=164.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCC------CCCccceeeEEeeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR------HRNIVKILGYCASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~~  153 (373)
                      ..+|.+....|+|-|+.|.+|.. +.|..||||++..+..- .+.=+.|+++|++|+      --|+++++..|...+++
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            35677777889999999999965 45789999999765432 244578999999995      34899999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC-
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-  232 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~-  232 (373)
                      |||||.+ ..+|.+.|.+.+.+..            |....+..++.|+.-||..|.  +.+++|.||||+|||+++.. 
T Consensus       510 ClVFE~L-slNLRevLKKyG~nvG------------L~ikaVRsYaqQLflALklLK--~c~vlHaDIKPDNiLVNE~k~  574 (752)
T KOG0670|consen  510 CLVFEPL-SLNLREVLKKYGRNVG------------LHIKAVRSYAQQLFLALKLLK--KCGVLHADIKPDNILVNESKN  574 (752)
T ss_pred             EEEehhh-hchHHHHHHHhCcccc------------eeehHHHHHHHHHHHHHHHHH--hcCeeecccCccceEeccCcc
Confidence            9999999 6699999998876543            888899999999999999999  88999999999999999764 


Q ss_pred             ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCC
Q 043074          233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN  297 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  297 (373)
                      .+||||||.|...+...   .+...-+..|.|||++.|-. |+...|+||.||+||||.||+.-|
T Consensus       575 iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlF  635 (752)
T KOG0670|consen  575 ILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILF  635 (752)
T ss_pred             eeeeccCcccccccccc---ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceec
Confidence            57999999998764332   23344566899999999654 788999999999999999998764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-30  Score=212.53  Aligned_cols=254  Identities=19%  Similarity=0.319  Sum_probs=186.1

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceee-EEeeCCeeEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILG-YCASGLDRVLI  156 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~~~~lv  156 (373)
                      ..+.|.+.+.||+|.||.+.++.++ +...+++|.+..... ..++|.+|...--.| .|.||+.-++ .|.+.+.++++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            3467889999999999999999765 577889998865433 457889998776566 4899998776 46777788899


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC--CCCce
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD--SDFEA  234 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~--~~~~~  234 (373)
                      +||++.|+|.+-+...+                +.+....+++.|+++|+.|+|  ++++||||||.+||||-  +..++
T Consensus       101 qE~aP~gdL~snv~~~G----------------igE~~~K~v~~ql~SAi~fMH--sknlVHRdlK~eNiLif~~df~rv  162 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG----------------IGEANTKKVFAQLLSAIEFMH--SKNLVHRDLKAENILIFDADFYRV  162 (378)
T ss_pred             eccCccchhhhhcCccc----------------ccHHHHHHHHHHHHHHHHHhh--ccchhhcccccceEEEecCCccEE
Confidence            99999999988776543                777888999999999999999  79999999999999993  34589


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  310 (373)
                      ||+|||+.+..+..-    ....-+..|.+||.+..    .-...+.+|+|.||++++.++||..||......+  ..+.
T Consensus       163 KlcDFG~t~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d--~~Y~  236 (378)
T KOG1345|consen  163 KLCDFGLTRKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD--KPYW  236 (378)
T ss_pred             EeeecccccccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC--chHH
Confidence            999999998754321    11223557899998752    2234667899999999999999999987443333  2233


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      +|..  ...+...     .+.+.  ....++.+..+..+-+..+|++|-...+..+.
T Consensus       237 ~~~~--w~~rk~~-----~~P~~--F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  237 EWEQ--WLKRKNP-----ALPKK--FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             HHHH--HhcccCc-----cCchh--hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            3322  2222222     11111  12224467788888999999999666555443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.3e-29  Score=253.76  Aligned_cols=194  Identities=19%  Similarity=0.240  Sum_probs=133.6

Q ss_pred             CCC-CCccceeeEE-------eeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHH
Q 043074          135 LRH-RNIVKILGYC-------ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL  206 (373)
Q Consensus       135 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l  206 (373)
                      ++| +||.++++++       ......+.++|++ +++|.+++.....              ++++.+++.++.||++||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~al   93 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR--------------SVDAFECFHVFRQIVEIV   93 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc--------------cccHHHHHHHHHHHHHHH
Confidence            445 5777888877       2234566778887 7799999975322              389999999999999999


Q ss_pred             HHHhcCCCCceeecCCCCceEeCCCC-------------------ceEEeeeccccccCCCCC---------------cc
Q 043074          207 AYLHGLEKPIIHRDIKSSNVLLDSDF-------------------EAHISDFGLARRIDTSHS---------------HV  252 (373)
Q Consensus       207 ~~lh~~~~~i~H~dlk~~Nill~~~~-------------------~~kl~Dfg~~~~~~~~~~---------------~~  252 (373)
                      +|||  +++|+||||||+|||++..+                   .+|++|||+++.......               ..
T Consensus        94 ~~lH--~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~  171 (793)
T PLN00181         94 NAAH--SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMK  171 (793)
T ss_pred             HHHH--hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccc
Confidence            9999  79999999999999996544                   455566666543211000               00


Q ss_pred             cccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCcccc
Q 043074          253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISR  332 (373)
Q Consensus       253 ~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (373)
                      .....||+.|+|||++.+. .++.++|||||||+||||++|..|+...         ..........     .+.+.   
T Consensus       172 ~~~~~gt~~Y~APE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~---------~~~~~~~~~~-----~~~~~---  233 (793)
T PLN00181        172 QILAMEMSWYTSPEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEK---------SRTMSSLRHR-----VLPPQ---  233 (793)
T ss_pred             ccccCCCcceEChhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhH---------HHHHHHHHHh-----hcChh---
Confidence            1113578889999998754 4789999999999999999987763210         0011111000     00110   


Q ss_pred             ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          333 EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                         ..........++.+||+.||.+||++.++++
T Consensus       234 ---~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        234 ---ILLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             ---hhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence               0111234568889999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.5e-27  Score=196.01  Aligned_cols=167  Identities=23%  Similarity=0.178  Sum_probs=122.7

Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|.+++.....              ++++.+++.++.|++.||.|||  +.+      ||+||+++.++.+|+  ||++
T Consensus         1 GsL~~~l~~~~~--------------~l~~~~~~~i~~qi~~~L~~lH--~~~------kp~Nil~~~~~~~~~--fG~~   56 (176)
T smart00750        1 VSLADILEVRGR--------------PLNEEEIWAVCLQCLRALRELH--RQA------KSGNILLTWDGLLKL--DGSV   56 (176)
T ss_pred             CcHHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHH--hcC------CcccEeEcCccceee--ccce
Confidence            689999876432              3999999999999999999999  555      999999999999999  9998


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE  322 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (373)
                      .......      ..||+.|+|||++.+. .++.++|||||||++|||++|..|+.......  ..+..+......    
T Consensus        57 ~~~~~~~------~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~----  123 (176)
T smart00750       57 AFKTPEQ------SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPA----  123 (176)
T ss_pred             Eeecccc------CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhcc----
Confidence            8654321      2588999999999754 47889999999999999999999964322111  111111111110    


Q ss_pred             cccccCccccccCCHHHHH--HHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          323 IEMVDSNISREELSEAGVR--EYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~--~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                         ....  ..........  ++.+++.+||+.||.+||++.++++.+..+
T Consensus       124 ---~~~~--~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      124 ---DDPR--DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             ---CCcc--ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence               0000  0011222333  699999999999999999999999988654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.5e-29  Score=204.72  Aligned_cols=248  Identities=25%  Similarity=0.391  Sum_probs=191.5

Q ss_pred             CCCeeecCCCceEEEEEeCCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCC
Q 043074           86 TDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENG  163 (373)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  163 (373)
                      +..+|.+...|+.|+|+++ |..++.|++.....  ...++|..|.-.++...||||.+++|.|....+..++..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            3457889999999999997 55666777644322  23467889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe--eecc
Q 043074          164 SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS--DFGL  241 (373)
Q Consensus       164 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~--Dfg~  241 (373)
                      +|.+.++....-             .++-.++.+++.++++|++|||++..-|.---|.+..++||++.+.+|.  |--+
T Consensus       273 slynvlhe~t~v-------------vvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kf  339 (448)
T KOG0195|consen  273 SLYNVLHEQTSV-------------VVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKF  339 (448)
T ss_pred             HHHHHHhcCccE-------------EEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccccee
Confidence            999999876542             2677899999999999999999876666666799999999999888774  3222


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCC--CCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTA--ATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      +..        .....-.|.||+||.++..+.  .-.++|+|||.+++|||.|...||.+.+.-+-.+.           
T Consensus       340 sfq--------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-----------  400 (448)
T KOG0195|consen  340 SFQ--------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-----------  400 (448)
T ss_pred             eee--------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-----------
Confidence            211        111233678999999975332  24578999999999999999999876554332211           


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                       -..+.+...+     +...+..+..++.-|++.||.+||.+.+++-.|+++.
T Consensus       401 -ialeglrv~i-----ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  401 -IALEGLRVHI-----PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -hhhccccccC-----CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence             1122233333     4455678999999999999999999999999999874

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.8e-26  Score=206.03  Aligned_cols=259  Identities=21%  Similarity=0.268  Sum_probs=192.8

Q ss_pred             CCCCCCeeecCCCceEEEEEeCC--CCEEEEEEeCccccccHHHHHHHHHHHhcCCC----CCccceeeEE-eeCCeeEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLSS--GVTVAIKKLDKDAFQGFREFRAEMETLGKLRH----RNIVKILGYC-ASGLDRVL  155 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l  155 (373)
                      +|.+.+.||+|+||.||.+...+  ...+|+|............+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            89999999999999999997654  35788888765433332367788888888863    6888888888 57778899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC----
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD----  231 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~----  231 (373)
                      ||+.+ |.+|.++.......             .++..+.++++.|++.+|+++|  +.|++||||||.|+++...    
T Consensus        99 VM~l~-G~sL~dl~~~~~~~-------------~fs~~T~l~ia~q~l~~l~~lH--~~G~iHRDiKp~N~~~g~~~~~~  162 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPG-------------RFSRKTVLRIAIQNLNALEDLH--SKGFIHRDIKPENFVVGQSSRSE  162 (322)
T ss_pred             EEecc-CccHHHHHHhCCCC-------------CcCHhHHHHHHHHHHHHHHHHH--hcCcccCCcCHHHeeecCCCCcc
Confidence            99998 88999988665522             2999999999999999999999  8999999999999999865    


Q ss_pred             -CceEEeeecccc--ccCCCCC------cc-cccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcc
Q 043074          232 -FEAHISDFGLAR--RIDTSHS------HV-STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVV  301 (373)
Q Consensus       232 -~~~kl~Dfg~~~--~~~~~~~------~~-~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  301 (373)
                       ..+.|.|||+++  .+.....      .. .....||..|+++....+ ...+.+.|+||++.++.|+..|..||....
T Consensus       163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence             369999999999  4322211      11 234569999999999875 447889999999999999999999974333


Q ss_pred             cCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          302 LDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .....   ..... ......    ...      .....+.++.++...+-..+..++|....+...|++..
T Consensus       242 ~~~~~---~~~~~-~~~~~~----~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  242 MTDLK---SKFEK-DPRKLL----TDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             ccchH---HHHHH-Hhhhhc----ccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence            22211   11100 000000    000      12223456777777777799999999999999987753

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=8.4e-27  Score=208.71  Aligned_cols=164  Identities=20%  Similarity=0.197  Sum_probs=127.3

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeC--CCCEEEEEEeCccc-----cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLS--SGVTVAIKKLDKDA-----FQGFREFRAEMETLGKLRHRNIVKILGYCASGL  151 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  151 (373)
                      ...++|.+.+.||+|+||.||+|..+  +++.+|||++....     ....+.+.+|++++++++|+|+++.+..   ..
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            34578999999999999999999764  57778999875331     1124568999999999999999863332   24


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecC-CCCceEeCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDI-KSSNVLLDS  230 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dl-k~~Nill~~  230 (373)
                      ..++||||+++++|... .  .                ..   ...++.|++++|.|||  +++|+|||| ||+|||++.
T Consensus        92 ~~~LVmE~~~G~~L~~~-~--~----------------~~---~~~~~~~i~~aL~~lH--~~gIiHrDL~KP~NILv~~  147 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-R--P----------------HG---DPAWFRSAHRALRDLH--RAGITHNDLAKPQNWLMGP  147 (365)
T ss_pred             CcEEEEEccCCCCHHHh-C--c----------------cc---hHHHHHHHHHHHHHHH--HCCCeeCCCCCcceEEEcC
Confidence            57999999999999632 1  0                11   1467889999999999  799999999 999999999


Q ss_pred             CCceEEeeeccccccCCCCCcc-------cccccccccccCccccC
Q 043074          231 DFEAHISDFGLARRIDTSHSHV-------STQVAGTMGYMPPEYLG  269 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~  269 (373)
                      ++.+||+|||+++.+.......       .....+++.|+|||.+.
T Consensus       148 ~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        148 DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            9999999999999765432111       13456788899999885

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=3.9e-26  Score=192.43  Aligned_cols=259  Identities=24%  Similarity=0.337  Sum_probs=204.7

Q ss_pred             CCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEEec
Q 043074           83 NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      +|.++++||+|+||.++.|+ +-+++.||||.-...+.  ..++..|....+.|. .++|.+++.+-..+.+-.||+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            79999999999999999995 56899999997644332  357788998888885 799999998888888999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC-----CceE
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-----FEAH  235 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~-----~~~k  235 (373)
                       |-||+|+..-+.+.              ++..+++.++.|++.-++|+|  .+.+|+|||||+|+||...     ..+.
T Consensus       107 -GPSLEDLFD~CgR~--------------FSvKTV~miA~Qmi~rie~vH--~k~LIYRDIKPdNFLIGrp~~k~~n~Ih  169 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGRR--------------FSVKTVAMIAKQMITRIEYVH--EKDLIYRDIKPDNFLIGRPGTKDANVIH  169 (449)
T ss_pred             -CcCHHHHHHHhcCc--------------ccHHhHHHHHHHHHHHHHHHH--hcceeecccCccceeecCCCCCCCceEE
Confidence             88999999888764              999999999999999999999  8999999999999999754     3589


Q ss_pred             EeeeccccccCCCCCc------ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          236 ISDFGLARRIDTSHSH------VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      ++|||+|+.+.++...      ......||.+||+=-...|.. -+.+.|+-|||-+++..+-|..||...-.+....  
T Consensus       170 iiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~--  246 (449)
T KOG1165|consen  170 IIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE--  246 (449)
T ss_pred             EEeccchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHH--
Confidence            9999999988655332      334567999999988777543 5778999999999999999999976544432111  


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                           ..+..+..    ...-..+.+....|.++..-+...-..+-.+-|..+.+...+.+++
T Consensus       247 -----kYeKIGe~----Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl  300 (449)
T KOG1165|consen  247 -----KYEKIGET----KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL  300 (449)
T ss_pred             -----HHHHhccc----cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                 11111111    1111112223445778888888888999999999999998888776

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=4.1e-26  Score=184.13  Aligned_cols=260  Identities=23%  Similarity=0.307  Sum_probs=199.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEE-eCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ..+|.+.+.||+|+||.+|.|. ..+|..||||.-+.....  .++..|.++.+.|+ ...|..+..+..+...-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4689999999999999999994 678999999987655433  56788999999997 4677788888888889999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC---CceE
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD---FEAH  235 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~---~~~k  235 (373)
                      .+ |-||+++..-+...              ++..+.+..+-|++.-++|+|  .++++||||||+|+|..-+   ..+.
T Consensus        92 LL-GPsLEdLfnfC~R~--------------ftmkTvLMLaDQml~RiEyvH--~r~fiHRDIKPdNFLMGlgrh~~kl~  154 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSRR--------------FTMKTVLMLADQMLSRIEYVH--LRNFIHRDIKPDNFLMGLGRHCNKLY  154 (341)
T ss_pred             cc-CccHHHHHHHHhhh--------------hhHHhHHHHHHHHHHHHHHHH--hhccccccCCccceeeccccccceEE
Confidence            99 88999998877654              899999999999999999999  8999999999999999643   5689


Q ss_pred             EeeeccccccCCCCC------cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          236 ISDFGLARRIDTSHS------HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      ++|||+++.+-....      .......||.+|.+=-...+- ..+.+.|+-|+|.+|...--|..||...-....... 
T Consensus       155 LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK-  232 (341)
T KOG1163|consen  155 LIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK-  232 (341)
T ss_pred             EEeccchhhhccccccccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH-
Confidence            999999998754322      234456789999887766542 346788999999999999999999765433321110 


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                        +.+-.   +...     ....+.+....|.++...+..|-..--++-|....+-+.+.-+
T Consensus       233 --yEkI~---EkK~-----s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL  284 (341)
T KOG1163|consen  233 --YEKIS---EKKM-----STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL  284 (341)
T ss_pred             --HHHHH---Hhhc-----CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence              00000   0011     1111112223366889999999999999999998887766543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=1.5e-26  Score=220.32  Aligned_cols=254  Identities=21%  Similarity=0.233  Sum_probs=189.2

Q ss_pred             CCCCeeecCCCceEEEEEe-CCCCEEEEEEeC----ccc-ccc-HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           85 STDKIIGDGSFGFVYKAKL-SSGVTVAIKKLD----KDA-FQG-FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~----~~~-~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ....++|.|++|.|+.... ........|.+.    ... ... ...+..|+.+-..+.|||++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4567899999997776643 233333333332    111 111 122667888888899999988888777666666669


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      |||++ +|..++.....               ++..++-.++.|++.|+.|+|  ..|+.|||+|++|++++.+|.+||+
T Consensus       401 E~~~~-Dlf~~~~~~~~---------------~~~~e~~c~fKqL~~Gv~y~h--~~GiahrdlK~enll~~~~g~lki~  462 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGK---------------LTPLEADCFFKQLLRGVKYLH--SMGLAHRDLKLENLLVTENGILKII  462 (601)
T ss_pred             hcccH-HHHHHHhcccc---------------cchhhhhHHHHHHHHHHHHHH--hcCceeccCccccEEEecCCceEEe
Confidence            99999 99999987632               778889999999999999999  8999999999999999999999999


Q ss_pred             eeccccccCCCCC---cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          238 DFGLARRIDTSHS---HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       238 Dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      |||.+..+.....   ......+|+..|+|||++.+..+.....||||.|+++..|++|+.||..........      .
T Consensus       463 Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~  536 (601)
T KOG0590|consen  463 DFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------K  536 (601)
T ss_pred             ecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------h
Confidence            9999987765544   455678899999999999988877888999999999999999999976554443221      0


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                          ................+....+.+...++..+|+.||.+|.|+++|++
T Consensus       537 ----~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  537 ----TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ----hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence                000000000111111224456778999999999999999999999975

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=1.3e-22  Score=183.59  Aligned_cols=261  Identities=30%  Similarity=0.406  Sum_probs=195.1

Q ss_pred             CCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccccc---HHHHHHHHHHHhcCCCC-CccceeeEEeeCCeeEEEEEe
Q 043074           84 FSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQG---FREFRAEMETLGKLRHR-NIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  159 (373)
                      |...+.||.|+||.||++...  ..+++|.+.......   ...+.+|+..+..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999876  788999986654432   56789999999999988 799999999777778999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC-ceEEee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-EAHISD  238 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~-~~kl~D  238 (373)
                      +.++++.+++......            ..++......++.|++.++.|+|  ..+++|||+||+||+++..+ .++++|
T Consensus        80 ~~~~~l~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~l~~~H--~~~~~hrd~kp~nil~~~~~~~~~l~d  145 (384)
T COG0515          80 VDGGSLEDLLKKIGRK------------GPLSESEALFILAQILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLID  145 (384)
T ss_pred             CCCCcHHHHHHhcccc------------cCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeecCCCCeEEEec
Confidence            9999999777655421            12888999999999999999999  78899999999999999998 799999


Q ss_pred             eccccccCCCCCc-----ccccccccccccCccccCCC--CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          239 FGLARRIDTSHSH-----VSTQVAGTMGYMPPEYLGGN--TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       239 fg~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      ||.++........     ......|+..|+|||.+.+.  ...+...|+||+|++++++++|..|+......   .....
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~  222 (384)
T COG0515         146 FGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQ  222 (384)
T ss_pred             cCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHH
Confidence            9999865433321     23567899999999999864  56788999999999999999999994332221   00111


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...........  .......... .......+.+++..|+..+|..|.+..+...
T Consensus       223 ~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         223 TLKIILELPTP--SLASPLSPSN-PELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             HHHHHHhcCCc--ccccccCccc-cchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            11111111100  0000010000 0122357889999999999999999887664

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-23  Score=192.05  Aligned_cols=217  Identities=27%  Similarity=0.419  Sum_probs=163.0

Q ss_pred             HhcCCCCCccceeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 043074          132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHG  211 (373)
Q Consensus       132 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~  211 (373)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.....              .++|.....+.++++.||.|||+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--------------~~d~~F~~s~~rdi~~Gl~ylh~   66 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--------------KLDYFFILSFIRDISKGLAYLHN   66 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--------------CccHHHHHHHHHHHHHHHHHHhc
Confidence            4568899999999999999999999999999999999987443              28899999999999999999994


Q ss_pred             CCCCc-eeecCCCCceEeCCCCceEEeeeccccccCCC-CCcccccccccccccCccccCCCC------CCCccccchhh
Q 043074          212 LEKPI-IHRDIKSSNVLLDSDFEAHISDFGLARRIDTS-HSHVSTQVAGTMGYMPPEYLGGNT------AATVMLDVYSF  283 (373)
Q Consensus       212 ~~~~i-~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~------~~~~~~Diwsl  283 (373)
                        .+| .|+.+++.|++++..+.+||+|||+....... ............-|.|||.+.+..      ..+.++|||||
T Consensus        67 --s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~  144 (484)
T KOG1023|consen   67 --SPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF  144 (484)
T ss_pred             --CcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence              444 89999999999999999999999998765321 111111122345699999997531      14667999999


Q ss_pred             hHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 043074          284 GILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY  363 (373)
Q Consensus       284 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~  363 (373)
                      |++++|+++...||...........+....+.     .....+.+.+..   ..+.++++..++.+||..+|.+||++++
T Consensus       145 ~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~---~~e~~~~l~~l~~~cw~e~P~~rPs~~~  216 (484)
T KOG1023|consen  145 GIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIEL---LNELPPELLLLVARCWEEIPEKRPSIEQ  216 (484)
T ss_pred             HHHHHHHHhccCccccccccCChHHHHHHHHh-----cCCCCcCcchhh---hhhcchHHHHHHHHhcccChhhCccHHH
Confidence            99999999999997654444433223222221     111112222211   1144557999999999999999999999


Q ss_pred             HHHHHHhhh
Q 043074          364 VVQLLDELV  372 (373)
Q Consensus       364 l~~~L~~l~  372 (373)
                      +-..++.+.
T Consensus       217 i~~~~~~~~  225 (484)
T KOG1023|consen  217 IRSKLLTIN  225 (484)
T ss_pred             HHhhhhhhc
Confidence            998887653

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=4.8e-24  Score=177.68  Aligned_cols=171  Identities=11%  Similarity=0.125  Sum_probs=131.7

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHH---------HHHHHHHHHhcCCCCCccceeeEEeeC
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFR---------EFRAEMETLGKLRHRNIVKILGYCASG  150 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~e~~~l~~l~h~niv~l~~~~~~~  150 (373)
                      ..++|+..+++|.|+||.||.... ++..+|+|.+.........         .+.+|+..+.++.|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            368999999999999999999866 5778999999654433222         257899999999999999999886533


Q ss_pred             --------CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCC
Q 043074          151 --------LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIK  222 (373)
Q Consensus       151 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk  222 (373)
                              ...+++|||++|.+|.++..                   ++.    ....+++.++..+|  ..|++|||++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------------~~~----~~~~~i~~~l~~lH--~~gi~H~Dik  162 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------------------ISE----DVKAKIKASIESLH--QHGMVSGDPH  162 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------------------ccH----HHHHHHHHHHHHHH--HcCCccCCCC
Confidence                    35789999999999988631                   332    24568999999999  8999999999


Q ss_pred             CCceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHH
Q 043074          223 SSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA  291 (373)
Q Consensus       223 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~  291 (373)
                      |+||+++.++ ++|+|||...........  ..           ... ...+..++|+||||+++.-..
T Consensus       163 p~Nili~~~g-i~liDfg~~~~~~e~~a~--d~-----------~vl-er~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        163 KGNFIVSKNG-LRIIDLSGKRCTAQRKAK--DR-----------IDL-ERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             hHHEEEeCCC-EEEEECCCcccccchhhH--HH-----------HHH-HhHhcccccccceeEeehHHH
Confidence            9999999988 999999988654211100  00           111 233557899999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.9e-23  Score=172.38  Aligned_cols=140  Identities=22%  Similarity=0.204  Sum_probs=107.7

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCccccc--c-------H-----------------HHHHHHHHHHhcCCCCCc
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ--G-------F-----------------REFRAEMETLGKLRHRNI  140 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~ni  140 (373)
                      .+.||+|+||.||+|...+|+.||+|+++.....  .       .                 .....|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999998778999999998654221  0       0                 112349999999988776


Q ss_pred             cceeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCceee
Q 043074          141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL-HGLEKPIIHR  219 (373)
Q Consensus       141 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~l-h~~~~~i~H~  219 (373)
                      .....+..  ...++||||++++++........               ++++.+...++.|++.+|.++ |  +.+++||
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~---------------~~~~~~~~~i~~qi~~~L~~l~H--~~giiHr  142 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA---------------PLSESKARELYLQVIQIMRILYQ--DCRLVHA  142 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC---------------CCCHHHHHHHHHHHHHHHHHHHH--hCCcccC
Confidence            44333222  23489999998877765432221               288899999999999999999 6  6899999


Q ss_pred             cCCCCceEeCCCCceEEeeeccccccC
Q 043074          220 DIKSSNVLLDSDFEAHISDFGLARRID  246 (373)
Q Consensus       220 dlk~~Nill~~~~~~kl~Dfg~~~~~~  246 (373)
                      ||||+||+++ ++.++|+|||++...+
T Consensus       143 DlkP~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         143 DLSEYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCCHHHEEEE-CCcEEEEEccccccCC
Confidence            9999999998 4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.1e-23  Score=180.11  Aligned_cols=198  Identities=20%  Similarity=0.241  Sum_probs=144.4

Q ss_pred             CCCCccceeeEEee---------------------------CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCC
Q 043074          136 RHRNIVKILGYCAS---------------------------GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLC  188 (373)
Q Consensus       136 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~  188 (373)
                      +|||||++.++|.+                           +...|+||.-+ .-+|..++....               
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---------------  337 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---------------  337 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---------------
Confidence            59999999988743                           23568999888 459999997765               


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC--CC--CceEEeeeccccccCC-----CCCccccccccc
Q 043074          189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD--SD--FEAHISDFGLARRIDT-----SHSHVSTQVAGT  259 (373)
Q Consensus       189 ~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~--~~--~~~kl~Dfg~~~~~~~-----~~~~~~~~~~g~  259 (373)
                       .+.....-++.|+++|+.|||  ++++.|||+|++|||+.  +|  ....|+|||++-.-..     +.....-...|.
T Consensus       338 -~s~r~~~~~laQlLEav~hL~--~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGN  414 (598)
T KOG4158|consen  338 -RSYRTGRVILAQLLEAVTHLH--KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGN  414 (598)
T ss_pred             -CchHHHHHHHHHHHHHHHHHH--HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCc
Confidence             667788889999999999999  89999999999999993  33  3578999999864322     111122234577


Q ss_pred             ccccCccccCCCCC-----CCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCcccccc
Q 043074          260 MGYMPPEYLGGNTA-----ATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREE  334 (373)
Q Consensus       260 ~~y~aPE~~~~~~~-----~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (373)
                      ..-||||+....+.     .-.++|.|+.|.+.||+++...||+..  .+.......+..              . .-..
T Consensus       415 a~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r--Gem~L~~r~Yqe--------------~-qLPa  477 (598)
T KOG4158|consen  415 AKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR--GEMLLDTRTYQE--------------S-QLPA  477 (598)
T ss_pred             ceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCccccc--chheechhhhhh--------------h-hCCC
Confidence            78999999763221     134799999999999999999998861  111111111100              0 0122


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          335 LSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                      ++..++..+.+++...|+.||++||+..-....|.
T Consensus       478 lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  478 LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             CcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            36677889999999999999999999876665553

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=4.2e-24  Score=204.76  Aligned_cols=251  Identities=19%  Similarity=0.205  Sum_probs=183.3

Q ss_pred             CCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccc-cccHHHHHH---HHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDA-FQGFREFRA---EMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ++...+.||++.|=+|.+|+..+|. |+||++-+.. .-..+.+.+   |++ ...++|||++++.-+-.+....|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5667789999999999999988887 8999985544 333444444   444 555689999999888888888899999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |. .-+|.|.+.....               +...+..-|+.|++.|+.-+|  +.||+|||||.+||||++-+.+.|+|
T Consensus       102 yv-khnLyDRlSTRPF---------------L~~iEKkWiaFQLL~al~qcH--~~gVcHGDIKsENILiTSWNW~~LtD  163 (1431)
T KOG1240|consen  102 YV-KHNLYDRLSTRPF---------------LVLIEKKWIAFQLLKALSQCH--KLGVCHGDIKSENILITSWNWLYLTD  163 (1431)
T ss_pred             HH-hhhhhhhhccchH---------------HHHHHHHHHHHHHHHHHHHHH--HcCccccccccceEEEeeechhhhhc
Confidence            99 5599998876653               777888889999999999999  89999999999999999999999999


Q ss_pred             eccccccCCCCCc------ccccccccccccCccccCC----------CCCCCccccchhhhHHHHHHHhCCCCCCCccc
Q 043074          239 FGLARRIDTSHSH------VSTQVAGTMGYMPPEYLGG----------NTAATVMLDVYSFGILMIEIATQIRPNLPVVL  302 (373)
Q Consensus       239 fg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~----------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~  302 (373)
                      |..-+..-.++..      ...+......|.|||.+..          ....+++.||||+||++.||++-+.|.+... 
T Consensus       164 FAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-  242 (1431)
T KOG1240|consen  164 FASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-  242 (1431)
T ss_pred             ccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-
Confidence            9877654322211      1122334457999997742          1125778999999999999999766643311 


Q ss_pred             CCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          303 DGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                           ++..+....   ....+.+-+.+     .   ...+++++..|++.||++|.++++.++.-.+
T Consensus       243 -----QL~aYr~~~---~~~~e~~Le~I-----e---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  243 -----QLLAYRSGN---ADDPEQLLEKI-----E---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             -----HHHhHhccC---ccCHHHHHHhC-----c---CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence                 122221110   00001111111     1   1268899999999999999999999987443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=4.1e-22  Score=165.18  Aligned_cols=139  Identities=23%  Similarity=0.305  Sum_probs=109.5

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCccccc---------------------c-----HHHHHHHHHHHhcCCCCCc
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ---------------------G-----FREFRAEMETLGKLRHRNI  140 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~ni  140 (373)
                      .+.||+|++|.||+|...+|+.||||+++.....                     .     ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999998778999999998754221                     0     1123578899999999987


Q ss_pred             cceeeEEeeCCeeEEEEEecCCCCHHHH-hhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCcee
Q 043074          141 VKILGYCASGLDRVLIYEFVENGSLDQW-LHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLE-KPIIH  218 (373)
Q Consensus       141 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~-~~i~H  218 (373)
                      .....+...  ..++||||++++++... +...                +++..+...++.|++.++.++|  . .|++|
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~----------------~~~~~~~~~i~~~l~~~l~~lH--~~~givH  141 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV----------------PLEEEEAEELYEQVVEQMRRLY--QEAGLVH  141 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhhc----------------cCCHHHHHHHHHHHHHHHHHHH--HhCCEec
Confidence            554444333  24899999988755433 3321                2777889999999999999999  6 89999


Q ss_pred             ecCCCCceEeCCCCceEEeeeccccccC
Q 043074          219 RDIKSSNVLLDSDFEAHISDFGLARRID  246 (373)
Q Consensus       219 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~  246 (373)
                      |||||+||+++ ++.++|+|||++....
T Consensus       142 rDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         142 GDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCChhhEEEE-CCCEEEEEcccceecC
Confidence            99999999999 7899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=4.9e-22  Score=162.07  Aligned_cols=186  Identities=16%  Similarity=0.129  Sum_probs=139.4

Q ss_pred             CCCeeecCCCceEEEEEeCCCCEEEEEEeCcccccc----HHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEEec
Q 043074           86 TDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQG----FREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      ....|++|+||+|+.+.. .+.+++.+.+.....-.    ...+.+|+++|+++. |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            456899999999998866 68888888886655421    124789999999995 5889999886    3468999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecC-CCCceEeCCCCceEEeee
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDI-KSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dl-k~~Nill~~~~~~kl~Df  239 (373)
                      .|.+|...+..                      ....++.|++.+|.++|  ..|++|||| ||+||+++.++.++|+||
T Consensus        81 ~G~~L~~~~~~----------------------~~~~~~~qi~~~L~~lH--~~GIvHrDL~kp~NILv~~~g~i~LIDF  136 (218)
T PRK12274         81 AGAAMYQRPPR----------------------GDLAYFRAARRLLQQLH--RCGVAHNDLAKEANWLVQEDGSPAVIDF  136 (218)
T ss_pred             cCccHHhhhhh----------------------hhHHHHHHHHHHHHHHH--HCcCccCCCCCcceEEEcCCCCEEEEEC
Confidence            99888653211                      11347789999999999  899999999 799999999999999999


Q ss_pred             ccccccCCCCCc----c--------cccccccccccCccccCCCCCCC-ccccchhhhHHHHHHHhCCCCCCCc
Q 043074          240 GLARRIDTSHSH----V--------STQVAGTMGYMPPEYLGGNTAAT-VMLDVYSFGILMIEIATQIRPNLPV  300 (373)
Q Consensus       240 g~~~~~~~~~~~----~--------~~~~~g~~~y~aPE~~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~  300 (373)
                      |++.........    .        ......++.|+.|+.-.--...+ ...+.++-|.-+|.++|++.+....
T Consensus       137 G~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        137 QLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             CCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            999865433210    0        01123567778887543222222 4568899999999999999986543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=1.1e-21  Score=168.59  Aligned_cols=237  Identities=19%  Similarity=0.246  Sum_probs=148.2

Q ss_pred             CCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCC----------CCccceeeEE--
Q 043074           84 FSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRH----------RNIVKILGYC--  147 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~--  147 (373)
                      +...+.||.|+++.||.+.+. +++++++|++....   ....+++.+|.-....+.+          -.++-.++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345678999999999999764 69999999873322   2245667777655555322          1222222222  


Q ss_pred             -------eeC---C-----eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 043074          148 -------ASG---L-----DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGL  212 (373)
Q Consensus       148 -------~~~---~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~  212 (373)
                             ...   .     +.+++|+-+ .++|.+++.........        ..++....++.+..|+++.+++||  
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~--------~~~l~~~arl~lT~Q~I~lvA~Lh--  162 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT--------HSPLAFAARLSLTVQMIRLVANLH--  162 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT--------SHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc--------cchhHHHHHHHHHHHHHHHHHHHh--
Confidence                   111   1     236677777 67888876532211100        001445566778899999999999  


Q ss_pred             CCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCC-------CCCCCccccchhhhH
Q 043074          213 EKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG-------NTAATVMLDVYSFGI  285 (373)
Q Consensus       213 ~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~DiwslG~  285 (373)
                      ..|++|+||+|+|++++.+|.++|+||+.....+....    ....+..|.+||....       ...++.+.|.|+||+
T Consensus       163 ~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~  238 (288)
T PF14531_consen  163 SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI  238 (288)
T ss_dssp             HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred             hcceEecccceeeEEEcCCCCEEEcChHHHeecCceee----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence            79999999999999999999999999998876543211    1234577999997642       124688899999999


Q ss_pred             HHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCC
Q 043074          286 LMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRER  358 (373)
Q Consensus       286 ~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  358 (373)
                      ++|.|.||..|+.-.........                      .-..+. +.|+.+..+|..+|+.||.+|
T Consensus       239 ~ly~lWC~~lPf~~~~~~~~~~~----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  239 TLYSLWCGRLPFGLSSPEADPEW----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHSS-STCCCGGGSTSGG----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHccCCCCCCCccccccc----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999999999654332221110                      112224 678899999999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=5.6e-21  Score=159.03  Aligned_cols=136  Identities=19%  Similarity=0.246  Sum_probs=105.8

Q ss_pred             CCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcC-----CCCCccceeeEEeeCC---e-eEE
Q 043074           85 STDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-----RHRNIVKILGYCASGL---D-RVL  155 (373)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l  155 (373)
                      .-.+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+     +||||++++|++.++.   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3456899999999996 3334444 69988765444557889999999999     5799999999998874   3 347


Q ss_pred             EEEe--cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCceeecCCCCceEeCC--
Q 043074          156 IYEF--VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL-AYLHGLEKPIIHRDIKSSNVLLDS--  230 (373)
Q Consensus       156 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l-~~lh~~~~~i~H~dlk~~Nill~~--  230 (373)
                      |+||  +.+++|.+++.+..                +++.  ..++.|++.++ +|||  +++|+||||||+||+++.  
T Consensus        83 I~e~~G~~~~tL~~~l~~~~----------------~~e~--~~~~~~~L~~l~~yLh--~~~IvhrDlKp~NILl~~~~  142 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR----------------YEED--VAQLRQLLKKLKRYLL--DNRIVTMELKPQNILCQRIS  142 (210)
T ss_pred             EecCCCCcchhHHHHHHccc----------------ccHh--HHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEeccC
Confidence            8999  55799999997532                4444  35678888777 9999  899999999999999974  


Q ss_pred             --CCceEEeeeccc
Q 043074          231 --DFEAHISDFGLA  242 (373)
Q Consensus       231 --~~~~kl~Dfg~~  242 (373)
                        ++.++|+||+-+
T Consensus       143 ~~~~~~~LiDg~G~  156 (210)
T PRK10345        143 ESEVIPVVCDNIGE  156 (210)
T ss_pred             CCCCcEEEEECCCC
Confidence              347999995433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.5e-22  Score=184.88  Aligned_cols=225  Identities=24%  Similarity=0.271  Sum_probs=177.0

Q ss_pred             eeecCCCceEEEEE----eCCCCEEEEEEeCcccccc--HHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEEecC
Q 043074           89 IIGDGSFGFVYKAK----LSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        89 ~lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      .+|+|+||.|+++.    ...+..+++|.+.+.....  ......|..++...+ ||.++++...+..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999999873    2347778888886644332  113456778888886 9999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +|.|...+.....               +++.........++-+++++|  +.+++|||+|++||+++.+|++++.|||+
T Consensus        81 gg~lft~l~~~~~---------------f~~~~~~~~~aelaLald~lh--~l~iiyrd~k~enilld~~Ghi~~tdfgl  143 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM---------------FDELDVAFYLAELALALDHLH--KLGIAYRDYKLENVLLLLEGHIKLTDFGL  143 (612)
T ss_pred             cchhhhccccCCc---------------hHHHHHHHHHHHHHHHHhhcc--hhHHHHhcccccceeecccCccccCCchh
Confidence            9999888876553               667777777888999999999  89999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK  321 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (373)
                      ++..-....     .+||..|||||++.+   ...++|.||||++++||+||..||..           +..+....   
T Consensus       144 ske~v~~~~-----~cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~---  201 (612)
T KOG0603|consen  144 SKEAVKEKI-----ACGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILK---  201 (612)
T ss_pred             hhHhHhhhh-----cccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhh---
Confidence            987533221     289999999999873   45688999999999999999999754           11111111   


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                            .+   -..+.........++.+++..+|.+|--.
T Consensus       202 ------~~---~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  202 ------AE---LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ------hc---cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence                  01   11266667788889999999999988665

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=1.2e-20  Score=183.88  Aligned_cols=250  Identities=21%  Similarity=0.194  Sum_probs=181.5

Q ss_pred             HHhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC---CCCccceeeEEeeCCeeE
Q 043074           78 IDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR---HRNIVKILGYCASGLDRV  154 (373)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~  154 (373)
                      +...+.|.+.+.+|+|+||.||+|...+|+.||+|+-+......   |.=-.+++.+|+   -+.|.++...+.-.+..+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            34457888899999999999999988789999999976655432   000112233333   345566666666667788


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC-----
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-----  229 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~-----  229 (373)
                      +|+||.+.|+|.+++...+.               ++|.-...++.|++.-+++||  ..+|||+||||+|+||.     
T Consensus       771 lv~ey~~~Gtlld~~N~~~~---------------m~e~lv~~~~~qml~ive~lH--~~~IIHgDiKPDNfll~~~~~~  833 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLINTNKV---------------MDEYLVMFFSCQMLRIVEHLH--AMGIIHGDIKPDNFLLRREICA  833 (974)
T ss_pred             eeeeccccccHHHhhccCCC---------------CCchhhhHHHHHHHHHHHHHH--hcceecccCCcceeEeecccCC
Confidence            99999999999999984432               889999999999999999999  89999999999999994     


Q ss_pred             --CCCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          230 --SDFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       230 --~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                        +...++|+|||.+..+..-.. ......++|-.+-.+|...| ..++..+|.|-|+.+++-|+.|..--         
T Consensus       834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y~q---------  903 (974)
T KOG1166|consen  834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKYME---------  903 (974)
T ss_pred             CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHHHH---------
Confidence              234689999999987643332 24456778899999999985 55899999999999999999985321         


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                                 ..+.....++..+.+-. .   -....+++..+|+.|-..=|...++...|+..+
T Consensus       904 -----------~~~g~~~~~~~~~~Ry~-~---~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~  954 (974)
T KOG1166|consen  904 -----------VKNGSSWMVKTNFPRYW-K---RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL  954 (974)
T ss_pred             -----------hcCCcceeccccchhhh-h---HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence                       01111111122111111 1   123456777788877777788888888887765

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=5.7e-20  Score=156.83  Aligned_cols=141  Identities=19%  Similarity=0.206  Sum_probs=109.5

Q ss_pred             CCCCCCeeecCCCceEEEEE--eCCCCEEEEEEeCccccc------------------------cHHHHHHHHHHHhcCC
Q 043074           83 NFSTDKIIGDGSFGFVYKAK--LSSGVTVAIKKLDKDAFQ------------------------GFREFRAEMETLGKLR  136 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  136 (373)
                      .|.+.+.||+|++|.||+|.  ..+|+.||+|++......                        ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            57888999999999999997  568999999998653211                        0123568999999997


Q ss_pred             CCC--ccceeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 043074          137 HRN--IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEK  214 (373)
Q Consensus       137 h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~  214 (373)
                      +.+  +.++++.    ...++||||+++++|........               ++...+...++.|++.++.+||  +.
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---------------~~~~~~~~~i~~qi~~~l~~LH--~~  167 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---------------EPEEEEEFELYDDILEEMRKLY--KE  167 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---------------CcchHHHHHHHHHHHHHHHHHH--hc
Confidence            533  3344432    23589999999988876542221               1555667899999999999999  78


Q ss_pred             C-ceeecCCCCceEeCCCCceEEeeecccccc
Q 043074          215 P-IIHRDIKSSNVLLDSDFEAHISDFGLARRI  245 (373)
Q Consensus       215 ~-i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  245 (373)
                      + ++|+||||+||+++ ++.++|+|||.+...
T Consensus       168 g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      168 GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            8 99999999999999 889999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.5e-19  Score=150.61  Aligned_cols=134  Identities=22%  Similarity=0.352  Sum_probs=113.0

Q ss_pred             CeeecCCCceEEEEEeCCCCEEEEEEeCccccc--------cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           88 KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ--------GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      +.||+|++|.||+|.. +|..+++|........        ....+.+|+.++..+.|+++.....++.+....+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 6788999986543221        123577899999999999988878777777888999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      ++|++|.+++...                  .+ .+..++.+++.+|.++|  ..+++|+|++|.||+++ ++.++|+||
T Consensus        81 ~~G~~L~~~~~~~------------------~~-~~~~i~~~i~~~l~~lH--~~~i~H~Dl~p~Nil~~-~~~~~liDf  138 (211)
T PRK14879         81 IEGEPLKDLINSN------------------GM-EELELSREIGRLVGKLH--SAGIIHGDLTTSNMILS-GGKIYLIDF  138 (211)
T ss_pred             eCCcCHHHHHHhc------------------cH-HHHHHHHHHHHHHHHHH--hCCcccCCCCcccEEEE-CCCEEEEEC
Confidence            9999999988642                  22 77889999999999999  89999999999999999 789999999


Q ss_pred             ccccc
Q 043074          240 GLARR  244 (373)
Q Consensus       240 g~~~~  244 (373)
                      |.+..
T Consensus       139 ~~a~~  143 (211)
T PRK14879        139 GLAEF  143 (211)
T ss_pred             CcccC
Confidence            98864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=2.4e-20  Score=167.33  Aligned_cols=123  Identities=29%  Similarity=0.549  Sum_probs=104.9

Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..++.|++|...+|.+|+.......            ..++...+.++.|++.|++|     ++.+|+|+||.||+...+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e------------~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d  392 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGE------------ERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDD  392 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCccc------------ccchhHHHHHHHhhccchhh-----ccchhhhccccccccccc
Confidence            5689999999999999997554332            27788999999999999999     669999999999999999


Q ss_pred             CceEEeeeccccccCCCC-----CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh
Q 043074          232 FEAHISDFGLARRIDTSH-----SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT  292 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~  292 (373)
                      ..+||+|||+........     ....+...||..||+||.+.++ .|+.++||||||++|+|++.
T Consensus       393 ~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  393 DQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHH
Confidence            999999999998764433     2234556799999999999865 48999999999999999987

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=1.4e-18  Score=145.25  Aligned_cols=139  Identities=21%  Similarity=0.169  Sum_probs=108.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccc----------------------cHHHHHHHHHHHhcCCCC
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ----------------------GFREFRAEMETLGKLRHR  138 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~  138 (373)
                      ...|...+.||+|+||.||++...+|+.||||++......                      ....+..|...+..+.|+
T Consensus        14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   93 (198)
T cd05144          14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE   93 (198)
T ss_pred             CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence            3347788999999999999998888999999987543210                      011256788888888777


Q ss_pred             C--ccceeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc
Q 043074          139 N--IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPI  216 (373)
Q Consensus       139 n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i  216 (373)
                      +  +...++    ....++||||+++++|......                     .....++.+++.++.++|  ..++
T Consensus        94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------------------~~~~~~~~~i~~~l~~lh--~~gi  146 (198)
T cd05144          94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------------------EDPEEVLDEILEEIVKAY--KHGI  146 (198)
T ss_pred             CCCCCceee----cCCceEEEEEeCCcchhhcccc---------------------ccHHHHHHHHHHHHHHHH--HCCC
Confidence            4  444443    2345899999999998764321                     234578899999999999  7999


Q ss_pred             eeecCCCCceEeCCCCceEEeeeccccccC
Q 043074          217 IHRDIKSSNVLLDSDFEAHISDFGLARRID  246 (373)
Q Consensus       217 ~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  246 (373)
                      +|+||+|+||++++++.++|+|||.+....
T Consensus       147 ~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         147 IHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            999999999999999999999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=1.1e-18  Score=146.18  Aligned_cols=130  Identities=21%  Similarity=0.403  Sum_probs=106.5

Q ss_pred             eeecCCCceEEEEEeCCCCEEEEEEeCccccc--------cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           89 IIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ--------GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      .||+|+||.||+|.. ++..+++|........        ..+.+.+|++++..++|+++.....++......+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999985 5788999986443211        1245678999999999887666666666677789999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      +|++|.+++....                .      .++.|++.+|.+||  +.+++|+|++|+||+++ ++.++++|||
T Consensus        80 ~g~~l~~~~~~~~----------------~------~~~~~i~~~l~~lH--~~gi~H~Dl~~~Nil~~-~~~~~liDfg  134 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------------D------ELLREIGRLVGKLH--KAGIVHGDLTTSNIIVR-DDKLYLIDFG  134 (199)
T ss_pred             CCccHHHHHhhcH----------------H------HHHHHHHHHHHHHH--HCCeecCCCCcceEEEE-CCcEEEEECC
Confidence            9999998875321                1      78999999999999  89999999999999999 7899999999


Q ss_pred             cccc
Q 043074          241 LARR  244 (373)
Q Consensus       241 ~~~~  244 (373)
                      ++..
T Consensus       135 ~a~~  138 (199)
T TIGR03724       135 LGKY  138 (199)
T ss_pred             CCcC
Confidence            8865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=2.3e-18  Score=165.03  Aligned_cols=137  Identities=24%  Similarity=0.336  Sum_probs=110.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEe-Ccc-cc------ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKL-DKD-AF------QGFREFRAEMETLGKLRHRNIVKILGYCASGLD  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~-~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  152 (373)
                      ...|...+.||+|+||.||+|.+... .+++|+. .+. ..      ...+.+.+|++++..++|++++....++.+...
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            34556678999999999999987543 3444432 221 11      112457899999999999999988888877778


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++||||+++++|.+++.                       ....++.|++.+|.+||  +.+++||||||+||++ +++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------------------~~~~~~~~i~~~L~~lH--~~giiHrDlkp~NILl-~~~  464 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------------------GNPELVRKVGEIVAKLH--KAGIVHGDLTTSNFIV-RDD  464 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------------------HHHHHHHHHHHHHHHHH--hCCCccCCCChHHEEE-ECC
Confidence            899999999999998774                       23568999999999999  8999999999999999 677


Q ss_pred             ceEEeeeccccc
Q 043074          233 EAHISDFGLARR  244 (373)
Q Consensus       233 ~~kl~Dfg~~~~  244 (373)
                      .++|+|||+++.
T Consensus       465 ~~~liDFGla~~  476 (535)
T PRK09605        465 RLYLIDFGLGKY  476 (535)
T ss_pred             cEEEEeCccccc
Confidence            999999999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.74  E-value=8.9e-19  Score=168.30  Aligned_cols=211  Identities=25%  Similarity=0.328  Sum_probs=140.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|..++.+..|+||.||..+++ +.+..|+| ++++..-    +++   ++....+|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCccee------------------
Confidence            468888999999999999999876 45667773 4332211    111   22222334333                  


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                         |+=...+.....               ++..        ++.+++|||  +.+|+|||+||+|.+|+.-|++|++||
T Consensus       136 ---gDc~tllk~~g~---------------lPvd--------mvla~Eylh--~ygivhrdlkpdnllIT~mGhiKlTDf  187 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGP---------------LPVD--------MVLAVEYLH--SYGIVHRDLKPDNLLITSMGHIKLTDF  187 (1205)
T ss_pred             ---chhhhhcccCCC---------------Ccch--------hhHHhHhhc--cCCeecCCCCCCcceeeecccccccch
Confidence               333333433221               2211        267899999  799999999999999999999999999


Q ss_pred             ccccccCCCC--------------CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCC
Q 043074          240 GLARRIDTSH--------------SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ  305 (373)
Q Consensus       240 g~~~~~~~~~--------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~  305 (373)
                      |+.+......              .-.....+||+.|.|||++.. +.|....|.|++|+++||.+.|..||+..-.++-
T Consensus       188 gLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeel  266 (1205)
T KOG0606|consen  188 GLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL  266 (1205)
T ss_pred             hhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence            9998642211              111234689999999999974 4589999999999999999999999765422210


Q ss_pred             cccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 043074          306 EVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMS  362 (373)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (373)
                             ..........    .+    +. .+..+.+..+++.+.|+.+|..|--..
T Consensus       267 -------fg~visd~i~----wp----E~-dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  267 -------FGQVISDDIE----WP----EE-DEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             -------Hhhhhhhhcc----cc----cc-CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence                   0001000000    00    00 223355889999999999999995443

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=5.7e-17  Score=134.37  Aligned_cols=136  Identities=25%  Similarity=0.281  Sum_probs=97.3

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCcccccc--HHH----------------------HHHHHHHHhcCCCC--Cc
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQG--FRE----------------------FRAEMETLGKLRHR--NI  140 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~--ni  140 (373)
                      .+.||+|+||.||+|...+++.||||++.......  ...                      ...|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999988789999999986533211  111                      13455555555433  24


Q ss_pred             cceeeEEeeCCeeEEEEEecCCCCHHH-HhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCcee
Q 043074          141 VKILGYCASGLDRVLIYEFVENGSLDQ-WLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLE-KPIIH  218 (373)
Q Consensus       141 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~-~~i~H  218 (373)
                      .+.+++    ...++||||++++++.. .+....                .. .+...++.+++.++.++|  . .+++|
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----------------~~-~~~~~~~~~~~~~l~~lh--~~~~ivH  138 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----------------LL-EDPEELYDQILELMRKLY--REAGLVH  138 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----------------hc-ccHHHHHHHHHHHHHHHh--hccCcCc
Confidence            444433    24689999999865321 111110                11 456789999999999999  6 89999


Q ss_pred             ecCCCCceEeCCCCceEEeeeccccccC
Q 043074          219 RDIKSSNVLLDSDFEAHISDFGLARRID  246 (373)
Q Consensus       219 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~  246 (373)
                      +||||+||+++ ++.++++|||.+....
T Consensus       139 ~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         139 GDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCCChhhEEEE-CCcEEEEECccccccc
Confidence            99999999999 8899999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=1.9e-16  Score=135.42  Aligned_cols=135  Identities=19%  Similarity=0.279  Sum_probs=104.2

Q ss_pred             CCeee-cCCCceEEEEEeCCCCEEEEEEeCcccc-------------ccHHHHHHHHHHHhcCCCCCc--cceeeEEeeC
Q 043074           87 DKIIG-DGSFGFVYKAKLSSGVTVAIKKLDKDAF-------------QGFREFRAEMETLGKLRHRNI--VKILGYCASG  150 (373)
Q Consensus        87 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~  150 (373)
                      ...|| .|+.|+||.++.. +..+++|.+.....             .....+.+|+.++..++|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35688 8999999999875 77899998753210             112457889999999998775  6677664332


Q ss_pred             C----eeEEEEEecCC-CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCc
Q 043074          151 L----DRVLIYEFVEN-GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSN  225 (373)
Q Consensus       151 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~N  225 (373)
                      .    ..++|+|++++ .+|.+++....                ++..    .+.|++.++.+||  +.||+|+||||.|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~----------------l~~~----~~~~i~~~l~~lH--~~GI~HrDlkp~N  172 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAP----------------LSEE----QWQAIGQLIARFH--DAGVYHADLNAHN  172 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCC----------------CCHH----HHHHHHHHHHHHH--HCCCCCCCCCchh
Confidence            2    23599999997 69998876432                4433    3578999999999  8999999999999


Q ss_pred             eEeCCCCceEEeeeccccc
Q 043074          226 VLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       226 ill~~~~~~kl~Dfg~~~~  244 (373)
                      ||++.++.++|+|||.+..
T Consensus       173 ILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        173 ILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             EEEcCCCCEEEEECCCccc
Confidence            9999989999999998865

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.2e-16  Score=127.62  Aligned_cols=133  Identities=25%  Similarity=0.218  Sum_probs=110.9

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCC--CCccceeeEEeeCCeeEEEEEecCCCC
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH--RNIVKILGYCASGLDRVLIYEFVENGS  164 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  164 (373)
                      .+.||+|.++.||++...+ ..+++|.......  ...+.+|+..+..++|  .++++++++....+..++++||++++.
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            4679999999999998754 7899999866543  4578899999999976  589999998888888999999998877


Q ss_pred             HHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCceeecCCCCceEeCCCCceEEeeecccc
Q 043074          165 LDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLE-KPIIHRDIKSSNVLLDSDFEAHISDFGLAR  243 (373)
Q Consensus       165 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  243 (373)
                      +..+                      +......++.+++++++++|... .+++|+|++|+||+++.++.+++.|||.+.
T Consensus        80 ~~~~----------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          80 LDEV----------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             cccC----------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            6543                      33556778899999999999421 479999999999999998999999999886


Q ss_pred             c
Q 043074          244 R  244 (373)
Q Consensus       244 ~  244 (373)
                      .
T Consensus       138 ~  138 (155)
T cd05120         138 Y  138 (155)
T ss_pred             C
Confidence            4

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=2e-18  Score=164.96  Aligned_cols=255  Identities=24%  Similarity=0.277  Sum_probs=186.2

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC--CCCEEEEEEeCccc--cccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS--SGVTVAIKKLDKDA--FQGFREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  156 (373)
                      ..|...+.||+|+|+.|-.....  ....++.|.+....  ....+....|..+-..+. |+|++++++...+....++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            45667778999999999888543  34456666664433  122334455777777776 99999999999999999999


Q ss_pred             EEecCCCCHHHHhh-cCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC-ce
Q 043074          157 YEFVENGSLDQWLH-DTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-EA  234 (373)
Q Consensus       157 ~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~-~~  234 (373)
                      ++|..++++.+-+. ....              ..+....-..+.|+..++.|+|. ..++.|+|+||+|.+++..+ ..
T Consensus       100 ~~~s~g~~~f~~i~~~~~~--------------~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l  164 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDST--------------GTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSAL  164 (601)
T ss_pred             cCcccccccccccccCCcc--------------CCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchhccCCCcc
Confidence            99999999988873 2211              14556667889999999999995 57899999999999999999 99


Q ss_pred             EEeeeccccccCC-C-CCcccccccc-cccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          235 HISDFGLARRIDT-S-HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       235 kl~Dfg~~~~~~~-~-~~~~~~~~~g-~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +++|||+|..+.. . ........+| ++.|+|||...+..+..+..|+||.|+++.-+++|..|+.......  .....
T Consensus       165 ~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~  242 (601)
T KOG0590|consen  165 KIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSS  242 (601)
T ss_pred             cCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--cccee
Confidence            9999999988755 2 2233344677 9999999999865566778999999999999999999965443332  11112


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVV  365 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~  365 (373)
                      |...-   ...         .............++..+++..+|+.|.+.+++.
T Consensus       243 ~~~~~---~~~---------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  243 WKSNK---GRF---------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ecccc---ccc---------ccCccccCChhhhhcccccccCCchhcccccccc
Confidence            21110   000         0111222334678888999999999999988764

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.61  E-value=4.4e-14  Score=130.99  Aligned_cols=169  Identities=17%  Similarity=0.199  Sum_probs=129.1

Q ss_pred             eCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCccc
Q 043074          103 LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSK  182 (373)
Q Consensus       103 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  182 (373)
                      ..++.+|.|+..+...........+-++.|+.++||||+++++.+......|+|+|-+.  .|..++.+           
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----------  100 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----------  100 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----------
Confidence            34688888888866655334556778899999999999999999999999999999883  66666664           


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCcccccccccccc
Q 043074          183 QLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY  262 (373)
Q Consensus       183 ~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y  262 (373)
                             ++.....--+.||+.||.|||. +.+++|+++.-+.|++++.|+.||++|.++........ ......--..|
T Consensus       101 -------l~~~~v~~Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~  171 (690)
T KOG1243|consen  101 -------LGKEEVCLGLFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESF  171 (690)
T ss_pred             -------hHHHHHHHHHHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcc
Confidence                   3345556678999999999986 78899999999999999999999999998865422111 01111222357


Q ss_pred             cCccccCCCCCCCccccchhhhHHHHHHHhCCCC
Q 043074          263 MPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP  296 (373)
Q Consensus       263 ~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p  296 (373)
                      ..|+.+..+   ....|.|-||++++|++.|..+
T Consensus       172 ~~P~~~~~s---~~s~D~~~Lg~li~el~ng~~~  202 (690)
T KOG1243|consen  172 DDPEEIDPS---EWSIDSWGLGCLIEELFNGSLL  202 (690)
T ss_pred             cChhhcCcc---ccchhhhhHHHHHHHHhCcccC
Confidence            788776432   2456999999999999999444

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=1.7e-15  Score=128.45  Aligned_cols=203  Identities=22%  Similarity=0.299  Sum_probs=140.0

Q ss_pred             HHHhcCCCCCccceeeEEeeC-----CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHH
Q 043074          130 ETLGKLRHRNIVKILGYCASG-----LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN  204 (373)
Q Consensus       130 ~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~  204 (373)
                      ..+-.+.|.||++++.|+.+.     ....+++|||+.|+|..+|++.+....           .+......+|+.||+.
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~-----------a~~~~~wkkw~tqIls  187 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQK-----------ALFQKAWKKWCTQILS  187 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhh-----------hhhHHHHHHHHHHHHh
Confidence            445556799999999988654     356899999999999999998775432           2677788899999999


Q ss_pred             HHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCC----CcccccccccccccCccccCCCCCCCccccc
Q 043074          205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSH----SHVSTQVAGTMGYMPPEYLGGNTAATVMLDV  280 (373)
Q Consensus       205 ~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di  280 (373)
                      ||.|||+++.+++|+++..+.|++..+|-+|++--. ......+.    ........+-++|.+||.=. ....+.++||
T Consensus       188 al~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dI  265 (458)
T KOG1266|consen  188 ALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDI  265 (458)
T ss_pred             hhhhhhccCCccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhh
Confidence            999999999999999999999999999888875321 11111111    11112234567899999743 3345678999


Q ss_pred             hhhhHHHHHHHhCCCCC-CCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC
Q 043074          281 YSFGILMIEIATQIRPN-LPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP  359 (373)
Q Consensus       281 wslG~~l~el~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  359 (373)
                      |+||....||.-+..-. ...+....          .....+....+.+.+            -..++..|++..|..||
T Consensus       266 y~fgmcAlemailEiq~tnseS~~~~----------ee~ia~~i~~len~l------------qr~~i~kcl~~eP~~rp  323 (458)
T KOG1266|consen  266 YKFGMCALEMAILEIQSTNSESKVEV----------EENIANVIIGLENGL------------QRGSITKCLEGEPNGRP  323 (458)
T ss_pred             hhhhHHHHHHHHheeccCCCcceeeh----------hhhhhhheeeccCcc------------ccCcCcccccCCCCCCc
Confidence            99999999998765331 11110000          011112222222232            23467889999999999


Q ss_pred             CHHHHHHH
Q 043074          360 AMSYVVQL  367 (373)
Q Consensus       360 s~~~l~~~  367 (373)
                      ++++++..
T Consensus       324 ~ar~llfH  331 (458)
T KOG1266|consen  324 DARLLLFH  331 (458)
T ss_pred             chhhhhcC
Confidence            99988643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=2.7e-15  Score=137.50  Aligned_cols=248  Identities=23%  Similarity=0.276  Sum_probs=179.1

Q ss_pred             CCCCCCCeeec--CCCceEEEEEe---CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCee
Q 043074           82 DNFSTDKIIGD--GSFGFVYKAKL---SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLR-HRNIVKILGYCASGLDR  153 (373)
Q Consensus        82 ~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~  153 (373)
                      ..+...+.+|.  |.+|.+|.+..   .++..+|+|.-+..-.  ..-..=.+|+...++++ |+|.++....+..++..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45667788999  99999999965   4678889887432111  11122246777777774 99999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCceeecCCCCceEeC
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN----GLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~----~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      ++-+|++ +.+|..+.+.....              ++....+....+..+    |+.++|  ..+++|.|+||.||+..
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~--------------~p~~~l~~~~~~~~~~~~~al~~~h--s~~~~~~~~kp~~i~~~  256 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNF--------------LPDNLLWNSLRDWLSRDVTALSHLH--SNNIVHDDLKPANIFTT  256 (524)
T ss_pred             eeeeccc-cchhHHhhhccccc--------------CCchhhhhHHhhhhhcccccccccC--CCcccccccchhheecc
Confidence            9999999 67888888765432              566677778888888    999999  78999999999999999


Q ss_pred             CC-CceEEeeeccccccCCCCCc----ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCC
Q 043074          230 SD-FEAHISDFGLARRIDTSHSH----VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDG  304 (373)
Q Consensus       230 ~~-~~~kl~Dfg~~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  304 (373)
                      .+ ..++++|||+...++...-.    ......|...|++||...+  -++..+|+|++|.++.+-.++..++....   
T Consensus       257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~---  331 (524)
T KOG0601|consen  257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGK---  331 (524)
T ss_pred             cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCC---
Confidence            99 88999999999987654421    1222367788999999864  46788999999999999998876532210   


Q ss_pred             CcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                          ...|..           ++.......+.......+...+.+|++.+|..|++.+.+..
T Consensus       332 ----~~~W~~-----------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  332 ----NSSWSQ-----------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ----CCCccc-----------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                011110           00000000111222345666899999999999999887753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=1e-14  Score=135.40  Aligned_cols=141  Identities=22%  Similarity=0.282  Sum_probs=99.6

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCccccccH----------------------------------------HHHH
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGF----------------------------------------REFR  126 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  126 (373)
                      .+.||.|++|.||+|++++|+.||||+.........                                        -++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999865421110                                        0134


Q ss_pred             HHHHHHhcC----CCCCccceeeEEe-eCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHH
Q 043074          127 AEMETLGKL----RHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG  201 (373)
Q Consensus       127 ~e~~~l~~l----~h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  201 (373)
                      +|+..+.++    +|.+-+.+-.++. -....++||||++|++|.++.......              .   ....++.+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--------------~---~~~~ia~~  264 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--------------L---DRKALAEN  264 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--------------C---CHHHHHHH
Confidence            455555554    2333333333332 234578999999999998876532211              2   23446666


Q ss_pred             HHH-HHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccC
Q 043074          202 VAN-GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID  246 (373)
Q Consensus       202 i~~-~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  246 (373)
                      ++. .+..+|  ..|++|+|++|.||+++++++++++|||++..+.
T Consensus       265 ~~~~~l~ql~--~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       265 LARSFLNQVL--RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHH--hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            655 467888  7899999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=9.4e-13  Score=107.22  Aligned_cols=127  Identities=22%  Similarity=0.218  Sum_probs=93.9

Q ss_pred             CeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCcc-ceeeEEeeCCeeEEEEEecCCCCHH
Q 043074           88 KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV-KILGYCASGLDRVLIYEFVENGSLD  166 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L~  166 (373)
                      +.++.|.++.||++... +..+++|........ ...+..|+..+..+.+.+++ +++.+.  ....++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL-LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCccc-ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            56889999999999875 778999997654321 23456889999988655554 444433  33458999999998875


Q ss_pred             HHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-----ceeecCCCCceEeCCCCceEEeeecc
Q 043074          167 QWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP-----IIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       167 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~-----i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      ..    .                ..   ....+.+++++|+.||  ..+     ++|+|++|.||+++ ++.++++|||.
T Consensus        80 ~~----~----------------~~---~~~~~~~l~~~l~~LH--~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~  133 (170)
T cd05151          80 TE----D----------------FS---DPENLEKIAKLLKKLH--SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY  133 (170)
T ss_pred             cc----c----------------cc---CHHHHHHHHHHHHHHh--CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence            42    0                10   1235678999999999  454     59999999999999 66899999998


Q ss_pred             ccc
Q 043074          242 ARR  244 (373)
Q Consensus       242 ~~~  244 (373)
                      +..
T Consensus       134 a~~  136 (170)
T cd05151         134 AGM  136 (170)
T ss_pred             ccC
Confidence            753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.43  E-value=2e-13  Score=128.33  Aligned_cols=147  Identities=18%  Similarity=0.232  Sum_probs=95.2

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCC-CCEEEEEEeCcccccc----------------------------------HH---
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQG----------------------------------FR---  123 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~---  123 (373)
                      ..|+. +.||+|++|.||+|.+++ |+.||||+..+.....                                  .+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 689999999999999887 9999999987542110                                  01   


Q ss_pred             ---HHHHHHHHHhcCC----CCCccceeeEEee-CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHH
Q 043074          124 ---EFRAEMETLGKLR----HRNIVKILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR  195 (373)
Q Consensus       124 ---~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~  195 (373)
                         ++.+|+..+.++.    +.+.+.+-.++.+ ....++||||++|+++.++-.-...+.+         ...+.....
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d---------~~~la~~~v  269 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD---------MKLLAERGV  269 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC---------HHHHHHHHH
Confidence               1334444444442    3444444444433 4567899999999999875321111100         000222333


Q ss_pred             HHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC----ceEEeeeccccccCC
Q 043074          196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF----EAHISDFGLARRIDT  247 (373)
Q Consensus       196 ~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg~~~~~~~  247 (373)
                      ..++.|+       .  ..|++|+|++|.||+++.++    .+++.|||+...++.
T Consensus       270 ~~~~~Qi-------f--~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        270 EVFFTQV-------F--RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHH-------H--hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3334444       3  47799999999999999888    999999999987643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.38  E-value=9.4e-12  Score=101.87  Aligned_cols=137  Identities=18%  Similarity=0.196  Sum_probs=97.6

Q ss_pred             CCeeecCCCceEEEEEeC-------CCCEEEEEEeCcccc--c-------------------c-HHHH----HHHHHHHh
Q 043074           87 DKIIGDGSFGFVYKAKLS-------SGVTVAIKKLDKDAF--Q-------------------G-FREF----RAEMETLG  133 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~-------~~~~vavK~~~~~~~--~-------------------~-~~~~----~~e~~~l~  133 (373)
                      ...||.|.-+.||.|...       ++..+|||+.+....  +                   . ...+    .+|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            356899999999999644       247999998632111  0                   0 1122    37999999


Q ss_pred             cCCC--CCccceeeEEeeCCeeEEEEEecCCCCHHH-HhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHH-
Q 043074          134 KLRH--RNIVKILGYCASGLDRVLIYEFVENGSLDQ-WLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL-  209 (373)
Q Consensus       134 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~l-  209 (373)
                      ++..  -++.+.+++    ...++||||+.+..+.. .+...                .++..+...+..+++.+|..+ 
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----------------~~~~~~~~~i~~~i~~~l~~l~  141 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----------------KLNDEEMKNAYYQVLSMMKQLY  141 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----------------ccCHHHHHHHHHHHHHHHHHHH
Confidence            9853  466666654    56789999996643321 12211                144556677889999999999 


Q ss_pred             hcCCCCceeecCCCCceEeCCCCceEEeeeccccccC
Q 043074          210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID  246 (373)
Q Consensus       210 h~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  246 (373)
                      |  +.+++|+||++.||++++ +.+.++|||.+....
T Consensus       142 H--~~glVHGDLs~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         142 K--ECNLVHADLSEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             H--hCCeecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence            7  789999999999999974 679999999887643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.34  E-value=1.5e-11  Score=104.77  Aligned_cols=141  Identities=23%  Similarity=0.329  Sum_probs=104.8

Q ss_pred             CeeecCCCceEEEEEeCCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCC--CCccceeeEEeeCC---eeEEEEEecC
Q 043074           88 KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRH--RNIVKILGYCASGL---DRVLIYEFVE  161 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~  161 (373)
                      +.|+.|.++.+|++...+|..+++|....... .....+..|+.+++.+.+  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999887678999999765432 134567899999999975  44677777766542   5689999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGL-----------------------------  212 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~-----------------------------  212 (373)
                      |.++.+.+...                +++..+...++.+++++|..||+.                             
T Consensus        84 G~~l~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (223)
T cd05154          84 GRVLRDRLLRP----------------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYD  147 (223)
T ss_pred             CEecCCCCCCC----------------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHH
Confidence            98887654321                155556666666666666666631                             


Q ss_pred             -------------------------CCCceeecCCCCceEeCC--CCceEEeeeccccc
Q 043074          213 -------------------------EKPIIHRDIKSSNVLLDS--DFEAHISDFGLARR  244 (373)
Q Consensus       213 -------------------------~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~  244 (373)
                                               ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         148 ASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             hhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                     234699999999999998  66789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.33  E-value=4e-11  Score=94.39  Aligned_cols=143  Identities=23%  Similarity=0.316  Sum_probs=107.1

Q ss_pred             CCCeeecCCCceEEEEEeCCCCEEEEEEeCccccc--------cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           86 TDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ--------GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ....+-+|+-+.|+++.+. |+.++||.-......        ......+|+..+.++.--.|.--.-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4568899999999999885 788788753221111        1334678999999887556655555677777888999


Q ss_pred             EecCC-CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC---c
Q 043074          158 EFVEN-GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF---E  233 (373)
Q Consensus       158 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~---~  233 (373)
                      ||.++ .++.+++...-...             ....-...++++|-+.+.-||  .++++|+||..+||++.+++   .
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-------------~~d~~~~~~~~~iG~~igklH--~ndiiHGDLTTSNill~~~~~~~~  154 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-------------SEDEGLAELARRIGELIGKLH--DNDIIHGDLTTSNILLRSDGNQIT  154 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-------------ccchhHHHHHHHHHHHHHHhh--hCCeecccccccceEEecCCCcCc
Confidence            99966 38888887665432             222333678888999999999  89999999999999997654   4


Q ss_pred             eEEeeeccccc
Q 043074          234 AHISDFGLARR  244 (373)
Q Consensus       234 ~kl~Dfg~~~~  244 (373)
                      +.++|||++..
T Consensus       155 ~~lIdfgls~~  165 (229)
T KOG3087|consen  155 PILIDFGLSSV  165 (229)
T ss_pred             eEEEeecchhc
Confidence            58999999865

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.31  E-value=8.2e-11  Score=106.39  Aligned_cols=229  Identities=16%  Similarity=0.178  Sum_probs=154.1

Q ss_pred             CCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEe----eCCeeEEEEEecCCC-CHHH
Q 043074           94 SFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA----SGLDRVLIYEFVENG-SLDQ  167 (373)
Q Consensus        94 ~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~g-~L~~  167 (373)
                      ...+.|++.. .+|..|++|++.......-.....-++.++++.|+|+|++.+++.    .+...++||+|.++. +|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            3456788854 489999999994433333223345678999999999999999886    345778999998754 7777


Q ss_pred             HhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCC
Q 043074          168 WLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT  247 (373)
Q Consensus       168 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  247 (373)
                      +-................+....++...|.++.|+..||.++|  +.|+.-+-|.+.+|+++.+-+++|...|.......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH--ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH--SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH--hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            6655544332222222223334788999999999999999999  78898899999999999998899988877655432


Q ss_pred             CCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcccccccc
Q 043074          248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD  327 (373)
Q Consensus       248 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (373)
                      ..             .  |-+.+.    .+-|.=.||.+++.|.||......              .......+      
T Consensus       446 d~-------------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~--------------~d~~~~s~------  486 (655)
T KOG3741|consen  446 DP-------------T--EPLESQ----QQNDLRDLGLLLLALATGTENSNR--------------TDSTQSSH------  486 (655)
T ss_pred             CC-------------C--cchhHH----hhhhHHHHHHHHHHHhhccccccc--------------ccchHHHH------
Confidence            22             0  112211    245888999999999998654111              00000000      


Q ss_pred             CccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 043074          328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLL  368 (373)
Q Consensus       328 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L  368 (373)
                          ...+....+.++++++......++++ -+.++++..+
T Consensus       487 ----~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  487 ----LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             ----HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                01113334557778888888888776 5666666543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=2.4e-12  Score=118.38  Aligned_cols=244  Identities=20%  Similarity=0.194  Sum_probs=171.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe--CCCCEEEEEEeCccccccHHH--HHHHHHHHhcC-CCCCccceeeEEeeCCeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL--SSGVTVAIKKLDKDAFQGFRE--FRAEMETLGKL-RHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  155 (373)
                      ..+|.....||.|.|+.|++...  .++..+++|.+.+.......+  -..|+.+...+ .|.++++....+......++
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            34677788999999999999853  367888999876544332222  24566665555 48899988888877788889


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC-Cce
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-FEA  234 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~-~~~  234 (373)
                      -.|||+++++...+....               .+.....+++..|++.++.++|  ...++|+|++|+||++..+ +..
T Consensus       344 p~e~~~~~s~~l~~~~~~---------------~~d~~~~~~~~~q~~~~l~~i~--s~~~~~~d~~psni~i~~~~~~~  406 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTSQ---------------MLDEDPRLRLTAQILTALNVIH--SKLFVHLDVKPSNILISNDGFFS  406 (524)
T ss_pred             chhhhcCcchhhhhHHHH---------------hcCcchhhhhHHHHHhcccccc--chhhhcccccccceeeccchhhh
Confidence            999999998877763222               1677788999999999999999  7889999999999999886 788


Q ss_pred             EEeeeccccccCCCCCccccccccccccc-CccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYM-PPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~-aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +++|||++..+...    .......-+++ .+|.+.....+..+.|++|||.-+.|.+++..-...    ..     .|.
T Consensus       407 ~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~----~~-----~~~  473 (524)
T KOG0601|consen  407 KLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES----GV-----QSL  473 (524)
T ss_pred             hcccccccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcc----cc-----cce
Confidence            99999998653211    11122333445 356665566678899999999999999987643111    00     010


Q ss_pred             HHHHHhccccccccCc-cccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 043074          314 RTMEARNKEIEMVDSN-ISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLL  368 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L  368 (373)
                      .           +... ....  +.. ..++..+...+...++..||.+.++....
T Consensus       474 ~-----------i~~~~~p~~--~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  474 T-----------IRSGDTPNL--PGL-KLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             e-----------eecccccCC--Cch-HHhhhhhhhhhcCCccccchhhhhhcccc
Confidence            0           0000 0010  111 25677788889999999999998876544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=4.8e-11  Score=94.36  Aligned_cols=131  Identities=22%  Similarity=0.371  Sum_probs=100.3

Q ss_pred             CeeecCCCceEEEEEeCCCCEEEEEEeCccccc--------cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           88 KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ--------GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ..+++|+-+.++.+.+. |.++++|.-.+....        ..+.-.+|+.++.++.--.|.-..=+..+.....++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999775 555777754322221        122356899999988765555555566777888999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      .+|..|.+++....                      ..++..+-.-+.-||  ..+|+|+||.++||+++.++ +.++||
T Consensus        81 I~G~~lkd~l~~~~----------------------~~~~r~vG~~vg~lH--~~givHGDLTtsNiIl~~~~-i~~IDf  135 (204)
T COG3642          81 IEGELLKDALEEAR----------------------PDLLREVGRLVGKLH--KAGIVHGDLTTSNIILSGGR-IYFIDF  135 (204)
T ss_pred             eCChhHHHHHHhcc----------------------hHHHHHHHHHHHHHH--hcCeecCCCccceEEEeCCc-EEEEEC
Confidence            99999998887541                      356777778889999  89999999999999998775 999999


Q ss_pred             ccccc
Q 043074          240 GLARR  244 (373)
Q Consensus       240 g~~~~  244 (373)
                      |++..
T Consensus       136 GLg~~  140 (204)
T COG3642         136 GLGEF  140 (204)
T ss_pred             Ccccc
Confidence            99864

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.16  E-value=1.6e-09  Score=93.82  Aligned_cols=141  Identities=18%  Similarity=0.202  Sum_probs=101.6

Q ss_pred             CeeecCCCceEEEEEeCCCCEEEEEEeCcccccc-H----------HHHHHHHHHHhcCCC--CCccceeeEEee-----
Q 043074           88 KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQG-F----------REFRAEMETLGKLRH--RNIVKILGYCAS-----  149 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~e~~~l~~l~h--~niv~l~~~~~~-----  149 (373)
                      +.+-......|++..+ +|+.+.||......... .          ..+.+|...+.++..  -...+.+++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4566555566778766 57899999774433110 1          136788888888843  333445555543     


Q ss_pred             CCeeEEEEEecCCC-CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe
Q 043074          150 GLDRVLIYEFVENG-SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL  228 (373)
Q Consensus       150 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill  228 (373)
                      ....++|+|++++. +|.+++......             +.+......++.+++..+.-||  ..|++|+|++++|||+
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~-------------~~~~~~~~~ll~~la~~i~~LH--~~Gi~HgDL~~~NiLl  171 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATN-------------PPDPRLKRMLIKRVATMVRDMH--AAGINHRDCYICHFLL  171 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhccc-------------CCCHHHHHHHHHHHHHHHHHHH--HCcCccCCCChhhEEE
Confidence            23578999999876 899988643211             1456677889999999999999  8999999999999999


Q ss_pred             CC-------CCceEEeeeccccc
Q 043074          229 DS-------DFEAHISDFGLARR  244 (373)
Q Consensus       229 ~~-------~~~~kl~Dfg~~~~  244 (373)
                      +.       ++.+.++||+.+..
T Consensus       172 ~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        172 HLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eccccCCCCCceEEEEECCcccc
Confidence            75       46899999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.10  E-value=1.2e-09  Score=89.25  Aligned_cols=126  Identities=25%  Similarity=0.316  Sum_probs=82.2

Q ss_pred             eEEEEEeCCCCEEEEEEeCccccc---------------------c-----HHHHHHHHHHHhcCCCC--CccceeeEEe
Q 043074           97 FVYKAKLSSGVTVAIKKLDKDAFQ---------------------G-----FREFRAEMETLGKLRHR--NIVKILGYCA  148 (373)
Q Consensus        97 ~V~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~--niv~l~~~~~  148 (373)
                      .||.|...+|..+|+|+.......                     .     .....+|.+.|.++...  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            389998888999999986432110                     0     12356899999999765  456665442 


Q ss_pred             eCCeeEEEEEecC--CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCceeecCCCCc
Q 043074          149 SGLDRVLIYEFVE--NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY-LHGLEKPIIHRDIKSSN  225 (373)
Q Consensus       149 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~-lh~~~~~i~H~dlk~~N  225 (373)
                         ..++||||++  |..+..+....                 ++......++.+++..+.. +|  ..|++|+||.+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----------------~~~~~~~~~~~~il~~~~~~~~--~~givHGDLs~~N  137 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----------------LSPEEPKELLEEILEEIIKMLH--KAGIVHGDLSEYN  137 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----------------GGGSTHHHHHHHHHHHHHHHHH--CTTEEESS-STTS
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----------------ccchhHHHHHHHHHHHHHHHHH--hcCceecCCChhh
Confidence               4579999998  55554433321                 1223456677888886555 57  7899999999999


Q ss_pred             eEeCCCCceEEeeeccccccC
Q 043074          226 VLLDSDFEAHISDFGLARRID  246 (373)
Q Consensus       226 ill~~~~~~kl~Dfg~~~~~~  246 (373)
                      |+++++ .+.++|||.+....
T Consensus       138 Ilv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  138 ILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             EEEETT-CEEE--GTTEEETT
T ss_pred             EEeecc-eEEEEecCcceecC
Confidence            999988 89999999887643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.06  E-value=1.9e-08  Score=89.20  Aligned_cols=268  Identities=15%  Similarity=0.123  Sum_probs=155.7

Q ss_pred             CCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeE------EeeCC-eeEEE
Q 043074           85 STDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGY------CASGL-DRVLI  156 (373)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~------~~~~~-~~~lv  156 (373)
                      .....||+|+-+.+|..-.  -.-.+-|+..........+   .+..|... .||-+..=+.+      -.++. ..-+.
T Consensus        14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            3456799999999996521  1223557775544332222   22333333 46644331111      01122 24466


Q ss_pred             EEecCCC-CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          157 YEFVENG-SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       157 ~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |...++. ....++.-......         .--.+|...+++++.++.+.+-||  ..|.+-+|+.++|+|+++++.|.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs---------~P~~~w~fllrvaRnlA~aFA~lH--~~Gh~vGDVn~~~~lVsd~~~V~  157 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQS---------YPHCAWDFLLRVARNLASAFATLH--EHGHVVGDVNQNSFLVSDDSKVV  157 (637)
T ss_pred             cccCCCccchhhhcCchhhccc---------CCccccHHHHHHHHHHHHHHHHHH--hcCCcccccCccceeeecCceEE
Confidence            6666544 22222222111111         112789999999999999999999  89999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhC-CCCCCCcccCCCcccHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQ-IRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~  310 (373)
                      |.|-..-.... . ........|...|.+||...-    .-.-+..+|.|-||+++++++.| ..|+...........-.
T Consensus       158 LVdsDsfqi~~-n-g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~  235 (637)
T COG4248         158 LVDSDSFQINA-N-GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL  235 (637)
T ss_pred             EEcccceeecc-C-CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc
Confidence            99855433321 1 112233567889999998751    11235678999999999999988 55544333222221111


Q ss_pred             H--HHHHHHHhcc-ccccccCccccccCCHHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHHHHhh
Q 043074          311 E--WARTMEARNK-EIEMVDSNISREELSEAGVREYFRIACMCTNE--KSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       311 ~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~~l~~~L~~l  371 (373)
                      +  ........-. .-..+.+ -.+...-.-.+..+..+..+|+..  ++.-|||++-++..|..+
T Consensus       236 E~~Ia~g~f~ya~~~~~g~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         236 ETDIAHGRFAYASDQRRGLKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             hhhhhcceeeechhccCCCCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            1  0000000000 0000000 011222234466788899999964  467899999999988765

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.04  E-value=7.3e-11  Score=114.73  Aligned_cols=249  Identities=23%  Similarity=0.257  Sum_probs=158.2

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeC---ccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLD---KDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~---~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ..+.+.+.+-+.+|.++.++.+.-. .|...++|...   +-.....+....+-.++-...+|-++...-.+.-....+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4456777778889999999877432 23222333221   1111112222333333333445666555544556678899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      +++|..+++|...++....               .+..-.......+..+++|||  ...+.|+|++|.|.++..+++.+
T Consensus       882 ~~~~~~~~~~~Skl~~~~~---------------~saepaRs~i~~~vqs~e~L~--s~~r~h~~~~p~~~l~~~~gh~~  944 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC---------------LSAEPARSPILERVQSLESLH--SSLRKHRDLKPDSLLIAYDGHRP  944 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC---------------cccccccchhHHHHhhhhccc--cchhhcccccccchhhcccCCcc
Confidence            9999999999999887663               222223334555778899999  56689999999999999999999


Q ss_pred             EeeeccccccCCC---------------------C---------CcccccccccccccCccccCCCCCCCccccchhhhH
Q 043074          236 ISDFGLARRIDTS---------------------H---------SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGI  285 (373)
Q Consensus       236 l~Dfg~~~~~~~~---------------------~---------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~  285 (373)
                      ++|||.....+.-                     .         ........+|+.|.+||...+.. ....+|.|++|+
T Consensus       945 l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~ 1023 (1205)
T KOG0606|consen  945 LTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGV 1023 (1205)
T ss_pred             cCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhh
Confidence            9999844332100                     0         01122356899999999998654 566789999999


Q ss_pred             HHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 043074          286 LMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMS  362 (373)
Q Consensus       286 ~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (373)
                      .++|.++|.+|+........-             ..+.   ...+.-..-+...+.+..+++...+..+|.+|-.+.
T Consensus      1024 ~l~e~l~g~pp~na~tpq~~f-------------~ni~---~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1024 CLFEVLTGIPPFNAETPQQIF-------------ENIL---NRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhhhcCCCCCCCcchhhhh-------------hccc---cCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            999999999996543222110             0000   001111111334455778888888888998887664

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.98  E-value=5.9e-09  Score=87.69  Aligned_cols=137  Identities=22%  Similarity=0.221  Sum_probs=98.6

Q ss_pred             CCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccc----------------------ccHHHHHHHHHHHhcCCCC--
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF----------------------QGFREFRAEMETLGKLRHR--  138 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--  138 (373)
                      -..++..||-|.-+.||.|...+|.+++||.=.....                      .......+|.+.|.+|...  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            3456789999999999999998999999995211100                      0122457899999998654  


Q ss_pred             CccceeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 043074          139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIH  218 (373)
Q Consensus       139 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H  218 (373)
                      .+.+.+++    +...+|||+.+|--|...-                    ++....-.++..|++-+.-+-  ..|++|
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------------------~~~en~~~il~~il~~~~~~~--~~GiVH  225 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR--------------------LDVENPDEILDKILEEVRKAY--RRGIVH  225 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc--------------------CcccCHHHHHHHHHHHHHHHH--HcCccc
Confidence            66666654    5567999999886654422                    122333445556666665555  588999


Q ss_pred             ecCCCCceEeCCCCceEEeeecccccc
Q 043074          219 RDIKSSNVLLDSDFEAHISDFGLARRI  245 (373)
Q Consensus       219 ~dlk~~Nill~~~~~~kl~Dfg~~~~~  245 (373)
                      +|+++-||+++++|.+.++||--+...
T Consensus       226 GDlSefNIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         226 GDLSEFNILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             cCCchheEEEecCCCEEEEeCcccccC
Confidence            999999999999999999999766543

>PRK09902 hypothetical protein; Provisional

Probab=98.92  E-value=3.1e-08  Score=81.42  Aligned_cols=154  Identities=16%  Similarity=0.203  Sum_probs=109.1

Q ss_pred             hHHHHHhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccc------cccHHHHHHHHHHHhcCCC--CCccceee
Q 043074           74 MSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDA------FQGFREFRAEMETLGKLRH--RNIVKILG  145 (373)
Q Consensus        74 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--~niv~l~~  145 (373)
                      ++........+-..---|.||.+-|+.-... |..+-+|.-...-      .-+...|.+|...+.++..  -.+.+.. 
T Consensus        10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-   87 (216)
T PRK09902         10 FNHWWATEGDWVEEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-   87 (216)
T ss_pred             HHHHHhCCCceecCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-
Confidence            3334433333333334567999999998775 4578889764211      2245689999999999853  2344444 


Q ss_pred             EEe-e----CCeeEEEEEecCC-CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceee
Q 043074          146 YCA-S----GLDRVLIYEFVEN-GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHR  219 (373)
Q Consensus       146 ~~~-~----~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~  219 (373)
                      ++. .    ....+||+|-+.+ -+|.+++.+....             +.+......+..+++..+.-||  +.|+.|+
T Consensus        88 f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~-------------~~~~~~k~~il~~va~~ia~LH--~~Gv~Hg  152 (216)
T PRK09902         88 FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVS-------------PYSDEVRQAMLKAVALAFKKMH--SVNRQHG  152 (216)
T ss_pred             eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcC-------------CcchHHHHHHHHHHHHHHHHHH--HCCCcCC
Confidence            332 1    1245799997753 4899988665432             2567778899999999999999  8999999


Q ss_pred             cCCCCceEeCCCCc--eEEeeeccccc
Q 043074          220 DIKSSNVLLDSDFE--AHISDFGLARR  244 (373)
Q Consensus       220 dlk~~Nill~~~~~--~kl~Dfg~~~~  244 (373)
                      |+.+.||+++.++.  ++++||.-++.
T Consensus       153 dly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        153 CCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             CCCHhheeecCCCCeeEEEEEhhccch
Confidence            99999999986666  99999987764

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=4.7e-10  Score=105.05  Aligned_cols=151  Identities=21%  Similarity=0.308  Sum_probs=103.5

Q ss_pred             HHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCc----c----cccccccccccCccccCCC
Q 043074          200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH----V----STQVAGTMGYMPPEYLGGN  271 (373)
Q Consensus       200 ~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~----~----~~~~~g~~~y~aPE~~~~~  271 (373)
                      .+++.|+.|+|. +.++||++|.|++|.++.++.+||+.|+.+.........    .    ..-......|.|||.+.+ 
T Consensus       106 ~~v~dgl~flh~-sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR-SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-  183 (700)
T ss_pred             hcccchhhhhcc-CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-
Confidence            345589999997 778999999999999999999999999988754331110    0    011123457999999985 


Q ss_pred             CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhc
Q 043074          272 TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCT  351 (373)
Q Consensus       272 ~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  351 (373)
                      ...+.++|+||+|+++|.+..|+.+-.......     ..+.....        .+ .......+.+.|.++.+=+.+++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~~~~~--------~~-~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYSFSRN--------LL-NAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCc-----chhhhhhc--------cc-ccccccccccCcHHHHHHHHHHh
Confidence            557889999999999999997777632211110     00000000        00 11111124556778999999999


Q ss_pred             CCCCCCCCCHHHHHH
Q 043074          352 NEKSRERPAMSYVVQ  366 (373)
Q Consensus       352 ~~~p~~RPs~~~l~~  366 (373)
                      ..++.-||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998877653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.85  E-value=4e-08  Score=82.37  Aligned_cols=105  Identities=26%  Similarity=0.318  Sum_probs=82.7

Q ss_pred             HHHHHHHHHHhcCC--CCCccceeeEEeeC----CeeEEEEEecCCC-CHHHHhhcCCCCCCCCcccccCCCCCCCHHHH
Q 043074          123 REFRAEMETLGKLR--HRNIVKILGYCASG----LDRVLIYEFVENG-SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR  195 (373)
Q Consensus       123 ~~~~~e~~~l~~l~--h~niv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~  195 (373)
                      ....+|...+..+.  .-.+.+.+++....    ...++|+|++++. +|.+++.....               .+....
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---------------~~~~~~  120 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---------------LDPSQR  120 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---------------cchhhH
Confidence            45678888877774  33455666666543    2458999999874 89999876432               345567


Q ss_pred             HHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC---ceEEeeeccccc
Q 043074          196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF---EAHISDFGLARR  244 (373)
Q Consensus       196 ~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~  244 (373)
                      ..++.+++..++-||  ..|++|+|+++.|||++.++   .+.++||+-++.
T Consensus       121 ~~ll~~l~~~i~~lH--~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  121 RELLRALARLIAKLH--DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHHHHHHHHHH--HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            889999999999999  89999999999999999887   899999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.72  E-value=3.5e-07  Score=77.63  Aligned_cols=72  Identities=17%  Similarity=0.174  Sum_probs=53.8

Q ss_pred             CeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCC--ccceeeEEeeCCeeEEEEEecCCCC
Q 043074           88 KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN--IVKILGYCASGLDRVLIYEFVENGS  164 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~  164 (373)
                      ..||.|..+.||+.   .+..+++|......  ......+|.+.++.+..-.  +.+.+++....+...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            46899999999984   25567888876533  2345688999999886433  4667777777777889999998863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.68  E-value=1.1e-07  Score=89.34  Aligned_cols=142  Identities=23%  Similarity=0.278  Sum_probs=93.3

Q ss_pred             CeeecCCCceEEEEEeCCCCEEEEEEeCccccccH------------------------------H----------HHHH
Q 043074           88 KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGF------------------------------R----------EFRA  127 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~  127 (373)
                      +-|+.++-|.||+|.+++|+.||||+....-.+..                              +          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            57999999999999999999999998755332210                              0          1334


Q ss_pred             HHHHHhcCC----CCCccceeeEEe-eCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHH
Q 043074          128 EMETLGKLR----HRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV  202 (373)
Q Consensus       128 e~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi  202 (373)
                      |...+.+++    +..-+.+-.++. -.+...|+|||++|-.+.+...-...+              ++...   ++..+
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--------------~d~k~---ia~~~  273 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--------------IDRKE---LAELL  273 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--------------CCHHH---HHHHH
Confidence            555555542    222233333333 346778999999999888874332221              33222   22222


Q ss_pred             HHH-HHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCC
Q 043074          203 ANG-LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS  248 (373)
Q Consensus       203 ~~~-l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  248 (373)
                      +++ +.-+-  ..|+.|.|..|.||+++.+|++.+.|||+...++..
T Consensus       274 ~~~f~~q~~--~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         274 VRAFLRQLL--RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHHHHHHHH--hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            222 12222  467999999999999999999999999999876543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.58  E-value=1.2e-06  Score=72.44  Aligned_cols=138  Identities=16%  Similarity=0.223  Sum_probs=92.1

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHH---------HHHHHHHHhcCC---CCCccceeeEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFRE---------FRAEMETLGKLR---HRNIVKILGYC  147 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~---h~niv~l~~~~  147 (373)
                      ...+|...+++.......|.+-.. +|..+++|..........+.         ..+.+..+.++.   -...+.++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            356788888888888777877766 47899999876544332222         223444444443   23333333322


Q ss_pred             e-----eCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCC
Q 043074          148 A-----SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIK  222 (373)
Q Consensus       148 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk  222 (373)
                      .     -....++++||++|..|.+...                   ++.    .++..+.+++.-+|  +.|+.|+|..
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------------------i~e----~~~~ki~~~ikqlH--~~G~~HGD~h  162 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------------------IDE----DLAEKIVEAIKQLH--KHGFYHGDPH  162 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------------------cCH----HHHHHHHHHHHHHH--HcCCccCCCC
Confidence            2     2245568999999988866532                   222    24556778899999  8999999999


Q ss_pred             CCceEeCCCCceEEeeeccccc
Q 043074          223 SSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       223 ~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                      |.|++++++ .++++||+..+.
T Consensus       163 pgNFlv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  163 PGNFLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             cCcEEEECC-cEEEEECccccc
Confidence            999999865 499999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.49  E-value=2.4e-06  Score=73.83  Aligned_cols=76  Identities=16%  Similarity=0.134  Sum_probs=54.3

Q ss_pred             eeecCCC-ceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEEecCCCCHH
Q 043074           89 IIGDGSF-GFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLIYEFVENGSLD  166 (373)
Q Consensus        89 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  166 (373)
                      .|..|.+ +.||+.... +..+++|......   ...+.+|+.+++.+. +--+.+++++...++..++|||+++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3555555 788999764 4788888876543   235667888888874 444667777776666789999999988776


Q ss_pred             HH
Q 043074          167 QW  168 (373)
Q Consensus       167 ~~  168 (373)
                      ..
T Consensus        81 ~~   82 (244)
T cd05150          81 AL   82 (244)
T ss_pred             Hh
Confidence            44

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.48  E-value=3.2e-06  Score=70.72  Aligned_cols=156  Identities=24%  Similarity=0.319  Sum_probs=101.4

Q ss_pred             cccChHHHHHhcCCCCCCCeee---cCCCceEEEEEeCCCCEEEEEEeCcccccc-------------------HHH---
Q 043074           70 SQISMSELIDATDNFSTDKIIG---DGSFGFVYKAKLSSGVTVAIKKLDKDAFQG-------------------FRE---  124 (373)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~lg---~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------~~~---  124 (373)
                      ...+...+....++..+....|   +|.-+.||+|...++..+|+|++.......                   .++   
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            4445555655566666655544   666678999988889999999985433221                   011   


Q ss_pred             --HHHHHHHHhcCC--CCCccceeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHH
Q 043074          125 --FRAEMETLGKLR--HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR  200 (373)
Q Consensus       125 --~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  200 (373)
                        ..+|..-|.++.  +-.+.+-+++.    +..|||||+.....              ++..+... ++...+...+..
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~--------------pAP~LkDv-~~e~~e~~~~~~  173 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGL--------------PAPRLKDV-PLELEEAEGLYE  173 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCC--------------CCCCcccC-CcCchhHHHHHH
Confidence              235666777663  34444444442    45699999954310              00111111 133346777788


Q ss_pred             HHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccC
Q 043074          201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID  246 (373)
Q Consensus       201 qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  246 (373)
                      ++++.+.-|-. ..++||+||+.-|||+. ++.+.++|||-+....
T Consensus       174 ~~v~~~~~l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         174 DVVEYMRRLYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHHHHHH-hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            88888887762 48899999999999999 7799999999886544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.42  E-value=3.7e-06  Score=72.02  Aligned_cols=77  Identities=18%  Similarity=0.270  Sum_probs=56.3

Q ss_pred             CeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCC--CccceeeEEee---CCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHR--NIVKILGYCAS---GLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~~  162 (373)
                      +.++.|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  .+.+++.+...   ....+++++++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            568999999999999876 69999997655  3346677888888888533  35566664422   3356899999998


Q ss_pred             CCHHH
Q 043074          163 GSLDQ  167 (373)
Q Consensus       163 g~L~~  167 (373)
                      ..+..
T Consensus        80 ~~~~~   84 (239)
T PF01636_consen   80 RPLDD   84 (239)
T ss_dssp             EEHHH
T ss_pred             ccccc
Confidence            88877

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.35  E-value=7.4e-08  Score=89.80  Aligned_cols=191  Identities=20%  Similarity=0.159  Sum_probs=130.2

Q ss_pred             HHHhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCC-ccceeeEEeeCCeeEE
Q 043074           77 LIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN-IVKILGYCASGLDRVL  155 (373)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~l  155 (373)
                      +++.+..+...+-+++|+++.++|.+-.-.+....+.+...     ....-++++|.+++||| .+..++-+..+...++
T Consensus       237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i  311 (829)
T KOG0576|consen  237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI  311 (829)
T ss_pred             ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence            34445566666778999999999886433334445555332     34456889999999999 6666666666677889


Q ss_pred             EEEecCCC-CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          156 IYEFVENG-SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       156 v~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      .++++..+ +-......              ....+...+...+.+.-+++++++|  +..-+|+|    ||+..+ +..
T Consensus       312 ~~~i~s~~rs~~~~~~~--------------se~~~~~~~~~~~~r~et~~l~~l~--~~~~~~~d----~~l~s~-~~~  370 (829)
T KOG0576|consen  312 PMRICSTGRSSALEMTV--------------SEIALEQYQFAYPLRKETRPLAELH--SSYKVHRD----NILGSE-EEV  370 (829)
T ss_pred             hhhhhcCCccccccCCh--------------hhHhhhhhhhhhhhhhhcccccccc--cccccCcc----cccccc-ccc
Confidence            99999776 21111100              0001333344555666778899999  43357888    777665 579


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCC
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP  296 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p  296 (373)
                      +.+||+....+....  ......+++.|+|||+..++ .+....|.|++|+-..++.-|.+|
T Consensus       371 ~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  371 KLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             ccccccCCcccCccc--ccccCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCC
Confidence            999999987765432  34556789999999988744 477788999999877777777666

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.35  E-value=6.1e-06  Score=65.27  Aligned_cols=129  Identities=21%  Similarity=0.267  Sum_probs=88.3

Q ss_pred             CCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCC
Q 043074           85 STDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGS  164 (373)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  164 (373)
                      ...+.|++|.+|.||+|.+. |..+|+|+-..++..  ..+..|++++..+.-.++.+=+-.+..   .++.|||..|-.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcc
Confidence            34567999999999999986 568899987665544  678899999999987776654333322   234499998888


Q ss_pred             HHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCC--CceEeCCCCceEEeeeccc
Q 043074          165 LDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKS--SNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       165 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~--~Nill~~~~~~kl~Dfg~~  242 (373)
                      |.++-....                      .+-...+++.---|-  ..||-|+.|.-  .||++++ +.+.|+||..|
T Consensus        99 L~~~~~~~~----------------------rk~l~~vlE~a~~LD--~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~A  153 (201)
T COG2112          99 LGKLEIGGD----------------------RKHLLRVLEKAYKLD--RLGIEHGELSRPWKNVLVND-RDVYIIDFDSA  153 (201)
T ss_pred             hhhhhhccc----------------------HHHHHHHHHHHHHHH--HhccchhhhcCCceeEEecC-CcEEEEEccch
Confidence            876544211                      122333444433444  67788988864  4555554 48999999988


Q ss_pred             cc
Q 043074          243 RR  244 (373)
Q Consensus       243 ~~  244 (373)
                      ..
T Consensus       154 t~  155 (201)
T COG2112         154 TF  155 (201)
T ss_pred             hh
Confidence            63

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.32  E-value=2.8e-05  Score=64.17  Aligned_cols=132  Identities=20%  Similarity=0.357  Sum_probs=90.2

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCccc----------------cccHHHHHHHHHHHhcCC------CCCcccee
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDA----------------FQGFREFRAEMETLGKLR------HRNIVKIL  144 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~l~  144 (373)
                      ...||+|+.-.||.-  .++....||+.....                ....++..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            457999999988854  345567888886655                122456677776666555      88999999


Q ss_pred             eEEeeCCeeEEEEEecCC------CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 043074          145 GYCASGLDRVLIYEFVEN------GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIH  218 (373)
Q Consensus       145 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H  218 (373)
                      |+..++.-.-+|+|...+      -+|.+++....                ++. ...+.+.++   ..||-  +.+|+.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------------~~~-~~~~~L~~f---~~~l~--~~~Iv~  141 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----------------LTE-ELRQALDEF---KRYLL--DHHIVI  141 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----------------ccH-HHHHHHHHH---HHHHH--HcCCee
Confidence            999999888888887643      26888885443                444 333333333   45555  567999


Q ss_pred             ecCCCCceEeCCCC----ceEEee-eccc
Q 043074          219 RDIKSSNVLLDSDF----EAHISD-FGLA  242 (373)
Q Consensus       219 ~dlk~~Nill~~~~----~~kl~D-fg~~  242 (373)
                      +|++|+||++....    .+.|+| ||..
T Consensus       142 ~dl~~~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  142 RDLNPHNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             cCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence            99999999995332    466665 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.32  E-value=1.3e-05  Score=81.26  Aligned_cols=79  Identities=18%  Similarity=0.305  Sum_probs=57.3

Q ss_pred             CCeeecCCCceEEEEEeCCC---CEEEEEEeCcccc-ccHHHHHHHHHHHhcCC-CCCc--cceeeEEeeC---CeeEEE
Q 043074           87 DKIIGDGSFGFVYKAKLSSG---VTVAIKKLDKDAF-QGFREFRAEMETLGKLR-HRNI--VKILGYCASG---LDRVLI  156 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  156 (373)
                      .+.++.|.++.+|+....++   ..+++|+...... .....+.+|+.+++.+. |+++  .+++.+|.+.   ...++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46788999999999876543   4677787644322 23356889999999995 6664  7777877664   467899


Q ss_pred             EEecCCCCH
Q 043074          157 YEFVENGSL  165 (373)
Q Consensus       157 ~e~~~~g~L  165 (373)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.27  E-value=5.2e-06  Score=68.19  Aligned_cols=103  Identities=23%  Similarity=0.239  Sum_probs=78.8

Q ss_pred             HHHHHHhcCCC-CCccceeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHH
Q 043074          127 AEMETLGKLRH-RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG  205 (373)
Q Consensus       127 ~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~  205 (373)
                      .|.-+++.+++ +++.+++|+|..    +.+.||...+++...-..            +......+|..+.+++.++++.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~------------l~~~~~~~w~~R~~iA~~lL~~   71 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRP------------LSQFLQSPWEQRAKIALQLLEL   71 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccc------------cccccccCHHHHHHHHHHHHHH
Confidence            57888888875 699999999953    578999987765432000            0011127899999999999999


Q ss_pred             HHHHhc-CCCCceeecCCCCceEeCCCCceEEeeecccccc
Q 043074          206 LAYLHG-LEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI  245 (373)
Q Consensus       206 l~~lh~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  245 (373)
                      +.++++ ....+.-.|++++|+-+++++++|++|.......
T Consensus        72 l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   72 LEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             HHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            999984 1234778999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.21  E-value=1.2e-05  Score=75.56  Aligned_cols=141  Identities=20%  Similarity=0.255  Sum_probs=89.7

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCcccccc-------------------------------HH------HHHHHH
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQG-------------------------------FR------EFRAEM  129 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~e~  129 (373)
                      .+-||..+.|.|++|++++|+.||||+-++.-...                               .+      +|.+|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            35799999999999999999999999865432210                               00      133444


Q ss_pred             HHHhcC----CCCCc---cceeeEEe-eCCeeEEEEEecCCCCHHHH--hhcCCCCCCCCcccccCCCCCCCHHHHHHHH
Q 043074          130 ETLGKL----RHRNI---VKILGYCA-SGLDRVLIYEFVENGSLDQW--LHDTSRNDDVDGSKQLNSLCPLSWETRVKIV  199 (373)
Q Consensus       130 ~~l~~l----~h~ni---v~l~~~~~-~~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~  199 (373)
                      +-..+.    .|-+.   |.+-.++. -.....|+|||++|..+.+.  +.+.+                ++-..+..-+
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g----------------i~~~~i~~~l  309 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG----------------ISPHDILNKL  309 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC----------------CCHHHHHHHH
Confidence            433333    34441   12223332 23567899999999877654  33332                4444443333


Q ss_pred             HHHHHHHHHHhcCCCCceeecCCCCceEeCC----CCceEEeeeccccccCC
Q 043074          200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDS----DFEAHISDFGLARRIDT  247 (373)
Q Consensus       200 ~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~----~~~~kl~Dfg~~~~~~~  247 (373)
                      .+...-+-+    ..|++|+|=.|.||+++.    ++.+.+.|||+......
T Consensus       310 ~~~~~~qIf----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  310 VEAYLEQIF----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHHHHH----hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            333222222    356999999999999984    67899999999876543

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.18  E-value=1.8e-05  Score=67.95  Aligned_cols=73  Identities=15%  Similarity=0.210  Sum_probs=44.8

Q ss_pred             CeeecCCCc-eEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCC---CccceeeEEeeC---CeeEEEEEec
Q 043074           88 KIIGDGSFG-FVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHR---NIVKILGYCASG---LDRVLIYEFV  160 (373)
Q Consensus        88 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~  160 (373)
                      +.++.|+.. .||+.    +..+++|......  ....+.+|.+.+..+...   .+.++++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            456766655 58875    2357778755422  235788899999887532   334444433322   2347899999


Q ss_pred             CCCCHH
Q 043074          161 ENGSLD  166 (373)
Q Consensus       161 ~~g~L~  166 (373)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            887664

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.08  E-value=3.8e-05  Score=66.83  Aligned_cols=141  Identities=15%  Similarity=0.125  Sum_probs=77.6

Q ss_pred             eecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCc-cceeeEEeeCCeeEEEEEecCCCCHHHH
Q 043074           90 IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI-VKILGYCASGLDRVLIYEFVENGSLDQW  168 (373)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~~~  168 (373)
                      +..|-.+.+|+... ++..+++|........-.-...+|..+++.+....+ .++++...    ..+|+||++|..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            55688889998874 567888887654332211134678888888864433 33444322    3689999988665321


Q ss_pred             --------------hhcCCCCCCCCcccccCCCCCCCHHHH-HHHHHH---------HHHHHHHHhc------CCCCcee
Q 043074          169 --------------LHDTSRNDDVDGSKQLNSLCPLSWETR-VKIVRG---------VANGLAYLHG------LEKPIIH  218 (373)
Q Consensus       169 --------------l~~~~~~~~~~~~~~~~~~~~l~~~~~-~~i~~q---------i~~~l~~lh~------~~~~i~H  218 (373)
                                    +.+-..... .       ..+++.... .....+         +...+..+-.      ....++|
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~-~-------~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H  150 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPR-F-------GYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH  150 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCC-C-------CCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence                          111111000 0       001121111 111111         1111111111      1235899


Q ss_pred             ecCCCCceEeCCCCceEEeeeccccc
Q 043074          219 RDIKSSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       219 ~dlk~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                      +|+.|.||++++++ +.++||+.+..
T Consensus       151 ~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       151 MDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCCcCcEEEeCCC-CEEEeccccCc
Confidence            99999999999877 78999988754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.07  E-value=6.2e-05  Score=64.56  Aligned_cols=73  Identities=18%  Similarity=0.165  Sum_probs=48.1

Q ss_pred             CeeecCCCceEEEEEeCC--CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCc-cceeeEEeeCCeeEEEEEecCCCC
Q 043074           88 KIIGDGSFGFVYKAKLSS--GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI-VKILGYCASGLDRVLIYEFVENGS  164 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  164 (373)
                      +.|..|-.+.+|+....+  +..+++|......... -...+|+.++..+...++ .++++...    ..+++||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            457788889999998764  6789999875433221 223478888888854333 34444332    247999998876


Q ss_pred             H
Q 043074          165 L  165 (373)
Q Consensus       165 L  165 (373)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=98.02  E-value=0.00013  Score=64.69  Aligned_cols=77  Identities=14%  Similarity=0.058  Sum_probs=56.5

Q ss_pred             CCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCC---CCccceeeEEeeC---CeeEEEEEe
Q 043074           86 TDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH---RNIVKILGYCASG---LDRVLIYEF  159 (373)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~e~  159 (373)
                      -.+.||.|..+.||.....++ .+++|..+...  ....+..|...++.+.-   -.+.++++++..+   +..++|||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            345799999999999976555 46667753311  22578899999998853   4678888877543   568999999


Q ss_pred             cCCCCH
Q 043074          160 VENGSL  165 (373)
Q Consensus       160 ~~~g~L  165 (373)
                      ++++++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            988765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.02  E-value=1.7e-05  Score=79.45  Aligned_cols=195  Identities=22%  Similarity=0.259  Sum_probs=129.9

Q ss_pred             HHHHHHHhcCCCCCccceeeEEeeCCeeE----EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHH
Q 043074          126 RAEMETLGKLRHRNIVKILGYCASGLDRV----LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG  201 (373)
Q Consensus       126 ~~e~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  201 (373)
                      ..|.+.+.++.|+|++.++.+.......-    +..++++..++...+....               .++..+.+.+..+
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---------------~i~~~~~r~~~~~  294 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---------------SIPLETLRILHQK  294 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---------------ccCHHHHHHHHHH
Confidence            45677788889999999998875543322    3357777777777776544               3788888899999


Q ss_pred             HHHHHHHHhcCCCCceeecCCCC---ceEeCCCCceEEe--eeccccccCCCCCcccccccccccccCccccCCCC-CCC
Q 043074          202 VANGLAYLHGLEKPIIHRDIKSS---NVLLDSDFEAHIS--DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNT-AAT  275 (373)
Q Consensus       202 i~~~l~~lh~~~~~i~H~dlk~~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~  275 (373)
                      +..||+|+|+  ....|.-+..+   +.-.+.++.+..+  ||+..+.......  ......+..+.+||...... ...
T Consensus       295 ~~~GL~~~h~--~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~  370 (1351)
T KOG1035|consen  295 LLEGLAYLHS--LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKS  370 (1351)
T ss_pred             HhhhHHHHHH--hccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhh
Confidence            9999999994  44555545444   4445666777777  8888876543322  22223455677888775322 223


Q ss_pred             ccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCC
Q 043074          276 VMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKS  355 (373)
Q Consensus       276 ~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p  355 (373)
                      ...|+|++|.++..+..|..+..-..      .                  ...+    ++........+...+|+..++
T Consensus       371 r~~dL~~lgll~~~~~~~~~i~~~~~------~------------------~~~~----l~~~~~~~~~d~~~~~~~~~~  422 (1351)
T KOG1035|consen  371 RLTDLWCLGLLLLQLSQGEDISEKSA------V------------------PVSL----LDVLSTSELLDALPKCLDEDS  422 (1351)
T ss_pred             hhhHHHHHHHHHhhhhhcCccccccc------c------------------hhhh----hccccchhhhhhhhhhcchhh
Confidence            34799999999999998876521100      0                  0000    011122267788899999999


Q ss_pred             CCCCCHHHHHHH
Q 043074          356 RERPAMSYVVQL  367 (373)
Q Consensus       356 ~~RPs~~~l~~~  367 (373)
                      ++|++..+++..
T Consensus       423 ~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  423 EERLSALELLTH  434 (1351)
T ss_pred             hhccchhhhhhc
Confidence            999999998764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.88  E-value=0.00028  Score=57.86  Aligned_cols=125  Identities=26%  Similarity=0.465  Sum_probs=87.5

Q ss_pred             CCCCCCCeeecCCC-ceEEEEEeCCCCEEEEEEeCc---ccc------------------ccHHHHHHHHHHHhcCC---
Q 043074           82 DNFSTDKIIGDGSF-GFVYKAKLSSGVTVAIKKLDK---DAF------------------QGFREFRAEMETLGKLR---  136 (373)
Q Consensus        82 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l~---  136 (373)
                      .+++..+.||.|.- |.||+++.. |+.+|+|.+..   ...                  .....|..|.....+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            68888999999999 999999985 78999999321   000                  01234778888888875   


Q ss_pred             CCCc--cceeeEEeeC------------------CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHH
Q 043074          137 HRNI--VKILGYCASG------------------LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV  196 (373)
Q Consensus       137 h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~  196 (373)
                      +.++  ++++|+..-.                  ..+-+|.||.+...                        .++    .
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------------------~~~----~  167 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------------------PLQ----I  167 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------------------ccc----h
Confidence            4456  8888887321                  11245666554432                        022    2


Q ss_pred             HHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       197 ~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      +-+.+|.+-+..+|  ..+|+-+|+++.|..     .-+|+|||.+
T Consensus       168 ~~~~~~~~dl~~~~--k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  168 RDIPQMLRDLKILH--KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             hHHHHHHHHHHHHH--HCCeeeccCcccccc-----CCEEEecccC
Confidence            33566777788999  899999999999975     3489999864

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.87  E-value=0.00026  Score=64.95  Aligned_cols=75  Identities=21%  Similarity=0.257  Sum_probs=52.7

Q ss_pred             CeeecCCCceEEEEEeCCC-CEEEEEEeCcc------c-cccHHHHHHHHHHHhcCC---CCCccceeeEEeeCCeeEEE
Q 043074           88 KIIGDGSFGFVYKAKLSSG-VTVAIKKLDKD------A-FQGFREFRAEMETLGKLR---HRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  156 (373)
                      +.||.|.++.||++...+| +.++||.-...      . ....+....|.+.|..+.   ..++.+++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4689999999999988776 58999985321      1 113355677888888763   2456666666  44567899


Q ss_pred             EEecCCCC
Q 043074          157 YEFVENGS  164 (373)
Q Consensus       157 ~e~~~~g~  164 (373)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99997643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.82  E-value=0.00022  Score=63.73  Aligned_cols=75  Identities=23%  Similarity=0.303  Sum_probs=48.9

Q ss_pred             CeeecCCCceEEEEEeCC-------CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCc-cceeeEEeeCCeeEEEEEe
Q 043074           88 KIIGDGSFGFVYKAKLSS-------GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI-VKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  159 (373)
                      +.+..|-...+|+....+       ++.+++|....... ......+|..++..+....+ .++++++..    ..|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            356677788999987654       57899999765432 22345678888888753333 345555432    358999


Q ss_pred             cCCCCHHH
Q 043074          160 VENGSLDQ  167 (373)
Q Consensus       160 ~~~g~L~~  167 (373)
                      ++|..+..
T Consensus        79 i~G~~l~~   86 (302)
T cd05156          79 IPSRTLTT   86 (302)
T ss_pred             eCCCcCCH
Confidence            98876643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.81  E-value=0.0011  Score=59.79  Aligned_cols=151  Identities=19%  Similarity=0.236  Sum_probs=77.7

Q ss_pred             CeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCC--Cccceee------EEeeCCeeEEEEEe
Q 043074           88 KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHR--NIVKILG------YCASGLDRVLIYEF  159 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~------~~~~~~~~~lv~e~  159 (373)
                      +.++.|....+|+.+..+| .+++|++....   .+.+..|...+..|...  .+.+.+.      +....+..+++++|
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4566787789999876655 68889875211   23344455555555311  1333332      11234567899999


Q ss_pred             cCCCCHH-----------HHhhcCCCC-CCCCcccccCCCCCCCH-HHHHH------------HHHH-HHHHHHHHhc--
Q 043074          160 VENGSLD-----------QWLHDTSRN-DDVDGSKQLNSLCPLSW-ETRVK------------IVRG-VANGLAYLHG--  211 (373)
Q Consensus       160 ~~~g~L~-----------~~l~~~~~~-~~~~~~~~~~~~~~l~~-~~~~~------------i~~q-i~~~l~~lh~--  211 (373)
                      ++|..+.           ..+.+.... ...... . .....+.| .....            ...+ +...+..+..  
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  181 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLE-R-PNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA  181 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCcc-C-CCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence            9886431           111111110 000000 0 00001112 11111            1111 1112223221  


Q ss_pred             ---CCCCceeecCCCCceEeCCCCceEEeeeccccc
Q 043074          212 ---LEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       212 ---~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                         ...+++|+|+.|.||+++.+...-|+||+.+..
T Consensus       182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence               345799999999999999765568999998753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.77  E-value=0.00091  Score=59.85  Aligned_cols=153  Identities=21%  Similarity=0.203  Sum_probs=81.6

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCC--CccceeeEE------eeCCeeEEEEE
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHR--NIVKILGYC------ASGLDRVLIYE  158 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~------~~~~~~~lv~e  158 (373)
                      .+.++.|....+|+....++ .+++|.......  ...+..|..++..|...  .+.+++...      ...+..+++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            34577777789999876544 677887754321  23455667777666422  234444321      22356789999


Q ss_pred             ecCCCCHH-----------HHhhcCCC-CCCCCcccccCCCCCCCHHHHH------------HHHHHHHHHHHHHh----
Q 043074          159 FVENGSLD-----------QWLHDTSR-NDDVDGSKQLNSLCPLSWETRV------------KIVRGVANGLAYLH----  210 (373)
Q Consensus       159 ~~~~g~L~-----------~~l~~~~~-~~~~~~~~~~~~~~~l~~~~~~------------~i~~qi~~~l~~lh----  210 (373)
                      |++|..+.           ..+..... ....+..... ....-.|....            .....+...++++.    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~-~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKN-SLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCC-CCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            99875432           11111110 0010000000 00001111100            11112333444443    


Q ss_pred             -cCCCCceeecCCCCceEeCCCCceEEeeecccc
Q 043074          211 -GLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR  243 (373)
Q Consensus       211 -~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  243 (373)
                       ....+++|+|+.+.|+++++++.+.|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             135679999999999999988777899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.70  E-value=0.00076  Score=60.04  Aligned_cols=152  Identities=22%  Similarity=0.215  Sum_probs=84.3

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCC--CccceeeE------EeeCCeeEEEEE
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHR--NIVKILGY------CASGLDRVLIYE  158 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e  158 (373)
                      .+.+..|....+|+....+ ..+++|+....   ....+..|+.++..+.+.  .+.+++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4467778888999987654 47888987642   224566778777777432  24444432      123345689999


Q ss_pred             ecCCCCHHH-----------HhhcCCCC-CCCCcccccCCCCCCCHHHHH----------HHHHHHHHHHHHHh-----c
Q 043074          159 FVENGSLDQ-----------WLHDTSRN-DDVDGSKQLNSLCPLSWETRV----------KIVRGVANGLAYLH-----G  211 (373)
Q Consensus       159 ~~~~g~L~~-----------~l~~~~~~-~~~~~~~~~~~~~~l~~~~~~----------~i~~qi~~~l~~lh-----~  211 (373)
                      +++|..+..           .+.+.... ......  ........|....          .....+..++.++.     .
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~  172 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGE--RNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD  172 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCcc--CCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            998876532           11110000 000000  0000112222111          01111223334433     1


Q ss_pred             CCCCceeecCCCCceEeCCCCceEEeeeccccc
Q 043074          212 LEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       212 ~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                      ...+++|+|+.|.|+++++++.+.|.||+.+..
T Consensus       173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            235699999999999999987778999988753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PLN02236 choline kinase

Probab=97.43  E-value=0.0023  Score=58.15  Aligned_cols=146  Identities=19%  Similarity=0.296  Sum_probs=80.9

Q ss_pred             CeeecCCCceEEEEEeCC-----CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCcc-ceeeEEeeCCeeEEEEEecC
Q 043074           88 KIIGDGSFGFVYKAKLSS-----GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV-KILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~  161 (373)
                      ..+..|-...+|+....+     ++.+++|.......... .-.+|..++..+...++. ++++.+..+    .|.+|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            345568888999987532     36889998865443222 225788888888644444 455655433    5789987


Q ss_pred             CCCHHHH--------------hhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHH-----------------HHHHHHH-
Q 043074          162 NGSLDQW--------------LHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV-----------------ANGLAYL-  209 (373)
Q Consensus       162 ~g~L~~~--------------l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi-----------------~~~l~~l-  209 (373)
                      +.+|...              +.+..... .+..     ..+..+.+...+..++                 ...+..| 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~-~~~~-----~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~  190 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLD-MPGP-----KNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE  190 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCC-CCCC-----CCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence            7665421              11111100 0000     0011122222222111                 1111111 


Q ss_pred             ---hc--CCCCceeecCCCCceEeCC-CCceEEeeeccccc
Q 043074          210 ---HG--LEKPIIHRDIKSSNVLLDS-DFEAHISDFGLARR  244 (373)
Q Consensus       210 ---h~--~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~  244 (373)
                         ..  ....++|+|+++.||++++ ++.+.++||..+..
T Consensus       191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence               11  1335899999999999976 46899999988753

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.40  E-value=0.0019  Score=56.74  Aligned_cols=31  Identities=23%  Similarity=0.481  Sum_probs=25.7

Q ss_pred             CCceeecCCCCceEeCCCCc-eEEeeeccccc
Q 043074          214 KPIIHRDIKSSNVLLDSDFE-AHISDFGLARR  244 (373)
Q Consensus       214 ~~i~H~dlk~~Nill~~~~~-~kl~Dfg~~~~  244 (373)
                      ..++|+|++|.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            34899999999999997555 56999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.37  E-value=0.0031  Score=55.86  Aligned_cols=155  Identities=16%  Similarity=0.249  Sum_probs=81.4

Q ss_pred             CeeecCCCceEEEEEeCCCCEEEEEEeCc--cccccHHHHHHHHHHHhcCC--CCCccceeeEEeeCC--eeEEEEEecC
Q 043074           88 KIIGDGSFGFVYKAKLSSGVTVAIKKLDK--DAFQGFREFRAEMETLGKLR--HRNIVKILGYCASGL--DRVLIYEFVE  161 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~--~~~lv~e~~~  161 (373)
                      +.+..|....+|..... ++++++. ...  ..........+|..+++.+.  ---+...++.|.++.  ..+.||+|..
T Consensus        31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve  108 (321)
T COG3173          31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE  108 (321)
T ss_pred             eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence            33444444455555433 7788888 331  22233455667888887774  233455677777666  7799999998


Q ss_pred             CCCHHHHh------------------hcCCCCCCCCcccccC-----CCCCC-CHHHHHHHH--------HHHHHHHHHH
Q 043074          162 NGSLDQWL------------------HDTSRNDDVDGSKQLN-----SLCPL-SWETRVKIV--------RGVANGLAYL  209 (373)
Q Consensus       162 ~g~L~~~l------------------~~~~~~~~~~~~~~~~-----~~~~l-~~~~~~~i~--------~qi~~~l~~l  209 (373)
                      |..+.+.+                  ..-..-. ..+.....     ...++ .|....+.+        -....-..++
T Consensus       109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~id-a~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl  187 (321)
T COG3173         109 GEVVWSALPPESLGRQFALDALADFLAELHSID-AAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL  187 (321)
T ss_pred             ceeccCcCCcccchHHHHHHHHHHHHHHHhCCC-CcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence            74322211                  1111100 00000000     00001 111111000        0111223444


Q ss_pred             hc------CCCCceeecCCCCceEeCCCCceEEeeecccccc
Q 043074          210 HG------LEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI  245 (373)
Q Consensus       210 h~------~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  245 (373)
                      +.      -...++|+|+.+.|++++.++.+-+.||+++..-
T Consensus       188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            42      1225899999999999999988999999998753

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.16  E-value=0.00052  Score=59.97  Aligned_cols=136  Identities=18%  Similarity=0.180  Sum_probs=90.3

Q ss_pred             CCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCc--ccc---------------ccH-----HHHHHHHHHHhcCC-CC-
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDK--DAF---------------QGF-----REFRAEMETLGKLR-HR-  138 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~---------------~~~-----~~~~~e~~~l~~l~-h~-  138 (373)
                      -+..++.||-|.-+.||.+-..+|++.++|.=..  .+.               ..+     -...+|...|+.|. |- 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            4567889999999999999888899998884211  000               001     12356777777774 32 


Q ss_pred             CccceeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 043074          139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIH  218 (373)
Q Consensus       139 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H  218 (373)
                      -+.+.++    -+..++|||+..+-.|...-+-                  .+   .-.+...+..-+--|.  ++|+||
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------------------~d---~~~ly~~lm~~Iv~la--~~GlIH  225 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV------------------ED---PPTLYDDLMGLIVRLA--NHGLIH  225 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeeeec------------------CC---hHHHHHHHHHHHHHHH--HcCcee
Confidence            2333333    3456789999988777553221                  11   1223344444455666  789999


Q ss_pred             ecCCCCceEeCCCCceEEeeecccccc
Q 043074          219 RDIKSSNVLLDSDFEAHISDFGLARRI  245 (373)
Q Consensus       219 ~dlk~~Nill~~~~~~kl~Dfg~~~~~  245 (373)
                      +|+.-=||++++++.++++||--....
T Consensus       226 gDFNEFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  226 GDFNEFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             cccchheeEEecCCCEEEeechHhhcc
Confidence            999999999999999999999755443

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.15  E-value=0.0043  Score=54.57  Aligned_cols=75  Identities=23%  Similarity=0.352  Sum_probs=48.1

Q ss_pred             CCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC---CCCccceeeEEeeCCeeEEEEEecC
Q 043074           85 STDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR---HRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      +..+.++-|..+.+|+.+ .+++.+.+|.-...   ....|..|..-|+.|.   --.+.+++++....+..+|++||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            334678889999999988 56889999987622   2246778888888873   4557788888877777899999997


Q ss_pred             CC
Q 043074          162 NG  163 (373)
Q Consensus       162 ~g  163 (373)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.07  E-value=0.01  Score=53.43  Aligned_cols=82  Identities=16%  Similarity=0.158  Sum_probs=50.9

Q ss_pred             eeecCCCceEEEEEeCCC-CEEEEEEeCc------cc-cccHHHHHHHHHHHhcCC--CCC-ccceeeEEeeCCeeEEEE
Q 043074           89 IIGDGSFGFVYKAKLSSG-VTVAIKKLDK------DA-FQGFREFRAEMETLGKLR--HRN-IVKILGYCASGLDRVLIY  157 (373)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~------~~-~~~~~~~~~e~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv~  157 (373)
                      .||.|....||++...+| +.++||.-..      .. .-..+...-|...|+...  .|. +.+++.  .+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            479999999999987654 6899997522      11 112344456777776653  353 444443  3555667999


Q ss_pred             EecCCC-CHHHHhhcC
Q 043074          158 EFVENG-SLDQWLHDT  172 (373)
Q Consensus       158 e~~~~g-~L~~~l~~~  172 (373)
                      |+++.. .|...+...
T Consensus        80 EdL~~~~ilR~~Li~g   95 (370)
T TIGR01767        80 EDLSHHKIARKGLIEG   95 (370)
T ss_pred             hhCccchHHHHHHHcC
Confidence            998543 454555443

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.06  E-value=0.013  Score=53.78  Aligned_cols=82  Identities=18%  Similarity=0.128  Sum_probs=53.0

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCcccc-------ccHHHHHHHHHHHhcCC---CCCccceeeEEeeCCeeEEE
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF-------QGFREFRAEMETLGKLR---HRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  156 (373)
                      .+.||.|....||+.... +..++||.-.....       .....-..|+..|+.+.   ..++.+++.++.  ...+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            457899999999999764 56799998641111       12233344566666553   347777888776  446789


Q ss_pred             EEecCC--CCHHHHhhc
Q 043074          157 YEFVEN--GSLDQWLHD  171 (373)
Q Consensus       157 ~e~~~~--g~L~~~l~~  171 (373)
                      ||++++  ..+.+-+-.
T Consensus       114 ME~L~~~~~ilr~~Ll~  130 (418)
T PLN02756        114 MRYLEPPHIILRKGLIA  130 (418)
T ss_pred             EeecCCcceehhhhhcc
Confidence            999976  345554433

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.97  E-value=0.0018  Score=60.05  Aligned_cols=50  Identities=18%  Similarity=0.304  Sum_probs=39.9

Q ss_pred             HHHHHHHHHHhcCCCCCccceeeEEeeCC-eeEEEEEecCCCCHHHHhhcCC
Q 043074          123 REFRAEMETLGKLRHRNIVKILGYCASGL-DRVLIYEFVENGSLDQWLHDTS  173 (373)
Q Consensus       123 ~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~  173 (373)
                      .++.....+++.+.|+|..+.+++..... ...+|+|++ +.||++.+....
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence            45667788899999999999998875543 467789999 779999887654

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.93  E-value=0.012  Score=53.18  Aligned_cols=73  Identities=19%  Similarity=0.326  Sum_probs=45.9

Q ss_pred             CeeecCCCceEEEEEeCC----CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCcc-ceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLSS----GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV-KILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.+..|-...+|+....+    +..|++|+........ -.-.+|..+++.+...++. ++++++..+    +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence            345567788899886543    3478999876543322 1235788888888655554 455555322    58888876


Q ss_pred             CCH
Q 043074          163 GSL  165 (373)
Q Consensus       163 g~L  165 (373)
                      ..|
T Consensus        95 ~~l   97 (330)
T PLN02421         95 RTL   97 (330)
T ss_pred             CCC
Confidence            654

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.87  E-value=0.13  Score=46.38  Aligned_cols=95  Identities=14%  Similarity=0.091  Sum_probs=56.2

Q ss_pred             CcccChHHHHHhcCCCCCC---C-eeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCC--Cccc
Q 043074           69 LSQISMSELIDATDNFSTD---K-IIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHR--NIVK  142 (373)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~---~-~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~  142 (373)
                      ...++...+.++.+.+.+.   + ..=.+.-..||+....++..+++|...... ....++..|...+..|...  .++.
T Consensus         8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~   86 (325)
T PRK11768          8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVA   86 (325)
T ss_pred             CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCC
Confidence            3456666666666555332   1 222345678999988778889999875433 2345666777777766321  1222


Q ss_pred             ee---e--EEeeCCeeEEEEEecCCCC
Q 043074          143 IL---G--YCASGLDRVLIYEFVENGS  164 (373)
Q Consensus       143 l~---~--~~~~~~~~~lv~e~~~~g~  164 (373)
                      ..   |  ...-++..+.++++.+|..
T Consensus        87 p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         87 PLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             CccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            11   2  1223456778899987664

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.69  E-value=0.0077  Score=53.69  Aligned_cols=53  Identities=25%  Similarity=0.340  Sum_probs=46.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccc
Q 043074          190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       190 l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                      -.|++.+.++.+.+.-++-+.. +-+.-|||+.-.||+|+ +|++.|+||.+++.
T Consensus       318 ~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeeeec
Confidence            5688999999988887777764 66789999999999999 99999999999984

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.69  E-value=0.017  Score=51.76  Aligned_cols=140  Identities=21%  Similarity=0.221  Sum_probs=92.2

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCcccc--cc--------------------HHH----HHHHHHHHhcCCCCCc
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF--QG--------------------FRE----FRAEMETLGKLRHRNI  140 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~--------------------~~~----~~~e~~~l~~l~h~ni  140 (373)
                      ...|..|.-+-||.+.-.+|..+|||+++.+-.  .+                    .+.    ...|+.-|.+++...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            456888999999999888999999998743111  00                    000    2357777887765553


Q ss_pred             cceeeEEeeCCeeEEEEEecCCCCHH-HHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceee
Q 043074          141 VKILGYCASGLDRVLIYEFVENGSLD-QWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHR  219 (373)
Q Consensus       141 v~l~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~  219 (373)
                      .-.--+..  ....|||+|+...... -.|..                .+++...+..+-.|++.-|.-|.. ..++||.
T Consensus       229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLKd----------------~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHA  289 (520)
T KOG2270|consen  229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLKD----------------ASLSTSKARELYQQCVRIMRRLYQ-KCRLVHA  289 (520)
T ss_pred             CCCCceee--ecceEeeeeccCCCCcCccccc----------------ccCChHHHHHHHHHHHHHHHHHHH-Hhceecc
Confidence            32111111  2346999999422110 01111                127777888888888888888764 6779999


Q ss_pred             cCCCCceEeCCCCceEEeeeccccccC
Q 043074          220 DIKSSNVLLDSDFEAHISDFGLARRID  246 (373)
Q Consensus       220 dlk~~Nill~~~~~~kl~Dfg~~~~~~  246 (373)
                      ||+--|+|+-+ |.+.++|.+-+....
T Consensus       290 DLSEfN~Lyhd-G~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  290 DLSEFNLLYHD-GKLYIIDVSQSVEHD  315 (520)
T ss_pred             chhhhhheEEC-CEEEEEEccccccCC
Confidence            99999998854 579999998776543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.69  E-value=0.041  Score=49.26  Aligned_cols=30  Identities=27%  Similarity=0.390  Sum_probs=25.9

Q ss_pred             CCCceeecCCCCceEeCCCCceEEeeecccc
Q 043074          213 EKPIIHRDIKSSNVLLDSDFEAHISDFGLAR  243 (373)
Q Consensus       213 ~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  243 (373)
                      ..+++|+|+.+.||+++. +.+.++||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            357899999999999987 578999998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.58  E-value=0.00023  Score=73.56  Aligned_cols=159  Identities=9%  Similarity=-0.019  Sum_probs=109.1

Q ss_pred             HHHHHHHHhcCCCCCccceeeEEee--CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHH
Q 043074          125 FRAEMETLGKLRHRNIVKILGYCAS--GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV  202 (373)
Q Consensus       125 ~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi  202 (373)
                      ...|....+...|+++.....-...  ....+..++|+.+|.+.+.+-+.....           .++...-......+.
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~-----------~~ld~~~v~~~~kvs 1344 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEES-----------PDLDRSPVHLRHKVS 1344 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccC-----------CcchhchHHHHHHHH
Confidence            3445556666789988766554432  235578899999999999987665321           123333333334443


Q ss_pred             HHHHHHHhc---CCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCcccc
Q 043074          203 ANGLAYLHG---LEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLD  279 (373)
Q Consensus       203 ~~~l~~lh~---~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~D  279 (373)
                      ..+..-+|+   ..+--+|+++|+-|.+|..+..++++++|+.+...+ .........+++-|+.|+... .-.++.++|
T Consensus      1345 vl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsd 1422 (2724)
T KOG1826|consen 1345 VLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKN-EIKFTKRSD 1422 (2724)
T ss_pred             HhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHH-HHhhhhHHH
Confidence            556666664   233378999999999999999999999999983322 222333455777888898875 344677799


Q ss_pred             chhhhHHHHHHHhCCCC
Q 043074          280 VYSFGILMIEIATQIRP  296 (373)
Q Consensus       280 iwslG~~l~el~~g~~p  296 (373)
                      +|..|+.+|+.-.|..+
T Consensus      1423 ilr~s~~ly~rs~~n~~ 1439 (2724)
T KOG1826|consen 1423 ILRRSLSLYLRSDGNAY 1439 (2724)
T ss_pred             HHHHHHHHHHHhcccHH
Confidence            99999999998777665

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.58  E-value=0.012  Score=48.87  Aligned_cols=102  Identities=12%  Similarity=0.097  Sum_probs=64.7

Q ss_pred             EEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCC
Q 043074          109 VAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL  187 (373)
Q Consensus       109 vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~  187 (373)
                      ..+|++...... ...-+..+..+++++.  .|+++..  .++..+-++.|+|..-..                      
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i----------------------  141 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI----------------------  141 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc----------------------
Confidence            445555443333 3345677788877653  3455441  133455688998843211                      


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          188 CPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       188 ~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                        ..    ..+...=+.+|.-.|+.+.+.+|+|..|+||+-|..|.+||.|=+.-
T Consensus       142 --~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 --NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             --ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence              00    11222224567788976788999999999999999999999997754

The function of this family is unknown.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.56  E-value=0.039  Score=49.51  Aligned_cols=145  Identities=21%  Similarity=0.280  Sum_probs=80.3

Q ss_pred             eecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC---CCC---ccceee----EEeeCCeeEEEEEe
Q 043074           90 IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR---HRN---IVKILG----YCASGLDRVLIYEF  159 (373)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~n---iv~l~~----~~~~~~~~~lv~e~  159 (373)
                      |.+ .-..+|+....+|+. ++|+....  ....++..|...+..+.   .+=   +..+-|    ....+...+-+++|
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            444 566789998777766 88888776  33356677777777773   111   122112    11222367788999


Q ss_pred             cCCCCHHH---------------HhhcCCCCCC--CCcccccCCCCCCCHH-------------HHHHHHHHHHHHHHHH
Q 043074          160 VENGSLDQ---------------WLHDTSRNDD--VDGSKQLNSLCPLSWE-------------TRVKIVRGVANGLAYL  209 (373)
Q Consensus       160 ~~~g~L~~---------------~l~~~~~~~~--~~~~~~~~~~~~l~~~-------------~~~~i~~qi~~~l~~l  209 (373)
                      ++|..+..               .++.....-.  .+....     ...|.             .......++...+..+
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~-----~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~  184 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALR-----RLEWDILEPRALLRLDLVEPEDLRAALLAALDRL  184 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCccc-----ccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence            99887773               0111111000  000000     01121             0011222333333333


Q ss_pred             hc-----CCCC---ceeecCCCCceEeCCCCc-eEEeeecccc
Q 043074          210 HG-----LEKP---IIHRDIKSSNVLLDSDFE-AHISDFGLAR  243 (373)
Q Consensus       210 h~-----~~~~---i~H~dlk~~Nill~~~~~-~kl~Dfg~~~  243 (373)
                      .+     ....   ++|+|+.|.||+++.+.. +.+.||+-+.
T Consensus       185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            31     1223   899999999999999885 8999999775

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.53  E-value=0.051  Score=48.65  Aligned_cols=32  Identities=19%  Similarity=0.232  Sum_probs=28.3

Q ss_pred             CCCceeecCCCCceEeCCCCceEEeeeccccc
Q 043074          213 EKPIIHRDIKSSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       213 ~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                      ..+++|+|+.++|+++++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999999999999987753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.47  E-value=0.0085  Score=50.38  Aligned_cols=30  Identities=30%  Similarity=0.499  Sum_probs=21.1

Q ss_pred             CceeecCCCCceEe-CCCCceEEeeeccccc
Q 043074          215 PIIHRDIKSSNVLL-DSDFEAHISDFGLARR  244 (373)
Q Consensus       215 ~i~H~dlk~~Nill-~~~~~~kl~Dfg~~~~  244 (373)
                      .++|+|+.|.||++ +.++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            47899999999999 8889999999988754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK06148 hypothetical protein; Provisional

Probab=96.43  E-value=0.13  Score=53.65  Aligned_cols=150  Identities=19%  Similarity=0.259  Sum_probs=79.1

Q ss_pred             eeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcC-------CCCCcccee-e----EEee-CC--ee
Q 043074           89 IIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-------RHRNIVKIL-G----YCAS-GL--DR  153 (373)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~l~-~----~~~~-~~--~~  153 (373)
                      .|+ |..-.+|+.+..+|..+++|+.+.....  .....|...+..|       .-|.+++-. |    .... +.  ..
T Consensus        32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         32 PLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             ecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            453 4568889998778889999999764322  2333444555444       223333322 1    1111 12  45


Q ss_pred             EEEEEecCCCCHHHHhhcC--------------CC-CCCCCcccccCCCCCCCH-----------------HHHHHHHHH
Q 043074          154 VLIYEFVENGSLDQWLHDT--------------SR-NDDVDGSKQLNSLCPLSW-----------------ETRVKIVRG  201 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~--------------~~-~~~~~~~~~~~~~~~l~~-----------------~~~~~i~~q  201 (373)
                      +-+++|.+|..+.+.....              .. ..+.....   ....+.|                 .....++.+
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~---~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~  185 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPG---ALRDLDWDLRHAGRARDRLHFIDDPEDRALVER  185 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCC---cccccccccccchhhhhhhhhcCCHHHHHHHHH
Confidence            6789999987776511100              00 00000000   0000111                 112222333


Q ss_pred             HHHHHH-----HHhcCCCCceeecCCCCceEeCCCC--ceE-Eeeeccccc
Q 043074          202 VANGLA-----YLHGLEKPIIHRDIKSSNVLLDSDF--EAH-ISDFGLARR  244 (373)
Q Consensus       202 i~~~l~-----~lh~~~~~i~H~dlk~~Nill~~~~--~~k-l~Dfg~~~~  244 (373)
                      ++....     .+..+..++||+|+.+.||+++.++  ++. |+|||.+..
T Consensus       186 ~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        186 FLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            333222     2333456799999999999999875  454 999998754

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.39  E-value=0.02  Score=52.32  Aligned_cols=83  Identities=18%  Similarity=0.231  Sum_probs=52.2

Q ss_pred             CeeecCCCceEEEEEeCC-CCEEEEEEeCcc-----c-cccHHHHHHHHHHHhcCC--CCC-ccceeeEEeeCCeeEEEE
Q 043074           88 KIIGDGSFGFVYKAKLSS-GVTVAIKKLDKD-----A-FQGFREFRAEMETLGKLR--HRN-IVKILGYCASGLDRVLIY  157 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-----~-~~~~~~~~~e~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv~  157 (373)
                      +.||.|.-..||++...+ ++.|+||.-...     + .-..+...-|.+.|+...  .|. +.+++.  .+.....+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHHH
Confidence            468999999999998743 578999974221     1 112455566778877763  454 444443  3455667889


Q ss_pred             EecCCC-CHHHHhhcC
Q 043074          158 EFVENG-SLDQWLHDT  172 (373)
Q Consensus       158 e~~~~g-~L~~~l~~~  172 (373)
                      |+++.. .|.+.+-..
T Consensus       113 EdL~~~~ilR~~Li~G  128 (409)
T PRK12396        113 EDLSDHTILRTALINH  128 (409)
T ss_pred             HhCcccHHHHHHHHcC
Confidence            988543 344444433

>PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []

Probab=96.21  E-value=0.013  Score=33.17  Aligned_cols=15  Identities=20%  Similarity=0.450  Sum_probs=6.3

Q ss_pred             hhHHHHHHHHHHHHH
Q 043074            5 IQALIAAAASFVVIT   19 (373)
Q Consensus         5 ~~~ii~~~~~~~~i~   19 (373)
                      +.+++++++++++++
T Consensus         6 IaIIv~V~vg~~iii   20 (38)
T PF02439_consen    6 IAIIVAVVVGMAIII   20 (38)
T ss_pred             hhHHHHHHHHHHHHH
Confidence            334444444444433

This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.90  E-value=0.18  Score=42.28  Aligned_cols=75  Identities=20%  Similarity=0.294  Sum_probs=51.0

Q ss_pred             CeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC---CCCccceeeEEeeCCeeEEEEEecCCCC
Q 043074           88 KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR---HRNIVKILGYCASGLDRVLIYEFVENGS  164 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g~  164 (373)
                      +.+.-|.-...|.... ...++.+|+-..   .....|..|+.-|+.+.   .-++.+++.+-.+..+.|+|+||++.+.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            3455555455555443 356788886433   33456778887777764   4567788888888899999999999866


Q ss_pred             HH
Q 043074          165 LD  166 (373)
Q Consensus       165 L~  166 (373)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            54

>PTZ00384 choline kinase; Provisional

Probab=95.85  E-value=0.15  Score=46.89  Aligned_cols=74  Identities=26%  Similarity=0.283  Sum_probs=44.5

Q ss_pred             CeeecCCCceEEEEEeCCC--C-----EEEEEEeCccccccHHHHHHHHHHHhcCCCCCccc-eeeEEeeCCeeEEEEEe
Q 043074           88 KIIGDGSFGFVYKAKLSSG--V-----TVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVK-ILGYCASGLDRVLIYEF  159 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~--~-----~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~  159 (373)
                      +.|..|-.+.+|++...++  .     .|.++......... -.-.+|..+++.+...++.+ +++.+..    .++.||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceE-eccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            4566688899999975432  1     24444432221111 12257889999987555544 4555432    599999


Q ss_pred             cCCCCHH
Q 043074          160 VENGSLD  166 (373)
Q Consensus       160 ~~~g~L~  166 (373)
                      ++|.+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9887664

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	373
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-51
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-50
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-41
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-41
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-41
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-39
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-39
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-26
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-24
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-24
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-24
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-22
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-22
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-22
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-22
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-22
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-22
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-22
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-22
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-22
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-21
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-21
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-20
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-20
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		9e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-19
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-19
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-19
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-19
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-19
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-19
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-19
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		8e-19
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-18
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-18
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-18
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-18
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-18
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-18
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-18
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-18
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-17
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-17
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-17
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-17
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-17
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-17
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-17
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-17
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-17
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-17
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		8e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-16
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-16
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-16
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-16
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-16
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-16
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-16
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-16
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-15
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-15
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-15
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-15
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-15
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-15
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-15
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-15
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-15
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-15
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-15
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-15
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-15
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-15
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-15
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-14
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-14
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-14
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-14
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-14
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-14
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-14
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-14
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-14
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-14
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-14
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-14
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-14
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-14
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-14
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-14
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-14
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-14
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-14
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-14
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-14
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-14
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-14
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-14
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-14
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-14
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-14
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-14
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-14
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		9e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-13
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-13
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		9e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-10
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		8e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		8e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-08
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-07
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		9e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		8e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-05
3soa_A	444	Full-Length Human Camkii Length = 444		1e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  199 bits (506), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 111/305 (36%), Positives = 176/305 (57%), Gaps = 16/305 (5%)
Query: 68  SLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFR-EFR 126
            L + S+ EL  A+DNFS   I+G G FG VYK +L+ G  VA+K+L ++  QG   +F+
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 127 AEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNS 186
            E+E +    HRN++++ G+C +  +R+L+Y ++ NGS+   L +              S
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP-----------ES 132
Query: 187 LCPLSWETRVKIVRGVANGLAYLHGLEKP-IIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
             PL W  R +I  G A GLAYLH    P IIHRD+K++N+LLD +FEA + DFGLA+ +
Sbjct: 133 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 192
Query: 246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP-NLPVVLDG 304
           D    HV   V GT+G++ PEYL    ++    DV+ +G++++E+ T  R  +L  + + 
Sbjct: 193 DYKDXHVXXAVRGTIGHIAPEYLSTGKSSE-KTDVFGYGVMLLELITGQRAFDLARLAND 251
Query: 305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYV 364
            +V LL+W + +    K   +VD ++      E  V +  ++A +CT     ERP MS V
Sbjct: 252 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE-VEQLIQVALLCTQSSPMERPKMSEV 310
Query: 365 VQLLD 369
           V++L+
Sbjct: 311 VRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  195 bits (495), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 109/305 (35%), Positives = 174/305 (57%), Gaps = 16/305 (5%)
Query: 68  SLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFR-EFR 126
            L + S+ EL  A+DNF    I+G G FG VYK +L+ G  VA+K+L ++  QG   +F+
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 127 AEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNS 186
            E+E +    HRN++++ G+C +  +R+L+Y ++ NGS+   L +              S
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP-----------ES 124
Query: 187 LCPLSWETRVKIVRGVANGLAYLHGLEKP-IIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
             PL W  R +I  G A GLAYLH    P IIHRD+K++N+LLD +FEA + DFGLA+ +
Sbjct: 125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
Query: 246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP-NLPVVLDG 304
           D    HV   V G +G++ PEYL    ++    DV+ +G++++E+ T  R  +L  + + 
Sbjct: 185 DYKDXHVXXAVRGXIGHIAPEYLSTGKSSE-KTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYV 364
            +V LL+W + +    K   +VD ++      E  V +  ++A +CT     ERP MS V
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE-VEQLIQVALLCTQSSPMERPKMSEV 302
Query: 365 VQLLD 369
           V++L+
Sbjct: 303 VRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 112/321 (34%), Positives = 168/321 (52%), Gaps = 36/321 (11%)
Query: 66  DPSLSQISMSELIDATDNFSTDKI------IGDGSFGFVYKAKLSSGVTVAIKKL----D 115
           D      S  EL + T+NF    I      +G+G FG VYK  +++  TVA+KKL    D
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVD 67
Query: 116 KDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRN 175
               +  ++F  E++ + K +H N+V++LG+ + G D  L+Y ++ NGSL          
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL---------- 117
Query: 176 DDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH 235
             +D    L+   PLSW  R KI +G ANG+ +LH  E   IHRDIKS+N+LLD  F A 
Sbjct: 118 --LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAK 173
Query: 236 ISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
           ISDFGLAR  +  + + + +++ GT  YM PE L G    T   D+YSFG++++EI T  
Sbjct: 174 ISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGEI--TPKSDIYSFGVVLLEIIT-- 229
Query: 295 RPNLPVVLDGQEVGLL--EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTN 352
              LP V + +E  LL        +      + +D  ++  +     V   + +A  C +
Sbjct: 230 --GLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLH 285
Query: 353 EKSRERPAMSYVVQLLDELVA 373
           EK  +RP +  V QLL E+ A
Sbjct: 286 EKKNKRPDIKKVQQLLQEMTA 306

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 112/321 (34%), Positives = 167/321 (52%), Gaps = 36/321 (11%)
Query: 66  DPSLSQISMSELIDATDNFSTDKI------IGDGSFGFVYKAKLSSGVTVAIKKL----D 115
           D      S  EL + T+NF    I      +G+G FG VYK  +++  TVA+KKL    D
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVD 67
Query: 116 KDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRN 175
               +  ++F  E++ + K +H N+V++LG+ + G D  L+Y ++ NGSL          
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL---------- 117
Query: 176 DDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH 235
             +D    L+   PLSW  R KI +G ANG+ +LH  E   IHRDIKS+N+LLD  F A 
Sbjct: 118 --LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAK 173
Query: 236 ISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
           ISDFGLAR  +  + + +  ++ GT  YM PE L G    T   D+YSFG++++EI T  
Sbjct: 174 ISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEI--TPKSDIYSFGVVLLEIIT-- 229
Query: 295 RPNLPVVLDGQEVGLL--EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTN 352
              LP V + +E  LL        +      + +D  ++  +     V   + +A  C +
Sbjct: 230 --GLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLH 285
Query: 353 EKSRERPAMSYVVQLLDELVA 373
           EK  +RP +  V QLL E+ A
Sbjct: 286 EKKNKRPDIKKVQQLLQEMTA 306

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 112/321 (34%), Positives = 166/321 (51%), Gaps = 36/321 (11%)
Query: 66  DPSLSQISMSELIDATDNFSTDKI------IGDGSFGFVYKAKLSSGVTVAIKKL----D 115
           D      S  EL + T+NF    I      +G+G FG VYK  +++  TVA+KKL    D
Sbjct: 3   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVD 61
Query: 116 KDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRN 175
               +  ++F  E++ + K +H N+V++LG+ + G D  L+Y ++ NGSL          
Sbjct: 62  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL---------- 111
Query: 176 DDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH 235
             +D    L+   PLSW  R KI +G ANG+ +LH  E   IHRDIKS+N+LLD  F A 
Sbjct: 112 --LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAK 167
Query: 236 ISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
           ISDFGLAR  +  +   +  ++ GT  YM PE L G    T   D+YSFG++++EI T  
Sbjct: 168 ISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEI--TPKSDIYSFGVVLLEIIT-- 223
Query: 295 RPNLPVVLDGQEVGLL--EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTN 352
              LP V + +E  LL        +      + +D  ++  +     V   + +A  C +
Sbjct: 224 --GLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLH 279
Query: 353 EKSRERPAMSYVVQLLDELVA 373
           EK  +RP +  V QLL E+ A
Sbjct: 280 EKKNKRPDIKKVQQLLQEMTA 300

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 172/302 (56%), Gaps = 21/302 (6%)
Query: 71  QISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEME 130
           ++ + +L +AT+NF    +IG G FG VYK  L  G  VA+K+   ++ QG  EF  E+E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 131 TLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL 190
           TL   RH ++V ++G+C    + +LIY+++ENG+L + L+ +           L ++  +
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS----------DLPTMS-M 136
Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR-IDTSH 249
           SWE R++I  G A GL YLH   + IIHRD+KS N+LLD +F   I+DFG++++  +   
Sbjct: 137 SWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQ 194
Query: 250 SHVSTQVAGTMGYMPPEYL--GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV 307
           +H+   V GT+GY+ PEY   G  T  +   DVYSFG+++ E+    R  +   L  + V
Sbjct: 195 THLXXVVKGTLGYIDPEYFIKGRLTEKS---DVYSFGVVLFEVLCA-RSAIVQSLPREMV 250
Query: 308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL 367
            L EWA       +  ++VD N++ +++    +R++   A  C    S +RP+M  V+  
Sbjct: 251 NLAEWAVESHNNGQLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309
Query: 368 LD 369
           L+
Sbjct: 310 LE 311

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 172/302 (56%), Gaps = 21/302 (6%)
Query: 71  QISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEME 130
           ++ + +L +AT+NF    +IG G FG VYK  L  G  VA+K+   ++ QG  EF  E+E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 131 TLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL 190
           TL   RH ++V ++G+C    + +LIY+++ENG+L + L+ +           L ++  +
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS----------DLPTMS-M 136
Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR-IDTSH 249
           SWE R++I  G A GL YLH   + IIHRD+KS N+LLD +F   I+DFG++++  +   
Sbjct: 137 SWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 250 SHVSTQVAGTMGYMPPEYL--GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV 307
           +H+   V GT+GY+ PEY   G  T  +   DVYSFG+++ E+    R  +   L  + V
Sbjct: 195 THLXXVVKGTLGYIDPEYFIKGRLTEKS---DVYSFGVVLFEVLCA-RSAIVQSLPREMV 250
Query: 308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL 367
            L EWA       +  ++VD N++ +++    +R++   A  C    S +RP+M  V+  
Sbjct: 251 NLAEWAVESHNNGQLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309
Query: 368 LD 369
           L+
Sbjct: 310 LE 311

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 110/313 (35%), Positives = 158/313 (50%), Gaps = 32/313 (10%)
Query: 72  ISMSELIDATDNFSTDKI------IGDGSFGFVYKAKLSSGVTVAIKKL----DKDAFQG 121
            S  EL + T+NF    I       G+G FG VYK  +++  TVA+KKL    D    + 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS 181
            ++F  E++   K +H N+V++LG+ + G D  L+Y +  NGSL            +D  
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL------------LDRL 112
Query: 182 KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
             L+   PLSW  R KI +G ANG+ +LH  E   IHRDIKS+N+LLD  F A ISDFGL
Sbjct: 113 SCLDGTPPLSWHXRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGL 170
Query: 242 ARRIDTSHSHV-STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPV 300
           AR  +     V  +++ GT  Y  PE L G    T   D+YSFG++++EI T     LP 
Sbjct: 171 ARASEKFAQXVXXSRIVGTTAYXAPEALRGEI--TPKSDIYSFGVVLLEIIT----GLPA 224
Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
           V + +E  LL   +      ++      +    +     V   + +A  C +EK  +RP 
Sbjct: 225 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPD 284
Query: 361 MSYVVQLLDELVA 373
           +  V QLL E  A
Sbjct: 285 IKKVQQLLQEXTA 297

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 73/209 (34%), Positives = 111/209 (53%), Gaps = 17/209 (8%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFR--EFRAEMETLGKLRHRNIVKILGYC 147
           IG GSFG V++A+   G  VA+K L +  F   R  EF  E+  + +LRH NIV  +G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
               +  ++ E++  GSL + LH +   + +D  +            R+ +   VA G+ 
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR------------RLSMAYDVAKGMN 151
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           YLH    PI+HRD+KS N+L+D  +   + DFGL+ R+  S    S   AGT  +M PE 
Sbjct: 152 YLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKASXFLXSKXAAGTPEWMAPEV 210
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRP 296
           L  +  +    DVYSFG+++ E+AT  +P
Sbjct: 211 L-RDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 111/209 (53%), Gaps = 17/209 (8%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFR--EFRAEMETLGKLRHRNIVKILGYC 147
           IG GSFG V++A+   G  VA+K L +  F   R  EF  E+  + +LRH NIV  +G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
               +  ++ E++  GSL + LH +   + +D  +            R+ +   VA G+ 
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR------------RLSMAYDVAKGMN 151
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           YLH    PI+HR++KS N+L+D  +   + DFGL+ R+  S    S   AGT  +M PE 
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS-RLKASTFLSSKSAAGTPEWMAPEV 210
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRP 296
           L  +  +    DVYSFG+++ E+AT  +P
Sbjct: 211 L-RDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 90/307 (29%), Positives = 144/307 (46%), Gaps = 46/307 (14%)
Query: 79  DATDNF-------STDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMET 131
           DA D++       +  + IG GSFG VYK K    V V +  +     Q  + F+ E+  
Sbjct: 14  DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           L K RH NI+  +GY ++     ++ ++ E  SL   LH +    ++   K+L       
Sbjct: 74  LRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEM---KKL------- 122
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA-RRIDTSHS 250
               + I R  A G+ YLH   K IIHRD+KS+N+ L  D    I DFGLA  +   S S
Sbjct: 123 ----IDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176
Query: 251 HVSTQVAGTMGYMPPEY--LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG 308
           H   Q++G++ +M PE   +  +   +   DVY+FGI++ E+ T               G
Sbjct: 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT---------------G 221
Query: 309 LLEWARTMEARNKEIEMVDSNISREELSEAGV---REYFRIACMCTNEKSRERPAMSYVV 365
            L ++  +  R++ IEMV       +LS+      +   R+   C  +K  ERP+   ++
Sbjct: 222 QLPYS-NINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280
Query: 366 QLLDELV 372
             ++EL 
Sbjct: 281 AEIEELA 287

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 87/288 (30%), Positives = 137/288 (47%), Gaps = 39/288 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG GSFG VYK K    V V +  +     Q  + F+ E+  L K RH NI+  +GY ++
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 78
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ ++ E  SL   LH +    ++   K+L           + I R  A G+ YL
Sbjct: 79  KPQLAIVTQWCEGSSLYHHLHASETKFEM---KKL-----------IDIARQTARGMDYL 124
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR-RIDTSHSHVSTQVAGTMGYMPPEY- 267
           H   K IIHRD+KS+N+ L  D    I DFGLA  +   S SH   Q++G++ +M PE  
Sbjct: 125 HA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 182
Query: 268 -LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            +  +   +   DVY+FGI++ E+ T               G L ++  +  R++ IEMV
Sbjct: 183 RMQDSNPYSFQSDVYAFGIVLYELMT---------------GQLPYS-NINNRDQIIEMV 226
Query: 327 DSNISREELSEAGV---REYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
                  +LS+      +   R+   C  +K  ERP+   ++  ++EL
Sbjct: 227 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 274

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 87/289 (30%), Positives = 137/289 (47%), Gaps = 39/289 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG GSFG VYK K    V V +  +     Q  + F+ E+  L K RH NI+  +GY ++
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 90
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ ++ E  SL   LH +    ++   K+L           + I R  A G+ YL
Sbjct: 91  KPQLAIVTQWCEGSSLYHHLHASETKFEM---KKL-----------IDIARQTARGMDYL 136
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA-RRIDTSHSHVSTQVAGTMGYMPPEY- 267
           H   K IIHRD+KS+N+ L  D    I DFGLA  +   S SH   Q++G++ +M PE  
Sbjct: 137 HA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 268 -LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            +  +   +   DVY+FGI++ E+ T               G L ++  +  R++ IEMV
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMT---------------GQLPYS-NINNRDQIIEMV 238
Query: 327 DSNISREELSEAGV---REYFRIACMCTNEKSRERPAMSYVVQLLDELV 372
                  +LS+      +   R+   C  +K  ERP+   ++  ++EL 
Sbjct: 239 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 140/317 (44%), Gaps = 50/317 (15%)
Query: 70  SQISMSELIDATDN-FSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKL-------DKDAFQ 120
           S+   S L    DN    +K IG G FG V+K +L      VAIK L       + +  +
Sbjct: 6   SEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE 65
Query: 121 GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
            F+EF+ E+  +  L H NIVK+ G   +    V+  EFV  G L   L D +       
Sbjct: 66  KFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAH------ 117
Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE-----AH 235
                   P+ W  +++++  +A G+ Y+     PI+HRD++S N+ L S  E     A 
Sbjct: 118 --------PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169
Query: 236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAA-TVMLDVYSFGILMIEIATQI 294
           ++DFGL+++      H  + + G   +M PE +G    + T   D YSF +++  I T  
Sbjct: 170 VADFGLSQQ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
Query: 295 RPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEK 354
            P      D    G +++          I M+     R  + E        +  +C +  
Sbjct: 226 GP-----FDEYSYGKIKF----------INMIREEGLRPTIPEDCPPRLRNVIELCWSGD 270
Query: 355 SRERPAMSYVVQLLDEL 371
            ++RP  SY+V+ L EL
Sbjct: 271 PKKRPHFSYIVKELSEL 287

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 129/282 (45%), Gaps = 39/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG GSFG VYK K    V V +  +     Q  + F+ E+  L K RH NI+  +GY ++
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 74
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ ++ E  SL   LH       ++   ++  L        + I R  A G+ YL
Sbjct: 75  APQLAIVTQWCEGSSLYHHLH------IIETKFEMIKL--------IDIARQTAQGMDYL 120
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR-RIDTSHSHVSTQVAGTMGYMPPEY- 267
           H   K IIHRD+KS+N+ L  D    I DFGLA  +   S SH   Q++G++ +M PE  
Sbjct: 121 HA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 268 -LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            +      +   DVY+FGI++ E+ T               G L ++  +  R++ I MV
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMT---------------GQLPYS-NINNRDQIIFMV 222
Query: 327 DSNISREELSEAGV---REYFRIACMCTNEKSRERPAMSYVV 365
                  +LS+      +   R+   C  +K  ERP    ++
Sbjct: 223 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 139/317 (43%), Gaps = 50/317 (15%)
Query: 70  SQISMSELIDATDN-FSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKL-------DKDAFQ 120
           S+   S L    DN    +K IG G FG V+K +L      VAIK L       + +  +
Sbjct: 6   SEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE 65
Query: 121 GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
            F+EF+ E+  +  L H NIVK+ G   +    V+  EFV  G L   L D +       
Sbjct: 66  KFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAH------ 117
Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE-----AH 235
                   P+ W  +++++  +A G+ Y+     PI+HRD++S N+ L S  E     A 
Sbjct: 118 --------PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169
Query: 236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAA-TVMLDVYSFGILMIEIATQI 294
           ++DFG +++      H  + + G   +M PE +G    + T   D YSF +++  I T  
Sbjct: 170 VADFGTSQQ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
Query: 295 RPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEK 354
            P      D    G +++          I M+     R  + E        +  +C +  
Sbjct: 226 GP-----FDEYSYGKIKF----------INMIREEGLRPTIPEDCPPRLRNVIELCWSGD 270
Query: 355 SRERPAMSYVVQLLDEL 371
            ++RP  SY+V+ L EL
Sbjct: 271 PKKRPHFSYIVKELSEL 287

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 129/282 (45%), Gaps = 39/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG GSFG VYK K    V V +  +     Q  + F+ E+  L K RH NI+  +GY ++
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 74
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ ++ E  SL   LH       ++   ++  L        + I R  A G+ YL
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKL--------IDIARQTAQGMDYL 120
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA-RRIDTSHSHVSTQVAGTMGYMPPEY- 267
           H   K IIHRD+KS+N+ L  D    I DFGLA  +   S SH   Q++G++ +M PE  
Sbjct: 121 HA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 268 -LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            +      +   DVY+FGI++ E+ T               G L ++  +  R++ I MV
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMT---------------GQLPYS-NINNRDQIIFMV 222
Query: 327 DSNISREELSEAGV---REYFRIACMCTNEKSRERPAMSYVV 365
                  +LS+      +   R+   C  +K  ERP    ++
Sbjct: 223 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 129/282 (45%), Gaps = 39/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG GSFG VYK K    V V +  +     Q  + F+ E+  L K RH NI+  +GY ++
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 76
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ ++ E  SL   LH       ++   ++  L        + I R  A G+ YL
Sbjct: 77  KPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKL--------IDIARQTAQGMDYL 122
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR-RIDTSHSHVSTQVAGTMGYMPPEY- 267
           H   K IIHRD+KS+N+ L  D    I DFGLA  +   S SH   Q++G++ +M PE  
Sbjct: 123 HA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 180
Query: 268 -LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            +      +   DVY+FGI++ E+ T               G L ++  +  R++ I MV
Sbjct: 181 RMQDKNPYSFQSDVYAFGIVLYELMT---------------GQLPYS-NINNRDQIIFMV 224
Query: 327 DSNISREELSEAGV---REYFRIACMCTNEKSRERPAMSYVV 365
                  +LS+      +   R+   C  +K  ERP    ++
Sbjct: 225 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 266

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 139/317 (43%), Gaps = 50/317 (15%)
Query: 70  SQISMSELIDATDN-FSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKL-------DKDAFQ 120
           S+   S L    DN    +K IG G FG V+K +L      VAIK L       + +  +
Sbjct: 6   SEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE 65
Query: 121 GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
            F+EF+ E+  +  L H NIVK+ G   +    V+  EFV  G L   L D +       
Sbjct: 66  KFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAH------ 117
Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE-----AH 235
                   P+ W  +++++  +A G+ Y+     PI+HRD++S N+ L S  E     A 
Sbjct: 118 --------PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169
Query: 236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAA-TVMLDVYSFGILMIEIATQI 294
           ++DF L+++      H  + + G   +M PE +G    + T   D YSF +++  I T  
Sbjct: 170 VADFSLSQQ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
Query: 295 RPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEK 354
            P      D    G +++          I M+     R  + E        +  +C +  
Sbjct: 226 GP-----FDEYSYGKIKF----------INMIREEGLRPTIPEDCPPRLRNVIELCWSGD 270
Query: 355 SRERPAMSYVVQLLDEL 371
            ++RP  SY+V+ L EL
Sbjct: 271 PKKRPHFSYIVKELSEL 287

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 129/282 (45%), Gaps = 39/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG GSFG VYK K    V V +  +     Q  + F+ E+  L K RH NI+  +GY ++
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 94
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ ++ E  SL   LH       ++   ++  L        + I R  A G+ YL
Sbjct: 95  KPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKL--------IDIARQTAQGMDYL 140
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA-RRIDTSHSHVSTQVAGTMGYMPPEY- 267
           H   K IIHRD+KS+N+ L  D    I DFGLA  +   S SH   Q++G++ +M PE  
Sbjct: 141 HA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 198
Query: 268 -LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            +      +   DVY+FGI++ E+ T               G L ++  +  R++ I MV
Sbjct: 199 RMQDKNPYSFQSDVYAFGIVLYELMT---------------GQLPYS-NINNRDQIIFMV 242
Query: 327 DSNISREELSEAGV---REYFRIACMCTNEKSRERPAMSYVV 365
                  +LS+      +   R+   C  +K  ERP    ++
Sbjct: 243 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 284

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 74/207 (35%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG GSFG VYK K    V V I K+     + F+ FR E+  L K RH NI+  +GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLAY 208
             +  ++ ++ E  SL + LH       V  +K Q+  L        + I R  A G+ Y
Sbjct: 104 D-NLAIVTQWCEGSSLYKHLH-------VQETKFQMFQL--------IDIARQTAQGMDY 147
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR-RIDTSHSHVSTQVAGTMGYMPPEY 267
           LH   K IIHRD+KS+N+ L       I DFGLA  +   S S    Q  G++ +M PE 
Sbjct: 148 LHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEV 205
Query: 268 --LGGNTAATVMLDVYSFGILMIEIAT 292
             +  N   +   DVYS+GI++ E+ T
Sbjct: 206 IRMQDNNPFSFQSDVYSYGIVLYELMT 232

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 129/282 (45%), Gaps = 39/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG GSFG VYK K    V V +  +     Q  + F+ E+  L K RH NI+  +GY ++
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 79
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ ++ E  SL   LH       ++   ++  L        + I R  A G+ YL
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKL--------IDIARQTAQGMDYL 125
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR-RIDTSHSHVSTQVAGTMGYMPPEY- 267
           H   K IIHRD+KS+N+ L  D    I DFGLA  +   S SH   Q++G++ +M PE  
Sbjct: 126 HA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183
Query: 268 -LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            +      +   DVY+FGI++ E+ T               G L ++  +  R++ I MV
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMT---------------GQLPYS-NINNRDQIIFMV 227
Query: 327 DSNISREELSEAGV---REYFRIACMCTNEKSRERPAMSYVV 365
                  +LS+      +   R+   C  +K  ERP    ++
Sbjct: 228 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 269

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 129/282 (45%), Gaps = 39/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG GSFG VYK K    V V +  +     Q  + F+ E+  L K RH NI+  +GY ++
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 74
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ ++ E  SL   LH       ++   ++  L        + I R  A G+ YL
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKL--------IDIARQTAQGMDYL 120
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR-RIDTSHSHVSTQVAGTMGYMPPEY- 267
           H   K IIHRD+KS+N+ L  D    I DFGLA  +   S SH   Q++G++ +M PE  
Sbjct: 121 HA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 268 -LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            +      +   DVY+FGI++ E+ T               G L ++  +  R++ I MV
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMT---------------GQLPYS-NINNRDQIIFMV 222
Query: 327 DSNISREELSEAGV---REYFRIACMCTNEKSRERPAMSYVV 365
                  +LS+      +   R+   C  +K  ERP    ++
Sbjct: 223 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 129/282 (45%), Gaps = 39/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG GSFG VYK K    V V +  +     Q  + F+ E+  L K RH NI+  +GY ++
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 79
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ ++ E  SL   LH       ++   ++  L        + I R  A G+ YL
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKL--------IDIARQTAQGMDYL 125
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR-RIDTSHSHVSTQVAGTMGYMPPEY- 267
           H   K IIHRD+KS+N+ L  D    I DFGLA  +   S SH   Q++G++ +M PE  
Sbjct: 126 HA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183
Query: 268 -LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            +      +   DVY+FGI++ E+ T               G L ++  +  R++ I MV
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMT---------------GQLPYS-NINNRDQIIFMV 227
Query: 327 DSNISREELSEAGV---REYFRIACMCTNEKSRERPAMSYVV 365
                  +LS+      +   R+   C  +K  ERP    ++
Sbjct: 228 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 269

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 134/290 (46%), Gaps = 40/290 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG GSFG VYK K    V V +  +     Q  + F+ E+  L K RH NI+  +GY ++
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 102
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ ++ E  SL   LH       ++   ++  L        + I R  A G+ YL
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKL--------IDIARQTAQGMDYL 148
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA-RRIDTSHSHVSTQVAGTMGYMPPEY- 267
           H   K IIHRD+KS+N+ L  D    I DFGLA  +   S SH   Q++G++ +M PE  
Sbjct: 149 HA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 206
Query: 268 -LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            +      +   DVY+FGI++ E+ T               G L ++  +  R++ I MV
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMT---------------GQLPYS-NINNRDQIIFMV 250
Query: 327 DSNISREELSEAGV---REYFRIACMCTNEKSRERPAMSYVVQLLDELVA 373
                  +LS+      +   R+   C  +K  ERP    ++  + EL+A
Sbjct: 251 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI-ELLA 299

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 134/290 (46%), Gaps = 40/290 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG GSFG VYK K    V V +  +     Q  + F+ E+  L K RH NI+  +GY ++
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 101
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ ++ E  SL   LH       ++   ++  L        + I R  A G+ YL
Sbjct: 102 KPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKL--------IDIARQTAQGMDYL 147
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR-RIDTSHSHVSTQVAGTMGYMPPEY- 267
           H   K IIHRD+KS+N+ L  D    I DFGLA  +   S SH   Q++G++ +M PE  
Sbjct: 148 HA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 205
Query: 268 -LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            +      +   DVY+FGI++ E+ T               G L ++  +  R++ I MV
Sbjct: 206 RMQDKNPYSFQSDVYAFGIVLYELMT---------------GQLPYS-NINNRDQIIFMV 249
Query: 327 DSNISREELSEAGV---REYFRIACMCTNEKSRERPAMSYVVQLLDELVA 373
                  +LS+      +   R+   C  +K  ERP    ++  + EL+A
Sbjct: 250 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI-ELLA 298

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 138/294 (46%), Gaps = 44/294 (14%)
Query: 88  KIIGDGSFGFVYKA--KLSSG---VTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIV 141
           K+IG G FG VYK   K SSG   V VAIK L     +  R +F  E   +G+  H NI+
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++ G  +     ++I E++ENG+LD++L +       DG   +  L        V ++RG
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREK------DGEFSVLQL--------VGMLRG 155
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +A G+ YL  +    +HRD+ + N+L++S+    +SDFGL+R ++       T   G + 
Sbjct: 156 IAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 262 --YMPPEYLGGNTAATVMLDVYSFGILMIEIATQ-IRPNLPVVLDGQEVGLLEWARTMEA 318
             +  PE +      T   DV+SFGI+M E+ T   RP               W    E 
Sbjct: 214 IRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPY--------------W----EL 254
Query: 319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV 372
            N E+    ++  R           +++   C  ++   RP  + +V +LD+L+
Sbjct: 255 SNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 134/290 (46%), Gaps = 40/290 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG GSFG VYK K    V V +  +     Q  + F+ E+  L K RH NI+  +GY ++
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 102
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ ++ E  SL   LH       ++   ++  L        + I R  A G+ YL
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKL--------IDIARQTAQGMDYL 148
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR-RIDTSHSHVSTQVAGTMGYMPPEY- 267
           H   K IIHRD+KS+N+ L  D    I DFGLA  +   S SH   Q++G++ +M PE  
Sbjct: 149 HA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 206
Query: 268 -LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            +      +   DVY+FGI++ E+ T               G L ++  +  R++ I MV
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMT---------------GQLPYS-NINNRDQIIFMV 250
Query: 327 DSNISREELSEAGV---REYFRIACMCTNEKSRERPAMSYVVQLLDELVA 373
                  +LS+      +   R+   C  +K  ERP    ++  + EL+A
Sbjct: 251 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI-ELLA 299

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 120/226 (53%), Gaps = 20/226 (8%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK------LSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGK 134
           +N    + IG+G+FG V++A+            VA+K L ++A    + +F+ E   + +
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS-------RNDDVDGSKQLNS- 186
             + NIVK+LG CA G    L++E++  G L+++L   S        + D+    +++S 
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 187 -LCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
              PLS   ++ I R VA G+AYL   E+  +HRD+ + N L+  +    I+DFGL+R I
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 246 DTS-HSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            ++ +       A  + +MPPE +  N   T   DV+++G+++ EI
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTES-DVWAYGVVLWEI 269

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 120/234 (51%), Gaps = 25/234 (10%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQG 121
           DP+ +    ++ +DAT N S DK++G G FG V   +L       ++VAIK L     + 
Sbjct: 30  DPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 122 -FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
             R+F  E   +G+  H NI+++ G        +++ E++ENGSLD +L    ++D    
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFT 145
Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG 240
             QL           V ++RG+A+G+ YL  +    +HRD+ + N+L++S+    +SDFG
Sbjct: 146 VIQL-----------VGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFG 192
Query: 241 LARRIDTSHSHVSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           LAR ++       T   G +   +  PE +      T   DV+S+GI++ E+ +
Sbjct: 193 LARVLEDDPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 109/210 (51%), Gaps = 10/210 (4%)
Query: 90  IGDGSFGFVYKAKLSS------GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKI 143
           +G+G+FG V+ A+  +       + VA+K L + +    ++F+ E E L  L+H++IV+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA 203
            G C  G   ++++E++ +G L+++L     +  +    +  +  PL     + +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 204 NGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTMGY 262
            G+ YL GL    +HRD+ + N L+       I DFG++R I  T +  V  +    + +
Sbjct: 146 AGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 203
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           MPPE +      T   DV+SFG+++ EI T
Sbjct: 204 MPPESILYRKFTTES-DVWSFGVVLWEIFT 232

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 109/210 (51%), Gaps = 10/210 (4%)
Query: 90  IGDGSFGFVYKAKLSS------GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKI 143
           +G+G+FG V+ A+  +       + VA+K L + +    ++F+ E E L  L+H++IV+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA 203
            G C  G   ++++E++ +G L+++L     +  +    +  +  PL     + +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 204 NGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTMGY 262
            G+ YL GL    +HRD+ + N L+       I DFG++R I  T +  V  +    + +
Sbjct: 140 AGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 197
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           MPPE +      T   DV+SFG+++ EI T
Sbjct: 198 MPPESILYRKFTTES-DVWSFGVVLWEIFT 226

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 84/315 (26%), Positives = 146/315 (46%), Gaps = 44/315 (13%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQG 121
           DP+ +    ++ +DAT N S DK++G G FG V   +L       ++VAIK L     + 
Sbjct: 30  DPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 122 -FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
             R+F  E   +G+  H NI+++ G        +++ E++ENGSLD +L    ++D    
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFT 145
Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG 240
             QL           V ++RG+A+G+ YL  +    +HRD+ + N+L++S+    +SDFG
Sbjct: 146 VIQL-----------VGMLRGIASGMKYLSDMG--FVHRDLAARNILINSNLVCKVSDFG 192
Query: 241 LARRIDTSHSHVSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIATQ-IRPN 297
           L+R ++       T   G +   +  PE +      T   DV+S+GI++ E+ +   RP 
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 298 LPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRE 357
               +  Q+V               I+ VD         +     Y ++   C  +    
Sbjct: 252 WE--MSNQDV---------------IKAVDEGYRLPPPMDCPAALY-QLMLDCWQKDRNN 293
Query: 358 RPAMSYVVQLLDELV 372
           RP    +V +LD+L+
Sbjct: 294 RPKFEQIVSILDKLI 308

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 122/235 (51%), Gaps = 27/235 (11%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAF-- 119
           DP+ +    ++ +DAT N S DK++G G FG V   +L       ++VAIK L K  +  
Sbjct: 28  DPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTE 85
Query: 120 QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVD 179
           +  R+F  E   +G+  H NI+++ G        +++ E++ENGSLD +L    ++D   
Sbjct: 86  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQF 142
Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
              QL           V ++RG+A+G+ YL  +    +HRD+ + N+L++S+    +SDF
Sbjct: 143 TVIQL-----------VGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDF 189
Query: 240 GLARRIDTSHSHVSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           GL+R ++       T   G +   +  PE +      T   DV+S+GI++ E+ +
Sbjct: 190 GLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 120/234 (51%), Gaps = 25/234 (10%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQG 121
           DP+ +    ++ +DAT N S DK++G G FG V   +L       ++VAIK L     + 
Sbjct: 30  DPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 122 -FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
             R+F  E   +G+  H NI+++ G        +++ E++ENGSLD +L    ++D    
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFT 145
Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG 240
             QL           V ++RG+A+G+ YL  +    +HRD+ + N+L++S+    +SDFG
Sbjct: 146 VIQL-----------VGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFG 192
Query: 241 LARRIDTSHSHVSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           L+R ++       T   G +   +  PE +      T   DV+S+GI++ E+ +
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 123/240 (51%), Gaps = 26/240 (10%)
Query: 61  DSASF-DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLD 115
           D  +F DP+ +    ++ +DAT N S DK++G G FG V   +L       ++VAIK L 
Sbjct: 24  DPHTFEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 116 KDAFQG-FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSR 174
               +   R+F  E   +G+  H NI+++ G        +++ E++ENGSLD +L    +
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---K 139
Query: 175 NDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA 234
           +D      QL           V ++RG+A+G+ YL  +    +HRD+ + N+L++S+   
Sbjct: 140 HDAQFTVIQL-----------VGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVC 186
Query: 235 HISDFGLARRIDTSHSHVSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +SDFGL+R ++       T   G +   +  PE +      T   DV+S+GI++ E+ +
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 120/234 (51%), Gaps = 25/234 (10%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQG 121
           DP+ +    ++ +DAT N S DK++G G FG V   +L       ++VAIK L     + 
Sbjct: 30  DPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 122 -FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
             R+F  E   +G+  H NI+++ G        +++ E++ENGSLD +L    ++D    
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFT 145
Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG 240
             QL           V ++RG+A+G+ YL  +    +HRD+ + N+L++S+    +SDFG
Sbjct: 146 VIQL-----------VGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFG 192
Query: 241 LARRIDTSHSHVSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           L+R ++       T   G +   +  PE +      T   DV+S+GI++ E+ +
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 109/210 (51%), Gaps = 10/210 (4%)
Query: 90  IGDGSFGFVYKAKLSS------GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKI 143
           +G+G+FG V+ A+  +       + VA+K L + +    ++F+ E E L  L+H++IV+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA 203
            G C  G   ++++E++ +G L+++L     +  +    +  +  PL     + +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 204 NGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTMGY 262
            G+ YL GL    +HRD+ + N L+       I DFG++R I  T +  V  +    + +
Sbjct: 169 AGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           MPPE +      T   DV+SFG+++ EI T
Sbjct: 227 MPPESI-LYRKFTTESDVWSFGVVLWEIFT 255

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 120/234 (51%), Gaps = 25/234 (10%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQG 121
           DP+ +    ++ +DAT N S DK++G G FG V   +L       ++VAIK L     + 
Sbjct: 30  DPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 122 -FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
             R+F  E   +G+  H NI+++ G        +++ E++ENGSLD +L    ++D    
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFT 145
Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG 240
             QL           V ++RG+A+G+ YL  +    +HRD+ + N+L++S+    +SDFG
Sbjct: 146 VIQL-----------VGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFG 192
Query: 241 LARRIDTSHSHVSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           L+R ++       T   G +   +  PE +      T   DV+S+GI++ E+ +
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/321 (26%), Positives = 148/321 (46%), Gaps = 45/321 (14%)
Query: 61  DSASF-DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLD 115
           D  +F DP+ +    ++ +DAT N S DK++G G FG V   +L       ++VAIK L 
Sbjct: 24  DPHTFEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 116 KDAFQG-FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSR 174
               +   R+F  E   +G+  H NI+++ G        +++ E++ENGSLD +L    +
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---K 139
Query: 175 NDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA 234
           +D      QL           V ++RG+A+G+ YL  +    +HRD+ + N+L++S+   
Sbjct: 140 HDAQFTVIQL-----------VGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVC 186
Query: 235 HISDFGLARRIDTSHSHVSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +SDFGL R ++       T   G +   +  PE +      T   DV+S+GI++ E+ +
Sbjct: 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMS 245
Query: 293 Q-IRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCT 351
              RP     +  Q+V               I+ VD         +     Y ++   C 
Sbjct: 246 YGERPYWE--MSNQDV---------------IKAVDEGYRLPPPMDCPAALY-QLMLDCW 287
Query: 352 NEKSRERPAMSYVVQLLDELV 372
            +    RP    +V +LD+L+
Sbjct: 288 QKDRNNRPKFEQIVSILDKLI 308

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 140/302 (46%), Gaps = 47/302 (15%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
            +ID  +    ++++G G+FG V KAK  +   VAIK+++ ++ +  + F  E+  L ++
Sbjct: 4   HMIDYKE-IEVEEVVGRGAFGVVCKAKWRAK-DVAIKQIESESER--KAFIVELRQLSRV 59
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
            H NIVK+ G C + +   L+ E+ E GSL   LH                  PL + T 
Sbjct: 60  NHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAE---------------PLPYYTA 102
Query: 196 VKIVRG---VANGLAYLHGLE-KPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHS 250
              +      + G+AYLH ++ K +IHRD+K  N+LL +      I DFG A  I T   
Sbjct: 103 AHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 160
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL 310
              T   G+  +M PE   G+  +    DV+S+GI++ E+ T+ +P   +   G     +
Sbjct: 161 --MTNNKGSAAWMAPEVFEGSNYSE-KCDVFSWGIILWEVITRRKPFDEI---GGPAFRI 214
Query: 311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
            WA     R   I+ +   I               +   C ++   +RP+M  +V+++  
Sbjct: 215 MWAVHNGTRPPLIKNLPKPIE-------------SLMTRCWSKDPSQRPSMEEIVKIMTH 261
Query: 371 LV 372
           L+
Sbjct: 262 LM 263

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 115/232 (49%), Gaps = 25/232 (10%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAFQ- 120
           +P  +  S +  I+A+     +KIIG G  G V   +L       V VAIK L     + 
Sbjct: 34  EPGRAGRSFTREIEAS-RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER 92
Query: 121 GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
             R+F +E   +G+  H NI+++ G    G   +++ E++ENGSLD +L         DG
Sbjct: 93  QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH------DG 146
Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG 240
              +  L        V ++RGV  G+ YL  L    +HRD+ + NVL+DS+    +SDFG
Sbjct: 147 QFTIMQL--------VGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 241 LARRIDTSHSHVSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           L+R ++       T   G +   +  PE +   T ++   DV+SFG++M E+
Sbjct: 197 LSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSAS-DVWSFGVVMWEV 247

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 25/219 (11%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKLRH 137
           ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    LRH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NI+++ GY        LI E+   G++ + L   SR D+   +  +  L          
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL---------- 121
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
                AN L+Y H   K +IHRDIK  N+LL S+ E  I+DFG +    +S     T + 
Sbjct: 122 -----ANALSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RTTLC 171
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT+ Y+PPE + G       +D++S G+L  E    + P
Sbjct: 172 GTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEFLVGMPP 209

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 123/237 (51%), Gaps = 29/237 (12%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSG----VTVAIKKLDKDAF-- 119
           DP+ +    ++ ID +     +++IG G FG V + +L +       VAIK L K  +  
Sbjct: 1   DPNEAVREFAKEIDVS-YVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTE 58
Query: 120 QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVD 179
           +  REF +E   +G+  H NI+++ G   + +  +++ EF+ENG+LD +L     ND   
Sbjct: 59  RQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQF 115
Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
              QL           V ++RG+A+G+ YL   E   +HRD+ + N+L++S+    +SDF
Sbjct: 116 TVIQL-----------VGMLRGIASGMRYLA--EMSYVHRDLAARNILVNSNLVCKVSDF 162
Query: 240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
           GL+R ++ + S   T+ +   G +P  +      A    T   D +S+GI+M E+ +
Sbjct: 163 GLSRFLEENSSD-PTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 140/302 (46%), Gaps = 47/302 (15%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
            +ID  +    ++++G G+FG V KAK  +   VAIK+++ ++ +  + F  E+  L ++
Sbjct: 3   HMIDYKE-IEVEEVVGRGAFGVVCKAKWRAK-DVAIKQIESESER--KAFIVELRQLSRV 58
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
            H NIVK+ G C + +   L+ E+ E GSL   LH                  PL + T 
Sbjct: 59  NHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAE---------------PLPYYTA 101
Query: 196 VKIVRG---VANGLAYLHGLE-KPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHS 250
              +      + G+AYLH ++ K +IHRD+K  N+LL +      I DFG A  I T   
Sbjct: 102 AHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL 310
              T   G+  +M PE   G+  +    DV+S+GI++ E+ T+ +P   +   G     +
Sbjct: 160 --MTNNKGSAAWMAPEVFEGSNYSE-KCDVFSWGIILWEVITRRKPFDEI---GGPAFRI 213
Query: 311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
            WA     R   I+ +   I               +   C ++   +RP+M  +V+++  
Sbjct: 214 MWAVHNGTRPPLIKNLPKPIE-------------SLMTRCWSKDPSQRPSMEEIVKIMTH 260
Query: 371 LV 372
           L+
Sbjct: 261 LM 262

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 115/232 (49%), Gaps = 25/232 (10%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAFQ- 120
           +P  +  S +  I+A+     +KIIG G  G V   +L       V VAIK L     + 
Sbjct: 34  EPGRAGRSFTREIEAS-RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER 92
Query: 121 GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
             R+F +E   +G+  H NI+++ G    G   +++ E++ENGSLD +L         DG
Sbjct: 93  QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH------DG 146
Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG 240
              +  L        V ++RGV  G+ YL  L    +HRD+ + NVL+DS+    +SDFG
Sbjct: 147 QFTIMQL--------VGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 241 LARRIDTSHSHVSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           L+R ++       T   G +   +  PE +   T ++   DV+SFG++M E+
Sbjct: 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSAS-DVWSFGVVMWEV 247

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAF-- 119
           DP+ +    ++ +DAT N S DK++G G FG V   +L       ++VAIK L K  +  
Sbjct: 30  DPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTE 87
Query: 120 QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVD 179
           +  R+F  E   +G+  H NI+++ G        +++ E +ENGSLD +L    ++D   
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR---KHDAQF 144
Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
              QL           V ++RG+A+G+ YL  +    +HRD+ + N+L++S+    +SDF
Sbjct: 145 TVIQL-----------VGMLRGIASGMKYLSDMGA--VHRDLAARNILINSNLVCKVSDF 191
Query: 240 GLARRIDTSHSHVSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           GL+R ++       T   G +   +  PE +      T   DV+S+GI++ E+ +
Sbjct: 192 GLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 127/257 (49%), Gaps = 26/257 (10%)
Query: 66  DPSLSQISMSELI-DATDNFSTDKI-----IGDGSFGFVY--------KAKLSSGVTVAI 111
           DP L+ +S  EL  D    F  DK+     +G+G+FG V         K K    VTVA+
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAV 72
Query: 112 KKLDKDAFQG-FREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWL 169
           K L  DA +    +  +EME +  + +H+NI+ +LG C       +I E+   G+L ++L
Sbjct: 73  KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 170 HDTSRNDDVDGSKQLNSLCP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVL 227
               R   ++ S  +N +    ++++  V     +A G+ YL    +  IHRD+ + NVL
Sbjct: 133 R-ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL 189
Query: 228 LDSDFEAHISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
           +  +    I+DFGLAR I+   +   +T     + +M PE L  +   T   DV+SFG+L
Sbjct: 190 VTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVL 248
Query: 287 MIEIAT---QIRPNLPV 300
           M EI T      P +PV
Sbjct: 249 MWEIFTLGGSPYPGIPV 265

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAF-- 119
           DP+ +    ++ +DAT N S DK++G G FG V   +L       ++VAIK L K  +  
Sbjct: 30  DPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTE 87
Query: 120 QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVD 179
           +  R+F  E   +G+  H NI+++ G        +++ E +ENGSLD +L    ++D   
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR---KHDAQF 144
Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
              QL           V ++RG+A+G+ YL  +    +HRD+ + N+L++S+    +SDF
Sbjct: 145 TVIQL-----------VGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDF 191
Query: 240 GLARRIDTSHSHVSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           GL+R ++       T   G +   +  PE +      T   DV+S+GI++ E+ +
Sbjct: 192 GLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 127/257 (49%), Gaps = 26/257 (10%)
Query: 66  DPSLSQISMSELI-DATDNFSTDKI-----IGDGSFGFVY--------KAKLSSGVTVAI 111
           DP L+ +S  EL  D    F  DK+     +G+G+FG V         K K    VTVA+
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAV 72
Query: 112 KKLDKDAFQ-GFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWL 169
           K L  DA +    +  +EME +  + +H+NI+ +LG C       +I E+   G+L ++L
Sbjct: 73  KMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 170 HDTSRNDDVDGSKQLNSLCP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVL 227
               R   ++ S  +N +    ++++  V     +A G+ YL    +  IHRD+ + NVL
Sbjct: 133 R-ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL 189
Query: 228 LDSDFEAHISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
           +  +    I+DFGLAR I+   +   +T     + +M PE L  +   T   DV+SFG+L
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVL 248
Query: 287 MIEIAT---QIRPNLPV 300
           M EI T      P +PV
Sbjct: 249 MWEIFTLGGSPYPGIPV 265

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 127/257 (49%), Gaps = 26/257 (10%)
Query: 66  DPSLSQISMSELI-DATDNFSTDKI-----IGDGSFGFVY--------KAKLSSGVTVAI 111
           DP L+ +S  EL  D    F  DK+     +G+G+FG V         K K    VTVA+
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAV 72
Query: 112 KKLDKDAFQG-FREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWL 169
           K L  DA +    +  +EME +  + +H+NI+ +LG C       +I E+   G+L ++L
Sbjct: 73  KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 170 HDTSRNDDVDGSKQLNSLCP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVL 227
               R   ++ S  +N +    ++++  V     +A G+ YL    +  IHRD+ + NVL
Sbjct: 133 R-ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL 189
Query: 228 LDSDFEAHISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
           +  +    I+DFGLAR I+   +   +T     + +M PE L  +   T   DV+SFG+L
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVL 248
Query: 287 MIEIAT---QIRPNLPV 300
           M EI T      P +PV
Sbjct: 249 MWEIFTLGGSPYPGIPV 265

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 117
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T+
Sbjct: 118 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTE 165
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 199

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 126/257 (49%), Gaps = 26/257 (10%)
Query: 66  DPSLSQISMSELI-DATDNFSTDKI-----IGDGSFGFVY--------KAKLSSGVTVAI 111
           DP L+ +S  EL  D    F  DK+     +G+G+FG V         K K    VTVA+
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAV 72
Query: 112 KKLDKDAFQG-FREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWL 169
           K L  DA +    +  +EME +  + +H+NI+ +LG C       +I E+   G+L ++L
Sbjct: 73  KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 170 HDTSRNDDVDGSKQLNSLCP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVL 227
               R   ++ S  +N +    ++++  V     +A G+ YL    +  IHRD+ + NVL
Sbjct: 133 R-ARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL 189
Query: 228 LDSDFEAHISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
           +  +    I+DFGLAR I+       +T     + +M PE L  +   T   DV+SFG+L
Sbjct: 190 VTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVL 248
Query: 287 MIEIAT---QIRPNLPV 300
           M EI T      P +PV
Sbjct: 249 MWEIFTLGGSPYPGIPV 265

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 127/257 (49%), Gaps = 26/257 (10%)
Query: 66  DPSLSQISMSELI-DATDNFSTDKI-----IGDGSFGFVY--------KAKLSSGVTVAI 111
           DP L+ +S  EL  D    F  DK+     +G+G+FG V         K K    VTVA+
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAV 72
Query: 112 KKLDKDAFQG-FREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWL 169
           K L  DA +    +  +EME +  + +H+NI+ +LG C       +I E+   G+L ++L
Sbjct: 73  KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 170 HDTSRNDDVDGSKQLNSLCP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVL 227
               R   ++ S  +N +    ++++  V     +A G+ YL    +  IHRD+ + NVL
Sbjct: 133 R-ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL 189
Query: 228 LDSDFEAHISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
           +  +    I+DFGLAR I+   +   +T     + +M PE L  +   T   DV+SFG+L
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVL 248
Query: 287 MIEIAT---QIRPNLPV 300
           M EI T      P +PV
Sbjct: 249 MWEIFTLGGSPYPGIPV 265

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 127/257 (49%), Gaps = 26/257 (10%)
Query: 66  DPSLSQISMSELI-DATDNFSTDKI-----IGDGSFGFVY--------KAKLSSGVTVAI 111
           DP L+ +S  EL  D    F  DK+     +G+G+FG V         K K    VTVA+
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAV 72
Query: 112 KKLDKDAFQ-GFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWL 169
           K L  DA +    +  +EME +  + +H+NI+ +LG C       +I E+   G+L ++L
Sbjct: 73  KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 170 HDTSRNDDVDGSKQLNSLCP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVL 227
               R   ++ S  +N +    ++++  V     +A G+ YL    +  IHRD+ + NVL
Sbjct: 133 R-ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL 189
Query: 228 LDSDFEAHISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
           +  +    I+DFGLAR I+   +   +T     + +M PE L  +   T   DV+SFG+L
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVL 248
Query: 287 MIEIAT---QIRPNLPV 300
           M EI T      P +PV
Sbjct: 249 MWEIFTLGGSPYPGIPV 265

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 114/222 (51%), Gaps = 25/222 (11%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQG-FREFRAEMETL 132
           +DAT N S DK++G G FG V   +L       ++VAIK L     +   R+F  E   +
Sbjct: 13  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           G+  H NI+++ G        +++ E++ENGSLD +L    ++D      QL        
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQL-------- 120
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
              V ++RG+A+G+ YL  +    +HRD+ + N+L++S+    +SDFGL+R ++      
Sbjct: 121 ---VGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 253 STQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            T   G +   +  PE +      T   DV+S+GI++ E+ +
Sbjct: 176 YTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 90  IGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKI 143
           +G+G+FG V+ A+          + VA+K L        ++F+ E E L  L+H +IVK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 144 LGYCASGLDRVLIYEFVENGSLDQWL--HDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            G C  G   ++++E++++G L+++L  H       VDG  +  +   L     + I   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR-QAKGELGLSQMLHIASQ 141
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTM 260
           +A+G+ YL    +  +HRD+ + N L+ ++    I DFG++R +  T +  V       +
Sbjct: 142 IASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +MPPE +      T   DV+SFG+++ EI T
Sbjct: 200 RWMPPESIMYRKFTTES-DVWSFGVILWEIFT 230

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G + + L   S+ D+   +  +  L        
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL-------- 122
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 123 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTT 170
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 171 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 204

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 114/222 (51%), Gaps = 25/222 (11%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQG-FREFRAEMETL 132
           +DAT N S DK++G G FG V   +L       ++VAIK L     +   R+F  E   +
Sbjct: 30  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           G+  H NI+++ G        +++ E++ENGSLD +L    ++D      QL        
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQL-------- 137
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
              V ++RG+A+G+ YL  +    +HRD+ + N+L++S+    +SDFGL+R ++      
Sbjct: 138 ---VGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 192
Query: 253 STQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            T   G +   +  PE +      T   DV+S+GI++ E+ +
Sbjct: 193 YTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMS 233

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 134/284 (47%), Gaps = 39/284 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VA+K L + +      F AE   + +L+H+ +V++  Y   
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL--YAVV 86
Query: 150 GLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLA 207
             + + +I E++ENGSL  +L   S      G K  +N L        + +   +A G+A
Sbjct: 87  TQEPIYIITEYMENGSLVDFLKTPS------GIKLTINKL--------LDMAAQIAEGMA 132
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           ++   E+  IHRD++++N+L+       I+DFGLAR I+ +           + +  PE 
Sbjct: 133 FIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 190
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE         +   MV 
Sbjct: 191 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---------RGYRMVR 240
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            +   EEL        +++  +C  E+  +RP   Y+  +L++ 
Sbjct: 241 PDNCPEEL--------YQLMRLCWKERPEDRPTFDYLRSVLEDF 276

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 134/284 (47%), Gaps = 39/284 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VA+K L + +      F AE   + +L+H+ +V++  Y   
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL--YAVV 85
Query: 150 GLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLA 207
             + + +I E++ENGSL  +L   S      G K  +N L        + +   +A G+A
Sbjct: 86  TQEPIYIITEYMENGSLVDFLKTPS------GIKLTINKL--------LDMAAQIAEGMA 131
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           ++   E+  IHRD++++N+L+       I+DFGLAR I+ +           + +  PE 
Sbjct: 132 FIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 189
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE         +   MV 
Sbjct: 190 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---------RGYRMVR 239
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            +   EEL        +++  +C  E+  +RP   Y+  +L++ 
Sbjct: 240 PDNCPEEL--------YQLMRLCWKERPEDRPTFDYLRSVLEDF 275

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 134/284 (47%), Gaps = 39/284 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VA+K L + +      F AE   + +L+H+ +V++  Y   
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL--YAVV 83
Query: 150 GLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLA 207
             + + +I E++ENGSL  +L   S      G K  +N L        + +   +A G+A
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPS------GIKLTINKL--------LDMAAQIAEGMA 129
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           ++   E+  IHRD++++N+L+       I+DFGLAR I+ +           + +  PE 
Sbjct: 130 FIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 187
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE         +   MV 
Sbjct: 188 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---------RGYRMVR 237
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            +   EEL        +++  +C  E+  +RP   Y+  +L++ 
Sbjct: 238 PDNCPEEL--------YQLMRLCWKERPEDRPTFDYLRSVLEDF 273

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 134/284 (47%), Gaps = 39/284 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VA+K L + +      F AE   + +L+H+ +V++  Y   
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL--YAVV 79
Query: 150 GLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLA 207
             + + +I E++ENGSL  +L   S      G K  +N L        + +   +A G+A
Sbjct: 80  TQEPIYIITEYMENGSLVDFLKTPS------GIKLTINKL--------LDMAAQIAEGMA 125
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           ++   E+  IHRD++++N+L+       I+DFGLAR I+ +           + +  PE 
Sbjct: 126 FIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 183
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE         +   MV 
Sbjct: 184 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---------RGYRMVR 233
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            +   EEL        +++  +C  E+  +RP   Y+  +L++ 
Sbjct: 234 PDNCPEEL--------YQLMRLCWKERPEDRPTFDYLRSVLEDF 269

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 113/216 (52%), Gaps = 28/216 (12%)
Query: 87  DKIIGDGSFGFVYKAKLSSG----VTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNI 140
           +++IG G FG V + +L +       VAIK L K  +  +  REF +E   +G+  H NI
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           +++ G   + +  +++ EF+ENG+LD +L     ND      QL           V ++R
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQL-----------VGMLR 123
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
           G+A+G+ YL   E   +HRD+ + N+L++S+    +SDFGL+R ++ + S   T  +   
Sbjct: 124 GIASGMRYLA--EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSD-PTYTSSLG 180
Query: 261 GYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
           G +P  +      A    T   D +S+GI+M E+ +
Sbjct: 181 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 134/284 (47%), Gaps = 39/284 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VA+K L + +      F AE   + +L+H+ +V++  Y   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL--YAVV 77
Query: 150 GLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLA 207
             + + +I E++ENGSL  +L   S      G K  +N L        + +   +A G+A
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPS------GIKLTINKL--------LDMAAQIAEGMA 123
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           ++   E+  IHRD++++N+L+       I+DFGLAR I+ +           + +  PE 
Sbjct: 124 FIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE         +   MV 
Sbjct: 182 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---------RGYRMVR 231
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            +   EEL        +++  +C  E+  +RP   Y+  +L++ 
Sbjct: 232 PDNCPEEL--------YQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 134/284 (47%), Gaps = 39/284 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VA+K L + +      F AE   + +L+H+ +V++  Y   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL--YAVV 77
Query: 150 GLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLA 207
             + + +I E++ENGSL  +L   S      G K  +N L        + +   +A G+A
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPS------GIKLTINKL--------LDMAAQIAEGMA 123
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           ++   E+  IHRD++++N+L+       I+DFGLAR I+ +           + +  PE 
Sbjct: 124 FIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE         +   MV 
Sbjct: 182 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---------RGYRMVR 231
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            +   EEL        +++  +C  E+  +RP   Y+  +L++ 
Sbjct: 232 PDNCPEEL--------YQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 126/257 (49%), Gaps = 26/257 (10%)
Query: 66  DPSLSQISMSELI-DATDNFSTDKI-----IGDGSFGFVY--------KAKLSSGVTVAI 111
           DP L+ +S  EL  D    F  DK+     +G+G+FG V         K K    VTVA+
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAV 72
Query: 112 KKLDKDAFQG-FREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWL 169
           K L  DA +    +  +EME +  + +H+NI+ +LG C       +I E+   G+L ++L
Sbjct: 73  KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 170 HDTSRNDDVDGSKQLNSLCP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVL 227
               R   ++ S  +N +    ++++  V     +A G+ YL    +  IHRD+ + NVL
Sbjct: 133 R-ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL 189
Query: 228 LDSDFEAHISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
           +  +    I+DFGLAR I+       +T     + +M PE L  +   T   DV+SFG+L
Sbjct: 190 VTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVL 248
Query: 287 MIEIAT---QIRPNLPV 300
           M EI T      P +PV
Sbjct: 249 MWEIFTLGGSPYPGIPV 265

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 134/284 (47%), Gaps = 39/284 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VA+K L + +      F AE   + +L+H+ +V++  Y   
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL--YAVV 82
Query: 150 GLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLA 207
             + + +I E++ENGSL  +L   S      G K  +N L        + +   +A G+A
Sbjct: 83  TQEPIYIITEYMENGSLVDFLKTPS------GIKLTINKL--------LDMAAQIAEGMA 128
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           ++   E+  IHRD++++N+L+       I+DFGLAR I+ +           + +  PE 
Sbjct: 129 FIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 186
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE         +   MV 
Sbjct: 187 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---------RGYRMVR 236
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            +   EEL        +++  +C  E+  +RP   Y+  +L++ 
Sbjct: 237 PDNCPEEL--------YQLMRLCWKERPEDRPTFDYLRSVLEDF 272

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 134/284 (47%), Gaps = 39/284 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VA+K L + +      F AE   + +L+H+ +V++  Y   
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL--YAVV 83
Query: 150 GLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLA 207
             + + +I E++ENGSL  +L   S      G K  +N L        + +   +A G+A
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPS------GIKLTINKL--------LDMAAQIAEGMA 129
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           ++   E+  IHRD++++N+L+       I+DFGLAR I+ +           + +  PE 
Sbjct: 130 FIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 187
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE         +   MV 
Sbjct: 188 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---------RGYRMVR 237
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            +   EEL        +++  +C  E+  +RP   Y+  +L++ 
Sbjct: 238 PDNCPEEL--------YQLMRLCWKERPEDRPTFDYLRSVLEDF 273

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 134/284 (47%), Gaps = 39/284 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VA+K L + +      F AE   + +L+H+ +V++  Y   
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL--YAVV 78
Query: 150 GLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLA 207
             + + +I E++ENGSL  +L   S      G K  +N L        + +   +A G+A
Sbjct: 79  TQEPIYIITEYMENGSLVDFLKTPS------GIKLTINKL--------LDMAAQIAEGMA 124
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           ++   E+  IHRD++++N+L+       I+DFGLAR I+ +           + +  PE 
Sbjct: 125 FIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 182
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE         +   MV 
Sbjct: 183 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---------RGYRMVR 232
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            +   EEL        +++  +C  E+  +RP   Y+  +L++ 
Sbjct: 233 PDNCPEEL--------YQLMRLCWKERPEDRPTFDYLRSVLEDF 268

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 117
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 118 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTD 165
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 199

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 143
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 144 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTT 191
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 192 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 225

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 120
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 121 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTT 168
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 169 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 202

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 134
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 135 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTT 182
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 183 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 216

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 134/284 (47%), Gaps = 39/284 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VA+K L + +      F AE   + +L+H+ +V++  Y   
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL--YAVV 87
Query: 150 GLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLA 207
             + + +I E++ENGSL  +L   S      G K  +N L        + +   +A G+A
Sbjct: 88  TQEPIYIITEYMENGSLVDFLKTPS------GIKLTINKL--------LDMAAQIAEGMA 133
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           ++   E+  IHRD++++N+L+       I+DFGLAR I+ +           + +  PE 
Sbjct: 134 FIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 191
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE         +   MV 
Sbjct: 192 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---------RGYRMVR 241
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            +   EEL        +++  +C  E+  +RP   Y+  +L++ 
Sbjct: 242 PDNCPEEL--------YQLMRLCWKERPEDRPTFDYLRSVLEDF 277

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 117
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 118 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTT 165
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 199

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 118
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 119 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTD 166
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 167 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 200

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 116
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 117 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTT 164
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 165 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 198

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 120
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 121 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTT 168
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 169 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 202

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 117
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 118 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTD 165
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 199

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 134/284 (47%), Gaps = 39/284 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VA+K L + +      F AE   + +L+H+ +V++  Y   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL--YAVV 77
Query: 150 GLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLA 207
             + + +I E++ENGSL  +L   S      G K  +N L        + +   +A G+A
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPS------GIKLTINKL--------LDMAAQIAEGMA 123
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           ++   E+  IHRD++++N+L+       I+DFGLAR I+ +           + +  PE 
Sbjct: 124 FIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE         +   MV 
Sbjct: 182 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---------RGYRMVR 231
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            +   EEL        +++  +C  E+  +RP   Y+  +L++ 
Sbjct: 232 PDNCPEEL--------YQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKLRH 137
           ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    LRH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NI+++ GY        LI E+   G++ + L   SR D+   +  +  L          
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL---------- 121
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
                AN L+Y H   K +IHRDIK  N+LL S+ E  I+DFG +    +S       + 
Sbjct: 122 -----ANALSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT---LC 171
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT+ Y+PPE + G       +D++S G+L  E    + P
Sbjct: 172 GTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEFLVGMPP 209

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 117
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 118 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTX 165
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 199

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 122
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 123 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTT 170
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 171 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 204

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 118
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 119 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR---RTT 166
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           ++GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 167 LSGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 200

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 116/234 (49%), Gaps = 25/234 (10%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQG 121
           DP+ +    ++ +DA+     +++IG G FG V   +L       V VAIK L     + 
Sbjct: 28  DPNRAVHQFAKELDAS-CIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEK 86
Query: 122 -FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
             R+F  E   +G+  H N+V + G    G   +++ EF+ENG+LD +L         DG
Sbjct: 87  QRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKH------DG 140
Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG 240
              +  L        V ++RG+A G+ YL  +    +HRD+ + N+L++S+    +SDFG
Sbjct: 141 QFTVIQL--------VGMLRGIAAGMRYLADMG--YVHRDLAARNILVNSNLVCKVSDFG 190
Query: 241 LARRIDTSHSHVSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           L+R I+     V T   G +   +  PE +      T   DV+S+GI+M E+ +
Sbjct: 191 LSRVIEDDPEAVYTTTGGKIPVRWTAPEAI-QYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 135/284 (47%), Gaps = 39/284 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VA+K L + +      F AE   + +L+H+ +V++  Y   
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL--YAVV 72
Query: 150 GLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLA 207
             + + +I E++ENGSL  +L   S      G K  +N L  ++ +        +A G+A
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTPS------GIKLTINKLLDMAAQ--------IAEGMA 118
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           ++   E+  IHRD++++N+L+       I+DFGLAR I+ +           + +  PE 
Sbjct: 119 FIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 176
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE         +   MV 
Sbjct: 177 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---------RGYRMVR 226
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            +   EEL        +++  +C  E+  +RP   Y+  +L++ 
Sbjct: 227 PDNCPEEL--------YQLMRLCWKERPEDRPTFDYLRSVLEDF 262

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 122
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 123 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTT 170
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 171 LCGTLDYLPPEXIEGRXHDE-KVDLWSLGVLCYEF 204

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 35/290 (12%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           ++   +K +G G FG V+ A  +    VA+K + K        F AE   +  L+H  +V
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 73
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           K L    +     +I EF+  GSL  +L         +GSKQ     PL     +     
Sbjct: 74  K-LHAVVTKEPIYIITEFMAKGSLLDFLKSD------EGSKQ-----PLP--KLIDFSAQ 119
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +A G+A++   ++  IHRD++++N+L+ +     I+DFGLAR I+ +           + 
Sbjct: 120 IAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 177
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK 321
           +  PE +   +  T+  DV+SFGIL++EI T  R   P + + + +  LE    M     
Sbjct: 178 WTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR--- 233
Query: 322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
                          E    E + I   C   +  ERP   Y+  +LD+ 
Sbjct: 234 --------------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 269

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 121
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 122 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTT 169
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 170 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 122
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 123 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTD 170
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 171 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 204

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/220 (35%), Positives = 110/220 (50%), Gaps = 39/220 (17%)
Query: 93  GSFGFVYKAKL-SSGVTVAIKKL-DKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASG 150
           G FG V+KA+L +  V V I  + DK ++Q       E+ +L  ++H NI++ +G    G
Sbjct: 35  GRFGCVWKAQLLNEYVAVKIFPIQDKQSWQN----EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 151 ----LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
               +D  LI  F E GSL  +L                    +SW     I   +A GL
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKANV----------------VSWNELCHIAETMARGL 134
Query: 207 AYLH----GLE---KPII-HRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ-VA 257
           AYLH    GL+   KP I HRDIKS NVLL ++  A I+DFGLA + +   S   T    
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 258 GTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQ 293
           GT  YM PE L G       A + +D+Y+ G+++ E+A++
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAF--QGFREFRAEMET 131
           +DAT N S DK++G G FG V   +L       ++VAIK L K  +  +  R+F  E   
Sbjct: 13  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASI 70
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           +G+  H NI+++ G        +++ E +ENGSLD +L    ++D      QL       
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR---KHDAQFTVIQL------- 120
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
               V ++RG+A+G+ YL  +    +HRD+ + N+L++S+    +SDFGL+R ++     
Sbjct: 121 ----VGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 174
Query: 252 VSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             T   G +   +  PE +      T   DV+S+GI++ E+
Sbjct: 175 AYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEV 214

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 84  FSTDKIIGDGSFGFVYKAKLSSGVTVAIKKL----DKDAFQGFREFRAEMETLGKLRHRN 139
            + ++IIG G FG VY+A    G  VA+K      D+D  Q     R E +    L+H N
Sbjct: 9   LTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           I+ + G C    +  L+ EF   G L++          V   K++     ++W  +    
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNR----------VLSGKRIPPDILVNWAVQ---- 113
Query: 200 RGVANGLAYLHGLE-KPIIHRDIKSSNVLLDSDFE--------AHISDFGLARRIDTSHS 250
             +A G+ YLH     PIIHRD+KSSN+L+    E          I+DFGLAR     H 
Sbjct: 114 --IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHR 168
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
                 AG   +M PE +  +  +    DV+S+G+L+ E+ T
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGS-DVWSYGVLLWELLT 209

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 126/263 (47%), Gaps = 26/263 (9%)
Query: 60  FDSASFDPSLSQISMSELID------ATDNFSTDKIIGDGSFGFVY--------KAKLSS 105
             S +  P L+ +S  EL +        D  +  K +G+G FG V         K K   
Sbjct: 53  LSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKE 112
Query: 106 GVTVAIKKLDKDAFQG-FREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVENG 163
            VTVA+K L  DA +    +  +EME +  + +H+NI+ +LG C       +I E+   G
Sbjct: 113 AVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 172
Query: 164 SLDQWLHDTSRNDDVDGSKQLNSLCP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDI 221
           +L ++L    R   ++ S  +N +    ++++  V     +A G+ YL    +  IHRD+
Sbjct: 173 NLREYLR-ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDL 229
Query: 222 KSSNVLLDSDFEAHISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDV 280
            + NVL+  +    I+DFGLAR I+   +   +T     + +M PE L  +   T   DV
Sbjct: 230 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDV 288
Query: 281 YSFGILMIEIAT---QIRPNLPV 300
           +SFG+LM EI T      P +PV
Sbjct: 289 WSFGVLMWEIFTLGGSPYPGIPV 311

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 126/257 (49%), Gaps = 26/257 (10%)
Query: 66  DPSLSQISMSELI-DATDNFSTDKI-----IGDGSFGFVY--------KAKLSSGVTVAI 111
           DP L+ +S  EL  D    F  DK+     +G+G+FG V         K K    VTVA+
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAV 72
Query: 112 KKLDKDAFQG-FREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWL 169
           K L  DA +    +  +EME +  + +H+NI+ +LG C       +I  +   G+L ++L
Sbjct: 73  KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYL 132
Query: 170 HDTSRNDDVDGSKQLNSLCP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVL 227
               R   ++ S  +N +    ++++  V     +A G+ YL    +  IHRD+ + NVL
Sbjct: 133 R-ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL 189
Query: 228 LDSDFEAHISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
           +  +    I+DFGLAR I+   +   +T     + +M PE L  +   T   DV+SFG+L
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVL 248
Query: 287 MIEIAT---QIRPNLPV 300
           M EI T      P +PV
Sbjct: 249 MWEIFTLGGSPYPGIPV 265

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/256 (31%), Positives = 125/256 (48%), Gaps = 26/256 (10%)
Query: 67  PSLSQISMSELI-DATDNFSTDKI-----IGDGSFGFVY--------KAKLSSGVTVAIK 112
           P L+ +S  EL  D    F  DK+     +G+G FG V         K K    VTVA+K
Sbjct: 1   PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK 60
Query: 113 KLDKDAFQG-FREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH 170
            L  DA +    +  +EME +  + +H+NI+ +LG C       +I E+   G+L ++L 
Sbjct: 61  MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 120
Query: 171 DTSRNDDVDGSKQLNSLCP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL 228
              R   ++ S  +N +    ++++  V     +A G+ YL    +  IHRD+ + NVL+
Sbjct: 121 -ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLTARNVLV 177
Query: 229 DSDFEAHISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
             +    I+DFGLAR I+   +   +T     + +M PE L  +   T   DV+SFG+LM
Sbjct: 178 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLM 236
Query: 288 IEIAT---QIRPNLPV 300
            EI T      P +PV
Sbjct: 237 WEIFTLGGSPYPGIPV 252

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 130/290 (44%), Gaps = 35/290 (12%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           ++   +K +G G FG V+ A  +    VA+K + K        F AE   +  L+H  +V
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           K L    +     +I EF+  GSL  +L    ++D+  GSKQ     PL     +     
Sbjct: 247 K-LHAVVTKEPIYIITEFMAKGSLLDFL----KSDE--GSKQ-----PLP--KLIDFSAQ 292
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +A G+A++   ++  IHRD++++N+L+ +     I+DFGLAR I+ +           + 
Sbjct: 293 IAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK 321
           +  PE +   +  T+  DV+SFGIL++EI T  R   P + + + +  LE    M     
Sbjct: 351 WTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR--- 406
Query: 322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
                          E    E + I   C   +  ERP   Y+  +LD+ 
Sbjct: 407 --------------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/311 (27%), Positives = 144/311 (46%), Gaps = 41/311 (13%)
Query: 64  SFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGF 122
           S DPS       E+ + TD  +    +G G +G VY+       +TVA+K L +D  +  
Sbjct: 2   SMDPSSPNYDKWEM-ERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-V 58
Query: 123 REFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSK 182
            EF  E   + +++H N+V++LG C       +I EF+  G+L  +L + +R       +
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-------Q 111
Query: 183 QLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA 242
           ++N++  L   T+      +++ + YL   +K  IHRD+ + N L+  +    ++DFGL+
Sbjct: 112 EVNAVVLLYMATQ------ISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLS 163
Query: 243 RRI--DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPV 300
           R +  DT  +H   +    + +  PE L  N   ++  DV++FG+L+ EIAT      P 
Sbjct: 164 RLMTGDTYTAHAGAKFP--IKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
           +   Q   LLE               D  + R E     V E  R AC   N    +RP+
Sbjct: 221 IDLSQVYELLE--------------KDYRMERPEGCPEKVYELMR-ACWQWN--PSDRPS 263
Query: 361 MSYVVQLLDEL 371
            + + Q  + +
Sbjct: 264 FAEIHQAFETM 274

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G + + L   S+ D+   +  +  L        
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL-------- 122
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S       
Sbjct: 123 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXX 170
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 171 LXGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 204

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/256 (31%), Positives = 125/256 (48%), Gaps = 26/256 (10%)
Query: 67  PSLSQISMSELI-DATDNFSTDKI-----IGDGSFGFVY--------KAKLSSGVTVAIK 112
           P L+ +S  EL  D    F  DK+     +G+G FG V         K K    VTVA+K
Sbjct: 6   PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK 65
Query: 113 KLDKDAFQG-FREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH 170
            L  DA +    +  +EME +  + +H+NI+ +LG C       +I E+   G+L ++L 
Sbjct: 66  MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 125
Query: 171 DTSRNDDVDGSKQLNSLCP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL 228
              R   ++ S  +N +    ++++  V     +A G+ YL    +  IHRD+ + NVL+
Sbjct: 126 -ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLV 182
Query: 229 DSDFEAHISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
             +    I+DFGLAR I+   +   +T     + +M PE L  +   T   DV+SFG+LM
Sbjct: 183 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLM 241
Query: 288 IEIAT---QIRPNLPV 300
            EI T      P +PV
Sbjct: 242 WEIFTLGGSPYPGIPV 257

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 12/217 (5%)
Query: 83  NFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR 136
           N    + +G+G+FG V+ A+          + VA+K L   +    ++F  E E L  L+
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H +IVK  G C  G   ++++E++++G L+++L   +   D     + N    L+    +
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL--RAHGPDAVLMAEGNPPTELTQSQML 131
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQ 255
            I + +A G+ YL    +  +HRD+ + N L+  +    I DFG++R +  T +  V   
Sbjct: 132 HIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 189
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
               + +MPPE +      T   DV+S G+++ EI T
Sbjct: 190 TMLPIRWMPPESIMYRKFTTES-DVWSLGVVLWEIFT 225

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/256 (31%), Positives = 125/256 (48%), Gaps = 26/256 (10%)
Query: 67  PSLSQISMSELI-DATDNFSTDKI-----IGDGSFGFVY--------KAKLSSGVTVAIK 112
           P L+ +S  EL  D    F  DK+     +G+G FG V         K K    VTVA+K
Sbjct: 3   PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK 62
Query: 113 KLDKDAFQG-FREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH 170
            L  DA +    +  +EME +  + +H+NI+ +LG C       +I E+   G+L ++L 
Sbjct: 63  MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 122
Query: 171 DTSRNDDVDGSKQLNSLCP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL 228
              R   ++ S  +N +    ++++  V     +A G+ YL    +  IHRD+ + NVL+
Sbjct: 123 -ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLV 179
Query: 229 DSDFEAHISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
             +    I+DFGLAR I+   +   +T     + +M PE L  +   T   DV+SFG+LM
Sbjct: 180 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLM 238
Query: 288 IEIAT---QIRPNLPV 300
            EI T      P +PV
Sbjct: 239 WEIFTLGGSPYPGIPV 254

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 142/311 (45%), Gaps = 41/311 (13%)
Query: 64  SFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGF 122
           S DPS       E+ + TD  +    +G G +G VY+       +TVA+K L +D  +  
Sbjct: 2   SMDPSSPNYDKWEM-ERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-V 58
Query: 123 REFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSK 182
            EF  E   + +++H N+V++LG C       +I EF+  G+L  +L + +R       +
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-------Q 111
Query: 183 QLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA 242
           ++N++  L   T+      +++ + YL   +K  IHRD+ + N L+  +    ++DFGL+
Sbjct: 112 EVNAVVLLYMATQ------ISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLS 163
Query: 243 RRI--DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPV 300
           R +  DT  +H   +    + +  PE L  N   ++  DV++FG+L+ EIAT      P 
Sbjct: 164 RLMTGDTYTAHAGAKFP--IKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
           +   Q   LLE               D  + R E     V E  R    C      +RP+
Sbjct: 221 IDLSQVYELLE--------------KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPS 263
Query: 361 MSYVVQLLDEL 371
            + + Q  + +
Sbjct: 264 FAEIHQAFETM 274

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 119
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I++FG +    +S     T 
Sbjct: 120 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTT 167
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 168 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 201

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 120/284 (42%), Gaps = 34/284 (11%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           K +G G FG V+    ++   VA+K L K      + F  E   +  L+H  +V++    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  +I E++  GSL  +L       D  G   L  L   S +        +A G+A
Sbjct: 78  TREEPIYIITEYMAKGSLLDFL-----KSDEGGKVLLPKLIDFSAQ--------IAEGMA 124
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           Y+    K  IHRD++++NVL+       I+DFGLAR I+ +           + +  PE 
Sbjct: 125 YIE--RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 182
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +      T+  DV+SFGIL+ EI T  +   P              RT    N ++    
Sbjct: 183 INFG-CFTIKSDVWSFGILLYEIVTYGKIPYP-------------GRT----NADVMTAL 224
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           S   R    E    E + I  MC  EK+ ERP   Y+  +LD+ 
Sbjct: 225 SQGYRMPRVENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDF 268

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 120
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I++FG +    +S     T 
Sbjct: 121 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTT 168
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 169 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 202

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 117
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S       
Sbjct: 118 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAA 165
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 199

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 126/257 (49%), Gaps = 26/257 (10%)
Query: 66  DPSLSQISMSELI-DATDNFSTDKI-----IGDGSFGFVY--------KAKLSSGVTVAI 111
           DP L+ +S  EL  D    F  DK+     +G+G+FG V         K K    VTVA+
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAV 72
Query: 112 KKLDKDAFQG-FREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWL 169
           K L  DA +    +  +EME +  + +H+NI+ +LG C       +I  +   G+L ++L
Sbjct: 73  KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYL 132
Query: 170 HDTSRNDDVDGSKQLNSLCP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVL 227
               R   ++ S  +N +    ++++  V     +A G+ YL    +  IHRD+ + NVL
Sbjct: 133 R-ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL 189
Query: 228 LDSDFEAHISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
           +  +    I+DFGLAR I+   +   +T     + +M PE L  +   T   DV+SFG+L
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVL 248
Query: 287 MIEIAT---QIRPNLPV 300
           M EI T      P +PV
Sbjct: 249 MWEIFTLGGSPYPGIPV 265

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 84/316 (26%), Positives = 148/316 (46%), Gaps = 46/316 (14%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAF-- 119
           DP+ +    ++ IDA+     +K+IG G FG V   +L       + VAIK L K  +  
Sbjct: 14  DPNQAVREFAKEIDAS-CIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTD 71
Query: 120 QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVD 179
           +  R+F +E   +G+  H NI+ + G        ++I E++ENGSLD +L    +ND   
Sbjct: 72  KQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR---KNDGRF 128
Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
              QL           V ++RG+ +G+ YL  +    +HRD+ + N+L++S+    +SDF
Sbjct: 129 TVIQL-----------VGMLRGIGSGMKYLSDMSA--VHRDLAARNILVNSNLVCKVSDF 175
Query: 240 GLARRIDTSHSHVSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIATQ-IRP 296
           G++R ++       T   G +   +  PE +      T   DV+S+GI+M E+ +   RP
Sbjct: 176 GMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERP 234
Query: 297 NLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSR 356
                +  Q+V      + +E   +    +D  I+  +L              C  ++  
Sbjct: 235 YWD--MSNQDV-----IKAIEEGYRLPPPMDCPIALHQL-----------MLDCWQKERS 276
Query: 357 ERPAMSYVVQLLDELV 372
           +RP    +V +LD+L+
Sbjct: 277 DRPKFGQIVNMLDKLI 292

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+  +S   +A+K L K   +      + R E+E    L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 117
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S       
Sbjct: 118 -------ANALSYCHS--KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAA 165
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 199

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 135/284 (47%), Gaps = 39/284 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VA+K L + +      F AE   + +L+H+ +V++  Y   
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL--YAVV 73
Query: 150 GLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLA 207
             + + +I E++ENGSL  +L   S      G K  +N L  ++ +        +A G+A
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPS------GIKLTINKLLDMAAQ--------IAEGMA 119
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           ++   E+  IHR+++++N+L+       I+DFGLAR I+ +           + +  PE 
Sbjct: 120 FIE--ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 177
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE         +   MV 
Sbjct: 178 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---------RGYRMVR 227
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            +   EEL        +++  +C  E+  +RP   Y+  +L++ 
Sbjct: 228 PDNCPEEL--------YQLMRLCWKERPEDRPTFDYLRSVLEDF 263

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 120/284 (42%), Gaps = 34/284 (11%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           K +G G FG V+    ++   VA+K L K      + F  E   +  L+H  +V++    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  +I EF+  GSL  +L       D  G   L  L   S +        +A G+A
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFL-----KSDEGGKVLLPKLIDFSAQ--------IAEGMA 123
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           Y+    K  IHRD++++NVL+       I+DFGLAR I+ +           + +  PE 
Sbjct: 124 YIE--RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 181
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +      T+  +V+SFGIL+ EI T  +   P              RT    N ++    
Sbjct: 182 INFG-CFTIKSNVWSFGILLYEIVTYGKIPYP-------------GRT----NADVMSAL 223
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           S   R    E    E + I  MC  EK+ ERP   Y+  +LD+ 
Sbjct: 224 SQGYRMPRMENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDF 267

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 119
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S       
Sbjct: 120 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXX 167
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 168 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 201

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+       +A+K L K   +      + R E+E    L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 114
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S     T 
Sbjct: 115 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTT 162
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 163 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 196

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 120
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S       
Sbjct: 121 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXX 168
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 169 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 202

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 117
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S       
Sbjct: 118 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXX 165
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 199

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/312 (25%), Positives = 142/312 (45%), Gaps = 41/312 (13%)
Query: 63  ASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQG 121
            + DPS       E+ + TD  +    +G G +G VY+       +TVA+K L +D  + 
Sbjct: 1   GAMDPSSPNYDKWEM-ERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME- 57
Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS 181
             EF  E   + +++H N+V++LG C       +I EF+  G+L  +L + +R       
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR------- 110
Query: 182 KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
           +++N++  L   T+      +++ + YL   +K  IHRD+ + N L+  +    ++DFGL
Sbjct: 111 QEVNAVVLLYMATQ------ISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGL 162
Query: 242 ARRI--DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           +R +  DT  +H   +    + +  PE L  N   ++  DV++FG+L+ EIAT      P
Sbjct: 163 SRLMTGDTXTAHAGAKFP--IKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYP 219
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
            +   Q   LLE               D  + R E     V E  R    C      +RP
Sbjct: 220 GIDLSQVYELLE--------------KDYRMERPEGCPEKVYELMRA---CWQWNPSDRP 262
Query: 360 AMSYVVQLLDEL 371
           + + + Q  + +
Sbjct: 263 SFAEIHQAFETM 274

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 120
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S       
Sbjct: 121 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAA 168
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 169 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 202

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 118
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S       
Sbjct: 119 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT--- 166
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 167 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 200

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 143
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S       
Sbjct: 144 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDD 191
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 192 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 225

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 133/284 (46%), Gaps = 39/284 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G  G V+    +    VA+K L + +      F AE   + +L+H+ +V++  Y   
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL--YAVV 77
Query: 150 GLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSK-QLNSLCPLSWETRVKIVRGVANGLA 207
             + + +I E++ENGSL  +L   S      G K  +N L        + +   +A G+A
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPS------GIKLTINKL--------LDMAAQIAEGMA 123
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           ++   E+  IHRD++++N+L+       I+DFGLAR I+ +           + +  PE 
Sbjct: 124 FIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEA 181
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE         +   MV 
Sbjct: 182 INYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---------RGYRMVR 231
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            +   EEL        +++  +C  E+  +RP   Y+  +L++ 
Sbjct: 232 PDNCPEEL--------YQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 144/312 (46%), Gaps = 44/312 (14%)
Query: 63  ASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQG 121
            + DP+  +  M    + TD  +    +G G +G VY+       +TVA+K L +D  + 
Sbjct: 1   GAMDPNYDKWEM----ERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME- 54
Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS 181
             EF  E   + +++H N+V++LG C       +I EF+  G+L  +L + +R       
Sbjct: 55  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR------- 107
Query: 182 KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
           +++N++  L   T+      +++ + YL   +K  IHRD+ + N L+  +    ++DFGL
Sbjct: 108 QEVNAVVLLYMATQ------ISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGL 159
Query: 242 ARRI--DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           +R +  DT  +H   +    + +  PE L  N   ++  DV++FG+L+ EIAT      P
Sbjct: 160 SRLMTGDTYTAHAGAKFP--IKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYP 216
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
            +   Q   LLE               D  + R E     V E  R AC   N    +RP
Sbjct: 217 GIDLSQVYELLE--------------KDYRMERPEGCPEKVYELMR-ACWQWN--PSDRP 259
Query: 360 AMSYVVQLLDEL 371
           + + + Q  + +
Sbjct: 260 SFAEIHQAFETM 271

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 144/312 (46%), Gaps = 41/312 (13%)
Query: 63  ASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQG 121
            + DPS       E+ + TD  +    +G G +G VY+       +TVA+K L +D  + 
Sbjct: 1   GAMDPSSPNYDKWEM-ERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME- 57
Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS 181
             EF  E   + +++H N+V++LG C       +I EF+  G+L  +L + +R       
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR------- 110
Query: 182 KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
           +++N++  L   T+      +++ + YL   +K  IHRD+ + N L+  +    ++DFGL
Sbjct: 111 QEVNAVVLLYMATQ------ISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGL 162
Query: 242 ARRI--DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           +R +  DT  +H   +    + +  PE L  N   ++  DV++FG+L+ EIAT      P
Sbjct: 163 SRLMTGDTYTAHAGAKFP--IKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYP 219
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
            +   Q   LLE               D  + R E     V E  R AC   N    +RP
Sbjct: 220 GIDLSQVYELLE--------------KDYRMERPEGCPEKVYELMR-ACWQWN--PSDRP 262
Query: 360 AMSYVVQLLDEL 371
           + + + Q  + +
Sbjct: 263 SFAEIHQAFETM 274

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKL 135
           A ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++ GY        LI E+   G++ + L   S+ D+   +  +  L        
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL-------- 120
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S       
Sbjct: 121 -------ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDD 168
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + GT+ Y+PPE + G       +D++S G+L  E 
Sbjct: 169 LCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEF 202

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 134/285 (47%), Gaps = 39/285 (13%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       +++N++  L   T+      +++ + Y
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNR-------QEVNAVVLLYMATQ------ISSAMEY 127
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHRD+ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 128 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP--IKWTAPE 183
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L  N   ++  DV++FG+L+ EIAT      P +   Q   LLE               
Sbjct: 184 SLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------K 228
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           D  + R E     V E  R AC   N    +RP+ + + Q  + +
Sbjct: 229 DYRMERPEGCPEKVYELMR-ACWQWN--PSDRPSFAEIHQAFETM 270

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 134/285 (47%), Gaps = 39/285 (13%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G FG VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       ++++++  L   T+      +++ + Y
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQ------ISSAMEY 124
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHRD+ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 125 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP--IKWTAPE 180
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L  N   ++  DV++FG+L+ EIAT      P +   Q   LLE               
Sbjct: 181 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE--------------K 225
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           D  + R E     V E  R AC   N    +RP+ + + Q  + +
Sbjct: 226 DYRMERPEGCPEKVYELMR-ACWQWN--PSDRPSFAEIHQAFETM 267

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 132/285 (46%), Gaps = 39/285 (13%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       +++N++  L   T+      +++ + Y
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR-------QEVNAVVLLYMATQ------ISSAMEY 126
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHRD+ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 127 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPE 182
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L  N   ++  DV++FG+L+ EIAT      P +   Q   LLE               
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------K 227
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           D  + R E     V E  R    C      +RP+ + + Q  + +
Sbjct: 228 DYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETM 269

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 132/285 (46%), Gaps = 39/285 (13%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       +++N++  L   T+      +++ + Y
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNR-------QEVNAVVLLYMATQ------ISSAMEY 130
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHRD+ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 131 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPE 186
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L  N   ++  DV++FG+L+ EIAT      P +   Q   LLE               
Sbjct: 187 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------K 231
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           D  + R E     V E  R    C      +RP+ + + Q  + +
Sbjct: 232 DYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETM 273

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 132/285 (46%), Gaps = 39/285 (13%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       +++N++  L   T+      +++ + Y
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR-------QEVNAVVLLYMATQ------ISSAMEY 126
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHRD+ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 127 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPE 182
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L  N   ++  DV++FG+L+ EIAT      P +   Q   LLE               
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------K 227
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           D  + R E     V E  R    C      +RP+ + + Q  + +
Sbjct: 228 DYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETM 269

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 134/285 (47%), Gaps = 39/285 (13%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       +++N++  L   T+      +++ + Y
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR-------QEVNAVVLLYMATQ------ISSAMEY 128
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHRD+ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 129 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPE 184
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L  N   ++  DV++FG+L+ EIAT      P +   Q   LLE               
Sbjct: 185 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------K 229
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           D  + R E     V E  R AC   N    +RP+ + + Q  + +
Sbjct: 230 DYRMERPEGCPEKVYELMR-ACWQWN--PSDRPSFAEIHQAFETM 271

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 134/285 (47%), Gaps = 39/285 (13%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       +++N++  L   T+      +++ + Y
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNR-------QEVNAVVLLYMATQ------ISSAMEY 139
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHRD+ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 140 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPE 195
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L  N   ++  DV++FG+L+ EIAT      P +   Q   LLE               
Sbjct: 196 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------K 240
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           D  + R E     V E  R AC   N    +RP+ + + Q  + +
Sbjct: 241 DYRMERPEGCPEKVYELMR-ACWQWN--PSDRPSFAEIHQAFETM 282

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 28/216 (12%)
Query: 87  DKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNI 140
           +++IG G FG V    L       + VAIK L K  +  +  R+F +E   +G+  H N+
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNV 96
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           + + G        ++I EF+ENGSLD +L         DG   +  L        V ++R
Sbjct: 97  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQN------DGQFTVIQL--------VGMLR 142
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAG 258
           G+A G+ YL  +    +HRD+ + N+L++S+    +SDFGL+R +  DTS    ++ + G
Sbjct: 143 GIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 200
Query: 259 TMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +   +  PE +      T   DV+S+GI+M E+ +
Sbjct: 201 KIPIRWTAPEAI-QYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 134/285 (47%), Gaps = 39/285 (13%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       ++++++  L   T+      +++ + Y
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQ------ISSAMEY 124
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHRD+ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 125 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP--IKWTAPE 180
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L  N   ++  DV++FG+L+ EIAT      P +   Q   LLE               
Sbjct: 181 SLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE--------------K 225
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           D  + R E     V E  R AC   N    +RP+ + + Q  + +
Sbjct: 226 DYRMERPEGCPEKVYELMR-ACWQWN--PSDRPSFAEIHQAFETM 267

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 142/304 (46%), Gaps = 46/304 (15%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAF--QGFREFRAEMET 131
           IDA+     +K+IG G FG V   +L       + VAIK L K  +  +  R+F +E   
Sbjct: 5   IDAS-CIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDKQRRDFLSEASI 62
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           +G+  H NI+ + G        ++I E++ENGSLD +L    +ND      QL       
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQL------- 112
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
               V ++RG+ +G+ YL  +    +HRD+ + N+L++S+    +SDFG++R ++     
Sbjct: 113 ----VGMLRGIGSGMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA 166
Query: 252 VSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIATQ-IRPNLPVVLDGQEVG 308
             T   G +   +  PE +      T   DV+S+GI+M E+ +   RP     +  Q+V 
Sbjct: 167 AYTTRGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWD--MSNQDV- 222
Query: 309 LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLL 368
                + +E   +    +D  I+  +L              C  ++  +RP    +V +L
Sbjct: 223 ----IKAIEEGYRLPPPMDCPIALHQL-----------MLDCWQKERSDRPKFGQIVNML 267
Query: 369 DELV 372
           D+L+
Sbjct: 268 DKLI 271

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 142/304 (46%), Gaps = 46/304 (15%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAF--QGFREFRAEMET 131
           IDA+     +K+IG G FG V   +L       + VAIK L K  +  +  R+F +E   
Sbjct: 11  IDAS-CIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDKQRRDFLSEASI 68
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           +G+  H NI+ + G        ++I E++ENGSLD +L    +ND      QL       
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQL------- 118
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
               V ++RG+ +G+ YL  +    +HRD+ + N+L++S+    +SDFG++R ++     
Sbjct: 119 ----VGMLRGIGSGMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA 172
Query: 252 VSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIATQ-IRPNLPVVLDGQEVG 308
             T   G +   +  PE +      T   DV+S+GI+M E+ +   RP     +  Q+V 
Sbjct: 173 AYTTRGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWD--MSNQDV- 228
Query: 309 LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLL 368
                + +E   +    +D  I+  +L              C  ++  +RP    +V +L
Sbjct: 229 ----IKAIEEGYRLPPPMDCPIALHQL-----------MLDCWQKERSDRPKFGQIVNML 273
Query: 369 DELV 372
           D+L+
Sbjct: 274 DKLI 277

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 123/235 (52%), Gaps = 16/235 (6%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRA-EMETLGKL 135
           + ++  F   + +G+G++  VYK    ++GV VA+K++  D+ +G       E+  + +L
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           +H NIV++     +     L++EF++N  L +++ D+    +     +LN +    W+  
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQ-- 116
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                 +  GLA+ H  E  I+HRD+K  N+L++   +  + DFGLAR      +  S++
Sbjct: 117 ------LLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL 310
           V  T+ Y  P+ L G+   +  +D++S G ++ E+ T  +P  P   D +++ L+
Sbjct: 169 VV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTNDEEQLKLI 221

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 112/222 (50%), Gaps = 18/222 (8%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSSGVT-------VAIKKLDKDAFQGFR-EFRAEMET 131
           A +  +  + +G GSFG VY+  ++ GV        VAIK +++ A    R EF  E   
Sbjct: 23  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           + +    ++V++LG  + G   ++I E +  G L  +L   S   +++ +     L P S
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNP---VLAPPS 136
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHS 250
               +++   +A+G+AYL+      +HRD+ + N ++  DF   I DFG+ R I +T + 
Sbjct: 137 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
               +    + +M PE L  +   T   DV+SFG+++ EIAT
Sbjct: 195 RKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 144/312 (46%), Gaps = 41/312 (13%)
Query: 63  ASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQG 121
            + DPS       E+ + TD  +    +G G +G VY+       +TVA+K L +D  + 
Sbjct: 1   GAMDPSSPNYDKWEM-ERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME- 57
Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS 181
             EF  E   + +++H N+V++LG C       +I EF+  G+L  +L + +R       
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR------- 110
Query: 182 KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
           ++++++  L   T+      +++ + YL   +K  IHRD+ + N L+  +    ++DFGL
Sbjct: 111 QEVSAVVLLYMATQ------ISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGL 162
Query: 242 ARRI--DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           +R +  DT  +H   +    + +  PE L  N   ++  DV++FG+L+ EIAT      P
Sbjct: 163 SRLMTGDTYTAHAGAKFP--IKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYP 219
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
            +   Q   LLE               D  + R E     V E  R AC   N    +RP
Sbjct: 220 GIDLSQVYELLE--------------KDYRMERPEGCPEKVYELMR-ACWQWN--PSDRP 262
Query: 360 AMSYVVQLLDEL 371
           + + + Q  + +
Sbjct: 263 SFAEIHQAFETM 274

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 24/225 (10%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSSGVT-------VAIKKLDKDAFQGFR-EFRAEMET 131
           A +  +  + +G GSFG VY+  ++ GV        VAIK +++ A    R EF  E   
Sbjct: 16  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS---RNDDVDGSKQLNSLC 188
           + +    ++V++LG  + G   ++I E +  G L  +L        N+ V        L 
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV--------LA 126
Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DT 247
           P S    +++   +A+G+AYL+      +HRD+ + N ++  DF   I DFG+ R I +T
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 184
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +     +    + +M PE L  +   T   DV+SFG+++ EIAT
Sbjct: 185 DYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/241 (31%), Positives = 115/241 (47%), Gaps = 29/241 (12%)
Query: 68  SLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR 126
           SL +I +S L D    F   +++G+G++G VYK + + +G   AIK +D    +   E +
Sbjct: 10  SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIK 68
Query: 127 AEMETLGKL-RHRNIVKILG----YCASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVD 179
            E+  L K   HRNI    G        G+D  L  + EF   GS+   + +T  N    
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT--- 125
Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
                     L  E    I R +  GL++LH  +  +IHRDIK  NVLL  + E  + DF
Sbjct: 126 ----------LKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDF 173
Query: 240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLG--GNTAATVML--DVYSFGILMIEIATQIR 295
           G++ ++D +    +T + GT  +M PE +    N  AT     D++S GI  IE+A    
Sbjct: 174 GVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 296 P 296
           P
Sbjct: 233 P 233

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/315 (25%), Positives = 143/315 (45%), Gaps = 44/315 (13%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQG 121
           DP+ +    ++ I+A+   + +++IG G FG V   +L       + VAIK L     + 
Sbjct: 7   DPNQAVHEFAKEIEAS-CITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEK 65
Query: 122 -FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
             R+F  E   +G+  H NI+ + G        +++ E++ENGSLD +L    +ND    
Sbjct: 66  QRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL---KKNDGQFT 122
Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG 240
             QL           V ++RG++ G+ YL  +    +HRD+ + N+L++S+    +SDFG
Sbjct: 123 VIQL-----------VGMLRGISAGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFG 169
Query: 241 LARRIDTSHSHVSTQVAGTMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIATQ-IRPN 297
           L+R ++       T   G +   +  PE +      +   DV+S+GI+M E+ +   RP 
Sbjct: 170 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSAS-DVWSYGIVMWEVVSYGERPY 228
Query: 298 LPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRE 357
                         W  T +   K +E      S  +   A     +++   C  ++   
Sbjct: 229 --------------WEMTNQDVIKAVEEGYRLPSPMDCPAA----LYQLMLDCWQKERNS 270
Query: 358 RPAMSYVVQLLDELV 372
           RP    +V +LD+L+
Sbjct: 271 RPKFDEIVNMLDKLI 285

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 24/225 (10%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSSGVT-------VAIKKLDKDAFQGFR-EFRAEMET 131
           A +  +  + +G GSFG VY+  ++ GV        VAIK +++ A    R EF  E   
Sbjct: 16  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS---RNDDVDGSKQLNSLC 188
           + +    ++V++LG  + G   ++I E +  G L  +L        N+ V        L 
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV--------LA 126
Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DT 247
           P S    +++   +A+G+AYL+      +HRD+ + N ++  DF   I DFG+ R I +T
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 184
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +     +    + +M PE L  +   T   DV+SFG+++ EIAT
Sbjct: 185 DYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 24/225 (10%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSSGVT-------VAIKKLDKDAFQGFR-EFRAEMET 131
           A +  +  + +G GSFG VY+  ++ GV        VAIK +++ A    R EF  E   
Sbjct: 14  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS---RNDDVDGSKQLNSLC 188
           + +    ++V++LG  + G   ++I E +  G L  +L        N+ V        L 
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV--------LA 124
Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DT 247
           P S    +++   +A+G+AYL+      +HRD+ + N ++  DF   I DFG+ R I +T
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 182
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +     +    + +M PE L  +   T   DV+SFG+++ EIAT
Sbjct: 183 DYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 24/225 (10%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSSGVT-------VAIKKLDKDAFQGFR-EFRAEMET 131
           A +  +  + +G GSFG VY+  ++ GV        VAIK +++ A    R EF  E   
Sbjct: 10  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS---RNDDVDGSKQLNSLC 188
           + +    ++V++LG  + G   ++I E +  G L  +L        N+ V        L 
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV--------LA 120
Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DT 247
           P S    +++   +A+G+AYL+      +HRD+ + N ++  DF   I DFG+ R I +T
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 178
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +     +    + +M PE L  +   T   DV+SFG+++ EIAT
Sbjct: 179 DYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 87/313 (27%), Positives = 136/313 (43%), Gaps = 50/313 (15%)
Query: 82  DNFSTDKIIGDGSFGFVY--------KAKLSSGVTVAIKKLDKDAFQG-FREFRAEMETL 132
           D     K +G+G+FG V         K K +    VA+K L  DA +    +  +EME +
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 133 GKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH-------DTSRNDDVDGSKQL 184
             + +H+NI+ +LG C       +I E+   G+L ++L        + S N   +  +QL
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR 244
           +S      +  V     VA G+ YL    K  IHRD+ + NVL+  D    I+DFGLAR 
Sbjct: 141 SS------KDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARD 192
Query: 245 IDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPV 300
           I     H+      T G +P +++      +   T   DV+SFG+L+ EI T      P 
Sbjct: 193 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 248
Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
           V   +   LL+    M+          SN +          E + +   C +    +RP 
Sbjct: 249 VPVEELFKLLKEGHRMDK--------PSNCT---------NELYMMMRDCWHAVPSQRPT 291
Query: 361 MSYVVQLLDELVA 373
              +V+ LD +VA
Sbjct: 292 FKQLVEDLDRIVA 304

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 24/225 (10%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSSGVT-------VAIKKLDKDAFQGFR-EFRAEMET 131
           A +  +  + +G GSFG VY+  ++ GV        VAIK +++ A    R EF  E   
Sbjct: 23  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHD---TSRNDDVDGSKQLNSLC 188
           + +    ++V++LG  + G   ++I E +  G L  +L        N+ V        L 
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV--------LA 133
Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DT 247
           P S    +++   +A+G+AYL+      +HRD+ + N ++  DF   I DFG+ R I +T
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +     +    + +M PE L  +   T   DV+SFG+++ EIAT
Sbjct: 192 DYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 24/225 (10%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSSGVT-------VAIKKLDKDAFQGFR-EFRAEMET 131
           A +  +  + +G GSFG VY+  ++ GV        VAIK +++ A    R EF  E   
Sbjct: 45  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS---RNDDVDGSKQLNSLC 188
           + +    ++V++LG  + G   ++I E +  G L  +L        N+ V        L 
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV--------LA 155
Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DT 247
           P S    +++   +A+G+AYL+      +HRD+ + N ++  DF   I DFG+ R I +T
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 213
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +     +    + +M PE L  +   T   DV+SFG+++ EIAT
Sbjct: 214 DYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 24/225 (10%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSSGVT-------VAIKKLDKDAFQGFR-EFRAEMET 131
           A +  +  + +G GSFG VY+  ++ GV        VAIK +++ A    R EF  E   
Sbjct: 17  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS---RNDDVDGSKQLNSLC 188
           + +    ++V++LG  + G   ++I E +  G L  +L        N+ V        L 
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV--------LA 127
Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DT 247
           P S    +++   +A+G+AYL+      +HRD+ + N ++  DF   I DFG+ R I +T
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 185
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +     +    + +M PE L  +   T   DV+SFG+++ EIAT
Sbjct: 186 DYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 87/313 (27%), Positives = 136/313 (43%), Gaps = 50/313 (15%)
Query: 82  DNFSTDKIIGDGSFGFVY--------KAKLSSGVTVAIKKLDKDAFQG-FREFRAEMETL 132
           D     K +G+G+FG V         K K +    VA+K L  DA +    +  +EME +
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 133 GKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH-------DTSRNDDVDGSKQL 184
             + +H+NI+ +LG C       +I E+   G+L ++L        + S N   +  +QL
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR 244
           +S      +  V     VA G+ YL    K  IHRD+ + NVL+  D    I+DFGLAR 
Sbjct: 148 SS------KDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 245 IDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPV 300
           I     H+      T G +P +++      +   T   DV+SFG+L+ EI T      P 
Sbjct: 200 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255
Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
           V   +   LL+    M+          SN +          E + +   C +    +RP 
Sbjct: 256 VPVEELFKLLKEGHRMDK--------PSNCT---------NELYMMMRDCWHAVPSQRPT 298
Query: 361 MSYVVQLLDELVA 373
              +V+ LD +VA
Sbjct: 299 FKQLVEDLDRIVA 311

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 134/285 (47%), Gaps = 39/285 (13%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       ++++++  L   T+      +++ + Y
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQ------ISSAMEY 124
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHRD+ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 125 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFP--IKWTAPE 180
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L  N   ++  DV++FG+L+ EIAT      P +   Q   LLE               
Sbjct: 181 SLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE--------------K 225
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           D  + R E     V E  R AC   N    +RP+ + + Q  + +
Sbjct: 226 DYRMERPEGCPEKVYELMR-ACWQWN--PSDRPSFAEIHQAFETM 267

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 87/313 (27%), Positives = 136/313 (43%), Gaps = 50/313 (15%)
Query: 82  DNFSTDKIIGDGSFGFVY--------KAKLSSGVTVAIKKLDKDAFQG-FREFRAEMETL 132
           D     K +G+G+FG V         K K +    VA+K L  DA +    +  +EME +
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 133 GKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH-------DTSRNDDVDGSKQL 184
             + +H+NI+ +LG C       +I E+   G+L ++L        + S N   +  +QL
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR 244
           +S      +  V     VA G+ YL    K  IHRD+ + NVL+  D    I+DFGLAR 
Sbjct: 148 SS------KDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 245 IDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPV 300
           I     H+      T G +P +++      +   T   DV+SFG+L+ EI T      P 
Sbjct: 200 I----HHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255
Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
           V   +   LL+    M+          SN +          E + +   C +    +RP 
Sbjct: 256 VPVEELFKLLKEGHRMDK--------PSNCT---------NELYMMMRDCWHAVPSQRPT 298
Query: 361 MSYVVQLLDELVA 373
              +V+ LD +VA
Sbjct: 299 FKQLVEDLDRIVA 311

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 87/313 (27%), Positives = 136/313 (43%), Gaps = 50/313 (15%)
Query: 82  DNFSTDKIIGDGSFGFVY--------KAKLSSGVTVAIKKLDKDAFQG-FREFRAEMETL 132
           D     K +G+G+FG V         K K +    VA+K L  DA +    +  +EME +
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 133 GKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH-------DTSRNDDVDGSKQL 184
             + +H+NI+ +LG C       +I E+   G+L ++L        + S N   +  +QL
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR 244
           +S      +  V     VA G+ YL    K  IHRD+ + NVL+  D    I+DFGLAR 
Sbjct: 137 SS------KDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARD 188
Query: 245 IDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPV 300
           I     H+      T G +P +++      +   T   DV+SFG+L+ EI T      P 
Sbjct: 189 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 244
Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
           V   +   LL+    M+          SN +          E + +   C +    +RP 
Sbjct: 245 VPVEELFKLLKEGHRMDK--------PSNCT---------NELYMMMRDCWHAVPSQRPT 287
Query: 361 MSYVVQLLDELVA 373
              +V+ LD +VA
Sbjct: 288 FKQLVEDLDRIVA 300

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 87/313 (27%), Positives = 136/313 (43%), Gaps = 50/313 (15%)
Query: 82  DNFSTDKIIGDGSFGFVY--------KAKLSSGVTVAIKKLDKDAFQG-FREFRAEMETL 132
           D     K +G+G+FG V         K K +    VA+K L  DA +    +  +EME +
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 133 GKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH-------DTSRNDDVDGSKQL 184
             + +H+NI+ +LG C       +I E+   G+L ++L        + S N   +  +QL
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR 244
           +S      +  V     VA G+ YL    K  IHRD+ + NVL+  D    I+DFGLAR 
Sbjct: 148 SS------KDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 245 IDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPV 300
           I     H+      T G +P +++      +   T   DV+SFG+L+ EI T      P 
Sbjct: 200 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255
Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
           V   +   LL+    M+          SN +          E + +   C +    +RP 
Sbjct: 256 VPVEELFKLLKEGHRMDK--------PSNCT---------NELYMMMRDCWHAVPSQRPT 298
Query: 361 MSYVVQLLDELVA 373
              +V+ LD +VA
Sbjct: 299 FKQLVEDLDRIVA 311

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 87/313 (27%), Positives = 136/313 (43%), Gaps = 50/313 (15%)
Query: 82  DNFSTDKIIGDGSFGFVY--------KAKLSSGVTVAIKKLDKDAFQG-FREFRAEMETL 132
           D     K +G+G+FG V         K K +    VA+K L  DA +    +  +EME +
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 133 GKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH-------DTSRNDDVDGSKQL 184
             + +H+NI+ +LG C       +I E+   G+L ++L        + S N   +  +QL
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR 244
           +S      +  V     VA G+ YL    K  IHRD+ + NVL+  D    I+DFGLAR 
Sbjct: 140 SS------KDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 191
Query: 245 IDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPV 300
           I     H+      T G +P +++      +   T   DV+SFG+L+ EI T      P 
Sbjct: 192 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 247
Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
           V   +   LL+    M+          SN +          E + +   C +    +RP 
Sbjct: 248 VPVEELFKLLKEGHRMDK--------PSNCT---------NELYMMMRDCWHAVPSQRPT 290
Query: 361 MSYVVQLLDELVA 373
              +V+ LD +VA
Sbjct: 291 FKQLVEDLDRIVA 303

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 24/225 (10%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSSGVT-------VAIKKLDKDAFQGFR-EFRAEMET 131
           A +  +  + +G GSFG VY+  ++ GV        VAIK +++ A    R EF  E   
Sbjct: 13  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHD---TSRNDDVDGSKQLNSLC 188
           + +    ++V++LG  + G   ++I E +  G L  +L        N+ V        L 
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV--------LA 123
Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DT 247
           P S    +++   +A+G+AYL+      +HRD+ + N ++  DF   I DFG+ R I +T
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 181
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +     +    + +M PE L  +   T   DV+SFG+++ EIAT
Sbjct: 182 DYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 24/225 (10%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSSGVT-------VAIKKLDKDAFQGFR-EFRAEMET 131
           A +  +  + +G GSFG VY+  ++ GV        VAIK +++ A    R EF  E   
Sbjct: 8   AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS---RNDDVDGSKQLNSLC 188
           + +    ++V++LG  + G   ++I E +  G L  +L        N+ V        L 
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV--------LA 118
Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DT 247
           P S    +++   +A+G+AYL+      +HRD+ + N ++  DF   I DFG+ R I +T
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXET 176
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
                  +    + +M PE L  +   T   DV+SFG+++ EIAT
Sbjct: 177 DXXRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 134/285 (47%), Gaps = 39/285 (13%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       ++++++  L   T+      +++ + Y
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQ------ISSAMEY 126
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHRD+ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 127 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPE 182
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L  N   ++  DV++FG+L+ EIAT      P +   Q   LLE               
Sbjct: 183 SLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------K 227
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           D  + R E     V E  R AC   N    +RP+ + + Q  + +
Sbjct: 228 DYRMERPEGCPEKVYELMR-ACWQWN--PSDRPSFAEIHQAFETM 269

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/218 (33%), Positives = 110/218 (50%), Gaps = 13/218 (5%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +N    K +G G+FG V +A      K  + + VA+K L   A    +E   +E++ +  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           L +H NIV +LG C  G   ++I E+   G L  +L   SR  + D +  + +   LS  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN-STLSTR 164
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHV 252
             +     VA G+A+L    K  IHRD+ + NVLL +   A I DFGLAR I + S+  V
Sbjct: 165 DLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
                  + +M PE +  +   TV  DV+S+GIL+ EI
Sbjct: 223 KGNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEI 259

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 134/285 (47%), Gaps = 39/285 (13%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       ++++++  L   T+      +++ + Y
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQ------ISSAMEY 126
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHRD+ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 127 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPE 182
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L  N   ++  DV++FG+L+ EIAT      P +   Q   LLE               
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------K 227
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           D  + R E     V E  R AC   N    +RP+ + + Q  + +
Sbjct: 228 DYRMERPEGCPEKVYELMR-ACWQWN--PSDRPSFAEIHQAFETM 269

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 87/313 (27%), Positives = 136/313 (43%), Gaps = 50/313 (15%)
Query: 82  DNFSTDKIIGDGSFGFVY--------KAKLSSGVTVAIKKLDKDAFQG-FREFRAEMETL 132
           D     K +G+G+FG V         K K +    VA+K L  DA +    +  +EME +
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 133 GKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH-------DTSRNDDVDGSKQL 184
             + +H+NI+ +LG C       +I E+   G+L ++L        + S N   +  +QL
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR 244
           +S      +  V     VA G+ YL    K  IHRD+ + NVL+  D    I+DFGLAR 
Sbjct: 189 SS------KDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 245 IDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPV 300
           I     H+      T G +P +++      +   T   DV+SFG+L+ EI T      P 
Sbjct: 241 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
           V   +   LL+    M+          SN +          E + +   C +    +RP 
Sbjct: 297 VPVEELFKLLKEGHRMDK--------PSNCT---------NELYMMMRDCWHAVPSQRPT 339
Query: 361 MSYVVQLLDELVA 373
              +V+ LD +VA
Sbjct: 340 FKQLVEDLDRIVA 352

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 112/215 (52%), Gaps = 21/215 (9%)
Query: 89  IIGDGSFGFVYKAKLSSG---VTVAIKKLDKDAFQG-FREFRAEMETLGKL-RHRNIVKI 143
           +IG+G+FG V KA++      +  AIK++ + A +   R+F  E+E L KL  H NI+ +
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL--NSLCPLSWETRVKIVRG 201
           LG C       L  E+  +G+L  +L   SR  + D +  +  ++   LS +  +     
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           VA G+ YL   +K  IHRD+ + N+L+  ++ A I+DFGL+R  +         V  TMG
Sbjct: 141 VARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTMG 191
Query: 262 YMPPEYLG----GNTAATVMLDVYSFGILMIEIAT 292
            +P  ++       +  T   DV+S+G+L+ EI +
Sbjct: 192 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 24/225 (10%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSSGVT-------VAIKKLDKDAFQGFR-EFRAEMET 131
           A +  +  + +G GSFG VY+  ++ GV        VAIK +++ A    R EF  E   
Sbjct: 17  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS---RNDDVDGSKQLNSLC 188
           + +    ++V++LG  + G   ++I E +  G L  +L        N+ V        L 
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV--------LA 127
Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DT 247
           P S    +++   +A+G+AYL+      +HRD+ + N ++  DF   I DFG+ R I +T
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXET 185
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
                  +    + +M PE L  +   T   DV+SFG+++ EIAT
Sbjct: 186 DXXRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 134/285 (47%), Gaps = 39/285 (13%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       ++++++  L   T+      +++ + Y
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQ------ISSAMEY 126
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHRD+ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 127 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPE 182
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L  N   ++  DV++FG+L+ EIAT      P +   Q   LLE               
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------K 227
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           D  + R E     V E  R AC   N    +RP+ + + Q  + +
Sbjct: 228 DYRMERPEGCPEKVYELMR-ACWQWN--PSDRPSFAEIHQAFETM 269

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       +++N++  L   T+      +++ + Y
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNR-------QEVNAVVLLYMATQ------ISSAMEY 127
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL 268
           L   +K  IHRD+ + N L+  +    ++DFGL+R +              + +  PE L
Sbjct: 128 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESL 185
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
             N   ++  DV++FG+L+ EIAT      P +   Q   LLE               D 
Sbjct: 186 AYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDY 230
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            + R E     V E  R AC   N    +RP+ + + Q  + +
Sbjct: 231 RMERPEGCPEKVYELMR-ACWQWN--PSDRPSFAEIHQAFETM 270

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI EF+  GSL ++L      + +D  K L            +    +
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQ--KHKERIDHIKLL------------QYTSQI 126
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTM 260
             G+ YL    K  IHRD+ + N+L++++    I DFGL + +  D     V       +
Sbjct: 127 CKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 184
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 185 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 217

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 134/285 (47%), Gaps = 39/285 (13%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       ++++++  L   T+      +++ + Y
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQ------ISSAMEY 126
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHRD+ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 127 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPE 182
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L  N   ++  DV++FG+L+ EIAT      P +   Q   LLE               
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------K 227
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           D  + R E     V E  R AC   N    +RP+ + + Q  + +
Sbjct: 228 DYRMERPEGCPEKVYELMR-ACWQWN--PSDRPSFAEIHQAFETM 269

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       +++N++  L   T+      +++ + Y
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR-------QEVNAVVLLYMATQ------ISSAMEY 128
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL 268
           L   +K  IHRD+ + N L+  +    ++DFGL+R +              + +  PE L
Sbjct: 129 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESL 186
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
             N   ++  DV++FG+L+ EIAT      P +   Q   LLE               D 
Sbjct: 187 AYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDY 231
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            + R E     V E  R AC   N    +RP+ + + Q  + +
Sbjct: 232 RMERPEGCPEKVYELMR-ACWQWN--PSDRPSFAEIHQAFETM 271

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 24/225 (10%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSSGVT-------VAIKKLDKDAFQGFR-EFRAEMET 131
           A +  +  + +G GSFG VY+  ++ GV        VAIK +++ A    R EF  E   
Sbjct: 10  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS---RNDDVDGSKQLNSLC 188
           + +    ++V++LG  + G   ++I E +  G L  +L        N+ V        L 
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV--------LA 120
Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DT 247
           P S    +++   +A+G+AYL+      +HRD+ + N  +  DF   I DFG+ R I +T
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYET 178
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +     +    + +M PE L  +   T   DV+SFG+++ EIAT
Sbjct: 179 DYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG---FREFRAEMETLGK 134
           +  ++F    ++G GSF  VY+A+ + +G+ VAIK +DK A       +  + E++   +
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           L+H +I+++  Y        L+ E   NG ++++L               N + P S   
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK--------------NRVKPFSENE 113
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
               +  +  G+ YLH     I+HRD+  SN+LL  +    I+DFGLA ++   H    T
Sbjct: 114 ARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT 171
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
            + GT  Y+ PE +   +A  +  DV+S G +
Sbjct: 172 -LCGTPNYISPE-IATRSAHGLESDVWSLGCM 201

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 112/215 (52%), Gaps = 21/215 (9%)
Query: 89  IIGDGSFGFVYKAKLSSG---VTVAIKKLDKDAFQG-FREFRAEMETLGKL-RHRNIVKI 143
           +IG+G+FG V KA++      +  AIK++ + A +   R+F  E+E L KL  H NI+ +
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL--NSLCPLSWETRVKIVRG 201
           LG C       L  E+  +G+L  +L   SR  + D +  +  ++   LS +  +     
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           VA G+ YL   +K  IHRD+ + N+L+  ++ A I+DFGL+R  +         V  TMG
Sbjct: 151 VARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTMG 201
Query: 262 YMPPEYLG----GNTAATVMLDVYSFGILMIEIAT 292
            +P  ++       +  T   DV+S+G+L+ EI +
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 134/285 (47%), Gaps = 39/285 (13%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       +++N++  L   T+      +++ + Y
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNR-------QEVNAVVLLYMATQ------ISSAMEY 372
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHR++ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 373 LE--KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPE 428
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L  N   ++  DV++FG+L+ EIAT      P +   Q   LLE               
Sbjct: 429 SLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------K 473
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           D  + R E     V E  R AC   N    +RP+ + + Q  + +
Sbjct: 474 DYRMERPEGCPEKVYELMR-ACWQWN--PSDRPSFAEIHQAFETM 515

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 110/220 (50%), Gaps = 21/220 (9%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHRNIVKILGYC 147
           +G+G++G VYKAK S G  VA+K++  DA        A  E+  L +L H NIV ++   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
            S     L++EF+E         D  +  D + +   +S   +      +++RGVA    
Sbjct: 89  HSERCLTLVFEFMEK--------DLKKVLDENKTGLQDSQIKI---YLYQLLRGVA---- 133
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
             H  +  I+HRD+K  N+L++SD    ++DFGLAR         + +V  T+ Y  P+ 
Sbjct: 134 --HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDV 190
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV 307
           L G+   +  +D++S G +  E+ T  +P  P V D  ++
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVTDDDQL 229

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 135/313 (43%), Gaps = 50/313 (15%)
Query: 82  DNFSTDKIIGDGSFGFVY--------KAKLSSGVTVAIKKLDKDAFQG-FREFRAEMETL 132
           D     K +G+G+FG V         K K +    VA+K L  DA +    +  +EME +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 133 GKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH-------DTSRNDDVDGSKQL 184
             + +H+NI+ +LG C       +I E+   G+L ++L        +   N   +  +QL
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR 244
           +S      +  V     VA G+ YL    K  IHRD+ + NVL+  D    I+DFGLAR 
Sbjct: 133 SS------KDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 245 IDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPV 300
           I     H+      T G +P +++      +   T   DV+SFG+L+ EI T      P 
Sbjct: 185 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240
Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
           V   +   LL+    M+          SN +          E + +   C +    +RP 
Sbjct: 241 VPVEELFKLLKEGHRMDK--------PSNCT---------NELYMMMRDCWHAVPSQRPT 283
Query: 361 MSYVVQLLDELVA 373
              +V+ LD +VA
Sbjct: 284 FKQLVEDLDRIVA 296

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 28/216 (12%)
Query: 87  DKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNI 140
           +++IG G FG V    L       + VAIK L K  +  +  R+F +E   +G+  H N+
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           + + G        ++I EF+ENGSLD +L    +ND      QL           V ++R
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDGQFTVIQL-----------VGMLR 116
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAG 258
           G+A G+ YL  +    +HR + + N+L++S+    +SDFGL+R +  DTS    ++ + G
Sbjct: 117 GIAAGMKYLADMN--YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 174
Query: 259 TMG--YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +   +  PE +      T   DV+S+GI+M E+ +
Sbjct: 175 KIPIRWTAPEAI-QYRKFTSASDVWSYGIVMWEVMS 209

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/218 (33%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +N    K +G G+FG V +A      K  + + VA+K L   A    +E   +E++ +  
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           L +H NIV +LG C  G   ++I E+   G L  +L    R  + D  K+     PL   
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR---RKAEADLDKEDGR--PLELR 152
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHV 252
             +     VA G+A+L    K  IHRD+ + NVLL +   A I DFGLAR I + S+  V
Sbjct: 153 DLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 210
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
                  + +M PE +  +   TV  DV+S+GIL+ EI
Sbjct: 211 KGNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEI 247

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 110/220 (50%), Gaps = 21/220 (9%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHRNIVKILGYC 147
           +G+G++G VYKAK S G  VA+K++  DA        A  E+  L +L H NIV ++   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
            S     L++EF+E         D  +  D + +   +S   +      +++RGVA    
Sbjct: 89  HSERCLTLVFEFMEK--------DLKKVLDENKTGLQDSQIKI---YLYQLLRGVA---- 133
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
             H  +  I+HRD+K  N+L++SD    ++DFGLAR         + +V  T+ Y  P+ 
Sbjct: 134 --HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDV 190
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV 307
           L G+   +  +D++S G +  E+ T  +P  P V D  ++
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVTDDDQL 229

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 135/313 (43%), Gaps = 50/313 (15%)
Query: 82  DNFSTDKIIGDGSFGFVY--------KAKLSSGVTVAIKKLDKDAFQG-FREFRAEMETL 132
           D     K +G+G+FG V         K K +    VA+K L  DA +    +  +EME +
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 133 GKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH-------DTSRNDDVDGSKQL 184
             + +H+NI+ +LG C       +I E+   G+L ++L        +   N   +  +QL
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR 244
           +S      +  V     VA G+ YL    K  IHRD+ + NVL+  D    I+DFGLAR 
Sbjct: 148 SS------KDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 245 IDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPV 300
           I     H+      T G +P +++      +   T   DV+SFG+L+ EI T      P 
Sbjct: 200 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255
Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
           V   +   LL+    M+          SN +          E + +   C +    +RP 
Sbjct: 256 VPVEELFKLLKEGHRMDK--------PSNCT---------NELYMMMRDCWHAVPSQRPT 298
Query: 361 MSYVVQLLDELVA 373
              +V+ LD +VA
Sbjct: 299 FKQLVEDLDRIVA 311

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 25/213 (11%)
Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +GDG+FG VYKA+   + V  A K +D  + +   ++  E++ L    H NIVK+L    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV-RGVANGLA 207
              +  ++ EF   G++D  + +  R              PL+ E+++++V +   + L 
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER--------------PLT-ESQIQVVCKQTLDALN 149
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           YLH  +  IIHRD+K+ N+L   D +  ++DFG++ + +T          GT  +M PE 
Sbjct: 150 YLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRXIQRRDSFIGTPYWMAPEV 206
Query: 268 LGGNTAA----TVMLDVYSFGILMIEIATQIRP 296
           +   T+         DV+S GI +IE+A +I P
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEMA-EIEP 238

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/218 (33%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +N    K +G G+FG V +A      K  + + VA+K L   A    +E   +E++ +  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           L +H NIV +LG C  G   ++I E+   G L  +L    R  + D  K+     PL   
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR---RKAEADLDKEDGR--PLELR 160
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHV 252
             +     VA G+A+L    K  IHRD+ + NVLL +   A I DFGLAR I + S+  V
Sbjct: 161 DLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 218
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
                  + +M PE +  +   TV  DV+S+GIL+ EI
Sbjct: 219 KGNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEI 255

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 25/213 (11%)
Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +GDG+FG VYKA+   + V  A K +D  + +   ++  E++ L    H NIVK+L    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV-RGVANGLA 207
              +  ++ EF   G++D  + +  R              PL+ E+++++V +   + L 
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER--------------PLT-ESQIQVVCKQTLDALN 149
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           YLH  +  IIHRD+K+ N+L   D +  ++DFG++ + +T          GT  +M PE 
Sbjct: 150 YLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRXIQRRDXFIGTPYWMAPEV 206
Query: 268 LGGNTAA----TVMLDVYSFGILMIEIATQIRP 296
           +   T+         DV+S GI +IE+A +I P
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEMA-EIEP 238

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 116/231 (50%), Gaps = 22/231 (9%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY        +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 ++ E++  G+L  +L + +R       +++ ++  L   T+      +++ + Y
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNR-------EEVTAVVLLYMATQ------ISSAMEY 145
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHRD+ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 146 LE--KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPE 201
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME 317
            L  NT  ++  DV++FG+L+ EIAT      P +   Q   LLE    ME
Sbjct: 202 SLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRME 251

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 25/213 (11%)
Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +GDG+FG VYKA+   + V  A K +D  + +   ++  E++ L    H NIVK+L    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV-RGVANGLA 207
              +  ++ EF   G++D  + +  R              PL+ E+++++V +   + L 
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER--------------PLT-ESQIQVVCKQTLDALN 149
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           YLH  +  IIHRD+K+ N+L   D +  ++DFG++ + +T          GT  +M PE 
Sbjct: 150 YLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDSFIGTPYWMAPEV 206
Query: 268 LGGNTAA----TVMLDVYSFGILMIEIATQIRP 296
           +   T+         DV+S GI +IE+A +I P
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEMA-EIEP 238

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKK--LDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           IG+G++G VYKA+ + G T A+KK  L+K+          E+  L +L+H NIVK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE--TRVKIVRGVANG 205
            +    VL++E      LDQ L            K+L  +C    E  T    +  + NG
Sbjct: 70  HTKKRLVLVFE-----HLDQDL------------KKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
           +AY H  ++ ++HRD+K  N+L++ + E  I+DFGLAR         + +V  T+ Y  P
Sbjct: 113 IAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAP 169
Query: 266 EYLGGNTAATVMLDVYSFGILMIEIAT 292
           + L G+   +  +D++S G +  E+  
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVN 196

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKK--LDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           IG+G++G VYKA+ + G T A+KK  L+K+          E+  L +L+H NIVK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE--TRVKIVRGVANG 205
            +    VL++E      LDQ L            K+L  +C    E  T    +  + NG
Sbjct: 70  HTKKRLVLVFE-----HLDQDL------------KKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
           +AY H  ++ ++HRD+K  N+L++ + E  I+DFGLAR         + +V  T+ Y  P
Sbjct: 113 IAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAP 169
Query: 266 EYLGGNTAATVMLDVYSFGILMIEIAT 292
           + L G+   +  +D++S G +  E+  
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVN 196

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 112/215 (52%), Gaps = 21/215 (9%)
Query: 89  IIGDGSFGFVYKAKLSSG---VTVAIKKLDKDAFQG-FREFRAEMETLGKL-RHRNIVKI 143
           +IG+G+FG V KA++      +  AIK++ + A +   R+F  E+E L KL  H NI+ +
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL--NSLCPLSWETRVKIVRG 201
           LG C       L  E+  +G+L  +L   SR  + D +  +  ++   LS +  +     
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           VA G+ YL   +K  IHR++ + N+L+  ++ A I+DFGL+R  +         V  TMG
Sbjct: 148 VARGMDYLS--QKQFIHRNLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTMG 198
Query: 262 YMPPEYLG----GNTAATVMLDVYSFGILMIEIAT 292
            +P  ++       +  T   DV+S+G+L+ EI +
Sbjct: 199 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/219 (33%), Positives = 110/219 (50%), Gaps = 15/219 (6%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +N    K +G G+FG V +A      K  + + VA+K L   A    +E   +E++ +  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL-NSLCPLSW 192
           L +H NIV +LG C  G   ++I E+   G L  +L   SR  + D +  + NS    S 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA--ST 163
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSH 251
              +     VA G+A+L    K  IHRD+ + NVLL +   A I DFGLAR I + S+  
Sbjct: 164 RDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           V       + +M PE +  +   TV  DV+S+GIL+ EI
Sbjct: 222 VKGNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEI 259

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 35/282 (12%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG G FG V+     +   VAIK + + A     +F  E E + KL H  +V++ G C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                L++EF+E+G L  +L  T R                + ET + +   V  G+AYL
Sbjct: 72  QAPICLVFEFMEHGCLSDYLR-TQRG-------------LFAAETLLGMCLDVCEGMAYL 117
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG 269
              E  +IHRD+ + N L+  +    +SDFG+ R +       ST     + +  PE   
Sbjct: 118 E--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 270 GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSN 329
            +  ++   DV+SFG+LM E+ ++              G + +     +   E       
Sbjct: 176 FSRYSSKS-DVWSFGVLMWEVFSE--------------GKIPYENRSNSEVVEDISTGFR 220
Query: 330 ISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           + +  L+   V   ++I   C  E+  +RPA S +++ L E+
Sbjct: 221 LYKPRLASTHV---YQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKK--LDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           IG+G++G VYKA+ + G T A+KK  L+K+          E+  L +L+H NIVK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE--TRVKIVRGVANG 205
            +    VL++E      LDQ L            K+L  +C    E  T    +  + NG
Sbjct: 70  HTKKRLVLVFE-----HLDQDL------------KKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
           +AY H  ++ ++HRD+K  N+L++ + E  I+DFGLAR         + ++  T+ Y  P
Sbjct: 113 IAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAP 169
Query: 266 EYLGGNTAATVMLDVYSFGILMIEIAT 292
           + L G+   +  +D++S G +  E+  
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVN 196

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI E++  GSL  +L      + +D  K L            +    +
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLL------------QYTSQI 127
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTM 260
             G+ YL    K  IHRD+ + N+L++++    I DFGL + +  D     V       +
Sbjct: 128 CKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 185
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 186 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 218

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 124/291 (42%), Gaps = 53/291 (18%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG G FG V+     +   VAIK + + A     +F  E E + KL H  +V++ G C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                L++EF+E+G L  +L  T R                + ET + +   V  G+AYL
Sbjct: 74  QAPICLVFEFMEHGCLSDYLR-TQRG-------------LFAAETLLGMCLDVCEGMAYL 119
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG 269
              E  +IHRD+ + N L+  +    +SDFG+ R +       ST     + +  PE   
Sbjct: 120 E--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 177
Query: 270 GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSN 329
            +  ++   DV+SFG+LM E+ ++ +                    +   N+    V  +
Sbjct: 178 FSRYSSKS-DVWSFGVLMWEVFSEGK--------------------IPYENRSNSEVVED 216
Query: 330 ISREELSEAGVREY---------FRIACMCTNEKSRERPAMSYVVQLLDEL 371
           IS       G R Y         ++I   C  E+  +RPA S +++ L E+
Sbjct: 217 IS------TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 261

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI E++  GSL  +L      + +D  K L            +    +
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLL------------QYTSQI 122
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTM 260
             G+ YL    K  IHRD+ + N+L++++    I DFGL + +  D     V       +
Sbjct: 123 CKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 180
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 181 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 213

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/225 (32%), Positives = 113/225 (50%), Gaps = 25/225 (11%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +N    K +G G+FG V +A      K  + + VA+K L   A    +E   +E++ +  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH-------DTSRNDDVDGSKQLNS 186
           L +H NIV +LG C  G   ++I E+   G L  +L        + S N   +  +QL+S
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 187 LCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI- 245
              L + ++V      A G+A+L    K  IHRD+ + NVLL +   A I DFGLAR I 
Sbjct: 166 RDLLHFSSQV------AQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 217
Query: 246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + S+  V       + +M PE +  +   TV  DV+S+GIL+ EI
Sbjct: 218 NDSNYIVKGNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEI 261

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI E++  GSL  +L      + +D  K L            +    +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLL------------QYTSQI 123
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTM 260
             G+ YL    K  IHRD+ + N+L++++    I DFGL + +  D     V       +
Sbjct: 124 CKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 181
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 182 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 214

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 45/290 (15%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           ++   +K +G G FG V+ A  +    VA+K + K        F AE   +  L+H  +V
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 240
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           K L    +     +I EF+  GSL  +L    ++D+  GSKQ     PL     +     
Sbjct: 241 K-LHAVVTKEPIYIITEFMAKGSLLDFL----KSDE--GSKQ-----PLP--KLIDFSAQ 286
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +A G+A++   ++  IHRD++++N+L+ +     I+DFGLAR                + 
Sbjct: 287 IAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLAR----------VGAKFPIK 334
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK 321
           +  PE +   +  T+  DV+SFGIL++EI T  R   P + + + +  LE    M     
Sbjct: 335 WTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR--- 390
Query: 322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
                          E    E + I   C   +  ERP   Y+  +LD+ 
Sbjct: 391 --------------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 426

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 90  IGDGSFGFVYK-AKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVKILGYC 147
           +G G FG+V +     +G  VAIK+  ++     RE +  E++ + KL H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA-REV 80
Query: 148 ASGLDRV-------LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
             GL ++       L  E+ E G L ++L+            Q  + C L       ++ 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN------------QFENCCGLKEGPIRTLLS 128
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA---HISDFGLARRIDTSHSHVSTQVA 257
            +++ L YLH  E  IIHRD+K  N++L    +     I D G A+ +D     + T+  
Sbjct: 129 DISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFV 184
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           GT+ Y+ PE L      TV +D +SFG L  E  T  RP LP
Sbjct: 185 GTLQYLAPELLE-QKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI E++  GSL  +L      + +D  K L            +    +
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLL------------QYTSQI 121
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTM 260
             G+ YL    K  IHRD+ + N+L++++    I DFGL + +  D     V       +
Sbjct: 122 CKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 179
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 180 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 212

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 111/248 (44%), Gaps = 34/248 (13%)
Query: 73  SMSELIDATDNFSTDKIIGDGSFGFVYK-AKLSSGVTVAIKKLDKDAFQGFREFRAEMET 131
           SM   I    +    +++G G FG   K     +G  + +K+L +   +  R F  E++ 
Sbjct: 1   SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKV 60
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           +  L H N++K +G          I E+++ G+L   +            K ++S  P  
Sbjct: 61  MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII------------KSMDSQYP-- 106
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA--------- 242
           W  RV   + +A+G+AYLH +   IIHRD+ S N L+  +    ++DFGLA         
Sbjct: 107 WSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164
Query: 243 ----RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN- 297
               R +          V G   +M PE + G +     +DV+SFGI++ EI  ++  + 
Sbjct: 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDE-KVDVFSFGIVLCEIIGRVNADP 223
Query: 298 --LPVVLD 303
             LP  +D
Sbjct: 224 DYLPRTMD 231

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 134/285 (47%), Gaps = 39/285 (13%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+V++LG C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
                 +I EF+  G+L  +L + +R       ++++++  L   T+      +++ + Y
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQ------ISSAMEY 333
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPE 266
           L   +K  IHR++ + N L+  +    ++DFGL+R +  DT  +H   +    + +  PE
Sbjct: 334 LE--KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPE 389
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L  N   ++  DV++FG+L+ EIAT      P +   Q   LLE               
Sbjct: 390 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------K 434
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           D  + R E     V E  R AC   N    +RP+ + + Q  + +
Sbjct: 435 DYRMERPEGCPEKVYELMR-ACWQWN--PSDRPSFAEIHQAFETM 476

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI E++  GSL  +L      + +D  K L            +    +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLL------------QYTSQI 154
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTM 260
             G+ YL    K  IHRD+ + N+L++++    I DFGL + +  D     V       +
Sbjct: 155 CKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 212
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 213 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 245

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 90  IGDGSFGFVYK-AKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVKILGYC 147
           +G G FG+V +     +G  VAIK+  ++     RE +  E++ + KL H N+V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA-REV 81
Query: 148 ASGLDRV-------LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
             GL ++       L  E+ E G L ++L+            Q  + C L       ++ 
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN------------QFENCCGLKEGPIRTLLS 129
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA---HISDFGLARRIDTSHSHVSTQVA 257
            +++ L YLH  E  IIHRD+K  N++L    +     I D G A+ +D     + T+  
Sbjct: 130 DISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFV 185
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           GT+ Y+ PE L      TV +D +SFG L  E  T  RP LP
Sbjct: 186 GTLQYLAPELLE-QKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 138/310 (44%), Gaps = 42/310 (13%)
Query: 73  SMSELIDAT-DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDK-DAFQGFRE 124
           S+S+L +    N +  + +G G+FG VY+ ++S      S + VA+K L +  + Q   +
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           F  E   + KL H+NIV+ +G     L R ++ E +  G L  +L +T        S  +
Sbjct: 81  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGL 241
             L        + + R +A G  YL   E   IHRDI + N LL        A I DFG+
Sbjct: 141 LDL--------LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 190
Query: 242 ARRIDTSHSHVSTQVAG-TMGYMPPE-YLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           AR I  +  +     A   + +MPPE ++ G    T   D +SFG+L+ EI +       
Sbjct: 191 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFS------- 241
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
                  +G + +       N+E+    ++  R +  +      +RI   C   +  +RP
Sbjct: 242 -------LGYMPYP---SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 291
Query: 360 AMSYVVQLLD 369
             + +++ ++
Sbjct: 292 NFAIILERIE 301

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI E++  GSL  +L      + +D  K L            +    +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLL------------QYTSQI 123
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTM 260
             G+ YL    K  IHRD+ + N+L++++    I DFGL + +  D     V       +
Sbjct: 124 CKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 181
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 182 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 214

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 124/291 (42%), Gaps = 53/291 (18%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG G FG V+     +   VAIK + + A     +F  E E + KL H  +V++ G C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                L++EF+E+G L  +L  T R                + ET + +   V  G+AYL
Sbjct: 77  QAPICLVFEFMEHGCLSDYLR-TQRG-------------LFAAETLLGMCLDVCEGMAYL 122
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG 269
              E  +IHRD+ + N L+  +    +SDFG+ R +       ST     + +  PE   
Sbjct: 123 E--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 180
Query: 270 GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSN 329
            +  ++   DV+SFG+LM E+ ++ +                    +   N+    V  +
Sbjct: 181 FSRYSSKS-DVWSFGVLMWEVFSEGK--------------------IPYENRSNSEVVED 219
Query: 330 ISREELSEAGVREY---------FRIACMCTNEKSRERPAMSYVVQLLDEL 371
           IS       G R Y         ++I   C  E+  +RPA S +++ L E+
Sbjct: 220 IS------TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 138/310 (44%), Gaps = 42/310 (13%)
Query: 73  SMSELIDAT-DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDK-DAFQGFRE 124
           S+S+L +    N +  + +G G+FG VY+ ++S      S + VA+K L +  + Q   +
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 94
Query: 125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           F  E   + KL H+NIV+ +G     L R ++ E +  G L  +L +T        S  +
Sbjct: 95  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGL 241
             L        + + R +A G  YL   E   IHRDI + N LL        A I DFG+
Sbjct: 155 LDL--------LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 204
Query: 242 ARRIDTSHSHVSTQVAG-TMGYMPPE-YLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           AR I  +  +     A   + +MPPE ++ G    T   D +SFG+L+ EI +       
Sbjct: 205 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFS------- 255
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
                  +G + +       N+E+    ++  R +  +      +RI   C   +  +RP
Sbjct: 256 -------LGYMPYP---SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 305
Query: 360 AMSYVVQLLD 369
             + +++ ++
Sbjct: 306 NFAIILERIE 315

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI E++  GSL  +L      + +D  K L            +    +
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLL------------QYTSQI 126
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTM 260
             G+ YL    K  IHRD+ + N+L++++    I DFGL + +  D     V       +
Sbjct: 127 CKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 184
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 185 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 217

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI E++  GSL  +L   +  + +D  K L            +    +
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--AHAERIDHIKLL------------QYTSQI 126
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTM 260
             G+ YL    K  IHRD+ + N+L++++    I DFGL + +  D     V       +
Sbjct: 127 CKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 184
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 185 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 217

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 123/284 (43%), Gaps = 35/284 (12%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG G FG V+     +   VAIK + + A     +F  E E + KL H  +V++ G C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                L++EF+E+G L  +L  T R                + ET + +   V  G+AYL
Sbjct: 74  QAPICLVFEFMEHGCLSDYLR-TQRG-------------LFAAETLLGMCLDVCEGMAYL 119
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG 269
              E  +IHRD+ + N L+  +    +SDFG+ R +       ST     + +  PE   
Sbjct: 120 E--EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 177
Query: 270 GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSN 329
            +  ++   DV+SFG+LM E+ ++              G + +     +   E       
Sbjct: 178 FSRYSSKS-DVWSFGVLMWEVFSE--------------GKIPYENRSNSEVVEDISTGFR 222
Query: 330 ISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA 373
           + +  L+   V   ++I   C  E+  +RPA S +++ L  + A
Sbjct: 223 LYKPRLASTHV---YQIMNHCWKERPEDRPAFSRLLRQLAAIAA 263

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI E++  GSL  +L      + +D  K L            +    +
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLL------------QYTSQI 130
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTM 260
             G+ YL    K  IHRD+ + N+L++++    I DFGL + +  D     V       +
Sbjct: 131 CKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 188
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 189 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 221

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI E++  GSL  +L      + +D  K L            +    +
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLL------------QYTSQI 129
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTM 260
             G+ YL    K  IHRD+ + N+L++++    I DFGL + +  D     V       +
Sbjct: 130 CKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 187
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 188 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 220

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI E++  GSL  +L      + +D  K L            +    +
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLL------------QYTSQI 128
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTM 260
             G+ YL    K  IHRD+ + N+L++++    I DFGL + +  D     V       +
Sbjct: 129 CKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 186
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 187 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 219

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 35/282 (12%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG G FG V+     +   VAIK + K+      +F  E E + KL H  +V++ G C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                L++EF+E+G L  +L  T R                + ET + +   V  G+AYL
Sbjct: 94  QAPICLVFEFMEHGCLSDYLR-TQRG-------------LFAAETLLGMCLDVCEGMAYL 139
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG 269
              E  +IHRD+ + N L+  +    +SDFG+ R +       ST     + +  PE   
Sbjct: 140 E--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 197
Query: 270 GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSN 329
            +  ++   DV+SFG+LM E+ ++              G + +     +   E       
Sbjct: 198 FSRYSSKS-DVWSFGVLMWEVFSE--------------GKIPYENRSNSEVVEDISTGFR 242
Query: 330 ISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           + +  L+   V   ++I   C  E+  +RPA S +++ L E+
Sbjct: 243 LYKPRLASTHV---YQIMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI E++  GSL  +L      + +D  K L            +    +
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLL------------QYTSQI 141
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTM 260
             G+ YL    K  IHRD+ + N+L++++    I DFGL + +  D     V       +
Sbjct: 142 CKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 199
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 200 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 232

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKL---DKDAFQGFREFRAEMETLGKLRHRNIVKILG 145
           +G G    VY A+ +   + VAIK +    ++  +  + F  E+    +L H+NIV ++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
                    L+ E++E  +L +++                S  PLS +T +     + +G
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYI---------------ESHGPLSVDTAINFTNQILDG 123
Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
           + + H +   I+HRDIK  N+L+DS+    I DFG+A+ +  +    +  V GT+ Y  P
Sbjct: 124 IKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181
Query: 266 EYLGGNTAATVMLDVYSFGILMIEI 290
           E   G  A     D+YS GI++ E+
Sbjct: 182 EQAKGE-ATDECTDIYSIGIVLYEM 205

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI E++  GSL  +L      + +D  K L            +    +
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLL------------QYTSQI 141
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTM 260
             G+ YL    K  IHRD+ + N+L++++    I DFGL + +  D     V       +
Sbjct: 142 CKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 199
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 200 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 232

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI E++  GSL  +L      + +D  K L            +    +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLL------------QYTSQI 123
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT--M 260
             G+ YL    K  IHRD+ + N+L++++    I DFGL + +         +  G   +
Sbjct: 124 CKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 182 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 214

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILG-YC 147
           +GDG+FG VYKAK   +G   A K ++  + +   ++  E+E L    H  IVK+LG Y 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
             G   ++I EF   G++D  + +  R        Q+  +C           R +   L 
Sbjct: 87  HDGKLWIMI-EFCPGGAVDAIMLELDRGL---TEPQIQVVC-----------RQMLEALN 131
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL-ARRIDTSHSHVSTQVAGTMGYMPPE 266
           +LH   K IIHRD+K+ NVL+  + +  ++DFG+ A+ + T     S    GT  +M PE
Sbjct: 132 FLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPE 187
Query: 267 YL----GGNTAATVMLDVYSFGILMIEIATQIRP 296
            +      +T      D++S GI +IE+A QI P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMA-QIEP 220

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 137/311 (44%), Gaps = 44/311 (14%)
Query: 73  SMSELIDAT-DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDK-DAFQGFRE 124
           S+S+L +    N +  + +G G+FG VY+ ++S      S + VA+K L +  + Q   +
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           F  E   + K  H+NIV+ +G     L R ++ E +  G L  +L +T        S  +
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGL 241
             L        + + R +A G  YL   E   IHRDI + N LL        A I DFG+
Sbjct: 140 LDL--------LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
Query: 242 ARRIDTSHSHVSTQVAG-TMGYMPPEYL--GGNTAATVMLDVYSFGILMIEIATQIRPNL 298
           AR I  +  +     A   + +MPPE    G  T+ T   D +SFG+L+ EI +      
Sbjct: 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKT---DTWSFGVLLWEIFS------ 240
Query: 299 PVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRER 358
                   +G + +       N+E+    ++  R +  +      +RI   C   +  +R
Sbjct: 241 --------LGYMPYP---SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289
Query: 359 PAMSYVVQLLD 369
           P  + +++ ++
Sbjct: 290 PNFAIILERIE 300

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 142/318 (44%), Gaps = 59/318 (18%)
Query: 83  NFSTDKIIGDGSFGFVYKA-----KLSSG-VTVAIKKLDKDAFQG-FREFRAEMETLGKL 135
           N    K +G+G FG V KA     K  +G  TVA+K L ++A     R+  +E   L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSR-----------------NDDV 178
            H +++K+ G C+     +LI E+ + GSL  +L ++ +                 +   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 179 DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD 238
           + +  +  L   +W+        ++ G+ YL   E  ++HRD+ + N+L+    +  ISD
Sbjct: 144 ERALTMGDLISFAWQ--------ISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNT----AATVMLDVYSFGILMIEIATQI 294
           FGL+R +    S+V      + G +P +++   +      T   DV+SFG+L+ EI T  
Sbjct: 194 FGLSRDVYEEDSYVKR----SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 295 RPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEK 354
               P +   +   LL+    ME  +        N S          E +R+   C  ++
Sbjct: 250 GNPYPGIPPERLFNLLKTGHRMERPD--------NCS---------EEMYRLMLQCWKQE 292
Query: 355 SRERPAMSYVVQLLDELV 372
             +RP  + + + L++++
Sbjct: 293 PDKRPVFADISKDLEKMM 310

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 137/311 (44%), Gaps = 44/311 (14%)
Query: 73  SMSELIDAT-DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDK-DAFQGFRE 124
           S+S+L +    N +  + +G G+FG VY+ ++S      S + VA+K L +  + Q   +
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           F  E   + K  H+NIV+ +G     L R ++ E +  G L  +L +T        S  +
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGL 241
             L        + + R +A G  YL   E   IHRDI + N LL        A I DFG+
Sbjct: 140 LDL--------LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
Query: 242 ARRIDTSHSHVSTQVAG-TMGYMPPEYL--GGNTAATVMLDVYSFGILMIEIATQIRPNL 298
           AR I  +  +     A   + +MPPE    G  T+ T   D +SFG+L+ EI +      
Sbjct: 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKT---DTWSFGVLLWEIFS------ 240
Query: 299 PVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRER 358
                   +G + +       N+E+    ++  R +  +      +RI   C   +  +R
Sbjct: 241 --------LGYMPYP---SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289
Query: 359 PAMSYVVQLLD 369
           P  + +++ ++
Sbjct: 290 PNFAIILERIE 300

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G C S   R   LI E++  GSL  +L      + +D  K L            +    +
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLL------------QYTSQI 124
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTM 260
             G+ YL    K  IHR++ + N+L++++    I DFGL + +  D  +  V       +
Sbjct: 125 CKGMEYLGT--KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 182
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
            +  PE L   +  +V  DV+SFG+++ E+ T I
Sbjct: 183 FWYAPESL-TESKFSVASDVWSFGVVLYELFTYI 215

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILG-YC 147
           +GDG+FG VYKAK   +G   A K ++  + +   ++  E+E L    H  IVK+LG Y 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
             G   ++I EF   G++D  + +  R        Q+  +C           R +   L 
Sbjct: 79  HDGKLWIMI-EFCPGGAVDAIMLELDRGL---TEPQIQVVC-----------RQMLEALN 123
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL-ARRIDTSHSHVSTQVAGTMGYMPPE 266
           +LH   K IIHRD+K+ NVL+  + +  ++DFG+ A+ + T     S    GT  +M PE
Sbjct: 124 FLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPE 179
Query: 267 YL----GGNTAATVMLDVYSFGILMIEIATQIRP 296
            +      +T      D++S GI +IE+A QI P
Sbjct: 180 VVMCETMKDTPYDYKADIWSLGITLIEMA-QIEP 212

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 137/311 (44%), Gaps = 44/311 (14%)
Query: 73  SMSELIDAT-DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDK-DAFQGFRE 124
           S+S+L +    N +  + +G G+FG VY+ ++S      S + VA+K L +  + Q   +
Sbjct: 12  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 71
Query: 125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           F  E   + K  H+NIV+ +G     L R ++ E +  G L  +L +T        S  +
Sbjct: 72  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 131
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGL 241
             L        + + R +A G  YL   E   IHRDI + N LL        A I DFG+
Sbjct: 132 LDL--------LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 181
Query: 242 ARRIDTSHSHVSTQVAG-TMGYMPPEYL--GGNTAATVMLDVYSFGILMIEIATQIRPNL 298
           AR I  +  +     A   + +MPPE    G  T+ T   D +SFG+L+ EI +      
Sbjct: 182 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKT---DTWSFGVLLWEIFS------ 232
Query: 299 PVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRER 358
                   +G + +       N+E+    ++  R +  +      +RI   C   +  +R
Sbjct: 233 --------LGYMPYP---SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 281
Query: 359 PAMSYVVQLLD 369
           P  + +++ ++
Sbjct: 282 PNFAIILERIE 292

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 21/213 (9%)
Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKK--LDKDAFQGFREFRAEMETLGKLRHRNIVKILGY 146
           IG+G++G V+KAK   +   VA+K+  LD D          E+  L +L+H+NIV++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
             S     L++EF +   L ++    S N D+D             E     +  +  GL
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDP------------EIVKSFLFQLLKGL 114
Query: 207 AYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE 266
            + H   + ++HRD+K  N+L++ + E  ++DFGLAR         S +V  T+ Y PP+
Sbjct: 115 GFCHS--RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPD 171
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
            L G    +  +D++S G +  E+A   RP  P
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAARPLFP 204

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 137/310 (44%), Gaps = 42/310 (13%)
Query: 73  SMSELIDAT-DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDK-DAFQGFRE 124
           S+S+L +    N +  + +G G+FG VY+ ++S      S + VA+K L +  + Q   +
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           F  E   + K  H+NIV+ +G     L R ++ E +  G L  +L +T        S  +
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGL 241
             L        + + R +A G  YL   E   IHRDI + N LL        A I DFG+
Sbjct: 141 LDL--------LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 190
Query: 242 ARRIDTSHSHVSTQVAG-TMGYMPPE-YLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           AR I  +  +     A   + +MPPE ++ G    T   D +SFG+L+ EI +       
Sbjct: 191 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFS------- 241
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
                  +G + +       N+E+    ++  R +  +      +RI   C   +  +RP
Sbjct: 242 -------LGYMPYP---SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 291
Query: 360 AMSYVVQLLD 369
             + +++ ++
Sbjct: 292 NFAIILERIE 301

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKK-LDKDAFQGFREFRA-EMETLGKLR 136
           + + +    ++G+GS+G V K +   +G  VAIKK L+ D  +  ++    E++ L +LR
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP--LSWET 194
           H N+V +L  C       L++EFV++  LD                    L P  L ++ 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDL-----------------ELFPNGLDYQV 125
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
             K +  + NG+ + H     IIHRDIK  N+L+       + DFG AR +         
Sbjct: 126 VQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           +VA T  Y  PE L G+      +DV++ G L+ E+
Sbjct: 184 EVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 137/310 (44%), Gaps = 42/310 (13%)
Query: 73  SMSELIDAT-DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDK-DAFQGFRE 124
           S+S+L +    N +  + +G G+FG VY+ ++S      S + VA+K L +  + Q   +
Sbjct: 37  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 96
Query: 125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           F  E   + K  H+NIV+ +G     L R ++ E +  G L  +L +T        S  +
Sbjct: 97  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 156
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGL 241
             L        + + R +A G  YL   E   IHRDI + N LL        A I DFG+
Sbjct: 157 LDL--------LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 206
Query: 242 ARRIDTSHSHVSTQVAG-TMGYMPPE-YLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           AR I  +  +     A   + +MPPE ++ G    T   D +SFG+L+ EI +       
Sbjct: 207 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFS------- 257
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
                  +G + +       N+E+    ++  R +  +      +RI   C   +  +RP
Sbjct: 258 -------LGYMPYP---SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 307
Query: 360 AMSYVVQLLD 369
             + +++ ++
Sbjct: 308 NFAIILERIE 317

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 137/310 (44%), Gaps = 42/310 (13%)
Query: 73  SMSELIDAT-DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDK-DAFQGFRE 124
           S+S+L +    N +  + +G G+FG VY+ ++S      S + VA+K L +  + Q   +
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 94
Query: 125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           F  E   + K  H+NIV+ +G     L R ++ E +  G L  +L +T        S  +
Sbjct: 95  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGL 241
             L        + + R +A G  YL   E   IHRDI + N LL        A I DFG+
Sbjct: 155 LDL--------LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 204
Query: 242 ARRIDTSHSHVSTQVAG-TMGYMPPE-YLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           AR I  +  +     A   + +MPPE ++ G    T   D +SFG+L+ EI +       
Sbjct: 205 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFS------- 255
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
                  +G + +       N+E+    ++  R +  +      +RI   C   +  +RP
Sbjct: 256 -------LGYMPYP---SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 305
Query: 360 AMSYVVQLLD 369
             + +++ ++
Sbjct: 306 NFAIILERIE 315

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 137/310 (44%), Gaps = 42/310 (13%)
Query: 73  SMSELIDAT-DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDK-DAFQGFRE 124
           S+S+L +    N +  + +G G+FG VY+ ++S      S + VA+K L +  + Q   +
Sbjct: 27  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 86
Query: 125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           F  E   + K  H+NIV+ +G     L R ++ E +  G L  +L +T        S  +
Sbjct: 87  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 146
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGL 241
             L        + + R +A G  YL   E   IHRDI + N LL        A I DFG+
Sbjct: 147 LDL--------LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 196
Query: 242 ARRIDTSHSHVSTQVAG-TMGYMPPE-YLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           AR I  +  +     A   + +MPPE ++ G    T   D +SFG+L+ EI +       
Sbjct: 197 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFS------- 247
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
                  +G + +       N+E+    ++  R +  +      +RI   C   +  +RP
Sbjct: 248 -------LGYMPYP---SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 297
Query: 360 AMSYVVQLLD 369
             + +++ ++
Sbjct: 298 NFAIILERIE 307

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 137/310 (44%), Gaps = 42/310 (13%)
Query: 73  SMSELIDAT-DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDK-DAFQGFRE 124
           S+S+L +    N +  + +G G+FG VY+ ++S      S + VA+K L +  + Q   +
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELD 94
Query: 125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           F  E   + K  H+NIV+ +G     L R ++ E +  G L  +L +T        S  +
Sbjct: 95  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGL 241
             L        + + R +A G  YL   E   IHRDI + N LL        A I DFG+
Sbjct: 155 LDL--------LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 204
Query: 242 ARRIDTSHSHVSTQVAG-TMGYMPPE-YLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           AR I  +  +     A   + +MPPE ++ G    T   D +SFG+L+ EI +       
Sbjct: 205 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFS------- 255
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
                  +G + +       N+E+    ++  R +  +      +RI   C   +  +RP
Sbjct: 256 -------LGYMPYP---SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 305
Query: 360 AMSYVVQLLD 369
             + +++ ++
Sbjct: 306 NFAIILERIE 315

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 137/310 (44%), Gaps = 42/310 (13%)
Query: 73  SMSELIDAT-DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDK-DAFQGFRE 124
           S+S+L +    N +  + +G G+FG VY+ ++S      S + VA+K L +  + Q   +
Sbjct: 61  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 120
Query: 125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           F  E   + K  H+NIV+ +G     L R ++ E +  G L  +L +T        S  +
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGL 241
             L        + + R +A G  YL   E   IHRDI + N LL        A I DFG+
Sbjct: 181 LDL--------LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230
Query: 242 ARRIDTSHSHVSTQVAG-TMGYMPPE-YLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           AR I  +  +     A   + +MPPE ++ G    T   D +SFG+L+ EI +       
Sbjct: 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFS------- 281
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
                  +G + +       N+E+    ++  R +  +      +RI   C   +  +RP
Sbjct: 282 -------LGYMPYP---SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 331
Query: 360 AMSYVVQLLD 369
             + +++ ++
Sbjct: 332 NFAIILERIE 341

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 137/311 (44%), Gaps = 44/311 (14%)
Query: 73  SMSELIDAT-DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDK-DAFQGFRE 124
           S+S+L +    N +  + +G G+FG VY+ ++S      S + VA+K L +  + Q   +
Sbjct: 47  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 106
Query: 125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           F  E   + K  H+NIV+ +G     L R ++ E +  G L  +L +T        S  +
Sbjct: 107 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 166
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGL 241
             L        + + R +A G  YL   E   IHRDI + N LL        A I DFG+
Sbjct: 167 LDL--------LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 216
Query: 242 ARRIDTSHSHVSTQVAG-TMGYMPPEYL--GGNTAATVMLDVYSFGILMIEIATQIRPNL 298
           AR I  +  +     A   + +MPPE    G  T+ T   D +SFG+L+ EI +      
Sbjct: 217 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKT---DTWSFGVLLWEIFS------ 267
Query: 299 PVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRER 358
                   +G + +       N+E+    ++  R +  +      +RI   C   +  +R
Sbjct: 268 --------LGYMPYP---SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 316
Query: 359 PAMSYVVQLLD 369
           P  + +++ ++
Sbjct: 317 PNFAIILERIE 327

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 141/318 (44%), Gaps = 59/318 (18%)
Query: 83  NFSTDKIIGDGSFGFVYKA-----KLSSG-VTVAIKKLDKDAFQG-FREFRAEMETLGKL 135
           N    K +G+G FG V KA     K  +G  TVA+K L ++A     R+  +E   L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSR-----------------NDDV 178
            H +++K+ G C+     +LI E+ + GSL  +L ++ +                 +   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 179 DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD 238
           + +  +  L   +W+        ++ G+ YL   E  ++HRD+ + N+L+    +  ISD
Sbjct: 144 ERALTMGDLISFAWQ--------ISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNT----AATVMLDVYSFGILMIEIATQI 294
           FGL+R +    S V      + G +P +++   +      T   DV+SFG+L+ EI T  
Sbjct: 194 FGLSRDVYEEDSXVKR----SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 295 RPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEK 354
               P +   +   LL+    ME  +        N S          E +R+   C  ++
Sbjct: 250 GNPYPGIPPERLFNLLKTGHRMERPD--------NCS---------EEMYRLMLQCWKQE 292
Query: 355 SRERPAMSYVVQLLDELV 372
             +RP  + + + L++++
Sbjct: 293 PDKRPVFADISKDLEKMM 310

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 137/310 (44%), Gaps = 42/310 (13%)
Query: 73  SMSELIDAT-DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDK-DAFQGFRE 124
           S+S+L +    N +  + +G G+FG VY+ ++S      S + VA+K L +  + Q   +
Sbjct: 38  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 97
Query: 125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           F  E   + K  H+NIV+ +G     L R ++ E +  G L  +L +T        S  +
Sbjct: 98  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 157
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGL 241
             L        + + R +A G  YL   E   IHRDI + N LL        A I DFG+
Sbjct: 158 LDL--------LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 207
Query: 242 ARRIDTSHSHVSTQVAG-TMGYMPPE-YLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           AR I  +  +     A   + +MPPE ++ G    T   D +SFG+L+ EI +       
Sbjct: 208 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFS------- 258
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
                  +G + +       N+E+    ++  R +  +      +RI   C   +  +RP
Sbjct: 259 -------LGYMPYP---SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 308
Query: 360 AMSYVVQLLD 369
             + +++ ++
Sbjct: 309 NFAIILERIE 318

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 116/221 (52%), Gaps = 30/221 (13%)
Query: 88  KIIGDGSFGFVYKAKLS----SGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           KI+G+G FG V +  L     + + VA+K  KLD  + +   EF +E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 142 KILGYC----ASGLDR-VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           ++LG C    + G+ + ++I  F++ G L  +L   SR +   G K +    PL  +T +
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL-YSRLET--GPKHI----PL--QTLL 150
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           K +  +A G+ YL    +  +HRD+ + N +L  D    ++DFGL+++I +   +   ++
Sbjct: 151 KFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI 208
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIATQ 293
           A     MP +++   + A    T   DV++FG+ M EIAT+
Sbjct: 209 AK----MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 141/318 (44%), Gaps = 59/318 (18%)
Query: 83  NFSTDKIIGDGSFGFVYKA-----KLSSG-VTVAIKKLDKDAFQG-FREFRAEMETLGKL 135
           N    K +G+G FG V KA     K  +G  TVA+K L ++A     R+  +E   L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSR-----------------NDDV 178
            H +++K+ G C+     +LI E+ + GSL  +L ++ +                 +   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 179 DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD 238
           + +  +  L   +W+        ++ G+ YL   E  ++HRD+ + N+L+    +  ISD
Sbjct: 144 ERALTMGDLISFAWQ--------ISQGMQYL--AEMSLVHRDLAARNILVAEGRKMKISD 193
Query: 239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNT----AATVMLDVYSFGILMIEIATQI 294
           FGL+R +    S V      + G +P +++   +      T   DV+SFG+L+ EI T  
Sbjct: 194 FGLSRDVYEEDSXVKR----SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 295 RPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEK 354
               P +   +   LL+    ME  +        N S          E +R+   C  ++
Sbjct: 250 GNPYPGIPPERLFNLLKTGHRMERPD--------NCS---------EEMYRLMLQCWKQE 292
Query: 355 SRERPAMSYVVQLLDELV 372
             +RP  + + + L++++
Sbjct: 293 PDKRPVFADISKDLEKMM 310

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 53/291 (18%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           IG G FG V+     +   VAIK + + A     +F  E E + KL H  +V++ G C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                L+ EF+E+G L  +L  T R                + ET + +   V  G+AYL
Sbjct: 75  QAPICLVTEFMEHGCLSDYLR-TQRG-------------LFAAETLLGMCLDVCEGMAYL 120
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG 269
              E  +IHRD+ + N L+  +    +SDFG+ R +       ST     + +  PE   
Sbjct: 121 E--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 178
Query: 270 GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSN 329
            +  ++   DV+SFG+LM E+ ++ +                    +   N+    V  +
Sbjct: 179 FSRYSSKS-DVWSFGVLMWEVFSEGK--------------------IPYENRSNSEVVED 217
Query: 330 ISREELSEAGVREY---------FRIACMCTNEKSRERPAMSYVVQLLDEL 371
           IS       G R Y         ++I   C  E+  +RPA S +++ L E+
Sbjct: 218 IS------TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIK-----KLDKDAFQGFREFRAEMETLGKL 135
           D+F   + +G G FG VY A+   +   +A+K     +L+K+  +   + R E+E    L
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQLRREIEIQSHL 72
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++  Y        L+ EF   G L + L    R D+   +  +  L        
Sbjct: 73  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL-------- 124
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  A+ L Y H  E+ +IHRDIK  N+L+    E  I+DFG +     + S     
Sbjct: 125 -------ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRX 172
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           + GT+ Y+PPE + G T     +D++  G+L  E    + P
Sbjct: 173 MCGTLDYLPPEMIEGKTHDE-KVDLWCAGVLCYEFLVGMPP 212

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 106/228 (46%), Gaps = 40/228 (17%)
Query: 88  KIIGDGSFGFVYKAKLSSG-VTVAIKKL-DKDAFQGFREFRAEMETLGKLRHRNIVKILG 145
           +I   G FG V+KA+L +  V V I  L DK ++Q  RE      T G ++H N+++ + 
Sbjct: 21  EIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREI---FSTPG-MKHENLLQFIA 76
Query: 146 YCASG----LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
               G    ++  LI  F + GSL  +L                    ++W     +   
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSLTDYLKGNI----------------ITWNELCHVAET 120
Query: 202 VANGLAYLH---------GLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           ++ GL+YLH         G +  I HRD KS NVLL SD  A ++DFGLA R +      
Sbjct: 121 MSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPG 180
Query: 253 STQ-VAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIR 295
            T    GT  YM PE L G       A + +D+Y+ G+++ E+ ++ +
Sbjct: 181 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCK 228

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 109/227 (48%), Gaps = 22/227 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +N    K +G G+FG V +A      K  + + VA+K L   A    +E   +E++ +  
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSR---------NDDVDGSKQL 184
           L +H NIV +LG C  G   ++I E+   G L  +L   +            D +G  + 
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR 244
           +   PL     +     VA G+A+L    K  IHRD+ + NVLL +   A I DFGLAR 
Sbjct: 151 DGR-PLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 245 I-DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           I + S+  V       + +M PE +  +   TV  DV+S+GIL+ EI
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEI 253

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRN 139
           D++   ++IG G+   V  A  +     VAIK+++ +  Q    E   E++ + +  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 140 IVKILGYCASGLDRVLIYEFVENGS-LDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           IV          +  L+ + +  GS LD   H  ++ +   G         L   T   I
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV--------LDESTIATI 121
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG----LARRIDTSHSHVST 254
           +R V  GL YLH  +   IHRD+K+ N+LL  D    I+DFG    LA   D + + V  
Sbjct: 122 LREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 179
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
              GT  +M PE +          D++SFGI  IE+AT   P
Sbjct: 180 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRN 139
           D++   ++IG G+   V  A  +     VAIK+++ +  Q    E   E++ + +  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 140 IVKILGYCASGLDRVLIYEFVENGS-LDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           IV          +  L+ + +  GS LD   H  ++ +   G         L   T   I
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV--------LDESTIATI 126
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG----LARRIDTSHSHVST 254
           +R V  GL YLH  +   IHRD+K+ N+LL  D    I+DFG    LA   D + + V  
Sbjct: 127 LREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
              GT  +M PE +          D++SFGI  IE+AT   P
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 122/252 (48%), Gaps = 21/252 (8%)
Query: 53  DLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAI 111
           DL S  L  +A+   +  ++   ++ D    ++    IG+G++G V  A  + + V VAI
Sbjct: 2   DLGSDELMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAI 61
Query: 112 KKLDKDAFQGF--REFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWL 169
           KK+     Q +  R  R E++ L + RH NI+ I     + + R    E +++  + Q L
Sbjct: 62  KKISPFEHQTYCQRTLR-EIKILLRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDL 115
Query: 170 HDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD 229
            +T      D  K L +   LS +     +  +  GL Y+H     ++HRD+K SN+LL+
Sbjct: 116 MET------DLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN 166
Query: 230 SDFEAHISDFGLARRIDTSHSHVS--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           +  +  I DFGLAR  D  H H    T+   T  Y  PE +  +   T  +D++S G ++
Sbjct: 167 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 226
Query: 288 IEIATQIRPNLP 299
            E+ +  RP  P
Sbjct: 227 AEMLSN-RPIFP 237

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 111/239 (46%), Gaps = 23/239 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +N    K++G G+FG V  A      K    + VA+K L + A    RE   +E++ + +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRN---DDVDGSKQL-----N 185
           L  H NIV +LG C       LI+E+   G L  +L         D+++   Q       
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
            L  L++E  +     VA G+ +L    K  +HRD+ + NVL+       I DFGLAR I
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 246 DTSHSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI---ATQIRPNLPV 300
            +  ++V    A   + +M PE L      T+  DV+S+GIL+ EI        P +PV
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 123/284 (43%), Gaps = 37/284 (13%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           K +G+G FG V+    +    VAIK L K        F  E + + KL+H  +V++    
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYA-V 72
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
            S     ++ E++  GSL  +L D        G  +   L  L     V +   VA G+A
Sbjct: 73  VSEEPIYIVTEYMNKGSLLDFLKD--------GEGRALKLPNL-----VDMAAQVAAGMA 119
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE- 266
           Y+  +    IHRD++S+N+L+ +     I+DFGLAR I+ +           + +  PE 
Sbjct: 120 YIERMN--YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEA 177
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L G    T+  DV+SFGIL+ E+ T+ R   P + + + +  +E    M          
Sbjct: 178 ALYGRF--TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQ------ 229
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
           D  IS  EL              C  +   ERP   Y+   L++
Sbjct: 230 DCPISLHEL-----------MIHCWKKDPEERPTFEYLQSFLED 262

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIK-----KLDKDAFQGFREFRAEMETLGKL 135
           D+F   + +G G FG VY A+   +   +A+K     +L+K+  +   + R E+E    L
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQLRREIEIQSHL 71
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NI+++  Y        L+ EF   G L + L    R D+   +  +  L        
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL-------- 123
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                  A+ L Y H  E+ +IHRDIK  N+L+    E  I+DFG +     + S     
Sbjct: 124 -------ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRX 171
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           + GT+ Y+PPE + G T     +D++  G+L  E    + P
Sbjct: 172 MCGTLDYLPPEMIEGKTHDE-KVDLWCAGVLCYEFLVGMPP 211

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 73
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L       +     +L  L        V +   +A+G+AY+
Sbjct: 74  EEPIXIVTEYMSKGSLLDFL-----KGETGKYLRLPQL--------VDMAAQIASGMAYV 120
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 121 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAAL 178
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 179 YGRF--TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 236
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  ++  ERP   Y+   L++
Sbjct: 237 -----------------LMCQCWRKEPEERPTFEYLQAFLED 261

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 39/287 (13%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           K +G G FG V   K      VAIK + K+      EF  E + +  L H  +V++ G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  +I E++ NG L  +L +         ++QL  +C           + V   + 
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQ---TQQLLEMC-----------KDVCEAME 114
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           YL    K  +HRD+ + N L++      +SDFGL+R +       S      + + PPE 
Sbjct: 115 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           L  +  ++   D+++FG+LM EI +              +G + + R   +   E     
Sbjct: 173 LMYSKFSSKS-DIWAFGVLMWEIYS--------------LGKMPYERFTNSETAEHIAQG 217
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPA----MSYVVQLLDE 370
             + R  L+   V   + I   C +EK+ ERP     +S ++ ++DE
Sbjct: 218 LRLYRPHLASEKV---YTIMYSCWHEKADERPTFKILLSNILDVMDE 261

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 39/287 (13%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           K +G G FG V   K      VAIK + K+      EF  E + +  L H  +V++ G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  +I E++ NG L  +L +         ++QL  +C           + V   + 
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQ---TQQLLEMC-----------KDVCEAME 134
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           YL    K  +HRD+ + N L++      +SDFGL+R +       S      + + PPE 
Sbjct: 135 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEV 192
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           L  +  ++   D+++FG+LM EI +              +G + + R   +   E     
Sbjct: 193 LMYSKFSSKS-DIWAFGVLMWEIYS--------------LGKMPYERFTNSETAEHIAQG 237
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPA----MSYVVQLLDE 370
             + R  L+   V   + I   C +EK+ ERP     +S ++ ++DE
Sbjct: 238 LRLYRPHLASEKV---YTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 115/212 (54%), Gaps = 20/212 (9%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     R    E++ + KL H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 142 KI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-V 199
           ++   + +SG  + ++Y  +    + + ++  +R+     S+   +L P+ +   VK+ +
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLYM 128
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVAG 258
             +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS     
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--IC 184
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 124/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
               ++I E++  GSL  +L       ++    +L  L        V +   +A+G+AY+
Sbjct: 85  EPIYIVI-EYMSKGSLLDFL-----KGEMGKYLRLPQL--------VDMAAQIASGMAYV 130
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 131 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAAL 188
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 189 YGRF--TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  +   ERP   Y+   L++
Sbjct: 247 -----------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 80
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 81  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 128
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 129 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 186
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 187 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 234

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 23  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 81
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 82  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 129
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 130 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 187
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 188 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 235

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 14  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 72
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 73  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 120
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 121 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 178
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 179 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 226

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 79
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 80  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 127
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 128 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 233

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 77
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 78  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 125
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 126 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 183
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 184 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 231

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 137/310 (44%), Gaps = 42/310 (13%)
Query: 73  SMSELIDAT-DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDK-DAFQGFRE 124
           S+S+L +    N +  + +G G+FG VY+ ++S      S + VA+K L +  + Q   +
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           F  E   + K  H+NIV+ +G     L R ++ E +  G L  +L +T        S  +
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGL 241
             L        + + R +A G  YL   E   IHRDI + N LL        A I DFG+
Sbjct: 141 LDL--------LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 190
Query: 242 ARRIDTSHSHVSTQVAG-TMGYMPPE-YLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           A+ I  +  +     A   + +MPPE ++ G    T   D +SFG+L+ EI +       
Sbjct: 191 AQDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFS------- 241
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
                  +G + +       N+E+    ++  R +  +      +RI   C   +  +RP
Sbjct: 242 -------LGYMPYP---SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 291
Query: 360 AMSYVVQLLD 369
             + +++ ++
Sbjct: 292 NFAIILERIE 301

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 73
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 74  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 121
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 122 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 179
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 180 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 227

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 75
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 76  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 123
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 124 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 181
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 182 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 75
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 76  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 123
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 124 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 181
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 182 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 73
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 74  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 121
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 122 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 179
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 180 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 227

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 79
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 80  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 127
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 128 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 185
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 233

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 39/287 (13%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           K +G G FG V   K      VAIK + K+      EF  E + +  L H  +V++ G C
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  +I E++ NG L  +L +         ++QL  +C           + V   + 
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQ---TQQLLEMC-----------KDVCEAME 118
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           YL    K  +HRD+ + N L++      +SDFGL+R +       S      + + PPE 
Sbjct: 119 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 176
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           L  +  ++   D+++FG+LM EI +              +G + + R   +   E     
Sbjct: 177 LMYSKFSSKS-DIWAFGVLMWEIYS--------------LGKMPYERFTNSETAEHIAQG 221
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPA----MSYVVQLLDE 370
             + R  L+   V   + I   C +EK+ ERP     +S ++ ++DE
Sbjct: 222 LRLYRPHLASEKV---YTIMYSCWHEKADERPTFKILLSNILDVMDE 265

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGK 134
           + + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           L H NIVK+L    +     L++EF+   S+D         D +D S       PL    
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL---SMDL-------KDFMDASALTGIPLPLIKSY 111
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
             ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           
Sbjct: 112 LFQLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 165
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           +V  T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 166 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 31/218 (14%)
Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKK-LDKDAFQGFR-EFRAEMETLGKLRHRNIVKILGY 146
           IG G+FG V+KA+   +G  VA+KK L ++  +GF      E++ L  L+H N+V ++  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 147 C---ASGLDRV-----LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           C   AS  +R      L+++F E+              D+ G    N L   +     ++
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH--------------DLAGLLS-NVLVKFTLSEIKRV 130
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           ++ + NGL Y+H     I+HRD+K++NVL+  D    ++DFGLAR    + +    +   
Sbjct: 131 MQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 259 ---TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
              T+ Y PPE L G       +D++  G +M E+ T+
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 39/287 (13%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           K +G G FG V   K      VAIK + K+      EF  E + +  L H  +V++ G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  +I E++ NG L  +L +         ++QL  +C           + V   + 
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQ---TQQLLEMC-----------KDVCEAME 134
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           YL    K  +HRD+ + N L++      +SDFGL+R +       S      + + PPE 
Sbjct: 135 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 192
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           L  +  ++   D+++FG+LM EI +              +G + + R   +   E     
Sbjct: 193 LMYSKFSSKS-DIWAFGVLMWEIYS--------------LGKMPYERFTNSETAEHIAQG 237
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPA----MSYVVQLLDE 370
             + R  L+   V   + I   C +EK+ ERP     +S ++ ++DE
Sbjct: 238 LRLYRPHLASEKV---YTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 112/230 (48%), Gaps = 33/230 (14%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKK-LDKDAFQGF--REFRAEMETLGK 134
           D    +     IG G+FG V+KA+   +G  VA+KK L ++  +GF     R E++ L  
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQL 72
Query: 135 LRHRNIVKILGYC---ASGLDRV-----LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNS 186
           L+H N+V ++  C   AS  +R      L+++F E+              D+ G    N 
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH--------------DLAGLLS-NV 117
Query: 187 LCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID 246
           L   +     ++++ + NGL Y+H     I+HRD+K++NVL+  D    ++DFGLAR   
Sbjct: 118 LVKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175
Query: 247 TSHSHVSTQVAG---TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
            + +    +      T+ Y PPE L G       +D++  G +M E+ T+
Sbjct: 176 LAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 112/230 (48%), Gaps = 33/230 (14%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKK-LDKDAFQGF--REFRAEMETLGK 134
           D    +     IG G+FG V+KA+   +G  VA+KK L ++  +GF     R E++ L  
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQL 73
Query: 135 LRHRNIVKILGYC---ASGLDRV-----LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNS 186
           L+H N+V ++  C   AS  +R      L+++F E+              D+ G    N 
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH--------------DLAGLLS-NV 118
Query: 187 LCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID 246
           L   +     ++++ + NGL Y+H     I+HRD+K++NVL+  D    ++DFGLAR   
Sbjct: 119 LVKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFS 176
Query: 247 TSHSHVSTQVAG---TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
            + +    +      T+ Y PPE L G       +D++  G +M E+ T+
Sbjct: 177 LAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 39/287 (13%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           K +G G FG V   K      VAIK + K+      EF  E + +  L H  +V++ G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  +I E++ NG L  +L +         ++QL  +C           + V   + 
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQ---TQQLLEMC-----------KDVCEAME 119
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           YL    K  +HRD+ + N L++      +SDFGL+R +       S      + + PPE 
Sbjct: 120 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 177
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           L  +  ++   D+++FG+LM EI +              +G + + R   +   E     
Sbjct: 178 LMYSKFSSKS-DIWAFGVLMWEIYS--------------LGKMPYERFTNSETAEHIAQG 222
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPA----MSYVVQLLDE 370
             + R  L+   V   + I   C +EK+ ERP     +S ++ ++DE
Sbjct: 223 LRLYRPHLASEKV---YTIMYSCWHEKADERPTFKILLSNILDVMDE 266

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 76
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L       +     +L  L        V +   +A+G+AY+
Sbjct: 77  EEPIYIVTEYMSKGSLLDFL-----KGETGKYLRLPQL--------VDMAAQIASGMAYV 123
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 124 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 181
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 182 YGRF--TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 239
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  ++  ERP   Y+   L++
Sbjct: 240 -----------------LMCQCWRKEPEERPTFEYLQAFLED 264

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 75
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 76  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 123
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 124 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 181
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 182 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 75
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 76  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 123
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 124 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 181
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 182 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 229

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 133/310 (42%), Gaps = 43/310 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +  S  K +G G+FG V +A      K  + +TVA+K L   A    RE   +E++ L  
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           L  H NIV +LG C  G   ++I E+   G L  +L    + D    SK   ++      
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR--RKRDSFICSKTSPAIMEDDEL 163
Query: 194 TRVKIVRG-----VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
                        VA G+A+L    K  IHRD+ + N+LL       I DFGLAR I   
Sbjct: 164 ALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKND 221
Query: 249 HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIE---IATQIRPNLPVVLDG 304
            ++V    A   + +M PE +  N   T   DV+S+GI + E   + +   P +PV  D 
Sbjct: 222 SNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--DS 278
Query: 305 QEVGLL-EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY 363
           +   ++ E  R +   +   EM D                  I   C +    +RP    
Sbjct: 279 KFYKMIKEGFRMLSPEHAPAEMYD------------------IMKTCWDADPLKRPTFKQ 320
Query: 364 VVQLLDELVA 373
           +VQL+++ ++
Sbjct: 321 IVQLIEKQIS 330

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR-EIKIL 79
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 80  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 127
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 128 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 185
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 233

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 124/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
               ++I E++  GSL  +L       ++    +L  L        V +   +A+G+AY+
Sbjct: 85  EPIYIVI-EYMSKGSLLDFL-----KGEMGKYLRLPQL--------VDMAAQIASGMAYV 130
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 131 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 189 YGRF--TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  +   ERP   Y+   L++
Sbjct: 247 -----------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGK 134
           + + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           L H NIVK+L    +     L++EF+   S+D         D +D S       PL    
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL---SMDL-------KDFMDASALTGIPLPLIKSY 110
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
             ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           
Sbjct: 111 LFQLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 164
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           +V  T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 165 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 95
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 96  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 143
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 144 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 201
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 202 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 249

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 79
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L     LS 
Sbjct: 80  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKCQ-HLSN 127
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 128 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 233

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 111/229 (48%), Gaps = 31/229 (13%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKK-LDKDAFQGFR-EFRAEMETLGKL 135
           D    +     IG G+FG V+KA+   +G  VA+KK L ++  +GF      E++ L  L
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 136 RHRNIVKILGYC---ASGLDRV-----LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL 187
           +H N+V ++  C   AS  +R      L+++F E+              D+ G    N L
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH--------------DLAGLLS-NVL 119
Query: 188 CPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT 247
              +     ++++ + NGL Y+H     I+HRD+K++NVL+  D    ++DFGLAR    
Sbjct: 120 VKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 177
Query: 248 SHSHVSTQVAG---TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           + +    +      T+ Y PPE L G       +D++  G +M E+ T+
Sbjct: 178 AKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 118/242 (48%), Gaps = 23/242 (9%)
Query: 59  LFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIK 112
           +F S+ F P   ++S  ++       +  + +G GSFG VY+       K  +   VA+K
Sbjct: 1   VFPSSVFVPDEWEVSREKI-------TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVK 53
Query: 113 KLDKDAFQGFR-EFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHD 171
            +++ A    R EF  E   +      ++V++LG  + G   +++ E + +G L  +L  
Sbjct: 54  TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
Query: 172 TSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD 231
                + +  +      P + +  +++   +A+G+AYL+   K  +HRD+ + N ++  D
Sbjct: 114 LRPEAENNPGRP-----PPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHD 166
Query: 232 FEAHISDFGLARRI-DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           F   I DFG+ R I +T++     +    + +M PE L  +   T   D++SFG+++ EI
Sbjct: 167 FTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESL-KDGVFTTSSDMWSFGVVLWEI 225
Query: 291 AT 292
            +
Sbjct: 226 TS 227

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 75
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 76  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 123
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 124 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHT 181
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 182 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 229

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 39/287 (13%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           K +G G FG V   K      VAIK + K+      EF  E + +  L H  +V++ G C
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  +I E++ NG L  +L +         ++QL  +C           + V   + 
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHRFQ---TQQLLEMC-----------KDVCEAME 125
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           YL    K  +HRD+ + N L++      +SDFGL+R +       S      + + PPE 
Sbjct: 126 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 183
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           L  +  ++   D+++FG+LM EI +              +G + + R   +   E     
Sbjct: 184 LMYSKFSSKS-DIWAFGVLMWEIYS--------------LGKMPYERFTNSETAEHIAQG 228
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPA----MSYVVQLLDE 370
             + R  L+   V   + I   C +EK+ ERP     +S ++ ++DE
Sbjct: 229 LRLYRPHLASEKV---YTIMYSCWHEKADERPTFKILLSNILDVMDE 272

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L       +     +L  L        V +   +A+G+AY+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFL-----KGETGKYLRLPQL--------VDMAAQIASGMAYV 296
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 297 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 355 YGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 412
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  ++  ERP   Y+   L++
Sbjct: 413 -----------------LMCQCWRKEPEERPTFEYLQAFLED 437

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L       +     +L  L        V +   +A+G+AY+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFL-----KGETGKYLRLPQL--------VDMAAQIASGMAYV 296
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 297 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 355 YGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 412
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  ++  ERP   Y+   L++
Sbjct: 413 -----------------LMCQCWRKEPEERPTFEYLQAFLED 437

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 74
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L       ++    +L  L        V +   +A+G+AY+
Sbjct: 75  EEPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQL--------VDMAAQIASGMAYV 121
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 122 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 179
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 180 YGRF--TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 237
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  +   ERP   Y+   L++
Sbjct: 238 -----------------LMCQCWRKDPEERPTFEYLQAFLED 262

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 21/213 (9%)
Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKK--LDKDAFQGFREFRAEMETLGKLRHRNIVKILGY 146
           IG+G++G V+KAK   +   VA+K+  LD D          E+  L +L+H+NIV++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
             S     L++EF +   L ++    S N D+D             E     +  +  GL
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDP------------EIVKSFLFQLLKGL 114
Query: 207 AYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE 266
            + H   + ++HRD+K  N+L++ + E  +++FGLAR         S +V  T+ Y PP+
Sbjct: 115 GFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPD 171
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
            L G    +  +D++S G +  E+A   RP  P
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 25/213 (11%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---REFRAEMETLGKLRH 137
           D+F   + +G G FG VY A+   S   VA+K L K   +      + R E+E    L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NI+++  Y        LI E+   G L                K+L   C    +    
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGEL---------------YKELQKSCTFDEQRTAT 127
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           I+  +A+ L Y HG  K +IHRDIK  N+LL    E  I+DFG +     + S     + 
Sbjct: 128 IMEELADALMYCHG--KKVIHRDIKPENLLLGLKGELKIADFGWSVH---APSLRRKTMC 182
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           GT+ Y+PPE + G       +D++  G+L  E+
Sbjct: 183 GTLDYLPPEMIEGRMHNE-KVDLWCIGVLCYEL 214

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 72
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L       ++    +L  L        V +   +A+G+AY+
Sbjct: 73  EEPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQL--------VDMAAQIASGMAYV 119
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 120 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 177
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 178 YGRF--TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 235
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  +   ERP   Y+   L++
Sbjct: 236 -----------------LMCQCWRKDPEERPTFEYLQAFLED 260

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           K +G G FG V   K      VA+K + K+      EF  E +T+ KL H  +VK  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
           +      ++ E++ NG L  +L    +  +     QL  +C             V  G+A
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLE---PSQLLEMC-----------YDVCEGMA 118
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPP 265
           +L   +   IHRD+ + N L+D D    +SDFG+ R +  D   S V T+    + +  P
Sbjct: 119 FLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP--VKWSAP 174
Query: 266 E---YLGGNTAATVMLDVYSFGILMIEI 290
           E   Y   ++ +    DV++FGILM E+
Sbjct: 175 EVFHYFKYSSKS----DVWAFGILMWEV 198

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 124/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 80
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L       +     +L  L  +S +        +A+G+AY+
Sbjct: 81  EEPIYIVTEYMNKGSLLDFL-----KGETGKYLRLPQLVDMSAQ--------IASGMAYV 127
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 128 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 185
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 186 YGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 243
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  ++  ERP   Y+   L++
Sbjct: 244 -----------------LMCQCWRKEPEERPTFEYLQAFLED 268

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLR 136
           + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L    +     L++EF         LH   + D +D S       PL      
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLK-DFMDASALTGIPLPLIKSYLF 110
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V
Sbjct: 111 QLLQG----LAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV 164
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
             T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 165 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L       ++    +L  L        V +   +A+G+AY+
Sbjct: 84  EEPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQL--------VDMAAQIASGMAYV 130
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 131 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 189 YGRF--TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  +   ERP   Y+   L++
Sbjct: 247 -----------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L       ++    +L  L        V +   +A+G+AY+
Sbjct: 84  EEPIYIVCEYMSKGSLLDFL-----KGEMGKYLRLPQL--------VDMAAQIASGMAYV 130
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 131 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 189 YGRF--TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  +   ERP   Y+   L++
Sbjct: 247 -----------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 124/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 80
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L       +     +L  L  +S +        +A+G+AY+
Sbjct: 81  EEPIYIVTEYMNKGSLLDFL-----KGETGKYLRLPQLVDMSAQ--------IASGMAYV 127
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 128 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAAL 185
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 186 YGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 243
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  ++  ERP   Y+   L++
Sbjct: 244 -----------------LMCQCWRKEPEERPTFEYLQAFLED 268

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAI+K+     Q +  R  R E++ L
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR-EIKIL 79
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 80  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 127
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 128 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 233

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 133/310 (42%), Gaps = 43/310 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +  S  K +G G+FG V +A      K  + +TVA+K L   A    RE   +E++ L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           L  H NIV +LG C  G   ++I E+   G L  +L    + D    SK   ++      
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR--RKRDSFICSKTSPAIMEDDEL 140
Query: 194 TRVKIVRG-----VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
                        VA G+A+L    K  IHRD+ + N+LL       I DFGLAR I   
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 249 HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIE---IATQIRPNLPVVLDG 304
            ++V    A   + +M PE +  N   T   DV+S+GI + E   + +   P +PV  D 
Sbjct: 199 SNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--DS 255
Query: 305 QEVGLL-EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY 363
           +   ++ E  R +   +   EM D                  I   C +    +RP    
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYD------------------IMKTCWDADPLKRPTFKQ 297
Query: 364 VVQLLDELVA 373
           +VQL+++ ++
Sbjct: 298 IVQLIEKQIS 307

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 133/310 (42%), Gaps = 43/310 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +  S  K +G G+FG V +A      K  + +TVA+K L   A    RE   +E++ L  
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           L  H NIV +LG C  G   ++I E+   G L  +L    + D    SK   ++      
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR--RKRDSFICSKTSPAIMEDDEL 163
Query: 194 TRVKIVRG-----VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
                        VA G+A+L    K  IHRD+ + N+LL       I DFGLAR I   
Sbjct: 164 ALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 221
Query: 249 HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIE---IATQIRPNLPVVLDG 304
            ++V    A   + +M PE +  N   T   DV+S+GI + E   + +   P +PV  D 
Sbjct: 222 SNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--DS 278
Query: 305 QEVGLL-EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY 363
           +   ++ E  R +   +   EM D                  I   C +    +RP    
Sbjct: 279 KFYKMIKEGFRMLSPEHAPAEMYD------------------IMKTCWDADPLKRPTFKQ 320
Query: 364 VVQLLDELVA 373
           +VQL+++ ++
Sbjct: 321 IVQLIEKQIS 330

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 133/310 (42%), Gaps = 43/310 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +  S  K +G G+FG V +A      K  + +TVA+K L   A    RE   +E++ L  
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           L  H NIV +LG C  G   ++I E+   G L  +L    + D    SK   ++      
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR--RKRDSFICSKTSPAIMEDDEL 158
Query: 194 TRVKIVRG-----VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
                        VA G+A+L    K  IHRD+ + N+LL       I DFGLAR I   
Sbjct: 159 ALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 216
Query: 249 HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIE---IATQIRPNLPVVLDG 304
            ++V    A   + +M PE +  N   T   DV+S+GI + E   + +   P +PV  D 
Sbjct: 217 SNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--DS 273
Query: 305 QEVGLL-EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY 363
           +   ++ E  R +   +   EM D                  I   C +    +RP    
Sbjct: 274 KFYKMIKEGFRMLSPEHAPAEMYD------------------IMKTCWDADPLKRPTFKQ 315
Query: 364 VVQLLDELVA 373
           +VQL+++ ++
Sbjct: 316 IVQLIEKQIS 325

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 77
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
              RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 78  LAFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 125
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 126 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 183
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 184 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 231

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 117/242 (48%), Gaps = 23/242 (9%)
Query: 59  LFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIK 112
           +F S+ F P   ++S  ++       +  + +G GSFG VY+       K  +   VA+K
Sbjct: 1   VFPSSVFVPDEWEVSREKI-------TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVK 53
Query: 113 KLDKDAFQGFR-EFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHD 171
            +++ A    R EF  E   +      ++V++LG  + G   +++ E + +G L  +L  
Sbjct: 54  TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
Query: 172 TSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD 231
                + +  +      P + +  +++   +A+G+AYL+   K  +HRD+ + N ++  D
Sbjct: 114 LRPEAENNPGRP-----PPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHD 166
Query: 232 FEAHISDFGLARRI-DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           F   I DFG+ R I +T +     +    + +M PE L  +   T   D++SFG+++ EI
Sbjct: 167 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL-KDGVFTTSSDMWSFGVVLWEI 225
Query: 291 AT 292
            +
Sbjct: 226 TS 227

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L       +     +L  L        V +   +A+G+AY+
Sbjct: 250 EEPIYIVGEYMSKGSLLDFL-----KGETGKYLRLPQL--------VDMAAQIASGMAYV 296
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 297 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 355 YGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 412
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  ++  ERP   Y+   L++
Sbjct: 413 -----------------LMCQCWRKEPEERPTFEYLQAFLED 437

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 133/310 (42%), Gaps = 43/310 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +  S  K +G G+FG V +A      K  + +TVA+K L   A    RE   +E++ L  
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           L  H NIV +LG C  G   ++I E+   G L  +L    + D    SK   ++      
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR--RKRDSFICSKTSPAIMEDDEL 156
Query: 194 TRVKIVRG-----VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
                        VA G+A+L    K  IHRD+ + N+LL       I DFGLAR I   
Sbjct: 157 ALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 214
Query: 249 HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIE---IATQIRPNLPVVLDG 304
            ++V    A   + +M PE +  N   T   DV+S+GI + E   + +   P +PV  D 
Sbjct: 215 SNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--DS 271
Query: 305 QEVGLL-EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY 363
           +   ++ E  R +   +   EM D                  I   C +    +RP    
Sbjct: 272 KFYKMIKEGFRMLSPEHAPAEMYD------------------IMKTCWDADPLKRPTFKQ 313
Query: 364 VVQLLDELVA 373
           +VQL+++ ++
Sbjct: 314 IVQLIEKQIS 323

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 332
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L       +     +L  L        V +   +A+G+AY+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFL-----KGETGKYLRLPQL--------VDMAAQIASGMAYV 379
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 380 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 437
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 438 YGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 495
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  ++  ERP   Y+   L++
Sbjct: 496 -----------------LMCQCWRKEPEERPTFEYLQAFLED 520

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 114/212 (53%), Gaps = 20/212 (9%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     R    E++ + KL H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 142 KI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-V 199
           ++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLYM 128
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVAG 258
             +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS     
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--IC 184
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 114/212 (53%), Gaps = 20/212 (9%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     R    E++ + KL H NIV
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 77
Query: 142 KI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-V 199
           ++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ +
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLYM 129
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVAG 258
             +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS     
Sbjct: 130 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--IC 185
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 186 SRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 217

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 20/215 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHR 138
           +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+L    +     L++EF+    L +++         D S       PL      ++
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLFQL 119
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           ++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR         + +V  
Sbjct: 120 LQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 172
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 173 TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTR 207

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 89  IIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILG-Y 146
           ++G G++G VY  + LS+ V +AIK++ +   +  +    E+     L+H+NIV+ LG +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
             +G  ++ + E V  GSL   L   S+   +  ++Q                + +  GL
Sbjct: 89  SENGFIKIFM-EQVPGGSLSALLR--SKWGPLKDNEQTIGF----------YTKQILEGL 135
Query: 207 AYLHGLEKPIIHRDIKSSNVLLDS-DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
            YLH  +  I+HRDIK  NVL+++      ISDFG ++R+   +    T   GT+ YM P
Sbjct: 136 KYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAP 192
Query: 266 EYL-GGNTAATVMLDVYSFGILMIEIATQIRP 296
           E +  G        D++S G  +IE+AT   P
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 114/212 (53%), Gaps = 20/212 (9%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     R    E++ + KL H NIV
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 84
Query: 142 KI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-V 199
           ++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ +
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLYM 136
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVAG 258
             +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS     
Sbjct: 137 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--IC 192
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 193 SRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 224

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 114/212 (53%), Gaps = 20/212 (9%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     R    E++ + KL H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 142 KI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-V 199
           ++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLYM 128
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVAG 258
             +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS     
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--IC 184
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 114/212 (53%), Gaps = 20/212 (9%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     R    E++ + KL H NIV
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 95
Query: 142 KI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-V 199
           ++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ +
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLYM 147
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVAG 258
             +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS     
Sbjct: 148 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--IC 203
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 204 SRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 235

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 114/212 (53%), Gaps = 20/212 (9%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     R    E++ + KL H NIV
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 89
Query: 142 KI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-V 199
           ++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ +
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLYM 141
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVAG 258
             +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS     
Sbjct: 142 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YIC 197
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 198 SRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 229

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 20/215 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHR 138
           +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+L    +     L++EF+    L +++         D S       PL      ++
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLFQL 112
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           ++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR         + +V  
Sbjct: 113 LQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 165
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 166 TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTR 200

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 116/213 (54%), Gaps = 22/213 (10%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFR-AEMETLGKLRHRNI 140
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     + F+  E++ + KL H NI
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 141 VKI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI- 198
           V++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLY 161
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVA 257
           +  +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS    
Sbjct: 162 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--I 217
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 250

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 114/212 (53%), Gaps = 20/212 (9%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     R    E++ + KL H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 142 KI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-V 199
           ++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLYM 128
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVAG 258
             +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS     
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YIC 184
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 114/212 (53%), Gaps = 20/212 (9%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     R    E++ + KL H NIV
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 88
Query: 142 KI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-V 199
           ++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ +
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLYM 140
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVAG 258
             +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS     
Sbjct: 141 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--IC 196
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 228

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 116/213 (54%), Gaps = 22/213 (10%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFR-AEMETLGKLRHRNI 140
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     + F+  E++ + KL H NI
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 141 VKI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI- 198
           V++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLY 161
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVA 257
           +  +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS    
Sbjct: 162 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YI 217
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 250

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 116/213 (54%), Gaps = 22/213 (10%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFR-AEMETLGKLRHRNI 140
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     + F+  E++ + KL H NI
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 141 VKI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI- 198
           V++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ 
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLY 139
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVA 257
           +  +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS    
Sbjct: 140 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--I 195
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 196 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 228

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 116/213 (54%), Gaps = 22/213 (10%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA-EMETLGKLRHRNI 140
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     + F+  E++ + KL H NI
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 103
Query: 141 VKI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI- 198
           V++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ 
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLY 155
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVA 257
           +  +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS    
Sbjct: 156 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YI 211
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 212 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 244

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 90  IGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVK 142
           +G GSFG VY+       K  +   VA+K +++ A    R EF  E   +      ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           +LG  + G   +++ E + +G L  +L       + +  +      P + +  +++   +
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP-----PPTLQEMIQMAAEI 138
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTMG 261
           A+G+AYL+   K  +HRD+ + N ++  DF   I DFG+ R I +T +     +    + 
Sbjct: 139 ADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           +M PE L  +   T   D++SFG+++ EI +
Sbjct: 197 WMAPESL-KDGVFTTSSDMWSFGVVLWEITS 226

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 77
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
              RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 78  LAFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 125
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 126 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHT 183
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 184 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 231

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 116/242 (47%), Gaps = 23/242 (9%)
Query: 59  LFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIK 112
           +F S+ F P   ++S  ++       +  + +G GSFG VY+       K  +   VA+K
Sbjct: 1   VFPSSVFVPDEWEVSREKI-------TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVK 53
Query: 113 KLDKDAFQGFR-EFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHD 171
            +++ A    R EF  E   +      ++V++LG  + G   +++ E + +G L  +L  
Sbjct: 54  TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
Query: 172 TSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD 231
                + +  +      P + +  +++   +A+G+AYL+   K  +HRD+ + N ++  D
Sbjct: 114 LRPEAENNPGRP-----PPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHD 166
Query: 232 FEAHISDFGLARRI-DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           F   I DFG+ R I +T       +    + +M PE L  +   T   D++SFG+++ EI
Sbjct: 167 FTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESL-KDGVFTTSSDMWSFGVVLWEI 225
Query: 291 AT 292
            +
Sbjct: 226 TS 227

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 116/213 (54%), Gaps = 22/213 (10%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFR-AEMETLGKLRHRNI 140
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     + F+  E++ + KL H NI
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 80
Query: 141 VKI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI- 198
           V++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ 
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLY 132
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVA 257
           +  +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS    
Sbjct: 133 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YI 188
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 189 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 221

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 116/213 (54%), Gaps = 22/213 (10%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFR-AEMETLGKLRHRNI 140
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     + F+  E++ + KL H NI
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 111
Query: 141 VKI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI- 198
           V++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ 
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLY 163
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVA 257
           +  +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS    
Sbjct: 164 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YI 219
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 220 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 252

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 20/215 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHR 138
           +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+L    +     L++EF+    L +++         D S       PL      ++
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLFQL 119
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           ++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR         + +V  
Sbjct: 120 LQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 172
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 173 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 207

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 114/212 (53%), Gaps = 20/212 (9%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     R    E++ + KL H NIV
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 80
Query: 142 KI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI-V 199
           ++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ +
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLYM 132
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVAG 258
             +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS     
Sbjct: 133 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--IC 188
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 189 SRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 220

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 89  IIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILG-Y 146
           ++G G++G VY  + LS+ V +AIK++ +   +  +    E+     L+H+NIV+ LG +
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
             +G  ++ + E V  GSL   L   S+   +  ++Q                + +  GL
Sbjct: 75  SENGFIKIFM-EQVPGGSLSALLR--SKWGPLKDNEQTIGF----------YTKQILEGL 121
Query: 207 AYLHGLEKPIIHRDIKSSNVLLDS-DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
            YLH  +  I+HRDIK  NVL+++      ISDFG ++R+   +    T   GT+ YM P
Sbjct: 122 KYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAP 178
Query: 266 EYL-GGNTAATVMLDVYSFGILMIEIATQIRP 296
           E +  G        D++S G  +IE+AT   P
Sbjct: 179 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 20/215 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHR 138
           +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+L    +     L++EF+    L +++         D S       PL      ++
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLFQL 111
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           ++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR         + +V  
Sbjct: 112 LQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 164
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLR 136
           + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L    +     L++EF+    L +++         D S       PL      
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLF 111
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR         + +V
Sbjct: 112 QLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 165
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
             T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 166 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 20/215 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHR 138
           +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+L    +     L++EF+    L +++         D S       PL      ++
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLFQL 112
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           ++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR         + +V  
Sbjct: 113 LQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 165
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 20/215 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHR 138
           +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+L    +     L++EF+    L +++         D S       PL      ++
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLFQL 111
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           ++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR         + +V  
Sbjct: 112 LQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 164
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 21/220 (9%)
Query: 77  LIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLG 133
           L+D  +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L 
Sbjct: 3   LVD-MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 134 KLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           +L H NIVK+L    +     L++EF+    L +++         D S       PL   
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKS 111
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
              ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR         +
Sbjct: 112 YLFQLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 165
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
            +V  T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 166 HEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 204

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 20/215 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHR 138
           +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+L    +     L++EF+    L +++         D S       PL      ++
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLFQL 112
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           ++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR         + +V  
Sbjct: 113 LQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 165
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + K+RH  +V++     S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYA-VVS 83
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L       ++    +L  L        V +   +A+G+AY+
Sbjct: 84  EEPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQL--------VDMAAQIASGMAYV 130
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 131 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 189 YGRF--TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  +   ERP   Y+   L++
Sbjct: 247 -----------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 114/256 (44%), Gaps = 53/256 (20%)
Query: 60  FDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF 119
            ++A+ +PSL            DN    ++IG G +G VYK  L     VA+K       
Sbjct: 1   MEAAASEPSLD----------LDNLKLLELIGRGRYGAVYKGSLDER-PVAVKVFSFANR 49
Query: 120 QGFREFRAEMETLGKLRHRNIVK-ILG---YCASG-LDRVLIYEFVENGSLDQWLHDTSR 174
           Q F   +  +  +  + H NI + I+G     A G ++ +L+ E+  NGSL ++L     
Sbjct: 50  QNFINEK-NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----- 103
Query: 175 NDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLH------GLEKPII-HRDIKSSNVL 227
                      SL    W +  ++   V  GLAYLH         KP I HRD+ S NVL
Sbjct: 104 -----------SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL 152
Query: 228 LDSDFEAHISDFGLARRIDTS-------HSHVSTQVAGTMGYMPPEYLGG------NTAA 274
           + +D    ISDFGL+ R+  +         + +    GT+ YM PE L G        +A
Sbjct: 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA 212
Query: 275 TVMLDVYSFGILMIEI 290
              +D+Y+ G++  EI
Sbjct: 213 LKQVDMYALGLIYWEI 228

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 112/241 (46%), Gaps = 27/241 (11%)
Query: 56  SIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKL 114
           ++AL  + SFD +          D  D +   + IG+G++G V  A+   +G  VAIKK+
Sbjct: 38  NLALLKARSFDVTF---------DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI 88
Query: 115 DK--DAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDT 172
               D     +    E++ L   +H NI+ I         + ++   V  G     ++  
Sbjct: 89  PNAFDVVTNAKRTLRELKILKHFKHDNIIAI---------KDILRPTVPYGEFKS-VYVV 138
Query: 173 SRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF 232
               + D  + ++S  PL+ E     +  +  GL Y+H  +  +IHRD+K SN+L++ + 
Sbjct: 139 LDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENC 196
Query: 233 EAHISDFGLARRIDTS---HSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
           E  I DFG+AR + TS   H +  T+   T  Y  PE +      T  +D++S G +  E
Sbjct: 197 ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGE 256
Query: 290 I 290
           +
Sbjct: 257 M 257

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 20/221 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D  +  K +G G+FG V +A      K ++  TVA+K L + A     E RA M  L  L
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 136 ----RHRNIVKILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL 190
                H N+V +LG C   G   ++I EF + G+L  +L  + RN+ V           L
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKDLYKDF--L 141
Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS 250
           + E  +     VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I     
Sbjct: 142 TLEHLIXYSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPD 199
Query: 251 HVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           +V    A   + +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 200 YVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEI 239

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D     K +G G+FG V +A      K ++  TVA+K L + A     E RA M  L  L
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 86
Query: 136 ----RHRNIVKILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP- 189
                H N+V +LG C   G   ++I EF + G+L  +L  + RN+ V   +    L   
Sbjct: 87  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKEAPEDLYKD 145
Query: 190 -LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
            L+ E  +     VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I   
Sbjct: 146 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 203
Query: 249 HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             +V    A   + +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 204 PDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEI 245

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 16/211 (7%)
Query: 90  IGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVK 142
           +G GSFG VY+       K  +   VA+K +++ A    R EF  E   +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           +LG  + G   +++ E + +G L  +L       + +  +      P + +  +++   +
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP-----PPTLQEMIQMAAEI 139
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTMG 261
           A+G+AYL+   K  +HRD+ + N ++  DF   I DFG+ R I +T       +    + 
Sbjct: 140 ADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           +M PE L  +   T   D++SFG+++ EI +
Sbjct: 198 WMAPESL-KDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 16/211 (7%)
Query: 90  IGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVK 142
           +G GSFG VY+       K  +   VA+K +++ A    R EF  E   +      ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           +LG  + G   +++ E + +G L  +L       + +  +      P + +  +++   +
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP-----PPTLQEMIQMAAEI 136
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTMG 261
           A+G+AYL+   K  +HRD+ + N ++  DF   I DFG+ R I +T       +    + 
Sbjct: 137 ADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           +M PE L  +   T   D++SFG+++ EI +
Sbjct: 195 WMAPESL-KDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 114/213 (53%), Gaps = 22/213 (10%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKK-LDKDAFQGFREFRAEMETLGKLRHRNI 140
           +++  K+IG+GSFG VY+AKL  SG  VAIKK L   AF+       E++ + KL H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----RELQIMRKLDHCNI 75
Query: 141 VKI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI- 198
           V++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLY 127
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVA 257
           +  +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS    
Sbjct: 128 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YI 183
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 116/213 (54%), Gaps = 22/213 (10%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFR-AEMETLGKLRHRNI 140
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     + F+  E++ + KL H NI
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 113
Query: 141 VKI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI- 198
           V++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ 
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLY 165
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVA 257
           +  +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS    
Sbjct: 166 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YI 221
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 222 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 254

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 122/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L       ++    +L  L        V +   +A+G+AY+
Sbjct: 84  EEPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQL--------VDMAAQIASGMAYV 130
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD+ ++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 131 ERMN--YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 189 YGRF--TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  +   ERP   Y+   L++
Sbjct: 247 -----------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 79
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 80  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 127
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 128 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
               +   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 186 GFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 233

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 20/221 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D  +  K +G G+FG V +A      K ++  TVA+K L + A     E RA M  L  L
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 136 ----RHRNIVKILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL 190
                H N+V +LG C   G   ++I EF + G+L  +L  + RN+ V           L
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKDLYKDF--L 141
Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS 250
           + E  +     VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I     
Sbjct: 142 TLEHLICYSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 199
Query: 251 HVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           +V    A   + +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 200 YVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEI 239

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 80
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+ I     + + R    E +++  + Q L +T      D  K L +   LS 
Sbjct: 81  LRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMET------DLYKLLKTQH-LSN 128
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 129 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 186
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
               +   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 187 GFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 234

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 114/213 (53%), Gaps = 22/213 (10%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKK-LDKDAFQGFREFRAEMETLGKLRHRNI 140
           +++  K+IG+GSFG VY+AKL  SG  VAIKK L   AF+       E++ + KL H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----RELQIMRKLDHCNI 75
Query: 141 VKI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI- 198
           V++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLY 127
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVA 257
           +  +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS    
Sbjct: 128 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YI 183
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 122/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  G L  +L       ++    +L  L        V +   +A+G+AY+
Sbjct: 84  EEPIYIVMEYMSKGCLLDFL-----KGEMGKYLRLPQL--------VDMAAQIASGMAYV 130
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 131 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 189 YGRF--TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  +   ERP   Y+   L++
Sbjct: 247 -----------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 114/273 (41%), Gaps = 35/273 (12%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           K +G G FG V   K      VAIK + K+      EF  E + +  L H  +V++ G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  +I E++ NG L  +L +         ++QL  +C           + V   + 
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQ---TQQLLEMC-----------KDVCEAME 119
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY 267
           YL    K  +HRD+ + N L++      +SDFGL+R +       S      + + PPE 
Sbjct: 120 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEV 177
Query: 268 LGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVD 327
           L  +  ++   D+++FG+LM EI +              +G + + R   +   E     
Sbjct: 178 LMYSKFSSKS-DIWAFGVLMWEIYS--------------LGKMPYERFTNSETAEHIAQG 222
Query: 328 SNISREELSEAGVREYFRIACMCTNEKSRERPA 360
             + R  L+   V   + I   C +EK+ ERP 
Sbjct: 223 LRLYRPHLASEKV---YTIMYSCWHEKADERPT 252

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 116/213 (54%), Gaps = 22/213 (10%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFR-AEMETLGKLRHRNI 140
           +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     + F+  E++ + KL H NI
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 154
Query: 141 VKI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI- 198
           V++   + +SG  +  +Y  +    + + ++  +R+     S+   +L P+ +   VK+ 
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTL-PVIY---VKLY 206
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVA 257
           +  +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS    
Sbjct: 207 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YI 262
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 263 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 295

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 20/219 (9%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGK 134
           + + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           L H NIVK+L    +     L++EF+    L +++         D S       PL    
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSY 111
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
             ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           
Sbjct: 112 LFQLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 165
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           +V  T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 166 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 27/242 (11%)
Query: 55  SSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKK 113
            ++AL  + SFD +          D  D +   + IG+G++G V  A+   +G  VAIKK
Sbjct: 36  KNLALLKARSFDVTF---------DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKK 86
Query: 114 LDK--DAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHD 171
           +    D     +    E++ L   +H NI+ I         + ++   V  G     ++ 
Sbjct: 87  IPNAFDVVTNAKRTLRELKILKHFKHDNIIAI---------KDILRPTVPYGEFKS-VYV 136
Query: 172 TSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD 231
                + D  + ++S  PL+ E     +  +  GL Y+H  +  +IHRD+K SN+L++ +
Sbjct: 137 VLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNEN 194
Query: 232 FEAHISDFGLARRIDTS---HSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMI 288
            E  I DFG+AR + TS   H +  T+   T  Y  PE +      T  +D++S G +  
Sbjct: 195 CELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFG 254
Query: 289 EI 290
           E+
Sbjct: 255 EM 256

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 20/219 (9%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGK 134
           + + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           L H NIVK+L    +     L++EF+    L +++         D S       PL    
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSY 112
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
             ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           
Sbjct: 113 LFQLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 166
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           +V  T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 167 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 204

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 27/212 (12%)
Query: 84  FSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVK 142
           F   + +G+GS+G VYKA    +G  VAIK++  ++    +E   E+  + +    ++VK
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVK 88
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
             G      D  ++ E+   GS+   +   ++               L+ +    I++  
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--------------LTEDEIATILQST 134
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
             GL YLH + K  IHRDIK+ N+LL+++  A ++DFG+A ++ T        V GT  +
Sbjct: 135 LKGLEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVAGQL-TDXMAKRNXVIGTPFW 191
Query: 263 MPPEY---LGGNTAATVMLDVYSFGILMIEIA 291
           M PE    +G N  A    D++S GI  IE+A
Sbjct: 192 MAPEVIQEIGYNCVA----DIWSLGITAIEMA 219

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 122/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  G L  +L       ++    +L  L        V +   +A+G+AY+
Sbjct: 84  EEPIYIVTEYMSKGCLLDFL-----KGEMGKYLRLPQL--------VDMAAQIASGMAYV 130
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGLAR I+ +           + +  PE  L
Sbjct: 131 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 189 YGRF--TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  +   ERP   Y+   L++
Sbjct: 247 -----------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLR 136
           + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L    +     L++EF+    L +++         D S       PL      
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLF 110
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V
Sbjct: 111 QLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 164
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
             T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 165 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           IG+GS G V  A+   SG  VA+K +D    Q       E+  +   +H N+V++     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
            G +  ++ EF++ G+L   +     N++     Q+ ++C             V   LAY
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEE-----QIATVC-----------EAVLQALAY 156
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL 268
           LH   + +IHRDIKS ++LL  D    +SDFG   +I          + GT  +M PE +
Sbjct: 157 LHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKXLVGTPYWMAPEVI 213
Query: 269 GGNTAATVMLDVYSFGILMIEIA 291
             +  AT  +D++S GI++IE+ 
Sbjct: 214 SRSLYAT-EVDIWSLGIMVIEMV 235

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLR 136
           + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L    +     L++EF+    L +++         D S       PL      
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLF 112
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V
Sbjct: 113 QLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 166
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
             T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 167 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLR 136
           + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L    +     L++EF+    L +++         D S       PL      
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLF 110
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V
Sbjct: 111 QLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 164
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
             T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 165 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHR 138
           +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+L    +     L++EF+    L +++         D S       PL      ++
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLFQL 111
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           ++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V  
Sbjct: 112 LQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 164
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 20/219 (9%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGK 134
           + + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           L H NIVK+L    +     L++EF+   S+D           +D S       PL    
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL---SMDL-------KKFMDASALTGIPLPLIKSY 111
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
             ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           
Sbjct: 112 LFQLLQG----LAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH 165
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           +V  T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 166 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLR 136
           + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L    +     L++EF+    L +++         D S       PL      
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLF 112
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V
Sbjct: 113 QLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 166
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
             T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 167 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLR 136
           + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L    +     L++EF+    L +++         D S       PL      
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLF 110
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V
Sbjct: 111 QLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 164
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
             T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 165 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLR 136
           + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L    +     L++EF+    L +++         D S       PL      
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLF 112
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V
Sbjct: 113 QLLQG----LAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV 166
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
             T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 167 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLR 136
           + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L    +     L++EF+    L +++         D S       PL      
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLF 111
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V
Sbjct: 112 QLLQG----LAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV 165
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
             T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 166 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLR 136
           + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L    +     L++EF+    L +++         D S       PL      
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLF 113
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V
Sbjct: 114 QLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 167
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
             T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 168 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHR 138
           +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+L    +     L++EF+    L +++         D S       PL      ++
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLFQL 111
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           ++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V  
Sbjct: 112 LQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 164
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 111/238 (46%), Gaps = 21/238 (8%)
Query: 67  PSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVT-VAIKKLDKDAFQGF--R 123
           P   ++   +  D    ++  + IG+G++G V  A      T VAIKK+     Q +  R
Sbjct: 28  PGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQR 87
Query: 124 EFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQ 183
             R E++ L + RH N++ I       + R    E + +  + Q L +T      D  K 
Sbjct: 88  TLR-EIQILLRFRHENVIGI-----RDILRASTLEAMRDVYIVQDLMET------DLYKL 135
Query: 184 LNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR 243
           L S   LS +     +  +  GL Y+H     ++HRD+K SN+L+++  +  I DFGLAR
Sbjct: 136 LKSQ-QLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLINTTCDLKICDFGLAR 192
Query: 244 RIDTSHSHVS--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
             D  H H    T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 193 IADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 249

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLR 136
           + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L    +     L++EF+    L +++         D S       PL      
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLF 110
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V
Sbjct: 111 QLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 164
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
             T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 165 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLR 136
           + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L    +     L++EF+    L +++         D S       PL      
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLF 111
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V
Sbjct: 112 QLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 165
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
             T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 166 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D     K +G G+FG V +A      K ++  TVA+K L + A     E RA M  L  L
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS--EHRALMSELKIL 86
Query: 136 ----RHRNIVKILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL 190
                H N+V +LG C   G   ++I EF + G+L  +L  + RN+ V    +      L
Sbjct: 87  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKPEDLYKDFL 145
Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS 250
           + E  +     VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I     
Sbjct: 146 TLEHLIXYSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 251 HVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            V    A   + +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 204 XVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEI 243

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           DNF     IG+GS G V  A + SSG  VA+KK+D    Q       E+  +   +H N+
Sbjct: 32  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V++      G +  ++ EF+E G+L   +  T  N++     Q+ ++C            
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----QIAAVC-----------L 132
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            V   L+ LH   + +IHRDIKS ++LL  D    +SDFG   ++          + GT 
Sbjct: 133 AVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTP 189
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +M PE +         +D++S GI++IE+
Sbjct: 190 YWMAPELI-SRLPYGPEVDIWSLGIMVIEM 218

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHR 138
           +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+L    +     L++EF+    L +++         D S       PL      ++
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLFQL 113
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           ++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V  
Sbjct: 114 LQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 166
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 167 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           DNF     IG+GS G V  A + SSG  VA+KK+D    Q       E+  +   +H N+
Sbjct: 34  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V++      G +  ++ EF+E G+L   +  T  N++     Q+ ++C            
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----QIAAVC-----------L 134
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            V   L+ LH   + +IHRDIKS ++LL  D    +SDFG   ++          + GT 
Sbjct: 135 AVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTP 191
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +M PE +         +D++S GI++IE+
Sbjct: 192 YWMAPELI-SRLPYGPEVDIWSLGIMVIEM 220

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLR 136
           + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L    +     L++EF+   S+D           +D S       PL      
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDL-------KKFMDASALTGIPLPLIKSYLF 111
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V
Sbjct: 112 QLLQG----LAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV 165
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
             T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 166 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLR 136
           + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L    +     L++EF         LH   +   +D S       PL      
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKTF-MDASALTGIPLPLIKSYLF 113
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V
Sbjct: 114 QLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 167
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
             T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 168 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 41/226 (18%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +F   ++IG G FG V+KAK    G T  IK++  +  +  RE +A    L KL H NIV
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKA----LAKLDHVNIV 67
Query: 142 KILGYCASGLDR-----------------VLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
              G C  G D                   +  EF + G+L+QW+ +  R + +D    L
Sbjct: 68  HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR 244
                       ++   +  G+ Y+H   K +I+RD+K SN+ L    +  I DFGL   
Sbjct: 126 ------------ELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 245 IDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           +        ++  GT+ YM PE +         +D+Y+ G+++ E+
Sbjct: 172 LKNDGKRXRSK--GTLRYMSPEQISSQDYGK-EVDLYALGLILAEL 214

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGF--REFRAEMETL 132
           ++ D    ++    IG+G++G V  A  + + V VAIKK+     Q +  R  R E++ L
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 95
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            + RH NI+        G++ ++    +E    D +L       D+    +L     LS 
Sbjct: 96  LRFRHENII--------GINDIIRAPTIEQMK-DVYLVTHLMGADL---YKLLKTQHLSN 143
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +     +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H 
Sbjct: 144 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 201
Query: 253 S--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              T+   T  Y  PE +  +   T  +D++S G ++ E+ +  RP  P
Sbjct: 202 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 249

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 122/282 (43%), Gaps = 37/282 (13%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS 149
           +G G FG V+    +    VAIK L K        F  E + + KLRH  +V++     S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 250
Query: 150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
                ++ E++  GSL  +L       ++    +L  L        V +   +A+G+AY+
Sbjct: 251 EEPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQL--------VDMAAQIASGMAYV 297
Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE-YL 268
             +    +HRD++++N+L+  +    ++DFGL R I+ +           + +  PE  L
Sbjct: 298 ERMN--YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAAL 355
Query: 269 GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDS 328
            G    T+  DV+SFGIL+ E+ T+ R   P +++ + +  +E    M    +  E +  
Sbjct: 356 YGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 413
Query: 329 NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                            + C C  +   ERP   Y+   L++
Sbjct: 414 -----------------LMCQCWRKDPEERPTFEYLQAFLED 438

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 106/223 (47%), Gaps = 20/223 (8%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D     K +G G+FG V +A      K ++  TVA+K L + A     E RA M  L  L
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 75
Query: 136 ----RHRNIVKILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP- 189
                H N+V +LG C   G   ++I EF + G+L  +L  + RN+ V        L   
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKD 134
Query: 190 -LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
            L+ E  +     VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I   
Sbjct: 135 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 192
Query: 249 HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             +V    A   + +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 193 PDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEI 234

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 106/223 (47%), Gaps = 20/223 (8%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D     K +G G+FG V +A      K ++  TVA+K L + A     E RA M  L  L
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 136 ----RHRNIVKILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP- 189
                H N+V +LG C   G   ++I EF + G+L  +L  + RN+ V        L   
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKD 143
Query: 190 -LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
            L+ E  +     VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I   
Sbjct: 144 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 249 HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             +V    A   + +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 202 PDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEI 243

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           DNF     IG+GS G V  A + SSG  VA+KK+D    Q       E+  +   +H N+
Sbjct: 23  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V++      G +  ++ EF+E G+L   +  T  N++     Q+ ++C            
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----QIAAVC-----------L 123
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            V   L+ LH   + +IHRDIKS ++LL  D    +SDFG   ++          + GT 
Sbjct: 124 AVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTP 180
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +M PE +         +D++S GI++IE+
Sbjct: 181 YWMAPELI-SRLPYGPEVDIWSLGIMVIEM 209

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 106/223 (47%), Gaps = 20/223 (8%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D     K +G G+FG V +A      K ++  TVA+K L + A     E RA M  L  L
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 121
Query: 136 ----RHRNIVKILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP- 189
                H N+V +LG C   G   ++I EF + G+L  +L  + RN+ V        L   
Sbjct: 122 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKD 180
Query: 190 -LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
            L+ E  +     VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I   
Sbjct: 181 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 238
Query: 249 HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             +V    A   + +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 239 PDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEI 280

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 22/213 (10%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKK-LDKDAFQGFREFRAEMETLGKLRHRNI 140
           +++  K+IG+GSFG VY+AKL  SG  VAIKK L   AF+       E++ + KL H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----RELQIMRKLDHCNI 75
Query: 141 VKI-LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI- 198
           V++   + +SG  +  +Y  +    +   ++  +R+     S+   +L P+ +   VK+ 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARH----YSRAKQTL-PVIY---VKLY 127
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQVA 257
           +  +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS    
Sbjct: 128 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--I 183
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +  Y  PE + G T  T  +DV+S G ++ E+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           DNF     IG+GS G V  A + SSG  VA+KK+D    Q       E+  +   +H N+
Sbjct: 27  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V++      G +  ++ EF+E G+L   +  T  N++     Q+ ++C            
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----QIAAVC-----------L 127
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            V   L+ LH   + +IHRDIKS ++LL  D    +SDFG   ++          + GT 
Sbjct: 128 AVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTP 184
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +M PE +         +D++S GI++IE+
Sbjct: 185 YWMAPELI-SRLPYGPEVDIWSLGIMVIEM 213

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 20/215 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHR 138
           +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+L    +     L++EF+    L +++         D S       PL      ++
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLFQL 112
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           ++G    L++ H     ++HRD+K  N+L++++    ++DFGLAR         + +V  
Sbjct: 113 LQG----LSFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 165
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 106/223 (47%), Gaps = 20/223 (8%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D     K +G G+FG V +A      K ++  TVA+K L + A     E RA M  L  L
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 75
Query: 136 ----RHRNIVKILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP- 189
                H N+V +LG C   G   ++I EF + G+L  +L  + RN+ V        L   
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKD 134
Query: 190 -LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
            L+ E  +     VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I   
Sbjct: 135 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 192
Query: 249 HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             +V    A   + +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 193 PDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEI 234

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 90  IGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVK 142
           +G GSFG VY+       K  +   VA+K +++ A    R EF  E   +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           +LG  + G   +++ E + +G L  +L       + +  +      P + +  +++   +
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP-----PPTLQEMIQMAAEI 139
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTMG 261
           A+G+AYL+   K  +HR++ + N ++  DF   I DFG+ R I +T +     +    + 
Sbjct: 140 ADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           +M PE L  +   T   D++SFG+++ EI +
Sbjct: 198 WMAPESL-KDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 90  IGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVK 142
           +G GSFG VY+       K  +   VA+K +++ A    R EF  E   +      ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           +LG  + G   +++ E + +G L  +L       + +  +      P + +  +++   +
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP-----PPTLQEMIQMAAEI 140
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTMG 261
           A+G+AYL+   K  +HR++ + N ++  DF   I DFG+ R I +T +     +    + 
Sbjct: 141 ADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           +M PE L  +   T   D++SFG+++ EI +
Sbjct: 199 WMAPESL-KDGVFTTSSDMWSFGVVLWEITS 228

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 23/202 (11%)
Query: 90  IGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFR---EFRAEMETLGKLRHRNIVKILG 145
           +G G+FG V   K   +G  VA+K L++   +      + R E++ L   RH +I+K+  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
             ++  D  ++ E+V  G L  ++    R D+               E+R ++ + + +G
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEK--------------ESR-RLFQQILSG 128
Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
           + Y H     ++HRD+K  NVLLD+   A I+DFGL+  +  S         G+  Y  P
Sbjct: 129 VDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRXSCGSPNYAAP 184
Query: 266 EYLGGNTAATVMLDVYSFGILM 287
           E + G   A   +D++S G+++
Sbjct: 185 EVISGRLYAGPEVDIWSSGVIL 206

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLR 136
           + +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L    +     L++E V          D      +D S       PL      
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV----------DQDLKKFMDASALTGIPLPLIKSYLF 113
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR           +V
Sbjct: 114 QLLQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV 167
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
             T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 168 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 24/233 (10%)
Query: 72  ISMSELIDATDNFSTDKIIGDGSFGFVYK-AKLSSGVTVAIKKLDKDAFQGFR-EFRAEM 129
           +++ EL D  D+F     +G G+ G V+K +   SG+ +A K +  +     R +   E+
Sbjct: 1   MALGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL 58
Query: 130 ETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP 189
           + L +     IV   G   S  +  +  E ++ GSLDQ L    R               
Sbjct: 59  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--------------- 103
Query: 190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSH 249
           +  +   K+   V  GL YL    K I+HRD+K SN+L++S  E  + DFG++ ++    
Sbjct: 104 IPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--- 159
Query: 250 SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVL 302
             ++ +  GT  YM PE L G T  +V  D++S G+ ++E+A    P  P+ +
Sbjct: 160 DEMANEFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPRPPMAI 211

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D     K +G G+FG V +A      K ++  TVA+K L + A     E RA M  L  L
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 75
Query: 136 ----RHRNIVKILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP- 189
                H N+V +LG C   G   ++I EF + G+L  +L  + RN+ V        L   
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKD 134
Query: 190 -LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
            L+ E  +     VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I   
Sbjct: 135 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 192
Query: 249 HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
              V    A   + +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 193 PDXVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEI 234

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D     K +G G+FG V +A      K ++  TVA+K L + A     E RA M  L  L
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 136 ----RHRNIVKILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP- 189
                H N+V +LG C   G   ++I EF + G+L  +L  + RN+ V        L   
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKD 143
Query: 190 -LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
            L+ E  +     VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I   
Sbjct: 144 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201
Query: 249 HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
              V    A   + +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 202 PDXVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEI 243

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 117/251 (46%), Gaps = 32/251 (12%)
Query: 59  LFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKL 114
           + DS      L +  + +++     F+  +++G G FG V +A+L     S V VA+K L
Sbjct: 1   MLDSLGISDELKE-KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML 59
Query: 115 DKD--AFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDR------VLIYEFVENGSLD 166
             D  A     EF  E   + +  H ++ K++G       +      ++I  F+++G L 
Sbjct: 60  KADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLH 119
Query: 167 QWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV 226
            +L   SR     G    N    L  +T V+ +  +A G+ YL    +  IHRD+ + N 
Sbjct: 120 AFLL-ASRI----GENPFN----LPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNC 168
Query: 227 LLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAA----TVMLDVYS 282
           +L  D    ++DFGL+R+I +   +      G    +P ++L   + A    TV  DV++
Sbjct: 169 MLAEDMTVCVADFGLSRKIYSGDYYRQ----GCASKLPVKWLALESLADNLYTVHSDVWA 224
Query: 283 FGILMIEIATQ 293
           FG+ M EI T+
Sbjct: 225 FGVTMWEIMTR 235

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 129/295 (43%), Gaps = 34/295 (11%)
Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKL---DKDAFQGFREFRAEMETLGKLRHR 138
           NF  +K IG G F  VY+A  L  GV VA+KK+   D    +   +   E++ L +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N++K         +  ++ E  + G L + +    +   +   + +       W+  V++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-------WKYFVQL 145
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
                + L ++H   + ++HRDIK +NV + +     + D GL R   +S +  +  + G
Sbjct: 146 ----CSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVG 198
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA 318
           T  YM PE +  N       D++S G L+ E+A    P       G ++ L    + +E 
Sbjct: 199 TPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSP-----FYGDKMNLYSLCKKIE- 251
Query: 319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA 373
              +   + S+   EEL +        +  MC N    +RP ++YV  +   + A
Sbjct: 252 -QCDYPPLPSDHYSEELRQ--------LVNMCINPDPEKRPDVTYVYDVAKRMHA 297

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           DNF     IG+GS G V  A + SSG  VA+KK+D    Q       E+  +   +H N+
Sbjct: 154 DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V++      G +  ++ EF+E G+L   +  T  N++     Q+ ++C            
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----QIAAVC-----------L 254
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            V   L+ LH   + +IHRDIKS ++LL  D    +SDFG   ++ +        + GT 
Sbjct: 255 AVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKXLVGTP 311
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +M PE +         +D++S GI++IE+
Sbjct: 312 YWMAPELI-SRLPYGPEVDIWSLGIMVIEM 340

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D     K +G G+FG V +A      K ++  TVA+K L + A     E RA M  L  L
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 75
Query: 136 ----RHRNIVKILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP- 189
                H N+V +LG C   G   ++I EF + G+L  +L  + RN+ V        L   
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKD 134
Query: 190 -LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
            L+ E  +     VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I   
Sbjct: 135 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 192
Query: 249 HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
              V    A   + +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 193 PDXVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEI 234

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           DNF     IG+GS G V  A + SSG  VA+KK+D    Q       E+  +   +H N+
Sbjct: 77  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V++      G +  ++ EF+E G+L   +  T  N++     Q+ ++C            
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----QIAAVC-----------L 177
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            V   L+ LH   + +IHRDIKS ++LL  D    +SDFG   ++          + GT 
Sbjct: 178 AVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTP 234
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +M PE +         +D++S GI++IE+
Sbjct: 235 YWMAPELI-SRLPYGPEVDIWSLGIMVIEM 263

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 118/265 (44%), Gaps = 32/265 (12%)
Query: 52  SDLSSIAL-----FDSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL-- 103
           SD+SS  L      D ++ +P L Q     +I  +      +++IG G FG VY   L  
Sbjct: 12  SDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLD 71
Query: 104 --SSGVTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEF 159
                +  A+K L++    G   +F  E   +    H N++ +LG C  S    +++  +
Sbjct: 72  NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 131
Query: 160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHR 219
           +++G L  ++ + + N  V              +  +     VA G+ YL    K  +HR
Sbjct: 132 MKHGDLRNFIRNETHNPTV--------------KDLIGFGLQVAKGMKYL--ASKKFVHR 175
Query: 220 DIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTM--GYMPPEYLGGNTAATV 276
           D+ + N +LD  F   ++DFGLAR + D  +  V  +    +   +M  E L      T 
Sbjct: 176 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL-QTQKFTT 234
Query: 277 MLDVYSFGILMIEIATQIRPNLPVV 301
             DV+SFG+L+ E+ T+  P  P V
Sbjct: 235 KSDVWSFGVLLWELMTRGAPPYPDV 259

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHR 138
           +NF   + IG+G++G VYKA+   +G  VA+ K+  D         A  E+  L +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+L    +     L++EF+    L +++         D S       PL      ++
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLFQL 112
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           ++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR         + +V  
Sbjct: 113 LQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 165
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHR 138
           +NF   + IG+G++G VYKA+   +G  VA+ K+  D         A  E+  L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+L    +     L++EF+    L +++         D S       PL      ++
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---------DASALTGIPLPLIKSYLFQL 111
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           ++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR         + +V  
Sbjct: 112 LQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 164
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 104/226 (46%), Gaps = 44/226 (19%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKL-DKDAFQGFREFRAEMETLGKLRHRNIVKILGY 146
           K IG G +G V+  K   G  VA+K     +    FRE       L  +RH NI   LG+
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVL--MRHENI---LGF 96
Query: 147 CASGLDRV-------LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
            A+ +          LI ++ ENGSL  +L  T+                L  ++ +K+ 
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----------------LDAKSMLKLA 140
Query: 200 RGVANGLAYLHG-----LEKPII-HRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSH 251
               +GL +LH        KP I HRD+KS N+L+  +    I+D GLA +   DT+   
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 252 VSTQV-AGTMGYMPPEYLG-----GNTAATVMLDVYSFGILMIEIA 291
           +      GT  YMPPE L       +  + +M D+YSFG+++ E+A
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D     K +G G+FG V +A      K ++  TVA+K L + A     E RA M  L  L
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 136 ----RHRNIVKILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP- 189
                H N+V +LG C   G   ++I EF + G+L  +L  + RN+ V        L   
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKD 143
Query: 190 -LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
            L+ E  +     VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I   
Sbjct: 144 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 249 HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
              V    A   + +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 202 PDXVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEI 243

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 108/215 (50%), Gaps = 31/215 (14%)
Query: 88  KIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKD-AFQGFREFRAEMETLGKLRHRNIV 141
           K++G G+FG VYK        +  + VAIK L++    +   EF  E   +  + H ++V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++LG C S   + L+ + + +G L +++H+   + D  GS+ L     L+W  ++     
Sbjct: 104 RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHE---HKDNIGSQLL-----LNWCVQI----- 149
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
            A G+ YL   E+ ++HRD+ + NVL+ S     I+DFGLAR ++      +       G
Sbjct: 150 -AKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD----GG 202
Query: 262 YMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
            MP +++          T   DV+S+G+ + E+ T
Sbjct: 203 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA--EMETLGKLRHR 138
           +NF   + IG+G++G VYKA+   +G  VA+KK+  D         A  E+  L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+L    +     L++E V                 +D S       PL      ++
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQ----------DLKTFMDASALTGIPLPLIKSYLFQL 111
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           ++G    LA+ H     ++HRD+K  N+L++++    ++DFGLAR         + +V  
Sbjct: 112 LQG----LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 164
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           T+ Y  PE L G    +  +D++S G +  E+ T+
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 54/239 (22%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +F   ++IG G FG V+KAK    G T  I+++  +  +  RE +A    L KL H NIV
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKA----LAKLDHVNIV 68
Query: 142 KILGYCASGLDR------------------------------VLIYEFVENGSLDQWLHD 171
              G C  G D                                +  EF + G+L+QW+ +
Sbjct: 69  HYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-E 126
Query: 172 TSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD 231
             R + +D    L            ++   +  G+ Y+H   K +IHRD+K SN+ L   
Sbjct: 127 KRRGEKLDKVLAL------------ELFEQITKGVDYIHS--KKLIHRDLKPSNIFLVDT 172
Query: 232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +  I DFGL   +        T+  GT+ YM PE +         +D+Y+ G+++ E+
Sbjct: 173 KQVKIGDFGLVTSLKNDGKR--TRSKGTLRYMSPEQISSQDYGK-EVDLYALGLILAEL 228

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           IG+GS G V  A +  +G  VA+KK+D    Q       E+  +    H N+V +     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY 208
            G +  ++ EF+E G+L   +  T  N++     Q+ ++C LS          V   L+Y
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTRMNEE-----QIATVC-LS----------VLRALSY 156
Query: 209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL 268
           LH   + +IHRDIKS ++LL SD    +SDFG   ++ +        + GT  +M PE +
Sbjct: 157 LHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV-SKEVPKRKXLVGTPYWMAPEVI 213
Query: 269 GGNTAATVMLDVYSFGILMIEI 290
                 T  +D++S GI++IE+
Sbjct: 214 SRLPYGT-EVDIWSLGIMVIEM 234

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 113/239 (47%), Gaps = 26/239 (10%)
Query: 74  MSELIDATDNFSTDKIIGDGSFGFVYK-AKLSSGVTVAIKKLDKDAFQGFR-EFRAEMET 131
           + EL D  D+F     +G G+ G V+K +   SG+ +A K +  +     R +   E++ 
Sbjct: 62  VGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 119
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           L +     IV   G   S  +  +  E ++ GSLDQ L    R               + 
Sbjct: 120 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------------IP 164
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
            +   K+   V  GL YL    K I+HRD+K SN+L++S  E  + DFG++ ++  S   
Sbjct: 165 EQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 220
Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL 310
           ++    GT  YM PE L G T  +V  D++S G+ ++E+A    P  P   D +E+ L+
Sbjct: 221 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPP--DAKELELM 276

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 110/234 (47%), Gaps = 52/234 (22%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G V++     G  VA+K    +D    FRE   E+     LRH NI   LG+ A
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENI---LGFIA 69
Query: 149 SGLDR-------VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           S +          LI  + E GSL  +L             QL +L  +S    ++IV  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL-------------QLTTLDTVS---CLRIVLS 113
Query: 202 VANGLAYLH----GLE-KPII-HRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +A+GLA+LH    G + KP I HRD+KS N+L+  + +  I+D GLA      HS  + Q
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA----VMHSQSTNQ 169
Query: 256 V-------AGTMGYMPPEYLGGNTAATVM-----LDVYSFGILMIEIATQIRPN 297
           +        GT  YM PE L              +D+++FG+++ E+A ++  N
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 110/234 (47%), Gaps = 52/234 (22%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G +G V++     G  VA+K    +D    FRE   E+     LRH NI   LG+ A
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENI---LGFIA 69
Query: 149 SGLDR-------VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           S +          LI  + E GSL  +L             QL +L  +S    ++IV  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL-------------QLTTLDTVS---CLRIVLS 113
Query: 202 VANGLAYLH----GLE-KPII-HRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +A+GLA+LH    G + KP I HRD+KS N+L+  + +  I+D GLA      HS  + Q
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA----VMHSQSTNQ 169
Query: 256 V-------AGTMGYMPPEYLGGNTAATVM-----LDVYSFGILMIEIATQIRPN 297
           +        GT  YM PE L              +D+++FG+++ E+A ++  N
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 106/223 (47%), Gaps = 21/223 (9%)
Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
           D  +  K +G G+FG V +A      K ++  TVA+K L + A     E RA M  L  L
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 85
Query: 136 ----RHRNIVKILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP- 189
                H N+V +LG C   G   ++I EF + G+L  +L   S+ ++    K    L   
Sbjct: 86  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR--SKRNEFVPYKTPEDLYKD 143
Query: 190 -LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
            L+ E  +     VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I   
Sbjct: 144 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201
Query: 249 HSHVSTQVAG-TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
              V    A   + +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 202 PDXVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEI 243

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 111/251 (44%), Gaps = 27/251 (10%)
Query: 61  DSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL----SSGVTVAIKKLD 115
           D ++ +P L Q     +I  +      +++IG G FG VY   L       +  A+K L+
Sbjct: 7   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 66
Query: 116 KDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLHDTS 173
           +    G   +F  E   +    H N++ +LG C  S    +++  ++++G L  ++ + +
Sbjct: 67  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 126
Query: 174 RNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
            N  V              +  +     VA G+ YL    K  +HRD+ + N +LD  F 
Sbjct: 127 HNPTV--------------KDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFT 170
Query: 234 AHISDFGLARRI---DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             ++DFGLAR +   +    H  T     + +M  E L      T   DV+SFG+L+ E+
Sbjct: 171 VKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWEL 229
Query: 291 ATQIRPNLPVV 301
            T+  P  P V
Sbjct: 230 MTRGAPPYPDV 240

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 114/258 (44%), Gaps = 27/258 (10%)
Query: 54  LSSIALFDSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL----SSGVT 108
           L +    D ++ +P L Q     +I  +      +++IG G FG VY   L       + 
Sbjct: 20  LQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 79
Query: 109 VAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVENGSLD 166
            A+K L++    G   +F  E   +    H N++ +LG C  S    +++  ++++G L 
Sbjct: 80  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 139
Query: 167 QWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV 226
            ++ + + N  V              +  +     VA G+ YL    K  +HRD+ + N 
Sbjct: 140 NFIRNETHNPTV--------------KDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNC 183
Query: 227 LLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGTM--GYMPPEYLGGNTAATVMLDVYSF 283
           +LD  F   ++DFGLAR + D  +  V  +    +   +M  E L      T   DV+SF
Sbjct: 184 MLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSF 242
Query: 284 GILMIEIATQIRPNLPVV 301
           G+L+ E+ T+  P  P V
Sbjct: 243 GVLLWELMTRGAPPYPDV 260

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 27/251 (10%)
Query: 61  DSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL----SSGVTVAIKKLD 115
           D ++ +P L Q     +I  +      +++IG G FG VY   L       +  A+K L+
Sbjct: 8   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 67
Query: 116 KDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLHDTS 173
           +    G   +F  E   +    H N++ +LG C  S    +++  ++++G L  ++ + +
Sbjct: 68  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 127
Query: 174 RNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
            N  V              +  +     VA G+ YL    K  +HRD+ + N +LD  F 
Sbjct: 128 HNPTV--------------KDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFT 171
Query: 234 AHISDFGLARRI-DTSHSHVSTQVAGTM--GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             ++DFGLAR + D  +  V  +    +   +M  E L      T   DV+SFG+L+ E+
Sbjct: 172 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWEL 230
Query: 291 ATQIRPNLPVV 301
            T+  P  P V
Sbjct: 231 MTRGAPPYPDV 241

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 31/215 (14%)
Query: 88  KIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKD-AFQGFREFRAEMETLGKLRHRNIV 141
           K++G G+FG VYK        +  + VAIK L++    +   EF  E   +  + H ++V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++LG C S   + L+ + + +G L +++H+   N    GS+ L     L+W  ++     
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNI---GSQLL-----LNWCVQI----- 126
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
            A G+ YL   E+ ++HRD+ + NVL+ S     I+DFGLAR ++      +       G
Sbjct: 127 -AKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD----GG 179
Query: 262 YMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
            MP +++          T   DV+S+G+ + E+ T
Sbjct: 180 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRN 139
           D F   + +G G+FG V+  +  SSG+   IK ++KD  Q    +  AE+E L  L H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 140 IVKILGYCASGLDRVLIYEFVENGS-LDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           I+KI        +  ++ E  E G  L++ +   +R               LS     ++
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK------------ALSEGYVAEL 129
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH----ISDFGLARRIDTSHSHVST 254
           ++ + N LAY H   + ++H+D+K  N+L   D   H    I DFGLA    +     ST
Sbjct: 130 MKQMMNALAYFHS--QHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEH--ST 184
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             AGT  YM PE    +   T   D++S G++M  + T   P
Sbjct: 185 NAAGTALYMAPEVFKRDV--TFKCDIWSAGVVMYFLLTGCLP 224

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 24/231 (10%)
Query: 82  DNFSTDKIIGDGSFGFVYK-AKLSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRN 139
           D+F     +G G+ G V+K +   SG+ +A K +  +     R +   E++ L +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IV   G   S  +  +  E ++ GSLDQ L    R               +  +   K+ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------------IPEQILGKVS 110
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             V  GL YL    K I+HRD+K SN+L++S  E  + DFG++ ++  S   ++    GT
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGT 166
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL 310
             YM PE L G T  +V  D++S G+ ++E+A    P  P   D +E+ L+
Sbjct: 167 RSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPP--DAKELELM 214

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 27/251 (10%)
Query: 61  DSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL----SSGVTVAIKKLD 115
           D ++ +P L Q     +I  +      +++IG G FG VY   L       +  A+K L+
Sbjct: 8   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 67
Query: 116 KDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLHDTS 173
           +    G   +F  E   +    H N++ +LG C  S    +++  ++++G L  ++ + +
Sbjct: 68  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 127
Query: 174 RNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
            N  V              +  +     VA G+ YL    K  +HRD+ + N +LD  F 
Sbjct: 128 HNPTV--------------KDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFT 171
Query: 234 AHISDFGLARRI-DTSHSHVSTQVAGTM--GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             ++DFGLAR + D  +  V  +    +   +M  E L      T   DV+SFG+L+ E+
Sbjct: 172 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWEL 230
Query: 291 ATQIRPNLPVV 301
            T+  P  P V
Sbjct: 231 MTRGAPPYPDV 241

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 27/251 (10%)
Query: 61  DSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL----SSGVTVAIKKLD 115
           D ++ +P L Q     +I  +      +++IG G FG VY   L       +  A+K L+
Sbjct: 5   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 116 KDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLHDTS 173
           +    G   +F  E   +    H N++ +LG C  S    +++  ++++G L  ++ + +
Sbjct: 65  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124
Query: 174 RNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
            N  V              +  +     VA G+ YL    K  +HRD+ + N +LD  F 
Sbjct: 125 HNPTV--------------KDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFT 168
Query: 234 AHISDFGLARRI-DTSHSHVSTQVAGTM--GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             ++DFGLAR + D  +  V  +    +   +M  E L      T   DV+SFG+L+ E+
Sbjct: 169 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWEL 227
Query: 291 ATQIRPNLPVV 301
            T+  P  P V
Sbjct: 228 MTRGAPPYPDV 238

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 27/251 (10%)
Query: 61  DSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL----SSGVTVAIKKLD 115
           D ++ +P L Q     +I  +      +++IG G FG VY   L       +  A+K L+
Sbjct: 7   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 66
Query: 116 KDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLHDTS 173
           +    G   +F  E   +    H N++ +LG C  S    +++  ++++G L  ++ + +
Sbjct: 67  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 126
Query: 174 RNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
            N  V              +  +     VA G+ YL    K  +HRD+ + N +LD  F 
Sbjct: 127 HNPTV--------------KDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFT 170
Query: 234 AHISDFGLARRI-DTSHSHVSTQVAGTM--GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             ++DFGLAR + D  +  V  +    +   +M  E L      T   DV+SFG+L+ E+
Sbjct: 171 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWEL 229
Query: 291 ATQIRPNLPVV 301
            T+  P  P V
Sbjct: 230 MTRGAPPYPDV 240

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 27/251 (10%)
Query: 61  DSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL----SSGVTVAIKKLD 115
           D ++ +P L Q     +I  +      +++IG G FG VY   L       +  A+K L+
Sbjct: 6   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 65
Query: 116 KDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLHDTS 173
           +    G   +F  E   +    H N++ +LG C  S    +++  ++++G L  ++ + +
Sbjct: 66  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 125
Query: 174 RNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
            N  V              +  +     VA G+ YL    K  +HRD+ + N +LD  F 
Sbjct: 126 HNPTV--------------KDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFT 169
Query: 234 AHISDFGLARRI-DTSHSHVSTQVAGTM--GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             ++DFGLAR + D  +  V  +    +   +M  E L      T   DV+SFG+L+ E+
Sbjct: 170 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWEL 228
Query: 291 ATQIRPNLPVV 301
            T+  P  P V
Sbjct: 229 MTRGAPPYPDV 239

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 27/251 (10%)
Query: 61  DSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL----SSGVTVAIKKLD 115
           D ++ +P L Q     +I  +      +++IG G FG VY   L       +  A+K L+
Sbjct: 3   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 62
Query: 116 KDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLHDTS 173
           +    G   +F  E   +    H N++ +LG C  S    +++  ++++G L  ++ + +
Sbjct: 63  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 122
Query: 174 RNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
            N  V              +  +     VA G+ YL    K  +HRD+ + N +LD  F 
Sbjct: 123 HNPTV--------------KDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFT 166
Query: 234 AHISDFGLARRI-DTSHSHVSTQVAGTM--GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             ++DFGLAR + D  +  V  +    +   +M  E L      T   DV+SFG+L+ E+
Sbjct: 167 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWEL 225
Query: 291 ATQIRPNLPVV 301
            T+  P  P V
Sbjct: 226 MTRGAPPYPDV 236

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 93/219 (42%), Gaps = 36/219 (16%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAI-------KKLDKDAFQGFREFRAEMETLGKLRHRNIVK 142
           IG GSF  VYK  L +  TV +       +KL K   Q F+E   E E L  L+H NIV+
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKE---EAEXLKGLQHPNIVR 89
Query: 143 ILGYCASGLDR----VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
                 S +      VL+ E   +G+L  +L    +   V   K L S C          
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYL----KRFKVXKIKVLRSWC---------- 135
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-EAHISDFGLARRIDTSHSHVSTQVA 257
            R +  GL +LH    PIIHRD+K  N+ +        I D GLA       +  +  V 
Sbjct: 136 -RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVI 191
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  +  PE        +V  DVY+FG   +E AT   P
Sbjct: 192 GTPEFXAPEXYEEKYDESV--DVYAFGXCXLEXATSEYP 228

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 111/236 (47%), Gaps = 52/236 (22%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHRNIVKILGY 146
           + +G G +G V++     G  VA+K    +D    FRE   E+     LRH NI   LG+
Sbjct: 43  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENI---LGF 96
Query: 147 CASGLDR-------VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
            AS +          LI  + E GSL  +L             QL +L  +S    ++IV
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYL-------------QLTTLDTVS---CLRIV 140
Query: 200 RGVANGLAYLH----GLE-KPII-HRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
             +A+GLA+LH    G + KP I HRD+KS N+L+  + +  I+D GLA      HS  +
Sbjct: 141 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA----VMHSQST 196
Query: 254 TQV-------AGTMGYMPPEYLGGNTAATVM-----LDVYSFGILMIEIATQIRPN 297
            Q+        GT  YM PE L              +D+++FG+++ E+A ++  N
Sbjct: 197 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 252

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 24/231 (10%)
Query: 82  DNFSTDKIIGDGSFGFVYK-AKLSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRN 139
           D+F     +G G+ G V+K +   SG+ +A K +  +     R +   E++ L +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IV   G   S  +  +  E ++ GSLDQ L    R               +  +   K+ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------------IPEQILGKVS 110
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             V  GL YL    K I+HRD+K SN+L++S  E  + DFG++ ++  S   ++    GT
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGT 166
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL 310
             YM PE L G T  +V  D++S G+ ++E+A    P  P   D +E+ L+
Sbjct: 167 RSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPP--DAKELELM 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 24/231 (10%)
Query: 82  DNFSTDKIIGDGSFGFVYK-AKLSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRN 139
           D+F     +G G+ G V+K +   SG+ +A K +  +     R +   E++ L +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IV   G   S  +  +  E ++ GSLDQ L    R               +  +   K+ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------------IPEQILGKVS 110
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             V  GL YL    K I+HRD+K SN+L++S  E  + DFG++ ++  S   ++    GT
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGT 166
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL 310
             YM PE L G T  +V  D++S G+ ++E+A    P  P   D +E+ L+
Sbjct: 167 RSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPP--DAKELELM 214

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 90  IGDGSFG----FVY-KAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVKI 143
           +G+G FG    + Y      +G  VA+K L  DA    R  ++ E++ L  L H +I+K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 144 LGYC--ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            G C  A      L+ E+V  GSL  +L   S      G  QL           +   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSI-----GLAQL-----------LLFAQQ 142
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG--T 259
           +  G+AYLH   +  IHRD+ + NVLLD+D    I DFGLA+ +   H     +  G   
Sbjct: 143 ICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSP 200
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           + +  PE L          DV+SFG+ + E+ T 
Sbjct: 201 VFWYAPECL-KEYKFYYASDVWSFGVTLYELLTH 233

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 24/231 (10%)
Query: 82  DNFSTDKIIGDGSFGFVYK-AKLSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRN 139
           D+F     +G G+ G V+K +   SG+ +A K +  +     R +   E++ L +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IV   G   S  +  +  E ++ GSLDQ L    R               +  +   K+ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------------IPEQILGKVS 110
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             V  GL YL    K I+HRD+K SN+L++S  E  + DFG++ ++  S   ++    GT
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGT 166
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL 310
             YM PE L G T  +V  D++S G+ ++E+A    P  P   D +E+ L+
Sbjct: 167 RSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPP--DAKELELM 214

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH 137
           D    ++  + IG G+ G VY A  +++G  VAI++++            E+  + + ++
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV  L     G +  ++ E++  GSL   + +T  ++      Q+ ++C         
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-----QIAAVC--------- 122
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
             R     L +LH  +  +IHRDIKS N+LL  D    ++DFG   +I    S  ST V 
Sbjct: 123 --RECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 177
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           GT  +M PE +    A    +D++S GI+ IE+
Sbjct: 178 GTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEM 209

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 113/239 (47%), Gaps = 26/239 (10%)
Query: 74  MSELIDATDNFSTDKIIGDGSFGFVYK-AKLSSGVTVAIKKLDKDAFQGFR-EFRAEMET 131
           + EL D  D+F     +G G+ G V+K +   SG+ +A K +  +     R +   E++ 
Sbjct: 27  VGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 84
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           L +     IV   G   S  +  +  E ++ GSLDQ L    R               + 
Sbjct: 85  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------------IP 129
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
            +   K+   V  GL YL    K I+HRD+K SN+L++S  E  + DFG++ ++  S   
Sbjct: 130 EQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185
Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL 310
           ++    GT  YM PE L G T  +V  D++S G+ ++E+A    P  P   D +E+ L+
Sbjct: 186 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPP--DAKELELM 241

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRN 139
           N+   K IG G+F  V  A+ + +G  VAIK +DK        ++   E+  +  L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IVK+     +     LI E+   G +  +L    R  +               E R K  
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK--------------EARSKF- 117
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
           R + + + Y H  +K I+HRD+K+ N+LLD+D    I+DFG +    T    + T   G+
Sbjct: 118 RQIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDT-FCGS 173
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV 307
             Y  PE   G       +DV+S G+++    T +  +LP   DGQ +
Sbjct: 174 PPYAAPELFQGKKYDGPEVDVWSLGVILY---TLVSGSLP--FDGQNL 216

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           D F  +++ G G+FG V   K  S+G++VAIKK+ +D     RE +  M+ L  L H NI
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNI 81
Query: 141 VKILGYCAS--GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           V++  Y  +    DR  IY  V    +   LH   RN           + P     +V +
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRN------YYRRQVAPPPILIKVFL 135
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLL-DSDFEAHISDFGLARRIDTSHSHVSTQVA 257
            + +   +  LH     + HRDIK  NVL+ ++D    + DFG A+++  S  +V+    
Sbjct: 136 FQ-LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA--YI 192
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +  Y  PE + GN   T  +D++S G +  E+
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEM 225

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRN 139
           N+   K IG G+F  V  A+ + +G  VA+K +DK        ++   E+  +  L H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IVK+     +     L+ E+   G +  +L    R  +               E R K  
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK--------------EARAKF- 120
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
           R + + + Y H  +K I+HRD+K+ N+LLD D    I+DFG +    T  + + T   G+
Sbjct: 121 RQIVSAVQYCH--QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEF-TVGNKLDT-FCGS 176
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV 307
             Y  PE   G       +DV+S G+++    T +  +LP   DGQ +
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILY---TLVSGSLP--FDGQNL 219

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 108/228 (47%), Gaps = 24/228 (10%)
Query: 74  MSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR-EFRAEMET 131
           + EL D  D+F     +G G+ G V K +   SG+ +A K +  +     R +   E++ 
Sbjct: 10  VGELKD--DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQV 67
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           L +     IV   G   S  +  +  E ++ GSLDQ L +  R               + 
Sbjct: 68  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---------------IP 112
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
            E   K+   V  GLAYL    + I+HRD+K SN+L++S  E  + DFG++ ++  S   
Sbjct: 113 EEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 168
Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           ++    GT  YM PE L G T  +V  D++S G+ ++E+A    P  P
Sbjct: 169 MANSFVGTRSYMAPERLQG-THYSVQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           + IG G FG V       G  VA+K +  DA    + F AE   + +LRH N+V++LG  
Sbjct: 18  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 148 A---SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
                GL   ++ E++  GSL  +L   SR   V G   L           +K    V  
Sbjct: 75  VEEKGGL--YIVTEYMAKGSLVDYLR--SRGRSVLGGDCL-----------LKFSLDVCE 119
Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM--GY 262
            + YL G     +HRD+ + NVL+  D  A +SDFGL +         STQ  G +   +
Sbjct: 120 AMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKW 171
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIATQIR---PNLPV 300
             PE L    A +   DV+SFGIL+ EI +  R   P +P+
Sbjct: 172 TAPEAL-REAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 211

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 82  DNFSTDKIIGDGSFGFVYK-AKLSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLRHRN 139
           D+F     +G G+ G V+K +   SG+ +A K +  +     R +   E++ L +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IV   G   S  +  +  E ++ GSLDQ L    R               +  +   K+ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------------IPEQILGKVS 110
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             V  GL YL    K I+HRD+K SN+L++S  E  + DFG++ ++  S   ++    GT
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGT 166
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
             YM PE L G T  +V  D++S G+ ++E+A    P  P
Sbjct: 167 RSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRN 139
           N+   K IG G+F  V  A+ + +G  VA+K +DK        ++   E+  +  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IVK+     +     L+ E+   G +  +L    R  +               E R K  
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK--------------EARAKF- 119
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
           R + + + Y H  +K I+HRD+K+ N+LLD+D    I+DFG +    T  + + T   G+
Sbjct: 120 RQIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDT-FCGS 175
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV 307
             Y  PE   G       +DV+S G+++    T +  +LP   DGQ +
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILY---TLVSGSLP--FDGQNL 218

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 30/222 (13%)
Query: 86  TDKIIGDGSFGFVYKAKL----SSGVTVAIKKLDK-DAFQGFREFRAEMETLGKLRHRNI 140
           +D++IG G FG VY  +      + +  AIK L +    Q    F  E   +  L H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 141 VKILGYC--ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           + ++G      GL  VL+  ++ +G L Q++    RN  V   K L S            
Sbjct: 85  LALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTV---KDLISFG---------- 130
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
              VA G+ YL   E+  +HRD+ + N +LD  F   ++DFGLAR I     + S Q   
Sbjct: 131 -LQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQ-QH 185
Query: 259 TMGYMPPEYLGGNTAATVML----DVYSFGILMIEIATQIRP 296
               +P ++    +  T       DV+SFG+L+ E+ T+  P
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 30/237 (12%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLD---KDAFQG 121
           DP ++++   +  D    FS  + IG GSFG VY A+ + +   VAIKK+    K + + 
Sbjct: 1   DPDVAELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 58
Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS 181
           +++   E+  L KLRH N ++  G         L+ E+             S +D ++  
Sbjct: 59  WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG----------SASDLLEVH 108
Query: 182 KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
           K+     PL       +  G   GLAYLH     +IHRD+K+ N+LL       + DFG 
Sbjct: 109 KK-----PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGS 161
Query: 242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATV--MLDVYSFGILMIEIATQIRP 296
           A  +  ++  V     GT  +M PE +           +DV+S GI  IE+A +  P
Sbjct: 162 ASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRN 139
           N+   K IG G+F  V  A+ + +G  VA+K +DK        ++   E+  +  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IVK+     +     L+ E+   G +  +L    R  +               E R K  
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK--------------EARAKF- 119
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
           R + + + Y H  +K I+HRD+K+ N+LLD+D    I+DFG +    T  + + T   G+
Sbjct: 120 RQIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDT-FCGS 175
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV 307
             Y  PE   G       +DV+S G+++    T +  +LP   DGQ +
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILY---TLVSGSLP--FDGQNL 218

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 27/213 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKI 143
           +G+G FG V   +      ++G  VA+K L  ++      + + E+E L  L H NIVK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 144 LGYCAS--GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            G C    G    LI EF+ +GSL ++L    +N +    KQ           ++K    
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQ-----------QLKYAVQ 134
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH--VSTQVAGT 259
           +  G+ YL    +  +HRD+ + NVL++S+ +  I DFGL + I+T      V       
Sbjct: 135 ICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSP 192
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           + +  PE L   +   +  DV+SFG+ + E+ T
Sbjct: 193 VFWYAPECL-MQSKFYIASDVWSFGVTLHELLT 224

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 26/224 (11%)
Query: 87  DKIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIV 141
           +++IG G FG VY   L       +  A+K L++    G   +F  E   +    H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 142 KILGYCA-SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
            +LG C  S    +++  ++++G L  ++ + + N  V              +  +    
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--------------KDLIGFGL 132
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVSTQVAGT 259
            VA G+ YL    K  +HRD+ + N +LD  F   ++DFGLAR + D  +  V  +    
Sbjct: 133 QVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 190
Query: 260 M--GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVV 301
           +   +M  E L      T   DV+SFG+L+ E+ T+  P  P V
Sbjct: 191 LPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 233

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 27/213 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKI 143
           +G+G FG V   +      ++G  VA+K L  ++      + + E+E L  L H NIVK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 144 LGYCA--SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            G C    G    LI EF+ +GSL ++L    +N +    KQ           ++K    
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQ-----------QLKYAVQ 122
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH--VSTQVAGT 259
           +  G+ YL    +  +HRD+ + NVL++S+ +  I DFGL + I+T      V       
Sbjct: 123 ICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSP 180
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           + +  PE L   +   +  DV+SFG+ + E+ T
Sbjct: 181 VFWYAPECL-MQSKFYIASDVWSFGVTLHELLT 212

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 30/237 (12%)
Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLD---KDAFQG 121
           DP ++++   +  D    FS  + IG GSFG VY A+ + +   VAIKK+    K + + 
Sbjct: 40  DPDVAELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 97
Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS 181
           +++   E+  L KLRH N ++  G         L+ E+             S +D ++  
Sbjct: 98  WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG----------SASDLLEVH 147
Query: 182 KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
           K+     PL       +  G   GLAYLH     +IHRD+K+ N+LL       + DFG 
Sbjct: 148 KK-----PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGS 200
Query: 242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATV--MLDVYSFGILMIEIATQIRP 296
           A  +  ++  V     GT  +M PE +           +DV+S GI  IE+A +  P
Sbjct: 201 ASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 31/259 (11%)
Query: 55  SSIALFDSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL----SSGVTV 109
           S+    D ++ +P L Q     +I  +      +++IG G FG VY   L       +  
Sbjct: 7   SNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 66
Query: 110 AIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQ 167
           A+K L++    G   +F  E   +    H N++ +LG C  S    +++  ++++G L  
Sbjct: 67  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 126
Query: 168 WLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVL 227
           ++ + + N  V              +  +     VA G+ +L    K  +HRD+ + N +
Sbjct: 127 FIRNETHNPTV--------------KDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCM 170
Query: 228 LDSDFEAHISDFGLAR-----RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYS 282
           LD  F   ++DFGLAR       D+ H+    ++   + +M  E L      T   DV+S
Sbjct: 171 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP--VKWMALESL-QTQKFTTKSDVWS 227
Query: 283 FGILMIEIATQIRPNLPVV 301
           FG+L+ E+ T+  P  P V
Sbjct: 228 FGVLLWELMTRGAPPYPDV 246

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 113/253 (44%), Gaps = 31/253 (12%)
Query: 61  DSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL----SSGVTVAIKKLD 115
           D ++ +P L Q     +I  +      +++IG G FG VY   L       +  A+K L+
Sbjct: 67  DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 126
Query: 116 KDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLHDTS 173
           +    G   +F  E   +    H N++ +LG C  S    +++  ++++G L  ++ + +
Sbjct: 127 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 186
Query: 174 RNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
            N  V              +  +     VA G+ +L    K  +HRD+ + N +LD  F 
Sbjct: 187 HNPTV--------------KDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFT 230
Query: 234 AHISDFGLAR-----RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMI 288
             ++DFGLAR       D+ H+    ++   + +M  E L      T   DV+SFG+L+ 
Sbjct: 231 VKVADFGLARDMYDKEFDSVHNKTGAKLP--VKWMALESL-QTQKFTTKSDVWSFGVLLW 287
Query: 289 EIATQIRPNLPVV 301
           E+ T+  P  P V
Sbjct: 288 ELMTRGAPPYPDV 300

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 113/253 (44%), Gaps = 31/253 (12%)
Query: 61  DSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL----SSGVTVAIKKLD 115
           D ++ +P L Q     +I  +      +++IG G FG VY   L       +  A+K L+
Sbjct: 6   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 65
Query: 116 KDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLHDTS 173
           +    G   +F  E   +    H N++ +LG C  S    +++  ++++G L  ++ + +
Sbjct: 66  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 125
Query: 174 RNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
            N  V              +  +     VA G+ +L    K  +HRD+ + N +LD  F 
Sbjct: 126 HNPTV--------------KDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFT 169
Query: 234 AHISDFGLAR-----RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMI 288
             ++DFGLAR       D+ H+    ++   + +M  E L      T   DV+SFG+L+ 
Sbjct: 170 VKVADFGLARDMYDKEFDSVHNKTGAKLP--VKWMALESL-QTQKFTTKSDVWSFGVLLW 226
Query: 289 EIATQIRPNLPVV 301
           E+ T+  P  P V
Sbjct: 227 ELMTRGAPPYPDV 239

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 113/253 (44%), Gaps = 31/253 (12%)
Query: 61  DSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL----SSGVTVAIKKLD 115
           D ++ +P L Q     +I  +      +++IG G FG VY   L       +  A+K L+
Sbjct: 8   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 67
Query: 116 KDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLHDTS 173
           +    G   +F  E   +    H N++ +LG C  S    +++  ++++G L  ++ + +
Sbjct: 68  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 127
Query: 174 RNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
            N  V              +  +     VA G+ +L    K  +HRD+ + N +LD  F 
Sbjct: 128 HNPTV--------------KDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFT 171
Query: 234 AHISDFGLAR-----RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMI 288
             ++DFGLAR       D+ H+    ++   + +M  E L      T   DV+SFG+L+ 
Sbjct: 172 VKVADFGLARDMYDKEFDSVHNKTGAKLP--VKWMALESL-QTQKFTTKSDVWSFGVLLW 228
Query: 289 EIATQIRPNLPVV 301
           E+ T+  P  P V
Sbjct: 229 ELMTRGAPPYPDV 241

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           + IG G FG V       G  VA+K +  DA    + F AE   + +LRH N+V++LG  
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 148 A---SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
                GL   ++ E++  GSL  +L   SR   V G   L           +K    V  
Sbjct: 69  VEEKGGL--YIVTEYMAKGSLVDYLR--SRGRSVLGGDCL-----------LKFSLDVCE 113
Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM--GY 262
            + YL G     +HRD+ + NVL+  D  A +SDFGL +         STQ  G +   +
Sbjct: 114 AMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKW 165
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIATQIR---PNLPV 300
             PE L     +T   DV+SFGIL+ EI +  R   P +P+
Sbjct: 166 TAPEALREKKFSTKS-DVWSFGILLWEIYSFGRVPYPRIPL 205

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 113/253 (44%), Gaps = 31/253 (12%)
Query: 61  DSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL----SSGVTVAIKKLD 115
           D ++ +P L Q     +I  +      +++IG G FG VY   L       +  A+K L+
Sbjct: 9   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 68
Query: 116 KDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLHDTS 173
           +    G   +F  E   +    H N++ +LG C  S    +++  ++++G L  ++ + +
Sbjct: 69  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 128
Query: 174 RNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
            N  V              +  +     VA G+ +L    K  +HRD+ + N +LD  F 
Sbjct: 129 HNPTV--------------KDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFT 172
Query: 234 AHISDFGLAR-----RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMI 288
             ++DFGLAR       D+ H+    ++   + +M  E L      T   DV+SFG+L+ 
Sbjct: 173 VKVADFGLARDMLDKEFDSVHNKTGAKLP--VKWMALESL-QTQKFTTKSDVWSFGVLLW 229
Query: 289 EIATQIRPNLPVV 301
           E+ T+  P  P V
Sbjct: 230 ELMTRGAPPYPDV 242

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 113/253 (44%), Gaps = 31/253 (12%)
Query: 61  DSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL----SSGVTVAIKKLD 115
           D ++ +P L Q     +I  +      +++IG G FG VY   L       +  A+K L+
Sbjct: 8   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 67
Query: 116 KDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLHDTS 173
           +    G   +F  E   +    H N++ +LG C  S    +++  ++++G L  ++ + +
Sbjct: 68  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 127
Query: 174 RNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
            N  V              +  +     VA G+ +L    K  +HRD+ + N +LD  F 
Sbjct: 128 HNPTV--------------KDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFT 171
Query: 234 AHISDFGLAR-----RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMI 288
             ++DFGLAR       D+ H+    ++   + +M  E L      T   DV+SFG+L+ 
Sbjct: 172 VKVADFGLARDMYDKEFDSVHNKTGAKLP--VKWMALESL-QTQKFTTKSDVWSFGVLLW 228
Query: 289 EIATQIRPNLPVV 301
           E+ T+  P  P V
Sbjct: 229 ELMTRGAPPYPDV 241

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           + IG G FG V       G  VA+K +  DA    + F AE   + +LRH N+V++LG  
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 148 A---SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
                GL   ++ E++  GSL  +L   SR   V G   L           +K    V  
Sbjct: 256 VEEKGGL--YIVTEYMAKGSLVDYLR--SRGRSVLGGDCL-----------LKFSLDVCE 300
Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM--GY 262
            + YL G     +HRD+ + NVL+  D  A +SDFGL +         STQ  G +   +
Sbjct: 301 AMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKW 352
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIATQIR---PNLPV 300
             PE L     +T   DV+SFGIL+ EI +  R   P +P+
Sbjct: 353 TAPEALREKKFSTKS-DVWSFGILLWEIYSFGRVPYPRIPL 392

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 113/253 (44%), Gaps = 31/253 (12%)
Query: 61  DSASFDPSLSQISMSELIDATDNF-STDKIIGDGSFGFVYKAKL----SSGVTVAIKKLD 115
           D ++ +P L Q     +I  +      +++IG G FG VY   L       +  A+K L+
Sbjct: 9   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 68
Query: 116 KDAFQG-FREFRAEMETLGKLRHRNIVKILGYCA-SGLDRVLIYEFVENGSLDQWLHDTS 173
           +    G   +F  E   +    H N++ +LG C  S    +++  ++++G L  ++ + +
Sbjct: 69  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 128
Query: 174 RNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
            N  V              +  +     VA G+ +L    K  +HRD+ + N +LD  F 
Sbjct: 129 HNPTV--------------KDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFT 172
Query: 234 AHISDFGLAR-----RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMI 288
             ++DFGLAR       D+ H+    ++   + +M  E L      T   DV+SFG+L+ 
Sbjct: 173 VKVADFGLARDMYDKEFDSVHNKTGAKLP--VKWMALESL-QTQKFTTKSDVWSFGVLLW 229
Query: 289 EIATQIRPNLPVV 301
           E+ T+  P  P V
Sbjct: 230 ELMTRGAPPYPDV 242

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           + IG G FG V       G  VA+K +  DA    + F AE   + +LRH N+V++LG  
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 148 A---SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
                GL   ++ E++  GSL  +L   SR   V G   L           +K    V  
Sbjct: 84  VEEKGGL--YIVTEYMAKGSLVDYLR--SRGRSVLGGDCL-----------LKFSLDVCE 128
Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM--GY 262
            + YL G     +HRD+ + NVL+  D  A +SDFGL +         STQ  G +   +
Sbjct: 129 AMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKW 180
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIATQIR---PNLPV 300
             PE L     +T   DV+SFGIL+ EI +  R   P +P+
Sbjct: 181 TAPEALREKKFSTKS-DVWSFGILLWEIYSFGRVPYPRIPL 220

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRN 139
           N+   K IG G+F  V  A+ + +G  VA++ +DK        ++   E+  +  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IVK+     +     L+ E+   G +  +L    R  +               E R K  
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK--------------EARAKF- 119
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
           R + + + Y H  +K I+HRD+K+ N+LLD+D    I+DFG +     +  +   +  G+
Sbjct: 120 RQIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDEFCGS 175
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV 307
             Y  PE   G       +DV+S G+++    T +  +LP   DGQ +
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILY---TLVSGSLP--FDGQNL 218

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH 137
           D    ++  + IG G+ G VY A  +++G  VAI++++            E+  + + ++
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 77
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV  L     G +  ++ E++  GSL   + +T  ++      Q+ ++C         
Sbjct: 78  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-----QIAAVC--------- 123
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
             R     L +LH  +  +IHR+IKS N+LL  D    ++DFG   +I    S  ST V 
Sbjct: 124 --RECLQALEFLHSNQ--VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 178
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           GT  +M PE +    A    +D++S GI+ IE+
Sbjct: 179 GTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEM 210

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 88/179 (49%), Gaps = 18/179 (10%)
Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS 181
           + +F+ E++ +  +++   +   G   +  +  +IYE++EN S+ ++       D+    
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF-------DEYFFV 139
Query: 182 KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
              N  C +  +    I++ V N  +Y+H  EK I HRD+K SN+L+D +    +SDFG 
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFG- 197
Query: 242 ARRIDTSHSHVSTQVAGTMG---YMPPEYLGGNTAAT-VMLDVYSFGILMIEIATQIRP 296
                 S   V  ++ G+ G   +MPPE+    ++     +D++S GI +  +   + P
Sbjct: 198 -----ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 27/228 (11%)
Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRN 139
           N+   K IG G+F  V  A+ + +G  VAIK +DK        ++   E+  +  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IVK+     +     LI E+   G +  +L    R  +               E R K  
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK--------------EARSKF- 120
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
           R + + + Y H  +K I+HRD+K+ N+LLD+D    I+DFG +               G 
Sbjct: 121 RQIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGA 176
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV 307
             Y  PE   G       +DV+S G+++    T +  +LP   DGQ +
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILY---TLVSGSLP--FDGQNL 219

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/311 (22%), Positives = 127/311 (40%), Gaps = 59/311 (18%)
Query: 56  SIALFDSASFDPSLSQIS--MSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKK 113
           +++L  + SF    SQ S  + E     +     ++IG G FG VY  +    V + +  
Sbjct: 5   NLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLID 64
Query: 114 LDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS 173
           +++D     + F+ E+    + RH N+V  +G C S     +I    +  +L   + D  
Sbjct: 65  IERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK 124
Query: 174 RNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
              DV+ ++Q              I + +  G+ YLH   K I+H+D+KS NV  D+  +
Sbjct: 125 IVLDVNKTRQ--------------IAQEIVKGMGYLHA--KGILHKDLKSKNVFYDNG-K 167
Query: 234 AHISDFGL---------ARRIDTSH------SHVSTQVAGTMGYMPPEYLGGNTAATVML 278
             I+DFGL          RR D          H++ ++   +  + P+        +   
Sbjct: 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI---IRQLSPDTEEDKLPFSKHS 224
Query: 279 DVYSFGILMIEI-------------------ATQIRPNLPVVLDGQEVG---LLEWARTM 316
           DV++ G +  E+                    T ++PNL  +  G+E+    L  WA   
Sbjct: 225 DVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQ 284
Query: 317 EARNKEIEMVD 327
           E R    +++D
Sbjct: 285 EERPTFTKLMD 295

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRN 139
           N+   K IG G+F  V  A+ + +G  VA++ +DK        ++   E+  +  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IVK+     +     L+ E+   G +  +L    R  +               E R K  
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK--------------EARAKF- 119
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
           R + + + Y H  +K I+HRD+K+ N+LLD+D    I+DFG +    T  + + T   G+
Sbjct: 120 RQIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDT-FCGS 175
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV 307
             Y  PE   G       +DV+S G+++    T +  +LP   DGQ +
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILY---TLVSGSLP--FDGQNL 218

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 27/228 (11%)
Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRN 139
           N+   K IG G+F  V  A+ + +G  VA+K +DK        ++   E+  +  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IVK+     +     L+ E+   G +  +L    R  +               E R K  
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK--------------EARAKF- 119
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
           R + + + Y H  +K I+HRD+K+ N+LLD+D    I+DFG +     +  +      G 
Sbjct: 120 RQIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDAFCGA 175
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV 307
             Y  PE   G       +DV+S G+++    T +  +LP   DGQ +
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILY---TLVSGSLP--FDGQNL 218

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH 137
           D    ++  + IG G+ G VY A  +++G  VAI++++            E+  + + ++
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 77
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV  L     G +  ++ E++  GSL   + +T  ++      Q+ ++C         
Sbjct: 78  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-----QIAAVC--------- 123
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
             R     L +LH  +  +IHRDIKS N+LL  D    ++DFG   +I    S  S  V 
Sbjct: 124 --RECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV- 178
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           GT  +M PE +    A    +D++S GI+ IE+
Sbjct: 179 GTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEM 210

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH 137
           D    ++  + IG G+ G VY A  +++G  VAI++++            E+  + + ++
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV  L     G +  ++ E++  GSL   + +T  ++      Q+ ++C         
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-----QIAAVC--------- 122
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
             R     L +LH  +  +IHRDIKS N+LL  D    ++DFG   +I    S  S  V 
Sbjct: 123 --RECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV- 177
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           GT  +M PE +    A    +D++S GI+ IE+
Sbjct: 178 GTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEM 209

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 90  IGDGSFG----FVY-KAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVKI 143
           +G+G FG    + Y      +G  VA+K L  D     R  ++ E++ L  L H +I+K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 144 LGYCASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            G C    ++ L  + E+V  GSL  +L   S      G  QL           +   + 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-----IGLAQL-----------LLFAQQ 125
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG--T 259
           +  G+AYLH   +  IHR++ + NVLLD+D    I DFGLA+ +   H +   +  G   
Sbjct: 126 ICEGMAYLHA--QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 183
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           + +  PE L          DV+SFG+ + E+ T 
Sbjct: 184 VFWYAPECL-KEYKFYYASDVWSFGVTLYELLTH 216

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 103/232 (44%), Gaps = 35/232 (15%)
Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRN 139
           N+   K IG G+F  V  A+ + +G  VA+K +DK        ++   E+  +  L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW----ETR 195
           IVK+     +     L+ E+   G +                   + L    W    E R
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEV------------------FDYLVAHGWMKEKEAR 109
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
            K  R + + + Y H  +K I+HRD+K+ N+LLD+D    I+DFG +    T  + + T 
Sbjct: 110 AKF-RQIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDT- 164
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV 307
             G+  Y  PE   G       +DV+S G+++    T +  +LP   DGQ +
Sbjct: 165 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY---TLVSGSLP--FDGQNL 211

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 90  IGDGSFGFVYK--AKLSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRNIVKILG 145
           +G+G++  VYK  +KL+  + VA+K++  +  +G      R E+  L  L+H NIV +  
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 67
Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
              +     L++E+++   L Q+L D     ++   K                +  +  G
Sbjct: 68  IIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLF--------------LFQLLRG 112
Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
           LAY H   + ++HRD+K  N+L++   E  ++DFGLAR           +V  T+ Y PP
Sbjct: 113 LAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPP 169
Query: 266 EYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           + L G+T  +  +D++  G +  E+AT  RP  P
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFP 202

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH 137
           D    ++  + IG G+ G VY A  +++G  VAI++++            E+  + + ++
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV  L     G +  ++ E++  GSL   + +T  ++      Q+ ++C         
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-----QIAAVC--------- 122
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
             R     L +LH  +  +IHRDIKS N+LL  D    ++DFG   +I    S  S  V 
Sbjct: 123 --RECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV- 177
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           GT  +M PE +    A    +D++S GI+ IE+
Sbjct: 178 GTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEM 209

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 25/217 (11%)
Query: 89  IIGDGSFGFVYKAK-LSSGVTVAIKKLD----KDAFQGF-REFRAEMETLGKLRHRNIVK 142
            +G+G F  VYKA+  ++   VAIKK+      +A  G  R    E++ L +L H NI+ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           +L       +  L+++F+E               D++   + NSL       +  ++  +
Sbjct: 77  LLDAFGHKSNISLVFDFMET--------------DLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
             GL YLH  +  I+HRD+K +N+LLD +    ++DFGLA+   + +     QV  T  Y
Sbjct: 123 -QGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWY 178
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
             PE L G     V +D+++ G ++ E+  ++ P LP
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRV-PFLP 214

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 74  MSELIDATDNFSTDKIIGDGSFGFVYK-AKLSSGVTVAIKKLDKDAFQGFR-EFRAEMET 131
           + EL D  D+F     +G G+ G V+K +   SG+ +A K +  +     R +   E++ 
Sbjct: 19  VGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 76
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           L +     IV   G   S  +  +  E ++ GSLDQ L    R               + 
Sbjct: 77  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------------IP 121
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
            +   K+   V  GL YL    K I+HRD+K SN+L++S  E  + DFG++ ++  S   
Sbjct: 122 EQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 177
Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           ++    GT  YM PE L G T  +V  D++S G+ ++E+A    P
Sbjct: 178 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 90  IGDGSFG----FVY-KAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVKI 143
           +G+G FG    + Y      +G  VA+K L  D     R  ++ E++ L  L H +I+K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 144 LGYCASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            G C    ++ L  + E+V  GSL  +L   S      G  QL           +   + 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-----IGLAQL-----------LLFAQQ 125
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG--T 259
           +  G+AYLH   +  IHR++ + NVLLD+D    I DFGLA+ +   H +   +  G   
Sbjct: 126 ICEGMAYLHS--QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 183
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
           + +  PE L          DV+SFG+ + E+ T 
Sbjct: 184 VFWYAPECL-KEYKFYYASDVWSFGVTLYELLTH 216

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 113/235 (48%), Gaps = 31/235 (13%)
Query: 67  PSLSQISMSELI-DATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF-- 122
           P+  +  +++ I +  + + T   +G G++G V  +  + SG+ +A+KKL +  FQ    
Sbjct: 35  PTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSR-PFQSIIH 93
Query: 123 --REFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
             R +R E+  L  ++H N++ +L              F    SL++  +D      + G
Sbjct: 94  AKRTYR-ELRLLKHMKHENVIGLLDV------------FTPATSLEE-FNDVYLVTHLMG 139
Query: 181 SKQLNSL--CPLSWETRVK-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS 237
           +  LN++  C    +  V+ ++  +  GL Y+H  +  IIHRD+K SN+ ++ D E  I 
Sbjct: 140 A-DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKIL 196
Query: 238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           DFGLAR  D       T    T  Y  PE +       + +D++S G +M E+ T
Sbjct: 197 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 30/224 (13%)
Query: 84  FSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKI 143
           ++  K+IG+GSFG V++AKL     VAIKK+ +D     R    E++ +  ++H N+V +
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDL 97
Query: 144 LGYCASGLDRV------LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +  S  D+       L+ E+V      + ++  SR+       +L    P+     +K
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRH-----YAKLKQTMPMLL---IK 144
Query: 198 I-VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-HISDFGLARRIDTSHSHVSTQ 255
           + +  +   LAY+H +   I HRDIK  N+LLD       + DFG A+ +     +VS  
Sbjct: 145 LYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXI 202
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
            +    Y  PE + G T  T  +D++S G +M E+  Q +P  P
Sbjct: 203 CSRY--YRAPELIFGATNYTTNIDIWSTGCVMAEL-MQGQPLFP 243

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 109/244 (44%), Gaps = 32/244 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTV----AIKKLDKDAF----QGFREFRAEMETLG 133
           +NF   K++G G++G V+  +  SG       A+K L K       +     R E + L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 134 KLRHRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            +R    +  L Y      ++ LI +++  G L   L    R                  
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT---------------- 157
Query: 193 ETRVKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
           E  V+I  G +   L +LH L   II+RDIK  N+LLDS+    ++DFGL++      + 
Sbjct: 158 EHEVQIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 252 VSTQVAGTMGYMPPEYL-GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL 310
            +    GT+ YM P+ + GG++     +D +S G+LM E+ T      P  +DG++    
Sbjct: 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQA 272
Query: 311 EWAR 314
           E +R
Sbjct: 273 EISR 276

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 90  IGDGSFG----FVY-KAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVKI 143
           +G+G FG    + Y      +G  VA+K L +      R  ++ E+E L  L H +IVK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 144 LGYCASGLDRV--LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            G C    ++   L+ E+V  GSL  +L          G  QL           +   + 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQL-----------LLFAQQ 120
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG--T 259
           +  G+AYLH   +  IHR + + NVLLD+D    I DFGLA+ +   H +   +  G   
Sbjct: 121 ICEGMAYLHA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 178
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN 297
           + +  PE L          DV+SFG+ + E+ T    N
Sbjct: 179 VFWYAPECL-KECKFYYASDVWSFGVTLYELLTYCDSN 215

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 90  IGDGSFG----FVY-KAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVKI 143
           +G+G FG    + Y      +G  VA+K L +      R  ++ E+E L  L H +IVK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 144 LGYCASGLDRV--LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            G C    ++   L+ E+V  GSL  +L          G  QL           +   + 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQL-----------LLFAQQ 119
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG--T 259
           +  G+AYLH   +  IHR + + NVLLD+D    I DFGLA+ +   H +   +  G   
Sbjct: 120 ICEGMAYLHA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 177
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN 297
           + +  PE L          DV+SFG+ + E+ T    N
Sbjct: 178 VFWYAPECL-KECKFYYASDVWSFGVTLYELLTYCDSN 214

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 50/238 (21%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +F    ++G G+FG V KA+ +      AIKK+ +   +      +E+  L  L H+ +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 142 KILGYCASGLDR----------------VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN 185
           +   Y A+ L+R                 +  E+ ENG+L   +H          S+ LN
Sbjct: 66  R---YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH----------SENLN 112
Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
                 W    ++ R +   L+Y+H   + IIHRD+K  N+ +D      I DFGLA+ +
Sbjct: 113 QQRDEYW----RLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 246 DTS-------------HSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             S              S   T   GT  Y+  E L G       +D+YS GI+  E+
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 27/228 (11%)
Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRN 139
           N+   K IG G+F  V  A+ + +G  VA+K +DK        ++   E+     L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IVK+     +     L+ E+   G +  +L    R  +               E R K  
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEK--------------EARAKF- 119
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
           R + + + Y H  +K I+HRD+K+ N+LLD+D    I+DFG +     +  +      G 
Sbjct: 120 RQIVSAVQYCH--QKFIVHRDLKAENLLLDADXNIKIADFGFSNEF--TFGNKLDAFCGA 175
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV 307
             Y  PE   G       +DV+S G+++    T +  +LP   DGQ +
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILY---TLVSGSLP--FDGQNL 218

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLSSGVTV----AIKKLDKDAFQGFREFRAEME--TLGKLR 136
            F   K++G GSFG V+  K  SG       A+K L K   +     R +ME   L ++ 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H  IVK+     +     LI +F+  G L   L           SK++     +  E  V
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-----------SKEV-----MFTEEDV 128
Query: 197 KI-VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           K  +  +A  L +LH L   II+RD+K  N+LLD +    ++DFGL++     H   +  
Sbjct: 129 KFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYS 185
Query: 256 VAGTMGYMPPEYLG--GNTAATVMLDVYSFGILMIEIATQIRP 296
             GT+ YM PE +   G+T +    D +SFG+LM E+ T   P
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSA---DWWSFGVLMFEMLTGTLP 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLSSGVTV----AIKKLDKDAFQGFREFRAEME--TLGKLR 136
            F   K++G GSFG V+  K  SG       A+K L K   +     R +ME   L ++ 
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 85
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H  IVK+     +     LI +F+  G L   L       + D    L  L         
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL--------- 136
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A  L +LH L   II+RD+K  N+LLD +    ++DFGL++     H   +   
Sbjct: 137 ------ALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSF 187
Query: 257 AGTMGYMPPEYLG--GNTAATVMLDVYSFGILMIEIATQIRP 296
            GT+ YM PE +   G+T +    D +SFG+LM E+ T   P
Sbjct: 188 CGTVEYMAPEVVNRRGHTQSA---DWWSFGVLMFEMLTGTLP 226

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 30/234 (12%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKL---DKDAFQGFREFRAEMETLGK 134
           + + +F    ++G+G++G V  A    +G  VAIKK+   DK  F   R  R E++ L  
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF-ALRTLR-EIKILKH 65
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
            +H NI+ I       + R   +E      + Q L  T  +  +  S Q+     LS + 
Sbjct: 66  FKHENIITIFN-----IQRPDSFENFNEVYIIQELMQTDLHRVI--STQM-----LSDDH 113
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS- 253
               +      +  LHG    +IHRD+K SN+L++S+ +  + DFGLAR ID S +  S 
Sbjct: 114 IQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 254 --------TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
                   T+   T  Y  PE +  +   +  +DV+S G ++ E+  + RP  P
Sbjct: 172 PTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFP 224

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 30/234 (12%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKL---DKDAFQGFREFRAEMETLGK 134
           + + +F    ++G+G++G V  A    +G  VAIKK+   DK  F   R  R E++ L  
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF-ALRTLR-EIKILKH 65
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
            +H NI+ I       + R   +E      + Q L  T  +  +  S Q+     LS + 
Sbjct: 66  FKHENIITIFN-----IQRPDSFENFNEVYIIQELMQTDLHRVI--STQM-----LSDDH 113
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS- 253
               +      +  LHG    +IHRD+K SN+L++S+ +  + DFGLAR ID S +  S 
Sbjct: 114 IQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 254 --------TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
                   T+   T  Y  PE +  +   +  +DV+S G ++ E+  + RP  P
Sbjct: 172 PTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFP 224

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLSSGVTV----AIKKLDKDAFQGFREFRAEME--TLGKLR 136
            F   K++G GSFG V+  K  SG       A+K L K   +     R +ME   L ++ 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H  IVK+     +     LI +F+  G L   L       + D    L  L         
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL--------- 135
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A  L +LH L   II+RD+K  N+LLD +    ++DFGL++     H   +   
Sbjct: 136 ------ALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSF 186
Query: 257 AGTMGYMPPEYLG--GNTAATVMLDVYSFGILMIEIATQIRP 296
            GT+ YM PE +   G+T +    D +SFG+LM E+ T   P
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSA---DWWSFGVLMFEMLTGTLP 225

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 28/204 (13%)
Query: 90  IGDGSFGFV-----YKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G+GSFG V     YK +    +    ++L K +    R  R E+  L  LRH +I+K+ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKLY 75
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL-CPLSWETRVKIVRGVA 203
               +  D V++ E+   G L  ++ +  R  + +G +    + C + +  R KIV    
Sbjct: 76  DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIV---- 130
Query: 204 NGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYM 263
                         HRD+K  N+LLD +    I+DFGL+  I T  + + T   G+  Y 
Sbjct: 131 --------------HRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTS-CGSPNYA 174
Query: 264 PPEYLGGNTAATVMLDVYSFGILM 287
            PE + G   A   +DV+S GI++
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVL 198

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL K  FQ      R +R E+  L  ++H N++ +L
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSK-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 99
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 100 DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 145
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 146 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 199
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 104/225 (46%), Gaps = 36/225 (16%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLD-KDAFQGF-----REFRAEMETL 132
           AT  +     IG G++G VYKA+   SG  VA+K +   +  +G      RE  A +  L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREV-ALLRRL 60
Query: 133 GKLRHRNIVKILGYCA-SGLDR----VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL 187
               H N+V+++  CA S  DR     L++E V                D D    L+  
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV----------------DQDLRTYLDKA 104
Query: 188 CP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
            P  L  ET   ++R    GL +LH     I+HRD+K  N+L+ S     ++DFGLAR  
Sbjct: 105 PPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARIY 162
Query: 246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             S+      V  T+ Y  PE L  +T AT  +D++S G +  E+
Sbjct: 163 --SYQMALAPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEM 204

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 53/233 (22%)
Query: 88  KIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQG-------FREFRAEMETLGKLRHRN 139
           K +G G++G V+K+    +G  VA+KK+  DAFQ        FRE     E  G   H N
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTDAQRTFREIMILTELSG---HEN 70
Query: 140 IVKILGYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           IV +L    +  DR   L+++++E               D+    + N L P+    +  
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMET--------------DLHAVIRANILEPVH---KQY 113
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR-----RIDTSHSHV 252
           +V  +   + YLH     ++HRD+K SN+LL+++    ++DFGL+R     R  T++  +
Sbjct: 114 VVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 253 S---------------TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           S               T    T  Y  PE L G+T  T  +D++S G ++ EI
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 29/214 (13%)
Query: 88  KIIGDGSFGFVYKAKL-----SSGVTVAIKKL-DKDAFQGFREFRAEMETLGKLRHRNIV 141
           K++G G FG V+K        S  + V IK + DK   Q F+     M  +G L H +IV
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++LG C  G    L+ +++  GSL   L    ++    G + L     L+W  ++     
Sbjct: 79  RLLGLC-PGSSLQLVTQYLPLGSL---LDHVRQHRGALGPQLL-----LNWGVQI----- 124
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT-M 260
            A G+ YL   E  ++HR++ + NVLL S  +  ++DFG+A  +      +    A T +
Sbjct: 125 -AKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181
Query: 261 GYMPPE--YLGGNTAATVMLDVYSFGILMIEIAT 292
            +M  E  + G  T  +   DV+S+G+ + E+ T
Sbjct: 182 KWMALESIHFGKYTHQS---DVWSYGVTVWELMT 212

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 94
Query: 136 RHRNIVKILGYCASGLDRVLI-YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
            H   VK L +C    +++     + +NG L +++      D+          C     T
Sbjct: 95  DHPFFVK-LYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C-----T 139
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV-S 253
           R      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        +
Sbjct: 140 RFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 196
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
               GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 197 NXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 238

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           IG G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 92
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 93  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 138
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 139 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVATRW 192
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAF-----QGFREFRAEMETLGKLR 136
           N+   K +G+GSFG V  A   ++G  VA+K ++K        QG      E+  L  LR
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 62
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H +I+K+     S  + +++ E+  N   D  +     ++                E R 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ---------------EAR- 106
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +  + + + + Y H     I+HRD+K  N+LLD      I+DFGL+  I T  + + T  
Sbjct: 107 RFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTS- 162
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
            G+  Y  PE + G   A   +DV+S G+++
Sbjct: 163 CGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 193

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKD---------AFQGFREFRAEM 129
           AT  +     IG G++G VYKA+   SG  VA+K +                 RE  A +
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV-ALL 65
Query: 130 ETLGKLRHRNIVKILGYCA-SGLDR----VLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
             L    H N+V+++  CA S  DR     L++E V                D D    L
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV----------------DQDLRTYL 109
Query: 185 NSLCP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA 242
           +   P  L  ET   ++R    GL +LH     I+HRD+K  N+L+ S     ++DFGLA
Sbjct: 110 DKAPPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLA 167
Query: 243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           R    S+    T V  T+ Y  PE L  +T AT  +D++S G +  E+
Sbjct: 168 RIY--SYQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEM 212

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 113/243 (46%), Gaps = 37/243 (15%)
Query: 69  LSQISMSELIDA------TDNFSTDKIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDA 118
           L +IS++  + A        +F   K++G GSFG V+  +      SG   A+K L K  
Sbjct: 9   LKEISITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKAT 68
Query: 119 FQGFREFRAEME--TLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRND 176
            +     R +ME   L  + H  +VK+     +     LI +F+  G L   L       
Sbjct: 69  LKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL------- 121
Query: 177 DVDGSKQLNSLCPLSWETRVKI-VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH 235
               SK++     +  E  VK  +  +A GL +LH L   II+RD+K  N+LLD +    
Sbjct: 122 ----SKEV-----MFTEEDVKFYLAELALGLDHLHSLG--IIYRDLKPENILLDEEGHIK 170
Query: 236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG--GNTAATVMLDVYSFGILMIEIATQ 293
           ++DFGL++     H   +    GT+ YM PE +   G++ +    D +S+G+LM E+ T 
Sbjct: 171 LTDFGLSKEA-IDHEKKAYSFCGTVEYMAPEVVNRQGHSHSA---DWWSYGVLMFEMLTG 226
Query: 294 IRP 296
             P
Sbjct: 227 SLP 229

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 29/214 (13%)
Query: 88  KIIGDGSFGFVYKAKL-----SSGVTVAIKKL-DKDAFQGFREFRAEMETLGKLRHRNIV 141
           K++G G FG V+K        S  + V IK + DK   Q F+     M  +G L H +IV
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++LG C  G    L+ +++  GSL   L    ++    G + L     L+W  ++     
Sbjct: 97  RLLGLC-PGSSLQLVTQYLPLGSL---LDHVRQHRGALGPQLL-----LNWGVQI----- 142
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT-M 260
            A G+ YL   E  ++HR++ + NVLL S  +  ++DFG+A  +      +    A T +
Sbjct: 143 -AKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 199
Query: 261 GYMPPE--YLGGNTAATVMLDVYSFGILMIEIAT 292
            +M  E  + G  T  +   DV+S+G+ + E+ T
Sbjct: 200 KWMALESIHFGKYTHQS---DVWSYGVTVWELMT 230

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 90  IGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQGFR---EFRAEMETLGKLRHRNIVK 142
           +G G+FG   K K+     +G  VA+K L++   +      + + E++ L   RH +I+K
Sbjct: 19  LGVGTFG---KVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           +    ++  D  ++ E+V  G L  ++    R ++++  +               + + +
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---------------LFQQI 120
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
            + + Y H     ++HRD+K  NVLLD+   A I+DFGL+  +  S         G+  Y
Sbjct: 121 LSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTSCGSPNY 176
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             PE + G   A   +D++S G+++  +     P
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 90  IGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFR---EFRAEMETLGKLRHRNIVKILG 145
           +G G+FG V   +   +G  VA+K L++   +      + + E++ L   RH +I+K+  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
             ++  D  ++ E+V  G L  ++    R ++++  +               + + + + 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---------------LFQQILSA 123
Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
           + Y H     ++HRD+K  NVLLD+   A I+DFGL+  +  S         G+  Y  P
Sbjct: 124 VDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRDSCGSPNYAAP 179
Query: 266 EYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           E + G   A   +D++S G+++  +     P
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 113
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 114 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 197

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 137/310 (44%), Gaps = 56/310 (18%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKL 135
           +D  + F+  + IG GSFG V+K     +   VAIK +D ++A     + + E+  L + 
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 62
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGS-LDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
               + K  G         +I E++  GS LD                 L    PL    
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-----------------LLEPGPLDETQ 105
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
              I+R +  GL YLH  +K  IHRDIK++NVLL    E  ++DFG+A ++  +    +T
Sbjct: 106 IATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 163
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA------TQIRP---------NLP 299
            V GT  +M PE +   +A     D++S GI  IE+A      +++ P         N P
Sbjct: 164 FV-GTPFWMAPEVI-KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP 221
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
             L+G       +++ ++      E V++ +++E       +E  +   +  N K     
Sbjct: 222 PTLEGN------YSKPLK------EFVEACLNKEPSFRPTAKELLKHKFILRNAKK---- 265
Query: 360 AMSYVVQLLD 369
             SY+ +L+D
Sbjct: 266 -TSYLTELID 274

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAF-----QGFREFRAEMETLGKLR 136
           N+   K +G+GSFG V  A   ++G  VA+K ++K        QG      E+  L  LR
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 66
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H +I+K+     S  + +++ E+  N   D  +     ++                E R 
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ---------------EAR- 110
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +  + + + + Y H     I+HRD+K  N+LLD      I+DFGL+  I T  + + T  
Sbjct: 111 RFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTS- 166
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
            G+  Y  PE + G   A   +DV+S G+++
Sbjct: 167 CGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 197

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAF-----QGFREFRAEMETLGKLR 136
           N+   K +G+GSFG V  A   ++G  VA+K ++K        QG      E+  L  LR
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 72
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H +I+K+     S  + +++ E+  N   D  +     ++                E R 
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ---------------EAR- 116
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +  + + + + Y H     I+HRD+K  N+LLD      I+DFGL+  I T  + + T  
Sbjct: 117 RFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTS- 172
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
            G+  Y  PE + G   A   +DV+S G+++
Sbjct: 173 CGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 203

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 111/234 (47%), Gaps = 30/234 (12%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKL---DKDAFQGFREFRAEMETLGK 134
           + + +F    ++G+G++G V  A    +G  VAIKK+   DK  F   R  R E++ L  
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF-ALRTLR-EIKILKH 65
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
            +H NI+ I       + R   +E      + Q L  T  +  +  S Q+     LS + 
Sbjct: 66  FKHENIITIFN-----IQRPDSFENFNEVYIIQELMQTDLHRVI--STQM-----LSDDH 113
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS---HSH 251
               +      +  LHG    +IHRD+K SN+L++S+ +  + DFGLAR ID S   +S 
Sbjct: 114 IQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 252 VSTQVAG------TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
            + Q +G      T  Y  PE +  +   +  +DV+S G ++ E+  + RP  P
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFP 224

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAF-----QGFREFRAEMETLGKLR 136
           N+   K +G+GSFG V  A   ++G  VA+K ++K        QG      E+  L  LR
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 71
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H +I+K+     S  + +++ E+  N   D  +     ++                E R 
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ---------------EAR- 115
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +  + + + + Y H     I+HRD+K  N+LLD      I+DFGL+  I T  + + T  
Sbjct: 116 RFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTS- 171
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
            G+  Y  PE + G   A   +DV+S G+++
Sbjct: 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 202

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 104/225 (46%), Gaps = 36/225 (16%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLD-KDAFQGF-----REFRAEMETL 132
           AT  +     IG G++G VYKA+   SG  VA+K +   +  +G      RE  A +  L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREV-ALLRRL 60
Query: 133 GKLRHRNIVKILGYCA-SGLDR----VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL 187
               H N+V+++  CA S  DR     L++E V                D D    L+  
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV----------------DQDLRTYLDKA 104
Query: 188 CP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
            P  L  ET   ++R    GL +LH     I+HRD+K  N+L+ S     ++DFGLAR  
Sbjct: 105 PPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARIY 162
Query: 246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             S+      V  T+ Y  PE L  +T AT  +D++S G +  E+
Sbjct: 163 --SYQMALDPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEM 204

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 44/224 (19%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           IG G FG V++ K   G  VA+K    ++    FRE  AE+     LRH NI   LG+ A
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENI---LGFIA 64
Query: 149 -------SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
                  +     L+ ++ E+GSL  +L+  +                ++ E  +K+   
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------------VTVEGMIKLALS 108
Query: 202 VANGLAYLH----GLE-KPII-HRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS-- 253
            A+GLA+LH    G + KP I HRD+KS N+L+  +    I+D GLA R D++   +   
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168
Query: 254 -TQVAGTMGYMPPEYLGGNT-----AATVMLDVYSFGILMIEIA 291
                GT  YM PE L  +       +    D+Y+ G++  EIA
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGXVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 136/309 (44%), Gaps = 54/309 (17%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKL 135
           +D  + F+  + IG GSFG V+K     +   VAIK +D ++A     + + E+  L + 
Sbjct: 23  MDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 82
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
               + K  G         +I E++  GS                +  L    PL     
Sbjct: 83  DSPYVTKYYGSYLKDTKLWIIMEYLGGGS----------------ALDLLEPGPLDETQI 126
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
             I+R +  GL YLH  +K  IHRDIK++NVLL    E  ++DFG+A ++  +    +T 
Sbjct: 127 ATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 184
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA------TQIRP---------NLPV 300
           V GT  +M PE +   +A     D++S GI  IE+A      +++ P         N P 
Sbjct: 185 V-GTPFWMAPEVI-KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP 242
Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
            L+G       +++ ++      E V++ +++E       +E  +   +  N K      
Sbjct: 243 TLEGN------YSKPLK------EFVEACLNKEPSFRPTAKELLKHKFILRNAKK----- 285
Query: 361 MSYVVQLLD 369
            SY+ +L+D
Sbjct: 286 TSYLTELID 294

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 92
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 93  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 138
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 139 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVATRW 192
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 92
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 93  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 138
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 139 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 192
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 86
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 87  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 132
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 133 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 186
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 187 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLR 136
           D  D +    ++G G+F  V  A+   +   VAIK + K+A +G       E+  L K++
Sbjct: 15  DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIV +     SG    LI + V  G L   + +     + D S               
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS--------------- 119
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVL---LDSDFEAHISDFGLARRIDTSHSHVS 253
           +++  V + + YLH L   I+HRD+K  N+L   LD D +  ISDFGL++  D     V 
Sbjct: 120 RLIFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVL 175
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE 311
           +   GT GY+ PE L     +   +D +S G+    IA  +    P   D  +  L E
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKA-VDCWSIGV----IAYILLCGYPPFYDENDAKLFE 228

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 114
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 115 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 168
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 198

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 94
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 95  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 140
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 141 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 194
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 89
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 90  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDET---------C----- 133
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 134 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A+    D+++ G ++ ++   + P
Sbjct: 191 ANSFVGTAQYVSPELLTEKSASKSS-DLWALGCIIYQLVAGLPP 233

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 92
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 93  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 138
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 139 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 192
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 89
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 90  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 135
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 136 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 189
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLR 136
           D  D +    ++G G+F  V  A+   +   VAIK + K+A +G       E+  L K++
Sbjct: 15  DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIV +     SG    LI + V  G L   + +     + D S               
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS--------------- 119
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVL---LDSDFEAHISDFGLARRIDTSHSHVS 253
           +++  V + + YLH L   I+HRD+K  N+L   LD D +  ISDFGL++  D     V 
Sbjct: 120 RLIFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVL 175
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE 311
           +   GT GY+ PE L     +   +D +S G+    IA  +    P   D  +  L E
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKA-VDCWSIGV----IAYILLCGYPPFYDENDAKLFE 228

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 104/225 (46%), Gaps = 36/225 (16%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLD-KDAFQGF-----REFRAEMETL 132
           AT  +     IG G++G VYKA+   SG  VA+K +   +  +G      RE  A +  L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREV-ALLRRL 60
Query: 133 GKLRHRNIVKILGYCA-SGLDR----VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL 187
               H N+V+++  CA S  DR     L++E V                D D    L+  
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV----------------DQDLRTYLDKA 104
Query: 188 CP--LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
            P  L  ET   ++R    GL +LH     I+HRD+K  N+L+ S     ++DFGLAR  
Sbjct: 105 PPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARIY 162
Query: 246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             S+      V  T+ Y  PE L  +T AT  +D++S G +  E+
Sbjct: 163 --SYQMALFPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEM 204

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 84
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 85  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 130
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 131 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 184
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 67
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 68  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 111
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 112 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 168
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 169 ANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 211

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 98
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 99  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 144
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 145 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVATRW 198
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 114
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 115 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 198

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 44/224 (19%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           IG G FG V++ K   G  VA+K    ++    FRE  AE+     LRH NI   LG+ A
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENI---LGFIA 103
Query: 149 -------SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
                  +     L+ ++ E+GSL  +L+  +                ++ E  +K+   
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------------VTVEGMIKLALS 147
Query: 202 VANGLAYLH----GLE-KPII-HRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS-- 253
            A+GLA+LH    G + KP I HRD+KS N+L+  +    I+D GLA R D++   +   
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 254 -TQVAGTMGYMPPEYLGGNT-----AATVMLDVYSFGILMIEIA 291
                GT  YM PE L  +       +    D+Y+ G++  EIA
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLR 136
           D  D +    ++G G+F  V  A+   +   VAIK + K+A +G       E+  L K++
Sbjct: 15  DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIV +     SG    LI + V  G L   + +     + D S               
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS--------------- 119
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVL---LDSDFEAHISDFGLARRIDTSHSHVS 253
           +++  V + + YLH L   I+HRD+K  N+L   LD D +  ISDFGL++  D     V 
Sbjct: 120 RLIFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVL 175
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE 311
           +   GT GY+ PE L     +   +D +S G+    IA  +    P   D  +  L E
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKA-VDCWSIGV----IAYILLCGYPPFYDENDAKLFE 228

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 44/224 (19%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           IG G FG V++ K   G  VA+K    ++    FRE  AE+     LRH NI   LG+ A
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENI---LGFIA 65
Query: 149 -------SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
                  +     L+ ++ E+GSL  +L+  +                ++ E  +K+   
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------------VTVEGMIKLALS 109
Query: 202 VANGLAYLH----GLE-KPII-HRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS-- 253
            A+GLA+LH    G + KP I HRD+KS N+L+  +    I+D GLA R D++   +   
Sbjct: 110 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 169
Query: 254 -TQVAGTMGYMPPEYLGGNT-----AATVMLDVYSFGILMIEIA 291
                GT  YM PE L  +       +    D+Y+ G++  EIA
Sbjct: 170 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 113
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 114 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 197

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 84
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 85  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 130
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 131 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 184
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 93
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 94  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 139
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 140 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 193
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 99
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 100 DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 145
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 146 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 199
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 99
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 100 DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 145
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 146 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 199
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 93
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 94  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 139
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 140 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 193
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 66
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 67  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 110
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 111 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 167
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 168 ANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 210

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 90
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 91  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 134
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 135 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 191
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 192 ANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 234

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 89
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 90  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 135
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 136 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 189
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 83
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 84  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 129
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 130 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 183
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 89
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 90  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 135
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 136 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 189
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 44/224 (19%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           IG G FG V++ K   G  VA+K    ++    FRE  AE+     LRH NI   LG+ A
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENI---LGFIA 90
Query: 149 -------SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
                  +     L+ ++ E+GSL  +L+  +                ++ E  +K+   
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------------VTVEGMIKLALS 134
Query: 202 VANGLAYLH----GLE-KPII-HRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS-- 253
            A+GLA+LH    G + KP I HRD+KS N+L+  +    I+D GLA R D++   +   
Sbjct: 135 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 194
Query: 254 -TQVAGTMGYMPPEYLGGNT-----AATVMLDVYSFGILMIEIA 291
                GT  YM PE L  +       +    D+Y+ G++  EIA
Sbjct: 195 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 98
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 99  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 144
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 145 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 198
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 107
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 108 DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 153
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 154 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 207
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 89
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 90  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 133
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 134 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 191 ANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 90
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 91  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 134
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 135 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 191
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 192 ANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 234

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 110
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 111 DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 156
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 157 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 210
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 65
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 66  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 109
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 110 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 167 ANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 209

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 85
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 86  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 131
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 132 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 185
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 112
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 113 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 196

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 113
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 114 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 197

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 86
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 87  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 130
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 131 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 187
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 188 ANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 230

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 93
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 94  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 139
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 140 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDE----MTGYVATRW 193
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 44/224 (19%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           IG G FG V++ K   G  VA+K    ++    FRE  AE+     LRH NI   LG+ A
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENI---LGFIA 70
Query: 149 -------SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
                  +     L+ ++ E+GSL  +L+  +                ++ E  +K+   
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------------VTVEGMIKLALS 114
Query: 202 VANGLAYLH----GLE-KPII-HRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS-- 253
            A+GLA+LH    G + KP I HRD+KS N+L+  +    I+D GLA R D++   +   
Sbjct: 115 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 174
Query: 254 -TQVAGTMGYMPPEYLGGNT-----AATVMLDVYSFGILMIEIA 291
                GT  YM PE L  +       +    D+Y+ G++  EIA
Sbjct: 175 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 114
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 115 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 198

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 106
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 107 DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 152
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 153 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 206
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 22/222 (9%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKL 135
           +D  + F+    IG GSFG VYK     +   VAIK +D ++A     + + E+  L + 
Sbjct: 15  VDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC 74
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
               I +  G         +I E++  GS                +  L    PL     
Sbjct: 75  DSPYITRYFGSYLKSTKLWIIMEYLGGGS----------------ALDLLKPGPLEETYI 118
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
             I+R +  GL YLH   K  IHRDIK++NVLL    +  ++DFG+A ++  +    +  
Sbjct: 119 ATILREILKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXF 176
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN 297
           V GT  +M PE +   +A     D++S GI  IE+A    PN
Sbjct: 177 V-GTPFWMAPEVI-KQSAYDFKADIWSLGITAIELAKGEPPN 216

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 44/224 (19%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           IG G FG V++ K   G  VA+K    ++    FRE  AE+     LRH NI   LG+ A
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENI---LGFIA 67
Query: 149 -------SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
                  +     L+ ++ E+GSL  +L+  +                ++ E  +K+   
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------------VTVEGMIKLALS 111
Query: 202 VANGLAYLH----GLE-KPII-HRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS-- 253
            A+GLA+LH    G + KP I HRD+KS N+L+  +    I+D GLA R D++   +   
Sbjct: 112 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 171
Query: 254 -TQVAGTMGYMPPEYLGGNT-----AATVMLDVYSFGILMIEIA 291
                GT  YM PE L  +       +    D+Y+ G++  EIA
Sbjct: 172 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 89
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 90  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 133
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 134 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 191 ANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 233

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 89
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 90  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 135
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 136 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDE----MTGYVATRW 189
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 64
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 65  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 108
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 109 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 165
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 166 ANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 208

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 87
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 88  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 131
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 132 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 189 ANAFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 231

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 86
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 87  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 130
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 131 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 187
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 188 ANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 230

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/230 (31%), Positives = 104/230 (45%), Gaps = 52/230 (22%)
Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHRNIVKILGY 146
           + +G G +G V++  L  G +VA+K    +D    FRE   E+     LRH NI   LG+
Sbjct: 14  ECVGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRE--TEIYNTVLLRHDNI---LGF 67
Query: 147 CASGLDR-------VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
            AS +          LI  + E+GSL  +L             Q  +L P      +++ 
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFL-------------QRQTLEP---HLALRLA 111
Query: 200 RGVANGLAYLH----GLE-KPII-HRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
              A GLA+LH    G + KP I HRD KS NVL+ S+ +  I+D GLA      HS  S
Sbjct: 112 VSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA----VMHSQGS 167
Query: 254 TQV-------AGTMGYMPPEYLGGNTAATVM-----LDVYSFGILMIEIA 291
             +        GT  YM PE L               D+++FG+++ EIA
Sbjct: 168 DYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 114
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 115 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 198

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 113
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 114 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 197

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 92
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 93  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 136
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 137 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 193
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 194 ANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 236

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 71
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 72  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 115
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 116 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 172
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 173 ANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 215

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 87
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 88  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 131
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 132 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 189 ANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 231

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 114
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 115 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 198

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 87
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 88  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 131
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 132 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 189 ANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 231

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 114
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 115 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 198

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 89
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 90  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 133
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 134 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 191 ANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 233

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 114
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 115 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 198

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 113
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 114 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 197

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 90  IGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVK 142
           +G G++G V   Y A+L     VA+KKL +  FQ      R +R E+  L  L+H N++ 
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSR-PFQSLIHARRTYR-ELRLLKHLKHENVIG 83
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           +L           I +F E      +L  T    D++   +  +L   S E    +V  +
Sbjct: 84  LLDVFTPATS---IEDFSEV-----YLVTTLMGADLNNIVKCQAL---SDEHVQFLVYQL 132
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
             GL Y+H     IIHRD+K SNV ++ D E  I DFGLAR+ D       T    T  Y
Sbjct: 133 LRGLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE----MTGYVATRWY 186
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEI 290
             PE +         +D++S G +M E+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAEL 214

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 113
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 114 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 197

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 113
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 114 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 197

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 89
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 90  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 133
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 134 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 191 ANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 233

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 113
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 114 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 197

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF  V  A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 89
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 90  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 133
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 134 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 191 ANXFVGTAQYVSPELLTEKSAXKSS-DLWALGCIIYQLVAGLPP 233

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 100/238 (42%), Gaps = 50/238 (21%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +F    ++G G+FG V KA+ +      AIKK+ +   +      +E+  L  L H+ +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 142 KILGYCASGLDR----------------VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN 185
           +   Y A+ L+R                 +  E+ EN +L   +H          S+ LN
Sbjct: 66  R---YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIH----------SENLN 112
Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
                 W    ++ R +   L+Y+H   + IIHRD+K  N+ +D      I DFGLA+ +
Sbjct: 113 QQRDEYW----RLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 246 DTS-------------HSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             S              S   T   GT  Y+  E L G       +D+YS GI+  E+
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG---FREFRAEMETLGKLR 136
           +D +   +I+G G    V+ A+ L     VA+K L  D  +    +  FR E +    L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 137 HRNIVKIL----GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           H  IV +         +G    ++ E+V+  +L   +H               +  P++ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---------------TEGPMTP 115
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +  ++++      L + H  +  IIHRD+K +N+L+ +     + DFG+AR I  S + V
Sbjct: 116 KRAIEVIADACQALNFSH--QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSV 173
Query: 253 --STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             +  V GT  Y+ PE   G++      DVYS G ++ E+ T   P
Sbjct: 174 XQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
                   R L  E   +  L   L     N+ V   K  +            ++  +  
Sbjct: 88  DVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-------LIYQILR 136
Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
           GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  Y  
Sbjct: 137 GLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVATRWYRA 190
Query: 265 PEYLGGNTAATVMLDVYSFGILMIEIAT 292
           PE +         +D++S G +M E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG---FREFRAEMETLGKLR 136
           +D +   +I+G G    V+ A+ L     VA+K L  D  +    +  FR E +    L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 137 HRNIVKIL----GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           H  IV +         +G    ++ E+V+  +L   +H               +  P++ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---------------TEGPMTP 115
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +  ++++      L + H  +  IIHRD+K +N+++ +     + DFG+AR I  S + V
Sbjct: 116 KRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 253 STQVA--GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +   A  GT  Y+ PE   G++      DVYS G ++ E+ T   P
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 113
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 114 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 197

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG---FREFRAEMETLGKLR 136
           +D +   +I+G G    V+ A+ L     VA+K L  D  +    +  FR E +    L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 137 HRNIVKIL----GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           H  IV +         +G    ++ E+V+  +L   +H               +  P++ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---------------TEGPMTP 115
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +  ++++      L + H  +  IIHRD+K +N+++ +     + DFG+AR I  S + V
Sbjct: 116 KRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 253 STQVA--GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +   A  GT  Y+ PE   G++      DVYS G ++ E+ T   P
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I D+GLAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLARHTDDE----MTGYVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 20/203 (9%)
Query: 88  KIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHRNIVKILG 145
           + +G+G++G V  A    +   VA+K +D K A       + E+     L H N+VK  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
           +   G  + L  E+   G L   +       + D  +  + L                 G
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---------------MAG 116
Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVAGTMGYMP 264
           + YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ GT+ Y+ 
Sbjct: 117 VVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 265 PEYLGGNTAATVMLDVYSFGILM 287
           PE L         +DV+S GI++
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVL 197

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G++G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 113
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 114 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 197

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 20/203 (9%)
Query: 88  KIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHRNIVKILG 145
           + +G+G++G V  A    +   VA+K +D K A       + E+     L H N+VK  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
           +   G  + L  E+   G L   +       + D  +  + L                 G
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---------------MAG 117
Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVAGTMGYMP 264
           + YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ GT+ Y+ 
Sbjct: 118 VVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 265 PEYLGGNTAATVMLDVYSFGILM 287
           PE L         +DV+S GI++
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVL 198

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 87  DKIIGDGSFGFVYKAKLS-----SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           DK +G G+FG V K           V V I K + +      E  AE   + +L +  IV
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           +++G C +    +L+ E  E G L+++L       D               +  +++V  
Sbjct: 92  RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD---------------KNIIELVHQ 135
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQVAGT 259
           V+ G+ YL   E   +HRD+ + NVLL +   A ISDFGL++  R D ++    T     
Sbjct: 136 VSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 193
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
           + +  PE +     ++   DV+SFG+LM E
Sbjct: 194 VKWYAPECINYYKFSSKS-DVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 87  DKIIGDGSFGFVYKAKLS-----SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           DK +G G+FG V K           V V I K + +      E  AE   + +L +  IV
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           +++G C +    +L+ E  E G L+++L       D               +  +++V  
Sbjct: 92  RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD---------------KNIIELVHQ 135
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQVAGT 259
           V+ G+ YL   E   +HRD+ + NVLL +   A ISDFGL++  R D ++    T     
Sbjct: 136 VSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 193
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
           + +  PE +     ++   DV+SFG+LM E
Sbjct: 194 VKWYAPECINYYKFSSKS-DVWSFGVLMWE 222

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
                   R L  E   +  L   L     N+ V   K  +            ++  +  
Sbjct: 88  DVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-------LIYQILR 136
Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
           GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  Y  
Sbjct: 137 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRA 190
Query: 265 PEYLGGNTAATVMLDVYSFGILMIEIAT 292
           PE +         +D++S G +M E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 90  IGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVK 142
           +G G++G V   Y A+L     VA+KKL +  FQ      R +R E+  L  L+H N++ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSR-PFQSLIHARRTYR-ELRLLKHLKHENVIG 91
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           +L           I +F E      +L  T    D++   +  +L   S E    +V  +
Sbjct: 92  LLDVFTPATS---IEDFSEV-----YLVTTLMGADLNNIVKCQAL---SDEHVQFLVYQL 140
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
             GL Y+H     IIHRD+K SNV ++ D E  I DFGLAR+ D       T    T  Y
Sbjct: 141 LRGLKYIHS--AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE----MTGYVATRWY 194
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEI 290
             PE +         +D++S G +M E+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAEL 222

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G  VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 97
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 98  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 143
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 144 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 197
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 198 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 94
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 95  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 140
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG--- 258
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR       H + ++ G   
Sbjct: 141 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVA 191
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           T  Y  PE +         +D++S G +M E+ T
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G  VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G  VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 83
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 84  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCAKLTDDHVQFLIYQ 129
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 130 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 183
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 94
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 95  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 140
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG--- 258
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR       H + ++ G   
Sbjct: 141 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVA 191
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           T  Y  PE +         +D++S G +M E+ T
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G  VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 83
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 84  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 129
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 130 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 183
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 94
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 95  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 140
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG--- 258
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR       H + ++ G   
Sbjct: 141 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVA 191
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           T  Y  PE +         +D++S G +M E+ T
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 87  DKIIGDGSFGFVYKAKLS-----SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           DK +G G+FG V K           V V I K + +      E  AE   + +L +  IV
Sbjct: 30  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           +++G C +    +L+ E  E G L+++L       D               +  +++V  
Sbjct: 90  RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD---------------KNIIELVHQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQVAGT 259
           V+ G+ YL   E   +HRD+ + NVLL +   A ISDFGL++  R D ++    T     
Sbjct: 134 VSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 191
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
           + +  PE +     ++   DV+SFG+LM E
Sbjct: 192 VKWYAPECINYYKFSSKS-DVWSFGVLMWE 220

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 136/310 (43%), Gaps = 56/310 (18%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKL 135
           +D  + F+  + IG GSFG V+K     +   VAIK +D ++A     + + E+  L + 
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 62
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGS-LDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
               + K  G         +I E++  GS LD                 L    PL    
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-----------------LLEPGPLDETQ 105
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
              I+R +  GL YLH  +K  IHRDIK++NVLL    E  ++DFG+A ++  +    + 
Sbjct: 106 IATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX 163
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA------TQIRP---------NLP 299
            V GT  +M PE +   +A     D++S GI  IE+A      +++ P         N P
Sbjct: 164 FV-GTPFWMAPEVI-KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP 221
Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
             L+G       +++ ++      E V++ +++E       +E  +   +  N K     
Sbjct: 222 PTLEGN------YSKPLK------EFVEACLNKEPSFRPTAKELLKHKFILRNAKK---- 265
Query: 360 AMSYVVQLLD 369
             SY+ +L+D
Sbjct: 266 -TSYLTELID 274

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G  VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 93
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 94  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 139
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 140 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 193
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 87  DKIIGDGSFGFVYKAKLS-----SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           DK +G G+FG V K           V V I K + +      E  AE   + +L +  IV
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           +++G C +    +L+ E  E G L+++L       D               +  +++V  
Sbjct: 82  RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD---------------KNIIELVHQ 125
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQVAGT 259
           V+ G+ YL   E   +HRD+ + NVLL +   A ISDFGL++  R D ++    T     
Sbjct: 126 VSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
           + +  PE +     ++   DV+SFG+LM E
Sbjct: 184 VKWYAPECINYYKFSSKS-DVWSFGVLMWE 212

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 104/238 (43%), Gaps = 29/238 (12%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR-EFRAEMETLGKLR 136
           D  D +    ++G G+F  V  A+   +   VAIK + K A +G       E+  L K++
Sbjct: 15  DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 74
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIV +     SG    LI + V  G L   + +     + D S               
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS--------------- 119
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVL---LDSDFEAHISDFGLARRIDTSHSHVS 253
           +++  V + + YLH L   I+HRD+K  N+L   LD D +  ISDFGL++  D     V 
Sbjct: 120 RLIFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVL 175
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE 311
           +   GT GY+ PE L     +   +D +S G+    IA  +    P   D  +  L E
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKA-VDCWSIGV----IAYILLCGYPPFYDENDAKLFE 228

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG---FREFRAEMETLGKLR 136
           +D +   +I+G G    V+ A+ L     VA+K L  D  +    +  FR E +    L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 137 HRNIVKILGY----CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           H  IV +         +G    ++ E+V+  +L   +H                  P++ 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------------PMTP 115
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +  ++++      L + H  +  IIHRD+K +N+++ +     + DFG+AR I  S + V
Sbjct: 116 KRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 253 STQVA--GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +   A  GT  Y+ PE   G++      DVYS G ++ E+ T   P
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 87  DKIIGDGSFGFVYKAKLS-----SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           DK +G G+FG V K           V V I K + +      E  AE   + +L +  IV
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           +++G C +    +L+ E  E G L+++L       D               +  +++V  
Sbjct: 72  RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD---------------KNIIELVHQ 115
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQVAGT 259
           V+ G+ YL   E   +HRD+ + NVLL +   A ISDFGL++  R D ++    T     
Sbjct: 116 VSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
           + +  PE +     ++   DV+SFG+LM E
Sbjct: 174 VKWYAPECINYYKFSSKS-DVWSFGVLMWE 202

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G  VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 107
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 108 DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 153
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 154 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 207
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 87  DKIIGDGSFGFVYKAKLS-----SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           DK +G G+FG V K           V V I K + +      E  AE   + +L +  IV
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           +++G C +    +L+ E  E G L+++L       D               +  +++V  
Sbjct: 76  RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD---------------KNIIELVHQ 119
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQVAGT 259
           V+ G+ YL   E   +HRD+ + NVLL +   A ISDFGL++  R D ++    T     
Sbjct: 120 VSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 177
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
           + +  PE +     ++   DV+SFG+LM E
Sbjct: 178 VKWYAPECINYYKFSSKS-DVWSFGVLMWE 206

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG---FREFRAEMETLGKLR 136
           +D +   +I+G G    V+ A+ L     VA+K L  D  +    +  FR E +    L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 137 HRNIVKIL----GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           H  IV +         +G    ++ E+V+  +L   +H               +  P++ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---------------TEGPMTP 115
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +  ++++      L + H  +  IIHRD+K +N+++ +     + DFG+AR I  S + V
Sbjct: 116 KRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 253 STQVA--GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +   A  GT  Y+ PE   G++      DVYS G ++ E+ T   P
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G  VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 106
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 107 DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 152
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D       T    T  
Sbjct: 153 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRW 206
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 135/309 (43%), Gaps = 56/309 (18%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLR 136
           D  + F+  + IG GSFG V+K     +   VAIK +D ++A     + + E+  L +  
Sbjct: 19  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGS-LDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
              + K  G         +I E++  GS LD                 L    PL     
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-----------------LLEPGPLDETQI 121
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
             I+R +  GL YLH  +K  IHRDIK++NVLL    E  ++DFG+A ++  +    +  
Sbjct: 122 ATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXF 179
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA------TQIRP---------NLPV 300
           V GT  +M PE +   +A     D++S GI  IE+A      +++ P         N P 
Sbjct: 180 V-GTPFWMAPEVI-KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP 237
Query: 301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
            L+G       +++ ++      E V++ +++E       +E  +   +  N K      
Sbjct: 238 TLEGN------YSKPLK------EFVEACLNKEPSFRPTAKELLKHKFILRNAKK----- 280
Query: 361 MSYVVQLLD 369
            SY+ +L+D
Sbjct: 281 TSYLTELID 289

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 87  DKIIGDGSFGFVYKAKLS-----SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           DK +G G+FG V K           V V I K + +      E  AE   + +L +  IV
Sbjct: 10  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           +++G C +    +L+ E  E G L+++L       D               +  +++V  
Sbjct: 70  RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD---------------KNIIELVHQ 113
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQVAGT 259
           V+ G+ YL   E   +HRD+ + NVLL +   A ISDFGL++  R D ++    T     
Sbjct: 114 VSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 171
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
           + +  PE +     ++   DV+SFG+LM E
Sbjct: 172 VKWYAPECINYYKFSSKS-DVWSFGVLMWE 200

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 90  IGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVK 142
           +G G++G V   Y A+L     VA+KKL +  FQ      R +R E+  L  L+H N++ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSR-PFQSLIHARRTYR-ELRLLKHLKHENVIG 91
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           +L           I +F E      +L  T    D++   +  +L   S E    +V  +
Sbjct: 92  LLDVFTPATS---IEDFSEV-----YLVTTLMGADLNNIVKSQAL---SDEHVQFLVYQL 140
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
             GL Y+H     IIHRD+K SNV ++ D E  I DFGLAR+ D       T    T  Y
Sbjct: 141 LRGLKYIHS--AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE----MTGYVATRWY 194
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEI 290
             PE +         +D++S G +M E+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAEL 222

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 106/248 (42%), Gaps = 38/248 (15%)
Query: 62  SASFDPSLSQISMSELIDAT------DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKL 114
           +AS  P  + +     ID +      D F  +  +G G+   VY+ K   +    A+K L
Sbjct: 27  TASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL 86
Query: 115 DKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDT-- 172
            K   +  +  R E+  L +L H NI+K+     +  +  L+ E V  G L   + +   
Sbjct: 87  KKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY 144
Query: 173 -SRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS- 230
            S  D  D  KQ                  +   +AYLH  E  I+HRD+K  N+L  + 
Sbjct: 145 YSERDAADAVKQ------------------ILEAVAYLH--ENGIVHRDLKPENLLYATP 184
Query: 231 --DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMI 288
             D    I+DFGL++ ++  H  +   V GT GY  PE L G  A    +D++S GI+  
Sbjct: 185 APDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITY 241
Query: 289 EIATQIRP 296
            +     P
Sbjct: 242 ILLCGFEP 249

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G  VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG--- 258
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR       H   ++AG   
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVA 184
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           T  Y  PE +         +D++S G +M E+ T
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G  VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG--- 258
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR       H   ++AG   
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVA 184
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           T  Y  PE +         +D++S G +M E+ T
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 31/224 (13%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA-----EMETLGKL 135
           ++F   KI+G+GSF     A+ L++    AIK L+K      +E +      E + + +L
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 87
Query: 136 RHRNIVKILGYCASGLDRVLIY--EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
            H   VK+  Y     D  L +   + +NG L +++      D+          C     
Sbjct: 88  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---------C----- 131
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV- 252
           TR      + + L YLHG  K IIHRD+K  N+LL+ D    I+DFG A+ +        
Sbjct: 132 TRFYTAE-IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  Y+ PE L   +A     D+++ G ++ ++   + P
Sbjct: 189 ANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPP 231

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 22/215 (10%)
Query: 90  IGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVK 142
           +G+  FG VYK  L           VAIK L   A    RE FR E     +L+H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDV---DGSKQLNSLCPLSWETRVKIV 199
           +LG         +I+ +  +G L ++L   S + DV   D  + + S   L     V +V
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA--LEPPDFVHLV 151
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             +A G+ YL      ++H+D+ + NVL+       ISD GL R +  +  +   ++ G 
Sbjct: 152 AQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY---KLLGN 206
Query: 260 ----MGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
               + +M PE +      ++  D++S+G+++ E+
Sbjct: 207 SLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEV 240

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G  VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 83
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 84  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 129
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG--- 258
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR       H   ++AG   
Sbjct: 130 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVA 180
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           T  Y  PE +         +D++S G +M E+ T
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 110
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 111 DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 156
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D            T  
Sbjct: 157 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MXGYVATRW 210
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 81  TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA---EMETLGKLR 136
           +D +   +++G GSFG V   K   +G   A+K + K   +   +  +   E++ L +L 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NI+K+  +        L+ E    G L   +    R  +VD ++              
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-------------- 136
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHISDFGLARRIDTSHSHVS 253
            I+R V +G+ Y+H  +  I+HRD+K  N+LL+S   D    I DFGL+   + S     
Sbjct: 137 -IIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 193
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
               GT  Y+ PE L G        DV+S G+++
Sbjct: 194 K--IGTAYYIAPEVLHGTYDEKC--DVWSTGVIL 223

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 24/226 (10%)
Query: 75  SELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETL 132
           + + D  + F+  + IG GSFG V+K     +   VAIK +D ++A     + + E+  L
Sbjct: 16  NNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVL 75
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGS-LDQWLHDTSRNDDVDGSKQLNSLCPLS 191
            +     + K  G    G    +I E++  GS LD                 L    P  
Sbjct: 76  SQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALD-----------------LLRAGPFD 118
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
                 +++ +  GL YLH  +K  IHRDIK++NVLL    +  ++DFG+A ++  +   
Sbjct: 119 EFQIATMLKEILKGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 176
Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN 297
            +T V GT  +M PE +   +A     D++S GI  IE+A    PN
Sbjct: 177 RNTFV-GTPFWMAPEVI-QQSAYDSKADIWSLGITAIELAKGEPPN 220

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD-KDAFQGFREFRAEMETLGKLRHR 138
            +++   + +G+G+ G V  A    +   VA+K +D K A       + E+     L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N+VK  G+   G  + L  E+   G L   +       + D  +  + L           
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 113
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVA 257
                 G+ YLHG+   I HRDIK  N+LLD      ISDFGLA      +   +  ++ 
Sbjct: 114 ----MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT+ Y+ PE L         +DV+S GI++
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 197

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 98/237 (41%), Gaps = 50/237 (21%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +F    ++G G+FG V KA+ +      AIKK+ +   +      +E+  L  L H+ +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVV 65
Query: 142 KILGYCASGLDR----------------VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN 185
           +   Y A+ L+R                 +  E+ EN +L   +H          S+ LN
Sbjct: 66  R---YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIH----------SENLN 112
Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
                 W    ++ R +   L+Y+H   + IIHR++K  N+ +D      I DFGLA+ +
Sbjct: 113 QQRDEYW----RLFRQILEALSYIHS--QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNV 166
Query: 246 DTS-------------HSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
             S              S   T   GT  Y+  E L G       +D YS GI+  E
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG---FREFRAEMETLGKLR 136
           +D +   +I+G G    V+ A+ L     VA+K L  D  +    +  FR E +    L 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 137 HRNIVKIL----GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           H  IV +         +G    ++ E+V+  +L   +H                  P++ 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------------PMTP 132
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +  ++++      L + H  +  IIHRD+K +N+++ +     + DFG+AR I  S + V
Sbjct: 133 KRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 190
Query: 253 STQVA--GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +   A  GT  Y+ PE   G++      DVYS G ++ E+ T   P
Sbjct: 191 TQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPP 235

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 22/215 (10%)
Query: 90  IGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVK 142
           +G+  FG VYK  L           VAIK L   A    RE FR E     +L+H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDV---DGSKQLNSLCPLSWETRVKIV 199
           +LG         +I+ +  +G L ++L   S + DV   D  + + S   L     V +V
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA--LEPPDFVHLV 134
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             +A G+ YL      ++H+D+ + NVL+       ISD GL R +  +  +   ++ G 
Sbjct: 135 AQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY---KLLGN 189
Query: 260 ----MGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
               + +M PE +      ++  D++S+G+++ E+
Sbjct: 190 SLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEV 223

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 87  DKIIGDGSFGFVYKA-----KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           DK +G G+FG V K      K+   V V I K + +      E  AE   + +L +  IV
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           +++G C +    +L+ E  E G L+++L       D               +  +++V  
Sbjct: 434 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD---------------KNIIELVHQ 477
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQVAGT 259
           V+ G+ YL   E   +HRD+ + NVLL +   A ISDFGL++  R D ++    T     
Sbjct: 478 VSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 535
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
           + +  PE +     ++   DV+SFG+LM E
Sbjct: 536 VKWYAPECINYYKFSSKS-DVWSFGVLMWE 564

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
                   R L  E   +  L   L     N+ V   K  +            ++  +  
Sbjct: 88  DVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF-------LIYQILR 136
Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
           GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGL R  D       T    T  Y  
Sbjct: 137 GLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE----MTGYVATRWYRA 190
Query: 265 PEYLGGNTAATVMLDVYSFGILMIEIAT 292
           PE +         +D++S G +M E+ T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 23/237 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSS----GVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           A ++   ++I+G+G FG VY+   ++     + VA+K   KD     +E F +E   +  
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           L H +IVK++G        +++ E    G L  +L    RN         NSL  L   T
Sbjct: 66  LDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYL---ERNK--------NSLKVL---T 110
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
            V     +   +AYL  +    +HRDI   N+L+ S     + DFGL+R I+    + ++
Sbjct: 111 LVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS 168
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE 311
                + +M PE +      T   DV+ F + M EI +  +     + +   +G+LE
Sbjct: 169 VTRLPIKWMSPESINFRRFTTAS-DVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 224

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 87  DKIIGDGSFGFVYKA-----KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           DK +G G+FG V K      K+   V V I K + +      E  AE   + +L +  IV
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           +++G C +    +L+ E  E G L+++L       D               +  +++V  
Sbjct: 435 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD---------------KNIIELVHQ 478
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQVAGT 259
           V+ G+ YL   E   +HRD+ + NVLL +   A ISDFGL++  R D ++    T     
Sbjct: 479 VSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 536
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
           + +  PE +     ++   DV+SFG+LM E
Sbjct: 537 VKWYAPECINYYKFSSKS-DVWSFGVLMWE 565

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I  FGLAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLARHTDDE----MTGYVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 23/237 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSS----GVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           A ++   ++I+G+G FG VY+   ++     + VA+K   KD     +E F +E   +  
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           L H +IVK++G         +I E    G L  +L    RN         NSL  L   T
Sbjct: 82  LDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLE---RNK--------NSLKVL---T 126
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
            V     +   +AYL  +    +HRDI   N+L+ S     + DFGL+R I+    + ++
Sbjct: 127 LVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS 184
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE 311
                + +M PE +      T   DV+ F + M EI +  +     + +   +G+LE
Sbjct: 185 VTRLPIKWMSPESINFRRFTTAS-DVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 240

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 127/266 (47%), Gaps = 35/266 (13%)
Query: 33  YKPPTYRTRAVNRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKI-IG 91
           Y P   R  + ++P+P         ++F+S   DP   ++   +L    DN     I +G
Sbjct: 292 YTPEPARITSPDKPRPMP----MDTSVFESPFSDPE--ELKDKKLFLKRDNLLIADIELG 345
Query: 92  DGSFGFV----YKAKLSSGVTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKILGY 146
            G+FG V    Y+ +    + VAIK L +   +    E   E + + +L +  IV+++G 
Sbjct: 346 CGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 147 C-ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
           C A  L  +L+ E    G L ++L    + +++          P+S     +++  V+ G
Sbjct: 405 CQAEAL--MLVMEMAGGGPLHKFL--VGKREEI----------PVS--NVAELLHQVSMG 448
Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG--TMGYM 263
           + YL   EK  +HR++ + NVLL +   A ISDFGL++ +    S+ + + AG   + + 
Sbjct: 449 MKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 506
Query: 264 PPEYLGGNTAATVMLDVYSFGILMIE 289
            PE +     ++   DV+S+G+ M E
Sbjct: 507 APECINFRKFSSRS-DVWSYGVTMWE 531

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 87  DKIIGDGSFGFVYKAKLS-----SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           DK +G G+FG V K           V V I K + +      E  AE   + +L +  IV
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           +++G C +    +L+ E  E G L+++L       D               +  +++V  
Sbjct: 76  RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD---------------KNIIELVHQ 119
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQVAGT 259
           V+ G+ YL   E   +HRD+ + NVLL +   A ISDFGL++  R D +     T     
Sbjct: 120 VSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWP 177
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
           + +  PE +     ++   DV+SFG+LM E
Sbjct: 178 VKWYAPECINYYKFSSKS-DVWSFGVLMWE 206

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 81  TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA---EMETLGKLR 136
           +D +   +++G GSFG V   K   +G   A+K + K   +   +  +   E++ L +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NI+K+  +        L+ E    G L   +    R  +VD ++              
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-------------- 130
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHISDFGLARRIDTSHSHVS 253
            I+R V +G+ Y+H  +  I+HRD+K  N+LL+S   D    I DFGL+   + S     
Sbjct: 131 -IIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
               GT  Y+ PE L G        DV+S G+++
Sbjct: 188 K--IGTAYYIAPEVLHGTYDEKC--DVWSTGVIL 217

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 23/237 (9%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLSS----GVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           A ++   ++I+G+G FG VY+   ++     + VA+K   KD     +E F +E   +  
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           L H +IVK++G        +++ E    G L  +L    RN         NSL  L   T
Sbjct: 70  LDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLE---RNK--------NSLKVL---T 114
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
            V     +   +AYL  +    +HRDI   N+L+ S     + DFGL+R I+    + ++
Sbjct: 115 LVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS 172
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE 311
                + +M PE +      T   DV+ F + M EI +  +     + +   +G+LE
Sbjct: 173 VTRLPIKWMSPESINFRRFTTAS-DVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I D GLAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLARHTDDE----MTGYVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I D GLAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLARHTDDE----MTGYVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 81  TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA---EMETLGKLR 136
           +D +   +++G GSFG V   K   +G   A+K + K   +   +  +   E++ L +L 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NI+K+  +        L+ E    G L   +    R  +VD ++              
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-------------- 153
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHISDFGLARRIDTSHSHVS 253
            I+R V +G+ Y+H  +  I+HRD+K  N+LL+S   D    I DFGL+   + S     
Sbjct: 154 -IIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 210
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
               GT  Y+ PE L G        DV+S G+++
Sbjct: 211 K--IGTAYYIAPEVLHGTYDEKC--DVWSTGVIL 240

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G  VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 107
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 108 DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 153
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR  D            T  
Sbjct: 154 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MXGXVATRW 207
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 37/285 (12%)
Query: 90  IGDGSFGFVYKAKLSSGVT-VAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVKILGYC 147
           IG G+FG V+  +L +  T VA+K   +      + +F  E   L +  H NIV+++G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  ++ E V+ G    +L         +G++       L  +T +++V   A G+ 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR-------TEGAR-------LRVKTLLQMVGDAAAGME 227
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR-RIDTSHSHVSTQVAGTMGYMPPE 266
           YL    K  IHRD+ + N L+       ISDFG++R   D  ++         + +  PE
Sbjct: 228 YLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE 285
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L     ++   DV+SFGIL+ E  +              +G   +      + +E    
Sbjct: 286 ALNYGRYSSES-DVWSFGILLWETFS--------------LGASPYPNLSNQQTREFVEK 330
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
              +   EL    V   FR+   C   +  +RP+ S + Q L  +
Sbjct: 331 GGRLPCPELCPDAV---FRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G+ VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I D GLAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLARHTDDE----MTGYVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 81  TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA---EMETLGKLR 136
           +D +   +++G GSFG V   K   +G   A+K + K   +   +  +   E++ L +L 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NI+K+  +        L+ E    G L   +    R  +VD ++              
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-------------- 154
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHISDFGLARRIDTSHSHVS 253
            I+R V +G+ Y+H  +  I+HRD+K  N+LL+S   D    I DFGL+   + S     
Sbjct: 155 -IIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 211
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
               GT  Y+ PE L G        DV+S G+++
Sbjct: 212 K--IGTAYYIAPEVLHGTYDEKC--DVWSTGVIL 241

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 31/234 (13%)
Query: 67  PSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKL----DKDAFQG 121
           P    +S +    + D +     +G+G++G VYKA    +  TVAIK++    +++   G
Sbjct: 19  PGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPG 78
Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS 181
               R E+  L +L+HRNI+++           LI+E+ EN  L +++    +N DV   
Sbjct: 79  -TAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDV--- 129
Query: 182 KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFEA----HI 236
                    S       +  + NG+ + H   +  +HRD+K  N+LL  SD        I
Sbjct: 130 ---------SMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKI 178
Query: 237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            DFGLAR         + ++  T+ Y PPE L G+   +  +D++S   +  E+
Sbjct: 179 GDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEM 231

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 88  KIIGDGSFGFV----YKAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVK 142
           + IG+G FG V    Y +  +  + VAIK          RE F  E  T+ +  H +IVK
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           ++G         +I E    G L  +L    R   +D    L SL   +++        +
Sbjct: 73  LIGVITEN-PVWIIMELCTLGELRSFLQ--VRKYSLD----LASLILYAYQ--------L 117
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
           +  LAYL    K  +HRDI + NVL+ S+    + DFGL+R ++ S  + +++    + +
Sbjct: 118 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 263 MPPEYLGGN--TAATVMLDVYSFGILMIEI 290
           M PE +     T+A+   DV+ FG+ M EI
Sbjct: 176 MAPESINFRRFTSAS---DVWMFGVCMWEI 202

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 88  KIIGDGSFGFV----YKAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVK 142
           + IG+G FG V    Y +  +  + VAIK          RE F  E  T+ +  H +IVK
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           ++G         +I E    G L  +L    R   +D    L SL   +++        +
Sbjct: 76  LIGVITEN-PVWIIMELCTLGELRSFLQ--VRKYSLD----LASLILYAYQ--------L 120
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
           +  LAYL    K  +HRDI + NVL+ S+    + DFGL+R ++ S  + +++    + +
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 263 MPPEYLGGN--TAATVMLDVYSFGILMIEI 290
           M PE +     T+A+   DV+ FG+ M EI
Sbjct: 179 MAPESINFRRFTSAS---DVWMFGVCMWEI 205

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 88  KIIGDGSFGFV----YKAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVK 142
           + IG+G FG V    Y +  +  + VAIK          RE F  E  T+ +  H +IVK
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           ++G         +I E    G L  +L    R   +D    L SL   +++        +
Sbjct: 76  LIGVITEN-PVWIIMELCTLGELRSFLQ--VRKYSLD----LASLILYAYQ--------L 120
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
           +  LAYL    K  +HRDI + NVL+ S+    + DFGL+R ++ S  + +++    + +
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 263 MPPEYLGGN--TAATVMLDVYSFGILMIEI 290
           M PE +     T+A+   DV+ FG+ M EI
Sbjct: 179 MAPESINFRRFTSAS---DVWMFGVCMWEI 205

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 88  KIIGDGSFGFV----YKAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVK 142
           + IG+G FG V    Y +  +  + VAIK          RE F  E  T+ +  H +IVK
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           ++G         +I E    G L  +L    R   +D    L SL   +++        +
Sbjct: 78  LIGVITEN-PVWIIMELCTLGELRSFLQ--VRKYSLD----LASLILYAYQ--------L 122
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
           +  LAYL    K  +HRDI + NVL+ S+    + DFGL+R ++ S  + +++    + +
Sbjct: 123 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 180
Query: 263 MPPEYLGGN--TAATVMLDVYSFGILMIEI 290
           M PE +     T+A+   DV+ FG+ M EI
Sbjct: 181 MAPESINFRRFTSAS---DVWMFGVCMWEI 207

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKL---DKDAFQGFREFRAEMETLGKLRHRNIVKILG 145
           IG+GS+G V+K +   +G  VAIKK    + D        R E+  L +L+H N+V +L 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLE 69
Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
                    L++E+ ++  L    H+  R         + S+   +W+T           
Sbjct: 70  VFRRKRRLHLVFEYCDHTVL----HELDRYQRGVPEHLVKSI---TWQT--------LQA 114
Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
           + + H  +   IHRD+K  N+L+       + DFG AR +     +   +VA T  Y  P
Sbjct: 115 VNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSP 171
Query: 266 EYLGGNTAATVMLDVYSFGILMIEIATQI 294
           E L G+T     +DV++ G +  E+ + +
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 88  KIIGDGSFGFV----YKAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVK 142
           + IG+G FG V    Y +  +  + VAIK          RE F  E  T+ +  H +IVK
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           ++G         +I E    G L  +L    R   +D    L SL   +++        +
Sbjct: 104 LIGVITEN-PVWIIMELCTLGELRSFLQ--VRKYSLD----LASLILYAYQ--------L 148
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
           +  LAYL    K  +HRDI + NVL+ S+    + DFGL+R ++ S  + +++    + +
Sbjct: 149 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 206
Query: 263 MPPEYLGGN--TAATVMLDVYSFGILMIEI 290
           M PE +     T+A+   DV+ FG+ M EI
Sbjct: 207 MAPESINFRRFTSAS---DVWMFGVCMWEI 233

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 37/231 (16%)
Query: 86  TDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKIL 144
           ++KI+G GS G V       G  VA+K++  D       E +   E+     H N+++  
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY- 74
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
            YC+   DR L Y  +E  +L+      S+N   +  K      P+S      ++R +A+
Sbjct: 75  -YCSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS------LLRQIAS 126
Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLD--SDFEAH-----------ISDFGLARRIDTSHSH 251
           G+A+LH L+  IIHRD+K  N+L+   S F A            ISDFGL +++D+  S 
Sbjct: 127 GVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 252 VSTQV---AGTMGYMPPEYLGGNTA------ATVMLDVYSFGILMIEIATQ 293
             T +   +GT G+  PE L  +         T  +D++S G +   I ++
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 86  TDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKIL 144
           ++KI+G GS G V       G  VA+K++  D       E +   E+     H N+++  
Sbjct: 37  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY- 92
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
            YC+   DR L Y  +E  +L+      S+N   +  K      P+S      ++R +A+
Sbjct: 93  -YCSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS------LLRQIAS 144
Query: 205 GLAYLHGLEKPIIHRDIKSSNVLL--DSDFEAH-----------ISDFGLARRIDTSHSH 251
           G+A+LH L+  IIHRD+K  N+L+   S F A            ISDFGL +++D+    
Sbjct: 145 GVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 252 VSTQV---AGTMGYMPPEYLGGNTAA--TVMLDVYSFGILMIEIATQ 293
               +   +GT G+  PE L  +T    T  +D++S G +   I ++
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSK 249

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 88  KIIGDGSFGFV----YKAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVK 142
           + IG+G FG V    Y +  +  + VAIK          RE F  E  T+ +  H +IVK
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           ++G         +I E    G L  +L    R   +D    L SL   +++        +
Sbjct: 81  LIGVITEN-PVWIIMELCTLGELRSFLQ--VRKYSLD----LASLILYAYQ--------L 125
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
           +  LAYL    K  +HRDI + NVL+ S+    + DFGL+R ++ S  + +++    + +
Sbjct: 126 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 263 MPPEYLGGN--TAATVMLDVYSFGILMIEI 290
           M PE +     T+A+   DV+ FG+ M EI
Sbjct: 184 MAPESINFRRFTSAS---DVWMFGVCMWEI 210

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 88  KIIGDGSFGFV----YKAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVK 142
           + IG+G FG V    Y +  +  + VAIK          RE F  E  T+ +  H +IVK
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           ++G         +I E    G L  +L    R   +D    L SL   +++        +
Sbjct: 79  LIGVITEN-PVWIIMELCTLGELRSFLQ--VRKYSLD----LASLILYAYQ--------L 123
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
           +  LAYL    K  +HRDI + NVL+ S+    + DFGL+R ++ S  + +++    + +
Sbjct: 124 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 181
Query: 263 MPPEYLGGN--TAATVMLDVYSFGILMIEI 290
           M PE +     T+A+   DV+ FG+ M EI
Sbjct: 182 MAPESINFRRFTSAS---DVWMFGVCMWEI 208

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 9/161 (5%)
Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILG 145
           +++ +G F FVY+A+ + SG   A+K+L  +  +  R    E+  + KL  H NIV+   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 146 YCASGLDRVLIYEFVENGSLD-QWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
             + G       E  + G  +   L +  +   V+  K++ S  PLS +T +KI      
Sbjct: 94  AASIG------KEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
            + ++H  + PIIHRD+K  N+LL +     + DFG A  I
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 86  TDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKIL 144
           ++KI+G GS G V       G  VA+K++  D       E +   E+     H N+++  
Sbjct: 37  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY- 92
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
            YC+   DR L Y  +E  +L+      S+N   +  K      P+S      ++R +A+
Sbjct: 93  -YCSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS------LLRQIAS 144
Query: 205 GLAYLHGLEKPIIHRDIKSSNVLL--DSDFEAH-----------ISDFGLARRIDTSHSH 251
           G+A+LH L+  IIHRD+K  N+L+   S F A            ISDFGL +++D+    
Sbjct: 145 GVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 252 VSTQV---AGTMGYMPPEYLGGNTAA--TVMLDVYSFGILMIEIATQ 293
               +   +GT G+  PE L  +T    T  +D++S G +   I ++
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSK 249

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 82  DNFSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQGFRE------FRAEMETL 132
           D +   K +G G+ G V   ++ K    V + I    K A    RE         E+E L
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN-SLCPLS 191
            KL H  I+KI  +     D  ++ E +E G L          D V G+K+L  + C L 
Sbjct: 69  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL---------FDKVVGNKRLKEATCKLY 118
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGLARRIDTS 248
           +   +  V+       YLH  E  IIHRD+K  NVLL S  E     I+DFG ++ +   
Sbjct: 119 FYQMLLAVQ-------YLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--G 167
Query: 249 HSHVSTQVAGTMGYMPPEYL--GGNTAATVMLDVYSFGILM 287
            + +   + GT  Y+ PE L   G       +D +S G+++
Sbjct: 168 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 208

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRH 137
           D F   +++G G FG V+  ++ ++G   A KKL+K   +   G++    E + L K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           R IV +     +  D  L+   +  G +   +++   ++D  G ++  +         + 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNV--DEDNPGFQEPRA---------IF 293
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
               + +GL +LH  ++ II+RD+K  NVLLD D    ISD GLA  +    +  +   A
Sbjct: 294 YTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA 350
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           GT G+M PE L G       +D ++ G+ + E+
Sbjct: 351 GTPGFMAPELLLGEE-YDFSVDYFALGVTLYEM 382

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G  VA+KKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL--CPLSWETRVK-IVRG 201
                         F    SL+++ +D      + G+  LN++  C    +  V+ ++  
Sbjct: 88  DV------------FTPARSLEEF-NDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DF LAR  D       T    T  
Sbjct: 134 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLARHTDDE----MTGYVATRW 187
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           Y  PE +         +D++S G +M E+ T
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 82  DNFSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQGFRE------FRAEMETL 132
           D +   K +G G+ G V   ++ K    V + I    K A    RE         E+E L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN-SLCPLS 191
            KL H  I+KI  +     D  ++ E +E G L          D V G+K+L  + C L 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL---------FDKVVGNKRLKEATCKLY 119
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGLARRIDTS 248
           +   +  V+       YLH  E  IIHRD+K  NVLL S  E     I+DFG ++ +   
Sbjct: 120 FYQMLLAVQ-------YLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--G 168
Query: 249 HSHVSTQVAGTMGYMPPEYL--GGNTAATVMLDVYSFGILM 287
            + +   + GT  Y+ PE L   G       +D +S G+++
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 93/218 (42%), Gaps = 26/218 (11%)
Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRHR 138
           +F   + +G GSFG V+  +   +G   A+K L K+     ++      E   L  + H 
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
            I+++ G         +I +++E G L   L  + R  +         +C          
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC---------- 116
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
                  L YLH   K II+RD+K  N+LLD +    I+DFG A+ +      V+  + G
Sbjct: 117 -----LALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCG 165
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           T  Y+ PE +         +D +SFGIL+ E+     P
Sbjct: 166 TPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 82  DNFSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQGFRE------FRAEMETL 132
           D +   K +G G+ G V   ++ K    V + I    K A    RE         E+E L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN-SLCPLS 191
            KL H  I+KI  +     D  ++ E +E G L          D V G+K+L  + C L 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL---------FDKVVGNKRLKEATCKLY 119
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGLARRIDTS 248
           +   +  V+       YLH  E  IIHRD+K  NVLL S  E     I+DFG ++ +   
Sbjct: 120 FYQMLLAVQ-------YLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--G 168
Query: 249 HSHVSTQVAGTMGYMPPEYL--GGNTAATVMLDVYSFGILM 287
            + +   + GT  Y+ PE L   G       +D +S G+++
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 123/298 (41%), Gaps = 51/298 (17%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLSSG-VTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           NF T   + +   G ++K +     + V + K+   + +  R+F  E   L    H N++
Sbjct: 13  NFLTK--LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 142 KILGYCAS--GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
            +LG C S       LI  ++  GSL   LH+ + N  VD S+             VK  
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQA------------VKFA 117
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             +A G+A+LH LE  I    + S +V++D D  A         RI  +    S Q  G 
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTA---------RISMADVKFSFQSPGR 168
Query: 260 M---GYMPPEYLGGNTAATVM--LDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR 314
           M    ++ PE L      T     D++SF +L+ E+ T+  P     L   E+G+     
Sbjct: 169 MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF--ADLSNMEIGM----- 221
Query: 315 TMEARNKEIEMVDSNISREELSEAGVREYF-RIACMCTNEKSRERPAMSYVVQLLDEL 371
                   +E +   I        G+  +  ++  +C NE   +RP    +V +L+++
Sbjct: 222 -----KVALEGLRPTIP------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNI 140
           +F   + +G G FG V++AK        AIK++     +  RE    E++ L KL H  I
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLH---DTSRNDDVDGSKQLNSLCPLSWETR-- 195
           V+   Y  + L++    E ++  S   +L+      R +++     +N  C +    R  
Sbjct: 66  VR---YFNAWLEKNTT-EKLQPSSPKVYLYIQMQLCRKENL--KDWMNGRCTIEERERSV 119
Query: 196 -VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS- 253
            + I   +A  + +LH   K ++HRD+K SN+    D    + DFGL   +D      + 
Sbjct: 120 CLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 254 ----------TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
                     T   GT  YM PE + GN+ +   +D++S G+++ E+
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH-KVDIFSLGLILFEL 223

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 82  DNFSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQGFRE------FRAEMETL 132
           D +   K +G G+ G V   ++ K    V + I    K A    RE         E+E L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN-SLCPLS 191
            KL H  I+KI  +     D  ++ E +E G L          D V G+K+L  + C L 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL---------FDKVVGNKRLKEATCKLY 119
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGLARRIDTS 248
           +   +  V+       YLH  E  IIHRD+K  NVLL S  E     I+DFG ++ +   
Sbjct: 120 FYQMLLAVQ-------YLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--G 168
Query: 249 HSHVSTQVAGTMGYMPPEYL--GGNTAATVMLDVYSFGILM 287
            + +   + GT  Y+ PE L   G       +D +S G+++
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEM---ETLGKL 135
             DNF   +++G GSFG V  A++  +G   A+K L KD      +    M     L   
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 136 RHRNIVKILGYCASGLDRVL-IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           R+   +  L  C    DR+  + EFV  G L   +  + R D                E 
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----------------EA 124
Query: 195 RVKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
           R +     + + L +LH  +K II+RD+K  NVLLD +    ++DFG+ +     +   +
Sbjct: 125 RARFYAAEIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTT 181
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
               GT  Y+ PE L         +D ++ G+L+ E+
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEM 217

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 118/285 (41%), Gaps = 37/285 (12%)
Query: 90  IGDGSFGFVYKAKLSSGVT-VAIKKLDKDAFQGFR-EFRAEMETLGKLRHRNIVKILGYC 147
           IG G+FG V+  +L +  T VA+K   +      + +F  E   L +  H NIV+++G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 148 ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
                  ++ E V+ G    +L         +G++       L  +T +++V   A G+ 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR-------TEGAR-------LRVKTLLQMVGDAAAGME 227
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR-RIDTSHSHVSTQVAGTMGYMPPE 266
           YL    K  IHRD+ + N L+       ISDFG++R   D   +         + +  PE
Sbjct: 228 YLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPE 285
Query: 267 YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMV 326
            L     ++   DV+SFGIL+ E  +              +G   +      + +E    
Sbjct: 286 ALNYGRYSSES-DVWSFGILLWETFS--------------LGASPYPNLSNQQTREFVEK 330
Query: 327 DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
              +   EL    V   FR+   C   +  +RP+ S + Q L  +
Sbjct: 331 GGRLPCPELCPDAV---FRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 113/281 (40%), Gaps = 47/281 (16%)
Query: 90  IGDGSFGFV----YKAKLSSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVK 142
           +GDGSFG V    + A     V+VA+K L  D     +   +F  E+  +  L HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           + G   +   + ++ E    GSL        R     G   L +L         +    V
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSL------LDRLRKHQGHFLLGTLS--------RYAVQV 120
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM-- 260
           A G+ YL    K  IHRD+ + N+LL +     I DFGL R +  +  H   Q    +  
Sbjct: 121 AEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF 178
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE--VGLLEWARTMEA 318
            +  PE L   T +    D + FG+ + E+ T           GQE  +GL         
Sbjct: 179 AWCAPESLKTRTFSHAS-DTWMFGVTLWEMFTY----------GQEPWIGL--------N 219
Query: 319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
            ++ +  +D    R    E   ++ + +   C   K  +RP
Sbjct: 220 GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRP 260

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 82  DNFSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQGFRE------FRAEMETL 132
           D +   K +G G+ G V   ++ K    V + I    K A    RE         E+E L
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN-SLCPLS 191
            KL H  I+KI  +     D  ++ E +E G L          D V G+K+L  + C L 
Sbjct: 76  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL---------FDKVVGNKRLKEATCKLY 125
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGLARRIDTS 248
           +   +  V+       YLH  E  IIHRD+K  NVLL S  E     I+DFG ++ +   
Sbjct: 126 FYQMLLAVQ-------YLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--G 174
Query: 249 HSHVSTQVAGTMGYMPPEYL--GGNTAATVMLDVYSFGILM 287
            + +   + GT  Y+ PE L   G       +D +S G+++
Sbjct: 175 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 215

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+K+L        R+F+ E++ L  L    IVK  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 145 G--YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G  Y     +  L+ E++ +G L  +L        +D S+ L                 +
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQ--RHRARLDASRLL------------LYSSQI 120
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQVAGTM 260
             G+ YL    +  +HRD+ + N+L++S+    I+DFGLA+   +D     V       +
Sbjct: 121 CKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPI 178
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +  PE L  N  +    DV+SFG+++ E+ T
Sbjct: 179 FWYAPESLSDNIFSR-QSDVWSFGVVLYELFT 209

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 113/282 (40%), Gaps = 47/282 (16%)
Query: 90  IGDGSFGFV----YKAKLSSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVK 142
           +GDGSFG V    + A     V+VA+K L  D     +   +F  E+  +  L HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           + G   +   + ++ E    GSL        R     G   L +L         +    V
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSL------LDRLRKHQGHFLLGTLS--------RYAVQV 120
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM-- 260
           A G+ YL    K  IHRD+ + N+LL +     I DFGL R +  +  H   Q    +  
Sbjct: 121 AEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE--VGLLEWARTMEA 318
            +  PE L   T +    D + FG+ + E+ T           GQE  +GL         
Sbjct: 179 AWCAPESLKTRTFSHAS-DTWMFGVTLWEMFTY----------GQEPWIGL--------N 219
Query: 319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
            ++ +  +D    R    E   ++ + +   C   K  +RP 
Sbjct: 220 GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRH 137
           D F   +++G G FG V+  ++ ++G   A KKL+K   +   G++    E + L K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           R IV +     +  D  L+   +  G +   +++   ++D  G ++  +         + 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNV--DEDNPGFQEPRA---------IF 293
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
               + +GL +LH  ++ II+RD+K  NVLLD D    ISD GLA  +    +  +   A
Sbjct: 294 YTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA 350
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           GT G+M PE L G       +D ++ G+ + E+
Sbjct: 351 GTPGFMAPELLLGEE-YDFSVDYFALGVTLYEM 382

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRH 137
           D F   +++G G FG V+  ++ ++G   A KKL+K   +   G++    E + L K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           R IV +     +  D  L+   +  G +   +++   ++D  G ++  +         + 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNV--DEDNPGFQEPRA---------IF 293
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
               + +GL +LH  ++ II+RD+K  NVLLD D    ISD GLA  +    +  +   A
Sbjct: 294 YTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA 350
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           GT G+M PE L G       +D ++ G+ + E+
Sbjct: 351 GTPGFMAPELLLGEE-YDFSVDYFALGVTLYEM 382

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRH 137
           D F   +++G G FG V+  ++ ++G   A KKL+K   +   G++    E + L K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           R IV +     +  D  L+   +  G +   +++   ++D  G ++  +         + 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNV--DEDNPGFQEPRA---------IF 293
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
               + +GL +LH  ++ II+RD+K  NVLLD D    ISD GLA  +    +  +   A
Sbjct: 294 YTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA 350
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           GT G+M PE L G       +D ++ G+ + E+
Sbjct: 351 GTPGFMAPELLLGEE-YDFSVDYFALGVTLYEM 382

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 88  KIIGDGSFGFV----YKAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVK 142
           + IG+G FG V    Y +  +  + VAIK          RE F  E  T+ +  H +IVK
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           ++G         +I E    G L  +L    R   +D    L SL   +++        +
Sbjct: 76  LIGVITEN-PVWIIMELCTLGELRSFLQ--VRKFSLD----LASLILYAYQ--------L 120
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
           +  LAYL    K  +HRDI + NVL+ S+    + DFGL+R ++ S    +++    + +
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKW 178
Query: 263 MPPEYLGGN--TAATVMLDVYSFGILMIEI 290
           M PE +     T+A+   DV+ FG+ M EI
Sbjct: 179 MAPESINFRRFTSAS---DVWMFGVCMWEI 205

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 113/281 (40%), Gaps = 47/281 (16%)
Query: 90  IGDGSFGFV----YKAKLSSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVK 142
           +GDGSFG V    + A     V+VA+K L  D     +   +F  E+  +  L HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           + G   +   + ++ E    GSL        R     G   L +L         +    V
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSL------LDRLRKHQGHFLLGTLS--------RYAVQV 120
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM-- 260
           A G+ YL    K  IHRD+ + N+LL +     I DFGL R +  +  H   Q    +  
Sbjct: 121 AEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE--VGLLEWARTMEA 318
            +  PE L   T +    D + FG+ + E+ T           GQE  +GL         
Sbjct: 179 AWCAPESLKTRTFSHAS-DTWMFGVTLWEMFTY----------GQEPWIGL--------N 219
Query: 319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
            ++ +  +D    R    E   ++ + +   C   K  +RP
Sbjct: 220 GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRP 260

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 113/282 (40%), Gaps = 47/282 (16%)
Query: 90  IGDGSFGFV----YKAKLSSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVK 142
           +GDGSFG V    + A     V+VA+K L  D     +   +F  E+  +  L HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           + G   +   + ++ E    GSL        R     G   L +L         +    V
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSL------LDRLRKHQGHFLLGTLS--------RYAVQV 124
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM-- 260
           A G+ YL    K  IHRD+ + N+LL +     I DFGL R +  +  H   Q    +  
Sbjct: 125 AEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 182
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE--VGLLEWARTMEA 318
            +  PE L   T +    D + FG+ + E+ T           GQE  +GL         
Sbjct: 183 AWCAPESLKTRTFSHAS-DTWMFGVTLWEMFTY----------GQEPWIGL--------N 223
Query: 319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
            ++ +  +D    R    E   ++ + +   C   K  +RP 
Sbjct: 224 GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 88  KIIGDGSFGFV----YKAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVK 142
           + IG+G FG V    Y +  +  + VAIK          RE F  E  T+ +  H +IVK
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           ++G         +I E    G L  +L    R   +D    L SL   +++        +
Sbjct: 456 LIGVITEN-PVWIIMELCTLGELRSFLQ--VRKFSLD----LASLILYAYQ--------L 500
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
           +  LAYL    K  +HRDI + NVL+ S+    + DFGL+R ++ S  + +++    + +
Sbjct: 501 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 263 MPPEYLGGN--TAATVMLDVYSFGILMIEI 290
           M PE +     T+A+   DV+ FG+ M EI
Sbjct: 559 MAPESINFRRFTSAS---DVWMFGVCMWEI 585

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 81  TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA---EMETLGKLR 136
           +D +   +++G GSFG V   K   +G   A+K + K   +   +  +   E++ L +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NI K+  +        L+ E    G L   +    R  +VD ++              
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-------------- 130
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHISDFGLARRIDTSHSHVS 253
            I+R V +G+ Y H  +  I+HRD+K  N+LL+S   D    I DFGL+   + S     
Sbjct: 131 -IIRQVLSGITYXH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--X 185
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
               GT  Y+ PE L G        DV+S G+++
Sbjct: 186 KDKIGTAYYIAPEVLHGTYDEKC--DVWSTGVIL 217

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 121/298 (40%), Gaps = 48/298 (16%)
Query: 73  SMSELIDATDNFSTDKIIGDGSFGFV----YKAKLSSGVTVAIKKLDKDAF---QGFREF 125
           S++ LI   D    +K+ GDGSFG V    + A     V+VA+K L  D     +   +F
Sbjct: 4   SLTCLIGEKDLRLLEKL-GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 62
Query: 126 RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN 185
             E+  +  L HRN++++ G   +   + ++ E    GSL        R     G   L 
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSL------LDRLRKHQGHFLLG 115
Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
           +L         +    VA G+ YL    K  IHRD+ + N+LL +     I DFGL R +
Sbjct: 116 TLS--------RYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165
Query: 246 DTSHSHVSTQVAGTM--GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD 303
             +  H   Q    +   +  PE L   T +    D + FG+ + E+ T           
Sbjct: 166 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS-DTWMFGVTLWEMFTY---------- 214
Query: 304 GQE--VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
           GQE  +GL          ++ +  +D    R    E   ++ + +   C   K  +RP
Sbjct: 215 GQEPWIGL--------NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRP 264

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 121/298 (40%), Gaps = 48/298 (16%)
Query: 73  SMSELIDATDNFSTDKIIGDGSFGFV----YKAKLSSGVTVAIKKLDKDAF---QGFREF 125
           S++ LI   D    +K+ GDGSFG V    + A     V+VA+K L  D     +   +F
Sbjct: 10  SLTCLIGEKDLRLLEKL-GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 126 RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN 185
             E+  +  L HRN++++ G   +   + ++ E    GSL        R     G   L 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSL------LDRLRKHQGHFLLG 121
Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
           +L         +    VA G+ YL    K  IHRD+ + N+LL +     I DFGL R +
Sbjct: 122 TLS--------RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171
Query: 246 DTSHSHVSTQVAGTM--GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD 303
             +  H   Q    +   +  PE L   T +    D + FG+ + E+ T           
Sbjct: 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS-DTWMFGVTLWEMFTY---------- 220
Query: 304 GQE--VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
           GQE  +GL          ++ +  +D    R    E   ++ + +   C   K  +RP
Sbjct: 221 GQEPWIGL--------NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRP 270

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 121/298 (40%), Gaps = 48/298 (16%)
Query: 73  SMSELIDATDNFSTDKIIGDGSFGFV----YKAKLSSGVTVAIKKLDKDAF---QGFREF 125
           S++ LI   D    +K+ GDGSFG V    + A     V+VA+K L  D     +   +F
Sbjct: 10  SLTCLIGEKDLRLLEKL-GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 126 RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN 185
             E+  +  L HRN++++ G   +   + ++ E    GSL        R     G   L 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSL------LDRLRKHQGHFLLG 121
Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
           +L         +    VA G+ YL    K  IHRD+ + N+LL +     I DFGL R +
Sbjct: 122 TLS--------RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171
Query: 246 DTSHSHVSTQVAGTM--GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD 303
             +  H   Q    +   +  PE L   T +    D + FG+ + E+ T           
Sbjct: 172 PQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHAS-DTWMFGVTLWEMFTY---------- 220
Query: 304 GQE--VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
           GQE  +GL          ++ +  +D    R    E   ++ + +   C   K  +RP
Sbjct: 221 GQEPWIGL--------NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRP 270

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+K+L        R+F+ E++ L  L    IVK  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 145 G--YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G  Y        L+ E++ +G L  +L        +D S+ L                 +
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLL------------LYSSQI 123
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQVAGTM 260
             G+ YL    +  +HRD+ + N+L++S+    I+DFGLA+   +D  +  V       +
Sbjct: 124 CKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 181
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +  PE L  N  +    DV+SFG+++ E+ T
Sbjct: 182 FWYAPESLSDNIFSR-QSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+K+L        R+F+ E++ L  L    IVK  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 145 G--YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G  Y        L+ E++ +G L  +L        +D S+ L                 +
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLL------------LYSSQI 124
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQVAGTM 260
             G+ YL    +  +HRD+ + N+L++S+    I+DFGLA+   +D  +  V       +
Sbjct: 125 CKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 182
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +  PE L  N  +    DV+SFG+++ E+ T
Sbjct: 183 FWYAPESLSDNIFSR-QSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 90  IGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V   +      ++G  VA+K+L        R+F+ E++ L  L    IVK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 145 G--YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           G  Y        L+ E++ +G L  +L        +D S+ L                 +
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLL------------LYSSQI 136
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQVAGTM 260
             G+ YL    +  +HRD+ + N+L++S+    I+DFGLA+   +D  +  V       +
Sbjct: 137 CKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            +  PE L  N  +    DV+SFG+++ E+ T
Sbjct: 195 FWYAPESLSDNIFSR-QSDVWSFGVVLYELFT 225

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 88  KIIGDGSFGFVYKA-KLSSG----VTVAIKKLDKD-AFQGFREFRAEMETLGKLRHRNIV 141
           K++G G+FG VYK   +  G    + VAIK L ++ + +  +E   E   +  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++LG C +   + L+ + +  G L   L     N    GS+ L + C             
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCL---LDHVRENRGRLGSQDLLNWC-----------MQ 127
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +A G++YL  +   ++HRD+ + NVL+ S     I+DFGLAR +D       T+     G
Sbjct: 128 IAKGMSYLEDVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYHADGG 181
Query: 262 YMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
            +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 182 KVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 15/210 (7%)
Query: 82  DNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           ++FS  +IIG G FG VY   K  +G   A+K LDK   +       + ETL  L  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-----MKQGETLA-LNERIM 242
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           + ++          + Y F     L  ++ D     D+     L+     S         
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLS-FILDLMNGGDL--HYHLSQHGVFSEADMRFYAA 299
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +  GL ++H   + +++RD+K +N+LLD      ISD GLA        H S    GT 
Sbjct: 300 EIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 354
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           GYM PE L    A     D +S G ++ ++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 15/210 (7%)
Query: 82  DNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           ++FS  +IIG G FG VY   K  +G   A+K LDK   +       + ETL  L  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-----MKQGETLA-LNERIM 242
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           + ++          + Y F     L  ++ D     D+     L+     S         
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLS-FILDLMNGGDL--HYHLSQHGVFSEADMRFYAA 299
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +  GL ++H   + +++RD+K +N+LLD      ISD GLA        H S    GT 
Sbjct: 300 EIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 354
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           GYM PE L    A     D +S G ++ ++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  L +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           ++H N++ +     +  D +LI E V  G L  +L +                  L+ E 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---------------SLTEEE 115
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDF---EAHISDFGLARRIDTSHS 250
             + ++ + NG+ YLH L+  I H D+K  N+ LLD +       I DFGLA +ID  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 174 F--KNIFGTPAFVAPEIVNYEPLG-LEADMWSIGVI 206

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 82  DNFSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQGFRE------FRAEMETL 132
           D +   K +G G+ G V   ++ K    V + I    K A    RE         E+E L
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN-SLCPLS 191
            KL H  I+KI  +     D  ++ E +E G L          D V G+K+L  + C L 
Sbjct: 209 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL---------FDKVVGNKRLKEATCKLY 258
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGLARRIDTS 248
           +   +  V+       YLH  E  IIHRD+K  NVLL S  E     I+DFG ++ +   
Sbjct: 259 FYQMLLAVQ-------YLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--G 307
Query: 249 HSHVSTQVAGTMGYMPPEYL--GGNTAATVMLDVYSFGILMI 288
            + +   + GT  Y+ PE L   G       +D +S G+++ 
Sbjct: 308 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 349

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLD--KDAFQGFREFRAEMETLGKLRHRNIVKILGY 146
           IG+GSFG     K +  G    IK+++  + + +   E R E+  L  ++H NIV+   Y
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ---Y 88
Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
             S         F ENGSL   + D     D+   K++N+   + ++    +   V   L
Sbjct: 89  RES---------FEENGSL-YIVMDYCEGGDL--FKRINAQKGVLFQEDQILDWFVQICL 136
Query: 207 AYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE 266
           A  H  ++ I+HRDIKS N+ L  D    + DFG+AR ++++   ++    GT  Y+ PE
Sbjct: 137 ALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VELARACIGTPYYLSPE 195
Query: 267 YLGGNTAATVMLDVYSFGILMIEIAT 292
            +  N       D+++ G ++ E+ T
Sbjct: 196 -ICENKPYNNKSDIWALGCVLYELCT 220

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 15/210 (7%)
Query: 82  DNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           ++FS  +IIG G FG VY   K  +G   A+K LDK   +       + ETL  L  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-----MKQGETLA-LNERIM 242
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           + ++          + Y F     L  ++ D     D+     L+     S         
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLS-FILDLMNGGDL--HYHLSQHGVFSEADMRFYAA 299
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +  GL ++H   + +++RD+K +N+LLD      ISD GLA        H S    GT 
Sbjct: 300 EIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 354
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           GYM PE L    A     D +S G ++ ++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 88  KIIGDGSFGFV----YKAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVK 142
           + IG+G FG V    Y +  +  + VAIK          RE F  E  T+ +  H +IVK
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           ++G         +I E    G L  +L    R   +D    L SL   +++        +
Sbjct: 76  LIGVITEN-PVWIIMELCTLGELRSFLQ--VRKFSLD----LASLILYAYQ--------L 120
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
           +  LAYL    K  +HRDI + NVL+ +     + DFGL+R ++ S  + +++    + +
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 263 MPPEYLGGN--TAATVMLDVYSFGILMIEI 290
           M PE +     T+A+   DV+ FG+ M EI
Sbjct: 179 MAPESINFRRFTSAS---DVWMFGVCMWEI 205

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQ----GFREFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    +G  VAIKKL +  FQ      R +R E+  L  +RH N++   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYR-ELRLLKHMRHENVI--- 87
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK-IVRGVA 203
                GL  V   +   +   D +L       D+    +   L     E R++ +V  + 
Sbjct: 88  -----GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG----EDRIQFLVYQML 138
Query: 204 NGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYM 263
            GL Y+H     IIHRD+K  N+ ++ D E  I DFGLAR+ D   S +   V  T  Y 
Sbjct: 139 KGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMXGXVV-TRWYR 192
Query: 264 PPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            PE +      T  +D++S G +M E+ T
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMIT 221

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 15/210 (7%)
Query: 82  DNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           ++FS  +IIG G FG VY   K  +G   A+K LDK   +       + ETL  L  R +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-----MKQGETLA-LNERIM 241
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           + ++          + Y F     L  ++ D     D+     L+     S         
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLS-FILDLMNGGDL--HYHLSQHGVFSEADMRFYAA 298
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +  GL ++H   + +++RD+K +N+LLD      ISD GLA        H S    GT 
Sbjct: 299 EIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 353
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           GYM PE L    A     D +S G ++ ++
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKL 383

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 82  DNFSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQGFRE------FRAEMETL 132
           D +   K +G G+ G V   ++ K    V + I    K A    RE         E+E L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN-SLCPLS 191
            KL H  I+KI  +     D  ++ E +E G L          D V G+K+L  + C L 
Sbjct: 195 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL---------FDKVVGNKRLKEATCKLY 244
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGLARRIDTS 248
           +   +  V+       YLH  E  IIHRD+K  NVLL S  E     I+DFG ++ +   
Sbjct: 245 FYQMLLAVQ-------YLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--G 293
Query: 249 HSHVSTQVAGTMGYMPPEYL--GGNTAATVMLDVYSFGILMI 288
            + +   + GT  Y+ PE L   G       +D +S G+++ 
Sbjct: 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKA---KLSSGVTVAIKKLDK---DAF---QGFREFRAEM 129
           + +  +ST   +G G+FGFV+ A   + +  V V   K +K   D +       +   E+
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 130 ETLGKLRHRNIVKILG-YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLC 188
             L ++ H NI+K+L  +   G  ++++ +      L  ++    R D+           
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE----------- 129
Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS 248
           PL+      I R + + + YL    K IIHRDIK  N+++  DF   + DFG A  ++  
Sbjct: 130 PLA----SYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-- 181
Query: 249 HSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
              +     GT+ Y  PE L GN      L+++S G+ +  +  +  P
Sbjct: 182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 82  DNFSTDKIIGDGSFGFVYK-AKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           D++   + +G G+FG V++  + ++G   A K +           R E++T+  LRH  +
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V +        + V+IYEF+  G L + + D                  +S +  V+ +R
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--------------MSEDEAVEYMR 262
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDS--DFEAHISDFGLARRIDTSHSHVSTQVAG 258
            V  GL ++H  E   +H D+K  N++  +    E  + DFGL   +D   S   T   G
Sbjct: 263 QVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TG 318
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           T  +  PE   G        D++S G+L   + + + P
Sbjct: 319 TAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSP 355

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 70  SQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD--KDAFQGFREFR 126
           S+  M+     +DN+   + +G G+F  V +    ++G+  A K ++  K + + F++  
Sbjct: 17  SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE 76
Query: 127 AEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNS 186
            E     KL+H NIV++           L+++ V  G L + +       + D S     
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---- 132
Query: 187 LCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA---HISDFGLAR 243
                       ++ +   +AY H     I+HR++K  N+LL S  +     ++DFGLA 
Sbjct: 133 -----------CIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA- 178
Query: 244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
            I+ + S      AGT GY+ PE L  +  +   +D+++ G+++
Sbjct: 179 -IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVIL 220

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI 130
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 131 ------AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 181
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 182 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 90  IGDGSFGFV----YKAKLSSGVTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKIL 144
           +G G+FG V    Y+ +    + VAIK L +   +    E   E + + +L +  IV+++
Sbjct: 18  LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 145 GYC-ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA 203
           G C A  L  +L+ E    G L ++L    + +++          P+S     +++  V+
Sbjct: 77  GVCQAEAL--MLVMEMAGGGPLHKFL--VGKREEI----------PVS--NVAELLHQVS 120
Query: 204 NGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT--MG 261
            G+ YL   EK  +HRD+ + NVLL +   A ISDFGL++ +    S+ + + AG   + 
Sbjct: 121 MGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIE 289
           +  PE +     ++   DV+S+G+ M E
Sbjct: 179 WYAPECINFRKFSS-RSDVWSYGVTMWE 205

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 84  FSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIV 141
           F   + +G G+F  V  A+  ++G   A+K + K A +G       E+  L K++H NIV
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +     S     L+ + V  G L   + +     + D S                ++R 
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS---------------TLIRQ 128
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLL---DSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           V + + YLH +   I+HRD+K  N+L    D + +  ISDFGL++        V +   G
Sbjct: 129 VLDAVYYLHRM--GIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACG 184
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGIL 286
           T GY+ PE L     +   +D +S G++
Sbjct: 185 TPGYVAPEVLAQKPYSKA-VDCWSIGVI 211

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++
Sbjct: 79  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI 129
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 130 ------AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 180
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 181 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD--KDAFQGFREFRAEMETLGKLRH 137
           +DN+   + +G G+F  V +    ++G+  A K ++  K + + F++   E     KL+H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV++           L+++ V  G L + +       + D S                
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--------------- 109
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA---HISDFGLARRIDTSHSHVST 254
            ++ +   +AY H     I+HR++K  N+LL S  +     ++DFGLA  I+ + S    
Sbjct: 110 CIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH 165
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
             AGT GY+ PE L  +  +   +D+++ G+++
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSK-PVDIWACGVIL 197

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMET 131
           +  D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           L +++H N++ +     +  D +LI E V  G L  +L +                  L+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---------------SLT 112
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDF---EAHISDFGLARRIDT 247
            E   + ++ + NG+ YLH L+  I H D+K  N+ LLD +       I DFGLA +ID 
Sbjct: 113 EEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
            +      + GT  ++ PE +       +  D++S G++
Sbjct: 171 GNEF--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 206

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI 127
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 128 ------AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 178
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 179 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 82  DNFSTDKIIGDGSFGFVYK-AKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           D++   + +G G+FG V++  + ++G   A K +           R E++T+  LRH  +
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V +        + V+IYEF+  G L + + D                  +S +  V+ +R
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--------------MSEDEAVEYMR 156
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSD--FEAHISDFGLARRIDTSHSHVSTQVAG 258
            V  GL ++H  E   +H D+K  N++  +    E  + DFGL   +D   S   T   G
Sbjct: 157 QVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TG 212
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           T  +  PE   G        D++S G+L   + + + P
Sbjct: 213 TAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSP 249

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++
Sbjct: 76  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI 126
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 127 ------AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 177
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 178 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD--KDAFQGFREFRAEMETLGKLRH 137
           +DN+   + +G G+F  V +    ++G+  A K ++  K + + F++   E     KL+H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV++           L+++ V  G L + +       + D S                
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--------------- 108
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA---HISDFGLARRIDTSHSHVST 254
            ++ +   +AY H     I+HR++K  N+LL S  +     ++DFGLA  I+ + S    
Sbjct: 109 CIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH 164
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
             AGT GY+ PE L  +  +   +D+++ G+++
Sbjct: 165 GFAGTPGYLSPEVLKKDPYSK-PVDIWACGVIL 196

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI 126
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 127 ------AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 177
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 178 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L + C       V
Sbjct: 86  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWC-------V 134
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +I    A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 135 QI----AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 187
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 188 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI 129
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 130 ------AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 180
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 181 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI 128
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 129 ------AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 179
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 180 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L + C       V
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVRE---HKDNIGSQYLLNWC-------V 125
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +I    A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 126 QI----AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 178
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 179 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI 129
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 130 ------AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 180
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 181 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI 133
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 134 ------AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 184
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 185 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI 128
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 129 ------AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 179
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 180 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L + C       V
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWC-------V 127
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +I    A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 128 QI----AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 180
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 181 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L + C        
Sbjct: 70  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWC-------- 117
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                +A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 118 ---VQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 171
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 172 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L + C       V
Sbjct: 73  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWC-------V 121
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +I    A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 122 QI----AEGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 174
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 175 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 85  STDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKI 143
           S  +I+G G FG V+K +  ++G+ +A K +     +   E + E+  + +L H N++++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA 203
                S  D VL+ E+V+ G L   + D S N              L+    +  ++ + 
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYN--------------LTELDTILFMKQIC 197
Query: 204 NGLAYLHGLEKPIIHRDIKSSNVL-LDSDF-EAHISDFGLARRIDTSHSHVSTQVAGTMG 261
            G+ ++H +   I+H D+K  N+L ++ D  +  I DFGLARR             GT  
Sbjct: 198 EGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN--FGTPE 253
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNL 298
           ++ PE +  +   +   D++S G++   + + + P L
Sbjct: 254 FLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPFL 289

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L + C       V
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWC-------V 124
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +I    A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 125 QI----AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 177
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 178 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD--KDAFQGFREFRAEMETLGKLRH 137
           +DN+   + +G G+F  V +    ++G+  A K ++  K + + F++   E     KL+H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV++           L+++ V  G L + +       + D S                
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--------------- 109
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA---HISDFGLARRIDTSHSHVST 254
            ++ +   +AY H     I+HR++K  N+LL S  +     ++DFGLA  I+ + S    
Sbjct: 110 CIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH 165
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
             AGT GY+ PE L  +  +   +D+++ G+++
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSK-PVDIWACGVIL 197

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 33/224 (14%)
Query: 84  FSTDKIIGDGSFGFVYKAKLSSGVTV----AIKKLDKDAF----QGFREFRAEMETLGKL 135
           F   +++G G +G V++ +  +G       A+K L K       +     +AE   L ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           +H  IV ++    +G    LI E++  G L   L       + +G    ++ C    E  
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL-------EREGIFMEDTACFYLAE-- 129
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                 ++  L +LH  +K II+RD+K  N++L+      ++DFGL +        V+  
Sbjct: 130 ------ISMALGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHX 180
Query: 256 VAGTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
             GT+ YM PE L   G N A    +D +S G LM ++ T   P
Sbjct: 181 FCGTIEYMAPEILMRSGHNRA----VDWWSLGALMYDMLTGAPP 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 84  FSTDKIIGDGSFGFVYKAKLSSGVTV----AIKKLDKDAF----QGFREFRAEMETLGKL 135
           F   +++G G +G V++ +  +G       A+K L K       +     +AE   L ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           +H  IV ++    +G    LI E++  G L   L       + +G    ++ C    E  
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL-------EREGIFMEDTACFYLAE-- 129
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                 ++  L +LH  +K II+RD+K  N++L+      ++DFGL +  ++ H    T 
Sbjct: 130 ------ISMALGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTH 179
Query: 256 V-AGTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
              GT+ YM PE L   G N A    +D +S G LM ++ T   P
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRA----VDWWSLGALMYDMLTGAPP 220

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L + C       V
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVRE---HKDNIGSQYLLNWC-------V 124
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +I    A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 125 QI----AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 177
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 178 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++
Sbjct: 82  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI 132
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 133 ------AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 183
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 184 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 88  KIIGDGSFGFV----YKAKLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVK 142
           + IG+G FG V    Y +  +  + VAIK          RE F  E  T+ +  H +IVK
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           ++G         +I E    G L  +L    R   +D    L SL   +++        +
Sbjct: 456 LIGVITEN-PVWIIMELCTLGELRSFLQ--VRKFSLD----LASLILYAYQ--------L 500
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
           +  LAYL    K  +HRDI + NVL+ +     + DFGL+R ++ S  + +++    + +
Sbjct: 501 STALAYLES--KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 263 MPPEYLGGN--TAATVMLDVYSFGILMIEI 290
           M PE +     T+A+   DV+ FG+ M EI
Sbjct: 559 MAPESINFRRFTSAS---DVWMFGVCMWEI 585

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  L +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           ++H N++ +     +  D +LI E V  G L  +L +                  L+ E 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------------LTEEE 115
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFEA---HISDFGLARRIDTSHS 250
             + ++ + NG+ YLH L+  I H D+K  N+ LLD +       I DFGLA +ID  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 174 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMET 131
           +  D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           L +++H N++ +     +  D +LI E V  G L  +L +                  L+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------------LT 112
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFEA---HISDFGLARRIDT 247
            E   + ++ + NG+ YLH L+  I H D+K  N+ LLD +       I DFGLA +ID 
Sbjct: 113 EEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
            +      + GT  ++ PE +       +  D++S G++
Sbjct: 171 GNEF--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 206

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  L +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           ++H N++ +     +  D +LI E V  G L  +L +                  L+ E 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------------LTEEE 114
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFEA---HISDFGLARRIDTSHS 250
             + ++ + NG+ YLH L+  I H D+K  N+ LLD +       I DFGLA +ID  + 
Sbjct: 115 ATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 173 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 205

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  L +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           ++H N++ +     +  D +LI E V  G L  +L +                  L+ E 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---------------SLTEEE 115
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFEA---HISDFGLARRIDTSHS 250
             + ++ + NG+ YLH L+  I H D+K  N+ LLD +       I DFGLA +ID  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 174 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 206

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  L +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           ++H N++ +     +  D +LI E V  G L  +L +                  L+ E 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---------------SLTEEE 115
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFEA---HISDFGLARRIDTSHS 250
             + ++ + NG+ YLH L+  I H D+K  N+ LLD +       I DFGLA +ID  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 174 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 206

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  L +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           ++H N++ +     +  D +LI E V  G L  +L +                  L+ E 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------------LTEEE 115
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFEA---HISDFGLARRIDTSHS 250
             + ++ + NG+ YLH L+  I H D+K  N+ LLD +       I DFGLA +ID  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 174 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 206

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++
Sbjct: 101 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI 151
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 152 ------AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 202
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 203 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  L +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           ++H N++ +     +  D +LI E V  G L  +L +                  L+ E 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------------LTEEE 114
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFEA---HISDFGLARRIDTSHS 250
             + ++ + NG+ YLH L+  I H D+K  N+ LLD +       I DFGLA +ID  + 
Sbjct: 115 ATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 173 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 205

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMET 131
           +  D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           L +++H N++ +     +  D +LI E V  G L  +L +                  L+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------------LT 112
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFEA---HISDFGLARRIDT 247
            E   + ++ + NG+ YLH L+  I H D+K  N+ LLD +       I DFGLA +ID 
Sbjct: 113 EEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
            +      + GT  ++ PE +       +  D++S G++
Sbjct: 171 GNEF--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 206

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  L +
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           ++H N++ +     +  D +LI E V  G L  +L +                  L+ E 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------------LTEEE 115
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFEA---HISDFGLARRIDTSHS 250
             + ++ + NG+ YLH L+  I H D+K  N+ LLD +       I DFGLA +ID  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 174 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 206

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 33/214 (15%)
Query: 90  IGDGSFGFVYKAK--LSSGVTVAIKKL------DKDAFQGFREFRAEMETLGKLRHRNIV 141
           IG+G++G V+KA+   + G  VA+K++      +       RE  A +  L    H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPNVV 77
Query: 142 KILGYCA-SGLDR----VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           ++   C  S  DR     L++E V     DQ L  T+  D V           +  ET  
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-----DQDL--TTYLDKVPEPG-------VPTETIK 123
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            ++  +  GL +LH     ++HRD+K  N+L+ S  +  ++DFGLAR    S     T V
Sbjct: 124 DMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSV 179
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             T+ Y  PE L  ++ AT + D++S G +  E+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEM 212

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 37/231 (16%)
Query: 86  TDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKIL 144
           ++KI+G GS G V       G  VA+K++  D       E +   E+     H N+++  
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY- 74
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
            YC+   DR L Y  +E  +L+      S+N   +  K      P+S      ++R +A+
Sbjct: 75  -YCSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS------LLRQIAS 126
Query: 205 GLAYLHGLEKPIIHRDIKSSNVLL--DSDFEAH-----------ISDFGLARRIDTSHSH 251
           G+A+LH L+  IIHRD+K  N+L+   S F A            ISDFGL +++D+    
Sbjct: 127 GVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 184
Query: 252 VSTQV---AGTMGYMPPEYLGGNTA------ATVMLDVYSFGILMIEIATQ 293
               +   +GT G+  PE L  +         T  +D++S G +   I ++
Sbjct: 185 FRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 24/219 (10%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLSSG-VTVAIKKLDKDAFQGFREFRAEMET----LGKLRH 137
           +F   K+IG GSFG V  A+  +  V  A+K L K A    +E +  M      L  ++H
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +V +     +      + +++  G L   L                  C L    R  
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ--------------RERCFLEPRARFY 144
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
               +A+ L YLH L   I++RD+K  N+LLDS     ++DFGL +  +  H+  ++   
Sbjct: 145 AAE-IASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFC 200
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE L        + D +  G ++ E+   + P
Sbjct: 201 GTPEYLAPEVLHKQPYDRTV-DWWCLGAVLYEMLYGLPP 238

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 27/218 (12%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFRE--FRAEMETLGKLRHRNIVKILGY 146
           IG GS+G   K +  S G  +  K+LD  +     +    +E+  L +L+H NIV+   Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR---Y 70
Query: 147 CASGLDRV-----LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
               +DR      ++ E+ E G L   +          G+K+   L     E  ++++  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVI--------TKGTKERQYL---DEEFVLRVMTQ 119
Query: 202 VANGLAYLHGLE---KPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           +   L   H        ++HRD+K +NV LD      + DFGLAR ++   S   T V G
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-G 178
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           T  YM PE +    +     D++S G L+ E+   + P
Sbjct: 179 TPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 31/206 (15%)
Query: 88  KIIGDGSFG--FVYKAKLSSGVTVAIKKLDKDAFQGFRE--FRAEMETLGKLRHRNIVKI 143
           +++G G+F   F+ K +L+ G   A+K + K     FR+     E+  L K++H NIV +
Sbjct: 15  EVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTL 71
Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA 203
                S     L+ + V  G L   + +     + D S                +++ V 
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS---------------LVIQQVL 116
Query: 204 NGLAYLHGLEKPIIHRDIKSSNVLL---DSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
           + + YLH  E  I+HRD+K  N+L    + + +  I+DFGL++      + + +   GT 
Sbjct: 117 SAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTACGTP 171
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGIL 286
           GY+ PE L     +   +D +S G++
Sbjct: 172 GYVAPEVLAQKPYSKA-VDCWSIGVI 196

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 33/214 (15%)
Query: 90  IGDGSFGFVYKAK--LSSGVTVAIKKL------DKDAFQGFREFRAEMETLGKLRHRNIV 141
           IG+G++G V+KA+   + G  VA+K++      +       RE  A +  L    H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPNVV 77
Query: 142 KILGYCA-SGLDR----VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           ++   C  S  DR     L++E V     DQ L  T+  D V           +  ET  
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-----DQDL--TTYLDKVPEPG-------VPTETIK 123
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            ++  +  GL +LH     ++HRD+K  N+L+ S  +  ++DFGLAR    S     T V
Sbjct: 124 DMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSV 179
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             T+ Y  PE L  ++ AT + D++S G +  E+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEM 212

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKAKLSSGVTV--AIKKLDKDAFQGFREFRAEMETLGKLR 136
           D    ++ +  IG GS+G V K  +  G  +  A KK+ K   +    F+ E+E +  L 
Sbjct: 6   DINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSL-DQWLHD-TSRNDDVDGSKQLNSLCPLSWET 194
           H NI+++        D  L+ E    G L ++ +H    R  D                 
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA---------------- 108
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL---DSDFEAHISDFGLARRIDTSHSH 251
             +I++ V + +AY H L   + HRD+K  N L      D    + DFGLA R       
Sbjct: 109 -ARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KM 164
Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           + T+V GT  Y+ P+ L G        D +S G++M
Sbjct: 165 MRTKV-GTPYYVSPQVLEGLYGPEC--DEWSAGVMM 197

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 38/215 (17%)
Query: 90  IGDGSFGFVYKAKLSSGVT-VAIKKLDKDAFQGFR-------------EFRAEMETLGKL 135
           +G G++G V   K  +G +  AIK + K  F   R             E   E+  L  L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
            H NI+K+           L+ EF E G L + + +  + D+ D +              
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN------------- 150
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD---FEAHISDFGLARRIDTSHSHV 252
             I++ + +G+ YLH  +  I+HRDIK  N+LL++        I DFGL+     S  + 
Sbjct: 151 --IMKQILSGICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYK 204
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
                GT  Y+ PE L          DV+S G++M
Sbjct: 205 LRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIM 237

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  L +
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           ++H N++ +     +  D +LI E V  G L  +L +                  L+ E 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------------LTEEE 115
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFEA---HISDFGLARRIDTSHS 250
             + ++ + NG+ YLH L+  I H D+K  N+ LLD +       I DFGLA +ID  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 174 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 206

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 25/221 (11%)
Query: 82  DNFSTDKIIGDGSFGFV-YKAKLSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRH 137
           D+F   + IG GSFG V    K  +    A+K ++K       E R    E++ +  L H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +V +        D  ++ + +  G L                  L        ET   
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDL---------------RYHLQQNVHFKEETVKL 119
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
            +  +   L YL    + IIHRD+K  N+LLD     HI+DF +A  +    + ++T +A
Sbjct: 120 FICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT-MA 175
Query: 258 GTMGYMPPEYLGGNTAA--TVMLDVYSFGILMIEIATQIRP 296
           GT  YM PE       A  +  +D +S G+   E+    RP
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  L +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           ++H N++ +     +  D +LI E V  G L  +L +                  L+ E 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---------------SLTEEE 115
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFEA---HISDFGLARRIDTSHS 250
             + ++ + NG+ YLH L+  I H D+K  N+ LLD +       I DFGLA +ID  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 174 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 206

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 33/214 (15%)
Query: 90  IGDGSFGFVYKAK--LSSGVTVAIKKL------DKDAFQGFREFRAEMETLGKLRHRNIV 141
           IG+G++G V+KA+   + G  VA+K++      +       RE  A +  L    H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPNVV 77
Query: 142 KILGYCA-SGLDR----VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           ++   C  S  DR     L++E V     DQ L  T+  D V           +  ET  
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-----DQDL--TTYLDKVPEPG-------VPTETIK 123
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            ++  +  GL +LH     ++HRD+K  N+L+ S  +  ++DFGLAR    S     T V
Sbjct: 124 DMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSV 179
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             T+ Y  PE L  ++ AT + D++S G +  E+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEM 212

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  L +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           ++H N++ +     +  D +LI E V  G L  +L +                  L+ E 
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES---------------LTEEE 115
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFEA---HISDFGLARRIDTSHS 250
             + ++ + NG+ YLH L+  I H D+K  N+ LLD +       I DFGLA +ID  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 174 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 206

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKAKLSSGVTV--AIKKLDKDAFQGFREFRAEMETLGKLR 136
           D    ++ +  IG GS+G V K  +  G  +  A KK+ K   +    F+ E+E +  L 
Sbjct: 23  DINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 81
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSL-DQWLHD-TSRNDDVDGSKQLNSLCPLSWET 194
           H NI+++        D  L+ E    G L ++ +H    R  D                 
Sbjct: 82  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA---------------- 125
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL---DSDFEAHISDFGLARRIDTSHSH 251
             +I++ V + +AY H L   + HRD+K  N L      D    + DFGLA R       
Sbjct: 126 -ARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KM 181
Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           + T+V GT  Y+ P+ L G        D +S G++M
Sbjct: 182 MRTKV-GTPYYVSPQVLEGLYGPEC--DEWSAGVMM 214

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAI +L +  + +  +E   E   +  + 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L + C       V
Sbjct: 110 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWC-------V 158
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +I    A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 159 QI----AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 211
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 212 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 111/249 (44%), Gaps = 48/249 (19%)
Query: 82  DNFSTDKIIGDGSFGFVYKA--KLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLR 136
           D +    +IG GS+G V +A  KL   V VAIKK+ +   D     R  R E+  L +L 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRV-VAIKKILRVFEDLIDCKRILR-EIAILNRLN 110
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H ++VK+L         ++I + VE    D+ L+      D D  K   +   L+ E  +
Sbjct: 111 HDHVVKVLD--------IVIPKDVE--KFDE-LYVVLEIADSDFKKLFRTPVYLT-ELHI 158
Query: 197 K-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS----- 250
           K ++  +  G+ Y+H     I+HRD+K +N L++ D    + DFGLAR +D   +     
Sbjct: 159 KTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 251 ------------------HVSTQVAG---TMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
                             ++  Q+ G   T  Y  PE +      T  +DV+S G +  E
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276
Query: 290 IATQIRPNL 298
           +   I+ N+
Sbjct: 277 LLNMIKENV 285

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQ----GFREFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    SG  VAIKKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYR-ELLLLKHMQHENVIGLL 89
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
                       Y+F       Q           D  K +      S E    +V  +  
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQ----------TDLQKIMG--LKFSEEKIQYLVYQMLK 137
Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
           GL Y+H     ++HRD+K  N+ ++ D E  I DFGLAR  D       T    T  Y  
Sbjct: 138 GLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRA 191
Query: 265 PEYLGGNTAATVMLDVYSFGILMIEIAT 292
           PE +         +D++S G +M E+ T
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLT 219

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L + C       V
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE---HKDNIGSQYLLNWC-------V 128
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +I    A G+ YL   ++ ++HRD+ + NVL+ +     I+DFG A+ +         + 
Sbjct: 129 QI----AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE- 181
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 182 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 22/173 (12%)
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           KI   +   L +LH  +  +IHRD+K SNVL+++  +  + DFG++  +    S   T  
Sbjct: 157 KIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDSVAKTID 213
Query: 257 AGTMGYMPPEYLG---GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA 313
           AG   YM PE +         +V  D++S GI MIE+A    P               W 
Sbjct: 214 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP------------YDSWG 261
Query: 314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ 366
              +   + +E     +  ++ S     E+      C  + S+ERP    ++Q
Sbjct: 262 TPFQQLKQVVEEPSPQLPADKFSA----EFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++  G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++
Sbjct: 83  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI 133
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 134 ------AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 184
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 185 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQ----GFREFRAEMETLGKLRHRNIVKIL 144
           +G G++G V  A    SG  VAIKKL +  FQ      R +R E+  L  ++H N++ +L
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYR-ELLLLKHMQHENVIGLL 107
Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
                       Y+F       Q           D  K +      S E    +V  +  
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQ----------TDLQKIMG--MEFSEEKIQYLVYQMLK 155
Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMP 264
           GL Y+H     ++HRD+K  N+ ++ D E  I DFGLAR  D       T    T  Y  
Sbjct: 156 GLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRA 209
Query: 265 PEYLGGNTAATVMLDVYSFGILMIEIAT 292
           PE +         +D++S G +M E+ T
Sbjct: 210 PEVILSWMHYNQTVDIWSVGCIMAEMLT 237

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L + C       V
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE---HKDNIGSQYLLNWC-------V 126
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +I    A G+ YL   ++ ++HRD+ + NVL+ +     I+DFG A+ +         + 
Sbjct: 127 QI----AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE- 179
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 180 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L + C       V
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE---HKDNIGSQYLLNWC-------V 126
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +I    A G+ YL   ++ ++HRD+ + NVL+ +     I+DFG A+ +         + 
Sbjct: 127 QI----AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE- 179
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 180 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L + C       V
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWC-------V 124
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +I    A G+ YL   ++ ++HRD+ + NVL+ +     I+DFG A+ +         + 
Sbjct: 125 QI----AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE- 177
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 178 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 23/164 (14%)
Query: 128 EMETLGKLRHRNIVKILGYCASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLN 185
           E+  L KL H N+VK++       +  L  ++E V  G +                 ++ 
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----------------MEVP 129
Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
           +L PLS +      + +  G+ YLH   + IIHRDIK SN+L+  D    I+DFG++   
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLH--YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 246 DTSHSHVSTQVAGTMGYMPPEYLGGNTA--ATVMLDVYSFGILM 287
             S + +S  V GT  +M PE L       +   LDV++ G+ +
Sbjct: 188 KGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++  G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI 126
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 127 ------AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 177
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 178 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L + C       V
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWC-------V 131
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +I    A G+ YL   ++ ++HRD+ + NVL+ +     I+DFG A+ +         + 
Sbjct: 132 QI----AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE- 184
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 185 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++  G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L     L+W  ++
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYL-----LNWCVQI 133
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                 A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ +         + 
Sbjct: 134 ------AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE- 184
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 185 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSG----VTVAIKKL-DKDAFQGFREFRAEMETLGKLR 136
            F   K++G G+FG VYK   +  G    + VAIK+L +  + +  +E   E   +  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + ++ ++LG C +   + LI + +  G L  ++ +   + D  GS+ L + C       V
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWC-------V 126
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +I    A G+ YL   ++ ++HRD+ + NVL+ +     I+DFG A+ +         + 
Sbjct: 127 QI----AKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE- 179
Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
               G +P +++   +      T   DV+S+G+ + E+ T
Sbjct: 180 ---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 89  IIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRNIVKILG 145
           ++G GSFG V K K   +    A+K ++K + +         E+E L KL H NI+K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
                    ++ E    G L   +    R  + D ++               I++ V +G
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---------------IIKQVFSG 133
Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
           + Y+H  +  I+HRD+K  N+LL+S   D +  I DFGL+      ++ +  ++ GT  Y
Sbjct: 134 ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRI-GTAYY 189
Query: 263 MPPEYLGGNTAATVMLDVYSFGILM 287
           + PE L G        DV+S G+++
Sbjct: 190 IAPEVLRGTYDEKC--DVWSAGVIL 212

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 89  IIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRNIVKILG 145
           ++G GSFG V K K   +    A+K ++K + +         E+E L KL H NI+K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
                    ++ E    G L   +    R  + D ++               I++ V +G
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---------------IIKQVFSG 133
Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
           + Y+H  +  I+HRD+K  N+LL+S   D +  I DFGL+      ++ +  ++ GT  Y
Sbjct: 134 ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-GTAYY 189
Query: 263 MPPEYLGGNTAATVMLDVYSFGILM 287
           + PE L G        DV+S G+++
Sbjct: 190 IAPEVLRGTYDEKC--DVWSAGVIL 212

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 104/236 (44%), Gaps = 40/236 (16%)
Query: 70  SQISMSELIDAT----DNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDK---DAFQG 121
           +Q    E+ D+T      +   K IG G+ G V  A     G+ VA+KKL +   +    
Sbjct: 8   NQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA 67
Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASG------LDRVLIYEFVENGSLDQWLHDTSRN 175
            R +R E+  L  + H+NI+ +L             D  L+ E + + +L Q +H     
Sbjct: 68  KRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIH----- 120
Query: 176 DDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH 235
                         L  E    ++  +  G+ +LH     IIHRD+K SN+++ SD    
Sbjct: 121 ------------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLK 166
Query: 236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEY-LGGNTAATVMLDVYSFGILMIEI 290
           I DFGLAR   T  + + T    T  Y  PE  LG   AA V  D++S G +M E+
Sbjct: 167 ILDFGLARTACT--NFMMTPYVVTRYYRAPEVILGMGYAANV--DIWSVGCIMGEL 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 89  IIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRNIVKILG 145
           ++G GSFG V K K   +    A+K ++K + +         E+E L KL H NI+K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
                    ++ E    G L   +    R  + D ++               I++ V +G
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---------------IIKQVFSG 133
Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHISDFGLARRIDTSHSHVSTQVAGTMGY 262
           + Y+H  +  I+HRD+K  N+LL+S   D +  I DFGL+      ++ +  ++ GT  Y
Sbjct: 134 ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-GTAYY 189
Query: 263 MPPEYLGGNTAATVMLDVYSFGILM 287
           + PE L G        DV+S G+++
Sbjct: 190 IAPEVLRGTYDEKC--DVWSAGVIL 212

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFRE--FRAEMETLGKLRHRNIVKILGY 146
           IG GS+G   K +  S G  +  K+LD  +     +    +E+  L +L+H NIV+   Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR---Y 70
Query: 147 CASGLDRV-----LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
               +DR      ++ E+ E G L   +          G+K+   L     E  ++++  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVI--------TKGTKERQYL---DEEFVLRVMTQ 119
Query: 202 VANGLAYLHGLE---KPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           +   L   H        ++HRD+K +NV LD      + DFGLAR ++   S     V G
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-G 178
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           T  YM PE +    +     D++S G L+ E+   + P
Sbjct: 179 TPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 90  IGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFRE--FRAEMETLGKLRHRNIVKILGY 146
           IG GS+G   K +  S G  +  K+LD  +     +    +E+  L +L+H NIV+   Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR---Y 70
Query: 147 CASGLDRV-----LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
               +DR      ++ E+ E G L   +          G+K+   L     E  ++++  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVI--------TKGTKERQYL---DEEFVLRVMTQ 119
Query: 202 VANGLAYLHGLE---KPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           +   L   H        ++HRD+K +NV LD      + DFGLAR ++      + +  G
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED-FAKEFVG 178
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           T  YM PE +    +     D++S G L+ E+   + P
Sbjct: 179 TPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 89/362 (24%), Positives = 135/362 (37%), Gaps = 95/362 (26%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFREFRAEMETLG 133
           A +     K +G G+FG V +A      K  +  TVA+K L + A     E++A M  L 
Sbjct: 25  ARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATAS--EYKALMTELK 82
Query: 134 KL----RHRNIVKILG--------------YCASG------------------------- 150
            L     H N+V +LG              YC  G                         
Sbjct: 83  ILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHMEP 142
Query: 151 ----------------LDRVLIYE-FVENG-SLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
                           LD V   E F  +G   D+ L D    +D DG  +     P++ 
Sbjct: 143 KKEKMEPGLEQGKKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKE----PITM 198
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           E  +     VA G+ +L    +  IHRD+ + N+LL  +    I DFGLAR I  +  +V
Sbjct: 199 EDLISYSFQVARGMEFLSS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYV 256
Query: 253 ST-QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP-VVLDGQEVGLL 310
                   + +M PE +     +T   DV+S+G+L+ EI +      P V +D      L
Sbjct: 257 RKGDTRLPLKWMAPESIFDKIYSTKS-DVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRL 315
Query: 311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                M A                  E    E ++I   C +   +ERP  + +V+ L +
Sbjct: 316 REGMRMRA-----------------PEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGD 358
Query: 371 LV 372
           L+
Sbjct: 359 LL 360

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 104/248 (41%), Gaps = 39/248 (15%)
Query: 77  LIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTV-AIKKLDKDAF-----QGFREFRAEME 130
           L++    +     IG GS+G V  A  +    + AIK ++K+       +     + E+ 
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 131 TLGKLRHRNIVKILGYCASGLDRVLIYEFVENG----SLDQWLHDTSRNDDVDGSKQLNS 186
            + KL H NI ++           L+ E    G     L+ ++ D++    +D  K    
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 187 LCP-----------------LSWETRVK----IVRGVANGLAYLHGLEKPIIHRDIKSSN 225
            CP                 L +  R K    I+R + + L YLH   + I HRDIK  N
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN--QGICHRDIKPEN 198
Query: 226 VLLDSD--FEAHISDFGLAR---RIDTSHSHVSTQVAGTMGYMPPEYLG-GNTAATVMLD 279
            L  ++  FE  + DFGL++   +++    +  T  AGT  ++ PE L   N +     D
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 280 VYSFGILM 287
            +S G+L+
Sbjct: 259 AWSAGVLL 266

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 47/89 (52%), Gaps = 4/89 (4%)
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           +R +  G  YLH     +IHRD+K  N+ L+ D E  I DFGLA +++       T + G
Sbjct: 123 LRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCG 179
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           T  Y+ PE L      +  +DV+S G +M
Sbjct: 180 TPNYIAPEVL-SKKGHSFEVDVWSIGCIM 207

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 47/89 (52%), Gaps = 4/89 (4%)
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           +R +  G  YLH     +IHRD+K  N+ L+ D E  I DFGLA +++       T + G
Sbjct: 123 LRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCG 179
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           T  Y+ PE L      +  +DV+S G +M
Sbjct: 180 TPNYIAPEVL-SKKGHSFEVDVWSIGCIM 207

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 47/89 (52%), Gaps = 4/89 (4%)
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           +R +  G  YLH     +IHRD+K  N+ L+ D E  I DFGLA +++       T + G
Sbjct: 127 LRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCG 183
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           T  Y+ PE L      +  +DV+S G +M
Sbjct: 184 TPNYIAPEVL-SKKGHSFEVDVWSIGCIM 211

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN- 139
           D F   K +G GSFG V   K   SG   A+K LDK      ++    +     L+  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 140 --IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  +A
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLA 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G GSFG V++ K   +G   A+KK+  + F+       E+     L    IV + G   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVR 120
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA-NGLA 207
            G    +  E +E GSL Q +            KQ+  L P   E R     G A  GL 
Sbjct: 121 EGPWVNIFMELLEGGSLGQLI------------KQMGCL-P---EDRALYYLGQALEGLE 164
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSD-FEAHISDFG--LARRIDTSHSHVSTQ--VAGTMGY 262
           YLH   + I+H D+K+ NVLL SD   A + DFG  L  + D     + T   + GT  +
Sbjct: 165 YLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           M PE + G       +D++S   +M+ +     P
Sbjct: 223 MAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K IG GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA-RRIDTSHSHVSTQ 255
           KI   +   L +LH  +  +IHRD+K SNVL+++  +  + DFG++   +D     +   
Sbjct: 113 KIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-- 169
Query: 256 VAGTMGYMPPEYLG---GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW 312
            AG   YM PE +         +V  D++S GI MIE+A    P               W
Sbjct: 170 -AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP------------YDSW 216
Query: 313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ 366
               +   + +E     +  ++ S     E+      C  + S+ERP    ++Q
Sbjct: 217 GTPFQQLKQVVEEPSPQLPADKFSA----EFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 150
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 151 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 200
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 201 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 238

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G GSFG V++ K   +G   A+KK+  + F+       E+     L    IV + G   
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVR 136
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA-NGLA 207
            G    +  E +E GSL Q +            KQ+  L P   E R     G A  GL 
Sbjct: 137 EGPWVNIFMELLEGGSLGQLI------------KQMGCL-P---EDRALYYLGQALEGLE 180
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSD-FEAHISDFG--LARRIDTSHSHVSTQ--VAGTMGY 262
           YLH   + I+H D+K+ NVLL SD   A + DFG  L  + D     + T   + GT  +
Sbjct: 181 YLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 238
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           M PE + G       +D++S   +M+ +     P
Sbjct: 239 MAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 98/230 (42%), Gaps = 39/230 (16%)
Query: 89  IIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEM---ETLGKLRHRNIVKIL 144
           I+G G+   V++ +   +G   AIK  +  +F   R    +M   E L KL H+NIVK+ 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
                   R  VLI EF   GSL   L + S    +  S+ L             ++R V
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL------------IVLRDV 121
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLL----DSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
             G+ +L   E  I+HR+IK  N++     D      ++DFG AR ++     VS  + G
Sbjct: 122 VGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYG 177
Query: 259 TMGYMPPEYL---------GGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           T  Y+ P+                ATV  D++S G+     AT   P  P
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATV--DLWSIGVTFYHAATGSLPFRP 225

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 92/229 (40%), Gaps = 49/229 (21%)
Query: 88  KIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVK---I 143
           K +G G  G V+ A        VAIKK+     Q  +    E++ + +L H NIVK   I
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLC--------------- 188
           LG   S L                        DDV    +LNS+                
Sbjct: 77  LGPSGSQL-----------------------TDDVGSLTELNSVYIVQEYMETDLANVLE 113
Query: 189 --PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-DFEAHISDFGLARRI 245
             PL  E     +  +  GL Y+H     ++HRD+K +N+ +++ D    I DFGLAR +
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 246 DTSHSHVSTQVAG--TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           D  +SH      G  T  Y  P  L      T  +D+++ G +  E+ T
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 106/245 (43%), Gaps = 43/245 (17%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDK---DAFQGFREFRAEMETLG 133
           +   DN+    +IG GS+G+VY A   ++   VAIKK+++   D     R  R E+  L 
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILN 80
Query: 134 KLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQW--LHDTSRNDDVDGSKQLNSLCPLS 191
           +L+   I+++             Y+ +    L ++  L+      D D  K   +   L+
Sbjct: 81  RLKSDYIIRL-------------YDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT 127
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS--- 248
            E    I+  +  G  ++H  E  IIHRD+K +N LL+ D    + DFGLAR I++    
Sbjct: 128 EEHIKTILYNLLLGENFIH--ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 249 ---------------HSHVSTQVAG---TMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
                          + ++  Q+     T  Y  PE +      T  +D++S G +  E+
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 291 ATQIR 295
              ++
Sbjct: 246 LNMLQ 250

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      +E      E   L  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+   G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+++D      ++DFGLA+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN- 139
           D F   K +G GSFG V   K + +G   A+K LDK      ++    +     L+  N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 140 --IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 150
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 151 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLC 200
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 201 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 238

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 108/249 (43%), Gaps = 42/249 (16%)
Query: 78  IDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDK---DAFQGFREFRAEMETLG 133
           +   DN+    +IG GS+G+VY A   ++   VAIKK+++   D     R  R E+  L 
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILR-EITILN 82
Query: 134 KLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           +L+   I+++        D ++  + ++   L   L       D D  K   +   L+ +
Sbjct: 83  RLKSDYIIRLH-------DLIIPEDLLKFDELYIVLEIA----DSDLKKLFKTPIFLTEQ 131
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTS----- 248
               I+  +  G  ++H  E  IIHRD+K +N LL+ D    I DFGLAR I++      
Sbjct: 132 HVKTILYNLLLGEKFIH--ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHI 189
Query: 249 ----------------HSHVSTQVAG---TMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
                           + ++  Q+     T  Y  PE +      T  +D++S G +  E
Sbjct: 190 VNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAE 249
Query: 290 IATQIRPNL 298
           +   ++ ++
Sbjct: 250 LLNMMKSHI 258

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G GSFG V++ K   +G   A+KK+  + F+       E+     L    IV + G   
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVR 134
Query: 149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA-NGLA 207
            G    +  E +E GSL Q +            KQ+  L P   E R     G A  GL 
Sbjct: 135 EGPWVNIFMELLEGGSLGQLI------------KQMGCL-P---EDRALYYLGQALEGLE 178
Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDF-EAHISDFG--LARRIDTSHSHVSTQ--VAGTMGY 262
           YLH   + I+H D+K+ NVLL SD   A + DFG  L  + D     + T   + GT  +
Sbjct: 179 YLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 236
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           M PE + G       +D++S   +M+ +     P
Sbjct: 237 MAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 135
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 136 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLC 185
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 186 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 223

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 31/219 (14%)
Query: 79  DATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFR------EFRAEMET 131
           D  D++   + +G G F  V K +   +G   A K + K      R      E   E+  
Sbjct: 9   DVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 68
Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           L ++RH NI+ +     +  D VLI E V  G L  +L +                  L+
Sbjct: 69  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---------------SLT 113
Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDF---EAHISDFGLARRIDT 247
            +   + ++ + +G+ YLH   K I H D+K  N+ LLD +       + DFG+A +I+ 
Sbjct: 114 EDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 171
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
            +      + GT  ++ PE +       +  D++S G++
Sbjct: 172 GNEF--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 207

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 30/235 (12%)
Query: 67  PSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREF 125
           PSL QI +       ++F   K++G GSFG V+ A+   +    AIK L KD      + 
Sbjct: 9   PSL-QIKLK-----IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV 62
Query: 126 RAEMETLGKL----RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS 181
              M     L     H  +  +     +  +   + E++  G L   +    + D     
Sbjct: 63  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD----- 117
Query: 182 KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
                   LS  T       +  GL +LH   K I++RD+K  N+LLD D    I+DFG+
Sbjct: 118 --------LSRATFY--AAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGM 165
Query: 242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
            +  +      + +  GT  Y+ PE L G       +D +SFG+L+ E+     P
Sbjct: 166 CKE-NMLGDAKTNEFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSP 218

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE-----------PHARFYAAQ 150
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 151 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 200
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 201 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   SG   A+K LDK      ++      E   L  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----------PHARFYAAQ 170
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+  +    +  + 
Sbjct: 171 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA----TWTLC 220
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 221 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 258

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      +E      E   L  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+   G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+++D      ++DFGLA+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 114/294 (38%), Gaps = 45/294 (15%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLSSG-VTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           NF T   + +   G ++K +     + V + K+   + +  R+F  E   L    H N++
Sbjct: 13  NFLTK--LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 142 KILGYCAS--GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
            +LG C S       LI  +   GSL   LH+ + N  VD S+             VK  
Sbjct: 71  PVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGT-NFVVDQSQA------------VKFA 117
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
              A G A+LH LE  I    + S +V +D D  A IS        D   S  S      
Sbjct: 118 LDXARGXAFLHTLEPLIPRHALNSRSVXIDEDXTARIS------XADVKFSFQSPGRXYA 171
Query: 260 MGYMPPEYLGGNTAATVM--LDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME 317
             ++ PE L      T     D +SF +L+ E+ T+  P     L   E+G         
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVPF--ADLSNXEIGX-------- 221
Query: 318 ARNKEIEMVDSNISREELSEAGVREYF-RIACMCTNEKSRERPAMSYVVQLLDE 370
                +E +   I        G+  +  ++  +C NE   +RP    +V +L++
Sbjct: 222 --KVALEGLRPTIP------PGISPHVSKLXKICXNEDPAKRPKFDXIVPILEK 267

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 86  TDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKI 143
           T +++G+G++  V  A  L +G   A+K ++K A         E+ETL + + ++NI+++
Sbjct: 17  TSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILEL 76
Query: 144 LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA 203
           + +        L++E ++ GS+   +      ++ + S+               +VR VA
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASR---------------VVRDVA 121
Query: 204 NGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDF--GLARRIDTSHSHVS----T 254
             L +LH   K I HRD+K  N+L +S  +     I DF  G   +++ S + ++    T
Sbjct: 122 AALDFLH--TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELT 179
Query: 255 QVAGTMGYMPPE----YLGGNTAATVMLDVYSFGILM 287
              G+  YM PE    +    T      D++S G+++
Sbjct: 180 TPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVL 216

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   SG   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   SG   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   SG   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN- 139
           D F   K +G GSFG V   K   SG   A+K LDK      ++    +     L+  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 140 --IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN- 139
           D F   K +G GSFG V   K   SG   A+K LDK      ++    +     L+  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 140 --IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN- 139
           D F   K +G GSFG V   K   SG   A+K LDK      ++    +     L+  N 
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 140 --IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----------PHARFYAAQ 150
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 151 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 200
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 201 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   SG   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 38/235 (16%)
Query: 70  SQISMSELIDAT----DNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDK---DAFQG 121
           SQ    ++ D+T      +   K IG G+ G V  A     G+ VA+KKL +   +    
Sbjct: 6   SQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA 65
Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASG------LDRVLIYEFVENGSLDQWLHDTSRN 175
            R +R E+  L  + H+NI+ +L             D  L+ E + + +L Q +H     
Sbjct: 66  KRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIH----- 118
Query: 176 DDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH 235
                         L  E    ++  +  G+ +LH     IIHRD+K SN+++ SD    
Sbjct: 119 ------------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLK 164
Query: 236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           I DFGLAR   T  + + T    T  Y  PE + G       +D++S G +M E+
Sbjct: 165 ILDFGLARTAST--NFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEL 216

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 107/243 (44%), Gaps = 38/243 (15%)
Query: 67  PSLSQISMSE----LIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ-G 121
           PSL Q    E    +I    +F    ++G G+ G +    +     VA+K++  + F   
Sbjct: 5   PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA 64
Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE--NGSLDQWLHDTSRNDDVD 179
            RE +   E+     H N+++   Y  +  DR   Y  +E    +L +++          
Sbjct: 65  DREVQLLRESD---EHPNVIR---YFCTEKDRQFQYIAIELCAATLQEYV---------- 108
Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-----SDFEA 234
              +      L  E  + +++   +GLA+LH L   I+HRD+K  N+L+         +A
Sbjct: 109 ---EQKDFAHLGLEP-ITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKA 162
Query: 235 HISDFGLARRIDTSHSHVSTQ--VAGTMGYMPPEYLGGNTA--ATVMLDVYSFGILMIEI 290
            ISDFGL +++       S +  V GT G++ PE L  +     T  +D++S G +   +
Sbjct: 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 291 ATQ 293
            ++
Sbjct: 223 ISE 225

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   SG   A+K LDK      ++      E   L  +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----------PHARFYAAQ 136
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 137 IVLT----FEYLHSLD--LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXLC 186
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 187 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 224

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K IG GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E++  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   SG   A+K LDK      ++      E   L  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE-----------PHARFYAAQ 170
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 171 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 220
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 221 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 258

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN- 139
           D F   K +G GSFG V   K   SG   A+K LDK      ++    +     L+  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 140 --IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K IG GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E++  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   SG   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           +R +  G  YLH     +IHRD+K  N+ L+ D E  I DFGLA +++         + G
Sbjct: 121 LRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCG 177
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           T  Y+ PE L      +  +DV+S G +M
Sbjct: 178 TPNYIAPEVL-SKKGHSFEVDVWSIGCIM 205

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           +R +  G  YLH     +IHRD+K  N+ L+ D E  I DFGLA +++         + G
Sbjct: 145 LRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCG 201
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           T  Y+ PE L      +  +DV+S G +M
Sbjct: 202 TPNYIAPEVL-SKKGHSFEVDVWSIGCIM 229

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   +G   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           +R +  G  YLH     +IHRD+K  N+ L+ D E  I DFGLA +++         + G
Sbjct: 147 LRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCG 203
Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           T  Y+ PE L      +  +DV+S G +M
Sbjct: 204 TPNYIAPEVL-SKKGHSFEVDVWSIGCIM 231

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   SG   A+K LDK      ++      E   L  +  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE-----------PHARFYAAQ 144
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 145 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 194
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 195 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 232

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN- 139
           D F   K +G GSFG V   K   SG   A+K LDK      ++    +     L+  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 140 --IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLX 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   +G   A+K LDK      ++      E   L  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 150
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 151 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 200
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 201 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   +G   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   +G   A+K LDK      ++      E   L  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 150
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 151 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 200
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 201 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   +G   A+K LDK      ++      E   L  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 150
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 151 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 200
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 201 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN- 139
           D F   K +G GSFG V   K   SG   A+K LDK      ++    +     L+  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 140 --IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   +G   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   +G   A+K LDK      ++      E   L  +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 170
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 171 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 220
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 221 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 258

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 24/156 (15%)
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NI+++     +     L+++ ++ G L  +L      + V  S++         ETR 
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEK---------ETR- 114
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           KI+R +   +  LH L   I+HRD+K  N+LLD D    ++DFG + ++D        +V
Sbjct: 115 KIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREV 170
Query: 257 AGTMGYMPPEYL-----GGNTAATVMLDVYSFGILM 287
            GT  Y+ PE +       +      +D++S G++M
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 206

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   +G   A+K LDK      ++      E   L  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 142
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 143 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 192
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 193 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 230

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQ----GFREFRAEMETLGKLRHRNI 140
           K IG G+ G V   Y A L   V  AIKKL +  FQ      R +R E+  +  + H+NI
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNV--AIKKLSR-PFQNQTHAKRAYR-ELVLMKXVNHKNI 85
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           + +L              F    +L+++       + +D +        L  E    ++ 
Sbjct: 86  ISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLY 133
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T 
Sbjct: 134 QMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTR 189
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            Y  PE + G       +D++S G +M E+ 
Sbjct: 190 YYRAPEVILG-MGYKENVDIWSVGCIMGEMV 219

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 97/230 (42%), Gaps = 39/230 (16%)
Query: 89  IIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEM---ETLGKLRHRNIVKIL 144
           I+G G+   V++ +   +G   AIK  +  +F   R    +M   E L KL H+NIVK+ 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
                   R  VLI EF   GSL   L + S    +  S+ L             ++R V
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL------------IVLRDV 121
Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLL----DSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
             G+ +L   E  I+HR+IK  N++     D      ++DFG AR ++     V   + G
Sbjct: 122 VGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX--LYG 177
Query: 259 TMGYMPPEYL---------GGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           T  Y+ P+                ATV  D++S G+     AT   P  P
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATV--DLWSIGVTFYHAATGSLPFRP 225

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   +G   A+K LDK      ++      E   L  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE-----------PHARFYAAQ 142
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 143 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 192
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 193 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 230

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 24/156 (15%)
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NI+++     +     L+++ ++ G L  +L      + V  S++         ETR 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEK---------ETR- 127
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           KI+R +   +  LH L   I+HRD+K  N+LLD D    ++DFG + ++D        +V
Sbjct: 128 KIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREV 183
Query: 257 AGTMGYMPPEYL-----GGNTAATVMLDVYSFGILM 287
            GT  Y+ PE +       +      +D++S G++M
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 24/156 (15%)
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NI+++     +     L+++ ++ G L  +L      + V  S++         ETR 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEK---------ETR- 127
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           KI+R +   +  LH L   I+HRD+K  N+LLD D    ++DFG + ++D      S  V
Sbjct: 128 KIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS--V 183
Query: 257 AGTMGYMPPEYL-----GGNTAATVMLDVYSFGILM 287
            GT  Y+ PE +       +      +D++S G++M
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 57/104 (54%), Gaps = 8/104 (7%)
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF---EAHISDFGLARRIDTSHSHV 252
           +++++ +  G+ YLH  +  I+H D+K  N+LL S +   +  I DFG++R+I   H+  
Sbjct: 134 IRLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACE 189
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             ++ GT  Y+ PE L  +   T   D+++ GI+   + T   P
Sbjct: 190 LREIMGTPEYLAPEILNYDPITTAT-DMWNIGIIAYMLLTHTSP 232

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   SG   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+++D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIIISKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   SG   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ ++A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYQMAAGYPP 237

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQ----GFREFRAEMETLGKLRHRNI 140
           K IG G+ G V   Y A L   V  AIKKL +  FQ      R +R E+  +  + H+NI
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNV--AIKKLSR-PFQNQTHAKRAYR-ELVLMKVVNHKNI 85
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           + +L              F    SL+++       + +D +        L  E    ++ 
Sbjct: 86  IGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY 133
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T 
Sbjct: 134 QMLVGIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTR 189
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            Y  PE + G       +D++S G++M E+
Sbjct: 190 YYRAPEVILG-MGYKENVDIWSVGVIMGEM 218

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 24/220 (10%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKL----R 136
           ++F   K++G GSFG V+ A+   +    AIK L KD      +    M     L     
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H  +  +     +  +   + E++  G L   +    + D             LS  T  
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD-------------LSRATFY 123
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                +  GL +LH   K I++RD+K  N+LLD D    I+DFG+ +  +      +   
Sbjct: 124 --AAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNXF 178
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
            GT  Y+ PE L G       +D +SFG+L+ E+     P
Sbjct: 179 CGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSP 217

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQ----GFREFRAEMETLGKLRHRNI 140
           K IG G+ G V   Y A L   V  AIKKL +  FQ      R +R E+  +  + H+NI
Sbjct: 30  KPIGSGAQGIVVAAYDAILERNV--AIKKLSR-PFQNQTHAKRAYR-ELVLMKVVNHKNI 85
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           + +L              F    SL+++       + +D +        L  E    ++ 
Sbjct: 86  IGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY 133
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T 
Sbjct: 134 QMLVGIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTR 189
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            Y  PE + G       +D++S G++M E+
Sbjct: 190 YYRAPEVILG-MGYKENVDIWSVGVIMGEM 218

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 26/215 (12%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRH 137
           + F   K++G G+FG V   K  ++G   A+K L K+      E      E   L   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
              +  L Y     DR+  + E+   G L       SR                  E R 
Sbjct: 208 -PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-------------EDRA 250
Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     + + L YLH  EK +++RD+K  N++LD D    I+DFGL +      + + T 
Sbjct: 251 RFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT- 308
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             GT  Y+ PE L  N      +D +  G++M E+
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEM 342

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D++   + +G G F  V K +   +G   A K + K      R      E   E+  L +
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           +RH NI+ +     +  D VLI E V  G L  +L +                  L+ + 
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---------------SLTEDE 109
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDF---EAHISDFGLARRIDTSHS 250
             + ++ + +G+ YLH   K I H D+K  N+ LLD +       + DFG+A +I+  + 
Sbjct: 110 ATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 168 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 200

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+   G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+++D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 32/222 (14%)
Query: 83  NFSTDKI-IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           +++T ++ +G GSFG V++ +   +G   A+KK+  + F+       E+     L    I
Sbjct: 93  HWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA-----EELMACAGLTSPRI 147
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V + G    G    +  E +E GSL Q +            K+   L     E R     
Sbjct: 148 VPLYGAVREGPWVNIFMELLEGGSLGQLV------------KEQGCLP----EDRALYYL 191
Query: 201 GVA-NGLAYLHGLEKPIIHRDIKSSNVLLDSD-FEAHISDFGLARRIDTSHSHVS----T 254
           G A  GL YLH   + I+H D+K+ NVLL SD   A + DFG A  +       S     
Sbjct: 192 GQALEGLEYLH--SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGD 249
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
            + GT  +M PE + G +     +DV+S   +M+ +     P
Sbjct: 250 YIPGTETHMAPEVVLGRS-CDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIV 141
           K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H+NI+
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNII 86
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L              F    +L+++       + +D +        L  E    ++  
Sbjct: 87  SLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQ 134
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T  
Sbjct: 135 MLCGIKHLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRY 190
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
           Y  PE + G       +D++S G +M E+ 
Sbjct: 191 YRAPEVILG-MGYKENVDIWSVGCIMGEMV 219

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 81  TDNFSTDKIIGDGSFGFVY--KAKLSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKL 135
           +D +   K +G G++G V   K KL+ G   AIK + K +        A   E+  L +L
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
            H NI+K+  +     +  L+ E    G L   +    +  +VD +              
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV------------- 125
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHISDFGLARRIDTSHSHV 252
             I++ V +G  YLH  +  I+HRD+K  N+LL+S   D    I DFGL     ++H  V
Sbjct: 126 --IMKQVLSGTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGL-----SAHFEV 176
Query: 253 STQVA---GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
             ++    GT  Y+ PE L          DV+S G+++
Sbjct: 177 GGKMKERLGTAYYIAPEVLRKKYDEKC--DVWSCGVIL 212

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 25/213 (11%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD--KDAFQGFREFRAEMETLGKLRH 137
           TD +   + IG G+F  V +  KL +G   A K ++  K + +  ++   E      L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV++    +      L+++ V  G L + +       + D S  +  +          
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------- 114
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA---HISDFGLARRIDTSHSHVST 254
                    A LH  +  ++HRD+K  N+LL S  +     ++DFGLA  +         
Sbjct: 115 ---------AVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD-QQAWF 164
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
             AGT GY+ PE L    A    +D+++ G+++
Sbjct: 165 GFAGTPGYLSPEVL-RKEAYGKPVDIWACGVIL 196

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 26/215 (12%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRH 137
           + F   K++G G+FG V   K  ++G   A+K L K+      E      E   L   RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
              +  L Y     DR+  + E+   G L       SR                  E R 
Sbjct: 211 -PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-------------EDRA 253
Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     + + L YLH  EK +++RD+K  N++LD D    I+DFGL +      + + T 
Sbjct: 254 RFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT- 311
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             GT  Y+ PE L  N      +D +  G++M E+
Sbjct: 312 FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEM 345

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D++   + +G G F  V K +   +G   A K + K      R      E   E+  L +
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           +RH NI+ +     +  D VLI E V  G L  +L +                  L+ + 
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---------------SLTEDE 130
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDF---EAHISDFGLARRIDTSHS 250
             + ++ + +G+ YLH   K I H D+K  N+ LLD +       + DFG+A +I+  + 
Sbjct: 131 ATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 188
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 189 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 221

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 197 KIVRGVANGLAYL---HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
           K+   +   L YL   HG    +IHRD+K SN+LLD   +  + DFG++ R+        
Sbjct: 128 KMTVAIVKALYYLKEKHG----VIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAK 181
Query: 254 TQVAGTMGYMPPEYLGGNTAAT----VMLDVYSFGILMIEIATQIRP 296
            + AG   YM PE +           +  DV+S GI ++E+AT   P
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D +   + +G G F  V K +  S+G+  A K + K   +  R      E   E+  L +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           + H NI+ +     +  D VLI E V  G L  +L                    LS E 
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------------SLSEEE 116
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFE-AHIS--DFGLARRIDTSHS 250
               ++ + +G+ YLH   K I H D+K  N+ LLD +    HI   DFGLA  I+    
Sbjct: 117 ATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 175 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 207

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 84  FSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRH 137
           +   K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           +NI+ +L              F    +L+++       + +D +        L  E    
Sbjct: 76  KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY 123
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           ++  +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T   
Sbjct: 124 LLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYV 179
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            T  Y  PE + G       +D++S G +M E+ 
Sbjct: 180 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMV 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQ----GFREFRAEMETLGKLRHRNI 140
           K IG G+ G V   Y A L   V  AIKKL +  FQ      R +R E+  +  + H+NI
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNV--AIKKLSR-PFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           + +L              F    +L+++       + +D +        L  E    ++ 
Sbjct: 86  ISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLY 133
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T 
Sbjct: 134 QMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTR 189
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            Y  PE + G       +D++S G +M E+ 
Sbjct: 190 YYRAPEVILG-MGYKENVDIWSVGCIMGEMV 219

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D +   + +G G F  V K +  S+G+  A K + K   +  R      E   E+  L +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           + H N++ +     +  D VLI E V  G L  +L                    LS E 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------------SLSEEE 116
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFE-AHIS--DFGLARRIDTSHS 250
               ++ + +G+ YLH   K I H D+K  N+ LLD +    HI   DFGLA  I+    
Sbjct: 117 ATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 175 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 207

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 108/248 (43%), Gaps = 30/248 (12%)
Query: 53  DLSSIALFDSASFDPSLSQISMSELIDAT----DNFSTDKIIGDGSFGFV---YKAKLSS 105
           D+S IA   + S     +Q    E+ D+T      +   K IG G+ G V   Y A L  
Sbjct: 29  DVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDR 88
Query: 106 GVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVEN 162
            V  AIKKL +   +     R +R E+  +  + H+NI+ +L              F   
Sbjct: 89  NV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV------------FTPQ 133
Query: 163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIK 222
            +L+++       + +D +        L  E    ++  +  G+ +LH     IIHRD+K
Sbjct: 134 KTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLK 191
Query: 223 SSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYS 282
            SN+++ SD    I DFGLAR   T  S + T    T  Y  PE + G       +D++S
Sbjct: 192 PSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWS 248
Query: 283 FGILMIEI 290
            G +M E+
Sbjct: 249 VGCIMGEM 256

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 83/189 (43%), Gaps = 17/189 (8%)
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           KI       L +L    K IIHRDIK SN+LLD      + DFG++ ++    S   T+ 
Sbjct: 129 KITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRD 185
Query: 257 AGTMGYMPPEYLGGNTAAT---VMLDVYSFGILMIEIATQIRP---------NLPVVLDG 304
           AG   YM PE +  + +     V  DV+S GI + E+AT   P          L  V+ G
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG 245
Query: 305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYV 364
               L   +   E     I  V+  ++++E      +E  +   +   E+ R      YV
Sbjct: 246 DPPQLSN-SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE-RAVEVACYV 303
Query: 365 VQLLDELVA 373
            ++LD++ A
Sbjct: 304 CKILDQMPA 312

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 83  NFSTDKI-IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           +++T ++ +G GSFG V++ +   +G   A+KK+  + F+       E+     L    I
Sbjct: 74  HWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA-----EELMACAGLTSPRI 128
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V + G    G    +  E +E GSL Q +            K+   L     E R     
Sbjct: 129 VPLYGAVREGPWVNIFMELLEGGSLGQLV------------KEQGCLP----EDRALYYL 172
Query: 201 GVA-NGLAYLHGLEKPIIHRDIKSSNVLLDSD-FEAHISDFGLA--RRIDTSHSHVSTQ- 255
           G A  GL YLH   + I+H D+K+ NVLL SD   A + DFG A   + D     + T  
Sbjct: 173 GQALEGLEYLH--SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGD 230
Query: 256 -VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
            + GT  +M PE + G +     +DV+S   +M+ +     P
Sbjct: 231 YIPGTETHMAPEVVLGRS-CDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 81  TDNFSTDKIIGDGSFGF--VYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHR 138
           +D +   K IG G+FG   + + KL+  + VA+K +++ A       + E+     LRH 
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKEL-VAVKYIERGAAID-ENVQREIINHRSLRHP 76
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIV+      +     +I E+   G L + + +  R                S +     
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR---------------FSEDEARFF 121
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH--ISDFGLARRIDTSHSHVSTQV 256
            + + +G++Y H ++  I HRD+K  N LLD        I DFG ++     HS   + V
Sbjct: 122 FQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTV 178
Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
            GT  Y+ PE L        + DV+S G+ +
Sbjct: 179 -GTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+   G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+++D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 108/248 (43%), Gaps = 30/248 (12%)
Query: 53  DLSSIALFDSASFDPSLSQISMSELIDAT----DNFSTDKIIGDGSFGFV---YKAKLSS 105
           D+S IA   + S     +Q    E+ D+T      +   K IG G+ G V   Y A L  
Sbjct: 29  DVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDR 88
Query: 106 GVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVEN 162
            V  AIKKL +   +     R +R E+  +  + H+NI+ +L              F   
Sbjct: 89  NV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV------------FTPQ 133
Query: 163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIK 222
            +L+++       + +D +        L  E    ++  +  G+ +LH     IIHRD+K
Sbjct: 134 KTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLK 191
Query: 223 SSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYS 282
            SN+++ SD    I DFGLAR   T  S + T    T  Y  PE + G       +D++S
Sbjct: 192 PSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWS 248
Query: 283 FGILMIEI 290
            G +M E+
Sbjct: 249 VGCIMGEM 256

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D +   + +G G F  V K +  S+G+  A K + K   +  R      E   E+  L +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           + H N++ +     +  D VLI E V  G L  +L                    LS E 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------------SLSEEE 116
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFE-AHIS--DFGLARRIDTSHS 250
               ++ + +G+ YLH   K I H D+K  N+ LLD +    HI   DFGLA  I+    
Sbjct: 117 ATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 175 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 207

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
            +R    G+ YLH     +IHRD+K  N+ L+ D +  I DFGLA +I+       T + 
Sbjct: 147 FMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LC 203
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT  Y+ PE L      +  +D++S G ++
Sbjct: 204 GTPNYIAPEVL-CKKGHSFEVDIWSLGCIL 232

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D +   + +G G F  V K +  S+G+  A K + K   +  R      E   E+  L +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           + H N++ +     +  D VLI E V  G L  +L                    LS E 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------------SLSEEE 116
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFE-AHIS--DFGLARRIDTSHS 250
               ++ + +G+ YLH   K I H D+K  N+ LLD +    HI   DFGLA  I+    
Sbjct: 117 ATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 175 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 207

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 91/191 (47%), Gaps = 26/191 (13%)
Query: 107 VTVAIKKLDKDAFQGFRE-FRAEMETLGKLR-HRNIVKILGYCASGLDRVLIYEFVENGS 164
           + V  ++L  +  +  RE  R E   L ++  H +I+ ++    S     L+++ +  G 
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 165 LDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS 224
           L  +L      + V  S++         ETR  I+R +   +++LH     I+HRD+K  
Sbjct: 187 LFDYL-----TEKVALSEK---------ETR-SIMRSLLEAVSFLHA--NNIVHRDLKPE 229
Query: 225 NVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAAT-----VMLD 279
           N+LLD + +  +SDFG +  ++        ++ GT GY+ PE L  +   T       +D
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 280 VYSFGILMIEI 290
           +++ G+++  +
Sbjct: 288 LWACGVILFTL 298

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D +   + +G G F  V K +  S+G+  A K + K   +  R      E   E+  L +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           + H N++ +     +  D VLI E V  G L  +L                    LS E 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------------SLSEEE 116
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFE-AHIS--DFGLARRIDTSHS 250
               ++ + +G+ YLH   K I H D+K  N+ LLD +    HI   DFGLA  I+    
Sbjct: 117 ATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 175 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 207

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 33/229 (14%)
Query: 68  SLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR 126
           ++++++M+E       F   K++G G+FG V   K  ++G   A+K L K+      E  
Sbjct: 2   AMARVTMNE-------FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA 54
Query: 127 ---AEMETLGKLRHRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSK 182
               E   L   RH   +  L Y     DR+  + E+   G L  + H +          
Sbjct: 55  HTLTENRVLQNSRH-PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRER------- 104
Query: 183 QLNSLCPLSWETRVKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
                  +  E R +     + + L YLH  EK +++RD+K  N++LD D    I+DFGL
Sbjct: 105 -------VFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGL 156
Query: 242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +              GT  Y+ PE L  N      +D +  G++M E+
Sbjct: 157 CKE-GIKDGATMKXFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEM 203

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIV 141
           K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H+NI+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 86
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L              F    SL+++       + +D +        L  E    ++  
Sbjct: 87  GLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ 134
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T  
Sbjct: 135 MLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY 190
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           Y  PE + G       +D++S G +M E+
Sbjct: 191 YRAPEVILG-MGYKENVDIWSVGCIMGEM 218

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+   G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+++D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIV 141
           K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H+NI+
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNII 86
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L              F    +L+++       + +D +        L  E    ++  
Sbjct: 87  SLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T  
Sbjct: 135 MLCGIKHLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRY 190
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
           Y  PE + G       +D++S G +M E+ 
Sbjct: 191 YRAPEVILG-MGYKENVDIWSVGCIMGEMV 219

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D +   + +G G F  V K +  S+G+  A K + K   +  R      E   E+  L +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           + H N++ +     +  D VLI E V  G L  +L                    LS E 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------------SLSEEE 116
Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV-LLDSDFE-AHIS--DFGLARRIDTSHS 250
               ++ + +G+ YLH   K I H D+K  N+ LLD +    HI   DFGLA  I+    
Sbjct: 117 ATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
                + GT  ++ PE +       +  D++S G++
Sbjct: 175 F--KNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 207

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   SG   A+K LDK      ++      E   L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ P  +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEYLAPAIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 27/215 (12%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRH 137
           ++F   K++G G+FG V   +  ++G   A+K L K+      E      E   L   RH
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
              +  L Y     DR+  + E+   G L  + H +                 +  E R 
Sbjct: 68  -PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRER--------------VFTEERA 110
Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     + + L YLH   + +++RDIK  N++LD D    I+DFGL +   +  + + T 
Sbjct: 111 RFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 167
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             GT  Y+ PE L  N      +D +  G++M E+
Sbjct: 168 FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEM 201

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 33/227 (14%)
Query: 70  SQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR-- 126
           S+++M+E       F   K++G G+FG V   K  ++G   A+K L K+      E    
Sbjct: 3   SRVTMNE-------FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT 55
Query: 127 -AEMETLGKLRHRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
             E   L   RH   +  L Y     DR+  + E+   G L  + H +            
Sbjct: 56  LTENRVLQNSRH-PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRER--------- 103
Query: 185 NSLCPLSWETRVKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR 243
                +  E R +     + + L YLH  EK +++RD+K  N++LD D    I+DFGL +
Sbjct: 104 -----VFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 157
Query: 244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
                         GT  Y+ PE L  N      +D +  G++M E+
Sbjct: 158 E-GIKDGATMKXFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEM 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 27/215 (12%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRH 137
           ++F   K++G G+FG V   +  ++G   A+K L K+      E      E   L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
              +  L Y     DR+  + E+   G L  + H +                 +  E R 
Sbjct: 65  -PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRER--------------VFTEERA 107
Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     + + L YLH   + +++RDIK  N++LD D    I+DFGL +   +  + + T 
Sbjct: 108 RFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 164
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             GT  Y+ PE L  N      +D +  G++M E+
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEM 198

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 84  FSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRH 137
           +   K IG G+ G V   Y A L     VAIKKL +   +     R +R E+  +  + H
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILER--NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 84
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           +NI+ +L              F    SL+++       + +D +        L  E    
Sbjct: 85  KNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY 132
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           ++  +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   TS   V   V 
Sbjct: 133 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV- 189
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            T  Y  PE + G       +D++S G +M E+
Sbjct: 190 -TRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 220

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIV 141
           K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H+NI+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNII 86
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L              F    SL+++       + +D +        L  E    ++  
Sbjct: 87  GLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ 134
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T  
Sbjct: 135 MLCGIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRY 190
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           Y  PE + G       +D++S G +M E+
Sbjct: 191 YRAPEVILG-MGYKENVDIWSVGCIMGEM 218

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 27/215 (12%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRH 137
           ++F   K++G G+FG V   +  ++G   A+K L K+      E      E   L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
              +  L Y     DR+  + E+   G L  + H +                 +  E R 
Sbjct: 65  -PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRER--------------VFTEERA 107
Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     + + L YLH   + +++RDIK  N++LD D    I+DFGL +   +  + + T 
Sbjct: 108 RFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 164
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             GT  Y+ PE L  N      +D +  G++M E+
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEM 198

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 89  IIGDGSFGFVYKAKLSS------GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVK 142
           ++G+GS+G V K  L S       V +  KK  +    G    + E++ L +LRH+N+++
Sbjct: 12  LLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 143 ILG--YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           ++   Y        ++ E+   G   Q + D+         +     C L          
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEKRFPVCQAHGYFCQL---------- 118
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA-GT 259
              +GL YLH   + I+H+DIK  N+LL +     IS  G+A  +    +  + + + G+
Sbjct: 119 --IDGLEYLH--SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 260 MGYMPPEYLGG-NTAATVMLDVYSFGILMIEIATQIRP 296
             + PPE   G +T +   +D++S G+ +  I T + P
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 84  FSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRH 137
           +   K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           +NI+ +L              F    +L+++       + +D +        L  E    
Sbjct: 77  KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 124
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           ++  +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T   
Sbjct: 125 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYV 180
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            T  Y  PE + G       +D++S G +M E+ 
Sbjct: 181 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMV 213

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIV 141
           K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H+NI+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 86
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L              F    SL+++       + +D +        L  E    ++  
Sbjct: 87  GLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T  
Sbjct: 135 MLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY 190
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           Y  PE + G       +D++S G +M E+
Sbjct: 191 YRAPEVILG-MGYKENVDIWSVGCIMGEM 218

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIV 141
           K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H+NI+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 86
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L              F    SL+++       + +D +        L  E    ++  
Sbjct: 87  GLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ 134
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T  
Sbjct: 135 MLCGIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRY 190
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           Y  PE + G       +D++S G +M E+
Sbjct: 191 YRAPEVILG-MGYKENVDIWSVGCIMGEM 218

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 84  FSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRH 137
           +   K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           +NI+ +L              F    SL+++       + +D +        L  E    
Sbjct: 77  KNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY 124
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           ++  +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T   
Sbjct: 125 LLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYV 180
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
            T  Y  PE + G       +D++S G +M E+   
Sbjct: 181 VTRYYRAPEVILG-MGYKENVDLWSVGCIMGEMVCH 215

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 35/218 (16%)
Query: 90  IGDGSFGFVYKA-KLSSG-------VTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNI 140
           +G G+F  ++K  +   G         V +K LDK A + + E F      + KL H+++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-AHRNYSESFFEAASMMSKLSHKHL 74
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V   G C  G + +L+ EFV+ GSLD +L            K+  +   + W  ++++ +
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYL------------KKNKNCINILW--KLEVAK 120
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT- 259
            +A  + +L   E  +IH ++ + N+LL  + +      G    I  S   +S  V    
Sbjct: 121 QLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKT---GNPPFIKLSDPGISITVLPKD 175
Query: 260 -----MGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
                + ++PPE +       +  D +SFG  + EI +
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIV 141
           K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H+NI+
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 86
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L              F    +L+++       + +D +        L  E    ++  
Sbjct: 87  SLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T  
Sbjct: 135 MLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY 190
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           Y  PE + G       +D++S G +M E+
Sbjct: 191 YRAPEVILG-MGYKENVDIWSVGCIMGEM 218

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 84  FSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRH 137
           +   K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           +NI+ +L              F    +L+++       + +D +        L  E    
Sbjct: 76  KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 123
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           ++  +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T   
Sbjct: 124 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYV 179
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            T  Y  PE + G       +D++S G +M E+ 
Sbjct: 180 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMV 212

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 27/215 (12%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRH 137
           ++F   K++G G+FG V   +  ++G   A+K L K+      E      E   L   RH
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
              +  L Y     DR+  + E+   G L  + H +                 +  E R 
Sbjct: 70  -PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRER--------------VFTEERA 112
Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     + + L YLH   + +++RDIK  N++LD D    I+DFGL +    S       
Sbjct: 113 RFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKX 169
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             GT  Y+ PE L  N      +D +  G++M E+
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEM 203

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 84  FSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRH 137
           +   K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           +NI+ +L              F    +L+++       + +D +        L  E    
Sbjct: 77  KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 124
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           ++  +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T   
Sbjct: 125 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYV 180
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            T  Y  PE + G       +D++S G +M E+ 
Sbjct: 181 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMV 213

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 27/215 (12%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRH 137
           ++F   K++G G+FG V   +  ++G   A+K L K+      E      E   L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
              +  L Y     DR+  + E+   G L  + H +                 +  E R 
Sbjct: 65  -PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRER--------------VFTEERA 107
Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     + + L YLH   + +++RDIK  N++LD D    I+DFGL +    S       
Sbjct: 108 RFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKX 164
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             GT  Y+ PE L  N      +D +  G++M E+
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEM 198

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 84  FSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRH 137
           +   K IG G+ G V   Y A L     VAIKKL +   +     R +R E+  +  + H
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILER--NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           +NI+ +L              F    SL+++       + +D +        L  E    
Sbjct: 84  KNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY 131
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           ++  +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T   
Sbjct: 132 LLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYV 187
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            T  Y  PE + G       +D++S G +M E+
Sbjct: 188 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 219

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIV 141
           K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H+NI+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNII 86
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L              F    SL+++       + +D +        L  E    ++  
Sbjct: 87  GLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ 134
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T  
Sbjct: 135 MLVGIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRY 190
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           Y  PE + G       +D++S G +M E+
Sbjct: 191 YRAPEVILG-MGYKENVDIWSVGCIMGEM 218

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIV 141
           K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H+NI+
Sbjct: 31  KPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 87
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L              F    +L+++       + +D +        L  E    ++  
Sbjct: 88  SLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 135
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T  
Sbjct: 136 MLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY 191
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
           Y  PE + G       +D++S G +M E+ 
Sbjct: 192 YRAPEVILG-MGYKENVDIWSVGCIMGEMV 220

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 26/215 (12%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRH 137
           + F   K++G G+FG V   K  ++G   A+K L K+      E      E   L   RH
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
              +  L Y     DR+  + E+   G L  + H +                 +  E R 
Sbjct: 70  -PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRER--------------VFSEDRA 112
Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     + + L YLH  EK +++RD+K  N++LD D    I+DFGL +            
Sbjct: 113 RFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKX 170
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             GT  Y+ PE L  N      +D +  G++M E+
Sbjct: 171 FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEM 204

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIV 141
           K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H+NI+
Sbjct: 29  KPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 85
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L              F    +L+++       + +D +        L  E    ++  
Sbjct: 86  SLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 133
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T  
Sbjct: 134 MLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY 189
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
           Y  PE + G       +D++S G +M E+ 
Sbjct: 190 YRAPEVILG-MGYKENVDIWSVGCIMGEMV 218

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 81  TDNFSTDKIIGDGSFGFVY--KAKLSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKL 135
           +D +   K +G G++G V   K KL+ G   AIK + K +        A   E+  L +L
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
            H NI+K+  +     +  L+ E    G L   +    +  +VD +              
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV------------- 108
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHISDFGLARRIDTSHSHV 252
             I++ V +G  YLH  +  I+HRD+K  N+LL+S   D    I DFGL     ++H  V
Sbjct: 109 --IMKQVLSGTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGL-----SAHFEV 159
Query: 253 STQVA---GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
             ++    GT  Y+ PE L          DV+S G+++
Sbjct: 160 GGKMKERLGTAYYIAPEVLRKKYDEKC--DVWSCGVIL 195

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIV 141
           K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H+NI+
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 86
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L              F    +L+++       + +D +        L  E    ++  
Sbjct: 87  SLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T  
Sbjct: 135 MLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY 190
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
           Y  PE + G       +D++S G +M E+ 
Sbjct: 191 YRAPEVILG-MGYKENVDIWSVGCIMGEMV 219

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 27/215 (12%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRH 137
           ++F   K++G G+FG V   +  ++G   A+K L K+      E      E   L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
              +  L Y     DR+  + E+   G L  + H +                 +  E R 
Sbjct: 65  -PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRER--------------VFTEERA 107
Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     + + L YLH   + +++RDIK  N++LD D    I+DFGL +    S       
Sbjct: 108 RFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKX 164
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             GT  Y+ PE L  N      +D +  G++M E+
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEM 198

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 27/215 (12%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRH 137
           ++F   K++G G+FG V   +  ++G   A+K L K+      E      E   L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
              +  L Y     DR+  + E+   G L  + H +                 +  E R 
Sbjct: 65  -PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRER--------------VFTEERA 107
Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     + + L YLH   + +++RDIK  N++LD D    I+DFGL +    S       
Sbjct: 108 RFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKX 164
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             GT  Y+ PE L  N      +D +  G++M E+
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEM 198

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIV 141
           K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H+NI+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 86
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L              F    SL+++       + +D +        L  E    ++  
Sbjct: 87  GLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T  
Sbjct: 135 MLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY 190
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           Y  PE + G       +D++S G +M E+
Sbjct: 191 YRAPEVILG-MGYKENVDIWSVGCIMGEM 218

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIV 141
           K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H+NI+
Sbjct: 31  KPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 87
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L              F    +L+++       + +D +        L  E    ++  
Sbjct: 88  SLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 135
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T  
Sbjct: 136 MLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY 191
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
           Y  PE + G       +D++S G +M E+ 
Sbjct: 192 YRAPEVILG-MGYKENVDIWSVGCIMGEMV 220

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 84  FSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRH 137
           +   K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 87
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           +NI+ +L              F    SL+++       + +D +        L  E    
Sbjct: 88  KNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY 135
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           ++  +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T   
Sbjct: 136 LLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYV 191
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
            T  Y  PE + G       +D++S G +M E+   
Sbjct: 192 VTRYYRAPEVILG-MGYKENVDLWSVGCIMGEMVCH 226

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 88  KIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRHRNIV 141
           K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H+NI+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 86
Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L              F    SL+++       + +D +        L  E    ++  
Sbjct: 87  GLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  S + T    T  
Sbjct: 135 MLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPEVVTRY 190
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           Y  PE + G       +D++S G +M E+
Sbjct: 191 YRAPEVILG-MGYKENVDIWSVGCIMGEM 218

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 104/243 (42%), Gaps = 44/243 (18%)
Query: 80  ATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHR 138
           ++  +S  K +G GSFG V +   + SG   A+KK+ +D     R    E++ +  L H 
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHV 60
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG-----------SKQLNSL 187
           NI+K++ Y  +  D     E       D       +N+ V+            +K LN +
Sbjct: 61  NIIKLVDYFYTTGDE----EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 188 CPLSWETRVKIVRG-------------------VANGLAYLHGLEKPIIHRDIKSSNVLL 228
                +T  K+++                    +   + ++H L   I HRDIK  N+L+
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLV 174
Query: 229 DS-DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           +S D    + DFG A+++  S   V+     +  Y  PE + G T  T  +D++S G + 
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAX--ICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 288 IEI 290
            E+
Sbjct: 233 GEL 235

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 107/253 (42%), Gaps = 36/253 (14%)
Query: 128 EMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL-DQWLHDTSRNDDVDGSKQLNS 186
           E+  L  L H NI+K+  +     +  L+ E  + G L D+ +H    N+ VD +     
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE-VDAAV---- 140
Query: 187 LCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHISDFGLAR 243
                      I++ V +G+ YLH  +  I+HRD+K  N+LL+S   D    I DFGL+ 
Sbjct: 141 -----------IIKQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP----NLP 299
             +        +  GT  Y+ PE L          DV+S G+++  +     P       
Sbjct: 188 VFENQKK--MKERLGTAYYIAPEVLRKKYDEKC--DVWSIGVILFILLAGYPPFGGQTDQ 243
Query: 300 VVLDGQEVGLL-----EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEK 354
            +L   E G       EW    E     I+ +    S+  +S     E+  I  MC+ ++
Sbjct: 244 EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKE 303
Query: 355 SR-ERPAMSYVVQ 366
           S  E P+++  ++
Sbjct: 304 SGIELPSLANAIE 316

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 4/90 (4%)
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
            +R    G+ YLH     +IHRD+K  N+ L+ D +  I DFGLA +I+         + 
Sbjct: 131 FMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKDLC 187
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT  Y+ PE L      +  +D++S G ++
Sbjct: 188 GTPNYIAPEVL-CKKGHSFEVDIWSLGCIL 216

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           ++  L YLH  E+ II+RD+K  NVLLDS+    ++D+G+ +         ++   GT  
Sbjct: 130 ISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSXFCGTPN 186
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           Y+ PE L G       +D ++ G+LM E+     P
Sbjct: 187 YIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSP 220

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 4/90 (4%)
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
            +R    G+ YLH     +IHRD+K  N+ L+ D +  I DFGLA +I+         + 
Sbjct: 147 FMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKDLC 203
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT  Y+ PE L      +  +D++S G ++
Sbjct: 204 GTPNYIAPEVL-CKKGHSFEVDIWSLGCIL 232

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 4/90 (4%)
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
            +R    G+ YLH     +IHRD+K  N+ L+ D +  I DFGLA +I+         + 
Sbjct: 147 FMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKXLC 203
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT  Y+ PE L      +  +D++S G ++
Sbjct: 204 GTPNYIAPEVL-CKKGHSFEVDIWSLGCIL 232

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             + K+        +  ++ E+   G +   L    R  +           P +     +
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 150
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+++D      ++DFG A+R+       +  + 
Sbjct: 151 IVLT----FEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLC 200
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 201 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 238

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           ++  L YLH  E+ II+RD+K  NVLLDS+    ++D+G+ +         ST   GT  
Sbjct: 162 ISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPN 218
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           Y+ PE L G       +D ++ G+LM E+     P
Sbjct: 219 YIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSP 252

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             + K+        +  ++ E+   G +   L    R  +           P +     +
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 150
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+++D      ++DFG A+R+       +  + 
Sbjct: 151 IVLT----FEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLC 200
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 201 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K   +G   A+K LDK      ++      E   L  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+   G +   L    R  +           P +     +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-----------PHARFYAAQ 150
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+++D      ++DFG A+R+       +  + 
Sbjct: 151 IVLT----FEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLC 200
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 201 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 238

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN- 139
           D F   K +G GSFG V   K   SG   A+K LDK      ++    +     L+  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 140 --IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +VK+        +  ++ E+V  G +   L    R  +           P +     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----------PHARFYAAQ 149
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + 
Sbjct: 150 IVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLC 199
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT   + PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 200 GTPEALAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 237

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           ++  L YLH  E+ II+RD+K  NVLLDS+    ++D+G+ +         ++   GT  
Sbjct: 115 ISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSXFCGTPN 171
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           Y+ PE L G       +D ++ G+LM E+     P
Sbjct: 172 YIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSP 205

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           ++  L YLH  E+ II+RD+K  NVLLDS+    ++D+G+ +         ++   GT  
Sbjct: 119 ISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSXFCGTPN 175
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           Y+ PE L G       +D ++ G+LM E+     P
Sbjct: 176 YIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSP 209

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 32/222 (14%)
Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA---EMETLGKLRH 137
           D F   K +G GSFG V   K + +G   A+K LDK      ++      E   L  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             + K+        +  ++ E+   G +   L    R  +           P +     +
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE-----------PHARFYAAQ 150
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           IV        YLH L+  +I+RD+K  N+++D      ++DFG A+R+       +  + 
Sbjct: 151 IVLT----FEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLC 200
Query: 258 GTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +   G N A    +D ++ G+L+ E+A    P
Sbjct: 201 GTPEYLAPEIILSKGYNKA----VDWWALGVLIYEMAAGYPP 238

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 84  FSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRH 137
           +   K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           +NI+ +L              F    SL+++       + +D +        L  E    
Sbjct: 83  KNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY 130
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           ++  +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   TS       V 
Sbjct: 131 LLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV- 187
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
            T  Y  PE + G       +D++S G +M E+   
Sbjct: 188 -TRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVCH 221

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 35/218 (16%)
Query: 90  IGDGSFGFVYKA-KLSSG-------VTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNI 140
           +G G+F  ++K  +   G         V +K LDK A + + E F      + KL H+++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-AHRNYSESFFEAASMMSKLSHKHL 74
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V   G C  G + +L+ EFV+ GSLD +L            K+  +   + W  ++++ +
Sbjct: 75  VLNYGVCFCGDENILVQEFVKFGSLDTYL------------KKNKNCINILW--KLEVAK 120
Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT- 259
            +A  + +L   E  +IH ++ + N+LL  + +      G    I  S   +S  V    
Sbjct: 121 QLAWAMHFLE--ENTLIHGNVCAKNILLIREEDRKT---GNPPFIKLSDPGISITVLPKD 175
Query: 260 -----MGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
                + ++PPE +       +  D +SFG  + EI +
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 35/233 (15%)
Query: 74  MSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDK------------DAFQG 121
           ++EL      ++  + I  GS+G V     S G+ VAIK++              D+F  
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 122 FREFRAEMETLGKLRHRNIVKI----LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDD 177
            R  R E+  L    H NI+ +    + +    + ++ +   +    L Q +HD      
Sbjct: 74  KRVLR-EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD------ 126
Query: 178 VDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS 237
                Q   + P   +     +  +  GL  LH  E  ++HRD+   N+LL  + +  I 
Sbjct: 127 -----QRIVISPQHIQY---FMYHILLGLHVLH--EAGVVHRDLHPGNILLADNNDITIC 176
Query: 238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           DF LAR  DT+ ++  T       Y  PE +      T ++D++S G +M E+
Sbjct: 177 DFNLARE-DTADAN-KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 35/233 (15%)
Query: 74  MSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDK------------DAFQG 121
           ++EL      ++  + I  GS+G V     S G+ VAIK++              D+F  
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 122 FREFRAEMETLGKLRHRNIVKI----LGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDD 177
            R  R E+  L    H NI+ +    + +    + ++ +   +    L Q +HD      
Sbjct: 74  KRVLR-EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD------ 126
Query: 178 VDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS 237
                Q   + P   +     +  +  GL  LH  E  ++HRD+   N+LL  + +  I 
Sbjct: 127 -----QRIVISPQHIQY---FMYHILLGLHVLH--EAGVVHRDLHPGNILLADNNDITIC 176
Query: 238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           DF LAR  DT+ ++  T       Y  PE +      T ++D++S G +M E+
Sbjct: 177 DFNLARE-DTADAN-KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEM---ETLGKLRHR 138
           +F+   ++G GSFG V  A +  +    AIK L KD      +    M     L  L   
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 139 NIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +  L  C   +DR+  + E+V  G L   +    +                     V 
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---------------FKEPQAVF 124
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
               ++ GL +LH  ++ II+RD+K  NV+LDS+    I+DFG+ +         + +  
Sbjct: 125 YAAEISIGLFFLH--KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-HMMDGVTTREFC 181
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           GT  Y+ PE +         +D +++G+L+ E+
Sbjct: 182 GTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEM 213

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG-TM 260
           VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I     +V    A   +
Sbjct: 202 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 260 KWMAPETI-FDRVYTIQSDVWSFGVLLWEI 288

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG-TM 260
           VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I     +V    A   +
Sbjct: 207 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 264
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 265 KWMAPETI-FDRVYTIQSDVWSFGVLLWEI 293

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG-TM 260
           VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I     +V    A   +
Sbjct: 200 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 257
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 258 KWMAPETI-FDRVYTIQSDVWSFGVLLWEI 286

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 104/251 (41%), Gaps = 41/251 (16%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 17  CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 64
Query: 110 AIKKLDKDAFQGFREF----RAEMET--LGKLR--HRNIVKILGYCASGLDRVLIYEFVE 161
           AIK ++KD    + E     R  ME   L K+      ++++L +       VLI E  E
Sbjct: 65  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 124
Query: 162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDI 221
               D +   T R     G+ Q        W+  ++ VR   N           ++HRDI
Sbjct: 125 PVQ-DLFDFITER-----GALQEELARSFFWQV-LEAVRHCHNC---------GVLHRDI 168
Query: 222 KSSNVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDV 280
           K  N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V
Sbjct: 169 KDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAV 225
Query: 281 YSFGILMIEIA 291
           +S GIL+ ++ 
Sbjct: 226 WSLGILLYDMV 236

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG-TM 260
           VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I     +V    A   +
Sbjct: 209 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 266
Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
            +M PE +  +   T+  DV+SFG+L+ EI
Sbjct: 267 KWMAPETI-FDRVYTIQSDVWSFGVLLWEI 295

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 70/174 (40%), Gaps = 24/174 (13%)
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR-IDTSHSHVSTQ 255
           KI   +   L +LH  +  +IHRD+K SNVL+++  +    DFG++   +D     +   
Sbjct: 140 KIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID-- 196
Query: 256 VAGTMGYMPPEYLG---GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW 312
            AG   Y  PE +         +V  D++S GI  IE+A    P               W
Sbjct: 197 -AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFP------------YDSW 243
Query: 313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ 366
               +   + +E     +  ++ S     E+      C  + S+ERP    + Q
Sbjct: 244 GTPFQQLKQVVEEPSPQLPADKFSA----EFVDFTSQCLKKNSKERPTYPELXQ 293

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 84  FSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDK---DAFQGFREFRAEMETLGKLRH 137
           +   K IG G+ G V   Y A L   V  AIKKL +   +     R +R E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           +NI+ +L              F    SL+++       + +D +        L  E    
Sbjct: 83  KNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY 130
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           ++  +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   TS       V 
Sbjct: 131 LLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV- 187
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ 293
            T  Y  PE + G       +D++S G +M E+   
Sbjct: 188 -TRYYRAPEVILG-MGYKENVDLWSVGCIMGEMVCH 221

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 104/251 (41%), Gaps = 41/251 (16%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 32  CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 79
Query: 110 AIKKLDKDAFQGFREF----RAEMET--LGKLR--HRNIVKILGYCASGLDRVLIYEFVE 161
           AIK ++KD    + E     R  ME   L K+      ++++L +       VLI E  E
Sbjct: 80  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 139
Query: 162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDI 221
               D +   T R     G+ Q        W+  ++ VR   N           ++HRDI
Sbjct: 140 PVQ-DLFDFITER-----GALQEELARSFFWQV-LEAVRHCHNC---------GVLHRDI 183
Query: 222 KSSNVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDV 280
           K  N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V
Sbjct: 184 KDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAV 240
Query: 281 YSFGILMIEIA 291
           +S GIL+ ++ 
Sbjct: 241 WSLGILLYDMV 251

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 104/247 (42%), Gaps = 35/247 (14%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 4   CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 51
Query: 110 AIKKLDKDAFQGFREF----RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL 165
           AIK ++KD    + E     R  ME +       ++K +    SG+ R+L  ++ E    
Sbjct: 52  AIKHVEKDRISDWGELPNGTRVPMEVV-------LLKKVSSGFSGVIRLL--DWFERP-- 100
Query: 166 DQWLHDTSRNDDV-DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS 224
           D ++    R + V D    +     L  E        V   + + H     ++HRDIK  
Sbjct: 101 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDE 158
Query: 225 NVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSF 283
           N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V+S 
Sbjct: 159 NILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 215
Query: 284 GILMIEI 290
           GIL+ ++
Sbjct: 216 GILLYDM 222

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL  LH   + I++RD+K  N+LLD      ISD GLA  +    + +  +V GT+G
Sbjct: 295 ICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVG 350
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           YM PE +  N   T   D ++ G L+ E+
Sbjct: 351 YMAPEVV-KNERYTFSPDWWALGCLLYEM 378

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 104/247 (42%), Gaps = 35/247 (14%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 5   CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 52
Query: 110 AIKKLDKDAFQGFREF----RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL 165
           AIK ++KD    + E     R  ME +       ++K +    SG+ R+L  ++ E    
Sbjct: 53  AIKHVEKDRISDWGELPNGTRVPMEVV-------LLKKVSSGFSGVIRLL--DWFERP-- 101
Query: 166 DQWLHDTSRNDDV-DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS 224
           D ++    R + V D    +     L  E        V   + + H     ++HRDIK  
Sbjct: 102 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDE 159
Query: 225 NVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSF 283
           N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V+S 
Sbjct: 160 NILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 216
Query: 284 GILMIEI 290
           GIL+ ++
Sbjct: 217 GILLYDM 223

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 104/251 (41%), Gaps = 41/251 (16%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 17  CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 64
Query: 110 AIKKLDKDAFQGFREF----RAEMET--LGKLR--HRNIVKILGYCASGLDRVLIYEFVE 161
           AIK ++KD    + E     R  ME   L K+      ++++L +       VLI E  E
Sbjct: 65  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 124
Query: 162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDI 221
               D +   T R     G+ Q        W+  ++ VR   N           ++HRDI
Sbjct: 125 PVQ-DLFDFITER-----GALQEELARSFFWQV-LEAVRHCHNC---------GVLHRDI 168
Query: 222 KSSNVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDV 280
           K  N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V
Sbjct: 169 KDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAV 225
Query: 281 YSFGILMIEIA 291
           +S GIL+ ++ 
Sbjct: 226 WSLGILLYDMV 236

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 104/250 (41%), Gaps = 41/250 (16%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 5   CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 52
Query: 110 AIKKLDKDAFQGFREF----RAEMET--LGKLR--HRNIVKILGYCASGLDRVLIYEFVE 161
           AIK ++KD    + E     R  ME   L K+      ++++L +       VLI E  E
Sbjct: 53  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 112
Query: 162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDI 221
               D +   T R     G+ Q        W+  ++ VR   N           ++HRDI
Sbjct: 113 PVQ-DLFDFITER-----GALQEELARSFFWQV-LEAVRHCHNC---------GVLHRDI 156
Query: 222 KSSNVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDV 280
           K  N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V
Sbjct: 157 KDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAV 213
Query: 281 YSFGILMIEI 290
           +S GIL+ ++
Sbjct: 214 WSLGILLYDM 223

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 104/247 (42%), Gaps = 35/247 (14%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 37  CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 84
Query: 110 AIKKLDKDAFQGFREF----RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL 165
           AIK ++KD    + E     R  ME +       ++K +    SG+ R+L  ++ E    
Sbjct: 85  AIKHVEKDRISDWGELPNGTRVPMEVV-------LLKKVSSGFSGVIRLL--DWFERP-- 133
Query: 166 DQWLHDTSRNDDV-DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS 224
           D ++    R + V D    +     L  E        V   + + H     ++HRDIK  
Sbjct: 134 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDE 191
Query: 225 NVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSF 283
           N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V+S 
Sbjct: 192 NILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 248
Query: 284 GILMIEI 290
           GIL+ ++
Sbjct: 249 GILLYDM 255

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 104/250 (41%), Gaps = 41/250 (16%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 17  CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 64
Query: 110 AIKKLDKDAFQGFREF----RAEMET--LGKLR--HRNIVKILGYCASGLDRVLIYEFVE 161
           AIK ++KD    + E     R  ME   L K+      ++++L +       VLI E  E
Sbjct: 65  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 124
Query: 162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDI 221
               D +   T R     G+ Q        W+  ++ VR   N           ++HRDI
Sbjct: 125 PVQ-DLFDFITER-----GALQEELARSFFWQV-LEAVRHCHNC---------GVLHRDI 168
Query: 222 KSSNVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDV 280
           K  N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V
Sbjct: 169 KDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAV 225
Query: 281 YSFGILMIEI 290
           +S GIL+ ++
Sbjct: 226 WSLGILLYDM 235

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 104/250 (41%), Gaps = 41/250 (16%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 18  CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 65
Query: 110 AIKKLDKDAFQGFREF----RAEMET--LGKLR--HRNIVKILGYCASGLDRVLIYEFVE 161
           AIK ++KD    + E     R  ME   L K+      ++++L +       VLI E  E
Sbjct: 66  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 125
Query: 162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDI 221
               D +   T R     G+ Q        W+  ++ VR   N           ++HRDI
Sbjct: 126 PVQ-DLFDFITER-----GALQEELARSFFWQV-LEAVRHCHNC---------GVLHRDI 169
Query: 222 KSSNVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDV 280
           K  N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V
Sbjct: 170 KDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAV 226
Query: 281 YSFGILMIEI 290
           +S GIL+ ++
Sbjct: 227 WSLGILLYDM 236

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 104/248 (41%), Gaps = 35/248 (14%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 24  CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 71
Query: 110 AIKKLDKDAFQGFREF----RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL 165
           AIK ++KD    + E     R  ME +       ++K +    SG+ R+L  ++ E    
Sbjct: 72  AIKHVEKDRISDWGELPNGTRVPMEVV-------LLKKVSSGFSGVIRLL--DWFERP-- 120
Query: 166 DQWLHDTSRNDDV-DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS 224
           D ++    R + V D    +     L  E        V   + + H     ++HRDIK  
Sbjct: 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDE 178
Query: 225 NVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSF 283
           N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V+S 
Sbjct: 179 NILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 235
Query: 284 GILMIEIA 291
           GIL+ ++ 
Sbjct: 236 GILLYDMV 243

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 104/247 (42%), Gaps = 35/247 (14%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 18  CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 65
Query: 110 AIKKLDKDAFQGFREF----RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL 165
           AIK ++KD    + E     R  ME +       ++K +    SG+ R+L  ++ E    
Sbjct: 66  AIKHVEKDRISDWGELPNGTRVPMEVV-------LLKKVSSGFSGVIRLL--DWFERP-- 114
Query: 166 DQWLHDTSRNDDV-DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS 224
           D ++    R + V D    +     L  E        V   + + H     ++HRDIK  
Sbjct: 115 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDE 172
Query: 225 NVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSF 283
           N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V+S 
Sbjct: 173 NILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 229
Query: 284 GILMIEI 290
           GIL+ ++
Sbjct: 230 GILLYDM 236

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 104/247 (42%), Gaps = 35/247 (14%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 5   CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 52
Query: 110 AIKKLDKDAFQGFREF----RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL 165
           AIK ++KD    + E     R  ME +       ++K +    SG+ R+L  ++ E    
Sbjct: 53  AIKHVEKDRISDWGELPNGTRVPMEVV-------LLKKVSSGFSGVIRLL--DWFERP-- 101
Query: 166 DQWLHDTSRNDDV-DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS 224
           D ++    R + V D    +     L  E        V   + + H     ++HRDIK  
Sbjct: 102 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDE 159
Query: 225 NVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSF 283
           N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V+S 
Sbjct: 160 NILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 216
Query: 284 GILMIEI 290
           GIL+ ++
Sbjct: 217 GILLYDM 223

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 104/248 (41%), Gaps = 35/248 (14%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 4   CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 51
Query: 110 AIKKLDKDAFQGFREF----RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL 165
           AIK ++KD    + E     R  ME +       ++K +    SG+ R+L  ++ E    
Sbjct: 52  AIKHVEKDRISDWGELPNGTRVPMEVV-------LLKKVSSGFSGVIRLL--DWFERP-- 100
Query: 166 DQWLHDTSRNDDV-DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS 224
           D ++    R + V D    +     L  E        V   + + H     ++HRDIK  
Sbjct: 101 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDE 158
Query: 225 NVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSF 283
           N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V+S 
Sbjct: 159 NILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 215
Query: 284 GILMIEIA 291
           GIL+ ++ 
Sbjct: 216 GILLYDMV 223

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 104/250 (41%), Gaps = 41/250 (16%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 18  CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 65
Query: 110 AIKKLDKDAFQGFREF----RAEMET--LGKLR--HRNIVKILGYCASGLDRVLIYEFVE 161
           AIK ++KD    + E     R  ME   L K+      ++++L +       VLI E  E
Sbjct: 66  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 125
Query: 162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDI 221
               D +   T R     G+ Q        W+  ++ VR   N           ++HRDI
Sbjct: 126 PVQ-DLFDFITER-----GALQEELARSFFWQV-LEAVRHCHNC---------GVLHRDI 169
Query: 222 KSSNVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDV 280
           K  N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V
Sbjct: 170 KDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAV 226
Query: 281 YSFGILMIEI 290
           +S GIL+ ++
Sbjct: 227 WSLGILLYDM 236

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 104/250 (41%), Gaps = 41/250 (16%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 32  CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 79
Query: 110 AIKKLDKDAFQGFREF----RAEMET--LGKLR--HRNIVKILGYCASGLDRVLIYEFVE 161
           AIK ++KD    + E     R  ME   L K+      ++++L +       VLI E  E
Sbjct: 80  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 139
Query: 162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDI 221
               D +   T R     G+ Q        W+  ++ VR   N           ++HRDI
Sbjct: 140 PVQ-DLFDFITER-----GALQEELARSFFWQV-LEAVRHCHNC---------GVLHRDI 183
Query: 222 KSSNVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDV 280
           K  N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V
Sbjct: 184 KDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAV 240
Query: 281 YSFGILMIEI 290
           +S GIL+ ++
Sbjct: 241 WSLGILLYDM 250

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 104/250 (41%), Gaps = 41/250 (16%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 18  CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 65
Query: 110 AIKKLDKDAFQGFREF----RAEMET--LGKLR--HRNIVKILGYCASGLDRVLIYEFVE 161
           AIK ++KD    + E     R  ME   L K+      ++++L +       VLI E  E
Sbjct: 66  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 125
Query: 162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDI 221
               D +   T R     G+ Q        W+  ++ VR   N           ++HRDI
Sbjct: 126 PVQ-DLFDFITER-----GALQEELARSFFWQV-LEAVRHCHNC---------GVLHRDI 169
Query: 222 KSSNVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDV 280
           K  N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V
Sbjct: 170 KDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAV 226
Query: 281 YSFGILMIEI 290
           +S GIL+ ++
Sbjct: 227 WSLGILLYDM 236

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 104/250 (41%), Gaps = 41/250 (16%)
Query: 51  CSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTV 109
           C+DL +  L      +P  SQ            +    ++G G FG VY   ++S  + V
Sbjct: 17  CNDLHATKLAPGKEKEPLESQ------------YQVGPLLGSGGFGSVYSGIRVSDNLPV 64
Query: 110 AIKKLDKDAFQGFREF----RAEMET--LGKLR--HRNIVKILGYCASGLDRVLIYEFVE 161
           AIK ++KD    + E     R  ME   L K+      ++++L +       VLI E  E
Sbjct: 65  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 124
Query: 162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDI 221
               D +   T R     G+ Q        W+  ++ VR   N           ++HRDI
Sbjct: 125 PVQ-DLFDFITER-----GALQEELARSFFWQV-LEAVRHCHNC---------GVLHRDI 168
Query: 222 KSSNVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDV 280
           K  N+L+D +  E  + DFG    +  +   V T   GT  Y PPE++  +        V
Sbjct: 169 KDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAV 225
Query: 281 YSFGILMIEI 290
           +S GIL+ ++
Sbjct: 226 WSLGILLYDM 235

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +  GL  LH   + I++RD+K  N+LLD      ISD GLA  +    + +  +V GT+G
Sbjct: 295 ICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVG 350
Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           YM PE +  N   T   D ++ G L+ E+     P
Sbjct: 351 YMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 13/94 (13%)
Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
             YLH L+  +I+RD+K  N+L+D      ++DFG A+R+       +  + GT  Y+ P
Sbjct: 155 FEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAP 208
Query: 266 EYL---GGNTAATVMLDVYSFGILMIEIATQIRP 296
           E +   G N A    +D ++ G+L+ E+A    P
Sbjct: 209 EIILSKGYNKA----VDWWALGVLIYEMAAGYPP 238

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 67  PSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREF 125
           P++S      ++  +D +   K IG G+FG     +   S   VA+K +++   +     
Sbjct: 4   PAVSGPMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE-KIAANV 62
Query: 126 RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN 185
           + E+     LRH NIV+      +     ++ E+   G L + + +  R           
Sbjct: 63  KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----------- 111
Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH--ISDFGLAR 243
                S +      + + +G++Y H ++  + HRD+K  N LLD        I DFG ++
Sbjct: 112 ----FSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 165
Query: 244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
                HS   + V GT  Y+ PE L        + DV+S G+ +
Sbjct: 166 S-SVLHSQPKSTV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTL 207

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 111/265 (41%), Gaps = 41/265 (15%)
Query: 81  TDNFSTDKIIGDGSFGFVYKAKLSSGVTV-AIKKLDKDAFQGFRE-----FRAEMETLGK 134
            +++   K+IG G+FG V   +  +   V A+K L K  F+  +      F  E + +  
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSK--FEMIKRSDSAFFWEERDIMAF 131
Query: 135 LRHRNIVKILGYCASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
                +V++  +CA   D+ L  + E++  G L   +     N DV          P  W
Sbjct: 132 ANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLM----SNYDV----------PEKW 175
Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSH 251
                    V   L  +H +   +IHRD+K  N+LLD      ++DFG   ++D T   H
Sbjct: 176 AKFY--TAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVH 231
Query: 252 VSTQVAGTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG 308
             T V GT  Y+ PE L   GG+       D +S G+ + E+     P     L G    
Sbjct: 232 CDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT--- 287
Query: 309 LLEWARTMEARNKEIEMVDSNISRE 333
              +++ M+ +N      D+ IS+ 
Sbjct: 288 ---YSKIMDHKNSLCFPEDAEISKH 309

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 94/271 (34%), Gaps = 71/271 (26%)
Query: 83  NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNI 140
           +F   + +G G FG V++AK        AIK++     +  RE    E++ L KL H  I
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTS-------------------RNDDVDGS 181
           V+               E  E      WL D S                   R D     
Sbjct: 67  VRYFNAWLETPPEKWQEEMDE-----IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 182 KQLNSLCPLS-------------------WETR------------VKIVRGVANGLAYLH 210
             +  L P S                   W  R            + I   +A  + +LH
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 211 GLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA-----------GT 259
              K ++HRD+K SN+    D    + DFGL   +D      +               GT
Sbjct: 182 S--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGT 239
Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             YM PE + GN  +   +D++S G+++ E+
Sbjct: 240 KLYMSPEQIHGNNYSH-KVDIFSLGLILFEL 269

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 23/210 (10%)
Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN 139
           +D +   K IG G+FG     +   S   VA+K +++   +     + E+     LRH N
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE-KIDENVKREIINHRSLRHPN 75
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IV+      +     ++ E+   G L + + +  R                S +      
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---------------FSEDEARFFF 120
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH--ISDFGLARRIDTSHSHVSTQVA 257
           + + +G++Y H ++  + HRD+K  N LLD        I DFG ++     HS   + V 
Sbjct: 121 QQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTV- 176
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT  Y+ PE L        + DV+S G+ +
Sbjct: 177 GTPAYIAPEVLLKKEYDGKVADVWSCGVTL 206

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 90  IGDGSFGFVYKA-KLSSGVTVAIKKLD--KDAFQGFREFRAEMETLGKLRHRNIVKILGY 146
           +G G+F  V +  K+ +G   A K ++  K + +  ++   E      L+H NIV++   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
            +      LI++ V  G L + +       + D S  +  +                   
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE----------------- 132
Query: 207 AYLHGLEKPIIHRDIKSSNVLLDSDFEA---HISDFGLARRIDTSHSHVSTQVAGTMGYM 263
           A LH  +  ++HRD+K  N+LL S  +     ++DFGLA  ++          AGT GY+
Sbjct: 133 AVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYL 191
Query: 264 PPEYLGGNTAATVMLDVYSFGILM 287
            PE L  +     + D+++ G+++
Sbjct: 192 SPEVLRKDPYGKPV-DLWACGVIL 214

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREF----RAEMET--LGKL 135
            +    ++G G FG VY   ++S  + VAIK ++KD    + E     R  ME   L K+
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 136 R--HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
                 ++++L +       VLI E +E    D +   T R     G+ Q        W+
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQ-DLFDFITER-----GALQEELARSFFWQ 122
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFEAHISDFGLARRIDTSHSHV 252
             ++ VR   N           ++HRDIK  N+L+D +  E  + DFG    +  +   V
Sbjct: 123 V-LEAVRHCHNC---------GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 169
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            T   GT  Y PPE++  +        V+S GIL+ ++ 
Sbjct: 170 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 74  MSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREF----RAE 128
           M E       +    ++G G FG VY   ++S  + VAIK ++KD    + E     R  
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 129 MET--LGKLR--HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           ME   L K+      ++++L +       VLI E  E    D +   T R     G+ Q 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITER-----GALQE 114
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFEAHISDFGLAR 243
                  W+  ++ VR   N           ++HRDIK  N+L+D +  E  + DFG   
Sbjct: 115 ELARSFFWQV-LEAVRHCHNC---------GVLHRDIKDENILIDLNRGELKLIDFGSGA 164
Query: 244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            +  +   V T   GT  Y PPE++  +        V+S GIL+ ++ 
Sbjct: 165 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREF----RAEMET--LGKL 135
            +    ++G G FG VY   ++S  + VAIK ++KD    + E     R  ME   L K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 136 R--HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
                 ++++L +       VLI E  E    D +   T R     G+ Q        W+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITER-----GALQEELARSFFWQ 118
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFEAHISDFGLARRIDTSHSHV 252
             ++ VR   N           ++HRDIK  N+L+D +  E  + DFG    +  +   V
Sbjct: 119 V-LEAVRHCHN---------XGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 165
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            T   GT  Y PPE++  +        V+S GIL+ ++ 
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 74  MSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREF----RAE 128
           M E       +    ++G G FG VY   ++S  + VAIK ++KD    + E     R  
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 129 MET--LGKLR--HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           ME   L K+      ++++L +       VLI E  E    D +   T R     G+ Q 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITER-----GALQE 114
Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFEAHISDFGLAR 243
                  W+  ++ VR   N           ++HRDIK  N+L+D +  E  + DFG   
Sbjct: 115 ELARSFFWQV-LEAVRHCHNC---------GVLHRDIKDENILIDLNRGELKLIDFGSGA 164
Query: 244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            +  +   V T   GT  Y PPE++  +        V+S GIL+ ++ 
Sbjct: 165 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD--KDAFQGFREFRAEMETLGKLRH 137
           TD +   + +G G+F  V +  K+ +G   A K ++  K + +  ++   E      L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV++    +      L+++ V  G L + +       + D S  +            +
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ-----------Q 111
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA---HISDFGLARRIDTSHSHVST 254
           I+  V +   +L+G    I+HRD+K  N+LL S  +     ++DFGLA  +         
Sbjct: 112 ILESVNH--CHLNG----IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD-QQAWF 164
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
             AGT GY+ PE L  +      +D+++ G+++
Sbjct: 165 GFAGTPGYLSPEVLRKDPYGKP-VDMWACGVIL 196

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 23/225 (10%)
Query: 74  MSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREF----RAE 128
           M E       +    ++G G FG VY   ++S  + VAIK ++KD    + E     R  
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 129 METLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDV-DGSKQLNSL 187
           ME +       ++K +    SG+ R+L  ++ E    D ++    R + V D    +   
Sbjct: 61  MEVV-------LLKKVSSGFSGVIRLL--DWFERP--DSFVLILERPEPVQDLFDFITER 109
Query: 188 CPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFEAHISDFGLARRID 246
             L  E        V   + + H     ++HRDIK  N+L+D +  E  + DFG    + 
Sbjct: 110 GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLK 167
Query: 247 TSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            +   V T   GT  Y PPE++  +        V+S GIL+ ++ 
Sbjct: 168 DT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD--KDAFQGFREFRAEMETLGKLRH 137
           TD +   + +G G+F  V +  K+ +G   A K ++  K + +  ++   E      L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV++    +      L+++ V  G L + +       + D S  +            +
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ-----------Q 111
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA---HISDFGLARRIDTSHSHVST 254
           I+  V +   +L+G    I+HRD+K  N+LL S  +     ++DFGLA  +         
Sbjct: 112 ILESVNH--CHLNG----IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWF 164
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
             AGT GY+ PE L  +      +D+++ G+++
Sbjct: 165 GFAGTPGYLSPEVLRKDPYGKP-VDMWACGVIL 196

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 23/210 (10%)
Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN 139
           +D +   K IG G+FG     +   +   VA+K +++   +     + E+     LRH N
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGE-KIDENVKREIINHRSLRHPN 76
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IV+      +     ++ E+   G L + + +  R  + +       L            
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI----------- 125
Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH--ISDFGLARRIDTSHSHVSTQVA 257
               +G++Y H ++  + HRD+K  N LLD        I+DFG + +    HS   + V 
Sbjct: 126 ----SGVSYAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYS-KASVLHSQPKSAV- 177
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT  Y+ PE L        + DV+S G+ +
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTL 207

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 23/225 (10%)
Query: 74  MSELIDATDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREF----RAE 128
           M E       +    ++G G FG VY   ++S  + VAIK ++KD    + E     R  
Sbjct: 23  MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 129 METLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDV-DGSKQLNSL 187
           ME +       ++K +    SG+ R+L  ++ E    D ++    R + V D    +   
Sbjct: 83  MEVV-------LLKKVSSGFSGVIRLL--DWFERP--DSFVLILERPEPVQDLFDFITER 131
Query: 188 CPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFEAHISDFGLARRID 246
             L  E        V   + + H     ++HRDIK  N+L+D +  E  + DFG    + 
Sbjct: 132 GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLK 189
Query: 247 TSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            +   V T   GT  Y PPE++  +        V+S GIL+ ++ 
Sbjct: 190 DT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 231

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREF----RAEMET--LGKL 135
            +    ++G G FG VY   ++S  + VAIK ++KD    + E     R  ME   L K+
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 136 R--HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
                 ++++L +       VLI E  E    D +   T R     G+ Q        W+
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITER-----GALQEELARSFFWQ 122
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFEAHISDFGLARRIDTSHSHV 252
             ++ VR   N           ++HRDIK  N+L+D +  E  + DFG    +  +   V
Sbjct: 123 V-LEAVRHCHNC---------GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 169
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            T   GT  Y PPE++  +        V+S GIL+ ++ 
Sbjct: 170 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREF----RAEMET--LGKL 135
            +    ++G G FG VY   ++S  + VAIK ++KD    + E     R  ME   L K+
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 136 R--HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
                 ++++L +       VLI E  E    D +   T R     G+ Q        W+
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITER-----GALQEELARSFFWQ 121
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFEAHISDFGLARRIDTSHSHV 252
             ++ VR   N           ++HRDIK  N+L+D +  E  + DFG    +  +   V
Sbjct: 122 V-LEAVRHCHNC---------GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 168
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            T   GT  Y PPE++  +        V+S GIL+ ++ 
Sbjct: 169 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 207

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREF----RAEMET--LGKL 135
            +    ++G G FG VY   ++S  + VAIK ++KD    + E     R  ME   L K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 136 R--HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
                 ++++L +       VLI E  E    D +   T R     G+ Q        W+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITER-----GALQEELARSFFWQ 118
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFEAHISDFGLARRIDTSHSHV 252
             ++ VR   N           ++HRDIK  N+L+D +  E  + DFG    +  +   V
Sbjct: 119 V-LEAVRHCHNC---------GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 165
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            T   GT  Y PPE++  +        V+S GIL+ ++ 
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 39/212 (18%)
Query: 87  DKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-------HR 138
           DK +G+GSF    K     S    A+K + K         R E  T  ++        H 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---------RMEANTQKEITALKLCEGHP 66
Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+       L   L+ E +  G L + +       + + S                I
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY---------------I 111
Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLL---DSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +R + + ++++H +   ++HRD+K  N+L    + + E  I DFG AR     +  + T 
Sbjct: 112 MRKLVSAVSHMHDV--GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169
Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
              T+ Y  PE L  N       D++S G+++
Sbjct: 170 CF-TLHYAAPELLNQN-GYDESCDLWSLGVIL 199

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 84  FSTDKIIGDGSFGFVYKAKLSSGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHRN-- 139
           +S  K IG G    V++         AIK   L++   Q    +R E+  L KL+  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLD--QWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           I+++  Y    +    IY  +E G++D   WL            K+  S+ P  WE R  
Sbjct: 118 IIRLYDY---EITDQYIYMVMECGNIDLNSWL------------KKKKSIDP--WE-RKS 159
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQ 255
             + +   +  +H  +  I+H D+K +N L+  D    + DFG+A ++  DT+     +Q
Sbjct: 160 YWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 256 VAGTMGYMPPEYLGGNTAA----------TVMLDVYSFGILM 287
           V GT+ YMPPE +   +++          +   DV+S G ++
Sbjct: 217 V-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 24/219 (10%)
Query: 83  NFSTDKIIGDGSFGFVY-KAKLSSGVTVAIKKLDKDAFQGFREFRAEM---ETLGKLRHR 138
           +F+   ++G GSFG V    +  +    A+K L KD      +    M     L      
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 139 NIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +  L  C   +DR+  + E+V  G L   +    R  +                  V 
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA---------------VF 125
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
               +A GL +L    K II+RD+K  NV+LDS+    I+DFG+ +  +      +    
Sbjct: 126 YAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKXFC 182
Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +         +D ++FG+L+ E+     P
Sbjct: 183 GTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAP 220

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 83  NFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREF----RAEMET--LGKL 135
            +    ++G G FG VY   ++S  + VAIK ++KD    + E     R  ME   L K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 136 R--HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
                 ++++L +       VLI E  E    D +   T R     G+ Q        W+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITER-----GALQEELARSFFWQ 118
Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFEAHISDFGLARRIDTSHSHV 252
             ++ VR   N           ++HRDIK  N+L+D +  E  + DFG    +  +   V
Sbjct: 119 V-LEAVRHCHNC---------GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 165
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
            T   GT  Y PPE++  +        V+S GIL+ ++ 
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 91/213 (42%), Gaps = 25/213 (11%)
Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVA--IKKLDKDAFQGFREFRAEMETLGKLRH 137
           T+ +   + +G G+F  V +  K+ +G   A  I    K + +  ++   E      L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV++    +      LI++ V  G L + +       + D S  +  +          
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------- 121
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA---HISDFGLARRIDTSHSHVST 254
                    A LH  +  ++HR++K  N+LL S  +     ++DFGLA  ++        
Sbjct: 122 ---------AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWF 171
Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
             AGT GY+ PE L  +      +D+++ G+++
Sbjct: 172 GFAGTPGYLSPEVLRKDPYGKP-VDLWACGVIL 203

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 89  IIGDGSFGFVY-KAKLSSGVTVAIKKLDKDAFQGFREFRAEM---ETLGKLRHRNIVKIL 144
           ++G GSFG V    +  +    A+K L KD      +    M     L        +  L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 145 GYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA 203
             C   +DR+  + E+V  G L   +    R  +                  V     +A
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA---------------VFYAAEIA 452
Query: 204 NGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ-VAGTMGY 262
            GL +L    K II+RD+K  NV+LDS+    I+DFG+ +  +     V+T+   GT  Y
Sbjct: 453 IGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDY 508
Query: 263 MPPEYLGGNTAATVMLDVYSFGILMIEI 290
           + PE +         +D ++FG+L+ E+
Sbjct: 509 IAPEIIAYQPYGKS-VDWWAFGVLLYEM 535

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 84  FSTDKIIGDGSFGFVYKAKLSSGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHRN-- 139
           +S  K IG G    V++         AIK   L++   Q    +R E+  L KL+  +  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 73
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLD--QWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           I+++  Y    +    IY  +E G++D   WL            K+  S+ P  WE R  
Sbjct: 74  IIRLYDY---EITDQYIYMVMECGNIDLNSWL------------KKKKSIDP--WE-RKS 115
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQ 255
             + +   +  +H  +  I+H D+K +N L+  D    + DFG+A ++  DT+     +Q
Sbjct: 116 YWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 172
Query: 256 VAGTMGYMPPEYLGGNTAA----------TVMLDVYSFGILM 287
           V GT+ YMPPE +   +++          +   DV+S G ++
Sbjct: 173 V-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 213

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 84  FSTDKIIGDGSFGFVYKAKLSSGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHRN-- 139
           +S  K IG G    V++         AIK   L++   Q    +R E+  L KL+  +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLD--QWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           I+++  Y    +    IY  +E G++D   WL            K+  S+ P  WE R  
Sbjct: 90  IIRLYDY---EITDQYIYMVMECGNIDLNSWL------------KKKKSIDP--WE-RKS 131
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQ 255
             + +   +  +H  +  I+H D+K +N L+  D    + DFG+A ++  DT+     +Q
Sbjct: 132 YWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 256 VAGTMGYMPPEYLGGNTAA----------TVMLDVYSFGILM 287
           V GT+ YMPPE +   +++          +   DV+S G ++
Sbjct: 189 V-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 84  FSTDKIIGDGSFGFVYKAKLSSGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHRN-- 139
           +S  K IG G    V++         AIK   L++   Q    +R E+  L KL+  +  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 69
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLD--QWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           I+++  Y    +    IY  +E G++D   WL            K+  S+ P  WE R  
Sbjct: 70  IIRLYDY---EITDQYIYMVMECGNIDLNSWL------------KKKKSIDP--WE-RKS 111
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQ 255
             + +   +  +H  +  I+H D+K +N L+  D    + DFG+A ++  DT+     +Q
Sbjct: 112 YWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 168
Query: 256 VAGTMGYMPPEYLGGNTAA----------TVMLDVYSFGILM 287
           V GT+ YMPPE +   +++          +   DV+S G ++
Sbjct: 169 V-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 209

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 84  FSTDKIIGDGSFGFVYKAKLSSGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHRN-- 139
           +S  K IG G    V++         AIK   L++   Q    +R E+  L KL+  +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLD--QWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           I+++  Y    +    IY  +E G++D   WL            K+  S+ P  WE R  
Sbjct: 71  IIRLYDY---EITDQYIYMVMECGNIDLNSWL------------KKKKSIDP--WE-RKS 112
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQ 255
             + +   +  +H  +  I+H D+K +N L+  D    + DFG+A ++  DT+     +Q
Sbjct: 113 YWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 256 VAGTMGYMPPEYLGGNTAA----------TVMLDVYSFGILM 287
           V GT+ YMPPE +   +++          +   DV+S G ++
Sbjct: 170 V-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 83/204 (40%), Gaps = 24/204 (11%)
Query: 98  VYKAKLSSGVTVAIKKLDKDAFQGFREFRA----EMETLGKLRHRNIVKILGYCASGLDR 153
           VY+A+ +    +   KL  +       FR     E  T G+L+  ++V I          
Sbjct: 50  VYEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPI---------- 99
Query: 154 VLIYEFVENGSLDQWLH-DTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGL 212
              ++F   G +D  L+ D    + VD +  L    PL+    V IVR +  G A     
Sbjct: 100 ---HDF---GEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQI--GSALDAAH 151
Query: 213 EKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNT 272
                HRD+K  N+L+ +D  A++ DFG+A               GT+ Y  PE     +
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERF-SES 210
Query: 273 AATVMLDVYSFGILMIEIATQIRP 296
            AT   D+Y+   ++ E  T   P
Sbjct: 211 HATYRADIYALTCVLYECLTGSPP 234

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 82  DNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQG-----FREFRAEMETLGKL 135
           D +   ++IG G+F  V +     +G   A+K +D   F         + + E      L
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           +H +IV++L   +S     +++EF++   L             +  K+ ++    S    
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLC-----------FEIVKRADAGFVYSEAVA 132
Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA---HISDFGLARRIDTSHSHV 252
              +R +   L Y H  +  IIHRD+K  NVLL S   +    + DFG+A ++  S   V
Sbjct: 133 SHYMRQILEALRYCH--DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGES-GLV 189
Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT  +M PE +         +DV+  G+++  + +   P
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLP 232

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 84  FSTDKIIGDGSFGFVYKAKLSSGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHRN-- 139
           +S  K IG G    V++         AIK   L++   Q    +R E+  L KL+  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 140 IVKILGYCASGLDRVLIYEFVENGSLD--QWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           I+++  Y    +    IY  +E G++D   WL            K+  S+ P  WE R  
Sbjct: 118 IIRLYDY---EITDQYIYMVMECGNIDLNSWL------------KKKKSIDP--WE-RKS 159
Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQ 255
             + +   +  +H  +  I+H D+K +N L+  D    + DFG+A ++  DT+     +Q
Sbjct: 160 YWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 256 VAGTMGYMPPEYLGGNTAA----------TVMLDVYSFGILM 287
           V GT+ YMPPE +   +++          +   DV+S G ++
Sbjct: 217 V-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 23/224 (10%)
Query: 67  PSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREF 125
           P++S      ++  +D +   K IG G+FG     +   S   VA+K +++   +     
Sbjct: 4   PAVSGPMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE-KIDENV 62
Query: 126 RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN 185
           + E+     LRH NIV+      +     ++ E+   G L + + +  R           
Sbjct: 63  KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----------- 111
Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH--ISDFGLAR 243
                S +      + + +G++Y H ++  + HRD+K  N LLD        I  FG ++
Sbjct: 112 ----FSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSK 165
Query: 244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
                HS   + V GT  Y+ PE L        + DV+S G+ +
Sbjct: 166 S-SVLHSQPKSTV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTL 207

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/220 (21%), Positives = 90/220 (40%), Gaps = 25/220 (11%)
Query: 74  MSELIDATDNFSTDKIIGDGSFGFV---YKAKLSSGVTVAIKKLDKDAFQGFREFRAEME 130
           M+     TD++   + +G G+F  V    K   +      I    K + +  ++   E  
Sbjct: 23  MATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREAR 82
Query: 131 TLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL 190
               L+H NIV++    +      L+++ V  G L + +       + D S         
Sbjct: 83  ICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH-------- 134
Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA---HISDFGLARRIDT 247
                   +  +   + ++H  +  I+HRD+K  N+LL S  +     ++DFGLA  +  
Sbjct: 135 -------CIHQILESVNHIH--QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ- 184
Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
                    AGT GY+ PE L  +      +D+++ G+++
Sbjct: 185 GEQQAWFGFAGTPGYLSPEVLRKDPYGKP-VDIWACGVIL 223

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 42/224 (18%)
Query: 90  IGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRA-EMETLGKLRHRNIVKILGYCA 148
           +G G++G VYKAK   G       L +    G       E+  L +L+H N++ +     
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 149 SGLDR--VLIYEFVENGSLDQW----LHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG- 201
           S  DR   L++++ E+   D W     H  S+ +                +  V++ RG 
Sbjct: 89  SHADRKVWLLFDYAEH---DLWHIIKFHRASKAN----------------KKPVQLPRGM 129
Query: 202 -------VANGLAYLHGLEKPIIHRDIKSSNVLLDSDF----EAHISDFGLARRIDTSHS 250
                  + +G+ YLH     ++HRD+K +N+L+  +        I+D G AR  ++   
Sbjct: 130 VKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 251 HVST--QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            ++    V  T  Y  PE L G    T  +D+++ G +  E+ T
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI---SDFGLARRIDTSHSHVS 253
           +I++ +   + YLH +   I HRD+K  N+L  S     I   +DFG A+   TSH+ ++
Sbjct: 165 EIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLT 221
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           T    T  Y+ PE LG         D++S G++M
Sbjct: 222 TPCY-TPYYVAPEVLGPEKYDKS-CDMWSLGVIM 253

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI---SDFGLARRIDTSHSHVS 253
           +I++ +   + YLH +   I HRD+K  N+L  S     I   +DFG A+   TSH+ ++
Sbjct: 126 EIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLT 182
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           T    T  Y+ PE LG         D++S G++M
Sbjct: 183 TPCY-TPYYVAPEVLGPEKYDKS-CDMWSLGVIM 214

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI---SDFGLARRIDTSHSHVS 253
           +I++ +   + YLH +   I HRD+K  N+L  S     I   +DFG A+   TSH+ ++
Sbjct: 125 EIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLT 181
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           T    T  Y+ PE LG         D++S G++M
Sbjct: 182 TPCY-TPYYVAPEVLGPEKYDKS-CDMWSLGVIM 213

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI---SDFGLARRIDTSHSHVS 253
           +I++ +   + YLH +   I HRD+K  N+L  S     I   +DFG A+   TSH+ ++
Sbjct: 119 EIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLT 175
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           T    T  Y+ PE LG         D++S G++M
Sbjct: 176 TPCY-TPYYVAPEVLGPEKYDKS-CDMWSLGVIM 207

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI---SDFGLARRIDTSHSHVS 253
           +I++ +   + YLH +   I HRD+K  N+L  S     I   +DFG A+   TSH+ ++
Sbjct: 127 EIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLT 183
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           T    T  Y+ PE LG         D++S G++M
Sbjct: 184 TPCY-TPYYVAPEVLGPEKYDKS-CDMWSLGVIM 215

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI---SDFGLARRIDTSHSHVS 253
           +I++ +   + YLH +   I HRD+K  N+L  S     I   +DFG A+   TSH+ ++
Sbjct: 121 EIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLT 177
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           T    T  Y+ PE LG         D++S G++M
Sbjct: 178 TPCY-TPYYVAPEVLGPEKYDKS-CDMWSLGVIM 209

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI---SDFGLARRIDTSHSHVS 253
           +I++ +   + YLH +   I HRD+K  N+L  S     I   +DFG A+   TSH+ ++
Sbjct: 120 EIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLT 176
Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           T    T  Y+ PE LG         D++S G++M
Sbjct: 177 TPCY-TPYYVAPEVLGPEKYDKS-CDMWSLGVIM 208
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	373
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-126
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-120
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-117
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-83
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-64
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-63
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-63
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-60
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-56
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-55
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-53
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-43
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-41
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-40
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-40
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-40
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-40
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-40
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-39
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-39
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-38
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-38
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-38
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-38
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-38
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-38
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-37
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-37
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-37
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-37
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-37
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-36
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-36
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-36
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-36
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-35
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-35
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-34
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-34
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-34
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-34
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-33
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-33
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-32
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-32
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-31
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-31
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-30
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-29
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-28
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-28
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-27
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-27
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-27
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-27
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-26
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-26
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-26
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-26
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-24
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-24
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-24
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-23
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-23
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-23
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-22
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-22
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-22
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-21
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-21
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-20
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-20
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-20
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-20
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-17
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  365 bits (939), Expect = e-126
 Identities = 109/302 (36%), Positives = 179/302 (59%), Gaps = 20/302 (6%)

Query: 73  SMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGF-REFRAEMET 131
           S+ EL  A+DNFS   I+G G FG VYK +L+ G  VA+K+L ++  QG   +F+ E+E 
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80

Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           +    HRN++++ G+C +  +R+L+Y ++ NGS+   L +   +             PL 
Sbjct: 81  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----------PPLD 129

Query: 192 WETRVKIVRGVANGLAYLH-GLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS 250
           W  R +I  G A GLAYLH   +  IIHRD+K++N+LLD +FEA + DFGLA+ +D   +
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189

Query: 251 HVSTQVAGTMGYMPPEYL--GGNTAATVMLDVYSFGILMIEIATQIRP-NLPVVLDGQEV 307
           HV+T V GT+G++ PEYL  G    ++   DV+ +G++++E+ T  R  +L  + +  +V
Sbjct: 190 HVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246

Query: 308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL 367
            LL+W + +    K   +VD ++ +    +  V +  ++A +CT     ERP MS VV++
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305

Query: 368 LD 369
           L+
Sbjct: 306 LE 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  350 bits (900), Expect = e-120
 Identities = 108/329 (32%), Positives = 176/329 (53%), Gaps = 25/329 (7%)

Query: 50  RCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTV 109
           + ++  + AL  S        ++ + +L +AT+NF    +IG G FG VYK  L  G  V
Sbjct: 7   KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66

Query: 110 AIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWL 169
           A+K+   ++ QG  EF  E+ETL   RH ++V ++G+C    + +LIY+++ENG+L + L
Sbjct: 67  ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126

Query: 170 HDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD 229
           + +                 +SWE R++I  G A GL YLH   + IIHRD+KS N+LLD
Sbjct: 127 YGSDLPT-----------MSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLD 173

Query: 230 SDFEAHISDFGLARRI-DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVML----DVYSFG 284
            +F   I+DFG++++  +   +H+ST V GT+GY+ PEY          L    DVYSFG
Sbjct: 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEY-----FIKGRLTEKSDVYSFG 228

Query: 285 ILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYF 344
           +++ E+    R  +   L  + V L EWA       +  ++VD N+  +++    +R++ 
Sbjct: 229 VVLFEVLCA-RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL-ADKIRPESLRKFG 286

Query: 345 RIACMCTNEKSRERPAMSYVVQLLDELVA 373
             A  C    S +RP+M  V+  L+  + 
Sbjct: 287 DTAVKCLALSSEDRPSMGDVLWKLEYALR 315

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  341 bits (877), Expect = e-117
 Identities = 112/320 (35%), Positives = 166/320 (51%), Gaps = 34/320 (10%)

Query: 66  DPSLSQISMSELIDATDNFSTDK------IIGDGSFGFVYKAKLSSGVTVAIKKL----D 115
           D      S  EL + T+NF           +G+G FG VYK  ++   TVA+KKL    D
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVD 67

Query: 116 KDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRN 175
               +  ++F  E++ + K +H N+V++LG+ + G D  L+Y ++ NGSL   L      
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC---- 123

Query: 176 DDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH 235
                   L+   PLSW  R KI +G ANG+ +LH  E   IHRDIKS+N+LLD  F A 
Sbjct: 124 --------LDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAK 173

Query: 236 ISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
           ISDFGLAR  +  + + +++++ GT  YM PE L G    T   D+YSFG++++EI T +
Sbjct: 174 ISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGL 231

Query: 295 RPNLPVVLDGQEVGLLEWARTMEARNKEIE-MVDSNISREELSEAGVREYFRIACMCTNE 353
                V    +   LL+    +E   K IE  +D  +   +     V   + +A  C +E
Sbjct: 232 P---AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHE 286

Query: 354 KSRERPAMSYVVQLLDELVA 373
           K  +RP +  V QLL E+ A
Sbjct: 287 KKNKRPDIKKVQQLLQEMTA 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  254 bits (650), Expect = 8e-83
 Identities = 86/328 (26%), Positives = 133/328 (40%), Gaps = 41/328 (12%)

Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREF 125
             S   +    L   +      ++   G FG V+KA+L     VA+K       Q + + 
Sbjct: 8   HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QN 65

Query: 126 RAEMETLGKLRHRNIVKILGYCASG----LDRVLIYEFVENGSLDQWLHDTSRNDDVDGS 181
             E+ +L  ++H NI++ +G    G    +D  LI  F E GSL  +L            
Sbjct: 66  EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--------- 116

Query: 182 KQLNSLCPLSWETRVKIVRGVANGLAYLH-------GLEKP-IIHRDIKSSNVLLDSDFE 233
                   +SW     I   +A GLAYLH          KP I HRDIKS NVLL ++  
Sbjct: 117 -------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169

Query: 234 AHISDFGLARRIDTSHSHV-STQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMI 288
           A I+DFGLA + +   S   +    GT  YM PE L G       A + +D+Y+ G+++ 
Sbjct: 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229

Query: 289 EIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREEL-----SEAGVREY 343
           E+A++       V D   +   E      +     E+V     R  L       AG+   
Sbjct: 230 ELASRCTAADGPV-DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML 288

Query: 344 FRIACMCTNEKSRERPAMSYVVQLLDEL 371
                 C +  +  R +   V + + ++
Sbjct: 289 CETIEECWDHDAEARLSAGCVGERITQM 316

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  208 bits (530), Expect = 1e-64
 Identities = 76/334 (22%), Positives = 124/334 (37%), Gaps = 50/334 (14%)

Query: 71  QISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEME 130
           + + SE     DN    ++IG G +G VYK  L     VA+K       Q F   +  + 
Sbjct: 2   EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQNFINEK-NIY 59

Query: 131 TLGKLRHRNIVKILGYCASGLDRV-----LIYEFVENGSLDQWLHDTSRNDDVDGSKQLN 185
            +  + H NI + +               L+ E+  NGSL ++L   +            
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------------ 107

Query: 186 SLCPLSWETRVKIVRGVANGLAYLH-------GLEKPIIHRDIKSSNVLLDSDFEAHISD 238
                 W +  ++   V  GLAYLH         +  I HRD+ S NVL+ +D    ISD
Sbjct: 108 ----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163

Query: 239 FGLARRIDTSH-------SHVSTQVAGTMGYMPPEYLGGN------TAATVMLDVYSFGI 285
           FGL+ R+  +         + +    GT+ YM PE L G        +A   +D+Y+ G+
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223

Query: 286 LMIEIATQIRPNLP-VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEA------ 338
           +  EI  +     P   +   ++                 +V     R +  EA      
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL 283

Query: 339 GVREYFRIACMCTNEKSRERPAMSYVVQLLDELV 372
            VR        C ++ +  R       + + EL+
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  203 bits (518), Expect = 2e-63
 Identities = 80/308 (25%), Positives = 130/308 (42%), Gaps = 50/308 (16%)

Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQG-------FREFRAEM 129
           +   +    +K IG G FG V+K +L      VAIK L     +G       F+EF+ E+
Sbjct: 16  LADNE-IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74

Query: 130 ETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP 189
             +  L H NIVK+ G   +     ++ EFV  G L   L D +               P
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH--------------P 118

Query: 190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE-----AHISDFGLARR 244
           + W  +++++  +A G+ Y+     PI+HRD++S N+ L S  E     A ++DFGL++ 
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ- 177

Query: 245 IDTSHSHVSTQVAGTMGYMPPE-YLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD 303
                 H  + + G   +M PE       + T   D YSF +++  I T   P       
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP------- 227

Query: 304 GQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY 363
                   +      + K I M+     R  + E        +  +C +   ++RP  SY
Sbjct: 228 --------FDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSY 279

Query: 364 VVQLLDEL 371
           +V+ L EL
Sbjct: 280 IVKELSEL 287

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  203 bits (519), Expect = 3e-63
 Identities = 86/298 (28%), Positives = 135/298 (45%), Gaps = 39/298 (13%)

Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKL 135
           I   D  +  + IG GSFG V++A+   G  VA+K L +  F      EF  E+  + +L
Sbjct: 34  IPWCD-LNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91

Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           RH NIV  +G      +  ++ E++  GSL + LH +   +             L    R
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE------------QLDERRR 139

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           + +   VA G+ YLH    PI+HR++KS N+L+D  +   + DFGL+ R+  S    S  
Sbjct: 140 LSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS-RLKASTFLSSKS 198

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP--NLPVVLDGQEVGLLEWA 313
            AGT  +M PE L     +    DVYSFG+++ E+AT  +P  N    L+  +V      
Sbjct: 199 AAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGN----LNPAQV------ 247

Query: 314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
                    +  V     R E+      +   I   C   +  +RP+ + ++ LL  L
Sbjct: 248 ---------VAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  202 bits (516), Expect = 6e-63
 Identities = 80/306 (26%), Positives = 136/306 (44%), Gaps = 47/306 (15%)

Query: 68  SLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRA 127
           SL  I   E+         ++++G G+FG V KAK      VAIK+++ ++ +  + F  
Sbjct: 1   SLHMIDYKEI-------EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIV 50

Query: 128 EMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL 187
           E+  L ++ H NIVK+ G C + +   L+ E+ E GSL   LH                L
Sbjct: 51  ELRQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGA------------EPL 96

Query: 188 CPLSWETRVKIVRGVANGLAYLHGLE-KPIIHRDIKSSNVLLDSDFE-AHISDFGLARRI 245
              +    +      + G+AYLH ++ K +IHRD+K  N+LL +      I DFG A  I
Sbjct: 97  PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156

Query: 246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ 305
            T      T   G+  +M PE   G+   +   DV+S+GI++ E+ T+ +P         
Sbjct: 157 QTH----MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKP--------- 202

Query: 306 EVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVV 365
                 +   +      I     N +R  L +   +    +   C ++   +RP+M  +V
Sbjct: 203 ------FDE-IGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIV 255

Query: 366 QLLDEL 371
           +++  L
Sbjct: 256 KIMTHL 261

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  196 bits (500), Expect = 6e-61
 Identities = 66/310 (21%), Positives = 112/310 (36%), Gaps = 54/310 (17%)

Query: 70  SQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQG--FREFRA 127
           S I   +L       +    + +   G ++K +   G  + +K L    +     R+F  
Sbjct: 5   SGIDFKQL-------NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNE 56

Query: 128 EMETLGKLRHRNIVKILGYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN 185
           E   L    H N++ +LG C S       LI  ++  GSL   LH+ +            
Sbjct: 57  ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF---------- 106

Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
               +     VK    +A G+A+LH LE  I    + S +V++D D  A IS   +    
Sbjct: 107 ---VVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-- 161

Query: 246 DTSHSHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRP--NLPVV 301
               S  S        ++ PE L            D++SF +L+ E+ T+  P  +L   
Sbjct: 162 ----SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-- 215

Query: 302 LDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM 361
                         ME        V     R  +         ++  +C NE   +RP  
Sbjct: 216 -------------NMEI----GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKF 258

Query: 362 SYVVQLLDEL 371
             +V +L+++
Sbjct: 259 DMIVPILEKM 268

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  197 bits (502), Expect = 1e-60
 Identities = 66/308 (21%), Positives = 116/308 (37%), Gaps = 48/308 (15%)

Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR 136
              +D     +++G G FG   K     +G  + +K+L +   +  R F  E++ +  L 
Sbjct: 7   FRPSD-LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE 65

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H N++K +G          I E+++ G+L   +                      W  RV
Sbjct: 66  HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS--------------QYPWSQRV 111

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH----- 251
              + +A+G+AYLH     IIHRD+ S N L+  +    ++DFGLAR +    +      
Sbjct: 112 SFAKDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169

Query: 252 --------VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD 303
                       V G   +M PE + G +     +DV+SFGI++ EI  ++  +      
Sbjct: 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNAD------ 222

Query: 304 GQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY 363
                          R  +  +                 +F I   C +    +RP+   
Sbjct: 223 ----------PDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVK 272

Query: 364 VVQLLDEL 371
           +   L+ L
Sbjct: 273 LEHWLETL 280

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  192 bits (490), Expect = 1e-58
 Identities = 77/333 (23%), Positives = 130/333 (39%), Gaps = 49/333 (14%)

Query: 62  SASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQG 121
           S S  P L Q ++++ I         K IG G +G V+  K   G  VA+K         
Sbjct: 23  SGSGLPLLVQRTIAKQIQ------MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEAS 75

Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASGLDRV----LIYEFVENGSLDQWLHDTSRNDD 177
           +     E+     +RH NI+  +     G        LI ++ ENGSL  +L  T     
Sbjct: 76  WF-RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----- 129

Query: 178 VDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEK------PIIHRDIKSSNVLLDSD 231
                       L  ++ +K+     +GL +LH           I HRD+KS N+L+  +
Sbjct: 130 -----------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178

Query: 232 FEAHISDFGLARRIDTSHSHV---STQVAGTMGYMPPEYLGG-----NTAATVMLDVYSF 283
               I+D GLA +  +  + V        GT  YMPPE L       +  + +M D+YSF
Sbjct: 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238

Query: 284 GILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSN-----ISREELSEA 338
           G+++ E+A +      V  +  ++   +   +  +     E+V              S+ 
Sbjct: 239 GLILWEVARRCVSGGIV--EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDE 296

Query: 339 GVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            +R+  ++   C       R     V + L ++
Sbjct: 297 CLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  183 bits (467), Expect = 5e-56
 Identities = 82/316 (25%), Positives = 124/316 (39%), Gaps = 62/316 (19%)

Query: 71  QISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKL----DKDAFQGFREFR 126
           +I  +EL         ++IIG G FG VY+A    G  VA+K      D+D  Q     R
Sbjct: 3   EIDFAELTL-------EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVR 54

Query: 127 AEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNS 186
            E +    L+H NI+ + G C    +  L+ EF   G L++ L                 
Sbjct: 55  QEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-------------- 100

Query: 187 LCPLSWETRVKIVRGVANGLAYLHGL-EKPIIHRDIKSSNVLLDSDFEAH--------IS 237
              +  +  V     +A G+ YLH     PIIHRD+KSSN+L+    E          I+
Sbjct: 101 --RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158

Query: 238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP- 296
           DFGLAR     H       AG   +M PE +  +   +   DV+S+G+L+ E+ T   P 
Sbjct: 159 DFGLAREW---HRTTKMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPF 214

Query: 297 -NLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKS 355
                 +DG  V                  V  N     +       + ++   C N   
Sbjct: 215 RG----IDGLAV---------------AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDP 255

Query: 356 RERPAMSYVVQLLDEL 371
             RP+ + ++  L  +
Sbjct: 256 HSRPSFTNILDQLTTI 271

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  183 bits (466), Expect = 1e-55
 Identities = 88/319 (27%), Positives = 140/319 (43%), Gaps = 45/319 (14%)

Query: 62  SASFDPSLSQISMSEL-IDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ 120
                   S+ +  +  I      +  + IG GSFG VYK K      VA+K L+  A  
Sbjct: 4   GHHHHHHGSRDAADDWEIPDGQ-ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPT 60

Query: 121 G--FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDV 178
               + F+ E+  L K RH NI+  +GY  +     ++ ++ E  SL   LH +      
Sbjct: 61  PQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASET---- 115

Query: 179 DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD 238
                         +  + I R  A G+ YLH   K IIHRD+KS+N+ L  D    I D
Sbjct: 116 ----------KFEMKKLIDIARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGD 163

Query: 239 FGLAR-RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAA--TVMLDVYSFGILMIEIATQIR 295
           FGLA  +   S SH   Q++G++ +M PE +    +   +   DVY+FGI++ E+ T   
Sbjct: 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223

Query: 296 PNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGV---REYFRIACMCTN 352
           P               ++  +  R++ IEMV       +LS+      +   R+   C  
Sbjct: 224 P---------------YS-NINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLK 267

Query: 353 EKSRERPAMSYVVQLLDEL 371
           +K  ERP+   ++  ++EL
Sbjct: 268 KKRDERPSFPRILAEIEEL 286

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  182 bits (464), Expect = 3e-55
 Identities = 67/308 (21%), Positives = 123/308 (39%), Gaps = 45/308 (14%)

Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGF-REFRAEMETLGKLRHRNIVKILGY 146
           + +G G +G V++     G  VA+K       + + RE   E+     LRH NI+  +  
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIAS 70

Query: 147 CASGLDRV----LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
             +         LI  + E GSL  +L  T                 L   + ++IV  +
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLT----------------TLDTVSCLRIVLSI 114

Query: 203 ANGLAYLHGLEK------PIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV---S 253
           A+GLA+LH           I HRD+KS N+L+  + +  I+D GLA     S + +   +
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174

Query: 254 TQVAGTMGYMPPEYLGG-----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG 308
               GT  YM PE L          +   +D+++FG+++ E+A ++  N  V  +  +  
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV--EDYKPP 232

Query: 309 LLEWARTMEARNKEIEMVDSN-----ISREELSEAGVREYFRIACMCTNEKSRERPAMSY 363
             +      +     ++V  +     I     S+  +    ++   C  +    R     
Sbjct: 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292

Query: 364 VVQLLDEL 371
           + + L ++
Sbjct: 293 IKKTLTKI 300

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  182 bits (463), Expect = 7e-55
 Identities = 69/323 (21%), Positives = 123/323 (38%), Gaps = 58/323 (17%)

Query: 67  PSLSQISMSEL-IDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQG--FR 123
            S + I + E  I         ++IG G FG VY  +      VAI+ +D +       +
Sbjct: 18  ASQTSIFLQEWDIPFEQ-LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLK 74

Query: 124 EFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQ 183
            F+ E+    + RH N+V  +G C S     +I    +  +L   + D            
Sbjct: 75  AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--------- 125

Query: 184 LNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR 243
                 L      +I + +  G+ YLH   K I+H+D+KS NV  D + +  I+DFGL  
Sbjct: 126 -----VLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFGLFS 177

Query: 244 ----RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVML--------DVYSFGILMIEIA 291
                             G + ++ PE +   +  T           DV++ G +  E+ 
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237

Query: 292 TQIRP--NLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGV-REYFRIAC 348
            +  P    P     + +               I  + + + +  LS+ G+ +E   I  
Sbjct: 238 AREWPFKTQP----AEAI---------------IWQMGTGM-KPNLSQIGMGKEISDILL 277

Query: 349 MCTNEKSRERPAMSYVVQLLDEL 371
            C   +  ERP  + ++ +L++L
Sbjct: 278 FCWAFEQEERPTFTKLMDMLEKL 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  179 bits (456), Expect = 1e-53
 Identities = 78/334 (23%), Positives = 133/334 (39%), Gaps = 49/334 (14%)

Query: 61  DSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ 120
            S S  P L Q +++  I         + IG G FG V++ K   G  VA+K       +
Sbjct: 27  GSGSGLPLLVQRTIARTIV------LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER 79

Query: 121 GFREFRAEMETLGKLRHRNIVKILGYCASGLDRV----LIYEFVENGSLDQWLHDTSRND 176
            +    AE+     LRH NI+  +              L+ ++ E+GSL  +L+      
Sbjct: 80  SWF-REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---- 134

Query: 177 DVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLH-----GLEKP-IIHRDIKSSNVLLDS 230
                        ++ E  +K+    A+GLA+LH        KP I HRD+KS N+L+  
Sbjct: 135 ------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182

Query: 231 DFEAHISDFGLARRIDTSHSHV---STQVAGTMGYMPPEYLGGNTA-----ATVMLDVYS 282
           +    I+D GLA R D++   +        GT  YM PE L  +       +    D+Y+
Sbjct: 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 242

Query: 283 FGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSN-----ISREELSE 337
            G++  EIA   R ++  + +  ++   +   +  +  +  ++V        I     S 
Sbjct: 243 MGLVFWEIAR--RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 300

Query: 338 AGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
             +R   +I   C       R     + + L +L
Sbjct: 301 EALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  151 bits (383), Expect = 2e-43
 Identities = 64/220 (29%), Positives = 91/220 (41%), Gaps = 32/220 (14%)

Query: 87  DKIIGDGSFGFVYKAK-LSSGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHRNIVKI 143
           D  IG GSF  VYK     + V VA    +  K      + F+ E E L  L+H NIV+ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 144 LGYCASGLDR----VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
                S +      VL+ E + +G+L  +L                    +  +      
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---------------KVMKIKVLRSWC 135

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-DFEAHISDFGLARRIDTSHSHVSTQVAG 258
           R +  GL +LH    PIIHRD+K  N+ +        I D GLA     S +     V G
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIG 192

Query: 259 TMGYMPPEYL--GGNTAATVMLDVYSFGILMIEIATQIRP 296
           T  +M PE      + +     DVY+FG+ M+E+AT   P
Sbjct: 193 TPEFMAPEMYEEKYDESV----DVYAFGMCMLEMATSEYP 228

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  147 bits (374), Expect = 4e-41
 Identities = 73/310 (23%), Positives = 114/310 (36%), Gaps = 71/310 (22%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRN 139
           ++    + IG G+FG V+  +L +    VA+K   +        +F  E   L +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IV+++G C       ++ E V+ G    +L                    L  +T +++V
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--------------LRVKTLLQMV 219

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
              A G+ YL    K  IHRD+ + N L+       ISDFG++R        V     G 
Sbjct: 220 GDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGL 274

Query: 260 MGY----MPPEYLGGN--TAATVMLDVYSFGILMIEIATQIR---PNLPVVLDGQEVGLL 310
                    PE L     ++ +   DV+SFGIL+ E  +      PNL      Q+    
Sbjct: 275 RQVPVKWTAPEALNYGRYSSES---DVWSFGILLWETFSLGASPYPNLSN----QQT--- 324

Query: 311 EWARTMEARNKEIEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERPAM 361
                        E V          E G R           FR+   C   +  +RP+ 
Sbjct: 325 ------------REFV----------EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSF 362

Query: 362 SYVVQLLDEL 371
           S + Q L  +
Sbjct: 363 STIYQELQSI 372

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  144 bits (365), Expect = 1e-40
 Identities = 73/306 (23%), Positives = 129/306 (42%), Gaps = 54/306 (17%)

Query: 88  KIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVK 142
           + +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 143 ILGYCASGLDRV--LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
             G C S   R   LI E++  GSL  +L    ++ +     +L           ++   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKL-----------LQYTS 121

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +  G+ YL    K  IHRD+ + N+L++++    I DFGL + +         +  G  
Sbjct: 122 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179

Query: 261 --GYMPPEYLGGN--TAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWART 315
              +  PE L  +  + A+   DV+SFG+++ E+ T   +   P     + +G  +    
Sbjct: 180 PIFWYAPESLTESKFSVAS---DVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-- 234

Query: 316 MEARNKE-IEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERPAMSYVV 365
            +      IE++          +   R         E + I   C N    +RP+   + 
Sbjct: 235 -QMIVFHLIELL----------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 283

Query: 366 QLLDEL 371
             +D++
Sbjct: 284 LRVDQI 289

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  143 bits (362), Expect = 3e-40
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 22/214 (10%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGY 146
            ++G G++G VY  + LS+ V +AIK++ +   +  +    E+     L+H+NIV+ LG 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 147 CASGLDRVLIY-EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK-IVRGVAN 204
            +     + I+ E V  GSL   L          G  + N       E  +    + +  
Sbjct: 88  FSEN-GFIKIFMEQVPGGSLSALLRSK------WGPLKDN-------EQTIGFYTKQILE 133

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDS-DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYM 263
           GL YLH  +  I+HRDIK  NVL+++      ISDFG ++R+   +    T   GT+ YM
Sbjct: 134 GLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYM 190

Query: 264 PPEYL-GGNTAATVMLDVYSFGILMIEIATQIRP 296
            PE +  G        D++S G  +IE+AT   P
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  143 bits (364), Expect = 3e-40
 Identities = 69/316 (21%), Positives = 126/316 (39%), Gaps = 63/316 (19%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQGFREFRAEMETLGKL 135
            +      +G+G+FG V+ A+          + VA+K L + +    ++F+ E E L  L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100

Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           +H++IV+  G C  G   ++++E++ +G L+++L     +  +    +  +  PL     
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           + +   VA G+ YL       +HRD+ + N L+       I DFG++R I ++       
Sbjct: 161 LAVASQVAAGMVYLA--GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST----DYY 214

Query: 256 VAGTMG-----YMPPEYLGGN--TAATVMLDVYSFGILMIEIAT---QIRPNLPVVLDGQ 305
             G        +MPPE +     T  +   DV+SFG+++ EI T   Q    L       
Sbjct: 215 RVGGRTMLPIRWMPPESILYRKFTTES---DVWSFGVVLWEIFTYGKQPWYQLSN----T 267

Query: 306 EVGLLEWARTMEARNKEIEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSR 356
           E                I+ +            G           E + I   C   + +
Sbjct: 268 EA---------------IDCI----------TQGRELERPRACPPEVYAIMRGCWQREPQ 302

Query: 357 ERPAMSYVVQLLDELV 372
           +R ++  V   L  L 
Sbjct: 303 QRHSIKDVHARLQALA 318

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  143 bits (362), Expect = 5e-40
 Identities = 73/304 (24%), Positives = 129/304 (42%), Gaps = 50/304 (16%)

Query: 88  KIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVK 142
           + +G G+FG V   +      ++G  VA+KKL     +  R+F  E+E L  L+H NIVK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 143 ILGYCASGLDRV--LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
             G C S   R   LI E++  GSL  +L    ++ +     +L           ++   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKL-----------LQYTS 152

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +  G+ YL    K  IHRD+ + N+L++++    I DFGL + +     +   +  G  
Sbjct: 153 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210

Query: 261 --GYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTME 317
              +  PE L  +   +V  DV+SFG+++ E+ T   +   P     + +G  +     +
Sbjct: 211 PIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG---Q 266

Query: 318 ARNKE-IEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERPAMSYVVQL 367
                 IE++          +   R         E + I   C N    +RP+   +   
Sbjct: 267 MIVFHLIELL----------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316

Query: 368 LDEL 371
           +D++
Sbjct: 317 VDQI 320

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  142 bits (361), Expect = 7e-40
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 21/222 (9%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSG---VTVAIKKLDKDA-FQGFREFRAEMETLGKL-R 136
           ++     +IG+G+FG V KA++      +  AIK++ + A     R+F  E+E L KL  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS-RNDDVDGSKQLNSLCPLSWETR 195
           H NI+ +LG C       L  E+  +G+L  +L  +     D   +   ++   LS +  
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     VA G+ YL   +K  IHRD+ + N+L+  ++ A I+DFGL+R  +         
Sbjct: 145 LHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VY 195

Query: 256 VAGTMG-----YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           V  TMG     +M  E L  +   T   DV+S+G+L+ EI +
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVS 236

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  142 bits (359), Expect = 2e-39
 Identities = 69/309 (22%), Positives = 123/309 (39%), Gaps = 61/309 (19%)

Query: 88  KIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVK 142
             +G G+FG V   +      ++G  VA+K+L        R+F+ E++ L  L    IVK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 143 ILGYCASGLDRV--LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
             G       +   L+ E++ +G L  +L    R+     + +L           +    
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRL-----------LLYSS 134

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +  G+ YL    +  +HRD+ + N+L++S+    I+DFGLA+ +     +    V    
Sbjct: 135 QICKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY---YVVREP 189

Query: 261 GYMP-----PEYLGGN--TAATVMLDVYSFGILMIEIATQ-IRPNLPVVLDGQEVGLLEW 312
           G  P     PE L  N  +  +   DV+SFG+++ E+ T   +   P     + +G    
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQS---DVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246

Query: 313 ARTMEARNKE-IEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERPAMS 362
                      +E++          E G R         E   +  +C     ++RP+ S
Sbjct: 247 VPA----LSRLLELL----------EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFS 292

Query: 363 YVVQLLDEL 371
            +   LD L
Sbjct: 293 ALGPQLDML 301

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  141 bits (357), Expect = 3e-39
 Identities = 55/238 (23%), Positives = 105/238 (44%), Gaps = 37/238 (15%)

Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSG-----VTVAIKKLDKDAFQ 120
            P+ + +    ++  T+ F   K++G G+FG VYK           + VAIK+L +    
Sbjct: 3   APNQALL---RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 58

Query: 121 G-FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVD 179
              +E   E   +  + + ++ ++LG C       LI + +  G L  ++ +   + D  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVRE---HKDNI 114

Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
           GS+ L           +     +A G+ YL   ++ ++HRD+ + NVL+ +     I+DF
Sbjct: 115 GSQYL-----------LNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDF 161

Query: 240 GLARRIDTSHSHVSTQVAGTM---GYMPPEYLGGN--TAATVMLDVYSFGILMIEIAT 292
           GLA+ +         +  G      +M  E +     T  +   DV+S+G+ + E+ T
Sbjct: 162 GLAKLLGAEEKEYHAE--GGKVPIKWMALESILHRIYTHQS---DVWSYGVTVWELMT 214

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  139 bits (352), Expect = 7e-39
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 24/220 (10%)

Query: 88  KIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNI 140
           + +G+  FG VYK  L           VAIK L   A      EFR E     +L+H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTS-RNDDVDGSKQLNSLCPLSWETRVKIV 199
           V +LG         +I+ +  +G L ++L   S  +D             L     V +V
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             +A G+ YL      ++H+D+ + NVL+       ISD GL R +  +           
Sbjct: 135 AQIAAGMEYLS--SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA----DYYKLLG 188

Query: 260 MG-----YMPPEYLGGN--TAATVMLDVYSFGILMIEIAT 292
                  +M PE +     +  +   D++S+G+++ E+ +
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDS---DIWSYGVVLWEVFS 225

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  139 bits (352), Expect = 8e-39
 Identities = 62/244 (25%), Positives = 104/244 (42%), Gaps = 31/244 (12%)

Query: 61  DSASFDPSLSQISMSELIDATDNFST-DKIIGDGSFGFVYKAKLSSG----VTVAIKKLD 115
           D ++ +P L Q     +I  +      +++IG G FG VY   L       +  A+K L+
Sbjct: 3   DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 62

Query: 116 KDA-FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL-IYEFVENGSLDQWLHDTS 173
           +        +F  E   +    H N++ +LG C       L +  ++++G L  ++ + +
Sbjct: 63  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 122

Query: 174 RNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
            N  V   K L           +     VA G+ YL    K  +HRD+ + N +LD  F 
Sbjct: 123 HNPTV---KDL-----------IGFGLQVAKGMKYLA--SKKFVHRDLAARNCMLDEKFT 166

Query: 234 AHISDFGLARRIDTSHSHVSTQVAGTM---GYMPPEYLGGN--TAATVMLDVYSFGILMI 288
             ++DFGLAR +     +      G      +M  E L     T  +   DV+SFG+L+ 
Sbjct: 167 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKS---DVWSFGVLLW 223

Query: 289 EIAT 292
           E+ T
Sbjct: 224 ELMT 227

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  143 bits (362), Expect = 1e-38
 Identities = 65/291 (22%), Positives = 126/291 (43%), Gaps = 35/291 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
            + +    +G G +G VY+       +TVA+K L K+      EF  E   + +++H N+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V++LG C       +I EF+  G+L  +L + +R               +S    + +  
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-------------EVSAVVLLYMAT 325

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +++ + YL   +K  IHR++ + N L+  +    ++DFGL+R +              +
Sbjct: 326 QISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 383

Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARN 320
            +  PE L  N   ++  DV++FG+L+ EIAT      P  +D  +V             
Sbjct: 384 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQV------------- 428

Query: 321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
              E+++ +  R E  E    + + +   C      +RP+ + + Q  + +
Sbjct: 429 --YELLEKDY-RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  139 bits (353), Expect = 2e-38
 Identities = 61/266 (22%), Positives = 97/266 (36%), Gaps = 33/266 (12%)

Query: 39  RTRAVNRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFV 98
                      +   L      +         +    E  +     +    +G GSFG V
Sbjct: 15  SLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEV 74

Query: 99  YKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY 157
           ++ K   +G   A+KK+  + F+       E+     L    IV + G    G   V I+
Sbjct: 75  HRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREG-PWVNIF 128

Query: 158 -EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK-IVRGVANGLAYLHGLEKP 215
            E +E GSL                + +  +  L  E R    +     GL YLH   + 
Sbjct: 129 MELLEGGSL---------------GQLIKQMGCLP-EDRALYYLGQALEGLEYLH--TRR 170

Query: 216 IIHRDIKSSNVLLDSD-FEAHISDFGLARRIDTSHSHVSTQ----VAGTMGYMPPEYLGG 270
           I+H D+K+ NVLL SD   A + DFG A  +       S      + GT  +M PE + G
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230

Query: 271 NTAATVMLDVYSFGILMIEIATQIRP 296
                  +D++S   +M+ +     P
Sbjct: 231 -KPCDAKVDIWSSCCMMLHMLNGCHP 255

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  138 bits (350), Expect = 2e-38
 Identities = 68/311 (21%), Positives = 129/311 (41%), Gaps = 64/311 (20%)

Query: 88  KIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           + +G+G+FG V+ A+          + VA+K L        ++F+ E E L  L+H +IV
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTS-RNDDVDGSKQLNSLCPLSWETRVKIVR 200
           K  G C  G   ++++E++++G L+++L         +   +   +   L     + I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +A+G+ YL    +  +HRD+ + N L+ ++    I DFG++R + ++  +      G  
Sbjct: 141 QIASGMVYLA--SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGGH 194

Query: 261 G-----YMPPEYLGGN--TAATVMLDVYSFGILMIEIAT---QIRPNLPVVLDGQEVGLL 310
                 +MPPE +     T  +   DV+SFG+++ EI T   Q    L       EV   
Sbjct: 195 TMLPIRWMPPESIMYRKFTTES---DVWSFGVILWEIFTYGKQPWFQLSN----TEV--- 244

Query: 311 EWARTMEARNKEIEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERPAM 361
                       IE +            G           E + +   C   + ++R  +
Sbjct: 245 ------------IECI----------TQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNI 282

Query: 362 SYVVQLLDELV 372
             + ++L  L 
Sbjct: 283 KEIYKILHALG 293

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  140 bits (356), Expect = 4e-38
 Identities = 69/303 (22%), Positives = 119/303 (39%), Gaps = 65/303 (21%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
                 + IG G FG V       G  VA+K +  DA    + F AE   + +LRH N+V
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249

Query: 142 KILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           ++LG        + ++ E++  GSL  +L    R+              L  +  +K   
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-------------VLGGDCLLKFSL 296

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            V   + YL       +HRD+ + NVL+  D  A +SDFGL +   ++    + ++   +
Sbjct: 297 DVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLP--V 350

Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIR---PNLPVVLDGQEVGLLEWARTME 317
            +  PE L      +   DV+SFGIL+ EI +  R   P +P+    ++V          
Sbjct: 351 KWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDV---------- 395

Query: 318 ARNKEIEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERPAMSYVVQLL 368
                +  V          E G +           + +   C +  +  RP    + + L
Sbjct: 396 -----VPRV----------EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440

Query: 369 DEL 371
           + +
Sbjct: 441 EHI 443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  138 bits (349), Expect = 5e-38
 Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 28/225 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDA-FQGFREFRAEMETLGK 134
           +  +  + +G GSFG VY+              VAIK +++ A  +   EF  E   + +
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
               ++V++LG  + G   ++I E +  G L  +L         +      SL  +    
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM---- 140

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
            +++   +A+G+AYL+      +HRD+ + N ++  DF   I DFG+ R I  +      
Sbjct: 141 -IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----DY 193

Query: 255 QVAGTMGY-----MPPEYLGGN--TAATVMLDVYSFGILMIEIAT 292
              G  G      M PE L     T  +   DV+SFG+++ EIAT
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 235

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  137 bits (347), Expect = 6e-38
 Identities = 70/306 (22%), Positives = 128/306 (41%), Gaps = 52/306 (16%)

Query: 88  KIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIV 141
           + +G+G FG V   +      ++G  VA+K L  ++      + + E+E L  L H NIV
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 142 KILGYCASGLDRV--LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           K  G C         LI EF+ +GSL ++L    +N +    KQ            +K  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQ-----------LKYA 132

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             +  G+ YL    +  +HRD+ + NVL++S+ +  I DFGL + I+T   + + +    
Sbjct: 133 VQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190

Query: 260 M--GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ-IRPNLPVVLDGQEVGLLEWARTM 316
               +  PE L  +    +  DV+SFG+ + E+ T     + P+ L  + +G      T 
Sbjct: 191 SPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT- 248

Query: 317 EARNKE-IEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERPAMSYVVQ 366
                  +  +          + G R         E +++   C   +   R +   +++
Sbjct: 249 ---VTRLVNTL----------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

Query: 367 LLDELV 372
             + L+
Sbjct: 296 GFEALL 301

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  137 bits (348), Expect = 7e-38
 Identities = 79/313 (25%), Positives = 122/313 (38%), Gaps = 55/313 (17%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDA-FQGFREFRAEMETLGK 134
           +N    K +G G+FG V +A         + + VA+K L   A         +E++ +  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           L +H NIV +LG C  G   ++I E+   G L  +L   SR  + D +  + +    S  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN-STASTR 164

Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
             +     VA G+A+L    K  IHRD+ + NVLL +   A I DFGLAR I       S
Sbjct: 165 DLLHFSSQVAQGMAFLA--SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND----S 218

Query: 254 TQVAGTMG-----YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG 308
             +          +M PE +      TV  DV+S+GIL+ EI +      P +L   +  
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF- 276

Query: 309 LLEWARTMEARNKEIEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERP 359
                          ++V          + G +           + I   C   +   RP
Sbjct: 277 --------------YKLV----------KDGYQMAQPAFAPKNIYSIMQACWALEPTHRP 312

Query: 360 AMSYVVQLLDELV 372
               +   L E  
Sbjct: 313 TFQQICSFLQEQA 325

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  138 bits (350), Expect = 8e-38
 Identities = 62/261 (23%), Positives = 106/261 (40%), Gaps = 31/261 (11%)

Query: 44  NRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFST-DKIIGDGSFGFVYKAK 102
                N     ++    D ++ +P L Q     +I  +      +++IG G FG VY   
Sbjct: 50  KAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGT 109

Query: 103 LSSG----VTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL-I 156
           L       +  A+K L++        +F  E   +    H N++ +LG C       L +
Sbjct: 110 LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169

Query: 157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPI 216
             ++++G L  ++ + + N  V   K L           +     VA G+ +L    K  
Sbjct: 170 LPYMKHGDLRNFIRNETHNPTV---KDL-----------IGFGLQVAKGMKFLA--SKKF 213

Query: 217 IHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM---GYMPPEYLGGN-- 271
           +HRD+ + N +LD  F   ++DFGLAR +            G      +M  E L     
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273

Query: 272 TAATVMLDVYSFGILMIEIAT 292
           T  +   DV+SFG+L+ E+ T
Sbjct: 274 TTKS---DVWSFGVLLWELMT 291

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  136 bits (344), Expect = 9e-38
 Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 30/215 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
                 + IG G FG V       G  VA+K +  DA    + F AE   + +LRH N+V
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77

Query: 142 KILGYCASGLDRVLI-YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           ++LG        + I  E++  GSL  +L    R+              L  +  +K   
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-------------VLGGDCLLKFSL 124

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT- 259
            V   + YL       +HRD+ + NVL+  D  A +SDFGL +   ++            
Sbjct: 125 DVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-------TGK 175

Query: 260 --MGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
             + +  PE L      +   DV+SFGIL+ EI +
Sbjct: 176 LPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYS 209

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  137 bits (346), Expect = 2e-37
 Identities = 90/345 (26%), Positives = 147/345 (42%), Gaps = 72/345 (20%)

Query: 62  SASFDPSLSQISMSELIDAT------DNFSTDKIIGDGSFGFVYKAKL--------SSGV 107
             S DP L+ +S  EL +        D  +  K +G+G+FG V  A+            V
Sbjct: 9   HHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAV 68

Query: 108 TVAIKKLDKDA-FQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSL 165
           TVA+K L  DA  +   +  +EME +  + +H+NI+ +LG C       +I E+   G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128

Query: 166 DQWLHDTSRNDDVDGSKQLNSLC--PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKS 223
            ++L    R   ++ S  +N +    ++++  V     +A G+ YL    +  IHRD+ +
Sbjct: 129 REYLRA-RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAA 185

Query: 224 SNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG-----YMPPEYLGGNTAATVML 278
            NVL+  +    I+DFGLAR I+            T G     +M PE L      T   
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNI----DYYKKTTNGRLPVKWMAPEALFDRV-YTHQS 240

Query: 279 DVYSFGILMIEIAT---QIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREEL 335
           DV+SFG+LM EI T      P +PV    +E+                +++         
Sbjct: 241 DVWSFGVLMWEIFTLGGSPYPGIPV----EEL---------------FKLL--------- 272

Query: 336 SEAGVR---------EYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            + G R         E + +   C +    +RP    +V+ LD +
Sbjct: 273 -KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  139 bits (352), Expect = 2e-37
 Identities = 69/299 (23%), Positives = 120/299 (40%), Gaps = 53/299 (17%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           ++   +  +G G FG V+    +    VAIK L K        F  E + + KLRH  +V
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++     S     ++ E++  GSL  +L   +                L     V +   
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGK-------------YLRLPQLVDMAAQ 288

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +A+G+AY+       +HRD++++N+L+  +    ++DFGLAR I+ +           + 
Sbjct: 289 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK 321
           +  PE        T+  DV+SFGIL+ E+ T+ R   P  +  +EV              
Sbjct: 347 WTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYP-GMVNREV-------------- 390

Query: 322 EIEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            ++ V          E G R             + C C  ++  ERP   Y+   L++ 
Sbjct: 391 -LDQV----------ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  136 bits (345), Expect = 2e-37
 Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 34/228 (14%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDA-FQGFREFRAEMETLGK 134
            N +  + +G G+FG VY+ ++       S + VA+K L +    Q   +F  E   + K
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
             H+NIV+ +G     L R ++ E +  G L  +L + +R      S        L+   
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRE-TRPRPSQPS-------SLAMLD 141

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH---ISDFGLARRIDTSHSH 251
            + + R +A G  YL   E   IHRDI + N LL          I DFG+AR I  +   
Sbjct: 142 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA--- 196

Query: 252 VSTQVAGTMGY-----MPPEYLGGN--TAATVMLDVYSFGILMIEIAT 292
            S    G         MPPE       T+ T   D +SFG+L+ EI +
Sbjct: 197 -SYYRKGGCAMLPVKWMPPEAFMEGIFTSKT---DTWSFGVLLWEIFS 240

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  135 bits (343), Expect = 2e-37
 Identities = 59/260 (22%), Positives = 100/260 (38%), Gaps = 34/260 (13%)

Query: 45  RPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-L 103
             Q                +  P +   ++        NF  +K IG G F  VY+A  L
Sbjct: 2   DEQSQGMQGPPVPQFQPQKALRPDMGYNTL-------ANFRIEKKIGRGQFSEVYRAACL 54

Query: 104 SSGVTVAIKKLDKDAFQGFRE---FRAEMETLGKLRHRNIVKILGYCASGLDRVLIY-EF 159
             GV VA+KK+        +       E++ L +L H N++K         + + I  E 
Sbjct: 55  LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-NELNIVLEL 113

Query: 160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHR 219
            + G L + +    +               +   T  K    + + L ++H   + ++HR
Sbjct: 114 ADAGDLSRMIKHFKKQKR-----------LIPERTVWKYFVQLCSALEHMH--SRRVMHR 160

Query: 220 DIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG---NTAATV 276
           DIK +NV + +     + D GL R   +  +   + V GT  YM PE +     N  +  
Sbjct: 161 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKS-- 217

Query: 277 MLDVYSFGILMIEIATQIRP 296
             D++S G L+ E+A    P
Sbjct: 218 --DIWSLGCLLYEMAALQSP 235

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  140 bits (354), Expect = 2e-37
 Identities = 69/299 (23%), Positives = 120/299 (40%), Gaps = 53/299 (17%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           ++   +  +G G FG V+    +    VAIK L K        F  E + + KLRH  +V
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++     S     ++ E++  GSL  +L   +                L     V +   
Sbjct: 326 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGK-------------YLRLPQLVDMAAQ 371

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +A+G+AY+       +HRD++++N+L+  +    ++DFGLAR I+ +           + 
Sbjct: 372 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 429

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK 321
           +  PE        T+  DV+SFGIL+ E+ T+ R   P  +  +EV              
Sbjct: 430 WTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYP-GMVNREV-------------- 473

Query: 322 EIEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            ++ V          E G R             + C C  ++  ERP   Y+   L++ 
Sbjct: 474 -LDQV----------ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  134 bits (339), Expect = 4e-37
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 28/216 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
              +  + IG G FG V+     +   VAIK + ++      +F  E E + KL H  +V
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++ G C       L+ EF+E+G L  +L        +  ++ L           + +   
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETL-----------LGMCLD 112

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM- 260
           V  G+AYL   E  +IHRD+ + N L+  +    +SDFG+ R +        T   GT  
Sbjct: 113 VCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKF 167

Query: 261 --GYMPPEYLGGN--TAATVMLDVYSFGILMIEIAT 292
              +  PE    +  ++ +   DV+SFG+LM E+ +
Sbjct: 168 PVKWASPEVFSFSRYSSKS---DVWSFGVLMWEVFS 200

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  136 bits (345), Expect = 4e-37
 Identities = 80/319 (25%), Positives = 131/319 (41%), Gaps = 64/319 (20%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL--------SSGVTVAIKKLDKDA-FQGFREFRAEMETL 132
           D  +  K +G+G FG V  A+            VTVA+K L  DA  +   +  +EME +
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 133 GKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS-RNDDVDGSKQLNSLCPL 190
             + +H+NI+ +LG C       +I E+   G+L ++L        +            +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS 250
           +++  V     +A G+ YL    +  IHRD+ + NVL+  +    I+DFGLAR I+    
Sbjct: 201 TFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI-- 256

Query: 251 HVSTQVAGTMG-----YMPPEYLGGNTAATVMLDVYSFGILMIEIAT---QIRPNLPVVL 302
                   T G     +M PE L      T   DV+SFG+LM EI T      P +PV  
Sbjct: 257 --DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 311

Query: 303 DGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVR---------EYFRIACMCTNE 353
             +E+                +++          + G R         E + +   C + 
Sbjct: 312 --EEL---------------FKLL----------KEGHRMDKPANCTNELYMMMRDCWHA 344

Query: 354 KSRERPAMSYVVQLLDELV 372
              +RP    +V+ LD ++
Sbjct: 345 VPSQRPTFKQLVEDLDRIL 363

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  134 bits (339), Expect = 6e-37
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 24/214 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
            + +  K +G G FG V   K      VAIK + K+      EF  E + +  L H  +V
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++ G C       +I E++ NG L  +L +         ++QL           +++ + 
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQL-----------LEMCKD 128

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM- 260
           V   + YL    K  +HRD+ + N L++      +SDFGL+R +        T   G+  
Sbjct: 129 VCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKF 183

Query: 261 --GYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
              + PPE L  +   +   D+++FG+LM EI +
Sbjct: 184 PVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS 216

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  136 bits (344), Expect = 6e-37
 Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 34/228 (14%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDA-FQGFREFRAEMETLGK 134
            N +  + +G G+FG VY+ ++       S + VA+K L +    Q   +F  E   + K
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
             H+NIV+ +G     L R ++ E +  G L  +L + +R      S        L+   
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPS-------SLAMLD 182

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH---ISDFGLARRIDTSHSH 251
            + + R +A G  YL   E   IHRDI + N LL          I DFG+AR I  +   
Sbjct: 183 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA--- 237

Query: 252 VSTQVAGTMGY-----MPPEYLGGN--TAATVMLDVYSFGILMIEIAT 292
                 G         MPPE       T+ T   D +SFG+L+ EI +
Sbjct: 238 -GYYRKGGCAMLPVKWMPPEAFMEGIFTSKT---DTWSFGVLLWEIFS 281

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  133 bits (337), Expect = 7e-37
 Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 24/214 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +  +  K +G G FG V   K      VA+K + K+      EF  E +T+ KL H  +V
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           K  G C+      ++ E++ NG L  +L    +               L     +++   
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--------------LEPSQLLEMCYD 112

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM- 260
           V  G+A+L       IHRD+ + N L+D D    +SDFG+ R +            GT  
Sbjct: 113 VCEGMAFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKF 167

Query: 261 --GYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
              +  PE        +   DV++FGILM E+ +
Sbjct: 168 PVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFS 200

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  134 bits (340), Expect = 7e-37
 Identities = 79/320 (24%), Positives = 126/320 (39%), Gaps = 63/320 (19%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDA-FQGFREFRAEMETLGK 134
           +  S  K +G G+FG V +A         + +TVA+K L   A         +E++ L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWL---HDTSRNDDVDGSKQLNSLCPL 190
           L  H NIV +LG C  G   ++I E+   G L  +L    D+        +   +    L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS 250
             E  +     VA G+A+L    K  IHRD+ + N+LL       I DFGLAR I    +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 251 HVSTQVAGTMG-----YMPPEYLGGNTAATVMLDVYSFGILMIEIAT---QIRPNLPVVL 302
           +    V          +M PE +      T   DV+S+GI + E+ +      P +PV  
Sbjct: 201 Y----VVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPV-- 253

Query: 303 DGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVR---------EYFRIACMCTNE 353
              +                 +M+          + G R         E + I   C + 
Sbjct: 254 -DSKF---------------YKMI----------KEGFRMLSPEHAPAEMYDIMKTCWDA 287

Query: 354 KSRERPAMSYVVQLLDELVA 373
              +RP    +VQL+++ ++
Sbjct: 288 DPLKRPTFKQIVQLIEKQIS 307

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  133 bits (338), Expect = 7e-37
 Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 45/235 (19%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
            +F   ++IG G FG V+KAK    G T  IK++  +      +   E++ L KL H NI
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 141 VK-------------ILGYCASGLDRVLIY---EFVENGSLDQWLHDTSRNDDVDGSKQL 184
           V                   +S      ++   EF + G+L+QW+               
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--------- 117

Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR 244
                L     +++   +  G+ Y+H   K +I+RD+K SN+ L    +  I DFGL   
Sbjct: 118 ----KLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171

Query: 245 IDTSHSHVSTQVAGTMGYMPPEYLGG---NTAATVMLDVYSFGILMIEIATQIRP 296
           +        T+  GT+ YM PE +             D+Y+ G+++ E+      
Sbjct: 172 LKNDGKR--TRSKGTLRYMSPEQISSQDYGKEV----DLYALGLILAELLHVCDT 220

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  134 bits (340), Expect = 8e-37
 Identities = 74/305 (24%), Positives = 120/305 (39%), Gaps = 54/305 (17%)

Query: 88  KIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIV 141
           + +G+G FG V           +G  VA+K L  DA  Q    ++ E++ L  L H +I+
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 142 KILGYCASGLDRV--LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           K  G C         L+ E+V  GSL  +L   S                +     +   
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----------------IGLAQLLLFA 140

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
           + +  G+AYLH   +  IHRD+ + NVLLD+D    I DFGLA+ +   H +   +  G 
Sbjct: 141 QQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198

Query: 260 M--GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ-IRPNLPVVLDGQEVGLLEWARTM 316
               +  PE L          DV+SFG+ + E+ T       P     + +G+ +   T 
Sbjct: 199 SPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT- 256

Query: 317 EARNKE-IEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERPAMSYVVQ 366
                   E++          E G R         E + +   C   ++  RP    ++ 
Sbjct: 257 ---VLRLTELL----------ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303

Query: 367 LLDEL 371
           +L  +
Sbjct: 304 ILKTV 308

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  133 bits (338), Expect = 1e-36
 Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 28/232 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDA-FQGFREFRAEMETLGK 134
            N    K +G+G FG V KA        +   TVA+K L ++A     R+  +E   L +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWL---------HDTSRNDDVDGSKQLN 185
           + H +++K+ G C+     +LI E+ + GSL  +L         +  S       S    
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
               L+    +     ++ G+ YL   E  ++HRD+ + N+L+    +  ISDFGL+R +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLA--EMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200

Query: 246 DTSHSHVSTQVAGTMG-----YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
               S+    V  + G     +M  E L  +   T   DV+SFG+L+ EI T
Sbjct: 201 YEEDSY----VKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVT 247

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  133 bits (338), Expect = 2e-36
 Identities = 83/331 (25%), Positives = 135/331 (40%), Gaps = 76/331 (22%)

Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSG----VTVAIKKLDKDAFQG 121
           +P  +  S +  I+A+     +KIIG G  G V   +L       V VAIK L     + 
Sbjct: 34  EPGRAGRSFTREIEASR-IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER 92

Query: 122 FR-EFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
            R +F +E   +G+  H NI+++ G    G   +++ E++ENGSLD +L           
Sbjct: 93  QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ----- 147

Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG 240
                     +    V ++RGV  G+ YL   +   +HRD+ + NVL+DS+    +SDFG
Sbjct: 148 ---------FTIMQLVGMLRGVGAGMRYLS--DLGYVHRDLAARNVLVDSNLVCKVSDFG 196

Query: 241 LARRIDTSHSHVSTQVAGTMGY--MPPEYLGGNTAA-----TVMLDVYSFGILMIEIATQ 293
           L+R ++       T   G +      PE      A      +   DV+SFG++M E+   
Sbjct: 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPE------AIAFRTFSSASDVWSFGVVMWEVLAY 250

Query: 294 IR---PNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVR--------- 341
                 N    +  ++V               I  V          E G R         
Sbjct: 251 GERPYWN----MTNRDV---------------ISSV----------EEGYRLPAPMGCPH 281

Query: 342 EYFRIACMCTNEKSRERPAMSYVVQLLDELV 372
              ++   C ++   +RP  S +V +LD L+
Sbjct: 282 ALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  134 bits (339), Expect = 2e-36
 Identities = 56/245 (22%), Positives = 102/245 (41%), Gaps = 38/245 (15%)

Query: 62  SASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF- 119
           S+  D     +    +    + +   + IG+GSFG     K    G    IK+++     
Sbjct: 8   SSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS 63

Query: 120 -QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY---EFVENGSLDQWLHDTSRN 175
            +   E R E+  L  ++H NIV+   Y  S  +   +Y   ++ E G L + +      
Sbjct: 64  SKEREESRREVAVLANMKHPNIVQ---YRESFEENGSLYIVMDYCEGGDLFKRI------ 114

Query: 176 DDVDGSKQLNSLCPLSWETRV-KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA 234
                + Q   L     E ++      +   L ++H  ++ I+HRDIKS N+ L  D   
Sbjct: 115 -----NAQKGVLFQ---EDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTV 164

Query: 235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG---NTAATVMLDVYSFGILMIEIA 291
            + DFG+AR ++++       + GT  Y+ PE       N  +    D+++ G ++ E+ 
Sbjct: 165 QLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNKS----DIWALGCVLYELC 219

Query: 292 TQIRP 296
           T    
Sbjct: 220 TLKHA 224

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  133 bits (338), Expect = 2e-36
 Identities = 54/236 (22%), Positives = 105/236 (44%), Gaps = 33/236 (13%)

Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSG-----VTVAIKKLDKDAFQ 120
            P+ + +    ++  T+ F   K++G G+FG VYK           + VAIK+L +    
Sbjct: 3   APNQALL---RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 58

Query: 121 G-FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVD 179
              +E   E   +  + + ++ ++LG C       LI + +  G L  ++ +   + D  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVRE---HKDNI 114

Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
           GS+ L           +     +A G+ YL   ++ ++HRD+ + NVL+ +     I+DF
Sbjct: 115 GSQYL-----------LNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDF 161

Query: 240 GLARRIDTSHSHVSTQVAGT-MGYMPPEYLGGN--TAATVMLDVYSFGILMIEIAT 292
           GLA+ +         +     + +M  E +     T  +   DV+S+G+ + E+ T
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS---DVWSYGVTVWELMT 214

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  132 bits (335), Expect = 2e-36
 Identities = 57/320 (17%), Positives = 113/320 (35%), Gaps = 84/320 (26%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL--------SSGVTVAIKKLDKDAFQGFREFRAEMETLG 133
           ++   ++ +G G+F  ++K                V +K LDK        F      + 
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 134 KLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           KL H+++V   G C  G + +L+ EFV+ GSLD +L                    ++  
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--------------CINIL 113

Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH--------ISDFGLARRI 245
            ++++ + +A  + +L   E  +IH ++ + N+LL  + +          +SD G++  +
Sbjct: 114 WKLEVAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171

Query: 246 DTSHSHVSTQVAGTMGY-------MPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNL 298
                                   +PPE +       +  D +SFG  + EI +     L
Sbjct: 172 LPK------------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219

Query: 299 PVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVR-------EYFRIACMCT 351
              LD Q                 ++            E   +       E   +   C 
Sbjct: 220 S-ALDSQRK---------------LQFY----------EDRHQLPAPKAAELANLINNCM 253

Query: 352 NEKSRERPAMSYVVQLLDEL 371
           + +   RP+   +++ L+ L
Sbjct: 254 DYEPDHRPSFRAIIRDLNSL 273

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  132 bits (334), Expect = 4e-36
 Identities = 58/239 (24%), Positives = 95/239 (39%), Gaps = 44/239 (18%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN 139
             +F    ++G G+FG V KA+        AIKK+     +      +E+  L  L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 140 IVKILG----------YCASGLDRVLIY---EFVENGSLDQWLHDTSRNDDVDGSKQLNS 186
           +V+                +   +  ++   E+ ENG+L   +H  + N   D       
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD------- 116

Query: 187 LCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID 246
                W    ++ R +   L+Y+H   + IIHRD+K  N+ +D      I DFGLA+ + 
Sbjct: 117 ---EYW----RLFRQILEALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167

Query: 247 TSHSHVS-------------TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            S   +              T   GT  Y+  E L G       +D+YS GI+  E+  
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  133 bits (336), Expect = 4e-36
 Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 32/228 (14%)

Query: 88  KIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNI 140
           + IG+G+FG V++A+            VA+K L ++A      +F+ E   + +  + NI
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWL---------HDTSRNDDVDGSKQLNSLCPLS 191
           VK+LG CA G    L++E++  G L+++L           +  +             PLS
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
              ++ I R VA G+AYL   E+  +HRD+ + N L+  +    I+DFGL+R I ++   
Sbjct: 173 CAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA--- 227

Query: 252 VSTQVAGTMGY-----MPPEYLGGN--TAATVMLDVYSFGILMIEIAT 292
                A          MPPE +  N  T  +   DV+++G+++ EI +
Sbjct: 228 -DYYKADGNDAIPIRWMPPESIFYNRYTTES---DVWAYGVVLWEIFS 271

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  135 bits (341), Expect = 5e-36
 Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 65/305 (21%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           ++   +K +G G FG V+ A  +    VA+K + K        F AE   +  L+H  +V
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           K+     +     +I EF+  GSL  +L     +                    +     
Sbjct: 247 KLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGS-------------KQPLPKLIDFSAQ 292

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +A G+A++   ++  IHRD++++N+L+ +     I+DFGLAR I     +  T   G   
Sbjct: 293 IAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKF 347

Query: 262 ---YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIR---PNLPVVLDGQEVGLLEWART 315
              +  PE +   +  T+  DV+SFGIL++EI T  R   P +       EV        
Sbjct: 348 PIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMS----NPEV-------- 394

Query: 316 MEARNKEIEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERPAMSYVVQ 366
                  I  +          E G R         E + I   C   +  ERP   Y+  
Sbjct: 395 -------IRAL----------ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437

Query: 367 LLDEL 371
           +LD+ 
Sbjct: 438 VLDDF 442

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  133 bits (337), Expect = 6e-36
 Identities = 74/310 (23%), Positives = 129/310 (41%), Gaps = 65/310 (20%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSG----VTVAIKKLDKDA-FQGFREFRAEMETLGKLR 136
            N S DK++G G FG V   +L       ++VAIK L      +  R+F  E   +G+  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NI+++ G        +++ E++ENGSLD +L                     +    V
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--------------FTVIQLV 150

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            ++RG+A+G+ YL   +   +HRD+ + N+L++S+    +SDFGL R ++       T  
Sbjct: 151 GMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208

Query: 257 AGTMGY--MPPEYLGGNTAATVMLDVYSFGILMIEIATQIR---PNLPVVLDGQEVGLLE 311
            G +      PE +      T   DV+S+GI++ E+ +            +  Q+V    
Sbjct: 209 GGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDV---- 259

Query: 312 WARTMEARNKEIEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERPAMS 362
                      I+ V          + G R           +++   C  +    RP   
Sbjct: 260 -----------IKAV----------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298

Query: 363 YVVQLLDELV 372
            +V +LD+L+
Sbjct: 299 QIVSILDKLI 308

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  132 bits (334), Expect = 6e-36
 Identities = 81/315 (25%), Positives = 127/315 (40%), Gaps = 58/315 (18%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDA-FQGFREFRAEMETLGK 134
           D     K +G G+FG V +A        ++  TVA+K L + A     R   +E++ L  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 135 L-RHRNIVKILGYC-ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP--L 190
           +  H N+V +LG C   G   ++I EF + G+L  +L  + RN+ V        L    L
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKDFL 145

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS 250
           + E  +     VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I     
Sbjct: 146 TLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203

Query: 251 HVSTQVAGTMG-----YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ 305
           +    V          +M PE +      T+  DV+SFG+L+ EI +      P V   +
Sbjct: 204 Y----VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258

Query: 306 EVGLLEWARTMEARNKEIEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSR 356
           E                   +          + G R         E ++    C + +  
Sbjct: 259 EF---------------CRRL----------KEGTRMRAPDYTTPEMYQTMLDCWHGEPS 293

Query: 357 ERPAMSYVVQLLDEL 371
           +RP  S +V+ L  L
Sbjct: 294 QRPTFSELVEHLGNL 308

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  131 bits (331), Expect = 6e-36
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 24/214 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +     + +G G FG V+    +    VA+K L K        F AE   + +L+H+ +V
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++     +     +I E++ENGSL  +L   S                L+    + +   
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGI-------------KLTINKLLDMAAQ 117

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM- 260
           +A G+A++   E+  IHRD++++N+L+       I+DFGLAR I     +  T   G   
Sbjct: 118 IAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKF 172

Query: 261 --GYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
              +  PE +   T  T+  DV+SFGIL+ EI T
Sbjct: 173 PIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVT 205

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  132 bits (333), Expect = 8e-36
 Identities = 64/253 (25%), Positives = 109/253 (43%), Gaps = 38/253 (15%)

Query: 59  LFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKL----SSGVTVAIKKL 114
           + DS      L +     LI     F+  +++G G FG V +A+L     S V VA+K L
Sbjct: 1   MLDSLGISDELKEKLEDVLIPE-QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML 59

Query: 115 DKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRV------LIYEFVENGSLD 166
             D        EF  E   + +  H ++ K++G       +       +I  F+++G L 
Sbjct: 60  KADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLH 119

Query: 167 QWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV 226
            +L  +   ++            L  +T V+ +  +A G+ YL    +  IHRD+ + N 
Sbjct: 120 AFLLASRIGENPF---------NLPLQTLVRFMVDIACGMEYLS--SRNFIHRDLAARNC 168

Query: 227 LLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG-----YMPPEYLGGN--TAATVMLD 279
           +L  D    ++DFGL+R+I +   +      G        ++  E L  N  T  +   D
Sbjct: 169 MLAEDMTVCVADFGLSRKIYSGDYY----RQGCASKLPVKWLALESLADNLYTVHS---D 221

Query: 280 VYSFGILMIEIAT 292
           V++FG+ M EI T
Sbjct: 222 VWAFGVTMWEIMT 234

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  130 bits (330), Expect = 1e-35
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 28/217 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
            + +    +G G +G VY+       +TVA+K L +D  +   EF  E   + +++H N+
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 71

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V++LG C       +I EF+  G+L  +L + +R               +S    + +  
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-------------EVSAVVLLYMAT 118

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            +++ + YL   +K  IHRD+ + N L+  +    ++DFGL+R +        T  A   
Sbjct: 119 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-----DTYTAHAG 171

Query: 261 G-----YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
                 +  PE L  N   ++  DV++FG+L+ EIAT
Sbjct: 172 AKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 207

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  132 bits (335), Expect = 1e-35
 Identities = 85/320 (26%), Positives = 131/320 (40%), Gaps = 64/320 (20%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL--------SSGVTVAIKKLDKDA-FQGFREFRAEMETL 132
           D     K +G+G+FG V  A+         +    VA+K L  DA  +   +  +EME +
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 133 GKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTS-RNDDVDGSKQLNSLCPL 190
             + +H+NI+ +LG C       +I E+   G+L ++L        +   +   N    L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS 250
           S +  V     VA G+ YL    K  IHRD+ + NVL+  D    I+DFGLAR I     
Sbjct: 189 SSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-- 244

Query: 251 HVSTQVAGTMG-----YMPPEYLGGNTAATVMLDVYSFGILMIEIAT---QIRPNLPVVL 302
                   T G     +M PE L      T   DV+SFG+L+ EI T      P +PV  
Sbjct: 245 --DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 299

Query: 303 DGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVR---------EYFRIACMCTNE 353
             +E+                +++          + G R         E + +   C + 
Sbjct: 300 --EEL---------------FKLL----------KEGHRMDKPSNCTNELYMMMRDCWHA 332

Query: 354 KSRERPAMSYVVQLLDELVA 373
              +RP    +V+ LD +VA
Sbjct: 333 VPSQRPTFKQLVEDLDRIVA 352

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  130 bits (329), Expect = 2e-35
 Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 32/227 (14%)

Query: 77  LIDATDNFSTDKIIGDGSFGFVYKAKLSSG----VTVAIKKLDKDAF---QGFREFRAEM 129
           LI   D     + +GDGSFG V + +  +     V+VA+K L  D     +   +F  E+
Sbjct: 14  LIGEKD-LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 72

Query: 130 ETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP 189
             +  L HRN++++ G         ++ E    GSL   L     +        L     
Sbjct: 73  NAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTL----- 123

Query: 190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSH 249
                  +    VA G+ YL    K  IHRD+ + N+LL +     I DFGL R +  + 
Sbjct: 124 ------SRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175

Query: 250 SHVSTQVAGTMGY--MPPEYLGGN--TAATVMLDVYSFGILMIEIAT 292
            H   Q    + +    PE L     + A+   D + FG+ + E+ T
Sbjct: 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHAS---DTWMFGVTLWEMFT 219

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  130 bits (329), Expect = 2e-35
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 26/222 (11%)

Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKL---SSGVTVAIKKLDKDAF--QGFREFRAEMETL 132
           +D       DK +G G+FG V K          TVA+K L  +A       E  AE   +
Sbjct: 13  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 72

Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            +L +  IV+++G C      +L+ E  E G L+++L                    +  
Sbjct: 73  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---------------VKD 116

Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +  +++V  V+ G+ YL   E   +HRD+ + NVLL +   A ISDFGL++ +    ++ 
Sbjct: 117 KNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174

Query: 253 STQVAGTM--GYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
             Q  G     +  PE +      +   DV+SFG+LM E  +
Sbjct: 175 KAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFS 215

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  130 bits (330), Expect = 2e-35
 Identities = 46/233 (19%), Positives = 91/233 (39%), Gaps = 36/233 (15%)

Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           ++   + +G+G F +V   + L  G   A+K++     Q   E + E +      H NI+
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 142 KILGYCASGLDRV----LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           +++ YC           L+  F + G+L   +       +            L+ +  + 
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN-----------FLTEDQILW 138

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR----RIDTSHSHVS 253
           ++ G+  GL  +H   K   HRD+K +N+LL  + +  + D G        ++ S   ++
Sbjct: 139 LLLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196

Query: 254 TQVA----GTMGYMPPE------YLGGNTAATVMLDVYSFGILMIEIATQIRP 296
            Q       T+ Y  PE      +   +       DV+S G ++  +     P
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERT----DVWSLGCVLYAMMFGEGP 245

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  130 bits (330), Expect = 2e-35
 Identities = 61/254 (24%), Positives = 114/254 (44%), Gaps = 41/254 (16%)

Query: 61  DSASFDPSLSQISMSEL----IDATDNFSTDKIIGDGSFGFVYKAKL----SSGVTVAIK 112
            S+   P  S+   ++L    ID  +     KI+G+G FG V +  L     + + VA+K
Sbjct: 10  HSSGLVPRGSEELQNKLEDVVIDR-NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVK 68

Query: 113 KLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYC-----ASGLDRVLIYEFVENGSL 165
            +  D    +   EF +E   +    H N++++LG C           ++I  F++ G L
Sbjct: 69  TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128

Query: 166 DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSN 225
             +L        ++   +      +  +T +K +  +A G+ YL    +  +HRD+ + N
Sbjct: 129 HTYL----LYSRLETGPK-----HIPLQTLLKFMVDIALGMEYLS--NRNFLHRDLAARN 177

Query: 226 VLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG-----YMPPEYLGGN--TAATVML 278
            +L  D    ++DFGL+++I +   +      G +      ++  E L     T+ +   
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMPVKWIAIESLADRVYTSKS--- 230

Query: 279 DVYSFGILMIEIAT 292
           DV++FG+ M EIAT
Sbjct: 231 DVWAFGVTMWEIAT 244

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (329), Expect = 2e-35
 Identities = 60/238 (25%), Positives = 97/238 (40%), Gaps = 30/238 (12%)

Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSG----VTVAIKKLDKDA-FQ 120
              L+++    +        +D++IG G FG VY  +        +  AIK L +    Q
Sbjct: 5   SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ 64

Query: 121 GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI-YEFVENGSLDQWLHDTSRNDDVD 179
               F  E   +  L H N++ ++G          +   ++ +G L Q++    RN  V 
Sbjct: 65  QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV- 123

Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
             K L           +     VA G+ YL   E+  +HRD+ + N +LD  F   ++DF
Sbjct: 124 --KDL-----------ISFGLQVARGMEYLA--EQKFVHRDLAARNCMLDESFTVKVADF 168

Query: 240 GLARRIDTSHSHVSTQVAGTM---GYMPPEYLGGN--TAATVMLDVYSFGILMIEIAT 292
           GLAR I     +   Q         +   E L     T  +   DV+SFG+L+ E+ T
Sbjct: 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKS---DVWSFGVLLWELLT 223

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  130 bits (330), Expect = 2e-35
 Identities = 57/225 (25%), Positives = 101/225 (44%), Gaps = 30/225 (13%)

Query: 77  LIDATDNFSTDKIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDA-FQGFREFRAEME 130
           +   T+     K++G G FG V+K        S  + V IK ++  +  Q F+     M 
Sbjct: 9   IFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML 67

Query: 131 TLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL 190
            +G L H +IV++LG C  G    L+ +++  GSL   +     +    G + L      
Sbjct: 68  AIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLL------ 117

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS 250
                +     +A G+ YL   E  ++HR++ + NVLL S  +  ++DFG+A  +     
Sbjct: 118 -----LNWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170

Query: 251 HVSTQVAGT-MGYMPPEYLGGN--TAATVMLDVYSFGILMIEIAT 292
            +    A T + +M  E +     T  +   DV+S+G+ + E+ T
Sbjct: 171 QLLYSEAKTPIKWMALESIHFGKYTHQS---DVWSYGVTVWELMT 212

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  130 bits (329), Expect = 4e-35
 Identities = 78/325 (24%), Positives = 125/325 (38%), Gaps = 68/325 (20%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDA-FQGFREFRAEMETLGK 134
           +N    K++G G+FG V  A           + VA+K L + A         +E++ + +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWL--------HDTSRNDDVDGSKQLN 185
           L  H NIV +LG C       LI+E+   G L  +L         D    ++    ++  
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
            L  L++E  +     VA G+ +L    K  +HRD+ + NVL+       I DFGLAR I
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222

Query: 246 DTSHSHVSTQVAGTMG-----YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIR---PN 297
            +        V          +M PE L      T+  DV+S+GIL+ EI +      P 
Sbjct: 223 MSDS----NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPG 277

Query: 298 LPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVR---------EYFRIAC 348
           +PV                       +++          + G +         E + I  
Sbjct: 278 IPV---DANF---------------YKLI----------QNGFKMDQPFYATEEIYIIMQ 309

Query: 349 MCTNEKSRERPAMSYVVQLLDELVA 373
            C    SR+RP+   +   L   +A
Sbjct: 310 SCWAFDSRKRPSFPNLTSFLGCQLA 334

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  128 bits (324), Expect = 8e-35
 Identities = 67/303 (22%), Positives = 114/303 (37%), Gaps = 65/303 (21%)

Query: 87  DKIIGDGSFGFVYKAKLSSG---VTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIVK 142
           D  +G G+FG V +         + VAIK L +        E   E + + +L +  IV+
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           ++G C      +L+ E    G L ++L                    +      +++  V
Sbjct: 75  LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--------------IPVSNVAELLHQV 119

Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM-- 260
           + G+ YL   EK  +HRD+ + NVLL +   A ISDFGL++ +    S+ + + AG    
Sbjct: 120 SMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 177

Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIR---PNLPVVLDGQEVGLLEWARTME 317
            +  PE +      +   DV+S+G+ M E  +  +     +     G EV          
Sbjct: 178 KWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMK----GPEV---------- 222

Query: 318 ARNKEIEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERPAMSYVVQLL 368
                +  +          E G R         E + +   C   K  +RP    V Q +
Sbjct: 223 -----MAFI----------EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267

Query: 369 DEL 371
              
Sbjct: 268 RAC 270

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  129 bits (327), Expect = 9e-35
 Identities = 78/313 (24%), Positives = 131/313 (41%), Gaps = 70/313 (22%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDA-FQGFREFRAEMETLGKL 135
              +  K+IG G FG VYK  L        V VAIK L      +   +F  E   +G+ 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
            H NI+++ G  +     ++I E++ENG+LD++L +                   S    
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------------FSVLQL 149

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           V ++RG+A G+ YL       +HRD+ + N+L++S+    +SDFGL+R ++       T 
Sbjct: 150 VGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207

Query: 256 VAGTMGY--MPPEYLGGN--TAATVMLDVYSFGILMIEIATQIR---PNLPVVLDGQEVG 308
             G +      PE +     T+A+   DV+SFGI+M E+ T            L   EV 
Sbjct: 208 SGGKIPIRWTAPEAISYRKFTSAS---DVWSFGIVMWEVMTYGERPYWE----LSNHEV- 259

Query: 309 LLEWARTMEARNKEIEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERP 359
                         ++ +            G R           +++   C  ++   RP
Sbjct: 260 --------------MKAI----------NDGFRLPTPMDCPSAIYQLMMQCWQQERARRP 295

Query: 360 AMSYVVQLLDELV 372
             + +V +LD+L+
Sbjct: 296 KFADIVSILDKLI 308

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  129 bits (325), Expect = 1e-34
 Identities = 58/238 (24%), Positives = 92/238 (38%), Gaps = 31/238 (13%)

Query: 74  MSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE-FRAEMET 131
           M     +   +    I+G G+   V++ +   +G   AIK  +  +F    +    E E 
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60

Query: 132 LGKLRHRNIVKILGYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP 189
           L KL H+NIVK+         R  VLI EF   GSL   L + S                
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA------------YG 108

Query: 190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH----ISDFGLARRI 245
           L     + ++R V  G+ +L   E  I+HR+IK  N++     +      ++DFG AR +
Sbjct: 109 LPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166

Query: 246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVML-------DVYSFGILMIEIATQIRP 296
           +         + GT  Y+ P+                   D++S G+     AT   P
Sbjct: 167 E--DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  128 bits (323), Expect = 1e-34
 Identities = 52/239 (21%), Positives = 89/239 (37%), Gaps = 46/239 (19%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRN 139
            +F   + +G G FG V++AK        AIK++     +  RE    E++ L KL H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 140 IVKILGY---------CASGLDRVLIY---EFVENGSLDQWLHDTSRNDDVDGSKQLNSL 187
           IV+                   +V +Y   +     +L  W+                ++
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM------------NGRCTI 112

Query: 188 CPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT 247
                   + I   +A  + +LH   K ++HRD+K SN+    D    + DFGL   +D 
Sbjct: 113 EERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 170

Query: 248 SHSHVSTQVA-----------GTMGYMPPEYLGG---NTAATVMLDVYSFGILMIEIAT 292
                +               GT  YM PE + G   +       D++S G+++ E+  
Sbjct: 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV----DIFSLGLILFELLY 225

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  132 bits (334), Expect = 2e-34
 Identities = 66/312 (21%), Positives = 116/312 (37%), Gaps = 65/312 (20%)

Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLSSG---VTVAIKKLDKDAFQGFR-EFRAEMETLG 133
           +   +    D  +G G+FG V +         + VAIK L +   +    E   E + + 
Sbjct: 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH 391

Query: 134 KLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           +L +  IV+++G C      +L+ E    G L ++L                    +   
Sbjct: 392 QLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--------------IPVS 436

Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
              +++  V+ G+ YL   EK  +HR++ + NVLL +   A ISDFGL++ +    S+ +
Sbjct: 437 NVAELLHQVSMGMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494

Query: 254 TQVAGTMGY--MPPEYLGGNTAATVMLDVYSFGILMIEIATQIR---PNLPVVLDGQEVG 308
            + AG        PE +      +   DV+S+G+ M E  +  +     +     G EV 
Sbjct: 495 ARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMK----GPEV- 548

Query: 309 LLEWARTMEARNKEIEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERP 359
                         +  +          E G R         E + +   C   K  +RP
Sbjct: 549 --------------MAFI----------EQGKRMECPPECPPELYALMSDCWIYKWEDRP 584

Query: 360 AMSYVVQLLDEL 371
               V Q +   
Sbjct: 585 DFLTVEQRMRAC 596

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  126 bits (320), Expect = 3e-34
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 27/222 (12%)

Query: 73  SMSELIDAT-DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQ--GFRE-FRA 127
           S++  I    ++F    ++G GSF  VY+A+ + +G+ VAIK +DK A    G  +  + 
Sbjct: 1   SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60

Query: 128 EMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL 187
           E++   +L+H +I+++  Y        L+ E   NG ++++L +  +             
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK------------- 107

Query: 188 CPLS-WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID 246
            P S  E R   +  +  G+ YLH     I+HRD+  SN+LL  +    I+DFGLA ++ 
Sbjct: 108 -PFSENEAR-HFMHQIITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163

Query: 247 TSHSHVSTQVAGTMGYMPPEYLGGNT-AATVMLDVYSFGILM 287
             H    T + GT  Y+ PE    +        DV+S G + 
Sbjct: 164 MPHEKHYT-LCGTPNYISPEIATRSAHGLES--DVWSLGCMF 202

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  127 bits (322), Expect = 4e-34
 Identities = 50/224 (22%), Positives = 98/224 (43%), Gaps = 30/224 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREF---------------- 125
           +++   + +  G F  +   +       A+KK +K   +  R+F                
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 126 -RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
            + E++ +  +++   +   G   +  +  +IYE++EN S+ ++       D        
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK------- 142

Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR 244
           N  C +  +    I++ V N  +Y+H  EK I HRD+K SN+L+D +    +SDFG +  
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201

Query: 245 IDTSHSHVSTQVAGTMGYMPPEYLGGNTA-ATVMLDVYSFGILM 287
           +       S    GT  +MPPE+    ++     +D++S GI +
Sbjct: 202 MVDKKIKGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  128 bits (323), Expect = 5e-34
 Identities = 31/288 (10%), Positives = 75/288 (26%), Gaps = 47/288 (16%)

Query: 41  RAVNRPQPNRCSDLSSIALFDSASFDPSLSQISM-SELIDATDNFSTDKIIGDGSFGFVY 99
             +   +     + +++    +A+  P  ++ ++ S L          + +  G    V+
Sbjct: 20  ELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVF 79

Query: 100 KAK-LSSGVTVAIKKLDKDAFQG---FREFRAEMETLGKLRHRNIVKILGYC-------- 147
             + +      A+K     A                  +L   +  +             
Sbjct: 80  LVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139

Query: 148 ------------------ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP 189
                              +  + +L+        L+             G         
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRG--------D 190

Query: 190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSH 249
                   +   +    A L    K ++H      N+ +  D    + D     ++ T  
Sbjct: 191 EGILALHILTAQLIRLAANLQ--SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR- 247

Query: 250 SHVSTQVAGTMGYMPPEYLGGNTAA-TVMLDVYSFGILMIEIATQIRP 296
                  +  + Y P E+L  +TA  T  L+ +  G+ +  +     P
Sbjct: 248 ---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  126 bits (318), Expect = 5e-34
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 33/229 (14%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHR 138
           +++     IG GS+G   K +  S G  +  K+LD  +      +   +E+  L +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 139 NIVKILGYCASGLDR-----VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           NIV+   Y    +DR      ++ E+ E G L   +   ++               L  E
Sbjct: 66  NIVR---YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-----------YLDEE 111

Query: 194 TRVKIVRGVANGLAYLH---GLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS 250
             ++++  +   L   H        ++HRD+K +NV LD      + DFGLAR ++   S
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171

Query: 251 HVSTQVAGTMGYMPPEYLGG---NTAATVMLDVYSFGILMIEIATQIRP 296
              T V GT  YM PE +     N  +    D++S G L+ E+   + P
Sbjct: 172 FAKTFV-GTPYYMSPEQMNRMSYNEKS----DIWSLGCLLYELCALMPP 215

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  128 bits (324), Expect = 6e-34
 Identities = 58/238 (24%), Positives = 92/238 (38%), Gaps = 31/238 (13%)

Query: 74  MSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE-FRAEMET 131
           M     +   +    I+G G+   V++ +   +G   AIK  +  +F    +    E E 
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60

Query: 132 LGKLRHRNIVKILGYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP 189
           L KL H+NIVK+         R  VLI EF   GSL   L + S                
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA------------YG 108

Query: 190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH----ISDFGLARRI 245
           L     + ++R V  G+ +L   E  I+HR+IK  N++     +      ++DFG AR +
Sbjct: 109 LPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166

Query: 246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVML-------DVYSFGILMIEIATQIRP 296
           +         + GT  Y+ P+                   D++S G+     AT   P
Sbjct: 167 E--DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  126 bits (319), Expect = 7e-34
 Identities = 62/249 (24%), Positives = 99/249 (39%), Gaps = 42/249 (16%)

Query: 64  SFDPSLSQISMSELIDAT-------DNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLD 115
           SF    S+   S   D +        +F     +G GS+G V+K      G   A+K+  
Sbjct: 32  SFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSM 91

Query: 116 KDAFQGFRE---FRAEMETLGKL-RHRNIVKILGYCASGLDRVLIY-EFVENGSLDQWLH 170
              F+G ++     AE+ +  K+ +H   V++      G   + +  E     SL Q   
Sbjct: 92  SP-FRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-GILYLQTELCG-PSLQQHCE 148

Query: 171 DTSRNDDVDGSKQLNSLCPLSWETRVK-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD 229
                              L  E +V   +R     LA+LH   + ++H D+K +N+ L 
Sbjct: 149 AWGA--------------SLP-EAQVWGYLRDTLLALAHLH--SQGLVHLDVKPANIFLG 191

Query: 230 SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILM 287
                 + DFGL   + T+      Q  G   YM PE L G   TAA    DV+S G+ +
Sbjct: 192 PRGRCKLGDFGLLVELGTA-GAGEVQE-GDPRYMAPELLQGSYGTAA----DVFSLGLTI 245

Query: 288 IEIATQIRP 296
           +E+A  +  
Sbjct: 246 LEVACNMEL 254

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  125 bits (317), Expect = 8e-34
 Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 31/220 (14%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSG----VTVAIKKLDKDA-FQGFREFRAEMETLGKLR 136
           +     + IG+G FG V++    S     + VAIK            +F  E  T+ +  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H +IVK++G   +     +I E    G L  +L     +              L   + +
Sbjct: 75  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--------------LDLASLI 119

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                ++  LAYL    K  +HRDI + NVL+ S+    + DFGL+R ++   S      
Sbjct: 120 LYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKAS 175

Query: 257 AGTM--GYMPPEYLGGN--TAATVMLDVYSFGILMIEIAT 292
            G +   +M PE +     T+A+   DV+ FG+ M EI  
Sbjct: 176 KGKLPIKWMAPESINFRRFTSAS---DVWMFGVCMWEILM 212

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  129 bits (327), Expect = 2e-33
 Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 23/216 (10%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSG----VTVAIKKLDKDA-FQGFREFRAEMETLGKLR 136
           +     + IG+G FG V++    S     + VAIK            +F  E  T+ +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H +IVK++G   +     +I E    G L  +L              L           +
Sbjct: 450 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQ---VRKFSLDLASL-----------I 494

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                ++  LAYL    K  +HRDI + NVL+ S+    + DFGL+R ++ S  + +++ 
Sbjct: 495 LYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
              + +M PE +      T   DV+ FG+ M EI  
Sbjct: 553 KLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILM 587

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  127 bits (321), Expect = 3e-33
 Identities = 49/246 (19%), Positives = 98/246 (39%), Gaps = 30/246 (12%)

Query: 61  DSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ 120
            S S +        S +I    +F    ++G G+ G +    +     VA+K++  + F 
Sbjct: 3   SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS 62

Query: 121 GFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVD 179
                  E++ L +   H N+++          + +  E     +L +++          
Sbjct: 63  FADR---EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA---- 114

Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL-----DSDFEA 234
                           + +++   +GLA+LH L   I+HRD+K  N+L+         +A
Sbjct: 115 ----------HLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKA 162

Query: 235 HISDFGLARRIDTSHS--HVSTQVAGTMGYMPPEYLGGNTAA--TVMLDVYSFGILMIEI 290
            ISDFGL +++          + V GT G++ PE L  +     T  +D++S G +   +
Sbjct: 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222

Query: 291 ATQIRP 296
            ++   
Sbjct: 223 ISEGSH 228

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  124 bits (313), Expect = 3e-33
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 27/213 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR---EFRAEMETLGKLRH 137
           ++F   + +G G FG VY A+   S   +A+K L K   +      + R E+E    LRH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NI+++ GY        LI E+   G++ + L   S+ D+                T   
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--------------QRTA-T 113

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
            +  +AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S       + 
Sbjct: 114 YITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LC 168

Query: 258 GTMGYMPPEYLGGNT-AATVMLDVYSFGILMIE 289
           GT+ Y+PPE + G      V  D++S G+L  E
Sbjct: 169 GTLDYLPPEMIEGRMHDEKV--DLWSLGVLCYE 199

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  123 bits (312), Expect = 4e-33
 Identities = 54/237 (22%), Positives = 84/237 (35%), Gaps = 45/237 (18%)

Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRA--EMETLGKL-R 136
           T  F   + IG G FG V+K  K   G   AIK+  K       E  A  E+     L +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 137 HRNIVKILGYCASGLDRVLIY-EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           H ++V+     A   D +LI  E+   GSL   +           S+    +     E  
Sbjct: 70  HSHVVRYFSAWAED-DHMLIQNEYCNGGSLADAI-----------SENYRIMSYFK-EAE 116

Query: 196 VK-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-------------------FEAH 235
           +K ++  V  GL Y+H     ++H DIK SN+ +                          
Sbjct: 117 LKDLLLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

Query: 236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           I D G   RI +          G   ++  E L  N       D+++  + ++  A 
Sbjct: 175 IGDLGHVTRISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  126 bits (317), Expect = 1e-32
 Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 37/238 (15%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNI 140
           +   ++KI+G GS G V       G  VA+K++  D          E++ L +   H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNV 71

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           ++      +     +  E     +L   +           +    +L        + ++R
Sbjct: 72  IRYYCSETTDRFLYIALELCN-LNLQDLV--------ESKNVSDENLKLQKEYNPISLLR 122

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDS-------------DFEAHISDFGLARRIDT 247
            +A+G+A+LH     IIHRD+K  N+L+ +             +    ISDFGL +++D+
Sbjct: 123 QIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 248 SHSHVSTQ---VAGTMGYMPPEYLGGNTAATVML------DVYSFGILMIEIATQIRP 296
             S   T     +GT G+  PE L  +             D++S G +   I ++ + 
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  121 bits (307), Expect = 2e-32
 Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 33/221 (14%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDA-FQGFREFRAEMETLGKLR 136
           ++   ++I+G+G FG VY+          + VA+K   KD       +F +E   +  L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H +IVK++G         +I E    G L  +L    RN +      L           V
Sbjct: 72  HPHIVKLIGII-EEEPTWIIMELYPYGELGHYLE---RNKNSLKVLTL-----------V 116

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                +   +AYL       +HRDI   N+L+ S     + DFGL+R I+        + 
Sbjct: 117 LYSLQICKAMAYLE--SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKA 171

Query: 257 AGTM---GYMPPEYLGGN--TAATVMLDVYSFGILMIEIAT 292
           + T     +M PE +     T A+   DV+ F + M EI +
Sbjct: 172 SVTRLPIKWMSPESINFRRFTTAS---DVWMFAVCMWEILS 209

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  122 bits (309), Expect = 2e-32
 Identities = 51/248 (20%), Positives = 96/248 (38%), Gaps = 36/248 (14%)

Query: 61  DSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF- 119
            S+  D     +    +      +S  K IG G    V++         AIK ++ +   
Sbjct: 7   HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD 66

Query: 120 -QGFREFRAEMETLGKLRHRN--IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRND 176
            Q    +R E+  L KL+  +  I+++  Y  +     ++ E   N  L+ WL       
Sbjct: 67  NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-- 123

Query: 177 DVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI 236
                        +    R    + +   +  +H  +  I+H D+K +N L+       +
Sbjct: 124 -------------IDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDG-MLKL 167

Query: 237 SDFGLARRI--DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVML----------DVYSFG 284
            DFG+A ++  DT+     +QV GT+ YMPPE +   +++              DV+S G
Sbjct: 168 IDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226

Query: 285 ILMIEIAT 292
            ++  +  
Sbjct: 227 CILYYMTY 234

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  123 bits (310), Expect = 2e-32
 Identities = 49/226 (21%), Positives = 90/226 (39%), Gaps = 36/226 (15%)

Query: 83  NFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRH--R 138
            +S  K IG G    V++         AIK ++ +    Q    +R E+  L KL+    
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
            I+++  Y  +     ++ E   N  L+ WL                    +    R   
Sbjct: 70  KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---------------IDPWERKSY 113

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQV 256
            + +   +  +H  +  I+H D+K +N L+       + DFG+A ++  DT+     +QV
Sbjct: 114 WKNMLEAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 170

Query: 257 AGTMGYMPPEYLGGNTAATVML----------DVYSFGILMIEIAT 292
            GT+ YMPPE +   +++              DV+S G ++  +  
Sbjct: 171 -GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  121 bits (306), Expect = 3e-32
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 27/213 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR---EFRAEMETLGKLRH 137
           D+F   + +G G FG VY A+   +   +A+K L K   +      + R E+E    LRH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NI+++  Y        L+ EF   G L + L    R D+                +   
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE--------------QRSA-T 118

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
            +  +A+ L Y H  E+ +IHRDIK  N+L+    E  I+DFG +    +          
Sbjct: 119 FMEELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM---C 173

Query: 258 GTMGYMPPEYLGGNT-AATVMLDVYSFGILMIE 289
           GT+ Y+PPE + G T    V  D++  G+L  E
Sbjct: 174 GTLDYLPPEMIEGKTHDEKV--DLWCAGVLCYE 204

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  126 bits (318), Expect = 4e-32
 Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 30/231 (12%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHR 138
              +   + +G G FG+V +     +G  VAIK+  ++     RE +  E++ + KL H 
Sbjct: 13  CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72

Query: 139 NIVKIL------GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           N+V            A     +L  E+ E G L ++L+                 C L  
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC------------CGLKE 120

Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH---ISDFGLARRIDTSH 249
                ++  +++ L YLH  E  IIHRD+K  N++L    +     I D G A+ +D   
Sbjct: 121 GPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--Q 176

Query: 250 SHVSTQVAGTMGYMPPEYLGGNT-AATVMLDVYSFGILMIEIATQIRPNLP 299
             + T+  GT+ Y+ PE L       TV  D +SFG L  E  T  RP LP
Sbjct: 177 GELCTEFVGTLQYLAPELLEQKKYTVTV--DYWSFGTLAFECITGFRPFLP 225

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  121 bits (306), Expect = 4e-32
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 24/231 (10%)

Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE 124
                 +      D  + +     +GDG+FG VYKAK   +G   A K ++  + +   +
Sbjct: 5   SREYEHVRRDL--DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED 62

Query: 125 FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
           +  E+E L    H  IVK+LG         ++ EF   G++D  + +  R          
Sbjct: 63  YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR---------- 112

Query: 185 NSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR 244
                L+      + R +   L +LH   K IIHRD+K+ NVL+  + +  ++DFG++ +
Sbjct: 113 ----GLTEPQIQVVCRQMLEALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166

Query: 245 IDTSHSHVSTQVAGTMGYMPPEYLGGNTAATV----MLDVYSFGILMIEIA 291
              +     + + GT  +M PE +   T          D++S GI +IE+A
Sbjct: 167 NLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (305), Expect = 1e-31
 Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 34/231 (14%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILG 145
           +++ +G F FVY+A+ + SG   A+K+L  +  +  R    E+  + KL  H NIV+   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 146 YCASGLDR-------VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
             + G +         L+   +  G L ++L                   PLS +T +KI
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG------------PLSCDTVLKI 141

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQV 256
                  + ++H  + PIIHRD+K  N+LL +     + DFG A        +S  + + 
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201

Query: 257 A---------GTMGYMPPE--YLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           A          T  Y  PE   L  N       D+++ G ++  +  +  P
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  120 bits (302), Expect = 1e-31
 Identities = 59/231 (25%), Positives = 96/231 (41%), Gaps = 29/231 (12%)

Query: 65  FDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR 123
               L  I      D    ++  + IG G+ G VY A  +++G  VAI++++        
Sbjct: 5   ILEKLRSIVSVG--DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62

Query: 124 EFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQ 183
               E+  + + ++ NIV  L     G +  ++ E++  GSL   + +T           
Sbjct: 63  LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----------- 111

Query: 184 LNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR 243
                 +       + R     L +LH     +IHRDIKS N+LL  D    ++DFG   
Sbjct: 112 -----CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164

Query: 244 RIDTSHSHVSTQVAGTMGYMPPEYLGG---NTAATVMLDVYSFGILMIEIA 291
           +I    S  ST V GT  +M PE +             D++S GI+ IE+ 
Sbjct: 165 QITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV----DIWSLGIMAIEMI 210

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  121 bits (305), Expect = 1e-31
 Identities = 51/210 (24%), Positives = 81/210 (38%), Gaps = 23/210 (10%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQ--GFRE-FRAEMETLGKLRH 137
             +   + +G G F   ++     +    A K + K        RE    E+     L H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           +++V   G+        ++ E     SL          +     K L        E R  
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSL---------LELHKRRKALTE-----PEAR-Y 145

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
            +R +  G  YLH     +IHRD+K  N+ L+ D E  I DFGLA +++         + 
Sbjct: 146 YLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LC 202

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT  Y+ PE L      +  +DV+S G +M
Sbjct: 203 GTPNYIAPEVLSKK-GHSFEVDVWSIGCIM 231

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  120 bits (303), Expect = 2e-31
 Identities = 71/237 (29%), Positives = 110/237 (46%), Gaps = 29/237 (12%)

Query: 68  SLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFR 126
           SL +I +S L D    F   +++G+G++G VYK + + +G   AIK +D        E +
Sbjct: 10  SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIK 68

Query: 127 AEMETLGKL-RHRNIVKILG-----YCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVD 179
            E+  L K   HRNI    G           D++ L+ EF   GS+   + +T  N    
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---- 124

Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
                     L  E    I R +  GL++LH  +  +IHRDIK  NVLL  + E  + DF
Sbjct: 125 ---------TLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDF 173

Query: 240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVM----LDVYSFGILMIEIAT 292
           G++ ++D +    +T   GT  +M PE +  +           D++S GI  IE+A 
Sbjct: 174 GVSAQLDRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  119 bits (301), Expect = 2e-31
 Identities = 51/210 (24%), Positives = 81/210 (38%), Gaps = 23/210 (10%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQ--GFRE-FRAEMETLGKLRH 137
             +   + +G G F   ++     +    A K + K        RE    E+     L H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           +++V   G+        ++ E     SL          +     K L        E R  
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSL---------LELHKRRKALTE-----PEAR-Y 119

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
            +R +  G  YLH     +IHRD+K  N+ L+ D E  I DFGLA +++         + 
Sbjct: 120 YLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LC 176

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           GT  Y+ PE L      +  +DV+S G +M
Sbjct: 177 GTPNYIAPEVLSKK-GHSFEVDVWSIGCIM 205

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  124 bits (314), Expect = 2e-31
 Identities = 46/216 (21%), Positives = 81/216 (37%), Gaps = 37/216 (17%)

Query: 90  IGDGSFGFVYKAK--LSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVKIL-- 144
           I  G  G++Y A     +G  V +K L        +    AE + L ++ H +IV+I   
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147

Query: 145 GYCASGLDRVLIY---EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
                     + Y   E+V   SL +                      L     +  +  
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----------------KLPVAEAIAYLLE 190

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +   L+YLH     +++ D+K  N++L  + +  + D G   RI++        + GT G
Sbjct: 191 ILPALSYLH--SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPG 242

Query: 262 YMPPE-YLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +  PE    G T AT   D+Y+ G  +  +   +  
Sbjct: 243 FQAPEIVRTGPTVAT---DIYTVGRTLAALTLDLPT 275

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  121 bits (306), Expect = 2e-31
 Identities = 48/226 (21%), Positives = 89/226 (39%), Gaps = 36/226 (15%)

Query: 83  NFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRH--R 138
            +S  K IG G    V++         AIK ++ +    Q    +R E+  L KL+    
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
            I+++  Y  +     ++ E   N  L+ WL                    +    R   
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---------------IDPWERKSY 160

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVSTQV 256
            + +   +  +H  +  I+H D+K +N L+       + DFG+A ++  DT+     +QV
Sbjct: 161 WKNMLEAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 217

Query: 257 AGTMGYMPPEYLGGNTAATVML----------DVYSFGILMIEIAT 292
            G + YMPPE +   +++              DV+S G ++  +  
Sbjct: 218 -GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (305), Expect = 2e-31
 Identities = 43/241 (17%), Positives = 87/241 (36%), Gaps = 35/241 (14%)

Query: 68  SLSQISMSELIDATDNFSTDKIIGDG--SFGFVYKAK-LSSGVTVAIKK--LDKDAFQGF 122
           +L    MS  +     +    +IG G      V  A+   +G  V +++  L+  + +  
Sbjct: 11  NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV 70

Query: 123 REFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSK 182
              + E+       H NIV       +  +  ++  F+  GS    +     +       
Sbjct: 71  TFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD------- 123

Query: 183 QLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA 242
                  ++      I++GV   L Y+H      +HR +K+S++L+  D + ++S     
Sbjct: 124 ------GMNELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSN 175

Query: 243 RRIDTSHSHVST------QVAGTMGYMPPEYL-----GGNTAATVMLDVYSFGILMIEIA 291
             + +                  + ++ PE L     G +  +    D+YS GI   E+A
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS----DIYSVGITACELA 231

Query: 292 T 292
            
Sbjct: 232 N 232

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  119 bits (301), Expect = 3e-31
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH 137
           D      +   IG+GS G V  A+   SG  VA+K +D    Q       E+  +   +H
Sbjct: 42  DPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            N+V++      G +  ++ EF++ G+L   +                    L+ E    
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----------------RLNEEQIAT 145

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           +   V   LAYLH   + +IHRDIKS ++LL  D    +SDFG   +I        + V 
Sbjct: 146 VCEAVLQALAYLH--AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV- 202

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA 291
           GT  +M PE +  +  AT + D++S GI++IE+ 
Sbjct: 203 GTPYWMAPEVISRSLYATEV-DIWSLGIMVIEMV 235

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  118 bits (298), Expect = 7e-31
 Identities = 54/217 (24%), Positives = 86/217 (39%), Gaps = 28/217 (12%)

Query: 87  DKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF--QGFRE-FRAEMETLGKLRHRNIVK 142
            +++G G  G VY+A+       VA+K + +       FR   + E  T G+L+  ++V 
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 143 ILGYCASGLDRVLIY---EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           I  +   G     +Y     +    L   L                   PL+    V IV
Sbjct: 99  IHDF---GEIDGQLYVDMRLINGVDLAAMLRRQG---------------PLAPPRAVAIV 140

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
           R + + L   H       HRD+K  N+L+ +D  A++ DFG+A               GT
Sbjct: 141 RQIGSALDAAH--AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGT 198

Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           + YM PE    +  AT   D+Y+   ++ E  T   P
Sbjct: 199 LYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPP 234

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  117 bits (295), Expect = 2e-30
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 28/219 (12%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG-FREFRAEMETLGKLR 136
           D  + F+  + IG GSFG V+K     +   VAIK +D +  +    + + E+  L +  
Sbjct: 19  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
              + K  G         +I E++  GS    L                   PL      
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----------------PLDETQIA 122

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            I+R +  GL YLH  +K  IHRDIK++NVLL    E  ++DFG+A ++  +    +T V
Sbjct: 123 TILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 180

Query: 257 AGTMGYMPPEYL---GGNTAATVMLDVYSFGILMIEIAT 292
            GT  +M PE +     ++ A    D++S GI  IE+A 
Sbjct: 181 -GTPFWMAPEVIKQSAYDSKA----DIWSLGITAIELAR 214

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  117 bits (295), Expect = 2e-30
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 21/220 (9%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRN 139
           D++   ++IG G+   V  A        VAIK+++ +  Q    E   E++ + +  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 140 IVKILGYCASGLDRV---LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           IV    Y  S + +    L+ + +  GS+   +       +            L   T  
Sbjct: 75  IVS---YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG-------VLDESTIA 124

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            I+R V  GL YLH   +  IHRD+K+ N+LL  D    I+DFG++  + T       +V
Sbjct: 125 TILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182

Query: 257 AGTM-G---YMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
             T  G   +M PE +          D++SFGI  IE+AT
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  117 bits (295), Expect = 2e-30
 Identities = 61/227 (26%), Positives = 110/227 (48%), Gaps = 29/227 (12%)

Query: 69  LSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA 127
           L + S+++     + F   + +G+GS+G VYKA    +G  VAIK++  +     +E   
Sbjct: 18  LDEDSLTK--QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIK 73

Query: 128 EMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL 187
           E+  + +    ++VK  G      D  ++ E+   GS+   +   ++             
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK------------- 120

Query: 188 CPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT 247
             L+ +    I++    GL YLH      IHRDIK+ N+LL+++  A ++DFG+A ++  
Sbjct: 121 -TLTEDEIATILQSTLKGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177

Query: 248 SHSHVSTQVAGTMGYMPPEYLGG---NTAATVMLDVYSFGILMIEIA 291
           + +  +T + GT  +M PE +     N  A    D++S GI  IE+A
Sbjct: 178 TMAKRNTVI-GTPFWMAPEVIQEIGYNCVA----DIWSLGITAIEMA 219

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  117 bits (296), Expect = 2e-30
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 20/217 (9%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKD-AFQGFREFRAEMETLGKL-RHR 138
           ++      IG G++G V K     SG  +A+K++      +  ++   +++ + +     
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
            IV+  G      D  +  E + + S D++        D            +  E   KI
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDD----------VIPEEILGKI 130

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
                  L +L    K IIHRDIK SN+LLD      + DFG++ ++  S +   T+ AG
Sbjct: 131 TLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAG 187

Query: 259 TMGYMPPEYLGGNTAA---TVMLDVYSFGILMIEIAT 292
              YM PE +  + +     V  DV+S GI + E+AT
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT 224

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  118 bits (297), Expect = 2e-30
 Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 25/286 (8%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRN 139
           D+F     +G G+ G V+K     SG+ +A K +  +       +   E++ L +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSR-NDDVDGSKQLNSLCPLSWETRVKI 198
           IV   G   S  +  +  E ++ GSLDQ L    R  + + G                K+
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG----------------KV 136

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
              V  GL YL   +  I+HRD+K SN+L++S  E  + DFG++ ++  S   ++    G
Sbjct: 137 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVG 192

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA 318
           T  YM PE L G    +V  D++S G+ ++E+A    P  P      E+          A
Sbjct: 193 TRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251

Query: 319 RNKEIEMVDSNISREELSE-AGVREYFRIACMCTNEKSRERPAMSY 363
                         +   +       F +     NE   + P+  +
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 297

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  115 bits (290), Expect = 7e-30
 Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 21/217 (9%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKD-AFQGFREFRAEMETLGKL-RHR 138
           D+      +G G++G V K + + SG  +A+K++      Q  +    +++   +     
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
             V   G      D  +  E + + SLD++               L            KI
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG-----------KI 114

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
              +   L +LH     +IHRD+K SNVL+++  +  + DFG++  +    +      AG
Sbjct: 115 AVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDAG 171

Query: 259 TMGYMPPEYLGGNTAA---TVMLDVYSFGILMIEIAT 292
              YM PE +         +V  D++S GI MIE+A 
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI 208

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  115 bits (290), Expect = 8e-30
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 28/217 (12%)

Query: 87  DKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKD--AFQGFRE-FRAEMETLGKLRHRNIVK 142
              +G G    VY A+     + VAIK +       +   + F  E+    +L H+NIV 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 143 ILGYCASGLDRVLIY---EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           ++       +    Y   E++E  +L +++                   PLS +T +   
Sbjct: 76  MIDV---DEEDDCYYLVMEYIEGPTLSEYIESHG---------------PLSVDTAINFT 117

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             + +G+ + H  +  I+HRDIK  N+L+DS+    I DFG+A+ +  +    +  V GT
Sbjct: 118 NQILDGIKHAH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGT 175

Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           + Y  PE   G        D+YS GI++ E+     P
Sbjct: 176 VQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPP 211

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  115 bits (289), Expect = 2e-29
 Identities = 73/268 (27%), Positives = 109/268 (40%), Gaps = 40/268 (14%)

Query: 31  RTYKPPTYRTRAVNRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKII 90
            T +   ++      P   R   L           DP ++++   +  D    FS  + I
Sbjct: 15  PTTENLYFQGAMDPMPAGGRAGSLK----------DPDVAELFFKD--DPEKLFSDLREI 62

Query: 91  GDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG---FREFRAEMETLGKLRHRNIVKILGY 146
           G GSFG VY A+ + +   VAIKK+     Q    +++   E+  L KLRH N ++  G 
Sbjct: 63  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 122

Query: 147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGL 206
                   L+ E+   GS    L    +              PL       +  G   GL
Sbjct: 123 YLREHTAWLVMEYCL-GSASDLLEVHKK--------------PLQEVEIAAVTHGALQGL 167

Query: 207 AYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE 266
           AYLH     +IHRD+K+ N+LL       + DFG A  +  ++S V     GT  +M PE
Sbjct: 168 AYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPE 220

Query: 267 YLGGNTAAT--VMLDVYSFGILMIEIAT 292
            +           +DV+S GI  IE+A 
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAE 248

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  114 bits (287), Expect = 5e-29
 Identities = 38/284 (13%), Positives = 86/284 (30%), Gaps = 39/284 (13%)

Query: 39  RTRAVNRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFV 98
           R    N    +     ++ +L  ++ ++        SEL +         ++G       
Sbjct: 30  RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAY 89

Query: 99  YKAK-LSSGVTVAIKKLDK------DAFQGFREFRAEMETLGKLRHRNIVKILGYCASGL 151
            +A    +G +  +           +A +  +E    +  L  ++++   K+        
Sbjct: 90  LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149

Query: 152 DRVLIYEFVENGSLDQWLHDTSRNDDV--------DGSKQLNSLC-------PLSWETRV 196
           D V   +  +   +     D               +       L         L    R+
Sbjct: 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 209

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           ++   V   LA LH     ++H  ++  +++LD      ++ F    R            
Sbjct: 210 QLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV-----S 262

Query: 257 AGTMGYMPPEYL----------GGNTAATVMLDVYSFGILMIEI 290
           + + G+ PPE               T  T   D ++ G+++  I
Sbjct: 263 SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  113 bits (284), Expect = 7e-29
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 30/221 (13%)

Query: 87  DKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG---FRE-FRAEMETLGKLRHRNIV 141
            +I+G G    V+ A+ L     VA+K L  D       F   FR E +    L H  IV
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 142 KILGY-CASGLDRVLIY---EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            +     A      L Y   E+V+  +L   +H                  P++ +  ++
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------------PMTPKRAIE 120

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV--STQ 255
           ++      L + H  +  IIHRD+K +N+++ +     + DFG+AR I  S + V  +  
Sbjct: 121 VIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           V GT  Y+ PE   G++      DVYS G ++ E+ T   P
Sbjct: 179 VIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPP 218

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  113 bits (286), Expect = 9e-29
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 34/226 (15%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN 139
            D F  +++ G G+FG V   K   +G++VAIKK+ +D     RE +  M+ L  L H N
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80

Query: 140 IVKILGYCASGLDR-------VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           IV++  Y  +  +R        ++ E+V        LH   RN      +          
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRN--YYRRQV-----APPP 128

Query: 193 ETRVK-----IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFEAHISDFGLARRID 246
              +K     ++R     +  LH     + HRDIK  NVL++ +D    + DFG A+++ 
Sbjct: 129 IL-IKVFLFQLIRS----IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183

Query: 247 TSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
            S  +V+  +  +  Y  PE + GN   T  +D++S G +  E+  
Sbjct: 184 PSEPNVAY-IC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  110 bits (277), Expect = 7e-28
 Identities = 48/230 (20%), Positives = 91/230 (39%), Gaps = 27/230 (11%)

Query: 71  QISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKD-AFQGFREFRAE 128
            I         ++      +G G+ G V+K +   +G  +A+K++ +    +  +    +
Sbjct: 14  TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD 73

Query: 129 METLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSR-NDDVDGSKQLNS 186
           ++ + K      IV+  G   +  D  +  E +   +            + + G      
Sbjct: 74  LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG------ 127

Query: 187 LCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID 246
                     K+   +   L YL      +IHRD+K SN+LLD   +  + DFG++ R+ 
Sbjct: 128 ----------KMTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176

Query: 247 TSHSHVSTQVAGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIAT 292
              +    + AG   YM PE +           +  DV+S GI ++E+AT
Sbjct: 177 DDKAK--DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT 224

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  112 bits (281), Expect = 8e-28
 Identities = 71/225 (31%), Positives = 111/225 (49%), Gaps = 38/225 (16%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN 139
             +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D      + R E++ + KL H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNR-ELQIMRKLDHCN 108

Query: 140 IVKILGYCASGLDRV------LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           IV++  +  S  ++       L+ ++V   ++ +     SR      +KQ      L   
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSR------AKQ-----TLP-V 155

Query: 194 TRVK-----IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-FEAHISDFGLARRIDT 247
             VK     + R     LAY+H     I HRDIK  N+LLD D     + DFG A+++  
Sbjct: 156 IYVKLYMYQLFR----SLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209

Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
              +VS  +  +  Y  PE + G T  T  +DV+S G ++ E+  
Sbjct: 210 GEPNVS-YIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  112 bits (282), Expect = 2e-27
 Identities = 53/261 (20%), Positives = 98/261 (37%), Gaps = 30/261 (11%)

Query: 34  KPPTYRTRAVNRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDG 93
           +   Y      +    + +  S+   +    +     Q    +     D++   + +G G
Sbjct: 109 RRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTG 168

Query: 94  SFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLD 152
           +FG V++    ++G   A K +           R E++T+  LRH  +V +        +
Sbjct: 169 AFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228

Query: 153 RVLIYEFVENGSL-DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHG 211
            V+IYEF+  G L +       +  D            +S +  V+ +R V  GL ++H 
Sbjct: 229 MVMIYEFMSGGELFE-------KVADEHNK--------MSEDEAVEYMRQVCKGLCHMH- 272

Query: 212 LEKPIIHRDIKSSNVLLDSDFEAHI--SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG 269
            E   +H D+K  N++  +     +   DFGL   +D           GT  +  PE   
Sbjct: 273 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVKVTTGTAEFAAPEVAE 329

Query: 270 G---NTAATVMLDVYSFGILM 287
           G           D++S G+L 
Sbjct: 330 GKPVGYYT----DMWSVGVLS 346

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  110 bits (275), Expect = 2e-27
 Identities = 79/360 (21%), Positives = 129/360 (35%), Gaps = 98/360 (27%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQG-FREFRAEMETLGK 134
           D     K +G G+FG V +A        ++  TVA+K L + A     R   +E++ L  
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 135 L-RHRNIVKILGYC-ASGLDRVLIYEFVENGSLDQWLHD--------TSRNDDVDGSKQL 184
           +  H N+V +LG C   G   ++I EF + G+L  +L           ++       K  
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141

Query: 185 NSLCPLSWETRVKIVRG------------------------------------------- 201
               P+  + R+  +                                             
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT-M 260
           VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I     +V    A   +
Sbjct: 202 VAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259

Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARN 320
            +M PE +  +   T+  DV+SFG+L+ EI +      P V   +E              
Sbjct: 260 KWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------------- 305

Query: 321 KEIEMVDSNISREELSEAGVR---------EYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
                +          + G R         E ++    C + +  +RP  S +V+ L  L
Sbjct: 306 --CRRL----------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (271), Expect = 3e-27
 Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 24/230 (10%)

Query: 64  SFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF 122
               S  + ++       D F   + +G G+FG V+  +  SSG+   IK ++KD  Q  
Sbjct: 4   HHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP 63

Query: 123 RE-FRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL-DQWLHDTSRNDDVDG 180
            E   AE+E L  L H NI+KI        +  ++ E  E G L ++ +   +R      
Sbjct: 64  MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK---- 119

Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH---IS 237
                    LS     ++++ + N LAY H   + ++H+D+K  N+L           I 
Sbjct: 120 --------ALSEGYVAELMKQMMNALAYFH--SQHVVHKDLKPENILFQDTSPHSPIKII 169

Query: 238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           DFGLA    +     ST  AGT  YM PE    +       D++S G++M
Sbjct: 170 DFGLAELFKS--DEHSTNAAGTALYMAPEVFKRDVTFKC--DIWSAGVVM 215

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  110 bits (276), Expect = 3e-27
 Identities = 46/264 (17%), Positives = 101/264 (38%), Gaps = 31/264 (11%)

Query: 30  KRTYKPPTYRTRAVNRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKI 89
           + ++    + ++   +    + +D           + P   ++    +    D +   + 
Sbjct: 2   RGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSV---YDYYDILEE 58

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA 148
           +G G+FG V++    ++G     K ++          + E+  + +L H  ++ +     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 149 SGLDRVLIYEFVENGSL-DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA 207
              + VLI EF+  G L D+   +                  +S    +  +R    GL 
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAED---------------YKMSEAEVINYMRQACEGLK 163

Query: 208 YLHGLEKPIIHRDIKSSNVLLDSDFEAH--ISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
           ++H  E  I+H DIK  N++ ++   +   I DFGLA +++     +      T  +  P
Sbjct: 164 HMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAP 219

Query: 266 EYLGGN--TAATVMLDVYSFGILM 287
           E +        T   D+++ G+L 
Sbjct: 220 EIVDREPVGFYT---DMWAIGVLG 240

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  107 bits (271), Expect = 3e-27
 Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 33/227 (14%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKK--LDKDAFQGF-----REFRAEMETLG 133
             +   + IG+G++G V+KAK   +   VA+K+  LD D  +G      RE    +  L 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALRE----ICLLK 56

Query: 134 KLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           +L+H+NIV++     S     L++EF +   L ++    +                L   
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG--------------DLD-P 100

Query: 194 TRVK-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
             VK  +  +  GL + H   + ++HRD+K  N+L++ + E  +++FGLAR         
Sbjct: 101 EIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158

Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           S +V  T+ Y PP+ L G    +  +D++S G +  E+A   RP  P
Sbjct: 159 SAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  111 bits (279), Expect = 4e-27
 Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 29/247 (11%)

Query: 47  QPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSS 105
             +  S   ++         P +   S    +  ++ +   K +G G++G V   +   +
Sbjct: 4   HHHHSSGRENLYFQGDLQATPGMFITSKKGHL--SEMYQRVKKLGSGAYGEVLLCRDKVT 61

Query: 106 GVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENG 163
            V  AIK + K +       +   E+  L  L H NI+K+  +     +  L+ E  + G
Sbjct: 62  HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121

Query: 164 SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKS 223
            L   +    + ++VD +                I++ V +G+ YLH  +  I+HRD+K 
Sbjct: 122 ELFDEIIHRMKFNEVDAAV---------------IIKQVLSGVTYLH--KHNIVHRDLKP 164

Query: 224 SNVLLDS---DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDV 280
            N+LL+S   D    I DFGL+   +  +     +  GT  Y+ PE L          DV
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEVLRKKYDEKC--DV 220

Query: 281 YSFGILM 287
           +S G+++
Sbjct: 221 WSIGVIL 227

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (275), Expect = 4e-27
 Identities = 40/280 (14%), Positives = 84/280 (30%), Gaps = 39/280 (13%)

Query: 45  RPQPNRCSDLSSIALFDSASFDPSLSQISM-SELIDATDNFSTDKIIGDGSFGFVYKAK- 102
             +       S+     S S   +     + SEL +         ++G        +A  
Sbjct: 40  NVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATD 99

Query: 103 LSSGVTVAIKKLDK------DAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI 156
             +G +  +           +A +  +E    +  L  ++++   K+        D V  
Sbjct: 100 QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159

Query: 157 YEFVENGSLDQWLHDTS-----------RNDDVDGSKQLNSLC----PLSWETRVKIVRG 201
            +  +   +     D             +++     + L S       L    R+++   
Sbjct: 160 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQ 219

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           V   LA LH     ++H  ++  +++LD      ++ F    R        S       G
Sbjct: 220 VIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIGRG 272

Query: 262 YMPPEYL---------GGNTAATVMLDVYSFGILMIEIAT 292
           + PPE              T  T   D ++ G+ +  I  
Sbjct: 273 FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  109 bits (273), Expect = 4e-27
 Identities = 38/239 (15%), Positives = 70/239 (29%), Gaps = 33/239 (13%)

Query: 67  PSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK------LSSGVTVAIKKLDKDAFQ 120
           P++   +  +L           ++G+G+F  VY+A         +     +K        
Sbjct: 52  PAIKPKTEFQLGS--KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW 109

Query: 121 GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDG 180
            F      ME L        +K           VL+ E    G+L   ++      +   
Sbjct: 110 EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEK-- 167

Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH----- 235
                    +     +     +   +  +H  E  IIH DIK  N +L + F        
Sbjct: 168 --------VMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDD 217

Query: 236 ------ISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
                 + D G +  +       + T    T G+   E L         +D +     +
Sbjct: 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATV 275

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  110 bits (278), Expect = 4e-27
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 28/216 (12%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG---FREFRAEMETLGK 134
             +D +   +++G GSFG V   K   +G   A+K + K   +          E++ L +
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82

Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           L H NI+K+  +        L+ E    G L   +    R  +VD ++            
Sbjct: 83  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR------------ 130

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHISDFGLARRIDTSHSH 251
              I+R V +G+ Y+H  +  I+HRD+K  N+LL+S   D    I DFGL+   + S   
Sbjct: 131 ---IIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185

Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
                 GT  Y+ PE L G        DV+S G+++
Sbjct: 186 --KDKIGTAYYIAPEVLHGTYDEKC--DVWSTGVIL 217

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  106 bits (267), Expect = 8e-27
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 25/213 (11%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH 137
           D    ++ +  IG GS+G V  A    + +  A KK+ K   +    F+ E+E +  L H
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH 65

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NI+++        D  L+ E    G L + +       + D ++               
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--------------- 110

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHISDFGLARRIDTSHSHVST 254
           I++ V + +AY H  +  + HRD+K  N L  +   D    + DFGLA R          
Sbjct: 111 IMKDVLSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--R 166

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
              GT  Y+ P+ L G        D +S G++M
Sbjct: 167 TKVGTPYYVSPQVLEGLYGPEC--DEWSAGVMM 197

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  106 bits (267), Expect = 2e-26
 Identities = 59/228 (25%), Positives = 113/228 (49%), Gaps = 24/228 (10%)

Query: 78  IDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF-----REFRAEMET 131
           + ++  F   + +G+G++  VYK    ++GV VA+K++  D+ +G      RE    +  
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISL 56

Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           + +L+H NIV++     +     L++EF++N  L +++   +           N+   L 
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRT---------VGNTPRGLE 106

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
                     +  GLA+ H  E  I+HRD+K  N+L++   +  + DFGLAR      + 
Sbjct: 107 LNLVKYFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT 164

Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
            S++V  T+ Y  P+ L G+   +  +D++S G ++ E+ T  +P  P
Sbjct: 165 FSSEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFP 210

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  107 bits (270), Expect = 2e-26
 Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 37/224 (16%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
              ++  K+IG+GSFG V++AKL     VAIKK+ +D      + R E++ +  ++H N+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---RFKNR-ELQIMRIVKHPNV 94

Query: 141 VKILGYCASGLDRV------LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           V +  +  S  D+       L+ E+V      + ++  SR       KQ      +    
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASR--HYAKLKQ-----TMP-ML 141

Query: 195 RVK-----IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-FEAHISDFGLARRIDTS 248
            +K     ++R     LAY+H +   I HRDIK  N+LLD       + DFG A+ +   
Sbjct: 142 LIKLYMYQLLR----SLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195

Query: 249 HSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
             +VS  +  +  Y  PE + G T  T  +D++S G +M E+  
Sbjct: 196 EPNVS-YIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  105 bits (265), Expect = 4e-26
 Identities = 65/241 (26%), Positives = 113/241 (46%), Gaps = 33/241 (13%)

Query: 67  PSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKK--LDKDAFQGF-- 122
              S           + +   + +G+G++G VYKAK S G  VA+K+  LD +  +G   
Sbjct: 6   HHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPS 64

Query: 123 ---REFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVD 179
              R    E+  L +L H NIV ++    S     L++EF+E   L + L +        
Sbjct: 65  TAIR----EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT----- 114

Query: 180 GSKQLNSLCPLSWETRVK-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD 238
                     L  ++++K  +  +  G+A+ H  +  I+HRD+K  N+L++SD    ++D
Sbjct: 115 ---------GLQ-DSQIKIYLYQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALKLAD 162

Query: 239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNL 298
           FGLAR         + +V  T+ Y  P+ L G+   +  +D++S G +  E+ T  +P  
Sbjct: 163 FGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLF 220

Query: 299 P 299
           P
Sbjct: 221 P 221

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  106 bits (266), Expect = 4e-26
 Identities = 57/253 (22%), Positives = 96/253 (37%), Gaps = 39/253 (15%)

Query: 72  ISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE-----F 125
                L++    +     IG GS+G V  A    +    AIK ++K+  +          
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75

Query: 126 RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL----DQWLHDTSRNDDVDGS 181
           + E+  + KL H NI ++           L+ E    G L    + ++ D++    +D  
Sbjct: 76  KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135

Query: 182 KQLNSLCPLSWETRV---------------------KIVRGVANGLAYLHGLEKPIIHRD 220
           K     CP   E  +                      I+R + + L YLH   + I HRD
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--NQGICHRD 193

Query: 221 IKSSNVLLDSDFEAH--ISDFGLARRI---DTSHSHVSTQVAGTMGYMPPEYLGGNTAA- 274
           IK  N L  ++      + DFGL++     +    +  T  AGT  ++ PE L     + 
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253

Query: 275 TVMLDVYSFGILM 287
               D +S G+L+
Sbjct: 254 GPKCDAWSAGVLL 266

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  105 bits (264), Expect = 5e-26
 Identities = 53/269 (19%), Positives = 89/269 (33%), Gaps = 67/269 (24%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRN 139
            +F   + +G G FG V++AK        AIK++     +  RE    E++ L KL H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 140 IVKILGYC--ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV- 196
           IV+                 + +           +S +     S ++  + P S +  V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 197 ------------------------------------------KIVRGVANGLAYLHGLEK 214
                                                      I   +A  + +LH   K
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH--SK 183

Query: 215 PIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA-----------GTMGYM 263
            ++HRD+K SN+    D    + DFGL   +D      +               GT  YM
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243

Query: 264 PPEYLGG---NTAATVMLDVYSFGILMIE 289
            PE + G   +       D++S G+++ E
Sbjct: 244 SPEQIHGNNYSHKV----DIFSLGLILFE 268

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  105 bits (264), Expect = 6e-26
 Identities = 60/252 (23%), Positives = 109/252 (43%), Gaps = 38/252 (15%)

Query: 61  DSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKK--LDKD 117
           ++ +  P    +S +    + D +     +G+G++G VYKA    +  TVAIK+  L+ +
Sbjct: 13  EAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE 72

Query: 118 AFQGF-----REFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDT 172
             +G      RE    +  L +L+HRNI+++           LI+E+             
Sbjct: 73  E-EGVPGTAIRE----VSLLKELQHRNIIELKSVIHHNHRLHLIFEYA------------ 115

Query: 173 SRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF 232
               + D  K ++    +S       +  + NG+ + H   +  +HRD+K  N+LL    
Sbjct: 116 ----ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH--SRRCLHRDLKPQNLLLSVSD 169

Query: 233 EAH-----ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
            +      I DFGLAR         + ++  T+ Y PPE L G+   +  +D++S   + 
Sbjct: 170 ASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIW 228

Query: 288 IEIATQIRPNLP 299
            E+  +  P  P
Sbjct: 229 AEMLMK-TPLFP 239

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  106 bits (267), Expect = 6e-26
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 31/225 (13%)

Query: 90  IGDGSFGFVYKAKLSSGVT---VAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKIL 144
           +G G++G VYKAK   G      A+K+++         RE    +  L +L+H N++ + 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 84

Query: 145 GYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK-IVRG 201
               S  DR   L++++ E+  L   +     +       QL           VK ++  
Sbjct: 85  KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLP-------RGMVKSLLYQ 136

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH----ISDFGLARRIDT---SHSHVST 254
           + +G+ YLH     ++HRD+K +N+L+  +        I+D G AR  ++     + +  
Sbjct: 137 ILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
            V  T  Y  PE L G    T  +D+++ G +  E+ T   P   
Sbjct: 195 VVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 237

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  105 bits (265), Expect = 7e-26
 Identities = 65/235 (27%), Positives = 111/235 (47%), Gaps = 38/235 (16%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKK--LDKDAFQGFREFRA--EMETLGKLR 136
             +     IG G+FG V+KA+   +G  VA+KK  ++ +  +GF    A  E++ L  L+
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFP-ITALREIKILQLLK 74

Query: 137 HRNIVKILGYCASGLDRV--------LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLC 188
           H N+V ++  C +             L+++F E        HD +           N L 
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDLAGLLS-------NVLV 119

Query: 189 PLSWETRVK-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT 247
             +  + +K +++ + NGL Y+H     I+HRD+K++NVL+  D    ++DFGLAR    
Sbjct: 120 KFT-LSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 176

Query: 248 SHSHVS---TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           + +      T    T+ Y PPE L G       +D++  G +M E+ T+  P + 
Sbjct: 177 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQ 230

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  104 bits (261), Expect = 1e-25
 Identities = 62/225 (27%), Positives = 109/225 (48%), Gaps = 31/225 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKK--LDKDAFQGF-----REFRAEMETLGK 134
           + +   + IG+G++G VYKA+ + G T A+KK  L+K+  +G      R    E+  L +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIR----EISILKE 56

Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           L+H NIVK+     +    VL++E ++   L + L                    L   T
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG--------------GLESVT 101

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
               +  + NG+AY H  ++ ++HRD+K  N+L++ + E  I+DFGLAR         + 
Sbjct: 102 AKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           ++  T+ Y  P+ L G+   +  +D++S G +  E+     P  P
Sbjct: 160 EIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFP 202

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  103 bits (260), Expect = 1e-25
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 27/213 (12%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRH 137
            + ++   ++G GSFG V K K   +    A+K ++K + +         E+E L KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NI+K+           ++ E    G L   +    R  + D ++               
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--------------- 125

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH---ISDFGLARRIDTSHSHVST 254
           I++ V +G+ Y+H  +  I+HRD+K  N+LL+S  +     I DFGL+     +      
Sbjct: 126 IIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--K 181

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
              GT  Y+ PE L G        DV+S G+++
Sbjct: 182 DRIGTAYYIAPEVLRGTYDEKC--DVWSAGVIL 212

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  104 bits (261), Expect = 1e-25
 Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 24/197 (12%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH 137
           +    F   +++G G+F  V+  K   +G   A+K + K           E+  L K++H
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV +     S     L+ + V  G L   + +     + D S                
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL--------------- 110

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH---ISDFGLARRIDTSHSHVST 254
           +++ V + + YLH  E  I+HRD+K  N+L  +  E     I+DFGL++      + + +
Sbjct: 111 VIQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMS 165

Query: 255 QVAGTMGYMPPEYLGGN 271
              GT GY+ PE L   
Sbjct: 166 TACGTPGYVAPEVLAQK 182

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  105 bits (263), Expect = 1e-25
 Identities = 55/258 (21%), Positives = 104/258 (40%), Gaps = 27/258 (10%)

Query: 35  PPTYRTRAVNRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGS 94
                       +  R S L+       A FD  +       +       S  +I+G G 
Sbjct: 43  WSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT-VSKTEILGGGR 101

Query: 95  FGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDR 153
           FG V+K +  ++G+ +A K +     +   E + E+  + +L H N++++     S  D 
Sbjct: 102 FGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161

Query: 154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLE 213
           VL+ E+V+ G L   +     +              L+    +  ++ +  G+ ++H  +
Sbjct: 162 VLVMEYVDGGELFDRI--IDES------------YNLTELDTILFMKQICEGIRHMH--Q 205

Query: 214 KPIIHRDIKSSNVLLDSDFEAHI--SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN 271
             I+H D+K  N+L  +     I   DFGLARR             GT  ++ PE +  +
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK--PREKLKVNFGTPEFLAPEVVNYD 263

Query: 272 --TAATVMLDVYSFGILM 287
             +  T   D++S G++ 
Sbjct: 264 FVSFPT---DMWSVGVIA 278

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  106 bits (267), Expect = 1e-25
 Identities = 61/258 (23%), Positives = 100/258 (38%), Gaps = 40/258 (15%)

Query: 47  QPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSS 105
             +  S       F   + +P +        I   +++   + +G G++G V   K  + 
Sbjct: 3   HHHHHSSGRENLYFQGIAINPGMYVRKKEGKI--GESYFKVRKLGSGAYGEVLLCKEKNG 60

Query: 106 GVTVAIKKLDKDAFQGFR-------------EFRAEMETLGKLRHRNIVKILGYCASGLD 152
               AIK + K  F   R             E   E+  L  L H NI+K+         
Sbjct: 61  HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120

Query: 153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGL 212
             L+ EF E G L + + +  + D+ D +                I++ + +G+ YLH  
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAAN---------------IMKQILSGICYLH-- 163

Query: 213 EKPIIHRDIKSSNVLLDS---DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG 269
           +  I+HRDIK  N+LL++        I DFGL+        +      GT  Y+ PE L 
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS--KDYKLRDRLGTAYYIAPEVLK 221

Query: 270 GNTAATVMLDVYSFGILM 287
                    DV+S G++M
Sbjct: 222 KKYNEKC--DVWSCGVIM 237

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  103 bits (260), Expect = 2e-25
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 26/223 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKK--LDKDAFQGFREFRA--EMETLGKLR 136
           + +     IG+GS+G V+K +   +G  VAIKK    +D      +  A  E+  L +L+
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-PVI-KKIALREIRMLKQLK 60

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H N+V +L          L++E+ ++ ++   L    R               +      
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQR--------------GVPEHLVK 105

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            I       + + H  +   IHRD+K  N+L+       + DFG AR +     +   +V
Sbjct: 106 SITWQTLQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           A T  Y  PE L G+T     +DV++ G +  E+ +   P  P
Sbjct: 164 A-TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWP 204

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  106 bits (266), Expect = 2e-25
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 29/216 (13%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKL 135
              + ++   ++G GSFG V K K   +    A+K ++K + +         E+E L KL
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78

Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
            H NI+K+           ++ E    G L          D++   K+ +       E  
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGEL---------FDEIIKRKRFS-------EHD 122

Query: 196 V-KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHISDFGLARRIDTSHSH 251
             +I++ V +G+ Y+H  +  I+HRD+K  N+LL+S   D +  I DFGL+       + 
Sbjct: 123 AARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NT 178

Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
                 GT  Y+ PE L G        DV+S G+++
Sbjct: 179 KMKDRIGTAYYIAPEVLRGTYDEKC--DVWSAGVIL 212

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  103 bits (258), Expect = 4e-25
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 31/225 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF-----REFRAEMETLGKL 135
           + +     +G+G++  VYK K   +   VA+K++  +  +G      RE    +  L  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57

Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           +H NIV +     +     L++E+++   L Q+L D                  ++    
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN--------------IIN-MHN 101

Query: 196 VK-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
           VK  +  +  GLAY H   + ++HRD+K  N+L++   E  ++DFGLAR           
Sbjct: 102 VKLFLFQLLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           +V  T+ Y PP+ L G+T  +  +D++  G +  E+AT  RP  P
Sbjct: 160 EVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFP 202

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  103 bits (259), Expect = 4e-25
 Identities = 53/276 (19%), Positives = 106/276 (38%), Gaps = 36/276 (13%)

Query: 28  FCKRTYKPPTYRTRAVNRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTD 87
           F +     P+     +   +    +           S  P       +   +    +   
Sbjct: 40  FIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPK 99

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE--------FRAEMETLGKLR-H 137
            +IG G    V +    ++G   A+K ++  A +   E         R E   L ++  H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSL-DQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
            +I+ ++    S     L+++ +  G L D      + ++                ETR 
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK---------------ETR- 203

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            I+R +   +++LH     I+HRD+K  N+LLD + +  +SDFG +  ++        ++
Sbjct: 204 SIMRSLLEAVSFLH--ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE--PGEKLREL 259

Query: 257 AGTMGYMPPEYLGGNTAATVML-----DVYSFGILM 287
            GT GY+ PE L  +   T        D+++ G+++
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  103 bits (258), Expect = 5e-25
 Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 26/223 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKK--LDKDAFQGFRE--FRAEMETLGKLR 136
           + +    ++G+GS+G V K +   +G  VAIKK     D  +  ++   R E++ L +LR
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMR-EIKLLKQLR 82

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H N+V +L  C       L++EFV++ ++   L                    L ++   
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN--------------GLDYQVVQ 127

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           K +  + NG+ + H     IIHRDIK  N+L+       + DFG AR +         +V
Sbjct: 128 KYLFQIINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV 185

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           A T  Y  PE L G+      +DV++ G L+ E+     P  P
Sbjct: 186 A-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFP 226

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  103 bits (258), Expect = 5e-25
 Identities = 62/226 (27%), Positives = 107/226 (47%), Gaps = 29/226 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE------FRAEMETLGK 134
             +     +G+G F  VYKA+  ++   VAIKK+        ++       R E++ L +
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQE 68

Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           L H NI+ +L       +  L+++F+E   L+  + D S                L+  +
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL--------------VLT-PS 112

Query: 195 RVK-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
            +K  +     GL YLH  +  I+HRD+K +N+LLD +    ++DFGLA+   + +   +
Sbjct: 113 HIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 170

Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
            QV  T  Y  PE L G     V +D+++ G ++ E+  +  P LP
Sbjct: 171 HQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLP 214

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  102 bits (256), Expect = 1e-24
 Identities = 47/200 (23%), Positives = 83/200 (41%), Gaps = 23/200 (11%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG-----FREFRAEMETLGK 134
            D +   ++IG G F  V +     +G   A+K +D   F         + + E      
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           L+H +IV++L   +S     +++EF++   L           ++   K+ ++    S   
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADL---------CFEI--VKRADAGFVYSEAV 131

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH---ISDFGLARRIDTSHSH 251
               +R +   L Y H  +  IIHRD+K   VLL S   +    +  FG+A ++  S   
Sbjct: 132 ASHYMRQILEALRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL- 188

Query: 252 VSTQVAGTMGYMPPEYLGGN 271
           V+    GT  +M PE +   
Sbjct: 189 VAGGRVGTPHFMAPEVVKRE 208

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  101 bits (253), Expect = 2e-24
 Identities = 47/216 (21%), Positives = 82/216 (37%), Gaps = 31/216 (14%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH 137
           +  + +   + +G G FG V++    SS  T   K +           + E+  L   RH
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARH 60

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHD--TSRNDDVDGSKQLNSLCPLSWETR 195
           RNI+ +     S  + V+I+EF+    +     +   +                L+    
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDI----FERINTSA------------FELNEREI 104

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH--ISDFGLARRIDTSHSHVS 253
           V  V  V   L +LH     I H DI+  N++  +   +   I +FG AR++        
Sbjct: 105 VSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNF 160

Query: 254 TQVAGTMGYMPPEYLGGN--TAATVMLDVYSFGILM 287
             +     Y  PE    +  + AT   D++S G L+
Sbjct: 161 RLLFTAPEYYAPEVHQHDVVSTAT---DMWSLGTLV 193

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  102 bits (256), Expect = 2e-24
 Identities = 60/223 (26%), Positives = 88/223 (39%), Gaps = 35/223 (15%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE--------FRAEMET 131
            D +   K +G G+ G V  A    +   VAI+ + K  F                E+E 
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           L KL H  I+KI  +  +  D  ++ E +E G L   +    R  +              
Sbjct: 194 LKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKL--------- 243

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH---ISDFGLARRIDTS 248
                     +   + YLH  E  IIHRD+K  NVLL S  E     I+DFG ++ +   
Sbjct: 244 ------YFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-- 293

Query: 249 HSHVSTQVAGTMGYMPPEYLGGNTAA--TVMLDVYSFG-ILMI 288
            + +   + GT  Y+ PE L     A     +D +S G IL I
Sbjct: 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 336

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =   99 bits (250), Expect = 2e-24
 Identities = 48/197 (24%), Positives = 85/197 (43%), Gaps = 25/197 (12%)

Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRH 137
           +DN+   + +G G+F  V +    ++G+  A K ++        F++   E     KL+H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV++           L+++ V  G L + +       + D S                
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--------------- 109

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH---ISDFGLARRIDTSHSHVST 254
            ++ +   +AY H     I+HR++K  N+LL S  +     ++DFGLA  ++   S    
Sbjct: 110 CIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWH 165

Query: 255 QVAGTMGYMPPEYLGGN 271
             AGT GY+ PE L  +
Sbjct: 166 GFAGTPGYLSPEVLKKD 182

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  101 bits (254), Expect = 3e-24
 Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 36/238 (15%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN 139
           +  +S  K +G GSFG V +     SG   A+KK+ +D     RE       +  L H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDHVN 61

Query: 140 IVKILGY-------CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           I+K++ Y                 +  +   +     H  S   +   +K LN +     
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 193 ETRVKIVRGVAN-------------------GLAYLHGLEKPIIHRDIKSSNVLLDS-DF 232
           +T  K+++                        + ++H L   I HRDIK  N+L++S D 
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDN 179

Query: 233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
              + DFG A+++  S   V+  +  +  Y  PE + G T  T  +D++S G +  E+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAY-IC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  100 bits (251), Expect = 5e-24
 Identities = 48/197 (24%), Positives = 85/197 (43%), Gaps = 25/197 (12%)

Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRH 137
           +DN+   + +G G+F  V +    ++G+  A K ++        F++   E     KL+H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV++           L+++ V  G L + +       + D S                
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--------------- 132

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH---ISDFGLARRIDTSHSHVST 254
            ++ +   +AY H     I+HR++K  N+LL S  +     ++DFGLA  ++   S    
Sbjct: 133 CIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWH 188

Query: 255 QVAGTMGYMPPEYLGGN 271
             AGT GY+ PE L  +
Sbjct: 189 GFAGTPGYLSPEVLKKD 205

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 99.6 bits (249), Expect = 6e-24
 Identities = 54/223 (24%), Positives = 87/223 (39%), Gaps = 37/223 (16%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMET 131
              D +   + +G G F  V K +  S+G+  A K + K   +  R      E   E+  
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68

Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL-DQWLHDTSRNDDVDGSKQLNSLCPL 190
           L ++ H N++ +     +  D VLI E V  G L D      S                L
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES----------------L 112

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH----ISDFGLARRID 246
           S E     ++ + +G+ YLH   K I H D+K  N++L           + DFGLA  I+
Sbjct: 113 SEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

Query: 247 TSHSHVSTQVAGTMGYMPPEYLGGN--TAATVMLDVYSFGILM 287
                    + GT  ++ PE +            D++S G++ 
Sbjct: 171 --DGVEFKNIFGTPEFVAPEIVNYEPLGLEA---DMWSIGVIT 208

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  100 bits (250), Expect = 6e-24
 Identities = 64/262 (24%), Positives = 105/262 (40%), Gaps = 33/262 (12%)

Query: 33  YKPPTYRTRAVNRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGD 92
           +   +              S +++ A   +AS  P    I  S     +D F  +  +G 
Sbjct: 5   HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYW-IDGSNRDALSDFFEVESELGR 63

Query: 93  GSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGL 151
           G+   VY+ K   +    A+K L K      +  R E+  L +L H NI+K+     +  
Sbjct: 64  GATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT 121

Query: 152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHG 211
           +  L+ E V  G L   + +     + D +                 V+ +   +AYLH 
Sbjct: 122 EISLVLELVTGGELFDRIVEKGYYSERDAAD---------------AVKQILEAVAYLH- 165

Query: 212 LEKPIIHRDIKSSNVLLDSDFEAH---ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL 268
            E  I+HRD+K  N+L  +        I+DFGL++ ++  H  +   V GT GY  PE L
Sbjct: 166 -ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPEIL 222

Query: 269 GG---NTAATVMLDVYSFGILM 287
            G           D++S GI+ 
Sbjct: 223 RGCAYGPEV----DMWSVGIIT 240

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 98.8 bits (247), Expect = 6e-24
 Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 37/223 (16%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMET 131
              D++   + +G G F  V K +   +G   A K + K      R      E   E+  
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL-DQWLHDTSRNDDVDGSKQLNSLCPL 190
           L ++RH NI+ +     +  D VLI E V  G L D      S                L
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES----------------L 105

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-DFEAH---ISDFGLARRID 246
           + +   + ++ + +G+ YLH   K I H D+K  N++L   +       + DFG+A +I+
Sbjct: 106 TEDEATQFLKQILDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163

Query: 247 TSHSHVSTQVAGTMGYMPPEYLGGN--TAATVMLDVYSFGILM 287
               +    + GT  ++ PE +            D++S G++ 
Sbjct: 164 --AGNEFKNIFGTPEFVAPEIVNYEPLGLEA---DMWSIGVIT 201

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 98.8 bits (247), Expect = 9e-24
 Identities = 65/236 (27%), Positives = 99/236 (41%), Gaps = 38/236 (16%)

Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKL----DKDAFQGF-----REFRAEM 129
           AT  +     IG G++G VYKA+   SG  VA+K +          G      RE     
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 130 ETLGKLRHRNIVKILGYCASGLDRV-----LIYEFVENGSLDQWLHDTSRNDDVDGSKQL 184
             L    H N+V+++  CA+          L++E V+         D     D      L
Sbjct: 67  R-LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDLRTYLDKAPPPGL 117

Query: 185 NSLCPLSWETRVK-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR 243
                      +K ++R    GL +LH     I+HRD+K  N+L+ S     ++DFGLAR
Sbjct: 118 P-------AETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168

Query: 244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
                 +   T V  T+ Y  PE L  +T AT  +D++S G +  E+  + +P   
Sbjct: 169 IYSYQMAL--TPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRR-KPLFC 220

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 61/237 (25%), Positives = 83/237 (35%), Gaps = 63/237 (26%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE--------FRAEMET 131
            D +   K +G G+ G V  A    +   VAIK + K  F                E+E 
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 132 LGKLRHRNIVKILG------------YCASG--LDRVLIYEFVENGSLDQWLHDTSRNDD 177
           L KL H  I+KI                  G   D+V     V N  L +          
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV-----VGNKRLKE--ATCKL--- 118

Query: 178 VDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH-- 235
                                   +   + YLH  E  IIHRD+K  NVLL S  E    
Sbjct: 119 --------------------YFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLI 156

Query: 236 -ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAA--TVMLDVYSFG-ILMI 288
            I+DFG ++ +    + +   + GT  Y+ PE L     A     +D +S G IL I
Sbjct: 157 KITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 211

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 37/223 (16%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMET 131
           +  D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL-DQWLHDTSRNDDVDGSKQLNSLCPL 190
           L +++H N++ +     +  D +LI E V  G L D      S                L
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----------------L 111

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL-DSDFEAH---ISDFGLARRID 246
           + E   + ++ + NG+ YLH     I H D+K  N++L D +       I DFGLA +ID
Sbjct: 112 TEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169

Query: 247 TSHSHVSTQVAGTMGYMPPEYLGGN--TAATVMLDVYSFGILM 287
               +    + GT  ++ PE +            D++S G++ 
Sbjct: 170 --FGNEFKNIFGTPEFVAPEIVNYEPLGLEA---DMWSIGVIT 207

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 50/223 (22%), Positives = 96/223 (43%), Gaps = 35/223 (15%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDK--------DAFQGFRE-FRAEME 130
            +N+   +I+G G    V +     +    A+K +D         +  Q  RE    E++
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 131 TLGKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP 189
            L K+  H NI+++     +     L+++ ++ G L  +L +     + +  K       
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK------- 128

Query: 190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSH 249
                   I+R +   +  LH  +  I+HRD+K  N+LLD D    ++DFG + ++D   
Sbjct: 129 --------IMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--P 176

Query: 250 SHVSTQVAGTMGYMPPEYLGGNTAATVM-----LDVYSFGILM 287
                +V GT  Y+ PE +  +           +D++S G++M
Sbjct: 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 55/223 (24%), Positives = 87/223 (39%), Gaps = 37/223 (16%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMET 131
              D +   + +G G F  V K +  S+G+  A K + K   +  R      E   E+  
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68

Query: 132 LGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL-DQWLHDTSRNDDVDGSKQLNSLCPL 190
           L ++ H NI+ +     +  D VLI E V  G L D      S                L
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES----------------L 112

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH----ISDFGLARRID 246
           S E     ++ + +G+ YLH   K I H D+K  N++L           + DFGLA  I+
Sbjct: 113 SEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

Query: 247 TSHSHVSTQVAGTMGYMPPEYLGGN--TAATVMLDVYSFGILM 287
                    + GT  ++ PE +            D++S G++ 
Sbjct: 171 --DGVEFKNIFGTPEFVAPEIVNYEPLGLEA---DMWSIGVIT 208

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 41/199 (20%), Positives = 78/199 (39%), Gaps = 24/199 (12%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE--FRAEMETLGKL 135
             T+ +   + +G G+F  V +   + +G   A   ++              E      L
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67

Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           +H NIV++    +      LI++ V  G L + +       + D S              
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH------------- 114

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH---ISDFGLARRIDTSHSHV 252
              ++ +   + + H  +  ++HR++K  N+LL S  +     ++DFGLA  ++      
Sbjct: 115 --CIQQILEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQA 169

Query: 253 STQVAGTMGYMPPEYLGGN 271
               AGT GY+ PE L  +
Sbjct: 170 WFGFAGTPGYLSPEVLRKD 188

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 97.3 bits (243), Expect = 5e-23
 Identities = 54/237 (22%), Positives = 100/237 (42%), Gaps = 32/237 (13%)

Query: 62  SASFDPSLSQISMSELIDATDNFS-TDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF 119
           S+  D     +    + +  + +  T K +G G F  V +    S+G   A K L K   
Sbjct: 8   SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67

Query: 120 QG--FREFRAEMETLGKLRHR-NIVKILGYCASGLDRVLIYEFVENGSL-DQWLHDTSRN 175
                 E   E+  L   +    ++ +     +  + +LI E+   G +    L      
Sbjct: 68  GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL------ 121

Query: 176 DDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH 235
            ++           +S    +++++ +  G+ YLH  +  I+H D+K  N+LL S +   
Sbjct: 122 PELAEM--------VSENDVIRLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLG 171

Query: 236 ---ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN--TAATVMLDVYSFGILM 287
              I DFG++R+I   H+    ++ GT  Y+ PE L  +  T AT   D+++ GI+ 
Sbjct: 172 DIKIVDFGMSRKIG--HACELREIMGTPEYLAPEILNYDPITTAT---DMWNIGIIA 223

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 96.6 bits (241), Expect = 9e-23
 Identities = 45/216 (20%), Positives = 88/216 (40%), Gaps = 35/216 (16%)

Query: 81  TDNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHR 138
           TD +   + IG GS+    +    ++ +  A+K +DK       E    +E L +  +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHP 76

Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NI+ +      G    ++ E ++ G L   +       + + S                +
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA---------------V 121

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH----ISDFGLARRIDTSHSHVST 254
           +  +   + YLH   + ++HRD+K SN+L   +        I DFG A+++  + + +  
Sbjct: 122 LFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLM 178

Query: 255 QVAGTMGYMPPEYLGGN---TAATVMLDVYSFGILM 287
               T  ++ PE L       A     D++S G+L+
Sbjct: 179 TPCYTANFVAPEVLERQGYDAAC----DIWSLGVLL 210

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 51/232 (21%), Positives = 88/232 (37%), Gaps = 47/232 (20%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGF------------REFRAE 128
              ++  + I  GS+G V     S G+ VAIK++      G             R  R E
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-E 79

Query: 129 METLGKLRHRNIVKILG----YCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQ 183
           +  L    H NI+ +      +    + ++ L+ E +     D  L            ++
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---D--LAQVIH------DQR 128

Query: 184 LNSLCPLSWETRVK-----IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD 238
           +     +S    ++     I+ G    L  LH     ++HRD+   N+LL  + +  I D
Sbjct: 129 I----VIS-PQHIQYFMYHILLG----LHVLHEAG--VVHRDLHPGNILLADNNDITICD 177

Query: 239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           F LAR      +   T       Y  PE +      T ++D++S G +M E+
Sbjct: 178 FNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 95.0 bits (237), Expect = 3e-22
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 38/233 (16%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK--LSSGVTVAIKK--LDKDAFQGF-----REFRAEMETL 132
             +     IG+G++G V+KA+   + G  VA+K+  +     +G      RE       L
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRH-L 68

Query: 133 GKLRHRNIVKIL----GYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL 187
               H N+V++             ++ L++E V+         D +   D      +   
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--------QDLTTYLDKVPEPGVP-- 118

Query: 188 CPLSWETRVK-IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID 246
                   +K ++  +  GL +LH     ++HRD+K  N+L+ S  +  ++DFGLAR   
Sbjct: 119 -----TETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

Query: 247 TSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
              +   T V  T+ Y  PE L  ++ AT  +D++S G +  E+  + +P   
Sbjct: 172 FQMAL--TSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRR-KPLFR 220

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 94.3 bits (235), Expect = 7e-22
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 36/223 (16%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF----REFRAEMETLG 133
           +    +   + +G G++G V  A    +G  VAIKKL    FQ      R +R E+  L 
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYR-ELRLLK 79

Query: 134 KLRHRNIVKIL-----GYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSL 187
            +RH N++ +L                L+  F+     D  L    +++           
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---D--LGKLMKHE----------- 123

Query: 188 CPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT 247
             L  +    +V  +  GL Y+H     IIHRD+K  N+ ++ D E  I DFGLAR+ D+
Sbjct: 124 -KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADS 180

Query: 248 SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
                 T    T  Y  PE +      T  +D++S G +M E+
Sbjct: 181 EM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 44/227 (19%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKL 135
              ++    IG+G++G V  A    + V VAIKK+    F+      R  R E++ L + 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTYCQRTLR-EIKILLRF 82

Query: 136 RHRNIVKILG-YCASGLDRV----LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL 190
           RH NI+ I     A  ++++    ++ + +E    D  L+   +      ++ L+     
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET---D--LYKLLK------TQHLS----- 126

Query: 191 SWETRVK-----IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
                +      I+RG    L Y+H     ++HRD+K SN+LL++  +  I DFGLAR  
Sbjct: 127 --NDHICYFLYQILRG----LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178

Query: 246 DTSHSHVS--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           D  H H    T+   T  Y  PE +  +   T  +D++S G ++ E+
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 93.2 bits (232), Expect = 1e-21
 Identities = 56/228 (24%), Positives = 88/228 (38%), Gaps = 55/228 (24%)

Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA--------EMETLG 133
            +ST   +G G+FGFV+ A        V +K + K+                  E+  L 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 134 KLRHRNIVK-------------ILGYCASGLDRVLIYEF-VENGSLDQWLHDTSRNDDVD 179
           ++ H NI+K             ++    SGLD   ++ F   +  LD+     +      
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLD---LFAFIDRHPRLDE---PLAS----- 133

Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF 239
                             I R + + + YL    K IIHRDIK  N+++  DF   + DF
Sbjct: 134 -----------------YIFRQLVSAVGYLR--LKDIIHRDIKDENIVIAEDFTIKLIDF 174

Query: 240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           G A  +        T   GT+ Y  PE L GN      L+++S G+ +
Sbjct: 175 GSAAYL-ERGKLFYTFC-GTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 57/231 (24%), Positives = 86/231 (37%), Gaps = 54/231 (23%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA------------------- 127
             IG GS+G V  A   +     A+K L K        F                     
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 128 -------EMETLGKLRHRNIVKILGY----CASGLDRVLIYEFVENGSLDQWLHDTSRND 176
                  E+  L KL H N+VK+         +     +++E V  G +     +     
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK 132

Query: 177 DVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI 236
                       PLS +      + +  G+ YLH   + IIHRDIK SN+L+  D    I
Sbjct: 133 ------------PLSEDQARFYFQDLIKGIEYLH--YQKIIHRDIKPSNLLVGEDGHIKI 178

Query: 237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTA--ATVMLDVYSFGI 285
           +DFG++     S + +S    GT  +M PE L       +   LDV++ G+
Sbjct: 179 ADFGVSNEFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 59/221 (26%), Positives = 90/221 (40%), Gaps = 37/221 (16%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKL 135
              + +   +G G++G V  A    SG  VAIKKL    FQ      R +R E+  L  +
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIFAKRAYR-ELLLLKHM 80

Query: 136 RHRNIVKIL------GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP 189
           +H N++ +L          +  D  L+  F++    D  L                    
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT---D--LQKIMGL-------------K 122

Query: 190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSH 249
            S E    +V  +  GL Y+H     ++HRD+K  N+ ++ D E  I DFGLAR  D   
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179

Query: 250 SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
               T    T  Y  PE +         +D++S G +M E+
Sbjct: 180 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 61/221 (27%), Positives = 89/221 (40%), Gaps = 36/221 (16%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKL 135
              +   K IG G+ G V  A        VAIKKL    FQ      R +R E+  +  +
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYR-ELVLMKCV 118

Query: 136 RHRNIVKIL------GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP 189
            H+NI+ +L             D  L+ E      +D  L    +               
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQM-------------E 160

Query: 190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSH 249
           L  E    ++  +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 216

Query: 250 SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           S + T    T  Y  PE +         +D++S G +M E+
Sbjct: 217 SFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEM 256

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 95.0 bits (236), Expect = 2e-21
 Identities = 63/244 (25%), Positives = 96/244 (39%), Gaps = 36/244 (14%)

Query: 61  DSASFDPSLSQISMSELIDAT-DNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDA 118
           +S  F       ++   I  T ++FS  +IIG G FG VY   K  +G   A+K LDK  
Sbjct: 167 ESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR 226

Query: 119 F---QGFREFRAE---METLGKLRHRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHD 171
               QG      E   +  +       IV  + Y     D++  I + +  G L   L  
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQ 285

Query: 172 TSRNDDVDGSKQLNSLCPLSWETRVKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDS 230
                                E  ++     +  GL ++H   + +++RD+K +N+LLD 
Sbjct: 286 HGVFS----------------EADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDE 327

Query: 231 DFEAHISDFGLARRI--DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMI 288
                ISD GLA        H+ V     GT GYM PE L    A     D +S G ++ 
Sbjct: 328 HGHVRISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382

Query: 289 EIAT 292
           ++  
Sbjct: 383 KLLR 386

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 50/232 (21%), Positives = 96/232 (41%), Gaps = 41/232 (17%)

Query: 80  ATDNFSTD---------KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEM 129
           +TD+FS            ++G+G+   V     L +    A+K ++K           E+
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61

Query: 130 ETLGKLR-HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLC 188
           E L + + HRN+++++ +        L++E +  GS+   +H     ++++ S       
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV------ 115

Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH---ISDFGLARRI 245
                    +V+ VA+ L +LH   K I HRD+K  N+L +   +     I DF L   I
Sbjct: 116 ---------VVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164

Query: 246 DTSHSHVS------TQVAGTMGYMPPEYLGGNTAATVM----LDVYSFGILM 287
             +               G+  YM PE +   +    +     D++S G+++
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 29/223 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFR---AEMETLGKLRH 137
           D+F   + IG GSFG V    K  +    A+K ++K       E R    E++ +  L H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
             +V  L Y     + + ++ + +  G L   L    +N                 E  V
Sbjct: 75  PFLVN-LWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFK-------------EETV 117

Query: 197 KI-VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           K+ +  +   L YL    + IIHRD+K  N+LLD     HI+DF +A  +       +  
Sbjct: 118 KLFICELVMALDYLQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-- 173

Query: 256 VAGTMGYMPPEYLGGNTAA--TVMLDVYSFGILMIEIATQIRP 296
           +AGT  YM PE       A  +  +D +S G+   E+    RP
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 65/239 (27%), Positives = 97/239 (40%), Gaps = 34/239 (14%)

Query: 61  DSASFDPSLSQISMSELIDAT-DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA 118
           DS  F+  L Q    E    T + F   +++G G FG V   ++ ++G   A KKL+K  
Sbjct: 163 DSIYFNRFL-QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR 221

Query: 119 F---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSR 174
               +G      E + L K+  R +V  L Y     D + L+   +  G L   ++   +
Sbjct: 222 IKKRKGEAMALNEKQILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ 280

Query: 175 NDDVDGSKQLNSLCPLSWETRVKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE 233
                             E R       +  GL  LH   + I++RD+K  N+LLD    
Sbjct: 281 --------------AGFPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGH 324

Query: 234 AHISDFGLARRI---DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
             ISD GLA  +    T    V     GT+GYM PE +      T   D ++ G L+ E
Sbjct: 325 IRISDLGLAVHVPEGQTIKGRV-----GTVGYMAPEVVKN-ERYTFSPDWWALGCLLYE 377

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 51/256 (19%), Positives = 91/256 (35%), Gaps = 31/256 (12%)

Query: 42  AVNRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKA 101
           + +    +    +   +     +   +       E       +    ++G G FG VY  
Sbjct: 3   SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62

Query: 102 K-LSSGVTVAIKKLDKDAFQGFREFRA------EMETLGKLRHR--NIVKILGYCASGLD 152
             +S  + VAIK ++KD    + E         E+  L K+      ++++L +      
Sbjct: 63  IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122

Query: 153 RVLIYEFVEN-GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHG 211
            VLI E  E    L  ++ +     +                 R      V   + + H 
Sbjct: 123 FVLILERPEPVQDLFDFITERGALQEE--------------LAR-SFFWQVLEAVRHCH- 166

Query: 212 LEKPIIHRDIKSSNVLLDSD-FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG 270
               ++HRDIK  N+L+D +  E  + DFG    +  +         GT  Y PPE++  
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIRY 222

Query: 271 NTAATVMLDVYSFGIL 286
           +        V+S GIL
Sbjct: 223 HRYHGRSAAVWSLGIL 238

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 33/211 (15%)

Query: 85  STDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVK 142
             DK +G+GSF    K     S    A+K + K      ++   E+  L     H NIVK
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVK 70

Query: 143 ILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGV 202
           +       L   L+ E +  G L + +       + + S                I+R +
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY---------------IMRKL 115

Query: 203 ANGLAYLHGLEKPIIHRDIKSSNVLL---DSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
            + ++++H  +  ++HRD+K  N+L    + + E  I DFG AR     +  + T    T
Sbjct: 116 VSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FT 172

Query: 260 MGYMPPEYLGGN---TAATVMLDVYSFGILM 287
           + Y  PE L  N    +     D++S G+++
Sbjct: 173 LHYAAPELLNQNGYDESC----DLWSLGVIL 199

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 22/221 (9%)

Query: 70  SQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQ--GFREFR 126
           S  S ++      N+   K IG G+F  V  A+ + +G  VAIK +DK        ++  
Sbjct: 3   SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF 62

Query: 127 AEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNS 186
            E+  +  L H NIVK+     +     LI E+   G +  +L    R            
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR------------ 110

Query: 187 LCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID 246
              +  +      R + + + Y H  +K I+HRD+K+ N+LLD+D    I+DFG +    
Sbjct: 111 ---MKEKEARSKFRQIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165

Query: 247 TSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
                +     G   Y  PE   G       +DV+S G+++
Sbjct: 166 VGG-KLDAFC-GAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 92.6 bits (230), Expect = 7e-21
 Identities = 61/266 (22%), Positives = 98/266 (36%), Gaps = 66/266 (24%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKL 135
            D +    +IG GS+G V +A        VAIKK+    F+      R  R E+  L +L
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKRILR-EIAILNRL 109

Query: 136 RHRNIVKIL----GYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL 190
            H ++VK+L           D + ++ E  +    D               K   +   L
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SD--FK-----------KLFRTPVYL 153

Query: 191 SWETRVK-----IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
           + E  +K     ++ G    + Y+H     I+HRD+K +N L++ D    + DFGLAR +
Sbjct: 154 T-ELHIKTLLYNLLVG----VKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206

Query: 246 DTSHSHVSTQVAGTMG--------------------------YMPPEYLGGNTAATVMLD 279
           D   +  S                                  Y  PE +      T  +D
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAID 266

Query: 280 VYSFGILMIEIATQIRPNLPVVLDGQ 305
           V+S G +  E+   I+ N+    D  
Sbjct: 267 VWSIGCIFAELLNMIKENVAYHADRG 292

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 92.9 bits (231), Expect = 9e-21
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 23/214 (10%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRH 137
           D F   +++G G FG V+  ++ ++G   A KKL+K      +G++    E + L K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           R IV  L Y       + L+   +  G +   +++   ++                E R 
Sbjct: 245 RFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-----------FQ-EPRA 291

Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
                 + +GL +LH  ++ II+RD+K  NVLLD D    ISD GLA  +    +     
Sbjct: 292 IFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY 349

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
             GT G+M PE L G       +D ++ G+ + E
Sbjct: 350 A-GTPGFMAPELLLG-EEYDFSVDYFALGVTLYE 381

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 58/221 (26%), Positives = 89/221 (40%), Gaps = 36/221 (16%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKL 135
              +   K IG G+ G V  A        VAIKKL    FQ      R +R E+  +  +
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYR-ELVLMKCV 81

Query: 136 RHRNIVKILGYCASGLDRV------LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP 189
            H+NI+ +L                ++ E ++    +  L    +               
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA---N--LCQVIQM-------------E 123

Query: 190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSH 249
           L  E    ++  +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   T  
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 179

Query: 250 SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
           S + T    T  Y  PE +         +D++S G +M E+
Sbjct: 180 SFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEM 219

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 65/244 (26%), Positives = 108/244 (44%), Gaps = 55/244 (22%)

Query: 74  MSELID--ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF----REFR 126
           M + I    + +F    ++G+G++G V  A    +G  VAIKK++   F       R  R
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PFDKPLFALRTLR 58

Query: 127 AEMETLGKLRHRNIVKILG-YCASGLDRV----LIYEFVENGSLDQWLHDTSRNDDVDGS 181
            E++ L   +H NI+ I         +      +I E ++    D  LH           
Sbjct: 59  -EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT---D--LH----------- 101

Query: 182 KQLNSLCPLSWETRVK-----IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI 236
            ++ S   LS +  ++      +R     +  LHG    +IHRD+K SN+L++S+ +  +
Sbjct: 102 -RVISTQMLS-DDHIQYFIYQTLRA----VKVLHGSN--VIHRDLKPSNLLINSNCDLKV 153

Query: 237 SDFGLARRIDTSHSHVSTQ----------VAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
            DFGLAR ID S +  S            VA T  Y  PE +  +   +  +DV+S G +
Sbjct: 154 CDFGLARIIDESAADNSEPTGQQSGMVEFVA-TRWYRAPEVMLTSAKYSRAMDVWSCGCI 212

Query: 287 MIEI 290
           + E+
Sbjct: 213 LAEL 216

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 89.3 bits (222), Expect = 2e-20
 Identities = 48/228 (21%), Positives = 83/228 (36%), Gaps = 53/228 (23%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA------EMETLGK 134
             +    ++G G FG V+    L+  + VAIK + ++   G+           E+  L K
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 135 LR----HRNIVKILGYCASGLDRVLIYEF-----------VENGSLDQWLHDTSRNDDVD 179
           +     H  ++++L +  +    +L+ E             E G L +     SR     
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE---GPSR----- 142

Query: 180 GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-FEAHISD 238
                                 V   + + H   + ++HRDIK  N+L+D     A + D
Sbjct: 143 -----------------CFFGQVVAAIQHCH--SRGVVHRDIKDENILIDLRRGCAKLID 183

Query: 239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
           FG    +            GT  Y PPE++  +    +   V+S GIL
Sbjct: 184 FGSGALLHDEPYTDF---DGTRVYSPPEWISRHQYHALPATVWSLGIL 228

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 35/219 (15%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREF---RAEMETLGKLRH 137
           ++F   KI+G+GSF  V  A+  ++    AIK L+K       +      E + + +L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
              VK L +     +++     + +NG L +++      D                ET  
Sbjct: 90  PFFVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD----------------ETCT 132

Query: 197 K-----IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
           +     IV      L YLHG    IIHRD+K  N+LL+ D    I+DFG A+ +      
Sbjct: 133 RFYTAEIVSA----LEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186

Query: 252 VSTQ-VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
                  GT  Y+ PE L    +A    D+++ G ++ +
Sbjct: 187 ARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQ 224

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 90.2 bits (224), Expect = 5e-20
 Identities = 51/210 (24%), Positives = 82/210 (39%), Gaps = 40/210 (19%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKL 135
            DN+    +IG GS+G+VY A   ++   VAIKK++   F+      R  R E+  L +L
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILR-EITILNRL 82

Query: 136 RHRNIVKILG-YCASGLDRV----LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL 190
           +   I+++        L +     ++ E       D  L            K   +   L
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEI-----ADSDLK-----------KLFKTPIFL 126

Query: 191 SWETRVK-----IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
           + E  +K     ++ G      ++H     IIHRD+K +N LL+ D    + DFGLAR I
Sbjct: 127 T-EEHIKTILYNLLLG----ENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179

Query: 246 DTSHSHVSTQVAGTMGYMPPEYLGGNTAAT 275
           ++                 P         T
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLT 209

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 87.7 bits (218), Expect = 9e-20
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 33/226 (14%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKL 135
              +   K +G G  G V+ A        VAIKK+               R E++ + +L
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI---VLTDPQSVKHALR-EIKIIRRL 65

Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRND--------DVDGSKQLNSL 187
            H NIVK+            I     +   D     T  N         + D +  L   
Sbjct: 66  DHDNIVKVFE----------ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG 115

Query: 188 CPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-DFEAHISDFGLARRID 246
            PL  E     +  +  GL Y+H     ++HRD+K +N+ +++ D    I DFGLAR +D
Sbjct: 116 -PLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 247 TSHSHVS--TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
             +SH    ++   T  Y  P  L      T  +D+++ G +  E+
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 88.2 bits (219), Expect = 1e-19
 Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 36/221 (16%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKL 135
            + +     +G G++G V  A    +G+ VA+KKL    FQ      R +R E+  L  +
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYR-ELRLLKHM 85

Query: 136 RHRNIVKIL------GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCP 189
           +H N++ +L             D  L+   +     D  L++  +               
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---D--LNNIVKCQ------------K 128

Query: 190 LSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSH 249
           L+ +    ++  +  GL Y+H  +  IIHRD+K SN+ ++ D E  I DFGLAR      
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185

Query: 250 SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI 290
               T    T  Y  PE +         +D++S G +M E+
Sbjct: 186 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 57/225 (25%), Positives = 89/225 (39%), Gaps = 29/225 (12%)

Query: 67  PSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREF 125
           P  +      ++  +D +   K IG G+FG     +   +   VA+K +++ A       
Sbjct: 5   PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ 64

Query: 126 RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSK--- 182
           R E+     LRH NIV+      +     +I E+   G L + + +  R  + +      
Sbjct: 65  R-EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ 123

Query: 183 QLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH--ISDFG 240
           QL S                  G++Y H     I HRD+K  N LLD        I DFG
Sbjct: 124 QLLS------------------GVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFG 163

Query: 241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGI 285
            + +    HS   + V GT  Y+ PE L        + DV+S G+
Sbjct: 164 YS-KSSVLHSQPKSTV-GTPAYIAPEVLLRQEYDGKIADVWSCGV 206

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 47/208 (22%), Positives = 89/208 (42%), Gaps = 27/208 (12%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRA----EMETLGKLRHRNIVK 142
            ++G+GS+G V +     +    A+K L K   +      A    E++ L +LRH+N+++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 143 ILG--YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           ++   Y        ++ E+   G  +  + D+         K+         +       
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPE------KRFPV-----CQAH-GYFC 116

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID--TSHSHVSTQVAG 258
            + +GL YLH   + I+H+DIK  N+LL +     IS  G+A  +    +     T   G
Sbjct: 117 QLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQG 173

Query: 259 TMGYMPPEYLGGNTA-ATVMLDVYSFGI 285
           +  + PPE   G    +   +D++S G+
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGV 201

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 85.3 bits (212), Expect = 4e-19
 Identities = 56/202 (27%), Positives = 83/202 (41%), Gaps = 22/202 (10%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRNIVKILG 145
           + +G+G++G V  A    +   VA+K +D        E  + E+     L H N+VK  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
           +   G  + L  E+   G L   +                    +      +    +  G
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIG---------------MPEPDAQRFFHQLMAG 117

Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA--RRIDTSHSHVSTQVAGTMGYM 263
           + YLHG    I HRDIK  N+LLD      ISDFGLA   R +     ++    GT+ Y+
Sbjct: 118 VVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYV 174

Query: 264 PPEYLGGNTAATVMLDVYSFGI 285
            PE L         +DV+S GI
Sbjct: 175 APELLKRREFHAEPVDVWSCGI 196

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 32/223 (14%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFRE---FRAEMETLGKLRH 137
           ++F   K+IG G+FG V   KL ++    A+K L+K       E   FR E + L     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           + I   L Y     + + L+ ++   G L   L   S+ +D            L  E   
Sbjct: 134 KWITT-LHYAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDR-----------LP-EEMA 177

Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI--SDFGLARRIDTSHSHVS 253
           +     +   +  +H L    +HRDIK  N+L+D +   HI  +DFG   ++    +  S
Sbjct: 178 RFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQS 233

Query: 254 TQVAGTMGYMPPEYL----GGNTAATVMLDVYSFGILMIEIAT 292
           +   GT  Y+ PE L    GG        D +S G+ M E+  
Sbjct: 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.0 bits (211), Expect = 6e-19
 Identities = 50/210 (23%), Positives = 97/210 (46%), Gaps = 25/210 (11%)

Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKLRH 137
           ++     +G G+FG V   +   +G  VA+K L++   +      +  R E++ L   RH
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRH 70

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            +I+K+    ++  D  ++ E+V  G L  ++    R               +      +
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR---------------VEEMEARR 115

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           + + + + + Y H     ++HRD+K  NVLLD+   A I+DFGL+  + +    + T   
Sbjct: 116 LFQQILSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTS-C 171

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           G+  Y  PE + G   A   +D++S G+++
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 33/219 (15%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFRE---FRAEMETLGKLRH 137
           +++   K+IG G+FG V   +  S+    A+K L K       +   F  E + +     
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
             +V+ L Y       + ++ E++  G L   +     N DV              E   
Sbjct: 129 PWVVQ-LFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVP-------------EKWA 170

Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI--SDFGLARRIDTSHSHVS 253
           +     V   L  +H +    IHRD+K  N+LLD     H+  +DFG   +++       
Sbjct: 171 RFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRC 226

Query: 254 TQVAGTMGYMPPEYL---GGNTAATVMLDVYSFGILMIE 289
               GT  Y+ PE L   GG+       D +S G+ + E
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 53/222 (23%), Positives = 86/222 (38%), Gaps = 34/222 (15%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFRE---FRAEMETLGKLRH 137
           D+F   K+IG G+F  V   K+  +G   A+K ++K       E   FR E + L     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           R I + L +     + + L+ E+   G L   L   S+  +            +      
Sbjct: 121 RWITQ-LHFAFQDENYLYLVMEYYVGGDLLTLL---SKFGER-----------IP-AEMA 164

Query: 197 KI-VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI--SDFGLARRIDTSHSHVS 253
           +  +  +   +  +H L    +HRDIK  N+LLD     HI  +DFG   ++    +  S
Sbjct: 165 RFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRS 220

Query: 254 TQVAGTMGYMPPEYLGGNTAA------TVMLDVYSFGILMIE 289
               GT  Y+ PE L                D ++ G+   E
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 56/203 (27%), Positives = 83/203 (40%), Gaps = 24/203 (11%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE--FRAEMETLGKLRHRNIVKIL 144
           + +G+G++G V  A    +   VA+K +D        E   + E+     L H N+VK  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFY 71

Query: 145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVAN 204
           G+   G  + L  E+   G L   +                    +      +    +  
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIG---------------MPEPDAQRFFHQLMA 116

Query: 205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR--RIDTSHSHVSTQVAGTMGY 262
           G+ YLHG    I HRDIK  N+LLD      ISDFGLA   R +     ++    GT+ Y
Sbjct: 117 GVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPY 173

Query: 263 MPPEYLGGNTAATVMLDVYSFGI 285
           + PE L         +DV+S GI
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGI 196

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 82.8 bits (205), Expect = 6e-18
 Identities = 47/215 (21%), Positives = 82/215 (38%), Gaps = 41/215 (19%)

Query: 86  TDKIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKI 143
           + +++G G  G V +     +G   A+K L         + R E++   +     +IV I
Sbjct: 33  SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCI 87

Query: 144 LGYCASGLDRV----LIYEFVENGSL-DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           L    +         +I E +E G L         R D              +     +I
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGELFS---RIQERGDQ-----------AFTEREAAEI 133

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLL---DSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +R +   + +LH     I HRD+K  N+L    + D    ++DFG A+       +    
Sbjct: 134 MRDIGTAIQFLH--SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQT 188

Query: 256 VAGTMGYMPPEYLGG---NTAATVMLDVYSFGILM 287
              T  Y+ PE LG    + +     D++S G++M
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSC----DMWSLGVIM 219

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 23/209 (11%)

Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREF---RAEMETLGKLRHR 138
           ++     +G G+FG V   K   +G  VA+K L++   +        R E++ L   RH 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           +I+K+    ++  D  ++ E+V  G L  ++    R               L  +   ++
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---------------LDEKESRRL 121

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
            + + +G+ Y H     ++HRD+K  NVLLD+   A I+DFGL+  + +    + T   G
Sbjct: 122 FQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-G 177

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           +  Y  PE + G   A   +D++S G+++
Sbjct: 178 SPNYAAPEVISGRLYAGPEVDIWSSGVIL 206

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 56/280 (20%), Positives = 101/280 (36%), Gaps = 59/280 (21%)

Query: 36  PTYRTRAVNRPQPNRCSDLSSIALFDSASFDPSLSQISMSE------LIDATDNFSTD-- 87
              ++  V  P P       + AL    +  P        +      L    +    D  
Sbjct: 5   SQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYK 64

Query: 88  ---KIIGDGSFGFVYKA-KLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVK 142
              +++G G  G V +     +    A+K L         + R E+E   +  +  +IV+
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVR 119

Query: 143 ILGYC---ASGLDRV-LIYEFVENGSL-DQWLHDTSRNDDV----DGSKQLNSLCPLSWE 193
           I+       +G   + ++ E ++ G L         R D      + S+           
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFS---RIQDRGDQAFTEREASE----------- 165

Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH---ISDFGLARRIDTSHS 250
               I++ +   + YLH     I HRD+K  N+L  S        ++DFG A+   + +S
Sbjct: 166 ----IMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219

Query: 251 HVSTQVAGTMGYMPPEYLGG---NTAATVMLDVYSFGILM 287
              T    T  Y+ PE LG    + +     D++S G++M
Sbjct: 220 L--TTPCYTPYYVAPEVLGPEKYDKSC----DMWSLGVIM 253

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 48/221 (21%), Positives = 90/221 (40%), Gaps = 30/221 (13%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HR 138
            D++   + +G G +  V++A  +++   V +K L     +  +  R E++ L  LR   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--KIKR-EIKILENLRGGP 91

Query: 139 NIVKILGYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           NI+ +       + R   L++E V N    Q     +  D      ++  L         
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI--LK-------- 141

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-EAHISDFGLARRIDTSHSHVSTQ 255
                    L Y H     I+HRD+K  NV++D +  +  + D+GLA        + + +
Sbjct: 142 --------ALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVR 190

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           VA +  +  PE L         LD++S G ++  +  +  P
Sbjct: 191 VA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 80.9 bits (200), Expect = 5e-17
 Identities = 63/243 (25%), Positives = 103/243 (42%), Gaps = 59/243 (24%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF----REFRAEMETLGKL 135
              +   K +G G++G V+K+    +G  VA+KK+  DAFQ      R FR E+  L +L
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTDAQRTFR-EIMILTEL 65

Query: 136 R-HRNIVKILG-YCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
             H NIV +L    A     V L+++++E    D  LH   R +             L  
Sbjct: 66  SGHENIVNLLNVLRADNDRDVYLVFDYMET---D--LHAVIRAN------------ILE- 107

Query: 193 ETRVK-----IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT 247
               +     +++     + YLH     ++HRD+K SN+LL+++    ++DFGL+R    
Sbjct: 108 PVHKQYVVYQLIKV----IKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161

Query: 248 SHSHVSTQVAGTMG--------------------YMPPEYLGGNTAATVMLDVYSFGILM 287
                +                            Y  PE L G+T  T  +D++S G ++
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221

Query: 288 IEI 290
            EI
Sbjct: 222 GEI 224

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 61/258 (23%), Positives = 101/258 (39%), Gaps = 35/258 (13%)

Query: 44  NRPQPNRCSDLSSIALFDSASFDPSLSQISMSELIDAT-DNFSTDKIIGDGSFGFVYKAK 102
           N     + S+  S+  F + + +  L +        A  D F   K +G GSFG V   K
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61

Query: 103 L-SSGVTVAIKKLDKDAFQGFREF---RAEMETLGKLRHRNIVKILGYCASGLDRVLIYE 158
              SG   A+K LDK      ++      E   L  +    +VK+        +  ++ E
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121

Query: 159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG-VANGLAYLHGLEKPII 217
           +V  G +   L    R                  E   +     +     YLH L+  +I
Sbjct: 122 YVAGGEMFSHLRRIGRFS----------------EPHARFYAAQIVLTFEYLHSLD--LI 163

Query: 218 HRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYL---GGNTAA 274
           +RD+K  N+L+D      ++DFG A+R+       +  + GT   + PE +   G N A 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYNKAV 219

Query: 275 TVMLDVYSFGILMIEIAT 292
               D ++ G+L+ E+A 
Sbjct: 220 ----DWWALGVLIYEMAA 233

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 80.5 bits (199), Expect = 7e-17
 Identities = 58/221 (26%), Positives = 87/221 (39%), Gaps = 26/221 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREF---RAEMETLGKLRH 137
           + F   K++G G+FG V   K  ++G   A+K L K+      E      E   L   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
             +   L Y     DR+  + E+   G L   L                       E R 
Sbjct: 208 PFLTA-LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS----------------EDRA 250

Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     + + L YLH  EK +++RD+K  N++LD D    I+DFGL +            
Sbjct: 251 RFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKT 308

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             GT  Y+ PE L  N      +D +  G++M E+     P
Sbjct: 309 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLP 348

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 78.2 bits (193), Expect = 1e-16
 Identities = 22/211 (10%), Positives = 54/211 (25%), Gaps = 52/211 (24%)

Query: 90  IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF--QGFRE-FRAEMETLGKLRHRNIVKILG 145
            G       ++A   +    VA+  +D          +   +    L ++    + ++L 
Sbjct: 39  HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98

Query: 146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
              +    +++ E++  GSL +                       S    ++ ++ +A  
Sbjct: 99  VVHTRAGGLVVAEWIRGGSLQEVADT-----------------SPSPVGAIRAMQSLAAA 141

Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPP 265
               H     +       S V +  D +  ++                         MP 
Sbjct: 142 ADAAH--RAGVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPD 178

Query: 266 EYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
                        D+   G  +  +     P
Sbjct: 179 A-----NPQD---DIRGIGASLYALLVNRWP 201

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)

Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQ----GFREFRAEMETLGKLRH 137
            +   + +G+GSFG V  A    +   VA+K + +   +      R  R E+  L  LRH
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRH 68

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            +I+K+     +  D V++ E+   G L  ++ +  R               ++ +   +
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR---------------MTEDEGRR 112

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
             + +   + Y H     I+HRD+K  N+LLD +    I+DFGL+  I T  + + T   
Sbjct: 113 FFQQIICAIEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTS-C 168

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILM 287
           G+  Y  PE + G   A   +DV+S GI++
Sbjct: 169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVL 198

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 74.9 bits (185), Expect = 3e-15
 Identities = 70/240 (29%), Positives = 103/240 (42%), Gaps = 39/240 (16%)

Query: 66  DPSLSQISMSELIDAT------DNFSTDKIIGDGSFGFVYKAKLSSGVTV----AIKKLD 115
           + S+ +I+++  +           F   K++G GSFG V+  K  SG       A+K L 
Sbjct: 2   EGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK 61

Query: 116 KDAFQGFREFRAEME--TLGKLRHRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDT 172
           K   +     R +ME   L ++ H  IVK L Y      ++ LI +F+  G L   L   
Sbjct: 62  KATLKVRDRVRTKMERDILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKE 120

Query: 173 SRNDDVDGSKQLNSLCPLSWETRVKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSD 231
                               E  VK     +A  L +LH     II+RD+K  N+LLD +
Sbjct: 121 VMFT----------------EEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEE 162

Query: 232 FEAHI--SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
              HI  +DFGL++     H   +    GT+ YM PE +      T   D +SFG+LM E
Sbjct: 163 --GHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFE 218

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 27/214 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREF---RAEMETLGKLRH 137
           ++F   K++G G+FG V   +  ++G   A+K L K+      E      E   L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
             +   L Y     DR+  + E+   G L   L                       E R 
Sbjct: 65  PFLTA-LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT----------------EERA 107

Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     + + L YLH   + +++RDIK  N++LD D    I+DFGL +    S       
Sbjct: 108 RFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKT 164

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
             GT  Y+ PE L  N      +D +  G++M E
Sbjct: 165 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYE 197

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 73.3 bits (181), Expect = 8e-15
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 42/220 (19%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREF---RAEMETLGKLRH 137
            +F   + +G GSFG V+  +   +G   A+K L K+     ++      E   L  + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 138 RNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
             I++ +        ++ +I +++E G L   L  + R                      
Sbjct: 66  PFIIR-MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP----------------NPVA 108

Query: 197 KIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI--SDFGLARRI-DTSHSHV 252
           K     V   L YLH  +  II+RD+K  N+LLD +   HI  +DFG A+ + D +++  
Sbjct: 109 KFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN--GHIKITDFGFAKYVPDVTYT-- 162

Query: 253 STQVAGTMGYMPPEYL---GGNTAATVMLDVYSFGILMIE 289
              + GT  Y+ PE +     N +     D +SFGIL+ E
Sbjct: 163 ---LCGTPDYIAPEVVSTKPYNKSI----DWWSFGILIYE 195

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 28/222 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREF---RAEMETLGK-LR 136
            +F+   ++G GSFG V  ++   +    A+K L KD      +      E   L    +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 137 HRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
              + + L  C   +DR+  + E+V  G L   +    R                  E  
Sbjct: 401 PPFLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----------------EPH 443

Query: 196 VKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
                  +A GL +L    K II+RD+K  NV+LDS+    I+DFG+ +  +      + 
Sbjct: 444 AVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTK 500

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
              GT  Y+ PE +         +D ++FG+L+ E+     P
Sbjct: 501 TFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAP 541

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 35/222 (15%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTV----AIKKLDKDAFQGFREF----RAEMETLG 133
           +NF   K++G G++G V+  +  SG       A+K L K       +     R E + L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 134 KLRHRN-IVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
            +R    +V  L Y      ++ LI +++  G L   L    R                 
Sbjct: 114 HIRQSPFLVT-LHYAFQTETKLHLILDYINGGELFTHLSQRERFT--------------- 157

Query: 192 WETRVKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI--SDFGLARRIDTS 248
            E  V+I  G +   L +LH  +  II+RDIK  N+LLDS+   H+  +DFGL++     
Sbjct: 158 -EHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVAD 212

Query: 249 HSHVSTQVAGTMGYMPPEYLGGNTAA-TVMLDVYSFGILMIE 289
            +  +    GT+ YM P+ + G  +     +D +S G+LM E
Sbjct: 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 71.8 bits (175), Expect = 3e-14
 Identities = 35/216 (16%), Positives = 62/216 (28%), Gaps = 34/216 (15%)

Query: 72  ISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKL--------DKDAFQGFR 123
           +  S  +  T+     + IG+G FG V++        VAIK +        +    + F 
Sbjct: 11  VPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFE 68

Query: 124 EFRAEMETLGKL---------RHRNIVKIL------GYCASGLDRVLIYEFVENGSLDQW 168
           E   E+    +L         R    + +       G     L +   +     GS +  
Sbjct: 69  EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128

Query: 169 LHDTSRNDD------VDGSKQLNSLC--PLSWETRVKIVRGVANGLAYLHGLEKPIIHRD 220
                 +          G   L  +     S  T   I+  +   LA      +   HRD
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR-FEHRD 187

Query: 221 IKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
           +   NVLL       +      +        +   +
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 32/217 (14%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREF---RAEMETLGK-LR 136
            +F   K+IG GSFG V  A+  +  V  A+K L K A    +E     +E   L K ++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 137 HRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           H  +V  L +     D++  + +++  G L   L                       E R
Sbjct: 98  HPFLVG-LHFSFQTADKLYFVLDYINGGELFYHLQRERCFL----------------EPR 140

Query: 196 VKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI--SDFGLARRIDTSHSHV 252
            +     +A+ L YLH     I++RD+K  N+LLDS    HI  +DFGL +  +  H+  
Sbjct: 141 ARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKE-NIEHNST 195

Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
           ++   GT  Y+ PE L         +D +  G ++ E
Sbjct: 196 TSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYE 231

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 70.6 bits (174), Expect = 7e-14
 Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 35/220 (15%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTV----AIKKLDKDA-FQGFREF---RAEMETLG 133
           + F   +++G G +G V++ +  +G       A+K L K    +  ++    +AE   L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 134 KLRHRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           +++H  IV  L Y      ++ LI E++  G L   L                       
Sbjct: 77  EVKHPFIVD-LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM---------------- 119

Query: 193 ETRVKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI--SDFGLARRIDTSH 249
           E         ++  L +LH  +K II+RD+K  N++L+     H+  +DFGL  +     
Sbjct: 120 EDTACFYLAEISMALGHLH--QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLC-KESIHD 174

Query: 250 SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
             V+    GT+ YM PE L  +      +D +S G LM +
Sbjct: 175 GTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYD 213

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.4 bits (168), Expect = 6e-13
 Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 28/215 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREF---RAEMETLGK-LR 136
            +F   ++IG GS+  V   +L  +    A+K + K+      +    + E     +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 137 HRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           H  +V  L  C     R+  + E+V  G L   +    +                  E  
Sbjct: 69  HPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----------------EEH 111

Query: 196 VKI-VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
            +     ++  L YLH  E+ II+RD+K  NVLLDS+    ++D+G+ +         ++
Sbjct: 112 ARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTS 168

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
              GT  Y+ PE L G       +D ++ G+LM E
Sbjct: 169 TFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFE 202

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 67.3 bits (165), Expect = 8e-13
 Identities = 37/183 (20%), Positives = 69/183 (37%), Gaps = 31/183 (16%)

Query: 70  SQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAE 128
           S + + +     D   T +++G G  G V +     +    A+K L         + R E
Sbjct: 6   SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARRE 60

Query: 129 METLGKL-RHRNIVKILGYCASGLDRV----LIYEFVENGSL-DQWLHDTSRNDDVDGSK 182
           +E   +  +  +IV+I+    +         ++ E ++ G L  +      R D      
Sbjct: 61  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQ----- 112

Query: 183 QLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH---ISDF 239
                   +     +I++ +   + YLH     I HRD+K  N+L  S        ++DF
Sbjct: 113 ------AFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDF 164

Query: 240 GLA 242
           G A
Sbjct: 165 GFA 167

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 67.6 bits (166), Expect = 8e-13
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 28/215 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREF---RAEMETLGK-LR 136
            +F+   ++G GSFG V  ++   +    A+K L KD      +      E   L    +
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 137 HRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
              + + L  C   +DR+  + E+V  G L   +    R                  E  
Sbjct: 80  PPFLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----------------EPH 122

Query: 196 VKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
                  +A GL +L    K II+RD+K  NV+LDS+    I+DFG+ +  +      + 
Sbjct: 123 AVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTK 179

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
              GT  Y+ PE +         +D ++FG+L+ E
Sbjct: 180 TFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYE 213

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 67.2 bits (165), Expect = 1e-12
 Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 32/217 (14%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREF---RAEMETLGK-LR 136
           ++F   K++G GSFG V+ A+   +    AIK L KD      +      E   L     
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 137 HRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           H  +   +       + +  + E++  G L   +    + D                 +R
Sbjct: 77  HPFLTH-MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD----------------LSR 119

Query: 196 VKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI--SDFGLARRIDTSHSHV 252
                  +  GL +LH   K I++RD+K  N+LLD   + HI  +DFG+ +  +      
Sbjct: 120 ATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDK--DGHIKIADFGMCKE-NMLGDAK 174

Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
           +    GT  Y+ PE L G       +D +SFG+L+ E
Sbjct: 175 TNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYE 210

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 28/215 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREF---RAEMETLGK-LR 136
            +F   ++IG GS+  V   +L  +    A++ + K+      +    + E     +   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 137 HRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           H  +V  L  C     R+  + E+V  G L   +    +                  E  
Sbjct: 112 HPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----------------EEH 154

Query: 196 VKI-VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
            +     ++  L YLH  E+ II+RD+K  NVLLDS+    ++D+G+ +         ++
Sbjct: 155 ARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTS 211

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
              GT  Y+ PE L G       +D ++ G+LM E
Sbjct: 212 TFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFE 245

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 28/215 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREF---RAEMETLGK-LR 136
           DNF   +++G GSFG V  A++  +G   A+K L KD      +      E   L     
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 137 HRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
           H  + + L  C    DR+  + EFV  G L   +  + R D                E R
Sbjct: 83  HPFLTQ-LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----------------EAR 125

Query: 196 VKIVRG-VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
            +     + + L +LH  +K II+RD+K  NVLLD +    ++DFG+ +     +   + 
Sbjct: 126 ARFYAAEIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTTA 182

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIE 289
              GT  Y+ PE L         +D ++ G+L+ E
Sbjct: 183 TFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYE 216

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 65.1 bits (159), Expect = 6e-12
 Identities = 53/206 (25%), Positives = 81/206 (39%), Gaps = 37/206 (17%)

Query: 73  SMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIK--KLDKDAFQGFREFRAEM 129
           SM  L+    NF   K IG G+FG +   K L +   VAIK   +   A Q   E+R   
Sbjct: 1   SMGVLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYK 59

Query: 130 ETLGKLRHRNIVKILGYCASGLDRVLIYEFVENG-SLDQWLHDTSRNDDVDGSKQLNSLC 188
           +         I ++  +   G    ++ E +  G SL+       R              
Sbjct: 60  QLGSG---DGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRT------------- 101

Query: 189 PLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-----HISDFGLAR 243
             S +T + I   + + + Y+H   K +I+RD+K  N L+           HI DF LA+
Sbjct: 102 -FSLKTVLMIAIQLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

Query: 244 R-ID-TSHSHV----STQVAGTMGYM 263
             ID  +  H+       + GT  YM
Sbjct: 159 EYIDPETKKHIPYREHKSLTGTARYM 184

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 70/311 (22%), Positives = 118/311 (37%), Gaps = 62/311 (19%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHR 138
           + +   + IG GSFG +Y    +++G  VAIK   +     Q   E +   + +      
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGGVG- 66

Query: 139 NIVKILGYCASGLDRVLIYEFVENG-SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            I  I    A G   V++ E +  G SL+   +  SR                S +T + 
Sbjct: 67  -IPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRK--------------FSLKTVLL 109

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLL---DSDFEAHISDFGLARR-ID-TSHSHV 252
           +   + + + Y+H   K  IHRD+K  N L+         +I DFGLA++  D  +H H+
Sbjct: 110 LADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167

Query: 253 ----STQVAGTMGYMPPEYLGGNTAATVML----DVYSFGILMIEIATQIRPNLPVVLDG 304
               +  + GT  Y        NT   +      D+ S G +++        +LP     
Sbjct: 168 PYRENKNLTGTARYASI-----NTHLGIEQSRRDDLESLGYVLMYF---NLGSLP----- 214

Query: 305 QEVGLLEW----ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
                  W    A T   + + I     +   E L +    E+      C + +  ++P 
Sbjct: 215 -------WQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 267

Query: 361 MSYVVQLLDEL 371
            SY+ QL   L
Sbjct: 268 YSYLRQLFRNL 278

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 61.7 bits (150), Expect = 8e-11
 Identities = 32/194 (16%), Positives = 67/194 (34%), Gaps = 42/194 (21%)

Query: 83  NFSTDKIIGDGSFGFVYKAK---------LSSGVTVAIKKLDKDAFQGFREFR------- 126
            +         + G +Y+A                 ++K LD    + F E         
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101

Query: 127 ----AEMETLGKLRHRNIVKILGYCASGLD-RVLIYEFVENG-SLDQWLHDTSRNDDVDG 180
                + + L       I   +G+       R L+   +  G SL   L  + ++     
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKH----- 154

Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA--HISD 238
                    LS  + +++   + + L +LH  E   +H ++ + N+ +D + ++   ++ 
Sbjct: 155 --------VLSERSVLQVACRLLDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAG 204

Query: 239 FGLARRIDTSHSHV 252
           +G A R   S  HV
Sbjct: 205 YGFAFRYCPSGKHV 218

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 61.2 bits (149), Expect = 9e-11
 Identities = 65/313 (20%), Positives = 113/313 (36%), Gaps = 64/313 (20%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHR 138
            ++   + IG+GSFG +++   L +   VAIK      DA Q   E+R      G     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66

Query: 139 NIVKILGYCASGLDRVLIYEFVENG-SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            I  +  +   GL  VL+ + +  G SL+  L    R                S +T   
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRK--------------FSVKTVAM 110

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA-----HISDFGLARR-ID-TSHS 250
             + +   +  +H  EK +++RDIK  N L+           ++ DFG+ +   D  +  
Sbjct: 111 AAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 168

Query: 251 HV----STQVAGTMGYMPPEYLGGNTAATVML----DVYSFGILMIEIATQIRPNLPVVL 302
           H+       ++GT  YM       NT          D+ + G + +     +R +LP   
Sbjct: 169 HIPYREKKNLSGTARYMSI-----NTHLGREQSRRDDLEALGHVFMYF---LRGSLP--- 217

Query: 303 DGQEVGLLEW----ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRER 358
                    W    A T + + + I     +    EL      E+++      N      
Sbjct: 218 ---------WQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 268

Query: 359 PAMSYVVQLLDEL 371
           P   Y+  L  ++
Sbjct: 269 PDYDYLQGLFSKV 281

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 73/311 (23%), Positives = 122/311 (39%), Gaps = 62/311 (19%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIK--KLDKDAFQGFREFRAEMETLGKLRHR 138
           + F   + IG GSFG +Y    + +   VAIK   +     Q   E +     L      
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI-YRILQGGTG- 64

Query: 139 NIVKILGYCASGLDRVLIYEFVENG-SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            I  +  +   G   VL+ + +  G SL+   +  SR               LS +T + 
Sbjct: 65  -IPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR--------------KLSLKTVLM 107

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH---ISDFGLARR-IDT-SHSHV 252
           +   + N + ++H   K  +HRDIK  N L+     A+   I DFGLA++  DT +H H+
Sbjct: 108 LADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165

Query: 253 ----STQVAGTMGYMPPEYLGGNTAATVML----DVYSFGILMIEIATQIRPNLPVVLDG 304
               +  + GT  Y        NT   +      D+ S G +++     +R +LP     
Sbjct: 166 PYRENKNLTGTARYASV-----NTHLGIEQSRRDDLESLGYVLMYF---LRGSLP----- 212

Query: 305 QEVGLLEW----ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA 360
                  W    A T + + ++I       S E L      E+      C + +  ++P 
Sbjct: 213 -------WQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPD 265

Query: 361 MSYVVQLLDEL 371
            SY+ +L  +L
Sbjct: 266 YSYLKRLFRDL 276

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 59.0 bits (143), Expect = 6e-10
 Identities = 33/189 (17%), Positives = 64/189 (33%), Gaps = 35/189 (18%)

Query: 83  NFSTDKIIGDGSFGFVYKAK-LSSGVTVAIK--KLD-KDAFQGFREFRAEMETLGKLRHR 138
            +   K IG G FG +Y A   +     A    K++ ++    F E +       K   +
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLD-------------QWLHDTSRNDDVDGSKQLN 185
             ++       G+         E                  Q +   +            
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT---------- 147

Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE--AHISDFGLAR 243
                   T +++   + + L Y+H  E   +H DIK++N+LL        +++D+GL+ 
Sbjct: 148 ----FKKSTVLQLGIRMLDVLEYIH--ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

Query: 244 RIDTSHSHV 252
           R   + +H 
Sbjct: 202 RYCPNGNHK 210

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 40/194 (20%), Positives = 70/194 (36%), Gaps = 42/194 (21%)

Query: 83  NFSTDKIIGDGSFGFVYKAKLSSG------VTVAIKKLDKDAFQGFREFR---------- 126
            +     IG G FG +Y A ++S           +K    D    F E +          
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 127 -AEMETLGKLRHRNIVKILGYCASGLD----RVLIYEFVENG-SLDQWLHDTSRNDDVDG 180
             +     KL++  + K  G      +    R +I +    G  L +     ++      
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAK------ 147

Query: 181 SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE--AHISD 238
                     S +T +++   + + L Y+H  E   +H DIK+SN+LL+       ++ D
Sbjct: 148 --------RFSRKTVLQLSLRILDILEYIH--EHEYVHGDIKASNLLLNYKNPDQVYLVD 197

Query: 239 FGLARRIDTSHSHV 252
           +GLA R      H 
Sbjct: 198 YGLAYRYCPEGVHK 211

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 51/225 (22%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKL-DKDAFQGFREFRAEMETLGKLRHR------N 139
            +IG GSFG V KA        VAIK + +K AF    + + E+  L  +          
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF--LNQAQIEVRLLELMNKHDTEMKYY 117

Query: 140 IVKILGY-------CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           IV +  +       C       L++E      L   L+D  RN          +   +S 
Sbjct: 118 IVHLKRHFMFRNHLC-------LVFE-----MLSYNLYDLLRN---------TNFRGVSL 156

Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS--DFGLARRIDTSHS 250
               K  + +   L +L   E  IIH D+K  N+LL +   + I   DFG +        
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQ 213

Query: 251 HVSTQVAGTMGYMPPEYLGG---NTAATVMLDVYSFGILMIEIAT 292
            +   +  +  Y  PE L G   + A    +D++S G +++E+ T
Sbjct: 214 RIYQYIQ-SRFYRSPEVLLGMPYDLA----IDMWSLGCILVEMHT 253

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 56.3 bits (136), Expect = 6e-09
 Identities = 56/224 (25%), Positives = 86/224 (38%), Gaps = 49/224 (21%)

Query: 87  DKIIGDGSFGFVYKAK-LSSGVTVAIKKL-DKDAFQGFREFRAEMETLGKLRHR------ 138
            K+IG GSFG V KA        VA+K + ++  F   R+   E+  L  LR +      
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF--HRQAAEEIRILEHLRKQDKDNTM 159

Query: 139 NIVKILGY-------CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
           N++ +L         C       + +E      L   L++  +          N     S
Sbjct: 160 NVIHMLENFTFRNHIC-------MTFE-----LLSMNLYELIKK---------NKFQGFS 198

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS--DFGLARRIDTSH 249
                K    +   L  LH     IIH D+K  N+LL     + I   DFG +      H
Sbjct: 199 LPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EH 253

Query: 250 SHVSTQVAGTMGYMPPE-YLGGNTAATVMLDVYSFGILMIEIAT 292
             V T +  +  Y  PE  LG      + +D++S G ++ E+ T
Sbjct: 254 QRVYTYIQ-SRFYRAPEVILGARY--GMPIDMWSLGCILAELLT 294

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 50/231 (21%), Positives = 89/231 (38%), Gaps = 51/231 (22%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR---------- 136
           + +G G F  V+ AK + +   VA+K + +           E++ L ++           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 137 -HRNIVKILGY----CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
              +I+K+L +      +G+  V+++E      L + L    +               + 
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKK---------YEHRGIP 129

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH------ISDFGLARRI 245
                +I + +  GL Y+H     IIH DIK  NVL++            I+D G A   
Sbjct: 130 LIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188

Query: 246 DTSHS-HVSTQVAGTMGYMPPEYLGG---NTAATVMLDVYSFGILMIEIAT 292
           D  ++  + T+      Y  PE L G      A    D++S   L+ E+ T
Sbjct: 189 DEHYTNSIQTRE-----YRSPEVLLGAPWGCGA----DIWSTACLIFELIT 230

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.8 bits (123), Expect = 2e-07
 Identities = 39/283 (13%), Positives = 85/283 (30%), Gaps = 57/283 (20%)

Query: 99  YKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE 158
            + +L +   V   K +    Q + + R   + L +LR    V I G   SG    +  +
Sbjct: 115 QRDRLYNDNQV-FAKYNVSRLQPYLKLR---QALLELRPAKNVLIDGVLGSG-KTWVALD 169

Query: 159 FVENGSLDQ-------WLHDTSRNDDVDGSKQLNSLC-------------PLSWETRVKI 198
              +  +         WL+  + N      + L  L                + + R+  
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229

Query: 199 VRGVANGL----AYLHGLEKPIIHRDIKSSNVLLDSDFEAHI----SDFGLARRIDTSHS 250
           ++     L     Y + L   ++  +++++      +    I        +   +  + +
Sbjct: 230 IQAELRRLLKSKPYENCL---LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT 286

Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL 310
              +    +M   P E          +L  Y       ++  ++    P  L      ++
Sbjct: 287 THISLDHHSMTLTPDEVKS-------LLLKY-LDCRPQDLPREVLTTNPRRL-----SII 333

Query: 311 -EWARTMEARNKEIEMVDSN-------ISREELSEAGVREYFR 345
            E  R   A     + V+ +        S   L  A  R+ F 
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD 376

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.1 bits (103), Expect = 6e-05
 Identities = 57/412 (13%), Positives = 118/412 (28%), Gaps = 122/412 (29%)

Query: 19  TLIFAIMLLFCKRTYKPPTYRTRA-----------VNRPQPNRC----SDLSSIALFDSA 63
            L++ I   +  R+      + R             ++P  N C     ++ +   +++ 
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN-CLLVLLNVQNAKAWNA- 261

Query: 64  SFDPSLSQISM----SELIDATDNFSTDKI-IGDGSFGFVY---KAKLSSGVTVAIKKLD 115
            F+ S  +I +     ++ D     +T  I +   S        K+ L   +    + L 
Sbjct: 262 -FNLS-CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP 319

Query: 116 KDAFQG-----------FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI---YE--- 158
           ++                R+  A  +    +    +  I+    + L+       ++   
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS 379

Query: 159 -FVEN--------GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL 209
            F  +          +  W      +  V     +N L   S      + +        +
Sbjct: 380 VFPPSAHIPTILLSLI--WFDVIKSDVMVV----VNKLHKYSL-----VEKQPKESTISI 428

Query: 210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG 269
             +     + ++K     L++++  H       R I                Y  P+   
Sbjct: 429 PSI-----YLELKVK---LENEYALH-------RSIVDH-------------YNIPKTFD 460

Query: 270 GNTAATVMLDVYSF--------GILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA--R 319
            +      LD Y +         I   E  T  R    V LD        +   +E   R
Sbjct: 461 SDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR---MVFLD------FRF---LEQKIR 508

Query: 320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           +       S      L +  ++ Y     +C N+   ER     V  +LD L
Sbjct: 509 HDSTAWNASGSILNTLQQ--LKFYKPY--ICDNDPKYER----LVNAILDFL 552

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 35/158 (22%), Positives = 59/158 (37%), Gaps = 39/158 (24%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKL-DKDAFQGFREFRAEMETLGKLRHR-----NI 140
           + +GDG+FG V   + + +    A+K + +   +   R  + E + L K+++      NI
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY--TRSAKIEADILKKIQNDDINNNNI 98

Query: 141 VKILGY-------CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           VK  G        C       LI+E      L   L++             N+      E
Sbjct: 99  VKYHGKFMYYDHMC-------LIFE-----PLGPSLYEIITR---------NNYNGFHIE 137

Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD 231
                   +   L YL  +   + H D+K  N+LLD  
Sbjct: 138 DIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDP 173

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 44/245 (17%), Positives = 81/245 (33%), Gaps = 75/245 (30%)

Query: 88  KIIGDGSFGFVYKA--KLSSGVTVAIKKL-DKDAFQGFREFRAEMETLGKLRHR------ 138
             +G+G+FG V +          VA+K + +   +      R E+  L K++ +      
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY--REAARLEINVLKKIKEKDKENKF 82

Query: 139 NIVKILGY-------CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
             V +  +       C       + +E      L +   +  +          N+  P  
Sbjct: 83  LCVLMSDWFNFHGHMC-------IAFE-----LLGKNTFEFLKE---------NNFQPYP 121

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR------- 244
                 +   + + L +LH  +  + H D+K  N+L  +     + +   +         
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179

Query: 245 ----ID-----TSHSHVSTQVAGTMGYMPPEYLGGNTAATVML--------DVYSFGILM 287
                D       H H +T VA T  Y PPE         V+L        DV+S G ++
Sbjct: 180 SIRVADFGSATFDHEHHTTIVA-TRHYRPPE---------VILELGWAQPCDVWSIGCIL 229

Query: 288 IEIAT 292
            E   
Sbjct: 230 FEYYR 234

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 33/149 (22%), Positives = 46/149 (30%), Gaps = 61/149 (40%)

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL---------------------------- 228
           KI++ V  GL YLH  +  IIH DIK  N+LL                            
Sbjct: 150 KIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208

Query: 229 ---------------------DSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPE- 266
                                    +  I+D G A  +    +        T  Y   E 
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEV 264

Query: 267 YLGG--NTAATVMLDVYSFGILMIEIATQ 293
            +G   NT A    D++S   +  E+AT 
Sbjct: 265 LIGSGYNTPA----DIWSTACMAFELATG 289

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 31/164 (18%), Positives = 60/164 (36%), Gaps = 49/164 (29%)

Query: 88  KIIGDGSFGFVYKAK--LSSGVTVAIKKL-DKDAFQGFREFRAEMETLGKLRHR------ 138
             +G+G+FG V +     + G  VA+K + + D +      R+E++ L  L         
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY--CEAARSEIQVLEHLNTTDPNSTF 77

Query: 139 NIVKILGY-------CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLS 191
             V++L +       C       +++E      L    +D  +          N   P  
Sbjct: 78  RCVQMLEWFEHHGHIC-------IVFE-----LLGLSTYDFIKE---------NGFLPFR 116

Query: 192 WETRVKIVRGVA----NGLAYLHGLEKPIIHRDIKSSNVLLDSD 231
               +  +R +A      + +LH  +  + H D+K  N+L    
Sbjct: 117 ----LDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQS 154

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	373
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.46
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.18
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.02
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.81
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.67
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.67
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.61
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.54
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.45
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.21
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.17
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.08
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.78
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.75
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.72
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.67
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.59
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.55
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.54
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.53
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.5
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.42
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.09
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.09
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.89
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	96.75
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	96.13
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.06
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	95.93
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.73
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	92.36
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	92.35
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.89
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.94
2knc_A	54	Integrin alpha-IIB; transmembrane signaling, prote	90.24
2l8s_A	54	Integrin alpha-1; transmembrane region, detergent	89.74
1iij_A	35	ERBB-2 receptor protein-tyrosine kinase; alpha-hel	89.65
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	87.89
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	85.91
1pi7_A	36	VPU protein, U ORF protein; alpha helix, viral pro	85.81
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.09
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	83.36
2l34_A	33	TYRO protein tyrosine kinase-binding protein; immu	82.8
2k1a_A	42	Integrin alpha-IIB; single-PASS transmembrane segm	81.78

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.9e-60  Score=425.50  Aligned_cols=270  Identities=25%  Similarity=0.425  Sum_probs=206.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ++|.+.+.||+|+||.||+|.+.      ++..||||+++.......+.|.+|+.+|++++|||||+++|+|.++...++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46677889999999999999764      478899999987766667789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |||||++|+|.++++..................+++|.++++++.||+.||+|||  +++|+||||||+|||+++++.+|
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLKp~NILl~~~~~~K  198 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA--GLHFVHRDLATRNCLVGQGLVVK  198 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTTEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHhhEEECCCCcEE
Confidence            9999999999999987654322111111112235999999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          236 ISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |+|||+++....... .......||+.|||||++.+ ..++.++|||||||++|||+| |..||....       ..+..
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~-------~~~~~  270 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLS-------NTEAI  270 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC-------HHHHH
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCC-------HHHHH
Confidence            999999987643322 23345679999999999985 458999999999999999999 888875421       11111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..... +.     ..     ..+..++.++.+++.+||+.||++|||++||++.|+.+.
T Consensus       271 ~~i~~-g~-----~~-----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          271 DCITQ-GR-----EL-----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             HHHHH-TC-----CC-----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHc-CC-----CC-----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence            11111 11     11     114456678999999999999999999999999999874

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.8e-60  Score=420.01  Aligned_cols=268  Identities=24%  Similarity=0.428  Sum_probs=211.1

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ++|.+.+.||+|+||.||+|.+.      ++..||||+++.......+.|.+|+++|++++|||||+++|+|.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46788899999999999999763      477899999987666667789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |||||++|+|.++++........  ........+++|.++++++.||+.||+|||  +++|+||||||+|||+++++.+|
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~--~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVL--MAEGNPPTELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHH--C----CCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEcCCCCcHHHHHHhcCccccc--ccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccCHhhEEECCCCcEE
Confidence            99999999999999865310000  000001124999999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          236 ISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |+|||+|+........ ......||+.|||||++.+ ..++.++|||||||++|||+| |..||....       ..+..
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~-------~~~~~  240 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-------NNEVI  240 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-------HHHHH
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------HHHHH
Confidence            9999999876433222 2334568999999999985 458999999999999999999 888865421       11112


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..... +..          ...+..++.++.+++.+||+.||++|||+++|.+.|+++.
T Consensus       241 ~~i~~-~~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          241 ECITQ-GRV----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHHHH-TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHc-CCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            21211 111          1114456778999999999999999999999999998864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.7e-60  Score=416.30  Aligned_cols=260  Identities=30%  Similarity=0.457  Sum_probs=203.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .+++.+.+.||+|+||+||+|.++  ..||||+++....  ...+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            457788899999999999999875  3699999865332  345679999999999999999999998865 56899999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      ||++|+|.+++.....              +++|.++++++.||+.||+|||  +++|+||||||+|||+++++.+||+|
T Consensus       112 y~~gGsL~~~l~~~~~--------------~l~~~~~~~i~~qia~gL~yLH--~~~IiHRDlKp~NILl~~~~~~Ki~D  175 (307)
T 3omv_A          112 WCEGSSLYKHLHVQET--------------KFQMFQLIDIARQTAQGMDYLH--AKNIIHRDMKSNNIFLHEGLTVKIGD  175 (307)
T ss_dssp             CCSSCBHHHHHHTSCC--------------CCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCSSSEEEETTEEEEECC
T ss_pred             cCCCCCHHHHHhhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCccCCccCHHHEEECCCCcEEEee
Confidence            9999999999976543              3999999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCC-CcccccccccccccCccccCC--CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          239 FGLARRIDTSH-SHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       239 fg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      ||+|+...... ........||+.|||||++.+  ...++.++|||||||++|||+||..||......       .....
T Consensus       176 FGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------~~~~~  248 (307)
T 3omv_A          176 FGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------DQIIF  248 (307)
T ss_dssp             CSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHH
T ss_pred             ccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------HHHHH
Confidence            99998754322 223345689999999999864  335899999999999999999999997532110       11111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ....+.    ..+.+  ...+.+++..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       249 ~~~~~~----~~p~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          249 MVGRGY----ASPDL--SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             HHHTTC----CCCCS--TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             HHhcCC----CCCCc--ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            111110    01111  1124456778999999999999999999999999998763

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.8e-60  Score=417.34  Aligned_cols=268  Identities=23%  Similarity=0.351  Sum_probs=209.2

Q ss_pred             CCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ++++.+.||+|+||.||+|.+.      +++.||||+++.... ...+.|.+|+.++++++|||||+++|+|.++...++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4566789999999999999762      468899999965433 335789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcc-cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGS-KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      |||||++|+|.++|............ ........++|.++++++.||+.||+|||  +++|+||||||+|||+++++.+
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS--SHHVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCE
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCccccceEECCCCCE
Confidence            99999999999999765432211100 00011234999999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCC-CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHH
Q 043074          235 HISDFGLARRIDTSH-SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  312 (373)
                      ||+|||+++...... ........||+.|||||++.+ ..++.++|||||||++|||+| |..||....       ..+.
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-------~~~~  256 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-------NQDV  256 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-------HHHH
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCC-------HHHH
Confidence            999999998764322 223345679999999999975 458999999999999999999 778864321       1111


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                      ...... +.         . ...+.+++.++.+++.+||+.||++|||+++|++.|+.+
T Consensus       257 ~~~i~~-~~---------~-~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          257 VEMIRN-RQ---------V-LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHT-TC---------C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHc-CC---------C-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            111111 11         0 112456677999999999999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.5e-58  Score=409.58  Aligned_cols=250  Identities=24%  Similarity=0.332  Sum_probs=207.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .+.|+..+.||+|+||.||+|..+ +|+.||||+++.......+.+.+|+.+|+.++|||||++++++.+++..|+||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            357999999999999999999764 7999999999766655567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      |++|+|.+++....                +++.++..++.||+.||+|||  +++|+||||||+|||++.+|.+||+||
T Consensus       153 ~~gg~L~~~l~~~~----------------l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DF  214 (346)
T 4fih_A          153 LEGGALTDIVTHTR----------------MNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDF  214 (346)
T ss_dssp             CTTEEHHHHHHHSC----------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred             CCCCcHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEECCCCCEEEecC
Confidence            99999999997643                899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |+|+...... ......+||+.|||||++.+ ..++.++|||||||++|||++|..||.....       .+....... 
T Consensus       215 Gla~~~~~~~-~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~-  284 (346)
T 4fih_A          215 GFCAQVSKEV-PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRD-  284 (346)
T ss_dssp             TTCEECCSSS-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHH-
T ss_pred             cCceecCCCC-CcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHc-
Confidence            9998765432 23445789999999999975 4589999999999999999999999754211       111111111 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                           .....+..   ....+.++.+|+.+||+.||++|||++|+++
T Consensus       285 -----~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          285 -----NLPPRLKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -----SSCCCCSC---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CCCCCCCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 11111111   2234568999999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.1e-58  Score=409.40  Aligned_cols=268  Identities=26%  Similarity=0.324  Sum_probs=203.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCC----eeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGL----DRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  157 (373)
                      ++|.+.+.||+|+||.||+|.+ +|+.||||+++...... .....|+..+.+++|||||++++++.+++    ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3577788999999999999988 58999999997543221 22334666667889999999999997654    579999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCceeecCCCCceEeCCC
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGL------EKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~------~~~i~H~dlk~~Nill~~~  231 (373)
                      |||++|+|.++++...                ++|..+++++.|++.||+|||+.      +.+|+||||||+|||++.+
T Consensus        81 Ey~~~gsL~~~l~~~~----------------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~  144 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRYT----------------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  144 (303)
T ss_dssp             ECCTTCBHHHHHHHCC----------------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred             cCCCCCcHHHHHHhCC----------------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC
Confidence            9999999999998653                89999999999999999999941      2389999999999999999


Q ss_pred             CceEEeeeccccccCCCCCc---ccccccccccccCccccCCCC-----CCCccccchhhhHHHHHHHhCCCCCCCcccC
Q 043074          232 FEAHISDFGLARRIDTSHSH---VSTQVAGTMGYMPPEYLGGNT-----AATVMLDVYSFGILMIEIATQIRPNLPVVLD  303 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~  303 (373)
                      +++||+|||+++........   ......||+.|||||++.+..     .++.++|||||||++|||+||..|+......
T Consensus       145 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~  224 (303)
T 3hmm_A          145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  224 (303)
T ss_dssp             SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred             CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccc
Confidence            99999999999876543322   123457999999999997532     3678999999999999999998775432221


Q ss_pred             CCc--------ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          304 GQE--------VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       304 ~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ...        ..........     ....+++.+.....+.+++..+.+++.+||+.||++|||+.||++.|+++.
T Consensus       225 ~~p~~~~~~~~~~~~~~~~~~-----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          225 QLPYYDLVPSDPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHH-----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccchhcccccchHHHHHHHH-----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            111        1111111111     112233444333335567889999999999999999999999999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.7e-58  Score=408.96  Aligned_cols=253  Identities=23%  Similarity=0.309  Sum_probs=205.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .+.|.+.++||+|+||.||+|..+ +|+.||||+++.....     .+|+.+++.++|||||++++++.++...|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356788889999999999999764 7999999999765432     4799999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC-ceEEee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-EAHISD  238 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~-~~kl~D  238 (373)
                      |++|+|.+++.+..               ++++.++..++.||+.||+|||  +++|+||||||+|||++.+| ++||+|
T Consensus       132 ~~gg~L~~~l~~~~---------------~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~~vKl~D  194 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG---------------CLPEDRALYYLGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCD  194 (336)
T ss_dssp             CTTCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCCGGGEEECTTSCCEEECC
T ss_pred             cCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEeCCCCEEEEee
Confidence            99999999998654               2999999999999999999999  79999999999999999987 699999


Q ss_pred             eccccccCCCCCc----ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          239 FGLARRIDTSHSH----VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       239 fg~~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      ||+|+........    .....+||+.|||||++.+ ..++.++|||||||++|||++|..||.......    +..   
T Consensus       195 FGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~---  266 (336)
T 4g3f_A          195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP----LCL---  266 (336)
T ss_dssp             CTTCEEC------------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC----CHH---
T ss_pred             CCCCeEccCCCcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----HHH---
Confidence            9999876543211    1234579999999999986 458899999999999999999999986433221    111   


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .......         .....+..++..+.+++.+||+.||++|||+.|+++.|.+.+
T Consensus       267 ~i~~~~~---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l  315 (336)
T 4g3f_A          267 KIASEPP---------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL  315 (336)
T ss_dssp             HHHHSCC---------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHcCCC---------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            1111100         001123445678999999999999999999999999887754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.5e-58  Score=410.24  Aligned_cols=250  Identities=20%  Similarity=0.328  Sum_probs=200.2

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++.+...  ...+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6899999999999999999976 4799999999965433  235678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      ||++|+|.+++......             .+++.+++.++.||+.||+|||  +++|+||||||+|||++.++.+||+|
T Consensus       104 y~~gg~L~~~i~~~~~~-------------~~~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~D  168 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGV-------------LFQEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTVQLGD  168 (350)
T ss_dssp             CCTTCBHHHHHHHTTTC-------------CCCHHHHHHHHHHHHHHHHHHH--HTTCEETTCCGGGEEECTTCCEEECS
T ss_pred             CCCCCcHHHHHHHcCCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCCEEEcc
Confidence            99999999999765432             2789999999999999999999  79999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||+|+..... .......+||+.|||||++.+. .++.++|||||||++|||++|..||....       ..+.......
T Consensus       169 FGla~~~~~~-~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~~i~~  239 (350)
T 4b9d_A          169 FGIARVLNST-VELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGS-------MKNLVLKIIS  239 (350)
T ss_dssp             TTEESCCCHH-HHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHH
T ss_pred             cccceeecCC-cccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHc
Confidence            9999875321 1123456799999999999854 58899999999999999999999975421       1122222211


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      . ..     +.     .+...+.++.+|+.+||+.||++|||++|+++
T Consensus       240 ~-~~-----~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          240 G-SF-----PP-----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             T-CC-----CC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-CC-----CC-----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1 00     11     12334568999999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.4e-57  Score=392.13  Aligned_cols=246  Identities=22%  Similarity=0.344  Sum_probs=192.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||+|.. .+|+.||+|++++...   ...+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5899999999999999999975 4799999999965432   23457899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+ +|+|.+++.+..               ++++.++..++.||+.||+|||  +++|+||||||+|||+++++.+||+
T Consensus        93 Ey~-~g~L~~~l~~~~---------------~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDiKP~NILl~~~~~vkl~  154 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD---------------KMSEQEARRFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIA  154 (275)
T ss_dssp             ECC-CEEHHHHHHHSC---------------SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTCCEEEC
T ss_pred             eCC-CCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCChHHeEECCCCCEEEe
Confidence            999 789999997654               2999999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+|+.....  ......+||+.|||||++.+..+++.++||||+||++|||++|..||....       .........
T Consensus       155 DFGla~~~~~~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-------~~~~~~~i~  225 (275)
T 3hyh_A          155 DFGLSNIMTDG--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-------IPVLFKNIS  225 (275)
T ss_dssp             CSSCC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHH
T ss_pred             ecCCCeecCCC--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHH
Confidence            99999875432  233457899999999999877767789999999999999999999975421       112222221


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...       ..+     +...+.++.+++.+||+.||++|||++|+++
T Consensus       226 ~~~-------~~~-----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          226 NGV-------YTL-----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HTC-------CCC-----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCC-------CCC-----CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            110       111     2234568899999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.7e-57  Score=410.93  Aligned_cols=250  Identities=24%  Similarity=0.332  Sum_probs=208.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .+.|+..+.||+|+||.||+|..+ +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++..|+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            357999999999999999999764 7999999999776666667789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      |++|+|.+++....                +++.++..++.||+.||+|||  +++|+||||||+|||++.+|.+||+||
T Consensus       230 ~~gG~L~~~i~~~~----------------l~e~~~~~~~~qil~aL~ylH--~~~IiHRDiKp~NILl~~~g~vKl~DF  291 (423)
T 4fie_A          230 LEGGALTDIVTHTR----------------MNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDF  291 (423)
T ss_dssp             CTTEEHHHHHHHSC----------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSTTTEEECTTCCEEECCC
T ss_pred             CCCCcHHHHHhccC----------------CCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCCEEEecC
Confidence            99999999997543                899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |+|+.+.... ......+||+.|||||++.+ ..|+.++|||||||++|||++|..||....       ..+....... 
T Consensus       292 Gla~~~~~~~-~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~-------~~~~~~~i~~-  361 (423)
T 4fie_A          292 GFCAQVSKEV-PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-------PLKAMKMIRD-  361 (423)
T ss_dssp             TTCEECCSSC-CCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHH-
T ss_pred             ccceECCCCC-ccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHc-
Confidence            9998765432 23445789999999999975 458999999999999999999999975421       1111111111 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                           .....+..   ....+.++.+|+.+||+.||++|||+.|+++
T Consensus       362 -----~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          362 -----NLPPRLKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             -----SCCCCCSC---TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CCCCCCcc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 11111111   2233558999999999999999999999876

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.4e-57  Score=397.26  Aligned_cols=244  Identities=28%  Similarity=0.410  Sum_probs=194.1

Q ss_pred             CCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEee----CCeeEEEE
Q 043074           85 STDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCAS----GLDRVLIY  157 (373)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  157 (373)
                      ++.+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|+.++++++|||||++++++.+    ....++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999764 689999999965432  234678999999999999999999999865    34579999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--ceeecCCCCceEeCC-CCce
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP--IIHRDIKSSNVLLDS-DFEA  234 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~--i~H~dlk~~Nill~~-~~~~  234 (373)
                      |||++|+|.+++.+..               ++++..+..++.||+.||+|||  +++  |+||||||+|||++. ++.+
T Consensus       109 Ey~~gg~L~~~l~~~~---------------~l~~~~~~~~~~qi~~aL~ylH--~~~~~IiHRDlKp~NILl~~~~g~v  171 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK---------------VMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTGSV  171 (290)
T ss_dssp             ECCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCCCCCGGGEEESSTTSCE
T ss_pred             eCCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCCCEEecccChhheeEECCCCCE
Confidence            9999999999998654               2899999999999999999999  555  999999999999984 7899


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      ||+|||+|+....   ......+||+.|||||++.+  .++.++|||||||++|||+||..||.....      ......
T Consensus       172 Kl~DFGla~~~~~---~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~~  240 (290)
T 3fpq_A          172 KIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYR  240 (290)
T ss_dssp             EECCTTGGGGCCT---TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHH
T ss_pred             EEEeCcCCEeCCC---CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHHHH
Confidence            9999999986432   23445789999999999864  489999999999999999999999753211      111111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ... ..     ..+.    ..+...++++.+++.+||+.||++|||++|+++
T Consensus       241 ~i~-~~-----~~~~----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          241 RVT-SG-----VKPA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHT-TT-----CCCG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHH-cC-----CCCC----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111 00     1111    112223457899999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.4e-58  Score=403.16  Aligned_cols=247  Identities=22%  Similarity=0.296  Sum_probs=205.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||+||+|.. .+++.||+|++.+..   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4799999999999999999975 479999999997543   233567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      |||++|+|.+++.+...               +++.++..++.||+.||+|||  +++|+||||||+|||++.++.+||+
T Consensus       112 Ey~~gG~L~~~i~~~~~---------------l~e~~~~~~~~qi~~al~ylH--~~~IiHRDlKPeNILl~~~g~vKl~  174 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGS---------------FDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQIT  174 (311)
T ss_dssp             CCCTTEEHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred             ecCCCCCHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEEcCCCCEEEE
Confidence            99999999999987542               999999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCC-CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          238 DFGLARRIDTSH-SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       238 Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      |||+|+.+.... .......+||+.|||||++.+ ..++.++||||+||++|||++|..||....       ..+.....
T Consensus       175 DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~-------~~~~~~~i  246 (311)
T 4aw0_A          175 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-------EGLIFAKI  246 (311)
T ss_dssp             CCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHH
T ss_pred             EcCCceecCCCCCcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHH
Confidence            999999875432 233456789999999999985 457899999999999999999999985421       11111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVV  365 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~  365 (373)
                      ...       +..+     +...+.++.+++.+||+.||++|||++|++
T Consensus       247 ~~~-------~~~~-----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          247 IKL-------EYDF-----PEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHT-------CCCC-----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             HcC-------CCCC-----CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            111       0111     223345789999999999999999999863

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3e-57  Score=407.97  Aligned_cols=278  Identities=27%  Similarity=0.377  Sum_probs=213.2

Q ss_pred             HHHHHhcCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCC-CCccceeeE
Q 043074           75 SELIDATDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRH-RNIVKILGY  146 (373)
Q Consensus        75 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h-~niv~l~~~  146 (373)
                      ++.+...++|++.+.||+|+||.||+|.+.      .++.||||.+...... ..+.+.+|+.+|.+++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            334445678999999999999999999753      2367999999765443 35679999999999965 999999999


Q ss_pred             EeeC-CeeEEEEEecCCCCHHHHhhcCCCCCCCC-cccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCC
Q 043074          147 CASG-LDRVLIYEFVENGSLDQWLHDTSRNDDVD-GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS  224 (373)
Q Consensus       147 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~-~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~  224 (373)
                      |.+. ...++|||||++|+|.++|+......... ..........+++.+++.++.||+.||+|||  +++|+||||||+
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH--~~~iiHRDLK~~  214 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAAR  214 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh--hCCeecCccCcc
Confidence            9764 56899999999999999998653211000 0000001224899999999999999999999  789999999999


Q ss_pred             ceEeCCCCceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCccc
Q 043074          225 NVLLDSDFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVL  302 (373)
Q Consensus       225 Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~  302 (373)
                      |||+++++.+||+|||+|+........ ......||+.|||||++.+ ..++.++|||||||++|||+| |..||.....
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999876543322 3345678999999999985 458999999999999999998 7888643221


Q ss_pred             CCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          303 DGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..      ........ +.     ..     ..+..++.++.+++.+||+.||++|||+.+|++.|++++
T Consensus       294 ~~------~~~~~i~~-g~-----~~-----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          294 DE------EFCRRLKE-GT-----RM-----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             SH------HHHHHHHH-TC-----CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH------HHHHHHHc-CC-----CC-----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            11      11111111 11     11     114445678999999999999999999999999999876

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.2e-57  Score=395.69  Aligned_cols=247  Identities=26%  Similarity=0.295  Sum_probs=195.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEe----CCCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ++|++.+.||+|+||.||+|+.    .+++.||+|++++....  ....+.+|+.++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4799999999999999999965    25789999999764322  23467889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |||||+||+|.+++.+...               +++.++..++.||+.||+|||  +++|+||||||+|||++.++.+|
T Consensus       104 vmEy~~gg~L~~~l~~~~~---------------l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vK  166 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVM---------------FTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIK  166 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCC---------------CCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTSCEE
T ss_pred             EEEcCCCCCHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHeEEcCCCCEE
Confidence            9999999999999987542               999999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||+|+...... ......+||+.|||||++.+ ..++.++|||||||++|||+||..||....       ..+....
T Consensus       167 l~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~~  237 (304)
T 3ubd_A          167 LTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-------RKETMTM  237 (304)
T ss_dssp             EESSEEEEC------CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHH
T ss_pred             ecccccceeccCCC-ccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcC-------HHHHHHH
Confidence            99999998654322 23345789999999999985 457899999999999999999999985421       1111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM-----SYVVQ  366 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~~l~~  366 (373)
                      ....       ...     ++...+.++.+++.+||+.||++|||+     +|+++
T Consensus       238 i~~~-------~~~-----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          238 ILKA-------KLG-----MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HHHC-------CCC-----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             HHcC-------CCC-----CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            1111       011     133345689999999999999999995     56653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.8e-55  Score=384.02  Aligned_cols=249  Identities=23%  Similarity=0.394  Sum_probs=185.6

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCC---------
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGL---------  151 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---------  151 (373)
                      +|++.+.||+|+||.||+|..+ +|+.||||+++..... ..+.+.+|+.+|++++|||||++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            5888899999999999999764 7999999999654433 3457899999999999999999999986544         


Q ss_pred             ---eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe
Q 043074          152 ---DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL  228 (373)
Q Consensus       152 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill  228 (373)
                         ..|+|||||++|+|.+++.......            ..++..++.++.||+.||+|||  +++|+||||||+|||+
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~------------~~~~~~~~~i~~qi~~al~ylH--~~~IiHRDlKp~NILl  151 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIE------------ERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFF  151 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGG------------GSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEE
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCC------------hhHHHHHHHHHHHHHHHHHHHH--HCcCccccCcHHHeEE
Confidence               3689999999999999998654321            2567778999999999999999  7899999999999999


Q ss_pred             CCCCceEEeeeccccccCCCCCc-----------ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCC
Q 043074          229 DSDFEAHISDFGLARRIDTSHSH-----------VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN  297 (373)
Q Consensus       229 ~~~~~~kl~Dfg~~~~~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  297 (373)
                      +.++.+||+|||+|+........           ..+..+||+.|||||++.+. .++.++|||||||++|||++   ||
T Consensus       152 ~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf  227 (299)
T 4g31_A          152 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PF  227 (299)
T ss_dssp             CTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CC
T ss_pred             CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CC
Confidence            99999999999999876433211           12345799999999999854 58999999999999999996   54


Q ss_pred             CCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          298 LPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....         +.........      ....  ........+...+++.+||+.||++|||+.|+++
T Consensus       228 ~~~~---------~~~~~~~~~~------~~~~--p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          228 STQM---------ERVRTLTDVR------NLKF--PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             SSHH---------HHHHHHHHHH------TTCC--CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCcc---------HHHHHHHHHh------cCCC--CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            3210         1111111000      0000  0112233456788999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-52  Score=384.74  Aligned_cols=264  Identities=23%  Similarity=0.319  Sum_probs=200.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEee------CC
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCAS------GL  151 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~  151 (373)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++++...  ...+.+.+|+.+|+.++|||||++++++..      ..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            36799999999999999999976 4799999999965433  234568899999999999999999998754      35


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..|+|||||+ |+|.+++....               ++++.++..++.||+.||.|||  +++|+||||||+|||++.+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~---------------~l~~~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NIl~~~~  194 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ---------------PLTLEHVRYFLYQLLRGLKYMH--SAQVIHRDLKPSNLLVNEN  194 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS---------------CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTT
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCcCcCCCcCccccccCCC
Confidence            7899999995 78999997654               3999999999999999999999  7999999999999999999


Q ss_pred             CceEEeeeccccccCCCC---CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc
Q 043074          232 FEAHISDFGLARRIDTSH---SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG  308 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  308 (373)
                      +.+||+|||+|+.+....   .......+||+.|+|||++.+..+++.++||||+||++|||++|..||.......    
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~----  270 (398)
T 4b99_A          195 CELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH----  270 (398)
T ss_dssp             CCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH----
T ss_pred             CCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH----
Confidence            999999999998764322   2234457899999999999877778999999999999999999999975432111    


Q ss_pred             HHHHHHHHHHhc--ccc------------ccccCcccc--ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          309 LLEWARTMEARN--KEI------------EMVDSNISR--EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       309 ~~~~~~~~~~~~--~~~------------~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...-........  ...            ..+......  .......+.++.+|+.+||+.||++|||++|+++
T Consensus       271 ~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          271 QLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            111000000000  000            000000000  0001122457899999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.2e-53  Score=381.54  Aligned_cols=201  Identities=24%  Similarity=0.360  Sum_probs=172.5

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeC----CCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCee
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDR  153 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  153 (373)
                      ...++|++.+.||+|+||.||+|..+    +++.||+|.+.+...  ...+.+|+++++.+ +||||+++++++.+.+..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34678999999999999999999642    578899999866443  35678999999998 699999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC-C
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-F  232 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~-~  232 (373)
                      ++||||+++|+|.+++..                  +++.++..++.|++.||+|||  +++|+||||||+|||++.+ +
T Consensus        96 ~lvmE~~~g~~L~~~~~~------------------l~~~~~~~~~~qll~al~ylH--~~gIiHRDiKPeNiLl~~~~~  155 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILNS------------------LSFQEVREYMLNLFKALKRIH--QFGIVHRDVKPSNFLYNRRLK  155 (361)
T ss_dssp             EEEEECCCCCCHHHHHTT------------------CCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTT
T ss_pred             EEEEeCCCcccHHHHHcC------------------CCHHHHHHHHHHHHHHHHHHH--HCCeEeCcCCHHHeEEeCCCC
Confidence            999999999999999841                  889999999999999999999  7999999999999999876 7


Q ss_pred             ceEEeeeccccccCCCCC---------------------------cccccccccccccCccccCCCCCCCccccchhhhH
Q 043074          233 EAHISDFGLARRIDTSHS---------------------------HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGI  285 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~---------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~  285 (373)
                      .+||+|||+|+.......                           ......+||+.|+|||++.+...++.++||||+||
T Consensus       156 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~  235 (361)
T 4f9c_A          156 KYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV  235 (361)
T ss_dssp             EEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred             eEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence            999999999986543211                           11233579999999999987777899999999999


Q ss_pred             HHHHHHhCCCCCCCcc
Q 043074          286 LMIEIATQIRPNLPVV  301 (373)
Q Consensus       286 ~l~el~~g~~p~~~~~  301 (373)
                      ++|||++|..||++..
T Consensus       236 il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          236 IFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             HHHHHHHTCSSSSCCS
T ss_pred             HHHHHHHCCCCCCCCC
Confidence            9999999999987543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1e-50  Score=364.94  Aligned_cols=285  Identities=36%  Similarity=0.647  Sum_probs=236.3

Q ss_pred             cChHHHHHhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCC
Q 043074           72 ISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGL  151 (373)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  151 (373)
                      ++..++...+++|+..+.||+|+||.||+|..++++.||+|++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            34445556789999999999999999999998889999999997766666778999999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..++||||+++|+|.+++.......           .++++.+++.++.|++.||.|||  +++++||||||+||+++.+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~  175 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPT-----------MSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDEN  175 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCS-----------CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCSTTEEECTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCc-----------cccCHHHHHHHHHHHHHHHHHhc--CCCeecCCCCHHHEEECCC
Confidence            9999999999999999997654221           13899999999999999999999  7899999999999999999


Q ss_pred             CceEEeeeccccccCCCC-CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH
Q 043074          232 FEAHISDFGLARRIDTSH-SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  310 (373)
                      +.+||+|||+++...... ........||+.|+|||.+.+. .++.++||||||+++|||++|..|+..... .......
T Consensus       176 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~-~~~~~~~  253 (321)
T 2qkw_B          176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLP-REMVNLA  253 (321)
T ss_dssp             CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSS-SSCCCHH
T ss_pred             CCEEEeecccccccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCc-HHHHHHH
Confidence            999999999998654322 2223345689999999998743 478899999999999999999999765433 2334556


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .|.............+++.+... ....++..+.+++.+||+.||++|||+.++++.|+.++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          254 EWAVESHNNGQLEQIVDPNLADK-IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             HHTHHHHTTTCCCSSSSSSCTTC-SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhhhccccccHHHhcChhhccc-cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            66655555554555555554433 37888999999999999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=9.2e-51  Score=366.12  Aligned_cols=288  Identities=38%  Similarity=0.707  Sum_probs=237.8

Q ss_pred             CCcccChHHHHHhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeE
Q 043074           68 SLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGY  146 (373)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~  146 (373)
                      ....++..++....++|+..+.||+|+||.||+|...+++.||+|++...... ....+.+|+.+++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            34567889999999999999999999999999998888999999999765432 23468899999999999999999999


Q ss_pred             EeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC---CceeecCCC
Q 043074          147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEK---PIIHRDIKS  223 (373)
Q Consensus       147 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~---~i~H~dlk~  223 (373)
                      +.+....++||||+++|+|.+++.......           .++++..+..++.|++.||+|||  +.   +++||||||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~ivH~Dlkp  162 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQ-----------PPLDWPKRQRIALGSARGLAYLH--DHCDPKIIHRDVKA  162 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTC-----------CCCCHHHHHHHHHHHHHHHHHHH--HSSSSCEECCCCSG
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccC-----------CCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeCCCch
Confidence            999999999999999999999998765322           14899999999999999999999  56   999999999


Q ss_pred             CceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcc-c
Q 043074          224 SNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVV-L  302 (373)
Q Consensus       224 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~-~  302 (373)
                      +||+++.++.+||+|||++...............||+.|+|||.+.+. .++.++||||||+++|||++|..||.... .
T Consensus       163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  241 (326)
T 3uim_A          163 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLA  241 (326)
T ss_dssp             GGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHT
T ss_pred             hhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccc
Confidence            999999999999999999987765544445556799999999998744 47889999999999999999999975332 2


Q ss_pred             CCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          303 DGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                      .........|..............+..+... .+...+..+.+++.+||+.||.+|||+.+|++.|++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQGN-YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTSCSBHHHHHTTTTSSCCSTTSSCTTCTTS-CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             cccchhHHHHHHHHhhchhhhhhcChhhccc-cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            2233445566554444444444444444333 378889999999999999999999999999999975

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.6e-51  Score=390.21  Aligned_cols=249  Identities=24%  Similarity=0.279  Sum_probs=200.1

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHH---HHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFR---AEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|++++...   .....+.   .++.+++.++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999764 799999999965332   1222333   3466777889999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +||||++||+|.+++.+...               +++..+..++.||+.||+|||  +++|+||||||+|||++.+|++
T Consensus       269 lVmEy~~GGdL~~~l~~~~~---------------l~E~~a~~y~~qIl~aL~yLH--~~gIiHRDLKPeNILld~~G~v  331 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGV---------------FSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHV  331 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCC---------------CCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTSCE
T ss_pred             EEEecCCCCcHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHeEEeCCCCE
Confidence            99999999999999987542               999999999999999999999  8999999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      ||+|||+|+......   ....+||+.|||||++.+...++.++|+|||||++|||++|..||.......    ......
T Consensus       332 KL~DFGlA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~----~~~i~~  404 (689)
T 3v5w_A          332 RISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDR  404 (689)
T ss_dssp             EECCCTTCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC----HHHHHH
T ss_pred             EecccceeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHH
Confidence            999999998765332   3456899999999999755668999999999999999999999986433221    111111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA-----MSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~l~~  366 (373)
                      .....       ...     ++...+.++.+|+.+||+.||++|++     ++||.+
T Consensus       405 ~i~~~-------~~~-----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          405 MTLTM-------AVE-----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHHC-------CCC-----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             hhcCC-------CCC-----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            11110       011     12334568999999999999999998     566643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.3e-51  Score=389.32  Aligned_cols=251  Identities=22%  Similarity=0.329  Sum_probs=205.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+.+|+.++||||+++++++.+....++|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            58999999999999999999764 79999999997766555677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC--CceEEee
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD--FEAHISD  238 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~--~~~kl~D  238 (373)
                      ++|+|.+++.....              .+++.++..++.||+.||+|||  +++|+||||||+|||++.+  +.+||+|
T Consensus       237 ~gg~L~~~i~~~~~--------------~l~e~~~~~~~~qi~~al~ylH--~~~iiHRDlKp~Nill~~~~~~~vKl~D  300 (573)
T 3uto_A          237 SGGELFEKVADEHN--------------KMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLID  300 (573)
T ss_dssp             CCCBHHHHHTCTTS--------------CEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             CCCcHHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhccccCCCCCCEEEee
Confidence            99999999965432              2899999999999999999999  7999999999999999854  8999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||+++.+...  ......+||+.|||||++.+. .++.++|||||||++|||++|..||.....       .+.......
T Consensus       301 FG~a~~~~~~--~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-------~~~~~~i~~  370 (573)
T 3uto_A          301 FGLTAHLDPK--QSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKS  370 (573)
T ss_dssp             CSSCEECCTT--SEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHT
T ss_pred             ccceeEccCC--CceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHh
Confidence            9999986543  233456899999999999864 579999999999999999999999754221       111111111


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..   ..+....     ....+.++.+|+.+||+.||++|||+.|+++
T Consensus       371 ~~---~~~~~~~-----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          371 CD---WNMDDSA-----FSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             TC---CCCCSGG-----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC---CCCCccc-----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10   0011111     1223457899999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.4e-49  Score=352.61  Aligned_cols=256  Identities=25%  Similarity=0.466  Sum_probs=210.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            57888999999999999999764 68999999997766666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++|+|.+++.....              .+++.+++.++.|++.||+|||  +++++||||||+||+++.++.+||+|||
T Consensus        90 ~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  153 (310)
T 3s95_A           90 KGGTLRGIIKSMDS--------------QYPWSQRVSFAKDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFG  153 (310)
T ss_dssp             TTCBHHHHHHHCCT--------------TSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEECTTSCEEECCCT
T ss_pred             CCCcHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCcCeEEECCCCCEEEeecc
Confidence            99999999987543              2899999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcc-------------cccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcc
Q 043074          241 LARRIDTSHSHV-------------STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV  307 (373)
Q Consensus       241 ~~~~~~~~~~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  307 (373)
                      ++..........             .....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+..........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~  232 (310)
T 3s95_A          154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF  232 (310)
T ss_dssp             TCEECC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS
T ss_pred             cceecccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH
Confidence            998764332211             114578999999999985 457889999999999999999998865543332221


Q ss_pred             c--HHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          308 G--LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       308 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .  ......             .     ..+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       233 ~~~~~~~~~-------------~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          233 GLNVRGFLD-------------R-----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             SBCHHHHHH-------------H-----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhhhhcccc-------------c-----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1  111100             0     012233457999999999999999999999999998864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.1e-49  Score=352.29  Aligned_cols=267  Identities=29%  Similarity=0.409  Sum_probs=209.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCC----eeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGL----DRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv  156 (373)
                      .++|++.+.||+|+||.||+|... ++.||+|++...... ......|+.++++++||||+++++++.+..    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            458899999999999999999875 799999999654432 344567899999999999999999998754    36999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----------CceeecCCCCce
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEK----------PIIHRDIKSSNV  226 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~----------~i~H~dlk~~Ni  226 (373)
                      |||+++|+|.+++....                +++..++.++.|++.||+|||  +.          +++||||||+||
T Consensus       101 ~e~~~~g~L~~~l~~~~----------------~~~~~~~~i~~qi~~al~~LH--~~~~~l~~~~~~~ivH~Dlkp~Ni  162 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV----------------VSWNELCHIAETMARGLAYLH--EDIPGLKDGHKPAISHRDIKSKNV  162 (322)
T ss_dssp             EECCTTCBHHHHHHHCC----------------BCHHHHHHHHHHHHHHHHHHT--CCEEEETTEEECEEECSCCSGGGE
T ss_pred             EecCCCCCHHHHHHhcC----------------CCHHHHHHHHHHHHHHHHHHH--hhccccccccCCCEEeCCCChHhE
Confidence            99999999999997643                899999999999999999999  67          999999999999


Q ss_pred             EeCCCCceEEeeeccccccCCCCCc-ccccccccccccCccccCCC----CCCCccccchhhhHHHHHHHhCCCCCCCcc
Q 043074          227 LLDSDFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGN----TAATVMLDVYSFGILMIEIATQIRPNLPVV  301 (373)
Q Consensus       227 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~el~~g~~p~~~~~  301 (373)
                      +++.++.+||+|||+++........ ......||+.|+|||.+.+.    ..++.++|||||||++|||++|..||....
T Consensus       163 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  242 (322)
T 3soc_A          163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV  242 (322)
T ss_dssp             EECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred             EECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999999999999876543322 23345789999999999753    345678899999999999999999976543


Q ss_pred             cCCCcc---------cHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          302 LDGQEV---------GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       302 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ......         ....+.....     .....+.+........++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          243 DEYMLPFEEEIGQHPSLEDMQEVVV-----HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHT-----TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhccchhhhhccCCchhhhhhhhh-----cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            322111         1111111111     11112222222224456778999999999999999999999999999874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.6e-47  Score=339.74  Aligned_cols=283  Identities=37%  Similarity=0.626  Sum_probs=226.6

Q ss_pred             CcccChHHHHHhcCCCCCC------CeeecCCCceEEEEEeCCCCEEEEEEeCccc----cccHHHHHHHHHHHhcCCCC
Q 043074           69 LSQISMSELIDATDNFSTD------KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDA----FQGFREFRAEMETLGKLRHR  138 (373)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~  138 (373)
                      ...++..++...+++|...      +.||+|+||.||+|.. +++.||+|++....    ....+.+.+|+.+++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4567888999999888877      8999999999999987 58899999986532    22356788999999999999


Q ss_pred             CccceeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 043074          139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIH  218 (373)
Q Consensus       139 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H  218 (373)
                      ||+++++++.+....++||||+++++|.+++.......            ++++..++.++.|++.||.|||  +.+++|
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------------~~~~~~~~~i~~~i~~~l~~lH--~~~i~H  156 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP------------PLSWHMRCKIAQGAANGINFLH--ENHHIH  156 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCC------------CCCHHHHHHHHHHHHHHHHHHH--HTTEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCC------------CCCHHHHHHHHHHHHHHHHHHh--cCCeec
Confidence            99999999999999999999999999999997543221            3899999999999999999999  789999


Q ss_pred             ecCCCCceEeCCCCceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCC
Q 043074          219 RDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN  297 (373)
Q Consensus       219 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  297 (373)
                      |||||+||+++.++.+||+|||++......... ......||+.|+|||.+.+  .++.++||||||+++|+|++|..|+
T Consensus       157 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~  234 (307)
T 2nru_A          157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAV  234 (307)
T ss_dssp             SCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred             CCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCc
Confidence            999999999999999999999999876433222 2334578999999999864  3788999999999999999999997


Q ss_pred             CCcccCCCcccHHHHHHHHHHhccc-cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhC
Q 043074          298 LPVVLDGQEVGLLEWARTMEARNKE-IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA  373 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~~  373 (373)
                      .......   ....+.......... ...++..+  ...+...+..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus       235 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          235 DEHREPQ---LLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             CTTBSSS---BTTHHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             ccCcchH---HHHHHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            6543322   222333322222111 12222222  22367788899999999999999999999999999998754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.4e-47  Score=340.56  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=206.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46899999999999999999975 57999999999766666667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++|+|.+++....                +++.++..++.|++.||.|||  +++++||||||+||+++.++.+||+||
T Consensus        99 ~~~~~L~~~~~~~~----------------~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Df  160 (297)
T 3fxz_A           99 LAGGSLTDVVTETC----------------MDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDF  160 (297)
T ss_dssp             CTTCBHHHHHHHSC----------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred             CCCCCHHHHHhhcC----------------CCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEECCCCCEEEeeC
Confidence            99999999997653                889999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++........ ......||+.|+|||.+.+. .++.++||||||+++|||++|..||.....       ..........
T Consensus       161 g~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~~~~  231 (297)
T 3fxz_A          161 GFCAQITPEQS-KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATN  231 (297)
T ss_dssp             TTCEECCSTTC-CBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHH
T ss_pred             CCceecCCccc-ccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhC
Confidence            99987654332 23446799999999999754 578899999999999999999999754211       1111111111


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...      ..   ..+...+..+.+++.+||+.||++|||+.++++
T Consensus       232 ~~~------~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          232 GTP------EL---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CSC------CC---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCC------CC---CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            100      00   012334567999999999999999999999975

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.3e-48  Score=347.99  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=206.7

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            356899999999999999999976 5899999999965432  2356688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++|+|.+++.....               +++.++..++.|++.||+|||  +++++||||||+||+++.++.+||
T Consensus        93 ~e~~~~~~L~~~l~~~~~---------------l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~NIll~~~~~~kl  155 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHGR---------------MKEKEARSKFRQIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKI  155 (328)
T ss_dssp             ECCCTTCBHHHHHHHHCC---------------CCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred             EECCCCCcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCEeccCCCHHHEEEcCCCCEEE
Confidence            999999999999976542               899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++.......  ......||+.|+|||.+.+....+.++|||||||++|||++|..||....       ........
T Consensus       156 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i  226 (328)
T 3fe3_A          156 ADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------LKELRERV  226 (328)
T ss_dssp             CSTTCCGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHH
T ss_pred             eeccCceecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHH
Confidence            9999998764332  33456799999999999876666789999999999999999999975421       11222211


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....       ..     .+...+.++.+++.+||+.||.+|||++++++
T Consensus       227 ~~~~-------~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          227 LRGK-------YR-----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HHCC-------CC-----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             HhCC-------CC-----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1110       01     12233557899999999999999999999975

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.7e-48  Score=345.34  Aligned_cols=260  Identities=30%  Similarity=0.491  Sum_probs=201.6

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ..++|++.+.||+|+||.||+|.. ++..||+|++.....  ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            356889999999999999999987 588999999866543  23457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--ceeecCCCCceEeCCCCceE
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP--IIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~--i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||+++|+|.+++.......            ++++..++.++.|++.||+|||  +.+  ++||||||+||+++.++.+|
T Consensus       114 e~~~~~~L~~~l~~~~~~~------------~~~~~~~~~i~~qi~~aL~~LH--~~~~~ivH~Dikp~NIll~~~~~~k  179 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGARE------------QLDERRRLSMAYDVAKGMNYLH--NRNPPIVHRNLKSPNLLVDKKYTVK  179 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHH------------HSCHHHHHHHHHHHHHHHHHHH--TSSSCCCCTTCCGGGEEECTTCCEE
T ss_pred             ecCCCCcHHHHHhhcCCCC------------CCCHHHHHHHHHHHHHHHHHHH--cCCCCEECCCCChhhEEEeCCCcEE
Confidence            9999999999998654211            2889999999999999999999  677  99999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||+++...... .......||+.|+|||.+.+. .++.++||||||+++|||++|..||.....       ......
T Consensus       180 L~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~-------~~~~~~  250 (309)
T 3p86_A          180 VCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNP-------AQVVAA  250 (309)
T ss_dssp             ECCCC------------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-------HHHHHH
T ss_pred             ECCCCCCccccccc-cccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH
Confidence            99999997643322 223345789999999999854 478899999999999999999999753211       111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhC
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA  373 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~~  373 (373)
                      ......          ....+..++.++.+++.+||+.||.+|||+.++++.|+.++.
T Consensus       251 ~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          251 VGFKCK----------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             HHHSCC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             HHhcCC----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            111110          111133445689999999999999999999999999998763

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.5e-48  Score=338.03  Aligned_cols=255  Identities=27%  Similarity=0.416  Sum_probs=209.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      ++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            57888899999999999999988899999999976543 34678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +++|.+++.....              .+++..++.++.|++.||+|||  +.+++||||||+||+++.++.+||+|||+
T Consensus        89 ~~~L~~~l~~~~~--------------~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  152 (269)
T 4hcu_A           89 HGCLSDYLRTQRG--------------LFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGM  152 (269)
T ss_dssp             TCBHHHHHHTTTT--------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred             CCcHHHHHHhcCc--------------ccCHHHHHHHHHHHHHHHHHHH--hCCeecCCcchheEEEcCCCCEEeccccc
Confidence            9999999976443              2899999999999999999999  78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      +...............+|+.|+|||.+.+ ..++.++||||||+++|||++ |..|+....       ..+........ 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-------~~~~~~~~~~~-  223 (269)
T 4hcu_A          153 TRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTG-  223 (269)
T ss_dssp             GGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTT-
T ss_pred             cccccccccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCC-------HHHHHHHHhcC-
Confidence            98764433233344556788999999874 447889999999999999999 787764321       11111111111 


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                           ....     .+...+..+.+++.+||+.||++||++.++++.|+++.
T Consensus       224 -----~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          224 -----FRLY-----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             -----CCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----ccCC-----CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence                 0011     12223568999999999999999999999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.4e-48  Score=352.92  Aligned_cols=271  Identities=28%  Similarity=0.425  Sum_probs=209.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe--------CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeC
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL--------SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASG  150 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  150 (373)
                      .++|.+.+.||+|+||.||+|..        .++..||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            46788899999999999999975        2356799999976543 2356789999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcc-cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGS-KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      ...++||||+++|+|.+++............ ........+++.+++.++.||+.||.|||  +++++||||||+|||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEC
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchhhEEEC
Confidence            9999999999999999999876532110000 00001123899999999999999999999  78999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcc
Q 043074          230 SDFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEV  307 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~  307 (373)
                      .++.+||+|||+++....... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |..|+.....    .
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~----~  312 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----E  312 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----G
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH----H
Confidence            999999999999987644322 22233457889999999875 458899999999999999999 8887643211    1


Q ss_pred             cHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .+.   ..... ..     .     ...+..++.++.+++.+||+.||.+||++.++++.|++++
T Consensus       313 ~~~---~~~~~-~~-----~-----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          313 ELF---KLLKE-GH-----R-----MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             GHH---HHHHT-TC-----C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH---HHHhc-CC-----C-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111   11111 10     0     1113345668999999999999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-47  Score=336.61  Aligned_cols=256  Identities=25%  Similarity=0.391  Sum_probs=209.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      .++|++.+.||+|+||.||+|..+++..||+|++..... ..+.+.+|+.++.+++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            457888999999999999999998888999999976543 3467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++++|.+++.....              .+++.+++.++.|++.||+|||  +.+++||||||+||+++.++.+||+|||
T Consensus        86 ~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~Dfg  149 (268)
T 3sxs_A           86 SNGCLLNYLRSHGK--------------GLEPSQLLEMCYDVCEGMAFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFG  149 (268)
T ss_dssp             TTCBHHHHHHHHGG--------------GCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCSGGGEEECTTCCEEECCTT
T ss_pred             CCCcHHHHHHHcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCcceEEECCCCCEEEccCc
Confidence            99999999976532              2899999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      ++...............+|+.|+|||.+.+ ..++.++||||||+++|||++ |..|+....       ...........
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~~~  221 (268)
T 3sxs_A          150 MTRYVLDDQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-------NSEVVLKVSQG  221 (268)
T ss_dssp             CEEECCTTCEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSC-------HHHHHHHHHTT
T ss_pred             cceecchhhhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccC-------hHHHHHHHHcC
Confidence            998765544333444556788999999874 347889999999999999999 888864321       11111111111


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .   ..        ..+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       222 ~---~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          222 H---RL--------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             C---CC--------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             C---CC--------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            0   00        012223457999999999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=345.42  Aligned_cols=257  Identities=28%  Similarity=0.469  Sum_probs=205.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC----CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      .++|++.+.||+|+||.||+|...    .+..||||.+..... ...+.+.+|+.++++++||||+++++++.++...++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            457888999999999999999764    345699999976433 335678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||+++|+|.+++.....              .+++.+++.++.|++.||.|||  +.+++||||||+||+++.++.+|
T Consensus       128 v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~k  191 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDG--------------QFTIMQLVGMLRGVGAGMRYLS--DLGYVHRDLAARNVLVDSNLVCK  191 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTT--------------CSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEE
T ss_pred             EeeCCCCCcHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEECCCCCEE
Confidence            9999999999999975432              2899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHH
Q 043074          236 ISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  312 (373)
                      |+|||+++........  ......+|+.|+|||.+.+ ..++.++||||||+++|||++ |..||.....       ...
T Consensus       192 l~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-------~~~  263 (325)
T 3kul_A          192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-------RDV  263 (325)
T ss_dssp             ECCCSSCEECC----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHH
T ss_pred             ECCCCcccccccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-------HHH
Confidence            9999999876543222  2223446778999999974 457889999999999999999 8888643211       111


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .......      ....     .+..++..+.+++.+||+.||++|||+.++++.|++++
T Consensus       264 ~~~~~~~------~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          264 ISSVEEG------YRLP-----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             HHHHHTT------CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHcC------CCCC-----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1111111      0111     13344568999999999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.1e-47  Score=340.28  Aligned_cols=264  Identities=25%  Similarity=0.393  Sum_probs=204.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhc--CCCCCccceeeEEee----CCeeE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGK--LRHRNIVKILGYCAS----GLDRV  154 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~~~~  154 (373)
                      .++|++.+.||+|+||.||+|.. +++.||+|++....   ...+..|.+++..  ++||||+++++++.+    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46899999999999999999987 68999999996543   2445566666665  789999999998654    34578


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCceeecCCCCceEe
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGL------EKPIIHRDIKSSNVLL  228 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~------~~~i~H~dlk~~Nill  228 (373)
                      +||||+++|+|.+++....                +++..++.++.|++.||+|||+.      +++++||||||+|||+
T Consensus        83 lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill  146 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLTT----------------LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV  146 (301)
T ss_dssp             EEECCCTTCBHHHHHTTCC----------------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE
T ss_pred             EehhhccCCCHHHHHhhcc----------------cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE
Confidence            9999999999999996432                89999999999999999999932      4789999999999999


Q ss_pred             CCCCceEEeeeccccccCCCCCcc---cccccccccccCccccCCCC-----CCCccccchhhhHHHHHHHhC-------
Q 043074          229 DSDFEAHISDFGLARRIDTSHSHV---STQVAGTMGYMPPEYLGGNT-----AATVMLDVYSFGILMIEIATQ-------  293 (373)
Q Consensus       229 ~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~-----~~~~~~DiwslG~~l~el~~g-------  293 (373)
                      +.++.+||+|||+++.........   .....||+.|+|||.+.+..     .++.++||||||+++|||++|       
T Consensus       147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~  226 (301)
T 3q4u_A          147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV  226 (301)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence            999999999999998654433221   22347899999999997543     345789999999999999999       


Q ss_pred             ---CCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          294 ---IRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       294 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                         ..||.........  .........     .....+.+.....+..++..+.+++.+||+.||++|||+.++++.|++
T Consensus       227 ~~~~~pf~~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          227 EDYKPPFYDVVPNDPS--FEDMRKVVC-----VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             CCCCCTTTTTSCSSCC--HHHHHHHHT-----TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccccccccCCCCcc--hhhhhHHHh-----ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence               6776544333222  111111111     111122222233345678899999999999999999999999999987


Q ss_pred             h
Q 043074          371 L  371 (373)
Q Consensus       371 l  371 (373)
                      +
T Consensus       300 i  300 (301)
T 3q4u_A          300 I  300 (301)
T ss_dssp             H
T ss_pred             c
Confidence            6

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.8e-47  Score=339.39  Aligned_cols=260  Identities=23%  Similarity=0.381  Sum_probs=203.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.+.....   ...+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            46899999999999999999975 4789999999854332   2345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++++|.+++....               ++++.+++.++.|++.||+|||  +.+++||||||+||+++.++.+||
T Consensus        90 ~e~~~g~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl  152 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG---------------PLSVDTAINFTNQILDGIKHAH--DMRIVHRDIKPQNILIDSNKTLKI  152 (294)
T ss_dssp             EECCCSCBHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred             EeCCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEE
Confidence            99999999999997654               2899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++...............||+.|+|||.+.+. .++.++||||||+++|||++|..||.....       .......
T Consensus       153 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~~~~~~~  224 (294)
T 4eqm_A          153 FDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETA-------VSIAIKH  224 (294)
T ss_dssp             CCCSSSTTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-------HHHHHHH
T ss_pred             EeCCCccccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHH
Confidence            99999987654433334456789999999999754 478899999999999999999999754211       1111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhhh
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-AMSYVVQLLDELV  372 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~l~~~L~~l~  372 (373)
                      ..  ........     ......+..+.+++.+||+.||.+|| +++++.+.|++++
T Consensus       225 ~~--~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          225 IQ--DSVPNVTT-----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HS--SCCCCHHH-----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             hh--ccCCCcch-----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            10  00000000     11223456899999999999999998 9999999998875

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.7e-46  Score=337.20  Aligned_cols=260  Identities=24%  Similarity=0.342  Sum_probs=209.9

Q ss_pred             ccChHHHHHhcCC----------CCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCC
Q 043074           71 QISMSELIDATDN----------FSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN  139 (373)
Q Consensus        71 ~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n  139 (373)
                      .++.+++..+++.          |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4566666655543          666779999999999999876 79999999997766666678899999999999999


Q ss_pred             ccceeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceee
Q 043074          140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHR  219 (373)
Q Consensus       140 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~  219 (373)
                      |+++++++......++||||+++++|.+++....                +++..+..++.|++.||.|||  +.+++||
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------l~~~~~~~i~~qi~~~L~~LH--~~~ivH~  165 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR----------------LNEEQIATVCEAVLQALAYLH--AQGVIHR  165 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCC----------------CCHHHHHHHHHHHHHHHHHHH--HTTEECC
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHhcC----------------CCHHHHHHHHHHHHHHHHHHH--HCCeecC
Confidence            9999999999999999999999999999987532                899999999999999999999  7899999


Q ss_pred             cCCCCceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCC
Q 043074          220 DIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP  299 (373)
Q Consensus       220 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  299 (373)
                      ||||+||+++.++.+||+|||++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|..|+..
T Consensus       166 Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~  243 (321)
T 2c30_A          166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFS  243 (321)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987643322 2344679999999999974 4578899999999999999999999754


Q ss_pred             cccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...       ..........      ..+.+..   ....+..+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~-------~~~~~~~~~~------~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          244 DSP-------VQAMKRLRDS------PPPKLKN---SHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             SCH-------HHHHHHHHHS------SCCCCTT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCH-------HHHHHHHhcC------CCCCcCc---cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            211       1111111111      1111111   1223457999999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.5e-48  Score=341.55  Aligned_cols=265  Identities=26%  Similarity=0.434  Sum_probs=205.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-----CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEee--CCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS--GLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  153 (373)
                      .++|++.+.||+|+||.||+|.+     .+++.||+|++........+.+.+|+.++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            35788999999999999999974     3688999999987766666789999999999999999999999854  3568


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++||||+++|+|.+++.....              .+++.+++.++.|++.||+|||  +.+++||||||+||+++.++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~  152 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKE--------------RIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENR  152 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGG--------------GCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTE
T ss_pred             EEEEEeCCCCCHHHHHHhccc--------------ccCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHhhEEEcCCCe
Confidence            999999999999999986542              2899999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCC--cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccC-------C
Q 043074          234 AHISDFGLARRIDTSHS--HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD-------G  304 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-------~  304 (373)
                      +||+|||++........  .......++..|+|||.+.+. .++.++||||||+++|||++|..|+......       .
T Consensus       153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~  231 (295)
T 3ugc_A          153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND  231 (295)
T ss_dssp             EEECCCCSCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTT
T ss_pred             EEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCc
Confidence            99999999987643322  122334567789999998744 4789999999999999999999886543211       0


Q ss_pred             CcccHHH-HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          305 QEVGLLE-WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       305 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ....... .....         +..... ...+..++.++.+++.+||+.||++|||+.++++.|+++.
T Consensus       232 ~~~~~~~~~~~~~---------~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          232 KQGQMIVFHLIEL---------LKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             CCTHHHHHHHHHH---------HHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccchhHHHHHHH---------HhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            0000000 00000         001111 1113445678999999999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.8e-48  Score=340.02  Aligned_cols=256  Identities=24%  Similarity=0.397  Sum_probs=206.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      .++|++.+.||+|+||.||++...++..||+|++...... .+.+.+|+.++.+++||||+++++++.+....++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            4578889999999999999999988889999999765433 467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++++|.+++.....              .+++.+++.++.|++.||.|||  +++++||||||+||+++.++.+||+|||
T Consensus       102 ~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nili~~~~~~kl~Dfg  165 (283)
T 3gen_A          102 ANGCLLNYLREMRH--------------RFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFG  165 (283)
T ss_dssp             TTCBHHHHHHCGGG--------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred             CCCcHHHHHHHhcc--------------CCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCccceEEEcCCCCEEEcccc
Confidence            99999999976432              2899999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      ++...............+|+.|+|||.+.+. .++.++||||||+++|||++ |..||.....       ..........
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-------~~~~~~~~~~  237 (283)
T 3gen_A          166 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQG  237 (283)
T ss_dssp             GGGGBCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHTT
T ss_pred             ccccccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccCh-------hHHHHHHhcc
Confidence            9987644322223344567889999998744 47889999999999999998 8888643221       1111111110


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                            ....     .+...+..+.+++.+||+.||.+|||+.++++.|++++
T Consensus       238 ------~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          238 ------LRLY-----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             ------CCCC-----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------cCCC-----CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence                  1111     12223458999999999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.5e-48  Score=352.00  Aligned_cols=257  Identities=26%  Similarity=0.486  Sum_probs=196.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC----CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      .++|.+.+.||+|+||.||+|..+    ++..||||.+..... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            358999999999999999999764    577899999976433 335678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||+++|+|.+++.....              ++++.+++.++.|++.||+|||  +.+++||||||+||+++.++.+|
T Consensus       124 v~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~k  187 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDA--------------QFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCK  187 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTT--------------CSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEE
T ss_pred             EEeCCCCCcHHHHHHhCCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEEcCCCCEE
Confidence            9999999999999976532              2899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCcc--cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHH
Q 043074          236 ISDFGLARRIDTSHSHV--STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  312 (373)
                      |+|||+++.........  .....+++.|+|||.+.+ ..++.++||||||+++|||++ |..|+....       ..+.
T Consensus       188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~-------~~~~  259 (373)
T 2qol_A          188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDV  259 (373)
T ss_dssp             ECCC----------------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC-------HHHH
T ss_pred             ECcCccccccccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCC-------HHHH
Confidence            99999998764332211  122345678999999874 457889999999999999998 888864321       1111


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .......      ...    . .+..++..+.+++.+||+.||++||++.++++.|++++
T Consensus       260 ~~~i~~~------~~~----~-~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          260 IKAVDEG------YRL----P-PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             HHHHHTT------EEC----C-CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHcC------CCC----C-CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence            1111110      000    1 13344668999999999999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.8e-48  Score=361.11  Aligned_cols=258  Identities=26%  Similarity=0.446  Sum_probs=208.6

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ...++|.+.+.||+|+||.||+|..+++..||||+++... ...+.+.+|+.++++++||||+++++++. ....++|||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            3456788899999999999999999888999999997654 34678999999999999999999999986 567899999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++|+|.+++......             .+++..++.++.|++.||+|||  +++++||||||+|||++.++.+||+|
T Consensus       263 ~~~~g~L~~~l~~~~~~-------------~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~D  327 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGS-------------KQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIAD  327 (454)
T ss_dssp             CCTTCBHHHHHHSHHHH-------------TCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTCCEEECS
T ss_pred             ecCCCcHHHHHHhccCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHHHEEECCCCcEEEee
Confidence            99999999999754321             2888999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      ||+++..............++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....       ..+......
T Consensus       328 FG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~-------~~~~~~~i~  399 (454)
T 1qcf_A          328 FGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-------NPEVIRALE  399 (454)
T ss_dssp             TTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHHH
T ss_pred             CCCceEcCCCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHH
Confidence            99998764322222233446788999999974 458899999999999999999 888864321       111111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..      ...     ..+..++.++.+++.+||+.||++|||+++|++.|+++.
T Consensus       400 ~~------~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          400 RG------YRM-----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             HT------CCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             cC------CCC-----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            11      000     113345678999999999999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.3e-47  Score=340.35  Aligned_cols=264  Identities=25%  Similarity=0.315  Sum_probs=202.7

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ..++|++.+.||+|+||.||+|...+++.||+|++......  ....+.+|+.++++++||||+++++++.++...++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            35789999999999999999999888999999999654332  2457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||++ ++|.+++.....              .+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+||+
T Consensus        99 e~~~-~~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~  161 (311)
T 3niz_A           99 EFME-KDLKKVLDENKT--------------GLQDSQIKIYLYQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALKLA  161 (311)
T ss_dssp             ECCS-EEHHHHHHTCTT--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             cCCC-CCHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCchHhEEECCCCCEEEc
Confidence            9996 588888876443              2899999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++....... ......||+.|+|||.+.+...++.++|||||||++|||++|..||........    ........
T Consensus       162 Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~  236 (311)
T 3niz_A          162 DFGLARAFGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ----LPKIFSIL  236 (311)
T ss_dssp             CCTTCEETTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH----HHHHHHHH
T ss_pred             cCcCceecCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHH
Confidence            9999987643322 233456899999999998766789999999999999999999999754332221    11111110


Q ss_pred             Hhcc----------------ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNK----------------EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....                ......... ........+.++.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          237 GTPNPREWPQVQELPLWKQRTFQVFEKKP-WSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCTTTSGGGTTSHHHHSCCCCCCCCCC-HHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCChHHhhhhhccchhhhcccccccCCc-HHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0000                000000000 00001123457899999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1e-47  Score=352.71  Aligned_cols=257  Identities=26%  Similarity=0.363  Sum_probs=205.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            457888899999999999999876 7899999998754332 23468899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++|+|.+++.....              .+++.+++.++.|++.||+|||  +++++||||||+|||++.++.+||+|
T Consensus       193 ~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nil~~~~~~~kl~D  256 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGA--------------RLRVKTLLQMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISD  256 (377)
T ss_dssp             CCTTCBHHHHHHHHGG--------------GCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             cCCCCCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCcCCcccCHHHEEEcCCCcEEECc
Confidence            9999999999976432              2889999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCccc-ccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVS-TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       239 fg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      ||+++.......... ....+++.|+|||.+.+ ..++.++||||||+++|||++ |..|+....       ........
T Consensus       257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~-------~~~~~~~~  328 (377)
T 3cbl_A          257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLS-------NQQTREFV  328 (377)
T ss_dssp             GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC-------HHHHHHHH
T ss_pred             CCCceecCCCceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHH
Confidence            999986433211111 12235778999999874 457889999999999999998 777754321       11111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .. +.     .     ...+..++..+.+++.+||+.||++|||++++++.|+++.
T Consensus       329 ~~-~~-----~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          329 EK-GG-----R-----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             HT-TC-----C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Hc-CC-----C-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            11 10     0     1113345668999999999999999999999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.3e-46  Score=339.59  Aligned_cols=260  Identities=22%  Similarity=0.253  Sum_probs=206.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++......  +.+.+|+.+++++ +||||+++++++.++...++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            36799999999999999999975 57899999998654332  4678999999999 89999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc-----
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE-----  233 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~-----  233 (373)
                      |+ +++|.+++.....              .+++.+++.++.|++.||+|||  +.+++||||||+|||++.++.     
T Consensus        86 ~~-~~~L~~~~~~~~~--------------~~~~~~~~~i~~qi~~~l~~LH--~~~iiHrDlkp~Nill~~~~~~~~~~  148 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDR--------------TFSLKTVLMIAIQLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQV  148 (330)
T ss_dssp             CC-CCBHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTCTTS
T ss_pred             eC-CCCHHHHHHHcCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeeccCCCCCCce
Confidence            99 9999999986532              2999999999999999999999  789999999999999999887     


Q ss_pred             eEEeeeccccccCCCCCc------ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcc
Q 043074          234 AHISDFGLARRIDTSHSH------VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV  307 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  307 (373)
                      +||+|||+++........      ......||+.|+|||.+.+ ..++.++||||||+++|||++|..||......... 
T Consensus       149 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~-  226 (330)
T 2izr_A          149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK-  226 (330)
T ss_dssp             EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH-
T ss_pred             EEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHH-
Confidence            999999999876433221      1245679999999999985 44789999999999999999999997654322211 


Q ss_pred             cHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..............          .......++ ++.+++.+||+.||.+||++.+|.+.|++++
T Consensus       227 ~~~~~i~~~~~~~~----------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          227 ERYQKIGDTKRATP----------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             HHHHHHHHHHHHSC----------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhhhccCC----------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            11111111110000          000011134 8999999999999999999999999998764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.3e-47  Score=363.52  Aligned_cols=257  Identities=25%  Similarity=0.454  Sum_probs=209.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|.+.+.||+|+||.||+|.++ ++..||||.+..... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            456888899999999999999876 488999999976543 457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++|+|.+++......             .+++..++.++.|++.||+|||  +++|+||||||+|||++.++.+||+||
T Consensus       298 ~~~g~L~~~l~~~~~~-------------~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DF  362 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQ-------------EVSAVVLLYMATQISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADF  362 (495)
T ss_dssp             CTTCBHHHHHHHSCTT-------------TSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred             cCCCCHHHHHHhcCcC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChhhEEECCCCcEEEeec
Confidence            9999999999875432             2899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      |+++..............++..|+|||.+.+ ..++.++||||||+++|||++ |..|+.....    .....   ....
T Consensus       363 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~----~~~~~---~~~~  434 (495)
T 1opk_A          363 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYE---LLEK  434 (495)
T ss_dssp             TCEECCTTCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG----GGHHH---HHHT
T ss_pred             ccceeccCCceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH----HHHHH---HHHc
Confidence            9998765433333334456789999999874 457889999999999999999 7777543211    11111   1111


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                                .... ..+..++..+.+++.+||+.||++|||+.+|++.|++++
T Consensus       435 ----------~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          435 ----------DYRM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             ----------TCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ----------CCCC-CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence                      1111 113445678999999999999999999999999999875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=336.05  Aligned_cols=272  Identities=22%  Similarity=0.303  Sum_probs=212.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCC--eeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGL--DRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv  156 (373)
                      .++|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            357889999999999999999765 589999999976443 33567889999999999999999999987665  77999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe----CCCC
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL----DSDF  232 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill----~~~~  232 (373)
                      |||+++++|.+++.......            .+++.+++.++.|++.||+|||  +.+++||||||+||++    +.++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~------------~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~  153 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAY------------GLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQS  153 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTT------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEECTTSCE
T ss_pred             EeCCCCCCHHHHHHHhcccc------------CCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEeccCCCCc
Confidence            99999999999998654321            2899999999999999999999  7899999999999999    7888


Q ss_pred             ceEEeeeccccccCCCCCcccccccccccccCccccCC-------CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCC
Q 043074          233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG-------NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ  305 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~  305 (373)
                      .+||+|||+++......  ......||+.|+|||.+.+       ...++.++|||||||++|||++|..||.+......
T Consensus       154 ~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  231 (319)
T 4euu_A          154 VYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR  231 (319)
T ss_dssp             EEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred             eEEEccCCCceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence            89999999998764432  2234568999999998752       35678899999999999999999999765433222


Q ss_pred             cccHHHHHHHHHHhcc--cccc----------ccCcc-ccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          306 EVGLLEWARTMEARNK--EIEM----------VDSNI-SREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       306 ~~~~~~~~~~~~~~~~--~~~~----------~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                      ....   .........  ....          ....+ .....+...+..+.+++.+||+.||++|||++|+++...+-
T Consensus       232 ~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          232 NKEV---MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             CHHH---HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             hHHH---HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            2111   111111100  0000          00011 11234678889999999999999999999999999988764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.2e-47  Score=340.57  Aligned_cols=247  Identities=21%  Similarity=0.263  Sum_probs=202.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||++..+ +|+.||+|++.+..   ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57888999999999999999765 69999999996542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.....               +++..+..++.||+.||+|||  +++|+||||||+|||++.++.+||+
T Consensus        85 E~~~gg~L~~~l~~~~~---------------~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~vkL~  147 (337)
T 1o6l_A           85 EYANGGELFFHLSRERV---------------FTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKIT  147 (337)
T ss_dssp             ECCTTCBHHHHHHHHSC---------------CCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             eCCCCCcHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeecCcCCHHHEEECCCCCEEEe
Confidence            99999999999976542               899999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.....       ........
T Consensus       148 DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~  218 (337)
T 1o6l_A          148 DFGLCKEGISDG-ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELIL  218 (337)
T ss_dssp             CCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHH
T ss_pred             eccchhhcccCC-CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCH-------HHHHHHHH
Confidence            999998643222 23345679999999999975 4578999999999999999999999754211       11111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                      .. .      ..     ++...+.++.+++.+||+.||++||     +++++++
T Consensus       219 ~~-~------~~-----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          219 ME-E------IR-----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HC-C------CC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             cC-C------CC-----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            10 0      01     1223456899999999999999999     8888865

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.3e-46  Score=333.07  Aligned_cols=261  Identities=20%  Similarity=0.284  Sum_probs=207.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++......  +.+.+|+.++..+ +|+|++++++++.++...++|+|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc--HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999975 57999999998654322  4578899999999 79999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc-----
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE-----  233 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~-----  233 (373)
                      |+ +++|.+++.....              ++++.++..++.|++.||.|||  +++++||||||+||+++.++.     
T Consensus        87 ~~-~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~~~~~~~~~~  149 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGR--------------KFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANM  149 (298)
T ss_dssp             CC-CCBHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTC
T ss_pred             ec-CCCHHHHHHHhcc--------------CCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEeccCCCCCCCe
Confidence            99 9999999986542              2899999999999999999999  899999999999999987776     


Q ss_pred             eEEeeeccccccCCCCCc------ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcc
Q 043074          234 AHISDFGLARRIDTSHSH------VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV  307 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  307 (373)
                      +||+|||+++........      ......||+.|+|||.+.+. .++.++||||||+++|||++|..||..........
T Consensus       150 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  228 (298)
T 1csn_A          150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ  228 (298)
T ss_dssp             EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred             EEEEECccccccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH
Confidence            999999999876543221      23446789999999999754 47899999999999999999999976533222111


Q ss_pred             cHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .... ..........          ......++..+.+++.+||+.||++||++++|++.|++++
T Consensus       229 ~~~~-~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          229 KYER-IGEKKQSTPL----------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             HHHH-HHHHHHHSCH----------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHH-HHhhccCccH----------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence            1111 1111000000          0001223568999999999999999999999999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.4e-47  Score=341.43  Aligned_cols=247  Identities=22%  Similarity=0.351  Sum_probs=202.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++.+...   .....+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999976 5789999999865322   2235788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+ +|+|.+++.....               +++.++..++.|++.||.|||  +.+++||||||+||++++++.+||
T Consensus        88 ~E~~-~g~l~~~l~~~~~---------------l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl  149 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKR---------------MTEDEGRRFFQQIICAIEYCH--RHKIVHRDLKPENLLLDDNLNVKI  149 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCS---------------CCHHHHHHHHHHHHHHHHHHH--HHTCCCCCCSTTTEEECTTCCEEE
T ss_pred             EECC-CCcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeEecCCchhhEEEcCCCCEEE
Confidence            9999 7899998876542               899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++......  .......||+.|+|||.+.+....+.++||||||+++|+|++|..||........           
T Consensus       150 ~DFG~s~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------  216 (336)
T 3h4j_B          150 ADFGLSNIMTDG--NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------  216 (336)
T ss_dssp             CCSSCTBTTTTS--BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------
T ss_pred             EEeccceeccCC--cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------
Confidence            999999865432  2334567999999999998766568899999999999999999999754322111           


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                            .+.+...  ....+...+..+.+++.+||+.||.+|||++|+++
T Consensus       217 ------~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          217 ------FKKVNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ------BCCCCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ------HHHHHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                  0111110  01113334568999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-46  Score=336.69  Aligned_cols=266  Identities=27%  Similarity=0.398  Sum_probs=202.3

Q ss_pred             HHhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcC--CCCCccceeeEEeeC----C
Q 043074           78 IDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL--RHRNIVKILGYCASG----L  151 (373)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~----~  151 (373)
                      ....++|++.+.||+|+||.||+|... ++.||+|++.....   .....|.+++...  +||||+++++++...    .
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            344568999999999999999999875 89999999854332   3445566665554  899999999999887    7


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC--------CceeecCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEK--------PIIHRDIKS  223 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~--------~i~H~dlk~  223 (373)
                      ..++||||+++|+|.+++....                +++..++.++.|++.||+|||  ..        +++||||||
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~i~~~i~~~l~~lH--~~~~~~~~~~~ivH~Dikp  170 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKSTT----------------LDAKSMLKLAYSSVSGLCHLH--TEIFSTQGKPAIAHRDLKS  170 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHHCC----------------BCHHHHHHHHHHHHHHHHHHH--SCBCSTTCBCCEECSCCCG
T ss_pred             ceEEEEeccCCCcHHHHhhccC----------------CCHHHHHHHHHHHHHHHHHHH--HhhhhhccCCCEEecccch
Confidence            8899999999999999997643                899999999999999999999  56        999999999


Q ss_pred             CceEeCCCCceEEeeeccccccCCCCCcc---cccccccccccCccccCCCCCCCc-----cccchhhhHHHHHHHhC--
Q 043074          224 SNVLLDSDFEAHISDFGLARRIDTSHSHV---STQVAGTMGYMPPEYLGGNTAATV-----MLDVYSFGILMIEIATQ--  293 (373)
Q Consensus       224 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~-----~~DiwslG~~l~el~~g--  293 (373)
                      +||+++.++.+||+|||++..........   .....||+.|+|||.+.+......     ++|||||||++|||++|  
T Consensus       171 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~  250 (337)
T 3mdy_A          171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV  250 (337)
T ss_dssp             GGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             HHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence            99999999999999999997664332221   224578999999999975432222     48999999999999999  


Q ss_pred             --------CCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 043074          294 --------IRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVV  365 (373)
Q Consensus       294 --------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~  365 (373)
                              ..|+.........  ...... ..    ......+..........++.++.+++.+||+.||++|||+.+++
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~--~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell  323 (337)
T 3mdy_A          251 SGGIVEEYQLPYHDLVPSDPS--YEDMRE-IV----CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK  323 (337)
T ss_dssp             BTTBCCCCCCTTTTTSCSSCC--HHHHHH-HH----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             cccccccccccHhhhcCCCCc--hhhhHH-HH----hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence                    5554332222211  111111 11    11122222322222447888999999999999999999999999


Q ss_pred             HHHHhhh
Q 043074          366 QLLDELV  372 (373)
Q Consensus       366 ~~L~~l~  372 (373)
                      +.|+++.
T Consensus       324 ~~L~~l~  330 (337)
T 3mdy_A          324 KTLAKMS  330 (337)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.8e-47  Score=342.47  Aligned_cols=253  Identities=23%  Similarity=0.307  Sum_probs=201.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999765 7899999998654332 23568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++|+|.+++....               .+++.++..++.|++.||+|||  +.+++||||||+||+++.++.+||+|
T Consensus        86 ~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~D  148 (323)
T 3tki_A           86 YCSGGELFDRIEPDI---------------GMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISD  148 (323)
T ss_dssp             CCTTEEGGGGSBTTT---------------BCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             cCCCCcHHHHHhhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccccchHHEEEeCCCCEEEEE
Confidence            999999999987543               2899999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCC-CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          239 FGLARRIDTSH-SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       239 fg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      ||++....... ........||+.|+|||++.+....+.++||||||+++|||++|..||.......  .....|.    
T Consensus       149 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~----  222 (323)
T 3tki_A          149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWK----  222 (323)
T ss_dssp             CTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS--HHHHHHH----
T ss_pred             eeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHh----
Confidence            99998653222 1223346799999999999866656889999999999999999999975432211  1111111    


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .....   ..       .....+..+.+++.+||+.||++|||+.|+++
T Consensus       223 ~~~~~---~~-------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          223 EKKTY---LN-------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             TTCTT---ST-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccc---CC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00000   00       01223457889999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.8e-47  Score=357.64  Aligned_cols=257  Identities=25%  Similarity=0.423  Sum_probs=202.2

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ..++|++.+.||+|+||.||+|.++++..||||++..... ..+.+.+|+.++++++||||+++++++.+ ...++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            3467888899999999999999998888899999976543 34678999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++|+|.+++......             .+++.+++.++.|++.||+|||  +++++||||||+|||++.++.+||+||
T Consensus       260 ~~~gsL~~~l~~~~~~-------------~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~Df  324 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGK-------------YLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADF  324 (452)
T ss_dssp             CTTCBHHHHHSHHHHT-------------TCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             hcCCCHHHHHHhcCCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEECCCCCEEECCC
Confidence            9999999999753211             2899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      |+++..............++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....       ..+.......
T Consensus       325 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-------~~~~~~~i~~  396 (452)
T 1fmk_A          325 GLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVER  396 (452)
T ss_dssp             CTTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHT
T ss_pred             ccceecCCCceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHc
Confidence            9998765433222333456789999999874 458899999999999999999 777754321       1111111111


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .      ...     ..+..++..+.+++.+||+.||++|||+++|++.|++++
T Consensus       397 ~------~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          397 G------YRM-----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             T------CCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             C------CCC-----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            1      111     113445678999999999999999999999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.9e-47  Score=336.42  Aligned_cols=264  Identities=25%  Similarity=0.358  Sum_probs=200.2

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|++.+.||+|+||.||+|...+++.||+|++......  ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            578899999999999999998888999999998654322  246788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      ++ ++|.+++.....              .+++..+..++.|++.||.|||  +++++||||||+||+++.++.+||+||
T Consensus        82 ~~-~~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Df  144 (288)
T 1ob3_A           82 LD-QDLKKLLDVCEG--------------GLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADF  144 (288)
T ss_dssp             CS-EEHHHHHHTSTT--------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCT
T ss_pred             cC-CCHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEeEC
Confidence            96 499999876532              2899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++........ ......||+.|+|||.+.+...++.++|||||||++|||++|..||.......   .+..........
T Consensus       145 g~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~  220 (288)
T 1ob3_A          145 GLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTP  220 (288)
T ss_dssp             THHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred             ccccccCcccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCC
Confidence            99987643322 22345689999999999866678999999999999999999999975422110   000000000000


Q ss_pred             c-------cccccccCccc------cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 N-------KEIEMVDSNIS------REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~-------~~~~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .       ......++...      ........+..+.+++.+||+.||++|||++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0       00000111110      00111224568899999999999999999999975

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.4e-46  Score=342.04  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=202.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc------cHHHHHHHHHHHhcCCCCCccceeeEEeeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ------GFREFRAEMETLGKLRHRNIVKILGYCASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  153 (373)
                      .++|.+.+.||+|+||.||+|..+ +|+.||+|.+.+....      ..+.+.+|+.+++.++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            457999999999999999999765 6899999999654332      246789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC-
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-  232 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~-  232 (373)
                      ++||||+++|+|.+++....               ++++..+..++.||+.||.|||  +.+++||||||+||+++.++ 
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~---------------~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~  153 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE---------------SLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNI  153 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS---------------CCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTS
T ss_pred             EEEEEcCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEeCCCC
Confidence            99999999999999997543               2899999999999999999999  78999999999999998877 


Q ss_pred             ---ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          233 ---EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       233 ---~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                         .+||+|||++.......  ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....       
T Consensus       154 ~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-------  223 (361)
T 2yab_A          154 PIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTK-------  223 (361)
T ss_dssp             SSCCEEECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------
T ss_pred             CccCEEEEecCCceEcCCCC--ccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------
Confidence               79999999998764322  2344679999999999975 4578999999999999999999999754211       


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .+.........   .......     ....+..+.+++.+||+.||++|||+.++++
T Consensus       224 ~~~~~~i~~~~---~~~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          224 QETLANITAVS---YDFDEEF-----FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHHHHHTTC---CCCCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHhcC---CCCCchh-----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11111111100   0000000     1123457899999999999999999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.1e-46  Score=353.42  Aligned_cols=251  Identities=26%  Similarity=0.416  Sum_probs=203.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-eeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGL-DRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  159 (373)
                      .++|++.+.||+|+||.||+|..+ ++.||||+++...  ..+.+.+|+.++++++||||+++++++.+.. ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            457888899999999999999885 7899999997654  3467899999999999999999999987665 78999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++|+|.+++......             .+++..++.++.|++.||+|||  +++++||||||+|||++.++.+||+||
T Consensus       269 ~~~g~L~~~l~~~~~~-------------~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~Df  333 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRS-------------VLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDF  333 (450)
T ss_dssp             CTTCBHHHHHHHHCTT-------------TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTSCEEECCC
T ss_pred             cCCCcHHHHHHhcCCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEECCCCCEEEeeC
Confidence            9999999999875432             2789999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      |+++.....    .....+++.|+|||.+.+ ..++.++||||||+++|||++ |..|+......    ..   ......
T Consensus       334 G~a~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~---~~~i~~  401 (450)
T 1k9a_A          334 GLTKEASST----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DV---VPRVEK  401 (450)
T ss_dssp             TTCEECC----------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT----TH---HHHHHT
T ss_pred             CCccccccc----ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HH---HHHHHc
Confidence            999864322    122356889999999974 458899999999999999998 88886432211    11   111111


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                       +     ...     ..+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       402 -~-----~~~-----~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          402 -G-----YKM-----DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             -T-----CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -C-----CCC-----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence             1     111     114455678999999999999999999999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.1e-48  Score=340.60  Aligned_cols=252  Identities=22%  Similarity=0.399  Sum_probs=205.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CC-------CEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SG-------VTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLD  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  152 (373)
                      .++|.+.+.||+|+||.||+|... ++       ..||+|.+........+.+.+|+.++++++||||+++++++.++..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            357888999999999999999654 23       5799999977666667789999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++||||+++|+|.+++.....              .+++..++.++.|++.||.|||  +++++||||||+||+++.++
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~  150 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKN--------------CINILWKLEVAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREE  150 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGG--------------GCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEEECC
T ss_pred             CEEEEECCCCCCHHHHHHhCCC--------------CCCHHHHHHHHHHHHHHHHHHh--hCCeECCCcCcceEEEecCC
Confidence            9999999999999999986542              2889999999999999999999  78999999999999999888


Q ss_pred             c--------eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCC
Q 043074          233 E--------AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDG  304 (373)
Q Consensus       233 ~--------~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  304 (373)
                      .        +||+|||++.....     .....+|+.|+|||.+.+...++.++||||||+++|||++|..|+.......
T Consensus       151 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~  225 (289)
T 4fvq_A          151 DRKTGNPPFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ  225 (289)
T ss_dssp             BGGGTBCCEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             cccccccceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH
Confidence            7        99999999875432     2234578899999999865668999999999999999999776654322111


Q ss_pred             CcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                            .........        ..+     +...+.++.+++.+||+.||++|||+.++++.|++++
T Consensus       226 ------~~~~~~~~~--------~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          226 ------RKLQFYEDR--------HQL-----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             ------HHHHHHHTT--------CCC-----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             ------HHHHHhhcc--------CCC-----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                  111111110        011     1112346899999999999999999999999999876

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.3e-46  Score=333.73  Aligned_cols=264  Identities=23%  Similarity=0.314  Sum_probs=201.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ++|++.+.||+|+||.||+|... +++.||+|++......  ....+.+|+.++++++||||+++++++.++...++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57889999999999999999764 6899999999654332  24678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++ +|.+++.....              .+++..+..++.|++.||+|||  +++++||||||+||+++.++.+||+|
T Consensus        82 ~~~~-~l~~~~~~~~~--------------~l~~~~~~~~~~ql~~~l~~lH--~~~ivH~dikp~Nil~~~~~~~kl~D  144 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNG--------------DLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLAN  144 (292)
T ss_dssp             CCSE-EHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             cCCC-CHHHHHHhCCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEee
Confidence            9965 66666654332              2899999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||+++...... .......||+.|+|||.+.+...++.++|||||||++|||++|..|+++.....   ...........
T Consensus       145 fg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~---~~~~~i~~~~~  220 (292)
T 3o0g_A          145 FGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLG  220 (292)
T ss_dssp             CTTCEECCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH---HHHHHHHHHHC
T ss_pred             cccceecCCcc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhC
Confidence            99998764332 223445789999999999876668999999999999999999999865432211   11111111000


Q ss_pred             hccc-----ccc---------ccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKE-----IEM---------VDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~-----~~~---------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....     ...         ..............+..+.+++.+||+.||++|||++|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0000     000         00000001112234568899999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-46  Score=329.16  Aligned_cols=255  Identities=27%  Similarity=0.407  Sum_probs=208.1

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      ++|++.+.||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            57888899999999999999988889999999976543 34678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +++|.+++.....              .+++..++.++.|++.||.|||  +++++|+||||+||+++.++.+||+|||+
T Consensus        87 ~~~L~~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~dfg~  150 (267)
T 3t9t_A           87 HGCLSDYLRTQRG--------------LFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGM  150 (267)
T ss_dssp             TCBHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred             CCcHHHHHhhCcc--------------cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEECCCCCEEEccccc
Confidence            9999999986542              2889999999999999999999  78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      +...............+++.|+|||.+.+ ..++.++||||||+++|||++ |..|+....       ........... 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~i~~~-  221 (267)
T 3t9t_A          151 TRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTG-  221 (267)
T ss_dssp             GGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTT-
T ss_pred             ccccccccccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCC-------HHHHHHHHhcC-
Confidence            98754322222233456788999999874 447889999999999999999 777764321       11111111111 


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                           ....     .+...+..+.+++.+||+.||++||++.++++.|+++.
T Consensus       222 -----~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          222 -----FRLY-----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             -----CCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CcCC-----CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                 0001     12233568999999999999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=344.50  Aligned_cols=272  Identities=29%  Similarity=0.406  Sum_probs=211.2

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC--------CCCEEEEEEeCccccc-cHHHHHHHHHHHhcC-CCCCccceeeEEee
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS--------SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKL-RHRNIVKILGYCAS  149 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  149 (373)
                      ..++|.+.+.||+|+||.||+|...        ++..||+|++...... ..+.+.+|+.+++++ +||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            3468899999999999999999752        2357999999765433 346788999999999 89999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhcCCCCCCC-CcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe
Q 043074          150 GLDRVLIYEFVENGSLDQWLHDTSRNDDV-DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL  228 (373)
Q Consensus       150 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill  228 (373)
                      +...++||||+++|+|.+++......... ...........+++.+++.++.|++.||.|||  +.+++||||||+|||+
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCcceEEE
Confidence            99999999999999999999876532110 00001111224899999999999999999999  7899999999999999


Q ss_pred             CCCCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCc
Q 043074          229 DSDFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQE  306 (373)
Q Consensus       229 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~  306 (373)
                      +.++.+||+|||+++....... .......+|+.|+|||.+.+ ..++.++||||||+++|||++ |..|+....     
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~-----  298 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----  298 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-----
Confidence            9999999999999987654322 22334567889999999975 458899999999999999999 888864321     


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                        ..+.........      ...     .+..++.++.+++.+||+.||++|||+.++++.|++++
T Consensus       299 --~~~~~~~~~~~~------~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          299 --VEELFKLLKEGH------RMD-----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             --HHHHHHHHHTTC------CCC-----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHHHHHcCC------CCC-----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              111222111110      001     12234568999999999999999999999999999886

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.9e-46  Score=344.20  Aligned_cols=251  Identities=21%  Similarity=0.312  Sum_probs=198.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  155 (373)
                      .++|++.+.||+|+||.||++..+ +++.||+|++++....   ..+.+..|..++.++ +||||+++++++.+....++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            457899999999999999999765 6889999999764322   234578899999887 89999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||+++|+|..++.....               +++..+..++.||+.||+|||  +++|+||||||+|||++.++.+|
T Consensus       131 V~E~~~gg~L~~~l~~~~~---------------l~~~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ik  193 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRK---------------LPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIK  193 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEE
T ss_pred             EEEcCCCCcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEECCCCCEE
Confidence            9999999999999986542               899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc-ccHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE-VGLLEWAR  314 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~  314 (373)
                      |+|||+++..... .......+||+.|+|||++.+. .++.++|||||||++|||++|..||......... .....+..
T Consensus       194 L~DFGla~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~  271 (396)
T 4dc2_A          194 LTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF  271 (396)
T ss_dssp             ECCCTTCBCCCCT-TCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH
T ss_pred             EeecceeeecccC-CCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH
Confidence            9999999863222 2234457899999999999854 5789999999999999999999998543222111 11111111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                      .......      ..     ++...+.++.+++.+||+.||++||++
T Consensus       272 ~~i~~~~------~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          272 QVILEKQ------IR-----IPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHHHCC------CC-----CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             HHHhccc------cC-----CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            1111110      11     123345689999999999999999996

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=332.12  Aligned_cols=250  Identities=23%  Similarity=0.346  Sum_probs=195.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc--------------------------cHHHHHHHHHHHh
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ--------------------------GFREFRAEMETLG  133 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~  133 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++......                          ..+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46899999999999999999976 46889999998654321                          1356889999999


Q ss_pred             cCCCCCccceeeEEee--CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 043074          134 KLRHRNIVKILGYCAS--GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHG  211 (373)
Q Consensus       134 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~  211 (373)
                      +++||||+++++++.+  ....++||||+++++|.+++...                ++++.++..++.|++.||+||| 
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~qi~~~l~~lH-  154 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----------------PLSEDQARFYFQDLIKGIEYLH-  154 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----------------CCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHH-
Confidence            9999999999999986  56889999999999998765322                3899999999999999999999 


Q ss_pred             CCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCC--CCccccchhhhHHHHH
Q 043074          212 LEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTA--ATVMLDVYSFGILMIE  289 (373)
Q Consensus       212 ~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~~DiwslG~~l~e  289 (373)
                       +++++||||||+||+++.++.+||+|||++........ ......||+.|+|||.+.+...  ++.++||||||+++||
T Consensus       155 -~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~  232 (298)
T 2zv2_A          155 -YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC  232 (298)
T ss_dssp             -HTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred             -HCCeeccCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence             78999999999999999999999999999987654322 2334578999999999975442  4778999999999999


Q ss_pred             HHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          290 IATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       290 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      |++|..||....       ...+........     .....     ....+..+.+++.+||+.||++|||+.++++
T Consensus       233 l~~g~~pf~~~~-------~~~~~~~~~~~~-----~~~~~-----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          233 FVFGQCPFMDER-------IMCLHSKIKSQA-----LEFPD-----QPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHSSCSSCCSS-------HHHHHHHHHHCC-----CCCCS-----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHCCCCCCCcc-------HHHHHHHHhccc-----CCCCC-----ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            999999975421       112211111110     00000     1123457999999999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.3e-47  Score=332.77  Aligned_cols=256  Identities=24%  Similarity=0.355  Sum_probs=193.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC----CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      .++|++.+.||+|+||.||+|...    .+..||+|.+...... ..+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            458889999999999999999764    2457999998664332 3467889999999999999999999984 457889


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||+++++|.+++.....              ++++..++.++.|++.||.|||  +++++||||||+||+++.++.+|
T Consensus        93 v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~k  156 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKY--------------SLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVK  156 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTT--------------TSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEE
T ss_pred             EEecCCCCCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHEEECCCCCEE
Confidence            9999999999999976542              2899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      |+|||+++..............+|+.|+|||.+.+ ..++.++||||||+++|||++ |..||......    ...   .
T Consensus       157 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~----~~~---~  228 (281)
T 1mp8_A          157 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVI---G  228 (281)
T ss_dssp             ECC-------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHH---H
T ss_pred             ECccccccccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH----HHH---H
Confidence            99999998765443333334456789999999874 457889999999999999997 77786532211    111   1


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..... .     ..     ..+..++..+.+++.+||+.||++|||+.++++.|++++
T Consensus       229 ~i~~~-~-----~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          229 RIENG-E-----RL-----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             HHHTT-C-----CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHcC-C-----CC-----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11110 0     00     113344568999999999999999999999999999875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.1e-46  Score=343.71  Aligned_cols=253  Identities=21%  Similarity=0.266  Sum_probs=193.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|++.+.||+|+||.||++... +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999765 7899999999654432 35688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc--eEEe
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE--AHIS  237 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~--~kl~  237 (373)
                      +++|+|.+++.....               +++..+..++.|++.||+|||  +++++||||||+||+++.++.  +||+
T Consensus        98 ~~~~~L~~~l~~~~~---------------~~~~~~~~i~~ql~~~L~~LH--~~~ivH~Dlkp~Nill~~~~~~~~kl~  160 (361)
T 3uc3_A           98 ASGGELYERICNAGR---------------FSEDEARFFFQQLLSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKIC  160 (361)
T ss_dssp             CCSCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--HTTCCSCCCCGGGEEECSSSSCCEEEC
T ss_pred             CCCCCHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCceEEEe
Confidence            999999999976542               899999999999999999999  789999999999999987765  9999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++.....  .......||+.|+|||++.+....+.++|||||||++|+|++|..||.......   ..........
T Consensus       161 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~~~~~~~  235 (361)
T 3uc3_A          161 DFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR---DYRKTIQRIL  235 (361)
T ss_dssp             CCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC---CHHHHHHHHH
T ss_pred             ecCcccccccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH---HHHHHHHHHh
Confidence            99999753221  122345699999999999866655666999999999999999999975433221   1111111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...       .....   ....+..+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~-------~~~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          236 SVK-------YSIPD---DIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             TTC-------CCCCT---TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cCC-------CCCCC---cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            100       00100   1122457899999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=344.01  Aligned_cols=250  Identities=25%  Similarity=0.336  Sum_probs=202.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||++... +++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            57889999999999999999764 68899999986533   233567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+.+|+|.+++....               .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+
T Consensus        95 e~~~gg~L~~~l~~~~---------------~l~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL~  157 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV---------------HFKEETVKLFICELVMALDYLQ--NQRIIHRDMKPDNILLDEHGHVHIT  157 (384)
T ss_dssp             CCCTTEEHHHHHHTTC---------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             ecCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEECCCCCEEEe
Confidence            9999999999998654               2899999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCC--CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |||++......  .......||+.|+|||++.+  ...++.++|||||||++|||++|..||.......    .......
T Consensus       158 DFG~a~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----~~~~~~~  231 (384)
T 4fr4_A          158 DFNIAAMLPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS----SKEIVHT  231 (384)
T ss_dssp             CCTTCEECCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC----HHHHHHH
T ss_pred             ccceeeeccCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc----HHHHHHH
Confidence            99999876432  23345679999999999864  2347889999999999999999999975432221    1111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA-MSYVVQ  366 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~l~~  366 (373)
                      .....       .     ..+...+..+.+++.+||+.||.+||+ ++++.+
T Consensus       232 ~~~~~-------~-----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          232 FETTV-------V-----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHCC-------C-----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             Hhhcc-------c-----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            11100       0     112334568999999999999999999 666653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=338.90  Aligned_cols=266  Identities=27%  Similarity=0.433  Sum_probs=199.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHH--HhcCCCCCccceeeEEee-----CCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMET--LGKLRHRNIVKILGYCAS-----GLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~~~  153 (373)
                      .++|++.+.||+|+||.||+|.. +++.||+|++.....   ..+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46899999999999999999977 589999999965432   334444444  455899999999985532     2356


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC---------CceeecCCCC
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEK---------PIIHRDIKSS  224 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~---------~i~H~dlk~~  224 (373)
                      ++||||+++|+|.+++....                .++..+..++.|++.||.|||  +.         +++||||||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~i~~qi~~~L~~LH--~~~~~~~~~~~~ivH~Dikp~  149 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT----------------SDWVSSCRLAHSVTRGLAYLH--TELPRGDHYKPAISHRDLNSR  149 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC----------------BCHHHHHHHHHHHHHHHHHHH--CCBCCGGGCBCCEECSSCSGG
T ss_pred             EEEEecCCCCcHHHHHhhcc----------------cchhHHHHHHHHHHHHHHHHH--hhhccccccccceeecccccc
Confidence            89999999999999997654                688999999999999999999  67         9999999999


Q ss_pred             ceEeCCCCceEEeeeccccccCCCC-------CcccccccccccccCccccCCC------CCCCccccchhhhHHHHHHH
Q 043074          225 NVLLDSDFEAHISDFGLARRIDTSH-------SHVSTQVAGTMGYMPPEYLGGN------TAATVMLDVYSFGILMIEIA  291 (373)
Q Consensus       225 Nill~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~~g~~~y~aPE~~~~~------~~~~~~~DiwslG~~l~el~  291 (373)
                      |||++.++.+||+|||+++......       ........||+.|+|||++.+.      ..++.++|||||||++|||+
T Consensus       150 Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell  229 (336)
T 3g2f_A          150 NVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF  229 (336)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHH
Confidence            9999999999999999998764321       1122345689999999999752      34567899999999999999


Q ss_pred             hCCCCCCCcccCCCcccHH----------HHHHHHHHhccccccccCccccc-cCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 043074          292 TQIRPNLPVVLDGQEVGLL----------EWARTMEARNKEIEMVDSNISRE-ELSEAGVREYFRIACMCTNEKSRERPA  360 (373)
Q Consensus       292 ~g~~p~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (373)
                      +|..|+++...........          ...........    ..+.+... .....++..+.+++.+||+.||++|||
T Consensus       230 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps  305 (336)
T 3g2f_A          230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT  305 (336)
T ss_dssp             TTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred             hcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcc
Confidence            9988876654433211110          00111111111    11111111 012346778999999999999999999


Q ss_pred             HHHHHHHHHhhh
Q 043074          361 MSYVVQLLDELV  372 (373)
Q Consensus       361 ~~~l~~~L~~l~  372 (373)
                      ++++++.|++++
T Consensus       306 ~~e~l~~L~~ll  317 (336)
T 3g2f_A          306 AQXAEERMAELM  317 (336)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHH
Confidence            999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-46  Score=340.02  Aligned_cols=273  Identities=27%  Similarity=0.453  Sum_probs=209.8

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCC
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGL  151 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  151 (373)
                      ...++|++.+.||+|+||.||+|...      +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.++.
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            35678999999999999999999764      3488999999765433 3567899999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCC---------cccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVD---------GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIK  222 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~---------~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk  222 (373)
                      ..++||||+++|+|.+++..........         .........++++.+++.++.|++.||.|||  +++++|||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlk  201 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLA  201 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCS
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCC
Confidence            9999999999999999998754211000         0000001124899999999999999999999  7899999999


Q ss_pred             CCceEeCCCCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCc
Q 043074          223 SSNVLLDSDFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPV  300 (373)
Q Consensus       223 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~  300 (373)
                      |+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+. .++.++||||||+++|||++ |..|+...
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            9999999999999999999986543221 122345678899999998744 47899999999999999999 88886532


Q ss_pred             ccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .       ..+....... ...          ...+..++..+.+++.+||+.||++||++.++++.|+++.
T Consensus       281 ~-------~~~~~~~~~~-~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          281 A-------HEEVIYYVRD-GNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             C-------HHHHHHHHHT-TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             C-------hHHHHHHHhC-CCc----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence            1       1111111111 111          0113344568999999999999999999999999999875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.9e-46  Score=336.56  Aligned_cols=250  Identities=22%  Similarity=0.371  Sum_probs=196.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCC--------
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGL--------  151 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------  151 (373)
                      ++|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            46888999999999999999875 7999999999654433 3567899999999999999999999986543        


Q ss_pred             -------------------------------------------------eeEEEEEecCCCCHHHHhhcCCCCCCCCccc
Q 043074          152 -------------------------------------------------DRVLIYEFVENGSLDQWLHDTSRNDDVDGSK  182 (373)
Q Consensus       152 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  182 (373)
                                                                       ..++||||+++++|.+++.......      
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~------  159 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE------  159 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG------
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc------
Confidence                                                             2799999999999999998755322      


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCC-----------c
Q 043074          183 QLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS-----------H  251 (373)
Q Consensus       183 ~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------~  251 (373)
                            ..++..++.++.|++.||+|||  +++++||||||+||+++.++.+||+|||+++.......           .
T Consensus       160 ------~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~  231 (332)
T 3qd2_B          160 ------DREHGVCLHIFIQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA  231 (332)
T ss_dssp             ------GSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------
T ss_pred             ------chhhHHHHHHHHHHHHHHHHHH--hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccc
Confidence                  2677789999999999999999  78999999999999999999999999999987654321           1


Q ss_pred             ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccc
Q 043074          252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNIS  331 (373)
Q Consensus       252 ~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (373)
                      ......||+.|+|||.+.+. .++.++||||||+++|||++|..|+..         ..........         ..  
T Consensus       232 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~---------~~~~~~~~~~---------~~--  290 (332)
T 3qd2_B          232 THTGQVGTKLYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME---------RVRIITDVRN---------LK--  290 (332)
T ss_dssp             CCCSCC-CGGGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH---------HHHHHHHHHT---------TC--
T ss_pred             cccccCCCcCccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH---------HHHHHHHhhc---------cC--
Confidence            22345789999999999754 578999999999999999998766210         0000000000         00  


Q ss_pred             cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          332 REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ........+..+.+++.+||+.||++|||+.++++
T Consensus       291 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            01112344567899999999999999999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-45  Score=326.15  Aligned_cols=254  Identities=30%  Similarity=0.535  Sum_probs=203.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccccc-------HHHHHHHHHHHhcCCCCCccceeeEEeeCCe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQG-------FREFRAEMETLGKLRHRNIVKILGYCASGLD  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  152 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.......       .+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46889999999999999999976 478999999986543321       257889999999999999999999987665 


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--ceeecCCCCceEeCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP--IIHRDIKSSNVLLDS  230 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~--i~H~dlk~~Nill~~  230 (373)
                       ++||||+++|+|.+++.....              ++++..++.++.|++.||+|||  +.+  ++||||||+||+++.
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~l~~~l~~lH--~~~~~ivH~dikp~Nil~~~  159 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAH--------------PIKWSVKLRLMLDIALGIEYMQ--NQNPPIVHRDLRSPNIFLQS  159 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTS--------------CCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCSCCSGGGEEESC
T ss_pred             -eEEEEecCCCCHHHHHhcccC--------------CccHHHHHHHHHHHHHHHHHHH--hCCCCeecCCCCcceEEEec
Confidence             699999999999998875442              3899999999999999999999  677  999999999999988


Q ss_pred             CCc-----eEEeeeccccccCCCCCcccccccccccccCccccCC-CCCCCccccchhhhHHHHHHHhCCCCCCCcccCC
Q 043074          231 DFE-----AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG-NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDG  304 (373)
Q Consensus       231 ~~~-----~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  304 (373)
                      ++.     +||+|||+++....    ......||+.|+|||.+.+ ...++.++||||||+++|||++|..||...... 
T Consensus       160 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-  234 (287)
T 4f0f_A          160 LDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-  234 (287)
T ss_dssp             CCTTCSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC-
T ss_pred             cCCCCceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc-
Confidence            776     99999999975432    2344678999999999843 344688999999999999999999997543221 


Q ss_pred             CcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                          ...+........     ....     .+..++..+.+++.+||+.||.+|||+.++++.|+++
T Consensus       235 ----~~~~~~~~~~~~-----~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          235 ----KIKFINMIREEG-----LRPT-----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ----HHHHHHHHHHSC-----CCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ----HHHHHHHHhccC-----CCCC-----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                111111111111     1111     1334466899999999999999999999999999875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-46  Score=334.34  Aligned_cols=251  Identities=21%  Similarity=0.268  Sum_probs=202.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999765 68899999986543 3345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC--CCceEEe
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS--DFEAHIS  237 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~--~~~~kl~  237 (373)
                      +++|+|.+++.....              ++++.+++.++.|++.||.|||  +++++||||||+||+++.  ++.+||+
T Consensus        83 ~~g~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~al~~lH--~~givH~Dlkp~NIl~~~~~~~~~kl~  146 (321)
T 1tki_A           83 ISGLDIFERINTSAF--------------ELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKII  146 (321)
T ss_dssp             CCCCBHHHHHTSSSC--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred             CCCCCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEccCCCCCEEEE
Confidence            999999999975432              2899999999999999999999  789999999999999987  7899999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||++.......  ......||+.|+|||++.+. .++.++||||||+++|+|++|..||.....       ........
T Consensus       147 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~  216 (321)
T 1tki_A          147 EFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIM  216 (321)
T ss_dssp             CCTTCEECCTTC--EEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHH
T ss_pred             ECCCCeECCCCC--ccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHHH
Confidence            999998764332  23445789999999999754 478899999999999999999999754221       11111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .....   .....     ....+.++.+++.+||+.||.+|||+.|+++
T Consensus       217 ~~~~~---~~~~~-----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          217 NAEYT---FDEEA-----FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HTCCC---CCHHH-----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCCC---CChhh-----hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11000   00000     0123458999999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2e-46  Score=334.14  Aligned_cols=264  Identities=24%  Similarity=0.421  Sum_probs=205.2

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-----CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeC--Cee
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASG--LDR  153 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  153 (373)
                      ++|++.+.||+|+||.||+|.+     .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4688889999999999999983     4689999999975433 3456789999999999999999999999776  668


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++||||+++++|.+++.....              .+++.+++.++.|++.||+|||  +++++||||||+||+++.++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~  164 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKN--------------KINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQ  164 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTT--------------TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTE
T ss_pred             EEEEEeCCCCcHHHHHHhccc--------------cCCHHHHHHHHHHHHHHHHHhh--cCCcccCCCchheEEEcCCCC
Confidence            999999999999999965442              2899999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCC--cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccC--------
Q 043074          234 AHISDFGLARRIDTSHS--HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD--------  303 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--------  303 (373)
                      +||+|||++........  .......+|..|+|||.+.+. .++.++||||||+++|||++|..|+......        
T Consensus       165 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  243 (302)
T 4e5w_A          165 VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT  243 (302)
T ss_dssp             EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC
T ss_pred             EEECcccccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCc
Confidence            99999999987654432  223345678889999998743 4788999999999999999999884322100        


Q ss_pred             CCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhC
Q 043074          304 GQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA  373 (373)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~~  373 (373)
                      ...............          .. ....+..++..+.+++.+||+.||.+|||+.++++.|++++.
T Consensus       244 ~~~~~~~~~~~~~~~----------~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          244 HGQMTVTRLVNTLKE----------GK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             CGGGHHHHHHHHHHT----------TC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             ccccCHHHHHHHHhc----------cC-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            000001111111110          00 011133445689999999999999999999999999999873

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.2e-47  Score=352.30  Aligned_cols=257  Identities=19%  Similarity=0.250  Sum_probs=205.2

Q ss_pred             HHHhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe
Q 043074           77 LIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLD  152 (373)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  152 (373)
                      +....++|++.+.||+|+||.||+|..+ +++.||+|++.+...   ...+.+.+|+.++..++||||+++++++.+...
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3345678999999999999999999765 689999999865322   223457899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++||||+++|+|.+++....                +++..+..++.||+.||+|||  +.+|+||||||+|||++.++
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~~----------------~~e~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g  205 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNYD----------------VPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSG  205 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHCC----------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTS
T ss_pred             EEEEEeCCCCCcHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeeECCCC
Confidence            999999999999999997643                889999999999999999999  78999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCcccccccccccccCccccCCCC---CCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNT---AATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      .+||+|||+++.............+||+.|+|||++.+..   .++.++|||||||++|||++|..||......      
T Consensus       206 ~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------  279 (410)
T 3v8s_A          206 HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------  279 (410)
T ss_dssp             CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------
T ss_pred             CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------
Confidence            9999999999876544433444678999999999987533   2678999999999999999999998642211      


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRE--RPAMSYVVQ  366 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~l~~  366 (373)
                       .............     ....   ....+.++.+++.+||+.+|.+  ||++++|++
T Consensus       280 -~~~~~i~~~~~~~-----~~p~---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          280 -GTYSKIMNHKNSL-----TFPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             -HHHHHHHTHHHHC-----CCCT---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             -hHHHHHHhccccc-----cCCC---cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence             1111111100000     0000   1123458999999999999988  999999875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.6e-47  Score=354.41  Aligned_cols=262  Identities=20%  Similarity=0.233  Sum_probs=207.0

Q ss_pred             HHHHHhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeC
Q 043074           75 SELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASG  150 (373)
Q Consensus        75 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  150 (373)
                      .++....++|++.+.||+|+||.||+|..+ +++.||+|++.+....   ....+.+|..++..++||||+++++++.+.
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            334445689999999999999999999875 5789999999653221   223478999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      ...++||||+++|+|.+++.....              .+++..+..++.|++.||.|||  +.+|+||||||+|||++.
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~~--------------~l~e~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILl~~  210 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFED--------------RLPEEMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDM  210 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTTT--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECT
T ss_pred             CEEEEEEecCCCCcHHHHHHHccC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeeEcC
Confidence            999999999999999999986432              2899999999999999999999  789999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCcccccccccccccCccccC----CCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          231 DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG----GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                      ++.+||+|||+++.............+||+.|+|||++.    +...++.++|||||||++|||++|..||......   
T Consensus       211 ~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---  287 (437)
T 4aw2_A          211 NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---  287 (437)
T ss_dssp             TSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---
T ss_pred             CCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---
Confidence            999999999999876554444445568999999999986    2455789999999999999999999998642211   


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRE--RPAMSYVVQ  366 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~l~~  366 (373)
                          +............. + +..     ....+.++.+++.+||..+|++  ||+++++++
T Consensus       288 ----~~~~~i~~~~~~~~-~-p~~-----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          288 ----ETYGKIMNHKERFQ-F-PTQ-----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             ----HHHHHHHTHHHHCC-C-CSS-----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ----HHHHhhhhcccccc-C-Ccc-----cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence                11111110000000 0 000     1123457899999999888888  999999875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=343.02  Aligned_cols=263  Identities=27%  Similarity=0.406  Sum_probs=206.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  153 (373)
                      .++|++.+.||+|+||.||+|.+.      +++.||||++..... .....+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467889999999999999999743      467899999965433 3345788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC-
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-  232 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~-  232 (373)
                      ++||||+++|+|.+++........        ....+++.+++.++.|++.||+|||  +++|+||||||+|||++.++ 
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~  219 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPS--------QPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGP  219 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSS--------SCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSST
T ss_pred             EEEEEeCCCCCHHHHHHhhccccC--------ccccccHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEEecCCC
Confidence            999999999999999987653211        1123899999999999999999999  78999999999999999555 


Q ss_pred             --ceEEeeeccccccCCCC-CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCccc
Q 043074          233 --EAHISDFGLARRIDTSH-SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVG  308 (373)
Q Consensus       233 --~~kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~  308 (373)
                        .+||+|||+++...... ........+|+.|+|||.+.+ ..++.++|||||||++|||++ |..||....       
T Consensus       220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~-------  291 (367)
T 3l9p_A          220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------  291 (367)
T ss_dssp             TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------
T ss_pred             CceEEECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-------
Confidence              59999999998642211 122334567899999999874 458899999999999999998 877764321       


Q ss_pred             HHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          309 LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..+.........      .     ...+..++..+.+++.+||+.||++||++.+|++.|+.+.
T Consensus       292 ~~~~~~~i~~~~------~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          292 NQEVLEFVTSGG------R-----MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             HHHHHHHHHTTC------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCC------C-----CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            111111111110      0     0113344568999999999999999999999999998764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.7e-46  Score=327.18  Aligned_cols=251  Identities=29%  Similarity=0.469  Sum_probs=192.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccc----cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ----GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|++.+.||+|+||.||+|... +..+|+|++......    ..+.+.+|+.+++.++||||+++++++.++...++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357888999999999999999875 889999998654332    246788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---ceeecCCCCceEeCC---
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP---IIHRDIKSSNVLLDS---  230 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~---i~H~dlk~~Nill~~---  230 (373)
                      |||+++++|.+++....                +++..++.++.|++.||.|||  +++   ++||||||+||+++.   
T Consensus        85 ~e~~~~~~L~~~~~~~~----------------~~~~~~~~i~~~l~~~l~~lH--~~~~~~i~H~dikp~Nil~~~~~~  146 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGKR----------------IPPDILVNWAVQIARGMNYLH--DEAIVPIIHRDLKSSNILILQKVE  146 (271)
T ss_dssp             EECCTTEEHHHHHTSSC----------------CCHHHHHHHHHHHHHHHHHHH--HSSSSCCCCSCCSGGGEEESSCCS
T ss_pred             EEcCCCCCHHHHhhcCC----------------CCHHHHHHHHHHHHHHHHHHH--hCCCCceeecCCchHHEEEecccc
Confidence            99999999999986432                899999999999999999999  666   999999999999986   


Q ss_pred             -----CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCC
Q 043074          231 -----DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ  305 (373)
Q Consensus       231 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~  305 (373)
                           ++.+||+|||++.......   .....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.....   
T Consensus       147 ~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---  219 (271)
T 3dtc_A          147 NGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---  219 (271)
T ss_dssp             SSCCSSCCEEECCCCC----------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---
T ss_pred             cccccCcceEEccCCccccccccc---ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---
Confidence                 6789999999998654322   224568999999999874 4478899999999999999999999753211   


Q ss_pred             cccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          306 EVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                          ......... ..    ...     ..+..++..+.+++.+||+.||.+|||+.++++.|+++
T Consensus       220 ----~~~~~~~~~-~~----~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          220 ----LAVAYGVAM-NK----LAL-----PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ----HHHHHHHHT-SC----CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ----HHHHHhhhc-CC----CCC-----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                111111111 00    111     11334456899999999999999999999999999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.4e-47  Score=337.49  Aligned_cols=244  Identities=23%  Similarity=0.298  Sum_probs=192.1

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|+..+.||+|+||+||+|... +++.||||++......  .......|+..+.++ +||||+++++++.++...++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57899999999999999999775 7999999998654332  233445566555555 8999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+ +++|.+++.....              ++++..++.++.|++.||+|||  +.+|+||||||+|||++.++.+||+
T Consensus       137 e~~-~~~L~~~~~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~  199 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGA--------------SLPEAQVWGYLRDTLLALAHLH--SQGLVHLDVKPANIFLGPRGRCKLG  199 (311)
T ss_dssp             ECC-CCBHHHHHHHHCS--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECGGGCEEEC
T ss_pred             ecc-CCCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEc
Confidence            999 7799998876543              2999999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||++.......  ......||+.|+|||++.+  .++.++|||||||++|||++|..|+....         .|.. . 
T Consensus       200 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~~~-~-  264 (311)
T 3p1a_A          200 DFGLLVELGTAG--AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQ-L-  264 (311)
T ss_dssp             CCTTCEECC--------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HHHH-H-
T ss_pred             cceeeeecccCC--CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHH-H-
Confidence            999998764322  2334568999999999875  47889999999999999999987754311         1110 0 


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....    .     ....+...+.++.+++.+||+.||++|||+.++++
T Consensus       265 ~~~~----~-----~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          265 RQGY----L-----PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             TTTC----C-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hccC----C-----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            0000    0     00011223568999999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.7e-46  Score=325.37  Aligned_cols=252  Identities=22%  Similarity=0.360  Sum_probs=203.2

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASG--LDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||+|..+ +..+|+|++.....  ...+.+.+|+.++++++||||+++++++.+.  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            47888999999999999999885 88999999976532  3346789999999999999999999999877  7889999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--ceeecCCCCceEeCCCCceE
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP--IIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~--i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||+++|+|.+++......             ++++.+++.++.|++.||.|||  +.+  ++||||||+||+++.++.++
T Consensus        89 e~~~~~~L~~~l~~~~~~-------------~~~~~~~~~i~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~~~  153 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNF-------------VVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALNSRSVMIDEDMTAR  153 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSC-------------CCCHHHHHHHHHHHHHHHHHHT--TSSSCCTTCCCSGGGEEECTTSCEE
T ss_pred             cccCCCcHHHHHhhcccC-------------CCCHHHHHHHHHHHHHHHHHHh--cCCCceecCCCccceEEEcCCccee
Confidence            999999999999865432             3899999999999999999999  667  99999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCC--CCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTA--ATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |+|||++.....      ....||+.|+|||.+.+...  ++.++||||||+++|||++|..||....       .....
T Consensus       154 l~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~  220 (271)
T 3kmu_A          154 ISMADVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-------NMEIG  220 (271)
T ss_dssp             EEGGGSCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-------HHHHH
T ss_pred             EEeccceeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-------hHHHH
Confidence            999988754322      23468999999999875432  3347999999999999999999975321       11111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .......     ....     .+..++..+.+++.+||+.||++|||++++++.|+++.
T Consensus       221 ~~~~~~~-----~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          221 MKVALEG-----LRPT-----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHHHHSC-----CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHHhcC-----CCCC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            1111111     1111     13344568999999999999999999999999999875

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=336.93  Aligned_cols=250  Identities=24%  Similarity=0.342  Sum_probs=201.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc------cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ------GFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+......      ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46888999999999999999765 6899999998654322      3567899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC--
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF--  232 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~--  232 (373)
                      +||||+++++|.+++....               ++++.++..++.|++.||.|||  +.+++||||||+||+++.++  
T Consensus        91 lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~  153 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKE---------------SLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVP  153 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSS---------------CCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSS
T ss_pred             EEEEcCCCCCHHHHHHhcC---------------CcCHHHHHHHHHHHHHHHHHHH--HCCeEcCCCCHHHEEEecCCCC
Confidence            9999999999999997543               2899999999999999999999  78999999999999999887  


Q ss_pred             --ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH
Q 043074          233 --EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       233 --~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  310 (373)
                        .+||+|||+++......  ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....       .
T Consensus       154 ~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~  223 (326)
T 2y0a_A          154 KPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTK-------Q  223 (326)
T ss_dssp             SCCEEECCCTTCEECCTTS--CCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------H
T ss_pred             CCCEEEEECCCCeECCCCC--ccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-------H
Confidence              89999999998764322  2334578999999999974 4578899999999999999999999754211       1


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      +.........       ....... ....+..+.+++.+||+.||++|||+.++++
T Consensus       224 ~~~~~~~~~~-------~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          224 ETLANVSAVN-------YEFEDEY-FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHHHHHTC-------CCCCHHH-HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcC-------CCcCccc-cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111111110       0000000 1123457899999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.4e-46  Score=340.47  Aligned_cols=267  Identities=21%  Similarity=0.228  Sum_probs=202.7

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeCC------CCEEEEEEeCcccccc-----------HHHHHHHHHHHhcCCCCCccc
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLSS------GVTVAIKKLDKDAFQG-----------FREFRAEMETLGKLRHRNIVK  142 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~  142 (373)
                      ..++|++.+.||+|+||.||+|.+.+      ++.||+|++.......           ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999997754      4789999986554221           112345667788889999999


Q ss_pred             eeeEEeeC----CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 043074          143 ILGYCASG----LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIH  218 (373)
Q Consensus       143 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H  218 (373)
                      +++++...    ...++||||+ +++|.+++.....              ++++.+++.++.|++.||+|||  +.+|+|
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--------------~l~~~~~~~i~~qi~~~l~~lH--~~~iiH  175 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--------------RFSRKTVLQLSLRILDILEYIH--EHEYVH  175 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEEC
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeEE
Confidence            99998764    4579999999 9999999987532              2999999999999999999999  789999


Q ss_pred             ecCCCCceEeC--CCCceEEeeeccccccCCCCCc------ccccccccccccCccccCCCCCCCccccchhhhHHHHHH
Q 043074          219 RDIKSSNVLLD--SDFEAHISDFGLARRIDTSHSH------VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEI  290 (373)
Q Consensus       219 ~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el  290 (373)
                      |||||+|||++  .++.+||+|||+++........      ......||+.|+|||.+.+. .++.++|||||||++|||
T Consensus       176 rDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el  254 (364)
T 3op5_A          176 GDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQW  254 (364)
T ss_dssp             CCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHH
T ss_pred             ecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHH
Confidence            99999999998  8899999999999875432111      11334599999999999854 489999999999999999


Q ss_pred             HhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 043074          291 ATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE  370 (373)
Q Consensus       291 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~  370 (373)
                      ++|..||.....+.   ....+..... .......++..+...    .++.++.+++..||+.||.+||++.+|++.|++
T Consensus       255 ~~g~~Pf~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~  326 (364)
T 3op5_A          255 LTGHLPWEDNLKDP---KYVRDSKIRY-RENIASLMDKCFPAA----NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ  326 (364)
T ss_dssp             HHSCCTTGGGTTCH---HHHHHHHHHH-HHCHHHHHHHHSCTT----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             HhCCCCccccccCH---HHHHHHHHHh-hhhHHHHHHHhcccc----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence            99999976432221   1111111111 111112222222111    234589999999999999999999999999998


Q ss_pred             hh
Q 043074          371 LV  372 (373)
Q Consensus       371 l~  372 (373)
                      ++
T Consensus       327 ~~  328 (364)
T 3op5_A          327 GL  328 (364)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-46  Score=333.30  Aligned_cols=258  Identities=25%  Similarity=0.455  Sum_probs=210.9

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ..++|++.+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            3567888999999999999999765 58899999997543 345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++++|.+++......             ++++..++.++.|++.||.|||  +.+++||||||+||+++.++.+||+|
T Consensus        90 ~~~~~~L~~~~~~~~~~-------------~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~D  154 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQ-------------EVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD  154 (288)
T ss_dssp             CCTTEEHHHHHHHCCTT-------------TSCHHHHHHHHHHHHHHHHHHH--HHTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             cCCCCcHHHHHHhcccC-------------CccHhHHHHHHHHHHHHHHHHH--HCCccCCCCCcceEEEcCCCCEEEcc
Confidence            99999999999875432             2899999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      ||++...............+|+.|+|||.+.+. .++.++||||||+++|+|++ |..|+......    ....   ...
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~----~~~~---~~~  226 (288)
T 3kfa_A          155 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYE---LLE  226 (288)
T ss_dssp             CCGGGTSCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHH---HHH
T ss_pred             CccceeccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH---HHh
Confidence            999987655444444445678899999998744 47889999999999999999 77775432211    1111   111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..      ...     ..+..++..+.+++.+||+.||.+|||+.++++.|++++
T Consensus       227 ~~------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          227 KD------YRM-----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             TT------CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cc------CCC-----CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence            10      001     113334568999999999999999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-46  Score=332.85  Aligned_cols=244  Identities=24%  Similarity=0.343  Sum_probs=201.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||++..+ +|+.||+|++.+...   ...+.+.+|..+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57888999999999999999765 799999999965432   33567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.....               +++..+..++.|++.||.|||  +++++||||||+||+++.++.+||+
T Consensus        86 e~~~gg~L~~~l~~~~~---------------~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~  148 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQR---------------FPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKIT  148 (318)
T ss_dssp             CCCCSCBHHHHHHHTSS---------------CCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             eCCCCCCHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCccccCCChheEEEcCCCCEEEe
Confidence            99999999999986542               899999999999999999999  8999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++....    ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.....       ........
T Consensus       149 Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~  216 (318)
T 1fot_A          149 DFGFAKYVPD----VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKIL  216 (318)
T ss_dssp             CCSSCEECSS----CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHH
T ss_pred             ecCcceecCC----ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHH
Confidence            9999987542    2334679999999999975 4578899999999999999999999754211       11111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                      ...       ..+     +...+.++.+++.+||+.||++||     +++++++
T Consensus       217 ~~~-------~~~-----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          217 NAE-------LRF-----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HCC-------CCC-----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             hCC-------CCC-----CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            110       011     223345899999999999999999     8888864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.3e-47  Score=348.55  Aligned_cols=279  Identities=27%  Similarity=0.386  Sum_probs=211.0

Q ss_pred             hHHHHHhcCCCCCCCeeecCCCceEEEEEe------CCCCEEEEEEeCccccc-cHHHHHHHHHHHhcC-CCCCccceee
Q 043074           74 MSELIDATDNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKL-RHRNIVKILG  145 (373)
Q Consensus        74 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~  145 (373)
                      ..+.....++|++.+.||+|+||.||+|.+      .+++.||||++...... ..+.+.+|+.++.++ +||||+++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            344445668999999999999999999963      34688999999765433 346789999999999 7999999999


Q ss_pred             EEeeCC-eeEEEEEecCCCCHHHHhhcCCCCCCCC---------------------------------------------
Q 043074          146 YCASGL-DRVLIYEFVENGSLDQWLHDTSRNDDVD---------------------------------------------  179 (373)
Q Consensus       146 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~---------------------------------------------  179 (373)
                      ++.+.. ..++||||+++|+|.+++..........                                             
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            998765 4899999999999999998764310000                                             


Q ss_pred             ------cccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCC-cc
Q 043074          180 ------GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS-HV  252 (373)
Q Consensus       180 ------~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  252 (373)
                            ..........+++..++.++.|++.||+|||  +++++||||||+||+++.++.+||+|||++........ ..
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR  251 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence                  0000000123889999999999999999999  78999999999999999999999999999986543322 23


Q ss_pred             cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccc
Q 043074          253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNIS  331 (373)
Q Consensus       253 ~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (373)
                      .....||+.|+|||++.+ ..++.++||||||+++|||++ |..||.......      ........ ...     ..  
T Consensus       252 ~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~-~~~-----~~--  316 (359)
T 3vhe_A          252 KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKE-GTR-----MR--  316 (359)
T ss_dssp             C--CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHH-TCC-----CC--
T ss_pred             ccccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHc-CCC-----CC--
Confidence            344568899999999874 457899999999999999998 888864322111      11111111 100     01  


Q ss_pred             cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          332 REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                         .+..++.++.+++.+||+.||.+|||+.++++.|++++
T Consensus       317 ---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          317 ---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence               12234568999999999999999999999999999876

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.3e-46  Score=335.47  Aligned_cols=271  Identities=26%  Similarity=0.427  Sum_probs=209.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe------CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  153 (373)
                      .++|.+.+.||+|+||.||+|..      .++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            46788899999999999999975      2458899999975433 3356788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCC---------CcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCC
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDV---------DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS  224 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~---------~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~  224 (373)
                      ++||||+++++|.+++.........         ...........+++.+++.++.|++.||.|||  +++++||||||+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dikp~  179 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMKLVHRDLAAR  179 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH--HCCCcccccchh
Confidence            9999999999999999876431100         00000001123889999999999999999999  789999999999


Q ss_pred             ceEeCCCCceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCccc
Q 043074          225 NVLLDSDFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVL  302 (373)
Q Consensus       225 Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~  302 (373)
                      ||+++.++.+||+|||++......... ......+|+.|+|||.+.+ ..++.++||||||+++|||++ |..|+.....
T Consensus       180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999876443222 2233457889999999874 447889999999999999999 8888643221


Q ss_pred             CCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          303 DGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .    ....   .... ..     ..     ..+..++..+.+++.+||+.||++||++.++++.|++++
T Consensus       259 ~----~~~~---~~~~-~~-----~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          259 E----RLFN---LLKT-GH-----RM-----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             G----GHHH---HHHT-TC-----CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H----HHHH---Hhhc-CC-----cC-----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1    1111   1111 10     00     112334568999999999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4e-46  Score=328.40  Aligned_cols=256  Identities=26%  Similarity=0.458  Sum_probs=206.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      .++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+ +..++|+||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            457888999999999999999988888999999976443 34678999999999999999999999864 4689999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++++|.+++......             .+++.+++.++.|++.||.|||  +++++||||||+||++++++.+||+|||
T Consensus        90 ~~~~L~~~l~~~~~~-------------~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg  154 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGI-------------KLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFG  154 (279)
T ss_dssp             TTCBHHHHTTSHHHH-------------TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CCCCHHHHHhcCCCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHhhEEEcCCCCEEECCCc
Confidence            999999999754211             2899999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      ++...............++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....       ..+........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~~~~~~~~~  226 (279)
T 1qpc_A          155 LARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERG  226 (279)
T ss_dssp             TCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTT
T ss_pred             ccccccCcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccC-------HHHHHHHHhcc
Confidence            998765443333344556789999999874 447889999999999999999 777754321       11111111111


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                            ....     .+..++..+.+++.+||+.||++|||+.++++.|++++
T Consensus       227 ------~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          227 ------YRMV-----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             ------CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------cCCC-----CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence                  0011     12334568999999999999999999999999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.4e-46  Score=335.39  Aligned_cols=250  Identities=22%  Similarity=0.310  Sum_probs=197.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ++|++.+.||+|+||.||++..+ +++.||+|++.+....   ..+.+.+|..++.++ +||||+++++++.+....++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            47888999999999999999765 6889999999765332   345678899999988 899999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++|+|.+++.....               +++..+..++.||+.||.|||  +++|+||||||+|||++.++.+||
T Consensus        89 ~e~~~gg~L~~~l~~~~~---------------l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL  151 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRK---------------LPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKL  151 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred             EeCCCCCcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEE
Confidence            999999999999976542               899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcc-cHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV-GLLEWART  315 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~  315 (373)
                      +|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.......... ........
T Consensus       152 ~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  229 (345)
T 3a8x_A          152 TDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ  229 (345)
T ss_dssp             CCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH
T ss_pred             EeccccccccCCC-CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH
Confidence            9999998643222 23345679999999999985 457899999999999999999999975422211110 00111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                      ......      ..     ++...+..+.+++.+||+.||++||++
T Consensus       230 ~i~~~~------~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          230 VILEKQ------IR-----IPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HHHHCC------CC-----CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             HHHcCC------CC-----CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            111110      11     123345689999999999999999996

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-45  Score=346.50  Aligned_cols=248  Identities=21%  Similarity=0.364  Sum_probs=204.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++.....   .....+.+|+.+++.++||||+++++++.+....++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            468899999999999999999765 799999999965432   2345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++|+|.+++....               .+++.++..++.||+.||.|||  +++++||||||+||+++.++.+||
T Consensus        95 ~E~~~gg~L~~~l~~~~---------------~l~~~~~~~i~~qi~~aL~~LH--~~givHrDLkp~NIll~~~~~vkL  157 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG---------------RLDEKESRRLFQQILSGVDYCH--RHMVVHRDLKPENVLLDAHMNAKI  157 (476)
T ss_dssp             EECCSSEEHHHHTTSSS---------------SCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEECTTCCEEE
T ss_pred             EeCCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCCCcccccHHHEEEecCCCeEE
Confidence            99999999999997543               2899999999999999999999  799999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++......  .......||+.|+|||++.+....+.++|||||||++|||++|..||.....       .......
T Consensus       158 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~~~~~i  228 (476)
T 2y94_A          158 ADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------PTLFKKI  228 (476)
T ss_dssp             CCCSSCEECCTT--CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-------HHHHHHH
T ss_pred             Eeccchhhcccc--ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-------HHHHHHH
Confidence            999999876432  2234567999999999998766668899999999999999999999754211       1111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .. .        ..   ..+...+..+.+++.+||+.||++|||+.++++
T Consensus       229 ~~-~--------~~---~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          229 CD-G--------IF---YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HT-T--------CC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hc-C--------Cc---CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            11 0        00   012223457999999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.4e-46  Score=335.78  Aligned_cols=269  Identities=21%  Similarity=0.314  Sum_probs=190.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            458899999999999999999764 6899999998654332 34678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |++ |+|.+++.......         ....+++..+..++.|++.||.|||  +++++||||||+||+++.++.+||+|
T Consensus        84 ~~~-~~L~~~l~~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~D  151 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGN---------TPRGLELNLVKYFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGD  151 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSS---------CCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             ecC-CCHHHHHHhccccc---------cccCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCChHHeEEcCCCCEEECc
Confidence            997 69999987643211         0113889999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||++........ ......||+.|+|||++.+...++.++|||||||++|||++|..||......    ...........
T Consensus       152 fg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~~~~~  226 (317)
T 2pmi_A          152 FGLARAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE----EQLKLIFDIMG  226 (317)
T ss_dssp             CSSCEETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHC
T ss_pred             CccceecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhC
Confidence            999987643322 2334568999999999986666899999999999999999999997543211    11111111000


Q ss_pred             hcc--------ccccccCccc-----------cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNK--------EIEMVDSNIS-----------REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~--------~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...        ........+.           ........+..+.+++.+||+.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             SCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            000        0000000000           00001123458999999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.7e-46  Score=328.22  Aligned_cols=260  Identities=31%  Similarity=0.503  Sum_probs=194.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|++.+.||+|+||.||+|...  ..+|+|++.....  ...+.+.+|+.++++++||||+++++++ .....++|+|
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            468999999999999999999864  4699999865443  2346789999999999999999999965 4556899999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++++|.+++.....              .+++.+++.++.|++.||.|||  +.+++||||||+||+++.++.+||+|
T Consensus       100 ~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~D  163 (289)
T 3og7_A          100 WCEGSSLYHHLHASET--------------KFEMKKLIDIARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGD  163 (289)
T ss_dssp             CCCEEEHHHHHTTC-----------------CCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTTEEEECC
T ss_pred             ecCCCcHHHHHhhccC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCcccccCccceEEECCCCCEEEcc
Confidence            9999999999965432              2899999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCC-CcccccccccccccCccccCC--CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          239 FGLARRIDTSH-SHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       239 fg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      ||++....... ........||+.|+|||.+..  ...++.++||||||+++|||++|..||......      ......
T Consensus       164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~  237 (289)
T 3og7_A          164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEM  237 (289)
T ss_dssp             CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHH
T ss_pred             ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHH
Confidence            99998654321 222334568999999999862  345788999999999999999999997542211      111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .. ....    ....  ......++..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       238 ~~-~~~~----~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          238 VG-RGSL----SPDL--SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             HH-HTSC----CCCT--TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             hc-cccc----Ccch--hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            11 1111    1110  1112344568999999999999999999999999999885

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=341.76  Aligned_cols=248  Identities=22%  Similarity=0.291  Sum_probs=197.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  155 (373)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++.+..   ....+.+.+|..++..+ +||||+++++++.+....++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            468999999999999999999765 68999999997542   22345678899999988 69999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||+++|+|.+++.....               +++..+..++.||+.||+|||  +++|+||||||+|||++.++.+|
T Consensus       102 v~E~~~gg~L~~~l~~~~~---------------~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NILl~~~g~ik  164 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRR---------------FDEARARFYAAEIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCK  164 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEE
T ss_pred             EEeCCCCCcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCHHHEEECCCCCEE
Confidence            9999999999999987542               899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||+++..... .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.....       .+....
T Consensus       165 L~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~  235 (353)
T 3txo_A          165 LADFGMCKEGICN-GVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEA  235 (353)
T ss_dssp             ECCCTTCBCSCC----------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHH
T ss_pred             EccccceeecccC-CccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCH-------HHHHHH
Confidence            9999999854322 223345679999999999874 4478899999999999999999999754221       111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM------SYVVQ  366 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~~l~~  366 (373)
                      ....         ..   .++...+..+.+++.+||+.||.+||++      +++++
T Consensus       236 i~~~---------~~---~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          236 ILND---------EV---VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHC---------CC---CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHcC---------CC---CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            1111         00   0122334578999999999999999998      66654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.6e-45  Score=326.32  Aligned_cols=260  Identities=20%  Similarity=0.255  Sum_probs=199.4

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccccc---HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQG---FREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ..++|++.+.||+|+||.||+|... +++.||+|++.......   .+.+.+|+.++.+++||||+++++++.++...++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999765 78899999997543322   4678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |+||+++++|.+++....               ++++.+++.++.|++.||.|||  +.+++||||||+||+++.++.+|
T Consensus       112 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~NIl~~~~~~~k  174 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG---------------PLAPPRAVAIVRQIGSALDAAH--AAGATHRDVKPENILVSADDFAY  174 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEE
T ss_pred             EEEecCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCcCCcCCCChHHEEEcCCCCEE
Confidence            999999999999998654               2899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||++...............|++.|+|||.+.+ ..++.++||||||+++|||++|..||.....        .....
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~  245 (309)
T 2h34_A          175 LVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQL--------SVMGA  245 (309)
T ss_dssp             ECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHH--------HHHHH
T ss_pred             EecCccCccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchH--------HHHHH
Confidence            99999998765433333345578999999999975 4578899999999999999999999753211        11111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhhhC
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-AMSYVVQLLDELVA  373 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~l~~~L~~l~~  373 (373)
                      .... ...   .    ........+..+.+++.+||+.||++|| +++++++.|+++++
T Consensus       246 ~~~~-~~~---~----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          246 HINQ-AIP---R----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             HHHS-CCC---C----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             Hhcc-CCC---C----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence            1110 000   0    0011233455899999999999999999 99999999998763

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=343.69  Aligned_cols=253  Identities=18%  Similarity=0.270  Sum_probs=201.5

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ..++|++.+.||+|+||.||+|.. .+|+.+|+|++.....  ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            345789999999999999999965 4789999999865443  2345688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC---CCCc
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD---SDFE  233 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~---~~~~  233 (373)
                      |||+++|+|.+++....               .+++..+..++.||+.||.|||  +++|+||||||+|||++   .++.
T Consensus        89 ~E~~~gg~L~~~i~~~~---------------~~~e~~~~~i~~qil~aL~~lH--~~givHrDlKp~NIll~~~~~~~~  151 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE---------------YYSEADASHCIQQILEAVLHCH--QMGVVHRNLKPENLLLASKLKGAA  151 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS---------------CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSSTTEEESBSSTTCC
T ss_pred             EEeCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEeccCCCCc
Confidence            99999999999998654               2899999999999999999999  78999999999999998   4678


Q ss_pred             eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          234 AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +||+|||++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.....       ....
T Consensus       152 vkL~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~-------~~~~  222 (444)
T 3soa_A          152 VKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQ-------HRLY  222 (444)
T ss_dssp             EEECCCSSCBCCCTTC-CBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHH
T ss_pred             EEEccCceeEEecCCC-ceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccH-------HHHH
Confidence            9999999998764332 223446799999999999754 578899999999999999999999754211       1111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ........  . ..    ... ....+.++.+++.+||+.||++|||+.++++
T Consensus       223 ~~i~~~~~--~-~~----~~~-~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          223 QQIKAGAY--D-FP----SPE-WDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHHHTCC--C-CC----TTT-TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhCCC--C-CC----ccc-cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11111100  0 00    000 1223558999999999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-46  Score=339.48  Aligned_cols=252  Identities=19%  Similarity=0.302  Sum_probs=204.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|++.+.||+|+||.||+|... +++.+|+|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999764 7899999999766555556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC--CCceEEe
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS--DFEAHIS  237 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~--~~~~kl~  237 (373)
                      +++|+|.+++.....              .+++.+++.++.|++.||+|||  +++++||||||+|||++.  ++.+||+
T Consensus       130 ~~gg~L~~~l~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~vkL~  193 (387)
T 1kob_A          130 LSGGELFDRIAAEDY--------------KMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKII  193 (387)
T ss_dssp             CCCCBHHHHTTCTTC--------------CBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEEC
T ss_pred             CCCCcHHHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeecccchHHeEEecCCCCceEEE
Confidence            999999999875432              2899999999999999999999  789999999999999974  4779999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++......  ......||+.|+|||++.+ ..++.++|||||||++|||++|..||....       .........
T Consensus       194 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~-------~~~~~~~i~  263 (387)
T 1kob_A          194 DFGLATKLNPDE--IVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGED-------DLETLQNVK  263 (387)
T ss_dssp             CCTTCEECCTTS--CEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHH
T ss_pred             ecccceecCCCc--ceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCC-------HHHHHHHHH
Confidence            999998764332  2234578999999999975 457889999999999999999999975421       111111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....   ......     ....+.++.+++.+||+.||++|||+.++++
T Consensus       264 ~~~~---~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          264 RCDW---EFDEDA-----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             HCCC---CCCSST-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hCCC---CCCccc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            1110   011111     1233568999999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.9e-46  Score=338.03  Aligned_cols=265  Identities=24%  Similarity=0.366  Sum_probs=209.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-----CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEe--eCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA--SGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~  153 (373)
                      .++|++.+.||+|+||.||++.+     .+++.||+|++........+.+.+|+.++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            35888999999999999999974     468899999998776666677999999999999999999999886  45678


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++||||+++++|.+++.....              ++++..++.++.|++.||+|||  +++++||||||+||+++.++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~  165 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRA--------------RLDASRLLLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEAH  165 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG--------------GCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTE
T ss_pred             EEEEeecCCCCHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChhhEEECCCCC
Confidence            999999999999999976432              2899999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCC-------
Q 043074          234 AHISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDG-------  304 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-------  304 (373)
                      +||+|||++.........  ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..|+.......       
T Consensus       166 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~  244 (327)
T 3lxl_A          166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE  244 (327)
T ss_dssp             EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC--
T ss_pred             EEEcccccceecccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc
Confidence            999999999876543322  2233567888999999874 447889999999999999999999865422110       


Q ss_pred             CcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..........         ..+...... ..+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       245 ~~~~~~~~~~---------~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          245 RDVPALSRLL---------ELLEEGQRL-PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             --CCHHHHHH---------HHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             cccccHHHHH---------HHhhcccCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0000000000         001111111 113445668999999999999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.9e-45  Score=330.84  Aligned_cols=272  Identities=27%  Similarity=0.368  Sum_probs=211.8

Q ss_pred             hHHHHHhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhc--CCCCCccceeeEEeeCC
Q 043074           74 MSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGK--LRHRNIVKILGYCASGL  151 (373)
Q Consensus        74 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~  151 (373)
                      ........++|.+.+.||+|+||.||+|.. +++.||+|++....   ...+.+|.+++..  ++||||+++++++....
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            333344567899999999999999999987 48999999996543   3567788888887  78999999999998776


Q ss_pred             ----eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCceeecC
Q 043074          152 ----DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGL------EKPIIHRDI  221 (373)
Q Consensus       152 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~------~~~i~H~dl  221 (373)
                          ..++||||+++|+|.+++....                +++.+++.++.|++.||.|||+.      +.+++||||
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl  173 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNRYT----------------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL  173 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHHCC----------------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCC
T ss_pred             CccceeEEEEeecCCCcHHHHHhccC----------------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCC
Confidence                7899999999999999997643                89999999999999999999932      468999999


Q ss_pred             CCCceEeCCCCceEEeeeccccccCCCCCc---ccccccccccccCccccCCCCC-----CCccccchhhhHHHHHHHhC
Q 043074          222 KSSNVLLDSDFEAHISDFGLARRIDTSHSH---VSTQVAGTMGYMPPEYLGGNTA-----ATVMLDVYSFGILMIEIATQ  293 (373)
Q Consensus       222 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~-----~~~~~DiwslG~~l~el~~g  293 (373)
                      ||+||+++.++.+||+|||++.........   ......||+.|+|||.+.+...     ++.++||||||+++|||++|
T Consensus       174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            999999999999999999999876543322   2234578999999999875422     23689999999999999999


Q ss_pred             ----------CCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 043074          294 ----------IRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY  363 (373)
Q Consensus       294 ----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~  363 (373)
                                ..||.......  .....+.....     .....+.+........++..+.+++.+||+.||++|||+.+
T Consensus       254 ~~~~~~~~~~~~p~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~  326 (342)
T 1b6c_B          254 CSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR  326 (342)
T ss_dssp             BCBTTBCCCCCCTTTTTSCSS--CCHHHHHHHHT-----TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             cCcCCcccccccCccccCcCc--ccHHHHHHHHH-----HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence                      56654433222  11222222111     11122223222234577889999999999999999999999


Q ss_pred             HHHHHHhhh
Q 043074          364 VVQLLDELV  372 (373)
Q Consensus       364 l~~~L~~l~  372 (373)
                      +++.|+++.
T Consensus       327 i~~~L~~i~  335 (342)
T 1b6c_B          327 IKKTLSQLS  335 (342)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999999874

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-45  Score=340.92  Aligned_cols=271  Identities=17%  Similarity=0.246  Sum_probs=202.7

Q ss_pred             cCCCCCCCeeecC--CCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           81 TDNFSTDKIIGDG--SFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      .++|++.+.||+|  +||.||+|... +++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.++...++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4589999999999  99999999775 799999999965442  234568889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||+++|+|.+++......             .+++..+..++.||+.||+|||  +++|+||||||+|||++.++.+|
T Consensus       104 v~e~~~~~~L~~~l~~~~~~-------------~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~~~~~k  168 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMD-------------GMNELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVY  168 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTT-------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEE
T ss_pred             EEEccCCCCHHHHHhhhccc-------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEE
Confidence            99999999999999875432             2899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCC------CcccccccccccccCccccCCC-CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc
Q 043074          236 ISDFGLARRIDTSH------SHVSTQVAGTMGYMPPEYLGGN-TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG  308 (373)
Q Consensus       236 l~Dfg~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  308 (373)
                      |+|||.+.......      ........||+.|+|||++.+. ..++.++|||||||++|||++|..||...........
T Consensus       169 l~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  248 (389)
T 3gni_B          169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE  248 (389)
T ss_dssp             ECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH
T ss_pred             EcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            99999986542211      1112234688999999999764 4688999999999999999999999765332221100


Q ss_pred             HHH-----HHHHHH-Hhcc---------ccccc------------cCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          309 LLE-----WARTME-ARNK---------EIEMV------------DSNISREELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       309 ~~~-----~~~~~~-~~~~---------~~~~~------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                      ...     ...... ....         .....            .........+...+..+.+++.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta  328 (389)
T 3gni_B          249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA  328 (389)
T ss_dssp             C--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred             HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence            000     000000 0000         00000            00000011133345689999999999999999999


Q ss_pred             HHHHH
Q 043074          362 SYVVQ  366 (373)
Q Consensus       362 ~~l~~  366 (373)
                      .++++
T Consensus       329 ~ell~  333 (389)
T 3gni_B          329 STLLN  333 (389)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99975

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.3e-46  Score=337.65  Aligned_cols=267  Identities=27%  Similarity=0.397  Sum_probs=203.9

Q ss_pred             CCCCCeeecCCCceEEEEEe-----CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEE
Q 043074           84 FSTDKIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASG--LDRVL  155 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  155 (373)
                      |++.+.||+|+||.||++.+     .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48889999999999998864     2688999999976543 2356789999999999999999999999874  67899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||+++|+|.+++....                +++.+++.++.|++.||.|||  +.+++||||||+||+++.++.+|
T Consensus       113 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~i~~~l~~~l~~LH--~~~ivH~Dikp~Nil~~~~~~~k  174 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS----------------IGLAQLLLFAQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVK  174 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC----------------CCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEE
T ss_pred             EEecccCCcHHHHHhhCC----------------CCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEEcCCCCEE
Confidence            999999999999997653                899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          236 ISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |+|||++.........  ......+|..|+|||.+.+. .++.++||||||+++|||++|..|+.........  ...+.
T Consensus       175 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~~~~~  251 (318)
T 3lxp_A          175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE--LIGIA  251 (318)
T ss_dssp             ECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--HHCSC
T ss_pred             ECCccccccccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh--hhccc
Confidence            9999999876543321  22345678889999999743 4788999999999999999999986432211000  00000


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ............+..... ...+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          252 QGQMTVLRLTELLERGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             CHHHHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccchhHHHHHHHHhcccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            000000000011111111 1113445668999999999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2e-45  Score=326.64  Aligned_cols=262  Identities=23%  Similarity=0.332  Sum_probs=202.3

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEE-eeCCeeEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC-ASGLDRVLIY  157 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  157 (373)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++......  ..+.+|+.+++.++|++++..++.+ .++...++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999975 57899999987544332  3577899999999988877777665 6677889999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe---CCCCce
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL---DSDFEA  234 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill---~~~~~~  234 (373)
                      ||+ +++|.+++.....              ++++.+++.++.|++.||.|||  +++++||||||+||++   +.++.+
T Consensus        85 e~~-~~~L~~~~~~~~~--------------~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~~~~~  147 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSR--------------KFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLV  147 (296)
T ss_dssp             ECC-CCBHHHHHHHTTS--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECCGGGTTCE
T ss_pred             Ecc-CCCHHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeeeeccCCCCeE
Confidence            999 9999999985432              2899999999999999999999  7899999999999999   788999


Q ss_pred             EEeeeccccccCCCCC------cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc
Q 043074          235 HISDFGLARRIDTSHS------HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG  308 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  308 (373)
                      ||+|||+++.......      .......||+.|+|||.+.+. .++.++||||||+++|||++|..||...........
T Consensus       148 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  226 (296)
T 4hgt_A          148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK  226 (296)
T ss_dssp             EECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred             EEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh
Confidence            9999999987654322      122346789999999999854 478999999999999999999999865443332222


Q ss_pred             HHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          309 LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ............  ...         ....++..+.+++.+||+.||++|||++++++.|++++
T Consensus       227 ~~~~~~~~~~~~--~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          227 YERISEKKMSTP--IEV---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             HHHHHHHHHHSC--HHH---------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             hhhhhcccccch--hhh---------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence            222111111100  000         01122458999999999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.1e-46  Score=337.60  Aligned_cols=255  Identities=22%  Similarity=0.375  Sum_probs=197.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCC----EEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGV----TVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ++|+..+.||+|+||.||+|.+. +++    +||+|.+..... ...+.+.+|+.++++++||||+++++++.++. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            57888999999999999999753 444    358888754332 34567899999999999999999999998764 778


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |+||+.+|+|.+++.....              .+++..++.++.|++.||.|||  +.+++||||||+|||++.++.+|
T Consensus        94 v~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIll~~~~~~k  157 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKD--------------NIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVK  157 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTT--------------SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEE
T ss_pred             EEEecCCCcHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCChheEEECCCCCEE
Confidence            9999999999999987543              2899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          236 ISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |+|||+++........ ......+|+.|+|||.+.+ ..++.++||||||+++|||++ |..||......    .+..  
T Consensus       158 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~--  230 (327)
T 3poz_A          158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISS--  230 (327)
T ss_dssp             ECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHH--
T ss_pred             EccCcceeEccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH----HHHH--
Confidence            9999999876543322 2233456889999999874 457899999999999999999 88886432211    1111  


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                       .... ...          ...+..++..+.+++.+||+.||++||++.++++.|+++.
T Consensus       231 -~~~~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          231 -ILEK-GER----------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             -HHHT-TCC----------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHc-CCC----------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence             1111 100          0113334568999999999999999999999999998764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-46  Score=339.56  Aligned_cols=274  Identities=28%  Similarity=0.416  Sum_probs=207.2

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe------CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCC
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASGL  151 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  151 (373)
                      ..++|.+.+.||+|+||.||+|..      .++..||+|.+..... ...+.+.+|+.++.++ +||||+++++++.+..
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            456899999999999999999975      2466899999975432 2346789999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcc--------cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGS--------KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKS  223 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~--------~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~  223 (373)
                      ..++||||+++|+|.+++............        ........+++..++.++.|++.||.|||  +++++||||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp  200 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAA  200 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEEETTCSG
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCh
Confidence            999999999999999999875432100000        00001124899999999999999999999  78999999999


Q ss_pred             CceEeCCCCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcc
Q 043074          224 SNVLLDSDFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVV  301 (373)
Q Consensus       224 ~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~  301 (373)
                      +||+++.++.+||+|||++........ .......+|+.|+|||.+.+ ..++.++||||||+++|||++ |..||....
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            999999999999999999986643322 22334557889999999874 447899999999999999998 888864432


Q ss_pred             cCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhC
Q 043074          302 LDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA  373 (373)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~~  373 (373)
                      ...   ..    .......     ....     .+..++..+.+++.+||+.||.+|||+.++++.|+.+++
T Consensus       280 ~~~---~~----~~~~~~~-----~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          280 VDA---NF----YKLIQNG-----FKMD-----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             CSH---HH----HHHHHTT-----CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cHH---HH----HHHHhcC-----CCCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            111   11    1111111     0111     123345689999999999999999999999999998764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.1e-46  Score=336.07  Aligned_cols=264  Identities=24%  Similarity=0.440  Sum_probs=192.3

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeCC-C---CEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLSS-G---VTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASGLD  152 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  152 (373)
                      ...++|++.+.||+|+||.||+|.... +   ..||+|.+....  ....+.+.+|+.++++++||||+++++++.+...
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345689999999999999999997653 3   279999996642  3345678999999999999999999999987765


Q ss_pred             e------EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCce
Q 043074          153 R------VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV  226 (373)
Q Consensus       153 ~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Ni  226 (373)
                      .      ++|+||+++|+|.+++........         ...+++.+++.++.|++.||+|||  +++++||||||+||
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~---------~~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~Dikp~NI  168 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGEN---------PFNLPLQTLVRFMVDIACGMEYLS--SRNFIHRDLAARNC  168 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC------------CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhcccc---------ccccCHHHHHHHHHHHHHHHHHHH--cCCcccCCCCcceE
Confidence            5      999999999999999976442211         113899999999999999999999  78999999999999


Q ss_pred             EeCCCCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCC
Q 043074          227 LLDSDFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDG  304 (373)
Q Consensus       227 ll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~  304 (373)
                      +++.++.+||+|||+++....... .......+++.|+|||.+.+ ..++.++||||||+++|||++ |..|+...... 
T Consensus       169 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-  246 (323)
T 3qup_A          169 MLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-  246 (323)
T ss_dssp             EECTTSCEEECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-
T ss_pred             EEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChH-
Confidence            999999999999999987543322 12233456788999999875 447899999999999999999 77776432211 


Q ss_pred             CcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                         ...   .......      ..     ..+..++..+.+++.+||+.||++|||+.++++.|++++
T Consensus       247 ---~~~---~~~~~~~------~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          247 ---EIY---NYLIGGN------RL-----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             ---GHH---HHHHTTC------CC-----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHH---HHHhcCC------CC-----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               111   1111100      00     112334568999999999999999999999999999886

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-47  Score=349.31  Aligned_cols=261  Identities=21%  Similarity=0.210  Sum_probs=205.1

Q ss_pred             HHHHHhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeC
Q 043074           75 SELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASG  150 (373)
Q Consensus        75 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  150 (373)
                      .+.....++|++.+.||+|+||.||++..+ +++.||+|++.+...   ...+.+.+|..++..++||||+++++++.+.
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            334445689999999999999999999774 799999999965322   2234578899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      ...++||||+++|+|.+++.+...              .+++..+..++.||+.||+|||  +++|+||||||+|||++.
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~~--------------~l~~~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILld~  197 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFGE--------------RIPAEMARFYLAEIVMAIDSVH--RLGYVHRDIKPDNILLDR  197 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSS--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeecccCHHHeeecC
Confidence            999999999999999999986432              2899999999999999999999  789999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCcccccccccccccCccccCC------CCCCCccccchhhhHHHHHHHhCCCCCCCcccCC
Q 043074          231 DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG------NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDG  304 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  304 (373)
                      ++++||+|||+++.............+||+.|+|||++.+      ...++.++|||||||++|||++|..||...... 
T Consensus       198 ~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-  276 (412)
T 2vd5_A          198 CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-  276 (412)
T ss_dssp             TSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-
T ss_pred             CCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-
Confidence            9999999999998765444333445689999999999862      345789999999999999999999997543211 


Q ss_pred             CcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHH
Q 043074          305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRER---PAMSYVVQ  366 (373)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~~l~~  366 (373)
                            +...........   +.    ........+.++.+++.+||+ +|.+|   |+++++++
T Consensus       277 ------~~~~~i~~~~~~---~~----~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          277 ------ETYGKIVHYKEH---LS----LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             ------HHHHHHHTHHHH---CC----CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             ------HHHHHHHhcccC---cC----CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence                  111111100000   00    000012335689999999999 99998   58888764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.1e-46  Score=338.85  Aligned_cols=249  Identities=22%  Similarity=0.311  Sum_probs=201.2

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCee
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDR  153 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  153 (373)
                      ...++|.+.+.||+|+||.||+|..+ +++.||+|++++..   ....+.+..|..++..+ +||||+++++++.+....
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34678999999999999999999875 68999999997643   22345678899998876 899999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++||||+++|+|.+++.....               +++..+..++.|++.||+|||  +++|+||||||+||+++.++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~~---------------~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~  156 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCHK---------------FDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGH  156 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSC
T ss_pred             EEEEeCCCCCcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCChhhEEECCCCC
Confidence            999999999999999986542               899999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          234 AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +||+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||.....       ....
T Consensus       157 vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~  227 (345)
T 1xjd_A          157 IKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELF  227 (345)
T ss_dssp             EEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHH
T ss_pred             EEEeEChhhhhcccCC-CcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCH-------HHHH
Confidence            9999999998643222 223456799999999999854 478999999999999999999999754221       1111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMS-YVV  365 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~l~  365 (373)
                      ......       ...     .+...+.++.+++.+||+.||++||++. +++
T Consensus       228 ~~i~~~-------~~~-----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          228 HSIRMD-------NPF-----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHHHHC-------CCC-----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHHHhC-------CCC-----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            111111       011     1223456899999999999999999997 554

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.8e-46  Score=342.37  Aligned_cols=274  Identities=23%  Similarity=0.308  Sum_probs=213.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCC--eeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGL--DRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv  156 (373)
                      .++|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357889999999999999999765 589999999976443 33567789999999999999999999997765  77999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe----CCCC
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL----DSDF  232 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill----~~~~  232 (373)
                      |||+++|+|.+++.......            .+++..++.++.|++.||+|||  +.+|+||||||+||++    +.++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~------------~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~  153 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAY------------GLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQS  153 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTT------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEECTTSCE
T ss_pred             EecCCCCCHHHHHHhhhccc------------CCCHHHHHHHHHHHHHHHHHHH--HCCEEECCcCHHHEEEeecCCCce
Confidence            99999999999998654321            2899999999999999999999  7899999999999999    7788


Q ss_pred             ceEEeeeccccccCCCCCcccccccccccccCccccCCC-------CCCCccccchhhhHHHHHHHhCCCCCCCcccCCC
Q 043074          233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN-------TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ  305 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~  305 (373)
                      .+||+|||+++.....  .......||+.|+|||.+.+.       ..++.++|||||||++|||++|..||.+......
T Consensus       154 ~~kL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~  231 (396)
T 4eut_A          154 VYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR  231 (396)
T ss_dssp             EEEECCGGGCEECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred             eEEEecCCCceEccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence            8999999999876432  223345689999999998531       3567899999999999999999999765433222


Q ss_pred             cccHHHHHHHHHHhcc--ccccc----------cCcc-ccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          306 EVGLLEWARTMEARNK--EIEMV----------DSNI-SREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       306 ~~~~~~~~~~~~~~~~--~~~~~----------~~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..   +..........  ....+          ...+ .....+...+..+.+++.+||+.||++||++.++++.+++++
T Consensus       232 ~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          232 NK---EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             CH---HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             hH---HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence            21   11111111100  00000          0011 112335788899999999999999999999999999999876


Q ss_pred             C
Q 043074          373 A  373 (373)
Q Consensus       373 ~  373 (373)
                      .
T Consensus       309 ~  309 (396)
T 4eut_A          309 H  309 (396)
T ss_dssp             T
T ss_pred             h
Confidence            3

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.9e-45  Score=324.79  Aligned_cols=261  Identities=23%  Similarity=0.335  Sum_probs=205.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEE-eeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC-ASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  158 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++......  +.+.+|+.+++.++|++++..+..+ ..+...++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            56899999999999999999976 57999999998654433  4688999999999988877766655 66678899999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC---CCCceE
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD---SDFEAH  235 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~---~~~~~k  235 (373)
                      |+ +++|.+++.....              ++++.+++.++.|++.||.|||  +++++||||||+||+++   .++.+|
T Consensus        86 ~~-~~~L~~~~~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~~~~k  148 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSR--------------KFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVY  148 (296)
T ss_dssp             CC-CCBHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEE
T ss_pred             ec-CCCHHHHHHhhcc--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHeEEecCCCCCeEE
Confidence            99 9999999975432              2899999999999999999999  78999999999999994   788999


Q ss_pred             EeeeccccccCCCCCc------ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          236 ISDFGLARRIDTSHSH------VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      |+|||++.........      ......||+.|+|||.+.+. .++.++||||||+++|||++|..||............
T Consensus       149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  227 (296)
T 3uzp_A          149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY  227 (296)
T ss_dssp             ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred             EeeCCCcccccccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh
Confidence            9999999876543321      12446789999999999854 4789999999999999999999997654333222222


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ...........  ..    .     ....++..+.+++.+||+.||++|||+.++++.|++++
T Consensus       228 ~~~~~~~~~~~--~~----~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  279 (296)
T 3uzp_A          228 ERISEKKMSTP--IE----V-----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             HHHHHHHHHSC--HH----H-----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             hhhcccccCCc--hH----H-----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence            22111111100  00    0     01223458999999999999999999999999999875

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.5e-45  Score=336.09  Aligned_cols=251  Identities=22%  Similarity=0.345  Sum_probs=201.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999764 689999999965433  23467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC---ce
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF---EA  234 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~---~~  234 (373)
                      ||+++|+|.+++....               .+++.++..++.||+.||.|||  +++|+||||||+||+++.++   .+
T Consensus       108 e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~  170 (362)
T 2bdw_A          108 DLVTGGELFEDIVARE---------------FYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAV  170 (362)
T ss_dssp             CCCCSCBHHHHHTTCS---------------CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEESCSSTTCCE
T ss_pred             ecCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCE
Confidence            9999999999987543               2899999999999999999999  78999999999999998654   59


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      ||+|||++.......  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.....       .....
T Consensus       171 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~  240 (362)
T 2bdw_A          171 KLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYA  240 (362)
T ss_dssp             EECCCTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred             EEeecCcceEecCCc--ccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHH
Confidence            999999998765322  23346799999999999754 578899999999999999999999754211       11111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .......  . ..    ... ....+.++.+++.+||+.||++||++.++++
T Consensus       241 ~i~~~~~--~-~~----~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          241 QIKAGAY--D-YP----SPE-WDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             HHHHTCC--C-CC----TTG-GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHhCCC--C-CC----ccc-ccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1111100  0 00    000 1223458999999999999999999999875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-46  Score=333.71  Aligned_cols=267  Identities=20%  Similarity=0.244  Sum_probs=198.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ++|++.+.||+|+||.||+|... +++.||+|++......  ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57899999999999999999765 6899999998654432  24567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++++|.+++....               .+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~l~~~~~~~~---------------~~~~~~~~~i~~~l~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~D  145 (311)
T 4agu_A           83 YCDHTVLHELDRYQR---------------GVPEHLVKSITWQTLQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCD  145 (311)
T ss_dssp             CCSEEHHHHHHHTSS---------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCCchHHHHHhhhc---------------CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCChhhEEEcCCCCEEEee
Confidence            999999999887543               2899999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH-------
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE-------  311 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~-------  311 (373)
                      ||++....... .......||+.|+|||.+.+...++.++||||||+++|+|++|..||..............       
T Consensus       146 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  224 (311)
T 4agu_A          146 FGFARLLTGPS-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP  224 (311)
T ss_dssp             CTTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             CCCchhccCcc-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccc
Confidence            99998764322 2233456899999999998767789999999999999999999999754322111000000       


Q ss_pred             HHHHHHHhccccccccCcccccc-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREE-----LSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .......................     .....+..+.+++.+||+.||++|||++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000111111000000000000     01123557899999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.9e-46  Score=358.79  Aligned_cols=257  Identities=25%  Similarity=0.423  Sum_probs=206.8

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ..++|++.+.||+|+||.||+|.++++..||||++..... ..+.+.+|+.++++++||||+++++++.+ ...++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            3457888899999999999999998888899999976543 34679999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++|+|.+++......             .+++.+++.++.||+.||+|||  +++|+||||||+|||++.++.+||+||
T Consensus       343 ~~~gsL~~~l~~~~~~-------------~l~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGK-------------YLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             CTTEEHHHHHSHHHHT-------------TCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCT
T ss_pred             hcCCcHHHHHhhcCCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEEcCCCcEEEccc
Confidence            9999999999753211             2889999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      |+++..............++..|+|||.+.+ ..++.++||||||+++|||++ |..|+....       ..+.......
T Consensus       408 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~-------~~~~~~~i~~  479 (535)
T 2h8h_A          408 GLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVER  479 (535)
T ss_dssp             TSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC-------HHHHHHHHHT
T ss_pred             ccceecCCCceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHc
Confidence            9998754322112223456788999999874 458899999999999999999 777754321       1111111111


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .      ...     ..+..++..+.+++.+||+.||++|||+++|++.|++++
T Consensus       480 ~------~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          480 G------YRM-----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             T------CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             C------CCC-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            1      000     113345668999999999999999999999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.7e-46  Score=335.80  Aligned_cols=244  Identities=22%  Similarity=0.294  Sum_probs=202.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||++... +|+.||+|++.+...   ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57888999999999999999765 789999999965432   33567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.....               +++..+..++.||+.||.|||  +++|+||||||+|||++.++.+||+
T Consensus       121 e~~~gg~L~~~l~~~~~---------------~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~  183 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIGR---------------FSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVT  183 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC---------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             cCCCCCcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCcccccCccceEEECCCCCEEEc
Confidence            99999999999986542               899999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++.....    .....||+.|+|||++.+. .++.++|||||||++|||++|..||....       .........
T Consensus       184 DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~i~  251 (350)
T 1rdq_E          184 DFGFAKRVKGR----TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQ-------PIQIYEKIV  251 (350)
T ss_dssp             CCTTCEECSSC----BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHH
T ss_pred             ccccceeccCC----cccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCC-------HHHHHHHHH
Confidence            99999875432    2345799999999999754 57899999999999999999999975421       111111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA-----MSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~l~~  366 (373)
                      .. .      ..     ++...+..+.+++.+||+.||.+||+     ++++++
T Consensus       252 ~~-~------~~-----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          252 SG-K------VR-----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HC-C------CC-----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             cC-C------CC-----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            11 0      01     12234568999999999999999998     777764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.5e-46  Score=333.49  Aligned_cols=273  Identities=27%  Similarity=0.413  Sum_probs=209.8

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe------CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCC
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASGL  151 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  151 (373)
                      ..++|++.+.||+|+||.||+|..      .+++.||+|.+..... ...+.+.+|+.++.++ +||||+++++++.++.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346888999999999999999974      3568899999976543 2356789999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCc---ccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDG---SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL  228 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~---~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill  228 (373)
                      ..++||||+++|+|.+++...........   ........++++.+++.++.|++.||.|||  +++++||||||+||++
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILL  178 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccceEEE
Confidence            99999999999999999987643210000   000001124899999999999999999999  7899999999999999


Q ss_pred             CCCCceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCc
Q 043074          229 DSDFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQE  306 (373)
Q Consensus       229 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~  306 (373)
                      +.++.+||+|||++......... ......+|+.|+|||.+.+ ..++.++||||||+++|||++ |..|+.......  
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--  255 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--  255 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--
Confidence            99999999999999876543322 2233457889999999874 457899999999999999999 888764322111  


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                          .........      ....     .+...+..+.+++.+||+.||.+|||+.++++.|++++
T Consensus       256 ----~~~~~~~~~------~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          256 ----KFYKMIKEG------FRML-----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             ----HHHHHHHHT------CCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHHHhccC------CCCC-----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                111111111      0000     12234568999999999999999999999999999875

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.8e-45  Score=334.49  Aligned_cols=255  Identities=21%  Similarity=0.270  Sum_probs=200.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-----ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-----QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....     ...+.+.+|+.+++.++||||+++++++.+....+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            357899999999999999999764 789999999854321     23567899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc-
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE-  233 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~-  233 (373)
                      +||||+++++|.+++.......           ..+++..+..++.||+.||.|||  +++++||||||+||+++.++. 
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~-----------~~~~~~~~~~i~~qi~~al~~lH--~~~ivHrDlkp~NIl~~~~~~~  169 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAG-----------FVYSEAVASHYMRQILEALRYCH--DNNIIHRDVKPHCVLLASKENS  169 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECSSSTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccC-----------CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChHHeEEecCCCC
Confidence            9999999999998886543211           12889999999999999999999  789999999999999987654 


Q ss_pred             --eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          234 --AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       234 --~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                        +||+|||++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.....        .
T Consensus       170 ~~vkl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~  239 (351)
T 3c0i_A          170 APVKLGGFGVAIQLGESG-LVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKE--------R  239 (351)
T ss_dssp             CCEEECCCTTCEECCTTS-CBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------H
T ss_pred             CcEEEecCcceeEecCCC-eeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------H
Confidence              9999999998765432 223445799999999999754 478999999999999999999999754210        1


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ........ ..  ......     ....+..+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~i~~~-~~--~~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          240 LFEGIIKG-KY--KMNPRQ-----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHHHHT-CC--CCCHHH-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcC-CC--CCCccc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11111110 00  000000     0123458999999999999999999999975

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-46  Score=343.05  Aligned_cols=256  Identities=24%  Similarity=0.410  Sum_probs=191.1

Q ss_pred             CCCCCCeeecCCCceEEEEEeC--C--CCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEee-CCeeEEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS--S--GVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCAS-GLDRVLI  156 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv  156 (373)
                      .|.+.+.||+|+||.||+|...  +  +..||+|.+..... ...+.+.+|+.++++++||||+++++++.+ ....++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4566789999999999999753  2  24689999865433 345678999999999999999999998754 5678999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++|+|.+++.....              .+++.+++.++.|++.||.|||  +++++||||||+||+++.++.+||
T Consensus       170 ~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL  233 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETH--------------NPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKV  233 (373)
T ss_dssp             EECCTTCBHHHHHHCTTC--------------CCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEE
T ss_pred             EECCCCCCHHHHHhhccc--------------CCCHHHHHHHHHHHHHHHHHHH--HCCEecCccchheEEECCCCCEEE
Confidence            999999999999976443              2889999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCc---ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          237 SDFGLARRIDTSHSH---VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +|||+++........   ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+++.....   ..... 
T Consensus       234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~-  308 (373)
T 3c1x_A          234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVY-  308 (373)
T ss_dssp             CCC---------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHH-
T ss_pred             eeccccccccccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHH-
Confidence            999999865432211   1233456789999999874 457899999999999999999655544332221   11111 


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                        ... ...          ...+..++..+.+++.+||+.||++||++.++++.|++++
T Consensus       309 --~~~-~~~----------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          309 --LLQ-GRR----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             --HHT-TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHc-CCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              111 100          0112334568999999999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.2e-45  Score=325.75  Aligned_cols=256  Identities=24%  Similarity=0.377  Sum_probs=201.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCC----CCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSS----GVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      .++|.+.+.||+|+||.||+|...+    +..||+|.+..... ...+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4578889999999999999997532    34699999976533 3456789999999999999999999998654 5689


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |+||+++++|.+++.....              .+++..+..++.|++.||.|||  +++++||||||+||+++.++.+|
T Consensus        90 v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~k  153 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKN--------------SLKVLTLVLYSLQICKAMAYLE--SINCVHRDIAVRNILVASPECVK  153 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTT--------------TCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEEETTEEE
T ss_pred             EEecCCCCCHHHHHHhccc--------------cCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEECCCCcEE
Confidence            9999999999999976542              2899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      |+|||++...............+++.|+|||.+.+ ..++.++||||||+++|||++ |..||......    ...   .
T Consensus       154 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~----~~~---~  225 (281)
T 3cc6_A          154 LGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENK----DVI---G  225 (281)
T ss_dssp             ECCCCGGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG----GHH---H
T ss_pred             eCccCCCcccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChH----HHH---H
Confidence            99999998765433333344567889999999874 447889999999999999998 99887532211    111   1


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .......      ..     .+..++..+.+++.+||+.||++||++.++++.|++++
T Consensus       226 ~~~~~~~------~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          226 VLEKGDR------LP-----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             HHHHTCC------CC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhcCCC------CC-----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence            1111100      00     12234568999999999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.5e-45  Score=331.63  Aligned_cols=271  Identities=28%  Similarity=0.414  Sum_probs=208.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC--------CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeC
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS--------SGVTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASG  150 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  150 (373)
                      .++|++.+.||+|+||.||+|...        ++..||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            468899999999999999999753        467899999976543 3356788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcc-cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGS-KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      ...++||||+++|+|.+++............ ........+++.+++.++.|++.||.|||  +.+++||||||+||+++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCccceEEEc
Confidence            9999999999999999999876432110000 00001123899999999999999999999  78999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcc
Q 043074          230 SDFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEV  307 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~  307 (373)
                      .++.+||+|||++......... ......+|+.|+|||.+.+ ..++.++||||||+++|||++ |..|+....      
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~------  264 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------  264 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCC------
Confidence            9999999999999876543221 2233456789999999874 447889999999999999999 888864321      


Q ss_pred             cHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                       ..+.........      ...     .+..++..+.+++.+||+.||.+||++.++++.|++++
T Consensus       265 -~~~~~~~~~~~~------~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          265 -VEELFKLLKEGH------RMD-----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             -HHHHHHHHHHTC------CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHHHHhcCC------CCC-----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             111222121111      011     12334568999999999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-45  Score=329.81  Aligned_cols=257  Identities=28%  Similarity=0.486  Sum_probs=198.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCC-----CCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSS-----GVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      .++|...+.||+|+||.||+|....     +..||+|.+...... ....+.+|+.++++++||||+++++++.+....+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3577788999999999999997542     245999999764332 3456889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +||||+++++|.+++.....              .+++.+++.++.|++.||.|||  +.+++||||||+||+++.++.+
T Consensus       123 lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~  186 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDG--------------EFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVC  186 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTT--------------CSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCE
T ss_pred             EEEeCCCCCcHHHHHHhCCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChheEEECCCCcE
Confidence            99999999999999976532              2899999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHH
Q 043074          235 HISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  311 (373)
                      ||+|||+++........  ......+|+.|+|||.+.+ ..++.++||||||+++|||++ |..||.....       .+
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~  258 (333)
T 1mqb_A          187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HE  258 (333)
T ss_dssp             EECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HH
T ss_pred             EECCCCcchhhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HH
Confidence            99999999876433221  1222345788999999874 457889999999999999999 8888643211       11


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ....... .     ....     .+..++..+.+++.+||+.||++||++.++++.|++++
T Consensus       259 ~~~~~~~-~-----~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          259 VMKAIND-G-----FRLP-----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             HHHHHHT-T-----CCCC-----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHHC-C-----CcCC-----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1111111 0     0001     12334568999999999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4e-46  Score=335.53  Aligned_cols=256  Identities=23%  Similarity=0.389  Sum_probs=198.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCE----EEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVT----VAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      .++|++.+.||+|+||.||+|... ++..    |++|.+..... .....+.+|+.+++.++||||+++++++. +...+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            357888999999999999999754 4444    78888754332 23356678999999999999999999986 45688


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +|+||+++|+|.+++.....              .+++..++.++.|++.||.|||  +.+++||||||+|||++.++.+
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~  154 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRG--------------ALGPQLLLNWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQV  154 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGG--------------GSCTTHHHHHHHHHHHHHHHHH--HTTCCCSCCSSTTEEESSSSCE
T ss_pred             EEEEeCCCCCHHHHHHHccc--------------cCCHHHHHHHHHHHHHHHHHHH--hCCCCCCccchheEEECCCCeE
Confidence            99999999999999976532              2888999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHH
Q 043074          235 HISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  312 (373)
                      ||+|||+++........ ......+|..|+|||.+.+ ..++.++||||||+++|||++ |..||......    ..   
T Consensus       155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~---  226 (325)
T 3kex_A          155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----EV---  226 (325)
T ss_dssp             EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT----HH---
T ss_pred             EECCCCcccccCcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHH----HH---
Confidence            99999999876544322 2334567889999999974 447899999999999999999 88886542211    11   


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ...... ...          ...+..++..+.+++.+||+.||.+||++.++++.|+++.
T Consensus       227 ~~~~~~-~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          227 PDLLEK-GER----------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             HHHHHT-TCB----------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHc-CCC----------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111111 100          0012223447889999999999999999999999998875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.3e-45  Score=342.88  Aligned_cols=201  Identities=27%  Similarity=0.431  Sum_probs=168.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeC-----Ce
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASG-----LD  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  152 (373)
                      .++|++.+.||+|+||.||+|... +++.||||++.....  ...+.+.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999764 688999999965322  2356788999999999999999999999766     57


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++||||+. ++|.+++....               .+++..+..++.||+.||.|||  +.+|+||||||+|||++.++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~---------------~l~~~~~~~i~~qil~aL~~LH--~~givHrDlkp~NILl~~~~  166 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI---------------FLTEEHIKTILYNLLLGENFIH--ESGIIHRDLKPANCLLNQDC  166 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC---------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTC
T ss_pred             EEEEEecCC-cCHHHHHhccC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCCCCCCCCHHHeEECCCC
Confidence            899999995 69999997643               2899999999999999999999  78999999999999999999


Q ss_pred             ceEEeeeccccccCCCCC---------------------cccccccccccccCccccCCCCCCCccccchhhhHHHHHHH
Q 043074          233 EAHISDFGLARRIDTSHS---------------------HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIA  291 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~---------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~  291 (373)
                      .+||+|||+++.......                     .......||+.|+|||++.+...++.++|||||||++|||+
T Consensus       167 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell  246 (432)
T 3n9x_A          167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL  246 (432)
T ss_dssp             CEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             CEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHH
Confidence            999999999987643221                     12345678999999999765667899999999999999999


Q ss_pred             hCCCCCCC
Q 043074          292 TQIRPNLP  299 (373)
Q Consensus       292 ~g~~p~~~  299 (373)
                      +|..|+..
T Consensus       247 ~g~~p~~~  254 (432)
T 3n9x_A          247 NMLQSHIN  254 (432)
T ss_dssp             TTCTTTCS
T ss_pred             hccccccc
Confidence            87665443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.5e-45  Score=327.77  Aligned_cols=258  Identities=25%  Similarity=0.415  Sum_probs=200.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCC----CCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEe-eCCeeE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSS----GVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCA-SGLDRV  154 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~  154 (373)
                      ..+|++.+.||+|+||.||+|...+    ...+|+|.+..... ...+.+.+|+.++++++||||+++++++. .+...+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3468888999999999999997542    23589999876433 33567889999999999999999999864 556789


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +||||+++|+|.+++.....              .+++.+++.++.|++.||.|||  +++++||||||+||+++.++.+
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~ql~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~  167 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETH--------------NPTVKDLIGFGLQVAKGMKYLA--SKKFVHRDLAARNCMLDEKFTV  167 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTC--------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCE
T ss_pred             EEEeCCCCCCHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEECCCCCE
Confidence            99999999999999976432              2889999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCC---cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          235 HISDFGLARRIDTSHS---HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      ||+|||+++.......   .......+|+.|+|||.+.+ ..++.++||||||+++|||++|..|++......   ....
T Consensus       168 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~  243 (298)
T 3f66_A          168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITV  243 (298)
T ss_dssp             EECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHH
T ss_pred             EECcccccccccccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHH
Confidence            9999999986543221   12233457789999999874 447889999999999999999766644432221   1111


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                         ..... .          ....+..++..+.+++.+||+.||++|||++++++.|++++
T Consensus       244 ---~~~~~-~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  290 (298)
T 3f66_A          244 ---YLLQG-R----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  290 (298)
T ss_dssp             ---HHHTT-C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHhcC-C----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               11110 0          00112233558999999999999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=332.27  Aligned_cols=268  Identities=26%  Similarity=0.425  Sum_probs=207.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-----CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCC--ee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-----SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGL--DR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~  153 (373)
                      .++|++.+.||+|+||.||++..     .+++.||+|++........+.+.+|+.++++++||||+++++++....  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35788899999999999999973     368999999998766666678999999999999999999999986644  78


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++|+||+++++|.+++.....              .+++.+++.++.|++.||.|||  +++++||||||+||+++.++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~~~~~  183 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKE--------------RIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENR  183 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTT--------------SSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTE
T ss_pred             EEEEECCCCCCHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEEcCCCc
Confidence            999999999999999987543              2899999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccC-----CCc
Q 043074          234 AHISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD-----GQE  306 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-----~~~  306 (373)
                      +||+|||++.........  ......++..|+|||.+.+. .++.++||||||+++|||++|..|+......     ...
T Consensus       184 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~  262 (326)
T 2w1i_A          184 VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND  262 (326)
T ss_dssp             EEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTT
T ss_pred             EEEecCcchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccc
Confidence            999999999876543321  12234567789999998743 4788999999999999999999885432100     000


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ...........      +.+...... ..+..++.++.+++.+||+.||++|||+.++++.|+++.
T Consensus       263 ~~~~~~~~~~~------~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          263 KQGQMIVFHLI------ELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             CCTHHHHHHHH------HHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchhhhHHHHH------HHhhcCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            00000000000      001110000 113345668999999999999999999999999999874

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.9e-46  Score=335.47  Aligned_cols=244  Identities=25%  Similarity=0.379  Sum_probs=202.0

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc--------cHHHHHHHHHHHhcCCCCCccceeeEEeeC
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ--------GFREFRAEMETLGKLRHRNIVKILGYCASG  150 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  150 (373)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++......        ....+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            346899999999999999999975 47899999998654321        223567899999999999999999999999


Q ss_pred             CeeEEEEEecCCC-CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          151 LDRVLIYEFVENG-SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       151 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      ...++||||+.+| +|.+++.....               +++..+..++.|++.||.|||  +++++||||||+||+++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~~---------------l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~  164 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHPR---------------LDEPLASYIFRQLVSAVGYLR--LKDIIHRDIKDENIVIA  164 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCCC---------------CCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHH--hCCeEEeccCHHHEEEc
Confidence            9999999999777 99999986542               899999999999999999999  78999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          230 SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      .++.+||+|||++.......  ......||+.|+|||.+.+....+.++||||||+++|||++|..||......      
T Consensus       165 ~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------  236 (335)
T 3dls_A          165 EDFTIKLIDFGSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------  236 (335)
T ss_dssp             TTSCEEECCCTTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------
T ss_pred             CCCcEEEeecccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------
Confidence            99999999999998764332  2334578999999999987665688999999999999999999997542110      


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                                      .......   +...+.++.+++.+||+.||++|||+.++++.
T Consensus       237 ----------------~~~~~~~---~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 ----------------VEAAIHP---PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----------------TTTCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----------------HhhccCC---CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                            0000000   11234579999999999999999999999873

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-46  Score=329.90  Aligned_cols=256  Identities=24%  Similarity=0.385  Sum_probs=201.4

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-C---CCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCee-EEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-S---GVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDR-VLI  156 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv  156 (373)
                      .|...+.||+|+||.||+|... +   +..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4555689999999999999753 2   23799999976443 3356788999999999999999999999776655 999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +||+.+|+|.+++.....              .+++.+++.++.|++.||+|||  +++++||||||+||+++.++.+||
T Consensus       102 ~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nili~~~~~~kl  165 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQR--------------NPTVKDLISFGLQVARGMEYLA--EQKFVHRDLAARNCMLDESFTVKV  165 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTC--------------CCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEE
T ss_pred             EecccCCCHHHHHhcccc--------------CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCcEEe
Confidence            999999999999976432              2889999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCC---CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          237 SDFGLARRIDTSH---SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       237 ~Dfg~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +|||+++......   ........+|+.|+|||.+.+ ..++.++||||||+++|+|++|..|++.....   .....  
T Consensus       166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---~~~~~--  239 (298)
T 3pls_A          166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTH--  239 (298)
T ss_dssp             CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG---GGHHH--
T ss_pred             CcCCCcccccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCH---HHHHH--
Confidence            9999998653321   112233567889999999975 45788999999999999999987775543221   11111  


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                       ..... .     ..     ..+..++..+.+++.+||+.||.+|||++++++.|++++
T Consensus       240 -~~~~~-~-----~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  286 (298)
T 3pls_A          240 -FLAQG-R-----RL-----PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV  286 (298)
T ss_dssp             -HHHTT-C-----CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HhhcC-C-----CC-----CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             11110 0     00     012234568999999999999999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.2e-46  Score=332.44  Aligned_cols=263  Identities=20%  Similarity=0.296  Sum_probs=203.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEe----eCCeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA----SGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~l  155 (373)
                      .++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46899999999999999999976 579999999987665556678899999999999999999999986    3347889


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |+||+++|+|.+++.......           .++++.+++.++.|++.||.|||  +++++||||||+||+++.++.+|
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dlkp~NIl~~~~~~~k  174 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKG-----------NFLTEDQILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPV  174 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTT-----------CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEE
T ss_pred             EEEeCCCCcHHHHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEcCCCCEE
Confidence            999999999999998642211           13899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCc--------ccccccccccccCccccCCCC--CCCccccchhhhHHHHHHHhCCCCCCCcccCCC
Q 043074          236 ISDFGLARRIDTSHSH--------VSTQVAGTMGYMPPEYLGGNT--AATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ  305 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~  305 (373)
                      |+|||++.........        ......||+.|+|||.+.+..  .++.++||||||+++|||++|..||........
T Consensus       175 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  254 (317)
T 2buj_A          175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD  254 (317)
T ss_dssp             ECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS
T ss_pred             EEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc
Confidence            9999998764321110        012245799999999987543  257899999999999999999999643211111


Q ss_pred             cccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          306 EVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .  ...    ... .        ...... ....+..+.+++.+||+.||.+||++.++++.|+++.
T Consensus       255 ~--~~~----~~~-~--------~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          255 S--VAL----AVQ-N--------QLSIPQ-SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             C--HHH----HHH-C--------C--CCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             h--hhH----Hhh-c--------cCCCCc-cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            1  000    000 0        000000 2233568999999999999999999999999998864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.6e-45  Score=336.61  Aligned_cols=201  Identities=27%  Similarity=0.400  Sum_probs=162.1

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc--cccHHHHHHHHHHHhcCC-CCCccceeeEEeeCC--ee
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA--FQGFREFRAEMETLGKLR-HRNIVKILGYCASGL--DR  153 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~  153 (373)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++....  ......+.+|+.++..+. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            357899999999999999999975 478999999986432  233456789999999997 999999999997544  68


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++||||++ ++|.+++....                +++..+..++.|++.||+|||  +.+|+||||||+|||++.++.
T Consensus        87 ~lv~e~~~-~~L~~~~~~~~----------------~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~  147 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRANI----------------LEPVHKQYVVYQLIKVIKYLH--SGGLLHRDMKPSNILLNAECH  147 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHTC----------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCC
T ss_pred             EEEecccC-cCHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHeEEcCCCC
Confidence            99999996 69999997642                889999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCC--------------------CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhC
Q 043074          234 AHISDFGLARRIDTSH--------------------SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ  293 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~--------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g  293 (373)
                      +||+|||+++......                    ........||+.|+|||++.+...++.++|||||||++|||++|
T Consensus       148 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g  227 (388)
T 3oz6_A          148 VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG  227 (388)
T ss_dssp             EEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             EEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhC
Confidence            9999999998653211                    11223457999999999998767789999999999999999999


Q ss_pred             CCCCCC
Q 043074          294 IRPNLP  299 (373)
Q Consensus       294 ~~p~~~  299 (373)
                      ..||..
T Consensus       228 ~~pf~~  233 (388)
T 3oz6_A          228 KPIFPG  233 (388)
T ss_dssp             SCSCCC
T ss_pred             CCCCCC
Confidence            999754

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-45  Score=345.91  Aligned_cols=198  Identities=26%  Similarity=0.404  Sum_probs=156.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeC-----Ce
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASG-----LD  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  152 (373)
                      .++|++.+.||+|+||.||+|... +++.||||++.....  ...+.+.+|+.+++.++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999654 789999999865322  2356788999999999999999999998433     57


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++||||+ +++|.+++....               .+++..+..++.||+.||+|||  +.+|+||||||+|||++.++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~---------------~l~~~~~~~~~~qi~~aL~~LH--~~~iiHrDlKp~NILl~~~~  193 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV---------------YLTELHIKTLLYNLLVGVKYVH--SAGILHRDLKPANCLVNQDC  193 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC---------------CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTC
T ss_pred             EEEEEecc-ccchhhhcccCC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCcCCCCCChhhEEECCCC
Confidence            89999998 679999987653               2899999999999999999999  78999999999999999999


Q ss_pred             ceEEeeeccccccCCCCC--------------------------cccccccccccccCccccCCCCCCCccccchhhhHH
Q 043074          233 EAHISDFGLARRIDTSHS--------------------------HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL  286 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~--------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~  286 (373)
                      .+||+|||+++.......                          .......||+.|+|||++.+...++.++|||||||+
T Consensus       194 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~i  273 (458)
T 3rp9_A          194 SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI  273 (458)
T ss_dssp             CEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred             CEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHH
Confidence            999999999987643211                          123345789999999987656678999999999999


Q ss_pred             HHHHHhCCCC
Q 043074          287 MIEIATQIRP  296 (373)
Q Consensus       287 l~el~~g~~p  296 (373)
                      +|||++|..|
T Consensus       274 l~elltg~~~  283 (458)
T 3rp9_A          274 FAELLNMIKE  283 (458)
T ss_dssp             HHHHHTTSTT
T ss_pred             HHHHHHhccc
Confidence            9999996444

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-45  Score=334.38  Aligned_cols=244  Identities=23%  Similarity=0.272  Sum_probs=198.4

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  154 (373)
                      ..++|++.+.||+|+||.||+|..+ +++.||+|++.+..   ....+.+..|..++..+ +||||+++++++.+....+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3568999999999999999999875 57899999997643   23356678999999988 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +||||+++|+|.+++.....               +++..+..++.||+.||.|||  +++|+||||||+|||++.++.+
T Consensus        98 lv~E~~~gg~L~~~l~~~~~---------------~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~v  160 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGR---------------FKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHI  160 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCE
T ss_pred             EEEeCCCCCcHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEEcCCCcE
Confidence            99999999999999986542               899999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      ||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.....       .....
T Consensus       161 kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~  231 (353)
T 2i0e_A          161 KIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQ  231 (353)
T ss_dssp             EECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred             EEEeCCcccccccCC-cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCH-------HHHHH
Confidence            999999998643222 23345679999999999975 4578999999999999999999999754211       11111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                      ......       ..     ++...+.++.+++.+||+.||.+||++
T Consensus       232 ~i~~~~-------~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          232 SIMEHN-------VA-----YPKSMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             HHHHCC-------CC-----CCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             HHHhCC-------CC-----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            111110       01     123345689999999999999999964

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.4e-45  Score=332.02  Aligned_cols=248  Identities=24%  Similarity=0.318  Sum_probs=191.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe----CCCCEEEEEEeCcccc----ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAF----QGFREFRAEMETLGKLRHRNIVKILGYCASGLD  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  152 (373)
                      .++|++.+.||+|+||.||++..    .+++.||+|++.+...    .....+.+|+.+++.++||||+++++++.+...
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35789999999999999999976    4789999999976432    233457889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++||||+++++|.+++.....               +++..+..++.|++.||.|||  +++++||||||+||+++.++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~Nill~~~~  158 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREGI---------------FMEDTACFYLAEISMALGHLH--QKGIIYRDLKPENIMLNHQG  158 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTS
T ss_pred             EEEEEeCCCCCcHHHHHHhCCC---------------CCHHHHHHHHHHHHHHHHHHH--hCCEEcccCCHHHeEECCCC
Confidence            9999999999999999976542               889999999999999999999  78999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      .+||+|||+++...... .......||+.|+|||.+.+ ..++.++||||||+++|||++|..||.....       ...
T Consensus       159 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~  229 (327)
T 3a62_A          159 HVKLTDFGLCKESIHDG-TVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENR-------KKT  229 (327)
T ss_dssp             CEEECCCSCC-----------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHH
T ss_pred             cEEEEeCCcccccccCC-ccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCH-------HHH
Confidence            99999999997643222 22334578999999999975 4478899999999999999999999754211       111


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                      ........       ..     .+...+.++.+++.+||+.||++||     ++.++++
T Consensus       230 ~~~i~~~~-------~~-----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          230 IDKILKCK-------LN-----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHHTC-------CC-----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHHhCC-------CC-----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            11111110       01     1223456899999999999999999     6667664

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=328.83  Aligned_cols=253  Identities=28%  Similarity=0.478  Sum_probs=194.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      ++|++.+.||+|+||.||+|... ++.||+|.+....  ..+.+.+|+.++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            46888899999999999999875 7899999996543  34678999999999999999999998874  4789999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCceeecCCCCceEeCCCCc-eEEeee
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLE-KPIIHRDIKSSNVLLDSDFE-AHISDF  239 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~-~~i~H~dlk~~Nill~~~~~-~kl~Df  239 (373)
                      +|+|.+++.......            .+++..++.++.|++.||+|||+.. ++++||||||+||+++.++. +||+||
T Consensus        83 ~~~L~~~l~~~~~~~------------~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df  150 (307)
T 2eva_A           83 GGSLYNVLHGAEPLP------------YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF  150 (307)
T ss_dssp             TCBHHHHHHCSSSEE------------CCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred             CCCHHHHHhccCCCC------------ccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence            999999998654211            2788999999999999999999321 78999999999999988886 799999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++......    .....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+......     .......... 
T Consensus       151 g~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~-  219 (307)
T 2eva_A          151 GTACDIQTH----MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-----AFRIMWAVHN-  219 (307)
T ss_dssp             CC----------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-----HHHHHHHHHT-
T ss_pred             ccccccccc----cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-----HHHHHHHHhc-
Confidence            999765322    223468999999999975 45788999999999999999999997532211     1111111111 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .     .....     ...++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       220 ~-----~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          220 G-----TRPPL-----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             T-----CCCCC-----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             C-----CCCCc-----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            0     01111     2233558999999999999999999999999998864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-46  Score=337.93  Aligned_cols=255  Identities=22%  Similarity=0.311  Sum_probs=203.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe----CCCCEEEEEEeCcccc----ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCC
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAF----QGFREFRAEMETLGKL-RHRNIVKILGYCASGL  151 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  151 (373)
                      .++|++.+.||+|+||.||++..    .+++.||+|++.....    ...+.+.+|+.++..+ +||||+++++++.+..
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            35899999999999999999976    3789999999875432    2345567899999999 6999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..++||||+++++|.+++....               ++++..+..++.|++.||.|||  +++|+||||||+|||++.+
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~  195 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE---------------RFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSN  195 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS---------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTT
T ss_pred             eEEEEeecCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCC
Confidence            9999999999999999998654               2899999999999999999999  7899999999999999999


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCC-CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN-TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  310 (373)
                      +.+||+|||+++..............||+.|+|||.+.+. ..++.++|||||||++|||++|..||.......   ...
T Consensus       196 ~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~  272 (355)
T 1vzo_A          196 GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQA  272 (355)
T ss_dssp             SCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHH
T ss_pred             CcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc---hHH
Confidence            9999999999987644333334456799999999999753 446889999999999999999999975432221   122


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQL  367 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~~  367 (373)
                      .........       ...     .+...+..+.+++.+||+.||.+||     +++++++.
T Consensus       273 ~~~~~~~~~-------~~~-----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          273 EISRRILKS-------EPP-----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHHHHHHC-------CCC-----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HHHHHHhcc-------CCC-----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            222222111       011     1233456789999999999999999     88988763

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.1e-46  Score=337.07  Aligned_cols=264  Identities=18%  Similarity=0.191  Sum_probs=197.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC----CCCEEEEEEeCccccc-----------cHHHHHHHHHHHhcCCCCCccceee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQ-----------GFREFRAEMETLGKLRHRNIVKILG  145 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~  145 (373)
                      .++|.+.+.||+|+||.||+|...    ++..+|+|.+......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            468999999999999999999875    5788999998654322           1124667889999999999999999


Q ss_pred             EEee----CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecC
Q 043074          146 YCAS----GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDI  221 (373)
Q Consensus       146 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dl  221 (373)
                      ++.+    ....++||||+ +++|.+++....               ++++.+++.++.|++.||+|||  +.+++||||
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dl  177 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---------------TFKKSTVLQLGIRMLDVLEYIH--ENEYVHGDI  177 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---------------BCCHHHHHHHHHHHHHHHHHHH--HTTEECSCC
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCc
Confidence            9987    67889999999 999999997654               2899999999999999999999  789999999


Q ss_pred             CCCceEeCCCC--ceEEeeeccccccCCCC------CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhC
Q 043074          222 KSSNVLLDSDF--EAHISDFGLARRIDTSH------SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ  293 (373)
Q Consensus       222 k~~Nill~~~~--~~kl~Dfg~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g  293 (373)
                      ||+||+++.++  .+||+|||+++......      ........||+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus       178 kp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g  256 (345)
T 2v62_A          178 KAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCG  256 (345)
T ss_dssp             SGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHS
T ss_pred             CHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhC
Confidence            99999998877  99999999998763221      1112345789999999999854 578999999999999999999


Q ss_pred             CCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          294 IRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       294 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                      ..||.......  ............  .....+.....    ...++.++.+++.+||+.||++||++++|++.|+++
T Consensus       257 ~~pf~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          257 KLPWEQNLKDP--VAVQTAKTNLLD--ELPQSVLKWAP----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             SCTTGGGTTCH--HHHHHHHHHHHH--TTTHHHHHHSC----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             CCCcccccccc--HHHHHHHHhhcc--cccHHHHhhcc----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            99975322111  111111111110  00000000000    012345899999999999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.1e-45  Score=325.83  Aligned_cols=255  Identities=26%  Similarity=0.396  Sum_probs=201.0

Q ss_pred             cCCCCCCC-eeecCCCceEEEEEe---CCCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           81 TDNFSTDK-IIGDGSFGFVYKAKL---SSGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        81 ~~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      .++|.+.+ .||+|+||.||+|..   .+++.||+|++......  ..+.+.+|+.+++.++||||+++++++ .....+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45777777 999999999999954   24688999999764332  256789999999999999999999999 567789


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +|+||+++++|.+++....               .+++..++.++.|++.||.|||  +.+++||||||+||+++.++.+
T Consensus        94 lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nil~~~~~~~  156 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR---------------HVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYA  156 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT---------------TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEE
T ss_pred             EEEEeCCCCCHHHHHHhCc---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeEcCCCCcceEEEeCCCcE
Confidence            9999999999999998754               2899999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCCcc--cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHH
Q 043074          235 HISDFGLARRIDTSHSHV--STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  311 (373)
                      ||+|||++..........  .....+++.|+|||.+.+ ..++.++||||||+++|||++ |..|+.....       ..
T Consensus       157 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~  228 (291)
T 1xbb_A          157 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SE  228 (291)
T ss_dssp             EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HH
T ss_pred             EEccCCcceeeccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-------HH
Confidence            999999998765433221  222346788999999874 347889999999999999999 8888654211       11


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ....... ..     ..     ..+..++..+.+++.+||+.||.+||++.++++.|++++
T Consensus       229 ~~~~~~~-~~-----~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          229 VTAMLEK-GE-----RM-----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             HHHHHHT-TC-----CC-----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHHc-CC-----CC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1111111 10     01     113344568999999999999999999999999999876

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2e-45  Score=330.59  Aligned_cols=270  Identities=25%  Similarity=0.410  Sum_probs=208.4

Q ss_pred             HHHhcCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEee
Q 043074           77 LIDATDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCAS  149 (373)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~  149 (373)
                      .....++|++.+.||+|+||.||+|...      +++.||+|.+...... ....+.+|+.+++.++||||+++++++.+
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            3445678999999999999999999653      3678999999754432 34568899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       150 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      +...++||||+++|+|.+++........     ......++++..++.++.|++.||.|||  +++++||||||+||+++
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~NIli~  172 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMA-----NNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVA  172 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHH-----HCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEEC
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhc-----cCCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCCccCCCccceEEEc
Confidence            9999999999999999999976421000     0000123789999999999999999999  78999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcc
Q 043074          230 SDFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEV  307 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~  307 (373)
                      .++.+||+|||++........ .......+|+.|+|||.+.+ ..++.++||||||+++|||++ |..|+....      
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~------  245 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------  245 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCC------
Confidence            999999999999986533221 12233456889999999874 447889999999999999999 677754321      


Q ss_pred             cHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                       .......... ...          ...+..++..+.+++.+||+.||.+|||+.++++.|++++
T Consensus       246 -~~~~~~~~~~-~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          246 -NEQVLRFVME-GGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             -HHHHHHHHHT-TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             -HHHHHHHHHc-CCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence             1111111111 100          0112334568999999999999999999999999998875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-45  Score=323.15  Aligned_cols=255  Identities=25%  Similarity=0.369  Sum_probs=203.5

Q ss_pred             CCCCCCC-eeecCCCceEEEEEeC---CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDK-IIGDGSFGFVYKAKLS---SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ++|.+.+ .||+|+||.||+|...   ++..||+|.+..... ...+.+.+|+.++++++||||+++++++ .....++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4555655 8999999999999753   678899999976533 3456789999999999999999999999 55678999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +||+++++|.+++.....              ++++..++.++.|++.||.|||  +.+++||||||+||+++.++.+||
T Consensus        88 ~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl  151 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKRE--------------EIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKI  151 (287)
T ss_dssp             EECCTTEEHHHHHTTCTT--------------TSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEE
T ss_pred             EEeCCCCCHHHHHHhCCc--------------cCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCchheEEEcCCCCEEE
Confidence            999999999999975432              2899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcc--cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          237 SDFGLARRIDTSHSHV--STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +|||++..........  .....+|+.|+|||.+.+ ..++.++||||||+++|||++ |..||.....       .+..
T Consensus       152 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~  223 (287)
T 1u59_A          152 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PEVM  223 (287)
T ss_dssp             CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-------HHHH
T ss_pred             CcccceeeeccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-------HHHH
Confidence            9999998765433221  223456889999999874 447889999999999999998 8888643221       1111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..... ..     .     ...+..++..+.+++.+||+.||++||++.++++.|++++
T Consensus       224 ~~i~~-~~-----~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          224 AFIEQ-GK-----R-----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             HHHHT-TC-----C-----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhc-CC-----c-----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11111 10     0     1113345668999999999999999999999999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=334.45  Aligned_cols=251  Identities=25%  Similarity=0.334  Sum_probs=187.0

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....  ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4567999999999999999999875 58899999997543  23567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC---CCceE
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---DFEAH  235 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~---~~~~k  235 (373)
                      |+++|+|.+++....               .+++.++..++.|++.||.|||  +.+++||||||+||+++.   ++.+|
T Consensus       129 ~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~NIll~~~~~~~~~k  191 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG---------------YYSERDAADAVKQILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLK  191 (349)
T ss_dssp             CCCSCBHHHHHTTCS---------------SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESSSSTTCCEE
T ss_pred             eCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCcccEEEecCCCCCCEE
Confidence            999999999997543               2899999999999999999999  789999999999999975   88999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||+++.....  .......||+.|+|||.+.+. .++.++|||||||++|||++|..||.......      .....
T Consensus       192 l~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~  262 (349)
T 2w4o_A          192 IADFGLSKIVEHQ--VLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRR  262 (349)
T ss_dssp             ECCCC------------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHH
T ss_pred             EccCccccccCcc--cccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHH
Confidence            9999999865432  123345789999999999854 47889999999999999999999975422110      00111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ... .. .. ....     .....+..+.+++.+||+.||++|||+.++++
T Consensus       263 i~~-~~-~~-~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          263 ILN-CE-YY-FISP-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHT-TC-CC-CCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHh-CC-Cc-cCCc-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111 00 00 0000     01234568999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.7e-45  Score=329.29  Aligned_cols=262  Identities=24%  Similarity=0.399  Sum_probs=197.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....   ......+.+|+.++++++||||+++++++.+....++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35789999999999999999976 578999999997533   22356788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++++|.+++.......           ..+++..++.++.|++.||.|||  +.+++|+||||+||+++.++.+||
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIl~~~~~~~kl  177 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQK-----------RLIPERTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKL  177 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred             EecCCCCCHHHHHHHhcccc-----------cCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCcHHHEEEcCCCCEEE
Confidence            99999999999997532111           13899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++....... .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.....     .........
T Consensus       178 ~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~  250 (310)
T 2wqm_A          178 GDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKI  250 (310)
T ss_dssp             CCC-------------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHHHH
T ss_pred             EeccceeeecCCC-ccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHHHh
Confidence            9999998654322 12234568999999999875 4578899999999999999999999754221     122222222


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .... .     +...    ....+.++.+++.+||+.||++|||+.++++.|+++.
T Consensus       251 ~~~~-~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          251 EQCD-Y-----PPLP----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             HTTC-S-----CCCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hccc-C-----CCCc----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            1110 0     0111    1233458999999999999999999999999999875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.3e-45  Score=321.92  Aligned_cols=253  Identities=23%  Similarity=0.309  Sum_probs=203.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.++...++|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            357888999999999999999765 789999999865433 334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++++|.+++....               .+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.+||+|
T Consensus        86 ~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~d  148 (276)
T 2yex_A           86 YCSGGELFDRIEPDI---------------GMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISD  148 (276)
T ss_dssp             CCTTEEGGGGSBTTT---------------BCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             ecCCCcHHHHHhhcc---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCChHHEEEccCCCEEEee
Confidence            999999999986543               2899999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          239 FGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       239 fg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      ||++........ .......||+.|+|||.+.+....+.++||||||+++|||++|..||.......  .....|.    
T Consensus       149 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~----  222 (276)
T 2yex_A          149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWK----  222 (276)
T ss_dssp             CTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--HHHHHHH----
T ss_pred             CCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHhh----
Confidence            999986532221 123345689999999999866656789999999999999999999975432211  1111111    


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .....   ..       .....+..+.+++.+||+.||++|||+.++++
T Consensus       223 ~~~~~---~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          223 EKKTY---LN-------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TTCTT---ST-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hcccc---cC-------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            10000   00       01123457899999999999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.2e-45  Score=320.43  Aligned_cols=250  Identities=22%  Similarity=0.296  Sum_probs=203.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|++.+.||+|+||.||+|... ++..+|+|++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            457899999999999999999765 5789999999776666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe---CCCCceEE
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL---DSDFEAHI  236 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill---~~~~~~kl  236 (373)
                      +++++|.+++.....               +++.++..++.|++.||.|||  +++++||||||+||++   +.++.+||
T Consensus        88 ~~~~~L~~~~~~~~~---------------~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~~~l  150 (277)
T 3f3z_A           88 CTGGELFERVVHKRV---------------FRESDAARIMKDVLSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKL  150 (277)
T ss_dssp             CCSCBHHHHHHHHCS---------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred             cCCCcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEecCCCCCcEEE
Confidence            999999999876542               899999999999999999999  7899999999999999   78899999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++.......  ......||+.|+|||.+.+.  ++.++||||||+++|||++|..||.....       .+.....
T Consensus       151 ~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~  219 (277)
T 3f3z_A          151 IDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTD-------SEVMLKI  219 (277)
T ss_dssp             CCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHH
T ss_pred             EecccceeccCcc--chhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCH-------HHHHHHH
Confidence            9999998764332  23345689999999998643  78899999999999999999999754221       1111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .....       ...... ....+..+.+++.+||+.||++|||+.++++
T Consensus       220 ~~~~~-------~~~~~~-~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          220 REGTF-------TFPEKD-WLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHCCC-------CCCHHH-HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HhCCC-------CCCchh-hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11000       000000 0023568999999999999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4e-45  Score=331.47  Aligned_cols=246  Identities=28%  Similarity=0.407  Sum_probs=198.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      +.|+..+.||+|+||.||+|.. .+++.||+|++.....   ...+.+.+|+.++++++||||+++++++.++...++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999975 5789999999865432   23457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+. |+|.+++.....              ++++.++..++.|++.||.|||  +++++||||||+||+++.++.+||+
T Consensus       134 e~~~-g~l~~~l~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~  196 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKK--------------PLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLG  196 (348)
T ss_dssp             ECCS-EEHHHHHHHHTS--------------CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEEC
T ss_pred             ecCC-CCHHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEe
Confidence            9996 688888865432              3899999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCC--CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |||++.....     .....||+.|+|||++.+  ...++.++|||||||++|||++|..|+....       .......
T Consensus       197 DfG~a~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-------~~~~~~~  264 (348)
T 1u5q_A          197 DFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYH  264 (348)
T ss_dssp             CCTTCBSSSS-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHH
T ss_pred             eccCceecCC-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHH
Confidence            9999986542     234578999999999852  4457889999999999999999999975421       1111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .....      .+...    +...+..+.+++.+||+.||++|||+.++++
T Consensus       265 ~~~~~------~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          265 IAQNE------SPALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             HHHSC------CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHhcC------CCCCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            11111      11111    1223457899999999999999999999875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.8e-45  Score=331.75  Aligned_cols=262  Identities=23%  Similarity=0.293  Sum_probs=193.4

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++......  ..+.+.+|+.++++++||||+++++++.++...++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            456899999999999999999975 47899999999654432  234677999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe-----CCC
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL-----DSD  231 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill-----~~~  231 (373)
                      |||++ |+|.+++.....               +++..+..++.|++.||.|||  +++++||||||+||++     +.+
T Consensus       112 ~e~~~-~~L~~~~~~~~~---------------~~~~~~~~i~~ql~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~  173 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKNPD---------------VSMRVIKSFLYQLINGVNFCH--SRRCLHRDLKPQNLLLSVSDASET  173 (329)
T ss_dssp             EECCS-EEHHHHHHHCTT---------------CCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEC-----C
T ss_pred             EecCC-CCHHHHHhhcCC---------------CCHHHHHHHHHHHHHHHHHHH--hCCEECCCCCHHHEEEecCCCCcc
Confidence            99996 599999987542               899999999999999999999  7899999999999999     455


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +.+||+|||++........ ......||+.|+|||++.+...++.++|||||||++|||++|..||.......   .+..
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~  249 (329)
T 3gbz_A          174 PVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFK  249 (329)
T ss_dssp             CEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred             ceEEECcCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHH
Confidence            6699999999987643322 23345679999999999876668999999999999999999999975422110   0111


Q ss_pred             HHHHHHHhcccccc----------cc---Cccccc----cCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEM----------VD---SNISRE----ELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~----------~~---~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                         ...........          ..   +.....    ......+.++.+++.+||+.||++|||+.|+++
T Consensus       250 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          250 ---IFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             ---HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence               01000000000          00   000000    001113457899999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.9e-45  Score=329.88  Aligned_cols=261  Identities=19%  Similarity=0.261  Sum_probs=197.5

Q ss_pred             cCCCCCC-CeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEE
Q 043074           81 TDNFSTD-KIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        81 ~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .+.|++. +.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3567774 7899999999999975 47899999999776655567889999999885 7999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc---e
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---A  234 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~---~  234 (373)
                      ||+++++|.+++....               ++++.++..++.|++.||+|||  +++++||||||+||+++.++.   +
T Consensus        91 e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~~~  153 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR---------------HFNELEASVVVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPV  153 (316)
T ss_dssp             ECCTTCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESCSSSSCSE
T ss_pred             EcCCCCcHHHHHhccC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEEccCCCcCce
Confidence            9999999999998654               2899999999999999999999  789999999999999998776   9


Q ss_pred             EEeeeccccccCCCCC------cccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCCcccCC
Q 043074          235 HISDFGLARRIDTSHS------HVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDG  304 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  304 (373)
                      ||+|||++........      .......||+.|+|||.+.+    ...++.++|||||||++|||++|..||.......
T Consensus       154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  233 (316)
T 2ac3_A          154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD  233 (316)
T ss_dssp             EECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC
T ss_pred             EEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc
Confidence            9999999976532211      11223468999999999863    1346789999999999999999999986544322


Q ss_pred             CcccH--------HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          305 QEVGL--------LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       305 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .....        ......... ..      ....... ....+..+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~i~~-~~------~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          234 CGWDRGEACPACQNMLFESIQE-GK------YEFPDKD-WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             SCC----CCHHHHHHHHHHHHH-CC------CCCCHHH-HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccccccchhHHHHHHHHHhc-cC------cccCchh-cccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            11000        001111111 00      0000000 0123457999999999999999999999986

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.6e-45  Score=332.19  Aligned_cols=273  Identities=22%  Similarity=0.241  Sum_probs=201.5

Q ss_pred             HHHhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc-----cccHHHHHHHHHHHhcCCCCCccceeeEEeeC
Q 043074           77 LIDATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA-----FQGFREFRAEMETLGKLRHRNIVKILGYCASG  150 (373)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  150 (373)
                      +....++|++.+.||+|+||.||+|.. .+++.||+|++....     ....+.+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            345567899999999999999999976 468899999986542     23456789999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccc-------------------------cCCCCCCCHHHHHHHHHHHHHH
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQ-------------------------LNSLCPLSWETRVKIVRGVANG  205 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~-------------------------~~~~~~l~~~~~~~i~~qi~~~  205 (373)
                      ...++||||+++|+|.+++..............                         -.....+++..+..++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999999964221110000000                         0000014677888999999999


Q ss_pred             HHHHhcCCCCceeecCCCCceEeCCCC--ceEEeeeccccccCCCCC---cccccccccccccCccccCC-CCCCCcccc
Q 043074          206 LAYLHGLEKPIIHRDIKSSNVLLDSDF--EAHISDFGLARRIDTSHS---HVSTQVAGTMGYMPPEYLGG-NTAATVMLD  279 (373)
Q Consensus       206 l~~lh~~~~~i~H~dlk~~Nill~~~~--~~kl~Dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~~D  279 (373)
                      |+|||  +.+++||||||+||+++.++  .+||+|||++........   .......||+.|+|||.+.+ ...++.++|
T Consensus       181 l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          181 LHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHH--HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHH--HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            99999  78999999999999998776  899999999986533221   12344678999999999864 256788999


Q ss_pred             chhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC
Q 043074          280 VYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP  359 (373)
Q Consensus       280 iwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  359 (373)
                      |||||+++|||++|..||.....       .+...........   ....    . ....+..+.+++.+||+.||.+||
T Consensus       259 iwslG~il~el~~g~~pf~~~~~-------~~~~~~~~~~~~~---~~~~----~-~~~~~~~~~~li~~~l~~~p~~Rp  323 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVND-------ADTISQVLNKKLC---FENP----N-YNVLSPLARDLLSNLLNRNVDERF  323 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC---TTSG----G-GGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred             HHHHHHHHHHHHHCCCCCCCCCh-------HHHHHHHHhcccc---cCCc----c-cccCCHHHHHHHHHHcCCChhHCC
Confidence            99999999999999999743221       1111111111100   0000    0 112345899999999999999999


Q ss_pred             CHHHHHH
Q 043074          360 AMSYVVQ  366 (373)
Q Consensus       360 s~~~l~~  366 (373)
                      ++.++++
T Consensus       324 s~~~~l~  330 (345)
T 3hko_A          324 DAMRALQ  330 (345)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHhc
Confidence            9999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=356.07  Aligned_cols=248  Identities=25%  Similarity=0.373  Sum_probs=195.7

Q ss_pred             eeecCCCceEEEEEeC---CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCC
Q 043074           89 IIGDGSFGFVYKAKLS---SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGS  164 (373)
Q Consensus        89 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  164 (373)
                      .||+|+||.||+|.+.   ++..||||+++.... ...+.+.+|+.++++++||||+++++++.+ +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999653   466799999976533 346789999999999999999999999976 56899999999999


Q ss_pred             HHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccc
Q 043074          165 LDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       165 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                      |.+++.....              .+++..++.++.||+.||+|||  +++|+||||||+|||++.++.+||+|||+++.
T Consensus       422 L~~~l~~~~~--------------~l~~~~~~~i~~qi~~~L~~LH--~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          422 LHKFLVGKRE--------------EIPVSNVAELLHQVSMGMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             HHHHHTTCTT--------------TSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             HHHHHhhccC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence            9999975432              2899999999999999999999  78999999999999999999999999999987


Q ss_pred             cCCCCCcc--cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhcc
Q 043074          245 IDTSHSHV--STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARNK  321 (373)
Q Consensus       245 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (373)
                      ........  .....+++.|+|||++.+ ..++.++|||||||++|||++ |..||.....    .   +....... +.
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~---~~~~~i~~-~~  556 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----P---EVMAFIEQ-GK  556 (613)
T ss_dssp             CC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS----H---HHHHHHHT-TC
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH----H---HHHHHHHc-CC
Confidence            64332211  122345689999999974 458899999999999999998 8888653221    1   11111111 10


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                                ....+..++.++.+++.+||+.||++||++.+|++.|+++.
T Consensus       557 ----------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          557 ----------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                      01113445678999999999999999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=337.18  Aligned_cols=246  Identities=23%  Similarity=0.323  Sum_probs=194.2

Q ss_pred             CCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCCCCH
Q 043074           87 DKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSL  165 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  165 (373)
                      .+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.++++++||||+++++++.+....++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56799999999999976 47899999999876655667899999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe--CCCCceEEeeecccc
Q 043074          166 DQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL--DSDFEAHISDFGLAR  243 (373)
Q Consensus       166 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill--~~~~~~kl~Dfg~~~  243 (373)
                      .+++.....              .+++..++.++.|++.||.|||  +.+++||||||+|||+  +.++.+||+|||+++
T Consensus       174 ~~~l~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~  237 (373)
T 2x4f_A          174 FDRIIDESY--------------NLTELDTILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLAR  237 (373)
T ss_dssp             HHHHHHTGG--------------GCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred             HHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence            998875432              2899999999999999999999  7899999999999999  677899999999998


Q ss_pred             ccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcccc
Q 043074          244 RIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEI  323 (373)
Q Consensus       244 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (373)
                      ......  ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.....       .+........... 
T Consensus       238 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~~~~-  306 (373)
T 2x4f_A          238 RYKPRE--KLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-------AETLNNILACRWD-  306 (373)
T ss_dssp             ECCTTC--BCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCCC-
T ss_pred             ecCCcc--ccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhccCC-
Confidence            764332  2234568999999999874 4578899999999999999999999754221       1111111111100 


Q ss_pred             ccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          324 EMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                        +....     ....+.++.+++.+||+.||.+|||+.++++
T Consensus       307 --~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          307 --LEDEE-----FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             --SCSGG-----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CChhh-----hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              00000     1123458999999999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4e-45  Score=328.71  Aligned_cols=250  Identities=22%  Similarity=0.273  Sum_probs=178.2

Q ss_pred             CCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEEecCCCC
Q 043074           87 DKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLIYEFVENGS  164 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  164 (373)
                      .+.||+|+||.||+|..+ +++.||+|++.+.   ....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999764 6899999999653   2356778999999997 9999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC---ceEEeeecc
Q 043074          165 LDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF---EAHISDFGL  241 (373)
Q Consensus       165 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~  241 (373)
                      |.+++....               ++++.++..++.|++.||+|||  +++++||||||+||+++.++   .+||+|||+
T Consensus        93 L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~  155 (325)
T 3kn6_A           93 LFERIKKKK---------------HFSETEASYIMRKLVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGF  155 (325)
T ss_dssp             HHHHHHHCS---------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred             HHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCHHHEEEecCCCcccEEEecccc
Confidence            999998754               2899999999999999999999  78999999999999997665   899999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK  321 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (373)
                      ++...... .......||+.|+|||.+.+ ..++.++||||||+++|||++|..||.............+........ .
T Consensus       156 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-~  232 (325)
T 3kn6_A          156 ARLKPPDN-QPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-D  232 (325)
T ss_dssp             CEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-C
T ss_pred             ceecCCCC-CcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-C
Confidence            98654322 22344568999999999975 457899999999999999999999976543322222222222111110 0


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                            ...... .....+.++.+++.+||+.||++|||++++++
T Consensus       233 ------~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          233 ------FSFEGE-AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             ------CCCCSH-HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ------CCCCcc-cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence                  000000 01224568999999999999999999998863

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=331.15  Aligned_cols=256  Identities=21%  Similarity=0.368  Sum_probs=196.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCE----EEEEEeCccc-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVT----VAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      .++|++.+.||+|+||.||+|... +++.    |++|.+.... ....+.+.+|+.++++++||||+++++++.++. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            468999999999999999999754 4444    5777775433 334678899999999999999999999998765 78


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +|++|+.+|+|.+++.....              .+++..++.++.|++.||.|||  +++++||||||+||+++.++.+
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~  156 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKD--------------NIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHV  156 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEE
T ss_pred             EEEEecCCCcHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHh--hCCCcCCCCCHHHEEEcCCCCE
Confidence            99999999999999987543              2899999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHH
Q 043074          235 HISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  312 (373)
                      ||+|||+++........ ......+|+.|+|||.+.+ ..++.++||||||+++|||++ |..||......    .+.. 
T Consensus       157 kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~-  230 (327)
T 3lzb_A          157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISS-  230 (327)
T ss_dssp             EECCTTC----------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHH-
T ss_pred             EEccCcceeEccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHH-
Confidence            99999999876433222 2233456788999999974 457899999999999999999 88886542221    1111 


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                        .... ..     .     ...+..++.++.+++.+||+.||.+||++.++++.|+++.
T Consensus       231 --~~~~-~~-----~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          231 --ILEK-GE-----R-----LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             --HHHT-TC-----C-----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHc-CC-----C-----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              1111 00     0     0112334568999999999999999999999999999875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.5e-45  Score=337.90  Aligned_cols=250  Identities=21%  Similarity=0.356  Sum_probs=195.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCC--CCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLR--HRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||++...+++.||||++.....  ...+.+.+|+.++.+++  ||||+++++++......++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            46999999999999999999888899999999865432  33567899999999996  599999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      | +.+++|.+++....               .+++.++..++.||+.||.|||  +.+|+||||||+|||++ ++.+||+
T Consensus       136 E-~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~-~~~~kl~  196 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK---------------SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLI  196 (390)
T ss_dssp             E-CCSEEHHHHHHHCS---------------SCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCCGGGEEES-SSCEEEC
T ss_pred             e-cCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEEE-CCeEEEE
Confidence            9 56889999998654               2889999999999999999999  78999999999999995 5799999


Q ss_pred             eeccccccCCCCCc-ccccccccccccCccccCC----------CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          238 DFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGG----------NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       238 Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~----------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                      |||+++........ ......||+.|+|||++.+          ...++.++|||||||++|||++|..||.....    
T Consensus       197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----  272 (390)
T 2zmd_A          197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----  272 (390)
T ss_dssp             CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC----
T ss_pred             ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH----
Confidence            99999876433222 2344679999999999864          13578899999999999999999999753211    


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                        .........         +...... .+...+..+.+++.+||+.||++||++.++++
T Consensus       273 --~~~~~~~~~---------~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          273 --QISKLHAII---------DPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             --HHHHHHHHH---------CTTSCCC-CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --HHHHHHHHh---------CccccCC-CCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence              111111111         1110000 01122457899999999999999999999975

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.1e-45  Score=334.55  Aligned_cols=206  Identities=25%  Similarity=0.281  Sum_probs=175.9

Q ss_pred             cChHHHHHhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-----CCCccceee
Q 043074           72 ISMSELIDATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-----HRNIVKILG  145 (373)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~  145 (373)
                      ++..+.....++|.+.+.||+|+||.||+|.. .+++.||+|++.... ...+.+..|+.+++.++     ||||+++++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            33344444568999999999999999999976 478999999996532 23356778999999986     999999999


Q ss_pred             EEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCc
Q 043074          146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSN  225 (373)
Q Consensus       146 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~N  225 (373)
                      ++......++||||+ +++|.+++......             .+++.++..++.||+.||+|||  +++|+||||||+|
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-------------~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~N  167 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYN-------------GFHIEDIKLYCIEILKALNYLR--KMSLTHTDLKPEN  167 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTTTC-------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGG
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcCCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCccc
Confidence            999999999999999 99999999876533             2899999999999999999999  7899999999999


Q ss_pred             eEeCC-------------------------CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccc
Q 043074          226 VLLDS-------------------------DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDV  280 (373)
Q Consensus       226 ill~~-------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di  280 (373)
                      ||++.                         ++.+||+|||++......    .....||+.|+|||++.+. .++.++||
T Consensus       168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Di  242 (360)
T 3llt_A          168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNL-GWDVSSDM  242 (360)
T ss_dssp             EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTC-CCCTTHHH
T ss_pred             EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCC-CCCCccch
Confidence            99975                         789999999999864332    2345789999999999854 48899999


Q ss_pred             hhhhHHHHHHHhCCCCCCC
Q 043074          281 YSFGILMIEIATQIRPNLP  299 (373)
Q Consensus       281 wslG~~l~el~~g~~p~~~  299 (373)
                      |||||++|||++|..||..
T Consensus       243 wslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          243 WSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             HHHHHHHHHHHHSSCSCCC
T ss_pred             HHHHHHHHHHHHCCCCCCC
Confidence            9999999999999999754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=334.76  Aligned_cols=252  Identities=21%  Similarity=0.353  Sum_probs=194.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCC--CCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRH--RNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|++.+.||+|+||.||++...+++.||+|++.....  ...+.+.+|+.++..++|  |||+++++++.++...++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            457899999999999999999888899999999865433  234678899999999976  9999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      ||+ .+++|.+++....               ++++.++..++.|++.||.|||  +.+|+||||||+|||++ ++.+||
T Consensus        88 ~e~-~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~al~~lH--~~~iiHrDikp~NIll~-~~~~kl  148 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK---------------SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKL  148 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC---------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEE-TTEEEE
T ss_pred             EeC-CCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEE-CCcEEE
Confidence            995 5889999998754               2899999999999999999999  78999999999999997 578999


Q ss_pred             eeeccccccCCCCCc-ccccccccccccCccccCC----------CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCC
Q 043074          237 SDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGG----------NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ  305 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~----------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~  305 (373)
                      +|||+++........ ......||+.|+|||.+.+          ...++.++|||||||++|||++|..||.....   
T Consensus       149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---  225 (343)
T 3dbq_A          149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---  225 (343)
T ss_dssp             CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS---
T ss_pred             eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh---
Confidence            999999876433222 2334679999999999853          24578899999999999999999999743211   


Q ss_pred             cccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          306 EVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                        .. .......         +..... ..+...+..+.+++.+||+.||.+|||+.++++.
T Consensus       226 --~~-~~~~~~~---------~~~~~~-~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          226 --QI-SKLHAII---------DPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             --HH-HHHHHHH---------CTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --HH-HHHHHHh---------cCCccc-CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence              11 1111111         111100 1122224578999999999999999999999753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.8e-45  Score=321.31  Aligned_cols=249  Identities=26%  Similarity=0.444  Sum_probs=183.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.+.....   ...+.+.+|+.++++++||||+++++++.+....++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            45789999999999999999976 5799999999865432   2246788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +||+++++|.+++.....              ++++..++.++.|++.||.|||  +.+++||||||+||+++.++.+||
T Consensus        90 ~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl  153 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVK--------------PFSENEARHFMHQIITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKI  153 (278)
T ss_dssp             EECCTTEEHHHHHHTCSS--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSSCCGGGEEECTTCCEEE
T ss_pred             EecCCCCcHHHHHhhccC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEE
Confidence            999999999999986432              3899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|..|+.........          
T Consensus       154 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------  221 (278)
T 3cok_A          154 ADFGLATQLKMPHE-KHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----------  221 (278)
T ss_dssp             CCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------
T ss_pred             EeecceeeccCCCC-cceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------
Confidence            99999987643322 2234568999999999874 44788999999999999999999997543221100          


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .      .......   ..+...+.++.+++.+||+.||++|||+.++++
T Consensus       222 ~------~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          222 N------KVVLADY---EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             --------CCSSCC---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             H------HHhhccc---CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            0      0000000   112234558999999999999999999999975

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.7e-46  Score=347.71  Aligned_cols=248  Identities=21%  Similarity=0.257  Sum_probs=193.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999975 478999999996532   22345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCceeecCCCCceEeCCCCceE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLE-KPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~-~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |||+++|+|.+++.....               +++..+..++.|++.||+|||  + ++|+||||||+|||++.++.+|
T Consensus       227 ~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~qi~~aL~~LH--~~~giiHrDlkp~NIll~~~~~~k  289 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERV---------------FSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIK  289 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSC---------------CCHHHHHHHHHHHHHHHHHHH--HHTCCCCCCCCGGGEEECSSSCEE
T ss_pred             EeeCCCCcHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHh--hcCCEEECCCCHHHEEECCCCCEE
Confidence            999999999999976542               899999999999999999999  6 8899999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||+++..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.....       ......
T Consensus       290 l~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~  360 (446)
T 4ejn_A          290 ITDFGLCKEGIKD-GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFEL  360 (446)
T ss_dssp             ECCCCCCCTTCC------CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHH
T ss_pred             EccCCCceeccCC-CcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHH
Confidence            9999999864322 223345679999999999975 4578999999999999999999999754221       111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                      .....       ..     ++...+.++.+++.+||+.||.+||     +++++++
T Consensus       361 i~~~~-------~~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          361 ILMEE-------IR-----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HHHCC-------CC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHhCC-------CC-----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            11110       01     1223456899999999999999999     9999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.7e-45  Score=329.37  Aligned_cols=257  Identities=23%  Similarity=0.332  Sum_probs=193.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCe----
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLD----  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  152 (373)
                      .++|++.+.||+|+||.||++.. .+++.||+|++......   ....+.+|+.++.+++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999975 57899999999765332   24568899999999999999999999876543    


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++||||+++++|.+++....               ++++.+++.++.|++.||+|||  +++++||||||+||+++.++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~  153 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG---------------PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATN  153 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEETTS
T ss_pred             cEEEEecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEcCCC
Confidence            399999999999999997654               2899999999999999999999  78999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH
Q 043074          233 EAHISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  310 (373)
                      .+||+|||++.........  ......||+.|+|||.+.+. .++.++||||||+++|||++|..||.....       .
T Consensus       154 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~  225 (311)
T 3ork_A          154 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------V  225 (311)
T ss_dssp             CEEECCCSCC------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------H
T ss_pred             CEEEeeccCcccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------H
Confidence            9999999999876443221  22335689999999999754 578899999999999999999999754221       1


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHHh
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVV-QLLDE  370 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~-~~L~~  370 (373)
                      ............    .    ........+.++.+++.+||+.||.+||+..+++ +.|.+
T Consensus       226 ~~~~~~~~~~~~----~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          226 SVAYQHVREDPI----P----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             HHHHHHHHCCCC----C----HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHhcCCCC----C----cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            111111111000    0    0000112355799999999999999999766654 44433

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-44  Score=317.96  Aligned_cols=252  Identities=26%  Similarity=0.372  Sum_probs=195.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|.+.+.||+|+||.||++... ++..+|+|++..... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            47888999999999999999764 689999999866443 3457889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe---CCCCceEE
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL---DSDFEAHI  236 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill---~~~~~~kl  236 (373)
                      +++|+|.+++.......           ..+++..+..++.|++.||+|||  +.+++||||||+||++   +.++.+||
T Consensus       102 ~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dikp~NIl~~~~~~~~~~kl  168 (285)
T 3is5_A          102 CEGGELLERIVSAQARG-----------KALSEGYVAELMKQMMNALAYFH--SQHVVHKDLKPENILFQDTSPHSPIKI  168 (285)
T ss_dssp             CSCCBHHHHHHHHHHHT-----------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred             CCCCcHHHHHHhhhhcc-----------cCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCCCHHHEEEecCCCCCCEEE
Confidence            99999999986542110           13899999999999999999999  7899999999999999   45678999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++.......  ......||+.|+|||.+.+  .++.++||||||+++|||++|..||....       ........
T Consensus       169 ~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~-------~~~~~~~~  237 (285)
T 3is5_A          169 IDFGLAELFKSDE--HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTS-------LEEVQQKA  237 (285)
T ss_dssp             CCCCCCCC------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHH
T ss_pred             EeeecceecCCcc--cCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCC-------HHHHHhhh
Confidence            9999997654322  2334568999999999863  47889999999999999999999975422       11111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .......     .....    ..+.++.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~-----~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          238 TYKEPNY-----AVECR----PLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHCCCCC-----CC--C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccCCccc-----ccccC----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111000     00001    12457899999999999999999999985

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.4e-44  Score=318.52  Aligned_cols=247  Identities=28%  Similarity=0.431  Sum_probs=198.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|++.+.||+|+||.||+|... ++..||+|++.....   .....+.+|+.++++++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            457889999999999999999764 678999999855332   2245788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++++|.+++.....               +++..+..++.|++.||.|||  +.+++||||||+||+++.++.++|
T Consensus        88 ~e~~~~~~l~~~l~~~~~---------------~~~~~~~~~~~qi~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l  150 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSK---------------FDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKI  150 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--TTTCEECCCCGGGEEECTTSCEEE
T ss_pred             EecCCCCcHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHhEEEcCCCCEEE
Confidence            999999999999976542               899999999999999999999  899999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++......   ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||....       ........
T Consensus       151 ~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~  219 (279)
T 3fdn_A          151 ADFGWSVHAPSS---RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT-------YQETYKRI  219 (279)
T ss_dssp             CSCCEESCC-----------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHH
T ss_pred             EeccccccCCcc---cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCc-------HHHHHHHH
Confidence            999998654322   2234568999999999975 457889999999999999999999975321       11111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      ...       ....     +...+..+.+++.+||+.||++|||+.++++.
T Consensus       220 ~~~-------~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          220 SRV-------EFTF-----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             HHT-------CCCC-----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             HhC-------CCCC-----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            110       1111     22335578999999999999999999999863

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.7e-45  Score=347.23  Aligned_cols=253  Identities=24%  Similarity=0.293  Sum_probs=204.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|+..+.||+|+||.||+|..+ +|+.||+|++.+..   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467888999999999999999764 79999999996542   22345688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++|+|.+++......             .+++..+..++.||+.||.|||  +++|+||||||+|||++.++.+||
T Consensus       263 mEy~~gg~L~~~l~~~~~~-------------~l~e~~~~~i~~qIl~aL~yLH--~~gIvHrDLKPeNILld~~g~vKL  327 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQA-------------GFPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRI  327 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSC-------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEE
T ss_pred             EEcCCCCcHHHHHHhcCCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCchheEEEeCCCCeEE
Confidence            9999999999999865432             2899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||+++......  ......||+.|+|||++.+ ..++.++|||||||++|||++|..||........   ........
T Consensus       328 ~DFGla~~~~~~~--~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~---~~~i~~~i  401 (576)
T 2acx_A          328 SDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLV  401 (576)
T ss_dssp             CCCTTCEECCTTC--CEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC---HHHHHHHH
T ss_pred             EecccceecccCc--cccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchh---HHHHHHHh
Confidence            9999998764332  2334579999999999985 4578999999999999999999999765332211   11111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                      ...       ....     +...+.++.+++.+||+.||.+||     +++++++
T Consensus       402 ~~~-------~~~~-----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          402 KEV-------PEEY-----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHC-------CCCC-----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             hcc-------cccC-----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            110       1111     223356899999999999999999     6777764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.1e-45  Score=335.54  Aligned_cols=245  Identities=22%  Similarity=0.276  Sum_probs=191.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHH-HhcCCCCCccceeeEEeeCCeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMET-LGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      .++|++.+.||+|+||.||++..+ +++.||+|++.+....   ....+..|..+ ++.++||||+++++++.+....++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357899999999999999999765 6889999999765432   23455667766 567899999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||+++|+|.+++.....               +++..+..++.||+.||+|||  +++|+||||||+|||++.++.+|
T Consensus       117 v~E~~~gg~L~~~l~~~~~---------------~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~ik  179 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERC---------------FLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIV  179 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEE
T ss_pred             EEeCCCCCcHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEE
Confidence            9999999999999986542               889999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||+++...... ......+||+.|+|||++.+ ..++.++|+|||||++|||++|..||.....       .+....
T Consensus       180 L~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~  250 (373)
T 2r5t_A          180 LTDFGLCKENIEHN-STTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDN  250 (373)
T ss_dssp             ECCCCBCGGGBCCC-CCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-------HHHHHH
T ss_pred             EeeCccccccccCC-CccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHH
Confidence            99999998643222 23345679999999999985 4578899999999999999999999754221       111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY  363 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~  363 (373)
                      .....       ..+     +...+..+.+++.+||+.||.+||++.+
T Consensus       251 i~~~~-------~~~-----~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          251 ILNKP-------LQL-----KPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             HHHSC-------CCC-----CSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             HHhcc-------cCC-----CCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            11110       011     2223457999999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=335.65  Aligned_cols=263  Identities=22%  Similarity=0.334  Sum_probs=194.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccccc-HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....... ...+.+|+.+++.++||||+++++++.+....++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999765 78999999986544322 12345799999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      ++ |+|.+++.....              .+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+||+||
T Consensus        82 ~~-~~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Df  144 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGN--------------IINMHNVKLFLFQLLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADF  144 (324)
T ss_dssp             CS-EEHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCCGGGEEECTTCCEEECSS
T ss_pred             cc-cCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCccCCCcCHHHEEECCCCCEEEccC
Confidence            96 699999876543              2899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |++....... .......||+.|+|||.+.+...++.++||||||+++|||++|..||......    ............
T Consensus       145 g~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~  219 (324)
T 3mtl_A          145 GLARAKSIPT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE----EQLHFIFRILGT  219 (324)
T ss_dssp             SEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCC
T ss_pred             cccccccCCc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCC
Confidence            9998654322 22334568999999999987677899999999999999999999997542211    111111111000


Q ss_pred             ccc---cccc--------c-Cccccc---cCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NKE---IEMV--------D-SNISRE---ELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~---~~~~--------~-~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...   ....        . +.....   ......+.++.+++.+||+.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            000   0000        0 000000   001123457899999999999999999999976

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.4e-45  Score=332.83  Aligned_cols=268  Identities=25%  Similarity=0.344  Sum_probs=198.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .++|++.+.||+|+||.||+|... +++.||+|++......  ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            357889999999999999999765 5899999998554332  2455789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++++|.+++....               .+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+||+
T Consensus       104 e~~~~~~l~~~~~~~~---------------~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~  166 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN---------------GLDYQVVQKYLFQIINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLC  166 (331)
T ss_dssp             ECCSEEHHHHHHHSTT---------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             ecCCcchHHHHHhhcc---------------CCCHHHHHHHHHHHHHHHHHHH--HCCEEccCcChheEEEcCCCcEEEE
Confidence            9999999988876543               2899999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH-------
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL-------  310 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~-------  310 (373)
                      |||++....... .......||+.|+|||.+.+...++.++||||||+++|||++|..||.............       
T Consensus       167 Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (331)
T 4aaa_A          167 DFGFARTLAAPG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI  245 (331)
T ss_dssp             CCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             eCCCceeecCCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Confidence            999998654322 223345689999999999876678999999999999999999999975432211000000       


Q ss_pred             HHHHHHHHhccccccc-cCcccccc----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 EWARTMEARNKEIEMV-DSNISREE----LSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ................ .+.+....    .....+..+.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000111110000 01110000    01124568999999999999999999999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-44  Score=334.66  Aligned_cols=252  Identities=20%  Similarity=0.264  Sum_probs=189.3

Q ss_pred             CCCCCC-CeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHh-cCCCCCccceeeEEee----CCeeE
Q 043074           82 DNFSTD-KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLG-KLRHRNIVKILGYCAS----GLDRV  154 (373)
Q Consensus        82 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~~  154 (373)
                      ++|.+. +.||+|+||.||++... +++.||||++...     ..+.+|+.++. ..+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456555 68999999999999764 6899999998532     45678888874 4589999999999875    56789


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC---C
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---D  231 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~---~  231 (373)
                      +||||+++|+|.+++......             .+++.++..++.||+.||.|||  +.+|+||||||+|||++.   +
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~-------------~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~  200 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQ-------------AFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPN  200 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----------------CCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSTT
T ss_pred             EEEEeCCCCcHHHHHHHhCCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCcceEEEecCCCC
Confidence            999999999999999865422             2899999999999999999999  789999999999999997   7


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +.+||+|||+++.....  .......||+.|+|||++.+ ..++.++|||||||++|||++|..||..............
T Consensus       201 ~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  277 (400)
T 1nxk_A          201 AILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT  277 (400)
T ss_dssp             CCEEECCCTTCEECC-------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH
T ss_pred             ccEEEEecccccccCCC--CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH
Confidence            89999999999865422  22345678999999999974 4578999999999999999999999865443322211211


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      ..   .. ...      ...... ...++.++.+++.+||+.||++|||+.++++.
T Consensus       278 ~i---~~-~~~------~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          278 RI---RM-GQY------EFPNPE-WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             HH---HH-TCC------CCCTTT-TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HH---Hc-Ccc------cCCCcc-cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11   11 000      000000 12235589999999999999999999999863

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.9e-45  Score=326.57  Aligned_cols=251  Identities=23%  Similarity=0.334  Sum_probs=201.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc------cHHHHHHHHHHHhcCCCCCccceeeEEeeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ------GFREFRAEMETLGKLRHRNIVKILGYCASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  153 (373)
                      .++|++.+.||+|+||.||+|... +++.||+|.+......      ..+.+.+|+.+++.++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            347889999999999999999765 6899999998654322      256789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC-
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-  232 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~-  232 (373)
                      ++||||+++++|.+++....               ++++..+..++.|++.||.|||  +.+++||||||+||+++.++ 
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~lH--~~~ivH~dikp~NIl~~~~~~  153 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE---------------SLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNI  153 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS---------------CEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTS
T ss_pred             EEEEEcCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChHHEEEecCCC
Confidence            99999999999999997643               2899999999999999999999  78999999999999999888 


Q ss_pred             ---ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          233 ---EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       233 ---~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                         .+||+|||++.......  ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.....       
T Consensus       154 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------  223 (321)
T 2a2a_A          154 PIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTK-------  223 (321)
T ss_dssp             SSCCEEECCCTTCEECCTTC--CCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------
T ss_pred             CcCCEEEccCccceecCccc--cccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCH-------
Confidence               79999999998764322  2234568999999999975 4578899999999999999999999754211       


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .+.........   .......     ....+..+.+++.+||+.||++|||+.++++
T Consensus       224 ~~~~~~i~~~~---~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          224 QETLANITSVS---YDFDEEF-----FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHHHHHTTC---CCCCHHH-----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhcc---cccChhh-----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11111111100   0000000     1123457999999999999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.4e-44  Score=316.86  Aligned_cols=251  Identities=22%  Similarity=0.341  Sum_probs=201.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|+.++++++||||+++++++.++...++|+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            568999999999999999999764 689999999865433  23467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc---e
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---A  234 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~---~  234 (373)
                      ||+++++|.+++....               .+++..+..++.|++.||.|||  +.+++||||||+||+++.++.   +
T Consensus        85 e~~~~~~l~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~~~  147 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE---------------FYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAV  147 (284)
T ss_dssp             CCCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSTTCCE
T ss_pred             ecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCcCcCCCCHHHEEEecCCCCCcE
Confidence            9999999999887654               2899999999999999999999  789999999999999986655   9


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      ||+|||++.......  ......||+.|+|||.+.+. .++.++||||||+++|+|++|..||.....       .....
T Consensus       148 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~  217 (284)
T 3kk8_A          148 KLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYA  217 (284)
T ss_dssp             EECCCTTCEECCSSC--BCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred             EEeeceeeEEcccCc--cccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCch-------hHHHH
Confidence            999999998764332  22345789999999999754 478899999999999999999999754211       11111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ........   .....     ....+.++.+++.+||+.||++|||+.++++
T Consensus       218 ~~~~~~~~---~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          218 QIKAGAYD---YPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHHHTCCC---CCTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHhcccc---CCchh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11111100   00000     1223457999999999999999999999976

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8e-46  Score=332.31  Aligned_cols=278  Identities=27%  Similarity=0.386  Sum_probs=210.2

Q ss_pred             HHHHHhcCCCCCCCeeecCCCceEEEEEe------CCCCEEEEEEeCccccc-cHHHHHHHHHHHhcC-CCCCccceeeE
Q 043074           75 SELIDATDNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKL-RHRNIVKILGY  146 (373)
Q Consensus        75 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~  146 (373)
                      .+.....++|++.+.||+|+||.||+|..      .+++.||+|++...... ..+.+.+|+.++.++ +||||++++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            34444567899999999999999999964      35688999999765433 345788999999999 69999999999


Q ss_pred             EeeCC-eeEEEEEecCCCCHHHHhhcCCCCCCCCc-ccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCC
Q 043074          147 CASGL-DRVLIYEFVENGSLDQWLHDTSRNDDVDG-SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS  224 (373)
Q Consensus       147 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~  224 (373)
                      +.... ..++|+||+++++|.+++........... .........+++..++.++.|++.||.|||  +.+++||||||+
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dikp~  177 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAAR  177 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGG
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH--hCCcccccCccc
Confidence            87654 58999999999999999987653210000 000000112789999999999999999999  789999999999


Q ss_pred             ceEeCCCCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCccc
Q 043074          225 NVLLDSDFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVL  302 (373)
Q Consensus       225 Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~  302 (373)
                      ||+++.++.+||+|||+++....... .......+|+.|+|||.+.+ ..++.++||||||+++|||++ |..|+.....
T Consensus       178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~  256 (316)
T 2xir_A          178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  256 (316)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence            99999999999999999987643322 22334567889999999874 447899999999999999998 8888643221


Q ss_pred             CCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          303 DGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..      ......... ..     ...     +...+..+.+++.+||+.||.+|||+.++++.|++++
T Consensus       257 ~~------~~~~~~~~~-~~-----~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          257 DE------EFCRRLKEG-TR-----MRA-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             SH------HHHHHHHHT-CC-----CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hH------HHHHHhccC-cc-----CCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11      111111111 00     011     2223558999999999999999999999999999876

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=330.94  Aligned_cols=255  Identities=15%  Similarity=0.157  Sum_probs=203.3

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEE------eCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC---CCCccceeeEEee
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAK------LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR---HRNIVKILGYCAS  149 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  149 (373)
                      ...++|.+.+.||+|+||.||+|.      ..+++.||+|++....   ...+..|+.++..++   |+||+++++++..
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            345789999999999999999993      4578999999997653   346677888888876   9999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       150 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      .+..++||||+++|+|.+++.......          ...+++..++.++.|++.||+|||  +.+|+||||||+|||++
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~l~~~~~~~i~~qi~~~L~~lH--~~~ivHrDiKp~NIll~  206 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTP----------EKVMPQGLVISFAMRMLYMIEQVH--DCEIIHGDIKPDNFILG  206 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTST----------TCSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEEC
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhccc----------ccCCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEec
Confidence            999999999999999999997532211          113999999999999999999999  78999999999999999


Q ss_pred             C-----------CCceEEeeeccccccCC-CCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCC
Q 043074          230 S-----------DFEAHISDFGLARRIDT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN  297 (373)
Q Consensus       230 ~-----------~~~~kl~Dfg~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  297 (373)
                      .           ++.+||+|||+++.... ..........||+.|+|||++.+.. ++.++|||||||++|||++|..||
T Consensus       207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf  285 (365)
T 3e7e_A          207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMK  285 (365)
T ss_dssp             GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCcc
Confidence            8           89999999999976532 2223345567999999999998644 899999999999999999999997


Q ss_pred             CCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhhh
Q 043074          298 LPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRER-PAMSYVVQLLDELV  372 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~~l~~~L~~l~  372 (373)
                      ........                   .+...+...    ..+..+.+++..|++.+|.+| |+++++.+.|++++
T Consensus       286 ~~~~~~~~-------------------~~~~~~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          286 VKNEGGEC-------------------KPEGLFRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             EEEETTEE-------------------EECSCCTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             ccCCCCce-------------------eechhcccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence            54322110                   011111111    124578899999999999998 77888888888765

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.8e-45  Score=323.68  Aligned_cols=247  Identities=26%  Similarity=0.443  Sum_probs=200.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEee----------
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS----------  149 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----------  149 (373)
                      .++|+..+.||+|+||.||+|... +++.||+|.+....    +.+.+|+.++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            347888999999999999999875 79999999996543    346789999999999999999998854          


Q ss_pred             ------CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCC
Q 043074          150 ------GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKS  223 (373)
Q Consensus       150 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~  223 (373)
                            ....++||||+++++|.+++......             .+++..++.++.|++.||.|||  +.+++|+||||
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp  150 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-------------KLDKVLALELFEQITKGVDYIH--SKKLINRDLKP  150 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGS-------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSG
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCH
Confidence                  44579999999999999999764321             2899999999999999999999  78999999999


Q ss_pred             CceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccC
Q 043074          224 SNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD  303 (373)
Q Consensus       224 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~  303 (373)
                      +||+++.++.+||+|||++.......  ......||+.|+|||.+.+ ..++.++||||||+++|||++|..|+...   
T Consensus       151 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~---  224 (284)
T 2a19_B          151 SNIFLVDTKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET---  224 (284)
T ss_dssp             GGEEEEETTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH---
T ss_pred             HHEEEcCCCCEEECcchhheeccccc--cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH---
Confidence            99999999999999999998765432  2234568999999999875 44788999999999999999998884210   


Q ss_pred             CCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          304 GQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                            ..+......         ..+     +...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       225 ------~~~~~~~~~---------~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          225 ------SKFFTDLRD---------GII-----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ------HHHHHHHHT---------TCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ------HHHHHHhhc---------ccc-----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                  111111110         001     2223457899999999999999999999999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8e-45  Score=325.42  Aligned_cols=263  Identities=25%  Similarity=0.433  Sum_probs=194.5

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC----CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCC--
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGL--  151 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--  151 (373)
                      ..++|.+.+.||+|+||.||+|...    ++..||+|.+.....  ...+.+.+|+.++++++||||+++++++.+..  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            4568888999999999999999653    345899999865432  23467889999999999999999999997655  


Q ss_pred             ---eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe
Q 043074          152 ---DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL  228 (373)
Q Consensus       152 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill  228 (373)
                         ..++|+||+++++|.+++.......         ....+++..++.++.|++.||.|||  +++++||||||+||++
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli  180 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLET---------GPKHIPLQTLLKFMVDIALGMEYLS--NRNFLHRDLAARNCML  180 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTT---------SCCCCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCSGGGEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhc---------CCccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEE
Confidence               3499999999999999996543211         0113899999999999999999999  7899999999999999


Q ss_pred             CCCCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCc
Q 043074          229 DSDFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQE  306 (373)
Q Consensus       229 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~  306 (373)
                      +.++.+||+|||++........ .......+++.|+|||.+.+ ..++.++||||||+++|||++ |..|+.....    
T Consensus       181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----  255 (313)
T 3brb_A          181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN----  255 (313)
T ss_dssp             CTTSCEEECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----
T ss_pred             cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCH----
Confidence            9999999999999987543321 12233456889999999974 457889999999999999999 6666533211    


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ....   ..... ..     ...     .+..++..+.+++.+||+.||.+|||+.++++.|++++
T Consensus       256 ~~~~---~~~~~-~~-----~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          256 HEMY---DYLLH-GH-----RLK-----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             GGHH---HHHHT-TC-----CCC-----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHH---HHHHc-CC-----CCC-----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1111   11111 00     011     12334568999999999999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3e-44  Score=315.84  Aligned_cols=249  Identities=21%  Similarity=0.364  Sum_probs=196.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+.....   ...+.+.+|+..++.++||||+++++++.+....++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            468999999999999999999875 799999999865432   2346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +||+++++|.+++.....               +++..+..++.|++.||.|||  +++++|+||||+||+++.++.+||
T Consensus        90 ~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l  152 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHGR---------------VEEMEARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKI  152 (276)
T ss_dssp             EECCCSCBHHHHHHHHCS---------------CCHHHHHHHHHHHHHHHHHHH--HHCSSCCCCCGGGEEECTTSCEEE
T ss_pred             EeccCCCcHHHHHhccCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChhhEEECCCCCEEE
Confidence            999999999999976542               899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++.......  ......+++.|+|||.+.+....+.++||||||+++|+|++|..|+....       ........
T Consensus       153 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~  223 (276)
T 2h6d_A          153 ADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-------VPTLFKKI  223 (276)
T ss_dssp             CCCCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHH
T ss_pred             eecccccccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHh
Confidence            9999998754322  22345689999999999866555789999999999999999999974321       11111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      ... .      ..     .+...+..+.+++.+||+.||++|||+.++++.
T Consensus       224 ~~~-~------~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          224 RGG-V------FY-----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HHC-C------CC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hcC-c------cc-----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            110 0      00     122234579999999999999999999999873

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-45  Score=331.40  Aligned_cols=262  Identities=15%  Similarity=0.217  Sum_probs=202.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCC---------CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccc---------
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSS---------GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVK---------  142 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  142 (373)
                      .++|++.+.||+|+||.||+|....         ++.||+|.+...     +.+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4689999999999999999997653         789999998654     35678999999999999887         


Q ss_pred             ------eeeEEee-CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 043074          143 ------ILGYCAS-GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP  215 (373)
Q Consensus       143 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~  215 (373)
                            +++++.. +...++||||+ +++|.+++......             ++++.+++.++.|++.||.|||  +++
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~-------------~l~~~~~~~i~~qi~~~L~~LH--~~~  179 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKH-------------VLSERSVLQVACRLLDALEFLH--ENE  179 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGG-------------CCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcC-------------CCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence                  5667765 67889999999 99999999865211             3999999999999999999999  789


Q ss_pred             ceeecCCCCceEeCCCC--ceEEeeeccccccCCCCC------cccccccccccccCccccCCCCCCCccccchhhhHHH
Q 043074          216 IIHRDIKSSNVLLDSDF--EAHISDFGLARRIDTSHS------HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM  287 (373)
Q Consensus       216 i~H~dlk~~Nill~~~~--~~kl~Dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l  287 (373)
                      ++||||||+||+++.++  .+||+|||+++.......      .......||+.|+|||.+.+. .++.++||||||+++
T Consensus       180 ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il  258 (352)
T 2jii_A          180 YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCM  258 (352)
T ss_dssp             CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHH
T ss_pred             ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHH
Confidence            99999999999999998  899999999987543211      112335789999999999754 578999999999999


Q ss_pred             HHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          288 IEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       288 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      |||++|..||.......  ..+..........  ............    ..+.++.+++.+||+.||++||+++++++.
T Consensus       259 ~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~--~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          259 LKWLYGFLPWTNCLPNT--EDIMKQKQKFVDK--PGPFVGPCGHWI----RPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             HHHHHSCCTTGGGTTCH--HHHHHHHHHHHHS--CCCEECTTSCEE----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHhCCCCcccCCcCH--HHHHHHHHhccCC--hhhhhhhccccC----CCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            99999999975432111  1122221111111  111111111111    124589999999999999999999999999


Q ss_pred             HHhhh
Q 043074          368 LDELV  372 (373)
Q Consensus       368 L~~l~  372 (373)
                      |++++
T Consensus       331 L~~~~  335 (352)
T 2jii_A          331 LEALL  335 (352)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.7e-45  Score=321.90  Aligned_cols=247  Identities=21%  Similarity=0.316  Sum_probs=197.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+..+..+ +||||+++++++.+....++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            357888999999999999999765 799999999865432  2345788999999999 899999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC-----
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-----  231 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~-----  231 (373)
                      |||+++++|.+++.......           .++++.+++.++.|++.||.|||  +++++||||||+||+++.+     
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~~~  156 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIM-----------SYFKEAELKDLLLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNA  156 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHT-----------CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC-------
T ss_pred             EEecCCCcHHHHHHhhcccc-----------cCCCHHHHHHHHHHHHHHHHHHH--hCCEeecCCCHHHEEEcCCCCCcc
Confidence            99999999999997642110           13899999999999999999999  7899999999999999844     


Q ss_pred             --------------CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCC
Q 043074          232 --------------FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN  297 (373)
Q Consensus       232 --------------~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  297 (373)
                                    ..+||+|||.+.......     ...||+.|+|||.+.+...++.++||||||+++|||++|..|+
T Consensus       157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~  231 (289)
T 1x8b_A          157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP  231 (289)
T ss_dssp             -------------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cccccccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence                          479999999998764322     2358999999999987666778999999999999999998774


Q ss_pred             CCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          298 LPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....         .+. ... ...     .+.+     +...+..+.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~---------~~~-~~~-~~~-----~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          232 RNGD---------QWH-EIR-QGR-----LPRI-----PQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             SSSH---------HHH-HHH-TTC-----CCCC-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cchh---------HHH-HHH-cCC-----CCCC-----CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            3210         111 111 110     0111     2233568999999999999999999999975

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-44  Score=327.08  Aligned_cols=264  Identities=23%  Similarity=0.316  Sum_probs=196.3

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccccc-----HHHHHHHHHHHhcCCCCCccceeeEEeeCCe
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQG-----FREFRAEMETLGKLRHRNIVKILGYCASGLD  152 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  152 (373)
                      ...++|++.+.||+|+||.||+|... +|+.||+|++.......     .+.+.+|+.+++.++||||+++++++.+...
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999765 68999999986533221     2467899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++||||+++ +|.+++.....              .+++.++..++.|++.||.|||  +.+++||||||+||+++.++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~  149 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSL--------------VLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENG  149 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCS--------------SCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTC
T ss_pred             eEEEEEcCCC-CHHHHHHhcCc--------------CCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCCHHHEEEcCCC
Confidence            9999999965 89988876432              2888899999999999999999  78999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      .+||+|||+++...... .......||+.|+|||.+.+...++.++|||||||++|||++|..|+.....    ..  ..
T Consensus       150 ~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~----~~--~~  222 (346)
T 1ua2_A          150 VLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----LD--QL  222 (346)
T ss_dssp             CEEECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HH--HH
T ss_pred             CEEEEecccceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH----HH--HH
Confidence            99999999998764332 2234457899999999997666688999999999999999999888643211    01  11


Q ss_pred             HHHHHHhccccc-------cccCccccc--------cCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          313 ARTMEARNKEIE-------MVDSNISRE--------ELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       313 ~~~~~~~~~~~~-------~~~~~~~~~--------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ............       .+.......        ......+..+.+++.+||+.||++|||+.|+++
T Consensus       223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            111111110000       000000000        001233468999999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.8e-45  Score=354.14  Aligned_cols=248  Identities=28%  Similarity=0.421  Sum_probs=195.8

Q ss_pred             CeeecCCCceEEEEEe---CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKL---SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||+|.+   ++++.||||+++....  ...+.+.+|+.++++++||||+++++++.+ ...++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            3799999999999954   2467899999976433  235789999999999999999999999864 468899999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|.+++.....               +++..++.++.||+.||+|||  +++|+||||||+|||++.++.+||+|||++
T Consensus       454 g~L~~~l~~~~~---------------l~~~~~~~i~~qi~~~L~yLH--~~~iiHrDLkp~NILl~~~~~~kL~DFGla  516 (635)
T 4fl3_A          454 GPLNKYLQQNRH---------------VKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLS  516 (635)
T ss_dssp             EEHHHHHHHCTT---------------CCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred             CCHHHHHhhCCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCEeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence            999999976542               899999999999999999999  789999999999999999999999999999


Q ss_pred             cccCCCCC--cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          243 RRIDTSHS--HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       243 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      +.......  .......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.....       .+....... 
T Consensus       517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------~~~~~~i~~-  587 (635)
T 4fl3_A          517 KALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEK-  587 (635)
T ss_dssp             HHTTC-------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHT-
T ss_pred             cccccCccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHc-
Confidence            87654332  12233456788999999974 458899999999999999998 8888643211       111111111 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..          ....+..++.++.+++.+||+.||++||++.+|++.|++++
T Consensus       588 ~~----------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          588 GE----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             TC----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CC----------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            10          01113445678999999999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.9e-45  Score=332.31  Aligned_cols=273  Identities=28%  Similarity=0.426  Sum_probs=207.1

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeCC-C-----CEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeC
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLSS-G-----VTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASG  150 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  150 (373)
                      ...++|.+.+.||+|+||.||+|.... +     ..||+|.+..... ...+.+.+|+.+++.+ +||||+++++++.++
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            345789999999999999999997642 2     4799999976543 2356788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      ...++||||+++|+|.+++............... ...++++..++.++.|++.||.|||  +++++||||||+||+++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI-ANSTASTRDLLHFSSQVAQGMAFLA--SKNCIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC--------CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccc-cccccCHHHHHHHHHHHHHHHHHHh--cCCcccCCcccceEEECC
Confidence            9999999999999999999764311000000000 0113899999999999999999999  789999999999999999


Q ss_pred             CCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCccc
Q 043074          231 DFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVG  308 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~  308 (373)
                      ++.+||+|||++........ .......+|+.|+|||.+.+ ..++.++||||||+++|||++ |..|+.......   .
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~  275 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---K  275 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH---H
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH---H
Confidence            99999999999986543322 12233456889999999874 447899999999999999999 777754322111   0


Q ss_pred             HHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          309 LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .    ........     ...     .+..++..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       276 ~----~~~~~~~~-----~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          276 F----YKLVKDGY-----QMA-----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             H----HHHHHHTC-----CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H----HHHHhcCC-----CCC-----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            1    11111110     000     12223568999999999999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=327.14  Aligned_cols=263  Identities=25%  Similarity=0.288  Sum_probs=195.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc-----ccHHHHHHHHHHHhcCC---CCCccceeeEEeeCC
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF-----QGFREFRAEMETLGKLR---HRNIVKILGYCASGL  151 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~  151 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....     .....+.+|+.+++.++   ||||+++++++.+..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            56899999999999999999975 5789999999864321     11245667777777764   999999999997765


Q ss_pred             -----eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCce
Q 043074          152 -----DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV  226 (373)
Q Consensus       152 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Ni  226 (373)
                           ..++|+||+. ++|.+++......             .+++.++..++.|++.||+|||  +++++||||||+||
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-------------~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Ni  151 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAPPP-------------GLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENI  151 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCCTT-------------CSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCTTTE
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhccCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHE
Confidence                 5789999995 6999999876532             2899999999999999999999  78999999999999


Q ss_pred             EeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          227 LLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       227 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                      +++.++.+||+|||+++......  ......||+.|+|||.+.+. .++.++|||||||++|||++|..||.......  
T Consensus       152 l~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--  226 (308)
T 3g33_A          152 LVTSGGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--  226 (308)
T ss_dssp             EECTTSCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--
T ss_pred             EEcCCCCEEEeeCccccccCCCc--ccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence            99999999999999998654322  23456789999999999754 47889999999999999999999975422111  


Q ss_pred             ccHHHHHHHHHHhcccc---ccc---cCcccc------ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          307 VGLLEWARTMEARNKEI---EMV---DSNISR------EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~---~~~---~~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                        ...............   ...   ......      .....+.+..+.+++.+||+.||++|||+.++++
T Consensus       227 --~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          227 --QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             --HHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --HHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence              111110000000000   000   000000      0001123468899999999999999999999975

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.4e-45  Score=330.35  Aligned_cols=256  Identities=23%  Similarity=0.329  Sum_probs=187.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CCCccceeeEEe--------eC
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILGYCA--------SG  150 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~~  150 (373)
                      ..+|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++.++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            458999999999999999999764 78999999986666555678899999999996 999999999984        34


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--ceeecCCCCceEe
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP--IIHRDIKSSNVLL  228 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~--i~H~dlk~~Nill  228 (373)
                      ...++|+||+ +|+|.+++.......            ++++.+++.++.|++.||.|||  +.+  ++||||||+||++
T Consensus       107 ~~~~lv~e~~-~g~L~~~l~~~~~~~------------~~~~~~~~~i~~qi~~~l~~LH--~~~~~ivH~Dikp~NIl~  171 (337)
T 3ll6_A          107 AEFLLLTELC-KGQLVEFLKKMESRG------------PLSCDTVLKIFYQTCRAVQHMH--RQKPPIIHRDLKVENLLL  171 (337)
T ss_dssp             EEEEEEEECC-SEEHHHHHHHHHTTC------------SCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCCCCCGGGCEE
T ss_pred             ceEEEEEEec-CCCHHHHHHHhhccC------------CCCHHHHHHHHHHHHHHHHHHH--hCCCCEEEccCCcccEEE
Confidence            4578999999 579999887633221            3899999999999999999999  677  9999999999999


Q ss_pred             CCCCceEEeeeccccccCCCCCc-----------ccccccccccccCccccC--CCCCCCccccchhhhHHHHHHHhCCC
Q 043074          229 DSDFEAHISDFGLARRIDTSHSH-----------VSTQVAGTMGYMPPEYLG--GNTAATVMLDVYSFGILMIEIATQIR  295 (373)
Q Consensus       229 ~~~~~~kl~Dfg~~~~~~~~~~~-----------~~~~~~g~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~el~~g~~  295 (373)
                      +.++.+||+|||++.........           ......||+.|+|||.+.  ....++.++||||||+++|||++|..
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~  251 (337)
T 3ll6_A          172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH  251 (337)
T ss_dssp             CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence            99999999999999876433211           111345899999999984  24457889999999999999999999


Q ss_pred             CCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          296 PNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       296 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ||.......    .   .      .   .......     ....+..+.+++.+||+.||.+||++.++++.|+++.
T Consensus       252 p~~~~~~~~----~---~------~---~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          252 PFEDGAKLR----I---V------N---GKYSIPP-----HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             CC----------------------------CCCCT-----TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcchhHHH----h---h------c---CcccCCc-----ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            974321110    0   0      0   0000000     1112346889999999999999999999999998874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-44  Score=336.86  Aligned_cols=253  Identities=24%  Similarity=0.314  Sum_probs=190.3

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--------ccHHHHHHHHHHHhcCCCCCccceeeEEeeC
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--------QGFREFRAEMETLGKLRHRNIVKILGYCASG  150 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  150 (373)
                      ..++|.+.+.||+|+||.||+|.. .+++.||+|++.+...        .....+.+|+.++++++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            467899999999999999999965 4689999999865321        11234789999999999999999999975 4


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      ...++||||+++|+|.+++....               ++++.++..++.|++.||+|||  +++++||||||+|||++.
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~  274 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNK---------------RLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSS  274 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSC---------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESS
T ss_pred             CceEEEEEcCCCCcHHHHHhccC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEec
Confidence            56899999999999999887543               2899999999999999999999  789999999999999975


Q ss_pred             CC---ceEEeeeccccccCCCCCcccccccccccccCccccCC--CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCC
Q 043074          231 DF---EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ  305 (373)
Q Consensus       231 ~~---~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~  305 (373)
                      ++   .+||+|||+++.....  .......||+.|+|||++.+  ...++.++|||||||++|||++|..||......  
T Consensus       275 ~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--  350 (419)
T 3i6u_A          275 QEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--  350 (419)
T ss_dssp             SSSSCCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--
T ss_pred             CCCcceEEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--
Confidence            44   5999999999876432  22345679999999999853  355788999999999999999999997543221  


Q ss_pred             cccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          306 EVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       ..+...   ... ... . ..+..     ....+..+.+++.+||+.||++|||+.++++
T Consensus       351 -~~~~~~---i~~-~~~-~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          351 -VSLKDQ---ITS-GKY-N-FIPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             -CCHHHH---HHT-TCC-C-CCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -HHHHHH---Hhc-CCC-C-CCchh-----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence             111111   100 000 0 00000     0123458999999999999999999999886

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.9e-44  Score=336.96  Aligned_cols=261  Identities=23%  Similarity=0.325  Sum_probs=204.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCC-CCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH-RNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||||++......  ..+.+|+++++.++| +++..+..++......++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999975 57999999987654433  457889999999986 556666667778888999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe---CCCCceE
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL---DSDFEAH  235 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill---~~~~~~k  235 (373)
                      |+ +++|.+++.....              .+++.+++.++.||+.||.|||  +++|+||||||+|||+   +.++.+|
T Consensus        84 ~~-g~sL~~ll~~~~~--------------~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDIKP~NILl~~~~~~~~vk  146 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSR--------------KLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVY  146 (483)
T ss_dssp             CC-CCBHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTTCEE
T ss_pred             CC-CCCHHHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCcceEEEecCCCCCeEE
Confidence            99 9999999986443              2999999999999999999999  7899999999999999   5889999


Q ss_pred             EeeeccccccCCCCCc------ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          236 ISDFGLARRIDTSHSH------VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      |+|||+++........      ......||+.|+|||.+.+. .++.++|||||||++|||++|..||...........+
T Consensus       147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~  225 (483)
T 3sv0_A          147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY  225 (483)
T ss_dssp             ECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH
T ss_pred             EEeCCcceeccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHH
Confidence            9999999876543321      12356799999999999854 4789999999999999999999997653332211111


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                       ............ .    .+     ...++.++.+++.+||+.||++||++.+|++.|++++
T Consensus       226 -~~i~~~~~~~~~-~----~l-----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~  277 (483)
T 3sv0_A          226 -EKISEKKVATSI-E----AL-----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF  277 (483)
T ss_dssp             -HHHHHHHHHSCH-H----HH-----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             -HHHhhccccccH-H----HH-----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence             111111110000 0    00     1122458999999999999999999999999999875

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-44  Score=329.16  Aligned_cols=263  Identities=24%  Similarity=0.315  Sum_probs=198.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEee--------
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCAS--------  149 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  149 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++......  ....+.+|+.+++.++||||+++++++.+        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            35899999999999999999976 57899999998554332  24567899999999999999999999977        


Q ss_pred             CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       150 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      ....++||||++ ++|.+.+.....              .+++.++..++.|++.||+|||  +++++||||||+||+++
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~  158 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNVLV--------------KFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLIT  158 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCTTS--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEC
T ss_pred             CceEEEEEeccC-CCHHHHHhhccC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEc
Confidence            446899999996 588777765432              2899999999999999999999  78999999999999999


Q ss_pred             CCCceEEeeeccccccCCCC---CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          230 SDFEAHISDFGLARRIDTSH---SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                      .++.+||+|||+++......   ........||+.|+|||++.+...++.++|||||||++|||++|..||......   
T Consensus       159 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---  235 (351)
T 3mi9_A          159 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---  235 (351)
T ss_dssp             TTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---
T ss_pred             CCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---
Confidence            99999999999998764322   122334578999999999987677899999999999999999999997542211   


Q ss_pred             ccHHHHHHHHHHhccccccccCcc------------cc--ccCCHH-----HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNI------------SR--EELSEA-----GVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~--~~~~~~-----~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       ..........  ........+..            ..  ......     .+..+.+++.+||+.||++|||+.|+++
T Consensus       236 -~~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          236 -HQLALISQLC--GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             -HHHHHHHHHH--CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHHHHh--CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence             1111111110  00000000000            00  000000     1346889999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.1e-45  Score=322.54  Aligned_cols=251  Identities=26%  Similarity=0.407  Sum_probs=195.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeC-CeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASG-LDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  159 (373)
                      .++|++.+.||+|+||.||++... ++.||+|.+....  ..+.+.+|+.++++++||||+++++++.+. ...++|+||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            457889999999999999999875 8899999997543  346788999999999999999999987554 478999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++++|.+++......             .+++..++.++.|++.||.|||  +++++||||||+||+++.++.+||+||
T Consensus        97 ~~~~~L~~~l~~~~~~-------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Df  161 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRS-------------VLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDF  161 (278)
T ss_dssp             CTTEEHHHHHHHHHHH-------------HCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             CCCCCHHHHHHhcccc-------------cCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCcceEEEeCCCcEEEeec
Confidence            9999999999764321             2788999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      |++......    .....+++.|+|||.+.+ ..++.++||||||+++|||++ |..|+......    ..   ......
T Consensus       162 g~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~---~~~~~~  229 (278)
T 1byg_A          162 GLTKEASST----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DV---VPRVEK  229 (278)
T ss_dssp             CC----------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GH---HHHHTT
T ss_pred             ccccccccc----ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----HH---HHHHhc
Confidence            999765332    123357889999999874 457889999999999999998 88886432211    11   111110


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                            ....     ..+..++..+.+++.+||+.||++||++.++++.|+++.
T Consensus       230 ------~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          230 ------GYKM-----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             ------TCCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCC-----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence                  0111     113344568999999999999999999999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.3e-44  Score=318.90  Aligned_cols=247  Identities=28%  Similarity=0.406  Sum_probs=195.3

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEee----CCeeE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCAS----GLDRV  154 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  154 (373)
                      ..|.+.+.||+|+||.||+|.. .++..||+|.+.....  ...+.+.+|+.+++.++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            4577788999999999999976 4688999999865432  235678899999999999999999998865    35689


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--ceeecCCCCceEeC-CC
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP--IIHRDIKSSNVLLD-SD  231 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~--i~H~dlk~~Nill~-~~  231 (373)
                      +||||+++++|.+++....               .+++..++.++.|++.||.|||  +.+  ++||||||+||+++ .+
T Consensus       106 lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~  168 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK---------------VMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPT  168 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCSCCCGGGEEESSTT
T ss_pred             EEEEecCCCCHHHHHHHcc---------------CCCHHHHHHHHHHHHHHHHHHH--cCCCCEEECCCCHHHEEEECCC
Confidence            9999999999999998653               2899999999999999999999  667  99999999999997 78


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +.+||+|||++......   ......||+.|+|||.+.+  .++.++||||||+++|+|++|..||.....      ...
T Consensus       169 ~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~  237 (290)
T 1t4h_A          169 GSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQ  237 (290)
T ss_dssp             SCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHH
T ss_pred             CCEEEeeCCCccccccc---ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCc------HHH
Confidence            99999999999764332   2334568999999999863  478899999999999999999999743211      111


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....... .     ..+.    ..+...+.++.+++.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~-~-----~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          238 IYRRVTS-G-----VKPA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHTT-T-----CCCG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhc-c-----CCcc----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1111110 0     0010    111222357999999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-44  Score=329.17  Aligned_cols=257  Identities=24%  Similarity=0.273  Sum_probs=194.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCC------
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGL------  151 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  151 (373)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            56899999999999999999976 4799999999855322  23456889999999999999999999997653      


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..++||||+ +++|.+++....                +++..+..++.|++.||.|||  +.+++||||||+||+++.+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~~----------------l~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~  164 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHEK----------------LGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNED  164 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC----------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTT
T ss_pred             eEEEEEecC-CCCHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHH--HCCccccCcCHHHEEEcCC
Confidence            459999999 889999997632                899999999999999999999  7899999999999999999


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +.+||+|||+++.....    .....+|+.|+|||++.+...++.++||||+||++|||++|..||.......   .+..
T Consensus       165 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~  237 (367)
T 1cm8_A          165 CELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKE  237 (367)
T ss_dssp             CCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred             CCEEEEeeecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH
Confidence            99999999999875432    3345789999999999875678999999999999999999999975432111   0000


Q ss_pred             HHHHHHHhcccc----------------ccccC--ccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEI----------------EMVDS--NISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~----------------~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .   ....+...                ..+..  ...........+..+.+++.+||+.||++|||+.++++
T Consensus       238 i---~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          238 I---MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             H---HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             H---HHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            0   00000000                00000  00001112234568999999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.4e-45  Score=327.26  Aligned_cols=268  Identities=28%  Similarity=0.432  Sum_probs=200.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCE--EEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVT--VAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ++|++.+.||+|+||.||+|... ++..  +++|.+..... ...+.+.+|+.+++++ +||||+++++++.+....++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            47888999999999999999754 5654  48998865322 2345788999999999 899999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcc-cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGS-KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |||+++++|.+++............ .......++++.+++.++.|++.||.|||  +++++||||||+||+++.++.+|
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~~~~~k  182 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAK  182 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECGGGCEE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCccceEEEcCCCeEE
Confidence            9999999999999865410000000 00000113899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      |+|||+++.....  .......+++.|+|||.+.+ ..++.++||||||+++|||++ |..||....       ......
T Consensus       183 L~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~-------~~~~~~  252 (327)
T 1fvr_A          183 IADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYE  252 (327)
T ss_dssp             ECCTTCEESSCEE--CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHH
T ss_pred             EcccCcCcccccc--ccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCc-------HHHHHH
Confidence            9999999743211  11223456889999999874 447889999999999999998 888864321       111111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ...      ......     .+..++..+.+++.+||+.||.+|||+.++++.|++++
T Consensus       253 ~~~------~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          253 KLP------QGYRLE-----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             HGG------GTCCCC-----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Hhh------cCCCCC-----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            111      001111     12334568999999999999999999999999999875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.9e-44  Score=319.63  Aligned_cols=250  Identities=22%  Similarity=0.339  Sum_probs=199.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|.+.+.||+|+||.||++... +|+.||+|.+........+.+.+|+.+++.++||||+++++++.+....++|+||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            357888999999999999999765 7899999999765544456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe---CCCCceEE
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL---DSDFEAHI  236 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill---~~~~~~kl  236 (373)
                      +++++|.+++....               ++++..+..++.|++.||.|||  +.+++||||||+||++   +.++.+||
T Consensus        88 ~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dikp~NIl~~~~~~~~~~kl  150 (304)
T 2jam_A           88 VSGGELFDRILERG---------------VYTEKDASLVIQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMI  150 (304)
T ss_dssp             CCSCBHHHHHHHHS---------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCSCCGGGCEESSSSTTCCEEB
T ss_pred             CCCccHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEecCCCCCCEEE
Confidence            99999999987654               2899999999999999999999  7899999999999999   78899999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++.....   .......||+.|+|||.+.+ ..++.++||||||+++|||++|..||.....       .......
T Consensus       151 ~Dfg~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i  219 (304)
T 2jam_A          151 TDFGLSKMEQN---GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETE-------SKLFEKI  219 (304)
T ss_dssp             CSCSTTCCCCC---BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHH
T ss_pred             ccCCcceecCC---CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHH
Confidence            99999875432   12234568999999999975 4578899999999999999999999754211       1111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .....   ......     ....+..+.+++.+||+.||++||++.++++
T Consensus       220 ~~~~~---~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          220 KEGYY---EFESPF-----WDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHCCC---CCCTTT-----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HcCCC---CCCccc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11100   001111     2234568999999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.5e-44  Score=330.26  Aligned_cols=273  Identities=21%  Similarity=0.251  Sum_probs=198.0

Q ss_pred             hHHHHHhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccc-----------cHHHHHHHHHHHhcCCCCCccc
Q 043074           74 MSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ-----------GFREFRAEMETLGKLRHRNIVK  142 (373)
Q Consensus        74 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~  142 (373)
                      ..++....++|++.+.||+|+||.||+|...+++.||+|++......           ..+.+.+|+.++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            45667788999999999999999999998888999999998553221           1367899999999999999999


Q ss_pred             eeeEEee-----CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCce
Q 043074          143 ILGYCAS-----GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPII  217 (373)
Q Consensus       143 l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~  217 (373)
                      +++++..     ....++||||++ |+|.+++.....              .+++..+..++.|++.||.|||  +.+++
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH--~~~iv  156 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--------------VISPQHIQYFMYHILLGLHVLH--EAGVV  156 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--------------CCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHH--HCcCE
Confidence            9999844     346799999996 688888875432              2899999999999999999999  78999


Q ss_pred             eecCCCCceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCC
Q 043074          218 HRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN  297 (373)
Q Consensus       218 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  297 (373)
                      ||||||+||+++.++.+||+|||++.......  ......||+.|+|||.+.+...++.++|||||||++|+|++|..||
T Consensus       157 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  234 (362)
T 3pg1_A          157 HRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF  234 (362)
T ss_dssp             CCCCCGGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ecCCChHHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence            99999999999999999999999997543222  2334568999999999986567899999999999999999999997


Q ss_pred             CCcccCCCcccHHHHHH--------------HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 043074          298 LPVVLDGQEVGLLEWAR--------------TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY  363 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~  363 (373)
                      ...........+.....              ................ ........+..+.+++.+||+.||++|||+.+
T Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  313 (362)
T 3pg1_A          235 RGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARA-WTAVVPTADPVALDLIAKMLEFNPQRRISTEQ  313 (362)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCC-HHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhh-HHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence            54321110000000000              0000000000000000 00011223457999999999999999999999


Q ss_pred             HHH
Q 043074          364 VVQ  366 (373)
Q Consensus       364 l~~  366 (373)
                      +++
T Consensus       314 ll~  316 (362)
T 3pg1_A          314 ALR  316 (362)
T ss_dssp             HHT
T ss_pred             HHc
Confidence            986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.1e-44  Score=321.08  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=198.4

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ..++|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|+.++..++||||+++++++.+....++|+|
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            4568999999999999999999875 689999999987766667889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++++|.+++.....              .+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+||+|
T Consensus        97 ~~~~~~l~~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~D  160 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDR--------------GLTEPQIQVVCRQMLEALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLAD  160 (302)
T ss_dssp             CCTTEEHHHHHHHHTS--------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTSCEEECC
T ss_pred             eCCCCcHHHHHHhhcc--------------CCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEECCCCCEEEEE
Confidence            9999999999876432              2899999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccC----CCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLG----GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      ||++...... ........||+.|+|||.+.    ....++.++||||||+++|+|++|..|+.....       .....
T Consensus       161 fg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~  232 (302)
T 2j7t_A          161 FGVSAKNLKT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLL  232 (302)
T ss_dssp             CHHHHHHHHH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHH
T ss_pred             CCCCcccccc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-------HHHHH
Confidence            9987643111 01122346899999999984    245578899999999999999999999654211       11111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .......      +..   ..+...+..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~------~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          233 KIAKSDP------PTL---LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHSCC------CCC---SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHhccCC------ccc---CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1111110      000   012233558999999999999999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.4e-44  Score=339.34  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=200.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .++|++.+.||+|+||.||+|... +++.||+|++.+..  ......+.+|+.++++++||||+++++++.+....++|+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            457999999999999999999765 78999999986432  234567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC---CCCce
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD---SDFEA  234 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~---~~~~~  234 (373)
                      ||+.+|+|.+++.....               +++..+..++.|++.||.|||  +++|+||||||+||+++   .++.+
T Consensus       101 e~~~~~~L~~~~~~~~~---------------~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~  163 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRKR---------------FSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDI  163 (486)
T ss_dssp             CCCCSCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEESSSSTTCCE
T ss_pred             EcCCCCcHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCE
Confidence            99999999998876542               899999999999999999999  78999999999999995   45679


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      ||+|||++.......  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.....       .+...
T Consensus       164 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~  232 (486)
T 3mwu_A          164 KIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILK  232 (486)
T ss_dssp             EECSCSCTTTBCCC------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred             EEEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence            999999998764332  2334579999999999975  378999999999999999999999754221       11112


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .........   .  .  .. ....+.++.+++.+||+.||++|||+.++++
T Consensus       233 ~i~~~~~~~---~--~--~~-~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          233 RVETGKYAF---D--L--PQ-WRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             HHHHTCCCS---C--S--GG-GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHhCCCCC---C--C--cc-cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            221111000   0  0  00 1223457999999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.9e-44  Score=340.99  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=201.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|...+.||+|+||.||+|..+ +|+.||+|++.+...   .....+.+|+.++++++||||+++++++.+....++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67888899999999999999875 699999999965432   23467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.......           ..+++..+..++.||+.||.|||  +++|+||||||+|||++.+|.+||+
T Consensus       265 E~~~gg~L~~~l~~~~~~~-----------~~l~e~~~~~~~~qi~~aL~~LH--~~gIvHrDLKP~NILl~~~g~vkL~  331 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDN-----------PGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRIS  331 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTS-----------CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             EeccCCCHHHHHHHhhccc-----------ccccHHHHHHHHHHHHHHHHHHH--HcCCcccCCChHHEEEeCCCCEEEe
Confidence            9999999999997654211           13899999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.......   ..........
T Consensus       332 DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~---~~~~~~~~i~  406 (543)
T 3c4z_A          332 DLGLAVELKAGQT-KTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQRVL  406 (543)
T ss_dssp             CCTTCEECCTTCC-CBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC---CHHHHHHHHH
T ss_pred             ecceeeeccCCCc-ccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccch---hHHHHHHHHh
Confidence            9999987643322 2334579999999999985 458899999999999999999999986532211   1112221111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                      ...       ..     .+...+..+.+++.+||+.||++||++
T Consensus       407 ~~~-------~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          407 EQA-------VT-----YPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HCC-------CC-----CCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             hcc-------cC-----CCcccCHHHHHHHHHhccCCHhHCCCC
Confidence            110       01     123345689999999999999999976

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.8e-44  Score=335.51  Aligned_cols=257  Identities=25%  Similarity=0.292  Sum_probs=190.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeC------C
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASG------L  151 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  151 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....  ....+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            57899999999999999999965 468999999996542  23356788999999999999999999999654      4


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..++||||+++ +|.+.+..                 .+++..+..++.|++.||+|||  +.+|+||||||+|||++.+
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~-----------------~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDlkp~NIll~~~  200 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM-----------------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSD  200 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS-----------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTT
T ss_pred             eEEEEEeCCCC-CHHHHHhh-----------------cCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChHhEEEeCC
Confidence            56999999965 56666642                 1889999999999999999999  7899999999999999999


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +.+||+|||+++.....  .......||+.|+|||++.+. .++.++|||||||++|||++|..||.......      .
T Consensus       201 ~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~------~  271 (464)
T 3ttj_A          201 CTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYID------Q  271 (464)
T ss_dssp             SCEEECCCCCC-----C--CCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------H
T ss_pred             CCEEEEEEEeeeecCCC--cccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH------H
Confidence            99999999999876432  223456799999999999864 58899999999999999999999975432111      1


Q ss_pred             HHHHHHHhccc---------------------c------ccccCcccc--ccCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 043074          312 WARTMEARNKE---------------------I------EMVDSNISR--EELSEAGVREYFRIACMCTNEKSRERPAMS  362 (373)
Q Consensus       312 ~~~~~~~~~~~---------------------~------~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (373)
                      +..-....+..                     .      ..+...+..  .......+.++.+++.+||+.||++|||++
T Consensus       272 ~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~  351 (464)
T 3ttj_A          272 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD  351 (464)
T ss_dssp             HHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             HHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHH
Confidence            11110000000                     0      000000000  000122366899999999999999999999


Q ss_pred             HHHH
Q 043074          363 YVVQ  366 (373)
Q Consensus       363 ~l~~  366 (373)
                      |+++
T Consensus       352 e~L~  355 (464)
T 3ttj_A          352 DALQ  355 (464)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.3e-44  Score=327.18  Aligned_cols=252  Identities=21%  Similarity=0.292  Sum_probs=197.8

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ..++|++.+.||+|+||.||++..+ +++.||+|++.+....    ..+|++++.++ +||||+++++++.++...++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3457999999999999999999765 6899999999765432    34688888887 7999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC----Cc
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD----FE  233 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~----~~  233 (373)
                      ||+++|+|.+++....               .+++.++..++.||+.||.|||  +++++||||||+||++.++    +.
T Consensus        96 E~~~gg~L~~~i~~~~---------------~~~~~~~~~~~~qi~~al~~lH--~~givHrDlkp~NIl~~~~~~~~~~  158 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK---------------FFSEREASAVLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPES  158 (342)
T ss_dssp             CCCCSCBHHHHHHTCT---------------TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSCSGGG
T ss_pred             eCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCcEeccCCHHHEEEecCCCCcCe
Confidence            9999999999997654               2899999999999999999999  7899999999999998543    35


Q ss_pred             eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          234 AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||......    ...+..
T Consensus       159 ~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~  232 (342)
T 2qr7_A          159 IRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDD----TPEEIL  232 (342)
T ss_dssp             EEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS----CHHHHH
T ss_pred             EEEEECCCcccCcCCCC-ceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC----CHHHHH
Confidence            99999999987643322 2334678999999999874 34788999999999999999999997643211    111222


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...... ..      .+... .....+.++.+++.+||+.||++||++.++++
T Consensus       233 ~~i~~~-~~------~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          233 ARIGSG-KF------SLSGG-YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHC-CC------CCCST-TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHccC-Cc------ccCcc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            222111 10      00000 01234568999999999999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.9e-44  Score=328.43  Aligned_cols=268  Identities=24%  Similarity=0.329  Sum_probs=200.8

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeC-----Ce
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASG-----LD  152 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  152 (373)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.++.+++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3468999999999999999999764 7889999999754433 346788999999999999999999998655     46


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++|+||+. |+|.+++....                +++.++..++.|++.||+|||  +++++||||||+||+++.++
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~~----------------~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~  165 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQH----------------LSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTC  165 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHCC----------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTC
T ss_pred             EEEEEcccC-cCHHHHHHhCC----------------CCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChHhEEECCCC
Confidence            899999995 69999987643                899999999999999999999  78999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH
Q 043074          233 EAHISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  310 (373)
                      .+||+|||++.........  ......||+.|+|||++.+...++.++|||||||++|||++|..||...........+.
T Consensus       166 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  245 (364)
T 3qyz_A          166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL  245 (364)
T ss_dssp             CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH
T ss_pred             CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence            9999999999875432211  12345789999999987766668999999999999999999999975432221110000


Q ss_pred             HHH-----HHHHH------hccccccc-cCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 EWA-----RTMEA------RNKEIEMV-DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ~~~-----~~~~~------~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...     .....      ........ .............+.++.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          246 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000     00000      00000000 0000000001223457899999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.8e-45  Score=325.23  Aligned_cols=269  Identities=24%  Similarity=0.384  Sum_probs=186.2

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ..++|.+.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            457899999999999999999975 4689999999865432 23467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++++|.+++.........       ....+++..++.++.|++.||.|||  +.+++||||||+||+++.++.+||+
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~  163 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEH-------KSGVLDESTIATILREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIA  163 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTT-------TTCSSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             hhccCCchHHHHHHHhhcccc-------ccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCCChhhEEEcCCCCEEEE
Confidence            999999999999752111000       0113899999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCC----cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          238 DFGLARRIDTSHS----HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       238 Dfg~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |||++........    .......||+.|+|||.+.+...++.++||||||+++|||++|..||.......    ..   
T Consensus       164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~---  236 (303)
T 2vwi_A          164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK----VL---  236 (303)
T ss_dssp             CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HH---
T ss_pred             eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh----HH---
Confidence            9999987543211    122345689999999998654457889999999999999999999975432211    10   


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..... . ..................+..+.+++.+||+.||.+||++.++++
T Consensus       237 ~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          237 MLTLQ-N-DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HHHHT-S-SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHhc-c-CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00100 0 000011111111111223457999999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.9e-44  Score=328.10  Aligned_cols=255  Identities=28%  Similarity=0.398  Sum_probs=200.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|++.+.||+|+||.||++... ++..||+|++..... ...+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357899999999999999999765 789999999876533 234678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CceeecCCCCceEeCCCCceEEe
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEK-PIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~-~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      |+++++|.+++.....               +++..+..++.|++.||.|||  +. +++||||||+||+++.++.+||+
T Consensus       112 ~~~~~~L~~~l~~~~~---------------~~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~~kl~  174 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAGR---------------IPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLC  174 (360)
T ss_dssp             CCTTCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--HHHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred             CCCCCCHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HhCCEEcCCccHHHEEECCCCCEEEE
Confidence            9999999999986542               899999999999999999999  54 89999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcc----------
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV----------  307 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~----------  307 (373)
                      |||++......   ......||+.|+|||.+.+ ..++.++||||||+++|||++|..||..........          
T Consensus       175 Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  250 (360)
T 3eqc_A          175 DFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA  250 (360)
T ss_dssp             CCCCCHHHHHH---C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------
T ss_pred             ECCCCcccccc---cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccC
Confidence            99999764321   2234578999999999975 457899999999999999999999975432211000          


Q ss_pred             -------------------------cHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 043074          308 -------------------------GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMS  362 (373)
Q Consensus       308 -------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (373)
                                               ...+......      ........    ....+.++.+++.+||+.||++|||++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~  320 (360)
T 3eqc_A          251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIV------NEPPPKLP----SGVFSLEFQDFVNKCLIKNPAERADLK  320 (360)
T ss_dssp             -----------------------CCCHHHHHHHHH------HSCCCCCC----TTTSCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred             CCCCCCcccCCCcccccccCCCCcccchhhhhHHh------ccCCCCCC----cccccHHHHHHHHHHhhcChhhCCCHH
Confidence                                     0000000000      00001111    122345799999999999999999999


Q ss_pred             HHHH
Q 043074          363 YVVQ  366 (373)
Q Consensus       363 ~l~~  366 (373)
                      ++++
T Consensus       321 ell~  324 (360)
T 3eqc_A          321 QLMV  324 (360)
T ss_dssp             HHHT
T ss_pred             HHhh
Confidence            9986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.9e-44  Score=317.53  Aligned_cols=254  Identities=26%  Similarity=0.366  Sum_probs=198.6

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      +.|.....||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.+....++|+||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            3455566999999999999975 468899999997766555678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC-CCceEEeee
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-DFEAHISDF  239 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~-~~~~kl~Df  239 (373)
                      ++++|.+++.......            ++++..+..++.|++.||.|||  +.+++|+||||+||+++. ++.+||+||
T Consensus       102 ~~~~L~~~l~~~~~~~------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~kl~Df  167 (295)
T 2clq_A          102 PGGSLSALLRSKWGPL------------KDNEQTIGFYTKQILEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDF  167 (295)
T ss_dssp             SEEEHHHHHHHTTCCC------------TTCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTCCEEECCT
T ss_pred             CCCCHHHHHHhhccCC------------CccHHHHHHHHHHHHHHHHHHH--hCCEEccCCChhhEEEECCCCCEEEeec
Confidence            9999999998654221            2678999999999999999999  789999999999999987 899999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCC-CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN-TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      |++....... .......||+.|+|||.+.+. ..++.++||||||+++|||++|..||......    ....+..... 
T Consensus       168 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~-  241 (295)
T 2clq_A          168 GTSKRLAGIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP----QAAMFKVGMF-  241 (295)
T ss_dssp             TTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH----HHHHHHHHHH-
T ss_pred             ccccccCCCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch----hHHHHhhccc-
Confidence            9998754322 122345689999999998643 23688999999999999999999997432111    0000100000 


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                            ...+.+     +...+.++.+++.+||+.||++||++.++++
T Consensus       242 ------~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          242 ------KVHPEI-----PESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ------CCCCCC-----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ------cccccc-----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                  011111     3334568999999999999999999999975

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=328.78  Aligned_cols=262  Identities=24%  Similarity=0.376  Sum_probs=201.0

Q ss_pred             HHHHHhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe
Q 043074           75 SELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLD  152 (373)
Q Consensus        75 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  152 (373)
                      .+.....++|++.+.||+|+||.||+|..++  .+++|.+.....  ...+.+.+|+.++++++||||+++++++.+...
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            3334456789999999999999999998753  599999865332  223457789999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++|+||+++++|.+++.....              .+++.+++.++.|++.||+|||  +.+++||||||+||+++ ++
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~NIl~~-~~  166 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKI--------------VLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NG  166 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCC--------------CCCSHHHHHHHHHHHHHHHHHH--HTTCCCCCCCSTTEEEC---
T ss_pred             eEEEeecccCCcHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChhhEEEe-CC
Confidence            9999999999999999976542              2889999999999999999999  78999999999999998 67


Q ss_pred             ceEEeeeccccccCCCC----CcccccccccccccCccccCC--------CCCCCccccchhhhHHHHHHHhCCCCCCCc
Q 043074          233 EAHISDFGLARRIDTSH----SHVSTQVAGTMGYMPPEYLGG--------NTAATVMLDVYSFGILMIEIATQIRPNLPV  300 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~~DiwslG~~l~el~~g~~p~~~~  300 (373)
                      .+||+|||++.......    ........||+.|+|||.+.+        ...++.++||||||+++|||++|..||...
T Consensus       167 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  246 (319)
T 2y4i_B          167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ  246 (319)
T ss_dssp             CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred             CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999987643211    112233468999999999864        234688999999999999999999997532


Q ss_pred             ccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          301 VLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..       ......... .     ..+...    ...++.++.+++.+||+.||.+|||+.++++.|+++.
T Consensus       247 ~~-------~~~~~~~~~-~-----~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~  301 (319)
T 2y4i_B          247 PA-------EAIIWQMGT-G-----MKPNLS----QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP  301 (319)
T ss_dssp             CH-------HHHHHHHHT-T-----CCCCCC----CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred             CH-------HHHHHHhcc-C-----CCCCCC----cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            11       111111111 1     111111    1122347899999999999999999999999998874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.9e-44  Score=324.15  Aligned_cols=259  Identities=19%  Similarity=0.259  Sum_probs=200.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CCCccceeeEEee--CCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILGYCAS--GLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv  156 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....   .+.+.+|+.++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            46899999999999999999965 578999999997543   367889999999997 9999999999987  6678999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC-ceE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-EAH  235 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~-~~k  235 (373)
                      |||+++++|.+++..                  +++.++..++.|++.||+|||  +++++||||||+||+++.++ .+|
T Consensus       112 ~e~~~~~~l~~~~~~------------------~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~~k  171 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT------------------LTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLR  171 (330)
T ss_dssp             EECCCCCCHHHHGGG------------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEE
T ss_pred             EeccCchhHHHHHHh------------------CCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEcCCCCEEE
Confidence            999999999998852                  788999999999999999999  78999999999999999776 899


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||+++......  ......+++.|+|||.+.+...++.++|||||||++|||++|..|+.........  +......
T Consensus       172 l~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--l~~~~~~  247 (330)
T 3nsz_A          172 LIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKV  247 (330)
T ss_dssp             ECCCTTCEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHH
T ss_pred             EEeCCCceEcCCCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH--HHHHHHh
Confidence            99999998754332  2334568999999999987677899999999999999999999997543322111  1100000


Q ss_pred             ---------HHHhccc------------cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          316 ---------MEARNKE------------IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       316 ---------~~~~~~~------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                               .......            .................+.++.+++.+||+.||++|||++++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                     0000000            00000000011112224568999999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.2e-44  Score=325.49  Aligned_cols=261  Identities=20%  Similarity=0.359  Sum_probs=201.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccccc-----------------HHHHHHHHHHHhcCCCCCccce
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQG-----------------FREFRAEMETLGKLRHRNIVKI  143 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l  143 (373)
                      .++|.+.+.||+|+||.||+|.. +++.||+|.+.......                 .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999988 89999999986533221                 1788999999999999999999


Q ss_pred             eeEEeeCCeeEEEEEecCCCCHHHH------hhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCc
Q 043074          144 LGYCASGLDRVLIYEFVENGSLDQW------LHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLE-KPI  216 (373)
Q Consensus       144 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~-~~i  216 (373)
                      ++++.+.+..++||||+++++|.++      +.....             .++++..++.++.|++.||.|||  + +++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~-------------~~~~~~~~~~i~~qi~~~l~~lH--~~~~i  173 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT-------------CFIPIQVIKCIIKSVLNSFSYIH--NEKNI  173 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSC-------------CCCCHHHHHHHHHHHHHHHHHHH--HTSCE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccc-------------cCCCHHHHHHHHHHHHHHHHHHh--ccCCE
Confidence            9999999999999999999999998      443211             23899999999999999999999  6 899


Q ss_pred             eeecCCCCceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCc-cccchhhhHHHHHHHhCCC
Q 043074          217 IHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATV-MLDVYSFGILMIEIATQIR  295 (373)
Q Consensus       217 ~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~~DiwslG~~l~el~~g~~  295 (373)
                      +||||||+||+++.++.+||+|||++......   ......||+.|+|||.+.+...++. ++||||||+++|||++|..
T Consensus       174 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~  250 (348)
T 2pml_X          174 CHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV  250 (348)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred             eecCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999875432   2344678999999999986644555 9999999999999999999


Q ss_pred             CCCCcccCCCcccHHHHHHHHHHhcccccc----ccCccc---cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          296 PNLPVVLDGQEVGLLEWARTMEARNKEIEM----VDSNIS---REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       296 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      |+......      .+..............    ......   ........+..+.+++.+||+.||.+|||+.++++
T Consensus       251 pf~~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          251 PFSLKISL------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SSCCSSCS------HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCCCcH------HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            97543221      1111111110000000    000000   00001334568999999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.9e-44  Score=317.16  Aligned_cols=249  Identities=27%  Similarity=0.388  Sum_probs=202.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .+.|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            45788899999999999999975 4789999999965443 345778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++++|.+++...                ++++..+..++.|++.||.|||  +.+++|+||||+||+++.++.+||+|
T Consensus       101 ~~~~~~L~~~~~~~----------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~D  162 (303)
T 3a7i_A          101 YLGGGSALDLLEPG----------------PLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLAD  162 (303)
T ss_dssp             CCTTEEHHHHHTTS----------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCCCcHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChheEEECCCCCEEEee
Confidence            99999999998653                2899999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||++....... .......||+.|+|||.+.+ ..++.++||||||+++|+|++|..|+.....       .........
T Consensus       163 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~  233 (303)
T 3a7i_A          163 FGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHP-------MKVLFLIPK  233 (303)
T ss_dssp             CTTCEECBTTB-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHH
T ss_pred             cccceecCccc-cccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCH-------HHHHHHhhc
Confidence            99998764332 12234568999999999975 4578899999999999999999999643211       111111111


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                       ..     ...+     ....+..+.+++.+||+.||++|||+.++++.
T Consensus       234 -~~-----~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          234 -NN-----PPTL-----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             -SC-----CCCC-----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             -CC-----CCCC-----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence             10     1111     22234579999999999999999999999863

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.1e-44  Score=322.18  Aligned_cols=263  Identities=27%  Similarity=0.409  Sum_probs=201.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe------CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  153 (373)
                      .++|++.+.||+|+||.||+|..      .++..||+|.+..... .....+.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46899999999999999999973      3577899999965433 3345788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC---
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---  230 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~---  230 (373)
                      ++||||+++++|.+++........        ....+++.+++.++.|++.||.|||  +.+++||||||+||+++.   
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~--------~~~~~~~~~~~~i~~qi~~al~~LH--~~~i~H~dlkp~NIli~~~~~  178 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPS--------QPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGP  178 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSS--------STTSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSST
T ss_pred             EEEEecCCCCcHHHHHHhhccccc--------ccccccHHHHHHHHHHHHHHHHHHh--hCCeecCcCCHhHEEEecCCC
Confidence            999999999999999987653211        1123899999999999999999999  789999999999999984   


Q ss_pred             CCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCccc
Q 043074          231 DFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVG  308 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~  308 (373)
                      +..+||+|||++........ .......+|+.|+|||.+.+ ..++.++||||||+++|||++ |..|+....       
T Consensus       179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~-------  250 (327)
T 2yfx_A          179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------  250 (327)
T ss_dssp             TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------
T ss_pred             cceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcC-------
Confidence            44699999999986533221 22234567889999999874 447889999999999999998 777754321       


Q ss_pred             HHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          309 LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ........... ..     .     ..+..++..+.+++.+||+.||.+||++.++++.|+.+.
T Consensus       251 ~~~~~~~~~~~-~~-----~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          251 NQEVLEFVTSG-GR-----M-----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HHHHHHHHHTT-CC-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcC-CC-----C-----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            11111111111 00     0     112334568999999999999999999999999998753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.1e-44  Score=340.41  Aligned_cols=250  Identities=24%  Similarity=0.329  Sum_probs=202.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|++.+.||+|+||.||+|... +++.||+|++.+..   ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            357899999999999999999765 78999999986543   23456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe---CCCCc
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL---DSDFE  233 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill---~~~~~  233 (373)
                      +||+.+|+|.+++....               ++++..+..++.|++.||.|||  +++++||||||+||++   +.++.
T Consensus       105 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~  167 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK---------------RFSEVDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDAN  167 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS---------------CCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCC
T ss_pred             EecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEecCCCCCc
Confidence            99999999999987654               2899999999999999999999  7899999999999999   56789


Q ss_pred             eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          234 AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +||+|||++.......  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.....       .+..
T Consensus       168 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~  236 (484)
T 3nyv_A          168 IRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANE-------YDIL  236 (484)
T ss_dssp             EEECCTTHHHHBCCCC--SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHH
T ss_pred             EEEEeeeeeEEccccc--ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-------HHHH
Confidence            9999999998765432  2334579999999999975  478899999999999999999999754211       1111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .........     ...  .. ....+..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~i~~~~~~-----~~~--~~-~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          237 KKVEKGKYT-----FEL--PQ-WKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHHCCCC-----CCS--GG-GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHcCCCC-----CCC--cc-cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            111111100     000  00 1223558999999999999999999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.6e-44  Score=316.22  Aligned_cols=248  Identities=21%  Similarity=0.328  Sum_probs=201.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|.+.+.||+|+||.||++... +++.+|+|.+.....   ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            357888999999999999999765 688999999865432   2345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      +||+++++|.+++....               .+++.++..++.|++.||.|||  +++++||||||+||+++.++.+||
T Consensus        94 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl  156 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK---------------ALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKI  156 (294)
T ss_dssp             EECCTTCBHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEE
T ss_pred             EecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEcCCCCEEE
Confidence            99999999999987654               2899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++....... .......||+.|+|||.+.+ ..++.++||||||+++|+|++|..|+.....       .+.....
T Consensus       157 ~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~  227 (294)
T 2rku_A          157 GDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYLRI  227 (294)
T ss_dssp             CCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHH
T ss_pred             EeccCceecccCc-cccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHH
Confidence            9999998754322 22334568999999999975 4478899999999999999999999754221       1111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...       ...+     +...+..+.+++.+||+.||++|||+.++++
T Consensus       228 ~~~-------~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          228 KKN-------EYSI-----PKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             HTT-------CCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhc-------cCCC-----ccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            110       0011     2233457999999999999999999999886

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.6e-44  Score=325.32  Aligned_cols=264  Identities=20%  Similarity=0.286  Sum_probs=203.8

Q ss_pred             cccChHHHHHhcCCCCCC-CeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCC-CCCcccee
Q 043074           70 SQISMSELIDATDNFSTD-KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLR-HRNIVKIL  144 (373)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~  144 (373)
                      .++.++......++|.+. +.||+|+||.||+|... +++.||+|++.....  .....+.+|+.++..+. ||||++++
T Consensus        16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            344455556666778777 88999999999999765 689999999865433  23567889999999995 79999999


Q ss_pred             eEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCC
Q 043074          145 GYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS  224 (373)
Q Consensus       145 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~  224 (373)
                      +++.+....++||||+++|+|.+++......             .+++.+++.++.|++.||+|||  +.+++||||||+
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------------~~~~~~~~~i~~ql~~~L~~LH--~~givH~Dikp~  160 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPELAE-------------MVSENDVIRLIKQILEGVYYLH--QNNIVHLDLKPQ  160 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSCC-C-------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGG
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHhccc-------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCChH
Confidence            9999999999999999999999998654322             3899999999999999999999  789999999999


Q ss_pred             ceEeCC---CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcc
Q 043074          225 NVLLDS---DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVV  301 (373)
Q Consensus       225 Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  301 (373)
                      ||+++.   ++.+||+|||+++......  ......||+.|+|||.+.+ ..++.++||||||+++|||++|..||....
T Consensus       161 NIl~~~~~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  237 (327)
T 3lm5_A          161 NILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGED  237 (327)
T ss_dssp             GEEESCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEEecCCCCCcEEEeeCccccccCCcc--ccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999988   7899999999998764322  2234578999999999974 457889999999999999999999974421


Q ss_pred             cCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          302 LDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .       ...........       ...... ....++..+.+++.+||+.||.+|||++++++
T Consensus       238 ~-------~~~~~~i~~~~-------~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          238 N-------QETYLNISQVN-------VDYSEE-TFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             H-------HHHHHHHHHTC-------CCCCTT-TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             c-------hHHHHHHHhcc-------cccCch-hhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            1       11111111110       000001 12234568999999999999999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.6e-44  Score=322.84  Aligned_cols=248  Identities=21%  Similarity=0.325  Sum_probs=202.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|.+.+.||+|+||.||++... +++.+|+|.+.....   ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            468999999999999999999765 588999999865432   2346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++++|.+++....               .+++.+++.++.|++.||.|||  +++++||||||+||+++.++.+||
T Consensus       120 ~e~~~~~~L~~~~~~~~---------------~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~~~~~kl  182 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK---------------ALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKI  182 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEE
T ss_pred             EecCCCCCHHHHHhccC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCCEecCCCchhEEEcCCCCEEE
Confidence            99999999999987653               2899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||++....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|..||....       ..+.....
T Consensus       183 ~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~  253 (335)
T 2owb_A          183 GDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC-------LKETYLRI  253 (335)
T ss_dssp             CCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHH
T ss_pred             eeccCceecccCc-ccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCC-------HHHHHHHH
Confidence            9999998764322 22334568999999999975 447889999999999999999999975321       11111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....       ..+     +...+..+.+++.+||+.||++||++.++++
T Consensus       254 ~~~~-------~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          254 KKNE-------YSI-----PKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HHTC-------CCC-----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hcCC-------CCC-----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1110       011     2233457899999999999999999999886

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.2e-46  Score=339.87  Aligned_cols=247  Identities=14%  Similarity=0.161  Sum_probs=188.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcc---ccccHHHHHHHH---HHHhcCCCCCcccee-------eE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKD---AFQGFREFRAEM---ETLGKLRHRNIVKIL-------GY  146 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~  146 (373)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|+   ..++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999985 57999999999643   223456788999   455556899999998       55


Q ss_pred             EeeCC-----------------eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 043074          147 CASGL-----------------DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYL  209 (373)
Q Consensus       147 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~l  209 (373)
                      +.+.+                 ..++||||+ +|+|.+++........        ...++++..++.++.|++.||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~--------~~~~l~~~~~~~i~~qi~~aL~~L  222 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS--------THKSLVHHARLQLTLQVIRLLASL  222 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT--------TTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc--------ccccccHHHHHHHHHHHHHHHHHH
Confidence            55443                 278999999 6899999986432110        001255688899999999999999


Q ss_pred             hcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCC----------CCCCcccc
Q 043074          210 HGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGN----------TAATVMLD  279 (373)
Q Consensus       210 h~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------~~~~~~~D  279 (373)
                      |  +++|+||||||+|||++.++.+||+|||+++....    ......| +.|+|||.+.+.          ..++.++|
T Consensus       223 H--~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  295 (377)
T 3byv_A          223 H--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD  295 (377)
T ss_dssp             H--HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred             H--hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence            9  78999999999999999999999999999986432    2334567 999999999754          25889999


Q ss_pred             chhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC
Q 043074          280 VYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP  359 (373)
Q Consensus       280 iwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  359 (373)
                      ||||||++|||++|..||.........                 ..+...      ...++..+.+++.+||+.||++||
T Consensus       296 vwSlG~il~elltg~~Pf~~~~~~~~~-----------------~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rp  352 (377)
T 3byv_A          296 AWALGLVIYWIWCADLPITKDAALGGS-----------------EWIFRS------CKNIPQPVRALLEGFLRYPKEDRL  352 (377)
T ss_dssp             HHHHHHHHHHHHHSSCCC------CCS-----------------GGGGSS------CCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred             HHHHHHHHHHHHHCCCCCcccccccch-----------------hhhhhh------ccCCCHHHHHHHHHHcCCCchhCC
Confidence            999999999999999997442211110                 000000      112245899999999999999999


Q ss_pred             CHHHHHH
Q 043074          360 AMSYVVQ  366 (373)
Q Consensus       360 s~~~l~~  366 (373)
                      |+.++++
T Consensus       353 t~~e~l~  359 (377)
T 3byv_A          353 LPLQAME  359 (377)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999985

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.8e-44  Score=337.86  Aligned_cols=250  Identities=24%  Similarity=0.307  Sum_probs=196.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .++|++.+.||+|+||.||+|..+ ++..+|+|++.+...  .....+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            347899999999999999999765 789999999865432  23567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC---Cce
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD---FEA  234 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~---~~~  234 (373)
                      ||+++|+|.+++....               ++++..+..++.||+.||.|||  +++|+||||||+||+++..   +.+
T Consensus       116 e~~~~g~L~~~~~~~~---------------~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~  178 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM---------------KFNEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALI  178 (494)
T ss_dssp             ECCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTCCE
T ss_pred             ecCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChhhEEEeCCCCCCcE
Confidence            9999999999887654               2899999999999999999999  7899999999999999764   459


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      ||+|||++.......  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.....       .+...
T Consensus       179 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~  247 (494)
T 3lij_A          179 KIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTD-------QEILR  247 (494)
T ss_dssp             EECCCTTCEECBTTB--CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred             EEEECCCCeECCCCc--cccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence            999999998764322  2344679999999999863  488999999999999999999999754221       11112


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ........   .....     ....+..+.+++.+||+.||.+|||+.++++
T Consensus       248 ~i~~~~~~---~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          248 KVEKGKYT---FDSPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HHHHTCCC---CCSGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhCCCC---CCchh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            22111100   00000     1123457999999999999999999999885

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.5e-44  Score=317.77  Aligned_cols=245  Identities=26%  Similarity=0.396  Sum_probs=200.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||+|... +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+....++|+
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57889999999999999999765 678899999865322   22467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++++|.+++....               .+++..+..++.|++.||.|||  +++++||||||+||+++.++.+||+
T Consensus        94 e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~  156 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG---------------RFDEQRSATFMEELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIA  156 (284)
T ss_dssp             CCCTTEEHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             EeCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEEcCCCCEEEe
Confidence            9999999999998654               2899999999999999999999  7999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||++......   ......|++.|+|||.+.+. .++.++||||||+++|+|++|..||.....       ........
T Consensus       157 Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~  225 (284)
T 2vgo_A          157 DFGWSVHAPSL---RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSH-------TETHRRIV  225 (284)
T ss_dssp             CCTTCEECSSS---CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHH
T ss_pred             cccccccCccc---ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCH-------hHHHHHHh
Confidence            99998765432   22345689999999999754 478899999999999999999999753211       11111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .       .+...     +...+..+.+++.+||+.||.+||++.++++
T Consensus       226 ~-------~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          226 N-------VDLKF-----PPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             T-------TCCCC-----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c-------cccCC-----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            1       01111     2233558899999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=314.29  Aligned_cols=251  Identities=20%  Similarity=0.324  Sum_probs=197.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc----ccHHHHHHHHHHHhcCCCCCccceeeEE--eeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF----QGFREFRAEMETLGKLRHRNIVKILGYC--ASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~--~~~~~~  153 (373)
                      .++|++.+.||+|+||.||++... +++.+|+|++.....    .....+.+|+.++++++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999764 689999999975432    2356789999999999999999999998  445688


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++||||++++ |.+++......             .+++..+..++.|++.||.|||  +++++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~-------------~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~NIl~~~~~~  147 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEK-------------RFPVCQAHGYFCQLIDGLEYLH--SQGIVHKDIKPGNLLLTTGGT  147 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTC-------------SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCC
T ss_pred             EEEehhccCC-HHHHHHhCccc-------------ccCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEcCCCc
Confidence            9999999766 77777665432             2899999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCC-CcccccccccccccCccccCCCC-CCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          234 AHISDFGLARRIDTSH-SHVSTQVAGTMGYMPPEYLGGNT-AATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +||+|||++....... ........||+.|+|||.+.+.. ..+.++||||||+++|||++|..|+....       ...
T Consensus       148 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~  220 (305)
T 2wtk_C          148 LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-------IYK  220 (305)
T ss_dssp             EEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHH
T ss_pred             EEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-------HHH
Confidence            9999999998764322 22233456899999999987533 34779999999999999999999975321       111


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .........       ..+     +..++..+.+++.+||+.||.+|||+.++++
T Consensus       221 ~~~~i~~~~-------~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          221 LFENIGKGS-------YAI-----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HHHHHHHCC-------CCC-----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHhcCC-------CCC-----CCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111111110       011     2233558899999999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.1e-44  Score=317.97  Aligned_cols=250  Identities=23%  Similarity=0.359  Sum_probs=198.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc------cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ------GFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      ++|++.+.||+|+||.||++... +++.||+|.+......      ..+.+.+|+.++++++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46888999999999999999775 6899999998654321      3567899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC--
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF--  232 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~--  232 (373)
                      +||||+++++|.+++....               ++++.++..++.|++.||.|||  +.+++||||||+||+++.++  
T Consensus        85 lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~  147 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE---------------SLTEDEATQFLKQILDGVHYLH--SKRIAHFDLKPENIMLLDKNVP  147 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSSS
T ss_pred             EEEeecCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChHHEEEecCCCC
Confidence            9999999999999997643               2899999999999999999999  78999999999999998877  


Q ss_pred             --ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH
Q 043074          233 --EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       233 --~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  310 (373)
                        .+||+|||++.......  ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..|+.....       .
T Consensus       148 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~  217 (283)
T 3bhy_A          148 NPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETK-------Q  217 (283)
T ss_dssp             SCCEEECCCTTCEECC----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------H
T ss_pred             CCceEEEecccceeccCCC--cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcch-------H
Confidence              89999999998754322  2234568999999999974 4578899999999999999999999754211       1


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..........   .......     ....+..+.+++.+||+.||++||++.++++
T Consensus       218 ~~~~~~~~~~---~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          218 ETLTNISAVN---YDFDEEY-----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHHHHHHTTC---CCCCHHH-----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhHhcc---cCCcchh-----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            1111111100   0000000     1123457999999999999999999999987

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.1e-43  Score=324.34  Aligned_cols=254  Identities=20%  Similarity=0.351  Sum_probs=201.8

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--------cHHHHHHHHHHHhcC-CCCCccceeeEEe
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--------GFREFRAEMETLGKL-RHRNIVKILGYCA  148 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~l~~~~~  148 (373)
                      ...++|.+.+.||+|+||.||+|... +|+.||||++......        ..+.+.+|+.++.++ +||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            34567999999999999999999875 7999999998654321        134678899999999 7999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe
Q 043074          149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL  228 (373)
Q Consensus       149 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill  228 (373)
                      .....++||||+++++|.+++....               .+++..+..++.|++.||.|||  +.+++|+||||+||++
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~~---------------~l~~~~~~~i~~qi~~~L~~LH--~~gi~H~Dlkp~NIl~  233 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEKV---------------ALSEKETRSIMRSLLEAVSFLH--ANNIVHRDLKPENILL  233 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEE
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEE
Confidence            9999999999999999999997643               2899999999999999999999  7899999999999999


Q ss_pred             CCCCceEEeeeccccccCCCCCcccccccccccccCccccCC-----CCCCCccccchhhhHHHHHHHhCCCCCCCcccC
Q 043074          229 DSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG-----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLD  303 (373)
Q Consensus       229 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~  303 (373)
                      +.++.+||+|||++.......  ......||+.|+|||.+.+     ...++.++|||||||++|||++|..||..... 
T Consensus       234 ~~~~~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-  310 (365)
T 2y7j_A          234 DDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-  310 (365)
T ss_dssp             CTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred             CCCCCEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-
Confidence            999999999999998765332  2344678999999998853     23478899999999999999999999754211 


Q ss_pred             CCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          304 GQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                            ........... .    .  ..... ....+..+.+++.+||+.||++|||+.++++
T Consensus       311 ------~~~~~~i~~~~-~----~--~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          311 ------ILMLRMIMEGQ-Y----Q--FSSPE-WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             ------HHHHHHHHHTC-C----C--CCHHH-HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ------HHHHHHHHhCC-C----C--CCCcc-cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  11111111100 0    0  00000 0112457999999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.4e-43  Score=337.28  Aligned_cols=251  Identities=24%  Similarity=0.302  Sum_probs=199.1

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-------------ccHHHHHHHHHHHhcCCCCCccceee
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-------------QGFREFRAEMETLGKLRHRNIVKILG  145 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~  145 (373)
                      ..++|.+.+.||+|+||.||+|... +++.+|+|++.+...             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4568999999999999999999765 688999999865432             22467889999999999999999999


Q ss_pred             EEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCc
Q 043074          146 YCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSN  225 (373)
Q Consensus       146 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~N  225 (373)
                      ++.+....++||||+++|+|.+++.....               +++..+..++.|++.||.|||  +.+|+||||||+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------------~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~N  176 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHK---------------FDECDAANIMKQILSGICYLH--KHNIVHRDIKPEN  176 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSC---------------CCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGG
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCcHHH
Confidence            99999999999999999999999876542               899999999999999999999  7899999999999


Q ss_pred             eEeCCCC---ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCccc
Q 043074          226 VLLDSDF---EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVL  302 (373)
Q Consensus       226 ill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~  302 (373)
                      |+++.++   .+||+|||++.......  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.....
T Consensus       177 il~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~  252 (504)
T 3q5i_A          177 ILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQND  252 (504)
T ss_dssp             EEESSTTCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEecCCCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9998776   69999999998764332  2344579999999999863  478899999999999999999999754221


Q ss_pred             CCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          303 DGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                             .+...........   .....     ....+.++.+++.+||+.||.+|||+.++++
T Consensus       253 -------~~~~~~i~~~~~~---~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          253 -------QDIIKKVEKGKYY---FDFND-----WKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             -------HHHHHHHHHCCCC---CCHHH-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------HHHHHHHHcCCCC---CCccc-----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                   1112222111000   00000     0123458999999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6.2e-44  Score=317.94  Aligned_cols=252  Identities=24%  Similarity=0.415  Sum_probs=192.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEee----------
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS----------  149 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----------  149 (373)
                      .++|++.+.||+|+||.||+|... +++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            357888999999999999999764 7999999999543 2335678899999999999999999998865          


Q ss_pred             ---CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCce
Q 043074          150 ---GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV  226 (373)
Q Consensus       150 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Ni  226 (373)
                         ....++||||+++++|.+++.....              .+++..++.++.|++.||+|||  +++++||||||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dlkp~Ni  147 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENL--------------NQQRDEYWRLFRQILEALSYIH--SQGIIHRDLKPMNI  147 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCG--------------GGCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGE
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcccc--------------ccchHHHHHHHHHHHHHHHHHH--hCCeecccCCHHhE
Confidence               3567899999999999999986432              2788999999999999999999  78999999999999


Q ss_pred             EeCCCCceEEeeeccccccCCCC-------------CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhC
Q 043074          227 LLDSDFEAHISDFGLARRIDTSH-------------SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ  293 (373)
Q Consensus       227 ll~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g  293 (373)
                      +++.++.+||+|||++.......             ........||+.|+|||.+.+...++.++||||||+++|||++ 
T Consensus       148 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-  226 (303)
T 1zy4_A          148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-  226 (303)
T ss_dssp             EECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred             EEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence            99999999999999998654321             1122345689999999999866668899999999999999998 


Q ss_pred             CCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          294 IRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       294 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                        |+....      ...........       ....... ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus       227 --p~~~~~------~~~~~~~~~~~-------~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          227 --PFSTGM------ERVNILKKLRS-------VSIEFPP-DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             --CCSSHH------HHHHHHHHHHS-------TTCCCCT-TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --ccCCch------hHHHHHHhccc-------cccccCc-cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence              432210      01111111111       0111111 123444567899999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.2e-44  Score=348.12  Aligned_cols=257  Identities=24%  Similarity=0.337  Sum_probs=201.7

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC----CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS----SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      ..++|++.+.||+|+||.||+|...    .+..||+|.+...... ..+.+.+|+.++++++||||+++++++. .+..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            4567888999999999999999764    2457999998654333 3467899999999999999999999985 45689


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +||||+++|+|.+++.....              ++++..++.++.|++.||.|||  +++++||||||+|||++.++.+
T Consensus       467 lv~E~~~~g~L~~~l~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH--~~givHrDikp~NILl~~~~~v  530 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKF--------------SLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCV  530 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTT--------------TCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEE
T ss_pred             EEEEcCCCCcHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCccccccchHhEEEeCCCCE
Confidence            99999999999999986542              2899999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      ||+|||+++..............+|+.|+|||.+.+ ..++.++||||||+++|||++ |..||.....       .+..
T Consensus       531 kL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-------~~~~  602 (656)
T 2j0j_A          531 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVI  602 (656)
T ss_dssp             EECCCCCCCSCCC----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHH
T ss_pred             EEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-------HHHH
Confidence            999999998765443333334557789999999874 457889999999999999997 7777643211       1111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .......      ..     ..+..++..+.+++.+||+.||++|||+.++++.|++++
T Consensus       603 ~~i~~~~------~~-----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          603 GRIENGE------RL-----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             HHHHHTC------CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHcCC------CC-----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1111110      00     113345668999999999999999999999999999875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=323.01  Aligned_cols=261  Identities=28%  Similarity=0.432  Sum_probs=198.1

Q ss_pred             cChHHHHHhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEee
Q 043074           72 ISMSELIDATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCAS  149 (373)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  149 (373)
                      +...++....++|++.+.||+|+||.||+|.. .+++.||+|++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            33444555678999999999999999999976 4789999999865433 346788999999999 79999999999976


Q ss_pred             ------CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCC
Q 043074          150 ------GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKS  223 (373)
Q Consensus       150 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~  223 (373)
                            ....++||||+++++|.+++......             .+++..+..++.|++.||.|||  +.+++|+||||
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp  157 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-------------TLKEEWIAYICREILRGLSHLH--QHKVIHRDIKG  157 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGG-------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSG
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCcH
Confidence                  46789999999999999999865321             2899999999999999999999  78999999999


Q ss_pred             CceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCC
Q 043074          224 SNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLP  299 (373)
Q Consensus       224 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~  299 (373)
                      +||+++.++.+||+|||++........ ......||+.|+|||.+.+    ...++.++||||||+++|+|++|..|+..
T Consensus       158 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  236 (326)
T 2x7f_A          158 QNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  236 (326)
T ss_dssp             GGEEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             HHEEEcCCCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999986543221 2234568999999999863    34578899999999999999999999743


Q ss_pred             cccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...       ......... ..     .+...    ....+..+.+++.+||+.||.+||++.++++
T Consensus       237 ~~~-------~~~~~~~~~-~~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          237 MHP-------MRALFLIPR-NP-----APRLK----SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             SCH-------HHHHHHHHH-SC-----CCCCS----CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CcH-------HHHHHHhhc-Cc-----cccCC----ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            211       011111111 10     11111    1122458999999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.4e-44  Score=318.92  Aligned_cols=257  Identities=25%  Similarity=0.394  Sum_probs=194.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC--CCC--EEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS--SGV--TVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  153 (373)
                      .++|++.+.||+|+||.||+|.+.  ++.  .||+|++....   ....+.+.+|+.++++++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357889999999999999999753  333  68999986543   233567889999999999999999999998765 8


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++|+||+++++|.+++.....              .+++..+..++.|++.||.|||  +++++|+||||+||+++.++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nili~~~~~  159 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQG--------------HFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDL  159 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG--------------GSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTE
T ss_pred             eeeEecccCCCHHHHHHhccC--------------CcCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEEcCCCC
Confidence            899999999999999976432              2889999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHH
Q 043074          234 AHISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~  310 (373)
                      +||+|||++.........  ......+|..|+|||.+.+ ..++.++||||||+++|||++ |..||....       ..
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~  231 (291)
T 1u46_A          160 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GS  231 (291)
T ss_dssp             EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HH
T ss_pred             EEEccccccccccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCC-------HH
Confidence            999999999876543322  1223457788999999874 347889999999999999999 888864321       11


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ............     .     ..+..++..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       232 ~~~~~~~~~~~~-----~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          232 QILHKIDKEGER-----L-----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             HHHHHHHTSCCC-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHccCCC-----C-----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            111111111100     0     112334568999999999999999999999999998864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.8e-43  Score=314.01  Aligned_cols=251  Identities=25%  Similarity=0.398  Sum_probs=197.1

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+....  ..+.+.+|+.++..++||||+++++++.+....++|+|
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4568999999999999999999765 68999999996543  33678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++++|.+++.....              .+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.+||+|
T Consensus       105 ~~~~~~L~~~~~~~~~--------------~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~d  168 (314)
T 3com_A          105 YCGAGSVSDIIRLRNK--------------TLTEDEIATILQSTLKGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLAD  168 (314)
T ss_dssp             CCTTEEHHHHHHHHTC--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred             cCCCCCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCcCHHHEEECCCCCEEEee
Confidence            9999999999974332              2899999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||++........ ......||+.|+|||.+.+. .++.++||||||+++|+|++|..||.....       .........
T Consensus       169 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~  239 (314)
T 3com_A          169 FGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHP-------MRAIFMIPT  239 (314)
T ss_dssp             CTTCEECBTTBS-CBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHH
T ss_pred             cccchhhhhhcc-ccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHhc
Confidence            999987543221 23345689999999999754 478899999999999999999999753211       111111111


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      . .     .....   .+...+..+.+++.+||+.||.+|||+.++++
T Consensus       240 ~-~-----~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          240 N-P-----PPTFR---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             S-C-----CCCCS---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C-C-----CcccC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            1 0     01110   02223458999999999999999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.8e-44  Score=329.48  Aligned_cols=260  Identities=22%  Similarity=0.276  Sum_probs=181.9

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeC------
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASG------  150 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  150 (373)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            357899999999999999999975 5789999999965322  2346788999999999999999999998654      


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      ...++|+|++ +++|.+++....                +++..+..++.||+.||.|||  +.+++||||||+||+++.
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~~~----------------l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~  167 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKCQK----------------LTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNE  167 (367)
T ss_dssp             CCCEEEEECC-CEECC-----CC----------------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECT
T ss_pred             CeEEEEeccc-CCCHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHhhEEECC
Confidence            5679999999 789999886532                899999999999999999999  789999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH
Q 043074          231 DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  310 (373)
                      ++.+||+|||+++.....    .....||+.|+|||++.+...++.++|||||||++|||++|..||.......    ..
T Consensus       168 ~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~l  239 (367)
T 2fst_X          168 DCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID----QL  239 (367)
T ss_dssp             TCCEEECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH----HH
T ss_pred             CCCEEEeecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HH
Confidence            999999999999865322    3345789999999999876678999999999999999999999975422110    00


Q ss_pred             HHHHHHHHhc------cc--------ccccc--CccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 EWARTMEARN------KE--------IEMVD--SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ~~~~~~~~~~------~~--------~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..........      ..        .+.+.  +...........+..+.+++.+||+.||++|||+.++++
T Consensus       240 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          240 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            0000000000      00        00000  000000001123457899999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=328.81  Aligned_cols=208  Identities=23%  Similarity=0.341  Sum_probs=156.7

Q ss_pred             CCCC-CCeeecCCCceEEEEEeC---CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeEEE
Q 043074           83 NFST-DKIIGDGSFGFVYKAKLS---SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS--GLDRVLI  156 (373)
Q Consensus        83 ~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  156 (373)
                      .|.+ .++||+|+||.||+|..+   +++.||+|++......  ..+.+|+.++++++||||+++++++..  ....++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            4555 558999999999999865   5789999999765433  567899999999999999999999954  6789999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe----CCCC
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL----DSDF  232 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill----~~~~  232 (373)
                      |||+. ++|.+++........      .....++++..+..++.||+.||+|||  +.+|+||||||+|||+    +.++
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKA------NKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECCSSTTTT
T ss_pred             EeCCC-CCHHHHHHHhccccc------cccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeCCCcCHHHeEEecCCCCCC
Confidence            99995 688888764321100      001113899999999999999999999  7899999999999999    6778


Q ss_pred             ceEEeeeccccccCCCCC--cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcc
Q 043074          233 EAHISDFGLARRIDTSHS--HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVV  301 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  301 (373)
                      .+||+|||+++.......  .......||+.|+|||++.+...++.++|||||||++|||++|..||....
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            999999999987643221  223446789999999999876678999999999999999999999986443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-43  Score=326.99  Aligned_cols=269  Identities=23%  Similarity=0.267  Sum_probs=195.3

Q ss_pred             HHhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeC------
Q 043074           78 IDATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASG------  150 (373)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  150 (373)
                      ....++|++.+.||+|+||.||+|.. .+|+.||+|++......    ..+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999975 57999999998654322    24799999999999999999998443      


Q ss_pred             --------------------------------CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHH
Q 043074          151 --------------------------------LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI  198 (373)
Q Consensus       151 --------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i  198 (373)
                                                      ...++||||++ |+|.+.+.......           ..+++..+..+
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-----------~~l~~~~~~~i  146 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSG-----------RSIPMNLISIY  146 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTT-----------CCCCHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcC-----------CCCCHHHHHHH
Confidence                                            34789999997 58887776422111           13899999999


Q ss_pred             HHHHHHHHHHHhcCCCCceeecCCCCceEeC-CCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCcc
Q 043074          199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVM  277 (373)
Q Consensus       199 ~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~  277 (373)
                      +.|++.||+|||  +.+++||||||+||+++ .++.+||+|||+++......  ......+|+.|+|||.+.+...++.+
T Consensus       147 ~~qi~~aL~~LH--~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~  222 (383)
T 3eb0_A          147 IYQLFRAVGFIH--SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPS  222 (383)
T ss_dssp             HHHHHHHHHHHH--TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred             HHHHHHHHHHHH--HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcc
Confidence            999999999999  89999999999999997 68899999999998764332  23345689999999999876778999


Q ss_pred             ccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH-----HHHHHHhcccccccc-Cccc----cccCCHHHHHHHHHHH
Q 043074          278 LDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW-----ARTMEARNKEIEMVD-SNIS----REELSEAGVREYFRIA  347 (373)
Q Consensus       278 ~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~l~~l~  347 (373)
                      +||||+||++|||++|..||......+....+...     ............... +...    ...++...+.++.+++
T Consensus       223 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  302 (383)
T 3eb0_A          223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLL  302 (383)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHH
T ss_pred             hhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHH
Confidence            99999999999999999997543221110000000     000000000000000 0000    0111333456899999


Q ss_pred             HHhcCCCCCCCCCHHHHHH
Q 043074          348 CMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       348 ~~cl~~~p~~RPs~~~l~~  366 (373)
                      .+||+.||++|||+.|+++
T Consensus       303 ~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          303 EQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHCCSSGGGSCCHHHHHT
T ss_pred             HHHccCChhhCCCHHHHhc
Confidence            9999999999999999974

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.5e-44  Score=315.21  Aligned_cols=255  Identities=24%  Similarity=0.359  Sum_probs=200.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEe--eCCeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCA--SGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l  155 (373)
                      .++|++.+.||+|+||.||++... +++.||+|.+.....  ...+.+.+|+.++++++||||+++++++.  +....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            457889999999999999999765 789999999965432  23467889999999999999999999874  4678899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-----ceeecCCCCceEeCC
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP-----IIHRDIKSSNVLLDS  230 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~-----i~H~dlk~~Nill~~  230 (373)
                      ||||+++++|.+++.......           .++++..++.++.|++.||.|||  +.+     ++||||||+||+++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~~~ivH~dl~p~NIl~~~  151 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKER-----------QYLDEEFVLRVMTQLTLALKECH--RRSDGGHTVLHRDLKPANVFLDG  151 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHH--HHC------CCCCCSGGGEEECS
T ss_pred             EEeCCCCCCHHHHHHhhcccC-----------CCCCHHHHHHHHHHHHHHHHHHh--cccCCCCeeEEeccchhhEEEcC
Confidence            999999999999997643211           13899999999999999999999  666     999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH
Q 043074          231 DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  310 (373)
                      ++.+||+|||++....... .......||+.|+|||.+.+. .++.++||||||+++|+|++|..|+....       ..
T Consensus       152 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~  222 (279)
T 2w5a_A          152 KQNVKLGDFGLARILNHDT-SFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-------QK  222 (279)
T ss_dssp             SSCEEECCCCHHHHC---C-HHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HH
T ss_pred             CCCEEEecCchheeecccc-ccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccC-------HH
Confidence            9999999999998754322 122335689999999999754 47889999999999999999999965421       11


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLL  368 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L  368 (373)
                      ......... ..     ..     .+...+.++.+++.+||+.||++||++.++++.+
T Consensus       223 ~~~~~i~~~-~~-----~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          223 ELAGKIREG-KF-----RR-----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHHHHHHHT-CC-----CC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             HHHHHHhhc-cc-----cc-----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            111111111 10     01     1233456899999999999999999999998764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.3e-43  Score=327.96  Aligned_cols=264  Identities=22%  Similarity=0.256  Sum_probs=200.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCC--------CCCccceeeEEe---
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR--------HRNIVKILGYCA---  148 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~---  148 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            46899999999999999999975 468899999997542 23467889999999885        788999999987   


Q ss_pred             -eCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CceeecCCCCce
Q 043074          149 -SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEK-PIIHRDIKSSNV  226 (373)
Q Consensus       149 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~-~i~H~dlk~~Ni  226 (373)
                       ++...++||||+ +++|.+++......             .+++..+..++.||+.||.|||  ++ +|+||||||+||
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~-------------~~~~~~~~~i~~qi~~aL~~lH--~~~givHrDikp~NI  178 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQ-------------GLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENI  178 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTS-------------CCCHHHHHHHHHHHHHHHHHHH--HTTCEECCCCSGGGE
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccC-------------CCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCCHHHe
Confidence             556889999999 66777766654322             2899999999999999999999  67 999999999999


Q ss_pred             EeCCCC-------------------------------------------------ceEEeeeccccccCCCCCccccccc
Q 043074          227 LLDSDF-------------------------------------------------EAHISDFGLARRIDTSHSHVSTQVA  257 (373)
Q Consensus       227 ll~~~~-------------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~  257 (373)
                      |++.++                                                 .+||+|||++......    .....
T Consensus       179 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~  254 (397)
T 1wak_A          179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDI  254 (397)
T ss_dssp             EECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCC
T ss_pred             eEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCC
Confidence            999775                                                 7999999999875432    23456


Q ss_pred             ccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccc----------c-ccc
Q 043074          258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKE----------I-EMV  326 (373)
Q Consensus       258 g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~-~~~  326 (373)
                      ||+.|+|||++.+. .++.++|||||||++|||++|..||.+....................+..          . ...
T Consensus       255 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  333 (397)
T 1wak_A          255 QTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF  333 (397)
T ss_dssp             SCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred             CCCcccCChhhcCC-CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence            89999999999854 47889999999999999999999986644333211111111111100000          0 000


Q ss_pred             cCc-----c-------------ccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          327 DSN-----I-------------SREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       327 ~~~-----~-------------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...     +             .....+...+..+.+++.+||+.||++|||+.|+++
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000     0             001225677889999999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.3e-44  Score=348.66  Aligned_cols=243  Identities=23%  Similarity=0.278  Sum_probs=199.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  155 (373)
                      .++|++.+.||+|+||.||+|..+ +++.||||++.+..   ....+.+..|..++..+ +||||+++++++.+....++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            468899999999999999999765 68899999997532   22345678899999988 69999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||+++|+|.+++.....               +++..+..++.||+.||+|||  +++|+||||||+|||++.++.+|
T Consensus       420 V~E~~~gg~L~~~l~~~~~---------------~~~~~~~~~~~qi~~aL~~LH--~~gIiHrDLKp~NILl~~~g~ik  482 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGR---------------FKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIK  482 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--HTSEECCCCCSTTEEECSSSCEE
T ss_pred             EEeCcCCCcHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHH--hCCeEeccCChhhEEEcCCCcEE
Confidence            9999999999999987542               899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||+++...... .......||+.|+|||++.+ ..++.++||||||+++|||++|..||.....       .+....
T Consensus       483 L~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-------~~~~~~  553 (674)
T 3pfq_A          483 IADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQS  553 (674)
T ss_dssp             ECCCTTCEECCCTT-CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHH
T ss_pred             EeecceeeccccCC-cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCH-------HHHHHH
Confidence            99999998643222 23445789999999999975 4579999999999999999999999754211       111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                      ...         ...   .++...+.++.+++.+||+.||++||++
T Consensus       554 i~~---------~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          554 IME---------HNV---AYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             HHS---------SCC---CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             HHh---------CCC---CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence            111         000   1133345689999999999999999998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.1e-43  Score=312.87  Aligned_cols=253  Identities=21%  Similarity=0.323  Sum_probs=202.1

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---------ccHHHHHHHHHHHhcCC-CCCccceeeEEe
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---------QGFREFRAEMETLGKLR-HRNIVKILGYCA  148 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~  148 (373)
                      ..++|++.+.||+|+||.||+|... +++.||+|++.....         ...+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999765 689999999865431         12356789999999995 999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe
Q 043074          149 SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL  228 (373)
Q Consensus       149 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill  228 (373)
                      +....++||||+++++|.+++....               .+++..+..++.|++.||.|||  +.+++|+||||+||++
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~  157 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV---------------TLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILL  157 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEE
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEE
Confidence            9999999999999999999997643               2899999999999999999999  7899999999999999


Q ss_pred             CCCCceEEeeeccccccCCCCCcccccccccccccCccccC-----CCCCCCccccchhhhHHHHHHHhCCCCCCCcccC
Q 043074          229 DSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG-----GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLD  303 (373)
Q Consensus       229 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~  303 (373)
                      +.++.+||+|||++.......  ......|++.|+|||.+.     ....++.++||||||+++|||++|..|+....  
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--  233 (298)
T 1phk_A          158 DDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--  233 (298)
T ss_dssp             CTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred             cCCCcEEEecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--
Confidence            999999999999998764332  233456899999999875     23457889999999999999999999975321  


Q ss_pred             CCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          304 GQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                           ..............   ..    ... ....+..+.+++.+||+.||++|||+.++++
T Consensus       234 -----~~~~~~~~~~~~~~---~~----~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          234 -----QMLMLRMIMSGNYQ---FG----SPE-WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -----HHHHHHHHHHTCCC---CC----TTT-GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -----HHHHHHHHhcCCcc---cC----ccc-ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                 11111111111100   00    000 1234568999999999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.7e-43  Score=322.22  Aligned_cols=263  Identities=21%  Similarity=0.263  Sum_probs=197.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeC-----Cee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASG-----LDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  153 (373)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+...... ....+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999765 6899999999654332 345678999999999999999999988654     678


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++|+||+. ++|.+++....                +++..+..++.|++.||.|||  +++++||||||+||+++.++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~~~----------------~~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~Nil~~~~~~  150 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQM----------------LSDDHIQYFIYQTLRAVKVLH--GSNVIHRDLKPSNLLINSNCD  150 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHCC----------------CCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCC
T ss_pred             EEEEeccC-ccHHHHHhhcC----------------CCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEcCCCc
Confidence            99999996 69999987632                899999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCCc---------ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCC
Q 043074          234 AHISDFGLARRIDTSHSH---------VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDG  304 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  304 (373)
                      +||+|||++.........         ......||+.|+|||++.+...++.++||||||+++|||++|..||.......
T Consensus       151 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  230 (353)
T 2b9h_A          151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH  230 (353)
T ss_dssp             EEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            999999999876432211         11234689999999988765678999999999999999999999975432110


Q ss_pred             CcccHHHHHHHHHHhcc---ccc------------ccc--CccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          305 QEVGLLEWARTMEARNK---EIE------------MVD--SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       305 ~~~~~~~~~~~~~~~~~---~~~------------~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                          .............   ...            .+.  +...........+..+.+++.+||+.||++|||+.++++
T Consensus       231 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          231 ----QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             ----HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                0000000000000   000            000  000000001234568899999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=318.73  Aligned_cols=265  Identities=23%  Similarity=0.240  Sum_probs=193.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEe-----------
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCA-----------  148 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-----------  148 (373)
                      .++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999775 58999999997766566678899999999999999999999873           


Q ss_pred             ---eCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCc
Q 043074          149 ---SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSN  225 (373)
Q Consensus       149 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~N  225 (373)
                         +....++|+||++ |+|.+++....                +++..+..++.|++.||+|||  +++++||||||+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------------~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~N  150 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQGP----------------LLEEHARLFMYQLLRGLKYIH--SANVLHRDLKPAN  150 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTCC----------------CCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGG
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcCC----------------ccHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHH
Confidence               3467899999996 69999986432                889999999999999999999  7899999999999


Q ss_pred             eEeC-CCCceEEeeeccccccCCCCC--cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCccc
Q 043074          226 VLLD-SDFEAHISDFGLARRIDTSHS--HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVL  302 (373)
Q Consensus       226 ill~-~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~  302 (373)
                      |+++ +++.+||+|||+++.......  .......+|..|+|||.+.+...++.++||||||+++|||++|..||.....
T Consensus       151 il~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  230 (320)
T 2i6l_A          151 LFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE  230 (320)
T ss_dssp             EEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence            9997 567999999999987643221  1223345789999999987656789999999999999999999999754321


Q ss_pred             CCCcccHH--------HHHHHHHHhcccccccc-----CccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          303 DGQEVGLL--------EWARTMEARNKEIEMVD-----SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       303 ~~~~~~~~--------~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ........        ........  .....+.     +...........+.++.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          231 LEQMQLILESIPVVHEEDRQELLS--VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHHHHHSCCCCHHHHHHHHT--TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHhcCCCchhhhhhhhh--cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            11000000        00000000  0000000     000000011224568999999999999999999999976

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7.1e-44  Score=320.52  Aligned_cols=252  Identities=25%  Similarity=0.307  Sum_probs=194.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--------ccHHHHHHHHHHHhcCCCCCccceeeEEeeCC
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--------QGFREFRAEMETLGKLRHRNIVKILGYCASGL  151 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  151 (373)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+.....        .....+.+|+.++++++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            357899999999999999999764 688999999865432        11235789999999999999999999987655


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                       .++||||+++++|.+++....               .+++..+..++.|++.||.|||  +++++||||||+||+++.+
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~  150 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNK---------------RLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQ  150 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTC---------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSS
T ss_pred             -eEEEEecCCCCcHHHHHhccC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEecC
Confidence             899999999999999987543               2899999999999999999999  7899999999999999876


Q ss_pred             Cc---eEEeeeccccccCCCCCcccccccccccccCccccC--CCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          232 FE---AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG--GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       232 ~~---~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                      +.   +||+|||++......  .......||+.|+|||.+.  +...++.++||||||+++|+|++|..||.......  
T Consensus       151 ~~~~~~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--  226 (322)
T 2ycf_A          151 EEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--  226 (322)
T ss_dssp             SSSCCEEECCCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--
T ss_pred             CCCCeEEEccCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--
Confidence            64   999999999875432  2223456899999999973  34557889999999999999999999975432221  


Q ss_pred             ccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       .+....   .. ....  ..+..     ....+..+.+++.+||+.||++||++.++++
T Consensus       227 -~~~~~~---~~-~~~~--~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          227 -SLKDQI---TS-GKYN--FIPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -CHHHHH---HH-TCCC--CCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HHHHHH---Hh-Cccc--cCchh-----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             111111   10 0000  00000     1123458999999999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.3e-44  Score=316.07  Aligned_cols=254  Identities=23%  Similarity=0.333  Sum_probs=185.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccccc--HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.......  .+.+.++...++.++||||+++++++.++...++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46788999999999999999976 578999999997643322  233445555688889999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CceeecCCCCceEeCCCCceEE
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEK-PIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~-~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      ||++ |+|.+++.......           .++++..+..++.|++.||+|||  ++ +++||||||+||+++.++.+||
T Consensus        86 e~~~-~~l~~~l~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH--~~~~i~H~dlkp~Nil~~~~~~~kl  151 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKG-----------QTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKM  151 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHH--HHSCCCCCCCSGGGCEECTTCCEEB
T ss_pred             ehhc-cchHHHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEEE
Confidence            9996 58888776521110           13899999999999999999999  66 9999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccC---CCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG---GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +|||++.......  ......||+.|+|||.+.   ....++.++||||||+++|||++|..|+.....     ......
T Consensus       152 ~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~  224 (290)
T 3fme_A          152 CDFGISGYLVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----PFQQLK  224 (290)
T ss_dssp             CCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----HHHHHH
T ss_pred             eecCCcccccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----hHHHHH
Confidence            9999998754322  223346899999999973   345678899999999999999999999743211     111111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       .....      ......    ....+.++.+++.+||+.||++|||+.++++
T Consensus       225 -~~~~~------~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          225 -QVVEE------PSPQLP----ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -HHHHS------CCCCCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -HHhcc------CCCCcc----cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence             11111      011111    1223458999999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.3e-43  Score=327.13  Aligned_cols=263  Identities=24%  Similarity=0.264  Sum_probs=192.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe------eE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLD------RV  154 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~  154 (373)
                      ..+|+..+.||+|+||.||+|...++..+|+|++......    ..+|+.+++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            3578999999999999999999877777999988543322    2369999999999999999999855433      78


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC-CCCc
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD-SDFE  233 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~-~~~~  233 (373)
                      +||||++++.+..........            ..+++..+..++.|++.||+|||  +.+|+||||||+|||++ .++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~  180 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLK------------QTMPMLLIKLYMYQLLRSLAYIH--SIGICHRDIKPQNLLLDPPSGV  180 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTT------------SCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTE
T ss_pred             EEeeccCccHHHHHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEcCCCCc
Confidence            999999765444333221111            13899999999999999999999  78999999999999998 7999


Q ss_pred             eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          234 AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +||+|||+++......  ......||+.|+|||.+.+...++.++|||||||++|||++|..||.......   .+....
T Consensus       181 ~kL~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~i~  255 (394)
T 4e7w_A          181 LKLIDFGSAKILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVEII  255 (394)
T ss_dssp             EEECCCTTCEECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred             EEEeeCCCcccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence            9999999998764332  22345689999999999877678999999999999999999999975432111   111111


Q ss_pred             HH--------HHHhccc-cccccCccc----cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          314 RT--------MEARNKE-IEMVDSNIS----REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       314 ~~--------~~~~~~~-~~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..        ....... ....-+...    ...+....+.++.+++.+||+.||++|||+.++++
T Consensus       256 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          256 KVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            10        0000000 000000000    00112224568999999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.4e-43  Score=322.98  Aligned_cols=256  Identities=22%  Similarity=0.272  Sum_probs=194.8

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCee---
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDR---  153 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---  153 (373)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|++......  ..+.+.+|+.+++.++||||+++++++......   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            4578999999999999999999754 7899999999764332  246788999999999999999999999877654   


Q ss_pred             ---EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          154 ---VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       154 ---~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                         ++||||+. ++|.+++..                 .+++..+..++.|++.||+|||  +.+++||||||+||+++.
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~-----------------~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~  179 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM-----------------EFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNE  179 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS-----------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECT
T ss_pred             eeEEEEEcccc-ccHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCcCHHHeEECC
Confidence               99999996 688887732                 2889999999999999999999  789999999999999999


Q ss_pred             CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH
Q 043074          231 DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  310 (373)
                      ++.+||+|||+++.....    .....||+.|+|||.+.+...++.++||||||+++|||++|..||......       
T Consensus       180 ~~~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------  248 (371)
T 4exu_A          180 DCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-------  248 (371)
T ss_dssp             TCCEEECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-------
T ss_pred             CCCEEEEecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-------
Confidence            999999999999865322    234568999999999987567899999999999999999999997542211       


Q ss_pred             HHHHHHHH-hccc----------------cccccCcccc--ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 EWARTMEA-RNKE----------------IEMVDSNISR--EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ~~~~~~~~-~~~~----------------~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      +....... .+..                ...+......  .......+..+.+++.+||+.||++|||+.++++
T Consensus       249 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          249 DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            11000000 0000                0000000000  0001223568999999999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.9e-43  Score=329.28  Aligned_cols=198  Identities=23%  Similarity=0.293  Sum_probs=168.7

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcC------CCCCccceeeEEeeCCe
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKL------RHRNIVKILGYCASGLD  152 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~  152 (373)
                      ...+|++.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.+++.+      +|+||+++++++.....
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            3468999999999999999999654 68999999997543 2235667788877776      57899999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++||||+. ++|.+++......             .+++..+..++.||+.||+|||  +.+|+||||||+|||++.++
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~-------------~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NILl~~~~  237 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQ-------------GFSLPLVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQG  237 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTC-------------CCCHHHHHHHHHHHHHHHHHHH--HHTEECSCCSGGGEEESSTT
T ss_pred             EEEEEeccC-CCHHHHHHhccCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEccCC
Confidence            999999995 7999999876533             2899999999999999999999  78999999999999999988


Q ss_pred             c--eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCC
Q 043074          233 E--AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP  299 (373)
Q Consensus       233 ~--~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  299 (373)
                      .  +||+|||++......    .....||+.|+|||++.+. .++.++|||||||++|||++|..||..
T Consensus       238 ~~~vkL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          238 RSGIKVIDFGSSCYEHQR----VYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             SCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CcceEEeecccceecCCc----ccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence            7  999999999764322    2345789999999999854 478999999999999999999988654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.8e-44  Score=326.80  Aligned_cols=253  Identities=12%  Similarity=0.060  Sum_probs=179.2

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHHHHH---HHHhcCCCCCcccee-------eEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFRAEM---ETLGKLRHRNIVKIL-------GYC  147 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~-------~~~  147 (373)
                      .+|...+.||+|+||.||+|... +++.||+|++.....   ...+.+.+|+   ..++. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            45888999999999999999764 789999999976543   2345677785   45555 799988755       444


Q ss_pred             eeC-----------------CeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHH------HHHHHHHHH
Q 043074          148 ASG-----------------LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR------VKIVRGVAN  204 (373)
Q Consensus       148 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~------~~i~~qi~~  204 (373)
                      ...                 ...++||||++ |+|.+++......              +.+..+      ..++.||+.
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--------------~~~~~~~~~~vk~~i~~qi~~  205 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--------------YVFRGDEGILALHILTAQLIR  205 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--------------cchhhhhhhhhHHHHHHHHHH
Confidence            332                 33799999998 8999999875321              444555      778899999


Q ss_pred             HHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCC-CCCCCccccchhh
Q 043074          205 GLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG-NTAATVMLDVYSF  283 (373)
Q Consensus       205 ~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Diwsl  283 (373)
                      ||+|||  +++|+||||||+|||++.++.+||+|||+++.....    .....+|+.|+|||.+.+ ...++.++|||||
T Consensus       206 aL~~LH--~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl  279 (371)
T 3q60_A          206 LAANLQ--SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQL  279 (371)
T ss_dssp             HHHHHH--HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred             HHHHHH--HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence            999999  789999999999999999999999999999875321    213456799999999974 2457999999999


Q ss_pred             hHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 043074          284 GILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSY  363 (373)
Q Consensus       284 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~  363 (373)
                      ||++|||++|..||...........         ................. ...++..+.+++.+||+.||++|||+.+
T Consensus       280 G~il~elltg~~Pf~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~e  349 (371)
T 3q60_A          280 GLSIYRVWCLFLPFGLVTPGIKGSW---------KRPSLRVPGTDSLAFGS-CTPLPDFVKTLIGRFLNFDRRRRLLPLE  349 (371)
T ss_dssp             HHHHHHHHHSSCSTTBCCTTCTTCC---------CBCCTTSCCCCSCCCTT-SSCCCHHHHHHHHHHTCSSTTTCCCHHH
T ss_pred             HHHHHHHHhCCCCCCCcCcccccch---------hhhhhhhccccccchhh-ccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            9999999999999765432211100         00000000011111111 1234568999999999999999999999


Q ss_pred             HHH
Q 043074          364 VVQ  366 (373)
Q Consensus       364 l~~  366 (373)
                      +++
T Consensus       350 ~l~  352 (371)
T 3q60_A          350 AME  352 (371)
T ss_dssp             HTT
T ss_pred             Hhc
Confidence            874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.9e-43  Score=319.58  Aligned_cols=263  Identities=24%  Similarity=0.241  Sum_probs=188.7

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCC------
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGL------  151 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  151 (373)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999754 689999999865322  23456889999999999999999999997654      


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..++||||++ ++|.+++..                 .+++..+..++.|++.||.|||  +++++||||||+||+++.+
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~-----------------~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIl~~~~  163 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM-----------------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSD  163 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS-----------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTT
T ss_pred             ceEEEEEcCC-CCHHHHHhh-----------------ccCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCC
Confidence            7899999996 578888752                 1889999999999999999999  7899999999999999999


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH--
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL--  309 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~--  309 (373)
                      +.+||+|||+++......  ......||+.|+|||++.+. .++.++|||||||++|||++|..||...........+  
T Consensus       164 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~  240 (371)
T 2xrw_A          164 CTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE  240 (371)
T ss_dssp             SCEEECCCCC------------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC
T ss_pred             CCEEEEEeeccccccccc--ccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999998654321  23345789999999999854 5788999999999999999999997543211000000  


Q ss_pred             ------HH-------HHHHHHHhcccccc-----ccCcccc---ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 ------LE-------WARTMEARNKEIEM-----VDSNISR---EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 ------~~-------~~~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                            .+       ..............     ..+....   .......+..+.+++.+||+.||++|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          241 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             -CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                  00       00000000000000     0000000   0011234678999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.2e-43  Score=322.22  Aligned_cols=274  Identities=23%  Similarity=0.284  Sum_probs=189.6

Q ss_pred             HHHHHhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe-
Q 043074           75 SELIDATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLD-  152 (373)
Q Consensus        75 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-  152 (373)
                      .+.....++|++.+.||+|+||.||+|... +++.||||++...... .....+++..+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            345566789999999999999999999764 6899999998554322 2455678888899999999999999866443 


Q ss_pred             ------eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCce
Q 043074          153 ------RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV  226 (373)
Q Consensus       153 ------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Ni  226 (373)
                            .++||||+++ +|...+......           ...+++..+..++.|++.||.|||..+++++||||||+||
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-----------~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NI  162 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRR-----------QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNV  162 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTT-----------TCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhc-----------ccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHE
Confidence                  7899999975 555544321111           1138899999999999999999995458899999999999


Q ss_pred             EeCC-CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCC
Q 043074          227 LLDS-DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ  305 (373)
Q Consensus       227 ll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~  305 (373)
                      |++. ++.+||+|||+++......  ......||+.|+|||++.+...++.++|||||||++|||++|..||....... 
T Consensus       163 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-  239 (360)
T 3e3p_A          163 LVNEADGTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-  239 (360)
T ss_dssp             EEETTTTEEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred             EEeCCCCcEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-
Confidence            9996 8999999999998765332  22345689999999999776668999999999999999999999975432211 


Q ss_pred             cccHHHHHHH-----------HHHhccccccccCc-cc----cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          306 EVGLLEWART-----------MEARNKEIEMVDSN-IS----REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       306 ~~~~~~~~~~-----------~~~~~~~~~~~~~~-~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                        .+......           .............. ..    ........+.++.+++.+||+.||.+|||+.|+++
T Consensus       240 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          240 --QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             --HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence              11111110           00000000000000 00    00011224678999999999999999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.1e-44  Score=320.18  Aligned_cols=261  Identities=20%  Similarity=0.328  Sum_probs=197.2

Q ss_pred             ccChHHHHHhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCC--CCCccceeeE
Q 043074           71 QISMSELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLR--HRNIVKILGY  146 (373)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~l~~~  146 (373)
                      .+.++.+....++|++.+.||+|+||.||++...+++.||+|.+.....  ...+.+.+|+.++.+++  ||||++++++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            3344444445678999999999999999999888899999999865432  33567889999999997  5999999999


Q ss_pred             EeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCce
Q 043074          147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV  226 (373)
Q Consensus       147 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Ni  226 (373)
                      +.+....++||| +.+++|.+++....               ++++..+..++.|++.||.|||  +.+++||||||+||
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NI  158 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKKK---------------SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANF  158 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHCS---------------SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGE
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccE
Confidence            999999999999 55889999998654               2899999999999999999999  78999999999999


Q ss_pred             EeCCCCceEEeeeccccccCCCCCc-ccccccccccccCccccCCC----------CCCCccccchhhhHHHHHHHhCCC
Q 043074          227 LLDSDFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGN----------TAATVMLDVYSFGILMIEIATQIR  295 (373)
Q Consensus       227 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~----------~~~~~~~DiwslG~~l~el~~g~~  295 (373)
                      ++++ +.+||+|||++......... ......||+.|+|||.+.+.          ..++.++||||||+++|||++|..
T Consensus       159 l~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~  237 (313)
T 3cek_A          159 LIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT  237 (313)
T ss_dssp             EEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             EEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCC
Confidence            9964 89999999999876433221 22345689999999998641          357889999999999999999999


Q ss_pred             CCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          296 PNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       296 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ||.....      ..........         ..... ..+...+..+.+++.+||+.||++||++.++++
T Consensus       238 pf~~~~~------~~~~~~~~~~---------~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          238 PFQQIIN------QISKLHAIID---------PNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             TTTTCCS------HHHHHHHHHC---------TTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhHHH------HHHHHHHHHh---------ccccc-CCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            9743211      1111111111         00000 012222457999999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.4e-43  Score=308.43  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=201.6

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ...++|++.+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+....++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34568999999999999999999775 789999999865432  345678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC---C
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD---F  232 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~---~  232 (373)
                      |+||+++++|.+++....               .+++.+++.++.|++.||.|||  +.+++|+||||+||+++.+   +
T Consensus        99 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIlv~~~~~~~  161 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK---------------RFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDC  161 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTC
T ss_pred             EEEccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChhhEEEecCCCcc
Confidence            999999999999887643               2899999999999999999999  7899999999999999764   4


Q ss_pred             ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      .+||+|||++.......  ......+|+.|+|||.+.+  .++.++||||||+++|+|++|..|+....       ....
T Consensus       162 ~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~  230 (287)
T 2wei_A          162 DIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN-------EYDI  230 (287)
T ss_dssp             CEEECSTTGGGTBCCCS--SCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHH
T ss_pred             cEEEeccCcceeecCCC--ccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCC-------HHHH
Confidence            69999999998764332  2233458899999999875  37889999999999999999999975421       1112


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..........     .....   ....+..+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~-----~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          231 LKRVETGKYA-----FDLPQ---WRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHHHHCCCC-----CCSGG---GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCC-----CCchh---hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            2222111100     00000   1123457999999999999999999999987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.8e-43  Score=326.51  Aligned_cols=262  Identities=26%  Similarity=0.288  Sum_probs=191.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeC------CeeE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASG------LDRV  154 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~  154 (373)
                      .+|+..+.||+|+||.||+|... +++.||||++.....    ...+|+++++.++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999875 689999999865432    234799999999999999999988542      2367


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC-Cc
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-FE  233 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~-~~  233 (373)
                      +||||+++ +|.+.+......           ...+++..+..++.||+.||+|||  +++|+||||||+|||++.+ +.
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NILl~~~~~~  195 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRA-----------KQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAV  195 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHT-----------TCCCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEEETTTTE
T ss_pred             eehhcccc-cHHHHHHHHhhc-----------cCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChhhEEEeCCCCe
Confidence            89999965 676666532111           013899999999999999999999  7999999999999999965 56


Q ss_pred             eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          234 AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +||+|||+++......  ......||+.|+|||++.+...++.++|||||||++|||++|..||......   ..+....
T Consensus       196 ~kl~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~  270 (420)
T 1j1b_A          196 LKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEII  270 (420)
T ss_dssp             EEECCCTTCEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH
T ss_pred             EEeccchhhhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH
Confidence            8999999998764322  2234578999999999976667899999999999999999999997543211   1111111


Q ss_pred             HH--------HHHhccccccc-cCccccc----cCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          314 RT--------MEARNKEIEMV-DSNISRE----ELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       314 ~~--------~~~~~~~~~~~-~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..        ..........+ .+.+...    .+....+.++.+|+.+||+.||.+||++.|+++
T Consensus       271 ~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          271 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            11        00000000000 0000000    012233568999999999999999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.8e-43  Score=318.70  Aligned_cols=260  Identities=17%  Similarity=0.247  Sum_probs=199.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe--CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCC------CccceeeEEeeCCe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL--SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHR------NIVKILGYCASGLD  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~~  152 (373)
                      .++|++.+.||+|+||.||+|..  .+++.||+|++.... ...+.+.+|+.+++.++|+      +++++++++.+...
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999976  368899999996543 2346678899998888655      59999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC--
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS--  230 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~--  230 (373)
                      .++||||+ +++|.+++......             ++++.++..++.|++.||+|||  +++++||||||+||+++.  
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~  155 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFL-------------PFRLDHIRKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSD  155 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTC-------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCCC
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCC-------------CCcHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHEEEeccc
Confidence            99999999 89999999875432             3889999999999999999999  789999999999999987  


Q ss_pred             -----------------CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhC
Q 043074          231 -----------------DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ  293 (373)
Q Consensus       231 -----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g  293 (373)
                                       ++.+||+|||++......    .....||+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g  230 (339)
T 1z57_A          156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLG  230 (339)
T ss_dssp             EEEEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHS
T ss_pred             cccccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhC
Confidence                             668999999999864322    2345789999999999754 478899999999999999999


Q ss_pred             CCCCCCcccCCCcccHHHHHHHHH--------Hhccccc---------------------cccCccccccCCHHHHHHHH
Q 043074          294 IRPNLPVVLDGQEVGLLEWARTME--------ARNKEIE---------------------MVDSNISREELSEAGVREYF  344 (373)
Q Consensus       294 ~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~---------------------~~~~~~~~~~~~~~~~~~l~  344 (373)
                      ..||.......    .........        .......                     ...............+..+.
T Consensus       231 ~~pf~~~~~~~----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  306 (339)
T 1z57_A          231 FTVFPTHDSKE----HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLF  306 (339)
T ss_dssp             SCSCCCSCHHH----HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred             CCCCCCCChHH----HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHH
Confidence            99975432111    000000000        0000000                     00000000112345678899


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHH
Q 043074          345 RIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       345 ~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      +++.+||+.||.+|||+.|+++
T Consensus       307 ~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          307 DLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHhCcCcccccCHHHHhc
Confidence            9999999999999999999985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.1e-43  Score=316.89  Aligned_cols=264  Identities=23%  Similarity=0.287  Sum_probs=196.8

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe--CCCCEEEEEEeCccccc--cHHHHHHHHHHHhcC---CCCCccceeeEEe----
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL--SSGVTVAIKKLDKDAFQ--GFREFRAEMETLGKL---RHRNIVKILGYCA----  148 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~~~~~----  148 (373)
                      ..++|++.+.||+|+||.||+|..  .+++.||+|++......  ....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            456899999999999999999987  46889999998643321  123456777776666   8999999999987    


Q ss_pred             -eCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceE
Q 043074          149 -SGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVL  227 (373)
Q Consensus       149 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nil  227 (373)
                       .....++|+||+. |+|.+++......             .+++..+..++.|++.||.|||  +.+++||||||+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH--~~gi~H~dlkp~Nil  152 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEP-------------GVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNIL  152 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTT-------------CSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEE
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHHHeE
Confidence             5567899999996 6999999876432             2899999999999999999999  789999999999999


Q ss_pred             eCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcc
Q 043074          228 LDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEV  307 (373)
Q Consensus       228 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  307 (373)
                      ++.++.+||+|||++......  .......||+.|+|||.+.+. .++.++||||||+++|||++|..||......    
T Consensus       153 i~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  225 (326)
T 1blx_A          153 VTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDV----  225 (326)
T ss_dssp             ECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----
T ss_pred             EcCCCCEEEecCcccccccCC--CCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHH----
Confidence            999999999999999765322  223345789999999999754 4788999999999999999999997543211    


Q ss_pred             cHHHHHHHHHHhccc---cc-------ccc--CccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          308 GLLEWARTMEARNKE---IE-------MVD--SNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       308 ~~~~~~~~~~~~~~~---~~-------~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...............   ..       ...  ............+..+.+++.+||+.||++|||+.++++
T Consensus       226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          226 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            111111000000000   00       000  000001112334568999999999999999999999984

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9.1e-43  Score=319.70  Aligned_cols=264  Identities=22%  Similarity=0.234  Sum_probs=197.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-----------CCCccceeeEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-----------HRNIVKILGYCA  148 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~  148 (373)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35899999999999999999976 578999999997543 23456788999988886           899999999987


Q ss_pred             eCC----eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CceeecCCC
Q 043074          149 SGL----DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEK-PIIHRDIKS  223 (373)
Q Consensus       149 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~-~i~H~dlk~  223 (373)
                      ...    ..++|+||+ +++|.+++......             .+++..+..++.||+.||+|||  ++ +++||||||
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-------------~~~~~~~~~i~~qi~~aL~~lH--~~~~ivH~Dikp  160 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHR-------------GIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKP  160 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTS-------------CCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSG
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhcc-------------CCcHHHHHHHHHHHHHHHHHHH--hcCCEEecCCCh
Confidence            654    789999999 99999999875432             2899999999999999999999  66 999999999


Q ss_pred             CceEeC------CCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCC
Q 043074          224 SNVLLD------SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPN  297 (373)
Q Consensus       224 ~Nill~------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  297 (373)
                      +|||++      ..+.+||+|||++......    .....||+.|+|||++.+. .++.++||||||+++|||++|..||
T Consensus       161 ~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf  235 (373)
T 1q8y_A          161 ENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLF  235 (373)
T ss_dssp             GGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             HHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCC
Confidence            999994      4458999999999875432    2345689999999999854 4789999999999999999999997


Q ss_pred             CCcccCCCcccHHHHHHHHHHhccc--------------------cccccCc---------cccccCCHHHHHHHHHHHH
Q 043074          298 LPVVLDGQEVGLLEWARTMEARNKE--------------------IEMVDSN---------ISREELSEAGVREYFRIAC  348 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~---------~~~~~~~~~~~~~l~~l~~  348 (373)
                      ......................+..                    ...+...         ......+...+.++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  315 (373)
T 1q8y_A          236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS  315 (373)
T ss_dssp             ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred             CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence            6543221111110000000000000                    0000000         0011235678889999999


Q ss_pred             HhcCCCCCCCCCHHHHHH
Q 043074          349 MCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       349 ~cl~~~p~~RPs~~~l~~  366 (373)
                      +||+.||++|||+.++++
T Consensus       316 ~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          316 PMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             GGGCSSTTTCBCHHHHHT
T ss_pred             HHhccCccccCCHHHHhh
Confidence            999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=9.1e-43  Score=314.00  Aligned_cols=258  Identities=24%  Similarity=0.302  Sum_probs=177.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHH-HHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEME-TLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .++|...+.||+|+||.||+|... +++.||+|++...... ....+..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            468899999999999999999774 7899999999654332 2345556665 677789999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CceeecCCCCceEeCCCCceEE
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEK-PIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~-~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      ||++ ++|.+++.......          ...+++..+..++.|++.||.|||  +. +++||||||+||+++.++.+||
T Consensus       101 e~~~-~~l~~~~~~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH--~~~~ivH~dlkp~NIll~~~~~~kl  167 (327)
T 3aln_A          101 ELMS-TSFDKFYKYVYSVL----------DDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKL  167 (327)
T ss_dssp             CCCS-EEHHHHHHHHHHTT----------CCCCCHHHHHHHHHHHHHHHHHHH--HHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred             eecC-CChHHHHHHHHhhh----------cccCcHHHHHHHHHHHHHHHHHHh--ccCCEeECCCCHHHEEEcCCCCEEE
Confidence            9996 58888776421100          013899999999999999999999  67 9999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccC---CCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG---GNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +|||+++......  ......||+.|+|||.+.   ....++.++||||||+++|||++|..|+........        
T Consensus       168 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------  237 (327)
T 3aln_A          168 CDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--------  237 (327)
T ss_dssp             CCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------
T ss_pred             ccCCCceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--------
Confidence            9999998654322  223346899999999984   234578899999999999999999999754221100        


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                          ..........+.+.... ...++..+.+++.+||+.||++||++.++++
T Consensus       238 ----~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          238 ----QLTQVVKGDPPQLSNSE-EREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ------CCCCCSCCCCCCCCS-SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----HHHHHhcCCCCCCCCcc-cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                00111111111111110 1234568999999999999999999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=316.16  Aligned_cols=255  Identities=22%  Similarity=0.265  Sum_probs=194.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCe-----
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLD-----  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  152 (373)
                      .++|...+.||+|+||.||+|... +|+.||+|++......  ..+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            468999999999999999999764 7899999999654322  24578899999999999999999999977654     


Q ss_pred             -eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          153 -RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       153 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                       .++||||+. ++|.+++..                 .+++..+..++.|++.||.|||  +++++||||||+||+++.+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-----------------~~~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~NIl~~~~  162 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-----------------KFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNED  162 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-----------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTT
T ss_pred             eEEEEecccc-CCHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEeECCC
Confidence             499999996 688877642                 2889999999999999999999  7899999999999999999


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +.+||+|||++......    .....+|+.|+|||.+.+...++.++||||||+++|||++|..||......       +
T Consensus       163 ~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~  231 (353)
T 3coi_A          163 CELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-------D  231 (353)
T ss_dssp             CCEEECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-------H
T ss_pred             CcEEEeecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H
Confidence            99999999999864322    234568999999999986567889999999999999999999997543211       1


Q ss_pred             HHHHHHH-hccc----------------cccccCcc--ccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEA-RNKE----------------IEMVDSNI--SREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~-~~~~----------------~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....... .+..                ...+....  .........+..+.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          232 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000000 0000                00000000  001112234568999999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7.2e-43  Score=315.58  Aligned_cols=252  Identities=20%  Similarity=0.294  Sum_probs=171.2

Q ss_pred             cCCCCCC-CeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEee----CCeeE
Q 043074           81 TDNFSTD-KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS----GLDRV  154 (373)
Q Consensus        81 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  154 (373)
                      .++|.+. +.||+|+||.||+|... +++.||+|++....    ....+....++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            4578885 46999999999999765 79999999986532    122223334666799999999999876    44589


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC---C
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---D  231 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~---~  231 (373)
                      +||||+++|+|.+++......             .+++.+++.++.|++.||.|||  +++++||||||+||+++.   +
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~-------------~l~~~~~~~i~~ql~~~l~~LH--~~~ivH~dlkp~NIll~~~~~~  167 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQ-------------AFTEREAAEIMRDIGTAIQFLH--SHNIAHRDVKPENLLYTSKEKD  167 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CC-------------CCBHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTT
T ss_pred             EEEeccCCCCHHHHHHhcCCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEEecCCC
Confidence            999999999999999865432             2899999999999999999999  789999999999999976   4


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +.+||+|||++......   ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||..............
T Consensus       168 ~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  243 (336)
T 3fhr_A          168 AVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR  243 (336)
T ss_dssp             CCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred             ceEEEeccccceecccc---ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH
Confidence            55999999999865422   2234568999999999864 4578899999999999999999999754332211100000


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                         ...       .......... ...++..+.+++.+||+.||++|||+.++++
T Consensus       244 ---~~~-------~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          244 ---RIR-------LGQYGFPNPE-WSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -----------------CCCTTT-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---hhh-------ccccccCchh-hccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               000       0000000000 1234568999999999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.2e-44  Score=320.08  Aligned_cols=245  Identities=23%  Similarity=0.331  Sum_probs=198.9

Q ss_pred             HHHhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc------cHHHHHHHHHHHhcCC--CCCccceeeEE
Q 043074           77 LIDATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ------GFREFRAEMETLGKLR--HRNIVKILGYC  147 (373)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~  147 (373)
                      .....++|++.+.||+|+||.||+|.. .+++.||+|.+......      ..+.+.+|+.++++++  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            344567899999999999999999975 47899999998654322      1234567999999996  59999999999


Q ss_pred             eeCCeeEEEEEecCC-CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCce
Q 043074          148 ASGLDRVLIYEFVEN-GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV  226 (373)
Q Consensus       148 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Ni  226 (373)
                      .+....++|+|++.+ ++|.+++....               ++++..++.++.|++.||+|||  +.+++||||||+||
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NI  180 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERG---------------ALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENI  180 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGE
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCcEeCCCCHHHE
Confidence            999999999999976 89999997643               2899999999999999999999  78999999999999


Q ss_pred             EeC-CCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCC
Q 043074          227 LLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ  305 (373)
Q Consensus       227 ll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~  305 (373)
                      +++ +++.+||+|||++......   ......||+.|+|||.+.+....+.++||||||+++|||++|..||....    
T Consensus       181 ll~~~~~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----  253 (320)
T 3a99_A          181 LIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----  253 (320)
T ss_dssp             EEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred             EEeCCCCCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----
Confidence            998 7889999999999876432   22345689999999998766656788999999999999999999974311    


Q ss_pred             cccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          306 EVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                               .... ...      ..     +...+.++.+++.+||+.||++|||+.++++
T Consensus       254 ---------~~~~-~~~------~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          254 ---------EIIR-GQV------FF-----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ---------HHHH-CCC------CC-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------hhhc-ccc------cc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     0000 000      00     1123457999999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=316.81  Aligned_cols=244  Identities=21%  Similarity=0.344  Sum_probs=191.0

Q ss_pred             HHhcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc------cHHHHHHHHHHHhcC----CCCCccceeeE
Q 043074           78 IDATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ------GFREFRAEMETLGKL----RHRNIVKILGY  146 (373)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~l~~~  146 (373)
                      ....++|++.+.||+|+||.||+|.. .+++.||+|++......      ....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34467899999999999999999976 47899999999664432      123355788888888    89999999999


Q ss_pred             EeeCCeeEEEEEe-cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCc
Q 043074          147 CASGLDRVLIYEF-VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSN  225 (373)
Q Consensus       147 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~N  225 (373)
                      +.+.+..++|+|+ +.+++|.+++....               ++++..++.++.|++.||.|||  +.+++||||||+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~N  169 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG---------------PLGEGPSRCFFGQVVAAIQHCH--SRGVVHRDIKDEN  169 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHH--HHTEECCCCSGGG
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChhh
Confidence            9999999999999 78999999998654               2899999999999999999999  7899999999999


Q ss_pred             eEeC-CCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCC
Q 043074          226 VLLD-SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDG  304 (373)
Q Consensus       226 ill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  304 (373)
                      |+++ .++.+||+|||++.......   .....|++.|+|||.+.+....+.++||||||+++|||++|..||....   
T Consensus       170 il~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---  243 (312)
T 2iwi_A          170 ILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---  243 (312)
T ss_dssp             EEEETTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---
T ss_pred             EEEeCCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---
Confidence            9998 88999999999998764322   2345689999999998766555678999999999999999999964310   


Q ss_pred             CcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                            .    ....       ...     .+...+..+.+++.+||+.||++|||+.++++
T Consensus       244 ------~----~~~~-------~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          244 ------E----ILEA-------ELH-----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ------H----HHHT-------CCC-----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------H----Hhhh-------ccC-----CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  0    0000       000     12233557899999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1e-42  Score=324.96  Aligned_cols=257  Identities=23%  Similarity=0.299  Sum_probs=186.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEEec
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      +.|...+.||+|+||+||.+...+|+.||||++....   .+.+.+|+.++.++ +||||+++++++.++...++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            4555678899999999987766789999999986532   34678899999876 8999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC---------
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD---------  231 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~---------  231 (373)
                      . |+|.+++.........        ....++..++.++.||+.||+|||  +++|+||||||+|||++.+         
T Consensus        92 ~-gsL~~~l~~~~~~~~~--------~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~~~~~~~  160 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDEN--------LKLQKEYNPISLLRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQT  160 (434)
T ss_dssp             S-EEHHHHHHTC--------------------CCHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred             C-CCHHHHHhccCCCchh--------hhhccchhHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEecCccccccccc
Confidence            5 6999999865432110        000234456789999999999999  7899999999999999654         


Q ss_pred             ----CceEEeeeccccccCCCCCc---ccccccccccccCccccCC------CCCCCccccchhhhHHHHHHHh-CCCCC
Q 043074          232 ----FEAHISDFGLARRIDTSHSH---VSTQVAGTMGYMPPEYLGG------NTAATVMLDVYSFGILMIEIAT-QIRPN  297 (373)
Q Consensus       232 ----~~~kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~el~~-g~~p~  297 (373)
                          +.+||+|||+++........   ......||+.|+|||++.+      ...++.++|||||||++|||++ |..|+
T Consensus       161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence                48999999999876543221   1234579999999999865      2457899999999999999999 78886


Q ss_pred             CCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          298 LPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ......     .    ...........    .. ........+.++.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~-----~----~~i~~~~~~~~----~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          241 GDKYSR-----E----SNIIRGIFSLD----EM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             CSTTTH-----H----HHHHHTCCCCC----CC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCchhh-----H----HHHhcCCCCcc----cc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            432110     0    01111000000    01 11124567789999999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.8e-43  Score=324.57  Aligned_cols=250  Identities=20%  Similarity=0.304  Sum_probs=185.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ..+|...+.||+|+||+|+.....+++.||||++......   .+.+|+.+++.+ +||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            3468888999999999976665668999999999664433   345799999999 799999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC-----CCce
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-----DFEA  234 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~-----~~~~  234 (373)
                      +. |+|.+++......              +.+.+++.++.|++.||.|||  +.+|+||||||+||+++.     ...+
T Consensus       100 ~~-g~L~~~l~~~~~~--------------~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NIll~~~~~~~~~~~  162 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFA--------------HLGLEPITLLQQTTSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKA  162 (432)
T ss_dssp             CS-EEHHHHHHSSSCC--------------CCSSCHHHHHHHHHHHHHHHH--HTTCCCCCCSTTSEEECCCBTTTBCCE
T ss_pred             CC-CCHHHHHHhcCCC--------------ccchhHHHHHHHHHHHHHHHH--HCcCEeCCCCHHHEEEecCCCCCceeE
Confidence            95 6999999865532              444556789999999999999  789999999999999953     3368


Q ss_pred             EEeeeccccccCCCCC--cccccccccccccCccccCC--CCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccH
Q 043074          235 HISDFGLARRIDTSHS--HVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~  309 (373)
                      ||+|||+++.......  .......||+.|+|||++.+  ...++.++|||||||++|||++ |..|+.....       
T Consensus       163 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-------  235 (432)
T 3p23_A          163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-------  235 (432)
T ss_dssp             EECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-------
T ss_pred             EEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-------
Confidence            8999999987643321  22344679999999999974  3446779999999999999999 7777532111       


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       ...... .....       ..........+..+.+++.+||+.||++|||+.++++
T Consensus       236 -~~~~~~-~~~~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          236 -RQANIL-LGACS-------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -HHHHHH-TTCCC-------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -HHHHHH-hccCC-------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence             000000 00000       0001112344567899999999999999999999984

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.4e-41  Score=312.67  Aligned_cols=200  Identities=27%  Similarity=0.320  Sum_probs=168.8

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CC-----CccceeeEEeeCCe
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HR-----NIVKILGYCASGLD  152 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~  152 (373)
                      ..++|++.+.||+|+||.||+|... +++.||||++.... ...+.+..|+.++..++ |+     +++++++++.....
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            4578999999999999999999765 68899999997543 23456778888888875 44     49999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC--C
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD--S  230 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~--~  230 (373)
                      .++||||++ ++|.+++......             .+++..+..++.|++.||.|||+.+.+|+||||||+|||++  .
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~-------------~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~  196 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFR-------------GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK  196 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTS-------------CCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT
T ss_pred             eEEEEecCC-CCHHHHHhhcCcC-------------CCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC
Confidence            999999995 6999999876432             28999999999999999999995457899999999999994  4


Q ss_pred             CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCC
Q 043074          231 DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP  299 (373)
Q Consensus       231 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  299 (373)
                      ++.+||+|||+++.....    .....||+.|+|||++.+. .++.++|||||||++|||++|..||..
T Consensus       197 ~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          197 RSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             SCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCcEEEEeccCceecccc----cccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            788999999999876432    2345789999999999854 478999999999999999999999764

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.5e-42  Score=313.59  Aligned_cols=260  Identities=18%  Similarity=0.234  Sum_probs=195.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CC-CEEEEEEeCccccccHHHHHHHHHHHhcCCCCC------ccceeeEEeeCCe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SG-VTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN------IVKILGYCASGLD  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  152 (373)
                      .++|++.+.||+|+||.||+|... ++ ..||+|++.... ...+.+.+|+.+++.++|++      ++.+.+++.....
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999764 44 689999996543 23456788999999987655      8999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe----
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL----  228 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill----  228 (373)
                      .++||||+ +++|.+++......             ++++.++..++.||+.||+|||  +++++||||||+|||+    
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~-------------~~~~~~~~~i~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~  160 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQ-------------PYPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSE  160 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTC-------------CCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEESCCC
T ss_pred             EEEEEecc-CCChHHHHHhccCC-------------CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEeccc
Confidence            99999999 67777777665422             3899999999999999999999  7899999999999999    


Q ss_pred             ---------------CCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhC
Q 043074          229 ---------------DSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ  293 (373)
Q Consensus       229 ---------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g  293 (373)
                                     +.++.+||+|||+++.....    .....||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g  235 (355)
T 2eu9_A          161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRG  235 (355)
T ss_dssp             EEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccccccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhC
Confidence                           56789999999999864322    2345789999999999754 578899999999999999999


Q ss_pred             CCCCCCcccCCCcccHHHHHHHHH--------Hhccccc-ccc--------------------CccccccCCHHHHHHHH
Q 043074          294 IRPNLPVVLDGQEVGLLEWARTME--------ARNKEIE-MVD--------------------SNISREELSEAGVREYF  344 (373)
Q Consensus       294 ~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~-~~~--------------------~~~~~~~~~~~~~~~l~  344 (373)
                      ..||.......    .........        ....... ...                    ............+.++.
T Consensus       236 ~~pf~~~~~~~----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  311 (355)
T 2eu9_A          236 FTLFQTHENRE----HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF  311 (355)
T ss_dssp             SCSCCCSSHHH----HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred             CCCCCCCCHHH----HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHH
Confidence            99975432111    000000000        0000000 000                    00000011234467899


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHH
Q 043074          345 RIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       345 ~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      +++.+||+.||++|||+.++++
T Consensus       312 ~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          312 DLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHhcCChhhCcCHHHHhc
Confidence            9999999999999999999974

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.9e-42  Score=308.55  Aligned_cols=252  Identities=22%  Similarity=0.350  Sum_probs=178.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccccc--HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .++|+..+.||+|+||.||+|... +++.||+|++.......  .+.+.++..+++.++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            457888899999999999999775 78999999996544322  233445556788889999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CceeecCCCCceEeCCCCceEE
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEK-PIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~-~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      ||+ ++.+..+......              ++++..+..++.|++.||.|||  ++ +++|+||||+||+++.++.+||
T Consensus       104 e~~-~~~~~~l~~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH--~~~~i~H~dlkp~Nil~~~~~~~kl  166 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQG--------------PIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKL  166 (318)
T ss_dssp             CCC-SEEHHHHHHHHTS--------------CCCHHHHHHHHHHHHHHHHHHH--HHHCCCCCCCCGGGEEECTTSCEEE
T ss_pred             ecc-CCcHHHHHHHhcc--------------CCCHHHHHHHHHHHHHHHHHHH--hhCCEEeCCCCHHHEEECCCCCEEE
Confidence            999 6666666554322              2899999999999999999999  64 8999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      +|||++.......  ......+|+.|+|||.+.+    ...++.++||||||+++|||++|..||.....      ....
T Consensus       167 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~  238 (318)
T 2dyl_A          167 CDFGISGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT------DFEV  238 (318)
T ss_dssp             CCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHH
T ss_pred             EECCCchhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc------cHHH
Confidence            9999997654322  2234568999999999852    34578899999999999999999999753211      1111


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ........      ...+..   ....+..+.+++.+||+.||.+||++.++++
T Consensus       239 ~~~~~~~~------~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          239 LTKVLQEE------PPLLPG---HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHHHHSC------CCCCCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHhccC------CCCCCc---cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            11111111      011100   1123457999999999999999999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-41  Score=327.02  Aligned_cols=269  Identities=26%  Similarity=0.395  Sum_probs=200.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEee------CCe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCAS------GLD  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  152 (373)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+.++++++||||+++++++..      +..
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36899999999999999999976 4689999999866432 335678899999999999999999998765      677


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++||||+++|+|.+++.......            ++++..++.++.|++.||+|||  +.+++||||||+||+++.++
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~------------~lse~~i~~I~~QLl~aL~yLH--s~gIVHrDLKP~NILl~~~g  158 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCC------------GLKEGPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGP  158 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTT------------CCCSSHHHHHHHHHHHHHHHHH--HTTBCCCCCCSTTEEEECCS
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCC------------CCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEeecCC
Confidence            899999999999999998754321            3888999999999999999999  78999999999999998776


Q ss_pred             c---eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          233 E---AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       233 ~---~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                      .   +||+|||++.......  ......||+.|+|||.+.+ ..++.++||||||+++|||++|..||.+...      .
T Consensus       159 ~~~~vKL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~------~  229 (676)
T 3qa8_A          159 QRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQ------P  229 (676)
T ss_dssp             SSCEEEECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH------H
T ss_pred             CceeEEEccccccccccccc--ccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccc------h
Confidence            5   9999999998764332  2344678999999999974 4578899999999999999999999765311      0


Q ss_pred             HHHHHHHH----Hhccccccc------cCcc-ccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHhhh
Q 043074          310 LEWARTME----ARNKEIEMV------DSNI-SREELSEAGVREYFRIACMCTNEKSRERPAMSY-----VVQLLDELV  372 (373)
Q Consensus       310 ~~~~~~~~----~~~~~~~~~------~~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~-----l~~~L~~l~  372 (373)
                      ..|.....    .........      ...+ .........+..+.+++.+||+.||++|||+.+     +.+.+++++
T Consensus       230 ~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          230 VQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             HHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence            11100000    000000000      0010 011234556789999999999999999999987     455555554

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.8e-41  Score=295.93  Aligned_cols=230  Identities=12%  Similarity=0.094  Sum_probs=183.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      .++|++.+.||+|+||.||+|... +++.||+|++......   ..+.+.+|+..+.+++||||+++++++.+.+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            368999999999999999999765 5899999999765432   246788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++++|.+++...                 ....++.+++.|++.||+|||  +++++||||||+||+++.++.+||
T Consensus       110 ~e~~~g~~L~~~l~~~-----------------~~~~~~~~i~~ql~~aL~~lH--~~givH~Dikp~NIll~~~g~~kl  170 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS-----------------PSPVGAIRAMQSLAAAADAAH--RAGVALSIDHPSRVRVSIDGDVVL  170 (286)
T ss_dssp             EECCCEEEHHHHHTTC-----------------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEETTSCEEE
T ss_pred             EEecCCCCHHHHHhcC-----------------CChHHHHHHHHHHHHHHHHHH--HCCCccCCCCcccEEEcCCCCEEE
Confidence            9999999999998532                 345578899999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +++|                     |++|        ++.++||||||+++|||++|..||..........         
T Consensus       171 ~~~~---------------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---------  212 (286)
T 3uqc_A          171 AYPA---------------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---------  212 (286)
T ss_dssp             CSCC---------------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---------
T ss_pred             Eecc---------------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---------
Confidence            7443                     3332        5778999999999999999999976533221000         


Q ss_pred             HHhccccccccCccc-cccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          317 EARNKEIEMVDSNIS-REELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                          .....+..... .......++.++.+++.+||+.||++| |+.++++.|+++.
T Consensus       213 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          213 ----PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             ----ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             ----HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence                00000000000 001122345689999999999999999 9999999999864

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.9e-41  Score=333.45  Aligned_cols=239  Identities=21%  Similarity=0.332  Sum_probs=192.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC--CCCEEEEEEeCcccc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe-----
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS--SGVTVAIKKLDKDAF-QGFREFRAEMETLGKLRHRNIVKILGYCASGLD-----  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  152 (373)
                      .++|++.+.||+|+||.||+|.+.  +++.||||++..... .....+.+|+.++.+++||||+++++++.....     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999865  689999999865433 334578899999999999999999999987665     


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++||||+++++|.+++..                 ++++.+++.++.||+.||.|||  +++|+||||||+|||++.+ 
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----------------~l~~~~~~~~~~qi~~aL~~lH--~~giiHrDlkp~NIll~~~-  218 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----------------KLPVAEAIAYLLEILPALSYLH--SIGLVYNDLKPENIMLTEE-  218 (681)
T ss_dssp             EEEEEECCCCEECC----C-----------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSS-
T ss_pred             eEEEEEeCCCCcHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHH--HCCCeecccChHHeEEeCC-
Confidence            6999999999999887654                 1899999999999999999999  7899999999999999986 


Q ss_pred             ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      .+||+|||+++.....     ....||+.|+|||++.+.  .+.++|||||||++|+|++|..|+.........      
T Consensus       219 ~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------  285 (681)
T 2pzi_A          219 QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------  285 (681)
T ss_dssp             CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------
T ss_pred             cEEEEecccchhcccC-----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccccc------
Confidence            8999999999876432     345689999999998643  488999999999999999998875432211100      


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHhh
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA-MSYVVQLLDEL  371 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~l~~~L~~l  371 (373)
                                         ........+..+.+++.+||+.||++||+ ++++.+.|.++
T Consensus       286 -------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 -------------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -------------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -------------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                               00001223457899999999999999995 66666666654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.2e-40  Score=292.77  Aligned_cols=226  Identities=19%  Similarity=0.256  Sum_probs=176.7

Q ss_pred             CCCCCC-CeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHH-hcCCCCCccceeeEEee----CCeeE
Q 043074           82 DNFSTD-KIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETL-GKLRHRNIVKILGYCAS----GLDRV  154 (373)
Q Consensus        82 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~  154 (373)
                      ++|.+. +.||+|+||.||++.. .+++.||+|++...     ..+.+|+.++ +..+||||+++++++.+    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456666 7899999999999976 57899999998542     4567888887 55689999999999877    67789


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC---C
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---D  231 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~---~  231 (373)
                      +||||+++|+|.+++......             ++++..++.++.|++.||.|||  +.+++||||||+||+++.   +
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~-------------~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~  156 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQ-------------AFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPN  156 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTC-------------CCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTT
T ss_pred             EEEeecCCCcHHHHHHhccCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEecCCCC
Confidence            999999999999999875432             2899999999999999999999  789999999999999998   7


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +.+||+|||++....                        ...++.++|||||||++|||++|..||.........     
T Consensus       157 ~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----  207 (299)
T 3m2w_A          157 AILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----  207 (299)
T ss_dssp             CCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------
T ss_pred             CcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----
Confidence            889999999986532                        123677899999999999999999997543221100     


Q ss_pred             HHHHHHHhccccccccCccccccCC----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELS----EAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                              ......+....  ...+    ...+.++.+++.+||+.||++|||+.++++
T Consensus       208 --------~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          208 --------PGMKTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             --------CCSCCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------HHHHHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                    00000000000  0001    123568999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1e-40  Score=309.46  Aligned_cols=246  Identities=16%  Similarity=0.171  Sum_probs=178.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCC-CCccce---------ee--
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRH-RNIVKI---------LG--  145 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h-~niv~l---------~~--  145 (373)
                      .+|...+.||+|+||.||+|.+ .+|+.||||++......   ..+.+.+|+.+++.++| +|....         ..  
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4577788999999999999975 57999999998743332   25678999999999987 322111         11  


Q ss_pred             ----------EEee-----CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 043074          146 ----------YCAS-----GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLH  210 (373)
Q Consensus       146 ----------~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh  210 (373)
                                ++..     ....+++|+++ +++|.+++........        ...++++..++.++.|++.||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH  228 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS--------THKSLVHHARLQLTLQVIRLLASLH  228 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTT--------TSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccc--------cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                      1111     22456777766 7899999853211000        0013788899999999999999999


Q ss_pred             cCCCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccC---------CCCCCCccccch
Q 043074          211 GLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG---------GNTAATVMLDVY  281 (373)
Q Consensus       211 ~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---------~~~~~~~~~Diw  281 (373)
                        +++|+||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++.         ....++.++|||
T Consensus       229 --~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw  301 (413)
T 3dzo_A          229 --HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW  301 (413)
T ss_dssp             --HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred             --hCCcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence              789999999999999999999999999998864322    344567 9999999983         344578899999


Q ss_pred             hhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 043074          282 SFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAM  361 (373)
Q Consensus       282 slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (373)
                      ||||++|||++|..||..........                ..+..       ....+..+.+++.+||+.||++||++
T Consensus       302 SlGvil~elltg~~Pf~~~~~~~~~~----------------~~~~~-------~~~~~~~~~~li~~~l~~dP~~Rpt~  358 (413)
T 3dzo_A          302 TLGLAIYWIWCADLPNTDDAALGGSE----------------WIFRS-------CKNIPQPVRALLEGFLRYPKEDRLLP  358 (413)
T ss_dssp             HHHHHHHHHHHSSCCCCTTGGGSCSG----------------GGGSS-------CCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHHCCCCCCCcchhhhHH----------------HHHhh-------cccCCHHHHHHHHHHccCChhhCcCH
Confidence            99999999999999975433221100                00110       01224589999999999999999998


Q ss_pred             HHHHH
Q 043074          362 SYVVQ  366 (373)
Q Consensus       362 ~~l~~  366 (373)
                      .++++
T Consensus       359 ~~~l~  363 (413)
T 3dzo_A          359 LQAME  363 (413)
T ss_dssp             HHHTT
T ss_pred             HHHHh
Confidence            77653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.3e-40  Score=298.31  Aligned_cols=243  Identities=18%  Similarity=0.182  Sum_probs=181.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCcccc--------ccHHHHHHHHHHHhcCC---------CCCccce
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF--------QGFREFRAEMETLGKLR---------HRNIVKI  143 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~niv~l  143 (373)
                      .++|++.+.||+|+||.||+|.. +|+.||||++.....        ...+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35788899999999999999987 689999999965432        23467888999888885         7777776


Q ss_pred             eeEE-----------------ee-------------CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHH
Q 043074          144 LGYC-----------------AS-------------GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE  193 (373)
Q Consensus       144 ~~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~  193 (373)
                      .+++                 .+             ....++||||+++|++.+.+.+.                .+++.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----------------~~~~~  161 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----------------LSSLA  161 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----------------CCCHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----------------CCCHH
Confidence            6653                 22             67899999999999776666432                28999


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC--------------------ceEEeeeccccccCCCCCccc
Q 043074          194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF--------------------EAHISDFGLARRIDTSHSHVS  253 (373)
Q Consensus       194 ~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~  253 (373)
                      ++..++.||+.||+|||+ +.+|+||||||+|||++.++                    .+||+|||+++....      
T Consensus       162 ~~~~i~~qi~~aL~~lH~-~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------  234 (336)
T 2vuw_A          162 TAKSILHQLTASLAVAEA-SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------  234 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHH-HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------
T ss_pred             HHHHHHHHHHHHHHHHHH-hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------
Confidence            999999999999999992 37799999999999999887                    899999999987542      


Q ss_pred             ccccccccccCccccCCCCCCCccccchhhhHH-HHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhccccccccCcccc
Q 043074          254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL-MIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISR  332 (373)
Q Consensus       254 ~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~-l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (373)
                      ....||+.|+|||++.+..  +.++||||+|++ .+++++|..|+.          -..|.......-......... ..
T Consensus       235 ~~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~----------~~~~~~~~~~~~~~~~~~~~~-~~  301 (336)
T 2vuw_A          235 GIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYS----------NVLWLHYLTDKMLKQMTFKTK-CN  301 (336)
T ss_dssp             TEEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHH----------HHHHHHHHHHHHHHTCCCSSC-CC
T ss_pred             CcEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCc----------chhhhhHHHHhhhhhhccCcc-cc
Confidence            2347899999999998654  789999998777 777888888742          112222111100000000111 11


Q ss_pred             ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 043074          333 EELSEAGVREYFRIACMCTNEKSRERPAMSYVV  365 (373)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~  365 (373)
                      .......+.++.+++.+||+.|     |++|++
T Consensus       302 ~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          302 TPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             SHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            1124467889999999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=4.5e-33  Score=266.85  Aligned_cols=184  Identities=17%  Similarity=0.107  Sum_probs=128.9

Q ss_pred             eecCCCceEEEEE-eCCCCEEEEEEeCcccc----------ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEE
Q 043074           90 IGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF----------QGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        90 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .+.|+.|....++ .-.|+.+++|.+.+...          ...+++.+|+++|+++ .|+||++++++++++...||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4455655555442 23588899999865421          1245699999999999 6999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||++|++|.++|.....               ++..   +|+.||+.||+|+|  ++||+||||||+|||++++|.+||+
T Consensus       322 Eyv~G~~L~d~i~~~~~---------------l~~~---~I~~QIl~AL~ylH--~~GIIHRDIKPeNILL~~dg~vKL~  381 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEE---------------IDRE---KILGSLLRSLAALE--KQGFWHDDVRPWNVMVDARQHARLI  381 (569)
T ss_dssp             ECCCSEEHHHHHHTTCC---------------CCHH---HHHHHHHHHHHHHH--HTTCEESCCCGGGEEECTTSCEEEC
T ss_pred             ecCCCCcHHHHHHhCCC---------------CCHH---HHHHHHHHHHHHHH--HCCceeccCchHhEEECCCCCEEEe
Confidence            99999999999986542               5543   58899999999999  8999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCC
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP  296 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p  296 (373)
                      |||+|+...... ......+||+.|+|||++.+.  +..++|+||+|++++++.++..+
T Consensus       382 DFGlAr~~~~~~-~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          382 DFGSIVTTPQDC-SWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CCTTEESCC----CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             ecccCeeCCCCC-ccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence            999998764332 223456799999999999753  56679999999998877655433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=5.9e-29  Score=237.09  Aligned_cols=185  Identities=16%  Similarity=0.205  Sum_probs=143.3

Q ss_pred             CCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccc--------cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           85 STDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ--------GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ...+.||+|+||.||+|.. .++.+++|........        ..+.+.+|++++++++||||+++..++......++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3457899999999999954 5788999986443221        123578999999999999999777777778888999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++++|.+++..                       +..++.|++.||.|||  +++|+||||||+|||++.  .+||
T Consensus       418 mE~~~ggsL~~~l~~-----------------------~~~i~~qi~~aL~~LH--~~gIiHrDiKp~NILl~~--~~kL  470 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------------------NLDIAYKIGEIVGKLH--KNDVIHNDLTTSNFIFDK--DLYI  470 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------------------CTHHHHHHHHHHHHHH--HTTEECTTCCTTSEEESS--SEEE
T ss_pred             EECCCCCCHHHHHHH-----------------------HHHHHHHHHHHHHHHH--HCcCccCCCCHHHEEECC--eEEE
Confidence            999999999999874                       2478999999999999  789999999999999999  9999


Q ss_pred             eeeccccccCCCCCcc------cccccccccccCccccCC-CCCCCccccchhhhHHHHHHHhCCCCC
Q 043074          237 SDFGLARRIDTSHSHV------STQVAGTMGYMPPEYLGG-NTAATVMLDVYSFGILMIEIATQIRPN  297 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~el~~g~~p~  297 (373)
                      +|||+++.........      .....||+.|+|||++.+ ...|+...|+||..+-..+-+.++.++
T Consensus       471 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          471 IDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            9999999865432211      235679999999999874 134677889999999888888776553

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=4.9e-25  Score=193.14  Aligned_cols=150  Identities=19%  Similarity=0.213  Sum_probs=119.5

Q ss_pred             HHHhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccc------------------cHHHHHHHHHHHhcCCCC
Q 043074           77 LIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ------------------GFREFRAEMETLGKLRHR  138 (373)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~  138 (373)
                      +......|.+.+.||+|+||.||+|...+|+.||+|.+......                  ....+.+|+.++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            33445667777999999999999998878999999999643221                  2346889999999999  


Q ss_pred             CccceeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 043074          139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIH  218 (373)
Q Consensus       139 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H  218 (373)
                      | +++.+++.. +..++||||+++++|.+ +.                   .  .....++.|++.||.|||  +.+++|
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------------------~--~~~~~i~~qi~~~l~~lH--~~giiH  216 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR-------------------V--ENPDEVLDMILEEVAKFY--HRGIVH  216 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-------------------C--SCHHHHHHHHHHHHHHHH--HTTEEC
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-cc-------------------h--hhHHHHHHHHHHHHHHHH--HCCCEe
Confidence            5 666765544 55699999999999988 42                   1  123469999999999999  799999


Q ss_pred             ecCCCCceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccC
Q 043074          219 RDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLG  269 (373)
Q Consensus       219 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  269 (373)
                      |||||+|||++ ++.+||+|||+++.              +..++|||.+.
T Consensus       217 rDlkp~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          217 GDLSQYNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             SCCSTTSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             CCCCHHHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            99999999999 99999999999864              33467888764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=3.2e-21  Score=166.94  Aligned_cols=138  Identities=20%  Similarity=0.250  Sum_probs=105.7

Q ss_pred             CCCCCCeeecCCCceEEEEEe-CCCCE--EEEEEeCccccc------------------------cHHHHHHHHHHHhcC
Q 043074           83 NFSTDKIIGDGSFGFVYKAKL-SSGVT--VAIKKLDKDAFQ------------------------GFREFRAEMETLGKL  135 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  135 (373)
                      -|.+.+.||+|+||.||+|.. .+|+.  ||||++......                        ....+.+|+..+.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            456778999999999999987 67888  999987543211                        012578899999999


Q ss_pred             CCCCc--cceeeEEeeCCeeEEEEEecCC-C----CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHH
Q 043074          136 RHRNI--VKILGYCASGLDRVLIYEFVEN-G----SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAY  208 (373)
Q Consensus       136 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~  208 (373)
                      .|+++  ..+++.    ...++||||+.+ |    +|.++...                  .++..+..++.|++.||.|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------------------~~~~~~~~i~~qi~~~l~~  185 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------------------LKELDVEGIFNDVVENVKR  185 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------------------GGGSCHHHHHHHHHHHHHH
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------------------cChHHHHHHHHHHHHHHHH
Confidence            88764  333332    356899999942 4    67666432                  2234567899999999999


Q ss_pred             HhcCCCCceeecCCCCceEeCCCCceEEeeecccccc
Q 043074          209 LHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI  245 (373)
Q Consensus       209 lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  245 (373)
                      ||. +.+++||||||+|||++.  .++|+|||++...
T Consensus       186 lH~-~~givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          186 LYQ-EAELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHH-TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHH-HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            993 368999999999999998  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=3.3e-19  Score=160.21  Aligned_cols=141  Identities=14%  Similarity=0.124  Sum_probs=100.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccc--------------cHHH--------HHHHHHHHhcCCCC
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ--------------GFRE--------FRAEMETLGKLRHR  138 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------~~~~--------~~~e~~~l~~l~h~  138 (373)
                      ..-|++.+.||.|++|.||+|...+|+.||||+++.....              ....        ..+|...|.++.+.
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            3458899999999999999999889999999987532110              0011        13456666666444


Q ss_pred             CccceeeEEeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 043074          139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIH  218 (373)
Q Consensus       139 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H  218 (373)
                      ++....-+..  ...++||||+++++|..+..                   .  .....++.|++.+|.+||  +.|++|
T Consensus       174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~-------------------~--~~~~~l~~qll~~l~~lH--~~gIVH  228 (397)
T 4gyi_A          174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS-------------------V--PDPASLYADLIALILRLA--KHGLIH  228 (397)
T ss_dssp             TCSCCCEEEE--ETTEEEEECCSCEEGGGCCC-------------------C--SCHHHHHHHHHHHHHHHH--HTTEEC
T ss_pred             CCCCCeeeec--cCceEEEEecCCccHhhhcc-------------------c--HHHHHHHHHHHHHHHHHH--HCCCcC
Confidence            3321111111  23479999999888865432                   1  123568899999999999  789999


Q ss_pred             ecCCCCceEeCCCC----------ceEEeeeccccccC
Q 043074          219 RDIKSSNVLLDSDF----------EAHISDFGLARRID  246 (373)
Q Consensus       219 ~dlk~~Nill~~~~----------~~kl~Dfg~~~~~~  246 (373)
                      |||||.|||+++++          .+.|+||+-+....
T Consensus       229 rDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          229 GDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            99999999998776          38999999776543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.46  E-value=1.6e-13  Score=118.76  Aligned_cols=144  Identities=16%  Similarity=0.109  Sum_probs=111.6

Q ss_pred             HhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEE
Q 043074           79 DATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  157 (373)
                      .....|.....++.|+.+.||+.... +..+++|............+.+|+.+++.+. +.++.++++++.+.+..++||
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            33456877778888889999999764 6899999986532222345788999999884 677889999999888999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLE------------------------  213 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~------------------------  213 (373)
                      ||++|.+|.+.+..                    ......++.+++++|..||+..                        
T Consensus        90 e~i~G~~l~~~~~~--------------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (263)
T 3tm0_A           90 SEADGVLCSEEYED--------------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND  149 (263)
T ss_dssp             ECCSSEEHHHHCCT--------------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred             EecCCeehhhccCC--------------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcc
Confidence            99999999876311                    1123467888999999999511                        


Q ss_pred             ---------------------------------CCceeecCCCCceEeCCCCceEEeeecccc
Q 043074          214 ---------------------------------KPIIHRDIKSSNVLLDSDFEAHISDFGLAR  243 (373)
Q Consensus       214 ---------------------------------~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  243 (373)
                                                       ..++|+|++|.||+++++..+.|+||+.+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                             348999999999999876566799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.33  E-value=1.9e-12  Score=111.89  Aligned_cols=135  Identities=17%  Similarity=0.141  Sum_probs=96.4

Q ss_pred             CCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCC--ccceeeEEeeCCeeEEEEEec
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN--IVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~  160 (373)
                      .+.+....+.|..+.||+....+|..+++|......   ...+.+|+.+++.+.+.+  +.+++++..+++..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            344333334566699999987778889999976542   245678999998886444  556888888777889999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLE---------------------------  213 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~---------------------------  213 (373)
                      +|.+|.  ...                  .+   ...++.+++..|..||+..                           
T Consensus        98 ~G~~l~--~~~------------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (264)
T 1nd4_A           98 PGQDLL--SSH------------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVD  154 (264)
T ss_dssp             SSEETT--TSC------------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCC
T ss_pred             CCcccC--cCc------------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCcc
Confidence            998874  111                  11   1245666667777777421                           


Q ss_pred             -----------------------------CCceeecCCCCceEeCCCCceEEeeecccc
Q 043074          214 -----------------------------KPIIHRDIKSSNVLLDSDFEAHISDFGLAR  243 (373)
Q Consensus       214 -----------------------------~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  243 (373)
                                                   ..++|+|++|.||++++++.+.|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          155 QDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                         129999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.18  E-value=6.8e-11  Score=107.10  Aligned_cols=141  Identities=18%  Similarity=0.217  Sum_probs=104.8

Q ss_pred             CCCeeecCCCceEEEEEeCCCCEEEEEEeC--cccc-ccHHHHHHHHHHHhcCC--CCCccceeeEEeeC---CeeEEEE
Q 043074           86 TDKIIGDGSFGFVYKAKLSSGVTVAIKKLD--KDAF-QGFREFRAEMETLGKLR--HRNIVKILGYCASG---LDRVLIY  157 (373)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  157 (373)
                      ..+.++.|.++.+|+.... +..+++|+..  .... .....+.+|+.+++.+.  +.++.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3567899999999999875 4678888775  3221 22346778999999886  45678888888776   4589999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGL-------------------------  212 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~-------------------------  212 (373)
                      ||++|..+.+...                 ..++..++..++.++++.|..||+.                         
T Consensus       121 e~v~G~~l~~~~~-----------------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (359)
T 3dxp_A          121 EFVSGRVLWDQSL-----------------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWT  183 (359)
T ss_dssp             ECCCCBCCCCTTC-----------------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHH
T ss_pred             EecCCeecCCCcc-----------------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHH
Confidence            9999877643110                 0267788889999999999999952                         


Q ss_pred             -------------------------------CCCceeecCCCCceEeCCCCc--eEEeeeccccc
Q 043074          213 -------------------------------EKPIIHRDIKSSNVLLDSDFE--AHISDFGLARR  244 (373)
Q Consensus       213 -------------------------------~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~~~  244 (373)
                                                     ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          184 KQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                           146899999999999997753  68999998865

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.02  E-value=1.4e-10  Score=102.51  Aligned_cols=183  Identities=17%  Similarity=0.192  Sum_probs=115.9

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CCC--ccceeeEEeeCC---eeEEEEEec
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRN--IVKILGYCASGL---DRVLIYEFV  160 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  160 (373)
                      .+.++.|.++.||+..    ..+++|.....  .....+.+|...++.+. +..  +.+++.......   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999863    56888986543  23457889999998873 333  334444433332   347899999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGL----------------------------  212 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~----------------------------  212 (373)
                      +|.+|.+....                 .++..++..++.|++..++.||+.                            
T Consensus        99 ~G~~l~~~~~~-----------------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (304)
T 3sg8_A           99 KGVPLTPLLLN-----------------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLL  161 (304)
T ss_dssp             CCEECCHHHHH-----------------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHH
T ss_pred             CCeECCccccc-----------------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHh
Confidence            99888653321                 155666667777777777777631                            


Q ss_pred             ----------------------------CCCceeecCCCCceEeCC--CCceEEeeeccccccCCCCCcccccc------
Q 043074          213 ----------------------------EKPIIHRDIKSSNVLLDS--DFEAHISDFGLARRIDTSHSHVSTQV------  256 (373)
Q Consensus       213 ----------------------------~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~------  256 (373)
                                                  ...++|+|++|.||++++  +..+.|+||+.+...... .......      
T Consensus       162 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~  240 (304)
T 3sg8_A          162 SRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEY  240 (304)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSC
T ss_pred             cccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhcccc
Confidence                                        124799999999999988  456789999998753221 1100000      


Q ss_pred             --------cccccccC-ccccCCCCCCCccccchhhhHHHHHHHhCCCC
Q 043074          257 --------AGTMGYMP-PEYLGGNTAATVMLDVYSFGILMIEIATQIRP  296 (373)
Q Consensus       257 --------~g~~~y~a-PE~~~~~~~~~~~~DiwslG~~l~el~~g~~p  296 (373)
                              ........ |+....   ...-.+.|++|.++|.+.+|..+
T Consensus       241 ~~~~~~~~l~~Y~~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          241 GMEFVSKILNHYKHKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             CHHHHHHHHHHHTCSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             CHHHHHHHHHHcCCCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHH
Confidence                    00001111 222110   11225899999999999999766

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.67  E-value=1.9e-07  Score=80.71  Aligned_cols=135  Identities=19%  Similarity=0.159  Sum_probs=93.8

Q ss_pred             CeeecCCCc-eEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEEecCCCC
Q 043074           88 KIIGDGSFG-FVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLIYEFVENGS  164 (373)
Q Consensus        88 ~~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  164 (373)
                      +.+..|..| .||+.... ++..+++|+-...   ....+.+|...|+.+. +--+.++++++.+++..++|||+++|.+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            346667666 58988654 4677899986543   2356778999888874 4447788899999999999999999988


Q ss_pred             HHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 043074          165 LDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGL--------------------------------  212 (373)
Q Consensus       165 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~--------------------------------  212 (373)
                      +.+......                   .....+..+++..|.-||+.                                
T Consensus       107 ~~~~~~~~~-------------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (272)
T 4gkh_A          107 AFQVLEEYP-------------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDF  167 (272)
T ss_dssp             HHHHHHHCG-------------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGC
T ss_pred             ccccccCCH-------------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhc
Confidence            776543211                   11223444444445555521                                


Q ss_pred             ------------------------CCCceeecCCCCceEeCCCCceEEeeeccccc
Q 043074          213 ------------------------EKPIIHRDIKSSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       213 ------------------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                                              ...++|+|+.+.||++++++.+-|+||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          168 DDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                    11268999999999999877777999998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.61  E-value=3.2e-07  Score=80.87  Aligned_cols=135  Identities=19%  Similarity=0.163  Sum_probs=89.6

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCC---CccceeeEEe-eCCeeEEEEEecCC
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHR---NIVKILGYCA-SGLDRVLIYEFVEN  162 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  162 (373)
                      .+.++.|....||+.    +..+++|+...  ......+.+|..+++.+.+.   .+.+.+.+.. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            346888999999988    56788888532  22345788999999999642   3556666653 34567899999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhc-------------------------------
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHG-------------------------------  211 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~-------------------------------  211 (373)
                      .++.......                 ++..+...++.++.+.|..||+                               
T Consensus        98 ~~l~~~~~~~-----------------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~  160 (306)
T 3tdw_A           98 QILGEDGMAV-----------------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV  160 (306)
T ss_dssp             EECHHHHHTT-----------------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred             eECchhhhhh-----------------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence            8886632110                 2333333334444444433332                               


Q ss_pred             ---------------------------CCCCceeecCCCCceEeCC---CCc-eEEeeeccccc
Q 043074          212 ---------------------------LEKPIIHRDIKSSNVLLDS---DFE-AHISDFGLARR  244 (373)
Q Consensus       212 ---------------------------~~~~i~H~dlk~~Nill~~---~~~-~kl~Dfg~~~~  244 (373)
                                                 ....++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                       1335699999999999987   455 48999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.45  E-value=2.2e-07  Score=83.77  Aligned_cols=80  Identities=6%  Similarity=-0.006  Sum_probs=55.4

Q ss_pred             Cee-ecCCCceEEEEEeC-------CCCEEEEEEeCccc---cccHHHHHHHHHHHhcCC-C--CCccceeeEEeeC---
Q 043074           88 KII-GDGSFGFVYKAKLS-------SGVTVAIKKLDKDA---FQGFREFRAEMETLGKLR-H--RNIVKILGYCASG---  150 (373)
Q Consensus        88 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~---  150 (373)
                      +.| +.|..+.+|+....       ++..+++|......   ......+.+|+.+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 78889999988654       26788999875433   111245678888888874 3  3567788877655   


Q ss_pred             CeeEEEEEecCCCCHHH
Q 043074          151 LDRVLIYEFVENGSLDQ  167 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~  167 (373)
                      ...++|||+++|.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999998877653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.21  E-value=1.6e-05  Score=70.91  Aligned_cols=149  Identities=16%  Similarity=0.233  Sum_probs=78.7

Q ss_pred             eeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-----CCCcccee-e--EEeeCCeeEEEEEec
Q 043074           89 IIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-----HRNIVKIL-G--YCASGLDRVLIYEFV  160 (373)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~~  160 (373)
                      .|+.|..+.+|+....++ .+++|......    ..+..|..+++.+.     .|.++... |  +....+..+++++|+
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            455677899999987655 58999986522    33344555555442     24433311 1  123456789999999


Q ss_pred             CCCCHH--------------HHhhcCCCCCCCCcccccCCCCCCCHHHH-------------------------------
Q 043074          161 ENGSLD--------------QWLHDTSRNDDVDGSKQLNSLCPLSWETR-------------------------------  195 (373)
Q Consensus       161 ~~g~L~--------------~~l~~~~~~~~~~~~~~~~~~~~l~~~~~-------------------------------  195 (373)
                      +|.++.              ..++........+..... ....-.|...                               
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPI-FTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCC-CBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchh-cccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            886542              111211110000000000 0000122211                               


Q ss_pred             HHHHHHHHHHHHHHhc-----------CCCCceeecCCCCceEeCCCCceEEeeecccc
Q 043074          196 VKIVRGVANGLAYLHG-----------LEKPIIHRDIKSSNVLLDSDFEAHISDFGLAR  243 (373)
Q Consensus       196 ~~i~~qi~~~l~~lh~-----------~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  243 (373)
                      ..+..++..++.+|+.           ....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1111223345555541           25679999999999999888899999999774

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.17  E-value=1.1e-05  Score=73.72  Aligned_cols=75  Identities=17%  Similarity=0.138  Sum_probs=48.8

Q ss_pred             CCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc-------ccHHHHHHHHHHHhcCCC--CC-ccceeeEEeeCCeeEE
Q 043074           87 DKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF-------QGFREFRAEMETLGKLRH--RN-IVKILGYCASGLDRVL  155 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l  155 (373)
                      .+.+|.|.++.||++... +++.+++|.......       ...+.+..|.++++.+..  +. +.+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999754 468899998643221       123456778888887742  33 3345543  3455789


Q ss_pred             EEEecCCC
Q 043074          156 IYEFVENG  163 (373)
Q Consensus       156 v~e~~~~g  163 (373)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.08  E-value=1.9e-05  Score=68.76  Aligned_cols=78  Identities=26%  Similarity=0.304  Sum_probs=56.7

Q ss_pred             CCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCC---CccceeeEEeeCCeeEEEEEec
Q 043074           84 FSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHR---NIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        84 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      ....+.+|.|..+.||+.+..+|+.+++|+...........+..|+..|+.+...   .+.+++++.    ..++||||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence            3445679999999999999999999999987655444445678899988888422   244444432    347899999


Q ss_pred             CCCCH
Q 043074          161 ENGSL  165 (373)
Q Consensus       161 ~~g~L  165 (373)
                      +++..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            87643

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.78  E-value=0.00011  Score=59.77  Aligned_cols=103  Identities=14%  Similarity=0.051  Sum_probs=67.9

Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      .||.+.|.....              |+++.++|.++.|.+.+|.-+-. ...-..+=+.|..|++..+|.|...+ +.+
T Consensus        33 vSL~eIL~~~~~--------------PlsEEqaWALc~Qc~~~L~~~~~-~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s   96 (229)
T 2yle_A           33 LSLEEILRLYNQ--------------PINEEQAWAVCYQCCGSLRAAAR-RRQPRHRVRSAAQIRVWRDGAVTLAP-AAD   96 (229)
T ss_dssp             EEHHHHHHHHTS--------------CCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSGGGEEEETTSCEEECC-C--
T ss_pred             ccHHHHHHHcCC--------------CcCHHHHHHHHHHHHHHHHhhhh-cccCCceecCCcceEEecCCceeccc-ccc
Confidence            389999987664              59999999999999999877621 11111233456899999999987753 111


Q ss_pred             cccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCC
Q 043074          243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP  296 (373)
Q Consensus       243 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p  296 (373)
                      .             .....+.|||...  ...+.+.=|||||+++|.-+--+.|
T Consensus        97 ~-------------~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           97 D-------------AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -----------------------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             c-------------ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            0             1223467888763  3456788999999999999876665

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.75  E-value=0.00012  Score=67.31  Aligned_cols=79  Identities=8%  Similarity=0.083  Sum_probs=47.3

Q ss_pred             CCCceeecCCCCceEeCCCCceEEeeeccccccCCCCCcccccc-cccccccCccccCCC--CCCCccccchhhhHHHHH
Q 043074          213 EKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV-AGTMGYMPPEYLGGN--TAATVMLDVYSFGILMIE  289 (373)
Q Consensus       213 ~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~e  289 (373)
                      ...++|+|++|.||+++.++ ++++||+.+....... ...... .-...|.+|+.....  .......++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            57799999999999999876 9999999886532110 101000 001245565544211  111223455677888888


Q ss_pred             HHhC
Q 043074          290 IATQ  293 (373)
Q Consensus       290 l~~g  293 (373)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.72  E-value=0.00056  Score=59.94  Aligned_cols=148  Identities=20%  Similarity=0.195  Sum_probs=92.8

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC---CCCccceeeEEeeCCeeEEEEEecCCC
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR---HRNIVKILGYCASGLDRVLIYEFVENG  163 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  163 (373)
                      .+.|+.|....+|+... ++..+++|.....   ....+..|...|+.+.   ...+.+++++....+..++|||++++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            45789999999999976 4678899987543   2456788988888874   366888888888778899999999987


Q ss_pred             CHH--------H---HhhcCCCCCCC----Cc----ccccCCCCCCCHHHHH---HHH----------------HHHHHH
Q 043074          164 SLD--------Q---WLHDTSRNDDV----DG----SKQLNSLCPLSWETRV---KIV----------------RGVANG  205 (373)
Q Consensus       164 ~L~--------~---~l~~~~~~~~~----~~----~~~~~~~~~l~~~~~~---~i~----------------~qi~~~  205 (373)
                      .+.        .   .++........    +.    ..+.+.. .-+|....   ++.                .+++..
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w-~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDW-QTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCC-BSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCC-cCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            642        1   22322211110    00    0011111 12454321   111                112222


Q ss_pred             H-HHHh--cCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          206 L-AYLH--GLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       206 l-~~lh--~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      + ..|.  .....++|+|+.+.|++++.++ +.|.|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            2 2342  2245699999999999999887 8899974

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.67  E-value=0.00017  Score=63.11  Aligned_cols=71  Identities=10%  Similarity=0.094  Sum_probs=44.7

Q ss_pred             CCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCc-cceeeEEeeCCeeEEEEEec-CCCC
Q 043074           87 DKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI-VKILGYCASGLDRVLIYEFV-ENGS  164 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~  164 (373)
                      .+.|+.|..+.+|+.     ..+++|+........ -...+|+..++.+...++ .+++++  +....++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            577999999999998     568888876532211 122467777777643233 455544  333457899999 6554


Q ss_pred             H
Q 043074          165 L  165 (373)
Q Consensus       165 L  165 (373)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.59  E-value=0.00064  Score=60.30  Aligned_cols=77  Identities=8%  Similarity=0.076  Sum_probs=40.6

Q ss_pred             eeecCCCce-EEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCC--CCccceeeEEeeCCeeEEEEEecCCCCH
Q 043074           89 IIGDGSFGF-VYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH--RNIVKILGYCASGLDRVLIYEFVENGSL  165 (373)
Q Consensus        89 ~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L  165 (373)
                      .|+.|.... +|+....++..+++|.......   ..+..|+.+++.+..  -.+.+++.+..+.  -+++||++.+.++
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l   99 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALF   99 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBH
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcch
Confidence            455565554 6677654467788876544321   223456666666532  2355666654333  3789999977777


Q ss_pred             HHHhh
Q 043074          166 DQWLH  170 (373)
Q Consensus       166 ~~~l~  170 (373)
                      .+++.
T Consensus       100 ~~~l~  104 (333)
T 3csv_A          100 TEVIN  104 (333)
T ss_dssp             HHHHH
T ss_pred             HHHhc
Confidence            66554

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.55  E-value=0.00016  Score=63.81  Aligned_cols=167  Identities=17%  Similarity=0.186  Sum_probs=85.7

Q ss_pred             cChHHHHHhcCCCCCC-----CeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCC--cccee
Q 043074           72 ISMSELIDATDNFSTD-----KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN--IVKIL  144 (373)
Q Consensus        72 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~  144 (373)
                      ++.+++......|...     +.|+.|....+|+....++ .+++|.......  ...+..|..++..+...+  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCccc
Confidence            4455565555566653     3456688889999987655 688998865311  134556777776663212  23333


Q ss_pred             eE------EeeCCeeEEEEEecCCCCHHH--------------HhhcCCCCCCCCcccccCCCCCCCHHHHHH-------
Q 043074          145 GY------CASGLDRVLIYEFVENGSLDQ--------------WLHDTSRNDDVDGSKQLNSLCPLSWETRVK-------  197 (373)
Q Consensus       145 ~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~-------  197 (373)
                      ..      ....+..++++++++|..+..              .++.....  ..... ........|.....       
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~--~~~~~-~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEG--FEIKR-PNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTT--CCCCC-BCTTSHHHHHHHHHHHGGGGG
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhcc--CCCcc-cCccChHHHHHHHHHHHHHHH
Confidence            21      122356789999998765321              11111100  00000 00000011211100       


Q ss_pred             -----HHHHHHHHHHHHhc-----CCCCceeecCCCCceEeCCCCceEEeeeccccc
Q 043074          198 -----IVRGVANGLAYLHG-----LEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       198 -----i~~qi~~~l~~lh~-----~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                           +...+...++.+..     ....++|+|+.+.||++++++.+.++||+.+..
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                 00113333444431     234689999999999998876668999987753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.54  E-value=0.00025  Score=63.92  Aligned_cols=146  Identities=15%  Similarity=0.230  Sum_probs=82.3

Q ss_pred             CeeecCCCceEEEEEeC--------CCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEE
Q 043074           88 KIIGDGSFGFVYKAKLS--------SGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      +.+..|-...+|+....        +++.+++|+.... ......+.+|..+++.+. +.-..++++++.++    +|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence            56777889999999764        2578999986432 223456678999988884 32235666666542    8999


Q ss_pred             ecCCCCHHHH--------------hhcCCCCCCCCcccccCCCCCC-CHHHHHHHHHHHHH-------------------
Q 043074          159 FVENGSLDQW--------------LHDTSRNDDVDGSKQLNSLCPL-SWETRVKIVRGVAN-------------------  204 (373)
Q Consensus       159 ~~~~g~L~~~--------------l~~~~~~~~~~~~~~~~~~~~l-~~~~~~~i~~qi~~-------------------  204 (373)
                      |++|.+|..-              +.+..... .+    +.. .+. -|.++.++..++..                   
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~-~~----~~~-~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  204 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGME-MP----FTK-EPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD  204 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCC-CS----SCC-SCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCC-CC----CCC-CcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence            9987655311              11000000 00    000 011 23445555444321                   


Q ss_pred             HHHH----Hhc--CCCCceeecCCCCceEeCCC----CceEEeeeccccc
Q 043074          205 GLAY----LHG--LEKPIIHRDIKSSNVLLDSD----FEAHISDFGLARR  244 (373)
Q Consensus       205 ~l~~----lh~--~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~~~  244 (373)
                      .+..    |..  ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            1222    221  13358999999999999876    7899999988753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.53  E-value=0.0026  Score=56.07  Aligned_cols=74  Identities=8%  Similarity=0.012  Sum_probs=48.1

Q ss_pred             eeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCC--CccceeeE-----EeeCCeeEEEEEecC
Q 043074           89 IIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHR--NIVKILGY-----CASGLDRVLIYEFVE  161 (373)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~~  161 (373)
                      .++ |....||+....+|+.+++|....... ....+..|...+..+...  .+.+++..     ....+..++++++++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            466 888899998777777899999864322 234566788777776421  23344432     122456678999998


Q ss_pred             CCC
Q 043074          162 NGS  164 (373)
Q Consensus       162 ~g~  164 (373)
                      |..
T Consensus       111 G~~  113 (328)
T 1zyl_A          111 GRQ  113 (328)
T ss_dssp             CEE
T ss_pred             CCC
Confidence            754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.50  E-value=0.00025  Score=65.35  Aligned_cols=73  Identities=18%  Similarity=0.196  Sum_probs=49.3

Q ss_pred             CCeeecCCCceEEEEEeCC--------CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCc-cceeeEEeeCCeeEEEE
Q 043074           87 DKIIGDGSFGFVYKAKLSS--------GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI-VKILGYCASGLDRVLIY  157 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  157 (373)
                      .+.|+.|....+|+....+        +..+++|+......  ...+..|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3467888899999998653        57899998843211  1455678888888853333 566666543    2899


Q ss_pred             EecCCCCH
Q 043074          158 EFVENGSL  165 (373)
Q Consensus       158 e~~~~g~L  165 (373)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99976443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.42  E-value=0.00065  Score=62.90  Aligned_cols=73  Identities=23%  Similarity=0.180  Sum_probs=46.8

Q ss_pred             CeeecCCCceEEEEEeCC-CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCc-cceeeEEeeCCeeEEEEEecCCCCH
Q 043074           88 KIIGDGSFGFVYKAKLSS-GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI-VKILGYCASGLDRVLIYEFVENGSL  165 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L  165 (373)
                      +.|+.|-...+|+....+ +..+++|+........ -....|..++..+...++ .++++++..    .+|+||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence            457788889999998764 4788899875432211 112478888888865444 466766632    259999987544

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.09  E-value=0.00075  Score=60.79  Aligned_cols=73  Identities=16%  Similarity=0.157  Sum_probs=43.8

Q ss_pred             CeeecCCCceEEEEEeCC---------CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCC-ccceeeEEeeCCeeEEEE
Q 043074           88 KIIGDGSFGFVYKAKLSS---------GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN-IVKILGYCASGLDRVLIY  157 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  157 (373)
                      +.++.|....+|+....+         +..+++|+....... ......|..+++.+...+ ..++++..  .  -++|+
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            457788889999997653         268888887543221 112357888887775333 34566544  2  36899


Q ss_pred             EecCCCCH
Q 043074          158 EFVENGSL  165 (373)
Q Consensus       158 e~~~~g~L  165 (373)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.09  E-value=0.0016  Score=57.87  Aligned_cols=31  Identities=26%  Similarity=0.309  Sum_probs=27.5

Q ss_pred             CCceeecCCCCceEeCCCCceEEeeeccccc
Q 043074          214 KPIIHRDIKSSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       214 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                      ..++|+|+.+.||++++++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4689999999999999888899999987754

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=96.75  E-value=0.0043  Score=35.95  Aligned_cols=28  Identities=11%  Similarity=0.118  Sum_probs=12.8

Q ss_pred             CcchhHHHHHHHHHHHHHHHHHHHHHHH
Q 043074            2 GPSIQALIAAAASFVVITLIFAIMLLFC   29 (373)
Q Consensus         2 ~~~~~~ii~~~~~~~~i~~~~~~~~~~~   29 (373)
                      ++.+.+|.+.+++.+++++++++.++++
T Consensus         6 ~s~~~aIA~gVVgGv~~v~ii~~~~~~~   33 (44)
T 2l2t_A            6 HARTPLIAAGVIGGLFILVIVGLTFAVY   33 (44)
T ss_dssp             SCSSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcceEEEeehHHHHHHHHHHHHHHHH
Confidence            3445555555555444444333333333

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=96.13  E-value=0.016  Score=33.47  Aligned_cols=29  Identities=14%  Similarity=0.372  Sum_probs=12.0

Q ss_pred             chhHHHHHHHHHHHHHHHHH-HHHHHHHhh
Q 043074            4 SIQALIAAAASFVVITLIFA-IMLLFCKRT   32 (373)
Q Consensus         4 ~~~~ii~~~~~~~~i~~~~~-~~~~~~~~~   32 (373)
                      .+..+.+.++++++++++.. +++|+++|+
T Consensus        10 ~~~~Ia~~vVGvll~vi~~l~~~~~~RRR~   39 (44)
T 2jwa_A           10 PLTSIISAVVGILLVVVLGVVFGILIKRRQ   39 (44)
T ss_dssp             SHHHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             cccchHHHHHHHHHHHHHHHHHHhheehhh
Confidence            34445555555333333333 333444443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.06  E-value=0.011  Score=54.04  Aligned_cols=74  Identities=18%  Similarity=0.214  Sum_probs=47.8

Q ss_pred             CCeeecCCCceEEEEEeCC--------CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCC-ccceeeEEeeCCeeEEEE
Q 043074           87 DKIIGDGSFGFVYKAKLSS--------GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRN-IVKILGYCASGLDRVLIY  157 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  157 (373)
                      .+.+..|-...+|+....+        +..+++++....... .-...+|..+++.+...+ ..++++.+.    -++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3467778899999998753        578999987543221 112357888887774223 345555332    37899


Q ss_pred             EecCCCCH
Q 043074          158 EFVENGSL  165 (373)
Q Consensus       158 e~~~~g~L  165 (373)
                      ||++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99988654

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=95.93  E-value=0.0083  Score=34.86  Aligned_cols=14  Identities=0%  Similarity=0.254  Sum_probs=5.5

Q ss_pred             HHHHHHHHHHHHHH
Q 043074            9 IAAAASFVVITLIF   22 (373)
Q Consensus         9 i~~~~~~~~i~~~~   22 (373)
                      .+++++++++++++
T Consensus        15 ~gVVgGv~~~~ii~   28 (44)
T 2ks1_B           15 TGMVGALLLLLVVA   28 (44)
T ss_dssp             HHHHHHHHHHHHHH
T ss_pred             eehhHHHHHHHHHH
Confidence            33444344433333

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.73  E-value=0.092  Score=47.63  Aligned_cols=29  Identities=24%  Similarity=0.405  Sum_probs=24.7

Q ss_pred             ceeecCCCCceEe------CCCCceEEeeeccccc
Q 043074          216 IIHRDIKSSNVLL------DSDFEAHISDFGLARR  244 (373)
Q Consensus       216 i~H~dlk~~Nill------~~~~~~kl~Dfg~~~~  244 (373)
                      ++|+|+.+.||++      +++..+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567799999988754

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=92.36  E-value=0.074  Score=30.55  Aligned_cols=10  Identities=20%  Similarity=0.238  Sum_probs=4.3

Q ss_pred             HHHHHHHHHH
Q 043074            8 LIAAAASFVV   17 (373)
Q Consensus         8 ii~~~~~~~~   17 (373)
                      ++++++++++
T Consensus        16 ~~~vv~Gv~l   25 (41)
T 2k9y_A           16 IGGVAVGVVL   25 (41)
T ss_dssp             HHHHHHHHHH
T ss_pred             EeehhHHHHH
Confidence            3444444444

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=92.35  E-value=0.27  Score=27.52  Aligned_cols=13  Identities=8%  Similarity=0.151  Sum_probs=5.6

Q ss_pred             hhHHHHHHHHHHH
Q 043074            5 IQALIAAAASFVV   17 (373)
Q Consensus         5 ~~~ii~~~~~~~~   17 (373)
                      ..+|.+++++.++
T Consensus        10 ~GaIAGiVvG~v~   22 (38)
T 2k1k_A           10 GGEIVAVIFGLLL   22 (38)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             CCceeeeehHHHH
Confidence            3344444444443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.89  E-value=0.7  Score=37.62  Aligned_cols=82  Identities=7%  Similarity=0.048  Sum_probs=59.6

Q ss_pred             CCCCccceeeEEeeCCeeEEEEEecCCC-CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHH-HHhcCC
Q 043074          136 RHRNIVKILGYCASGLDRVLIYEFVENG-SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLA-YLHGLE  213 (373)
Q Consensus       136 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~-~lh~~~  213 (373)
                      .||++  -..+-.+.+...+.++.-+++ ++. .+..                  ++..++++++.+|+.... +++   
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~~------------------~~~~eKlrll~nl~~L~~~~~~---  103 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIRK------------------TTLLSRIRAAIHLVSKVKHHSA---  103 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHHT------------------SCHHHHHHHHHHHHHHHSSCCS---
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHHh------------------cCHHHHHHHHHHHHHHHHHhhh---
Confidence            58888  344446667777777765444 333 3332                  788999999999887666 554   


Q ss_pred             CCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          214 KPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       214 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                       .-+|--+.|+|++++.++.+++.-.|+-
T Consensus       104 -~r~tf~l~P~NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          104 -RRLIFIVCPENLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             -SSEECCCCGGGEEECTTCCEEESCCEET
T ss_pred             -CceeEEEeCceEEEeCCCcEEEEEcCCc
Confidence             2678889999999999999999877764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.94  E-value=0.64  Score=37.69  Aligned_cols=116  Identities=9%  Similarity=0.049  Sum_probs=75.9

Q ss_pred             CCCCccceeeEEeeCCeeEEEEEecCCC-CHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 043074          136 RHRNIVKILGYCASGLDRVLIYEFVENG-SLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEK  214 (373)
Q Consensus       136 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~  214 (373)
                      .||++++. .+-.+.+...+.++.-+.+ ++.. +.                  .++...+++++.+|+....+++  . 
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik------------------~~~~~eKlr~l~ni~~l~~~~~--~-   99 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK------------------SFTKNEKLRYLLNIKNLEEVNR--T-   99 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG------------------GSCHHHHHHHHHHGGGGGGGGG--S-
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH------------------hcCHHHHHHHHHHHHHHHHHhc--C-
Confidence            68988876 4556666655555544322 2222 22                  2788999999999988776665  2 


Q ss_pred             CceeecCCCCceEeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCC
Q 043074          215 PIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI  294 (373)
Q Consensus       215 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~  294 (373)
                       -+|--|.|+|++++.++.+++.-.|+-..                  ++|..+      +...=.-.+=+++..+++++
T Consensus       100 -r~tf~L~P~NL~f~~~~~p~i~~RGik~~------------------l~P~~~------~ee~fL~qyKAliiall~~K  154 (215)
T 4ann_A          100 -RYTFVLAPDELFFTRDGLPIAKTRGLQNV------------------VDPLPV------SEAEFLTRYKALVICAFNEK  154 (215)
T ss_dssp             -SEECCCSGGGEEECTTSCEEESCCEETTT------------------BSCCCC------CHHHHHHHHHHHHHHHHCTT
T ss_pred             -ceEEEEecceEEEcCCCCEEEEEccCccC------------------CCCCCC------CHHHHHHHHHHHHHHHHcCC
Confidence             57888999999999999999987775432                  233211      11222335567778888877


Q ss_pred             CCCCC
Q 043074          295 RPNLP  299 (373)
Q Consensus       295 ~p~~~  299 (373)
                      ..|..
T Consensus       155 ~~Fe~  159 (215)
T 4ann_A          155 QSFDA  159 (215)
T ss_dssp             CCHHH
T ss_pred             CCHHH
Confidence            76443

>2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens}

Probab=90.24  E-value=1.4  Score=26.65  Aligned_cols=26  Identities=8%  Similarity=0.107  Sum_probs=13.0

Q ss_pred             chhHHHHHHHHHHHHHHHHHHHHHHH
Q 043074            4 SIQALIAAAASFVVITLIFAIMLLFC   29 (373)
Q Consensus         4 ~~~~ii~~~~~~~~i~~~~~~~~~~~   29 (373)
                      .++++++.+++.++++.++++++|-|
T Consensus        11 p~wiIi~svl~GLllL~li~~~LwK~   36 (54)
T 2knc_A           11 PIWWVLVGVLGGLLLLTILVLAMWKV   36 (54)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHHHHHHHHHHc
Confidence            34555555555555444455555444

>2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens}

Probab=89.74  E-value=1.2  Score=26.88  Aligned_cols=26  Identities=8%  Similarity=0.175  Sum_probs=13.1

Q ss_pred             hhHHHHHHHHHHHHHHHHHHHHHHHH
Q 043074            5 IQALIAAAASFVVITLIFAIMLLFCK   30 (373)
Q Consensus         5 ~~~ii~~~~~~~~i~~~~~~~~~~~~   30 (373)
                      +++|++.+++.++++.++++++|-|.
T Consensus         9 ~WiIi~svl~GLLLL~Lii~~LwK~G   34 (54)
T 2l8s_A            9 LWVILLSAFAGLLLLMLLILALWKIG   34 (54)
T ss_dssp             THHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHHHHHHHcC
Confidence            45555555555554444555555443

>1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1

Probab=89.65  E-value=0.088  Score=28.67  Aligned_cols=9  Identities=22%  Similarity=0.302  Sum_probs=3.9

Q ss_pred             hHHHHHHHH
Q 043074            6 QALIAAAAS   14 (373)
Q Consensus         6 ~~ii~~~~~   14 (373)
                      ..+.+.+++
T Consensus         8 ~sIaagVvg   16 (35)
T 1iij_A            8 TFIIATVVG   16 (35)
T ss_dssp             HHHHHHHHH
T ss_pred             cEeHHHHHH
Confidence            334444444

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=87.89  E-value=0.87  Score=26.34  Aligned_cols=20  Identities=15%  Similarity=0.313  Sum_probs=11.6

Q ss_pred             hhHHHHHHHHHHHHHHHHHH
Q 043074            5 IQALIAAAASFVVITLIFAI   24 (373)
Q Consensus         5 ~~~ii~~~~~~~~i~~~~~~   24 (373)
                      +..+++.+++++++++++.+
T Consensus        14 A~gVVgGv~~~~ii~~~~~~   33 (44)
T 2ks1_B           14 ATGMVGALLLLLVVALGIGL   33 (44)
T ss_dssp             THHHHHHHHHHHHHHHHHHH
T ss_pred             EeehhHHHHHHHHHHHHHHH
Confidence            45566655565565566554

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=85.91  E-value=1.1  Score=25.92  Aligned_cols=30  Identities=20%  Similarity=0.068  Sum_probs=16.9

Q ss_pred             hhHHHHHHHHHHHHHHHHHHHHHHHHhhcC
Q 043074            5 IQALIAAAASFVVITLIFAIMLLFCKRTYK   34 (373)
Q Consensus         5 ~~~ii~~~~~~~~i~~~~~~~~~~~~~~~~   34 (373)
                      +.+.+...+.+++++++...+++.++++++
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~~   41 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKSIKK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence            444444434444445577777778876554

>1pi7_A VPU protein, U ORF protein; alpha helix, viral protein; NMR {Human immunodeficiency virus 1} SCOP: j.35.1.1 PDB: 1pi8_A 1pje_A 2gof_A 2goh_A 2jpx_A

Probab=85.81  E-value=1.9  Score=23.61  Aligned_cols=34  Identities=18%  Similarity=0.379  Sum_probs=15.5

Q ss_pred             CCcchhHHHHHHHHHHHHHHHHHHHHHHHHhhcC
Q 043074            1 MGPSIQALIAAAASFVVITLIFAIMLLFCKRTYK   34 (373)
Q Consensus         1 ~~~~~~~ii~~~~~~~~i~~~~~~~~~~~~~~~~   34 (373)
                      |.+...++++.++++.+.+++=.+++.-|++..|
T Consensus         1 M~~l~i~ivalivalIiaIVVWtiv~ieYrk~~k   34 (36)
T 1pi7_A            1 MQPIQIAIVALVVAIIIAIVVWSIVIIEGRGGKK   34 (36)
T ss_pred             CchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence            3444334555444444444444444444554443

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.09  E-value=0.13  Score=47.50  Aligned_cols=62  Identities=8%  Similarity=0.074  Sum_probs=18.5

Q ss_pred             CCCCeeecCCCceEEEEEeCC-CCEEEE------EEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEee
Q 043074           85 STDKIIGDGSFGFVYKAKLSS-GVTVAI------KKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCAS  149 (373)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  149 (373)
                      .+.+.+|   ||.||+|.+.. ..+||+      |.......  +....+.+|..++..++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            3456666   99999998753 467888      66543222  223467788899999999999999887643

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=83.36  E-value=1.7  Score=25.08  Aligned_cols=7  Identities=14%  Similarity=0.041  Sum_probs=2.9

Q ss_pred             HHHHHHH
Q 043074           11 AAASFVV   17 (373)
Q Consensus        11 ~~~~~~~   17 (373)
                      ++++++.
T Consensus        14 Ia~~vVG   20 (44)
T 2jwa_A           14 IISAVVG   20 (44)
T ss_dssp             HHHHHHH
T ss_pred             hHHHHHH
Confidence            3444444

>2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B

Probab=82.80  E-value=2.5  Score=22.68  Aligned_cols=26  Identities=23%  Similarity=0.330  Sum_probs=11.8

Q ss_pred             chhHHHHHHHHHHHHHHHHHHHHHHH
Q 043074            4 SIQALIAAAASFVVITLIFAIMLLFC   29 (373)
Q Consensus         4 ~~~~ii~~~~~~~~i~~~~~~~~~~~   29 (373)
                      +..++.+.+++-++..+++++.+|+.
T Consensus         5 ~~gaIaGIVvgdi~~t~~i~~~vy~~   30 (33)
T 2l34_A            5 SPGVLAGIVVGDLVLTVLIALAVYFL   30 (33)
T ss_dssp             CTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CcceEEeEeHHHHHHHHHHHHHHhhe
Confidence            33445555555544444444444433

>2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A

Probab=81.78  E-value=3.5  Score=23.52  Aligned_cols=25  Identities=8%  Similarity=0.106  Sum_probs=12.3

Q ss_pred             hhHHHHHHHHHHHHHHHHHHHHHHH
Q 043074            5 IQALIAAAASFVVITLIFAIMLLFC   29 (373)
Q Consensus         5 ~~~ii~~~~~~~~i~~~~~~~~~~~   29 (373)
                      ++++++.+++.++++.+++.+++-|
T Consensus        10 ~wiIi~s~l~GLllL~li~~~LwK~   34 (42)
T 2k1a_A           10 IWWVLVGVLGGLLLLTILVLAMWKV   34 (42)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHHHHHHHHHHHHc
Confidence            4455555555544444444444444

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	373
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-69
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-65
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-61
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-61
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-60
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-59
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-56
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-54
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-54
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-53
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-51
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-50
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-48
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-43
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-38
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-35
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (555), Expect = 1e-69
 Identities = 79/293 (26%), Positives = 122/293 (41%), Gaps = 33/293 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
              +  + IG GSFG VYK K    V V +  +     Q  + F+ E+  L K RH NI+
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
             +GY  +     ++ ++ E  SL   LH                         + I R 
Sbjct: 68  LFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIET--------------KFEMIKLIDIARQ 112

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDT-SHSHVSTQVAGTM 260
            A G+ YLH   K IIHRD+KS+N+ L  D    I DFGLA      S SH   Q++G++
Sbjct: 113 TAQGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170

Query: 261 GYMPPEYL--GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA 318
            +M PE +        +   DVY+FGI++ E+ T   P      +      + +      
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIFMVGRGY 226

Query: 319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            + ++  V SN           +   R+   C  +K  ERP    ++  ++ L
Sbjct: 227 LSPDLSKVRSNCP---------KAMKRLMAECLKKKRDERPLFPQILASIELL 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 9e-65
 Identities = 70/290 (24%), Positives = 126/290 (43%), Gaps = 35/290 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           +     + +G G FG V+    +    VA+K L + +      F AE   + +L+H+ +V
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++           +I E++ENGSL  +L   S                L+    + +   
Sbjct: 72  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGI-------------KLTINKLLDMAAQ 117

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +A G+A++   E+  IHRD++++N+L+       I+DFGLAR I+ +           + 
Sbjct: 118 IAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK 321
           +  PE +   T  T+  DV+SFGIL+ EI T  R   P + + + +  LE    M     
Sbjct: 176 WTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---- 230

Query: 322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
                  N            E +++  +C  E+  +RP   Y+  +L++ 
Sbjct: 231 ----RPDNCP---------EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 3e-62
 Identities = 70/296 (23%), Positives = 123/296 (41%), Gaps = 36/296 (12%)

Query: 77  LIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR 136
           +ID     +  + IG G FG V+     +   VAIK + + A     +F  E E + KL 
Sbjct: 1   VIDP-SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLS 58

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H  +V++ G C       L++EF+E+G L  +L                     + ET +
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--------------TQRGLFAAETLL 104

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            +   V  G+AYL   E  +IHRD+ + N L+  +    +SDFG+ R +       ST  
Sbjct: 105 GMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM 316
              + +  PE    +   +   DV+SFG+LM E+ ++ +                 +  +
Sbjct: 163 KFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIP---------YENRSNSEVV 212

Query: 317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV 372
           E  +    +    ++   + +        I   C  E+  +RPA S +++ L E+ 
Sbjct: 213 EDISTGFRLYKPRLASTHVYQ--------IMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  199 bits (506), Expect = 4e-62
 Identities = 78/316 (24%), Positives = 139/316 (43%), Gaps = 37/316 (11%)

Query: 73  SMSELIDATDNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQGFR-EF 125
            +  L    +N    + IG+G+FG V++A+            VA+K L ++A    + +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 126 RAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLN 185
           + E   + +  + NIVK+LG CA G    L++E++  G L+++L   S +     S    
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 186 SL---------CPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI 236
           S           PLS   ++ I R VA G+AYL   E+  +HRD+ + N L+  +    I
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKI 181

Query: 237 SDFGLARRI-DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIR 295
           +DFGL+R I    +       A  + +MPPE +  N   T   DV+++G+++ EI +   
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGL 240

Query: 296 PNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKS 355
                       G+         R+  I     N            E + +  +C ++  
Sbjct: 241 QPYY--------GMAHEEVIYYVRDGNILACPENCP---------LELYNLMRLCWSKLP 283

Query: 356 RERPAMSYVVQLLDEL 371
            +RP+   + ++L  +
Sbjct: 284 ADRPSFCSIHRILQRM 299

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 1e-61
 Identities = 64/290 (22%), Positives = 114/290 (39%), Gaps = 35/290 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
           ++   +  +G G FG V+    +    VAIK L          F  E + + KLRH  +V
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           ++    +      ++ E++  GSL  +L   +                L     V +   
Sbjct: 76  QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGK-------------YLRLPQLVDMAAQ 121

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
           +A+G+AY+       +HRD++++N+L+  +    ++DFGLAR I+ +           + 
Sbjct: 122 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 179

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK 321
           +  PE        T+  DV+SFGIL+ E+ T+ R   P                    N+
Sbjct: 180 WTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYP-----------------GMVNR 221

Query: 322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           E+        R             + C C  ++  ERP   Y+   L++ 
Sbjct: 222 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 8e-61
 Identities = 64/294 (21%), Positives = 114/294 (38%), Gaps = 36/294 (12%)

Query: 78  IDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH 137
           ID   + +  K +G G FG V   K      VAIK + + +     EF  E + +  L H
Sbjct: 1   IDP-KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSH 58

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +V++ G C       +I E++ NG L  +L +                     +  ++
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--------------RFQTQQLLE 104

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           + + V   + YL    K  +HRD+ + N L++      +SDFGL+R +       S    
Sbjct: 105 MCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 162

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME 317
             + + PPE L  +   +   D+++FG+LM EI +  +                      
Sbjct: 163 FPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYE-----------------R 204

Query: 318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
             N E     +   R         + + I   C +EK+ ERP    ++  + ++
Sbjct: 205 FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 8e-61
 Identities = 81/304 (26%), Positives = 127/304 (41%), Gaps = 31/304 (10%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +  S  K +G G+FG V +A         + +TVA+K L   A    RE   +E++ L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH---DTSRNDDVDGSKQLNSLCPL 190
           L  H NIV +LG C  G   ++I E+   G L  +L    D+        +   +    L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSH 249
             E  +     VA G+A+L    K  IHRD+ + N+LL       I DFGLAR I + S+
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 250 SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL 309
             V       + +M PE +      T   DV+S+GI + E+ +                 
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSS------------- 246

Query: 310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD 369
                 M   +K  +M+     R    E    E + I   C +    +RP    +VQL++
Sbjct: 247 --PYPGMPVDSKFYKMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

Query: 370 ELVA 373
           + ++
Sbjct: 304 KQIS 307

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 2e-60
 Identities = 69/305 (22%), Positives = 119/305 (39%), Gaps = 39/305 (12%)

Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYC 147
           + IG G FG V++ K   G  VA+K       + +    AE+     LRH NI+  +   
Sbjct: 9   ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 66

Query: 148 ----ASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVA 203
                +     L+ ++ E+GSL  +L+                   ++ E  +K+    A
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRY----------------TVTVEGMIKLALSTA 110

Query: 204 NGLAYLH------GLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS---T 254
           +GLA+LH        +  I HRD+KS N+L+  +    I+D GLA R D++   +     
Sbjct: 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 170

Query: 255 QVAGTMGYMPPEYL-----GGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ---E 306
              GT  YM PE L       +  +    D+Y+ G++  EIA +               +
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230

Query: 307 VGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ 366
           +   + +     +    + +  NI     S   +R   +I   C       R     + +
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

Query: 367 LLDEL 371
            L +L
Sbjct: 291 TLSQL 295

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 5e-60
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 22/219 (10%)

Query: 80  ATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRH 137
             D+F     +G G+ G V+K     SG+ +A K +  +     R     E++ L +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             IV   G   S  +  +  E ++ GSLDQ L    R               +  +   K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------------IPEQILGK 108

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           +   V  GL YL   +  I+HRD+K SN+L++S  E  + DFG++ ++      ++    
Sbjct: 109 VSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFV 164

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  YM PE L G    +V  D++S G+ ++E+A    P
Sbjct: 165 GTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYP 202

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 1e-59
 Identities = 79/305 (25%), Positives = 125/305 (40%), Gaps = 36/305 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGK 134
           +N    K++G G+FG V  A      K    + VA+K L + A    RE   +E++ + +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 135 L-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLH--------DTSRNDDVDGSKQLN 185
           L  H NIV +LG C       LI+E+   G L  +L         D    ++    ++  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
            L  L++E  +     VA G+ +L    K  +HRD+ + NVL+       I DFGLAR I
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 246 DT-SHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDG 304
            + S+  V       + +M PE L      T+  DV+S+GIL+ EI +      P     
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYP----- 268

Query: 305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYV 364
                          +     +  N  + +       E + I   C    SR+RP+   +
Sbjct: 269 -----------GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317

Query: 365 VQLLD 369
              L 
Sbjct: 318 TSFLG 322

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  192 bits (490), Expect = 1e-59
 Identities = 76/307 (24%), Positives = 119/307 (38%), Gaps = 47/307 (15%)

Query: 66  DPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG--- 121
           DP ++++   +  D    FS  + IG GSFG VY A+ + +   VAIKK+     Q    
Sbjct: 1   DPDVAELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 58

Query: 122 FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS 181
           +++   E+  L KLRH N ++  G         L+ E+    + D               
Sbjct: 59  WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-------- 110

Query: 182 KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL 241
                  PL       +  G   GLAYLH     +IHRD+K+ N+LL       + DFG 
Sbjct: 111 -------PLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGS 161

Query: 242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRPNLP 299
           A  +  ++S V     GT  +M PE +           +DV+S GI  IE+A +  P   
Sbjct: 162 ASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP--- 213

Query: 300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP 359
                     L     M A     +     +     SE     +      C  +  ++RP
Sbjct: 214 ----------LFNMNAMSALYHIAQNESPALQSGHWSE----YFRNFVDSCLQKIPQDRP 259

Query: 360 AMSYVVQ 366
               +++
Sbjct: 260 TSEVLLK 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 3e-59
 Identities = 66/303 (21%), Positives = 115/303 (37%), Gaps = 42/303 (13%)

Query: 76  ELIDATDNFSTDKI-IGDGSFGFVYKAKL---SSGVTVAIKKLDKDAFQGFRE-FRAEME 130
           +L    DN     I +G G+FG V +         + VAIK L +   +   E    E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 131 TLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL 190
            + +L +  IV+++G C      +L+ E    G L ++L                    +
Sbjct: 62  IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--------------EI 106

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTS 248
                 +++  V+ G+ YL   EK  +HRD+ + NVLL +   A ISDFGL++ +  D S
Sbjct: 107 PVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164

Query: 249 HSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG 308
           +    +     + +  PE +      +   DV+S+G+ M E  +  +             
Sbjct: 165 YYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYK--------- 214

Query: 309 LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLL 368
                   + +  E+        R E       E + +   C   K  +RP    V Q +
Sbjct: 215 --------KMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

Query: 369 DEL 371
              
Sbjct: 267 RAC 269

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 3e-59
 Identities = 65/291 (22%), Positives = 112/291 (38%), Gaps = 41/291 (14%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIV 141
                 + IG G FG V       G  VA+K +  DA    + F AE   + +LRH N+V
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 142 KILGYCASGLDRV-LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           ++LG        + ++ E++  GSL  +L    R+              L  +  +K   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-------------VLGGDCLLKFSL 110

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTM 260
            V   + YL       +HRD+ + NVL+  D  A +SDFGL +   ++           +
Sbjct: 111 DVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPV 164

Query: 261 GYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARN 320
            +  PE L      +   DV+SFGIL+ EI +  R   P                     
Sbjct: 165 KWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYP-----------------RIPL 206

Query: 321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
           K++        + +  +      + +   C +  +  RP+   + + L+ +
Sbjct: 207 KDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  190 bits (484), Expect = 7e-59
 Identities = 68/309 (22%), Positives = 131/309 (42%), Gaps = 37/309 (11%)

Query: 64  SFDPSLSQISMSELIDATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGF 122
           + DPS       E+     + +    +G G +G VY+       +TVA+K L +D  +  
Sbjct: 1   AMDPSSPNYDKWEM--ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV- 57

Query: 123 REFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSK 182
            EF  E   + +++H N+V++LG C       +I EF+  G+L  +L + +R        
Sbjct: 58  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------- 110

Query: 183 QLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA 242
                  +S    + +   +++ + YL   +K  IHRD+ + N L+  +    ++DFGL+
Sbjct: 111 ------EVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLS 162

Query: 243 RRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVL 302
           R +              + +  PE L  N   ++  DV++FG+L+ EIAT      P   
Sbjct: 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYP--- 218

Query: 303 DGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMS 362
                            ++  E+++ +  R E  E    + + +   C      +RP+ +
Sbjct: 219 -------------GIDLSQVYELLEKDY-RMERPEGCPEKVYELMRACWQWNPSDRPSFA 264

Query: 363 YVVQLLDEL 371
            + Q  + +
Sbjct: 265 EIHQAFETM 273

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 2e-58
 Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 22/224 (9%)

Query: 78  IDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR 136
           ++  D +     +GDG+FG VYKA+   + V  A K +D  + +   ++  E++ L    
Sbjct: 8   LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIVK+L       +  ++ EF   G++D  + +  R              PL+     
Sbjct: 68  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--------------PLTESQIQ 113

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
            + +   + L YLH  +  IIHRD+K+ N+L   D +  ++DFG++ +   +     + +
Sbjct: 114 VVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171

Query: 257 AGTMGYMPPEYLGGNTAA----TVMLDVYSFGILMIEIATQIRP 296
            GT  +M PE +   T+         DV+S GI +IE+A    P
Sbjct: 172 -GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  187 bits (475), Expect = 2e-57
 Identities = 68/318 (21%), Positives = 127/318 (39%), Gaps = 52/318 (16%)

Query: 73  SMSELIDATDNFST---------DKIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAF 119
           +  +  +A   F+          +++IG G FG V    L       + VAIK L     
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 120 -QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDV 178
            +  R+F +E   +G+  H N++ + G        ++I EF+ENGSLD +L         
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-------- 119

Query: 179 DGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD 238
                  +    +    V ++RG+A G+ YL   +   +HRD+ + N+L++S+    +SD
Sbjct: 120 ------QNDGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSD 171

Query: 239 FGLARRIDTSHSHV----STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQI 294
           FGL+R ++   S      +      + +  PE +      +   DV+S+GI+M E+ +  
Sbjct: 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS-ASDVWSYGIVMWEVMSYG 230

Query: 295 RPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEK 354
                                 +  N+++        R            ++   C  + 
Sbjct: 231 ERPYW-----------------DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKD 273

Query: 355 SRERPAMSYVVQLLDELV 372
              RP    +V  LD+++
Sbjct: 274 RNHRPKFGQIVNTLDKMI 291

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 7e-57
 Identities = 76/297 (25%), Positives = 129/297 (43%), Gaps = 28/297 (9%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSG---VTVAIKKLDKDAF-QGFREFRAEMETLGKL-R 136
           ++     +IG+G+FG V KA++      +  AIK++ + A     R+F  E+E L KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLC-PLSWETR 195
           H NI+ +LG C       L  E+  +G+L  +L  +   +        NS    LS +  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ 255
           +     VA G+ YL   +K  IHRD+ + N+L+  ++ A I+DFGL+R  +       T 
Sbjct: 130 LHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TM 185

Query: 256 VAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART 315
               + +M  E L  +   T   DV+S+G+L+ EI +                       
Sbjct: 186 GRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYC---------------- 228

Query: 316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV 372
                +  E +     R E       E + +   C  EK  ERP+ + ++  L+ ++
Sbjct: 229 GMTCAELYEKLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 1e-56
 Identities = 75/299 (25%), Positives = 132/299 (44%), Gaps = 42/299 (14%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSG-----VTVAIKKLDKDAFQGFR-EFRAEMETLGKL 135
              +  K+IG G FG VYK  L +      V VAIK L     +  R +F  E   +G+ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 136 RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETR 195
            H NI+++ G  +     ++I E++ENG+LD++L +                   S    
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--------------GEFSVLQL 112

Query: 196 VKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI--DTSHSHVS 253
           V ++RG+A G+ YL       +HRD+ + N+L++S+    +SDFGL+R +  D   ++ +
Sbjct: 113 VGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 170

Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA 313
           +     + +  PE +      +   DV+SFGI+M E+ T                     
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERP---------------- 213

Query: 314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV 372
              E  N E+    ++  R           +++   C  ++   RP  + +V +LD+L+
Sbjct: 214 -YWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 7e-56
 Identities = 68/291 (23%), Positives = 115/291 (39%), Gaps = 43/291 (14%)

Query: 87  DKIIGDGSFGFVYKAKL---SSGVTVAIKKLDKDAFQG--FREFRAEMETLGKLRHRNIV 141
           DK +G G+FG V K          TVA+K L  +A       E  AE   + +L +  IV
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
           +++G C +    +L+ E  E G L+++L                    +  +  +++V  
Sbjct: 72  RMIGICEAE-SWMLVMEMAELGPLNKYLQQN---------------RHVKDKNIIELVHQ 115

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQ--VAGT 259
           V+ G+ YL   E   +HRD+ + NVLL +   A ISDFGL++ +    ++   Q      
Sbjct: 116 VSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173

Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR 319
           + +  PE +      +   DV+SFG+LM E  +  +                       +
Sbjct: 174 VKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYR-----------------GMK 215

Query: 320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
             E+  +     R        RE + +  +C       RP  + V   L  
Sbjct: 216 GSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-54
 Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 20/214 (9%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLRHRN 139
           +++   + +G+G++G V  A    +   VA+K +D        E  + E+     L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           +VK  G+   G  + L  E+   G L   +                    +      +  
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---------------MPEPDAQRFF 109

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQVAG 258
             +  G+ YLH     I HRDIK  N+LLD      ISDFGLA      +   +  ++ G
Sbjct: 110 HQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 167

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT 292
           T+ Y+ PE L         +DV+S GI++  +  
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 201

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 3e-54
 Identities = 70/288 (24%), Positives = 107/288 (37%), Gaps = 44/288 (15%)

Query: 87  DKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKI 143
           D  IG GSF  VYK     + V VA  +L          + F+ E E L  L+H NIV+ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 144 LGYCASGLDR----VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
                S +      VL+ E + +G+L  +L                    +  +      
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---------------VMKIKVLRSWC 118

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-DFEAHISDFGLARRIDTSHSHVSTQVAG 258
           R +  GL +LH    PIIHRD+K  N+ +        I D GLA       +  +  V G
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIG 175

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA 318
           T  +M PE           +DVY+FG+ M+E+AT   P                    + 
Sbjct: 176 TPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPY----------------SECQN 217

Query: 319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ 366
             +    V S +      +  + E   I   C  +   ER ++  ++ 
Sbjct: 218 AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 3e-54
 Identities = 71/323 (21%), Positives = 132/323 (40%), Gaps = 48/323 (14%)

Query: 61  DSASFDPSLSQISMSELIDATD---NFSTDKIIGDGSFGFVYKAKL----SSGVTVAIKK 113
           D ++ +P L Q     +I  +    +F  +++IG G FG VY   L       +  A+K 
Sbjct: 5   DLSALNPELVQAVQHVVIGPSSLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62

Query: 114 LDKDAFQGF-REFRAEMETLGKLRHRNIVKILGYCASGLDRV-LIYEFVENGSLDQWLHD 171
           L++    G   +F  E   +    H N++ +LG C        ++  ++++G L  ++ +
Sbjct: 63  LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 122

Query: 172 TSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD 231
            + N               + +  +     VA G+ +L    K  +HRD+ + N +LD  
Sbjct: 123 ETHN--------------PTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEK 166

Query: 232 FEAHISDFGLARRI---DTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMI 288
           F   ++DFGLAR +   +    H  T     + +M  E L      T   DV+SFG+L+ 
Sbjct: 167 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLW 225

Query: 289 EIATQIRPNLPVVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIAC 348
           E+ T+  P  P   D     +  +        +   ++      + L E        +  
Sbjct: 226 ELMTRGAPPYP---DVNTFDITVYLL------QGRRLLQPEYCPDPLYE--------VML 268

Query: 349 MCTNEKSRERPAMSYVVQLLDEL 371
            C + K+  RP+ S +V  +  +
Sbjct: 269 KCWHPKAEMRPSFSELVSRISAI 291

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 3e-54
 Identities = 68/307 (22%), Positives = 116/307 (37%), Gaps = 44/307 (14%)

Query: 74  MSELIDATDNFSTDKIIGDGSFGFVYKAKLSS----GVTVAIKKLDKDAF---QGFREFR 126
           ++ LI    +    + +GDGSFG V + +  +     V+VA+K L  D     +   +F 
Sbjct: 1   LTCLIGE-KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 59

Query: 127 AEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNS 186
            E+  +  L HRN++++ G   +     ++ E    GSL   L                 
Sbjct: 60  REVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQG------------ 106

Query: 187 LCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID 246
                  T  +    VA G+ YL    K  IHRD+ + N+LL +     I DFGL R + 
Sbjct: 107 --HFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162

Query: 247 TSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDG 304
            +  H  +         +  PE L   T  +   D + FG+ + E+ T  +      L+G
Sbjct: 163 QNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWI-GLNG 220

Query: 305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYV 364
            ++               +  +D    R    E   ++ + +   C   K  +RP    +
Sbjct: 221 SQI---------------LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

Query: 365 VQLLDEL 371
              L E 
Sbjct: 266 RDFLLEA 272

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 5e-54
 Identities = 61/293 (20%), Positives = 111/293 (37%), Gaps = 39/293 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHR 138
           +++     IG GS+G   K +  S G  +  K+LD  +      +   +E+  L +L+H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 139 NIVKILGYCASGLDRVL--IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           NIV+         +  L  + E+ E G L   +   ++               L  E  +
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-----------QYLDEEFVL 112

Query: 197 KIVRGVANGLAYLH---GLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
           +++  +   L   H        ++HRD+K +NV LD      + DFGLAR ++   +  +
Sbjct: 113 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFA 171

Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA 313
               GT  YM PE +   +      D++S G L+ E+   + P              +  
Sbjct: 172 KAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPF---------TAFSQKE 221

Query: 314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ 366
              + R  +   +    S          E   I     N K   RP++  +++
Sbjct: 222 LAGKIREGKFRRIPYRYS---------DELNEIITRMLNLKDYHRPSVEEILE 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 7e-54
 Identities = 68/299 (22%), Positives = 125/299 (41%), Gaps = 33/299 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQGFR-EFRAEMETLGK 134
           +  +  + +G GSFG VY+              VAIK +++ A    R EF  E   + +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
               ++V++LG  + G   ++I E +  G L  +L                 L P S   
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP-----AMANNPVLAPPSLSK 134

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI-DTSHSHVS 253
            +++   +A+G+AYL+      +HRD+ + N ++  DF   I DFG+ R I +T +    
Sbjct: 135 MIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192

Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA 313
            +    + +M PE L      T   DV+SFG+++ EIAT        + + Q +  +   
Sbjct: 193 GKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251

Query: 314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV 372
             ++  +   +M+                 F +  MC     + RP+   ++  + E +
Sbjct: 252 GLLDKPDNCPDML-----------------FELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 9e-54
 Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 25/219 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRH 137
           ++F   + +G G FG VY A+   S   +A+K L K          + R E+E    LRH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NI+++ GY        LI E+   G++ + L   S                   +    
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---------------KFDEQRTAT 110

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
            +  +AN L+Y H   K +IHRDIK  N+LL S  E  I+DFG +    +S       + 
Sbjct: 111 YITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLC 165

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT+ Y+PPE + G       +D++S G+L  E      P
Sbjct: 166 GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPP 203

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-53
 Identities = 81/304 (26%), Positives = 126/304 (41%), Gaps = 32/304 (10%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL--------SSGVTVAIKKLDKDAFQ-GFREFRAEMETL 132
           D     K +G+G+FG V  A+         +    VA+K L  DA +    +  +EME +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 133 GKL-RHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDT-SRNDDVDGSKQLNSLCPL 190
             + +H+NI+ +LG C       +I E+   G+L ++L        +   +   N    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS 250
           S +  V     VA G+ YL    K  IHRD+ + NVL+  D    I+DFGLAR I     
Sbjct: 133 SSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 251 HVSTQV-AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL 309
           +  T      + +M PE L      T   DV+SFG+L+ EI T      P          
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYP---------- 239

Query: 310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD 369
                      +E+  +     R +       E + +   C +    +RP    +V+ LD
Sbjct: 240 -------GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

Query: 370 ELVA 373
            +VA
Sbjct: 293 RIVA 296

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 5e-53
 Identities = 64/296 (21%), Positives = 110/296 (37%), Gaps = 40/296 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSS----GVTVAIKKLDKDAFQGFRE-FRAEMETLGKLR 136
           +     + IG+G FG V++    S     + VAIK          RE F  E  T+ +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H +IVK++G         +I E    G L  +L                    L   + +
Sbjct: 67  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ--------------VRKYSLDLASLI 111

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                ++  LAYL    K  +HRDI + NVL+ S+    + DFGL+R ++ S  + +++ 
Sbjct: 112 LYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 169

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM 316
              + +M PE +      +   DV+ FG+ M EI          V +   +G +E    +
Sbjct: 170 KLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228

Query: 317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV 372
                    +  N              + +   C       RP  + +   L  ++
Sbjct: 229 P--------MPPNCP---------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-51
 Identities = 57/306 (18%), Positives = 116/306 (37%), Gaps = 43/306 (14%)

Query: 73  SMSELIDATDNFSTDKIIGDGSFGFVYKAKLSS-----GVTVAIKKLDKDAF-QGFREFR 126
           ++  ++  T+ F   K++G G+FG VYK           + VAIK+L +    +  +E  
Sbjct: 1   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 59

Query: 127 AEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNS 186
            E   +  + + ++ ++LG C +     LI + +  G L  ++ +   N           
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNI---------- 108

Query: 187 LCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID 246
                 +  +     +A G+ YL   ++ ++HRD+ + NVL+ +     I+DFGLA+ + 
Sbjct: 109 ----GSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162

Query: 247 TSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQ 305
                + +      + +M  E +      T   DV+S+G+ + E+ T             
Sbjct: 163 AEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYD------ 215

Query: 306 EVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVV 365
                           EI  +     R         + + I   C    +  RP    ++
Sbjct: 216 -----------GIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 264

Query: 366 QLLDEL 371
               ++
Sbjct: 265 IEFSKM 270

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 4e-51
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 21/219 (9%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH 137
           D    ++  + IG G+ G VY A  +++G  VAI++++            E+  + + ++
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
            NIV  L     G +  ++ E++  GSL   + +T                 +       
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----------------CMDEGQIAA 120

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
           + R     L +LH     +IHRDIKS N+LL  D    ++DFG   +I    S  ST V 
Sbjct: 121 VCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 177

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  +M PE +    A    +D++S GI+ IE+     P
Sbjct: 178 GTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPP 215

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-50
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 30/302 (9%)

Query: 82  DNFSTDKIIGDGSFGFVYKA------KLSSGVTVAIKKLDKDAFQG-FREFRAEMETLGK 134
           D     K +G G+FG V +A      K ++  TVA+K L + A     R   +E++ L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 135 -LRHRNIVKILGYCASGLDRVLI-YEFVENGSLDQWLHDTSRN-DDVDGSKQLNSLCPLS 191
              H N+V +LG C      +++  EF + G+L  +L            + +      L+
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 192 WETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSH 251
            E  +     VA G+ +L    +  IHRD+ + N+LL       I DFGLAR I     +
Sbjct: 133 LEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 252 V-STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL 310
           V        + +M PE +      T+  DV+SFG+L+ EI +      P           
Sbjct: 191 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYP----------- 238

Query: 311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDE 370
                    ++E        +R    +    E ++    C + +  +RP  S +V+ L  
Sbjct: 239 -----GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293

Query: 371 LV 372
           L+
Sbjct: 294 LL 295

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  169 bits (429), Expect = 4e-50
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 22/218 (10%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           D++   + +G G+FG V++    ++G   A K +           R E++T+  LRH  +
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           V +        + V+IYEF+  G L + + D                  +S +  V+ +R
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--------------KMSEDEAVEYMR 131

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI--SDFGLARRIDTSHSHVSTQVAG 258
            V  GL ++H  E   +H D+K  N++  +     +   DFGL   +D   S   T   G
Sbjct: 132 QVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--G 187

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           T  +  PE   G        D++S G+L   + + + P
Sbjct: 188 TAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSP 224

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 8e-50
 Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 23/220 (10%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRH 137
           ++F   KI+G+GSF  V  A+ L++    AIK L+K              E + + +L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
              VK+               + +NG L +++                            
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---------------SFDETCTRF 112

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRID-TSHSHVSTQV 256
               + + L YLH   K IIHRD+K  N+LL+ D    I+DFG A+ +   S    +   
Sbjct: 113 YTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 170

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
            GT  Y+ PE L   + A    D+++ G ++ ++   + P
Sbjct: 171 VGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPP 209

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  166 bits (420), Expect = 1e-48
 Identities = 42/218 (19%), Positives = 86/218 (39%), Gaps = 22/218 (10%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           D +   + +G G+FG V++    ++G     K ++          + E+  + +L H  +
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           + +        + VLI EF+  G L   +                    +S    +  +R
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--------------KMSEAEVINYMR 134

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI--SDFGLARRIDTSHSHVSTQVAG 258
               GL ++H  E  I+H DIK  N++ ++   + +   DFGLA +++            
Sbjct: 135 QACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTA 190

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           T  +  PE +          D+++ G+L   + + + P
Sbjct: 191 TAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSP 227

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-46
 Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 18/225 (8%)

Query: 76  ELIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE-FRAEMETLG 133
           ++ D    ++    IG+G++G V  A    + V VAIKK+     Q + +    E++ L 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 134 KLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWE 193
           + RH NI+ I     +     +   ++    +   L+   +               LS +
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ------------HLSND 109

Query: 194 TRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVS 253
                +  +  GL Y+H     ++HRD+K SN+LL++  +  I DFGLAR  D  H H  
Sbjct: 110 HICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167

Query: 254 --TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             T+   T  Y  PE +  +   T  +D++S G ++ E+ +    
Sbjct: 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  156 bits (394), Expect = 1e-45
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 28/226 (12%)

Query: 81  TDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG---FREFRAEMETLGKLR 136
           +D +   +I+G G    V+ A+ L     VA+K L  D  +    +  FR E +    L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 137 HRNIVKILGYCAS----GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           H  IV +     +    G    ++ E+V+  +L   +H                  P++ 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------------PMTP 110

Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           +  ++++      L + H  +  IIHRD+K +N+++ +     + DFG+AR I  S + V
Sbjct: 111 KRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 168

Query: 253 --STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             +  V GT  Y+ PE   G++      DVYS G ++ E+ T   P
Sbjct: 169 TQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPP 213

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  157 bits (399), Expect = 1e-45
 Identities = 53/222 (23%), Positives = 81/222 (36%), Gaps = 27/222 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG------FREFRAEMETLGK 134
           ++FS  +IIG G FG VY  +   +G   A+K LDK   +           R  +  +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
                IV +     +      I + +  G L   L                         
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---------------EAD 108

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVST 254
                  +  GL ++H   + +++RD+K +N+LLD      ISD GLA        H   
Sbjct: 109 MRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--- 163

Query: 255 QVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
              GT GYM PE L    A     D +S G ++ ++     P
Sbjct: 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 205

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (389), Expect = 5e-45
 Identities = 51/231 (22%), Positives = 96/231 (41%), Gaps = 35/231 (15%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGF---------REFRAEMET 131
           +N+   +I+G G    V +     +    A+K +D      F              E++ 
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 132 LGKLR-HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL 190
           L K+  H NI+++     +     L+++ ++ G L  +L +                  L
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---------------TL 107

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS 250
           S +   KI+R +   +  LH  +  I+HRD+K  N+LLD D    ++DFG + ++D    
Sbjct: 108 SEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 165

Query: 251 HVSTQVAGTMGYMPPEYLGGNTAA-----TVMLDVYSFGILMIEIATQIRP 296
               +V GT  Y+ PE +  +           +D++S G++M  +     P
Sbjct: 166 L--REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (388), Expect = 1e-44
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE-FRAEMETLGKLR 136
           D  D +    ++G G+F  V  A+   +   VAIK + K A +G       E+  L K++
Sbjct: 6   DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H NIV +     SG    LI + V  G L   + +                   +     
Sbjct: 66  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---------------FYTERDAS 110

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL---DSDFEAHISDFGLARRIDTSHSHVS 253
           +++  V + + YLH  +  I+HRD+K  N+L    D D +  ISDFGL++  D     V 
Sbjct: 111 RLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVL 166

Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           +   GT GY+ PE L      +  +D +S G++   +     P
Sbjct: 167 STACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPP 208

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-44
 Identities = 47/218 (21%), Positives = 86/218 (39%), Gaps = 23/218 (10%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           + +   + +G G FG V++    SS  T   K +           + E+  L   RHRNI
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNI 63

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           + +     S  + V+I+EF+    + + ++ ++                L+    V  V 
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAF--------------ELNEREIVSYVH 109

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH--ISDFGLARRIDTSHSHVSTQVAG 258
            V   L +LH     I H DI+  N++  +   +   I +FG AR++    +        
Sbjct: 110 QVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--T 165

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
              Y  PE    +   +   D++S G L+  + + I P
Sbjct: 166 APEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINP 202

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 4e-44
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 24/220 (10%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF---QGFREFRAEMETLGK-LR 136
           ++F   K++G GSFG V+ A+   +    AIK L KD             E   L     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 137 HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRV 196
           H  +  +     +  +   + E++  G L   +    +                      
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------------FDLSRAT 106

Query: 197 KIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQV 256
                +  GL +LH   K I++RD+K  N+LLD D    I+DFG+ +      +  +T  
Sbjct: 107 FYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC 164

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
            GT  Y+ PE L G       +D +SFG+L+ E+     P
Sbjct: 165 -GTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSP 202

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-43
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 28/223 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
            +++  K+IG+GSFG VY+AKL  SG  VAIKK+ +D     R    E++ + KL H NI
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75

Query: 141 VKILGYCASGLDR------VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           V++  +  S  ++       L+ ++V         H +                 L    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ------------TLPVIY 123

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH-ISDFGLARRIDTSHSHVS 253
               +  +   LAY+H     I HRDIK  N+LLD D     + DFG A+++     +VS
Sbjct: 124 VKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

Query: 254 TQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
                +  Y  PE + G T  T  +DV+S G ++ E+      
Sbjct: 182 YIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (378), Expect = 3e-43
 Identities = 59/300 (19%), Positives = 109/300 (36%), Gaps = 40/300 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
           + +   + IG GSFG +Y    +++G  VAIK           +   E +    ++    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           +  + +C +  D  ++   +   SL+   +  SR                S +T + +  
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--------------KFSLKTVLLLAD 110

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVL---LDSDFEAHISDFGLARRIDTSHSHV----- 252
            + + + Y+H   K  IHRD+K  N L          +I DFGLA++   + +H      
Sbjct: 111 QMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168

Query: 253 -STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE 311
            +  + GT  Y       G    +   D+ S G +++               G       
Sbjct: 169 ENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNL-----------GSLPWQGL 216

Query: 312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL 371
            A T   + + I     +   E L +    E+      C + +  ++P  SY+ QL   L
Sbjct: 217 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 1e-42
 Identities = 52/225 (23%), Positives = 85/225 (37%), Gaps = 29/225 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFRE------FRAEMETLGK 134
             +    ++G G FG VY    +S  + VAIK ++KD    + E         E+  L K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 135 LR--HRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           +      ++++L +       VLI E  E                      +     L  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF--------------ITERGALQE 109

Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD-FEAHISDFGLARRIDTSHSH 251
           E        V   + + H     ++HRDIK  N+L+D +  E  + DFG    +  +   
Sbjct: 110 ELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY- 166

Query: 252 VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             T   GT  Y PPE++  +        V+S GIL+ ++     P
Sbjct: 167 --TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  148 bits (374), Expect = 2e-42
 Identities = 55/219 (25%), Positives = 87/219 (39%), Gaps = 26/219 (11%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRH 137
            +F   + +G GSFG V+  +   +G   A+K L K+     +       E   L  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             I+++ G         +I +++E G L   L  +                         
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---------------QRFPNPVAKF 108

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
               V   L YLH   K II+RD+K  N+LLD +    I+DFG A+ +          + 
Sbjct: 109 YAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLC 162

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE +         +D +SFGIL+ E+     P
Sbjct: 163 GTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTP 200

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  147 bits (371), Expect = 3e-42
 Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 20/217 (9%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRN 139
           + +   + IG+G++G VYKA+ + G T A+KK+  +            E+  L +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 140 IVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           IVK+     +    VL++E ++                            L   T    +
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---------------GLESVTAKSFL 106

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGT 259
             + NG+AY H  ++ ++HRD+K  N+L++ + E  I+DFGLAR         + ++   
Sbjct: 107 LQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL 164

Query: 260 MGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             Y  P+ L G+   +  +D++S G +  E+      
Sbjct: 165 -WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  147 bits (371), Expect = 4e-42
 Identities = 52/302 (17%), Positives = 99/302 (32%), Gaps = 42/302 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI 140
            ++   + IG+GSFG +++   L +   VAIK   + +     + R E  T   L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 141 VKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVR 200
           +  + Y        ++   +   SL+  L    R                S +T     +
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR--------------KFSVKTVAMAAK 108

Query: 201 GVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH-----ISDFGLARRID------TSH 249
            +   +  +H  EK +++RDIK  N L+      +     + DFG+ +            
Sbjct: 109 QMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166

Query: 250 SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL 309
                 ++GT  YM      G    +   D+ + G + +               G     
Sbjct: 167 YREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLR-----------GSLPWQ 214

Query: 310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD 369
              A T + + + I     +    EL      E+++      N      P   Y+  L  
Sbjct: 215 GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274

Query: 370 EL 371
           ++
Sbjct: 275 KV 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-41
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 20/218 (9%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHR 138
           +NF   + IG+G++G VYKA+   +G  VA+KK+  D            E+  L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIVK+L    +     L++EF+                             +        
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT--------------GIPLPLIKSY 107

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           +  +  GLA+ H     ++HRD+K  N+L++++    ++DFGLAR         + +V  
Sbjct: 108 LFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-V 164

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           T+ Y  PE L G    +  +D++S G +  E+ T+   
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 2e-41
 Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 24/215 (11%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG-----FREFRAEMETLGKLRHRNIV 141
             +G+G F  VYKA+  ++   VAIKK+             R    E++ L +L H NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 142 KILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRG 201
            +L       +  L+++F+E         ++                 L+       +  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNS---------------LVLTPSHIKAYMLM 108

Query: 202 VANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMG 261
              GL YLH  +  I+HRD+K +N+LLD +    ++DFGLA+   + +    T    T  
Sbjct: 109 TLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRW 165

Query: 262 YMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           Y  PE L G     V +D+++ G ++ E+  ++  
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 9e-40
 Identities = 54/226 (23%), Positives = 96/226 (42%), Gaps = 31/226 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFR------EFRAEMETLGK 134
           D + T + +G G F  V K +  S+G+  A K + K   +  R      +   E+  L +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 135 LRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWET 194
           ++H N++ +     +  D +LI E V  G L  +L +                  L+ E 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---------------ESLTEEE 114

Query: 195 RVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD----FEAHISDFGLARRIDTSHS 250
             + ++ + NG+ YLH     I H D+K  N++L           I DFGLA +ID  + 
Sbjct: 115 ATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172

Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
                + GT  ++ PE +       +  D++S G++   + +   P
Sbjct: 173 F--KNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASP 215

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 2e-39
 Identities = 46/220 (20%), Positives = 86/220 (39%), Gaps = 32/220 (14%)

Query: 86  TDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKL-RHRNIVKI 143
           T +++G G  G V +     +    A+K L         + R E+E   +  +  +IV+I
Sbjct: 16  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 70

Query: 144 LGYCASGLDR----VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIV 199
           +    +        +++ E ++ G L   + D                   +     +I+
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-------------AFTEREASEIM 117

Query: 200 RGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE---AHISDFGLARRIDTSHSHVSTQV 256
           + +   + YLH     I HRD+K  N+L  S        ++DFG A+   + +S  +   
Sbjct: 118 KSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 175

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             T  Y+ PE LG         D++S G++M  +     P
Sbjct: 176 --TPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPP 212

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 3e-39
 Identities = 59/234 (25%), Positives = 102/234 (43%), Gaps = 31/234 (13%)

Query: 77  LIDATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQG--FREFRAEMETLG 133
             D    +     IG G+FG V+KA+   +G  VA+KK+  +  +         E++ L 
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64

Query: 134 KLRHRNIVKILGYCASGLDRV--------LIYEFVENGSLDQWLHDTSRNDDVDGSKQLN 185
            L+H N+V ++  C +             L+++F E+       +               
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-------------- 110

Query: 186 SLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRI 245
            L   +     ++++ + NGL Y+H     I+HRD+K++NVL+  D    ++DFGLAR  
Sbjct: 111 -LVKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAF 167

Query: 246 D---TSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
                S  +  T    T+ Y PPE L G       +D++  G +M E+ T+   
Sbjct: 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (344), Expect = 2e-38
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 21/221 (9%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHR 138
             +   + IG+G++G V+KAK   +   VA+K++  D            E+  L +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           NIV++     S     L++EF +      +       D                E     
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---------------PEIVKSF 106

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           +  +  GL + H   + ++HRD+K  N+L++ + E  +++FGLAR         S +V  
Sbjct: 107 LFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV-V 163

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP 299
           T+ Y PP+ L G    +  +D++S G +  E+A   RP  P
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 3e-38
 Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 21/224 (9%)

Query: 80  ATDNFSTDKIIGDGSFGFVYKAK--LSSGVTVAIKKLDKD-----AFQGFREFRAEMETL 132
           A   +     IG+G++G V+KA+   + G  VA+K++                 A +  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 133 GKLRHRNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
               H N+V++   C            +    +DQ L          G         +  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---------VPT 115

Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           ET   ++  +  GL +LH     ++HRD+K  N+L+ S  +  ++DFGLAR      +  
Sbjct: 116 ETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL- 172

Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
            T V  T+ Y  PE L  ++     +D++S G +  E+  +   
Sbjct: 173 -TSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPL 214

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 6e-38
 Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 23/219 (10%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF---QGFREFRAEMETLGKLRH 137
           ++F   K++G G+FG V   +  ++G   A+K L K+             E   L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
             +  +     +      + E+   G L   L                     + E    
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---------------RVFTEERARF 109

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVA 257
               + + L YLH   + +++RDIK  N++LD D    I+DFGL +   +  + + T   
Sbjct: 110 YGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC- 166

Query: 258 GTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           GT  Y+ PE L  N      +D +  G++M E+     P
Sbjct: 167 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLP 204

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  133 bits (336), Expect = 7e-37
 Identities = 44/220 (20%), Positives = 85/220 (38%), Gaps = 30/220 (13%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRN 139
           D++   + +G G +  V++A  +++   V +K L     +   + + E++ L  LR   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91

Query: 140 IVKILGYCASGLDR--VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           I+ +       + R   L++E V N    Q                      L+      
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------------------TLTDYDIRF 133

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-EAHISDFGLARRIDTSHSHVSTQV 256
            +  +   L Y H     I+HRD+K  NV++D +  +  + D+GLA        +     
Sbjct: 134 YMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVR 189

Query: 257 AGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
             +  +  PE L         LD++S G ++  +  +  P
Sbjct: 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (335), Expect = 2e-36
 Identities = 57/250 (22%), Positives = 93/250 (37%), Gaps = 27/250 (10%)

Query: 52  SDLSSIALFDSASFDPSLSQISMSELIDAT-DNFSTDKIIGDGSFGFVYKAK-LSSGVTV 109
           S+  S+  F + + +  L +        A  D F   K +G GSFG V   K   SG   
Sbjct: 10  SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69

Query: 110 AIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVENGSLD 166
           A+K LDK      +       E   L  +    +VK+        +  ++ E+V  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129

Query: 167 QWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV 226
             L    R                S          +     YLH     +I+RD+K  N+
Sbjct: 130 SHLRRIGR---------------FSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENL 172

Query: 227 LLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGIL 286
           L+D      ++DFG A+R+          + GT   + PE +         +D ++ G+L
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEALAPEIILSKG-YNKAVDWWALGVL 227

Query: 287 MIEIATQIRP 296
           + E+A    P
Sbjct: 228 IYEMAAGYPP 237

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 5e-36
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 27/225 (12%)

Query: 82  DNFSTDKIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAF----QGFREFRAEMETLG 133
           +NF   K++G G++G V+  +      +G   A+K L K       +     R E + L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 134 KLRHR-NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
            +R    +V +     +     LI +++  G L   L                     + 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---------------ERFTE 128

Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
                 V  +   L +LH  +  II+RDIK  N+LLDS+    ++DFGL++      +  
Sbjct: 129 HEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 186

Query: 253 STQVAGTMGYMPPEYL-GGNTAATVMLDVYSFGILMIEIATQIRP 296
           +    GT+ YM P+ + GG++     +D +S G+LM E+ T   P
Sbjct: 187 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 9e-35
 Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 20/218 (9%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHR 138
             +   + +G G++G V  A    +G  VAIKKL +        +    E+  L  +RH 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 139 NIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKI 198
           N++ +L             +F                       +L     L  +    +
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG-----------KLMKHEKLGEDRIQFL 126

Query: 199 VRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHVSTQVAG 258
           V  +  GL Y+H     IIHRD+K  N+ ++ D E  I DFGLAR+ D+      T    
Sbjct: 127 VYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVV 180

Query: 259 TMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
           T  Y  PE +      T  +D++S G +M E+ T    
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 3e-31
 Identities = 51/226 (22%), Positives = 90/226 (39%), Gaps = 30/226 (13%)

Query: 79  DATDNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKL 135
           +  + +     +G G++G V  A    +G+ VA+KKL +        +    E+  L  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74

Query: 136 RHRNIVKILGYCASG-----LDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPL 190
           +H N++ +L            + V +   +    L+  +                    L
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----------------KL 118

Query: 191 SWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS 250
           + +    ++  +  GL Y+H     IIHRD+K SN+ ++ D E  I DFGLAR  D   +
Sbjct: 119 TDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176

Query: 251 HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
                   T  Y  PE +         +D++S G +M E+ T    
Sbjct: 177 GYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 4e-29
 Identities = 55/224 (24%), Positives = 84/224 (37%), Gaps = 32/224 (14%)

Query: 82  DNFSTDKIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHR 138
             +   K IG G+ G V  A        VAIKKL +        +    E+  +  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 139 NIVKILGYCAS------GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSW 192
           NI+ +L             D  L+ E ++         +                     
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------------------H 118

Query: 193 ETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHSHV 252
           E    ++  +  G+ +LH     IIHRD+K SN+++ SD    I DFGLAR   TS    
Sbjct: 119 ERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM- 175

Query: 253 STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
            T    T  Y  PE + G       +D++S G +M E+      
Sbjct: 176 -TPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKIL 217

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (267), Expect = 7e-27
 Identities = 43/213 (20%), Positives = 81/213 (38%), Gaps = 7/213 (3%)

Query: 88  KIIGDGSFGFVYKAK-LSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGY 146
           + +G G F  V+ AK + +   VA+K +  D          E++ L ++   +  K    
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSM 77

Query: 147 CASGLDRVLIY-EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANG 205
            A+ + ++L +        +   +      +++    +      +      +I + +  G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 206 LAYLHGLEKPIIHRDIKSSNVLLDS-DFEAHISDFGLARRIDTSHSHVS-TQVAGTMGYM 263
           L Y+H     IIH DIK  NVL++  D   ++    +A   +        T    T  Y 
Sbjct: 138 LDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 264 PPEYLGGNTAATVMLDVYSFGILMIEIATQIRP 296
            PE L G        D++S   L+ E+ T    
Sbjct: 197 SPEVLLGAP-WGCGADIWSTACLIFELITGDFL 228

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.7 bits (206), Expect = 1e-19
 Identities = 24/173 (13%), Positives = 49/173 (28%), Gaps = 31/173 (17%)

Query: 88  KIIGDGSFGFVYKAKLSSGVTVAIKKLDKDA----------FQGFREFRAEMETLGKLRH 137
           K++G+G    V+           +K                  G   F        +   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 138 RNIVKILGYCASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVK 197
           R + K+ G          +Y +  N  L + +                       E   +
Sbjct: 66  RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVR-------------VENPDE 107

Query: 198 IVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARRIDTSHS 250
           ++  +   +A  +   + I+H D+   NVL+  +    I DF  +  +     
Sbjct: 108 VLDMILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGW 157

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	373
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.81
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.24
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.91
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.36
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.23
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.06

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-59  Score=402.73  Aligned_cols=256  Identities=27%  Similarity=0.404  Sum_probs=201.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      ++|++.+.||+|+||.||+|.+.++..||||+++.... ..+++.+|+.++++++||||++++|++.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            47888899999999999999998889999999976443 34789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +|+|.+++.....              .+++..++.++.|++.||+|||  +++|+||||||+|||+++++.+||+|||+
T Consensus        84 ~g~L~~~l~~~~~--------------~~~~~~~~~i~~qia~gl~~lH--~~~iiHrDlKp~Nill~~~~~~Kl~DFGl  147 (263)
T d1sm2a_          84 HGCLSDYLRTQRG--------------LFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGM  147 (263)
T ss_dssp             TCBHHHHHHTTTT--------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCTTCSGGGEEECGGGCEEECSCC-
T ss_pred             CCcHHHHhhcccc--------------CCCHHHHHHHHHHHHHHHHhhh--ccceeecccchhheeecCCCCeEecccch
Confidence            9999999876543              2899999999999999999999  78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK  321 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (373)
                      ++..............||+.|+|||++.+. .++.++|||||||++|||+|++.|++....      ..+......... 
T Consensus       148 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~~~i~~~~-  219 (263)
T d1sm2a_         148 TRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGF-  219 (263)
T ss_dssp             -----------------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHHHHHHHTC-
T ss_pred             heeccCCCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHHHHHHHHhcC-
Confidence            987655444444456789999999999854 588999999999999999997666543221      111222221111 


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                        +   .     ..+..++.++.+++.+||+.||++|||+++|++.|+++.
T Consensus       220 --~---~-----~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         220 --R---L-----YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             --C---C-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --C---C-----CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence              0   1     113344568999999999999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-57  Score=394.52  Aligned_cols=260  Identities=30%  Similarity=0.481  Sum_probs=203.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccc--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDA--FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|++.+.||+|+||.||+|+.+  ..||||+++...  ....+.+.+|+.++++++||||+++++++.+ ...++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            468999999999999999999864  469999986543  3346789999999999999999999998755 56899999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++|+|.+++.....              ++++.+++.++.||++||+|||  +++|+||||||+|||++.++.+||+|
T Consensus        84 y~~~g~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~gl~yLH--~~~ivHrDlKp~NiLl~~~~~~Kl~D  147 (276)
T d1uwha_          84 WCEGSSLYHHLHIIET--------------KFEMIKLIDIARQTAQGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGD  147 (276)
T ss_dssp             CCCEEEHHHHHHTSCC--------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTSSEEECC
T ss_pred             cCCCCCHHHHHhhccC--------------CCCHHHHHHHHHHHHHHHHHHh--cCCEeccccCHHHEEEcCCCCEEEcc
Confidence            9999999999976543              2899999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCC-cccccccccccccCccccCCC--CCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          239 FGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGN--TAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       239 fg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      ||+++....... .......||+.|+|||++.+.  ..++.++|||||||++|||+||..||......       .....
T Consensus       148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-------~~~~~  220 (276)
T d1uwha_         148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIF  220 (276)
T ss_dssp             CCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHH
T ss_pred             ccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------HHHHH
Confidence            999987643322 233456799999999998643  34788999999999999999999997532111       01111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ....+..    .+.+  ...+.+++.++.+++.+||+.||++|||+++|++.|+.+.
T Consensus       221 ~~~~~~~----~p~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         221 MVGRGYL----SPDL--SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             HHHHTSC----CCCG--GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhcCCC----CCcc--hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1111110    1111  1123445678999999999999999999999999998864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-58  Score=404.62  Aligned_cols=258  Identities=24%  Similarity=0.423  Sum_probs=213.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|++.+.||+|+||+||+|.++ +++.||||+++.+.. ..+++.+|+.++++++||||+++++++.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            457888899999999999999775 688999999976543 457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++|+|.+++......             .+++..++.++.|++.||+|||  +++|+||||||+|||+++++.+||+||
T Consensus        95 ~~~g~l~~~l~~~~~~-------------~~~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          95 MTYGNLLDYLRECNRQ-------------EVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             CTTCBHHHHHHHSCTT-------------TSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             ccCcchHHHhhhcccc-------------chHHHHHHHHHHHHHHHHHHHH--HCCcccCccccCeEEECCCCcEEEccc
Confidence            9999999999765432             3899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |+++..............|++.|+|||.+.+ ..++.++|||||||++|||++|+.|+++....      ......... 
T Consensus       160 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~~~i~~-  231 (287)
T d1opja_         160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEK-  231 (287)
T ss_dssp             CCTTTCCSSSSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHT-
T ss_pred             cceeecCCCCceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchH------HHHHHHHhc-
Confidence            9998765544444445568899999999875 45889999999999999999988886543221      111111111 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      +     ...     ..+..++.++.+++.+||+.||++|||+++|++.|+.++
T Consensus       232 ~-----~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         232 D-----YRM-----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             T-----CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             C-----CCC-----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1     111     113445678999999999999999999999999998874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-58  Score=400.45  Aligned_cols=257  Identities=26%  Similarity=0.465  Sum_probs=210.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      .++|++.+.||+|+||.||+|.++++..||||+++.... ..+.+.+|+.++++++||||++++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            357888999999999999999998889999999976443 34679999999999999999999998765 5678999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++|+|.+++......             ++++.++++++.||++||.|||  +++|+||||||+|||+++++.+||+|||
T Consensus        90 ~~g~L~~~~~~~~~~-------------~l~~~~~~~i~~qi~~gl~~lH--~~~ivHrDiKp~NIll~~~~~~Kl~DFG  154 (272)
T d1qpca_          90 ENGSLVDFLKTPSGI-------------KLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFG  154 (272)
T ss_dssp             TTCBHHHHTTSHHHH-------------TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CCCcHHHHHhhcCCC-------------CCCHHHHHHHHHHHHHHHHHHH--hCCcccCccchhheeeecccceeecccc
Confidence            999999987654322             2899999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      +|+..............||+.|+|||++.+ ..++.++|||||||++|||+||+.|++.....      .+.......  
T Consensus       155 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~------~~~~~~i~~--  225 (272)
T d1qpca_         155 LARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--  225 (272)
T ss_dssp             TCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHT--
T ss_pred             ceEEccCCccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH------HHHHHHHHh--
Confidence            999876554444555678999999999874 45789999999999999999987775543211      111111111  


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                          .....     .+..++.++.+++.+||+.||++|||+++|++.|++++
T Consensus       226 ----~~~~~-----~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         226 ----GYRMV-----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             ----TCCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----cCCCC-----CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence                11111     13345668999999999999999999999999999875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-58  Score=395.90  Aligned_cols=253  Identities=23%  Similarity=0.294  Sum_probs=202.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|++.+.||+|+||+||+|..+ +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            357999999999999999999764 7999999999654432 34568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++|+|.+++....               ++++.++..++.|++.||+|||  +++|+||||||+|||+++++.+||+|
T Consensus        84 y~~gg~L~~~l~~~~---------------~l~e~~~~~i~~qi~~al~ylH--~~~IiHrDiKp~NILl~~~~~~KL~D  146 (271)
T d1nvra_          84 YCSGGELFDRIEPDI---------------GMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISD  146 (271)
T ss_dssp             CCTTEEGGGGSBTTT---------------BCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECC
T ss_pred             ccCCCcHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHHH--HcCCccCcccHHHEEECCCCCEEEcc
Confidence            999999999987543               2999999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCC-CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          239 FGLARRIDTSH-SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       239 fg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      ||+|+...... ........||+.|+|||++.+...++.++|||||||++|||++|..||.......     ..+ ....
T Consensus       147 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----~~~-~~~~  220 (271)
T d1nvra_         147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEY-SDWK  220 (271)
T ss_dssp             CTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-----HHH-HHHH
T ss_pred             chhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-----HHH-HHHh
Confidence            99998764332 2233456899999999999876666788999999999999999999975432211     011 0111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      . .....         ......+.++.+++.+||+.||++|||++|+++
T Consensus       221 ~-~~~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         221 E-KKTYL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             T-TCTTS---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c-CCCCC---------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0 00000         001223457889999999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-56  Score=388.90  Aligned_cols=250  Identities=24%  Similarity=0.359  Sum_probs=207.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            35799999999999999999975 57999999999776665667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +++|+|.+++....                +++.++..++.||+.||+|||  +++|+||||||+|||++.++++||+||
T Consensus        99 ~~gg~L~~~~~~~~----------------l~~~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~vkl~DF  160 (293)
T d1yhwa1          99 LAGGSLTDVVTETC----------------MDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDF  160 (293)
T ss_dssp             CTTCBHHHHHHHSC----------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred             cCCCcHHHHhhccC----------------CCHHHHHHHHHHHHHHHHHHH--HCCCcccCCcHHHeEECCCCcEeeccc
Confidence            99999999887543                899999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.....       ..........
T Consensus       161 G~a~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~~~~~  231 (293)
T d1yhwa1         161 GFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATN  231 (293)
T ss_dssp             TTCEECCSTT-CCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHH
T ss_pred             hhheeecccc-ccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCH-------HHHHHHHHhC
Confidence            9998765432 23345679999999999985 4578899999999999999999999753211       1111111111


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..      ..+   ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~------~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         232 GT------PEL---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CS------CCC---SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CC------CCC---CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10      011   112334568999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-56  Score=385.39  Aligned_cols=254  Identities=24%  Similarity=0.399  Sum_probs=211.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      ++|++.+.||+|+||+||+|..++++.||||++++... ..+++.+|+.++++++||||++++|++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            68899999999999999999998888999999976543 34789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +|+|.+++.....              .+++..+++++.|+++||+|||  +++|+||||||+||++++++.+||+|||+
T Consensus        83 ~g~l~~~~~~~~~--------------~~~~~~~~~i~~qi~~gl~~LH--~~~iiH~dlk~~Nill~~~~~~kl~DfG~  146 (258)
T d1k2pa_          83 NGCLLNYLREMRH--------------RFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGL  146 (258)
T ss_dssp             TEEHHHHHHSGGG--------------CCCHHHHHHHHHHHHHHHHHHH--HTTBCCSCCSGGGEEECTTCCEEECCCSS
T ss_pred             CCcHHHhhhcccc--------------CCcHHHHHHHHHHHHHHHHHHh--hcCcccccccceeEEEcCCCcEEECcchh
Confidence            9999999765543              2889999999999999999999  78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      ++..............||+.|+|||.+.+ ..++.++||||||+++|||+| |..||....       ..+....... +
T Consensus       147 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-------~~~~~~~i~~-~  217 (258)
T d1k2pa_         147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETAEHIAQ-G  217 (258)
T ss_dssp             CCBCSSSSCCCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-------HHHHHHHHHT-T
T ss_pred             heeccCCCceeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCC-------HHHHHHHHHh-C
Confidence            98765544444455678999999999974 457899999999999999998 677754321       1111111111 1


Q ss_pred             cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          321 KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                           ..     ...+..++.++.+++.+||+.||++|||+++|++.|.++
T Consensus       218 -----~~-----~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         218 -----LR-----LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -----CC-----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -----CC-----CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                 11     111344556899999999999999999999999998764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-56  Score=393.62  Aligned_cols=256  Identities=27%  Similarity=0.467  Sum_probs=196.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CC---CEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SG---VTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ++|++.+.||+|+||+||+|.++ ++   ..||||.+...... ..+.|.+|+.+|++++|||||+++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            46777889999999999999764 23   35889988654433 356799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      ||||++|+|.+++.....              .+++.+++.++.||+.||+|||  +++++||||||+|||++.++++||
T Consensus       106 ~Ey~~~g~L~~~~~~~~~--------------~l~~~~~~~i~~qia~gl~yLH--~~~iiHrDlKp~NILl~~~~~~Kl  169 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDG--------------QFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKV  169 (299)
T ss_dssp             EECCTTEEHHHHHHTTTT--------------CSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEE
T ss_pred             EEecCCCcceeeeccccC--------------CCCHHHHHHHHHHHHHHHHHHh--hCCCccCccccceEEECCCCcEEE
Confidence            999999999998876543              2899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCc----ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHH
Q 043074          237 SDFGLARRIDTSHSH----VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  311 (373)
                      +|||+++........    ......||+.|+|||.+.+ ..++.++|||||||++|||+| |..||....       ..+
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-------~~~  241 (299)
T d1jpaa_         170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMT-------NQD  241 (299)
T ss_dssp             CCC-----------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHH
T ss_pred             CCcccceEccCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCC-------HHH
Confidence            999999876433221    1122457899999999874 458899999999999999998 777764321       111


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ........      ...     ..+.+++..+.+++.+||+.||++|||+.+|++.|++++
T Consensus       242 ~~~~i~~~------~~~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         242 VINAIEQD------YRL-----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             HHHHHHTT------CCC-----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHHcC------CCC-----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            11111111      011     114455678999999999999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-56  Score=383.16  Aligned_cols=245  Identities=28%  Similarity=0.434  Sum_probs=203.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++.+..   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46888999999999999999764 78999999986533   223567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.....               +++.++..++.||+.||+|||  +++|+||||||+|||++.++.+||+
T Consensus        86 Ey~~~g~L~~~l~~~~~---------------l~e~~~~~i~~qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~~kl~  148 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSK---------------FDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIA  148 (263)
T ss_dssp             ECCTTCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             eecCCCcHHHHHhhcCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCeeeeeeccccceecCCCCEeec
Confidence            99999999999986542               899999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++.....   ......||+.|+|||++.+. .++.++|||||||++|||++|..||....       ..+......
T Consensus       149 DFG~a~~~~~~---~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~  217 (263)
T d2j4za1         149 DFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANT-------YQETYKRIS  217 (263)
T ss_dssp             CCCSCSCCCCC---CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHH
T ss_pred             ccceeeecCCC---cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCC-------HHHHHHHHH
Confidence            99999865432   23456799999999999864 57899999999999999999999974321       111111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..       ...     .+...+.++.+++.+||+.||++|||++|+++
T Consensus       218 ~~-------~~~-----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         218 RV-------EFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             TT-------CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cC-------CCC-----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            10       111     13334568999999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-56  Score=393.07  Aligned_cols=252  Identities=25%  Similarity=0.390  Sum_probs=205.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      +.|++.+.||+|+||.||+|.. .+++.||+|+++.......+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4788899999999999999976 478999999997766666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++|+|.+++.+...              ++++.++..++.||+.||.|||  +++|+||||||+|||++.++.+||+|||
T Consensus        92 ~~g~L~~~~~~~~~--------------~l~e~~~~~i~~qi~~gL~ylH--~~~ivHrDiKp~NIll~~~~~~Kl~DFG  155 (288)
T d2jfla1          92 AGGAVDAVMLELER--------------PLTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFG  155 (288)
T ss_dssp             TTEEHHHHHHHHTS--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCCcHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCEEEeecChhheeECCCCCEEEEech
Confidence            99999999875432              3899999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCC----CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGG----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +++...... .......||+.|+|||++.+    ...++.++|||||||++|||++|..||......    ...   ...
T Consensus       156 ~a~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~----~~~---~~i  227 (288)
T d2jfla1         156 VSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM----RVL---LKI  227 (288)
T ss_dssp             TCEECHHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG----GHH---HHH
T ss_pred             hhhccCCCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH----HHH---HHH
Confidence            997643211 12334679999999999852    345788999999999999999999997543211    111   111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ... ..     +.+   ..+...+.++.+++.+||+.||++|||++|+++
T Consensus       228 ~~~-~~-----~~~---~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         228 AKS-EP-----PTL---AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHS-CC-----CCC---SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HcC-CC-----CCC---CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111 00     011   112334568999999999999999999999976

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-56  Score=388.21  Aligned_cols=257  Identities=28%  Similarity=0.469  Sum_probs=200.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCC-----CEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSG-----VTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      +.|+..++||+|+||.||+|.++++     ..||||++...... ....+.+|+.++++++|||||+++|++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577889999999999999976532     47999999654443 34568999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |+||+.++++.+++.....              .+++.+++.++.|++.||+|||  +++|+||||||+|||++.++.+|
T Consensus        87 v~e~~~~~~l~~~~~~~~~--------------~~~~~~~~~i~~~i~~gl~~lH--~~~iiHrDlKp~NILl~~~~~~K  150 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG--------------EFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCK  150 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT--------------CSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEE
T ss_pred             EEEecccCcchhhhhcccc--------------cccHHHHHHHHHHHHHhhhhcc--ccccccCccccceEEECCCCeEE
Confidence            9999999999998876543              3899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          236 ISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |+|||+++........  ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+......      .+..
T Consensus       151 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~------~~~~  223 (283)
T d1mqba_         151 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVM  223 (283)
T ss_dssp             ECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHH
T ss_pred             EcccchhhcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCH------HHHH
Confidence            9999999876443222  2233568999999999975 45889999999999999999987775542211      1111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ....          ..... ..+.+++.++.+++.+||+.||++|||+.+|++.|++++
T Consensus       224 ~~i~----------~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         224 KAIN----------DGFRL-PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             HHHH----------TTCCC-CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHh----------ccCCC-CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence            1111          11111 114445678999999999999999999999999998874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=391.54  Aligned_cols=256  Identities=25%  Similarity=0.437  Sum_probs=202.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecC
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVE  161 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  161 (373)
                      ++|++.+.||+|+||.||+|.++++..||||+++.... ..+.|.+|+.++++++|||||+++|++.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            57899999999999999999998888999999965543 45789999999999999999999999854 56789999999


Q ss_pred             CCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeecc
Q 043074          162 NGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGL  241 (373)
Q Consensus       162 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  241 (373)
                      +|+|..++......             .++|.+++.++.||+.||+|||  +++++||||||+|||+++++++||+|||+
T Consensus        95 ~g~l~~~~~~~~~~-------------~l~~~~~~~i~~~i~~gl~~LH--~~~ivH~DlKp~NIll~~~~~~kl~DfGl  159 (285)
T d1fmka3          95 KGSLLDFLKGETGK-------------YLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGL  159 (285)
T ss_dssp             TCBHHHHHSHHHHT-------------TCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             CCchhhhhhhcccc-------------cchHHHHHHHHHHHHHHHHHHh--hhheecccccceEEEECCCCcEEEcccch
Confidence            99999988764322             2899999999999999999999  78999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhcc
Q 043074          242 ARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARNK  321 (373)
Q Consensus       242 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (373)
                      ++..............||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+......      .+........  
T Consensus       160 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------~~~~~~i~~~--  230 (285)
T d1fmka3         160 ARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERG--  230 (285)
T ss_dssp             TC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTT--
T ss_pred             hhhccCCCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH------HHHHHHHHhc--
Confidence            98765444444445678999999999974 45789999999999999999988776543221      1111111111  


Q ss_pred             ccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          322 EIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                          ....     .+..++.++.+++.+||+.||++||++++|++.|++.+
T Consensus       231 ----~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         231 ----YRMP-----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             ----CCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ----CCCC-----CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence                1111     13445668999999999999999999999999998865

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-56  Score=386.43  Aligned_cols=254  Identities=26%  Similarity=0.386  Sum_probs=203.3

Q ss_pred             CCCCCCCe-eecCCCceEEEEEeC---CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKI-IGDGSFGFVYKAKLS---SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ++|.+.+. ||+|+||.||+|.++   ++..||||+++..... ..+.+.+|++++++++||||++++|++.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45666664 999999999999653   4557999999765433 35679999999999999999999999865 468899


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++|+|.+++.....              ++++.+++.++.|++.||+|||  +++++||||||+||+++.++.+||
T Consensus        87 mE~~~~g~L~~~l~~~~~--------------~l~~~~~~~i~~qi~~gL~ylH--~~~iiHrDlKp~Nill~~~~~~Kl  150 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKRE--------------EIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKI  150 (285)
T ss_dssp             EECCTTEEHHHHHTTCTT--------------TSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEE
T ss_pred             EEeCCCCcHHHHhhcccc--------------CCCHHHHHHHHHHHHHHHHHHH--hCCeecCcCchhheeeccCCceee
Confidence            999999999999865432              2899999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          237 SDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +|||+++........  ......||+.|+|||++.+ ..++.++|||||||++|||+| |..||.....    .   +..
T Consensus       151 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~----~---~~~  222 (285)
T d1u59a_         151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----P---EVM  222 (285)
T ss_dssp             CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----H---HHH
T ss_pred             ccchhhhcccccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCH----H---HHH
Confidence            999999977543322  2234568899999999874 458999999999999999998 7888643211    1   111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                      ..... +.     .     ...+..++.++.+++.+||+.||++|||+.+|++.|+..
T Consensus       223 ~~i~~-~~-----~-----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         223 AFIEQ-GK-----R-----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             HHHHT-TC-----C-----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHc-CC-----C-----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11111 11     1     112445667899999999999999999999999999865

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-55  Score=381.86  Aligned_cols=247  Identities=28%  Similarity=0.418  Sum_probs=195.5

Q ss_pred             CeeecCCCceEEEEEeC---CCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEecCC
Q 043074           88 KIIGDGSFGFVYKAKLS---SGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFVEN  162 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  162 (373)
                      +.||+|+||.||+|.++   +++.||||+++.....  ..+.+.+|+.++++++||||++++++|.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999753   3568999999654332  34679999999999999999999999865 457899999999


Q ss_pred             CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeeccc
Q 043074          163 GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFGLA  242 (373)
Q Consensus       163 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  242 (373)
                      |+|.+++....               ++++.+++.++.||+.||+|||  +++++||||||+|||++.++.+||+|||++
T Consensus        92 g~L~~~l~~~~---------------~l~~~~~~~i~~qi~~gl~ylH--~~~iiHrDlKp~Nill~~~~~~kl~DFGla  154 (277)
T d1xbba_          92 GPLNKYLQQNR---------------HVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLS  154 (277)
T ss_dssp             EEHHHHHHHCT---------------TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CcHHHHHhhcc---------------CCCHHHHHHHHHHHHHHHhhHH--hCCcccCCCcchhhcccccCcccccchhhh
Confidence            99999998654               2999999999999999999999  789999999999999999999999999999


Q ss_pred             cccCCCCCcc--cccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          243 RRIDTSHSHV--STQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       243 ~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      +.........  .....||+.|+|||.+.+ ..++.++|||||||++|||+| |..||....       ..+....... 
T Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-------~~~~~~~i~~-  225 (277)
T d1xbba_         155 KALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEK-  225 (277)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHT-
T ss_pred             hhccccccccccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCC-------HHHHHHHHHc-
Confidence            8765443322  234578999999999974 457899999999999999998 788864321       1111111111 


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                      +.          +...+..++.++.+++.+||+.||++|||+++|++.|++.
T Consensus       226 ~~----------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         226 GE----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             TC----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CC----------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            11          1111444567899999999999999999999999998875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=382.07  Aligned_cols=254  Identities=24%  Similarity=0.363  Sum_probs=190.1

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCAS--GLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  156 (373)
                      ++|++.+.||+|+||.||+|.. .+|+.||+|.+......  ..+.+.+|+.++++++||||+++++++.+  ....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5799999999999999999976 47899999999765432  34568899999999999999999999864  4567999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcC---CCCceeecCCCCceEeCCCCc
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGL---EKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~---~~~i~H~dlk~~Nill~~~~~  233 (373)
                      |||+++|+|.+++.......           .++++.+++.++.|++.||.|||+.   .++|+||||||+|||++.++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~-----------~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~  152 (269)
T d2java1          84 MEYCEGGDLASVITKGTKER-----------QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN  152 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHT-----------CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC
T ss_pred             EecCCCCcHHHHHHhccccC-----------CCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc
Confidence            99999999999987542111           1399999999999999999999941   134999999999999999999


Q ss_pred             eEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHH
Q 043074          234 AHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      +||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||+||..||.....       .+..
T Consensus       153 vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------~~~~  223 (269)
T d2java1         153 VKLGDFGLARILNHDT-SFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELA  223 (269)
T ss_dssp             EEECCHHHHHHC------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHH
T ss_pred             EEEeeccceeecccCC-CccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-------HHHH
Confidence            9999999998865432 22345679999999999975 4578999999999999999999999753211       1111


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..... ...     ..     .+..++.++.+++.+||+.||++|||++|+++
T Consensus       224 ~~i~~-~~~-----~~-----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         224 GKIRE-GKF-----RR-----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHH-TCC-----CC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHc-CCC-----CC-----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11111 110     11     13334568999999999999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-55  Score=378.90  Aligned_cols=244  Identities=29%  Similarity=0.409  Sum_probs=193.5

Q ss_pred             CCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEee----CCeeEEEE
Q 043074           85 STDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCAS----GLDRVLIY  157 (373)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  157 (373)
                      ++.+.||+|+||+||+|... +++.||+|.+.....  ...+.+.+|++++++++||||+++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55678999999999999764 688999999865432  234578999999999999999999999865    34678999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--ceeecCCCCceEeC-CCCce
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKP--IIHRDIKSSNVLLD-SDFEA  234 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~--i~H~dlk~~Nill~-~~~~~  234 (373)
                      ||+++|+|.+++.+...               +++.++..++.||+.||+|||  +++  |+||||||+|||++ +++.+
T Consensus        92 E~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~qi~~gl~yLH--~~~~~IiHrDiKp~NILl~~~~~~~  154 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFKV---------------MKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTGSV  154 (270)
T ss_dssp             ECCCSCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--TSSSCCCCSCCCGGGEEESSTTSCE
T ss_pred             eCCCCCcHHHHHhcccc---------------ccHHHHHHHHHHHHHHHHHHH--HCCCCEEeCCcChhhceeeCCCCCE
Confidence            99999999999986542               899999999999999999999  565  99999999999996 57899


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      ||+|||+++.....   ......||+.|+|||++.+  .++.++|||||||++|||++|..||.....      ......
T Consensus       155 Kl~DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~------~~~~~~  223 (270)
T d1t4ha_         155 KIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYR  223 (270)
T ss_dssp             EECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHH
T ss_pred             EEeecCcceeccCC---ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCccc------HHHHHH
Confidence            99999999864322   2345679999999999864  489999999999999999999999743211      111111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....      ...+    ...+...++++.+++.+||+.||++|||++|+++
T Consensus       224 ~i~~------~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         224 RVTS------GVKP----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHTT------TCCC----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHc------CCCC----cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            1110      0111    1112223457899999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-55  Score=385.39  Aligned_cols=246  Identities=27%  Similarity=0.386  Sum_probs=200.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      +.|+..+.||+|+||.||+|.. .+++.||||++......   ..+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3588899999999999999975 47899999998765432   3456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      |||++|+|..++....               ++++.++..++.||+.||.|||  +++|+||||||+|||++.++.+||+
T Consensus        95 E~~~~g~l~~~~~~~~---------------~l~e~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~~Kl~  157 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK---------------PLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLG  157 (309)
T ss_dssp             ECCSEEHHHHHHHHTS---------------CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEEC
T ss_pred             EecCCCchHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEECCCCCEEEe
Confidence            9999999987766543               3999999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCC--CCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG--NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |||+++....     .....||+.|+|||++.+  ...++.++|||||||++|||++|..||.....       .+....
T Consensus       158 DFG~a~~~~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~~~~~  225 (309)
T d1u5ra_         158 DFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYH  225 (309)
T ss_dssp             CCTTCBSSSS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHH
T ss_pred             ecccccccCC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHH
Confidence            9999986532     234579999999999864  34578899999999999999999999753211       111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....      -.+...    +..++.++.+++.+||+.||++|||++|+++
T Consensus       226 i~~~------~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         226 IAQN------ESPALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHS------CCCCCS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHhC------CCCCCC----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1111      111111    2223558999999999999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-55  Score=391.68  Aligned_cols=262  Identities=25%  Similarity=0.351  Sum_probs=202.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      .++|++.+.||+|+||+||+|.. .+|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            56899999999999999999976 47899999999654333 34678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+++|+|.+++.+...               +++..+..++.|++.||.|||+ .++|+||||||+|||++.++.+||+|
T Consensus        85 y~~gg~L~~~l~~~~~---------------l~~~~~~~~~~qil~aL~yLH~-~~~IiHRDiKP~NILl~~~~~vkl~D  148 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGR---------------IPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCD  148 (322)
T ss_dssp             CCTTEEHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTCCEEECC
T ss_pred             cCCCCcHHHHHhhcCC---------------CCHHHHHHHHHHHHHHHHHHHH-hCCEEccccCHHHeeECCCCCEEEee
Confidence            9999999999986542               8999999999999999999993 24899999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH--------
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL--------  310 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~--------  310 (373)
                      ||+|+....   .......||+.|+|||++.+. .++.++||||+||++|||++|..||.+...........        
T Consensus       149 FGla~~~~~---~~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~  224 (322)
T d1s9ja_         149 FGVSGQLID---SMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA  224 (322)
T ss_dssp             CCCCHHHHH---HTC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------
T ss_pred             CCCccccCC---CccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcc
Confidence            999987532   223456899999999999864 58999999999999999999999986543221100000        


Q ss_pred             ------HHHHH----HHHh-----------ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 ------EWART----MEAR-----------NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ------~~~~~----~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                            .+...    ....           ........+.+..    ...+.++.+++.+||+.||++|||++|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS----GVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ---------------------CCCCHHHHHHHHHTSCCCCCCB----TTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCcccccccccccccccccccchhHHHHHhhhhccCCccCcc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                  00000    0000           0000000011111    112357899999999999999999999987

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=384.62  Aligned_cols=248  Identities=22%  Similarity=0.302  Sum_probs=200.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||+|.. .+++.||||++.+..   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            4699999999999999999976 479999999986533   223567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.....               +++..+..++.|++.||+|||  +++|+||||||+|||+++++.+||+
T Consensus        88 Ey~~gg~L~~~~~~~~~---------------l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~NIll~~~~~vkl~  150 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGS---------------FDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQIT  150 (288)
T ss_dssp             CCCTTEEHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred             EccCCCCHHHhhhccCC---------------CCHHHHHHHHHHHHHHHHhhc--cccEEcCcCCccccccCCCceEEec
Confidence            99999999999886552               999999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCC-CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          238 DFGLARRIDTSH-SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       238 Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      |||+|+...... ........||+.|+|||++.+. .++.++|||||||++|||++|..||....       ........
T Consensus       151 DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~~i  222 (288)
T d1uu3a_         151 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGN-------EYLIFQKI  222 (288)
T ss_dssp             CCTTCEECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHH
T ss_pred             ccccceecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcC-------HHHHHHHH
Confidence            999998765432 2233456799999999999854 57899999999999999999999975421       11111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .. .      ...+     +...+.++.+++.+||+.||++|||++|++.
T Consensus       223 ~~-~------~~~~-----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         223 IK-L------EYDF-----PEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HT-T------CCCC-----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             Hc-C------CCCC-----CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            11 0      0111     2234557899999999999999999998643

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-55  Score=388.75  Aligned_cols=269  Identities=28%  Similarity=0.424  Sum_probs=203.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCC-C-----CEEEEEEeCcccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSS-G-----VTVAIKKLDKDAF-QGFREFRAEMETLGKL-RHRNIVKILGYCASGLD  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  152 (373)
                      .++|++.+.||+|+||+||+|.... +     ..||+|.+..... .....+.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            4678899999999999999997542 2     3689999865433 3345788999999998 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCc--------ccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDG--------SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSS  224 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~--------~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~  224 (373)
                      .++|||||++|+|.+++...........        .........+++.+++.++.|++.||+|||  +++|+||||||+
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH--~~~IiHRDlKp~  193 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAAR  193 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEEETTCSGG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCchh
Confidence            9999999999999999987543211100        000011234899999999999999999999  789999999999


Q ss_pred             ceEeCCCCceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCccc
Q 043074          225 NVLLDSDFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVL  302 (373)
Q Consensus       225 Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~  302 (373)
                      ||+++.++.+||+|||+|+........ ......||+.|+|||.+.+ ..++.++|||||||++|||+| |..||.....
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999875443322 2334668999999999874 458999999999999999998 7887643222


Q ss_pred             CCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 043074          303 DGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLD  369 (373)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~  369 (373)
                      ..   .+.    .....+         .. ...+..++.++.+++.+||+.||++|||++||++.|.
T Consensus       273 ~~---~~~----~~~~~~---------~~-~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DA---NFY----KLIQNG---------FK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SH---HHH----HHHHTT---------CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH---HHH----HHHhcC---------CC-CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            11   111    111111         11 1114445678999999999999999999999999996

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.4e-55  Score=384.36  Aligned_cols=252  Identities=24%  Similarity=0.312  Sum_probs=188.6

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ..+.|++.+.||+|+||.||+|..+ +++.||||++.+.... ....+.+|+.++++++||||+++++++.+++..++||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3467999999999999999999764 7899999999765433 2346789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC---CCCce
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD---SDFEA  234 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~---~~~~~  234 (373)
                      |||++|+|.+++....               ++++.++..++.||+.||+|||  +++|+||||||+||++.   +++.+
T Consensus        87 E~~~gg~L~~~l~~~~---------------~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~Nil~~~~~~~~~v  149 (307)
T d1a06a_          87 QLVSGGELFDRIVEKG---------------FYTERDASRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKI  149 (307)
T ss_dssp             CCCCSCBHHHHHHTCS---------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCE
T ss_pred             eccCCCcHHHhhhccc---------------CCCHHHHHHHHHHHHHHHHhhh--hceeeeEEecccceeecccCCCceE
Confidence            9999999999997643               2999999999999999999999  78999999999999994   57899


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      ||+|||+++......  ......||+.|+|||++.+. .++.++|||||||++|||++|..||.....       .+...
T Consensus       150 kl~DFG~a~~~~~~~--~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~  219 (307)
T d1a06a_         150 MISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDEND-------AKLFE  219 (307)
T ss_dssp             EECCC--------------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHH
T ss_pred             EEeccceeEEccCCC--eeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence            999999998654322  23446799999999999854 578999999999999999999999754211       11111


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ......   ......     .....+.++.+++.+||+.||++|||++|+++
T Consensus       220 ~i~~~~---~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         220 QILKAE---YEFDSP-----YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHTTC---CCCCTT-----TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhccC---CCCCCc-----cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            111100   001111     12334568999999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=376.85  Aligned_cols=256  Identities=24%  Similarity=0.355  Sum_probs=194.2

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeCC----CCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLSS----GVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      .++|++.+.||+|+||.||+|.+..    +..||||.++..... ..+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            3578899999999999999997642    456899998654433 34678999999999999999999999864 67899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ||||+++|+|.+++.....              ++++..++.++.||++||.|||  +++++||||||+||++++++.+|
T Consensus        85 v~E~~~~g~l~~~~~~~~~--------------~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDlKp~NIll~~~~~~K  148 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKY--------------SLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVK  148 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTT--------------TSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEE
T ss_pred             EEEeccCCcHHhhhhccCC--------------CCCHHHHHHHHHHHHHHhhhhc--ccCeeccccchhheeecCCCcEE
Confidence            9999999999998876543              3899999999999999999999  79999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      |+|||+++..............||+.|+|||.+.+ ..++.++|||||||++|||++ |.+|+.....    ..+..   
T Consensus       149 l~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~----~~~~~---  220 (273)
T d1mp8a_         149 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIG---  220 (273)
T ss_dssp             ECC-------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHHH---
T ss_pred             EccchhheeccCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCH----HHHHH---
Confidence            99999998765544444455678999999999974 458899999999999999998 6666543221    11111   


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .... +.     ..     ..+..++.++.+++.+||+.||++|||+++|++.|++++
T Consensus       221 ~i~~-~~-----~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         221 RIEN-GE-----RL-----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             HHHT-TC-----CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHc-CC-----CC-----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1111 11     01     113445678999999999999999999999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-54  Score=383.21  Aligned_cols=277  Identities=27%  Similarity=0.418  Sum_probs=212.0

Q ss_pred             HHHhcCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCcccccc-HHHHHHHHHHHhcCCCCCccceeeEEee
Q 043074           77 LIDATDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQG-FREFRAEMETLGKLRHRNIVKILGYCAS  149 (373)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~  149 (373)
                      ++...++|++.+.||+|+||.||+|+.+      +++.||||+++...... .+.+.+|+.++++++||||+++++++.+
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3445678999999999999999999753      45789999997654433 4679999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcc---------cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeec
Q 043074          150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGS---------KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRD  220 (373)
Q Consensus       150 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~---------~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~d  220 (373)
                      ....++++||+++|+|.+++............         ........+++.+++.++.|++.||+|||  +++++|||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH--~~~ivHrD  165 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRD  165 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSC
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc--cCCeEeeE
Confidence            99999999999999999999765432111100         01111234899999999999999999999  78999999


Q ss_pred             CCCCceEeCCCCceEEeeeccccccCCCC-CcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCC
Q 043074          221 IKSSNVLLDSDFEAHISDFGLARRIDTSH-SHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLP  299 (373)
Q Consensus       221 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  299 (373)
                      |||+|||++.++.+||+|||+++...... ........||+.|+|||.+.+ ..++.++|||||||++|||++|..|++.
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCC
Confidence            99999999999999999999998654322 222334678899999999985 4588999999999999999999765433


Q ss_pred             cccCCCcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhC
Q 043074          300 VVLDGQEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA  373 (373)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~~  373 (373)
                      ....      .+....... +..          ...+..++.++.+++.+||+.||++|||+.||++.|+++..
T Consensus       245 ~~~~------~e~~~~v~~-~~~----------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         245 GMAH------EEVIYYVRD-GNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             TSCH------HHHHHHHHT-TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCH------HHHHHHHHc-CCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2211      111111111 111          11134456689999999999999999999999999999863

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-53  Score=383.15  Aligned_cols=251  Identities=22%  Similarity=0.336  Sum_probs=205.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.+++..++|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5899999999999999999976 479999999998766666678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC--CCceEEee
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS--DFEAHISD  238 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~--~~~~kl~D  238 (373)
                      ++|+|.+++.....              ++++.++..++.||+.||+|||  +++++||||||+|||++.  ++.+||+|
T Consensus       106 ~gg~L~~~l~~~~~--------------~l~e~~~~~i~~qi~~aL~ylH--~~~iiHrDiKp~NIll~~~~~~~vkL~D  169 (350)
T d1koaa2         106 SGGELFEKVADEHN--------------KMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLID  169 (350)
T ss_dssp             CSCBHHHHHTCTTS--------------CBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTSCCEEECC
T ss_pred             CCCCHHHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHH--hcCCeeeeechhHeeeccCCCCeEEEee
Confidence            99999999965432              3899999999999999999999  799999999999999964  67899999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||+++......  ......||+.|+|||++.+. .++.++|||||||++|||++|..||....       ..+.......
T Consensus       170 FG~a~~~~~~~--~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~  239 (350)
T d1koaa2         170 FGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGEN-------DDETLRNVKS  239 (350)
T ss_dssp             CTTCEECCTTS--CEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHH
T ss_pred             cchheeccccc--ccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCC-------HHHHHHHHHh
Confidence            99998765332  33456799999999999854 47889999999999999999999975321       1111122211


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ....   .....     ....+.++.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~---~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         240 CDWN---MDDSA-----FSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             TCCC---SCCGG-----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCC---CCccc-----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1100   11111     1223457899999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=373.62  Aligned_cols=250  Identities=26%  Similarity=0.396  Sum_probs=195.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEee-CCeeEEEEEec
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCAS-GLDRVLIYEFV  160 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  160 (373)
                      ++|++.+.||+|+||.||+|.++ |..||||+++...  ..+.+.+|++++++++||||++++|++.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            46778899999999999999985 7899999997643  34678999999999999999999999865 45689999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++|+|.+++......             ++++..+++++.||+.||.|||  +++++||||||+||+++.++.+||+|||
T Consensus        84 ~~g~L~~~l~~~~~~-------------~l~~~~~~~i~~~i~~al~ylH--~~~ivH~dlkp~Nil~~~~~~~kl~dfg  148 (262)
T d1byga_          84 AKGSLVDYLRSRGRS-------------VLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFG  148 (262)
T ss_dssp             TTEEHHHHHHHHHHH-------------HCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             CCCCHHHHHHhcCCC-------------CCCHHHHHHHHHHHHhhccccc--cCceeccccchHhheecCCCCEeecccc
Confidence            999999999764321             2899999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhC-CCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ-IRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      +++.....    .....+|..|+|||.+.+ ..++.++||||||+++|||+|+ ..|+....    ...+..+.   .  
T Consensus       149 ~s~~~~~~----~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~----~~~~~~~i---~--  214 (262)
T d1byga_         149 LTKEASST----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPRV---E--  214 (262)
T ss_dssp             C----------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC----GGGHHHHH---T--
T ss_pred             cceecCCC----CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCC----HHHHHHHH---H--
Confidence            99865432    233467889999999975 4589999999999999999995 55543211    11222211   1  


Q ss_pred             ccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          320 NKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                          ....+     ..+..++.++.+++.+||+.||.+|||+.+|++.|+++.
T Consensus       215 ----~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         215 ----KGYKM-----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             ----TTCCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----cCCCC-----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence                01111     124445678999999999999999999999999999874

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.5e-54  Score=384.52  Aligned_cols=251  Identities=20%  Similarity=0.304  Sum_probs=205.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      ++|++.+.||+|+||.||+|.. .+|+.||||+++.........+.+|+.++++++||||+++++++.++...++|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5799999999999999999976 579999999997765555667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC--CCCceEEee
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD--SDFEAHISD  238 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~--~~~~~kl~D  238 (373)
                      ++|+|.+++.....              ++++.++..++.||+.||+|||  +++|+||||||+|||++  .++.+||+|
T Consensus       109 ~gg~L~~~~~~~~~--------------~l~e~~~~~i~~qi~~aL~ylH--~~~iiHRDiKp~NILl~~~~~~~vkL~D  172 (352)
T d1koba_         109 SGGELFDRIAAEDY--------------KMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIID  172 (352)
T ss_dssp             CCCBHHHHTTCTTC--------------CBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECC
T ss_pred             CCChHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HCCeeecccccccccccccCCCeEEEee
Confidence            99999998765442              3899999999999999999999  79999999999999997  678999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||+|+.....  .......||+.|+|||++.+ ..++.++|||||||++|||+||..||.....       .+.......
T Consensus       173 FGla~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~  242 (352)
T d1koba_         173 FGLATKLNPD--EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQNVKR  242 (352)
T ss_dssp             CTTCEECCTT--SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHH
T ss_pred             cccceecCCC--CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHh
Confidence            9999886543  23345678999999999985 4589999999999999999999999753211       111111111


Q ss_pred             hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ...   .....     .....+.++.+++.+||+.||.+|||++|+++
T Consensus       243 ~~~---~~~~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         243 CDW---EFDED-----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             CCC---CCCSS-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCC---CCCcc-----cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            100   01111     12234568999999999999999999999976

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-54  Score=377.71  Aligned_cols=267  Identities=27%  Similarity=0.335  Sum_probs=202.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHH--HHHHHHhcCCCCCccceeeEEeeCC----eeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFR--AEMETLGKLRHRNIVKILGYCASGL----DRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~--~e~~~l~~l~h~niv~l~~~~~~~~----~~~l  155 (373)
                      ++|.+.+.||+|+||.||+|+. +|+.||||+++....   +.+.  .|+..+..++||||+++++++.+..    ..++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            4577788999999999999987 589999999965432   3333  4555566789999999999997654    5789


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCceeecCCCCceEeC
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGL------EKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~------~~~i~H~dlk~~Nill~  229 (373)
                      ||||+++|+|.+++++..                ++|.++++++.|++.||+|+|+.      +++|+||||||+|||++
T Consensus        79 v~Ey~~~g~L~~~l~~~~----------------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~  142 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRYT----------------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  142 (303)
T ss_dssp             EEECCTTCBHHHHHHHCC----------------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred             EEecccCCCHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc
Confidence            999999999999998653                89999999999999999999952      36899999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCc---ccccccccccccCccccCCCC-----CCCccccchhhhHHHHHHHhCCCCCCCcc
Q 043074          230 SDFEAHISDFGLARRIDTSHSH---VSTQVAGTMGYMPPEYLGGNT-----AATVMLDVYSFGILMIEIATQIRPNLPVV  301 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~  301 (373)
                      .++.+||+|||+++........   ......||+.|+|||.+.+..     .++.++|||||||++|||+||..|+....
T Consensus       143 ~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~  222 (303)
T d1vjya_         143 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  222 (303)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred             CCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence            9999999999999876443322   223467999999999987532     25778999999999999999988754333


Q ss_pred             cCCCcc-------cHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          302 LDGQEV-------GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       302 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ......       ..........    ....+++.+.....+.+.+..+.+++.+||+.||++|||+.||++.|+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         223 DYQLPYYDLVPSDPSVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHH----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccchhhcccccchHHHHHHHH----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            222110       0111111111    112223333333334456778999999999999999999999999999874

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=375.94  Aligned_cols=251  Identities=24%  Similarity=0.347  Sum_probs=203.3

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc------cHHHHHHHHHHHhcCCCCCccceeeEEeeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ------GFREFRAEMETLGKLRHRNIVKILGYCASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  153 (373)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++++....      ..+.+.+|+.++++++||||+++++++.+....
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46899999999999999999976 47999999998653321      256789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC-
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-  232 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~-  232 (373)
                      ++|||||++|+|.+++....               ++++..+..++.|++.||+|||  +++|+||||||+||+++.++ 
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~---------------~l~~~~~~~~~~qi~~al~yLH--~~~ivHrDiKp~Nill~~~~~  151 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE---------------SLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNV  151 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSS
T ss_pred             EEEEEcCCCccccchhcccc---------------ccchhHHHHHHHHHHHHHHhhh--hcceeecccccceEEEecCCC
Confidence            99999999999999997654               2999999999999999999999  78999999999999998776 


Q ss_pred             ---ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          233 ---EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       233 ---~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                         .+|++|||++.......  ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.....       
T Consensus       152 ~~~~vkl~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------  221 (293)
T d1jksa_         152 PKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTK-------  221 (293)
T ss_dssp             SSCCEEECCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------
T ss_pred             cccceEecchhhhhhcCCCc--cccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCH-------
Confidence               49999999998764332  2344678999999999985 4578999999999999999999999754211       


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .+.........       ...... .....+..+.+++.+||+.||++|||++|+++
T Consensus       222 ~~~~~~i~~~~-------~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         222 QETLANVSAVN-------YEFEDE-YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHHHHHTTC-------CCCCHH-HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcC-------CCCCch-hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111111110       000000 01223457899999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=374.06  Aligned_cols=247  Identities=21%  Similarity=0.270  Sum_probs=204.1

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||+|.. .+|+.||+|++++..   ....+.+.+|+.+|++++||||+++++++.+....++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            4788999999999999999976 479999999997543   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|.+++.....               +++..+..++.||+.||+|||  +++|+||||||+|||++.+|.+||+
T Consensus        85 ey~~gg~L~~~~~~~~~---------------~~e~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NILl~~~g~vkl~  147 (337)
T d1o6la_          85 EYANGGELFFHLSRERV---------------FTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKIT  147 (337)
T ss_dssp             ECCTTCBHHHHHHHHSC---------------CCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             eccCCCchhhhhhcccC---------------CcHHHHHHHHHHHhhhhhhhh--hcCccccccCHHHeEecCCCCEEEe
Confidence            99999999999987653               899999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+|+...... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||.....       ........
T Consensus       148 DFG~a~~~~~~~-~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~-------~~~~~~i~  218 (337)
T d1o6la_         148 DFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELIL  218 (337)
T ss_dssp             CCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHH
T ss_pred             ecccccccccCC-cccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCH-------HHHHHHHh
Confidence            999998654322 234457899999999999854 479999999999999999999999754321       11111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA-----MSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~l~~  366 (373)
                      . ..      ..+     +...+.++.+++.+||+.||++||+     ++++++
T Consensus       219 ~-~~------~~~-----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         219 M-EE------IRF-----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             H-CC------CCC-----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             c-CC------CCC-----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            1 10      111     2334567899999999999999995     777765

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-53  Score=378.50  Aligned_cols=254  Identities=22%  Similarity=0.375  Sum_probs=197.3

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCC----EEEEEEeCccc-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGV----TVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVL  155 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  155 (373)
                      ++|++.+.||+|+||+||+|.+. +|+    +||+|.++... ....+.+.+|+.++++++||||++++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46899999999999999999764 443    68999886543 33467899999999999999999999999875 5678


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      ++||+.+|+|.+++.....              .+++..+++++.||+.||+|||  +++|+||||||+|||++.++.+|
T Consensus        88 v~e~~~~~~l~~~~~~~~~--------------~~~~~~~~~i~~qi~~gl~yLH--~~~iiHrDlKp~NIll~~~~~~k  151 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKD--------------NIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVK  151 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSS--------------SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEE
T ss_pred             EEEeccCCccccccccccc--------------CCCHHHHHHHHHHHHHHHHHHH--HcCcccCcchhhcceeCCCCCeE
Confidence            8899999999998876543              3899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHHHH
Q 043074          236 ISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLEWA  313 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  313 (373)
                      |+|||+++........ ......||+.|+|||.+.+. .++.++|||||||++|||+| |..|+.. ...   ..+..  
T Consensus       152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~---~~~~~--  224 (317)
T d1xkka_         152 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDG-IPA---SEISS--  224 (317)
T ss_dssp             ECCCSHHHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCG---GGHHH--
T ss_pred             eeccccceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCC-CCH---HHHHH--
Confidence            9999999986543332 23345689999999998754 58999999999999999999 4555432 211   11111  


Q ss_pred             HHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          314 RTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                       .... +.     .     ...+..++..+.+++.+||+.||++|||+.+|++.|+++
T Consensus       225 -~i~~-~~-----~-----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         225 -ILEK-GE-----R-----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             -HHHH-TC-----C-----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHc-CC-----C-----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence             1111 10     0     011344567899999999999999999999999998875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=370.50  Aligned_cols=252  Identities=25%  Similarity=0.428  Sum_probs=200.6

Q ss_pred             CCeeecCCCceEEEEEeCCC----CEEEEEEeCccc-cccHHHHHHHHHHHhcCCCCCccceeeEEee-CCeeEEEEEec
Q 043074           87 DKIIGDGSFGFVYKAKLSSG----VTVAIKKLDKDA-FQGFREFRAEMETLGKLRHRNIVKILGYCAS-GLDRVLIYEFV  160 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  160 (373)
                      .++||+|+||+||+|.+.++    ..||||+++... ....+.+.+|++++++++||||++++|++.+ +...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            56899999999999976432    368999997533 3345779999999999999999999999876 45889999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      ++|+|.+++......              +++..+++++.|++.||.|||  +.+|+||||||+|||+++++.+||+|||
T Consensus       112 ~~g~l~~~~~~~~~~--------------~~~~~~~~i~~qia~gL~~lH--~~~iiHrDLK~~NILl~~~~~~kL~DFG  175 (311)
T d1r0pa_         112 KHGDLRNFIRNETHN--------------PTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFG  175 (311)
T ss_dssp             TTCBHHHHHHCTTCC--------------CBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred             ecCchhhhhcccccc--------------chHHHHHHHHHHHHHhhhhhc--ccCcccCCccHHhEeECCCCCEEEeccc
Confidence            999999998865432              788999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCCCc---ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          241 LARRIDTSHSH---VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       241 ~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      +++........   ......||+.|+|||.+.+ ..++.++||||||+++|||+||+.|+.......   .   +.....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~---~---~~~~i~  248 (311)
T d1r0pa_         176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---D---ITVYLL  248 (311)
T ss_dssp             GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHH
T ss_pred             chhhccccccccceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH---H---HHHHHH
Confidence            99876433222   2234568999999999874 458999999999999999999888865433221   1   111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      . +..     .     ..+..++.++.+++.+||+.||++||++.||++.|++++
T Consensus       249 ~-g~~-----~-----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         249 Q-GRR-----L-----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             T-TCC-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             c-CCC-----C-----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1 111     0     113344568999999999999999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=369.13  Aligned_cols=255  Identities=25%  Similarity=0.415  Sum_probs=193.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC--CC--CEEEEEEeCcccc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS--SG--VTVAIKKLDKDAF---QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      ++|++.+.||+|+||.||+|...  ++  ..||||++++...   ...+.+.+|+.++++++||||++++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            46888999999999999999753  22  3789999865432   3356799999999999999999999999764 678


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +|+||+++|++.+++.....              ++++..++.++.|++.||.|||  +++|+||||||+||+++.++.+
T Consensus        87 lv~e~~~~~~l~~~~~~~~~--------------~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDikp~NIll~~~~~v  150 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG--------------HFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLV  150 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG--------------GSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEE
T ss_pred             eeeeeecCcchhhhhhcccC--------------CCCHHHHHHHHHHHHHHHHHhh--hCCEeeeeecHHHhccccccce
Confidence            99999999999998876542              3999999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCCc--ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHh-CCCCCCCcccCCCcccHHH
Q 043074          235 HISDFGLARRIDTSHSH--VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIAT-QIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  311 (373)
                      ||+|||+++........  ......|+..|+|||.+.+ ..++.++||||||+++|||+| |..||....       ..+
T Consensus       151 kl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-------~~~  222 (273)
T d1u46a_         151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQ  222 (273)
T ss_dssp             EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHH
T ss_pred             eeccchhhhhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-------HHH
Confidence            99999999987544332  2233567889999999985 558899999999999999998 788864321       111


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDEL  371 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l  371 (373)
                      ........+..          ...+..++..+.+++.+||+.||++|||+.+|.+.|++.
T Consensus       223 ~~~~i~~~~~~----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         223 ILHKIDKEGER----------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHHTSCCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhCCCC----------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            11111111100          111334456899999999999999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-52  Score=371.20  Aligned_cols=244  Identities=24%  Similarity=0.342  Sum_probs=202.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++++..   ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4688999999999999999976 479999999996532   234567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+++|+|..++.....               +++..+..++.||+.||+|||  +++|+||||||+|||++.++.+||+
T Consensus        84 E~~~gg~l~~~~~~~~~---------------~~~~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NILl~~~g~vkL~  146 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR---------------FPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKIT  146 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS---------------CCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             eecCCcccccccccccc---------------ccccHHHHHHHHHHHhhhhhc--cCcEEccccCchheeEcCCCCEEEe
Confidence            99999999999887653               788999999999999999999  8999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++.....    .....||+.|+|||++.+. .++.++|||||||++|||++|..||....       ..+......
T Consensus       147 DFG~a~~~~~~----~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~i~  214 (316)
T d1fota_         147 DFGFAKYVPDV----TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSN-------TMKTYEKIL  214 (316)
T ss_dssp             CCSSCEECSSC----BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHH
T ss_pred             cCccceEeccc----cccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcC-------HHHHHHHHH
Confidence            99999876432    3356799999999999754 47889999999999999999999975421       111111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                      ...       ..     .+...+.++.+++.+||+.||.+||     |++++++
T Consensus       215 ~~~-------~~-----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         215 NAE-------LR-----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HCC-------CC-----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             cCC-------CC-----CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            110       01     1233455799999999999999996     8888875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.4e-52  Score=376.99  Aligned_cols=249  Identities=23%  Similarity=0.276  Sum_probs=199.4

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc---ccHHHHH---HHHHHHhcCCCCCccceeeEEeeCCeeE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF---QGFREFR---AEMETLGKLRHRNIVKILGYCASGLDRV  154 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~  154 (373)
                      ++|++.+.||+|+||.||+|... +|+.||||++.+...   .....+.   .|+.+++.++||||+++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999764 799999999864322   1222333   3467788889999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      +||||+++|+|.+++.....               +++..+..++.||+.||.|||  +++++||||||+|||++.++.+
T Consensus        84 ivmE~~~gg~L~~~l~~~~~---------------~~e~~~~~~~~qi~~aL~ylH--~~~iiHrDlKP~NILl~~~g~i  146 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHGV---------------FSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHV  146 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHCS---------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSSSCE
T ss_pred             EEEEecCCCcHHHHHHhccc---------------ccHHHHHHHHHHHHHHHHHHH--HCCccceeeccceeEEcCCCcE
Confidence            99999999999999987542               889999999999999999999  7999999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHH
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWAR  314 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  314 (373)
                      ||+|||+|+......   .....||+.|+|||++.+...++.++|||||||++|||+||..||.......    ..... 
T Consensus       147 Kl~DFGla~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~~-  218 (364)
T d1omwa3         147 RISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEID-  218 (364)
T ss_dssp             EECCCTTCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC----HHHHH-
T ss_pred             EEeeeceeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH----HHHHH-
Confidence            999999998765432   3446799999999999766678999999999999999999999976533221    11100 


Q ss_pred             HHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 043074          315 TMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA-----MSYVVQ  366 (373)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~l~~  366 (373)
                        .....    .....     +...+.++.+++.+||+.||++|||     ++++++
T Consensus       219 --~~~~~----~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         219 --RMTLT----MAVEL-----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             --HHSSS----CCCCC-----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             --Hhccc----CCCCC-----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence              00000    00111     2234558999999999999999999     577764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-53  Score=372.82  Aligned_cols=274  Identities=27%  Similarity=0.374  Sum_probs=198.1

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCccccc-cHHHHHHHHHHHhcC-CCCCccceeeEEeeC-
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKL-RHRNIVKILGYCASG-  150 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-  150 (373)
                      ..++|++.+.||+|+||.||+|...      +++.||||+++..... ..+.+.+|...+.++ +|+||+.+++++.+. 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            4468999999999999999999753      3468999999754433 345677888887777 689999999988654 


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCc-ccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDG-SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      ...++|||||++|+|.+++........... .........+++.+++.++.||+.||+|||  +++|+||||||+|||++
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLS  168 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEC
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH--hCCCcCCcCCccceeEC
Confidence            468999999999999999976542110000 000001124899999999999999999999  78999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc
Q 043074          230 SDFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG  308 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  308 (373)
                      +++.+||+|||+|+........ ......||+.|+|||.+.+ ..++.++|||||||++|||+||..|+++.....  . 
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~-  244 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E-  244 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--H-
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--H-
Confidence            9999999999999876443322 3345679999999999975 458999999999999999999876544322211  1 


Q ss_pred             HHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          309 LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                        ........ +.     ...     .+..++.++.+++.+||+.||++|||++|+++.|++++
T Consensus       245 --~~~~~~~~-~~-----~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         245 --EFCRRLKE-GT-----RMR-----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             --HHHHHHHH-TC-----CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHHhc-CC-----CCC-----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              11111111 11     111     13344568999999999999999999999999999876

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.5e-52  Score=363.81  Aligned_cols=259  Identities=22%  Similarity=0.310  Sum_probs=200.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCC----e
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---GFREFRAEMETLGKLRHRNIVKILGYCASGL----D  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  152 (373)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++++....   ....+.+|+.+++.++||||+++++++.+..    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46899999999999999999975 57999999999765433   2456889999999999999999999987654    3


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .|+||||+++++|.+++.....               +++.++..++.||+.||+|||  +++++||||||+|||++.++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~---------------l~~~~~~~i~~qi~~al~~lH--~~~iiHrDiKP~NIll~~~~  148 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGP---------------MTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATN  148 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCS---------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTS
T ss_pred             EEEEEECCCCCEehhhhcccCC---------------CCHHHHHHHHHHHHHHHHHHH--hCCccCccccCcccccCccc
Confidence            7899999999999999876652               999999999999999999999  79999999999999999999


Q ss_pred             ceEEeeeccccccCCCCC--cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH
Q 043074          233 EAHISDFGLARRIDTSHS--HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  310 (373)
                      ..+++|||.+........  .......||+.|+|||++.+ ..++.++|||||||++|||+||..||....       ..
T Consensus       149 ~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~  220 (277)
T d1o6ya_         149 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDS-------PV  220 (277)
T ss_dssp             CEEECCCTTCEECC----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HH
T ss_pred             cceeehhhhhhhhccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcC-------HH
Confidence            999999999876533222  23345679999999999975 457899999999999999999999975321       11


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhhh
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-AMSYVVQLLDELV  372 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~l~~~L~~l~  372 (373)
                      +...........    .+.    ......+.++.+++.+||+.||++|| |++++++.|.++.
T Consensus       221 ~~~~~~~~~~~~----~~~----~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         221 SVAYQHVREDPI----PPS----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHHHHHHHCCCC----CGG----GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCC----CCc----hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            111111111110    000    11223355899999999999999999 8999999998875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-52  Score=364.99  Aligned_cols=252  Identities=21%  Similarity=0.318  Sum_probs=203.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc---------cHHHHHHHHHHHhcCC-CCCccceeeEEee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ---------GFREFRAEMETLGKLR-HRNIVKILGYCAS  149 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  149 (373)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.+....         ..+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            36899999999999999999976 47899999998654322         1235789999999997 9999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       150 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      ++..++||||+++|+|.+++....               ++++.++..++.||+.||+|||  +++|+||||||+||+++
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~---------------~l~e~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~  144 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV---------------TLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLD  144 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHH--HcCCcccccccceEEEc
Confidence            999999999999999999997654               2999999999999999999999  78999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCcccccccccccccCccccCC-----CCCCCccccchhhhHHHHHHHhCCCCCCCcccCC
Q 043074          230 SDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGG-----NTAATVMLDVYSFGILMIEIATQIRPNLPVVLDG  304 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  304 (373)
                      .++.+||+|||+++......  ......||+.|+|||.+.+     ...++.++||||+||++|||++|..||.....  
T Consensus       145 ~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--  220 (277)
T d1phka_         145 DDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--  220 (277)
T ss_dssp             TTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred             CCCCeEEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--
Confidence            99999999999998765432  2345679999999999852     34568899999999999999999999754221  


Q ss_pred             CcccHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          305 QEVGLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                           ......... ... . ..    ... ....++++.+++.+||+.||++|||++|+++
T Consensus       221 -----~~~~~~i~~-~~~-~-~~----~~~-~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         221 -----MLMLRMIMS-GNY-Q-FG----SPE-WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             -----HHHHHHHHH-TCC-C-CC----TTT-GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -----HHHHHHHHh-CCC-C-CC----Ccc-cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 111111111 110 0 00    000 2234568999999999999999999999976

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-53  Score=373.23  Aligned_cols=269  Identities=28%  Similarity=0.415  Sum_probs=201.8

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCC--EEEEEEeCccc-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGV--TVAIKKLDKDA-FQGFREFRAEMETLGKL-RHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ++|++.+.||+|+||.||+|.++ +|.  .||||++.... ....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            57888899999999999999765 444  57888875433 33456799999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCC-cccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVD-GSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAH  235 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~-~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~k  235 (373)
                      |||+++|+|.++++......... ..........+++..+++++.||+.||.|||  +++++||||||+|||++.++.+|
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH--~~~iiHrDlkp~NIL~~~~~~~k  167 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAK  167 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECGGGCEE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh--cCCccccccccceEEEcCCCceE
Confidence            99999999999997652100000 0000001123899999999999999999999  78999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHH
Q 043074          236 ISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWART  315 (373)
Q Consensus       236 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  315 (373)
                      |+|||+++......  ......||..|+|||.+.+ ..++.++|||||||++|||++|..|++....      ..+....
T Consensus       168 l~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~~~~  238 (309)
T d1fvra_         168 IADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEK  238 (309)
T ss_dssp             ECCTTCEESSCEEC--CC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHH
T ss_pred             Eccccccccccccc--cccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHHHHH
Confidence            99999997643222  2234568999999999974 4588999999999999999998765432211      1111111


Q ss_pred             HHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          316 MEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ..      +....     ..+..++.++.+++.+||+.||++|||+++|++.|++++
T Consensus       239 i~------~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         239 LP------QGYRL-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             GG------GTCCC-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH------hcCCC-----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            11      11111     113445678999999999999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=372.04  Aligned_cols=273  Identities=27%  Similarity=0.389  Sum_probs=211.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe------CCCCEEEEEEeCccccc-cHHHHHHHHHHHhcC-CCCCccceeeEEeeCCe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL------SSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKL-RHRNIVKILGYCASGLD  152 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  152 (373)
                      .++|++.+.||+|+||.||+|++      .+++.||||+++..... ....+.+|+.++.++ +||||+++++++.++..
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            46888899999999999999975      24678999999765443 345788999999999 69999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcc---cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGS---KQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~---~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      .++|||||++|+|.+++............   ........+++.++..++.||+.||+|||  +++++||||||+||+++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH--~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLT  179 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccccccccccc
Confidence            99999999999999999876532211100   00112224899999999999999999999  78999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc
Q 043074          230 SDFEAHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG  308 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  308 (373)
                      .++.+|++|||+++....... .......||+.|+|||.+.+ ..++.++|||||||++|||+|++.|+........  .
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--~  256 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K  256 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH--H
Confidence            999999999999987654332 33345678999999999974 5589999999999999999997666543322211  1


Q ss_pred             HHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          309 LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      +....    ..+     ....     .+...+..+.+++.+||+.||++|||+.+|++.|++.+
T Consensus       257 ~~~~i----~~~-----~~~~-----~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         257 FYKMI----KEG-----FRML-----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             HHHHH----HHT-----CCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHH----hcC-----CCCC-----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence            11111    111     1111     13334568999999999999999999999999999865

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=369.34  Aligned_cols=272  Identities=30%  Similarity=0.404  Sum_probs=203.6

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC--------CCCEEEEEEeCccccc-cHHHHHHHHHHHhcC-CCCCccceeeEEeeC
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS--------SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKL-RHRNIVKILGYCASG  150 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  150 (373)
                      .++|.+.+.||+|+||.||+|+..        ++..||||++++.... ...++.+|...+.++ +||||++++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            457888999999999999999642        2347999999765543 346788899998888 799999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhcCCCCCCCCc-ccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          151 LDRVLIYEFVENGSLDQWLHDTSRNDDVDG-SKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       151 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      ...++||||+++|+|.+++........... .........+++.+++.++.|++.||+|||  +++++||||||+|||++
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH--~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEC
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh--hCCEEeeeecccceeec
Confidence            999999999999999999986653211100 000111234899999999999999999999  79999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCCc-ccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhC-CCCCCCcccCCCcc
Q 043074          230 SDFEAHISDFGLARRIDTSHSH-VSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQ-IRPNLPVVLDGQEV  307 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~  307 (373)
                      .++.+||+|||+++........ ......+|+.|+|||.+.+ ..++.++||||||+++|||+++ .+|+....    ..
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~----~~  244 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VE  244 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCC----HH
Confidence            9999999999999876543322 3344678999999999974 4589999999999999999985 55543211    11


Q ss_pred             cHHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhC
Q 043074          308 GLLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELVA  373 (373)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~~  373 (373)
                      .+.   ... ..+     .....     +..++..+.+++.+||+.||++|||+.||++.|++++|
T Consensus       245 ~~~---~~i-~~~-----~~~~~-----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         245 ELF---KLL-KEG-----HRMDK-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHH---HHH-HTT-----CCCCC-----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHH---HHH-HcC-----CCCCC-----CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            111   111 111     11111     33345689999999999999999999999999999875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-51  Score=369.06  Aligned_cols=244  Identities=22%  Similarity=0.292  Sum_probs=202.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccc---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDA---FQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  157 (373)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++.+..   ....+.+.+|+.+++.++||||+++++++.+....++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999976 479999999986532   233567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEe
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHIS  237 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~  237 (373)
                      ||+.+|+|..++.....               +++.++..++.||+.||.|||  +++|+||||||+|||++.++.+||+
T Consensus       121 e~~~~g~l~~~l~~~~~---------------l~e~~~~~i~~qi~~aL~yLH--~~~iiHRDIKP~NILl~~~g~ikL~  183 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGR---------------FSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVT  183 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC---------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             ccccccchhhhHhhcCC---------------CCHHHHHHHHHHHHHHHHHHH--hCCEecCcCCHHHcccCCCCCEEee
Confidence            99999999999987642               899999999999999999999  7899999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++.....    .....||+.|+|||++.+ ..++.++|||||||++|||++|..||....       .........
T Consensus       184 DFG~a~~~~~~----~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~i~  251 (350)
T d1rdqe_         184 DFGFAKRVKGR----TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-------PIQIYEKIV  251 (350)
T ss_dssp             CCTTCEECSSC----BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHH
T ss_pred             eceeeeecccc----cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcC-------HHHHHHHHh
Confidence            99999876432    234679999999999985 457899999999999999999999975321       111111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERP-----AMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~l~~  366 (373)
                      ...       ..     .+...+.++.+++.+||+.||.+|+     |++++++
T Consensus       252 ~~~-------~~-----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         252 SGK-------VR-----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HCC-------CC-----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             cCC-------CC-----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            110       01     1223456899999999999999994     8999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=370.62  Aligned_cols=258  Identities=22%  Similarity=0.250  Sum_probs=193.3

Q ss_pred             CCeeecCCCceEEEEEeC-CCCEEEEEEeCcccccc-----HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEec
Q 043074           87 DKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQG-----FREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEFV  160 (373)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  160 (373)
                      .++||+|+||+||+|..+ +|+.||||+++......     .+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999764 69999999986543321     246889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeeec
Q 043074          161 ENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDFG  240 (373)
Q Consensus       161 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  240 (373)
                      .++++..+.....               .+++.++..++.||+.||+|||  +++++||||||+|||++.++.+||+|||
T Consensus        83 ~~~~~~~~~~~~~---------------~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDiKp~NIli~~~~~~KL~DFG  145 (299)
T d1ua2a_          83 ETDLEVIIKDNSL---------------VLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFG  145 (299)
T ss_dssp             SEEHHHHHTTCCS---------------SCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             cchHHhhhhhccc---------------CCCHHHHHHHHHHHHHHHHHhh--ccceecccCCcceEEecCCCccccccCc
Confidence            8887776654332               2888999999999999999999  7999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHhc
Q 043074          241 LARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEARN  320 (373)
Q Consensus       241 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (373)
                      +++....... ......||+.|+|||++.+...++.++|||||||++|||++|..||......    ....-........
T Consensus       146 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~----~~l~~i~~~~~~~  220 (299)
T d1ua2a_         146 LAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL----DQLTRIFETLGTP  220 (299)
T ss_dssp             GGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCC
T ss_pred             cccccCCCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH----HHHHHHHHhcCCC
Confidence            9987654332 2334578999999999987777899999999999999999999886432211    1111111100000


Q ss_pred             cc------cccc----cCcccc---ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          321 KE------IEMV----DSNISR---EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       321 ~~------~~~~----~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..      ....    ......   .......+.++.+++.+||+.||++|||++|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         221 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00      0000    000000   0001123457999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=370.80  Aligned_cols=267  Identities=24%  Similarity=0.411  Sum_probs=209.1

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC------CCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCee
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS------SGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGLDR  153 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  153 (373)
                      .++|.+.+.||+|+||.||+|.++      ++..||||+++..... ....+.+|+.++++++||||+++++++......
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            467888999999999999999753      3578999999754433 345689999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCc
Q 043074          154 VLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFE  233 (373)
Q Consensus       154 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~  233 (373)
                      ++||||+++|+|.+++........     .......+++..+.+++.|+++||.|||  +++|+||||||+|||++++++
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~ia~gl~~LH--~~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMA-----NNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHH-----HCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEECTTCC
T ss_pred             eEEEeecCCCCHHHHHHhcccccc-----cccccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeeceEcCCceeecCCce
Confidence            999999999999999875431100     0011223799999999999999999999  789999999999999999999


Q ss_pred             eEEeeeccccccCCCCC-cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          234 AHISDFGLARRIDTSHS-HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       234 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      +||+|||+++....... .......||+.|+|||.+.+ ..++.++||||||+++|||+||..|++...      ...++
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~~~~~  244 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQV  244 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCC------CHHHH
Confidence            99999999987643322 22334568999999999975 457889999999999999999975544321      12222


Q ss_pred             HHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          313 ARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ...... +..          ...+..++..+.+++.+||+.||++|||+++|++.|++.+
T Consensus       245 ~~~i~~-~~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         245 LRFVME-GGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HHHHHT-TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHHHh-CCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            222211 111          1113345568999999999999999999999999998865

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-52  Score=367.39  Aligned_cols=251  Identities=21%  Similarity=0.262  Sum_probs=202.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      .++|++.+.||+|+||+||+|..+ +++.||+|.++..... ...+.+|+.+|++++||||+++++++.+.+..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            478999999999999999999764 7889999999765433 35678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC--CceEEe
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD--FEAHIS  237 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~--~~~kl~  237 (373)
                      |++|+|.+++.....              ++++.++..++.||+.||+|||  +++|+||||||+|||++.+  ..+||+
T Consensus        83 ~~gg~L~~~i~~~~~--------------~l~e~~~~~i~~qi~~al~yLH--~~~iiHrDlKp~NIll~~~~~~~ikl~  146 (321)
T d1tkia_          83 ISGLDIFERINTSAF--------------ELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKII  146 (321)
T ss_dssp             CCCCBHHHHHTSSSC--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred             CCCCcHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHH--HcCCCcccccccceeecCCCceEEEEc
Confidence            999999999976542              2899999999999999999999  7899999999999999854  589999


Q ss_pred             eeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHH
Q 043074          238 DFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTME  317 (373)
Q Consensus       238 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
                      |||+++......  ......+|+.|+|||.+.+ ..++.++|||||||++|||++|..||.....       .+......
T Consensus       147 DFG~~~~~~~~~--~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-------~~~~~~i~  216 (321)
T d1tkia_         147 EFGQARQLKPGD--NFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIM  216 (321)
T ss_dssp             CCTTCEECCTTC--EEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHH
T ss_pred             ccchhhccccCC--cccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCH-------HHHHHHHH
Confidence            999998764322  2344578999999999874 4588999999999999999999999754221       11111111


Q ss_pred             HhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          318 ARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .....   +....     ....+.++.+++.+||+.||++|||++|+++
T Consensus       217 ~~~~~---~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         217 NAEYT---FDEEA-----FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HTCCC---CCHHH-----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hCCCC---CChhh-----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11000   00000     1123457899999999999999999999987

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-52  Score=367.77  Aligned_cols=246  Identities=23%  Similarity=0.328  Sum_probs=199.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccc---cccHHHHHHHHHHHh-cCCCCCccceeeEEeeCCeeEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA---FQGFREFRAEMETLG-KLRHRNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  156 (373)
                      ++|++.+.||+|+||+||+|..+ +++.||||++++..   ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57899999999999999999764 79999999996532   223455667777665 68999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEE
Q 043074          157 YEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHI  236 (373)
Q Consensus       157 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl  236 (373)
                      |||+++|+|.+++.....               +++.++..++.||+.||+|||  +++++||||||+|||+++++.+||
T Consensus        82 mEy~~~g~L~~~i~~~~~---------------~~e~~~~~~~~qi~~al~ylH--~~~iiHrDikp~NiL~~~~~~~kl  144 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK---------------FDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKI  144 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred             EeecCCCcHHHHhhccCC---------------CCHHHHHHHHHHHHHHHHHHH--hCCeeeccCcccceeecCCCceec
Confidence            999999999999987653               889999999999999999999  789999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHH
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTM  316 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
                      +|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.....       .+.....
T Consensus       145 ~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i  215 (320)
T d1xjda_         145 ADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSI  215 (320)
T ss_dssp             CCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHH
T ss_pred             cccchhhhccccc-ccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHH
Confidence            9999998654332 233456799999999999854 578999999999999999999999754211       1111111


Q ss_pred             HHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 043074          317 EARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMS-YVV  365 (373)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~l~  365 (373)
                      .. .      ...     .+...+.++.+++.+||+.||++||++. +++
T Consensus       216 ~~-~------~~~-----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         216 RM-D------NPF-----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             HH-C------CCC-----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             Hc-C------CCC-----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence            11 0      111     1233456899999999999999999995 665

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=363.96  Aligned_cols=263  Identities=23%  Similarity=0.332  Sum_probs=199.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++....  ...+.+.+|++++++++||||+++++++.++...++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5899999999999999999976 5799999999965432  234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      |+.+ ++.+++......             .+++.++..++.|++.||+|||  +++|+||||||+|||++.++.+||+|
T Consensus        82 ~~~~-~~~~~~~~~~~~-------------~l~e~~~~~~~~qil~~L~yLH--~~~IiHrDiKpeNIl~~~~~~~kl~D  145 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALT-------------GIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLAD  145 (298)
T ss_dssp             CCSE-EHHHHHHHTTTT-------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECS
T ss_pred             ecCC-chhhhhhhhccc-------------CCCHHHHHHHHHHHHHHHHHhh--cCCEEccccCchheeecccCcceecc
Confidence            9965 555555433222             2999999999999999999999  79999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||+++...... .......||+.|+|||.+.....++.++|||||||++|+|++|..||......   .   .+......
T Consensus       146 FG~a~~~~~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~---~~~~i~~~  218 (298)
T d1gz8a_         146 FGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---D---QLFRIFRT  218 (298)
T ss_dssp             TTHHHHHCCCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---H---HHHHHHHH
T ss_pred             CCcceeccCCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---H---HHHHHHHh
Confidence            99998765433 23444679999999999887777789999999999999999999997532110   0   11111100


Q ss_pred             hcccccc----------ccCcc---cccc---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043074          319 RNKEIEM----------VDSNI---SREE---LSEAGVREYFRIACMCTNEKSRERPAMSYVVQL  367 (373)
Q Consensus       319 ~~~~~~~----------~~~~~---~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~  367 (373)
                      .+...+.          .....   ....   .....+.++.+++.+||+.||++|||++|+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         219 LGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             HCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0000000          00000   0000   011224578999999999999999999999873

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=366.37  Aligned_cols=251  Identities=21%  Similarity=0.287  Sum_probs=194.7

Q ss_pred             CCCCCC-CeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhc-CCCCCccceeeEEee----CCeeE
Q 043074           82 DNFSTD-KIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGK-LRHRNIVKILGYCAS----GLDRV  154 (373)
Q Consensus        82 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~~  154 (373)
                      ++|.+. +.||+|+||.||+|.. .+++.||||+++..     ..+.+|+.++.+ .+||||+++++++.+    ....|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            578776 4699999999999976 57999999998643     456789988665 489999999999865    45689


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC---C
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---D  231 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~---~  231 (373)
                      +|||||+||+|.+++......             ++++.++..++.||+.||+|||  +++|+||||||+|||++.   +
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~-------------~l~e~~~~~i~~qi~~al~ylH--~~~iiHRDiKp~NIll~~~~~~  150 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQ-------------AFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPN  150 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCC-------------CEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSTT
T ss_pred             EEEECCCCCcHHHHHHhcCCC-------------CcCHHHHHHHHHHHHHHHHHHH--HcCCcccccccccccccccccc
Confidence            999999999999999864322             2899999999999999999999  799999999999999985   5


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +.+||+|||+++......  ......||+.|+|||++.+ ..++.++|||||||++|+|+||..||...........   
T Consensus       151 ~~~Kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---  224 (335)
T d2ozaa1         151 AILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---  224 (335)
T ss_dssp             CCEEECCCTTCEECCCCC--CCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred             ccccccccceeeeccCCC--ccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---
Confidence            679999999998765432  2345679999999999975 4588999999999999999999999754322111100   


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                          ....   ...-...+... .....+.++.+++.+||+.||++|||+.|+++
T Consensus       225 ----~~~~---i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         225 ----MKTR---IRMGQYEFPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -------C---CCSCSSSCCTT-HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----HHHH---HhcCCCCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                0000   00000011000 02345678999999999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-51  Score=362.32  Aligned_cols=264  Identities=23%  Similarity=0.307  Sum_probs=201.2

Q ss_pred             CCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ--GFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|++.+.||+|+||+||+|..++|+.||||++......  ..+.+.+|+.++++++||||+++++++.+.+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            689999999999999999999889999999999654332  256789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEeee
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISDF  239 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~Df  239 (373)
                      +.++.+..+.....               .+++.++..++.||+.||+|||  +.+|+||||||+|||++.++.+|++||
T Consensus        82 ~~~~~~~~~~~~~~---------------~l~~~~~~~i~~qi~~~L~~LH--~~~IvHrDiKp~NIll~~~~~~kl~Df  144 (286)
T d1ob3a_          82 LDQDLKKLLDVCEG---------------GLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADF  144 (286)
T ss_dssp             CSEEHHHHHHTSTT---------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCT
T ss_pred             ehhhhHHHHHhhcC---------------CcchhhhHHHHHHHHHHHHHhc--cCcEEecCCCCceeeEcCCCCEEeccc
Confidence            98777666655433               2999999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHHh
Q 043074          240 GLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEAR  319 (373)
Q Consensus       240 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (373)
                      |.+.....+.. ......+++.|+|||.+.+...++.++|||||||++|||++|..||.+....+   .+..........
T Consensus       145 G~a~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~i~~~~~~~  220 (286)
T d1ob3a_         145 GLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTP  220 (286)
T ss_dssp             THHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred             ccceecccCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCC
Confidence            99987654332 23344689999999999877778999999999999999999999975432111   000000000000


Q ss_pred             --------cccccc---c--cCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          320 --------NKEIEM---V--DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       320 --------~~~~~~---~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                              ....+.   .  .............+..+.+++.+||+.||++|||++|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    000000   0  0000011112233458899999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=363.31  Aligned_cols=241  Identities=24%  Similarity=0.342  Sum_probs=197.0

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc------cHHHHHHHHHHHhcCC--CCCccceeeEEeeCC
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ------GFREFRAEMETLGKLR--HRNIVKILGYCASGL  151 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~  151 (373)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++.+....      ....+.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            35799999999999999999976 47999999998653321      1233568999999986  899999999999999


Q ss_pred             eeEEEEEecCC-CCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC
Q 043074          152 DRVLIYEFVEN-GSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS  230 (373)
Q Consensus       152 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~  230 (373)
                      ..++||||+.+ +++.+++.....               +++.++..++.|++.||+|||  +++|+||||||+|||++.
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~---------------l~e~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NIll~~  145 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGA---------------LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDL  145 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCS---------------CCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEET
T ss_pred             eEEEEEEeccCcchHHHHHhccCC---------------CCHHHHHHHHHHHHHHHHHHH--HCCCccccCcccceEEec
Confidence            99999999976 688888876542               899999999999999999999  799999999999999985


Q ss_pred             -CCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccH
Q 043074          231 -DFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGL  309 (373)
Q Consensus       231 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  309 (373)
                       ++.+||+|||+++.....   ..+...||+.|+|||++.+...++.++|||||||++|||++|..||....        
T Consensus       146 ~~~~vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------  214 (273)
T d1xwsa_         146 NRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------  214 (273)
T ss_dssp             TTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------
T ss_pred             CCCeEEECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------
Confidence             479999999999865432   23456799999999999876667888999999999999999999975321        


Q ss_pred             HHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          310 LEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                           .... ..      ..+     +...+.++.+++.+||+.||++|||++|+++
T Consensus       215 -----~i~~-~~------~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         215 -----EIIR-GQ------VFF-----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -----HHHH-CC------CCC-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----HHhh-cc------cCC-----CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                 0100 00      001     1223457999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.7e-49  Score=346.98  Aligned_cols=260  Identities=22%  Similarity=0.287  Sum_probs=197.9

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccce-eeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKI-LGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e~  159 (373)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++......  ..+..|+++++.++|+|++.. .++..++...++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5799999999999999999976 57899999998654332  457889999999987765554 5556777888999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC---CCceEE
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS---DFEAHI  236 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~---~~~~kl  236 (373)
                      + +++|.+.+.....              .+++..+..++.|++.||+|||  +++|+||||||+|||++.   +..+||
T Consensus        85 ~-~~~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH--~~~iiHrDiKp~NIl~~~~~~~~~vkl  147 (299)
T d1ckia_          85 L-GPSLEDLFNFCSR--------------KFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYI  147 (299)
T ss_dssp             C-CCBHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEE
T ss_pred             c-CCchhhhhhhccC--------------CCcHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHhhccccccCCCceeee
Confidence            9 6677776665443              2899999999999999999999  799999999999999864   457999


Q ss_pred             eeeccccccCCCCC------cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH
Q 043074          237 SDFGLARRIDTSHS------HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL  310 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  310 (373)
                      +|||+|+.......      .......||+.|+|||.+.+. .++.++|||||||++|||++|..||.............
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~  226 (299)
T d1ckia_         148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE  226 (299)
T ss_dssp             CCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH
T ss_pred             eccCcceeccccccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH
Confidence            99999997654322      123446799999999999854 48899999999999999999999986644433222222


Q ss_pred             HHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          311 EWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      .+....... .          .......++.++.+++.+||+.||++||+++++.+.|++++
T Consensus       227 ~~~~~~~~~-~----------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         227 RISEKKMST-P----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             HHHHHHHHS-C----------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             HhhcccCCC-C----------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            211111100 0          00002234568999999999999999999999999988764

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.8e-48  Score=342.44  Aligned_cols=260  Identities=20%  Similarity=0.291  Sum_probs=204.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCC-CCccceeeEEeeCCeeEEEEEe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH-RNIVKILGYCASGLDRVLIYEF  159 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~  159 (373)
                      ++|++.+.||+|+||.||+|... +|+.||||++......  ..+.+|++.+..++| +|++.+++++.++...++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            68999999999999999999754 7899999998554322  456789999999975 8999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCC-----CCce
Q 043074          160 VENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDS-----DFEA  234 (373)
Q Consensus       160 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~-----~~~~  234 (373)
                      + +++|.+++.....              .+++.++..++.|++.||+|||  +++|+||||||+|||++.     ++.+
T Consensus        83 ~-~~~l~~~~~~~~~--------------~~~~~~~~~i~~q~~~~l~~lH--~~giiHrDiKp~Nili~~~~~~~~~~v  145 (293)
T d1csna_          83 L-GPSLEDLLDLCGR--------------KFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMI  145 (293)
T ss_dssp             C-CCBHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCE
T ss_pred             c-CCCHHHHHHhhcc--------------chhhHHHHHHHHHHHHHHHHHH--HCCceeccCCccceeecCcccccCCce
Confidence            9 7899999876543              2899999999999999999999  899999999999999974     5789


Q ss_pred             EEeeeccccccCCCCC------cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc
Q 043074          235 HISDFGLARRIDTSHS------HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG  308 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  308 (373)
                      ||+|||+++.......      .......||+.|+|||.+.+ ..++.++||||||+++|||++|..||.......... 
T Consensus       146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~-  223 (293)
T d1csna_         146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-  223 (293)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-
T ss_pred             EEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH-
Confidence            9999999987643321      12334679999999999985 458999999999999999999999975433222111 


Q ss_pred             HHHHHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 043074          309 LLEWARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQLLDELV  372 (373)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~~L~~l~  372 (373)
                      ............. ..    .+     ...+|+++.+++..|++.+|++||+++.+.+.|++++
T Consensus       224 ~~~~i~~~~~~~~-~~----~l-----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         224 KYERIGEKKQSTP-LR----EL-----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHHHHHHHHHSC-HH----HH-----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHhccCCCC-hH----Hh-----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            1111111111000 00    01     2223568999999999999999999999999988764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=355.66  Aligned_cols=264  Identities=22%  Similarity=0.289  Sum_probs=195.5

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCC----eeE
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQ-GFREFRAEMETLGKLRHRNIVKILGYCASGL----DRV  154 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~  154 (373)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++.+.... ..+.+.+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            45799999999999999999965 58999999999764433 3457889999999999999999999986643    234


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCce
Q 043074          155 LIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEA  234 (373)
Q Consensus       155 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~  234 (373)
                      ++++++.+|+|.+++....                +++..+..++.|++.||+|||  +++|+||||||+|||++.++.+
T Consensus        87 ~l~~~~~~g~L~~~l~~~~----------------l~~~~i~~i~~qil~al~yLH--~~~iiHRDIKp~NILl~~~~~~  148 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQH----------------LSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDL  148 (345)
T ss_dssp             EEEEECCCEEHHHHHHHCC----------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCE
T ss_pred             EEEEeecCCchhhhhhcCC----------------CCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCcceEEECCCCCE
Confidence            5556677999999997543                899999999999999999999  7899999999999999999999


Q ss_pred             EEeeeccccccCCCCC--cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHH
Q 043074          235 HISDFGLARRIDTSHS--HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEW  312 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  312 (373)
                      ||+|||++........  .......||+.|+|||++.....++.++||||+||++|||++|..||.......    ....
T Consensus       149 kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~----~~~~  224 (345)
T d1pmea_         149 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD----QLNH  224 (345)
T ss_dssp             EECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHH
T ss_pred             EEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH----HHHH
Confidence            9999999986543221  223446789999999998766778899999999999999999999975432111    0000


Q ss_pred             HHHHHHhc--------------cccccccCc--cccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          313 ARTMEARN--------------KEIEMVDSN--ISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       313 ~~~~~~~~--------------~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ........              .........  ..........+.++.+++.+||+.||++|||++|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000000              000000000  0000001122347899999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-49  Score=347.86  Aligned_cols=264  Identities=22%  Similarity=0.263  Sum_probs=192.4

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CC-CCEEEEEEeCccccc--cHHHHHHHHHHHhcC---CCCCccceeeEEee----
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SS-GVTVAIKKLDKDAFQ--GFREFRAEMETLGKL---RHRNIVKILGYCAS----  149 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----  149 (373)
                      .++|++.+.||+|+||+||+|.. ++ ++.||||++......  ....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999976 34 567999998553322  223456777776665   79999999999853    


Q ss_pred             -CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEe
Q 043074          150 -GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLL  228 (373)
Q Consensus       150 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill  228 (373)
                       ....++++||+.++++.........              .+++..+..++.|++.||+|||  +++|+||||||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~qi~~aL~yLH--~~~ivHrDiKp~NILi  149 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEP--------------GVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILV  149 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTT--------------CSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEE
T ss_pred             cCceEEEEEEeccCCchhhhhhccCC--------------CCCHHHHHHHHHHHHHHHHHHH--hCCEEecCCCccEEEE
Confidence             3467899999988776655443332              2899999999999999999999  7999999999999999


Q ss_pred             CCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc
Q 043074          229 DSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG  308 (373)
Q Consensus       229 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  308 (373)
                      ++++.+||+|||+++....  ........||+.|+|||++.+ ..++.++||||+||++|||++|..||.......   .
T Consensus       150 ~~~~~~kl~dfg~~~~~~~--~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~  223 (305)
T d1blxa_         150 TSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---Q  223 (305)
T ss_dssp             CTTCCEEECSCCSCCCCCG--GGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H
T ss_pred             cCCCCeeecchhhhhhhcc--cccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---H
Confidence            9999999999999876432  223445679999999999985 458899999999999999999999975432111   0


Q ss_pred             HHHHHHHHHHhccc--------c-ccc--cCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          309 LLEWARTMEARNKE--------I-EMV--DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       309 ~~~~~~~~~~~~~~--------~-~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      +.............        . ...  .............+..+.+|+.+||+.||++|||++|+++
T Consensus       224 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00000000000000        0 000  0000011112233557899999999999999999999976

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-49  Score=346.44  Aligned_cols=261  Identities=22%  Similarity=0.286  Sum_probs=205.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGLDRVLIYE  158 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  158 (373)
                      ++|++.+.||+|+||+||+|.. .+++.||||+++....  .....+.+|+.+++.++||||+++++++.+....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5899999999999999999976 5789999999865433  235678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCCceEEee
Q 043074          159 FVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDFEAHISD  238 (373)
Q Consensus       159 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~~~kl~D  238 (373)
                      ++.+++|..++.....               +++..+..++.|++.||+|||  +++|+||||||+|||++.++.+||+|
T Consensus        82 ~~~~~~l~~~~~~~~~---------------~~~~~~~~~~~q~~~aL~~lH--~~~IvHrDiKP~NIli~~~~~~kl~D  144 (292)
T d1unla_          82 FCDQDLKKYFDSCNGD---------------LDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLAN  144 (292)
T ss_dssp             CCSEEHHHHHHHTTTC---------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred             eccccccccccccccc---------------cchhHHHHHHHHHHHHHHHhh--cCCEeeecccCcccccccCCceeeee
Confidence            9999999888775542               889999999999999999999  78999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHHHHHHHHH
Q 043074          239 FGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLEWARTMEA  318 (373)
Q Consensus       239 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (373)
                      ||.++....... ......+++.|+|||.+.+...++.++|||||||++|||++|+.|+++.....      +.......
T Consensus       145 FG~a~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~------~~~~~~~~  217 (292)
T d1unla_         145 FGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD------DQLKRIFR  217 (292)
T ss_dssp             CTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH------HHHHHHHH
T ss_pred             cchhhcccCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH------HHHHHHHh
Confidence            999987654332 23334577889999999877778999999999999999999999976432211      11111111


Q ss_pred             -hccc----------------cccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          319 -RNKE----------------IEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       319 -~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       ....                .................+..+.+|+.+||+.||++|||++|+++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         218 LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0000                00000011111122334557899999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-48  Score=345.57  Aligned_cols=265  Identities=22%  Similarity=0.282  Sum_probs=193.8

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEee--------
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCAS--------  149 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  149 (373)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++.....  .....+.+|+++|++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36899999999999999999976 5799999999855432  234678899999999999999999998855        


Q ss_pred             CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeC
Q 043074          150 GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLD  229 (373)
Q Consensus       150 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~  229 (373)
                      ....++||||+.++++..+.....               .+++..+..++.|++.||.|||  +++|+||||||+|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~---------------~~~~~~~~~i~~qil~~l~~lH--~~~ivHrDlKp~NILl~  151 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV---------------KFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLIT  151 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC---------------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEC
T ss_pred             CceEEEEEeccCCCccchhhhccc---------------ccccHHHHHHHHHHHHHHHHhc--cCCEEecCcCchheeec
Confidence            345789999997776665543332               2889999999999999999999  78999999999999999


Q ss_pred             CCCceEEeeeccccccCCCCC---cccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCc
Q 043074          230 SDFEAHISDFGLARRIDTSHS---HVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQE  306 (373)
Q Consensus       230 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  306 (373)
                      .++.+||+|||+++.......   .......||+.|+|||++.+...++.++||||+||++|||++|..||......   
T Consensus       152 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~---  228 (318)
T d3blha1         152 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---  228 (318)
T ss_dssp             TTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---
T ss_pred             CCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH---
Confidence            999999999999987653321   22334579999999999987777899999999999999999999997532111   


Q ss_pred             ccHHHHHHHHHHhc--cccccc---------cCcccccc-C-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          307 VGLLEWARTMEARN--KEIEMV---------DSNISREE-L-----SEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       307 ~~~~~~~~~~~~~~--~~~~~~---------~~~~~~~~-~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                       ....-........  ......         ........ .     .......+.+|+.+||+.||++|||++|+++
T Consensus       229 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         229 -HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             -HHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -HHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence             1111111111000  000000         00000000 0     0111346788999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=350.31  Aligned_cols=259  Identities=24%  Similarity=0.282  Sum_probs=193.9

Q ss_pred             cCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCC------
Q 043074           81 TDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASGL------  151 (373)
Q Consensus        81 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  151 (373)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++++...  ...+.+.+|+.+|+.++||||+++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            56899999999999999999976 4799999999975433  23457889999999999999999999997654      


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..++||||+ +.+|..+.....                +++..+..++.||+.||+|||  +++|+||||||+|||++.+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~~----------------l~~~~~~~~~~qi~~aL~~LH--~~~IiHrDiKp~NIL~~~~  157 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHEK----------------LGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNED  157 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC----------------CCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTT
T ss_pred             eEEEEEecc-cccHHHHHHhcc----------------ccHHHHHHHHHHHHHHHHHHH--hCCCcccccCcchhhcccc
Confidence            569999999 678888776543                999999999999999999999  7999999999999999999


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +.+|++|||+++.....    .+...||+.|+|||.+.+...++.++||||+||++|||++|..||.......   .+..
T Consensus       158 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~---~~~~  230 (346)
T d1cm8a_         158 CELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKE  230 (346)
T ss_dssp             CCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred             cccccccccceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH---HHHH
Confidence            99999999999875432    3456789999999999877778999999999999999999999975432111   0000


Q ss_pred             HHHHH-------HHhc---------cccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WARTM-------EARN---------KEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~~~~-------~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      .....       ....         ......... .........+..+.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK-DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCC-CGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhccCCCcHHHHhhhcchhhhhhhccCCccccc-chHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00000       0000         000000000 000111223457889999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=351.87  Aligned_cols=264  Identities=27%  Similarity=0.299  Sum_probs=191.4

Q ss_pred             CCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCccceeeEEeeC------CeeEE
Q 043074           83 NFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNIVKILGYCASG------LDRVL  155 (373)
Q Consensus        83 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l  155 (373)
                      +|+..++||+|+||+||+|... +|+.||||++......    ..+|+.++++++||||+++++++...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5777889999999999999764 7999999999664422    24799999999999999999998543      34689


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC-ce
Q 043074          156 IYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-EA  234 (373)
Q Consensus       156 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~-~~  234 (373)
                      ||||++++.+..+.......            .++++.++..++.||+.||+|||  +++|+||||||+|||++.++ .+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~------------~~l~~~~~~~i~~qil~aL~yLH--~~~IiHrDiKp~NILl~~~~~~~  162 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAK------------QTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVL  162 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTT------------CCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTTCCE
T ss_pred             EEeccCCccHHHHHhhhhcc------------CCCCHHHHHHHHHHHHHHHHHHH--hcCCcccCCCcceEEEecCCCce
Confidence            99999766444433221111            13999999999999999999999  79999999999999999775 89


Q ss_pred             EEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH----
Q 043074          235 HISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL----  310 (373)
Q Consensus       235 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~----  310 (373)
                      ||+|||++.......  ......||+.|+|||.+.+...++.++||||+||++|||++|..||...........+.    
T Consensus       163 kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g  240 (350)
T d1q5ka_         163 KLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG  240 (350)
T ss_dssp             EECCCTTCEECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred             eEecccchhhccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999998764332  23345789999999998877778999999999999999999999975432211000000    


Q ss_pred             ----HHHHHHHHhcccc--ccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 ----EWARTMEARNKEI--EMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 ----~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                          ++...........  ................+.++.+|+.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0000000000000  0000000000112234557899999999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-49  Score=349.27  Aligned_cols=253  Identities=23%  Similarity=0.335  Sum_probs=203.0

Q ss_pred             CCCCCCCeeecCCCceEEEEEe----CCCCEEEEEEeCcccc----ccHHHHHHHHHHHhcCCC-CCccceeeEEeeCCe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL----SSGVTVAIKKLDKDAF----QGFREFRAEMETLGKLRH-RNIVKILGYCASGLD  152 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  152 (373)
                      ++|++.+.||+|+||+||+|..    .+|+.||||++++...    ...+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            4699999999999999999964    2588999999865432    234567899999999976 899999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .++++||+.+|+|.+++.....               +++..+..++.||+.||+|||  +++++||||||+||+++.++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~---------------~~e~~~~~~~~Qi~~al~~lH--~~~ivHrDiKp~Nill~~~~  166 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER---------------FTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNG  166 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC---------------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTS
T ss_pred             eeeeeecccccHHHHHHHhccc---------------ccHHHHHHHHHHHHHHHHHhh--cCCEEeccCCccceeecCCC
Confidence            9999999999999999987653               788999999999999999999  78999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCcccccccccccccCccccCCCC-CCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNT-AATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      .+||+|||+++.+............|++.|+|||.+.+.. .++.++|||||||+||||++|..||.........   ..
T Consensus       167 ~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~  243 (322)
T d1vzoa_         167 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AE  243 (322)
T ss_dssp             CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HH
T ss_pred             CEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HH
Confidence            9999999999876544444455567999999999987543 4688999999999999999999997654332211   11


Q ss_pred             HHHHHHHhccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 043074          312 WARTMEARNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPA-----MSYVVQ  366 (373)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~l~~  366 (373)
                      ....... .      ...     .+...+.++.+++.+||+.||.+|||     ++|+++
T Consensus       244 i~~~~~~-~------~~~-----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         244 ISRRILK-S------EPP-----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHHH-C------CCC-----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HHHhccc-C------CCC-----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            1111111 0      011     12334568999999999999999995     778765

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.9e-48  Score=346.51  Aligned_cols=260  Identities=18%  Similarity=0.221  Sum_probs=197.3

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CCCccceeeEEeeC--CeeEEEE
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILGYCASG--LDRVLIY  157 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  157 (373)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++...   .+.+.+|+.+|+.++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999976 579999999997543   357889999999995 99999999998743  5689999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC-ceEE
Q 043074          158 EFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF-EAHI  236 (373)
Q Consensus       158 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~-~~kl  236 (373)
                      ||+++++|..+..                  .+++.++..++.||+.||+|||  +++|+||||||+|||++.++ .+||
T Consensus       112 e~~~~~~L~~~~~------------------~l~e~~i~~i~~qil~aL~~LH--~~gIvHrDiKp~NILi~~~~~~vkl  171 (328)
T d3bqca1         112 EHVNNTDFKQLYQ------------------TLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRL  171 (328)
T ss_dssp             ECCCSCBGGGTTT------------------SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEE
T ss_pred             eecCCCcHHHHhc------------------CCCHHHHHHHHHHHHHHHHHHh--hcccccccccccceEEcCCCCeeee
Confidence            9999999976532                  2899999999999999999999  79999999999999998655 6999


Q ss_pred             eeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCccc-HHHH---
Q 043074          237 SDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVG-LLEW---  312 (373)
Q Consensus       237 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-~~~~---  312 (373)
                      +|||+++......  ......+|+.|+|||.+.+...++.++||||+||++|||++|..|+........... +...   
T Consensus       172 ~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~  249 (328)
T d3bqca1         172 IDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  249 (328)
T ss_dssp             CCGGGCEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred             cccccceeccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCC
Confidence            9999998764332  234567899999999998777789999999999999999999999765432211100 0000   


Q ss_pred             --HHHHHHhccc--cccc-----------cCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          313 --ARTMEARNKE--IEMV-----------DSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       313 --~~~~~~~~~~--~~~~-----------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                        ..........  ....           .............+.++.+|+.+||+.||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0000000000  0000           0000111112233557899999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=345.31  Aligned_cols=263  Identities=22%  Similarity=0.271  Sum_probs=194.8

Q ss_pred             hcCCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeC-----C
Q 043074           80 ATDNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCASG-----L  151 (373)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  151 (373)
                      ..++|++.+.||+|+||+||+|.. .+|+.||||++.+...  ...+.+.+|+.++++++|||++++++++...     .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            357899999999999999999975 5799999999976433  2345688999999999999999999998533     3


Q ss_pred             eeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCC
Q 043074          152 DRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSD  231 (373)
Q Consensus       152 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~  231 (373)
                      ..+++++|+.+|+|.+++....                +++.++..++.||+.||+|||  +++|+||||||+|||++.+
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~~----------------l~e~~~~~i~~qil~aL~~LH--~~giiHrDiKp~NILi~~~  157 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQK----------------LTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNED  157 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTCC----------------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTT
T ss_pred             ceEEEEEeecCCchhhhccccc----------------ccHHHHHHHHHHHHHHHHHHH--hCCCcccccCCcccccccc
Confidence            4466777888999999986432                999999999999999999999  7899999999999999999


Q ss_pred             CceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHHH
Q 043074          232 FEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLLE  311 (373)
Q Consensus       232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  311 (373)
                      +.+|++|||++....    .......||+.|+|||.+.+...++.++|||||||++|+|++|..||...........+..
T Consensus       158 ~~~kl~dfg~a~~~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~  233 (348)
T d2gfsa1         158 CELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  233 (348)
T ss_dssp             CCEEECCC----CCT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             ccccccccchhcccC----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999987643    2334467899999999988777788999999999999999999999754321110000000


Q ss_pred             HH----HHHHH----------hccccccccCccccccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          312 WA----RTMEA----------RNKEIEMVDSNISREELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       312 ~~----~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                      ..    .....          .....+.....+  .......+.++.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNF--ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCH--HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcCCCChHHhhhccchhhhhhhhhcccCCCcch--hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            00    00000          000000000000  0001123457899999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=336.57  Aligned_cols=262  Identities=24%  Similarity=0.252  Sum_probs=185.7

Q ss_pred             CCCCCCCeeecCCCceEEEEEeC-CCCEEEEEEeCcccc--ccHHHHHHHHHHHhcCCCCCccceeeEEee------CCe
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDAF--QGFREFRAEMETLGKLRHRNIVKILGYCAS------GLD  152 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  152 (373)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.+...  .....+.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            68999999999999999999765 799999999965432  234568899999999999999999999853      468


Q ss_pred             eEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceEeCCCC
Q 043074          153 RVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVLLDSDF  232 (373)
Q Consensus       153 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nill~~~~  232 (373)
                      .|+||||+.++.+ +.+..                 .+++..+..++.||+.||.|||  ++||+||||||+|||++.++
T Consensus        97 ~~iv~Ey~~~~l~-~~~~~-----------------~~~~~~i~~~~~qil~gl~~LH--~~giiHrDlKP~Nil~~~~~  156 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQM-----------------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC  156 (355)
T ss_dssp             EEEEEECCSEEHH-HHHTS-----------------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTC
T ss_pred             eEEEEeccchHHH-Hhhhc-----------------CCCHHHHHHHHHHHHHHHHHhh--hcccccccCCcccccccccc
Confidence            8999999966544 44421                 1889999999999999999999  78999999999999999999


Q ss_pred             ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcccCCCcccHH--
Q 043074          233 EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVVLDGQEVGLL--  310 (373)
Q Consensus       233 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~--  310 (373)
                      .+|++|||+++.....  .......+|+.|+|||++.+ ..++.++||||+||+++||++|..||.............  
T Consensus       157 ~~kl~df~~~~~~~~~--~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~  233 (355)
T d2b1pa1         157 TLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ  233 (355)
T ss_dssp             CEEECCCCC-----------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             ceeeechhhhhccccc--cccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999998865432  23345578999999999986 457889999999999999999999875322110000000  


Q ss_pred             -------HH------HHHHHHhcccc------ccccCcccc--ccCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 043074          311 -------EW------ARTMEARNKEI------EMVDSNISR--EELSEAGVREYFRIACMCTNEKSRERPAMSYVVQ  366 (373)
Q Consensus       311 -------~~------~~~~~~~~~~~------~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~l~~  366 (373)
                             .|      ...........      .........  .......+.++.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                   00      00000000000      000000000  0112345678999999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-41  Score=306.63  Aligned_cols=266  Identities=21%  Similarity=0.186  Sum_probs=187.5

Q ss_pred             CCCCCCCeeecCCCceEEEEEe-CCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-----------CCCccceeeEEee
Q 043074           82 DNFSTDKIIGDGSFGFVYKAKL-SSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-----------HRNIVKILGYCAS  149 (373)
Q Consensus        82 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~  149 (373)
                      .+|++.+.||+|+||+||+|+. .+|+.||||++++.... .+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~-~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH-HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc-hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            3699999999999999999976 57999999999765432 356778888888775           5789999988754


Q ss_pred             --CCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCceE
Q 043074          150 --GLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNVL  227 (373)
Q Consensus       150 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Nil  227 (373)
                        ....+++++++..+............            ..+++..+..++.|++.||.|||+ ..+|+||||||+|||
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIl  158 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEH------------RGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVL  158 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTT------------SCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEE
T ss_pred             ccccceeeeeeecccccccccccccccc------------cCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHee
Confidence              35666777766555433332222211            138899999999999999999994 488999999999999


Q ss_pred             eCCCC------ceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHHHHHHhCCCCCCCcc
Q 043074          228 LDSDF------EAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILMIEIATQIRPNLPVV  301 (373)
Q Consensus       228 l~~~~------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  301 (373)
                      ++.++      .++++|||.+.....    ......||+.|+|||++.+ ..++.++||||+||+++||++|..||.+..
T Consensus       159 l~~~~~~~~~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         159 MEIVDSPENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             EEEEETTTTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             eeccCcccccceeeEeeccccccccc----ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence            98665      399999999976432    2344679999999999885 457889999999999999999999976644


Q ss_pred             cCCCcccHHHHHHHHHHhcc--------------------ccccccCc---------cccccCCHHHHHHHHHHHHHhcC
Q 043074          302 LDGQEVGLLEWARTMEARNK--------------------EIEMVDSN---------ISREELSEAGVREYFRIACMCTN  352 (373)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~---------~~~~~~~~~~~~~l~~l~~~cl~  352 (373)
                      ..................+.                    ....+...         ..........+.++.+|+.+||+
T Consensus       234 ~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~  313 (362)
T d1q8ya_         234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ  313 (362)
T ss_dssp             -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred             cccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCC
Confidence            33221111111111110000                    00000000         00112346678899999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 043074          353 EKSRERPAMSYVVQ  366 (373)
Q Consensus       353 ~~p~~RPs~~~l~~  366 (373)
                      .||.+|||++|+++
T Consensus       314 ~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         314 LDPRKRADAGGLVN  327 (362)
T ss_dssp             SSTTTCBCHHHHHT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=5.5e-26  Score=185.82  Aligned_cols=169  Identities=17%  Similarity=0.210  Sum_probs=119.0

Q ss_pred             CCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccc------------------cHHHHHHHHHHHhcCCCCCccceeeE
Q 043074           85 STDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQ------------------GFREFRAEMETLGKLRHRNIVKILGY  146 (373)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~l~~~  146 (373)
                      .+.+.||+|+||.||+|...+|+.||||++......                  .......|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            356899999999999998888999999987532110                  01234568889999999999988765


Q ss_pred             EeeCCeeEEEEEecCCCCHHHHhhcCCCCCCCCcccccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCceeecCCCCce
Q 043074          147 CASGLDRVLIYEFVENGSLDQWLHDTSRNDDVDGSKQLNSLCPLSWETRVKIVRGVANGLAYLHGLEKPIIHRDIKSSNV  226 (373)
Q Consensus       147 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lh~~~~~i~H~dlk~~Ni  226 (373)
                      .    ..+++|||+++..+.+                      ++......++.|++.+++|||  +.+++||||||+||
T Consensus        83 ~----~~~lvme~~~~~~~~~----------------------l~~~~~~~i~~ql~~~l~~lH--~~giiHrDiKP~NI  134 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------------------VRVENPDEVLDMILEEVAKFY--HRGIVHGDLSQYNV  134 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------------------CCCSCHHHHHHHHHHHHHHHH--HTTEECSCCSTTSE
T ss_pred             c----CCEEEEEeeccccccc----------------------hhhHHHHHHHHHHHHHHHHHh--hCCEEEccCChhhe
Confidence            3    2379999998755432                      334455689999999999999  78999999999999


Q ss_pred             EeCCCCceEEeeeccccccCCCCCcccccccccccccCccccCCCCCCCccccchhhhHHH
Q 043074          227 LLDSDFEAHISDFGLARRIDTSHSHVSTQVAGTMGYMPPEYLGGNTAATVMLDVYSFGILM  287 (373)
Q Consensus       227 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~DiwslG~~l  287 (373)
                      |++++ .++|+|||.|.....+.....  ....... -.+.+  ...++.++|+||..--+
T Consensus       135 Lv~~~-~~~liDFG~a~~~~~~~~~~~--l~rd~~~-~~~~f--~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         135 LVSEE-GIWIIDFPQSVEVGEEGWREI--LERDVRN-IITYF--SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EEETT-EEEECCCTTCEETTSTTHHHH--HHHHHHH-HHHHH--HHHHCCCCCHHHHHHHH
T ss_pred             eeeCC-CEEEEECCCcccCCCCCcHHH--HHHHHHH-HHHHH--cCCCCCcccHHHHHHHH
Confidence            99865 589999999977543321110  0000000 00111  23467789999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.81  E-value=1.3e-08  Score=85.55  Aligned_cols=93  Identities=15%  Similarity=0.009  Sum_probs=65.1

Q ss_pred             HHHHhcCCCCCCCeeecCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeE
Q 043074           76 ELIDATDNFSTDKIIGDGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR-HRNIVKILGYCASGLDRV  154 (373)
Q Consensus        76 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  154 (373)
                      ++...-+.|+..+..+-++.+.||+... ++..+++|+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4555556776655544444568998865 46678889886654444445678888877764 444677888888888999


Q ss_pred             EEEEecCCCCHHHHh
Q 043074          155 LIYEFVENGSLDQWL  169 (373)
Q Consensus       155 lv~e~~~~g~L~~~l  169 (373)
                      +||++.+|.++.+..
T Consensus        87 lv~~~l~G~~~~~~~  101 (263)
T d1j7la_          87 LLMSEADGVLCSEEY  101 (263)
T ss_dssp             EEEECCSSEEHHHHT
T ss_pred             EEEEecccccccccc
Confidence            999999988876543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.24  E-value=3.4e-06  Score=69.97  Aligned_cols=74  Identities=16%  Similarity=0.091  Sum_probs=53.1

Q ss_pred             eeecCCC-ceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCC--CCCccceeeEEeeCCeeEEEEEecCCCCH
Q 043074           89 IIGDGSF-GFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLR--HRNIVKILGYCASGLDRVLIYEFVENGSL  165 (373)
Q Consensus        89 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L  165 (373)
                      .+..|.. +.||+....++..+++|.......   ..+..|...++.+.  .-.+.+++++..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3445554 578999888888899998765443   24566777777663  33366778888888889999999987654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.91  E-value=3.6e-05  Score=67.89  Aligned_cols=75  Identities=19%  Similarity=0.163  Sum_probs=47.4

Q ss_pred             CeeecCCCceEEEEEeC-CCCEEEEEEeCccc-------cccHHHHHHHHHHHhcCC-C--CCccceeeEEeeCCeeEEE
Q 043074           88 KIIGDGSFGFVYKAKLS-SGVTVAIKKLDKDA-------FQGFREFRAEMETLGKLR-H--RNIVKILGYCASGLDRVLI  156 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  156 (373)
                      +.||.|....||+.... +++.+++|.-....       .........|...++.+. +  ..+.+++.+  ++...++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            46899999999999764 46789999753211       112234456887777663 2  334455543  45567899


Q ss_pred             EEecCCCC
Q 043074          157 YEFVENGS  164 (373)
Q Consensus       157 ~e~~~~g~  164 (373)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.36  E-value=0.00073  Score=57.59  Aligned_cols=70  Identities=9%  Similarity=-0.014  Sum_probs=46.3

Q ss_pred             CCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCc--ccee-----eEEeeCCeeEEEEEecCCC
Q 043074           93 GSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI--VKIL-----GYCASGLDRVLIYEFVENG  163 (373)
Q Consensus        93 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g  163 (373)
                      +.-..||++...+|..+++|+...... ..+++..|...+..|...++  +..+     .........+.++++.+|.
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cccceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            334689999998999999999865432 34667788888877742221  1111     1224456778899998654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.23  E-value=0.00037  Score=59.24  Aligned_cols=170  Identities=15%  Similarity=0.099  Sum_probs=85.2

Q ss_pred             cChHHHHHhcCCCCCCCeee-----cCCCceEEEEEeCCCCEEEEEEeCccccccHHHHHHHHHHHhcCCC-----CCcc
Q 043074           72 ISMSELIDATDNFSTDKIIG-----DGSFGFVYKAKLSSGVTVAIKKLDKDAFQGFREFRAEMETLGKLRH-----RNIV  141 (373)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg-----~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-----~niv  141 (373)
                      ++.+++.....+|.+++...     .|--.+.|+.+..+| .+++|+......  .+++..|+..+..+..     |..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            46677887788898866544     555678899987665 589999865422  2345556666666632     2222


Q ss_pred             ceee---EEeeCCeeEEEEEecCCCCHH--------------HHhhcCCCCCCCCccccc------------CCCCCCCH
Q 043074          142 KILG---YCASGLDRVLIYEFVENGSLD--------------QWLHDTSRNDDVDGSKQL------------NSLCPLSW  192 (373)
Q Consensus       142 ~l~~---~~~~~~~~~lv~e~~~~g~L~--------------~~l~~~~~~~~~~~~~~~------------~~~~~l~~  192 (373)
                      ...+   +..-......++.+..+....              ..++........+.....            ........
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            2111   112234455666666543221              111111100000000000            00000000


Q ss_pred             HHHHHHHHHHHHHHHHHh--cCCCCceeecCCCCceEeCCCCceEEeeeccccc
Q 043074          193 ETRVKIVRGVANGLAYLH--GLEKPIIHRDIKSSNVLLDSDFEAHISDFGLARR  244 (373)
Q Consensus       193 ~~~~~i~~qi~~~l~~lh--~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  244 (373)
                      ......+......+.-.+  ....+++|+|+.++|++++.+...-+.||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            111122222333333332  2456799999999999999887778999998753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.06  E-value=0.0013  Score=57.74  Aligned_cols=72  Identities=18%  Similarity=0.229  Sum_probs=48.8

Q ss_pred             CeeecCCCceEEEEEeCC--------CCEEEEEEeCccccccHHHHHHHHHHHhcCCCCCc-cceeeEEeeCCeeEEEEE
Q 043074           88 KIIGDGSFGFVYKAKLSS--------GVTVAIKKLDKDAFQGFREFRAEMETLGKLRHRNI-VKILGYCASGLDRVLIYE  158 (373)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  158 (373)
                      +.|+.|-...+|+....+        .+.|++++....  .......+|..+++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            568889999999998653        356777776532  223345678888888853344 467777643    58899


Q ss_pred             ecCCCCH
Q 043074          159 FVENGSL  165 (373)
Q Consensus       159 ~~~~g~L  165 (373)
                      |++|.++
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9976544